,ID,DMT,StartDate,EndDate,DMT_Dosage,DMT_Unit,DMT_Interval,DMT_Route,DMT_Stop
0,478,Rebif [44],2016-04-08,2020-11-25,1000, ,['/Month'], ,Lack of efficacy
1,478,Alemtuzumab (Campath),2016-03-17,2021-09-21,1000,MIU,['2 / Day'],IV,Persisting MRI activity
2,2202,Rebif [44],2015-12-06,, ,MIU,['2 / Day'], , 
3,2202,Copaxone,2016-05-30,2018-05-25, ,mg,['/Month'],IV,Patient Choice/Convenience
4,2202,IVIG,2016-01-16,2018-01-04,500,mg,['2 / Day'], ,Adverse Event
5,2202,Tysabri,2016-09-12,,5000,MIU,['2 / Day'],IV, 
6,4627,IVIG,2016-10-05,,500, ,['/Month'],IV, 
7,4627,Methylprednisolone,2016-10-14,2019-04-30,300, ,[' '], ,Persistence of relapses
8,1655,Avonex,2015-11-01,, , ,['/Month'],IV, 
9,1655,Betaferon,2016-08-15,2019-11-26, , ,['/Month'],IV,Patient Choice/Convenience
10,1655,Ledertrexaat,2016-06-06,,5000, ,['2 / Day'],Oral, 
11,1655,Tecfidera,2016-04-21,,5000, ,['/Month'],IV, 
12,4513,Gilenya,2016-01-12,2020-01-17,500,mg,['3 / Week'],IV,Adverse Event
13,4513,Endoxan,2016-02-13,,1000,mg,['3 / Week'], , 
14,3420,Tecfidera,2016-08-09,, ,mg,['/ Day'], , 
15,3420,Rebif [22],2015-12-11,,1000, ,['3 / Week'], , 
16,3420,Tysabri,2016-06-18,2017-11-13, , ,['3 / Week'], ,Lack of efficacy
17,3420,Rebif [44],2016-10-13,,500, ,['/Month'], , 
18,852,Teriflunomide,2015-11-09,2020-05-30, ,mg,['/Month'], ,Adverse Event
19,852,IVIG,2016-02-09,2021-08-01, , ,['3 / Week'],IV,Adverse Event
20,1428,Tysabri,2016-09-21,,1000, ,['2 / Day'], , 
21,1428,Endoxan,2016-09-04,,500, ,['/ Week'],IV, 
22,1428,Mitoxantrone,2016-03-04,,1000, ,['2 / Day'], , 
23,1428,Ledertrexaat,2016-06-21,, ,mg,['/ Day'],IV, 
24,4776,Tysabri,2016-08-16,, , ,['2 / Day'],IV, 
25,4789,Copaxone,2016-06-06,2018-08-01,300,mg,['3 / Week'],IV,Lack of efficacy
26,4789,D-cure (Vitamine D),2016-06-19,2020-10-12,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
27,696,Gilenya,2016-06-09,2018-04-15,1000,mg,['2 / Day'],IV,Persisting MRI activity
28,696,D-cure (Vitamine D),2016-10-05,,300,mg,['2 / Day'], , 
29,3454,Tecfidera,2016-04-07,2020-09-24, , ,[' '],IV,Patient Choice/Convenience
30,3887,Alemtuzumab (Campath),2016-09-04,,500,mg,['/ Day'], , 
31,3887,Betaferon,2015-11-21,2019-11-17, , ,['/ Day'],IV,Adverse Event
32,3887,Teriflunomide,2016-03-09,2017-12-10,300,mg,['2 / Day'],IV,Persisting MRI activity
33,3887,Mitoxantrone,2016-04-06,2019-03-10, ,mg,['2 / Day'],IV,Adverse Event
34,1846,Alemtuzumab (Campath),2016-05-02,2019-03-01, ,MIU,['/Month'],Oral,Lack of efficacy
35,1846,D-cure (Vitamine D),2016-08-16,2020-06-14, ,mg,['2 / Day'],IV,Patient Choice/Convenience
36,2648,Ledertrexaat,2015-12-26,,300, ,['/ Day'], , 
37,2648,Tysabri,2016-06-14,2018-09-23, ,mg,['/Month'],IV,Persisting MRI activity
38,372,Alemtuzumab (Campath),2015-12-25,, ,mcg,['2 / Day'],IV, 
39,372,Teriflunomide,2015-11-08,2020-06-12,5000, ,['/Month'], ,Adverse Event
40,2849,Tysabri,2016-06-17,, , ,['2 / Day'],Oral, 
41,2849,Rebif [22],2016-08-20,2019-07-29, ,mg,['/Month'],IV,Adverse Event
42,2425,Rebif [22],2016-10-01,,20, ,['/Month'], , 
43,2425,Gilenya,2016-10-13,, ,mg,['/Month'], , 
44,2054,Tysabri,2016-10-18,, ,mg,['3 / Week'], , 
45,3475,D-cure (Vitamine D),2016-05-02,,1000, ,['/Month'], , 
46,3475,D-cure (Vitamine D),2016-08-30,2021-06-16,20, ,['/Month'], ,Lack of efficacy
47,3475,Copaxone,2016-06-05,,5000,mg,['/ Day'], , 
48,4837,Avonex,2016-06-19,, ,mg,['/Month'],IV, 
49,4837,Avonex,2016-03-15,,500,mg,['/Month'],IV, 
50,4837,Gilenya,2016-09-22,,300, ,[' '],IV, 
51,1371,Avonex,2016-05-28,2018-03-28,20, ,[' '],IV,Patient Choice/Convenience
52,1371,IVIG,2016-05-07,, ,mg,[' '],IV, 
53,1500,D-cure (Vitamine D),2016-05-16,,1,mg,['3 / Week'], , 
54,1500,Endoxan,2016-02-19,,500, ,['2 / Day'], , 
55,1500,Gilenya,2016-03-23,2021-04-11,300,mcg,['/Month'],IV,Lack of efficacy
56,1500,Endoxan,2016-05-23,,5000,mcg,[' '],IV, 
57,4437,Rebif [44],2016-03-04,2018-11-21,300,mcg,['/Month'],IV,Persistence of relapses
58,4437,Rebif [22],2016-08-23,2017-10-25, , ,['3 / Week'], ,Patient Choice/Convenience
59,4437,Ledertrexaat,2016-03-27,,1000,mg,['/Month'], , 
60,4437,Avonex,2016-07-31,, , ,['2 / Day'],IV, 
61,608,Gilenya,2016-05-01,2018-05-25, ,mcg,['/Month'], ,Adverse Event
62,3188,IVIG,2016-09-24,,500,mg,['/Month'],IV, 
63,3188,IVIG,2016-01-31,,300,mg,['2 / Day'],IV, 
64,4193,Ledertrexaat,2016-02-27,2018-06-14,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
65,4529,Mitoxantrone,2016-01-09,2021-07-06,300,mg,[' '], ,Lack of efficacy
66,4529,Endoxan,2016-09-12,2018-08-29,5000, ,[' '],Oral,Adverse Event
67,4901,IVIG,2016-06-22,2019-01-16,500,mg,['3 / Week'],Oral,Persisting MRI activity
68,4901,Tecfidera,2016-09-29,, ,mg,['/Month'], , 
69,4901,Betaferon,2016-10-20,2021-06-27,400,mg,[' '], ,Lack of efficacy
70,4901,Methylprednisolone,2016-09-26,2021-03-15,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
71,3305,Alemtuzumab (Campath),2015-12-25,2021-04-06,5000,mcg,['/Month'],Oral,Adverse Event
72,3305,Tecfidera,2016-10-10,,5000,mcg,['/ Day'], , 
73,3305,Rebif [44],2016-04-26,, , ,['3 / Week'],Oral, 
74,3305,Alemtuzumab (Campath),2015-12-23,,20, ,['2 / Day'],IV, 
75,2939,Methylprednisolone,2016-01-03,,20,mcg,['2 / Day'], , 
76,2939,Methylprednisolone,2015-12-27,2018-02-28, , ,['3 / Week'], ,Adverse Event
77,2939,Tecfidera,2015-11-23,, ,MIU,['/Month'], , 
78,4161,Tecfidera,2016-05-14,,20,mcg,['3 / Week'], , 
79,4161,Tecfidera,2016-03-02,2018-11-23,20, ,['2 / Day'],IV,Patient Choice/Convenience
80,1170,Ledertrexaat,2016-08-22,2018-02-08,20,mcg,['2 / Day'],IV,Patient Choice/Convenience
81,1170,Gilenya,2016-08-13,2018-12-13, ,mcg,['2 / Day'], ,Lack of efficacy
82,1170,Copaxone,2015-12-08,,5000,mg,['2 / Day'],Oral, 
83,1170,Teriflunomide,2015-11-08,2018-11-22,500,mcg,['/Month'], ,Persisting MRI activity
84,2708,Mitoxantrone,2015-10-27,, , ,['2 / Day'],Oral, 
85,2708,Tysabri,2016-05-24,,1,mg,['2 / Day'],IV, 
86,2708,Tecfidera,2016-06-27,,500,mg,[' '],IV, 
87,2373,Tecfidera,2016-02-29,, , ,[' '], , 
88,2373,Rebif [44],2016-06-24,,500,mcg,['3 / Week'],IV, 
89,2373,Ledertrexaat,2015-11-28,2020-02-16,300,mg,['/Month'], ,Persisting MRI activity
90,1519,Alemtuzumab (Campath),2016-04-06,,400,mg,['/ Week'], , 
91,1519,Betaferon,2016-06-24,2019-03-01, ,mg,['/Month'], ,Lack of efficacy
92,4561,Tysabri,2016-07-13,2019-01-08,20,mg,['/Month'], ,Patient Choice/Convenience
93,4561,Tecfidera,2016-01-04,2021-05-13,400,mcg,['2 / Day'], ,Adverse Event
94,535,Gilenya,2016-06-11,2020-11-10, , ,['/ Day'], ,Lack of efficacy
95,535,Copaxone,2016-06-05,2018-01-10, , ,['/Month'],Oral,Adverse Event
96,535,Tecfidera,2016-09-28,,5000,mg,[' '],IV, 
97,4848,Avonex,2016-06-01,2018-12-19,500, ,['/ Day'],IV,Persisting MRI activity
98,4848,Gilenya,2016-09-26,2021-05-14, ,mg,['3 / Week'],IV,Adverse Event
99,4848,Gilenya,2016-08-01,, ,MIU,['/Month'],IV, 
100,4283,Mitoxantrone,2016-03-24,,1000, ,['2 / Day'],IV, 
101,4559,Gilenya,2016-08-07,,1000, ,['/Month'],IV, 
102,4559,Teriflunomide,2015-12-15,2018-09-13, ,mg,['/Month'], ,Patient Choice/Convenience
103,3285,Tysabri,2016-06-27,, ,mg,[' '],IV, 
104,3285,Rebif [44],2016-09-03,2020-08-07, ,mcg,['2 / Day'],IV,Persisting MRI activity
105,3285,IVIG,2016-07-25,2020-04-11, , ,['3 / Week'],IV,Persisting MRI activity
106,3285,D-cure (Vitamine D),2016-03-07,2021-05-19,1000,MIU,['3 / Week'],IV,Adverse Event
107,4031,Methylprednisolone,2016-04-04,2020-11-12,5000, ,['2 / Day'],IV,Lack of efficacy
108,3908,D-cure (Vitamine D),2016-01-31,,1, ,['2 / Day'], , 
109,3908,Tysabri,2016-02-14,2018-03-02,1000,mg,['/ Week'],IV,Adverse Event
110,3113,Methylprednisolone,2016-03-10,2019-05-12,1,mg,['/ Day'],IV,Adverse Event
111,3113,Tecfidera,2016-09-04,2021-04-28,300, ,[' '], ,Adverse Event
112,3113,Avonex,2016-09-01,2020-08-27,20, ,['/Month'],IV,Lack of efficacy
113,3113,Gilenya,2016-06-13,2020-08-13, ,mcg,['2 / Day'],IV,Adverse Event
114,3100,Gilenya,2015-12-19,, ,mg,['/ Day'],IV, 
115,1105,Endoxan,2016-03-29,, , ,['2 / Day'], , 
116,1105,Avonex,2016-06-22,,1,mg,['/Month'], , 
117,1105,Alemtuzumab (Campath),2016-06-20,,1,mg,['/Month'], , 
118,1105,Tysabri,2016-08-24,2021-10-05,300,mg,['/Month'],IV,Persistence of relapses
119,2679,Tysabri,2016-06-10,2020-11-02, ,MIU,['/Month'], ,Adverse Event
120,2679,Tysabri,2016-05-15,2019-08-07,5000, ,['/Month'],IV,Patient Choice/Convenience
121,2679,Tecfidera,2016-09-10,, ,mg,['/Month'],IV, 
122,2571,IVIG,2016-08-19,2018-07-07, , ,[' '], ,Patient Choice/Convenience
123,2961,Methylprednisolone,2016-09-29,,1,mg,['/ Day'],IV, 
124,2961,Tysabri,2016-01-06,, ,mg,['/ Day'], , 
125,2914,Tysabri,2016-03-19,,20, ,['/Month'],IV, 
126,3206,Copaxone,2016-04-08,2017-12-04,5000, ,['2 / Day'],IV,Adverse Event
127,3206,Methylprednisolone,2016-02-19,2019-08-15, , ,['/Month'],IV,Lack of efficacy
128,3206,Gilenya,2016-09-18,,1000,mg,['2 / Day'],Oral, 
129,3206,Betaferon,2016-05-09,,400,mg,['2 / Day'],Oral, 
130,407,Gilenya,2016-09-12,,20, ,['2 / Day'],IV, 
131,407,Endoxan,2016-08-16,2018-06-24,300, ,['/Month'],IV,Adverse Event
132,407,Tecfidera,2015-12-16,,1000,mg,['2 / Day'],Oral, 
133,407,Teriflunomide,2016-03-16,,300,mg,['3 / Week'],IV, 
134,1320,IVIG,2016-06-25,,1000, ,['2 / Day'],IV, 
135,1320,Rebif [44],2016-05-17,, ,MIU,['2 / Day'],IV, 
136,1320,Rebif [22],2016-07-31,2018-03-29, , ,[' '],IV,Patient Choice/Convenience
137,1320,Alemtuzumab (Campath),2015-11-21,2018-03-31,1000, ,['/Month'],IV,Persisting MRI activity
138,1910,Rebif [22],2016-05-07,,20,MIU,[' '],Oral, 
139,1910,Betaferon,2016-03-10,2020-03-14,400,mg,['2 / Day'], ,Persisting MRI activity
140,1910,Ledertrexaat,2016-07-21,2020-05-13,1000, ,['/Month'],IV,Persisting MRI activity
141,1910,Methylprednisolone,2015-12-30,,300,mg,['/Month'], , 
142,1586,Methylprednisolone,2016-01-02,2020-03-15, ,mg,['2 / Day'],Oral,Lack of efficacy
143,1586,Betaferon,2016-01-09,2021-02-14, , ,['/Month'],IV,Patient Choice/Convenience
144,1586,D-cure (Vitamine D),2016-10-20,2020-03-16,5000,mg,['/Month'], ,Persisting MRI activity
145,4591,Endoxan,2015-12-13,2019-12-04, , ,['/ Week'],IV,Adverse Event
146,4591,Copaxone,2016-04-03,2019-08-29,1000,mg,['/ Day'],IV,Adverse Event
147,4591,Methylprednisolone,2016-04-17,2019-07-06,300,mg,['/Month'], ,Adverse Event
148,4591,IVIG,2016-07-23,2021-10-04,1000, ,['3 / Week'],IV,Persisting MRI activity
149,4167,Tysabri,2016-02-29,,1,mg,['/ Day'],IV, 
150,4167,Avonex,2016-04-28,, , ,[' '],Oral, 
151,4167,Endoxan,2016-06-29,,500,mg,['3 / Week'],Oral, 
152,1436,Betaferon,2016-03-02,2019-11-29, , ,['/ Day'], ,Patient Choice/Convenience
153,1436,Gilenya,2015-11-24,2019-12-22,1000,mg,['/Month'], ,Lack of efficacy
154,1978,Betaferon,2016-08-17,,1,MIU,['/Month'],IV, 
155,1978,Alemtuzumab (Campath),2016-03-24,,5000,mg,['2 / Day'],IV, 
156,1978,Copaxone,2016-10-06,2019-01-09,1000,MIU,['/ Day'], ,Persisting MRI activity
157,1701,Rebif [44],2016-09-10,, ,mg,['2 / Day'], , 
158,1701,Methylprednisolone,2015-12-27,2021-09-30,300,mg,[' '],IV,Persisting MRI activity
159,1701,IVIG,2016-09-18,,1,mg,['3 / Week'],Oral, 
160,502,Alemtuzumab (Campath),2016-06-25,2019-02-18,1, ,['/ Day'], ,Adverse Event
161,502,Tecfidera,2015-11-28,, , ,[' '],IV, 
162,3416,IVIG,2016-04-04,,1,mg,['3 / Week'], , 
163,4039,Endoxan,2016-07-07,,300,mg,['3 / Week'],Oral, 
164,4039,Endoxan,2015-10-26,2018-07-03, ,mg,['/Month'],IV,Persistence of relapses
165,4039,Betaferon,2016-08-07,2019-09-18, ,mg,['2 / Day'], ,Adverse Event
166,4039,D-cure (Vitamine D),2016-02-06,,500,MIU,['2 / Day'], , 
167,476,Tecfidera,2016-10-22,,300, ,['/Month'],IV, 
168,476,Copaxone,2016-06-08,, ,mg,['/Month'], , 
169,476,Gilenya,2016-07-24,,500,mg,['3 / Week'], , 
170,476,IVIG,2016-01-31,, ,mg,['2 / Day'],IV, 
171,2185,Rebif [44],2016-02-03,,500,mg,[' '],IV, 
172,1304,Avonex,2016-08-01,,500, ,['/Month'], , 
173,4947,IVIG,2016-04-03,,20, ,[' '],IV, 
174,4947,Alemtuzumab (Campath),2016-06-18,, , ,['/Month'],Oral, 
175,4503,Alemtuzumab (Campath),2016-01-24,,300,mg,['/Month'],IV, 
176,4503,Tecfidera,2016-08-26,,5000, ,[' '], , 
177,4503,D-cure (Vitamine D),2016-08-26,,500, ,['2 / Day'],IV, 
178,4503,Gilenya,2016-01-23,, ,mg,['/Month'], , 
179,2645,IVIG,2016-06-22,2020-08-07,5000,mg,['2 / Day'], ,Adverse Event
180,2645,IVIG,2016-04-29,,300,mg,['2 / Day'], , 
181,2645,Tecfidera,2015-10-27,,5000,mg,['2 / Day'], , 
182,2645,Betaferon,2016-06-17,,1000, ,['2 / Day'],Oral, 
183,4116,Methylprednisolone,2016-10-16,, ,mg,['/ Day'],Oral, 
184,4116,Copaxone,2016-09-06,2021-01-08,1000, ,['2 / Day'], ,Adverse Event
185,4116,IVIG,2016-04-16,, ,mg,['3 / Week'], , 
186,4116,Ledertrexaat,2016-03-10,,400, ,['3 / Week'], , 
187,2604,Avonex,2016-06-02,, ,mg,['2 / Day'],IV, 
188,2604,Avonex,2016-07-02,2020-06-27,20,mg,['2 / Day'], ,Patient Choice/Convenience
189,2604,Gilenya,2016-05-11,2018-06-10,1000,MIU,['2 / Day'],IV,Persisting MRI activity
190,4305,Tysabri,2015-12-04,, ,mg,['/Month'],IV, 
191,4305,Alemtuzumab (Campath),2016-03-16,,1, ,['2 / Day'],IV, 
192,4305,Methylprednisolone,2016-06-03,2019-01-29,20, ,['/Month'], ,Adverse Event
193,3192,Betaferon,2016-06-23,,500,mcg,['2 / Day'], , 
194,3192,Teriflunomide,2016-08-27,2019-07-04, ,MIU,['/ Day'],IV,Adverse Event
195,3110,Endoxan,2015-11-12,, ,mg,['3 / Week'],IV, 
196,3110,Avonex,2016-01-01,2021-02-17,1, ,['/Month'], ,Adverse Event
197,3110,Betaferon,2016-01-07,, ,mg,[' '],Oral, 
198,3110,Endoxan,2016-10-18,2019-03-23,20,MIU,['2 / Day'],IV,Lack of efficacy
199,703,Tysabri,2016-07-01,,20, ,['/Month'], , 
200,4023,Gilenya,2015-12-02,,20,mg,['2 / Day'],Oral, 
201,4023,D-cure (Vitamine D),2016-03-29,,20, ,['/Month'],Oral, 
202,4023,Ledertrexaat,2016-02-08,,20,mg,['/Month'],IV, 
203,1494,Gilenya,2016-08-25,2018-03-02, ,mg,['2 / Day'], ,Persistence of relapses
204,4024,Mitoxantrone,2016-06-17,, ,mg,['2 / Day'],IV, 
205,4024,Alemtuzumab (Campath),2016-07-19,,1000,mg,['2 / Day'],IV, 
206,2060,Endoxan,2016-08-25,, ,mcg,['/ Week'],Oral, 
207,2060,Tecfidera,2015-11-06,2018-02-10, ,mg,[' '],IV,Persistence of relapses
208,2060,Tecfidera,2016-01-11,2018-07-24,300, ,['/Month'],IV,Persisting MRI activity
209,1888,Mitoxantrone,2016-03-23,,20,mg,['/Month'],IV, 
210,1888,Tysabri,2016-08-02,, ,mg,['2 / Day'],IV, 
211,1888,Rebif [22],2015-12-20,, ,mcg,['2 / Day'],IV, 
212,909,Tecfidera,2015-12-21,,1000,MIU,['2 / Day'],IV, 
213,909,Gilenya,2016-09-19,2021-07-04, , ,['/Month'],IV,Patient Choice/Convenience
214,909,Teriflunomide,2015-12-21,,1000,MIU,['/Month'],IV, 
215,2025,IVIG,2016-06-10,,400, ,['2 / Day'],IV, 
216,2025,Tysabri,2016-08-26,,300,mg,[' '],IV, 
217,831,Tecfidera,2016-01-24,2018-02-06, , ,['/Month'],IV,Patient Choice/Convenience
218,831,Teriflunomide,2015-11-30,,20, ,['3 / Week'],IV, 
219,831,Endoxan,2016-08-03,,1000,MIU,['/Month'],Oral, 
220,831,Alemtuzumab (Campath),2015-12-19,,300,mg,[' '],IV, 
221,3436,Copaxone,2016-01-29,,1000,mcg,[' '], , 
222,3436,D-cure (Vitamine D),2016-01-10,,300,mg,['/Month'],IV, 
223,3130,D-cure (Vitamine D),2016-01-26,2018-04-24,20,mcg,['/Month'], ,Adverse Event
224,519,D-cure (Vitamine D),2016-07-04,2018-04-24, ,mg,['2 / Day'],IV,Patient Choice/Convenience
225,1693,Ledertrexaat,2016-03-29,,300,mcg,['2 / Day'],IV, 
226,1693,Endoxan,2016-04-23,,400,MIU,['/Month'],IV, 
227,1693,Tysabri,2016-09-15,2020-05-24,300, ,['/Month'], ,Lack of efficacy
228,1693,Tecfidera,2016-07-23,,1, ,['/Month'],IV, 
229,885,Tysabri,2016-04-22,2019-05-14,5000,MIU,['/Month'], ,Persisting MRI activity
230,885,D-cure (Vitamine D),2016-05-28,,500, ,['/Month'],IV, 
231,885,Endoxan,2016-07-04,2019-09-26,20,mg,['3 / Week'], ,Persisting MRI activity
232,885,Endoxan,2016-05-31,2021-06-06, ,mg,['/Month'], ,Lack of efficacy
233,1443,Tecfidera,2016-10-15,,300,MIU,['2 / Day'],IV, 
234,1443,IVIG,2016-05-26,,1000, ,['/Month'], , 
235,753,Copaxone,2016-04-02,,20,MIU,['/Month'],IV, 
236,753,Rebif [44],2016-07-15,,5000,mg,['/ Day'], , 
237,2748,Mitoxantrone,2015-11-07,2018-02-12,500,mg,['2 / Day'],IV,Persistence of relapses
238,1682,Betaferon,2016-08-27,2017-11-26, , ,['2 / Day'],IV,Adverse Event
239,3014,Methylprednisolone,2016-04-27,,5000,mg,['3 / Week'], , 
240,1106,Tysabri,2015-12-30,,500,mg,['2 / Day'], , 
241,1344,Alemtuzumab (Campath),2016-05-31,,5000,MIU,['/ Day'], , 
242,2438,Gilenya,2016-09-21,2019-10-30,5000, ,['/ Week'],IV,Persisting MRI activity
243,2438,IVIG,2016-05-18,2018-10-30,500, ,['/Month'],IV,Adverse Event
244,2438,Rebif [44],2016-08-08,2020-11-09,300, ,['3 / Week'],IV,Adverse Event
245,2438,Gilenya,2016-05-16,,300, ,['/Month'], , 
246,495,Endoxan,2016-03-12,,300,MIU,['/ Day'],Oral, 
247,495,Gilenya,2016-02-06,, ,MIU,['/Month'],IV, 
248,495,Rebif [22],2016-04-21,, , ,['2 / Day'], , 
249,4246,Endoxan,2016-02-14,2020-01-24,500,mg,['2 / Day'],Oral,Patient Choice/Convenience
250,4246,Rebif [22],2016-09-07,,300, ,['2 / Day'],IV, 
251,4246,Rebif [44],2016-06-16,,1,mg,['2 / Day'],IV, 
252,3349,Methylprednisolone,2016-04-08,2018-10-05,1000,mg,['2 / Day'],IV,Adverse Event
253,3349,D-cure (Vitamine D),2016-01-21,, , ,[' '], , 
254,1561,Avonex,2016-02-02,2017-11-07,500,mg,['/ Day'], ,Patient Choice/Convenience
255,1561,Tecfidera,2016-04-01,, , ,['2 / Day'], , 
256,1561,Gilenya,2016-08-02,,1000, ,[' '],IV, 
257,4509,Copaxone,2015-12-19,2018-12-19,1000, ,['2 / Day'],IV,Adverse Event
258,4509,Methylprednisolone,2015-12-05,,1000, ,['/Month'],IV, 
259,4509,Endoxan,2015-12-01,,400,mg,['3 / Week'],IV, 
260,4509,Avonex,2016-09-20,,1, ,['3 / Week'],IV, 
261,1965,Rebif [22],2016-05-31,,1, ,['/Month'],IV, 
262,1757,Ledertrexaat,2016-08-17,2018-03-16,400,mg,['/Month'],Oral,Persisting MRI activity
263,1757,Methylprednisolone,2016-03-13,,5000, ,['/Month'], , 
264,1414,Tysabri,2016-02-27,2021-04-29,20, ,['/ Day'],IV,Persistence of relapses
265,1414,Tecfidera,2016-01-22,2019-02-08,1000, ,['/ Week'],IV,Adverse Event
266,1414,Copaxone,2016-09-02,2020-03-19, ,mg,['/ Day'],Oral,Persistence of relapses
267,1414,Endoxan,2016-06-08,2020-10-11,500,MIU,['3 / Week'], ,Persisting MRI activity
268,2929,Rebif [22],2016-02-28,,1,MIU,['/ Week'],Oral, 
269,2929,Ledertrexaat,2016-10-12,2019-09-27,1000, ,['2 / Day'], ,Persistence of relapses
270,2929,Copaxone,2016-10-03,,1000,mg,[' '], , 
271,1418,Avonex,2016-04-20,2020-11-26,20, ,['/Month'],IV,Patient Choice/Convenience
272,1418,Copaxone,2016-01-20,2018-06-25, , ,['2 / Day'],Oral,Adverse Event
273,4981,Teriflunomide,2016-09-26,,500,mg,['/Month'], , 
274,4981,Alemtuzumab (Campath),2016-05-14,2020-10-02, , ,['/Month'],IV,Persisting MRI activity
275,4981,Rebif [22],2016-04-24,2018-06-09, ,mg,['/Month'], ,Adverse Event
276,2587,Methylprednisolone,2016-09-02,2019-09-15,5000, ,['/ Week'],IV,Persisting MRI activity
277,2587,Avonex,2016-03-21,, ,mg,['/Month'],Oral, 
278,2587,Ledertrexaat,2016-07-04,, ,MIU,['2 / Day'],IV, 
279,698,Avonex,2016-04-14,, ,mg,['3 / Week'],IV, 
280,698,IVIG,2016-06-17,,500,mcg,[' '],IV, 
281,1421,Teriflunomide,2016-03-30,, ,mg,['/Month'],Oral, 
282,1421,IVIG,2015-11-14,, ,mg,['2 / Day'],Oral, 
283,4256,Methylprednisolone,2016-06-03,, , ,['2 / Day'], , 
284,4256,Avonex,2016-05-29,,1000,mcg,['/Month'], , 
285,4256,Avonex,2016-05-03,, ,mcg,[' '], , 
286,4256,Rebif [22],2016-05-26,, ,mg,['/Month'], , 
287,962,Rebif [44],2016-07-02,2019-02-02, , ,['/ Day'], ,Patient Choice/Convenience
288,962,Gilenya,2016-01-28,, , ,['/Month'],IV, 
289,962,IVIG,2016-02-04,,1000,mg,['/Month'],IV, 
290,196,IVIG,2016-03-12,,1, ,['2 / Day'],IV, 
291,1817,Gilenya,2016-03-08,2021-08-18, , ,['/Month'],Oral,Persistence of relapses
292,1817,IVIG,2016-01-29,2021-01-16,5000, ,['2 / Day'],IV,Adverse Event
293,1817,Copaxone,2016-04-21,2019-02-07,300,mcg,['2 / Day'],IV,Adverse Event
294,1817,D-cure (Vitamine D),2016-04-15,2020-04-25,500, ,['/ Day'], ,Patient Choice/Convenience
295,853,Avonex,2016-07-19,2020-12-26, ,mg,['3 / Week'],Oral,Lack of efficacy
296,853,Rebif [44],2016-04-02,2019-08-01, ,mg,['/ Week'],Oral,Adverse Event
297,853,Copaxone,2016-10-08,2017-11-04,400,mg,['/Month'],IV,Persisting MRI activity
298,853,Alemtuzumab (Campath),2016-06-08,,500,mg,['2 / Day'],IV, 
299,691,Gilenya,2015-11-25,, , ,['3 / Week'],IV, 
300,691,Alemtuzumab (Campath),2015-12-31,,500,mg,['/Month'],IV, 
301,317,Rebif [44],2016-10-14,,500,mg,['2 / Day'],IV, 
302,317,Alemtuzumab (Campath),2016-08-10,,1, ,['3 / Week'],Oral, 
303,317,Gilenya,2016-06-04,2018-02-16,300,mg,['/ Day'], ,Lack of efficacy
304,317,Alemtuzumab (Campath),2016-02-24,2020-10-02, ,mg,['/Month'], ,Lack of efficacy
305,2343,Gilenya,2016-09-05,2020-12-06, , ,[' '], ,Lack of efficacy
306,2343,Rebif [44],2016-08-23,,400, ,['/Month'], , 
307,2343,Betaferon,2016-04-09,2019-10-28,400,MIU,[' '],IV,Patient Choice/Convenience
308,2343,Mitoxantrone,2015-11-07,,500, ,['/Month'],IV, 
309,1815,Copaxone,2016-06-14,,500, ,['3 / Week'],IV, 
310,1815,Rebif [44],2016-08-10,,1000,mg,['/Month'],IV, 
311,1815,D-cure (Vitamine D),2016-01-08,2021-07-18,500, ,['2 / Day'], ,Patient Choice/Convenience
312,4877,Tecfidera,2016-03-29,2021-02-24,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
313,4877,IVIG,2016-08-13,, , ,['/Month'],IV, 
314,4877,D-cure (Vitamine D),2016-10-13,2018-08-23, , ,['/Month'],IV,Lack of efficacy
315,1416,Copaxone,2015-11-27,,300,mg,['/Month'],IV, 
316,1416,Rebif [22],2016-03-06,2020-08-03,1000,mg,['3 / Week'],Oral,Adverse Event
317,1416,Endoxan,2016-07-10,2020-04-23,400,mg,['2 / Day'],IV,Persistence of relapses
318,3394,Rebif [22],2015-12-26,,20,mg,['2 / Day'],IV, 
319,3394,Avonex,2016-09-05,, ,mg,['2 / Day'], , 
320,3394,Gilenya,2016-02-16,,500,mcg,['/Month'],IV, 
321,3394,D-cure (Vitamine D),2016-06-03,,500, ,['2 / Day'], , 
322,4956,Teriflunomide,2016-07-24,2021-08-19, ,mg,['3 / Week'], ,Persisting MRI activity
323,4956,Copaxone,2015-11-22,2018-11-15,300,mg,['/Month'],Oral,Persistence of relapses
324,4956,Tysabri,2016-10-20,2020-01-21,20, ,['2 / Day'],IV,Adverse Event
325,4670,Methylprednisolone,2016-10-08,2019-10-17,1000,mg,['3 / Week'],Oral,Adverse Event
326,4670,Avonex,2016-03-05,2019-07-14,500, ,['3 / Week'],IV,Patient Choice/Convenience
327,4670,Tecfidera,2016-01-25,2018-08-07,5000,mcg,['2 / Day'],IV,Patient Choice/Convenience
328,4670,Tysabri,2016-10-09,2020-01-03, , ,['/Month'],Oral,Patient Choice/Convenience
329,2207,Teriflunomide,2015-12-27,2019-03-12,1000,mg,['/Month'], ,Persistence of relapses
330,2207,Tysabri,2016-06-14,, , ,['/Month'], , 
331,2207,Rebif [44],2016-09-25,,500,mg,['/ Week'], , 
332,2995,D-cure (Vitamine D),2016-06-10,2019-11-01, , ,['2 / Day'], ,Lack of efficacy
333,2805,Mitoxantrone,2016-10-01,,1, ,['/Month'], , 
334,2805,Ledertrexaat,2016-09-17,,500,MIU,['/Month'],IV, 
335,1979,Rebif [22],2016-05-16,2018-01-01,300,mg,['/Month'],Oral,Adverse Event
336,1979,D-cure (Vitamine D),2016-04-25,,400,mg,['/ Day'],IV, 
337,1979,Alemtuzumab (Campath),2016-10-21,,300,mg,['2 / Day'],IV, 
338,1979,D-cure (Vitamine D),2016-01-06,2018-08-26,1000,MIU,['2 / Day'],IV,Adverse Event
339,1304,Methylprednisolone,2015-10-30,2018-11-02,1,mg,['2 / Day'], ,Patient Choice/Convenience
340,2475,Ledertrexaat,2016-07-19,2020-08-31,400,mg,['/Month'],IV,Lack of efficacy
341,2475,D-cure (Vitamine D),2016-07-14,,400,mg,['/Month'], , 
342,2475,IVIG,2016-03-11,2017-12-06,1000, ,['/ Day'],IV,Patient Choice/Convenience
343,2475,IVIG,2016-04-04,2018-11-04, , ,[' '], ,Adverse Event
344,3909,Avonex,2016-03-09,, , ,['2 / Day'],IV, 
345,3909,Teriflunomide,2016-08-26,,20, ,['2 / Day'], , 
346,4162,Methylprednisolone,2016-07-12,,20, ,['/ Week'], , 
347,4162,D-cure (Vitamine D),2016-04-28,, , ,['/Month'], , 
348,4162,Rebif [22],2016-04-06,, , ,[' '],IV, 
349,4162,Endoxan,2016-05-04,,20,mg,['2 / Day'],IV, 
350,486,Methylprednisolone,2015-11-08,, ,mg,['2 / Day'],IV, 
351,4329,Methylprednisolone,2016-06-03,, , ,['3 / Week'],IV, 
352,4329,Tecfidera,2016-02-15,2018-09-12, , ,[' '],IV,Adverse Event
353,4329,Rebif [44],2016-02-04,, ,mg,['/Month'],IV, 
354,1657,IVIG,2016-08-05,,20,mg,[' '],IV, 
355,1140,Rebif [44],2015-11-13,2020-05-20,500,mcg,[' '], ,Adverse Event
356,1140,Alemtuzumab (Campath),2016-06-10,2021-05-10,1000, ,['2 / Day'], ,Lack of efficacy
357,1140,Ledertrexaat,2016-01-14,,500,mg,['3 / Week'], , 
358,1140,Gilenya,2015-12-11,,5000,mg,['3 / Week'],IV, 
359,530,Endoxan,2016-10-21,, ,mg,['3 / Week'],IV, 
360,530,IVIG,2015-11-30,, , ,[' '],IV, 
361,2868,D-cure (Vitamine D),2016-06-26,,1,MIU,['/Month'], , 
362,2868,Methylprednisolone,2016-03-30,2020-03-22, ,MIU,['/Month'],IV,Persisting MRI activity
363,2868,Endoxan,2016-01-30,,20, ,['3 / Week'],IV, 
364,3882,Methylprednisolone,2016-05-20,,20, ,['/Month'], , 
365,913,Tysabri,2016-06-04,,20,mg,['2 / Day'],IV, 
366,913,Methylprednisolone,2016-05-02,,500,mcg,[' '],Oral, 
367,913,Betaferon,2015-11-02,,1000, ,[' '],IV, 
368,913,Rebif [22],2016-10-19,2019-01-03,20, ,['3 / Week'], ,Adverse Event
369,2049,Avonex,2016-03-16,2019-08-15, ,mg,['/Month'], ,Persisting MRI activity
370,2049,Alemtuzumab (Campath),2016-07-15,2018-05-04, ,mg,['/Month'],IV,Patient Choice/Convenience
371,2049,Rebif [44],2016-08-04,2020-08-08,1000, ,[' '],IV,Adverse Event
372,1920,Avonex,2016-10-07,,1,MIU,['/Month'], , 
373,4829,Rebif [44],2016-09-06,,1000,mg,['/Month'],Oral, 
374,3808,Betaferon,2016-06-24,,5000, ,['3 / Week'],IV, 
375,3808,Rebif [44],2016-03-30,,300,mg,['/Month'], , 
376,3808,IVIG,2016-10-20,,1000,mg,['/ Day'], , 
377,244,D-cure (Vitamine D),2015-12-20,2021-06-09,1,mg,['/Month'], ,Patient Choice/Convenience
378,621,Tysabri,2016-04-08,,5000, ,['/Month'], , 
379,621,Rebif [22],2016-10-18,2021-02-20,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
380,2949,Rebif [44],2016-03-07,,1000, ,['/ Week'],IV, 
381,4074,Gilenya,2015-12-09,,1, ,['/Month'],IV, 
382,4074,Rebif [44],2015-11-28,2017-12-15, , ,['/Month'], ,Persistence of relapses
383,158,Ledertrexaat,2016-03-30,2019-10-25, , ,['/Month'], ,Persistence of relapses
384,158,Copaxone,2015-12-11,, ,mg,[' '],IV, 
385,158,Tysabri,2016-08-03,2020-12-10, , ,['/Month'],Oral,Patient Choice/Convenience
386,158,Rebif [44],2016-07-27,,1000,mg,['/Month'],Oral, 
387,1272,IVIG,2016-03-03,,300,MIU,['2 / Day'],IV, 
388,1272,Avonex,2016-09-19,, , ,['/Month'], , 
389,1272,Methylprednisolone,2015-12-10,,300,mcg,['/Month'],Oral, 
390,835,IVIG,2016-04-01,,20, ,['3 / Week'],IV, 
391,835,Teriflunomide,2016-01-01,,300, ,['/Month'],Oral, 
392,835,Tysabri,2016-07-26,2020-06-07,5000, ,['2 / Day'],IV,Persisting MRI activity
393,835,Endoxan,2016-08-28,2020-01-07, ,mcg,[' '],IV,Adverse Event
394,1866,Rebif [22],2016-10-11,2018-01-05,500,mg,[' '], ,Adverse Event
395,4338,Gilenya,2016-07-27,, ,mcg,['/Month'], , 
396,2315,Avonex,2016-07-26,,400,mg,['/Month'], , 
397,2315,Methylprednisolone,2016-03-01,2019-02-13,1000,mg,['/Month'], ,Persistence of relapses
398,2315,Methylprednisolone,2016-04-03,2021-04-18,1, ,['/ Day'], ,Adverse Event
399,2315,Alemtuzumab (Campath),2016-02-19,,20,MIU,['2 / Day'], , 
400,1726,Copaxone,2016-05-26,2020-08-03,500,mcg,['/ Day'], ,Patient Choice/Convenience
401,1726,D-cure (Vitamine D),2015-12-23,,1000, ,['/ Day'], , 
402,1726,Avonex,2016-05-23,, ,mg,[' '],IV, 
403,2401,Tecfidera,2016-01-12,,1, ,['/ Day'], , 
404,2401,IVIG,2016-10-13,2021-10-03,300,mg,['/Month'], ,Persisting MRI activity
405,2962,Ledertrexaat,2016-07-24,,5000,mg,['3 / Week'],IV, 
406,2962,Rebif [22],2015-12-03,2020-07-21,1, ,['/ Day'],IV,Persisting MRI activity
407,2962,Tysabri,2016-04-23,,5000, ,['/ Week'],IV, 
408,2962,D-cure (Vitamine D),2016-05-05,2020-09-04, ,mg,['2 / Day'],IV,Persisting MRI activity
409,1639,Rebif [22],2016-07-29,2019-07-23,1,mg,[' '], ,Adverse Event
410,3651,Methylprednisolone,2016-05-23,2019-07-21, ,mg,['/Month'],IV,Lack of efficacy
411,3651,Copaxone,2016-02-04,,300, ,['/Month'], , 
412,3651,Avonex,2015-12-16,,300,mg,['3 / Week'], , 
413,3651,IVIG,2016-10-16,2021-01-29,500, ,[' '], ,Patient Choice/Convenience
414,4379,Endoxan,2016-02-19,,300,MIU,['2 / Day'],IV, 
415,4072,Methylprednisolone,2016-05-06,, , ,['2 / Day'],IV, 
416,4072,Tysabri,2015-10-27,, ,mg,['/Month'],IV, 
417,4072,Methylprednisolone,2016-03-10,2021-02-19, ,mg,[' '], ,Patient Choice/Convenience
418,4072,Copaxone,2016-05-30,,20, ,['/Month'],IV, 
419,4809,Tecfidera,2016-05-20,2021-05-01,1000,mg,['3 / Week'],IV,Lack of efficacy
420,4809,Alemtuzumab (Campath),2016-04-08,2018-12-25,5000,MIU,['/Month'],IV,Adverse Event
421,4809,Tecfidera,2016-05-27,2020-12-14, , ,[' '],Oral,Lack of efficacy
422,4809,Gilenya,2016-07-17,2018-10-10,1000,mg,['/Month'],IV,Patient Choice/Convenience
423,4790,Gilenya,2015-11-19,2019-01-09,300,mg,['2 / Day'],IV,Adverse Event
424,4790,Copaxone,2016-07-21,, , ,['/Month'], , 
425,3009,Tysabri,2016-04-13,,5000, ,['/ Day'], , 
426,3009,Copaxone,2016-09-14,2021-06-18,1000,mg,['2 / Day'], ,Adverse Event
427,3009,Teriflunomide,2016-02-17,2018-10-07, , ,['2 / Day'],IV,Patient Choice/Convenience
428,3009,Avonex,2015-10-28,,1,MIU,['/Month'],Oral, 
429,4527,Mitoxantrone,2016-01-09,,300,mcg,['/ Day'], , 
430,1488,Ledertrexaat,2016-07-02,,500,mg,['2 / Day'],IV, 
431,4163,Betaferon,2016-07-09,,20,mg,['2 / Day'],IV, 
432,4163,Rebif [44],2016-06-01,,1, ,['2 / Day'], , 
433,4259,D-cure (Vitamine D),2016-08-27,, ,mg,['2 / Day'],IV, 
434,4259,D-cure (Vitamine D),2016-06-19,2019-11-22, ,mcg,['/Month'],IV,Persistence of relapses
435,4259,Avonex,2016-04-29,,5000,mg,['/Month'], , 
436,4259,Rebif [44],2016-07-21,2021-03-30,1000,mg,['3 / Week'],IV,Persistence of relapses
437,1300,Avonex,2016-04-30,,20, ,[' '],IV, 
438,3936,Mitoxantrone,2015-12-09,, ,mcg,['2 / Day'], , 
439,3936,D-cure (Vitamine D),2016-09-26,, , ,['/Month'],Oral, 
440,2437,Tecfidera,2016-05-10,,5000, ,[' '], , 
441,2437,Betaferon,2016-10-20,2018-04-23, ,mg,['2 / Day'],IV,Persisting MRI activity
442,2437,Alemtuzumab (Campath),2016-08-28,,1000,mg,['2 / Day'],IV, 
443,2437,Ledertrexaat,2016-05-19,,1000, ,['/Month'],IV, 
444,3480,Teriflunomide,2016-02-06,,20,mg,['2 / Day'],IV, 
445,3480,Endoxan,2016-10-13,,300,mg,['/Month'],IV, 
446,3480,Gilenya,2015-10-26,,400,mcg,['/Month'],IV, 
447,3480,D-cure (Vitamine D),2016-07-30,2017-11-27,300, ,['3 / Week'], ,Patient Choice/Convenience
448,899,Copaxone,2016-01-23,,300, ,['/ Day'],IV, 
449,899,Gilenya,2016-02-29,2020-01-20, ,mg,[' '],IV,Persisting MRI activity
450,202,Gilenya,2016-10-04,2020-06-06,5000, ,['3 / Week'],IV,Persistence of relapses
451,202,Tecfidera,2016-01-15,, ,MIU,['2 / Day'],IV, 
452,1985,Ledertrexaat,2016-10-21,2018-02-16, , ,['3 / Week'],IV,Lack of efficacy
453,1985,Endoxan,2016-02-16,,20, ,['2 / Day'],IV, 
454,2030,Avonex,2016-03-27,2021-02-22, , ,['/Month'],IV,Persisting MRI activity
455,2030,Alemtuzumab (Campath),2016-06-04,2021-07-30,5000,mcg,['3 / Week'],Oral,Adverse Event
456,2030,Rebif [44],2016-04-10,2018-04-24,20,mg,['/ Day'],Oral,Patient Choice/Convenience
457,2030,Alemtuzumab (Campath),2015-12-01,2020-12-02,400, ,['2 / Day'],IV,Adverse Event
458,1619,Copaxone,2015-10-31,,500,mcg,['/Month'],IV, 
459,4677,D-cure (Vitamine D),2016-08-21,,400,mg,['/Month'],IV, 
460,4130,Copaxone,2015-12-26,2021-10-16,1, ,['2 / Day'], ,Lack of efficacy
461,4130,Endoxan,2015-11-30,, , ,['2 / Day'], , 
462,4130,Mitoxantrone,2016-05-22,2021-02-11,20, ,['/ Day'],IV,Persisting MRI activity
463,2721,Rebif [44],2016-01-16,,1,mcg,['2 / Day'],IV, 
464,2721,Teriflunomide,2016-04-22,, , ,['3 / Week'],IV, 
465,2721,Betaferon,2016-06-01,, ,MIU,['/Month'],IV, 
466,3178,Rebif [22],2015-12-11,,1000,mg,[' '],IV, 
467,3178,Tecfidera,2016-05-25,,1, ,['2 / Day'],IV, 
468,3178,D-cure (Vitamine D),2016-02-08,,300, ,[' '],IV, 
469,3178,Rebif [22],2015-11-18,, , ,['2 / Day'],Oral, 
470,4041,Tecfidera,2016-03-07,2020-02-08,1000,MIU,[' '], ,Patient Choice/Convenience
471,4041,Endoxan,2016-04-12,2021-08-20,5000, ,['/ Week'],IV,Adverse Event
472,597,Ledertrexaat,2015-10-24,2018-02-22,20,MIU,['2 / Day'],IV,Persisting MRI activity
473,597,D-cure (Vitamine D),2016-02-01,,400, ,['/Month'],IV, 
474,597,Betaferon,2016-04-30,,1000,MIU,[' '], , 
475,597,Mitoxantrone,2016-09-09,,20,mg,['2 / Day'],IV, 
476,508,Betaferon,2015-11-07,2021-05-18, ,mg,['2 / Day'],IV,Persisting MRI activity
477,508,Rebif [22],2015-12-18,2018-08-30,300,mcg,['/ Day'], ,Adverse Event
478,3727,Rebif [44],2016-04-05,, ,mg,['2 / Day'],IV, 
479,3727,Teriflunomide,2016-01-10,, ,mg,[' '], , 
480,3727,IVIG,2016-09-12,2020-03-03,20,mg,['/Month'],IV,Patient Choice/Convenience
481,3733,Gilenya,2016-10-11,,20, ,['2 / Day'],Oral, 
482,2242,Rebif [44],2016-09-11,,500, ,[' '], , 
483,4251,Gilenya,2016-10-18,2021-07-05, , ,[' '], ,Lack of efficacy
484,4251,Betaferon,2016-01-15,,300, ,['2 / Day'], , 
485,4251,Gilenya,2016-07-11,, ,MIU,['/ Week'],IV, 
486,4251,Mitoxantrone,2016-04-05,,5000,MIU,['/Month'], , 
487,3832,Rebif [44],2016-06-25,2020-03-14,300, ,[' '],IV,Adverse Event
488,638,Gilenya,2016-01-07,2019-02-20, ,mg,['2 / Day'],IV,Persisting MRI activity
489,638,Betaferon,2015-12-30,, , ,[' '], , 
490,638,Copaxone,2015-12-27,, , ,['2 / Day'],Oral, 
491,1208,Methylprednisolone,2016-02-14,,400,MIU,['3 / Week'],IV, 
492,1115,Tysabri,2016-07-19,2018-05-04,300, ,[' '],IV,Persistence of relapses
493,257,Tysabri,2016-07-22,2020-11-14,5000,mg,['/Month'],IV,Persisting MRI activity
494,257,Tecfidera,2016-06-12,,20, ,['/Month'], , 
495,257,Copaxone,2016-09-23,, ,mg,['/Month'],IV, 
496,4447,IVIG,2016-03-09,, ,mg,['/ Week'],IV, 
497,4447,Alemtuzumab (Campath),2015-12-15,,1, ,['/Month'], , 
498,1903,Avonex,2015-11-02,2018-03-30, , ,['/Month'], ,Patient Choice/Convenience
499,1903,Rebif [22],2016-05-30,, ,mg,['2 / Day'],IV, 
500,2438,D-cure (Vitamine D),2015-10-30,,500,mg,['/Month'],IV, 
501,2438,Rebif [44],2016-01-21,2021-01-31, , ,['/Month'],IV,Patient Choice/Convenience
502,2438,Betaferon,2015-12-20,2021-02-06, , ,['2 / Day'],IV,Patient Choice/Convenience
503,2438,Methylprednisolone,2016-07-05,,300,mg,['2 / Day'],IV, 
504,2834,Gilenya,2016-08-11,2021-03-25,500, ,['/Month'],Oral,Adverse Event
505,2834,IVIG,2016-04-05,,1000, ,['3 / Week'],IV, 
506,2834,Mitoxantrone,2016-01-18,2019-06-26, ,MIU,['/Month'],IV,Adverse Event
507,4178,Tysabri,2016-06-19,2019-07-20,300,mg,['/ Day'], ,Patient Choice/Convenience
508,4178,Tecfidera,2016-01-15,,1000,mg,['2 / Day'], , 
509,1085,Teriflunomide,2016-07-23,,20,mg,['2 / Day'], , 
510,1085,Methylprednisolone,2015-11-27,,500,MIU,['2 / Day'], , 
511,1085,Betaferon,2016-08-08,2020-10-08,500, ,['2 / Day'], ,Adverse Event
512,3102,Avonex,2016-09-08,, , ,['2 / Day'],IV, 
513,3102,Tecfidera,2016-05-17,2019-03-29,400, ,['/Month'],IV,Persistence of relapses
514,3102,Tecfidera,2016-04-06,,1000,MIU,['/Month'],IV, 
515,2568,IVIG,2016-08-08,,300,MIU,['/Month'],Oral, 
516,2568,Alemtuzumab (Campath),2016-05-22,2019-04-11, , ,['2 / Day'], ,Persisting MRI activity
517,2568,Gilenya,2016-04-04,2018-09-29,300,mg,['/Month'],Oral,Adverse Event
518,2568,D-cure (Vitamine D),2015-11-23,,5000, ,['2 / Day'],IV, 
519,3398,D-cure (Vitamine D),2016-05-03,2017-10-29,1000, ,['/Month'],IV,Persisting MRI activity
520,3398,Tysabri,2016-04-12,2019-02-05,400,mg,['3 / Week'],Oral,Lack of efficacy
521,3398,Alemtuzumab (Campath),2016-05-17,2019-12-02,500,mg,['/Month'],IV,Adverse Event
522,2130,Rebif [44],2016-04-16,2020-11-15,1,mg,['2 / Day'],IV,Patient Choice/Convenience
523,2130,Tysabri,2016-10-10,2021-08-06,1,mcg,['3 / Week'],IV,Patient Choice/Convenience
524,2130,Tysabri,2016-05-15,,300, ,['/Month'], , 
525,2130,Avonex,2016-09-17,,300,mg,[' '],IV, 
526,2788,Methylprednisolone,2015-11-10,2019-02-01,300, ,['/Month'],IV,Adverse Event
527,2788,Endoxan,2016-07-21,, ,mg,['/Month'],Oral, 
528,2788,Rebif [44],2016-09-13,, ,mg,['2 / Day'], , 
529,2788,Gilenya,2015-12-12,,400,mg,['/ Day'], , 
530,4412,D-cure (Vitamine D),2016-05-30,2021-03-28, ,mg,['3 / Week'],IV,Persisting MRI activity
531,4412,Copaxone,2016-07-19,,500,mg,['/ Week'],Oral, 
532,4412,Mitoxantrone,2015-11-22,2019-07-19,5000,mg,['2 / Day'],IV,Adverse Event
533,4412,Rebif [22],2015-11-27,,300, ,[' '],IV, 
534,4459,Methylprednisolone,2016-04-27,,400, ,['/ Day'],Oral, 
535,4459,Rebif [44],2016-08-07,, ,mg,['2 / Day'],IV, 
536,3509,Copaxone,2015-12-17,2021-09-26, , ,['2 / Day'], ,Adverse Event
537,3509,Tecfidera,2016-03-03,2019-12-23,5000, ,['/Month'],Oral,Lack of efficacy
538,3509,Endoxan,2016-09-14,, ,MIU,['/ Day'], , 
539,3509,Gilenya,2016-05-27,, ,mg,['/Month'],IV, 
540,4447,Copaxone,2016-06-12,,500,mg,['2 / Day'],IV, 
541,3767,Rebif [22],2016-03-28,2018-01-05,1,mg,['/ Week'],IV,Patient Choice/Convenience
542,3767,Tecfidera,2016-02-27,2020-05-27, ,mcg,['/Month'],Oral,Adverse Event
543,3736,Rebif [22],2015-10-30,2021-03-21,5000,mg,['2 / Day'], ,Lack of efficacy
544,3736,Betaferon,2016-06-11,2020-11-17,1, ,['2 / Day'],Oral,Patient Choice/Convenience
545,3390,Copaxone,2016-07-26,,20, ,['3 / Week'], , 
546,3390,Alemtuzumab (Campath),2016-04-27,,20,MIU,['3 / Week'], , 
547,3390,D-cure (Vitamine D),2016-07-17,2020-10-18,300, ,['3 / Week'], ,Patient Choice/Convenience
548,2028,Tecfidera,2016-04-28,,1,MIU,['2 / Day'],IV, 
549,2028,IVIG,2016-05-10,,1000,mg,[' '], , 
550,2028,Tecfidera,2016-08-17,,20,mg,['2 / Day'],IV, 
551,2711,Rebif [44],2016-07-19,2021-09-18, , ,['/Month'], ,Persisting MRI activity
552,2711,Methylprednisolone,2016-05-12,2019-06-13,1000, ,['2 / Day'], ,Adverse Event
553,2711,Avonex,2016-01-09,,300, ,[' '], , 
554,2711,Rebif [22],2016-06-04,,1000, ,['/ Week'],IV, 
555,1384,D-cure (Vitamine D),2016-01-01,2018-06-23,20,mg,['/Month'],IV,Patient Choice/Convenience
556,1384,Alemtuzumab (Campath),2016-07-24,2019-08-17, ,MIU,['/Month'],IV,Persistence of relapses
557,1384,Betaferon,2016-08-31,2020-11-03,20, ,['/Month'],IV,Persisting MRI activity
558,1384,Rebif [44],2016-06-26,,400,mg,['3 / Week'],IV, 
559,3548,Rebif [44],2016-05-21,,500,mg,['/Month'], , 
560,3548,Gilenya,2016-09-21,2017-12-12,20, ,[' '],Oral,Patient Choice/Convenience
561,3548,Copaxone,2016-03-28,,1000, ,['2 / Day'],IV, 
562,3690,Tecfidera,2016-01-18,,20,mg,['2 / Day'],IV, 
563,3690,Tysabri,2016-10-12,,1000,MIU,['2 / Day'],IV, 
564,4710,Methylprednisolone,2016-09-20,,500, ,['3 / Week'], , 
565,4710,Tecfidera,2015-11-28,,20,mg,['2 / Day'],IV, 
566,4710,IVIG,2016-05-16,2021-05-24,300, ,['/Month'],IV,Persistence of relapses
567,4710,Tysabri,2016-08-24,, ,mg,['2 / Day'], , 
568,4767,Methylprednisolone,2016-05-13,,1000,mg,['2 / Day'], , 
569,4767,Mitoxantrone,2016-03-17,,5000, ,['/Month'], , 
570,1717,Gilenya,2016-08-20,,5000, ,['/Month'],IV, 
571,2585,Rebif [22],2016-08-21,2021-06-04,20,mcg,['/Month'], ,Persisting MRI activity
572,4438,Endoxan,2015-12-05,,20,MIU,['/Month'],IV, 
573,4438,Copaxone,2016-06-17,,20,MIU,['3 / Week'], , 
574,4438,Teriflunomide,2016-09-08,, , ,['2 / Day'], , 
575,2861,Methylprednisolone,2015-12-10,,5000,mg,[' '],IV, 
576,2861,D-cure (Vitamine D),2016-04-24,,1000,mg,['/Month'],IV, 
577,2861,Tysabri,2016-08-15,,5000,mg,[' '],IV, 
578,3296,IVIG,2016-09-05,2019-05-01,1,mg,['/Month'],IV,Adverse Event
579,3296,Gilenya,2016-07-29,,20, ,['3 / Week'],IV, 
580,140,Gilenya,2016-09-29,, , ,['2 / Day'],Oral, 
581,140,Tecfidera,2016-06-28,2019-01-02,500, ,['2 / Day'],IV,Persisting MRI activity
582,140,Gilenya,2016-04-02,,300,mg,['2 / Day'], , 
583,140,Copaxone,2015-11-13,2020-01-07,1,MIU,['2 / Day'],IV,Persistence of relapses
584,3511,D-cure (Vitamine D),2015-12-03,, , ,['/Month'],Oral, 
585,3511,Tecfidera,2016-02-29,,5000,mg,['3 / Week'], , 
586,369,Mitoxantrone,2016-01-03,,5000,mg,['2 / Day'], , 
587,1241,Alemtuzumab (Campath),2016-08-04,2020-11-05,500,mcg,['/ Week'],IV,Persisting MRI activity
588,2596,Avonex,2016-01-19,,500,mg,['2 / Day'],IV, 
589,2596,D-cure (Vitamine D),2016-02-05,2018-09-26,1, ,[' '],IV,Adverse Event
590,2596,Gilenya,2016-04-08,, ,mg,['/ Week'], , 
591,2596,Gilenya,2016-07-18,,20, ,['3 / Week'],Oral, 
592,472,Tysabri,2015-12-25,2018-03-23,500, ,['2 / Day'], ,Persistence of relapses
593,472,Rebif [22],2016-05-06,2018-09-07,400,mg,['3 / Week'], ,Persistence of relapses
594,472,Endoxan,2016-05-27,2020-05-10,20, ,[' '], ,Persisting MRI activity
595,472,IVIG,2016-09-15,, ,mg,['3 / Week'], , 
596,1960,Tecfidera,2016-03-05,, , ,['2 / Day'],Oral, 
597,1960,Methylprednisolone,2016-06-18,, ,mg,['/ Week'],IV, 
598,1960,IVIG,2015-10-25,2020-08-08,1,mg,['/Month'],IV,Lack of efficacy
599,1960,Rebif [22],2016-03-04,, ,mg,['3 / Week'], , 
600,3246,Gilenya,2016-08-19,2020-01-21,500,mg,['/Month'], ,Persistence of relapses
601,2972,D-cure (Vitamine D),2016-03-22,2018-07-18, , ,['/Month'],IV,Lack of efficacy
602,2972,Tysabri,2016-06-01,, , ,['/Month'],IV, 
603,2972,D-cure (Vitamine D),2016-08-10,,5000,mg,['2 / Day'], , 
604,2972,D-cure (Vitamine D),2016-06-05,, , ,['3 / Week'], , 
605,2629,IVIG,2016-06-25,,400,mg,['/Month'],Oral, 
606,1031,Tecfidera,2016-07-08,,300, ,['2 / Day'],IV, 
607,1031,Rebif [44],2015-12-04,2018-11-09,500,mg,['2 / Day'],IV,Persisting MRI activity
608,2851,Tysabri,2016-05-03,2021-05-16,500,MIU,['3 / Week'],IV,Lack of efficacy
609,2851,D-cure (Vitamine D),2016-03-22,,20, ,['2 / Day'], , 
610,2851,Rebif [44],2015-11-25,,500,MIU,['2 / Day'],IV, 
611,464,Tysabri,2016-04-28,2020-06-14,500,mg,['2 / Day'], ,Persistence of relapses
612,1407,Endoxan,2016-07-19,,1,mg,['/ Day'], , 
613,3288,D-cure (Vitamine D),2016-04-04,2017-11-09, ,mg,['/ Day'],IV,Lack of efficacy
614,3288,Rebif [22],2016-02-03,,300,mg,['/Month'], , 
615,3288,Gilenya,2016-04-12,2018-04-21,1000, ,['/ Week'],IV,Persisting MRI activity
616,1966,D-cure (Vitamine D),2015-11-15,, ,mg,['2 / Day'],IV, 
617,1966,Gilenya,2015-11-10,,500, ,['2 / Day'],Oral, 
618,1966,Copaxone,2016-09-19,2021-03-07,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
619,1449,Ledertrexaat,2016-03-16,,20, ,['/ Day'], , 
620,1449,Copaxone,2016-02-29,2020-11-02, ,mg,['/Month'],IV,Persisting MRI activity
621,1449,Alemtuzumab (Campath),2016-07-19,,1000, ,['/Month'],IV, 
622,1449,Ledertrexaat,2016-07-23,,300,MIU,['/Month'], , 
623,2530,Avonex,2016-02-28,,500,mg,['/Month'],Oral, 
624,2530,Gilenya,2016-07-15,,400, ,['/Month'], , 
625,2530,Rebif [22],2015-12-24,, ,mg,['2 / Day'], , 
626,3813,Alemtuzumab (Campath),2016-10-06,2021-04-06,500,mg,['/ Day'], ,Lack of efficacy
627,3813,Tysabri,2016-04-17,,1000,mg,['3 / Week'],IV, 
628,3206,IVIG,2016-08-30,,300, ,['/Month'], , 
629,3206,IVIG,2016-07-16,2021-05-25, , ,['2 / Day'],IV,Persistence of relapses
630,4706,Endoxan,2015-12-10,,300,MIU,['/ Day'],Oral, 
631,4706,Tysabri,2016-01-03,, , ,['3 / Week'],Oral, 
632,4706,Rebif [44],2016-01-10,2021-07-21,300, ,['3 / Week'], ,Adverse Event
633,2179,Methylprednisolone,2016-08-30,2020-04-08,400,mcg,['/Month'], ,Adverse Event
634,2179,Ledertrexaat,2016-09-06,,1000, ,['3 / Week'], , 
635,2179,Tecfidera,2015-11-18,2021-08-12, , ,['3 / Week'], ,Patient Choice/Convenience
636,3104,D-cure (Vitamine D),2016-01-15,2021-06-07,5000, ,['/ Week'], ,Persisting MRI activity
637,3104,Rebif [44],2015-10-27,2020-10-26, , ,['3 / Week'], ,Persisting MRI activity
638,3104,Tysabri,2016-05-01,2021-03-09,1000,mg,['2 / Day'], ,Patient Choice/Convenience
639,3104,Methylprednisolone,2016-02-12,2019-01-19,20,mg,['/Month'], ,Patient Choice/Convenience
640,3072,Gilenya,2016-04-29,2021-01-07,5000,MIU,['2 / Day'], ,Adverse Event
641,3072,Alemtuzumab (Campath),2016-02-01,2019-03-28,5000, ,['3 / Week'],IV,Adverse Event
642,3072,Alemtuzumab (Campath),2016-08-21,2020-02-11,5000, ,['2 / Day'],IV,Patient Choice/Convenience
643,2214,Mitoxantrone,2016-08-29,2021-06-21, , ,['/Month'],IV,Lack of efficacy
644,4959,D-cure (Vitamine D),2016-03-17,,500,mg,['3 / Week'],IV, 
645,2334,Alemtuzumab (Campath),2016-01-20,,1000,mg,['/Month'],IV, 
646,2334,Avonex,2016-08-04,2019-01-25,20,MIU,['/Month'], ,Patient Choice/Convenience
647,2334,Tysabri,2016-06-28,2020-02-08, , ,['2 / Day'],IV,Lack of efficacy
648,1935,Tecfidera,2016-03-02,2019-09-28,300,mcg,[' '], ,Patient Choice/Convenience
649,1935,Methylprednisolone,2015-12-27,,1000,MIU,['2 / Day'], , 
650,1935,Endoxan,2015-11-30,,500, ,['3 / Week'], , 
651,4424,Gilenya,2016-03-27,, , ,['3 / Week'], , 
652,3483,Rebif [44],2016-08-02,2020-06-12,5000, ,['2 / Day'],IV,Adverse Event
653,3483,Tysabri,2016-02-12,, ,MIU,[' '],IV, 
654,3483,Gilenya,2016-10-21,, ,mg,['2 / Day'],IV, 
655,3483,Mitoxantrone,2016-01-01,2020-12-01,5000,mg,['/Month'], ,Adverse Event
656,209,IVIG,2016-07-16,,20, ,['2 / Day'],IV, 
657,209,Alemtuzumab (Campath),2016-07-03,,1000, ,['2 / Day'], , 
658,209,Betaferon,2016-09-06,2019-08-28,400,mg,['2 / Day'], ,Patient Choice/Convenience
659,209,Rebif [44],2015-11-26,,1,mg,['3 / Week'],IV, 
660,3539,Tecfidera,2016-05-01,,20,mg,[' '],Oral, 
661,3539,IVIG,2016-08-09,,5000,mg,['/ Day'],IV, 
662,3539,Alemtuzumab (Campath),2016-04-21,2019-11-12,20,mg,['/Month'], ,Lack of efficacy
663,3539,Tecfidera,2016-01-30,,1000,mg,['2 / Day'],IV, 
664,112,Ledertrexaat,2016-02-10,,300,mg,['2 / Day'], , 
665,3873,Alemtuzumab (Campath),2016-10-16,,20,mg,['2 / Day'], , 
666,3873,D-cure (Vitamine D),2016-04-16,,400, ,['/Month'],IV, 
667,3873,D-cure (Vitamine D),2016-09-21,, ,mg,['/Month'],IV, 
668,4688,Tecfidera,2016-09-19,, , ,['/Month'], , 
669,4688,IVIG,2016-09-26,,20, ,['/Month'],IV, 
670,4265,Gilenya,2015-10-30,,500, ,['/Month'],IV, 
671,4265,Rebif [22],2016-09-04,2018-11-13,1000,mg,['2 / Day'],IV,Lack of efficacy
672,4265,Avonex,2016-08-07,,300, ,['/Month'],IV, 
673,4265,Methylprednisolone,2016-07-17,2021-09-25,300,mg,['3 / Week'],IV,Persisting MRI activity
674,3030,Tecfidera,2016-03-07,2017-12-21,400, ,['2 / Day'], ,Persisting MRI activity
675,607,Rebif [22],2016-05-12,2018-05-23,400,mg,[' '],Oral,Adverse Event
676,607,Rebif [44],2015-10-28,,5000, ,['2 / Day'],IV, 
677,607,IVIG,2015-11-18,, ,mcg,['/Month'], , 
678,2853,Tysabri,2015-10-26,2021-07-16, ,mg,['/Month'],IV,Adverse Event
679,2853,Avonex,2015-12-14,2018-09-16,500,mg,['2 / Day'], ,Lack of efficacy
680,2853,Rebif [22],2015-12-07,2017-11-19, ,mg,['/Month'],IV,Persisting MRI activity
681,4017,Gilenya,2016-02-27,2018-10-15, ,mg,['3 / Week'],IV,Adverse Event
682,832,D-cure (Vitamine D),2016-09-30,,500,MIU,['2 / Day'], , 
683,832,Copaxone,2016-02-07,,5000, ,['/Month'],IV, 
684,3067,Tysabri,2016-02-29,,1,mg,['/Month'], , 
685,3067,Teriflunomide,2016-09-08,2019-03-20,500,mg,['/ Day'],IV,Adverse Event
686,2861,Tecfidera,2016-01-28,, ,mcg,['/Month'],IV, 
687,2861,D-cure (Vitamine D),2015-12-22,2018-03-27,1,mcg,['2 / Day'],IV,Lack of efficacy
688,230,Alemtuzumab (Campath),2015-11-28,,1000,MIU,['/ Week'],Oral, 
689,230,Tecfidera,2015-12-12,, , ,['/ Week'],IV, 
690,230,Methylprednisolone,2016-09-30,2021-02-01,500,mg,[' '],Oral,Adverse Event
691,3520,Rebif [44],2016-08-29,2019-05-22,5000,mcg,[' '],Oral,Adverse Event
692,3520,Rebif [44],2016-03-05,,1,MIU,['/ Week'],IV, 
693,3520,Endoxan,2016-07-15,,5000,mg,['/Month'], , 
694,3520,Tysabri,2016-06-25,2019-12-11,5000,mg,['2 / Day'], ,Persisting MRI activity
695,792,Rebif [44],2016-03-27,,500, ,['/Month'],IV, 
696,792,Rebif [44],2015-12-18,,400, ,['2 / Day'],IV, 
697,475,Alemtuzumab (Campath),2016-05-08,,1000,mg,['3 / Week'], , 
698,3304,D-cure (Vitamine D),2015-11-21,2021-06-30, , ,['/Month'],IV,Lack of efficacy
699,3336,Betaferon,2016-09-03,2019-10-03,20,mcg,['3 / Week'], ,Lack of efficacy
700,3336,Teriflunomide,2016-07-17,2019-04-10,20,MIU,['/Month'],IV,Persistence of relapses
701,852,Gilenya,2016-07-03,2020-08-10,300, ,['/ Week'],Oral,Adverse Event
702,852,Avonex,2016-08-26,2019-08-19, , ,['/Month'],Oral,Adverse Event
703,852,Ledertrexaat,2016-06-13,, , ,['/Month'], , 
704,387,Alemtuzumab (Campath),2016-10-17,2019-12-12,500,MIU,['/Month'],IV,Persistence of relapses
705,387,Methylprednisolone,2015-11-19,2020-02-16,300,MIU,['2 / Day'], ,Adverse Event
706,1044,Avonex,2016-04-07,2020-11-22,1000, ,['3 / Week'],IV,Persistence of relapses
707,1044,IVIG,2016-06-28,,1, ,['/Month'],IV, 
708,3771,IVIG,2016-06-25,2021-07-18,1,MIU,['/Month'],IV,Persisting MRI activity
709,3771,Rebif [22],2015-12-21,, ,mg,['3 / Week'],IV, 
710,495,Methylprednisolone,2016-01-10,2020-04-15,500,MIU,['/Month'],IV,Patient Choice/Convenience
711,495,Endoxan,2016-02-28,,5000,mg,['/Month'], , 
712,495,IVIG,2016-06-14,2020-05-13, ,mg,['/ Week'],IV,Persisting MRI activity
713,495,Avonex,2016-08-21,,400, ,['/Month'], , 
714,3431,Ledertrexaat,2015-12-03,2021-08-12,300, ,['3 / Week'],IV,Lack of efficacy
715,3431,Gilenya,2016-01-07,,1, ,['/ Day'],IV, 
716,3431,Rebif [44],2015-11-09,2018-03-14,1000,mg,['/ Day'],Oral,Adverse Event
717,3431,Methylprednisolone,2016-03-31,,1, ,['2 / Day'],IV, 
718,3119,Betaferon,2016-08-26,,5000, ,['2 / Day'],IV, 
719,3119,Tysabri,2016-09-07,,1000, ,['/Month'],IV, 
720,490,Endoxan,2015-12-16,2018-01-06,1000,mcg,['2 / Day'],IV,Lack of efficacy
721,490,Rebif [44],2016-05-22,2018-12-14, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
722,490,Avonex,2016-10-22,2019-04-09, ,mg,[' '],IV,Persisting MRI activity
723,490,Teriflunomide,2015-11-20,2021-06-01, , ,['/ Day'],Oral,Lack of efficacy
724,4708,Methylprednisolone,2015-10-27,, ,MIU,['/Month'], , 
725,2123,Endoxan,2016-05-10,,300, ,['/Month'],IV, 
726,2123,Tecfidera,2016-07-08,, ,mcg,['/Month'],IV, 
727,2123,IVIG,2016-03-08,,1000,mg,['2 / Day'],IV, 
728,2123,Ledertrexaat,2016-03-02,,300, ,['/Month'],IV, 
729,836,Gilenya,2015-11-04,2020-06-24, ,mg,['2 / Day'], ,Lack of efficacy
730,836,D-cure (Vitamine D),2016-09-13,2021-09-22,400, ,['2 / Day'], ,Adverse Event
731,729,Gilenya,2016-02-25,2019-03-28,1000, ,['/Month'],IV,Adverse Event
732,3378,Alemtuzumab (Campath),2015-11-12,2018-09-11,5000,mg,['3 / Week'],Oral,Adverse Event
733,3378,Teriflunomide,2016-10-02,2018-06-09,1,mg,['3 / Week'], ,Persistence of relapses
734,731,Tysabri,2016-02-01,, ,mg,['2 / Day'],IV, 
735,731,IVIG,2016-04-08,2020-04-16,20,mg,[' '],IV,Patient Choice/Convenience
736,600,Avonex,2015-10-26,2021-06-30,1, ,['/Month'],IV,Adverse Event
737,600,Teriflunomide,2015-12-31,2019-08-30, ,mg,['/Month'],Oral,Persistence of relapses
738,2824,Methylprednisolone,2016-04-18,2019-07-05,1000,mg,['/Month'],IV,Persistence of relapses
739,2824,Alemtuzumab (Campath),2016-01-08,,300,mg,['/Month'], , 
740,2824,Rebif [44],2016-09-06,2019-12-14,500,mcg,['2 / Day'],IV,Persistence of relapses
741,2824,Mitoxantrone,2016-08-03,,300,mcg,['3 / Week'],IV, 
742,1575,Rebif [44],2016-08-23,,300,mg,['/Month'],IV, 
743,1939,Tysabri,2015-11-05,2020-11-21,1, ,['2 / Day'], ,Adverse Event
744,1939,IVIG,2016-08-03,, ,mg,[' '],IV, 
745,1939,Gilenya,2016-06-21,,1,mg,[' '],IV, 
746,515,Copaxone,2016-09-17,,1000, ,['2 / Day'],IV, 
747,1455,Tecfidera,2016-09-14,2021-03-12, , ,['/ Week'], ,Adverse Event
748,1455,Methylprednisolone,2015-12-18,, ,mg,['3 / Week'], , 
749,4572,Mitoxantrone,2015-10-26,, ,mg,['2 / Day'],IV, 
750,4572,Alemtuzumab (Campath),2016-09-15,,5000, ,['3 / Week'],IV, 
751,683,D-cure (Vitamine D),2016-05-27,, , ,['2 / Day'],IV, 
752,187,Betaferon,2016-09-21,, , ,['2 / Day'], , 
753,187,IVIG,2016-02-07,,1000,mg,['2 / Day'],IV, 
754,187,Ledertrexaat,2016-06-17,,1000,mg,['/Month'], , 
755,3882,Gilenya,2016-07-18,,20,mcg,['/ Day'], , 
756,3882,Alemtuzumab (Campath),2016-01-25,,1000,MIU,['/Month'],IV, 
757,3882,Rebif [44],2016-08-06,2018-01-18,1,mcg,['2 / Day'], ,Adverse Event
758,3882,Alemtuzumab (Campath),2016-07-29,2020-09-08,5000,MIU,['2 / Day'], ,Adverse Event
759,3310,Gilenya,2016-09-26,2019-07-06,20, ,['3 / Week'], ,Lack of efficacy
760,1676,Ledertrexaat,2016-06-14,2021-04-29,400, ,['2 / Day'],IV,Persistence of relapses
761,1676,Betaferon,2016-05-14,2019-11-16,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
762,2868,Alemtuzumab (Campath),2016-05-07,,300,mg,['2 / Day'], , 
763,3727,Endoxan,2015-11-28,2021-01-05, , ,['2 / Day'], ,Adverse Event
764,744,Rebif [44],2016-10-08,,300, ,['2 / Day'], , 
765,744,Tecfidera,2016-09-20,2021-06-08,500, ,['/Month'],IV,Adverse Event
766,744,Tysabri,2016-02-20,2018-11-10,5000, ,['3 / Week'],IV,Patient Choice/Convenience
767,744,Endoxan,2016-08-18,,500,MIU,['2 / Day'],IV, 
768,4596,Rebif [22],2016-03-03,, ,mcg,[' '], , 
769,4596,Ledertrexaat,2016-07-23,,1000, ,['/Month'],IV, 
770,4596,Tecfidera,2016-06-26,, , ,['/ Day'],IV, 
771,1573,Alemtuzumab (Campath),2016-02-04,2018-11-16,1, ,['3 / Week'],Oral,Persistence of relapses
772,1573,D-cure (Vitamine D),2016-08-22,,500, ,['2 / Day'],IV, 
773,4438,Avonex,2016-10-08,, ,MIU,['3 / Week'], , 
774,4438,Mitoxantrone,2016-08-22,2019-04-01, ,mg,[' '], ,Persisting MRI activity
775,4438,Alemtuzumab (Campath),2016-07-11,2021-04-17,300, ,['/Month'],IV,Adverse Event
776,4438,Endoxan,2016-04-23,,1000, ,['/Month'],IV, 
777,1715,Tysabri,2016-06-15,,1000, ,[' '], , 
778,1715,Gilenya,2016-03-28,,400, ,['/Month'],IV, 
779,1715,Gilenya,2016-03-22,,500,mg,['2 / Day'],IV, 
780,4693,Endoxan,2016-07-10,2018-06-04,1,mg,['/Month'], ,Adverse Event
781,4693,Avonex,2016-06-09,, , ,['3 / Week'], , 
782,4693,Ledertrexaat,2016-09-13,,5000,mg,['/Month'],IV, 
783,4693,Tysabri,2016-09-02,2018-01-29,400,mg,[' '], ,Persistence of relapses
784,3824,Alemtuzumab (Campath),2015-12-26,,300,mcg,['/Month'],IV, 
785,3824,Mitoxantrone,2016-04-06,, , ,['/Month'], , 
786,3824,Ledertrexaat,2016-08-01,, , ,[' '],IV, 
787,1190,Rebif [22],2016-08-13,, , ,['2 / Day'],IV, 
788,1190,Rebif [22],2016-01-31,2021-05-20,5000,mg,['2 / Day'],Oral,Persisting MRI activity
789,783,D-cure (Vitamine D),2016-08-28,,1, ,['2 / Day'], , 
790,975,Teriflunomide,2016-05-22,,500,mg,['2 / Day'], , 
791,975,Avonex,2016-01-29,, ,MIU,['2 / Day'],IV, 
792,975,D-cure (Vitamine D),2016-05-08,,1000,mg,['2 / Day'],Oral, 
793,975,Teriflunomide,2016-10-10,,1, ,['2 / Day'],IV, 
794,4870,IVIG,2016-02-01,, , ,['2 / Day'], , 
795,4870,D-cure (Vitamine D),2016-05-02,, , ,['3 / Week'], , 
796,4870,D-cure (Vitamine D),2016-09-23,2018-02-24,500,mg,[' '],Oral,Lack of efficacy
797,4870,Rebif [22],2016-09-01,2020-12-18,5000, ,['3 / Week'], ,Adverse Event
798,3198,Gilenya,2016-01-13,, ,mg,['2 / Day'], , 
799,3586,Avonex,2015-11-18,2021-05-31, ,MIU,['/ Day'],IV,Patient Choice/Convenience
800,3586,IVIG,2015-12-09,2021-06-10, ,MIU,['2 / Day'],Oral,Persisting MRI activity
801,3265,Rebif [44],2016-04-04,,300,mg,['/Month'],IV, 
802,3265,IVIG,2016-05-04,,400,mg,['/Month'],Oral, 
803,3265,Alemtuzumab (Campath),2016-09-06,,300,mg,['/Month'],Oral, 
804,3265,Alemtuzumab (Campath),2016-07-11,2018-01-13,1,mg,['/ Week'],IV,Adverse Event
805,2435,Avonex,2016-06-29,2018-03-01,300,mg,['/Month'], ,Lack of efficacy
806,2435,Tecfidera,2016-02-20,2018-07-09,20,mg,['3 / Week'], ,Adverse Event
807,2435,Copaxone,2016-07-11,,20,mg,['3 / Week'], , 
808,4130,Rebif [22],2015-10-29,,500,mg,['3 / Week'],Oral, 
809,4130,Gilenya,2015-11-27,2021-09-17,20, ,[' '], ,Persistence of relapses
810,4130,Tysabri,2016-05-07,2020-06-08,1, ,['/ Week'],Oral,Persisting MRI activity
811,1853,Endoxan,2016-04-22,,5000,mg,['2 / Day'],IV, 
812,665,Tecfidera,2016-05-19,2018-01-11,1, ,['2 / Day'],Oral,Patient Choice/Convenience
813,665,Methylprednisolone,2016-02-22,2018-01-10,1000,MIU,['2 / Day'],Oral,Persisting MRI activity
814,631,Endoxan,2016-09-27,,5000,mg,['2 / Day'],IV, 
815,631,Methylprednisolone,2016-07-28,, , ,['/Month'],IV, 
816,3638,Betaferon,2016-06-03,2019-08-17, ,MIU,['/ Day'],IV,Adverse Event
817,1626,D-cure (Vitamine D),2015-11-05,2019-06-25, , ,['/Month'],IV,Persisting MRI activity
818,1626,Endoxan,2015-12-26,, ,mg,['/Month'],Oral, 
819,1626,Rebif [44],2016-05-24,,500, ,['/Month'], , 
820,2679,Gilenya,2016-08-15,2021-02-11,5000, ,['3 / Week'],IV,Persisting MRI activity
821,2679,Rebif [22],2016-01-29,,500, ,['/Month'],Oral, 
822,2679,Methylprednisolone,2016-03-09,2020-04-04,500, ,['/ Day'], ,Persistence of relapses
823,208,Methylprednisolone,2016-09-19,, ,mg,['/Month'],IV, 
824,4486,Gilenya,2016-05-23,2018-05-02,5000,mg,[' '], ,Patient Choice/Convenience
825,4486,Gilenya,2016-05-15,, ,mg,['2 / Day'],IV, 
826,4486,Methylprednisolone,2016-09-21,2020-10-02,300,mg,['2 / Day'],IV,Persisting MRI activity
827,3495,Rebif [22],2016-01-23,2019-04-05,1,mg,['2 / Day'],IV,Lack of efficacy
828,3495,Tecfidera,2016-06-29,, ,mcg,['/Month'],Oral, 
829,3177,Rebif [44],2016-09-28,2021-09-26,500, ,['2 / Day'], ,Lack of efficacy
830,3177,Copaxone,2015-11-09,,20,mg,['/Month'],IV, 
831,3177,Endoxan,2016-08-18,2018-11-14,500,mg,['/Month'],IV,Lack of efficacy
832,3177,Rebif [44],2016-05-30,,1000,mg,['3 / Week'], , 
833,2641,Methylprednisolone,2016-04-03,2021-10-22,1, ,['/Month'],IV,Adverse Event
834,2641,Copaxone,2016-02-01,2020-11-25,500, ,[' '],Oral,Patient Choice/Convenience
835,2641,Alemtuzumab (Campath),2016-08-28,,5000,mg,['/Month'], , 
836,4411,Teriflunomide,2016-02-19,2021-06-23, , ,['/Month'],IV,Lack of efficacy
837,4411,Tecfidera,2016-07-01,, , ,['2 / Day'],IV, 
838,4411,IVIG,2015-11-02,,500,MIU,['/Month'],Oral, 
839,4583,Endoxan,2016-04-05,,1,mg,['2 / Day'],IV, 
840,4583,Endoxan,2016-04-23,2019-06-25, ,mg,['/Month'], ,Persisting MRI activity
841,4583,Alemtuzumab (Campath),2016-02-05,2019-04-30,20,mg,['/Month'],IV,Adverse Event
842,4104,Tysabri,2016-06-26,,1000,mg,['/Month'],IV, 
843,4104,Avonex,2016-07-15,2019-03-06,300, ,['3 / Week'],IV,Persistence of relapses
844,4104,Alemtuzumab (Campath),2016-03-08,,1000,mg,['2 / Day'],Oral, 
845,4104,D-cure (Vitamine D),2016-09-23,, ,mg,['3 / Week'], , 
846,3510,Methylprednisolone,2016-06-10,,400,MIU,['3 / Week'], , 
847,3510,Mitoxantrone,2016-01-31,2019-07-25, ,MIU,[' '], ,Adverse Event
848,3510,Avonex,2016-01-31,2018-07-21,500,mg,['/Month'],IV,Persistence of relapses
849,3510,Alemtuzumab (Campath),2015-10-27,2020-01-23,5000,mcg,['/ Day'], ,Lack of efficacy
850,4070,IVIG,2016-07-10,, ,mg,['/Month'],IV, 
851,248,D-cure (Vitamine D),2016-07-19,2020-07-26,500, ,[' '],Oral,Lack of efficacy
852,248,Methylprednisolone,2016-02-19,, ,mg,[' '], , 
853,248,Mitoxantrone,2016-10-07,2018-05-30,1,mg,['/ Day'], ,Lack of efficacy
854,248,Endoxan,2015-12-25,2020-09-09,20, ,['/Month'],IV,Patient Choice/Convenience
855,2379,Tecfidera,2016-08-31,, , ,['3 / Week'],IV, 
856,2379,Ledertrexaat,2016-03-09,2018-03-11,20,mg,['2 / Day'], ,Lack of efficacy
857,1964,Mitoxantrone,2016-04-10,,1000, ,['/ Week'],IV, 
858,4523,Gilenya,2016-07-17,2019-12-20, ,mg,[' '],IV,Persistence of relapses
859,4523,Methylprednisolone,2016-09-29,2018-11-23,20,mg,['/Month'],IV,Adverse Event
860,4523,IVIG,2016-08-30,, ,mg,['2 / Day'],IV, 
861,2602,Methylprednisolone,2016-06-17,,1000, ,['3 / Week'],IV, 
862,2602,Ledertrexaat,2016-09-04,2019-01-22,20,mg,['/ Day'], ,Persisting MRI activity
863,1380,Gilenya,2016-06-03,2021-08-17,1000,mcg,['/Month'],IV,Persisting MRI activity
864,3990,Teriflunomide,2016-07-30,,1,mg,['/ Week'],Oral, 
865,3990,Tecfidera,2016-08-11,,20,mcg,['3 / Week'],IV, 
866,3990,D-cure (Vitamine D),2016-09-19,,300, ,['/Month'], , 
867,412,Rebif [44],2016-05-14,,1000, ,['3 / Week'],Oral, 
868,2219,Tysabri,2016-09-25,, , ,['2 / Day'], , 
869,2219,Copaxone,2015-12-31,,500,mg,['/ Day'],IV, 
870,4899,Ledertrexaat,2016-03-06,2020-08-26,20, ,['/Month'],IV,Persistence of relapses
871,4899,IVIG,2016-01-14,2019-05-31,500,mg,['3 / Week'], ,Patient Choice/Convenience
872,4899,Copaxone,2016-10-11,2018-04-30,400,MIU,['/Month'], ,Adverse Event
873,2706,Tysabri,2015-12-03,2018-03-28,500, ,['2 / Day'], ,Adverse Event
874,2706,Mitoxantrone,2016-08-17,2017-11-07,400,mg,['2 / Day'],IV,Persistence of relapses
875,4346,D-cure (Vitamine D),2016-03-10,2020-11-20,1000,MIU,['/Month'],IV,Persisting MRI activity
876,4346,Copaxone,2016-05-31,2021-08-26, ,mg,['3 / Week'],IV,Patient Choice/Convenience
877,369,Tysabri,2015-11-13,, , ,['/Month'], , 
878,369,IVIG,2016-07-27,2019-11-05, , ,['2 / Day'], ,Persistence of relapses
879,369,Tecfidera,2016-07-13,,20, ,['/Month'], , 
880,1879,Alemtuzumab (Campath),2016-06-21,,1000,mg,['2 / Day'],Oral, 
881,1879,D-cure (Vitamine D),2016-05-24,,1000,mcg,['2 / Day'], , 
882,2582,Rebif [22],2015-12-06,,5000,mg,['/Month'],IV, 
883,2582,Endoxan,2016-10-09,2018-07-06, ,mg,['2 / Day'], ,Persisting MRI activity
884,2582,IVIG,2016-06-20,, ,mg,['2 / Day'],Oral, 
885,2582,Rebif [44],2016-09-29,,20, ,['3 / Week'],IV, 
886,2684,Betaferon,2015-11-01,2021-10-10, ,mg,[' '],IV,Persisting MRI activity
887,2684,Endoxan,2016-06-26,, , ,['/Month'],Oral, 
888,2684,Alemtuzumab (Campath),2016-02-25,2021-03-27,5000,mg,['3 / Week'], ,Adverse Event
889,1950,Tecfidera,2016-06-26,2021-03-17, , ,['/Month'],IV,Adverse Event
890,1950,Endoxan,2016-01-22,2018-10-11,1000,mg,['/ Day'], ,Patient Choice/Convenience
891,1374,Ledertrexaat,2016-01-04,,500,mcg,['/Month'],IV, 
892,1374,Rebif [22],2015-12-16,,20, ,['/Month'], , 
893,1374,IVIG,2016-01-06,2020-04-07,1, ,['2 / Day'], ,Adverse Event
894,1480,Rebif [44],2016-07-06,2020-04-09,500,mcg,['2 / Day'], ,Lack of efficacy
895,1480,Avonex,2016-04-02,,500, ,['/Month'],IV, 
896,1480,Tysabri,2016-09-19,2021-04-26, , ,['/ Day'],IV,Patient Choice/Convenience
897,1480,Alemtuzumab (Campath),2016-09-14,, , ,['2 / Day'],IV, 
898,1132,Gilenya,2016-02-12,2018-09-16,1,mg,['/Month'],IV,Adverse Event
899,1132,Gilenya,2016-03-05,, ,mcg,['/Month'],IV, 
900,1132,Rebif [22],2016-01-09,2018-10-23,1000,mg,['2 / Day'], ,Persistence of relapses
901,1132,IVIG,2016-02-22,2020-02-04,500, ,['/Month'], ,Persisting MRI activity
902,1219,Methylprednisolone,2015-12-19,2018-08-26,500, ,[' '],Oral,Lack of efficacy
903,1219,Betaferon,2016-05-17,,500, ,[' '],Oral, 
904,1569,Tecfidera,2015-11-28,2019-08-24,5000, ,['/Month'], ,Patient Choice/Convenience
905,1569,Mitoxantrone,2016-04-16,,1, ,['3 / Week'],IV, 
906,1569,D-cure (Vitamine D),2015-11-11,, ,mg,['2 / Day'],IV, 
907,1569,Tecfidera,2016-02-29,2020-09-19,5000,MIU,['/Month'], ,Patient Choice/Convenience
908,2051,Teriflunomide,2016-09-24,, ,mg,['2 / Day'], , 
909,2051,Rebif [44],2015-12-05,2020-12-09,1000, ,['2 / Day'],Oral,Persisting MRI activity
910,2373,Methylprednisolone,2016-07-25,,5000,MIU,['/ Day'],IV, 
911,2373,Teriflunomide,2016-03-24,,1,mg,['2 / Day'],Oral, 
912,2373,Gilenya,2016-06-06,2019-08-29, ,mg,[' '],IV,Lack of efficacy
913,2373,D-cure (Vitamine D),2016-02-23,,300,mg,['3 / Week'], , 
914,2638,Tysabri,2016-09-06,,1, ,['/Month'], , 
915,4027,Alemtuzumab (Campath),2015-10-29,, ,mg,['/Month'], , 
916,4027,Rebif [44],2016-10-04,, , ,[' '],IV, 
917,4027,IVIG,2016-10-02,,300,mg,['3 / Week'], , 
918,4027,Endoxan,2016-08-23,2021-03-06, ,mcg,['2 / Day'],Oral,Adverse Event
919,1811,Gilenya,2015-11-03,,1,mg,[' '], , 
920,1811,Copaxone,2016-08-12,,1000, ,['/ Week'], , 
921,1811,Rebif [44],2016-01-16,,300,mg,['/Month'], , 
922,1811,Betaferon,2015-12-20,, ,mg,['2 / Day'],IV, 
923,3681,Alemtuzumab (Campath),2016-02-05,, ,MIU,['3 / Week'], , 
924,3681,Tecfidera,2016-06-15,2020-05-23,400,mg,['2 / Day'], ,Patient Choice/Convenience
925,2752,Copaxone,2016-02-16,2021-05-22,1000,mg,['/Month'],IV,Lack of efficacy
926,2752,Gilenya,2016-08-12,, ,mg,[' '], , 
927,2752,Rebif [44],2016-04-28,2020-11-28, , ,['/Month'],IV,Adverse Event
928,2752,Copaxone,2016-10-14,2019-01-28,400,mg,['3 / Week'],IV,Patient Choice/Convenience
929,443,Copaxone,2016-05-10,2020-04-05,500, ,['/Month'], ,Adverse Event
930,601,Betaferon,2016-05-15,2019-12-18,20,mg,[' '],IV,Persistence of relapses
931,601,Methylprednisolone,2016-08-11,2018-09-15, , ,['/Month'],IV,Adverse Event
932,601,Betaferon,2016-02-22,,5000,mcg,['2 / Day'], , 
933,1695,Betaferon,2016-03-01,2018-10-24,500,mg,['/ Week'],IV,Persistence of relapses
934,1695,Tecfidera,2016-01-16,2021-04-18,20,mg,['2 / Day'], ,Lack of efficacy
935,325,Rebif [22],2015-11-02,2021-02-19,300, ,['2 / Day'],IV,Persistence of relapses
936,2561,D-cure (Vitamine D),2016-02-12,,500,mcg,['2 / Day'],IV, 
937,799,D-cure (Vitamine D),2016-07-12,2019-05-29, ,mg,['2 / Day'],IV,Patient Choice/Convenience
938,4295,Tysabri,2016-10-20,2019-12-30,20,mg,['/Month'], ,Persisting MRI activity
939,3621,Endoxan,2016-05-07,2021-05-22,500, ,['/ Week'],Oral,Adverse Event
940,3621,Betaferon,2016-03-19,2021-06-07,400, ,['/Month'], ,Lack of efficacy
941,583,Betaferon,2016-07-03,,20,MIU,['2 / Day'],Oral, 
942,3021,Copaxone,2016-06-20,2018-10-09, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
943,4072,Betaferon,2016-09-25,, , ,['2 / Day'], , 
944,4072,IVIG,2016-06-03,2018-06-30, , ,['/Month'],Oral,Patient Choice/Convenience
945,4072,Teriflunomide,2015-11-10,,500,mg,['2 / Day'],Oral, 
946,4072,Copaxone,2016-02-11,, ,mg,['2 / Day'], , 
947,1785,Tecfidera,2015-11-23,2017-11-11,1000,mg,['3 / Week'],IV,Adverse Event
948,1785,Alemtuzumab (Campath),2016-02-18,,1,mg,['/Month'], , 
949,1785,Teriflunomide,2016-01-03,,300,mg,['2 / Day'],IV, 
950,1785,Gilenya,2016-05-24,,1000, ,['2 / Day'], , 
951,3991,Avonex,2016-08-02,,300,mg,['3 / Week'],IV, 
952,3991,Teriflunomide,2016-03-04,,1,mg,[' '], , 
953,3991,D-cure (Vitamine D),2016-08-10,2018-11-12, ,mg,['2 / Day'], ,Patient Choice/Convenience
954,335,Copaxone,2015-11-29,2021-08-03,300, ,['3 / Week'], ,Adverse Event
955,4548,Rebif [44],2016-07-05,,5000,mg,['/Month'],IV, 
956,2215,Tysabri,2016-01-15,2020-05-29, , ,['3 / Week'],IV,Lack of efficacy
957,2215,Ledertrexaat,2016-05-17,, ,MIU,['/ Week'], , 
958,2215,Alemtuzumab (Campath),2015-12-19,2017-11-27,20,mg,['2 / Day'],Oral,Adverse Event
959,2098,Tecfidera,2015-11-06,2018-02-14,5000,MIU,['2 / Day'],Oral,Patient Choice/Convenience
960,2098,D-cure (Vitamine D),2016-02-20,, , ,['2 / Day'],IV, 
961,1538,Copaxone,2016-05-19,2019-07-15, , ,['/ Day'],IV,Adverse Event
962,1538,Ledertrexaat,2016-08-12,,1,mcg,['/Month'],IV, 
963,1538,Mitoxantrone,2015-11-23,, ,MIU,['3 / Week'], , 
964,3361,Mitoxantrone,2015-12-31,,300, ,['/Month'], , 
965,3361,Ledertrexaat,2015-11-21,,1, ,['/Month'],IV, 
966,3361,D-cure (Vitamine D),2015-12-16,,500,mg,['2 / Day'],IV, 
967,1730,Endoxan,2016-02-12,, ,mg,['/Month'],IV, 
968,1474,Endoxan,2016-03-10,2017-12-01, ,mg,['/ Week'],IV,Adverse Event
969,1474,Tecfidera,2016-07-02,2021-01-26,300, ,['3 / Week'],Oral,Patient Choice/Convenience
970,3585,Methylprednisolone,2016-09-24,,400,mcg,['2 / Day'],IV, 
971,1785,Methylprednisolone,2016-09-12,,5000, ,[' '],IV, 
972,2135,Teriflunomide,2016-03-14,, ,mg,['2 / Day'],Oral, 
973,2682,IVIG,2016-10-04,2019-07-22, ,MIU,['/Month'],IV,Persisting MRI activity
974,2682,Rebif [44],2016-10-17,,20,mg,['/ Day'],IV, 
975,2682,Rebif [44],2016-03-11,,500,mg,['2 / Day'], , 
976,2867,Rebif [44],2016-01-12,,1,mg,['2 / Day'],IV, 
977,2886,Endoxan,2016-08-05,2019-08-24, , ,['/Month'], ,Lack of efficacy
978,341,Rebif [22],2016-03-30,2018-07-29, , ,['2 / Day'], ,Lack of efficacy
979,341,Tecfidera,2015-12-10,2020-04-01,1000, ,['2 / Day'],IV,Adverse Event
980,341,Ledertrexaat,2015-12-25,2020-02-26,1,mg,[' '], ,Patient Choice/Convenience
981,1044,Tecfidera,2016-09-28,2017-12-09,1,mg,['2 / Day'], ,Lack of efficacy
982,1044,Gilenya,2016-07-12,2018-04-28, ,mg,['2 / Day'], ,Adverse Event
983,1044,Methylprednisolone,2016-04-09,2020-10-24,1, ,['/Month'],IV,Persisting MRI activity
984,529,Avonex,2016-07-14,2021-06-23,400, ,['2 / Day'], ,Persisting MRI activity
985,529,Endoxan,2016-06-09,, , ,['3 / Week'],IV, 
986,529,Tysabri,2015-12-20,,300,mg,['2 / Day'], , 
987,529,Rebif [22],2016-10-19,2019-09-22,500,mg,['2 / Day'],IV,Persisting MRI activity
988,4864,Gilenya,2016-08-26,2021-10-01,5000,mcg,['2 / Day'],Oral,Patient Choice/Convenience
989,2425,D-cure (Vitamine D),2016-01-22,, ,MIU,['/ Week'],Oral, 
990,2425,IVIG,2016-07-05,,500, ,['2 / Day'],IV, 
991,2425,D-cure (Vitamine D),2016-05-29,2020-10-07,400, ,['/ Day'], ,Adverse Event
992,2826,Tecfidera,2016-03-19,2021-05-23, , ,['/Month'], ,Persisting MRI activity
993,3683,Alemtuzumab (Campath),2016-07-22,,500,mg,[' '], , 
994,4569,Gilenya,2016-06-11,2017-11-13,500,mcg,['/Month'],IV,Lack of efficacy
995,4569,Betaferon,2016-02-06,2018-02-22,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
996,3204,Alemtuzumab (Campath),2016-03-04,,1, ,['/Month'],IV, 
997,4171,IVIG,2016-09-05,,5000, ,['2 / Day'],IV, 
998,4171,Rebif [44],2016-09-26,,400,mcg,['2 / Day'],IV, 
999,4171,Gilenya,2016-07-15,, , ,['/Month'],IV, 
1000,4171,Mitoxantrone,2016-07-06,,20, ,['/Month'],IV, 
1001,3023,IVIG,2016-01-29,2019-02-17,5000,mg,['3 / Week'],IV,Adverse Event
1002,3023,Alemtuzumab (Campath),2016-04-30,, , ,[' '],IV, 
1003,3023,IVIG,2016-03-28,2021-01-29,1, ,['2 / Day'], ,Adverse Event
1004,2669,Endoxan,2016-08-13,, ,mg,[' '],IV, 
1005,2669,Betaferon,2016-01-19,2018-06-01,20, ,['/ Day'],IV,Persisting MRI activity
1006,371,Tysabri,2016-05-16,2019-12-21,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
1007,371,Methylprednisolone,2015-12-26,,1000, ,['2 / Day'], , 
1008,371,Betaferon,2016-08-06,2021-10-07,1,mg,['/Month'],IV,Adverse Event
1009,371,Tysabri,2016-08-10,2021-10-18,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
1010,1562,Gilenya,2016-10-09,, , ,['3 / Week'], , 
1011,1562,Methylprednisolone,2016-04-26,,20, ,['/Month'], , 
1012,1562,Tysabri,2016-01-06,, , ,['/Month'],Oral, 
1013,3834,Tysabri,2016-01-21,2019-06-04, , ,['3 / Week'],Oral,Adverse Event
1014,3221,Alemtuzumab (Campath),2016-02-08,2021-06-28,300, ,['2 / Day'],IV,Adverse Event
1015,3221,Teriflunomide,2015-11-27,2021-03-26,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
1016,2518,Avonex,2016-07-27,,1000, ,['/Month'],Oral, 
1017,2518,Tysabri,2015-11-02,2019-04-24,500,mg,['/Month'], ,Lack of efficacy
1018,2518,D-cure (Vitamine D),2016-05-19,, , ,['2 / Day'],IV, 
1019,3021,Rebif [22],2016-05-05,2021-05-21, , ,['/ Day'],IV,Persistence of relapses
1020,3021,D-cure (Vitamine D),2016-02-08,2019-08-01, , ,['2 / Day'],Oral,Patient Choice/Convenience
1021,3021,Tysabri,2016-08-02,, ,MIU,['/Month'], , 
1022,3021,D-cure (Vitamine D),2016-03-31,2018-05-12, ,mg,[' '], ,Adverse Event
1023,4383,Copaxone,2016-10-20,2018-12-22,1,mg,['/Month'],IV,Patient Choice/Convenience
1024,1460,Tecfidera,2016-09-06,,5000, ,[' '],IV, 
1025,1460,Tysabri,2016-04-08,, , ,['/ Day'], , 
1026,1460,Alemtuzumab (Campath),2016-04-24,,500,MIU,['2 / Day'],IV, 
1027,1460,Ledertrexaat,2016-05-17,2019-09-08,500,mg,['/ Day'], ,Adverse Event
1028,459,IVIG,2015-11-20,2019-09-25,500,mg,['/Month'],IV,Adverse Event
1029,459,Tecfidera,2016-09-20,, ,mcg,['2 / Day'],IV, 
1030,4311,Rebif [44],2016-01-18,, ,mg,['3 / Week'], , 
1031,3235,Methylprednisolone,2016-09-08,2020-02-08,500,mg,['3 / Week'], ,Adverse Event
1032,3235,Tysabri,2016-03-07,,1,MIU,['2 / Day'], , 
1033,3235,Alemtuzumab (Campath),2016-03-29,, ,MIU,['/Month'],IV, 
1034,3235,Copaxone,2016-03-25,, ,mg,['/ Week'],IV, 
1035,1027,Tysabri,2016-05-17,, ,MIU,['/Month'],Oral, 
1036,1027,Mitoxantrone,2016-05-20,, , ,['3 / Week'],Oral, 
1037,1027,Endoxan,2016-04-20,,300,mg,['/Month'], , 
1038,1027,Alemtuzumab (Campath),2016-09-29,,20,mg,['2 / Day'],IV, 
1039,1897,Ledertrexaat,2016-01-26,2021-03-18,1000,MIU,['2 / Day'], ,Lack of efficacy
1040,1897,Rebif [22],2016-05-09,,20,mg,['/Month'],Oral, 
1041,1897,Copaxone,2016-04-26,2019-09-20,5000, ,['2 / Day'],IV,Adverse Event
1042,1897,Rebif [22],2016-04-21,,5000, ,['/ Day'], , 
1043,809,Rebif [22],2016-05-17,,20, ,['3 / Week'],IV, 
1044,809,Tecfidera,2016-08-26,,5000,mg,['2 / Day'],IV, 
1045,376,Gilenya,2015-11-27,, , ,['/Month'], , 
1046,376,Tysabri,2016-06-26,2020-08-05,400,mg,['/ Week'],IV,Lack of efficacy
1047,1261,Mitoxantrone,2016-01-29,2020-09-24,20,mg,['/Month'],IV,Lack of efficacy
1048,1261,Endoxan,2015-11-11,2020-08-03,300,mg,['2 / Day'],Oral,Lack of efficacy
1049,4089,Methylprednisolone,2016-08-16,, , ,['2 / Day'], , 
1050,4089,Copaxone,2015-11-22,,400, ,['2 / Day'],Oral, 
1051,4089,D-cure (Vitamine D),2016-08-26,2021-09-03,1,mg,['/Month'], ,Persisting MRI activity
1052,2357,Endoxan,2016-02-05,, ,mg,[' '],IV, 
1053,3497,Gilenya,2015-11-25,,1000,mcg,['2 / Day'], , 
1054,3497,D-cure (Vitamine D),2016-05-01,2021-05-29,1000,mg,['2 / Day'], ,Lack of efficacy
1055,3497,Endoxan,2016-06-05,2019-09-19,500, ,['2 / Day'], ,Adverse Event
1056,3497,Copaxone,2016-10-03,2018-03-31,20,MIU,['/ Day'], ,Adverse Event
1057,4522,Rebif [22],2016-02-15,2018-07-04,1,mg,['2 / Day'],IV,Patient Choice/Convenience
1058,991,Rebif [22],2016-10-16,, ,mg,['/ Week'], , 
1059,1882,Rebif [44],2016-10-22,,5000,mg,['2 / Day'],Oral, 
1060,1882,Rebif [22],2016-05-07,2021-01-08, ,mg,['/Month'],Oral,Persisting MRI activity
1061,1882,Alemtuzumab (Campath),2015-11-01,,1, ,['2 / Day'], , 
1062,2331,D-cure (Vitamine D),2016-04-11,2020-02-14,1, ,['2 / Day'], ,Adverse Event
1063,4284,Methylprednisolone,2016-01-11,, , ,['/ Week'], , 
1064,4284,D-cure (Vitamine D),2015-12-01,,1,mg,['2 / Day'],Oral, 
1065,4284,D-cure (Vitamine D),2016-09-02,2019-04-03,1, ,['3 / Week'],IV,Persisting MRI activity
1066,4284,Rebif [22],2016-02-18,,20, ,['/Month'], , 
1067,3154,Methylprednisolone,2016-01-26,2020-07-24,300,mcg,['/ Week'], ,Adverse Event
1068,3154,Teriflunomide,2015-12-25,2018-12-06,1000, ,['3 / Week'], ,Persisting MRI activity
1069,3154,Rebif [44],2016-08-19,2018-06-19,1000,mg,['3 / Week'], ,Persistence of relapses
1070,3154,Avonex,2016-01-13,,500, ,['3 / Week'],IV, 
1071,1921,Betaferon,2016-05-16,2019-05-19,5000, ,['3 / Week'],Oral,Lack of efficacy
1072,2071,Alemtuzumab (Campath),2016-02-14,2019-04-27,1000,mg,['3 / Week'], ,Persistence of relapses
1073,2071,Avonex,2016-05-23,2021-03-10, ,mg,['2 / Day'], ,Adverse Event
1074,2071,Copaxone,2016-03-19,, , ,['2 / Day'],IV, 
1075,1451,Ledertrexaat,2016-09-09,,300, ,['/ Day'],Oral, 
1076,1451,Rebif [44],2016-01-03,2020-09-12, ,mcg,['2 / Day'], ,Patient Choice/Convenience
1077,1451,Gilenya,2015-11-30,2021-05-06, , ,['3 / Week'],IV,Patient Choice/Convenience
1078,1451,D-cure (Vitamine D),2016-01-19,2019-01-12, , ,['2 / Day'],Oral,Persisting MRI activity
1079,4880,Alemtuzumab (Campath),2016-05-27,,400,mcg,[' '], , 
1080,4880,Rebif [22],2016-02-22,, ,mg,['/Month'],IV, 
1081,4880,IVIG,2016-01-30,,300,mg,['2 / Day'],IV, 
1082,1906,Copaxone,2015-12-11,,1, ,['2 / Day'],IV, 
1083,1906,Endoxan,2016-06-06,, ,MIU,['/ Day'], , 
1084,1906,Tecfidera,2016-04-10,,500, ,['3 / Week'],Oral, 
1085,3577,Rebif [44],2016-06-06,,20, ,['/Month'],IV, 
1086,3577,Methylprednisolone,2016-05-08,, , ,['2 / Day'],Oral, 
1087,3577,Gilenya,2015-11-16,,300,mg,['/Month'],IV, 
1088,2310,Endoxan,2016-03-28,2021-03-17, ,mg,['3 / Week'], ,Adverse Event
1089,1141,Rebif [22],2016-10-15,2019-12-26,1000,mg,['/Month'], ,Adverse Event
1090,1141,IVIG,2016-03-07,,5000,mg,['/Month'], , 
1091,1141,Teriflunomide,2016-02-26,,20, ,['/Month'],IV, 
1092,347,Ledertrexaat,2016-10-20,2019-03-01, ,mcg,['/ Week'],IV,Adverse Event
1093,347,IVIG,2015-12-07,, ,mcg,[' '],IV, 
1094,539,Methylprednisolone,2016-02-06,, ,mg,['/Month'],IV, 
1095,539,Gilenya,2016-03-10,2021-06-20, ,mcg,['/ Day'],IV,Adverse Event
1096,539,Endoxan,2016-09-03,,500,mg,['2 / Day'],IV, 
1097,4845,Rebif [44],2015-11-20,2021-06-16,5000, ,['3 / Week'], ,Patient Choice/Convenience
1098,4845,Rebif [44],2016-06-09,2021-09-05,300,mcg,['/ Week'],IV,Lack of efficacy
1099,2654,IVIG,2015-12-19,2019-09-18, , ,['2 / Day'],IV,Persisting MRI activity
1100,2654,Mitoxantrone,2016-08-03,2021-01-25,1000,mg,['/Month'],Oral,Lack of efficacy
1101,2654,IVIG,2016-04-28,, ,mg,['/ Week'], , 
1102,2620,Rebif [22],2016-07-01,,1000, ,['3 / Week'], , 
1103,2620,D-cure (Vitamine D),2016-03-04,,1000,mg,['/Month'], , 
1104,2197,Rebif [44],2016-09-16,, , ,['/Month'],IV, 
1105,2197,Endoxan,2016-06-19,2019-06-10, , ,['/Month'], ,Persisting MRI activity
1106,993,Avonex,2016-03-20,2021-08-30,400,mcg,['2 / Day'],IV,Adverse Event
1107,993,IVIG,2016-01-07,, ,mg,['/Month'],IV, 
1108,2567,Endoxan,2016-06-30,2021-04-23,1000,mg,['2 / Day'], ,Adverse Event
1109,2567,Rebif [44],2016-05-11,2021-06-08,400, ,['2 / Day'],IV,Adverse Event
1110,2567,Endoxan,2016-01-29,2020-05-14, , ,['3 / Week'],Oral,Adverse Event
1111,4050,Tecfidera,2016-05-11,,1,MIU,['2 / Day'],IV, 
1112,3850,Endoxan,2016-10-16,, ,mg,['3 / Week'],IV, 
1113,3850,D-cure (Vitamine D),2016-02-20,2021-08-30,1000,mg,['/Month'], ,Lack of efficacy
1114,3850,IVIG,2016-07-16,2020-10-11,1000,mg,[' '],Oral,Patient Choice/Convenience
1115,2085,Endoxan,2016-01-29,, ,mg,[' '],IV, 
1116,3060,IVIG,2016-01-02,,500,MIU,['2 / Day'], , 
1117,3060,Endoxan,2016-04-24,2020-05-20, ,MIU,['/Month'],IV,Adverse Event
1118,4264,Endoxan,2016-06-07,, ,mg,['3 / Week'], , 
1119,4264,D-cure (Vitamine D),2015-12-13,, ,mcg,['3 / Week'], , 
1120,4264,Methylprednisolone,2016-03-18,2018-06-03, ,mg,['/Month'],IV,Lack of efficacy
1121,4264,Mitoxantrone,2015-11-25,2021-06-13,500,mg,['/ Week'], ,Patient Choice/Convenience
1122,4828,Rebif [22],2016-01-25,, ,mcg,['2 / Day'],IV, 
1123,4828,Tysabri,2016-03-18,2020-09-22,1,mg,[' '],IV,Persistence of relapses
1124,2308,Ledertrexaat,2016-04-05,,5000,mg,['2 / Day'], , 
1125,2308,Gilenya,2016-10-20,2019-02-26, ,mg,['2 / Day'],Oral,Persistence of relapses
1126,2308,Rebif [44],2016-01-07,2019-10-29,5000,mg,[' '], ,Adverse Event
1127,1041,Alemtuzumab (Campath),2016-09-11,2020-09-13, , ,['/ Week'],Oral,Persisting MRI activity
1128,1041,Mitoxantrone,2016-09-08,,500,mg,['/ Day'],Oral, 
1129,1041,Tysabri,2016-04-28,2018-10-06, ,mg,['3 / Week'],IV,Patient Choice/Convenience
1130,1041,Betaferon,2016-07-02,,5000, ,['/Month'], , 
1131,1958,Avonex,2016-10-11,, ,mcg,['2 / Day'],IV, 
1132,1416,Alemtuzumab (Campath),2016-03-14,,20,mcg,['3 / Week'], , 
1133,1569,Endoxan,2015-11-04,, , ,[' '],IV, 
1134,2166,Rebif [22],2016-02-14,,400, ,['2 / Day'],IV, 
1135,2166,Methylprednisolone,2016-04-05,,300,MIU,['2 / Day'],IV, 
1136,2166,Rebif [22],2016-07-23,, ,mg,['/Month'],Oral, 
1137,2166,Alemtuzumab (Campath),2016-07-14,2020-04-04, , ,['2 / Day'], ,Lack of efficacy
1138,2488,Copaxone,2016-06-01,2017-10-30, ,mg,['/Month'], ,Patient Choice/Convenience
1139,2488,Methylprednisolone,2015-12-16,2020-06-16,1000, ,['/ Day'],IV,Adverse Event
1140,2488,D-cure (Vitamine D),2016-05-17,,1000, ,[' '],IV, 
1141,2488,D-cure (Vitamine D),2016-10-19,2020-08-20, , ,['/Month'],Oral,Adverse Event
1142,781,Rebif [22],2016-05-04,2019-12-04,400,mg,['/Month'], ,Persisting MRI activity
1143,781,Tysabri,2016-07-21,,5000, ,['/Month'],IV, 
1144,781,Avonex,2016-08-06,,300, ,['3 / Week'],IV, 
1145,2156,Methylprednisolone,2016-04-02,, , ,['3 / Week'],IV, 
1146,2156,Tysabri,2015-12-14,, ,mg,[' '], , 
1147,2559,IVIG,2016-10-12,,1000,mg,['/Month'],Oral, 
1148,1353,Endoxan,2016-05-12,2021-08-08,400,mg,['/Month'],IV,Adverse Event
1149,2515,Tysabri,2016-08-09,2019-01-10,1, ,['/ Week'],Oral,Adverse Event
1150,2138,Copaxone,2016-07-22,2020-10-15,500, ,[' '],IV,Lack of efficacy
1151,2138,Methylprednisolone,2016-10-01,,1000,mg,['2 / Day'], , 
1152,2138,Copaxone,2016-08-16,, , ,['/Month'],IV, 
1153,2138,Teriflunomide,2015-10-31,2020-04-29, , ,['/Month'],Oral,Adverse Event
1154,405,Gilenya,2016-05-22,,1000,MIU,['/Month'], , 
1155,405,Gilenya,2016-08-02,2019-01-05,20,mg,['/Month'],IV,Adverse Event
1156,405,Ledertrexaat,2016-07-21,,5000,mg,['2 / Day'], , 
1157,405,Tysabri,2016-05-28,2021-09-05,500, ,['3 / Week'], ,Patient Choice/Convenience
1158,1022,Ledertrexaat,2016-03-29,,5000,mg,['/Month'],IV, 
1159,1022,Copaxone,2016-01-12,,500,mg,['/ Day'],Oral, 
1160,1022,Rebif [44],2016-10-16,2019-08-11,5000,mg,['/ Day'],Oral,Patient Choice/Convenience
1161,4327,Mitoxantrone,2016-05-07,2020-09-09,400,mg,['3 / Week'], ,Persisting MRI activity
1162,4327,Tysabri,2015-11-15,,20,mg,['2 / Day'], , 
1163,4327,Rebif [44],2016-03-20,,5000,mcg,['2 / Day'],Oral, 
1164,3634,Mitoxantrone,2016-05-26,,1000,mg,['/ Week'],IV, 
1165,868,Betaferon,2016-10-11,2021-10-06,300,mg,['3 / Week'],IV,Patient Choice/Convenience
1166,868,Gilenya,2015-12-12,,500,MIU,['2 / Day'],IV, 
1167,868,IVIG,2016-07-07,,500, ,['2 / Day'],IV, 
1168,868,Tysabri,2016-03-29,,1000,mg,['3 / Week'],IV, 
1169,2776,Tysabri,2016-07-29,,1,mcg,[' '],IV, 
1170,4390,Alemtuzumab (Campath),2016-09-03,,1000, ,['2 / Day'],IV, 
1171,4390,Rebif [44],2016-01-10,2017-11-08,5000,mg,['/Month'], ,Persisting MRI activity
1172,4390,Endoxan,2016-02-24,, ,mcg,['2 / Day'],IV, 
1173,4390,Copaxone,2015-12-24,,400,mg,['/ Day'],IV, 
1174,1482,IVIG,2015-12-23,2020-07-08,400, ,['/ Week'],IV,Adverse Event
1175,3712,Teriflunomide,2016-06-03,,400, ,['/Month'], , 
1176,4910,Endoxan,2016-04-16,,5000,mcg,['3 / Week'],IV, 
1177,2622,Endoxan,2016-03-15,, ,mg,['/Month'],IV, 
1178,2622,Copaxone,2016-04-01,2019-04-02, ,mg,['2 / Day'], ,Lack of efficacy
1179,2622,IVIG,2016-01-20,2021-04-21,1, ,['/Month'], ,Patient Choice/Convenience
1180,2622,D-cure (Vitamine D),2016-02-29,2018-10-21,300, ,['/Month'],IV,Persisting MRI activity
1181,362,Copaxone,2016-04-21,, ,mg,['2 / Day'], , 
1182,362,Avonex,2016-03-27,,5000,mcg,[' '],IV, 
1183,362,Alemtuzumab (Campath),2016-07-17,2018-12-18,5000,mg,['3 / Week'], ,Patient Choice/Convenience
1184,2906,D-cure (Vitamine D),2016-08-04,2018-01-04,1000,mg,['2 / Day'], ,Lack of efficacy
1185,2906,Gilenya,2016-05-08,,20,MIU,['2 / Day'], , 
1186,2906,Alemtuzumab (Campath),2016-05-01,, ,mg,['/ Day'],IV, 
1187,2622,Rebif [44],2016-04-06,,20,mcg,['/Month'], , 
1188,1910,Mitoxantrone,2015-11-28,, , ,['/Month'],IV, 
1189,1910,Gilenya,2016-07-08,,1,MIU,['3 / Week'],Oral, 
1190,1910,Gilenya,2016-05-06,,300,mg,['2 / Day'],IV, 
1191,1910,Gilenya,2016-09-04,, , ,['2 / Day'],IV, 
1192,4429,Tysabri,2016-02-03,,5000, ,['/Month'],IV, 
1193,4429,Betaferon,2016-09-23,2018-03-10,500,mg,['2 / Day'],Oral,Patient Choice/Convenience
1194,3674,Gilenya,2015-12-07,2019-11-25, ,mg,['3 / Week'],Oral,Persistence of relapses
1195,4588,Mitoxantrone,2016-09-28,,300, ,['2 / Day'],Oral, 
1196,4588,Tysabri,2016-04-19,2021-06-28,1000, ,['2 / Day'], ,Patient Choice/Convenience
1197,2927,Ledertrexaat,2015-12-24,,300,MIU,['2 / Day'],IV, 
1198,2927,Tecfidera,2016-02-19,,500,mg,['/Month'],Oral, 
1199,1687,Endoxan,2016-09-30,, , ,['3 / Week'],IV, 
1200,1687,Tecfidera,2016-04-17,,300, ,['/Month'],Oral, 
1201,560,Endoxan,2016-09-15,2018-09-23,500,MIU,['/Month'], ,Lack of efficacy
1202,560,Rebif [22],2016-09-05,,5000,mg,['2 / Day'],IV, 
1203,1925,Alemtuzumab (Campath),2016-01-06,,1000, ,['3 / Week'],IV, 
1204,1925,Rebif [44],2016-07-21,2017-12-13,400, ,['/ Day'],Oral,Adverse Event
1205,1925,Tecfidera,2015-12-18,, , ,['3 / Week'], , 
1206,2704,Gilenya,2016-07-06,2021-02-27,400, ,['/ Week'], ,Patient Choice/Convenience
1207,2704,IVIG,2016-06-19,,20,mg,['/Month'], , 
1208,2476,Ledertrexaat,2015-11-10,,300,mg,['/Month'],IV, 
1209,2476,Tysabri,2016-07-22,,1000, ,['/Month'], , 
1210,2476,Betaferon,2016-06-08,,500,mg,['/Month'], , 
1211,2476,Methylprednisolone,2016-07-19,2019-04-16,300,mg,['/Month'], ,Lack of efficacy
1212,239,Endoxan,2016-09-29,, ,mg,['/Month'],Oral, 
1213,239,Tecfidera,2016-04-18,,1000,mg,['2 / Day'],IV, 
1214,239,IVIG,2016-02-06,, ,mg,['/Month'],IV, 
1215,239,IVIG,2016-05-18,,1000,mg,['/Month'], , 
1216,2340,Avonex,2015-11-03,,1000,mcg,['/Month'],Oral, 
1217,2340,Copaxone,2015-12-24,,1000, ,[' '],IV, 
1218,2340,Avonex,2016-09-24,,1000,mg,['/Month'],IV, 
1219,1957,Ledertrexaat,2016-06-17,, ,mg,['/Month'],Oral, 
1220,1957,Rebif [22],2016-05-13,2018-02-13,20, ,['2 / Day'], ,Adverse Event
1221,1957,Mitoxantrone,2015-11-11,, , ,['/Month'], , 
1222,2510,Copaxone,2015-12-18,, ,mg,['2 / Day'], , 
1223,2510,Rebif [22],2015-11-03,, ,mg,['/Month'],IV, 
1224,2510,Rebif [44],2016-02-01,2018-06-16,1000, ,['2 / Day'], ,Persistence of relapses
1225,861,Avonex,2016-07-19,, ,mg,['3 / Week'],IV, 
1226,1280,Copaxone,2016-01-31,2020-02-01, ,MIU,['2 / Day'],IV,Lack of efficacy
1227,1280,Methylprednisolone,2016-01-06,2020-04-06,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
1228,4841,Rebif [44],2016-01-02,2018-09-26,400, ,['/ Day'], ,Patient Choice/Convenience
1229,4841,Avonex,2016-07-28,2021-04-06, , ,['/ Week'], ,Persisting MRI activity
1230,841,Copaxone,2016-09-02,, ,mg,['/Month'], , 
1231,841,Copaxone,2016-01-22,,1,mg,['3 / Week'],IV, 
1232,560,Rebif [22],2016-05-07,,1,mg,['/ Day'],IV, 
1233,560,Rebif [22],2016-09-22,2018-05-06, ,mg,['3 / Week'],IV,Lack of efficacy
1234,560,Rebif [44],2016-06-04,2017-12-28,300,mg,['3 / Week'],IV,Adverse Event
1235,560,Copaxone,2015-10-25,, ,MIU,['/ Week'],IV, 
1236,1218,Tysabri,2015-11-07,2018-02-12,500,mg,['/Month'], ,Lack of efficacy
1237,1218,IVIG,2016-06-26,2021-02-04, ,mg,['2 / Day'],IV,Adverse Event
1238,1218,Endoxan,2016-03-06,,20,mg,['/Month'],Oral, 
1239,1043,Ledertrexaat,2015-11-24,,1,mg,['/Month'],IV, 
1240,1043,Alemtuzumab (Campath),2016-04-28,,500,MIU,['3 / Week'], , 
1241,1043,IVIG,2015-12-17,2019-03-20,300,mg,['3 / Week'],IV,Patient Choice/Convenience
1242,1043,Tecfidera,2016-08-26,, ,mcg,['2 / Day'],IV, 
1243,690,Tecfidera,2016-08-18,2019-03-22, ,MIU,['/Month'],IV,Adverse Event
1244,2849,Ledertrexaat,2015-12-22,,400, ,['/Month'],Oral, 
1245,2849,Tecfidera,2016-09-15,2021-06-02,400, ,['3 / Week'],IV,Adverse Event
1246,2849,Avonex,2016-09-16,2018-09-23,1000,MIU,['/Month'], ,Persisting MRI activity
1247,2849,Mitoxantrone,2016-01-21,,1,mg,['3 / Week'],IV, 
1248,1690,Copaxone,2016-01-24,2021-06-12, , ,['2 / Day'], ,Adverse Event
1249,2492,Ledertrexaat,2016-06-09,2018-08-25,400,mg,['/Month'], ,Adverse Event
1250,3191,Methylprednisolone,2016-01-10,2021-02-10,5000, ,['3 / Week'], ,Adverse Event
1251,3191,Gilenya,2015-11-29,,1000,MIU,[' '],IV, 
1252,2364,IVIG,2016-02-03,,1000, ,['2 / Day'],IV, 
1253,4916,Gilenya,2016-09-03,,20,mg,['/Month'], , 
1254,4916,Endoxan,2016-03-29,2021-01-18,500, ,['2 / Day'], ,Adverse Event
1255,4916,D-cure (Vitamine D),2016-01-25,,20,mg,['2 / Day'], , 
1256,1108,Tecfidera,2016-03-15,2017-11-08,1000, ,[' '],IV,Adverse Event
1257,1108,Rebif [22],2016-05-14,,20,MIU,['/Month'], , 
1258,3496,Alemtuzumab (Campath),2015-11-13,,1000, ,['/ Day'],IV, 
1259,3496,Rebif [44],2015-10-31,2019-11-30,1000, ,['2 / Day'],Oral,Adverse Event
1260,3496,Avonex,2016-04-02,,300, ,['/Month'],Oral, 
1261,3496,Rebif [22],2016-08-02,2021-06-10,5000,mg,['/ Week'],IV,Lack of efficacy
1262,2146,Methylprednisolone,2016-06-13,2021-09-13, ,mg,[' '], ,Lack of efficacy
1263,2146,Tecfidera,2016-10-07,, ,MIU,['3 / Week'],IV, 
1264,2146,IVIG,2015-11-25,2020-07-21,1000,mcg,['/ Day'],IV,Persisting MRI activity
1265,2146,Methylprednisolone,2016-07-11,,1000, ,['/Month'],IV, 
1266,4428,Teriflunomide,2016-01-25,,20,mg,[' '],IV, 
1267,1105,Mitoxantrone,2016-03-30,,5000,mg,['2 / Day'],IV, 
1268,321,D-cure (Vitamine D),2016-04-12,,20,mg,['/Month'],IV, 
1269,1363,Teriflunomide,2016-03-09,,500, ,[' '],IV, 
1270,2894,Rebif [44],2016-08-25,2018-04-05, ,mg,['/Month'],IV,Persisting MRI activity
1271,2894,Gilenya,2016-02-18,2019-05-06,300,mg,['2 / Day'], ,Patient Choice/Convenience
1272,3184,Tysabri,2016-02-08,, , ,[' '], , 
1273,3184,Alemtuzumab (Campath),2016-04-02,, ,mg,['2 / Day'], , 
1274,3184,Rebif [44],2016-06-22,2019-04-03, , ,['2 / Day'], ,Adverse Event
1275,3184,D-cure (Vitamine D),2015-12-19,, ,mg,['2 / Day'],IV, 
1276,1164,Copaxone,2015-12-25,, , ,['2 / Day'],Oral, 
1277,2535,Methylprednisolone,2016-05-23,,5000,mg,['/Month'],IV, 
1278,2535,Tecfidera,2016-01-07,,400,mg,['2 / Day'],IV, 
1279,2535,D-cure (Vitamine D),2016-02-09,2019-06-25, , ,['/Month'],IV,Persisting MRI activity
1280,1010,IVIG,2016-01-01,,300, ,['2 / Day'],IV, 
1281,3583,D-cure (Vitamine D),2016-08-15,2019-03-29,400, ,[' '], ,Persisting MRI activity
1282,3583,Alemtuzumab (Campath),2016-01-05,2018-12-03,1000,MIU,['2 / Day'],IV,Persisting MRI activity
1283,3583,Tecfidera,2015-12-20,,1000,mg,['2 / Day'],IV, 
1284,3968,Tysabri,2016-02-13,,500, ,['3 / Week'],IV, 
1285,3968,D-cure (Vitamine D),2016-05-25,2020-03-15, ,mg,['3 / Week'], ,Adverse Event
1286,3968,Avonex,2016-06-28,, ,mg,['/ Week'], , 
1287,3968,Avonex,2016-03-16,2020-11-29,1000,mg,['3 / Week'], ,Persisting MRI activity
1288,4756,IVIG,2016-02-09,,300,mg,['/ Day'],IV, 
1289,4756,IVIG,2016-05-17,,400,mg,['2 / Day'], , 
1290,4756,Alemtuzumab (Campath),2016-06-10,,500,mg,['/Month'],Oral, 
1291,4756,Tecfidera,2015-11-24,2020-04-08,500, ,['/Month'],Oral,Adverse Event
1292,2453,D-cure (Vitamine D),2016-02-25,,500,mg,['3 / Week'], , 
1293,4753,D-cure (Vitamine D),2016-03-16,,1000,MIU,['2 / Day'],Oral, 
1294,4753,Gilenya,2015-12-09,2021-02-05,300,mg,['2 / Day'],IV,Persisting MRI activity
1295,4753,Betaferon,2016-07-12,2019-05-14,1, ,['/ Day'],IV,Patient Choice/Convenience
1296,4123,Mitoxantrone,2016-07-28,2017-12-02,500,mg,['/Month'],Oral,Persisting MRI activity
1297,4123,Methylprednisolone,2016-05-07,,300,MIU,['/Month'], , 
1298,4123,Gilenya,2016-01-22,2021-10-09,5000,mg,['/Month'],Oral,Persisting MRI activity
1299,4123,Rebif [22],2016-08-07,,20,mg,['/Month'], , 
1300,553,D-cure (Vitamine D),2016-01-11,2018-04-11,20,MIU,['2 / Day'],IV,Adverse Event
1301,4738,Endoxan,2016-02-16,2017-11-22,1, ,['2 / Day'], ,Persistence of relapses
1302,4738,Tysabri,2016-06-24,2018-09-15, ,mg,['2 / Day'],IV,Patient Choice/Convenience
1303,1869,Rebif [44],2015-10-26,,5000,mg,['/Month'],IV, 
1304,1869,Teriflunomide,2016-05-28,2021-07-24,1000,MIU,['3 / Week'], ,Lack of efficacy
1305,1869,Tecfidera,2016-05-07,2018-06-15,5000, ,['/Month'], ,Patient Choice/Convenience
1306,1869,Gilenya,2016-05-31,,5000,mcg,['/Month'], , 
1307,2950,D-cure (Vitamine D),2016-05-08,2018-08-29, , ,['3 / Week'], ,Persistence of relapses
1308,3889,Methylprednisolone,2016-01-18,,5000,mg,['2 / Day'],IV, 
1309,3986,Teriflunomide,2016-05-29,2020-08-13, ,mg,['/Month'], ,Persistence of relapses
1310,899,Rebif [44],2016-04-06,, , ,['3 / Week'],IV, 
1311,899,D-cure (Vitamine D),2016-09-04,,20, ,[' '],IV, 
1312,899,Tysabri,2016-03-06,,20, ,['/Month'], , 
1313,899,Gilenya,2016-05-05,,400, ,['/Month'], , 
1314,4478,D-cure (Vitamine D),2016-08-25,2018-01-02,300,mg,['/Month'],IV,Persisting MRI activity
1315,4478,Rebif [22],2016-09-16,,1000, ,['/Month'], , 
1316,4478,Tysabri,2016-03-14,,400,mg,['3 / Week'], , 
1317,4478,Gilenya,2016-04-05,,1000,mg,['2 / Day'], , 
1318,1485,Copaxone,2016-04-23,, ,MIU,['2 / Day'], , 
1319,1485,Avonex,2016-05-08,,1000,mcg,['/Month'], , 
1320,1485,Methylprednisolone,2015-12-15,2019-12-10,1, ,['/ Week'], ,Persisting MRI activity
1321,1223,Ledertrexaat,2016-01-16,2018-09-29,500, ,['/ Day'],Oral,Adverse Event
1322,1935,Tecfidera,2016-08-30,,20, ,[' '], , 
1323,1935,Methylprednisolone,2016-04-11,,1000,mg,['2 / Day'],IV, 
1324,3068,Rebif [22],2015-12-06,,5000,mg,['/ Day'],IV, 
1325,3068,Avonex,2016-03-18,2017-10-24, , ,['/ Day'], ,Persistence of relapses
1326,3068,Rebif [44],2016-08-29,2021-06-26,20, ,['/ Day'],Oral,Adverse Event
1327,3068,D-cure (Vitamine D),2016-08-10,, ,mcg,['2 / Day'],IV, 
1328,4519,IVIG,2015-11-20,,1,mg,['3 / Week'],IV, 
1329,2189,Tysabri,2016-10-01,, , ,['3 / Week'], , 
1330,378,Alemtuzumab (Campath),2016-08-31,2018-10-11,20,mg,['2 / Day'], ,Adverse Event
1331,1985,D-cure (Vitamine D),2016-07-16,2020-08-11,300,MIU,['3 / Week'], ,Persistence of relapses
1332,1055,Betaferon,2016-07-14,,400,mg,['2 / Day'],IV, 
1333,4893,Teriflunomide,2016-01-25,2020-10-13,500,MIU,['/Month'], ,Adverse Event
1334,4893,Gilenya,2016-09-25,,20, ,['/Month'],IV, 
1335,4893,Betaferon,2016-07-30,, ,mcg,['/Month'],IV, 
1336,1661,Gilenya,2015-11-16,,20, ,['/ Week'],IV, 
1337,1661,Rebif [44],2016-07-31,,500,mcg,['3 / Week'], , 
1338,2076,Gilenya,2016-05-20,2019-01-04,5000, ,['3 / Week'],IV,Adverse Event
1339,2076,D-cure (Vitamine D),2016-07-14,2020-09-09,1000,mg,['/Month'],Oral,Adverse Event
1340,2076,IVIG,2016-04-09,, , ,['/Month'],IV, 
1341,1990,Avonex,2016-05-28,,500, ,['2 / Day'], , 
1342,3773,IVIG,2016-09-10,2021-09-24,20, ,['3 / Week'],Oral,Lack of efficacy
1343,3248,Rebif [44],2016-06-07,,1,mg,['3 / Week'],Oral, 
1344,4997,Tysabri,2016-08-20,2019-10-29, , ,['/Month'], ,Adverse Event
1345,4997,D-cure (Vitamine D),2015-12-08,, ,mg,[' '], , 
1346,4851,Gilenya,2016-09-11,,300,mg,[' '],IV, 
1347,4851,Avonex,2016-07-29,, ,mg,['2 / Day'], , 
1348,4851,Betaferon,2016-02-29,, ,mg,['2 / Day'],IV, 
1349,4851,Tysabri,2015-11-21,, , ,['/ Week'], , 
1350,213,IVIG,2016-09-04,, ,mg,['/Month'],IV, 
1351,2418,Copaxone,2016-07-15,2020-07-21,300, ,['3 / Week'],IV,Lack of efficacy
1352,2418,Alemtuzumab (Campath),2016-10-18,2021-10-06,20,mg,['2 / Day'], ,Persisting MRI activity
1353,2418,Ledertrexaat,2016-01-13,2019-09-10,20, ,['/Month'], ,Adverse Event
1354,2418,Teriflunomide,2016-10-18,,1000, ,['3 / Week'], , 
1355,4025,Rebif [22],2016-02-24,, ,MIU,['/ Week'],Oral, 
1356,4025,D-cure (Vitamine D),2016-07-25,2017-12-27, ,mg,['3 / Week'],Oral,Lack of efficacy
1357,4025,Rebif [44],2015-12-06,,1000, ,['/Month'],IV, 
1358,4025,Tysabri,2016-04-06,2020-10-17,300,mg,['3 / Week'],IV,Adverse Event
1359,714,Gilenya,2016-09-12,,1000,mg,['2 / Day'],IV, 
1360,714,Avonex,2016-03-28,,300, ,['2 / Day'],IV, 
1361,714,Endoxan,2016-08-07,2018-11-01,20,mg,['3 / Week'], ,Persistence of relapses
1362,714,Methylprednisolone,2016-05-11,,500,mg,['/Month'], , 
1363,915,Copaxone,2015-11-25,2018-01-27, , ,[' '],IV,Patient Choice/Convenience
1364,915,Methylprednisolone,2016-09-10,2018-04-01,5000,MIU,['2 / Day'], ,Persisting MRI activity
1365,915,Rebif [22],2016-05-22,2020-11-22,20,MIU,['/ Week'],IV,Persisting MRI activity
1366,915,D-cure (Vitamine D),2016-09-05,,20,mg,['/Month'],Oral, 
1367,2311,D-cure (Vitamine D),2015-12-16,2018-06-26,500, ,[' '],IV,Lack of efficacy
1368,2311,IVIG,2015-10-27,2019-08-12,300,mg,['/ Day'], ,Adverse Event
1369,2311,Teriflunomide,2016-10-22,2018-08-25, ,mg,['/Month'],Oral,Lack of efficacy
1370,2311,Tysabri,2016-07-29,,1,MIU,['/ Day'],IV, 
1371,3845,Avonex,2016-08-31,2019-11-06,5000,mg,['2 / Day'], ,Adverse Event
1372,3845,D-cure (Vitamine D),2016-10-04,2020-10-21,500,mg,['2 / Day'], ,Lack of efficacy
1373,3845,Alemtuzumab (Campath),2016-01-25,2018-11-20,5000,mg,['2 / Day'],Oral,Patient Choice/Convenience
1374,3831,Rebif [22],2016-02-13,,300, ,['/Month'],IV, 
1375,3831,Tysabri,2016-07-22,2020-09-09, ,mg,[' '],IV,Persistence of relapses
1376,3831,Tecfidera,2016-06-03,,300, ,['/Month'],IV, 
1377,3831,Tecfidera,2016-05-02,2020-06-26, , ,['2 / Day'],IV,Persisting MRI activity
1378,4522,Ledertrexaat,2016-02-21,,20, ,['/Month'], , 
1379,4522,D-cure (Vitamine D),2016-07-27,2020-09-13,5000,mg,['/Month'],IV,Lack of efficacy
1380,4522,IVIG,2016-04-23,, , ,['/Month'],IV, 
1381,4522,IVIG,2016-02-29,2019-06-15, ,mg,['/Month'],IV,Lack of efficacy
1382,3792,Tecfidera,2015-11-14,,1, ,['3 / Week'], , 
1383,3792,Rebif [44],2016-07-04,2018-06-22,5000,mg,['/ Week'],IV,Patient Choice/Convenience
1384,3792,Betaferon,2016-03-03,,500, ,['2 / Day'],IV, 
1385,4055,Rebif [22],2015-12-19,,20,mcg,['3 / Week'],Oral, 
1386,4055,Betaferon,2016-08-29,2018-01-30,1000,MIU,['/ Day'], ,Patient Choice/Convenience
1387,140,Rebif [44],2015-12-01,,500,mg,['/Month'],IV, 
1388,140,Ledertrexaat,2016-04-25,2017-11-24,1,mg,['3 / Week'], ,Lack of efficacy
1389,140,Methylprednisolone,2015-11-10,2018-06-23,20,mg,['/Month'],IV,Patient Choice/Convenience
1390,140,Methylprednisolone,2016-08-17,2018-01-25,500, ,['/Month'], ,Patient Choice/Convenience
1391,4113,D-cure (Vitamine D),2016-02-19,2018-11-08,1000,mg,[' '],IV,Patient Choice/Convenience
1392,4942,Methylprednisolone,2016-03-24,,5000, ,['3 / Week'],IV, 
1393,4942,Endoxan,2016-01-01,2020-08-28,300,mg,['/Month'],Oral,Adverse Event
1394,4942,Gilenya,2016-02-22,2021-10-19,20,MIU,['/Month'],IV,Persisting MRI activity
1395,2336,Teriflunomide,2015-11-10,2018-05-18,5000, ,['3 / Week'], ,Persisting MRI activity
1396,4221,Alemtuzumab (Campath),2016-08-28,2021-09-17,5000,MIU,['2 / Day'],IV,Adverse Event
1397,4221,Tecfidera,2016-06-18,2021-06-17,1000,mg,['2 / Day'],IV,Lack of efficacy
1398,4221,Tysabri,2016-06-28,2020-10-03,400,mg,['/ Week'],IV,Patient Choice/Convenience
1399,238,Methylprednisolone,2016-04-03,2018-04-14, , ,['2 / Day'], ,Adverse Event
1400,2227,D-cure (Vitamine D),2015-12-24,,400, ,['/Month'], , 
1401,2227,Copaxone,2016-06-10,2017-11-25,1,mg,['/Month'],IV,Adverse Event
1402,2227,Copaxone,2015-11-01,,1,mcg,['/Month'],IV, 
1403,2227,IVIG,2016-08-11,, ,mg,['/ Day'],IV, 
1404,4832,Alemtuzumab (Campath),2016-04-06,, , ,['2 / Day'],IV, 
1405,4832,D-cure (Vitamine D),2016-07-21,, ,mg,['2 / Day'],Oral, 
1406,4832,Alemtuzumab (Campath),2015-11-22,, ,mg,['2 / Day'],IV, 
1407,4832,Gilenya,2015-12-03,, ,MIU,['/Month'],IV, 
1408,3614,Rebif [44],2016-10-05,2019-11-19,1000, ,['2 / Day'],IV,Adverse Event
1409,3614,Methylprednisolone,2015-12-17,,500, ,['3 / Week'],Oral, 
1410,319,Tecfidera,2016-01-03,,500, ,['/ Day'],IV, 
1411,319,Tysabri,2016-09-29,,1,mg,['2 / Day'],IV, 
1412,319,IVIG,2016-06-16,2019-12-21, ,mg,['/ Week'], ,Adverse Event
1413,4010,Gilenya,2016-08-31,2019-12-15,500, ,['/Month'], ,Lack of efficacy
1414,4010,Avonex,2016-09-13,2021-05-30,500,mg,['/Month'],IV,Lack of efficacy
1415,4173,Gilenya,2016-08-17,,500, ,['3 / Week'],Oral, 
1416,4173,Avonex,2016-04-16,2019-03-22, ,MIU,['2 / Day'],IV,Persisting MRI activity
1417,2239,Ledertrexaat,2016-02-20,,300,MIU,['3 / Week'], , 
1418,2657,IVIG,2016-07-31,2019-06-12, ,mg,['2 / Day'],IV,Patient Choice/Convenience
1419,2657,Avonex,2016-04-27,, , ,['/Month'],IV, 
1420,2657,Rebif [22],2015-10-31,2021-01-06, , ,['/Month'],IV,Lack of efficacy
1421,2657,Avonex,2016-06-09,,1000, ,['/ Day'],IV, 
1422,762,Rebif [44],2016-06-08,,1000, ,[' '],IV, 
1423,762,Tecfidera,2015-12-01,,20,MIU,['2 / Day'],IV, 
1424,762,D-cure (Vitamine D),2015-11-19,,400,mg,['/ Week'], , 
1425,4413,Tecfidera,2016-03-28,, ,mg,['3 / Week'],IV, 
1426,4413,Rebif [22],2016-08-26,,1000, ,['2 / Day'],IV, 
1427,4413,Tecfidera,2016-09-27,,1000,MIU,['2 / Day'], , 
1428,4227,Ledertrexaat,2016-06-05,2017-12-04,5000,mg,['/Month'],IV,Adverse Event
1429,4227,Avonex,2016-07-26,, , ,['/ Day'], , 
1430,2652,Rebif [44],2016-07-27,,300, ,['2 / Day'], , 
1431,2739,Avonex,2016-07-29,, , ,['/Month'], , 
1432,4113,Gilenya,2016-10-10,,300,mg,[' '],IV, 
1433,4113,Teriflunomide,2016-10-20,2017-12-19, ,mg,['3 / Week'], ,Patient Choice/Convenience
1434,4113,Rebif [44],2015-12-26,,300, ,[' '], , 
1435,2873,IVIG,2016-02-04,,1000, ,['2 / Day'],IV, 
1436,2873,Teriflunomide,2016-10-02,, ,MIU,['2 / Day'], , 
1437,4863,Rebif [22],2015-11-10,2020-08-08, , ,['2 / Day'], ,Lack of efficacy
1438,4863,Rebif [22],2016-10-18,, ,mcg,[' '],Oral, 
1439,4863,Copaxone,2016-01-23,, , ,['/ Day'], , 
1440,821,Alemtuzumab (Campath),2015-10-30,, ,mg,['2 / Day'], , 
1441,821,Rebif [22],2016-09-30,,400, ,['/Month'],Oral, 
1442,2114,Rebif [44],2016-02-11,, , ,['/ Week'],Oral, 
1443,2114,Endoxan,2016-03-29,, , ,['/ Week'],IV, 
1444,3307,Rebif [22],2015-11-09,, ,mg,['2 / Day'], , 
1445,3307,Copaxone,2016-06-19,,300,mcg,['3 / Week'], , 
1446,4073,Endoxan,2016-03-14,2020-04-17,5000,mcg,['/Month'], ,Adverse Event
1447,4073,Gilenya,2016-09-30,,1000,mg,[' '],IV, 
1448,4073,Tysabri,2015-11-24,,5000,mg,['3 / Week'],Oral, 
1449,4073,Endoxan,2016-08-23,,400, ,['/Month'], , 
1450,4203,Betaferon,2016-10-18,2018-05-07, , ,['/Month'], ,Patient Choice/Convenience
1451,4203,Rebif [22],2015-10-25,,300, ,['/Month'],Oral, 
1452,4203,Tysabri,2016-09-02,,20,MIU,['3 / Week'],Oral, 
1453,3866,Alemtuzumab (Campath),2016-04-06,,500,mg,['3 / Week'],IV, 
1454,809,Avonex,2016-10-05,,1000, ,['/Month'], , 
1455,809,Betaferon,2016-06-01,,5000,MIU,['/Month'],Oral, 
1456,809,Alemtuzumab (Campath),2016-09-13,2019-07-13, ,mg,[' '],IV,Patient Choice/Convenience
1457,3523,Rebif [22],2016-10-08,2021-08-12, , ,['/ Week'],IV,Lack of efficacy
1458,3523,IVIG,2016-05-01,,1, ,['2 / Day'],IV, 
1459,4637,IVIG,2015-12-23,2021-03-26,1,mg,['2 / Day'],IV,Adverse Event
1460,4637,Rebif [22],2016-03-01,,300,mg,['2 / Day'], , 
1461,647,D-cure (Vitamine D),2016-02-16,2018-05-21,300,mg,[' '],IV,Adverse Event
1462,647,Rebif [22],2016-02-02,2021-09-14,500, ,['2 / Day'], ,Patient Choice/Convenience
1463,647,Methylprednisolone,2015-11-15,,300,mg,['/ Day'],IV, 
1464,647,D-cure (Vitamine D),2016-02-14,2020-08-19,500, ,[' '], ,Adverse Event
1465,2518,D-cure (Vitamine D),2016-04-30,, ,mg,['/Month'], , 
1466,2518,Tecfidera,2016-03-25,,1, ,['2 / Day'], , 
1467,2518,Ledertrexaat,2016-01-25,,1, ,['/Month'],Oral, 
1468,814,Mitoxantrone,2016-07-25,2019-09-18, ,MIU,['/ Day'], ,Persisting MRI activity
1469,814,D-cure (Vitamine D),2016-01-07,,20, ,['/Month'],IV, 
1470,4875,Betaferon,2016-09-05,, ,mg,['2 / Day'],IV, 
1471,4875,Avonex,2016-10-04,2019-07-18,1000, ,['/ Week'],IV,Lack of efficacy
1472,4875,Tecfidera,2016-06-14,2021-09-28,5000,MIU,['/Month'],IV,Persisting MRI activity
1473,4875,Methylprednisolone,2016-03-17,2019-12-10,400,MIU,['2 / Day'],IV,Lack of efficacy
1474,3120,Ledertrexaat,2016-10-17,2020-05-31,20, ,['3 / Week'], ,Adverse Event
1475,3120,IVIG,2015-11-08,,5000,MIU,[' '],IV, 
1476,3120,IVIG,2016-05-28,2019-07-17,400,mg,['3 / Week'],IV,Lack of efficacy
1477,3120,Tecfidera,2016-05-05,,5000, ,['2 / Day'],IV, 
1478,2934,Alemtuzumab (Campath),2016-10-02,,400, ,['/ Day'],IV, 
1479,4565,IVIG,2016-02-25,, ,mg,[' '], , 
1480,4565,Tecfidera,2016-09-08,2020-08-27, , ,['/Month'], ,Persisting MRI activity
1481,4565,Avonex,2016-02-12,2021-03-06,20,mg,['/Month'],IV,Adverse Event
1482,1668,Tysabri,2016-03-03,2021-01-30,1000,mg,['/Month'],IV,Adverse Event
1483,1668,D-cure (Vitamine D),2016-09-02,,1, ,['/Month'], , 
1484,1668,Betaferon,2016-04-19,,500, ,['/ Day'],Oral, 
1485,1668,Tysabri,2015-12-02,,5000, ,['/ Week'], , 
1486,4853,Endoxan,2015-11-01,,300,mg,['2 / Day'],IV, 
1487,4853,Mitoxantrone,2016-04-11,,5000,mg,['/ Day'],IV, 
1488,4853,Alemtuzumab (Campath),2016-09-19,2021-05-07,500,mcg,['3 / Week'], ,Patient Choice/Convenience
1489,3925,Avonex,2016-02-12,2020-07-12, , ,[' '], ,Adverse Event
1490,3925,Betaferon,2016-01-13,,300, ,['2 / Day'],IV, 
1491,3925,Gilenya,2015-12-27,, , ,['3 / Week'], , 
1492,468,Rebif [44],2016-01-07,2018-07-17, ,mcg,['/Month'],IV,Adverse Event
1493,468,Tecfidera,2016-09-09,, ,MIU,['/Month'],IV, 
1494,468,Avonex,2016-07-20,2019-03-14,20,MIU,['/ Day'], ,Lack of efficacy
1495,468,Tysabri,2016-03-15,,1000, ,['2 / Day'],Oral, 
1496,2156,IVIG,2016-10-01,2021-08-13,400,mcg,['/Month'], ,Adverse Event
1497,528,Methylprednisolone,2015-11-20,,300,mg,['/Month'], , 
1498,528,Endoxan,2016-04-09,2018-09-16, ,mg,['3 / Week'], ,Patient Choice/Convenience
1499,1141,Betaferon,2016-10-15,,400,mg,['/Month'],IV, 
1500,1141,Copaxone,2016-02-13,2018-10-25, ,mg,['2 / Day'],IV,Patient Choice/Convenience
1501,1141,IVIG,2016-07-14,, ,mg,[' '],IV, 
1502,3548,D-cure (Vitamine D),2016-05-24,2020-05-25, ,mg,['2 / Day'],Oral,Adverse Event
1503,3548,Endoxan,2015-12-12,,20, ,['2 / Day'],IV, 
1504,1957,Rebif [44],2016-06-16,2019-03-14, , ,['/ Week'],IV,Patient Choice/Convenience
1505,1957,Betaferon,2016-07-08,,1000, ,['2 / Day'], , 
1506,1957,Rebif [44],2016-07-11,,20, ,['2 / Day'], , 
1507,1957,Rebif [22],2015-11-05,,500,mcg,[' '],Oral, 
1508,3026,Rebif [44],2015-11-16,,5000,MIU,['/Month'],IV, 
1509,3026,Tecfidera,2016-03-16,,400,mg,['/ Day'], , 
1510,3026,Rebif [22],2016-05-25,2019-04-13,1000,mg,['/Month'], ,Patient Choice/Convenience
1511,1298,Methylprednisolone,2016-08-15,2021-09-01,500,MIU,['/ Week'],Oral,Adverse Event
1512,4590,Alemtuzumab (Campath),2016-03-12,,5000,mg,['/Month'],IV, 
1513,4590,D-cure (Vitamine D),2015-11-24,2018-03-15,400, ,['/Month'],Oral,Adverse Event
1514,4590,Tysabri,2016-09-11,2020-05-18,1000,mg,['/ Day'],IV,Persistence of relapses
1515,4590,Ledertrexaat,2016-06-18,, , ,['/Month'], , 
1516,197,Tysabri,2016-08-16,,5000, ,['3 / Week'],IV, 
1517,197,Betaferon,2016-01-08,, ,mg,['3 / Week'],Oral, 
1518,197,Tysabri,2016-03-02,,1,mg,['2 / Day'],Oral, 
1519,4041,Methylprednisolone,2016-09-11,, , ,['/Month'],Oral, 
1520,4769,Rebif [22],2016-02-02,,1000, ,['3 / Week'], , 
1521,3175,Methylprednisolone,2016-04-01,2020-11-30, , ,['2 / Day'],IV,Patient Choice/Convenience
1522,3175,D-cure (Vitamine D),2016-06-30,2021-06-10,400,MIU,['/Month'],IV,Patient Choice/Convenience
1523,3175,D-cure (Vitamine D),2016-03-15,, ,mg,['2 / Day'],Oral, 
1524,3538,Mitoxantrone,2016-09-05,2019-07-01, , ,['3 / Week'], ,Adverse Event
1525,909,Alemtuzumab (Campath),2016-08-17,, , ,['/Month'],IV, 
1526,909,Alemtuzumab (Campath),2015-12-23,,20,mg,['2 / Day'], , 
1527,909,Methylprednisolone,2016-04-28,2021-04-25, ,mg,['/Month'],IV,Persisting MRI activity
1528,4832,Rebif [22],2016-05-29,2019-04-21,20,mg,[' '],Oral,Adverse Event
1529,4832,Rebif [22],2015-12-23,2020-03-24,500, ,['/ Week'], ,Persisting MRI activity
1530,4832,Tysabri,2015-11-21,,1,mg,[' '],IV, 
1531,4278,Alemtuzumab (Campath),2015-10-25,2019-09-26,5000, ,['/Month'], ,Adverse Event
1532,4278,Copaxone,2016-02-06,2020-10-19,400,MIU,['/Month'],IV,Persisting MRI activity
1533,4278,Rebif [44],2016-08-06,,500, ,['/Month'],IV, 
1534,4364,Tecfidera,2016-09-29,2019-01-29,500,mcg,['2 / Day'], ,Persisting MRI activity
1535,4364,Rebif [22],2016-01-07,2019-12-23, , ,['2 / Day'], ,Lack of efficacy
1536,4364,IVIG,2016-10-07,,500,mg,['2 / Day'],IV, 
1537,1702,Rebif [22],2016-03-19,2019-02-18,300, ,['/Month'],IV,Persistence of relapses
1538,1702,Ledertrexaat,2016-01-31,,1000, ,['/Month'],IV, 
1539,1702,Betaferon,2016-10-07,,500,mg,['3 / Week'], , 
1540,1702,Gilenya,2016-05-08,2018-10-27,5000,mg,['/Month'],IV,Patient Choice/Convenience
1541,1975,Alemtuzumab (Campath),2016-08-02,, , ,['/Month'],IV, 
1542,1975,Ledertrexaat,2016-09-17,,500, ,['/Month'], , 
1543,3180,Tysabri,2016-02-14,, ,mg,[' '],IV, 
1544,3180,Gilenya,2016-07-17,2020-01-17,1000, ,['2 / Day'],IV,Persisting MRI activity
1545,3180,Copaxone,2016-10-11,2018-04-20, ,MIU,['2 / Day'], ,Patient Choice/Convenience
1546,2243,Endoxan,2016-05-23,,1000,mg,['2 / Day'], , 
1547,2243,Tecfidera,2016-01-27,, ,mg,['/Month'],IV, 
1548,4841,Endoxan,2015-10-26,,500, ,['/Month'],IV, 
1549,3744,Methylprednisolone,2016-03-09,, ,mg,['/ Day'], , 
1550,3929,Gilenya,2016-03-17,,1000, ,['3 / Week'], , 
1551,3929,Betaferon,2016-09-10,,500, ,['2 / Day'], , 
1552,3929,Tysabri,2016-07-13,,5000,MIU,['/Month'],IV, 
1553,3562,Rebif [22],2016-08-23,2020-06-16, ,MIU,['/Month'],IV,Lack of efficacy
1554,3562,Mitoxantrone,2016-08-06,,1, ,['/Month'],IV, 
1555,3562,Endoxan,2016-08-02,, , ,['/Month'], , 
1556,3562,Tysabri,2016-05-19,,5000, ,['2 / Day'],IV, 
1557,4103,D-cure (Vitamine D),2016-03-08,2019-09-17,1000,mg,['/Month'],IV,Adverse Event
1558,4103,D-cure (Vitamine D),2016-06-28,, , ,['2 / Day'],Oral, 
1559,4103,IVIG,2015-12-27,2020-08-29,20,mcg,['/ Week'], ,Patient Choice/Convenience
1560,4103,Avonex,2016-09-18,2018-01-07,500,mg,['/Month'], ,Patient Choice/Convenience
1561,2163,IVIG,2016-06-29,2017-11-01,5000,mg,['2 / Day'],IV,Adverse Event
1562,4514,Ledertrexaat,2016-02-16,,400,mg,['/ Day'],Oral, 
1563,4514,Rebif [22],2016-09-17,,300, ,['3 / Week'], , 
1564,4514,Rebif [22],2016-03-05,, ,mg,['2 / Day'],IV, 
1565,4329,Tecfidera,2016-10-14,,20,mcg,['/ Day'],IV, 
1566,4329,Rebif [44],2016-05-02,, ,mg,['/Month'],IV, 
1567,4329,Gilenya,2016-04-26,2020-06-19, , ,['/Month'], ,Patient Choice/Convenience
1568,4329,Betaferon,2016-04-14,,500, ,['/Month'],IV, 
1569,4143,Tysabri,2016-07-08,2019-04-26, , ,['2 / Day'], ,Persistence of relapses
1570,4143,Tysabri,2016-06-21,2019-03-20,500,mg,['3 / Week'],Oral,Persistence of relapses
1571,4143,Methylprednisolone,2016-06-19,,400, ,['/Month'],IV, 
1572,4143,Gilenya,2016-05-27,, , ,['3 / Week'], , 
1573,785,Copaxone,2015-11-23,, , ,['2 / Day'],IV, 
1574,785,Teriflunomide,2015-10-25,2021-04-09,5000, ,['3 / Week'],IV,Patient Choice/Convenience
1575,785,D-cure (Vitamine D),2016-06-05,2020-09-27,300, ,['3 / Week'], ,Patient Choice/Convenience
1576,4791,Tysabri,2016-10-15,2021-08-03, ,mg,['2 / Day'],IV,Adverse Event
1577,4198,Endoxan,2016-04-03,,1,mg,['2 / Day'],IV, 
1578,4198,Gilenya,2016-06-15,, , ,[' '],IV, 
1579,1286,Betaferon,2015-12-04,2021-03-01,20, ,['/Month'],IV,Persisting MRI activity
1580,1286,Rebif [22],2016-05-27,2017-11-11, , ,['/Month'], ,Persistence of relapses
1581,3712,Betaferon,2016-07-15,,5000, ,['2 / Day'],IV, 
1582,3712,Avonex,2016-07-10,, , ,['2 / Day'],IV, 
1583,3712,Gilenya,2016-01-04,2020-04-21, ,mg,['/Month'],IV,Persisting MRI activity
1584,3712,Tecfidera,2016-04-28,2017-11-07,1,mg,['3 / Week'],Oral,Persisting MRI activity
1585,4135,Tysabri,2016-05-22,2018-03-09,20,mg,['/ Week'],IV,Patient Choice/Convenience
1586,2134,Rebif [44],2016-01-13,,1000,MIU,['3 / Week'], , 
1587,2134,Rebif [22],2016-10-10,,1, ,['/Month'], , 
1588,2134,Endoxan,2016-07-27,2021-07-22, ,mg,['/Month'],IV,Persisting MRI activity
1589,2134,IVIG,2016-02-08,,500,mg,['/Month'],IV, 
1590,3797,Rebif [22],2016-07-10,2018-12-05,1000,mg,['/Month'],IV,Persisting MRI activity
1591,3797,IVIG,2016-10-10,,5000, ,['3 / Week'],IV, 
1592,3797,Mitoxantrone,2016-01-18,,400,mg,['3 / Week'], , 
1593,4617,Betaferon,2016-06-17,2018-10-04,400,mg,['3 / Week'],IV,Patient Choice/Convenience
1594,4617,Mitoxantrone,2015-12-02,2017-10-28,5000,mg,['/ Day'],IV,Persisting MRI activity
1595,4617,Alemtuzumab (Campath),2016-03-15,2021-03-12, ,mcg,['2 / Day'], ,Persisting MRI activity
1596,4559,Rebif [44],2016-08-24,2019-02-18,400,MIU,['/Month'],IV,Persistence of relapses
1597,4559,Tecfidera,2015-11-16,,500,MIU,['/Month'],IV, 
1598,4000,Teriflunomide,2016-05-26,, ,MIU,[' '], , 
1599,4782,Tysabri,2016-06-04,2019-08-27,20,mg,[' '],Oral,Lack of efficacy
1600,4782,Alemtuzumab (Campath),2015-11-16,,5000,mcg,['3 / Week'], , 
1601,1958,Alemtuzumab (Campath),2016-03-30,2021-04-09,20,MIU,['/ Week'],IV,Adverse Event
1602,1958,Tecfidera,2016-07-14,,300,MIU,['/Month'],IV, 
1603,1958,Endoxan,2016-08-27,, ,mg,['/Month'],IV, 
1604,1958,Methylprednisolone,2016-06-06,,5000, ,['3 / Week'],IV, 
1605,4085,D-cure (Vitamine D),2016-10-02,,400,mg,['/ Week'],IV, 
1606,4517,Tysabri,2016-07-13,,300,mg,['/Month'], , 
1607,4517,Rebif [44],2016-04-09,,300,mg,['/ Day'], , 
1608,1758,Methylprednisolone,2015-11-27,,300,MIU,['/ Week'], , 
1609,4479,IVIG,2015-11-20,,1000, ,['2 / Day'],Oral, 
1610,4479,Tysabri,2016-10-17,,1000,mcg,[' '],IV, 
1611,4479,Alemtuzumab (Campath),2015-11-11,2020-12-02,1000, ,['2 / Day'],IV,Adverse Event
1612,4479,Endoxan,2016-05-17,2018-09-23, ,mg,['2 / Day'], ,Adverse Event
1613,149,Endoxan,2016-04-29,, ,mg,['/Month'],Oral, 
1614,913,Rebif [22],2016-03-25,, ,mg,['3 / Week'],Oral, 
1615,4408,IVIG,2016-09-14,2021-10-08, , ,['2 / Day'], ,Adverse Event
1616,4408,Alemtuzumab (Campath),2016-05-18,,500,MIU,['/ Day'], , 
1617,1838,Rebif [44],2016-04-28,,20, ,['/ Day'],IV, 
1618,1838,Ledertrexaat,2015-11-20,2018-04-18, ,mg,['2 / Day'], ,Adverse Event
1619,1838,Copaxone,2016-07-22,2020-03-11, , ,['2 / Day'], ,Persistence of relapses
1620,1838,Methylprednisolone,2016-04-28,2020-05-25, ,mg,['2 / Day'],IV,Adverse Event
1621,4610,Tysabri,2016-09-04,2020-06-27,1, ,['2 / Day'], ,Patient Choice/Convenience
1622,4009,Rebif [44],2016-06-19,,300, ,['/Month'], , 
1623,4009,IVIG,2015-11-11,2019-08-02, ,mg,['/ Day'], ,Lack of efficacy
1624,4009,Ledertrexaat,2016-01-01,2020-03-01, ,mcg,['3 / Week'],IV,Persistence of relapses
1625,3276,Methylprednisolone,2016-03-29,,20,mg,['2 / Day'],IV, 
1626,3276,Methylprednisolone,2016-06-14,2020-01-27,20,mg,['2 / Day'], ,Lack of efficacy
1627,1991,D-cure (Vitamine D),2016-01-11,,20,MIU,['/Month'],IV, 
1628,1991,Avonex,2016-03-01,,1, ,['2 / Day'],IV, 
1629,1991,Methylprednisolone,2016-10-09,2020-10-07,500, ,['3 / Week'],IV,Adverse Event
1630,1991,Copaxone,2015-10-28,,500,mg,['2 / Day'],Oral, 
1631,746,Ledertrexaat,2016-06-18,, ,mg,['2 / Day'],IV, 
1632,746,Methylprednisolone,2015-11-06,2018-02-28,1000,mg,['2 / Day'],IV,Adverse Event
1633,746,Avonex,2016-04-16,, , ,['/ Day'], , 
1634,3547,D-cure (Vitamine D),2016-05-07,,5000,mg,['2 / Day'], , 
1635,3547,Avonex,2016-10-09,2021-08-05,500, ,['2 / Day'],Oral,Persistence of relapses
1636,3547,Endoxan,2016-04-18,, , ,['/Month'], , 
1637,2630,IVIG,2015-11-06,, , ,['3 / Week'],IV, 
1638,3576,D-cure (Vitamine D),2015-12-15,2020-12-24, , ,['/ Week'],Oral,Persisting MRI activity
1639,3576,Endoxan,2016-03-10,,300, ,['2 / Day'], , 
1640,3576,IVIG,2015-12-29,,1,mg,['2 / Day'], , 
1641,3576,Avonex,2015-11-29,2021-05-26,20,mcg,['/Month'],Oral,Adverse Event
1642,4109,Teriflunomide,2015-12-17,2020-06-25,20, ,['2 / Day'],IV,Patient Choice/Convenience
1643,4109,Tysabri,2016-06-25,, , ,['/ Day'],IV, 
1644,4109,Ledertrexaat,2016-02-20,,1,mg,['2 / Day'], , 
1645,687,Alemtuzumab (Campath),2015-10-27,,20,mg,['/Month'],IV, 
1646,4250,Avonex,2015-12-06,2019-06-13,300, ,['/Month'], ,Patient Choice/Convenience
1647,4250,Betaferon,2016-03-03,,500, ,['2 / Day'],IV, 
1648,2762,Methylprednisolone,2015-11-01,2018-09-01,1, ,['2 / Day'],IV,Patient Choice/Convenience
1649,2762,Tysabri,2015-10-24,2021-06-04,400, ,['2 / Day'], ,Adverse Event
1650,1368,Ledertrexaat,2016-09-22,, , ,['/Month'],IV, 
1651,1368,Endoxan,2016-04-29,2021-01-08,500,mg,['/Month'],IV,Lack of efficacy
1652,1368,Ledertrexaat,2016-08-29,,300, ,['/ Day'], , 
1653,1368,Endoxan,2016-08-17,2019-06-23,20,MIU,['3 / Week'],IV,Lack of efficacy
1654,3514,Avonex,2016-04-25,2020-06-30,1000,mg,['/ Day'],Oral,Persistence of relapses
1655,542,Ledertrexaat,2016-09-08,2019-06-27,1,mg,['2 / Day'],IV,Patient Choice/Convenience
1656,542,Gilenya,2015-12-04,,5000,mg,['3 / Week'],IV, 
1657,542,Avonex,2016-02-15,, , ,['3 / Week'], , 
1658,542,Endoxan,2016-09-16,2021-02-10,300,mg,[' '], ,Adverse Event
1659,2379,Endoxan,2016-04-02,,1, ,['2 / Day'], , 
1660,2379,Alemtuzumab (Campath),2016-01-28,2020-07-27,400, ,['/ Day'], ,Lack of efficacy
1661,2379,Rebif [22],2016-07-12,2020-06-13, ,mg,['/ Day'], ,Adverse Event
1662,4625,Methylprednisolone,2016-09-08,2019-05-11,5000, ,['3 / Week'],Oral,Persisting MRI activity
1663,4625,Rebif [44],2016-10-09,2021-03-23, , ,['/Month'],IV,Adverse Event
1664,4625,Rebif [44],2016-03-12,,1,mg,['/ Week'],Oral, 
1665,4625,Endoxan,2015-11-10,,1,MIU,['2 / Day'],IV, 
1666,462,Alemtuzumab (Campath),2015-12-01,,500,mg,['/ Day'],Oral, 
1667,462,D-cure (Vitamine D),2016-04-08,2020-01-16, , ,['2 / Day'],IV,Adverse Event
1668,462,Rebif [22],2015-12-02,2020-06-15,1000,mg,['3 / Week'],IV,Persisting MRI activity
1669,4797,Copaxone,2016-07-15,2020-07-08,5000,mg,['2 / Day'],IV,Lack of efficacy
1670,4797,Methylprednisolone,2016-03-04,,20,mg,['2 / Day'],IV, 
1671,4797,Tysabri,2016-06-27,2020-05-19,500, ,['/Month'], ,Adverse Event
1672,4797,Copaxone,2016-09-02,,1000,mg,['3 / Week'],IV, 
1673,276,Rebif [44],2016-06-19,, ,mcg,['/ Week'],IV, 
1674,276,Rebif [22],2016-02-15,2019-06-06, ,mg,['/Month'],Oral,Lack of efficacy
1675,276,Ledertrexaat,2016-05-10,, ,MIU,['2 / Day'],IV, 
1676,4540,Copaxone,2015-11-01,, ,mg,[' '],IV, 
1677,4540,Methylprednisolone,2016-08-21,2018-07-03,5000,mg,['/Month'],Oral,Lack of efficacy
1678,4540,Tysabri,2016-04-23,, , ,['/Month'],IV, 
1679,1255,Alemtuzumab (Campath),2016-08-31,2018-04-19,300, ,['/Month'],Oral,Persisting MRI activity
1680,1255,Endoxan,2015-12-13,, ,mg,['2 / Day'],IV, 
1681,4056,Gilenya,2016-06-05,2019-01-29, ,mg,['3 / Week'],IV,Adverse Event
1682,952,Alemtuzumab (Campath),2016-07-20,2021-07-10,1000,mg,['/ Day'], ,Patient Choice/Convenience
1683,952,Avonex,2016-01-13,,1,mg,['/Month'],IV, 
1684,2743,Gilenya,2016-07-01,, , ,['3 / Week'],IV, 
1685,3031,Avonex,2015-12-18,,500,mg,['/Month'],IV, 
1686,3031,Alemtuzumab (Campath),2016-09-14,2020-08-17, ,MIU,['/Month'], ,Lack of efficacy
1687,3031,Ledertrexaat,2016-09-19,2020-02-18,5000,mg,['2 / Day'], ,Adverse Event
1688,3031,Methylprednisolone,2016-03-27,2020-03-13,5000,mg,['2 / Day'],Oral,Lack of efficacy
1689,1211,Methylprednisolone,2015-12-05,2020-10-17, ,mg,['2 / Day'], ,Persisting MRI activity
1690,1211,IVIG,2016-02-02,2020-02-22, ,mg,['/Month'], ,Persisting MRI activity
1691,1211,Tysabri,2016-08-01,,400, ,['3 / Week'],Oral, 
1692,1211,Mitoxantrone,2015-10-25,2019-05-13,20, ,[' '],IV,Patient Choice/Convenience
1693,3638,Ledertrexaat,2016-03-25,,1,mg,['/Month'],IV, 
1694,3638,Methylprednisolone,2016-05-27,,5000,MIU,['/Month'], , 
1695,4031,Ledertrexaat,2016-09-20,2019-06-22,500,mg,['2 / Day'], ,Adverse Event
1696,4031,Alemtuzumab (Campath),2016-03-02,,500, ,['/Month'],IV, 
1697,4441,Avonex,2016-03-29,,1000,mg,['2 / Day'], , 
1698,3384,Tysabri,2015-12-16,,500, ,[' '], , 
1699,3384,D-cure (Vitamine D),2016-07-19,2020-06-21,20, ,['3 / Week'],IV,Adverse Event
1700,3384,Alemtuzumab (Campath),2016-08-28,2018-07-20,20, ,['2 / Day'], ,Adverse Event
1701,3398,IVIG,2016-09-26,,1,mg,['2 / Day'],Oral, 
1702,3839,IVIG,2016-09-20,2021-09-01,300, ,['2 / Day'],IV,Adverse Event
1703,3839,Tecfidera,2016-01-22,,500,mcg,['2 / Day'],IV, 
1704,3839,Copaxone,2016-06-13,2020-01-24,500, ,['2 / Day'], ,Persistence of relapses
1705,2785,Ledertrexaat,2016-05-14,, ,mg,['/Month'],Oral, 
1706,2785,IVIG,2015-12-23,,5000,mg,['/Month'],IV, 
1707,4555,D-cure (Vitamine D),2016-01-06,,500,mcg,['2 / Day'],IV, 
1708,4555,Rebif [44],2016-06-21,,20,MIU,['/Month'], , 
1709,4555,Tecfidera,2016-01-05,2020-05-28,1,mcg,['/Month'],Oral,Lack of efficacy
1710,4555,Gilenya,2016-01-31,,1000,MIU,['2 / Day'], , 
1711,1876,Teriflunomide,2015-11-06,2019-01-13,500,mg,[' '],IV,Adverse Event
1712,1876,D-cure (Vitamine D),2016-09-29,, , ,['/Month'], , 
1713,2292,Endoxan,2016-03-28,2019-10-06,300,MIU,[' '], ,Adverse Event
1714,2292,Methylprednisolone,2015-11-21,,500,MIU,['/Month'], , 
1715,4552,Methylprednisolone,2016-10-16,2019-11-01,20, ,['/Month'],IV,Lack of efficacy
1716,3819,Betaferon,2015-10-31,2019-07-05,400,mg,['/Month'],IV,Adverse Event
1717,3819,Rebif [44],2016-08-11,2017-10-29,400,mg,[' '], ,Patient Choice/Convenience
1718,3819,Betaferon,2016-04-04,,300,mg,['/ Day'],IV, 
1719,3819,Tecfidera,2015-12-12,,1000,MIU,['/Month'],IV, 
1720,1304,Methylprednisolone,2016-05-31,, ,mg,['2 / Day'], , 
1721,1304,D-cure (Vitamine D),2016-09-30,,20,MIU,['3 / Week'],IV, 
1722,4223,IVIG,2016-03-01,, , ,['/Month'],Oral, 
1723,4223,Methylprednisolone,2015-11-11,,300,mg,['/Month'],Oral, 
1724,4223,D-cure (Vitamine D),2016-08-25,,500, ,['2 / Day'],IV, 
1725,2218,D-cure (Vitamine D),2015-10-26,2018-02-17,400, ,['3 / Week'],IV,Lack of efficacy
1726,2218,Tecfidera,2016-01-30,,5000, ,['/ Day'],IV, 
1727,2218,Endoxan,2016-09-09,2021-06-11,5000, ,['2 / Day'], ,Persisting MRI activity
1728,2218,IVIG,2016-06-21,,1000, ,['/ Day'],IV, 
1729,2463,D-cure (Vitamine D),2016-05-29,,5000, ,['/ Day'], , 
1730,2463,Methylprednisolone,2016-05-30,,300, ,['2 / Day'], , 
1731,2463,IVIG,2016-09-21,, , ,['2 / Day'],Oral, 
1732,2463,Methylprednisolone,2016-09-26,2020-08-19,1, ,['2 / Day'],IV,Persistence of relapses
1733,3341,D-cure (Vitamine D),2016-04-15,, ,MIU,['/Month'], , 
1734,3341,Betaferon,2016-05-13,, , ,['/Month'], , 
1735,845,Alemtuzumab (Campath),2016-09-01,,20, ,['/Month'],IV, 
1736,1210,Ledertrexaat,2016-03-30,2021-05-05,400,MIU,['/Month'],IV,Patient Choice/Convenience
1737,1210,Gilenya,2015-11-27,2021-09-23, ,mcg,['/Month'],Oral,Lack of efficacy
1738,2970,Gilenya,2016-07-10,, ,MIU,['/Month'], , 
1739,2970,Mitoxantrone,2016-08-13,, , ,['/Month'],IV, 
1740,2970,Mitoxantrone,2016-08-19,, , ,['/ Week'],IV, 
1741,1170,Teriflunomide,2015-10-25,,5000,mg,['2 / Day'],IV, 
1742,1170,Avonex,2016-03-26,,5000,mg,['/Month'],Oral, 
1743,1170,Mitoxantrone,2016-07-22,,5000,MIU,['3 / Week'],IV, 
1744,3777,Rebif [44],2016-01-08,2019-01-27,500, ,['/Month'],IV,Persisting MRI activity
1745,3777,Rebif [44],2016-09-25,,1000,mg,['2 / Day'], , 
1746,3777,Methylprednisolone,2016-05-12,,20,MIU,['/Month'], , 
1747,1316,Tecfidera,2016-03-16,2021-01-27, ,mg,['2 / Day'],IV,Adverse Event
1748,1316,Ledertrexaat,2015-10-24,2018-08-31,1000,mg,['/Month'],IV,Adverse Event
1749,1316,Gilenya,2016-03-13,2021-07-14,400,MIU,['/Month'],IV,Patient Choice/Convenience
1750,1316,Ledertrexaat,2016-03-12,,1000, ,['3 / Week'],IV, 
1751,2916,Tysabri,2015-12-19,,500, ,['2 / Day'], , 
1752,2916,Methylprednisolone,2016-04-16,, , ,['/ Week'], , 
1753,2916,Teriflunomide,2016-10-11,2018-12-12,20,mg,['2 / Day'], ,Adverse Event
1754,2224,Tysabri,2016-04-23,2019-12-30,300, ,['/Month'],IV,Adverse Event
1755,2224,Ledertrexaat,2015-11-18,2018-10-29,1000, ,['/Month'], ,Adverse Event
1756,2224,Avonex,2016-10-16,2018-12-17,400,mg,['/Month'], ,Adverse Event
1757,2224,Avonex,2016-08-12,,20,mg,[' '],IV, 
1758,2514,Mitoxantrone,2016-03-15,, ,mg,['2 / Day'],IV, 
1759,2514,IVIG,2015-10-30,, , ,['2 / Day'], , 
1760,2514,Gilenya,2016-08-30,2018-04-16, ,mg,['2 / Day'],IV,Persisting MRI activity
1761,1492,Mitoxantrone,2016-06-28,,1000, ,['2 / Day'],IV, 
1762,1492,Tysabri,2016-02-21,2021-08-31, ,mg,['2 / Day'],IV,Adverse Event
1763,1492,Tysabri,2016-02-10,,20, ,['/ Week'],IV, 
1764,1713,D-cure (Vitamine D),2016-06-18,,5000,mg,['2 / Day'],Oral, 
1765,1713,Teriflunomide,2016-07-28,,500,mg,['2 / Day'], , 
1766,636,Methylprednisolone,2016-06-18,,20, ,['/Month'], , 
1767,636,Endoxan,2016-04-11,2021-07-13,1,mg,['2 / Day'],IV,Adverse Event
1768,636,IVIG,2016-02-19,,5000, ,['3 / Week'], , 
1769,1521,Gilenya,2016-04-10,,1000,mg,['2 / Day'], , 
1770,4893,Endoxan,2016-10-07,2020-03-12,20,mg,['/Month'],IV,Patient Choice/Convenience
1771,4893,Tysabri,2016-04-08,2021-07-12, , ,['/ Day'],IV,Adverse Event
1772,4893,Tecfidera,2016-07-28,, ,mcg,['/Month'], , 
1773,1096,Gilenya,2016-05-31,,5000, ,['/Month'],IV, 
1774,3959,Rebif [44],2016-04-01,2019-11-16,5000,MIU,['/Month'],IV,Lack of efficacy
1775,3959,Alemtuzumab (Campath),2016-01-05,, ,mg,[' '],IV, 
1776,3959,Tysabri,2016-07-09,2020-03-09,1000, ,['2 / Day'], ,Patient Choice/Convenience
1777,3959,Methylprednisolone,2016-05-05,2019-10-04,1,MIU,['3 / Week'], ,Lack of efficacy
1778,2485,Rebif [22],2016-10-15,2021-09-13,5000, ,[' '],IV,Patient Choice/Convenience
1779,2485,IVIG,2015-12-02,2020-04-21,500, ,['/Month'],IV,Adverse Event
1780,2485,Methylprednisolone,2015-12-17,2018-02-16,20, ,['2 / Day'],IV,Persisting MRI activity
1781,2485,Teriflunomide,2016-04-14,2020-08-21,300,mg,['3 / Week'],IV,Persisting MRI activity
1782,2786,IVIG,2016-05-08,2019-05-15,300,mg,['/Month'],IV,Adverse Event
1783,2786,Tysabri,2015-11-23,,300, ,[' '],IV, 
1784,1787,D-cure (Vitamine D),2016-01-25,, ,mg,['2 / Day'], , 
1785,2456,Gilenya,2016-10-01,2020-10-15,1000,mg,['/Month'], ,Patient Choice/Convenience
1786,2099,Mitoxantrone,2016-03-26,2020-11-20,400,mg,['2 / Day'],IV,Patient Choice/Convenience
1787,3500,Copaxone,2016-09-01,,5000,mg,['/Month'],IV, 
1788,3500,Gilenya,2016-09-22,2019-01-06,1000,mg,[' '], ,Adverse Event
1789,1890,Ledertrexaat,2016-07-28,, ,MIU,['3 / Week'],IV, 
1790,1890,Avonex,2015-11-04,2020-02-13,300,mg,['/Month'],IV,Patient Choice/Convenience
1791,1890,D-cure (Vitamine D),2016-01-16,2019-08-29,1000,mg,['3 / Week'], ,Patient Choice/Convenience
1792,1890,D-cure (Vitamine D),2016-01-07,2018-12-28,500, ,['2 / Day'],Oral,Lack of efficacy
1793,2010,D-cure (Vitamine D),2016-07-16,2019-10-30,20,mcg,['2 / Day'],Oral,Adverse Event
1794,2010,Tecfidera,2016-03-31,2020-09-10,1000, ,['/Month'],Oral,Persistence of relapses
1795,2010,D-cure (Vitamine D),2016-06-05,,500, ,['2 / Day'],Oral, 
1796,2010,Tysabri,2016-02-20,,20,mcg,['/Month'],IV, 
1797,662,Betaferon,2015-12-10,,5000,mcg,['/Month'], , 
1798,662,Endoxan,2016-07-16,,1000,mg,['/ Week'],IV, 
1799,662,IVIG,2016-02-06,,5000, ,['/Month'],IV, 
1800,1089,IVIG,2016-01-09,2021-01-11,20,mg,['/Month'],IV,Adverse Event
1801,1089,Rebif [22],2016-09-13,2021-10-08,500,mg,[' '], ,Adverse Event
1802,1089,Teriflunomide,2016-09-02,2021-06-23,500,mg,[' '],IV,Adverse Event
1803,643,Ledertrexaat,2015-12-20,,1000,MIU,['/Month'],IV, 
1804,643,Mitoxantrone,2016-05-12,2019-09-22, ,mg,['2 / Day'],IV,Adverse Event
1805,643,Methylprednisolone,2016-03-25,2020-02-10,500, ,['/Month'],IV,Persistence of relapses
1806,643,Methylprednisolone,2015-12-07,2020-05-28,1,mg,['2 / Day'],IV,Persisting MRI activity
1807,4173,Mitoxantrone,2016-02-06,2020-05-20,1000, ,['/ Day'],IV,Patient Choice/Convenience
1808,4173,Avonex,2016-09-30,,400,mg,['2 / Day'],IV, 
1809,2114,Ledertrexaat,2016-10-14,,400,mg,['/Month'],IV, 
1810,2114,Tysabri,2015-12-31,, ,mg,['/Month'], , 
1811,2114,D-cure (Vitamine D),2016-05-28,, , ,['/Month'], , 
1812,2114,Copaxone,2016-09-11,, ,mg,['/ Day'],IV, 
1813,1810,Alemtuzumab (Campath),2016-09-14,2018-02-17, ,mg,['2 / Day'],IV,Adverse Event
1814,1810,IVIG,2016-03-19,,5000,mg,[' '], , 
1815,1810,Methylprednisolone,2016-10-16,,20,mg,['/Month'],IV, 
1816,2114,D-cure (Vitamine D),2016-06-01,,20,mg,['3 / Week'], , 
1817,2114,Tysabri,2016-04-24,,20,mg,['/Month'],Oral, 
1818,2114,Avonex,2016-01-25,,20,mg,['2 / Day'],IV, 
1819,2120,D-cure (Vitamine D),2016-06-09,,300, ,['/Month'], , 
1820,2120,Avonex,2016-08-10,, ,mcg,['/Month'],IV, 
1821,2120,Rebif [22],2016-08-19,,400, ,['/Month'],IV, 
1822,1987,D-cure (Vitamine D),2015-12-26,, , ,['2 / Day'], , 
1823,3501,Teriflunomide,2016-08-28,, ,mcg,['2 / Day'],IV, 
1824,3501,Tysabri,2016-06-16,, ,MIU,['3 / Week'],IV, 
1825,1054,Rebif [22],2016-03-22,2019-04-14,1000,mg,['2 / Day'], ,Adverse Event
1826,4066,Gilenya,2016-07-20,2018-11-19,1000, ,['/Month'], ,Patient Choice/Convenience
1827,4066,Rebif [44],2016-05-28,,20,mg,['2 / Day'],IV, 
1828,583,IVIG,2016-02-17,, ,mg,['/ Day'], , 
1829,583,Mitoxantrone,2016-04-23,2018-04-27,500,MIU,['/ Day'], ,Patient Choice/Convenience
1830,1582,Rebif [44],2016-01-05,2019-01-19,1000,mg,['3 / Week'], ,Persisting MRI activity
1831,1582,Avonex,2016-10-18,2021-10-08,400,MIU,['/ Day'], ,Patient Choice/Convenience
1832,2157,Gilenya,2016-05-03,, , ,['/ Day'], , 
1833,2157,Tecfidera,2016-10-19,2021-03-12,500,mg,['2 / Day'],Oral,Adverse Event
1834,1492,Endoxan,2015-12-24,2019-01-29,400,mcg,['/ Day'], ,Adverse Event
1835,1492,D-cure (Vitamine D),2016-07-13,2018-10-10, ,mg,['2 / Day'], ,Persisting MRI activity
1836,1492,Rebif [22],2016-04-23,,1000, ,['/Month'],IV, 
1837,374,IVIG,2016-10-13,,500, ,['3 / Week'],IV, 
1838,374,Methylprednisolone,2016-07-04,, , ,['2 / Day'],Oral, 
1839,374,Methylprednisolone,2016-04-14,, , ,['2 / Day'], , 
1840,374,Betaferon,2016-08-29,2020-07-23, , ,['/Month'], ,Adverse Event
1841,804,Rebif [44],2015-12-06,,300, ,['/Month'],IV, 
1842,804,IVIG,2016-01-26,, , ,['2 / Day'],IV, 
1843,804,Tysabri,2016-06-01,,300,MIU,['2 / Day'],IV, 
1844,1397,Teriflunomide,2016-01-29,,1000,mg,['/Month'], , 
1845,1397,Alemtuzumab (Campath),2016-10-08,2021-04-14, , ,['2 / Day'], ,Adverse Event
1846,1397,Betaferon,2016-04-24,,1000,mg,['/ Day'],IV, 
1847,1397,Betaferon,2016-03-14,,400, ,['/Month'],Oral, 
1848,755,Tecfidera,2016-04-19,2021-02-11,5000, ,['/ Week'],IV,Lack of efficacy
1849,755,Rebif [44],2015-11-17,,1000,mg,['2 / Day'], , 
1850,755,Rebif [44],2015-11-06,2018-12-11, ,mg,['3 / Week'],IV,Lack of efficacy
1851,1366,Ledertrexaat,2016-07-19,,300,mcg,['2 / Day'],Oral, 
1852,1366,Tysabri,2016-01-11,,1,mg,['2 / Day'], , 
1853,1366,Tysabri,2016-09-11,, , ,['/Month'],IV, 
1854,2354,Tysabri,2016-05-07,2019-06-13, ,mg,['/ Day'], ,Lack of efficacy
1855,2354,Endoxan,2016-06-01,2020-03-27,300, ,['/Month'],IV,Persisting MRI activity
1856,2354,Avonex,2016-08-25,2021-01-03,300,MIU,['/Month'],IV,Lack of efficacy
1857,2354,Tecfidera,2016-03-22,,1,mg,[' '],IV, 
1858,4987,Tecfidera,2016-10-22,,1,mg,['2 / Day'], , 
1859,1903,Rebif [22],2016-05-16,2019-04-17,1000, ,['3 / Week'], ,Lack of efficacy
1860,1903,D-cure (Vitamine D),2016-02-19,, ,mg,['/Month'],IV, 
1861,1903,D-cure (Vitamine D),2016-05-05,, ,mg,['2 / Day'], , 
1862,4707,Avonex,2016-09-20,,1000,mg,['/Month'],IV, 
1863,4707,Methylprednisolone,2016-10-07,2019-09-28,20,mcg,['2 / Day'],IV,Lack of efficacy
1864,556,Endoxan,2016-02-04,,20,MIU,['/Month'],IV, 
1865,1037,Ledertrexaat,2016-10-11,2018-09-08,1000,mg,['2 / Day'], ,Adverse Event
1866,1037,Mitoxantrone,2016-09-25,2019-12-17,5000,mcg,['/ Day'],IV,Lack of efficacy
1867,1037,Alemtuzumab (Campath),2016-01-31,2020-05-12,1, ,[' '],IV,Lack of efficacy
1868,851,Copaxone,2016-10-14,2018-05-06,400,mg,['/ Day'], ,Adverse Event
1869,2803,IVIG,2016-10-08,2018-02-14,1000,mg,[' '], ,Patient Choice/Convenience
1870,1379,Alemtuzumab (Campath),2016-08-31,,1,mg,['/ Day'],Oral, 
1871,1379,Rebif [22],2016-02-24,,1000,mg,['3 / Week'],IV, 
1872,1379,Alemtuzumab (Campath),2016-06-19,,20,mg,['/Month'],IV, 
1873,1379,Tecfidera,2016-04-08,2020-12-15,500,mg,['2 / Day'],Oral,Adverse Event
1874,3562,Rebif [44],2016-03-18,, ,MIU,['/Month'],IV, 
1875,3562,Endoxan,2016-10-08,2018-02-18,5000,MIU,['3 / Week'],IV,Adverse Event
1876,2092,Endoxan,2016-10-10,, , ,['3 / Week'], , 
1877,1511,Ledertrexaat,2016-02-06,, ,mg,['/Month'], , 
1878,1511,D-cure (Vitamine D),2016-09-22,, , ,['2 / Day'], , 
1879,1511,Copaxone,2016-09-02,,1000,MIU,['2 / Day'],IV, 
1880,1241,Rebif [44],2016-09-28,, , ,['/Month'],IV, 
1881,1241,Rebif [22],2016-06-26,2018-06-18, ,MIU,['/Month'], ,Patient Choice/Convenience
1882,438,Copaxone,2015-12-29,2019-11-19, ,mg,['/ Week'],IV,Adverse Event
1883,438,Methylprednisolone,2016-03-06,2018-05-21,300, ,['2 / Day'],IV,Lack of efficacy
1884,438,Gilenya,2015-11-20,,500,mcg,['/Month'],Oral, 
1885,3851,Tysabri,2016-09-14,, , ,['/Month'],IV, 
1886,3851,Rebif [22],2016-09-19,2019-11-10, ,MIU,[' '], ,Persisting MRI activity
1887,3851,Avonex,2016-06-21,,20,mg,['2 / Day'], , 
1888,3851,Ledertrexaat,2016-09-13,2018-07-04,5000,mg,['/ Week'], ,Patient Choice/Convenience
1889,4027,Gilenya,2016-07-30,2018-07-12, , ,['2 / Day'],IV,Adverse Event
1890,4027,Avonex,2016-04-21,,5000,mg,['2 / Day'], , 
1891,4027,Methylprednisolone,2016-07-01,,1,mg,[' '],Oral, 
1892,4027,D-cure (Vitamine D),2016-06-08,,300, ,['/ Week'],IV, 
1893,292,Tecfidera,2016-01-19,2019-06-17, ,mg,['/Month'],IV,Patient Choice/Convenience
1894,292,Ledertrexaat,2016-10-21,2018-11-25, ,MIU,['/Month'], ,Patient Choice/Convenience
1895,292,Copaxone,2016-02-08,,1,mg,[' '],IV, 
1896,2840,D-cure (Vitamine D),2016-04-04,, ,mg,[' '], , 
1897,1386,IVIG,2016-09-06,, ,mg,['/Month'], , 
1898,1386,Methylprednisolone,2016-05-02,, ,mg,['/ Week'],IV, 
1899,1386,Rebif [44],2016-02-20,,20,mg,['/ Day'], , 
1900,2273,Avonex,2015-12-31,,20,mg,['2 / Day'], , 
1901,2273,Teriflunomide,2016-02-06,,1, ,['3 / Week'],IV, 
1902,4795,Methylprednisolone,2016-03-27,2021-04-05, ,mg,['/Month'], ,Persisting MRI activity
1903,2751,Rebif [44],2016-02-25,, ,mcg,['2 / Day'],IV, 
1904,616,IVIG,2015-12-08,2020-08-30,500,mg,['2 / Day'], ,Persisting MRI activity
1905,616,Copaxone,2016-05-27,,1000,mg,['/Month'], , 
1906,1223,Ledertrexaat,2016-01-14,2019-11-29,5000, ,['/ Day'], ,Persisting MRI activity
1907,1223,Gilenya,2016-06-02,2019-02-04,500,mg,['3 / Week'], ,Adverse Event
1908,1223,D-cure (Vitamine D),2016-06-10,2021-04-18,20,MIU,[' '], ,Adverse Event
1909,2467,Tecfidera,2016-08-28,2018-03-26,500,mg,[' '],IV,Adverse Event
1910,2467,Rebif [44],2016-07-23,2020-05-20, , ,['/Month'],Oral,Adverse Event
1911,2467,Avonex,2016-04-20,2021-09-14,1,MIU,['/Month'], ,Lack of efficacy
1912,3427,IVIG,2016-10-07,2020-08-06,300,mg,['2 / Day'],IV,Lack of efficacy
1913,3427,Tysabri,2016-05-05,2017-10-29,20,mg,['3 / Week'], ,Patient Choice/Convenience
1914,2548,Endoxan,2015-12-01,, , ,['/Month'], , 
1915,2548,Mitoxantrone,2016-08-28,2019-06-16, ,MIU,['/Month'],IV,Adverse Event
1916,2548,Tysabri,2016-02-17,2019-07-29, ,mg,['/ Week'],IV,Patient Choice/Convenience
1917,554,Methylprednisolone,2016-07-04,, ,MIU,['/Month'], , 
1918,554,Betaferon,2016-02-04,2018-06-04,400,mg,['2 / Day'],Oral,Adverse Event
1919,554,IVIG,2016-06-30,,20,mg,['2 / Day'], , 
1920,324,Rebif [44],2016-08-24,2018-07-06,300,mg,['3 / Week'], ,Adverse Event
1921,324,IVIG,2016-08-12,2018-05-15,5000, ,['2 / Day'], ,Persisting MRI activity
1922,324,D-cure (Vitamine D),2016-01-14,,20,mg,['/ Week'], , 
1923,324,D-cure (Vitamine D),2016-05-03,,500,mg,[' '],Oral, 
1924,2611,Rebif [44],2015-12-25,,300,mg,['/Month'],IV, 
1925,2611,Ledertrexaat,2016-03-21,2018-12-31,5000,mg,['2 / Day'],IV,Persistence of relapses
1926,2611,Copaxone,2016-07-26,2021-01-16,1,MIU,['/Month'],IV,Persisting MRI activity
1927,2611,Gilenya,2016-06-15,, ,mcg,['2 / Day'], , 
1928,3876,D-cure (Vitamine D),2016-06-16,2020-08-21,20,mg,['3 / Week'],IV,Adverse Event
1929,3876,Gilenya,2016-02-01,,300, ,['3 / Week'], , 
1930,3876,Gilenya,2016-02-16,2019-08-25, ,mg,['/Month'],IV,Persisting MRI activity
1931,3876,Alemtuzumab (Campath),2016-03-10,,20, ,[' '], , 
1932,3027,Alemtuzumab (Campath),2016-01-22,, ,mg,['/Month'],Oral, 
1933,3027,Copaxone,2015-12-30,,1000,MIU,['/ Day'],IV, 
1934,2481,IVIG,2016-09-12,2018-05-08, , ,['/Month'],Oral,Adverse Event
1935,2481,Rebif [44],2016-03-30,, ,MIU,['/Month'], , 
1936,4702,Methylprednisolone,2016-07-25,,5000,mg,['2 / Day'], , 
1937,4702,Mitoxantrone,2016-05-01,,1000,MIU,['2 / Day'], , 
1938,4702,Tysabri,2016-04-14,2020-12-19,20,mg,['/ Week'], ,Persisting MRI activity
1939,4702,Avonex,2016-03-06,,20,mg,[' '],IV, 
1940,2071,Ledertrexaat,2016-03-05,2021-04-03,1,MIU,['/ Day'],IV,Adverse Event
1941,2071,Teriflunomide,2015-12-29,2019-06-03,1,mg,['3 / Week'],IV,Patient Choice/Convenience
1942,2071,Alemtuzumab (Campath),2016-07-16,,20, ,['3 / Week'], , 
1943,2071,Avonex,2016-05-09,2018-06-07,1000,mg,['/Month'],IV,Adverse Event
1944,1931,Ledertrexaat,2016-04-12,2021-07-17, ,mcg,['/ Week'], ,Persisting MRI activity
1945,1931,Tecfidera,2016-07-12,, , ,['/Month'],IV, 
1946,1931,Alemtuzumab (Campath),2016-04-17,, , ,['2 / Day'], , 
1947,4122,Mitoxantrone,2016-06-23,,1,mg,[' '], , 
1948,4659,Tysabri,2016-06-13,,500,mg,['2 / Day'], , 
1949,4659,Alemtuzumab (Campath),2016-03-29,2019-08-06, , ,['2 / Day'],IV,Persistence of relapses
1950,4659,Methylprednisolone,2016-05-09,2020-03-11,1000,mcg,['/Month'], ,Patient Choice/Convenience
1951,2546,Tecfidera,2016-04-16,, , ,['2 / Day'],IV, 
1952,2546,Rebif [22],2015-12-22,2018-01-20,500, ,['2 / Day'],IV,Adverse Event
1953,2546,Avonex,2016-07-02,2018-09-19,5000, ,['/Month'], ,Persisting MRI activity
1954,2546,D-cure (Vitamine D),2016-05-05,2021-04-19,1,mg,['2 / Day'],IV,Lack of efficacy
1955,4301,Rebif [22],2015-10-30,2018-04-20,20, ,['3 / Week'],IV,Lack of efficacy
1956,4301,D-cure (Vitamine D),2016-02-25,2020-12-22,5000,mg,['/Month'], ,Lack of efficacy
1957,4687,Gilenya,2016-01-22,, ,mg,['3 / Week'], , 
1958,4687,Betaferon,2016-07-22,2019-06-12,5000,mg,['2 / Day'],IV,Adverse Event
1959,1089,Gilenya,2016-06-30,2020-10-18,20, ,['/Month'], ,Lack of efficacy
1960,4690,Alemtuzumab (Campath),2016-10-19,,400, ,['/Month'],Oral, 
1961,4690,Copaxone,2016-02-25,,400,mcg,['/Month'], , 
1962,4690,Avonex,2016-06-09,2020-08-04,300, ,['/Month'],IV,Lack of efficacy
1963,1405,Copaxone,2016-10-15,,500,mg,['2 / Day'],IV, 
1964,1405,Methylprednisolone,2015-11-09,,300, ,['/Month'],Oral, 
1965,1405,Tysabri,2016-01-05,, ,mg,['/Month'],IV, 
1966,1405,Methylprednisolone,2016-04-12,,1000,mg,[' '],Oral, 
1967,198,Alemtuzumab (Campath),2016-05-25,2021-05-26,5000, ,['2 / Day'],Oral,Lack of efficacy
1968,198,Methylprednisolone,2016-02-09,,5000,mg,[' '],IV, 
1969,939,Teriflunomide,2016-03-09,2019-02-11,20,mg,['2 / Day'],IV,Persisting MRI activity
1970,2474,Rebif [22],2016-06-24,,500,mg,['3 / Week'], , 
1971,4221,Rebif [22],2016-03-07,,20,mg,[' '],IV, 
1972,4564,D-cure (Vitamine D),2016-07-06,, ,MIU,['2 / Day'], , 
1973,4564,Tysabri,2016-06-11,,5000,mg,['3 / Week'],IV, 
1974,4564,Tecfidera,2016-06-30,,1000,mg,['/Month'],IV, 
1975,4564,Alemtuzumab (Campath),2016-10-21,2018-09-12,1,mg,[' '],IV,Patient Choice/Convenience
1976,4096,Teriflunomide,2016-07-07,2020-01-28,5000,mcg,['2 / Day'],Oral,Lack of efficacy
1977,4096,Tecfidera,2016-04-24,2020-01-27,20, ,['/ Day'],IV,Lack of efficacy
1978,1024,Copaxone,2016-05-25,, ,MIU,['2 / Day'], , 
1979,1024,Rebif [22],2016-03-05,,500, ,['2 / Day'], , 
1980,4350,Gilenya,2015-11-30,,300, ,['/ Day'],IV, 
1981,4350,Rebif [44],2016-09-04,,1, ,[' '],IV, 
1982,4350,Avonex,2016-07-19,2019-06-26,5000, ,['2 / Day'], ,Adverse Event
1983,4350,Methylprednisolone,2016-09-16,,20, ,['/Month'],IV, 
1984,2667,Copaxone,2016-02-18,,300, ,['3 / Week'], , 
1985,2667,D-cure (Vitamine D),2015-12-24,,1000,mg,['2 / Day'],IV, 
1986,2667,Gilenya,2016-09-15,,400,mg,['/Month'],IV, 
1987,2667,Avonex,2016-07-15,2020-03-25, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
1988,3492,D-cure (Vitamine D),2015-12-04,2019-06-14,400, ,['3 / Week'],IV,Patient Choice/Convenience
1989,1557,Avonex,2016-05-03,,20, ,['/Month'],IV, 
1990,3023,D-cure (Vitamine D),2016-08-11,,5000,mg,['2 / Day'], , 
1991,3023,D-cure (Vitamine D),2016-07-02,2021-08-30, ,mcg,['/Month'],Oral,Patient Choice/Convenience
1992,4254,Endoxan,2016-08-21,,5000,mg,['2 / Day'],IV, 
1993,4254,Tecfidera,2016-06-22,2019-04-21, , ,['2 / Day'], ,Patient Choice/Convenience
1994,4853,Gilenya,2016-02-05,2019-01-03,1000, ,['2 / Day'], ,Persistence of relapses
1995,2780,Gilenya,2016-10-16,2018-06-14,300, ,['/ Week'],IV,Adverse Event
1996,2780,Teriflunomide,2015-11-08,2018-05-31,300, ,['2 / Day'],Oral,Persisting MRI activity
1997,1415,Tecfidera,2016-09-18,,500,mg,['/ Day'], , 
1998,1985,D-cure (Vitamine D),2016-04-19,,20,mg,['2 / Day'],IV, 
1999,1985,D-cure (Vitamine D),2016-03-27,,500,mg,['/Month'],IV, 
2000,1985,Tysabri,2016-07-21,, ,mcg,[' '],IV, 
2001,1985,Betaferon,2016-01-21,,300,mg,['/ Week'],IV, 
2002,776,Tecfidera,2016-01-07,,5000,mg,['3 / Week'],IV, 
2003,776,Alemtuzumab (Campath),2015-12-16,2020-02-07, ,mcg,[' '],Oral,Patient Choice/Convenience
2004,776,Betaferon,2016-07-08,,20,mg,['/Month'], , 
2005,532,Teriflunomide,2015-11-10,2021-03-22, , ,['/Month'], ,Persisting MRI activity
2006,4268,Betaferon,2016-01-28,,300,mg,['/Month'], , 
2007,4268,Methylprednisolone,2016-02-17,2020-03-17, , ,['2 / Day'],IV,Persisting MRI activity
2008,4268,Rebif [22],2016-06-13,,400, ,['2 / Day'],IV, 
2009,4268,Tysabri,2016-06-09,,1000, ,['/ Day'], , 
2010,2236,Gilenya,2016-08-23,,20, ,[' '],Oral, 
2011,2236,Tysabri,2016-02-11,,20, ,[' '],IV, 
2012,2236,Rebif [22],2016-06-24,,300,mg,['3 / Week'],IV, 
2013,2236,Tecfidera,2016-01-30,2019-09-12,300,mg,['2 / Day'],IV,Persisting MRI activity
2014,621,D-cure (Vitamine D),2016-01-12,,5000,MIU,['/Month'],IV, 
2015,1613,Copaxone,2016-09-28,, ,mg,['3 / Week'],Oral, 
2016,3202,D-cure (Vitamine D),2016-04-22,,20,mcg,['/ Week'],IV, 
2017,3202,IVIG,2015-11-09,,500, ,['/ Day'],IV, 
2018,2612,Rebif [44],2016-08-31,2020-09-13, , ,['2 / Day'],IV,Persisting MRI activity
2019,2612,Alemtuzumab (Campath),2016-03-16,, ,mg,['2 / Day'], , 
2020,2612,Avonex,2016-06-21,2020-07-08, ,mg,['3 / Week'], ,Patient Choice/Convenience
2021,2612,Methylprednisolone,2016-04-13,,300,mg,['2 / Day'], , 
2022,4895,Betaferon,2016-02-16,2021-01-14, ,mg,['/Month'], ,Lack of efficacy
2023,4895,Teriflunomide,2016-04-17,,5000, ,['/Month'],IV, 
2024,4895,Teriflunomide,2016-05-15,2020-03-27, , ,['2 / Day'],Oral,Adverse Event
2025,4496,IVIG,2016-05-26,2020-02-23,20,mg,['3 / Week'], ,Adverse Event
2026,4496,D-cure (Vitamine D),2015-12-23,,5000,mg,['/Month'], , 
2027,4644,Alemtuzumab (Campath),2016-09-30,2019-06-30,5000,mg,['3 / Week'],IV,Patient Choice/Convenience
2028,4644,Tecfidera,2015-12-25,2021-10-10,5000, ,['/ Day'],IV,Persisting MRI activity
2029,4644,Mitoxantrone,2015-12-23,, , ,['2 / Day'],IV, 
2030,4644,Alemtuzumab (Campath),2015-11-23,,20, ,['/ Week'], , 
2031,543,Endoxan,2016-09-11,,500,mg,['3 / Week'], , 
2032,543,Teriflunomide,2016-01-28,2019-07-14,400,mcg,['2 / Day'], ,Persistence of relapses
2033,2296,Rebif [44],2016-10-22,,1,mg,['/Month'],IV, 
2034,2296,Ledertrexaat,2016-03-16,2018-11-18, ,mcg,['/ Day'], ,Adverse Event
2035,1501,Copaxone,2016-10-16,,500, ,['3 / Week'],IV, 
2036,241,Alemtuzumab (Campath),2016-03-08,2019-12-13,1000,mcg,['2 / Day'], ,Patient Choice/Convenience
2037,241,Endoxan,2016-04-05,2020-05-11,500,mcg,['2 / Day'],IV,Persisting MRI activity
2038,241,Ledertrexaat,2015-12-29,,1000,MIU,['3 / Week'],IV, 
2039,2531,Copaxone,2015-12-22,, ,mg,['2 / Day'],IV, 
2040,2531,Betaferon,2016-10-07,,1,mg,['/ Day'],IV, 
2041,1170,Ledertrexaat,2016-04-11,2019-12-22, ,mg,['/Month'], ,Lack of efficacy
2042,1170,D-cure (Vitamine D),2016-04-17,,300,mg,['/Month'],Oral, 
2043,4746,Betaferon,2016-02-29,,500,mg,['/ Day'],IV, 
2044,2747,Gilenya,2016-02-11,,5000,mg,['2 / Day'], , 
2045,2747,Avonex,2015-12-08,2021-07-16,5000, ,['/Month'], ,Patient Choice/Convenience
2046,2747,Rebif [44],2016-08-28,2019-11-06,1, ,['/Month'],IV,Adverse Event
2047,3874,Endoxan,2016-05-22,,300,mg,['/ Day'],IV, 
2048,3874,Rebif [44],2016-10-22,2019-04-20, , ,['3 / Week'],IV,Adverse Event
2049,3874,IVIG,2016-04-05,,500, ,['/Month'],IV, 
2050,3874,Rebif [22],2015-11-11,, ,mg,['/Month'], , 
2051,1174,Rebif [44],2015-10-31,2019-01-09, , ,['/Month'],IV,Adverse Event
2052,1174,D-cure (Vitamine D),2016-03-16,2019-12-17, ,mg,['2 / Day'], ,Persistence of relapses
2053,1174,Methylprednisolone,2015-12-17,2020-04-28,500, ,['2 / Day'],IV,Persisting MRI activity
2054,1656,Gilenya,2016-09-05,, ,mg,[' '],IV, 
2055,4218,IVIG,2015-11-07,2019-11-12,1000, ,['2 / Day'], ,Patient Choice/Convenience
2056,4311,Alemtuzumab (Campath),2016-02-02,2019-09-19,1000, ,['/Month'],IV,Patient Choice/Convenience
2057,4311,Tysabri,2016-10-20,,20,mg,['/ Day'],IV, 
2058,4311,Tysabri,2015-12-18,2021-07-01,300, ,['2 / Day'],IV,Persisting MRI activity
2059,565,Alemtuzumab (Campath),2016-07-04,,1, ,['/Month'],IV, 
2060,565,Tecfidera,2016-07-28,, , ,['3 / Week'],IV, 
2061,565,Mitoxantrone,2016-09-03,2021-09-02, ,MIU,['/Month'],Oral,Adverse Event
2062,565,Methylprednisolone,2016-06-22,2020-08-09, ,mg,['/Month'],IV,Patient Choice/Convenience
2063,3978,Methylprednisolone,2016-03-12,2021-06-30,500,mg,['3 / Week'],IV,Adverse Event
2064,3978,Tecfidera,2016-05-01,,1000,mg,['/ Day'], , 
2065,3978,Alemtuzumab (Campath),2015-12-10,2020-08-19,1,mg,['/Month'],IV,Adverse Event
2066,3978,Teriflunomide,2016-06-15,,20,mg,['/Month'],IV, 
2067,428,Alemtuzumab (Campath),2016-01-18,2021-07-05, , ,['/Month'],IV,Lack of efficacy
2068,428,IVIG,2016-01-27,2021-04-27,20, ,[' '], ,Lack of efficacy
2069,3610,Tysabri,2015-11-30,,5000, ,['2 / Day'],Oral, 
2070,1052,Copaxone,2016-08-05,,20, ,[' '],IV, 
2071,1052,Rebif [44],2016-10-05,2020-08-30,500,mg,['/Month'], ,Adverse Event
2072,1052,Gilenya,2016-04-26,,20, ,['/Month'],IV, 
2073,4183,Gilenya,2016-10-17,2018-04-10, ,mg,['/Month'],IV,Persisting MRI activity
2074,1767,Ledertrexaat,2016-04-07,,1, ,['3 / Week'],Oral, 
2075,1767,Endoxan,2015-12-30,, ,mcg,['/Month'],IV, 
2076,667,IVIG,2016-03-22,2020-05-06, ,MIU,[' '], ,Persistence of relapses
2077,667,Endoxan,2016-06-25,,300,mg,['/Month'],IV, 
2078,667,Methylprednisolone,2016-04-26,2019-03-15,300,mcg,['2 / Day'], ,Patient Choice/Convenience
2079,667,IVIG,2016-05-04,, ,mg,['3 / Week'], , 
2080,3870,Endoxan,2016-02-13,, , ,['3 / Week'],IV, 
2081,3870,Tysabri,2016-08-22,,5000,MIU,['/Month'],IV, 
2082,975,Alemtuzumab (Campath),2016-04-02,2018-09-12,1000,mg,[' '], ,Persisting MRI activity
2083,975,Betaferon,2016-07-29,2018-06-29, ,MIU,['2 / Day'],IV,Adverse Event
2084,975,D-cure (Vitamine D),2016-04-14,2018-04-24, ,mg,['/Month'], ,Persistence of relapses
2085,975,Avonex,2016-09-30,,5000,mg,['/Month'], , 
2086,3197,Betaferon,2016-03-29,, ,mcg,['3 / Week'],Oral, 
2087,3197,Rebif [22],2016-07-24,2018-08-09, , ,['3 / Week'], ,Adverse Event
2088,3197,Rebif [22],2016-10-19,,500,mg,['/ Day'],Oral, 
2089,3197,D-cure (Vitamine D),2016-06-19,, ,MIU,['2 / Day'],IV, 
2090,2190,Methylprednisolone,2015-12-09,,5000,mg,['2 / Day'],Oral, 
2091,2190,Tecfidera,2015-12-16,,5000,MIU,[' '], , 
2092,2190,Rebif [22],2015-11-19,,300,mg,['/ Week'],IV, 
2093,2190,IVIG,2016-08-03,,1000,mg,['2 / Day'],Oral, 
2094,1523,Tecfidera,2016-02-11,,500,mg,['/Month'], , 
2095,1523,Mitoxantrone,2016-03-01,,20,mcg,['3 / Week'],IV, 
2096,1523,Rebif [44],2016-09-02,,400,mg,['2 / Day'],IV, 
2097,3237,D-cure (Vitamine D),2015-12-25,,5000, ,['/Month'],IV, 
2098,3762,Methylprednisolone,2016-01-24,, ,mg,['/Month'],IV, 
2099,3762,Tecfidera,2016-06-11,2020-06-23,300, ,['2 / Day'], ,Adverse Event
2100,3762,Tysabri,2016-09-21,2020-02-18, ,mg,['/ Day'],IV,Patient Choice/Convenience
2101,3762,Teriflunomide,2015-10-29,, ,mg,['2 / Day'],IV, 
2102,4555,Alemtuzumab (Campath),2016-05-10,, , ,[' '], , 
2103,4555,Gilenya,2016-06-20,,500,mg,['/Month'], , 
2104,4555,Methylprednisolone,2015-11-12,,1000, ,['/ Day'],IV, 
2105,3660,IVIG,2016-09-11,2018-04-12,5000,mg,['3 / Week'],IV,Adverse Event
2106,3660,D-cure (Vitamine D),2016-03-25,, ,mg,[' '],IV, 
2107,2685,Avonex,2016-02-28,, ,mg,['/Month'],IV, 
2108,2685,Methylprednisolone,2016-10-07,, ,mg,['3 / Week'],IV, 
2109,2356,Avonex,2016-02-17,, ,MIU,['2 / Day'], , 
2110,2356,D-cure (Vitamine D),2016-02-13,2021-02-12,400,mg,['/ Week'],IV,Adverse Event
2111,2356,Methylprednisolone,2015-12-28,,1000,mg,['/ Day'],IV, 
2112,3312,Copaxone,2015-12-16,2020-07-24,5000, ,['2 / Day'],IV,Persistence of relapses
2113,3312,Tysabri,2016-04-15,, ,mg,['/ Week'], , 
2114,3312,Copaxone,2016-10-16,2019-04-13,500, ,['/Month'],Oral,Persisting MRI activity
2115,3312,Mitoxantrone,2015-12-11,2021-07-20,20, ,['2 / Day'],IV,Lack of efficacy
2116,3509,Rebif [44],2016-01-31,,500,mg,['2 / Day'],IV, 
2117,3509,Rebif [22],2016-03-09,2018-09-11,400, ,['2 / Day'],IV,Adverse Event
2118,3509,Avonex,2016-08-08,2019-09-24,20, ,['2 / Day'], ,Adverse Event
2119,1974,Tecfidera,2016-01-19,2021-04-05, , ,[' '],IV,Lack of efficacy
2120,1974,Betaferon,2016-01-02,, ,mg,['2 / Day'],IV, 
2121,3641,IVIG,2016-05-04,2021-07-14,400,mcg,['2 / Day'], ,Persisting MRI activity
2122,3641,Endoxan,2016-09-02,, ,mg,['/Month'], , 
2123,4892,D-cure (Vitamine D),2016-10-04,2021-04-17, ,mg,['/ Day'],IV,Persisting MRI activity
2124,4203,Tecfidera,2016-08-18,,500, ,['/Month'],IV, 
2125,4203,Rebif [44],2015-12-13,2017-11-01, , ,['3 / Week'], ,Persisting MRI activity
2126,1170,Gilenya,2016-06-29,2018-05-11,300,MIU,['/Month'], ,Lack of efficacy
2127,1170,Tecfidera,2016-06-07,2021-02-27,1000,mg,['/ Day'], ,Persistence of relapses
2128,2150,Alemtuzumab (Campath),2016-02-18,,20, ,['2 / Day'],IV, 
2129,1508,Rebif [22],2015-10-28,,300,mg,['/Month'], , 
2130,1508,Avonex,2016-06-11,,5000, ,['2 / Day'], , 
2131,4910,Gilenya,2015-11-01,2020-03-21,300, ,['2 / Day'], ,Adverse Event
2132,4910,Tecfidera,2016-04-29,,20,mg,['2 / Day'],IV, 
2133,4910,Gilenya,2016-07-15,,20,mg,['3 / Week'],IV, 
2134,4910,Methylprednisolone,2016-07-13,, , ,['2 / Day'],IV, 
2135,4761,Tecfidera,2016-09-14,,500,mg,['3 / Week'],Oral, 
2136,3619,Alemtuzumab (Campath),2016-10-01,,300,mg,['/Month'],IV, 
2137,3619,Tecfidera,2016-03-26,,5000,mg,['/ Week'],IV, 
2138,3619,Ledertrexaat,2015-11-07,, ,MIU,['/Month'],IV, 
2139,1591,Rebif [22],2016-09-08,2019-06-28, ,mg,['/Month'], ,Lack of efficacy
2140,3705,Mitoxantrone,2016-01-03,, , ,['3 / Week'], , 
2141,1298,Avonex,2015-10-26,, ,mg,['3 / Week'],IV, 
2142,1298,Gilenya,2015-12-15,, , ,['/Month'],Oral, 
2143,4331,Rebif [22],2015-12-28,2019-10-20, , ,['3 / Week'],IV,Lack of efficacy
2144,4331,D-cure (Vitamine D),2015-11-05,2019-10-29,1000,mg,['2 / Day'],IV,Persistence of relapses
2145,322,Tecfidera,2016-04-16,2021-01-31, ,MIU,['/ Day'],IV,Adverse Event
2146,4203,Tysabri,2016-05-27,,500,MIU,['2 / Day'], , 
2147,4203,D-cure (Vitamine D),2015-12-03,, ,mg,['/ Day'], , 
2148,4203,Avonex,2016-07-19,2019-04-22, ,mg,['3 / Week'], ,Adverse Event
2149,1668,Ledertrexaat,2015-11-13,, ,mg,['/Month'],Oral, 
2150,1668,Alemtuzumab (Campath),2016-04-27,,300, ,['2 / Day'],IV, 
2151,1668,Rebif [22],2016-05-30,,20,mg,['/Month'], , 
2152,1668,Gilenya,2016-02-01,, , ,['/ Day'], , 
2153,147,Gilenya,2016-10-14,,1, ,['/Month'], , 
2154,147,Rebif [44],2016-06-20,, , ,[' '],IV, 
2155,147,Tecfidera,2016-04-11,,20, ,['/Month'],IV, 
2156,4503,Endoxan,2015-10-24,,20, ,['/Month'],IV, 
2157,4503,Gilenya,2016-02-13,2017-12-25,300,mcg,['3 / Week'],IV,Lack of efficacy
2158,4503,Mitoxantrone,2015-11-20,2017-12-17, ,mg,['/Month'],IV,Adverse Event
2159,4503,Gilenya,2016-03-18,2018-03-20,1000,MIU,['2 / Day'], ,Adverse Event
2160,4197,Ledertrexaat,2016-01-19,, , ,['/Month'],IV, 
2161,4197,Rebif [44],2016-02-20,2021-09-13,400, ,['/Month'], ,Adverse Event
2162,1792,Rebif [22],2016-09-01,2021-05-01,1000, ,['3 / Week'], ,Patient Choice/Convenience
2163,1942,Betaferon,2016-03-03,,5000, ,['/Month'],IV, 
2164,1511,Tysabri,2016-10-16,, ,mcg,['/Month'],IV, 
2165,1511,Tysabri,2016-02-14,,20, ,['3 / Week'],IV, 
2166,1511,Rebif [22],2016-06-02,2018-08-24, , ,['/ Week'],IV,Lack of efficacy
2167,3568,D-cure (Vitamine D),2015-12-09,,20, ,['2 / Day'],IV, 
2168,3568,Rebif [44],2015-12-08,,300,mg,['2 / Day'], , 
2169,3568,Alemtuzumab (Campath),2016-04-13,2018-03-29,1,mcg,['/Month'],IV,Lack of efficacy
2170,4156,D-cure (Vitamine D),2016-05-15,, , ,['2 / Day'], , 
2171,4156,D-cure (Vitamine D),2016-03-10,,1000,mg,['/Month'], , 
2172,2055,Rebif [22],2016-03-26,,300, ,['3 / Week'], , 
2173,2055,Avonex,2016-06-06,2018-01-23,1,mg,['3 / Week'],Oral,Patient Choice/Convenience
2174,2055,D-cure (Vitamine D),2016-08-12,,1000, ,['/ Day'],IV, 
2175,2325,Rebif [22],2016-08-06,,300, ,['3 / Week'],Oral, 
2176,2325,Rebif [22],2016-03-20,2020-07-25,500,MIU,['3 / Week'],IV,Patient Choice/Convenience
2177,2325,Mitoxantrone,2016-09-01,2019-01-13, ,mg,['/Month'],Oral,Adverse Event
2178,2325,Tysabri,2016-09-25,,1,MIU,['/ Week'],IV, 
2179,3005,Ledertrexaat,2016-02-14,2018-12-25,300, ,['2 / Day'],IV,Adverse Event
2180,3005,D-cure (Vitamine D),2016-02-14,2021-05-31, ,mg,['3 / Week'],Oral,Adverse Event
2181,3005,Copaxone,2016-02-22,,1000, ,[' '],IV, 
2182,655,Betaferon,2016-02-18,2019-08-31,20,mg,['3 / Week'], ,Adverse Event
2183,655,IVIG,2016-05-30,2020-03-17,1000, ,['/Month'], ,Persisting MRI activity
2184,3437,Tecfidera,2015-11-01,, ,mcg,['/Month'],Oral, 
2185,3437,Methylprednisolone,2016-03-21,, ,mg,['/Month'], , 
2186,3437,Methylprednisolone,2016-09-03,2020-07-28, , ,['2 / Day'],IV,Lack of efficacy
2187,3437,Ledertrexaat,2016-05-10,2017-12-12, ,MIU,['2 / Day'],IV,Persisting MRI activity
2188,2119,Tysabri,2016-04-27,, , ,['/ Day'],IV, 
2189,4934,Endoxan,2016-08-20,,500,mg,['/ Week'], , 
2190,4934,D-cure (Vitamine D),2016-05-17,,300,MIU,['2 / Day'],IV, 
2191,4934,Copaxone,2016-02-23,,1000,mg,['/Month'],IV, 
2192,4934,Methylprednisolone,2016-05-31,2021-05-14, , ,['/ Day'], ,Persisting MRI activity
2193,4886,Rebif [44],2016-05-14,2019-07-27, ,MIU,['2 / Day'], ,Lack of efficacy
2194,4886,Tecfidera,2016-07-15,,500,mg,['3 / Week'],IV, 
2195,4886,Tysabri,2016-02-03,,1000,MIU,['/ Week'],Oral, 
2196,4886,Rebif [44],2016-01-17,,400, ,['/Month'],IV, 
2197,4734,Gilenya,2016-02-26,2020-10-09,400, ,[' '], ,Persisting MRI activity
2198,4734,Tecfidera,2015-10-26,2021-10-08,400, ,[' '],IV,Adverse Event
2199,4734,D-cure (Vitamine D),2015-11-25,,500,mg,['3 / Week'], , 
2200,4734,Gilenya,2016-04-13,,1,mg,['3 / Week'], , 
2201,2556,Tysabri,2016-05-05,2021-08-01, , ,['/ Week'],IV,Persisting MRI activity
2202,2556,IVIG,2016-01-17,,300, ,['/Month'],IV, 
2203,1960,Tecfidera,2016-09-06,, ,mg,['2 / Day'],IV, 
2204,1960,IVIG,2015-11-22,,20,mg,['/Month'],IV, 
2205,1960,Endoxan,2016-04-17,2020-06-14,20, ,[' '], ,Lack of efficacy
2206,4047,Rebif [22],2016-01-12,2020-06-20,500,mg,['3 / Week'], ,Persisting MRI activity
2207,4047,Alemtuzumab (Campath),2016-04-03,2021-03-06,5000, ,['2 / Day'],IV,Adverse Event
2208,4047,IVIG,2016-02-27,,400,MIU,['/Month'],IV, 
2209,687,Betaferon,2016-04-18,2020-12-25,5000,mcg,['/ Week'],IV,Adverse Event
2210,687,Rebif [22],2016-10-20,,20,MIU,['/ Day'],IV, 
2211,2135,IVIG,2016-04-26,2021-08-22,20,mcg,['2 / Day'], ,Patient Choice/Convenience
2212,2135,Avonex,2016-09-19,2019-01-10,1000,MIU,['3 / Week'], ,Lack of efficacy
2213,1645,Avonex,2016-07-06,2020-08-11,500,mg,['2 / Day'],Oral,Adverse Event
2214,1645,Alemtuzumab (Campath),2016-09-01,, , ,['/Month'], , 
2215,226,Teriflunomide,2016-05-06,2018-02-21,20,MIU,['2 / Day'],IV,Lack of efficacy
2216,226,Alemtuzumab (Campath),2016-01-31,2018-12-18,500,MIU,[' '], ,Patient Choice/Convenience
2217,3117,Tecfidera,2016-03-05,2020-03-27,20,mg,[' '], ,Persisting MRI activity
2218,3117,Rebif [22],2016-09-09,2018-08-02,400,mg,['/ Week'], ,Adverse Event
2219,3117,Tysabri,2016-10-13,2020-04-04, , ,['/Month'],IV,Persistence of relapses
2220,3117,IVIG,2016-08-27,2018-12-18,5000, ,['2 / Day'],Oral,Adverse Event
2221,3123,Alemtuzumab (Campath),2016-09-04,,500,MIU,['/Month'],Oral, 
2222,3123,Gilenya,2016-01-06,, ,mg,[' '], , 
2223,3123,Ledertrexaat,2016-08-18,2020-07-17,20,mcg,['2 / Day'], ,Persistence of relapses
2224,3123,Methylprednisolone,2016-02-15,, , ,['/Month'], , 
2225,133,D-cure (Vitamine D),2015-12-29,, , ,[' '],Oral, 
2226,133,Gilenya,2015-12-02,, ,MIU,['2 / Day'],IV, 
2227,133,Betaferon,2015-11-22,2021-04-18, ,mg,['/Month'], ,Patient Choice/Convenience
2228,133,Teriflunomide,2016-02-26,,300, ,['3 / Week'],IV, 
2229,2220,Alemtuzumab (Campath),2016-05-09,,300,mg,['2 / Day'], , 
2230,697,Tysabri,2016-03-15,2018-10-13,1,MIU,['2 / Day'],Oral,Persistence of relapses
2231,3618,Alemtuzumab (Campath),2016-07-12,, , ,['/Month'],IV, 
2232,3618,IVIG,2016-10-19,2021-02-23,5000,mg,['/Month'], ,Patient Choice/Convenience
2233,479,Betaferon,2016-09-08,2020-10-31, ,mg,['/ Day'],IV,Lack of efficacy
2234,479,D-cure (Vitamine D),2016-08-13,, , ,[' '], , 
2235,479,Endoxan,2016-09-25,,500,mcg,['/Month'],Oral, 
2236,892,Endoxan,2016-07-14,2019-11-06,400, ,['/Month'],IV,Patient Choice/Convenience
2237,892,Ledertrexaat,2015-12-18,2020-01-26,20, ,['2 / Day'],IV,Adverse Event
2238,892,IVIG,2016-02-06,,20,mcg,['/ Day'],IV, 
2239,892,Avonex,2016-01-31,,5000, ,['/Month'], , 
2240,3222,Betaferon,2015-11-12,2021-10-13,5000,MIU,['/ Week'],IV,Lack of efficacy
2241,3222,Ledertrexaat,2016-06-03,,20,mg,[' '],Oral, 
2242,3222,Tecfidera,2015-12-24,2021-06-16,300,mg,['2 / Day'],IV,Persisting MRI activity
2243,3222,Methylprednisolone,2015-12-13,,5000,mcg,['2 / Day'],Oral, 
2244,3581,Tysabri,2016-04-11,,20,mg,[' '],Oral, 
2245,3581,Rebif [22],2016-05-14,,1000,mg,['2 / Day'],IV, 
2246,3581,Betaferon,2016-10-07,, , ,[' '],Oral, 
2247,3581,Copaxone,2016-04-25,2019-04-13,400,mg,['3 / Week'],Oral,Persistence of relapses
2248,3991,IVIG,2016-01-03,2018-05-07,1000, ,['3 / Week'],IV,Persisting MRI activity
2249,3991,Gilenya,2016-06-30,2018-05-04,5000,mg,['2 / Day'], ,Adverse Event
2250,3991,Copaxone,2016-09-30,,5000, ,[' '],IV, 
2251,3991,D-cure (Vitamine D),2015-12-28,,5000,mg,['/Month'],IV, 
2252,1238,Rebif [22],2016-05-30,2021-09-30,500, ,['2 / Day'], ,Patient Choice/Convenience
2253,4245,Tysabri,2015-11-04,2020-04-10,300,MIU,['2 / Day'],IV,Persistence of relapses
2254,4245,Rebif [22],2016-08-14,,500,MIU,[' '],IV, 
2255,4245,Mitoxantrone,2015-10-25,2019-03-07,1,mg,['3 / Week'], ,Patient Choice/Convenience
2256,3752,Gilenya,2016-09-04,2018-04-28,20,mg,['2 / Day'],Oral,Persistence of relapses
2257,1511,Methylprednisolone,2016-04-20,, ,mg,['2 / Day'],Oral, 
2258,1951,Betaferon,2016-06-07,, ,mg,[' '], , 
2259,1951,Rebif [22],2016-04-02,2019-02-13, ,mg,['/ Week'],IV,Persistence of relapses
2260,4029,D-cure (Vitamine D),2015-11-04,2019-10-13,300, ,['/Month'], ,Lack of efficacy
2261,4029,Rebif [22],2016-05-08,2020-02-26, , ,['/ Day'],Oral,Lack of efficacy
2262,4029,Copaxone,2016-08-19,2019-09-20,5000, ,['/ Week'],IV,Adverse Event
2263,2135,D-cure (Vitamine D),2016-09-13,2020-05-08,500, ,['2 / Day'], ,Lack of efficacy
2264,2135,Betaferon,2016-02-24,,500,mg,['3 / Week'],IV, 
2265,2135,Avonex,2016-05-23,2020-12-03, , ,[' '],IV,Adverse Event
2266,2135,Rebif [44],2016-04-02,,500, ,['2 / Day'],IV, 
2267,669,Tecfidera,2015-12-29,,300, ,['2 / Day'],IV, 
2268,669,Tysabri,2016-02-21,, ,mg,[' '],Oral, 
2269,3362,Teriflunomide,2016-09-13,, , ,['2 / Day'], , 
2270,3362,D-cure (Vitamine D),2016-04-25,,1,MIU,['3 / Week'],IV, 
2271,3362,Mitoxantrone,2015-12-11,2021-02-18,500,mcg,['/Month'],IV,Patient Choice/Convenience
2272,3362,Avonex,2015-12-19,,300,mg,['3 / Week'],IV, 
2273,3301,Mitoxantrone,2016-05-17,,500, ,['3 / Week'], , 
2274,3301,Copaxone,2016-06-24,2020-07-08,1, ,[' '], ,Persisting MRI activity
2275,3301,Endoxan,2016-08-02,2020-04-25, ,MIU,['2 / Day'],Oral,Adverse Event
2276,3301,Tysabri,2016-02-25,,20, ,['/ Week'],IV, 
2277,4776,Rebif [44],2016-06-24,,5000, ,['/Month'],IV, 
2278,4765,IVIG,2016-07-14,, ,mcg,['3 / Week'],IV, 
2279,852,Ledertrexaat,2016-03-24,, ,mg,['/Month'], , 
2280,852,Copaxone,2016-03-13,2019-01-20,500,mg,['/Month'],IV,Persistence of relapses
2281,852,Rebif [44],2016-02-04,,500,mg,['/Month'],IV, 
2282,401,Teriflunomide,2016-05-02,2019-08-02, ,MIU,['/ Week'],IV,Lack of efficacy
2283,401,Copaxone,2016-01-05,,500, ,['2 / Day'],IV, 
2284,401,Tecfidera,2016-06-21,,5000,mg,['/Month'], , 
2285,401,Gilenya,2016-08-06,2020-06-10, ,MIU,['2 / Day'],IV,Adverse Event
2286,3896,Tecfidera,2016-03-10,2021-06-28,300,mg,[' '],IV,Persisting MRI activity
2287,3896,IVIG,2016-03-29,2020-09-02,300,mg,['2 / Day'],Oral,Lack of efficacy
2288,3896,Teriflunomide,2016-02-09,2019-09-17,5000,mg,['3 / Week'], ,Persisting MRI activity
2289,1103,Rebif [22],2016-07-07,2019-08-01,500,mg,['/Month'], ,Persisting MRI activity
2290,2317,Endoxan,2016-07-21,,1, ,['/Month'], , 
2291,3083,Avonex,2016-02-02,,1000,mg,['/Month'], , 
2292,3083,Rebif [22],2016-06-06,,5000,MIU,['2 / Day'],IV, 
2293,3083,Gilenya,2016-09-10,,5000, ,['/Month'], , 
2294,3699,Gilenya,2016-05-15,,400, ,['3 / Week'], , 
2295,3699,Ledertrexaat,2016-01-23,,5000,MIU,[' '],IV, 
2296,3699,IVIG,2016-02-25,, ,MIU,['2 / Day'],IV, 
2297,229,Copaxone,2016-07-02,, ,mg,['/Month'],IV, 
2298,2060,Teriflunomide,2016-04-19,2018-11-05, ,mcg,['/Month'],IV,Patient Choice/Convenience
2299,243,Rebif [44],2016-08-08,2019-07-29,5000, ,['2 / Day'],IV,Adverse Event
2300,243,Avonex,2016-04-20,2019-12-25,5000,mg,['2 / Day'],IV,Adverse Event
2301,243,IVIG,2016-01-05,2017-11-18,5000,mg,[' '],Oral,Persistence of relapses
2302,243,Methylprednisolone,2015-11-14,2018-10-28,500,mg,[' '],IV,Adverse Event
2303,4339,Alemtuzumab (Campath),2016-09-13,,20,mg,['/Month'], , 
2304,4003,Teriflunomide,2016-04-15,2018-08-25,500,mg,['/Month'],IV,Lack of efficacy
2305,4003,Betaferon,2016-03-25,2020-10-28,1, ,['/Month'], ,Patient Choice/Convenience
2306,4003,Gilenya,2016-03-02,,1,mcg,['2 / Day'], , 
2307,4003,Avonex,2016-06-26,2018-02-13, , ,['/ Week'], ,Persisting MRI activity
2308,3886,Methylprednisolone,2016-09-10,2020-02-17,400,mg,['3 / Week'],IV,Adverse Event
2309,3886,Betaferon,2016-06-21,2020-03-19,1000, ,['/ Week'],IV,Lack of efficacy
2310,3495,Ledertrexaat,2016-08-23,,20, ,['/Month'],IV, 
2311,4568,Tysabri,2016-01-31,2021-04-17, ,mcg,[' '], ,Persisting MRI activity
2312,4568,Avonex,2016-03-03,2019-11-16, ,mg,[' '], ,Lack of efficacy
2313,4568,IVIG,2016-02-11,2020-03-15, ,mg,['/Month'], ,Patient Choice/Convenience
2314,4089,IVIG,2016-07-11,,1000,mcg,['/Month'],IV, 
2315,4089,Endoxan,2015-12-29,, ,mg,['2 / Day'],IV, 
2316,4089,Teriflunomide,2016-04-17,2019-04-29,400, ,['/ Week'],IV,Adverse Event
2317,3736,Tecfidera,2016-03-18,2018-12-21, ,mcg,['2 / Day'],Oral,Lack of efficacy
2318,3736,Betaferon,2016-02-07,2020-01-15, , ,['2 / Day'],IV,Persisting MRI activity
2319,1517,Avonex,2016-04-10,2019-07-19,300,MIU,['/ Day'], ,Patient Choice/Convenience
2320,1517,Mitoxantrone,2016-03-20,2020-04-26,500, ,['3 / Week'], ,Persistence of relapses
2321,1517,Mitoxantrone,2016-04-09,,1000, ,['/Month'],IV, 
2322,1517,Copaxone,2016-06-17,2021-09-05,300,mg,['/ Week'],IV,Lack of efficacy
2323,2913,Copaxone,2016-02-18,,5000,MIU,['2 / Day'], , 
2324,2913,Mitoxantrone,2016-02-08,2018-07-06,5000, ,['3 / Week'],IV,Adverse Event
2325,3767,Tecfidera,2016-07-04,,1000,mg,['/Month'],Oral, 
2326,3767,IVIG,2015-12-02,2018-09-01,300,mg,['3 / Week'],IV,Patient Choice/Convenience
2327,3767,Tecfidera,2015-11-02,,20,mg,['3 / Week'],IV, 
2328,716,D-cure (Vitamine D),2016-03-14,,300,mg,['2 / Day'], , 
2329,716,Rebif [44],2016-04-01,2020-05-08, ,mg,['3 / Week'], ,Patient Choice/Convenience
2330,716,IVIG,2016-09-11,2020-03-30,500, ,['3 / Week'], ,Persisting MRI activity
2331,4179,Avonex,2015-10-30,,500, ,[' '],IV, 
2332,807,Betaferon,2016-10-15,2018-05-18,20, ,['/Month'], ,Persisting MRI activity
2333,3074,Tecfidera,2015-12-04,,300, ,['2 / Day'],IV, 
2334,3074,Teriflunomide,2016-06-06,2018-02-20, , ,['2 / Day'],IV,Adverse Event
2335,3074,Methylprednisolone,2016-01-17,2019-11-16,1, ,['/ Day'],Oral,Adverse Event
2336,1591,Copaxone,2016-08-09,,20,mg,['/Month'], , 
2337,1591,Betaferon,2016-09-26,,1000, ,['/ Day'],Oral, 
2338,1591,IVIG,2015-11-16,2019-03-28,1000,mg,['2 / Day'],IV,Lack of efficacy
2339,1591,Copaxone,2016-09-03,, , ,['2 / Day'], , 
2340,3869,Alemtuzumab (Campath),2015-12-28,2018-07-28,400,MIU,['3 / Week'],IV,Persisting MRI activity
2341,2137,Gilenya,2016-06-29,,5000,mg,['2 / Day'],IV, 
2342,2137,Methylprednisolone,2016-10-20,, ,mg,['3 / Week'], , 
2343,2137,Methylprednisolone,2016-03-04,,1000,mg,[' '], , 
2344,3092,Alemtuzumab (Campath),2015-12-05,2021-10-05,400,mg,['2 / Day'], ,Lack of efficacy
2345,3092,Endoxan,2016-09-07,2020-08-09,1,MIU,['/Month'],IV,Persisting MRI activity
2346,3092,Rebif [44],2016-07-23,2018-06-23, , ,['/ Day'],IV,Persistence of relapses
2347,4235,Rebif [44],2016-05-05,2020-01-08,1,MIU,['2 / Day'],IV,Adverse Event
2348,4235,Gilenya,2016-01-20,, ,MIU,['2 / Day'], , 
2349,4235,Rebif [44],2015-11-16,2018-03-16,20,mg,['/ Day'],IV,Persisting MRI activity
2350,4235,Tecfidera,2015-11-20,,1, ,[' '], , 
2351,953,Methylprednisolone,2015-12-27,2018-12-09,20,mg,['3 / Week'],IV,Adverse Event
2352,1982,IVIG,2016-04-06,,5000,mg,['2 / Day'],IV, 
2353,409,Rebif [44],2016-03-31,,20, ,['/ Day'],IV, 
2354,385,IVIG,2016-06-21,2019-09-27, ,mg,[' '],Oral,Persisting MRI activity
2355,3131,Gilenya,2015-12-15,,5000,mg,['/Month'], , 
2356,3131,Rebif [22],2016-02-01,2021-06-12,400,mg,['2 / Day'],IV,Patient Choice/Convenience
2357,3131,Copaxone,2016-05-31,,1,MIU,['/ Day'],IV, 
2358,3131,Tecfidera,2016-03-18,2021-09-12, ,mg,['2 / Day'], ,Adverse Event
2359,2800,Copaxone,2016-01-22,2019-05-18,300, ,[' '], ,Lack of efficacy
2360,3881,Ledertrexaat,2015-11-21,2021-08-07,1000, ,['/ Day'], ,Lack of efficacy
2361,3881,IVIG,2016-07-18,2020-12-14, , ,['/ Day'],IV,Adverse Event
2362,3881,Ledertrexaat,2016-07-31,2020-06-22,500,mg,['3 / Week'],IV,Adverse Event
2363,3881,Methylprednisolone,2016-04-01,, , ,['/Month'],IV, 
2364,2550,Endoxan,2016-02-13,2020-12-20, ,MIU,['/ Day'], ,Patient Choice/Convenience
2365,2550,Rebif [22],2016-08-13,2020-10-24,1000, ,['3 / Week'],Oral,Adverse Event
2366,1321,Ledertrexaat,2015-11-07,2018-11-30, ,mg,['/Month'],IV,Adverse Event
2367,2136,Rebif [22],2015-10-26,2018-03-17,400, ,['2 / Day'], ,Adverse Event
2368,2136,Endoxan,2016-02-29,, ,mg,['2 / Day'], , 
2369,2136,Tecfidera,2016-06-28,,300, ,[' '],IV, 
2370,3713,Rebif [22],2015-11-10,2021-04-10, , ,['2 / Day'], ,Lack of efficacy
2371,3713,Alemtuzumab (Campath),2016-07-08,, , ,['/Month'],IV, 
2372,3713,Methylprednisolone,2016-06-03,,5000, ,['2 / Day'],Oral, 
2373,3713,Tecfidera,2016-08-22,,500, ,['/ Day'], , 
2374,3550,Methylprednisolone,2016-05-27,2021-01-25,400, ,['/ Day'],IV,Persisting MRI activity
2375,3550,Ledertrexaat,2016-06-14,2020-05-12,500,mg,['/Month'],IV,Persisting MRI activity
2376,2964,Rebif [22],2015-11-01,2021-10-18,20,mg,['/ Day'],IV,Adverse Event
2377,2964,Methylprednisolone,2016-09-27,2018-05-12,300,mg,['2 / Day'],Oral,Lack of efficacy
2378,2964,D-cure (Vitamine D),2016-07-25,, ,mg,['2 / Day'],IV, 
2379,1473,IVIG,2015-12-13,2019-04-09, , ,['/ Day'],IV,Persistence of relapses
2380,1473,Rebif [22],2016-02-03,2020-01-21,400, ,[' '],Oral,Adverse Event
2381,2513,Alemtuzumab (Campath),2016-06-21,2019-10-24, , ,['2 / Day'], ,Persistence of relapses
2382,2255,Alemtuzumab (Campath),2016-01-14,,20,MIU,['/ Day'],IV, 
2383,2255,Tecfidera,2016-05-26,2021-04-07,5000, ,['/ Week'],Oral,Lack of efficacy
2384,2255,Rebif [44],2016-10-02,2020-09-28,1,mg,['/Month'],Oral,Adverse Event
2385,2255,Rebif [22],2015-12-10,2019-05-04,500, ,['/Month'],IV,Lack of efficacy
2386,154,Methylprednisolone,2016-01-05,2021-07-15,300,mg,['2 / Day'], ,Adverse Event
2387,3055,Teriflunomide,2016-03-01,2018-12-27,1000,mcg,['3 / Week'],IV,Lack of efficacy
2388,4680,Methylprednisolone,2016-02-23,2020-09-13,1000, ,['/ Day'], ,Adverse Event
2389,2485,Teriflunomide,2016-01-06,2020-04-19,5000, ,['2 / Day'],IV,Persisting MRI activity
2390,2485,Methylprednisolone,2016-05-18,2021-04-30,20,MIU,['/Month'], ,Persisting MRI activity
2391,182,Rebif [44],2016-04-10,,500,MIU,['2 / Day'],IV, 
2392,2761,Endoxan,2016-07-15,2021-05-19,1000, ,['/ Day'],IV,Persistence of relapses
2393,2761,Mitoxantrone,2016-01-20,2018-03-09,5000, ,['/ Week'],Oral,Persistence of relapses
2394,2300,Betaferon,2016-03-17,2020-12-03,1000,mg,['2 / Day'], ,Patient Choice/Convenience
2395,4475,Betaferon,2016-03-22,, ,mg,['3 / Week'],IV, 
2396,4475,Alemtuzumab (Campath),2015-11-01,,1, ,['/Month'], , 
2397,4475,D-cure (Vitamine D),2016-05-21,,1,mcg,['3 / Week'], , 
2398,3410,D-cure (Vitamine D),2015-12-28,2020-12-01,1000, ,['/Month'],Oral,Persistence of relapses
2399,3410,Ledertrexaat,2016-09-13,,5000, ,['/Month'], , 
2400,3410,Copaxone,2016-01-18,,400, ,['2 / Day'], , 
2401,3410,Avonex,2016-01-06,2019-03-21,1000, ,['/Month'], ,Lack of efficacy
2402,4517,Betaferon,2016-07-02,,1,mcg,['2 / Day'],IV, 
2403,4517,Alemtuzumab (Campath),2016-05-11,, , ,[' '],IV, 
2404,4517,Copaxone,2016-09-25,2018-05-07,300, ,['/Month'], ,Persistence of relapses
2405,4517,IVIG,2015-11-24,,5000,mg,['2 / Day'],IV, 
2406,3293,Teriflunomide,2016-05-31,,5000, ,['/Month'], , 
2407,3293,Betaferon,2015-12-10,, , ,['/Month'], , 
2408,3293,Teriflunomide,2016-09-29,2021-04-16, , ,['3 / Week'],Oral,Lack of efficacy
2409,3293,Alemtuzumab (Campath),2016-05-15,,500, ,['3 / Week'], , 
2410,3471,Alemtuzumab (Campath),2016-04-15,,1000, ,['/ Day'],Oral, 
2411,3471,IVIG,2016-03-31,, , ,['3 / Week'],IV, 
2412,4434,Betaferon,2016-07-21,2020-12-31,1000,mg,['2 / Day'],Oral,Persistence of relapses
2413,3989,Tysabri,2015-11-20,,400, ,['3 / Week'],IV, 
2414,4576,Rebif [44],2016-10-13,2017-11-04,1,mg,['/Month'],IV,Patient Choice/Convenience
2415,4576,Tecfidera,2015-12-06,,1, ,['/Month'], , 
2416,4576,Rebif [44],2016-10-01,2018-09-04,1000, ,['/ Day'],Oral,Persistence of relapses
2417,4576,Methylprednisolone,2016-07-13,2021-01-31, , ,['2 / Day'],IV,Persisting MRI activity
2418,1851,Endoxan,2015-10-25,2021-07-10,20,mg,['/Month'],IV,Persisting MRI activity
2419,1851,IVIG,2016-01-29,, ,mcg,['3 / Week'],IV, 
2420,1851,Methylprednisolone,2015-12-13,,20,MIU,['3 / Week'],IV, 
2421,1851,Rebif [22],2016-08-21,,1,MIU,['/Month'], , 
2422,3799,Ledertrexaat,2016-10-13,,20,mg,['3 / Week'], , 
2423,3799,Teriflunomide,2016-01-31,2019-11-16,500, ,[' '],IV,Lack of efficacy
2424,3799,Tysabri,2016-01-23,2021-08-20,300,mg,['/Month'], ,Adverse Event
2425,3799,Endoxan,2016-10-05,2018-04-22,400, ,['/Month'],Oral,Patient Choice/Convenience
2426,3012,Copaxone,2016-06-14,2020-07-27,1, ,['2 / Day'],IV,Adverse Event
2427,1521,Endoxan,2016-10-06,2018-08-21,1000,mg,['/Month'],IV,Persisting MRI activity
2428,1521,Alemtuzumab (Campath),2016-09-26,2020-10-15,1000, ,['2 / Day'],IV,Adverse Event
2429,1521,Tysabri,2016-09-06,,1000,mg,['/Month'],IV, 
2430,1882,Rebif [22],2016-10-13,, , ,['/ Day'], , 
2431,3369,Methylprednisolone,2016-06-28,,20,mg,['/Month'],Oral, 
2432,2876,Gilenya,2016-01-20,2020-11-25,20,mg,[' '], ,Patient Choice/Convenience
2433,2876,Gilenya,2016-09-22,2019-02-11,500, ,['/Month'], ,Adverse Event
2434,2876,Gilenya,2016-05-05,2021-06-04, , ,['/ Day'], ,Patient Choice/Convenience
2435,2876,Methylprednisolone,2016-10-10,, ,MIU,['2 / Day'],IV, 
2436,2831,Endoxan,2016-10-08,,1, ,['/Month'], , 
2437,3084,Gilenya,2016-06-27,2021-01-19, , ,['/Month'], ,Persisting MRI activity
2438,3084,D-cure (Vitamine D),2016-06-20,,20,mcg,['/Month'], , 
2439,3760,Endoxan,2015-11-19,, , ,[' '],IV, 
2440,3760,Methylprednisolone,2015-12-07,,5000, ,['3 / Week'],IV, 
2441,3760,Gilenya,2015-12-14,2018-04-24, , ,['/Month'],Oral,Adverse Event
2442,742,Betaferon,2016-10-12,2019-12-22, ,MIU,['3 / Week'],IV,Adverse Event
2443,742,Mitoxantrone,2016-03-30,,5000,mg,['/Month'],IV, 
2444,742,Methylprednisolone,2016-04-21,2021-06-18,1,mg,['2 / Day'], ,Adverse Event
2445,742,Alemtuzumab (Campath),2015-12-01,2019-07-11,5000, ,['3 / Week'], ,Persistence of relapses
2446,4917,Rebif [22],2016-09-19,,500, ,['/Month'],IV, 
2447,4917,Rebif [44],2015-11-06,,500,mg,['3 / Week'], , 
2448,4917,Methylprednisolone,2016-09-24,, , ,[' '],IV, 
2449,1790,Tecfidera,2016-04-01,,1, ,[' '],IV, 
2450,1790,IVIG,2015-11-02,, , ,['2 / Day'],IV, 
2451,1790,D-cure (Vitamine D),2015-12-18,2021-06-24, , ,['2 / Day'],IV,Patient Choice/Convenience
2452,1790,Gilenya,2016-08-10,,20,mg,['3 / Week'], , 
2453,2074,Methylprednisolone,2016-10-11,,1000,mcg,['/Month'], , 
2454,3641,Teriflunomide,2016-05-06,, , ,['2 / Day'], , 
2455,3641,Rebif [22],2016-07-12,,300,mg,['3 / Week'],Oral, 
2456,3641,Gilenya,2015-12-09,2020-04-04,400,MIU,['2 / Day'],IV,Adverse Event
2457,441,Avonex,2016-07-16,, ,mg,['/Month'],IV, 
2458,4247,Endoxan,2016-09-07,,1000, ,['3 / Week'], , 
2459,4247,D-cure (Vitamine D),2015-12-09,,20, ,['/Month'],IV, 
2460,4247,Tecfidera,2016-09-30,,1000,MIU,[' '],IV, 
2461,2023,Tecfidera,2015-11-16,2018-06-17, ,mg,['/ Day'], ,Patient Choice/Convenience
2462,2023,Rebif [22],2016-09-26,2018-01-30, , ,['3 / Week'],IV,Patient Choice/Convenience
2463,583,Tecfidera,2016-07-31,2018-08-04, , ,['2 / Day'],IV,Persisting MRI activity
2464,583,IVIG,2016-05-30,, ,MIU,['/ Day'], , 
2465,3948,Alemtuzumab (Campath),2016-09-24,, , ,['/Month'],IV, 
2466,4133,Gilenya,2016-04-26,2018-01-25,1,mg,['2 / Day'],IV,Persistence of relapses
2467,4133,Alemtuzumab (Campath),2016-10-07,,1000,mcg,['/Month'],IV, 
2468,4133,Tecfidera,2016-05-05,2018-03-07,1000,mg,['2 / Day'],IV,Lack of efficacy
2469,4133,Betaferon,2016-01-08,2018-04-03,400, ,['/Month'], ,Patient Choice/Convenience
2470,566,Tysabri,2016-02-27,,300,mg,['/Month'],Oral, 
2471,566,Betaferon,2016-06-09,2018-04-28,20,mcg,['2 / Day'], ,Adverse Event
2472,4120,D-cure (Vitamine D),2016-06-09,,500,mg,['/Month'], , 
2473,4120,Copaxone,2016-04-22,, ,mcg,[' '],Oral, 
2474,4120,Alemtuzumab (Campath),2015-11-12,, ,mcg,['/Month'],IV, 
2475,4120,Gilenya,2016-10-06,,5000,mg,['3 / Week'],IV, 
2476,4119,IVIG,2016-04-03,2020-09-14,1,mg,['/Month'],IV,Persisting MRI activity
2477,4119,Copaxone,2015-12-22,,300, ,['/Month'],Oral, 
2478,2625,Tysabri,2016-09-25,2019-03-07,20,mg,['/Month'], ,Patient Choice/Convenience
2479,2625,IVIG,2016-03-14,2018-03-02, ,mg,['3 / Week'],Oral,Persisting MRI activity
2480,4593,Alemtuzumab (Campath),2016-05-02,2021-10-03,400,mg,['2 / Day'], ,Persisting MRI activity
2481,4593,Tecfidera,2016-06-14,,300,mg,['/Month'], , 
2482,4593,Betaferon,2016-03-02,,20, ,['2 / Day'],IV, 
2483,2721,Tysabri,2015-12-19,,5000,mg,['/ Day'],Oral, 
2484,2721,Rebif [22],2015-11-07,2021-04-18,400, ,['/ Week'],IV,Persisting MRI activity
2485,2721,Betaferon,2015-12-21,, ,mg,['/Month'],IV, 
2486,3323,IVIG,2016-04-06,, ,mg,[' '],IV, 
2487,3323,Ledertrexaat,2016-07-02,2021-05-27,400,mcg,['/Month'],IV,Patient Choice/Convenience
2488,3323,Teriflunomide,2015-11-05,, , ,['3 / Week'],IV, 
2489,1161,Tecfidera,2016-06-04,2018-01-31,20, ,['2 / Day'],IV,Persisting MRI activity
2490,4784,Rebif [22],2016-08-15,2021-06-19,500, ,['/ Day'],Oral,Adverse Event
2491,2170,Tysabri,2016-04-12,2020-05-29, , ,['3 / Week'], ,Patient Choice/Convenience
2492,1028,Copaxone,2016-07-22,2020-05-10, , ,['/Month'],IV,Patient Choice/Convenience
2493,1028,Endoxan,2016-09-16,,5000,mg,['3 / Week'],Oral, 
2494,1255,Alemtuzumab (Campath),2016-08-26,,20,MIU,['/Month'],Oral, 
2495,1255,Alemtuzumab (Campath),2016-03-19,,1, ,['/Month'],IV, 
2496,4053,Gilenya,2016-07-13,,500,mcg,['2 / Day'],Oral, 
2497,3353,Copaxone,2016-01-20,,1,MIU,['2 / Day'],IV, 
2498,3353,Alemtuzumab (Campath),2015-11-24,2019-07-20,500, ,['/Month'], ,Lack of efficacy
2499,3353,IVIG,2016-01-27,,500,mg,['/Month'],IV, 
2500,3353,Alemtuzumab (Campath),2016-02-18,2021-07-09,1,MIU,['2 / Day'],IV,Patient Choice/Convenience
2501,2795,Tysabri,2016-10-21,2020-10-02, ,MIU,['2 / Day'],IV,Adverse Event
2502,2795,Ledertrexaat,2016-02-04,, , ,['/Month'],IV, 
2503,2795,Endoxan,2016-10-19,2021-03-01, , ,['/Month'],IV,Lack of efficacy
2504,1516,Endoxan,2016-03-03,,5000,mg,['/Month'],IV, 
2505,1632,Tecfidera,2016-10-19,,20, ,['2 / Day'],IV, 
2506,1632,Copaxone,2016-08-25,,300, ,['2 / Day'],IV, 
2507,749,Avonex,2015-11-23,,5000,mg,['/Month'],IV, 
2508,749,Copaxone,2016-03-24,,20,mcg,['3 / Week'], , 
2509,519,Methylprednisolone,2016-06-06,,20, ,['3 / Week'],Oral, 
2510,2008,Endoxan,2016-05-07,2019-11-27,1, ,['/Month'],Oral,Adverse Event
2511,2008,Avonex,2016-04-02,,500, ,['/Month'], , 
2512,2008,Methylprednisolone,2016-06-13,,300, ,[' '],Oral, 
2513,3275,Mitoxantrone,2016-05-05,2019-04-09,1,mcg,[' '], ,Adverse Event
2514,3275,D-cure (Vitamine D),2016-04-20,,20, ,['2 / Day'], , 
2515,3275,D-cure (Vitamine D),2016-05-09,2018-09-07, , ,['2 / Day'], ,Persistence of relapses
2516,1165,Gilenya,2015-12-28,2018-07-08,5000, ,['/ Day'],IV,Lack of efficacy
2517,934,D-cure (Vitamine D),2016-01-17,, ,mg,['2 / Day'],IV, 
2518,934,Rebif [44],2016-09-12,2020-07-03, , ,['/ Week'], ,Lack of efficacy
2519,934,Endoxan,2016-03-05,2020-08-27,20,mg,['/ Day'], ,Patient Choice/Convenience
2520,934,D-cure (Vitamine D),2016-05-20,,1,mg,['/ Week'],IV, 
2521,4739,Rebif [22],2016-05-25,2018-01-30,5000, ,[' '],IV,Lack of efficacy
2522,3197,Teriflunomide,2015-12-08,2018-10-08,20,mg,['/Month'], ,Patient Choice/Convenience
2523,3197,Rebif [22],2015-12-03,,500,mg,['/Month'],Oral, 
2524,3197,Gilenya,2016-06-03,2019-04-10,1,mg,['3 / Week'],Oral,Persisting MRI activity
2525,1922,IVIG,2016-01-17,2019-01-23,1,mg,['2 / Day'],IV,Adverse Event
2526,1922,IVIG,2015-12-14,,400, ,['/ Day'],IV, 
2527,2641,Tysabri,2015-12-24,,500,mg,['/Month'],IV, 
2528,2641,D-cure (Vitamine D),2016-04-15,, ,mg,[' '], , 
2529,201,Betaferon,2016-01-03,,1000,mg,['/Month'], , 
2530,201,Tysabri,2016-04-22,,500,mg,['2 / Day'],IV, 
2531,152,Copaxone,2015-12-22,2019-11-20,1000, ,['2 / Day'],Oral,Persisting MRI activity
2532,152,Betaferon,2016-02-08,,500, ,['/Month'], , 
2533,3853,Ledertrexaat,2015-12-17,,300, ,['3 / Week'],Oral, 
2534,3127,Teriflunomide,2016-08-23,,20,mg,['2 / Day'],IV, 
2535,3127,Tecfidera,2016-09-02,2019-07-03,1,MIU,[' '], ,Lack of efficacy
2536,858,Alemtuzumab (Campath),2016-08-03,,300,mcg,[' '],IV, 
2537,858,Endoxan,2016-05-11,2020-05-27,500,mg,[' '],IV,Lack of efficacy
2538,1090,Betaferon,2015-12-18,, ,mg,['2 / Day'],IV, 
2539,1090,Rebif [22],2016-03-31,2019-09-23,5000,mg,['/ Day'],IV,Lack of efficacy
2540,1090,Teriflunomide,2016-09-29,,300, ,['/Month'], , 
2541,1090,Rebif [44],2016-08-11,2019-02-10,500, ,['/ Week'],Oral,Adverse Event
2542,423,Teriflunomide,2016-07-29,,5000,MIU,['2 / Day'],IV, 
2543,423,Tecfidera,2016-03-12,,5000, ,['/Month'],IV, 
2544,423,Tecfidera,2016-08-01,,500, ,[' '], , 
2545,423,Teriflunomide,2016-07-13,2020-07-06,1000,mcg,['2 / Day'], ,Patient Choice/Convenience
2546,1345,Gilenya,2015-11-04,, , ,['/Month'],IV, 
2547,1345,Rebif [22],2015-10-26,2019-05-05,1000,mg,['/Month'],Oral,Adverse Event
2548,2853,Rebif [22],2016-04-27,,400, ,['2 / Day'], , 
2549,2853,Rebif [44],2016-05-31,, , ,['2 / Day'],IV, 
2550,2853,Rebif [44],2016-01-25,, ,mg,['/Month'], , 
2551,2192,Tecfidera,2016-09-14,,1, ,['/Month'],IV, 
2552,2192,Alemtuzumab (Campath),2016-07-03,2020-03-27,500,mg,['2 / Day'],IV,Persistence of relapses
2553,2192,Ledertrexaat,2016-07-11,,300, ,['/Month'],IV, 
2554,2487,Gilenya,2015-12-18,,400,mg,['2 / Day'],IV, 
2555,2487,Rebif [44],2016-03-05,,20,mg,[' '],IV, 
2556,4837,Rebif [22],2016-05-12,, , ,['/ Day'],IV, 
2557,1166,Rebif [22],2016-06-17,,400, ,['/Month'],IV, 
2558,3976,Gilenya,2015-12-06,,20,mg,['/Month'], , 
2559,3976,Methylprednisolone,2016-05-07,,400, ,['2 / Day'], , 
2560,1020,Mitoxantrone,2015-11-25,2020-07-31, , ,['/ Week'],Oral,Adverse Event
2561,1020,Tecfidera,2015-11-12,2019-12-21,20,mg,['/Month'], ,Persistence of relapses
2562,1020,Tysabri,2016-03-16,,20,mg,['/Month'], , 
2563,1020,Alemtuzumab (Campath),2016-06-07,2019-11-07,20,mg,['2 / Day'],IV,Adverse Event
2564,405,Rebif [44],2016-01-27,, ,mg,['/ Week'],IV, 
2565,405,Gilenya,2016-08-14,,300, ,['/ Day'],IV, 
2566,3775,Gilenya,2016-05-19,2021-03-22,20,mg,['/Month'],IV,Persisting MRI activity
2567,3681,Rebif [44],2016-08-02,, , ,[' '], , 
2568,3681,Methylprednisolone,2016-03-13,2019-03-10,500, ,['2 / Day'],IV,Persisting MRI activity
2569,3681,D-cure (Vitamine D),2016-06-21,, ,mg,['2 / Day'], , 
2570,2221,Tecfidera,2016-06-18,, , ,['2 / Day'],IV, 
2571,2221,Gilenya,2016-03-13,2018-05-07,1000,mg,['2 / Day'],Oral,Lack of efficacy
2572,2221,Tysabri,2016-09-20,, , ,['2 / Day'], , 
2573,2221,Copaxone,2016-02-04,, , ,['/Month'], , 
2574,2572,Tecfidera,2016-03-19,,400,MIU,['3 / Week'],IV, 
2575,2572,Tysabri,2016-08-24,2020-01-29,300,MIU,['2 / Day'], ,Persisting MRI activity
2576,3902,Rebif [22],2016-06-25,,5000, ,['3 / Week'], , 
2577,4607,Rebif [22],2015-11-09,,5000,mg,['3 / Week'],Oral, 
2578,1108,IVIG,2016-02-15,,1000, ,['/ Week'], , 
2579,1108,Rebif [44],2016-10-21,, ,mg,['3 / Week'], , 
2580,1108,Methylprednisolone,2016-10-11,, ,MIU,['2 / Day'],IV, 
2581,1108,Methylprednisolone,2016-03-24,, , ,['/ Day'],IV, 
2582,4612,Ledertrexaat,2016-02-06,, , ,['3 / Week'],Oral, 
2583,4612,Avonex,2016-07-18,,500,MIU,['/Month'], , 
2584,273,Rebif [44],2016-07-09,2019-04-23,500,mg,['/ Day'], ,Adverse Event
2585,1165,IVIG,2015-11-03,2019-03-13,1000,mg,['/Month'], ,Persisting MRI activity
2586,3961,Ledertrexaat,2016-05-22,,300,mg,['2 / Day'],IV, 
2587,3961,Betaferon,2015-12-24,2020-09-20,20,mg,['2 / Day'], ,Lack of efficacy
2588,2550,Gilenya,2016-05-29,,500,mg,['/ Day'], , 
2589,1350,Avonex,2015-12-06,2021-07-02,300,mg,['/Month'],IV,Adverse Event
2590,3150,IVIG,2016-02-05,2019-12-12,20,mcg,['/ Day'],IV,Patient Choice/Convenience
2591,4386,D-cure (Vitamine D),2016-01-22,,300,mg,['3 / Week'],IV, 
2592,4386,Betaferon,2016-02-20,2018-05-10,1,mg,['2 / Day'], ,Persisting MRI activity
2593,4386,Methylprednisolone,2016-01-10,2020-09-12,1, ,['/ Day'],Oral,Persisting MRI activity
2594,4386,Tysabri,2016-01-18,,500,mg,['/Month'], , 
2595,4917,Copaxone,2016-06-15,,20,mg,['2 / Day'], , 
2596,4917,D-cure (Vitamine D),2015-12-08,,20,mg,['/ Week'], , 
2597,3377,Tysabri,2016-07-25,2019-03-08, , ,['3 / Week'],Oral,Patient Choice/Convenience
2598,619,IVIG,2016-04-16,,20,mg,['/Month'], , 
2599,619,Tysabri,2016-01-13,2020-10-06,500, ,[' '], ,Adverse Event
2600,3533,Ledertrexaat,2016-05-25,,20,MIU,[' '], , 
2601,3533,Copaxone,2016-04-16,, ,MIU,['2 / Day'], , 
2602,3533,Copaxone,2016-06-05,,500, ,['/Month'], , 
2603,3533,Rebif [44],2016-02-09,,300,mg,['/ Day'],IV, 
2604,2922,D-cure (Vitamine D),2016-04-25,2018-08-21,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
2605,2922,Tysabri,2016-04-28,2019-09-21,300, ,['3 / Week'],Oral,Adverse Event
2606,2922,Teriflunomide,2016-05-26,,500,mg,['2 / Day'], , 
2607,2922,Tecfidera,2015-11-07,2021-05-14,300, ,['2 / Day'], ,Lack of efficacy
2608,4532,Methylprednisolone,2016-02-20,,500, ,['2 / Day'],Oral, 
2609,4532,Rebif [44],2016-08-23,,1000, ,['/Month'],IV, 
2610,3180,Alemtuzumab (Campath),2015-10-25,2020-07-26,1,mg,['2 / Day'], ,Patient Choice/Convenience
2611,3180,Teriflunomide,2016-10-21,, , ,['3 / Week'],IV, 
2612,3180,Tysabri,2016-10-17,2020-04-09, ,mg,['3 / Week'],Oral,Adverse Event
2613,3180,IVIG,2016-07-21,,300,mcg,['2 / Day'], , 
2614,3060,Endoxan,2016-08-12,2018-06-16,300,MIU,['/Month'], ,Persistence of relapses
2615,3334,Endoxan,2016-09-11,2021-05-12,1000,mg,['/Month'],Oral,Adverse Event
2616,3334,Rebif [44],2016-04-24,, , ,['2 / Day'],IV, 
2617,4467,Endoxan,2015-12-01,, ,MIU,['2 / Day'],Oral, 
2618,129,Avonex,2015-11-09,2019-10-22,1, ,['2 / Day'],Oral,Lack of efficacy
2619,129,Avonex,2016-10-02,2018-05-26, ,mg,['2 / Day'],IV,Lack of efficacy
2620,129,Methylprednisolone,2016-07-09,2020-02-11,20,mg,['3 / Week'],IV,Patient Choice/Convenience
2621,4800,Methylprednisolone,2016-10-06,,1, ,['2 / Day'],IV, 
2622,4800,Tysabri,2016-07-29,2018-07-13,20,MIU,['3 / Week'],Oral,Persistence of relapses
2623,4800,Gilenya,2016-09-10,2019-04-13,400,mg,['/ Day'], ,Persisting MRI activity
2624,4800,Alemtuzumab (Campath),2016-06-22,, , ,['2 / Day'],IV, 
2625,1937,Rebif [44],2016-04-30,,5000, ,['/ Day'],IV, 
2626,4844,Tecfidera,2015-11-21,2020-07-26,500, ,[' '],IV,Adverse Event
2627,4844,Gilenya,2016-01-23,2018-08-15, ,mg,['2 / Day'],IV,Lack of efficacy
2628,397,Tysabri,2016-01-02,,5000, ,['/Month'], , 
2629,397,Alemtuzumab (Campath),2016-06-17,,400, ,['/ Week'],IV, 
2630,397,Rebif [44],2016-06-21,2019-06-23,1,mg,[' '],IV,Patient Choice/Convenience
2631,397,Rebif [22],2016-03-01,,20,mg,['2 / Day'], , 
2632,3222,Mitoxantrone,2016-07-17,,20, ,['2 / Day'],IV, 
2633,3222,Alemtuzumab (Campath),2016-10-01,,20,MIU,['3 / Week'],Oral, 
2634,3222,Avonex,2016-10-04,,20,mg,['/Month'],IV, 
2635,2305,D-cure (Vitamine D),2015-12-02,,500,mg,[' '],IV, 
2636,2305,Tysabri,2016-06-09,2018-07-15, ,mg,['/Month'], ,Persistence of relapses
2637,1165,Teriflunomide,2016-09-21,,400,mcg,['/ Week'],Oral, 
2638,1165,Teriflunomide,2016-08-13,,1000,MIU,['2 / Day'],IV, 
2639,1165,D-cure (Vitamine D),2016-08-18,, ,mg,['/Month'], , 
2640,1165,Copaxone,2016-07-23,,300,mg,['2 / Day'], , 
2641,2859,Rebif [22],2015-12-12,, ,MIU,['/Month'],IV, 
2642,2859,Rebif [44],2016-04-03,2017-10-31, , ,['2 / Day'],Oral,Adverse Event
2643,2859,Rebif [44],2016-03-14,,20, ,['/ Day'],IV, 
2644,2859,Teriflunomide,2016-09-30,,1, ,['2 / Day'],IV, 
2645,3317,Ledertrexaat,2016-03-28,2020-04-10, ,mg,['2 / Day'],IV,Patient Choice/Convenience
2646,3317,Gilenya,2016-03-15,,300,MIU,['/ Week'],IV, 
2647,3317,Copaxone,2016-04-08,,500,mg,['2 / Day'],IV, 
2648,3317,Mitoxantrone,2015-10-31,, ,MIU,['3 / Week'],IV, 
2649,3054,Rebif [44],2016-04-17,2019-05-28, , ,['2 / Day'],Oral,Lack of efficacy
2650,3054,Ledertrexaat,2016-07-19,2017-12-17,20,mcg,[' '],IV,Patient Choice/Convenience
2651,3054,Copaxone,2016-05-31,2021-09-16,300, ,[' '],IV,Lack of efficacy
2652,3054,D-cure (Vitamine D),2016-03-10,,300,mg,['/Month'],Oral, 
2653,4483,Methylprednisolone,2016-07-25,2021-07-07,400, ,['3 / Week'],IV,Adverse Event
2654,1751,Avonex,2016-10-03,,300,MIU,['2 / Day'],IV, 
2655,1751,IVIG,2015-10-28,,20, ,[' '],IV, 
2656,1751,Gilenya,2016-04-03,,20,mg,['/Month'],IV, 
2657,1751,Ledertrexaat,2015-11-30,, ,mg,['2 / Day'], , 
2658,1976,Ledertrexaat,2016-07-27,,1,mcg,['/ Day'],IV, 
2659,1976,Teriflunomide,2016-02-27,, , ,['2 / Day'],Oral, 
2660,4299,Rebif [44],2016-10-18,,5000, ,['2 / Day'],IV, 
2661,4299,Methylprednisolone,2016-04-02,2020-01-13,300,MIU,['2 / Day'], ,Adverse Event
2662,4299,IVIG,2016-07-01,, ,MIU,['/Month'], , 
2663,4299,D-cure (Vitamine D),2016-03-08,,500, ,[' '],IV, 
2664,3268,Rebif [44],2016-02-21,, ,mg,[' '], , 
2665,3268,Alemtuzumab (Campath),2016-07-23,2018-05-27, ,MIU,['2 / Day'],IV,Adverse Event
2666,1372,Methylprednisolone,2016-06-15,,1000, ,[' '],IV, 
2667,3714,Alemtuzumab (Campath),2016-09-09,2020-01-21,300,mg,['2 / Day'],IV,Persistence of relapses
2668,3714,Avonex,2015-12-13,2020-07-26,20,MIU,[' '], ,Adverse Event
2669,140,Teriflunomide,2016-04-03,2019-12-04,400,mg,['/ Day'],IV,Adverse Event
2670,140,Gilenya,2016-07-03,,1,mg,['/Month'],IV, 
2671,140,Mitoxantrone,2016-10-03,, , ,['/ Week'], , 
2672,140,Alemtuzumab (Campath),2015-11-14,2019-02-22,300, ,['/Month'],IV,Persisting MRI activity
2673,1136,Rebif [44],2016-05-27,,300,MIU,['2 / Day'], , 
2674,4773,Gilenya,2016-02-20,2020-07-09,500,mg,['/ Day'],Oral,Lack of efficacy
2675,4773,Teriflunomide,2016-01-14,2018-08-09,5000,mg,['/ Day'],IV,Patient Choice/Convenience
2676,367,Mitoxantrone,2016-01-14,,20,mg,[' '],IV, 
2677,367,Betaferon,2016-09-23,2020-07-21,5000,mg,['/ Week'], ,Adverse Event
2678,367,Mitoxantrone,2016-03-16,2019-09-10,300,mcg,['/Month'], ,Patient Choice/Convenience
2679,367,Rebif [44],2015-11-15,,300, ,['/Month'], , 
2680,4094,IVIG,2016-03-12,,20,mg,[' '], , 
2681,4094,Methylprednisolone,2016-08-10,2020-04-24, ,mg,['3 / Week'],IV,Patient Choice/Convenience
2682,4094,Avonex,2016-06-10,,20, ,['/ Day'], , 
2683,1361,Tysabri,2015-10-25,2021-01-22, ,mg,['/Month'],IV,Adverse Event
2684,1361,Mitoxantrone,2016-03-16,,500,MIU,['/ Day'],IV, 
2685,1361,Tysabri,2016-07-22,2020-09-08, , ,['2 / Day'], ,Persistence of relapses
2686,1361,Copaxone,2015-10-27,,500,mg,['2 / Day'],IV, 
2687,4258,Avonex,2016-08-30,2021-05-06, ,mg,['/ Week'],IV,Lack of efficacy
2688,155,Methylprednisolone,2016-06-11,, , ,['/Month'],IV, 
2689,155,Endoxan,2016-04-04,,20,mg,['/Month'],IV, 
2690,155,Teriflunomide,2015-11-17,,1, ,['/Month'], , 
2691,155,Rebif [44],2016-07-18,,1000,mcg,['2 / Day'],IV, 
2692,3067,Rebif [44],2016-01-28,2019-09-04, ,mg,['/Month'],Oral,Adverse Event
2693,3067,Tecfidera,2016-05-31,2021-08-02, , ,['3 / Week'],IV,Persistence of relapses
2694,2963,Mitoxantrone,2016-01-04,,1000,mg,['/ Day'],Oral, 
2695,2963,Rebif [44],2016-04-06,,20,mg,['2 / Day'],IV, 
2696,2170,Rebif [44],2015-12-07,2020-05-04,1, ,['2 / Day'],Oral,Adverse Event
2697,2170,Teriflunomide,2015-11-28,2018-03-19, ,mg,['3 / Week'],IV,Patient Choice/Convenience
2698,4015,IVIG,2016-03-09,,1000, ,[' '], , 
2699,4015,Avonex,2016-09-04,, ,MIU,['/Month'], , 
2700,4015,Gilenya,2016-03-26,,500,mg,['3 / Week'],Oral, 
2701,4015,Endoxan,2016-09-23,,1000,mcg,['/Month'],Oral, 
2702,1822,Alemtuzumab (Campath),2016-08-18,,500, ,['2 / Day'],IV, 
2703,1822,Gilenya,2016-03-28,2018-02-08,400,mg,['3 / Week'], ,Adverse Event
2704,4855,Rebif [22],2015-11-09,2019-03-25, , ,['/Month'],Oral,Patient Choice/Convenience
2705,4855,Gilenya,2016-05-05,,400,mg,['3 / Week'], , 
2706,4855,Rebif [44],2016-02-08,, ,mg,['/Month'], , 
2707,4855,Tecfidera,2016-04-26,,500, ,['/ Day'],IV, 
2708,4942,D-cure (Vitamine D),2016-01-17,2020-11-14, ,mcg,['/Month'],IV,Patient Choice/Convenience
2709,4942,Tecfidera,2016-02-12,, , ,['/Month'],IV, 
2710,390,Methylprednisolone,2016-10-16,, , ,['/Month'],Oral, 
2711,3553,Teriflunomide,2016-05-18,2019-04-17,300, ,['/Month'], ,Lack of efficacy
2712,3645,D-cure (Vitamine D),2016-07-12,2021-06-25,1, ,['2 / Day'],IV,Adverse Event
2713,3645,Copaxone,2016-01-23,,500, ,['/Month'], , 
2714,3645,Tysabri,2015-10-28,,1,MIU,['/Month'],IV, 
2715,1524,Endoxan,2016-03-19,,1, ,['3 / Week'],IV, 
2716,3197,Methylprednisolone,2016-04-22,2020-01-22,400,mg,['2 / Day'],IV,Lack of efficacy
2717,3197,Copaxone,2016-04-19,2019-03-26, ,mg,['/ Week'],IV,Lack of efficacy
2718,820,Rebif [44],2016-07-13,2021-03-25, ,mg,['2 / Day'], ,Patient Choice/Convenience
2719,2613,Methylprednisolone,2016-03-02,, ,mg,['/Month'], , 
2720,2613,Rebif [44],2015-10-24,, , ,['/ Week'],IV, 
2721,2613,Alemtuzumab (Campath),2016-02-24,2019-01-13, ,MIU,['/ Week'],IV,Adverse Event
2722,2613,Mitoxantrone,2016-10-02,,300,mcg,['/ Day'],Oral, 
2723,2759,Gilenya,2016-09-08,2018-02-09,1000, ,['/Month'],IV,Patient Choice/Convenience
2724,2759,Avonex,2016-03-15,,500, ,['2 / Day'],IV, 
2725,2759,Mitoxantrone,2016-01-06,2019-03-12,1000,mcg,['/Month'],IV,Patient Choice/Convenience
2726,2759,Mitoxantrone,2016-08-23,,300,mcg,['/Month'],IV, 
2727,540,Copaxone,2016-02-04,2018-01-31,500, ,['/Month'],Oral,Lack of efficacy
2728,540,Betaferon,2016-08-25,,300,mg,['/Month'], , 
2729,4652,Endoxan,2016-08-25,,300, ,['2 / Day'],IV, 
2730,1764,IVIG,2016-09-28,,300,mg,['3 / Week'],IV, 
2731,1764,Rebif [44],2016-08-08,2021-08-31,400,mg,['3 / Week'], ,Persistence of relapses
2732,247,IVIG,2016-10-13,2018-08-17,400, ,['/Month'],IV,Lack of efficacy
2733,1825,Rebif [44],2016-06-25,,300,mg,[' '], , 
2734,4996,Rebif [44],2015-12-17,,1000,MIU,['2 / Day'],IV, 
2735,3497,Betaferon,2015-12-30,,1,mg,['/Month'], , 
2736,3497,Copaxone,2016-08-13,2020-10-31, ,MIU,['/Month'], ,Persistence of relapses
2737,3497,Rebif [44],2016-04-05,,300, ,['/Month'],Oral, 
2738,4634,Rebif [44],2016-08-29,,1000,mg,['/Month'],IV, 
2739,4634,Tysabri,2016-08-19,, ,mg,['/ Week'],IV, 
2740,3807,Alemtuzumab (Campath),2016-01-12,2020-05-08,300,mg,[' '],IV,Persisting MRI activity
2741,886,Avonex,2016-03-09,,1000,mg,['2 / Day'], , 
2742,886,Tecfidera,2016-01-14,, , ,['3 / Week'], , 
2743,2719,D-cure (Vitamine D),2016-01-21,2019-10-06,20,mg,['/ Week'],IV,Adverse Event
2744,3064,Tecfidera,2015-12-03,,500, ,['/ Week'],IV, 
2745,3064,Alemtuzumab (Campath),2016-04-21,2020-10-07, ,mg,['3 / Week'], ,Lack of efficacy
2746,1353,D-cure (Vitamine D),2015-12-20,,500, ,['2 / Day'],IV, 
2747,1353,Rebif [22],2016-04-30,2018-05-19,5000, ,['/ Week'],IV,Persisting MRI activity
2748,1353,Methylprednisolone,2016-04-23,2017-12-26,1000,mg,[' '], ,Adverse Event
2749,1353,Alemtuzumab (Campath),2016-06-21,2021-07-19,20,mg,['/Month'], ,Adverse Event
2750,3370,Rebif [44],2016-07-11,,5000,mcg,['/ Week'],Oral, 
2751,2903,D-cure (Vitamine D),2016-01-23,2020-03-30,1000, ,['3 / Week'], ,Adverse Event
2752,2903,Copaxone,2015-12-08,,1000,mg,['/Month'],IV, 
2753,3584,Rebif [22],2016-02-14,, ,MIU,['3 / Week'],IV, 
2754,3584,Rebif [22],2015-12-08,,300, ,[' '], , 
2755,3584,Alemtuzumab (Campath),2016-06-14,, , ,['/ Week'],IV, 
2756,3762,Betaferon,2016-05-29,, ,mcg,['/ Day'],IV, 
2757,3762,Avonex,2016-02-19,, ,mg,['/ Day'],IV, 
2758,3762,D-cure (Vitamine D),2016-02-23,,20,mcg,[' '], , 
2759,3396,Teriflunomide,2015-12-16,, , ,['2 / Day'],Oral, 
2760,4212,Betaferon,2016-10-10,,20,mg,['3 / Week'],Oral, 
2761,4212,D-cure (Vitamine D),2016-04-20,2020-12-29,1,mg,[' '],IV,Adverse Event
2762,3316,Betaferon,2016-04-28,2020-04-13,500, ,['/Month'],IV,Patient Choice/Convenience
2763,3316,Rebif [22],2016-02-22,2020-07-18,500,mg,['/ Day'],IV,Persistence of relapses
2764,235,Rebif [22],2015-12-23,,20,mg,['/Month'],IV, 
2765,235,Betaferon,2016-05-20,, , ,['2 / Day'],IV, 
2766,519,Alemtuzumab (Campath),2015-11-20,,20,mg,['3 / Week'], , 
2767,519,Tysabri,2016-02-04,,5000,mg,['2 / Day'],Oral, 
2768,519,D-cure (Vitamine D),2016-02-03,,1,MIU,[' '],IV, 
2769,1542,Avonex,2016-10-06,, ,mg,['/Month'],Oral, 
2770,1542,Teriflunomide,2016-01-22,,1,MIU,['2 / Day'],IV, 
2771,1542,Gilenya,2016-07-27,, ,mg,[' '],Oral, 
2772,1542,D-cure (Vitamine D),2015-11-18,, , ,[' '],IV, 
2773,1780,D-cure (Vitamine D),2016-08-09,2020-08-20, , ,['/Month'],IV,Patient Choice/Convenience
2774,1780,Endoxan,2016-06-07,2020-01-24,5000,mg,['/Month'],Oral,Persisting MRI activity
2775,4952,Alemtuzumab (Campath),2016-09-05,2019-01-20,300, ,['/Month'],IV,Patient Choice/Convenience
2776,2033,D-cure (Vitamine D),2016-06-18,2019-10-02,400,mg,['2 / Day'],IV,Adverse Event
2777,2033,D-cure (Vitamine D),2016-01-18,,400,mg,['2 / Day'], , 
2778,2033,Teriflunomide,2016-02-11,2019-08-08,1,mg,['2 / Day'],IV,Lack of efficacy
2779,677,D-cure (Vitamine D),2016-02-24,2020-02-21, ,mg,['/Month'], ,Lack of efficacy
2780,677,Rebif [22],2016-06-27,2020-04-10,20,mg,['/Month'], ,Adverse Event
2781,3752,Gilenya,2016-09-10,, , ,['2 / Day'], , 
2782,3320,D-cure (Vitamine D),2016-03-12,,1000, ,['/Month'],IV, 
2783,3320,Ledertrexaat,2016-01-20,2018-03-15,1000, ,['2 / Day'],IV,Adverse Event
2784,3320,Tecfidera,2016-01-27,,500,mg,[' '],IV, 
2785,3886,Gilenya,2016-04-21,, ,mg,['/Month'],IV, 
2786,2735,Tysabri,2016-03-05,2017-10-24,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
2787,2735,D-cure (Vitamine D),2015-11-23,, , ,['/ Day'],IV, 
2788,2735,Rebif [44],2015-11-03,, , ,['/Month'],IV, 
2789,3457,Mitoxantrone,2016-02-13,2018-10-10,1000, ,[' '], ,Lack of efficacy
2790,359,Rebif [22],2016-05-10,2018-05-24,5000,mg,['2 / Day'],IV,Adverse Event
2791,359,Endoxan,2015-11-22,,1000,MIU,['/Month'],IV, 
2792,359,IVIG,2016-07-13,2020-08-24,1000,mg,['/Month'],IV,Persisting MRI activity
2793,533,Alemtuzumab (Campath),2015-10-28,,1000,mg,['2 / Day'],Oral, 
2794,533,Copaxone,2016-03-24,2021-04-13,500, ,['2 / Day'], ,Patient Choice/Convenience
2795,533,Rebif [22],2016-10-21,2021-06-19,1000, ,['2 / Day'], ,Persisting MRI activity
2796,533,Teriflunomide,2016-03-09,2018-04-18,5000,mg,[' '],Oral,Patient Choice/Convenience
2797,164,Avonex,2015-11-20,2019-02-12,400,mg,['/Month'],IV,Persistence of relapses
2798,1655,Rebif [22],2016-09-22,2020-05-07, , ,['/ Week'], ,Patient Choice/Convenience
2799,1655,Ledertrexaat,2016-07-29,,500,mcg,['3 / Week'], , 
2800,1655,D-cure (Vitamine D),2015-12-13,,20,mg,['2 / Day'],IV, 
2801,3532,D-cure (Vitamine D),2015-11-04,,1, ,['3 / Week'],IV, 
2802,1974,Gilenya,2016-08-07,2019-02-23, , ,['3 / Week'],IV,Persistence of relapses
2803,1974,Copaxone,2015-10-25,2018-12-31,5000,mg,['2 / Day'], ,Adverse Event
2804,1414,Gilenya,2015-12-25,,1000,mg,['/Month'],IV, 
2805,1414,Rebif [22],2016-02-12,,500, ,['/Month'],IV, 
2806,1414,IVIG,2016-02-29,,20, ,['/Month'],Oral, 
2807,2293,Betaferon,2016-07-15,2020-08-12,300, ,['/Month'],IV,Persisting MRI activity
2808,2293,Gilenya,2016-05-13,2019-08-13,500,mg,['2 / Day'],IV,Persisting MRI activity
2809,2293,Ledertrexaat,2015-11-28,,1000, ,['/ Day'],IV, 
2810,2293,Tysabri,2016-01-08,,1000, ,['/ Day'],IV, 
2811,2157,Teriflunomide,2016-05-24,2021-04-06,1000,mcg,['3 / Week'],IV,Patient Choice/Convenience
2812,2157,D-cure (Vitamine D),2016-07-15,,1000,mg,['/Month'],IV, 
2813,2157,D-cure (Vitamine D),2016-01-20,2021-03-01,1000,mg,['/Month'],IV,Patient Choice/Convenience
2814,3330,Copaxone,2016-08-05,,300,mg,['3 / Week'],IV, 
2815,3330,Alemtuzumab (Campath),2016-05-03,,1000, ,['3 / Week'], , 
2816,3330,Teriflunomide,2016-03-23,,5000,MIU,['/Month'], , 
2817,3330,D-cure (Vitamine D),2016-03-20,,20, ,['2 / Day'],Oral, 
2818,4745,Mitoxantrone,2015-12-13,2021-07-26, ,MIU,['/ Week'],IV,Adverse Event
2819,4745,Rebif [44],2015-12-01,, ,mg,['2 / Day'], , 
2820,1579,Rebif [22],2016-03-20,,20, ,['2 / Day'],IV, 
2821,1768,Tysabri,2015-11-22,2018-01-04,300, ,['2 / Day'],IV,Patient Choice/Convenience
2822,1768,Betaferon,2016-10-20,2020-01-13,500,mg,['2 / Day'], ,Adverse Event
2823,1768,Gilenya,2016-05-29,2021-07-18, ,mg,['/Month'],Oral,Persisting MRI activity
2824,965,Rebif [22],2016-04-05,2021-08-17,300, ,['/Month'], ,Adverse Event
2825,221,Avonex,2016-09-28,,5000,mg,['2 / Day'],Oral, 
2826,221,Copaxone,2015-12-21,2017-12-07, ,mg,['/Month'],Oral,Persisting MRI activity
2827,221,Methylprednisolone,2016-01-08,,5000,mg,['/Month'], , 
2828,2826,Avonex,2016-03-16,2020-08-12,500,mg,['2 / Day'], ,Adverse Event
2829,2826,Rebif [22],2016-04-08,, , ,['/Month'],IV, 
2830,3963,Rebif [22],2016-07-30,2019-11-22,300, ,['2 / Day'],IV,Adverse Event
2831,3963,Rebif [44],2016-02-10,, ,mg,['/Month'],IV, 
2832,3671,Rebif [22],2016-01-10,,1, ,['/ Day'],IV, 
2833,931,D-cure (Vitamine D),2016-07-18,2018-11-03, , ,['2 / Day'], ,Lack of efficacy
2834,931,Methylprednisolone,2016-10-08,2021-06-29,500,mg,['2 / Day'],Oral,Persisting MRI activity
2835,931,Methylprednisolone,2016-07-02,,1000,mg,['2 / Day'],IV, 
2836,931,Teriflunomide,2016-01-25,,1000,MIU,['/Month'],Oral, 
2837,2170,Copaxone,2016-06-11,2020-06-07,500,mg,[' '],IV,Persisting MRI activity
2838,2170,Tysabri,2016-03-22,,500,mg,['/Month'],IV, 
2839,2170,Ledertrexaat,2015-11-15,,5000, ,['/Month'],IV, 
2840,2170,Tecfidera,2016-09-18,2019-10-10, ,mcg,['2 / Day'], ,Patient Choice/Convenience
2841,2804,Teriflunomide,2016-09-24,2020-03-29,300, ,['2 / Day'],Oral,Patient Choice/Convenience
2842,2804,Tecfidera,2016-06-04,,1000,MIU,['2 / Day'],IV, 
2843,2804,Tysabri,2015-11-01,, , ,['/Month'], , 
2844,461,Rebif [44],2016-02-26,, , ,['3 / Week'], , 
2845,3554,Tysabri,2016-08-24,2020-06-26,20,mg,['/Month'],IV,Patient Choice/Convenience
2846,3256,Rebif [44],2016-05-08,,500,mg,['2 / Day'],IV, 
2847,3256,Mitoxantrone,2015-11-09,,20, ,['/Month'],Oral, 
2848,1360,Avonex,2016-05-15,2018-05-13, , ,['/ Day'], ,Lack of efficacy
2849,1360,Rebif [22],2016-03-03,,400, ,['2 / Day'],IV, 
2850,1360,Teriflunomide,2015-11-11,,400,mcg,['/Month'], , 
2851,1360,IVIG,2015-12-18,,1,mcg,['/Month'],Oral, 
2852,4664,Tecfidera,2016-02-21,,400,mg,['3 / Week'], , 
2853,4664,Gilenya,2016-06-21,,1000,MIU,['3 / Week'], , 
2854,4664,Copaxone,2016-08-25,,1000,mg,[' '],Oral, 
2855,2169,Mitoxantrone,2015-12-23,,5000,mg,['/Month'],IV, 
2856,2169,Tysabri,2016-06-15,2018-10-28,1, ,['/ Day'], ,Lack of efficacy
2857,2169,Methylprednisolone,2016-10-04,, ,mg,['2 / Day'], , 
2858,2169,Methylprednisolone,2016-06-06,, , ,['2 / Day'], , 
2859,3851,Copaxone,2016-03-24,, ,MIU,['/ Day'], , 
2860,3851,Betaferon,2016-01-23,2017-12-30,20,mg,['/Month'], ,Adverse Event
2861,3851,Gilenya,2016-08-07,2020-12-11, ,mg,['/Month'],IV,Persisting MRI activity
2862,3851,Ledertrexaat,2016-04-17,, , ,['/ Day'],Oral, 
2863,2142,IVIG,2016-07-07,2019-09-03, ,mg,['/Month'], ,Adverse Event
2864,1937,Avonex,2016-09-12,2021-03-18,1,mg,['3 / Week'],IV,Patient Choice/Convenience
2865,1937,Gilenya,2016-06-29,2018-01-02,400,mcg,['2 / Day'],Oral,Adverse Event
2866,1937,IVIG,2016-05-21,2017-11-22,500,mcg,[' '], ,Adverse Event
2867,1937,Betaferon,2016-03-14,, , ,['2 / Day'],IV, 
2868,2749,IVIG,2016-05-19,2018-07-06,300,mg,['2 / Day'],IV,Adverse Event
2869,2749,Tysabri,2016-05-15,,1000, ,['3 / Week'], , 
2870,2749,Mitoxantrone,2016-05-28,, , ,['/ Day'], , 
2871,2749,Teriflunomide,2015-12-02,,1000,mg,['2 / Day'],IV, 
2872,3546,Rebif [22],2016-09-29,, ,mg,['/ Day'],IV, 
2873,3546,D-cure (Vitamine D),2016-10-20,, ,mg,['/ Week'],IV, 
2874,3546,Gilenya,2016-05-23,,500,mcg,['/ Week'], , 
2875,3546,D-cure (Vitamine D),2016-02-23,2020-11-06, ,mcg,[' '], ,Persistence of relapses
2876,229,Rebif [44],2016-09-27,, ,MIU,['2 / Day'],Oral, 
2877,229,Tecfidera,2016-09-10,2019-06-19, ,MIU,['2 / Day'],Oral,Adverse Event
2878,229,Teriflunomide,2016-03-11,,300,MIU,['2 / Day'],IV, 
2879,229,IVIG,2016-09-21,, ,mg,['/Month'],IV, 
2880,295,D-cure (Vitamine D),2015-11-16,,5000,mg,['/ Day'],Oral, 
2881,295,Tysabri,2016-08-25,2019-10-22,1,MIU,['2 / Day'], ,Patient Choice/Convenience
2882,295,Copaxone,2016-09-18,2018-11-01,500,mg,['/Month'], ,Lack of efficacy
2883,295,Rebif [44],2016-03-24,, , ,['/Month'],IV, 
2884,2633,D-cure (Vitamine D),2016-07-14,,300,mg,[' '],IV, 
2885,2633,Mitoxantrone,2015-10-26,2018-08-15,400,mg,[' '], ,Patient Choice/Convenience
2886,2633,Mitoxantrone,2016-06-29,, ,mg,['2 / Day'],IV, 
2887,2633,Tysabri,2016-03-30,,1000,mg,['2 / Day'], , 
2888,4515,Rebif [44],2016-02-14,, , ,['/Month'],IV, 
2889,4515,Alemtuzumab (Campath),2016-09-27,2018-11-16, ,mg,['2 / Day'], ,Persistence of relapses
2890,4515,Rebif [44],2015-11-03,, , ,['/Month'],IV, 
2891,4515,Alemtuzumab (Campath),2015-11-05,,1, ,['/ Day'], , 
2892,1849,Rebif [22],2016-05-05,,300, ,['2 / Day'],IV, 
2893,1849,Tysabri,2015-12-17,,20,mg,['2 / Day'],IV, 
2894,3733,Copaxone,2016-02-27,2019-02-14,300,mg,['2 / Day'],IV,Lack of efficacy
2895,3892,D-cure (Vitamine D),2016-01-29,,1000,mcg,['/Month'], , 
2896,724,D-cure (Vitamine D),2016-09-11,, ,mg,['2 / Day'],IV, 
2897,724,Alemtuzumab (Campath),2016-08-06,2018-05-25, , ,['/Month'], ,Lack of efficacy
2898,984,D-cure (Vitamine D),2016-07-01,,1000,mg,['3 / Week'],Oral, 
2899,4263,Mitoxantrone,2015-12-02,2017-12-26, , ,['/Month'],IV,Persisting MRI activity
2900,4263,Gilenya,2016-09-07,2019-12-11,400,MIU,['3 / Week'],IV,Persisting MRI activity
2901,4716,Copaxone,2015-12-15,2019-02-28,400, ,['3 / Week'], ,Lack of efficacy
2902,4716,Mitoxantrone,2015-11-18,2021-09-17, ,mcg,['/Month'],IV,Patient Choice/Convenience
2903,3388,D-cure (Vitamine D),2016-04-03,,1000,mg,['/ Day'],IV, 
2904,3388,Tysabri,2016-04-23,2021-04-21,1,mg,['/Month'],Oral,Persisting MRI activity
2905,3388,Avonex,2016-09-05,2019-08-09,1, ,[' '],Oral,Persisting MRI activity
2906,3388,Tysabri,2015-12-20,, , ,['/ Week'],IV, 
2907,3984,Rebif [44],2015-11-15,, ,mg,['/Month'],IV, 
2908,3984,Alemtuzumab (Campath),2015-11-08,2020-12-14,20, ,['2 / Day'], ,Adverse Event
2909,3984,Methylprednisolone,2015-11-12,2019-12-19, ,MIU,['/ Week'],IV,Lack of efficacy
2910,2029,D-cure (Vitamine D),2015-11-02,2021-05-18,500, ,['2 / Day'],IV,Adverse Event
2911,2029,IVIG,2016-06-22,2021-06-09, , ,['3 / Week'], ,Lack of efficacy
2912,2029,D-cure (Vitamine D),2016-04-17,,20, ,['2 / Day'],IV, 
2913,2029,Tysabri,2015-12-23,2020-12-22, , ,['/Month'],Oral,Persistence of relapses
2914,3764,Rebif [44],2016-05-03,,1,mg,['/Month'],IV, 
2915,3764,Mitoxantrone,2016-04-02,,300,mg,['3 / Week'],IV, 
2916,3764,Avonex,2015-11-29,, ,MIU,['2 / Day'],IV, 
2917,3764,Mitoxantrone,2016-03-11,,300,mcg,['2 / Day'],IV, 
2918,4015,Methylprednisolone,2016-01-13,,5000, ,[' '],IV, 
2919,4015,Copaxone,2016-04-06,,1000,mg,['2 / Day'],IV, 
2920,4015,Tysabri,2016-09-08,,1,mg,['2 / Day'], , 
2921,4361,Rebif [22],2016-06-12,, ,mg,['/Month'],IV, 
2922,4361,Avonex,2015-12-08,, , ,['2 / Day'],IV, 
2923,4361,Ledertrexaat,2016-01-03,2021-04-29,20,mg,['2 / Day'], ,Lack of efficacy
2924,524,Tecfidera,2016-03-02,2020-11-20, , ,['2 / Day'],IV,Lack of efficacy
2925,524,Ledertrexaat,2016-05-18,, ,mg,['2 / Day'],IV, 
2926,524,Copaxone,2016-03-03,2019-04-02,300, ,['3 / Week'], ,Lack of efficacy
2927,524,D-cure (Vitamine D),2016-08-25,,20, ,['2 / Day'],IV, 
2928,3903,D-cure (Vitamine D),2016-02-28,,1,mg,['2 / Day'],IV, 
2929,3903,IVIG,2016-02-23,2020-12-27,500,mg,['2 / Day'], ,Patient Choice/Convenience
2930,3903,Methylprednisolone,2015-10-25,,1000, ,['2 / Day'],IV, 
2931,3903,Betaferon,2016-08-04,,500, ,[' '],Oral, 
2932,2242,Rebif [44],2016-10-19,,300,MIU,['/Month'], , 
2933,2242,Tecfidera,2016-07-09,,500,mg,['/Month'], , 
2934,2242,Copaxone,2016-01-09,2020-07-29,20,mg,['3 / Week'],Oral,Patient Choice/Convenience
2935,847,Ledertrexaat,2016-05-01,,20,MIU,['2 / Day'],Oral, 
2936,847,Rebif [44],2016-04-23,,400,MIU,['/ Day'],IV, 
2937,847,Methylprednisolone,2016-02-24,2020-10-06,1,mg,['2 / Day'],IV,Lack of efficacy
2938,3693,D-cure (Vitamine D),2016-04-23,2019-06-15, ,MIU,[' '],IV,Adverse Event
2939,3693,Teriflunomide,2016-03-22,,20,mg,['/Month'],IV, 
2940,3693,IVIG,2016-05-04,, , ,['2 / Day'],IV, 
2941,3693,D-cure (Vitamine D),2016-10-06,,1,mg,['/Month'], , 
2942,2525,Gilenya,2016-05-11,,5000, ,['3 / Week'], , 
2943,3774,Alemtuzumab (Campath),2016-09-12,,400,mg,['/Month'],Oral, 
2944,3774,Rebif [44],2016-03-15,, ,mcg,['2 / Day'], , 
2945,4742,Avonex,2015-12-27,,500,MIU,['/Month'],IV, 
2946,4742,Avonex,2016-08-29,2021-02-04, , ,['/Month'], ,Persistence of relapses
2947,1284,Rebif [44],2016-03-04,,400, ,['/Month'], , 
2948,993,Tecfidera,2016-07-21,2021-03-09,500, ,['/Month'], ,Patient Choice/Convenience
2949,993,Alemtuzumab (Campath),2016-09-08,,300,mg,['3 / Week'],IV, 
2950,3932,Gilenya,2016-07-26,2021-01-19,500,MIU,['3 / Week'], ,Patient Choice/Convenience
2951,3932,Tysabri,2016-09-21,, ,mcg,['2 / Day'],IV, 
2952,854,Rebif [22],2016-07-17,,1000, ,['3 / Week'],Oral, 
2953,854,Gilenya,2016-04-10,, , ,['2 / Day'], , 
2954,854,Methylprednisolone,2016-07-21,, ,mg,['/ Week'], , 
2955,854,Copaxone,2016-10-12,2017-12-25,500, ,['/Month'], ,Adverse Event
2956,1123,IVIG,2015-11-22,2017-10-26,300,mg,['/ Day'],Oral,Lack of efficacy
2957,1123,Tysabri,2016-06-05,,300, ,['2 / Day'],IV, 
2958,3686,Betaferon,2016-09-07,,300,mg,['2 / Day'],IV, 
2959,3686,Alemtuzumab (Campath),2015-12-31,,500,MIU,['2 / Day'], , 
2960,3686,D-cure (Vitamine D),2016-06-15,,400, ,['/ Day'],IV, 
2961,3686,D-cure (Vitamine D),2016-07-12,2018-06-27,20, ,['/Month'], ,Persisting MRI activity
2962,891,Gilenya,2016-01-24,,1000, ,['/Month'], , 
2963,891,Copaxone,2016-10-09,,500,mg,[' '],IV, 
2964,4870,Tysabri,2016-05-14,2018-02-19,300,mg,[' '], ,Persistence of relapses
2965,4870,Methylprednisolone,2016-01-25,, , ,['3 / Week'],Oral, 
2966,4870,Mitoxantrone,2015-12-26,2017-12-19,1,mg,['3 / Week'],IV,Persistence of relapses
2967,4870,Mitoxantrone,2016-03-31,, ,MIU,['2 / Day'], , 
2968,2685,Alemtuzumab (Campath),2016-01-25,2018-05-19, , ,['/ Week'], ,Persisting MRI activity
2969,2685,Alemtuzumab (Campath),2015-12-28,2020-05-23, ,mg,['/Month'], ,Adverse Event
2970,2685,Tecfidera,2016-01-12,,300,MIU,['2 / Day'], , 
2971,1970,Rebif [22],2016-02-29,2018-09-25, ,mg,['/Month'], ,Lack of efficacy
2972,1970,Tysabri,2016-01-31,, ,mg,['/ Day'],Oral, 
2973,1970,Rebif [44],2016-08-13,2021-09-24,500,mg,['2 / Day'],IV,Persisting MRI activity
2974,4231,Rebif [22],2016-01-17,,5000, ,['3 / Week'], , 
2975,4231,Gilenya,2016-01-23,2020-08-16,300,mg,['/Month'], ,Lack of efficacy
2976,4231,Teriflunomide,2016-05-13,,5000,mg,['/ Day'],IV, 
2977,4231,Ledertrexaat,2016-10-07,2018-04-12, , ,['2 / Day'],IV,Persistence of relapses
2978,1619,Methylprednisolone,2016-03-29,,1,mg,['/Month'], , 
2979,1619,Methylprednisolone,2016-02-22,2021-05-11,20,mcg,['/Month'], ,Patient Choice/Convenience
2980,1619,Methylprednisolone,2016-05-29,2020-12-27,20,mg,['2 / Day'],IV,Patient Choice/Convenience
2981,2530,Alemtuzumab (Campath),2015-11-05,,1000,mg,['2 / Day'],IV, 
2982,2530,Copaxone,2016-04-21,,400,mg,['/Month'],Oral, 
2983,2530,D-cure (Vitamine D),2016-09-19,2021-10-14, ,mg,['/ Day'],IV,Patient Choice/Convenience
2984,3228,Rebif [22],2016-05-14,2020-07-23,500,mg,['2 / Day'], ,Persisting MRI activity
2985,3228,D-cure (Vitamine D),2016-08-10,, ,mg,['2 / Day'],Oral, 
2986,3228,Endoxan,2016-08-12,,1, ,['/Month'], , 
2987,1620,Gilenya,2016-05-22,,20, ,['/Month'],IV, 
2988,1620,Alemtuzumab (Campath),2016-04-25,2020-02-13,20,mg,['/ Day'], ,Adverse Event
2989,1620,Copaxone,2016-05-31,,5000,mg,['/ Day'],IV, 
2990,1620,D-cure (Vitamine D),2015-11-30,2019-10-15,20,mg,['2 / Day'], ,Adverse Event
2991,4199,Methylprednisolone,2016-01-02,,20,MIU,['3 / Week'],IV, 
2992,4780,IVIG,2016-03-23,,500,MIU,['2 / Day'],IV, 
2993,4780,Rebif [44],2016-08-24,2020-08-27, ,mg,['/ Week'], ,Patient Choice/Convenience
2994,4780,Tecfidera,2016-08-08,,1, ,[' '],IV, 
2995,4780,Teriflunomide,2015-12-10,,5000,mg,['/ Day'],Oral, 
2996,2765,Ledertrexaat,2016-03-31,2019-04-14,300,mcg,['3 / Week'],IV,Adverse Event
2997,2765,Endoxan,2016-09-05,,20, ,['/Month'],IV, 
2998,2765,Alemtuzumab (Campath),2016-08-06,,1000, ,['/Month'],IV, 
2999,3602,Endoxan,2016-02-16,,20,mg,['3 / Week'],IV, 
3000,1886,D-cure (Vitamine D),2016-08-27,, ,mcg,[' '], , 
3001,1886,Tysabri,2016-09-22,2019-12-18,1,MIU,['2 / Day'],IV,Patient Choice/Convenience
3002,4100,IVIG,2016-02-23,, ,MIU,['/Month'], , 
3003,1867,Copaxone,2016-06-18,,1, ,['2 / Day'],IV, 
3004,1646,Betaferon,2016-07-22,2019-06-16,500, ,['2 / Day'], ,Lack of efficacy
3005,1646,Rebif [44],2016-02-05,2021-10-16, ,mg,['2 / Day'],Oral,Persisting MRI activity
3006,1646,Avonex,2016-08-29,,500,mg,['2 / Day'],IV, 
3007,1646,Mitoxantrone,2016-10-20,2021-03-02,20,mcg,['/Month'],IV,Adverse Event
3008,3807,Gilenya,2015-12-21,2020-10-26,300,mg,['/Month'],IV,Patient Choice/Convenience
3009,3807,Copaxone,2015-12-27,2020-12-29, ,mg,['/Month'], ,Adverse Event
3010,3807,Rebif [22],2016-07-08,,300, ,['2 / Day'], , 
3011,4326,Teriflunomide,2016-05-17,2020-08-11, ,mg,['/Month'],IV,Patient Choice/Convenience
3012,4326,D-cure (Vitamine D),2016-04-16,,500, ,['/Month'],IV, 
3013,4326,Tysabri,2016-01-20,2020-10-15,500, ,['/ Week'],IV,Persistence of relapses
3014,4326,Rebif [44],2016-01-18,, ,mg,['/Month'],Oral, 
3015,1333,Rebif [22],2016-06-08,,5000, ,['/Month'], , 
3016,1333,Methylprednisolone,2016-01-19,,1000, ,['/Month'],IV, 
3017,591,IVIG,2016-02-27,,1000,mg,['/Month'],IV, 
3018,591,Endoxan,2016-06-01,, ,mg,['2 / Day'], , 
3019,858,D-cure (Vitamine D),2016-07-05,2019-06-19,400, ,['2 / Day'],IV,Adverse Event
3020,1533,Endoxan,2016-07-21,2021-02-19,500, ,['/Month'], ,Patient Choice/Convenience
3021,1533,Mitoxantrone,2016-01-04,2019-05-01,300,mg,['/Month'],Oral,Adverse Event
3022,1035,IVIG,2016-09-20,,300, ,['/Month'],IV, 
3023,1035,Ledertrexaat,2016-03-05,, ,mg,['/ Day'],IV, 
3024,1035,Rebif [22],2016-01-27,,5000,mcg,['2 / Day'],IV, 
3025,1035,Copaxone,2015-12-14,2018-02-01,300,mg,['/Month'], ,Adverse Event
3026,3900,Endoxan,2016-06-29,2021-03-08,500, ,['3 / Week'], ,Patient Choice/Convenience
3027,3900,D-cure (Vitamine D),2016-01-16,2018-11-21,300,mg,['2 / Day'], ,Adverse Event
3028,3900,Mitoxantrone,2016-04-13,,20,mg,['/Month'], , 
3029,598,Copaxone,2015-10-31,,1000, ,['2 / Day'],IV, 
3030,4610,Copaxone,2016-08-27,2018-06-07,20, ,['/ Week'],Oral,Persistence of relapses
3031,852,Betaferon,2015-12-29,2020-08-28, ,mcg,['2 / Day'],IV,Persisting MRI activity
3032,852,Gilenya,2016-02-14,2018-12-25,1, ,['/ Day'],IV,Patient Choice/Convenience
3033,852,Rebif [44],2016-08-09,2021-07-11, ,mcg,['/Month'],IV,Persisting MRI activity
3034,4757,Tecfidera,2016-06-18,2021-10-11,500, ,['2 / Day'], ,Persisting MRI activity
3035,4757,IVIG,2015-12-06,2020-12-17,1000, ,['/Month'],IV,Lack of efficacy
3036,4757,Rebif [44],2015-10-27,2017-12-02,1000,mg,['2 / Day'], ,Lack of efficacy
3037,920,IVIG,2016-03-27,2020-05-20,5000, ,['2 / Day'],Oral,Adverse Event
3038,920,Tysabri,2015-11-19,2018-09-26,1,mg,['2 / Day'], ,Lack of efficacy
3039,920,Copaxone,2016-01-19,,1, ,['/ Day'],Oral, 
3040,4726,Alemtuzumab (Campath),2016-08-13,, , ,['/Month'],Oral, 
3041,4726,Mitoxantrone,2016-07-31,,500,MIU,['2 / Day'],IV, 
3042,4726,D-cure (Vitamine D),2016-06-13,,5000, ,[' '], , 
3043,183,Tysabri,2016-08-06,, ,mg,['2 / Day'],IV, 
3044,2533,Tecfidera,2016-09-15,2020-07-10,1, ,['3 / Week'],IV,Lack of efficacy
3045,2533,Methylprednisolone,2016-03-07,,300, ,['3 / Week'],Oral, 
3046,2498,Gilenya,2016-10-05,2021-05-08,20,mg,['/ Week'],IV,Persistence of relapses
3047,2498,IVIG,2016-06-28,, ,mg,['/Month'],IV, 
3048,2498,Betaferon,2016-01-25,,20,mg,[' '], , 
3049,3015,Rebif [22],2016-05-04,2019-04-07,300,mg,['3 / Week'],IV,Adverse Event
3050,3015,Tecfidera,2016-05-30,2018-09-23,20,mg,['3 / Week'],IV,Adverse Event
3051,3015,D-cure (Vitamine D),2016-03-20,, ,mg,['2 / Day'],IV, 
3052,1905,D-cure (Vitamine D),2016-02-06,,500,mg,['2 / Day'], , 
3053,1905,Alemtuzumab (Campath),2016-10-15,,1, ,['/Month'], , 
3054,1905,Methylprednisolone,2016-08-06,,400,mg,['2 / Day'], , 
3055,3615,Copaxone,2016-05-22,2018-08-29, , ,[' '],IV,Adverse Event
3056,3615,Methylprednisolone,2016-09-06,,400,MIU,['/Month'], , 
3057,4087,IVIG,2016-02-11,2018-03-01,500, ,['/Month'],Oral,Persistence of relapses
3058,3309,Tecfidera,2016-05-09,, ,mg,['3 / Week'], , 
3059,3309,Mitoxantrone,2016-03-20,,5000, ,['2 / Day'],IV, 
3060,3309,D-cure (Vitamine D),2016-07-02,,20, ,['2 / Day'],IV, 
3061,421,Ledertrexaat,2016-04-29,,400,mg,['2 / Day'], , 
3062,4798,Tecfidera,2015-10-26,,300,mg,['2 / Day'],IV, 
3063,4911,IVIG,2016-06-01,,500, ,[' '],IV, 
3064,4911,Methylprednisolone,2016-03-07,,20,mg,['2 / Day'],IV, 
3065,4252,Copaxone,2016-06-18,,500,MIU,['2 / Day'],IV, 
3066,3410,Tecfidera,2015-12-27,,400, ,['/Month'], , 
3067,3410,Gilenya,2016-08-13,,1000,mcg,['/Month'],IV, 
3068,3410,Teriflunomide,2015-11-26,2021-04-21,300,MIU,[' '],IV,Patient Choice/Convenience
3069,3410,IVIG,2015-12-11,,20,mg,[' '], , 
3070,1108,Teriflunomide,2016-07-25,2018-05-12, ,mg,[' '], ,Patient Choice/Convenience
3071,1108,Mitoxantrone,2016-06-16,, , ,['2 / Day'],IV, 
3072,1108,Alemtuzumab (Campath),2016-06-26,, ,mg,['/ Day'],IV, 
3073,1108,Gilenya,2016-09-23,,400,MIU,['/ Week'],IV, 
3074,2515,D-cure (Vitamine D),2016-06-23,, ,mg,['/ Day'],IV, 
3075,2515,Gilenya,2016-01-23,2021-07-09, ,MIU,['/Month'], ,Adverse Event
3076,2515,Methylprednisolone,2016-08-18,2020-09-28, ,mg,['2 / Day'],IV,Persistence of relapses
3077,2515,Betaferon,2016-06-06,2020-11-01, ,mg,['3 / Week'], ,Persisting MRI activity
3078,3708,Copaxone,2016-01-29,2021-09-16,5000, ,['/ Week'], ,Persisting MRI activity
3079,3708,Teriflunomide,2016-05-15,, , ,['/Month'], , 
3080,3708,Alemtuzumab (Campath),2015-11-06,2020-11-22,300, ,['3 / Week'],IV,Adverse Event
3081,4586,Gilenya,2016-09-28,,5000,mg,['2 / Day'],IV, 
3082,4586,Tysabri,2016-07-11,2019-06-30, , ,['/Month'],IV,Persisting MRI activity
3083,4586,Endoxan,2016-01-26,2018-10-24,400, ,[' '], ,Adverse Event
3084,4586,Avonex,2016-04-05,,1000, ,['2 / Day'],IV, 
3085,3355,Tysabri,2016-05-09,,1000, ,[' '],IV, 
3086,3355,Methylprednisolone,2016-09-02,,1,mg,['/ Day'],IV, 
3087,4562,D-cure (Vitamine D),2016-07-02,, , ,['/Month'], , 
3088,4562,Copaxone,2016-07-09,2021-07-25,20,mcg,['3 / Week'], ,Persisting MRI activity
3089,2193,Methylprednisolone,2016-01-03,, ,mg,['2 / Day'],IV, 
3090,2193,Tecfidera,2016-07-19,2018-11-05, ,mcg,['/ Day'], ,Adverse Event
3091,3559,Alemtuzumab (Campath),2016-10-19,,1000, ,['2 / Day'],IV, 
3092,3559,Methylprednisolone,2015-11-26,, ,mg,['2 / Day'],IV, 
3093,234,Teriflunomide,2015-12-09,2020-03-30,400, ,[' '], ,Persistence of relapses
3094,234,Rebif [44],2016-03-07,,500,mg,['/Month'],IV, 
3095,234,Betaferon,2015-11-09,, ,mg,['2 / Day'],IV, 
3096,956,Tysabri,2016-04-18,2019-07-19,400,mg,['/Month'],IV,Patient Choice/Convenience
3097,956,Tysabri,2016-05-07,2020-04-14,300, ,[' '],IV,Persisting MRI activity
3098,3512,Teriflunomide,2015-11-14,,1000, ,['3 / Week'],IV, 
3099,3512,Mitoxantrone,2016-10-20,,5000,mcg,['/ Week'],IV, 
3100,3512,Rebif [22],2016-05-02,,500,mg,['/Month'],IV, 
3101,3602,Tysabri,2016-10-10,,20, ,['3 / Week'],IV, 
3102,3602,Alemtuzumab (Campath),2016-01-15,2018-10-15,400, ,['3 / Week'],IV,Persistence of relapses
3103,784,Methylprednisolone,2016-10-09,, ,mg,['2 / Day'], , 
3104,784,Avonex,2016-09-19,,1000, ,['3 / Week'],IV, 
3105,784,IVIG,2016-06-07,2021-04-16,5000, ,['2 / Day'],Oral,Lack of efficacy
3106,784,Rebif [22],2015-10-24,,300, ,['/Month'],IV, 
3107,877,Endoxan,2016-05-24,2021-05-29,1000,MIU,['/Month'],IV,Adverse Event
3108,877,IVIG,2016-05-10,, ,mg,['3 / Week'],IV, 
3109,877,Rebif [22],2015-12-23,2018-02-11, , ,[' '],IV,Adverse Event
3110,877,Betaferon,2016-02-22,,5000,mg,['/ Week'], , 
3111,1393,Copaxone,2015-12-12,2020-08-18, ,mcg,['/ Week'],IV,Adverse Event
3112,1186,Rebif [44],2015-10-29,,20, ,['3 / Week'],IV, 
3113,1186,D-cure (Vitamine D),2016-04-30,,20,MIU,['/Month'],IV, 
3114,1186,Mitoxantrone,2016-10-20,2019-01-04,300,mg,['2 / Day'], ,Persisting MRI activity
3115,194,Copaxone,2016-10-12,,400, ,['/Month'],IV, 
3116,194,Endoxan,2016-08-29,,20, ,['/ Day'], , 
3117,194,Tecfidera,2016-01-29,2021-09-05,1000, ,['2 / Day'], ,Lack of efficacy
3118,194,D-cure (Vitamine D),2015-12-30,2020-03-13,1000, ,['2 / Day'],IV,Patient Choice/Convenience
3119,830,D-cure (Vitamine D),2016-09-22,,400, ,['2 / Day'], , 
3120,4128,Alemtuzumab (Campath),2016-07-12,2019-06-27, , ,[' '],IV,Persisting MRI activity
3121,4128,Copaxone,2016-07-20,,20,mg,['2 / Day'], , 
3122,4128,Rebif [44],2016-03-12,,400, ,['2 / Day'], , 
3123,2857,Rebif [44],2016-08-18,,500, ,['/Month'],IV, 
3124,2857,Avonex,2016-02-10,,20,mg,['2 / Day'],IV, 
3125,2857,Rebif [44],2016-05-11,,300,mg,['/Month'], , 
3126,2857,IVIG,2016-08-21,2021-02-13, ,mg,['2 / Day'],Oral,Lack of efficacy
3127,692,Rebif [44],2016-08-03,2018-07-08,5000,mg,[' '], ,Adverse Event
3128,692,Tysabri,2016-03-13,2020-01-23,1,mg,['2 / Day'],IV,Patient Choice/Convenience
3129,692,D-cure (Vitamine D),2016-07-19,2018-02-26, , ,['2 / Day'], ,Lack of efficacy
3130,2293,Methylprednisolone,2016-05-28,,5000,mg,['2 / Day'],IV, 
3131,2293,Tecfidera,2016-09-08,,300, ,['2 / Day'],Oral, 
3132,489,Ledertrexaat,2015-11-29,2017-11-20,400, ,['/ Day'],IV,Patient Choice/Convenience
3133,489,Rebif [22],2016-01-13,,1000,mcg,['2 / Day'], , 
3134,489,Tysabri,2016-10-12,,20,mcg,['/Month'],Oral, 
3135,1286,IVIG,2016-09-27,, ,mg,['2 / Day'], , 
3136,1286,Gilenya,2016-04-10,, ,mg,['/Month'], , 
3137,1286,Alemtuzumab (Campath),2016-03-13,, , ,['/ Day'], , 
3138,1286,D-cure (Vitamine D),2016-07-29,2020-03-01, , ,['/Month'],IV,Persistence of relapses
3139,2008,Tysabri,2015-12-15,2018-08-08,20, ,['/Month'],IV,Patient Choice/Convenience
3140,2008,D-cure (Vitamine D),2016-05-15,,1000, ,['/Month'],Oral, 
3141,3074,Tysabri,2016-09-03,,500, ,[' '], , 
3142,3074,Rebif [44],2016-09-17,,20,mg,['/Month'],Oral, 
3143,3074,Teriflunomide,2016-01-28,2017-11-19,400,mg,['3 / Week'],IV,Persisting MRI activity
3144,776,Ledertrexaat,2016-04-10,,1, ,['3 / Week'],IV, 
3145,776,Tysabri,2015-11-07,, , ,['/Month'], , 
3146,776,Gilenya,2016-04-17,2019-07-08, , ,['/Month'], ,Persisting MRI activity
3147,776,Betaferon,2016-07-09,2021-06-18,20,mg,['/Month'], ,Adverse Event
3148,4449,Teriflunomide,2016-04-19,2018-04-02,500,mcg,['/Month'], ,Persisting MRI activity
3149,4449,Methylprednisolone,2016-10-13,2020-03-07,1000,mg,[' '], ,Persisting MRI activity
3150,4449,D-cure (Vitamine D),2016-05-18,,500, ,['/Month'],IV, 
3151,4449,D-cure (Vitamine D),2016-06-14,2021-01-03,1000,mg,['/Month'], ,Adverse Event
3152,4075,Gilenya,2015-10-27,,5000,mg,['3 / Week'], , 
3153,2506,Teriflunomide,2016-01-04,2019-09-01,500, ,['2 / Day'],IV,Patient Choice/Convenience
3154,1719,D-cure (Vitamine D),2016-08-27,2020-11-28, ,mg,['/Month'],IV,Adverse Event
3155,1719,Endoxan,2015-12-31,, ,mg,['3 / Week'], , 
3156,1719,Gilenya,2015-11-22,,500,mg,['2 / Day'],IV, 
3157,1719,Copaxone,2015-12-12,2018-08-19,20, ,['3 / Week'], ,Lack of efficacy
3158,1863,Gilenya,2016-07-29,, ,mcg,['3 / Week'],Oral, 
3159,4043,Rebif [44],2016-06-01,2019-12-16,20,mg,['/ Day'], ,Lack of efficacy
3160,1706,Methylprednisolone,2015-11-18,2018-10-31, ,mg,['/Month'],IV,Persistence of relapses
3161,1706,Rebif [44],2016-06-14,2018-04-07,1,MIU,['2 / Day'],IV,Adverse Event
3162,3559,Avonex,2016-04-02,2021-07-25,1,mg,['2 / Day'], ,Adverse Event
3163,1350,Mitoxantrone,2016-06-11,2019-12-10, ,mg,[' '],IV,Persisting MRI activity
3164,351,Rebif [22],2016-02-11,2020-11-09,300, ,['2 / Day'],IV,Adverse Event
3165,351,Avonex,2015-12-26,,5000,MIU,['3 / Week'], , 
3166,689,Avonex,2016-09-27,2019-09-08,5000,MIU,['/ Day'], ,Adverse Event
3167,689,Tecfidera,2015-12-09,, , ,['2 / Day'], , 
3168,689,Endoxan,2016-09-25,, ,MIU,['3 / Week'],IV, 
3169,689,IVIG,2016-01-05,, , ,['3 / Week'], , 
3170,991,Mitoxantrone,2016-04-11,2021-04-14, , ,['2 / Day'],IV,Adverse Event
3171,991,Gilenya,2016-01-11,2018-10-17, ,mg,['/Month'],IV,Persisting MRI activity
3172,991,Methylprednisolone,2015-12-05,,1, ,['2 / Day'],IV, 
3173,991,IVIG,2015-12-05,,400,mg,[' '],IV, 
3174,4414,Avonex,2016-05-11,2020-12-09, ,mg,['2 / Day'],IV,Patient Choice/Convenience
3175,3690,Mitoxantrone,2016-02-17,2018-03-28,400,MIU,['2 / Day'],IV,Persisting MRI activity
3176,3690,Gilenya,2016-08-25,2019-05-03, ,mg,[' '], ,Adverse Event
3177,2141,Copaxone,2016-09-20,,500,mg,['/ Week'], , 
3178,2141,Methylprednisolone,2016-08-28,,5000, ,['/Month'], , 
3179,1132,Rebif [44],2016-03-02,2018-01-11,1,mcg,['/Month'],Oral,Adverse Event
3180,1585,D-cure (Vitamine D),2016-09-14,2021-04-27,400,mg,['3 / Week'], ,Adverse Event
3181,1585,Betaferon,2015-12-20,2019-04-03,5000, ,['/Month'],IV,Patient Choice/Convenience
3182,1585,Rebif [44],2016-05-18,, ,mg,['/Month'], , 
3183,1585,IVIG,2015-12-25,, ,mg,['2 / Day'],Oral, 
3184,327,Methylprednisolone,2016-05-14,,400,mg,['/Month'],IV, 
3185,327,IVIG,2015-11-29,2019-10-05,400, ,['/Month'],IV,Patient Choice/Convenience
3186,409,Methylprednisolone,2016-05-03,2020-08-10,1000,mg,[' '],IV,Persisting MRI activity
3187,409,Rebif [22],2016-06-30,, , ,['/Month'],IV, 
3188,111,D-cure (Vitamine D),2016-09-01,2018-01-19,400,mcg,['/Month'], ,Persistence of relapses
3189,1982,D-cure (Vitamine D),2016-05-05,2020-09-06,400, ,['2 / Day'],IV,Patient Choice/Convenience
3190,1982,Copaxone,2016-03-20,2018-05-17,1000,MIU,['/Month'],IV,Persistence of relapses
3191,4286,Tysabri,2016-06-06,2018-08-22,1000,MIU,[' '],IV,Persisting MRI activity
3192,4286,Methylprednisolone,2016-09-03,2018-10-25,1, ,['/Month'],IV,Persistence of relapses
3193,4286,Betaferon,2016-05-24,,400,mg,['2 / Day'],IV, 
3194,1843,Avonex,2016-08-10,2018-06-24, , ,['/ Week'],IV,Lack of efficacy
3195,1843,Gilenya,2016-02-17,,500, ,['/Month'], , 
3196,4057,Alemtuzumab (Campath),2016-04-05,,500,mg,['/ Day'],IV, 
3197,4057,Mitoxantrone,2016-07-10,,20,mcg,['2 / Day'],Oral, 
3198,4057,Gilenya,2016-09-24,2019-04-03,1, ,['2 / Day'],IV,Persisting MRI activity
3199,3420,Rebif [44],2016-04-26,,500,mcg,['2 / Day'],IV, 
3200,3420,Methylprednisolone,2016-01-14,2020-08-27, ,MIU,['/Month'],IV,Persisting MRI activity
3201,3420,D-cure (Vitamine D),2016-01-23,2019-07-22, ,mg,['/Month'],IV,Persisting MRI activity
3202,3206,Tysabri,2016-07-16,2019-08-07,20,mg,[' '],IV,Patient Choice/Convenience
3203,512,Rebif [22],2016-07-04,2021-02-12,20, ,['2 / Day'], ,Persistence of relapses
3204,512,Endoxan,2016-08-14,2019-02-02,20,mg,['/Month'], ,Adverse Event
3205,2228,Rebif [44],2016-08-13,, ,mg,['2 / Day'],IV, 
3206,2228,IVIG,2016-07-17,2018-02-22,1000, ,['/Month'],IV,Patient Choice/Convenience
3207,4607,IVIG,2016-10-16,, ,MIU,['/ Day'], , 
3208,4607,Avonex,2016-01-29,2020-09-09,400,mg,['2 / Day'],IV,Lack of efficacy
3209,4607,D-cure (Vitamine D),2016-05-07,2021-03-19, , ,['/Month'],IV,Lack of efficacy
3210,4607,Gilenya,2015-12-18,, ,mg,['2 / Day'],IV, 
3211,2369,Tecfidera,2016-06-18,2018-03-06,400,MIU,['3 / Week'],IV,Adverse Event
3212,2369,Teriflunomide,2016-07-21,,500, ,['/Month'], , 
3213,4801,Methylprednisolone,2016-05-12,2020-05-06, ,mg,[' '], ,Adverse Event
3214,4801,Tecfidera,2016-08-05,,500, ,['/Month'],IV, 
3215,3142,IVIG,2016-08-30,,1000, ,['2 / Day'],IV, 
3216,3142,IVIG,2016-04-24,,1000,mg,['/Month'], , 
3217,3142,Betaferon,2016-05-17,,1, ,['2 / Day'], , 
3218,4867,Tecfidera,2016-07-03,2020-08-08,1000,mg,['3 / Week'], ,Adverse Event
3219,4867,Methylprednisolone,2016-01-02,, , ,['2 / Day'],Oral, 
3220,3343,Rebif [22],2016-03-06,,5000,mcg,['/Month'],IV, 
3221,3343,Alemtuzumab (Campath),2015-11-12,,300, ,['2 / Day'], , 
3222,2835,Methylprednisolone,2016-02-25,,500,MIU,['2 / Day'],IV, 
3223,2780,Methylprednisolone,2016-10-07,2019-04-23, ,MIU,[' '], ,Patient Choice/Convenience
3224,332,Gilenya,2016-05-09,,400, ,[' '],IV, 
3225,569,Tysabri,2016-05-29,2021-04-08, , ,['/Month'],Oral,Adverse Event
3226,569,Tecfidera,2016-08-03,2019-09-13,1000,mg,['2 / Day'],IV,Adverse Event
3227,569,Ledertrexaat,2016-01-18,,5000, ,['/Month'], , 
3228,569,Tecfidera,2016-01-05,2018-01-27, ,mcg,['/Month'],IV,Persisting MRI activity
3229,4506,Gilenya,2016-03-17,,1, ,[' '],IV, 
3230,4506,Betaferon,2016-08-16,, ,mg,['/Month'],Oral, 
3231,4506,Tysabri,2016-09-04,2020-02-25,1,mg,['2 / Day'], ,Lack of efficacy
3232,4506,Alemtuzumab (Campath),2016-08-10,, ,mg,['/ Day'], , 
3233,3104,D-cure (Vitamine D),2016-08-25,2018-11-07, ,mg,['2 / Day'],IV,Lack of efficacy
3234,3104,Endoxan,2016-07-17,, ,mg,['2 / Day'],IV, 
3235,711,D-cure (Vitamine D),2016-10-11,,500,mg,[' '],IV, 
3236,711,IVIG,2016-03-01,, , ,['/Month'],Oral, 
3237,711,Rebif [22],2016-09-21,2018-07-22,5000, ,['2 / Day'],Oral,Adverse Event
3238,1755,Mitoxantrone,2015-11-21,2021-06-12,400, ,['2 / Day'],IV,Lack of efficacy
3239,1755,Gilenya,2015-11-07,,300,mg,['/ Week'],IV, 
3240,1755,Ledertrexaat,2016-06-10,,400, ,['/ Day'], , 
3241,4371,Methylprednisolone,2015-11-23,, , ,['2 / Day'],Oral, 
3242,4371,D-cure (Vitamine D),2016-05-03,,300,MIU,['/ Week'],IV, 
3243,549,Avonex,2015-11-03,,1000,mcg,['2 / Day'], , 
3244,549,Betaferon,2016-05-22,2019-08-30, , ,['2 / Day'],IV,Patient Choice/Convenience
3245,549,Ledertrexaat,2016-05-15,2018-03-30,20,mg,['/ Day'], ,Adverse Event
3246,549,Endoxan,2016-01-17,,300, ,['3 / Week'], , 
3247,1238,Gilenya,2016-05-19,,400,mg,['/Month'],Oral, 
3248,1238,Copaxone,2016-08-08,2021-07-01,5000, ,['/Month'],IV,Patient Choice/Convenience
3249,1238,Methylprednisolone,2016-06-26,,500,mg,['/Month'],IV, 
3250,1238,IVIG,2016-04-25,2018-03-19, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
3251,3583,Tecfidera,2016-03-13,2020-04-04,1,mg,['/ Week'],IV,Patient Choice/Convenience
3252,3583,Avonex,2016-05-03,,1,mg,['3 / Week'], , 
3253,3583,Gilenya,2016-02-25,2020-07-04,20,mg,['2 / Day'], ,Lack of efficacy
3254,3583,Teriflunomide,2016-07-17,2019-11-18, , ,['/ Day'], ,Adverse Event
3255,2575,Rebif [44],2016-10-16,,20,mcg,['2 / Day'],IV, 
3256,2575,Endoxan,2015-11-20,,20,mg,['/ Week'],IV, 
3257,3064,Gilenya,2016-04-18,,500, ,['/Month'],IV, 
3258,3064,Gilenya,2016-01-19,2021-08-05,1000, ,['3 / Week'],IV,Lack of efficacy
3259,3064,Mitoxantrone,2016-04-02,,400,mg,['3 / Week'],IV, 
3260,3064,Methylprednisolone,2016-06-19,2020-11-12,1000, ,[' '], ,Persisting MRI activity
3261,4175,D-cure (Vitamine D),2016-01-25,2020-09-05,20,mg,['/Month'],IV,Persisting MRI activity
3262,4175,Betaferon,2016-02-24,,20, ,['/Month'],Oral, 
3263,3489,Tecfidera,2015-12-27,2019-01-29,20,mg,['3 / Week'],Oral,Patient Choice/Convenience
3264,843,Rebif [44],2015-12-02,, ,MIU,['/ Day'],IV, 
3265,843,Rebif [22],2016-03-08,, ,mg,['/Month'], , 
3266,843,Tysabri,2015-12-13,, , ,['3 / Week'],IV, 
3267,1916,IVIG,2016-01-22,, , ,[' '],IV, 
3268,1916,IVIG,2016-04-12,2017-11-27,20,mg,['/Month'], ,Persistence of relapses
3269,1916,D-cure (Vitamine D),2015-12-06,, ,mg,['2 / Day'],IV, 
3270,1916,Methylprednisolone,2016-07-06,, ,mg,['2 / Day'],IV, 
3271,2610,Alemtuzumab (Campath),2016-10-21,2020-06-16,5000,mcg,[' '], ,Patient Choice/Convenience
3272,4178,Tysabri,2016-06-19,,300, ,['3 / Week'],IV, 
3273,4178,Rebif [44],2016-08-28,2021-07-25,20, ,['/Month'], ,Lack of efficacy
3274,4178,Tysabri,2016-04-23,2021-10-15, , ,['/Month'], ,Persistence of relapses
3275,3303,D-cure (Vitamine D),2016-03-09,,5000, ,['3 / Week'],IV, 
3276,3303,IVIG,2016-06-09,2020-12-22,300,mg,['/ Day'],Oral,Adverse Event
3277,3303,IVIG,2015-11-08,2018-09-19,1000,MIU,['/ Week'],IV,Patient Choice/Convenience
3278,3303,Endoxan,2016-06-16,,5000, ,['2 / Day'],IV, 
3279,3356,Endoxan,2016-06-12,2019-08-02,500, ,['2 / Day'],IV,Persisting MRI activity
3280,3356,Endoxan,2015-11-04,, ,mg,['3 / Week'],IV, 
3281,1903,Rebif [22],2015-12-19,, ,MIU,['2 / Day'], , 
3282,3421,Gilenya,2016-08-05,,1,MIU,['2 / Day'], , 
3283,3421,Teriflunomide,2016-09-21,2021-03-15,500, ,['3 / Week'], ,Lack of efficacy
3284,3421,Betaferon,2016-04-13,2017-11-12,400,mcg,['/Month'],IV,Persisting MRI activity
3285,3421,Avonex,2016-06-26,2020-11-06,1,mg,['2 / Day'],IV,Lack of efficacy
3286,1822,IVIG,2016-07-27,, , ,['/ Week'],IV, 
3287,1822,Alemtuzumab (Campath),2016-08-25,2021-03-14, , ,['/Month'], ,Adverse Event
3288,1822,Gilenya,2015-12-27,, ,MIU,['2 / Day'],IV, 
3289,1825,IVIG,2016-10-19,2021-06-14, , ,['/Month'],IV,Lack of efficacy
3290,1825,Endoxan,2016-09-14,2021-07-22,5000, ,['2 / Day'], ,Adverse Event
3291,2124,Alemtuzumab (Campath),2016-01-20,,5000,mg,['/ Week'],IV, 
3292,4048,Ledertrexaat,2016-05-14,,500,MIU,['2 / Day'],IV, 
3293,4048,Tecfidera,2016-05-19,,300,mg,['2 / Day'], , 
3294,4048,Gilenya,2016-04-19,2021-07-05,500,mg,['3 / Week'],IV,Persisting MRI activity
3295,4048,Tecfidera,2016-02-27,2017-11-30,1, ,['/Month'], ,Patient Choice/Convenience
3296,2244,Copaxone,2016-01-14,,5000,MIU,['2 / Day'],Oral, 
3297,2244,Alemtuzumab (Campath),2016-01-07,2018-09-28,500,mg,['/Month'], ,Adverse Event
3298,2244,Ledertrexaat,2016-06-29,2020-08-09,20, ,['/Month'],IV,Adverse Event
3299,2171,Teriflunomide,2016-07-06,, ,mg,['/Month'],IV, 
3300,2171,Tysabri,2016-06-18,2018-09-25,500,MIU,['/Month'],Oral,Patient Choice/Convenience
3301,2171,Methylprednisolone,2016-06-04,, ,mg,['/Month'],IV, 
3302,2171,Tysabri,2015-12-17,2018-08-12,500,MIU,['2 / Day'], ,Patient Choice/Convenience
3303,3780,Copaxone,2015-12-18,, , ,['/Month'],IV, 
3304,3780,Gilenya,2016-10-08,,300, ,['/Month'],Oral, 
3305,2515,Copaxone,2016-01-17,,300, ,['2 / Day'],IV, 
3306,2515,Rebif [22],2016-09-02,, , ,['2 / Day'],IV, 
3307,2515,Alemtuzumab (Campath),2016-07-16,2018-08-07,1000,MIU,['2 / Day'], ,Adverse Event
3308,1689,Endoxan,2016-01-14,2019-06-08,1000, ,[' '],Oral,Persisting MRI activity
3309,1689,Alemtuzumab (Campath),2016-04-21,2017-12-08,5000,MIU,['3 / Week'],Oral,Lack of efficacy
3310,1689,Betaferon,2016-09-26,,500,mcg,['2 / Day'],IV, 
3311,1118,Endoxan,2016-10-07,, ,MIU,['/ Day'],Oral, 
3312,1118,Betaferon,2016-04-29,, , ,['/ Week'],IV, 
3313,1349,Tecfidera,2016-01-06,,1, ,['/ Day'],IV, 
3314,1349,Gilenya,2016-07-19,,300,mcg,['/ Week'], , 
3315,1349,Gilenya,2016-03-24,2019-03-13,5000, ,['/ Day'],IV,Adverse Event
3316,4452,Endoxan,2016-10-08,,1, ,['/ Week'],IV, 
3317,2065,Endoxan,2016-02-19,2018-05-22,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
3318,2065,Endoxan,2016-03-04,,400, ,['2 / Day'], , 
3319,2342,IVIG,2016-08-31,2019-10-05,500, ,['3 / Week'],Oral,Persisting MRI activity
3320,2342,Gilenya,2015-11-02,,300,mg,['2 / Day'],IV, 
3321,2342,Tecfidera,2016-05-04,, ,mg,['/ Day'],IV, 
3322,3901,Avonex,2016-01-30,2019-12-12, ,mg,['3 / Week'], ,Adverse Event
3323,904,Rebif [22],2015-11-10,,5000,mg,['3 / Week'],Oral, 
3324,904,Avonex,2015-12-23,2020-04-04,1, ,['2 / Day'],IV,Patient Choice/Convenience
3325,888,Copaxone,2016-01-25,, ,mg,['3 / Week'],IV, 
3326,4435,Tecfidera,2016-02-23,, , ,[' '],Oral, 
3327,4435,Gilenya,2016-06-22,, , ,[' '],IV, 
3328,4435,Ledertrexaat,2016-07-31,2019-02-23, , ,['/Month'],IV,Persisting MRI activity
3329,2794,Tecfidera,2016-06-06,2019-02-19,300,MIU,['2 / Day'], ,Lack of efficacy
3330,2794,Rebif [22],2016-06-20,,400,mcg,['2 / Day'],Oral, 
3331,2794,IVIG,2016-07-02,2018-03-30,1,mg,['/Month'], ,Adverse Event
3332,2794,Rebif [44],2016-03-29,,300,mg,['3 / Week'],IV, 
3333,2907,Copaxone,2016-10-02,2019-07-14,20,MIU,['2 / Day'], ,Lack of efficacy
3334,2907,Betaferon,2016-01-04,, ,mg,['3 / Week'],Oral, 
3335,2907,Copaxone,2016-03-07,, , ,['/Month'],IV, 
3336,3198,Gilenya,2016-01-24,2021-07-14,300, ,['/ Day'],IV,Persisting MRI activity
3337,3198,Ledertrexaat,2016-07-28,2020-06-01, ,mg,['2 / Day'], ,Persistence of relapses
3338,3198,Tecfidera,2016-02-15,,400, ,[' '],IV, 
3339,3198,Teriflunomide,2015-12-18,2019-01-23,1000,mg,['/Month'],IV,Patient Choice/Convenience
3340,398,Rebif [22],2016-08-24,2018-11-30,300, ,['/Month'], ,Lack of efficacy
3341,398,Tecfidera,2015-12-26,2018-02-12,500, ,['/ Day'],IV,Patient Choice/Convenience
3342,398,Mitoxantrone,2015-12-06,, , ,['/Month'], , 
3343,398,D-cure (Vitamine D),2016-01-09,,300,mg,['3 / Week'], , 
3344,2297,Mitoxantrone,2016-05-22,2018-11-06,300,mg,[' '],IV,Adverse Event
3345,2297,Avonex,2016-01-10,,500, ,['2 / Day'],IV, 
3346,2297,D-cure (Vitamine D),2016-04-29,2020-08-09, ,mg,['3 / Week'],IV,Persisting MRI activity
3347,2297,Gilenya,2015-11-30,2018-11-28,5000,mcg,['/ Week'], ,Patient Choice/Convenience
3348,3060,Rebif [44],2016-01-01,, ,mcg,['/ Day'], , 
3349,3060,D-cure (Vitamine D),2016-06-22,,400, ,['2 / Day'],IV, 
3350,3060,IVIG,2016-09-30,, , ,['/Month'],IV, 
3351,3060,Ledertrexaat,2015-12-02,,1000,mg,['2 / Day'],IV, 
3352,2763,Gilenya,2016-09-12,2019-05-13, , ,[' '], ,Patient Choice/Convenience
3353,3942,Ledertrexaat,2016-05-13,, , ,['3 / Week'],IV, 
3354,3942,Betaferon,2016-07-26,, , ,['/Month'], , 
3355,3942,Avonex,2015-12-28,,20,mg,['3 / Week'],IV, 
3356,3942,Rebif [22],2016-04-25,,400, ,['2 / Day'],IV, 
3357,4508,Tecfidera,2016-03-04,2019-01-30,20,mg,[' '], ,Persisting MRI activity
3358,4508,Alemtuzumab (Campath),2016-03-20,2020-10-10,1000,mg,['/Month'],IV,Lack of efficacy
3359,4508,Tecfidera,2016-08-30,,300,mg,['/ Day'], , 
3360,4508,Rebif [22],2016-01-21,2019-03-11,20, ,['/Month'],IV,Adverse Event
3361,397,Tysabri,2016-07-05,2020-12-24, , ,['/Month'], ,Persisting MRI activity
3362,397,Methylprednisolone,2016-04-30,,1000,mg,[' '],IV, 
3363,4400,Tysabri,2015-11-27,,1,mg,['/Month'],IV, 
3364,4400,Methylprednisolone,2016-08-16,, ,MIU,[' '],Oral, 
3365,4400,Rebif [44],2016-06-02,2021-08-25,300,mg,['2 / Day'],Oral,Adverse Event
3366,2163,Teriflunomide,2016-02-27,,20, ,['3 / Week'], , 
3367,3045,Teriflunomide,2016-03-11,,500, ,['/ Week'],Oral, 
3368,3045,Endoxan,2016-04-06,2018-11-17, ,mg,['2 / Day'], ,Adverse Event
3369,3045,Methylprednisolone,2016-06-02,, ,mcg,['2 / Day'],IV, 
3370,3045,Rebif [44],2015-12-17,2020-08-22,300, ,[' '],IV,Patient Choice/Convenience
3371,1971,Endoxan,2016-06-01,2019-11-16,300,MIU,['/Month'],IV,Patient Choice/Convenience
3372,1971,Methylprednisolone,2016-05-14,,300, ,['/Month'],IV, 
3373,2511,Tysabri,2016-04-30,2021-10-07,500,mcg,['3 / Week'],IV,Persisting MRI activity
3374,3011,IVIG,2016-01-19,2021-09-04, ,mg,['2 / Day'],IV,Lack of efficacy
3375,979,D-cure (Vitamine D),2016-03-21,, ,mg,['2 / Day'],IV, 
3376,979,Mitoxantrone,2016-03-05,2019-10-19,300,mcg,['/ Day'],IV,Lack of efficacy
3377,979,Alemtuzumab (Campath),2015-12-17,,1000,mg,['3 / Week'],IV, 
3378,979,Tysabri,2016-02-29,2021-10-01,5000,mcg,['2 / Day'], ,Adverse Event
3379,3087,Alemtuzumab (Campath),2016-03-20,,300,mcg,[' '],IV, 
3380,3087,Tysabri,2016-08-03,2019-09-24,20, ,['2 / Day'],IV,Adverse Event
3381,2468,Gilenya,2016-02-07,2019-01-30,300, ,['/Month'],Oral,Patient Choice/Convenience
3382,2468,Endoxan,2015-10-31,2018-08-22,300,mg,[' '],Oral,Patient Choice/Convenience
3383,2468,IVIG,2016-02-28,,1000, ,['/Month'],IV, 
3384,2468,Teriflunomide,2015-12-02,2018-12-25,20, ,['/Month'], ,Persisting MRI activity
3385,4921,Endoxan,2016-03-04,2021-02-01,1,mg,[' '],IV,Persisting MRI activity
3386,4921,Endoxan,2016-07-28,, ,mg,['/ Day'], , 
3387,4921,D-cure (Vitamine D),2016-03-08,,1000,MIU,['3 / Week'],IV, 
3388,4921,Tecfidera,2016-08-09,, ,mg,['/Month'], , 
3389,410,Tysabri,2015-11-07,, , ,['/ Day'],IV, 
3390,410,Rebif [44],2016-05-27,,400,MIU,['/Month'], , 
3391,410,Rebif [44],2016-09-07,,1,MIU,['2 / Day'], , 
3392,410,Tysabri,2016-04-08,2018-09-20,300,mg,[' '],IV,Patient Choice/Convenience
3393,2905,IVIG,2016-10-21,2021-04-07,300,MIU,['/Month'],IV,Adverse Event
3394,2905,Ledertrexaat,2016-08-27,, ,mcg,['2 / Day'], , 
3395,171,D-cure (Vitamine D),2016-07-02,,300, ,['2 / Day'],IV, 
3396,3553,Betaferon,2016-06-16,2017-12-08,5000, ,['/Month'],IV,Adverse Event
3397,3553,Methylprednisolone,2016-05-30,2018-01-02, , ,['2 / Day'],IV,Lack of efficacy
3398,1145,D-cure (Vitamine D),2016-07-07,2021-01-15,500, ,['/Month'], ,Lack of efficacy
3399,1145,Gilenya,2016-10-14,,5000,MIU,['2 / Day'],Oral, 
3400,4147,Rebif [44],2016-10-01,2021-05-08,300,mg,['/ Day'],IV,Patient Choice/Convenience
3401,4147,Methylprednisolone,2016-09-25,,5000,mcg,['3 / Week'],IV, 
3402,1877,Gilenya,2015-12-06,2020-02-24, ,mg,['2 / Day'],Oral,Lack of efficacy
3403,1877,Betaferon,2016-02-18,2018-02-18, , ,['3 / Week'], ,Patient Choice/Convenience
3404,1877,Ledertrexaat,2016-03-22,2017-12-26,1000, ,['2 / Day'],IV,Lack of efficacy
3405,1877,Rebif [44],2016-03-08,2018-02-27,500, ,['/Month'],IV,Patient Choice/Convenience
3406,586,Endoxan,2016-04-12,2017-12-22,20, ,['2 / Day'],Oral,Patient Choice/Convenience
3407,1966,Tysabri,2016-02-14,2020-10-09,500,mg,['3 / Week'],IV,Persisting MRI activity
3408,1966,Avonex,2016-05-25,, ,mg,['3 / Week'],Oral, 
3409,1966,Gilenya,2016-02-23,2017-12-17,20,MIU,['2 / Day'], ,Lack of efficacy
3410,3496,Ledertrexaat,2016-05-30,, ,mg,['2 / Day'],IV, 
3411,3496,Endoxan,2016-07-27,,1000,mg,['/ Week'],Oral, 
3412,3496,D-cure (Vitamine D),2015-12-12,,5000, ,['/Month'],IV, 
3413,3496,IVIG,2015-11-10,,1, ,['2 / Day'],IV, 
3414,3981,Tecfidera,2015-12-29,, ,mg,['2 / Day'],Oral, 
3415,3981,Copaxone,2016-07-01,, , ,['2 / Day'],IV, 
3416,3981,D-cure (Vitamine D),2016-08-22,,1, ,['/Month'],Oral, 
3417,3981,Rebif [44],2016-10-03,,1000,mg,['3 / Week'], , 
3418,554,Ledertrexaat,2016-07-23,2018-08-21,5000, ,['3 / Week'],IV,Patient Choice/Convenience
3419,554,Betaferon,2015-12-20,2020-07-15,20,mg,['/Month'], ,Persistence of relapses
3420,3304,Copaxone,2016-09-05,2020-05-11, , ,['/Month'],IV,Persisting MRI activity
3421,3304,Copaxone,2016-01-18,,1000,mcg,['3 / Week'], , 
3422,3304,Rebif [44],2016-05-16,2019-02-01,1000,mg,['/ Week'],IV,Patient Choice/Convenience
3423,3650,Gilenya,2016-02-01,2017-11-04, ,mg,[' '],IV,Lack of efficacy
3424,3650,Rebif [22],2016-08-29,2021-03-05,400,mcg,['2 / Day'],IV,Persisting MRI activity
3425,3650,Endoxan,2016-09-18,, ,mg,['/ Week'],IV, 
3426,3650,Betaferon,2016-08-03,2021-04-25,400,mg,['/Month'],IV,Lack of efficacy
3427,3114,Tecfidera,2015-12-19,2021-06-03, ,mg,['/Month'],IV,Persisting MRI activity
3428,3114,Ledertrexaat,2016-05-12,,20, ,['2 / Day'],IV, 
3429,3114,Betaferon,2016-03-04,2021-03-26,5000,mg,['/Month'], ,Persisting MRI activity
3430,4927,Endoxan,2016-08-13,2020-06-26,1, ,['/Month'],IV,Adverse Event
3431,4927,Methylprednisolone,2016-03-17,2019-04-09,300,mg,['3 / Week'],IV,Persisting MRI activity
3432,1384,D-cure (Vitamine D),2016-01-27,,20,mg,['3 / Week'], , 
3433,1384,Ledertrexaat,2016-10-20,2019-05-20,20, ,['/Month'],IV,Lack of efficacy
3434,1384,Betaferon,2016-09-15,,1000,mg,['/Month'],Oral, 
3435,883,Rebif [22],2016-04-06,, , ,[' '], , 
3436,883,Betaferon,2016-03-03,2018-04-14,1, ,['/Month'],IV,Lack of efficacy
3437,883,Tecfidera,2016-01-18,,5000, ,['2 / Day'],IV, 
3438,883,D-cure (Vitamine D),2016-02-16,2019-12-04, ,MIU,['/ Week'], ,Patient Choice/Convenience
3439,2736,Gilenya,2016-03-05,,1,mg,['/ Week'],IV, 
3440,2736,D-cure (Vitamine D),2016-10-12,,20,mg,['/Month'],IV, 
3441,2736,Methylprednisolone,2016-08-21,,400, ,['/Month'], , 
3442,1642,Mitoxantrone,2015-11-09,2019-08-01,1000, ,[' '],IV,Persisting MRI activity
3443,1642,Rebif [22],2016-02-28,2020-05-15, ,MIU,['/Month'],Oral,Adverse Event
3444,3327,Rebif [22],2016-03-31,2019-03-28, , ,['2 / Day'], ,Patient Choice/Convenience
3445,3327,Gilenya,2016-08-23,, ,mg,[' '],IV, 
3446,2348,Gilenya,2015-12-03,2018-07-02,300, ,['2 / Day'], ,Adverse Event
3447,1197,Alemtuzumab (Campath),2016-09-03,2017-12-10,20,MIU,[' '], ,Persisting MRI activity
3448,1197,Copaxone,2016-08-07,2020-11-27,5000,mg,[' '],IV,Patient Choice/Convenience
3449,2965,IVIG,2016-05-12,2018-12-30, ,mg,[' '],IV,Persisting MRI activity
3450,3945,Endoxan,2016-10-09,,1,mcg,['3 / Week'],Oral, 
3451,3945,Methylprednisolone,2016-07-24,2020-07-19,20,mg,['2 / Day'], ,Adverse Event
3452,3945,Teriflunomide,2016-02-14,,5000, ,['2 / Day'],Oral, 
3453,1728,Tecfidera,2016-02-19,, , ,[' '], , 
3454,1728,IVIG,2016-03-28,2020-05-22,400, ,['3 / Week'],IV,Persisting MRI activity
3455,1728,Gilenya,2016-05-19,2020-05-10,500, ,['/ Day'], ,Lack of efficacy
3456,4119,IVIG,2016-01-09,2021-01-21,5000, ,['/Month'], ,Persisting MRI activity
3457,4119,Alemtuzumab (Campath),2015-10-25,2019-11-09,400, ,['/Month'],IV,Persistence of relapses
3458,4119,Gilenya,2016-09-27,, ,mg,['2 / Day'],Oral, 
3459,4119,Alemtuzumab (Campath),2016-10-12,2018-08-18,500, ,['2 / Day'],IV,Patient Choice/Convenience
3460,3697,IVIG,2016-05-31,,1000, ,['2 / Day'],IV, 
3461,3697,Endoxan,2016-10-07,2020-02-22, ,mg,['2 / Day'],IV,Persisting MRI activity
3462,3217,Methylprednisolone,2015-12-09,2018-07-22,300,mcg,['2 / Day'],IV,Lack of efficacy
3463,703,Rebif [44],2016-01-30,2020-10-16,1000, ,['3 / Week'], ,Adverse Event
3464,703,Tecfidera,2016-01-05,2020-01-05,1000, ,[' '],IV,Adverse Event
3465,703,Tysabri,2016-01-19,,20,mg,['2 / Day'],IV, 
3466,4820,Betaferon,2016-07-01,2018-10-29,500, ,[' '],Oral,Adverse Event
3467,4820,Avonex,2016-05-22,, , ,['2 / Day'],IV, 
3468,4820,Endoxan,2016-09-14,2019-03-05, ,mg,['3 / Week'], ,Adverse Event
3469,1987,IVIG,2016-10-07,,300, ,[' '], , 
3470,1987,Copaxone,2015-12-22,2019-08-21,20,mg,['/ Day'],IV,Persistence of relapses
3471,1987,Alemtuzumab (Campath),2016-10-12,2021-09-23,1, ,[' '], ,Lack of efficacy
3472,1987,Ledertrexaat,2016-03-02,,300,mg,['/Month'],IV, 
3473,1793,Tecfidera,2016-06-22,, ,mg,['2 / Day'],Oral, 
3474,1793,Rebif [44],2016-02-16,,400,mg,['2 / Day'],IV, 
3475,4483,Rebif [22],2016-02-04,,5000, ,['3 / Week'],IV, 
3476,4483,Methylprednisolone,2016-10-01,,300,mg,['/Month'],IV, 
3477,616,Gilenya,2015-11-02,,400,mg,['/ Week'],IV, 
3478,1323,D-cure (Vitamine D),2016-10-06,,20, ,['2 / Day'], , 
3479,4231,Ledertrexaat,2016-08-07,,500, ,['3 / Week'], , 
3480,4231,Avonex,2016-05-25,, ,mg,['/Month'],IV, 
3481,4231,Teriflunomide,2016-05-10,2021-03-09,500, ,['3 / Week'],Oral,Persisting MRI activity
3482,4231,D-cure (Vitamine D),2015-12-09,,500,mg,['3 / Week'],IV, 
3483,2607,Methylprednisolone,2016-01-16,, ,mg,['/ Day'],IV, 
3484,2283,Betaferon,2016-01-21,2019-10-18,300, ,['2 / Day'],IV,Patient Choice/Convenience
3485,4596,Endoxan,2016-02-26,, , ,[' '],IV, 
3486,4596,Rebif [44],2016-10-04,2020-06-21,20, ,['2 / Day'], ,Lack of efficacy
3487,2043,Alemtuzumab (Campath),2016-02-14,, , ,['3 / Week'],IV, 
3488,2043,Methylprednisolone,2016-09-10,,500, ,['2 / Day'],IV, 
3489,2043,Rebif [44],2015-11-26,,20, ,['3 / Week'],Oral, 
3490,2563,IVIG,2016-04-08,,1000,mg,['2 / Day'],IV, 
3491,4926,Ledertrexaat,2016-07-11,2018-10-11,300,mcg,['/Month'], ,Adverse Event
3492,4926,Rebif [22],2016-05-16,, , ,['2 / Day'],Oral, 
3493,4926,Alemtuzumab (Campath),2015-11-10,,20, ,[' '],IV, 
3494,4926,Ledertrexaat,2016-01-29,2019-08-13, , ,['/ Day'],IV,Persisting MRI activity
3495,4460,Methylprednisolone,2015-12-12,,500,mg,['/Month'],IV, 
3496,3461,Betaferon,2016-04-03,2018-03-27,400, ,['2 / Day'],IV,Lack of efficacy
3497,3461,D-cure (Vitamine D),2016-05-20,2018-09-08,400,mg,['2 / Day'],IV,Lack of efficacy
3498,3461,Rebif [22],2016-03-20,2018-05-28,1000, ,['3 / Week'], ,Patient Choice/Convenience
3499,2547,D-cure (Vitamine D),2015-10-31,,1000,mg,[' '],IV, 
3500,2547,Tecfidera,2016-03-08,2018-12-10, ,MIU,['3 / Week'], ,Adverse Event
3501,2547,Copaxone,2016-10-09,,300,mcg,['/ Week'],Oral, 
3502,2547,Rebif [44],2016-09-01,, ,mg,['/ Week'],Oral, 
3503,1390,Tecfidera,2016-02-14,2020-11-25,5000, ,['/Month'], ,Persistence of relapses
3504,1390,IVIG,2016-03-10,2018-12-09,300, ,['/Month'],IV,Lack of efficacy
3505,1804,Gilenya,2016-04-07,,1,mg,['/Month'],IV, 
3506,1804,Tecfidera,2016-10-05,2018-06-22,300, ,['/Month'], ,Persisting MRI activity
3507,2415,Tecfidera,2016-05-06,2020-10-18,400,mg,['3 / Week'],IV,Adverse Event
3508,2415,Avonex,2016-07-20,2020-08-21,1000, ,[' '], ,Adverse Event
3509,2415,D-cure (Vitamine D),2016-01-17,2019-12-31, ,mg,['/ Day'], ,Adverse Event
3510,2415,IVIG,2016-01-07,2019-12-19,300, ,['/Month'],IV,Lack of efficacy
3511,3648,Endoxan,2016-10-05,, ,mg,['3 / Week'], , 
3512,3648,D-cure (Vitamine D),2016-05-16,, ,mg,['/ Day'],IV, 
3513,3648,Rebif [22],2016-08-12,, ,mcg,['/Month'],IV, 
3514,3648,Rebif [22],2016-02-14,,20,mg,['/Month'],IV, 
3515,4400,Teriflunomide,2016-10-21,,400, ,[' '],IV, 
3516,4400,Betaferon,2016-03-22,,400,mg,['/ Day'],Oral, 
3517,4400,D-cure (Vitamine D),2016-09-25,, , ,['/ Day'], , 
3518,3318,D-cure (Vitamine D),2016-06-18,, ,mg,[' '], , 
3519,3318,Betaferon,2016-03-09,,400, ,['2 / Day'], , 
3520,3318,Betaferon,2016-03-22,2021-06-17, , ,['3 / Week'], ,Patient Choice/Convenience
3521,3318,Mitoxantrone,2016-10-05,,20, ,['/Month'],IV, 
3522,627,Teriflunomide,2015-11-29,, ,mg,['/Month'],Oral, 
3523,627,Methylprednisolone,2016-02-09,2019-01-05,500,MIU,['2 / Day'],Oral,Patient Choice/Convenience
3524,946,Avonex,2015-12-22,,300,MIU,[' '],IV, 
3525,946,Betaferon,2015-12-18,2020-08-05,300,MIU,['2 / Day'],Oral,Persisting MRI activity
3526,4175,Methylprednisolone,2016-07-06,2018-10-22,500,MIU,['3 / Week'], ,Patient Choice/Convenience
3527,4175,Teriflunomide,2016-02-25,, ,mg,[' '],IV, 
3528,4175,Teriflunomide,2016-01-22,,1000,mg,['/Month'],IV, 
3529,1574,Rebif [44],2015-12-15,,1000, ,['/Month'],IV, 
3530,1574,Endoxan,2016-04-11,,400,mg,['3 / Week'], , 
3531,1574,Gilenya,2016-07-10,2018-03-18, ,mcg,['3 / Week'], ,Patient Choice/Convenience
3532,2218,Gilenya,2015-12-03,,500, ,[' '],IV, 
3533,2218,Copaxone,2015-11-02,2019-10-28,500, ,['3 / Week'],IV,Adverse Event
3534,661,Endoxan,2016-03-16,2019-02-15, ,mg,['/ Day'],IV,Persistence of relapses
3535,661,Endoxan,2016-01-23,,1000,mg,[' '], , 
3536,661,Copaxone,2016-09-26,,300,mg,['2 / Day'],IV, 
3537,2282,Gilenya,2015-11-29,, , ,['2 / Day'],IV, 
3538,2282,Endoxan,2016-03-21,2018-07-05,1000,mg,['3 / Week'],Oral,Persisting MRI activity
3539,2282,Tysabri,2016-05-24,2021-04-23,400,mg,['/Month'], ,Adverse Event
3540,2282,Endoxan,2016-09-22,,500,mg,['2 / Day'], , 
3541,1497,Methylprednisolone,2016-04-18,,1000,mg,['2 / Day'], , 
3542,1497,Rebif [22],2016-03-15,, ,mg,['2 / Day'],IV, 
3543,1497,Gilenya,2016-08-09,,5000, ,['/Month'],Oral, 
3544,1497,Copaxone,2015-12-24,2020-06-15,1,mcg,['/ Week'], ,Lack of efficacy
3545,2910,IVIG,2016-07-13,,1000, ,['/Month'], , 
3546,2910,Mitoxantrone,2016-06-18,,20,mg,['/Month'], , 
3547,2910,Methylprednisolone,2015-12-30,, ,mg,[' '],IV, 
3548,2910,Ledertrexaat,2016-09-25,2021-08-17,20, ,['2 / Day'], ,Persistence of relapses
3549,4490,Gilenya,2016-08-18,, , ,['3 / Week'],IV, 
3550,4490,Betaferon,2016-03-25,,300,mg,['2 / Day'], , 
3551,4490,Betaferon,2015-11-07,, ,mg,['2 / Day'], , 
3552,4963,Avonex,2016-06-04,, ,mg,['2 / Day'], , 
3553,4963,D-cure (Vitamine D),2016-10-13,,300,mg,['/Month'],IV, 
3554,4963,Endoxan,2016-02-07,2019-11-03,500,mg,['3 / Week'], ,Adverse Event
3555,3528,Rebif [22],2016-07-14,,400,MIU,['3 / Week'],Oral, 
3556,3528,Methylprednisolone,2015-12-20,2020-11-21,5000,mg,['2 / Day'],Oral,Patient Choice/Convenience
3557,3528,IVIG,2016-03-30,,400, ,['/Month'], , 
3558,3713,D-cure (Vitamine D),2016-05-30,2020-01-04,300,mg,['/ Week'], ,Persistence of relapses
3559,3713,Tysabri,2016-04-20,,500,MIU,['/ Week'],IV, 
3560,3713,Endoxan,2015-12-17,,300, ,['2 / Day'],Oral, 
3561,3713,Endoxan,2016-03-28,2019-10-25,20,MIU,['2 / Day'],Oral,Lack of efficacy
3562,1744,Endoxan,2015-12-25,,500,MIU,['/ Day'],Oral, 
3563,3202,IVIG,2016-06-12,2019-02-15,1,mg,['/Month'],IV,Adverse Event
3564,3202,Betaferon,2016-10-02,2019-05-02,20,mg,['/Month'],IV,Persisting MRI activity
3565,4705,Betaferon,2016-01-25,,300,mg,['2 / Day'],IV, 
3566,4705,Rebif [22],2016-07-18,,300,mg,['3 / Week'], , 
3567,4705,Rebif [44],2016-05-20,2020-03-26,5000, ,['/Month'],IV,Persisting MRI activity
3568,4705,Rebif [22],2015-11-30,2018-08-27,1000, ,['2 / Day'],IV,Adverse Event
3569,315,Rebif [44],2016-08-30,,300,mg,['2 / Day'],IV, 
3570,315,Avonex,2016-09-10,2019-01-07, , ,[' '],Oral,Adverse Event
3571,315,D-cure (Vitamine D),2016-05-22,2018-08-13,5000,MIU,['/ Week'],IV,Persisting MRI activity
3572,315,Tecfidera,2016-04-14,,500,mg,['/Month'],IV, 
3573,3028,Tecfidera,2016-09-20,2018-09-13,300, ,[' '],IV,Patient Choice/Convenience
3574,3028,IVIG,2016-05-21,2020-09-29,5000, ,['/Month'], ,Patient Choice/Convenience
3575,3028,Alemtuzumab (Campath),2015-11-20,2020-09-02, , ,['/Month'],IV,Patient Choice/Convenience
3576,2935,IVIG,2016-01-14,2018-05-29,500, ,['3 / Week'], ,Persistence of relapses
3577,2935,Gilenya,2015-11-07,, , ,['/Month'],Oral, 
3578,2935,Methylprednisolone,2016-08-22,, ,MIU,['/Month'],IV, 
3579,3765,Rebif [22],2016-03-01,2021-04-07,300, ,['2 / Day'], ,Lack of efficacy
3580,3765,D-cure (Vitamine D),2015-10-29,2019-05-12,20, ,['/ Day'], ,Lack of efficacy
3581,3765,D-cure (Vitamine D),2016-01-26,2020-03-02,300,mg,['/Month'], ,Persisting MRI activity
3582,3438,Gilenya,2016-06-02,,1000,mg,['2 / Day'],Oral, 
3583,4779,Gilenya,2016-06-13,, , ,[' '],Oral, 
3584,4779,Rebif [22],2016-07-28,2020-12-24,1, ,['3 / Week'],IV,Patient Choice/Convenience
3585,4317,Rebif [44],2016-06-24,,1000,MIU,['2 / Day'],IV, 
3586,4317,Mitoxantrone,2016-04-16,2020-07-04,5000,mg,['/ Week'], ,Lack of efficacy
3587,4317,Rebif [22],2015-10-29,2021-05-05,5000, ,['/ Day'],Oral,Persisting MRI activity
3588,4317,Tecfidera,2016-05-20,2020-03-09,1000, ,['/Month'], ,Patient Choice/Convenience
3589,1363,Gilenya,2016-04-03,2018-07-22,1000, ,['/Month'],IV,Adverse Event
3590,1363,IVIG,2016-02-03,2021-01-29,20,mg,[' '], ,Persisting MRI activity
3591,1363,Gilenya,2016-08-27,, , ,['/Month'], , 
3592,1363,Tecfidera,2015-12-18,2019-01-07,300,mcg,['/Month'],IV,Persisting MRI activity
3593,629,Tysabri,2016-10-04,,1000,mg,['/Month'], , 
3594,793,Betaferon,2016-05-10,,300,mg,['/Month'],IV, 
3595,793,Avonex,2016-06-12,,1,MIU,['/Month'],IV, 
3596,793,Alemtuzumab (Campath),2016-05-26,2018-04-13,500, ,['/Month'],IV,Patient Choice/Convenience
3597,1168,Mitoxantrone,2016-03-12,2020-10-19, ,mg,['/Month'], ,Persisting MRI activity
3598,1168,Teriflunomide,2016-01-23,, , ,['2 / Day'], , 
3599,1168,Rebif [22],2015-12-14,,500,mg,['2 / Day'], , 
3600,4294,Gilenya,2016-04-24,2019-01-24, ,mg,['/Month'],IV,Persistence of relapses
3601,4294,Gilenya,2016-08-28,,1, ,['/Month'], , 
3602,4294,Tysabri,2016-09-04,2020-07-14, ,mg,['3 / Week'],Oral,Adverse Event
3603,3125,Endoxan,2016-01-14,,1000, ,['2 / Day'],Oral, 
3604,3125,Rebif [22],2016-05-16,, , ,[' '],IV, 
3605,3125,Methylprednisolone,2015-12-07,,1,mg,['/ Week'],IV, 
3606,3125,Gilenya,2016-04-28,2019-08-19,5000, ,['3 / Week'], ,Adverse Event
3607,4650,Avonex,2016-02-08,2020-12-24, ,mg,['3 / Week'], ,Lack of efficacy
3608,4650,Mitoxantrone,2016-08-25,,1000,mg,['2 / Day'],IV, 
3609,4650,Avonex,2016-09-27,2020-03-15,1000,MIU,['/ Day'],Oral,Persisting MRI activity
3610,4882,Ledertrexaat,2015-11-05,2018-11-11,300,mg,[' '],Oral,Persisting MRI activity
3611,4882,Gilenya,2016-05-23,2019-10-04,20, ,['3 / Week'],IV,Patient Choice/Convenience
3612,4882,Endoxan,2016-05-15,2020-08-19,300,mg,['/Month'],Oral,Patient Choice/Convenience
3613,1261,Tecfidera,2015-11-04,,1000,mg,['/Month'], , 
3614,1261,IVIG,2016-01-29,,400,MIU,['/Month'], , 
3615,4440,Endoxan,2016-03-25,2020-05-29,300,mcg,['2 / Day'], ,Patient Choice/Convenience
3616,4581,Mitoxantrone,2016-07-28,2021-06-05,20,mg,['/Month'],Oral,Lack of efficacy
3617,4581,Ledertrexaat,2015-12-17,2019-10-15,5000, ,['2 / Day'],IV,Lack of efficacy
3618,4581,Mitoxantrone,2016-03-17,, , ,['2 / Day'],IV, 
3619,4581,Endoxan,2016-09-17,,500,mcg,['2 / Day'], , 
3620,3258,Tecfidera,2016-09-16,, ,mg,['2 / Day'], , 
3621,3258,Gilenya,2016-01-06,,400, ,['/Month'],IV, 
3622,2504,Copaxone,2015-10-27,2020-07-07,1,mg,['/Month'],IV,Patient Choice/Convenience
3623,2504,IVIG,2016-05-23,,5000, ,['/ Week'], , 
3624,2504,Rebif [22],2016-04-18,, , ,[' '],IV, 
3625,2850,Rebif [44],2016-07-14,2020-05-04, , ,['2 / Day'], ,Adverse Event
3626,2850,D-cure (Vitamine D),2016-06-10,2018-11-17,20, ,['/Month'],IV,Adverse Event
3627,2850,Betaferon,2016-04-09,,300,MIU,['3 / Week'], , 
3628,2850,Avonex,2016-07-18,, ,mg,['2 / Day'],Oral, 
3629,221,Methylprednisolone,2016-03-25,,300, ,['2 / Day'],Oral, 
3630,221,IVIG,2016-06-02,2018-05-19,1000,mg,['2 / Day'],IV,Persistence of relapses
3631,221,Tecfidera,2016-03-27,,1,mg,[' '],IV, 
3632,221,IVIG,2016-07-15,2018-06-23,300,mg,['2 / Day'],Oral,Adverse Event
3633,2253,Endoxan,2016-04-26,,20,mg,['/Month'], , 
3634,2281,Endoxan,2016-04-23,,1000,mg,['/Month'], , 
3635,2315,Copaxone,2016-04-08,2020-09-16,1,mg,['2 / Day'],Oral,Persisting MRI activity
3636,2315,Tecfidera,2016-02-03,, ,MIU,['/Month'],IV, 
3637,2040,Teriflunomide,2015-12-07,,300, ,['2 / Day'],IV, 
3638,4812,Methylprednisolone,2015-11-09,, ,mg,['3 / Week'], , 
3639,4812,Copaxone,2015-11-08,2021-06-29, , ,['/ Week'], ,Persistence of relapses
3640,4812,Methylprednisolone,2016-04-06,2018-12-30, , ,['2 / Day'],Oral,Persisting MRI activity
3641,2267,Copaxone,2015-12-22,,5000,mg,['/Month'],IV, 
3642,2267,Mitoxantrone,2016-01-30,, , ,['/ Week'], , 
3643,2267,Tysabri,2016-05-06,,500,mg,['3 / Week'],IV, 
3644,2267,Rebif [22],2016-04-23,2018-12-24, ,MIU,['/Month'], ,Adverse Event
3645,4601,IVIG,2015-12-17,,5000,MIU,[' '], , 
3646,1862,Methylprednisolone,2015-11-21,,5000,mg,['/Month'],Oral, 
3647,987,IVIG,2016-05-17,2020-09-15, ,mg,['2 / Day'],Oral,Adverse Event
3648,987,Gilenya,2016-08-15,2018-05-19,300, ,['/Month'],IV,Patient Choice/Convenience
3649,3990,Betaferon,2016-10-11,,5000, ,['3 / Week'],Oral, 
3650,3990,Rebif [44],2016-02-03,2020-12-30, , ,[' '], ,Persistence of relapses
3651,3990,Alemtuzumab (Campath),2016-09-29,2019-09-20, ,mg,['2 / Day'], ,Persisting MRI activity
3652,1234,IVIG,2016-02-02,, ,mg,['/Month'],IV, 
3653,1234,D-cure (Vitamine D),2016-02-20,,500,mg,['/Month'], , 
3654,1234,Methylprednisolone,2016-01-09,,20,mg,['2 / Day'],IV, 
3655,545,Copaxone,2016-08-07,,1000,mg,['/Month'],IV, 
3656,2281,IVIG,2016-07-31,2018-06-30,20,mg,['/ Day'],IV,Adverse Event
3657,2033,Betaferon,2016-02-14,,20,mg,['3 / Week'], , 
3658,4315,IVIG,2015-11-16,, , ,['/ Day'], , 
3659,4315,D-cure (Vitamine D),2016-08-30,,500,mg,['2 / Day'], , 
3660,4315,D-cure (Vitamine D),2015-11-19,2018-03-26,300, ,['/Month'],IV,Persisting MRI activity
3661,4315,Alemtuzumab (Campath),2016-06-07,,20, ,['3 / Week'], , 
3662,1944,Rebif [22],2016-01-25,,1,mg,['/Month'],IV, 
3663,1944,Rebif [44],2016-06-20,,1000,MIU,['/ Day'],IV, 
3664,1944,Rebif [22],2016-06-09,, ,mg,['3 / Week'],Oral, 
3665,1494,Rebif [44],2016-10-05,,5000,mg,['2 / Day'],IV, 
3666,1494,Betaferon,2016-03-28,2020-07-16, , ,['/Month'], ,Persisting MRI activity
3667,633,Tysabri,2015-11-13,,5000,mg,['/ Day'],IV, 
3668,633,Rebif [22],2016-06-19,,300, ,['3 / Week'],IV, 
3669,633,Avonex,2016-09-26,,500, ,['2 / Day'],IV, 
3670,633,IVIG,2016-09-24,2019-11-23,500,mg,[' '], ,Patient Choice/Convenience
3671,793,Tecfidera,2016-09-26,2021-06-04, , ,['3 / Week'],IV,Patient Choice/Convenience
3672,4855,Copaxone,2015-12-13,2019-03-16, ,mg,['/ Day'],IV,Adverse Event
3673,4855,Alemtuzumab (Campath),2016-05-18,,500, ,['3 / Week'],IV, 
3674,4855,Betaferon,2016-08-06,,300, ,[' '], , 
3675,4855,Rebif [44],2016-05-09,, ,mcg,['3 / Week'],IV, 
3676,599,Tecfidera,2016-01-22,,500,mg,['/ Day'],IV, 
3677,1662,IVIG,2016-04-14,2021-04-12,1000,mg,['3 / Week'],Oral,Persistence of relapses
3678,1662,D-cure (Vitamine D),2015-11-03,, , ,['/Month'], , 
3679,1662,D-cure (Vitamine D),2016-09-21,,300, ,['/Month'], , 
3680,618,Methylprednisolone,2016-04-25,2020-07-29,1,mg,['3 / Week'],IV,Adverse Event
3681,1306,IVIG,2015-12-01,,400,mg,['2 / Day'], , 
3682,1306,Avonex,2016-08-19,2020-01-13,20,mcg,[' '],IV,Persisting MRI activity
3683,1306,D-cure (Vitamine D),2015-11-03,,500, ,['/ Week'],IV, 
3684,118,D-cure (Vitamine D),2016-02-15,2019-12-08,20, ,['2 / Day'],IV,Adverse Event
3685,118,Endoxan,2016-02-11,,300,mg,['/ Day'], , 
3686,118,IVIG,2016-06-29,2017-11-05,1, ,['3 / Week'],Oral,Adverse Event
3687,1810,Tecfidera,2016-09-23,2021-07-24,1000,mg,['/Month'],Oral,Adverse Event
3688,1810,Betaferon,2016-07-09,2019-09-01, , ,['/Month'], ,Lack of efficacy
3689,1810,Alemtuzumab (Campath),2016-05-02,2018-12-01,300,mcg,['2 / Day'], ,Patient Choice/Convenience
3690,4170,Mitoxantrone,2016-08-23,,5000,mg,['/Month'],Oral, 
3691,4170,Avonex,2016-02-15,2021-02-25, ,MIU,['3 / Week'], ,Lack of efficacy
3692,4170,Gilenya,2016-05-17,, , ,['/Month'], , 
3693,1119,Methylprednisolone,2015-12-12,,5000, ,[' '], , 
3694,1119,D-cure (Vitamine D),2016-05-02,,500, ,['/Month'], , 
3695,1119,D-cure (Vitamine D),2016-01-03,,5000,MIU,['/Month'],IV, 
3696,1119,IVIG,2016-07-12,,500,mg,['2 / Day'],IV, 
3697,136,Methylprednisolone,2015-10-31,, , ,['/ Day'],IV, 
3698,136,Methylprednisolone,2015-12-16,2019-08-14,400, ,['/ Week'],IV,Lack of efficacy
3699,136,Rebif [22],2016-04-26,2020-07-12, ,mg,['2 / Day'],IV,Patient Choice/Convenience
3700,2405,Methylprednisolone,2016-07-19,,300,mg,['3 / Week'],IV, 
3701,2372,IVIG,2015-12-19,2019-12-18,5000,mg,['3 / Week'],IV,Adverse Event
3702,2372,IVIG,2016-10-11,2019-10-20, ,mg,[' '],Oral,Persistence of relapses
3703,2372,D-cure (Vitamine D),2015-12-25,, , ,['/Month'],Oral, 
3704,2372,Tysabri,2016-01-02,2019-03-19,5000,mg,['/Month'],IV,Adverse Event
3705,4160,Copaxone,2016-09-03,, , ,['2 / Day'],IV, 
3706,4160,Avonex,2016-10-09,,1,mg,['3 / Week'],IV, 
3707,3732,Gilenya,2016-05-31,,20,mg,['/Month'], , 
3708,3809,Rebif [22],2015-12-22,2019-09-12,400, ,['/Month'], ,Adverse Event
3709,3809,Copaxone,2015-11-16,,20,mg,['2 / Day'], , 
3710,3809,Rebif [22],2016-10-16,2021-01-28,400, ,['/Month'],IV,Adverse Event
3711,3809,D-cure (Vitamine D),2016-01-20,, ,mg,['/Month'],IV, 
3712,164,Betaferon,2015-12-02,,1, ,['3 / Week'],IV, 
3713,164,Tecfidera,2016-05-10,,1000, ,['/ Day'],IV, 
3714,164,Betaferon,2016-08-17,2021-01-21,20, ,['/ Week'],IV,Persisting MRI activity
3715,164,Gilenya,2016-07-31,,300,mg,['/Month'], , 
3716,729,IVIG,2016-08-25,2018-11-12, ,mg,['/Month'], ,Persisting MRI activity
3717,729,Methylprednisolone,2016-03-20,2020-05-09,1,mg,['3 / Week'],IV,Patient Choice/Convenience
3718,1286,Rebif [44],2016-04-07,, ,MIU,['/Month'],IV, 
3719,1286,Rebif [44],2016-01-06,, , ,['/ Week'], , 
3720,1286,Endoxan,2016-05-14,2021-04-28,1000,mcg,['/ Week'],IV,Persisting MRI activity
3721,144,D-cure (Vitamine D),2016-02-26,2020-06-28,5000,MIU,['/ Week'],IV,Lack of efficacy
3722,3673,Ledertrexaat,2016-06-03,2017-12-06,500,mg,['3 / Week'],IV,Persistence of relapses
3723,3673,Copaxone,2016-05-23,,20,MIU,['2 / Day'],IV, 
3724,3673,Tecfidera,2016-06-10,,20, ,['2 / Day'],IV, 
3725,3673,Tysabri,2016-08-02,2019-06-12,20, ,['/ Day'],IV,Patient Choice/Convenience
3726,3368,Tysabri,2015-12-11,,1,mg,['/Month'],IV, 
3727,4735,Gilenya,2016-05-29,2021-02-09, ,mg,['2 / Day'], ,Persisting MRI activity
3728,2241,Gilenya,2016-10-05,,300,mg,['3 / Week'], , 
3729,2241,Avonex,2016-08-14,,1000, ,['/Month'],IV, 
3730,2241,Rebif [22],2016-10-04,, ,MIU,['2 / Day'],Oral, 
3731,2241,Methylprednisolone,2016-06-01,, , ,['/Month'],IV, 
3732,3886,Gilenya,2015-12-24,,1,mg,['/ Day'],IV, 
3733,3886,Rebif [44],2016-07-15,2020-06-19, , ,['2 / Day'],IV,Persisting MRI activity
3734,3886,Rebif [22],2016-02-19,2018-01-17, , ,['/Month'],IV,Persisting MRI activity
3735,3886,Avonex,2015-11-23,,400, ,['2 / Day'],IV, 
3736,3544,Mitoxantrone,2016-09-23,2020-01-22, , ,['2 / Day'], ,Adverse Event
3737,3544,D-cure (Vitamine D),2016-04-13,,20,MIU,['2 / Day'],IV, 
3738,4305,Rebif [44],2016-01-07,, ,mg,['/Month'],Oral, 
3739,4305,D-cure (Vitamine D),2016-01-07,,20, ,['/Month'],IV, 
3740,4305,Gilenya,2016-06-01,2019-03-30, ,mg,['3 / Week'],IV,Adverse Event
3741,2590,Copaxone,2016-07-13,2020-08-23,1000,MIU,['/Month'],IV,Persisting MRI activity
3742,2590,Rebif [44],2016-01-30,2019-04-23,1, ,['2 / Day'], ,Patient Choice/Convenience
3743,2590,Tysabri,2015-12-04,2020-08-22,300,mg,['/Month'], ,Patient Choice/Convenience
3744,2590,D-cure (Vitamine D),2016-01-11,, ,mg,['/Month'], , 
3745,580,Tysabri,2016-07-03,, ,mg,['/ Week'],IV, 
3746,580,Endoxan,2016-08-13,2021-06-15,20, ,['2 / Day'],IV,Persistence of relapses
3747,580,Methylprednisolone,2016-06-27,2019-08-12, , ,['2 / Day'],IV,Adverse Event
3748,580,Alemtuzumab (Campath),2016-01-01,,1, ,['/ Day'],IV, 
3749,654,Copaxone,2016-10-07,2018-10-22,500,mg,['/Month'],IV,Adverse Event
3750,654,Copaxone,2016-01-12,2021-09-03,300,mg,[' '], ,Patient Choice/Convenience
3751,3760,Betaferon,2016-09-09,2020-05-07, , ,[' '],Oral,Persisting MRI activity
3752,3760,Gilenya,2015-11-19,2018-03-18, , ,['2 / Day'], ,Adverse Event
3753,3760,Alemtuzumab (Campath),2016-09-25,,400,mg,['2 / Day'],IV, 
3754,3760,Copaxone,2016-06-28,2021-04-11, ,mg,['/Month'],IV,Persisting MRI activity
3755,4662,Alemtuzumab (Campath),2016-02-02,2020-05-02,1000,mg,['2 / Day'],Oral,Patient Choice/Convenience
3756,4662,Rebif [44],2016-08-11,, , ,['2 / Day'], , 
3757,4662,Mitoxantrone,2016-08-15,,20,mg,['3 / Week'],Oral, 
3758,2091,Rebif [22],2015-12-28,, , ,['2 / Day'], , 
3759,2501,Teriflunomide,2016-10-21,,1000,mg,[' '],Oral, 
3760,2501,Tysabri,2016-06-15,2020-05-27, ,mg,[' '], ,Persisting MRI activity
3761,2501,Copaxone,2016-06-21,, ,MIU,['/Month'],IV, 
3762,2501,Betaferon,2016-03-22,2018-05-20, ,mg,['/Month'],Oral,Lack of efficacy
3763,665,IVIG,2016-09-28,2018-12-28,1000, ,['3 / Week'], ,Adverse Event
3764,665,Tecfidera,2016-04-13,, ,MIU,['/ Week'], , 
3765,3495,IVIG,2016-03-23,2018-05-14,300,mg,['2 / Day'],Oral,Adverse Event
3766,4568,Avonex,2016-03-12,, ,MIU,['/Month'], , 
3767,4568,Avonex,2016-10-02,,300,mg,['/Month'],IV, 
3768,4568,Rebif [44],2016-08-15,,5000, ,['2 / Day'],IV, 
3769,1731,D-cure (Vitamine D),2016-10-16,,500,mg,['3 / Week'],IV, 
3770,1731,IVIG,2016-06-24,2020-11-25, , ,['/Month'],IV,Adverse Event
3771,1731,Tysabri,2016-06-06,,20,MIU,[' '], , 
3772,1748,IVIG,2016-05-31,2020-04-06,5000,mg,['/Month'],IV,Persistence of relapses
3773,1748,IVIG,2016-04-29,,300,mg,['/Month'],IV, 
3774,1748,Rebif [44],2016-08-20,2020-04-10,500, ,['/Month'],IV,Adverse Event
3775,2568,Teriflunomide,2016-10-09,2018-03-31,500, ,['/Month'], ,Adverse Event
3776,479,Mitoxantrone,2016-01-13,2018-03-03, , ,[' '], ,Adverse Event
3777,479,Endoxan,2015-11-08,,1000, ,[' '],IV, 
3778,479,IVIG,2016-05-25,,20,mg,['/Month'],IV, 
3779,479,Endoxan,2015-11-15,,300,mg,['2 / Day'],IV, 
3780,933,D-cure (Vitamine D),2016-02-08,2021-05-18,5000, ,['/Month'], ,Patient Choice/Convenience
3781,4370,Rebif [44],2016-05-13,,500,mcg,['/Month'],IV, 
3782,4370,Endoxan,2016-10-09,2019-02-02, , ,[' '], ,Lack of efficacy
3783,2753,Mitoxantrone,2016-06-25,,1,mcg,['/Month'],IV, 
3784,2753,Ledertrexaat,2016-05-15,2019-07-12, ,mg,['/ Day'],Oral,Adverse Event
3785,2680,Alemtuzumab (Campath),2016-06-06,, , ,['/Month'], , 
3786,2680,Methylprednisolone,2015-11-04,, ,mg,['2 / Day'],IV, 
3787,2680,Tysabri,2016-01-24,,1000,mg,['/Month'], , 
3788,3864,Rebif [22],2016-01-11,2020-03-03,500,mg,[' '],IV,Adverse Event
3789,3864,D-cure (Vitamine D),2016-02-03,2019-03-28, , ,['2 / Day'], ,Lack of efficacy
3790,3864,Copaxone,2016-04-21,,20, ,['3 / Week'], , 
3791,4622,Endoxan,2016-02-11,, , ,['/Month'],Oral, 
3792,4622,Alemtuzumab (Campath),2015-12-07,2017-12-25, ,mcg,['2 / Day'], ,Adverse Event
3793,4622,D-cure (Vitamine D),2016-10-12,,20,mg,['3 / Week'], , 
3794,4622,Methylprednisolone,2016-01-19,2018-06-12, ,mg,['2 / Day'], ,Persisting MRI activity
3795,1337,Endoxan,2016-07-16,,400,mg,['/Month'],IV, 
3796,3282,Alemtuzumab (Campath),2016-01-22,,300,mg,['2 / Day'],IV, 
3797,3282,Gilenya,2015-12-16,2018-07-23, ,mg,['/Month'],IV,Adverse Event
3798,3282,Gilenya,2016-10-14,, ,mg,['2 / Day'],IV, 
3799,1529,Methylprednisolone,2016-08-05,2018-11-15,500, ,['/Month'],IV,Adverse Event
3800,1420,IVIG,2015-12-24,2020-03-25, ,MIU,['2 / Day'],IV,Adverse Event
3801,1420,Mitoxantrone,2016-06-04,2021-08-21,20,mg,['/Month'], ,Adverse Event
3802,1420,Alemtuzumab (Campath),2016-04-23,,300, ,['/Month'], , 
3803,160,Rebif [22],2016-07-27,, ,mg,[' '],IV, 
3804,160,Mitoxantrone,2016-08-14,2020-06-09,500,MIU,['/Month'], ,Patient Choice/Convenience
3805,160,IVIG,2015-11-20,,300,mg,['3 / Week'], , 
3806,3371,IVIG,2016-06-17,2020-08-20,300, ,['2 / Day'], ,Adverse Event
3807,3371,Endoxan,2016-08-15,2018-07-29,20,mg,['2 / Day'],IV,Adverse Event
3808,2011,Tecfidera,2015-11-02,2019-04-21,1000,mg,['2 / Day'],Oral,Patient Choice/Convenience
3809,2011,D-cure (Vitamine D),2015-12-09,, , ,['2 / Day'], , 
3810,2011,Rebif [44],2016-09-28,2021-05-08,500,mg,['3 / Week'],IV,Patient Choice/Convenience
3811,2011,D-cure (Vitamine D),2016-02-16,,300,MIU,['/Month'], , 
3812,746,Rebif [44],2016-05-26,2019-07-03, , ,['3 / Week'], ,Persisting MRI activity
3813,746,Methylprednisolone,2016-02-12,2018-04-24,400,mg,['3 / Week'], ,Adverse Event
3814,746,Gilenya,2016-01-05,2018-01-02,500, ,['/ Day'],IV,Adverse Event
3815,746,Endoxan,2016-05-19,,500,mg,['/Month'],Oral, 
3816,2756,IVIG,2015-12-01,2020-09-02,1,mg,['3 / Week'], ,Adverse Event
3817,2756,Tecfidera,2016-02-06,, ,mg,['3 / Week'],IV, 
3818,2756,D-cure (Vitamine D),2016-03-01,2020-01-17,5000, ,['2 / Day'],IV,Patient Choice/Convenience
3819,2756,Betaferon,2016-07-23,,1, ,['3 / Week'],IV, 
3820,1839,Rebif [44],2016-05-18,2019-07-04,300,mg,['2 / Day'],Oral,Persisting MRI activity
3821,1839,Teriflunomide,2015-11-30,2017-12-01,300,mg,['2 / Day'],IV,Patient Choice/Convenience
3822,1839,Tysabri,2016-06-14,, ,mg,['/Month'], , 
3823,4565,Rebif [44],2015-11-25,2019-02-11, , ,['2 / Day'], ,Persisting MRI activity
3824,4565,Tysabri,2016-07-05,, , ,['/Month'],IV, 
3825,4565,Rebif [22],2016-02-29,2019-05-09, ,mg,['2 / Day'], ,Adverse Event
3826,4565,Rebif [44],2016-03-31,2017-11-23, , ,['/Month'],IV,Patient Choice/Convenience
3827,3631,IVIG,2016-05-03,,1000, ,['/Month'],IV, 
3828,3631,Tecfidera,2016-06-30,,500,mg,['2 / Day'],Oral, 
3829,3631,D-cure (Vitamine D),2016-04-26,,300, ,[' '],IV, 
3830,3714,Ledertrexaat,2016-02-22,2017-12-09, ,mg,['/ Week'],Oral,Adverse Event
3831,3714,IVIG,2016-06-08,,400,mg,[' '], , 
3832,3714,Tysabri,2016-04-19,2019-08-25,20,MIU,['2 / Day'], ,Persistence of relapses
3833,3714,Tysabri,2016-07-02,2020-12-10,300, ,[' '], ,Adverse Event
3834,4092,Rebif [22],2016-01-01,,5000, ,['3 / Week'], , 
3835,4092,Gilenya,2016-03-12,2020-08-09,5000,MIU,['2 / Day'],Oral,Persisting MRI activity
3836,4092,Betaferon,2015-12-21,,20,mg,[' '],IV, 
3837,4803,IVIG,2016-08-09,,300, ,['/ Day'],IV, 
3838,4803,IVIG,2015-10-29,2017-11-07,500, ,['2 / Day'], ,Persisting MRI activity
3839,4803,Rebif [22],2015-12-05,,1,MIU,['/Month'], , 
3840,3990,Copaxone,2015-10-27,, , ,['2 / Day'],IV, 
3841,3990,Ledertrexaat,2016-06-18,, ,mg,['2 / Day'], , 
3842,3990,Rebif [22],2016-08-18,2018-01-14,1,mg,[' '],IV,Persisting MRI activity
3843,3990,Alemtuzumab (Campath),2016-03-06,2019-05-22,500,mg,['2 / Day'], ,Lack of efficacy
3844,1532,Teriflunomide,2016-07-02,2020-03-21,500,mg,[' '],IV,Lack of efficacy
3845,1532,Tysabri,2016-10-16,2019-01-18,500,mg,['/Month'], ,Persistence of relapses
3846,1532,Rebif [22],2015-10-24,2019-12-05,1000,mg,['2 / Day'],IV,Persistence of relapses
3847,1408,Betaferon,2015-10-29,2019-06-18,500, ,['2 / Day'],IV,Persisting MRI activity
3848,1408,D-cure (Vitamine D),2016-09-29,2017-12-09,5000,mg,['/ Week'],IV,Adverse Event
3849,621,D-cure (Vitamine D),2016-10-04,2021-01-06,500,mg,['3 / Week'],IV,Lack of efficacy
3850,621,Gilenya,2016-04-16,,500,mcg,['/Month'], , 
3851,621,Alemtuzumab (Campath),2016-07-03,,500, ,[' '], , 
3852,621,Betaferon,2016-01-19,2019-03-26, ,mg,['/ Day'], ,Adverse Event
3853,4637,Tecfidera,2015-12-05,2018-02-28,20,mcg,['/ Day'],IV,Lack of efficacy
3854,4637,Rebif [44],2016-10-13,2019-02-28,300,mcg,['/Month'],IV,Adverse Event
3855,2487,Gilenya,2016-03-19,2019-09-05, , ,[' '], ,Persisting MRI activity
3856,2047,Copaxone,2015-12-21,2018-08-26, ,mg,['3 / Week'], ,Lack of efficacy
3857,2047,Rebif [22],2016-02-07,,500,mg,['2 / Day'], , 
3858,2047,Betaferon,2016-05-19,,5000, ,['/Month'],IV, 
3859,3270,Rebif [44],2016-01-13,,5000,MIU,['3 / Week'],IV, 
3860,3270,Endoxan,2016-05-10,2021-04-18, , ,['/Month'], ,Patient Choice/Convenience
3861,3270,Rebif [44],2016-08-24,, , ,['3 / Week'],Oral, 
3862,3270,Methylprednisolone,2016-05-26,,5000,mg,['/Month'],IV, 
3863,1244,Endoxan,2016-03-19,2021-01-09,20, ,['3 / Week'], ,Patient Choice/Convenience
3864,1244,Rebif [44],2016-10-20,,300, ,[' '], , 
3865,1244,D-cure (Vitamine D),2016-02-03,,300,mg,['2 / Day'],IV, 
3866,1244,IVIG,2016-10-20,, ,mg,['2 / Day'], , 
3867,408,Betaferon,2016-08-10,, ,mg,['2 / Day'], , 
3868,408,Tecfidera,2015-12-03,, ,MIU,['2 / Day'],Oral, 
3869,408,Betaferon,2016-06-08,2020-03-04,5000, ,['/ Day'], ,Persisting MRI activity
3870,975,Rebif [44],2016-06-12,2018-11-26, ,mg,['2 / Day'], ,Persisting MRI activity
3871,975,Gilenya,2015-12-23,2021-06-23,1, ,['3 / Week'],IV,Adverse Event
3872,975,D-cure (Vitamine D),2016-04-17,,500, ,['3 / Week'],Oral, 
3873,975,Teriflunomide,2016-09-20,2020-01-18,300, ,['/ Day'],IV,Lack of efficacy
3874,1856,Rebif [22],2016-06-12,,1,mg,['/ Day'], , 
3875,1856,Gilenya,2015-12-21,,500,MIU,['3 / Week'],IV, 
3876,1856,Alemtuzumab (Campath),2016-05-27,,20,mcg,['3 / Week'],IV, 
3877,1856,Betaferon,2016-05-21,,1,mg,['/Month'],IV, 
3878,3897,D-cure (Vitamine D),2016-04-16,,300, ,['/Month'],Oral, 
3879,2782,Gilenya,2015-11-22,2021-04-05,1, ,[' '],IV,Persisting MRI activity
3880,4279,Ledertrexaat,2016-06-16,2021-04-10,20,MIU,['/Month'], ,Lack of efficacy
3881,4279,Methylprednisolone,2016-01-25,2021-02-19, ,mcg,['3 / Week'], ,Lack of efficacy
3882,966,Methylprednisolone,2016-10-17,2021-09-12,500, ,['2 / Day'],IV,Patient Choice/Convenience
3883,966,Avonex,2016-10-14,,20,mg,['2 / Day'], , 
3884,3562,Avonex,2016-03-30,,500,mg,['/Month'], , 
3885,2836,Alemtuzumab (Campath),2016-10-16,,20,MIU,['3 / Week'],IV, 
3886,2836,Avonex,2015-12-22,,400,mg,['/Month'],IV, 
3887,2836,Endoxan,2016-07-19,,400,MIU,['3 / Week'],IV, 
3888,2836,Rebif [44],2015-11-24,,300, ,['/Month'],IV, 
3889,4545,D-cure (Vitamine D),2016-03-13,2018-01-13,500,mg,['/Month'],IV,Lack of efficacy
3890,4545,Methylprednisolone,2016-06-08,,1,MIU,['2 / Day'], , 
3891,4545,Alemtuzumab (Campath),2016-07-01,2018-05-08,1000,mg,['/Month'], ,Persisting MRI activity
3892,2450,IVIG,2016-01-16,2018-10-08,300,mg,['2 / Day'],Oral,Adverse Event
3893,2450,Gilenya,2016-02-25,,400,mg,['/ Day'],IV, 
3894,2192,D-cure (Vitamine D),2016-02-24,, , ,['3 / Week'],IV, 
3895,3331,Alemtuzumab (Campath),2016-02-20,,300,mg,['/ Day'],IV, 
3896,3331,D-cure (Vitamine D),2016-08-02,2018-06-19,20, ,['2 / Day'],IV,Persistence of relapses
3897,181,Rebif [22],2016-10-10,2020-12-08, , ,['2 / Day'], ,Lack of efficacy
3898,181,D-cure (Vitamine D),2016-05-23,,500, ,['/Month'], , 
3899,181,Rebif [44],2016-07-27,2019-01-13, ,mcg,['2 / Day'],IV,Persisting MRI activity
3900,181,Alemtuzumab (Campath),2015-12-07,,5000,mg,['/Month'], , 
3901,2909,Methylprednisolone,2016-03-31,2018-06-30,1, ,['/Month'],IV,Persisting MRI activity
3902,2909,IVIG,2016-08-06,2018-10-14, ,MIU,[' '],IV,Adverse Event
3903,3042,D-cure (Vitamine D),2016-03-02,,300,MIU,['2 / Day'],IV, 
3904,2406,Gilenya,2016-04-26,, ,mg,['/Month'],IV, 
3905,2460,Tysabri,2016-07-02,2019-02-27, ,MIU,[' '], ,Patient Choice/Convenience
3906,905,Endoxan,2015-11-01,2018-12-10,20, ,['/Month'], ,Persisting MRI activity
3907,905,Copaxone,2016-02-18,, , ,['/Month'], , 
3908,2806,Methylprednisolone,2015-12-05,,1, ,['/Month'],IV, 
3909,2806,Avonex,2016-09-13,2020-05-24,1,mg,[' '], ,Persistence of relapses
3910,2806,Rebif [44],2016-10-19,,400, ,[' '], , 
3911,3745,IVIG,2016-06-03,,20,MIU,['/ Day'],IV, 
3912,3745,IVIG,2015-11-28,2020-03-23, , ,['3 / Week'],IV,Persisting MRI activity
3913,3557,D-cure (Vitamine D),2016-07-10,,1000, ,['/ Day'],IV, 
3914,3557,Teriflunomide,2016-05-25,,1000,mg,[' '],Oral, 
3915,763,Tecfidera,2016-08-19,2018-09-22,20,MIU,['/Month'],IV,Lack of efficacy
3916,763,Copaxone,2015-10-28,,20, ,['2 / Day'],IV, 
3917,763,Mitoxantrone,2016-02-03,,5000,mg,['3 / Week'],IV, 
3918,3584,Mitoxantrone,2016-10-20,, ,mg,['2 / Day'],IV, 
3919,3584,Gilenya,2016-03-27,2021-08-02, , ,['2 / Day'], ,Persistence of relapses
3920,3584,Tecfidera,2016-03-24,, ,mg,['3 / Week'],IV, 
3921,1828,Gilenya,2016-07-16,,1000,mg,[' '],Oral, 
3922,1041,Tysabri,2016-07-25,2018-02-01,400,mg,['3 / Week'],Oral,Adverse Event
3923,1041,Tysabri,2016-04-27,2019-05-20,20,mcg,['/Month'],Oral,Patient Choice/Convenience
3924,1041,Tecfidera,2015-11-21,, , ,['/Month'],IV, 
3925,1041,Tysabri,2016-06-27,,500, ,['2 / Day'],IV, 
3926,1068,Rebif [44],2015-10-30,,1000,MIU,['3 / Week'], , 
3927,1068,Methylprednisolone,2015-10-24,2021-06-18,300,mcg,[' '],IV,Patient Choice/Convenience
3928,1068,Rebif [22],2016-04-01,2021-09-02,1,mg,['2 / Day'], ,Lack of efficacy
3929,909,Rebif [44],2016-09-18,2020-04-09, , ,['2 / Day'],Oral,Lack of efficacy
3930,909,Betaferon,2015-11-09,,500,mg,['/Month'], , 
3931,909,Ledertrexaat,2016-01-26,,1000,mg,['/Month'],IV, 
3932,909,Avonex,2016-02-27,2020-01-25, ,mg,['2 / Day'], ,Lack of efficacy
3933,3528,Gilenya,2016-02-01,,20,mg,['/ Day'], , 
3934,3528,Gilenya,2015-11-07,,500, ,['2 / Day'],IV, 
3935,3528,Tysabri,2016-08-14,,400,mg,[' '],IV, 
3936,3528,Rebif [44],2015-12-27,,20,mg,[' '], , 
3937,3642,Rebif [22],2016-02-23,,1000, ,['/Month'],IV, 
3938,1910,Tysabri,2016-06-25,,500,MIU,['/Month'],Oral, 
3939,1910,D-cure (Vitamine D),2016-06-14,, ,mcg,['/ Week'],IV, 
3940,1910,Methylprednisolone,2016-04-18,2018-05-24, , ,['/Month'],IV,Lack of efficacy
3941,1910,Tysabri,2016-08-28,,1,mg,[' '], , 
3942,4451,Gilenya,2016-01-21,,1000,mg,['/Month'], , 
3943,4451,Gilenya,2016-06-28,2019-05-02,1,mg,['3 / Week'],Oral,Lack of efficacy
3944,4451,Gilenya,2016-09-25,2020-11-07, ,MIU,['3 / Week'], ,Persisting MRI activity
3945,4451,Avonex,2016-07-27,2019-07-13, ,mg,['3 / Week'],IV,Adverse Event
3946,3265,Tecfidera,2015-12-04,2020-03-12,1000,mg,['2 / Day'],Oral,Lack of efficacy
3947,3265,Rebif [44],2016-01-02,, ,mg,['/Month'],IV, 
3948,3265,Endoxan,2016-02-25,2021-08-14, ,mg,['/Month'], ,Adverse Event
3949,2854,Methylprednisolone,2016-03-06,, ,mg,['/Month'],Oral, 
3950,2854,Rebif [22],2016-08-24,2018-03-28, ,mg,[' '], ,Persisting MRI activity
3951,2854,Gilenya,2016-10-19,, ,mg,['/Month'], , 
3952,2854,Avonex,2016-02-20,,300, ,[' '], , 
3953,4710,IVIG,2016-01-31,2020-09-29,20, ,[' '],IV,Persistence of relapses
3954,4710,Rebif [44],2016-08-06,,20, ,['2 / Day'], , 
3955,4710,Rebif [22],2016-05-20,, , ,['2 / Day'],IV, 
3956,2228,Ledertrexaat,2016-08-17,2018-10-03,1, ,['2 / Day'], ,Patient Choice/Convenience
3957,2228,Tysabri,2016-06-05,2020-02-17, , ,['/ Week'],IV,Lack of efficacy
3958,2228,Methylprednisolone,2016-06-12,, , ,['/ Day'],IV, 
3959,2228,IVIG,2016-09-09,, ,mg,['2 / Day'],Oral, 
3960,624,Tecfidera,2016-06-12,2021-03-13,500, ,['2 / Day'],Oral,Adverse Event
3961,624,Methylprednisolone,2016-10-22,, ,mg,['/ Day'], , 
3962,4565,Gilenya,2016-08-04,,500,MIU,['2 / Day'], , 
3963,517,Mitoxantrone,2016-04-04,,1,mg,['3 / Week'],IV, 
3964,517,IVIG,2016-09-06,2018-01-13,300, ,['/Month'],IV,Persisting MRI activity
3965,4027,Copaxone,2016-07-30,, , ,['2 / Day'],IV, 
3966,4027,Endoxan,2016-02-28,2021-01-04,20, ,['/Month'],Oral,Persistence of relapses
3967,326,Copaxone,2016-09-07,,1,mg,['2 / Day'],IV, 
3968,3045,Mitoxantrone,2016-05-07,,5000,mg,['/Month'], , 
3969,3045,Teriflunomide,2015-11-02,,20, ,['3 / Week'], , 
3970,4646,Tysabri,2016-09-21,2021-03-22,1000,mg,['2 / Day'], ,Persisting MRI activity
3971,4646,D-cure (Vitamine D),2016-08-23,2021-08-31,20,mg,[' '],Oral,Adverse Event
3972,4646,D-cure (Vitamine D),2016-09-08,2021-06-27,1,mg,['/ Day'],Oral,Patient Choice/Convenience
3973,1757,D-cure (Vitamine D),2016-01-01,,300, ,['/ Day'],IV, 
3974,1757,Betaferon,2016-08-30,2019-12-22,1, ,['/Month'],IV,Persistence of relapses
3975,1757,Methylprednisolone,2016-08-12,,500,mg,['3 / Week'],IV, 
3976,758,Alemtuzumab (Campath),2016-02-24,2018-04-28,300,mg,['/ Week'],IV,Adverse Event
3977,758,Avonex,2016-07-31,,300,mg,['2 / Day'], , 
3978,758,Avonex,2016-02-06,2021-06-29, , ,['/ Week'], ,Adverse Event
3979,4180,Tecfidera,2016-06-01,,400,mg,['2 / Day'], , 
3980,1745,Teriflunomide,2016-04-20,,20, ,['2 / Day'],Oral, 
3981,1745,D-cure (Vitamine D),2016-02-16,, ,mg,['2 / Day'], , 
3982,2901,Avonex,2016-06-25,2020-02-12, ,MIU,['/Month'], ,Persistence of relapses
3983,2901,Betaferon,2016-05-13,2020-07-10,300,mg,['2 / Day'],IV,Patient Choice/Convenience
3984,3360,Betaferon,2016-08-02,, ,mg,['/Month'], , 
3985,3360,Betaferon,2016-01-25,2020-02-03, , ,['2 / Day'],IV,Adverse Event
3986,1019,Tecfidera,2016-06-11,2020-09-01,1,mg,['3 / Week'], ,Persistence of relapses
3987,1019,Gilenya,2016-08-04,2018-10-03, , ,['3 / Week'],IV,Lack of efficacy
3988,1019,Betaferon,2016-01-24,,1000,mg,['3 / Week'], , 
3989,3934,Tysabri,2015-12-04,2020-02-12,500,mg,[' '],IV,Patient Choice/Convenience
3990,3934,Rebif [44],2016-08-31,,5000,MIU,['/Month'], , 
3991,3672,Tysabri,2016-09-01,2019-08-30,1000, ,['/Month'], ,Adverse Event
3992,3672,Endoxan,2016-07-02,,20,mg,['2 / Day'], , 
3993,3672,D-cure (Vitamine D),2016-04-25,, , ,['3 / Week'],IV, 
3994,1571,Mitoxantrone,2016-02-15,2018-09-16,1,mg,['2 / Day'],IV,Patient Choice/Convenience
3995,1571,Tecfidera,2016-10-16,,1000,mg,[' '],IV, 
3996,1571,Tysabri,2016-06-24,2018-05-17,1000, ,['/Month'],IV,Patient Choice/Convenience
3997,4696,Endoxan,2016-06-09,,300,MIU,['/Month'], , 
3998,1910,Alemtuzumab (Campath),2016-04-03,2018-10-21,1000,mg,[' '],IV,Adverse Event
3999,1874,IVIG,2016-01-11,,5000, ,['/Month'], , 
4000,1874,IVIG,2015-10-31,2019-12-25,500,mg,[' '],IV,Adverse Event
4001,1874,Rebif [22],2016-02-01,2018-09-06, , ,['2 / Day'],Oral,Patient Choice/Convenience
4002,476,D-cure (Vitamine D),2016-08-21,2019-05-22,1, ,['2 / Day'],Oral,Patient Choice/Convenience
4003,598,Ledertrexaat,2016-10-06,, , ,['/ Day'],IV, 
4004,598,Avonex,2015-12-19,,1000, ,['/ Day'],IV, 
4005,2564,Tysabri,2015-12-24,,5000,MIU,['/ Day'],IV, 
4006,4758,Rebif [22],2016-09-19,2020-01-14,500,mcg,['/ Day'], ,Adverse Event
4007,1508,Alemtuzumab (Campath),2015-12-25,, , ,['3 / Week'], , 
4008,1508,IVIG,2015-11-19,,20, ,['/Month'],Oral, 
4009,1508,Gilenya,2016-05-29,2020-12-17,400, ,['3 / Week'], ,Patient Choice/Convenience
4010,2078,Tecfidera,2016-02-01,,1000,mg,['2 / Day'],IV, 
4011,2078,Betaferon,2015-12-22,,20,mg,['/Month'], , 
4012,2078,D-cure (Vitamine D),2016-04-29,, , ,['/ Day'],IV, 
4013,1354,Endoxan,2016-10-10,2020-11-19,300,mg,['2 / Day'], ,Patient Choice/Convenience
4014,1354,D-cure (Vitamine D),2016-06-22,2021-03-31,1,mg,['3 / Week'],IV,Persistence of relapses
4015,1354,Copaxone,2016-06-20,,400, ,['2 / Day'],Oral, 
4016,1354,Copaxone,2016-01-06,,1,mg,['2 / Day'],IV, 
4017,4434,Rebif [44],2015-12-13,2021-07-05,500, ,['/Month'], ,Lack of efficacy
4018,4434,Betaferon,2016-01-14,,300, ,['2 / Day'],IV, 
4019,4434,Ledertrexaat,2016-06-12,,1000, ,['3 / Week'],Oral, 
4020,704,D-cure (Vitamine D),2016-03-01,2019-09-01,500, ,['/Month'], ,Persisting MRI activity
4021,2648,D-cure (Vitamine D),2016-02-10,,20, ,['/Month'], , 
4022,2648,IVIG,2016-01-14,2021-04-14, ,mg,['/Month'],IV,Persisting MRI activity
4023,2648,Endoxan,2016-05-18,,1000,MIU,['2 / Day'],Oral, 
4024,4185,Rebif [22],2016-07-26,, ,mg,['2 / Day'],IV, 
4025,4185,Ledertrexaat,2015-10-31,2021-07-23,400, ,['/ Day'], ,Patient Choice/Convenience
4026,4185,Copaxone,2016-06-09,2020-12-12,5000,mg,['3 / Week'],IV,Adverse Event
4027,4185,Rebif [22],2016-08-27,,1,mcg,['/ Day'], , 
4028,4146,Rebif [22],2016-05-19,2018-06-13, , ,['2 / Day'], ,Persisting MRI activity
4029,4146,D-cure (Vitamine D),2016-01-14,2021-10-14,500,mg,['/Month'], ,Adverse Event
4030,3105,Rebif [22],2016-05-29,,300,mg,['/ Week'],IV, 
4031,3105,Tysabri,2016-10-17,,500,MIU,['/Month'],IV, 
4032,3105,Methylprednisolone,2016-07-23,, , ,['/Month'], , 
4033,3900,Alemtuzumab (Campath),2016-03-21,2021-09-19,5000,mg,['/Month'],Oral,Adverse Event
4034,3900,IVIG,2016-06-15,2019-08-01,1000, ,['/Month'],IV,Lack of efficacy
4035,3900,Copaxone,2016-08-31,,20, ,['/Month'], , 
4036,3900,Gilenya,2015-12-27,,500,mg,['3 / Week'],IV, 
4037,556,Tecfidera,2016-06-07,2020-03-26, ,mg,['/ Day'],IV,Patient Choice/Convenience
4038,556,Endoxan,2016-06-04,2019-03-25, , ,['2 / Day'],IV,Persistence of relapses
4039,556,Gilenya,2016-05-14,,500,MIU,['/ Day'], , 
4040,556,Endoxan,2016-04-25,,500, ,['/Month'],Oral, 
4041,1760,Rebif [44],2016-02-11,2019-04-13,1,mg,['/Month'],IV,Patient Choice/Convenience
4042,1760,Teriflunomide,2016-04-22,,500,MIU,['2 / Day'],IV, 
4043,1760,Tecfidera,2016-06-26,,5000,mg,['/Month'], , 
4044,1760,Rebif [44],2016-02-01,, , ,['2 / Day'],IV, 
4045,1521,Tecfidera,2016-01-28,2020-10-11, ,mg,['/ Week'],IV,Persisting MRI activity
4046,1521,Rebif [44],2016-06-03,2021-04-23, ,mcg,['/ Week'], ,Adverse Event
4047,1521,Tysabri,2016-06-17,2021-06-21,500, ,[' '], ,Adverse Event
4048,2096,Copaxone,2016-03-01,, , ,['/ Day'],IV, 
4049,114,Avonex,2016-09-22,2018-01-02,500,MIU,[' '],IV,Lack of efficacy
4050,114,Tecfidera,2016-01-07,2021-08-17,1,mg,['2 / Day'],IV,Adverse Event
4051,3602,Alemtuzumab (Campath),2016-09-17,2020-12-31, ,mg,['2 / Day'],IV,Adverse Event
4052,3602,Teriflunomide,2016-07-10,2020-11-13,500, ,['/Month'],IV,Lack of efficacy
4053,3602,Mitoxantrone,2016-05-01,2018-10-28,5000, ,['3 / Week'],IV,Adverse Event
4054,3602,Rebif [22],2016-08-17,2019-01-02,300, ,['/Month'], ,Adverse Event
4055,2437,D-cure (Vitamine D),2015-11-07,2018-09-02,1,mcg,[' '], ,Persisting MRI activity
4056,2437,IVIG,2015-11-23,,1, ,['2 / Day'], , 
4057,2437,Methylprednisolone,2015-11-15,2019-12-08, , ,['2 / Day'], ,Patient Choice/Convenience
4058,4826,Rebif [22],2016-09-15,, ,mcg,['2 / Day'],IV, 
4059,2560,IVIG,2015-11-20,,5000, ,['2 / Day'],Oral, 
4060,2560,D-cure (Vitamine D),2016-03-07,2018-04-25,20,mg,[' '],IV,Persisting MRI activity
4061,2560,Rebif [22],2016-05-15,,500, ,['3 / Week'],IV, 
4062,1415,Gilenya,2016-02-15,, ,mcg,['2 / Day'],IV, 
4063,1415,Tecfidera,2016-01-23,2020-06-11,500,mg,['/Month'], ,Adverse Event
4064,1415,Tecfidera,2016-07-29,, , ,['/ Week'], , 
4065,1415,Gilenya,2016-08-09,2018-07-27,20,mg,['3 / Week'],IV,Adverse Event
4066,1208,Mitoxantrone,2016-09-29,2020-05-05,5000,mg,['2 / Day'],Oral,Lack of efficacy
4067,3302,Tecfidera,2016-01-30,, ,mg,['2 / Day'],IV, 
4068,3302,Betaferon,2015-12-13,,5000,mg,['2 / Day'], , 
4069,3302,Teriflunomide,2016-04-08,,5000,mg,['2 / Day'],IV, 
4070,711,D-cure (Vitamine D),2016-05-31,2021-04-25,20,MIU,['/Month'],IV,Persisting MRI activity
4071,4105,Endoxan,2016-07-14,,1000,MIU,['2 / Day'],Oral, 
4072,1359,Ledertrexaat,2016-01-08,,400,mg,['2 / Day'], , 
4073,1359,Tecfidera,2015-10-29,,1000,mg,['2 / Day'], , 
4074,1359,IVIG,2016-03-27,,1000, ,['/ Day'], , 
4075,1359,Avonex,2015-12-19,,20, ,['/ Day'], , 
4076,4810,Betaferon,2016-08-31,2018-08-13, ,mg,['3 / Week'],IV,Persistence of relapses
4077,4810,Gilenya,2016-01-05,2020-06-04,5000, ,['/ Day'], ,Adverse Event
4078,4810,Tecfidera,2015-12-24,, ,mg,['/ Day'],IV, 
4079,3772,IVIG,2016-03-19,2018-05-19,1, ,['/ Week'], ,Persistence of relapses
4080,3772,Teriflunomide,2016-05-24,,20, ,['3 / Week'], , 
4081,3772,Endoxan,2016-05-30,2021-06-19,500,mg,['/Month'], ,Patient Choice/Convenience
4082,3772,Tysabri,2016-09-19,, ,mg,['/Month'],IV, 
4083,4586,Rebif [44],2016-06-25,, ,mg,['/Month'], , 
4084,4586,Teriflunomide,2016-02-13,2020-04-29,5000,mg,['/Month'],IV,Adverse Event
4085,4586,D-cure (Vitamine D),2016-04-05,,400, ,['/Month'],IV, 
4086,3362,Gilenya,2015-11-29,, , ,['2 / Day'], , 
4087,3362,Mitoxantrone,2016-05-08,2020-03-11,400, ,['/Month'], ,Adverse Event
4088,2314,Ledertrexaat,2016-07-08,2019-05-23, , ,['3 / Week'],IV,Patient Choice/Convenience
4089,3190,IVIG,2015-11-06,2018-09-20,300,mg,['/ Day'], ,Adverse Event
4090,3190,Betaferon,2016-05-27,,300,mg,['/Month'],IV, 
4091,3190,Ledertrexaat,2016-05-23,,5000, ,['/Month'],IV, 
4092,1931,Rebif [22],2015-11-17,,1000,mcg,['2 / Day'], , 
4093,1931,Betaferon,2015-11-23,2021-10-11,1, ,['2 / Day'], ,Persistence of relapses
4094,1538,Gilenya,2015-11-17,, ,mg,['/ Week'],IV, 
4095,3573,Rebif [22],2016-04-09,,20,mg,['/ Day'], , 
4096,3573,Alemtuzumab (Campath),2016-08-23,2018-07-17, ,mg,['3 / Week'],Oral,Persisting MRI activity
4097,4959,IVIG,2016-05-10,2020-09-14, ,mg,['/ Day'], ,Persisting MRI activity
4098,4959,Rebif [22],2015-11-23,,500, ,['/ Day'], , 
4099,4959,Rebif [44],2016-05-04,,20, ,['3 / Week'],IV, 
4100,4959,Tecfidera,2016-07-14,,400,mg,['2 / Day'],IV, 
4101,558,Endoxan,2016-08-09,,500,mg,['/ Day'], , 
4102,558,Betaferon,2016-02-13,2018-03-05,500,mg,[' '],IV,Lack of efficacy
4103,558,Methylprednisolone,2016-08-22,, ,mg,['/Month'],Oral, 
4104,3309,Methylprednisolone,2016-05-26,, ,mg,['2 / Day'],IV, 
4105,3196,Copaxone,2016-04-27,,1000, ,['/Month'],IV, 
4106,2549,IVIG,2016-05-12,2019-02-09,20,MIU,['/Month'],IV,Patient Choice/Convenience
4107,3113,Tysabri,2016-05-15,,500,mcg,['/Month'],IV, 
4108,3113,Betaferon,2015-12-22,2019-03-05, ,mg,['3 / Week'], ,Adverse Event
4109,3113,Copaxone,2016-03-25,, ,mcg,['/Month'], , 
4110,3113,Copaxone,2016-01-07,,500,mg,['2 / Day'],IV, 
4111,1428,Tecfidera,2016-01-09,2020-01-22,1,mg,['/ Week'],IV,Patient Choice/Convenience
4112,1428,Tecfidera,2016-03-08,2019-05-17, ,mg,['/Month'],IV,Persisting MRI activity
4113,170,Gilenya,2016-08-28,,1, ,[' '],IV, 
4114,170,Avonex,2015-11-30,, ,mg,[' '],IV, 
4115,170,D-cure (Vitamine D),2016-01-19,,5000, ,['2 / Day'], , 
4116,170,Gilenya,2016-10-22,,500,MIU,['2 / Day'], , 
4117,1751,Alemtuzumab (Campath),2015-11-15,,300,mg,['/ Day'], , 
4118,1751,Tecfidera,2016-02-04,,1000,mg,['2 / Day'],Oral, 
4119,1751,Rebif [44],2015-12-31,,300, ,['2 / Day'], , 
4120,1751,Rebif [22],2016-05-16,,5000,mg,[' '],Oral, 
4121,1162,Betaferon,2016-04-12,2020-02-20,500,mg,['/Month'],IV,Lack of efficacy
4122,4269,IVIG,2016-09-10,2021-03-23,1000, ,['/Month'],IV,Lack of efficacy
4123,4269,D-cure (Vitamine D),2016-07-05,2018-04-24,5000,mg,['/Month'],IV,Lack of efficacy
4124,2921,Rebif [44],2015-12-28,, , ,['2 / Day'], , 
4125,2921,Methylprednisolone,2016-06-16,,500, ,['/Month'],IV, 
4126,3459,Betaferon,2016-02-10,, , ,['/ Week'],IV, 
4127,3362,Avonex,2016-04-20,2019-08-26,5000,mg,['/Month'], ,Patient Choice/Convenience
4128,834,Tysabri,2016-08-25,, , ,['/ Day'],IV, 
4129,834,Mitoxantrone,2016-01-23,2018-06-20,20, ,['/Month'],IV,Adverse Event
4130,2316,Gilenya,2016-06-20,2018-07-14,400,mg,['/Month'],IV,Patient Choice/Convenience
4131,2316,IVIG,2016-09-06,,500,MIU,[' '],IV, 
4132,2316,Gilenya,2015-11-13,,300,mg,[' '],IV, 
4133,2316,Methylprednisolone,2016-01-01,, ,mg,['2 / Day'], , 
4134,425,IVIG,2016-03-16,2018-05-23, , ,['2 / Day'],IV,Patient Choice/Convenience
4135,425,Ledertrexaat,2016-05-14,2018-03-09, ,mg,['2 / Day'],Oral,Adverse Event
4136,2290,Alemtuzumab (Campath),2015-12-06,,300,MIU,['2 / Day'],IV, 
4137,2290,Gilenya,2015-11-10,,500, ,['/Month'], , 
4138,1172,Avonex,2015-12-05,2020-09-06,300,mg,['2 / Day'],IV,Adverse Event
4139,1172,Avonex,2015-12-25,2020-08-29, ,mg,['3 / Week'], ,Persisting MRI activity
4140,4278,Methylprednisolone,2015-12-25,,500,MIU,[' '],IV, 
4141,4278,Alemtuzumab (Campath),2016-09-30,2021-09-04,1000,mg,['/ Week'],IV,Lack of efficacy
4142,4604,Gilenya,2015-10-28,,400, ,['2 / Day'],IV, 
4143,4604,IVIG,2016-03-07,,5000,mg,['/Month'], , 
4144,4604,Endoxan,2016-04-29,,500,mg,['/Month'],IV, 
4145,1492,Rebif [22],2016-01-06,,400,mg,['/ Day'], , 
4146,673,Copaxone,2016-08-18,,500,mcg,['/Month'],Oral, 
4147,4236,Methylprednisolone,2016-08-01,2020-04-18,400, ,['2 / Day'],Oral,Adverse Event
4148,4236,Tysabri,2016-07-02,,20, ,['2 / Day'],IV, 
4149,4822,Tecfidera,2016-03-11,2018-10-16,300,mg,['/Month'],IV,Patient Choice/Convenience
4150,4822,D-cure (Vitamine D),2015-11-04,2020-11-14,5000,MIU,[' '], ,Persistence of relapses
4151,4822,Alemtuzumab (Campath),2016-01-12,,500, ,['2 / Day'],IV, 
4152,4822,Methylprednisolone,2016-08-15,,500,mg,[' '],IV, 
4153,476,Ledertrexaat,2016-01-22,,500,mcg,['/Month'], , 
4154,1880,Betaferon,2016-08-11,2017-11-08,1000, ,['/Month'],IV,Persisting MRI activity
4155,1880,Ledertrexaat,2016-06-03,,500, ,['3 / Week'], , 
4156,310,Rebif [44],2016-08-06,, , ,['/Month'],IV, 
4157,2268,IVIG,2015-12-02,, ,mg,['2 / Day'],IV, 
4158,2268,Teriflunomide,2016-07-24,, , ,['/Month'], , 
4159,4800,Endoxan,2016-09-19,2019-08-05,5000,MIU,['/Month'],IV,Adverse Event
4160,4800,Alemtuzumab (Campath),2016-01-03,,1000,mg,['3 / Week'],IV, 
4161,2463,Copaxone,2016-07-08,,400,mg,['2 / Day'],IV, 
4162,2463,IVIG,2016-01-04,,500, ,['3 / Week'],IV, 
4163,2463,Endoxan,2016-09-29,2021-06-28,20, ,['/Month'],Oral,Lack of efficacy
4164,2463,Alemtuzumab (Campath),2016-02-25,2020-03-03,500, ,['/ Week'], ,Patient Choice/Convenience
4165,3939,Copaxone,2016-03-11,,1, ,['/Month'],IV, 
4166,3939,Rebif [22],2016-06-17,2020-04-17, , ,['2 / Day'], ,Patient Choice/Convenience
4167,4527,Methylprednisolone,2016-05-28,, ,mg,['/ Week'],IV, 
4168,4527,Teriflunomide,2016-07-20,2020-07-30, ,mg,['3 / Week'], ,Persisting MRI activity
4169,4527,Avonex,2016-08-31,2018-06-29,500,MIU,['2 / Day'],IV,Lack of efficacy
4170,4527,Tecfidera,2015-12-10,2019-09-14,5000,MIU,['2 / Day'], ,Lack of efficacy
4171,515,Tysabri,2015-11-03,,20,mg,[' '],IV, 
4172,515,IVIG,2016-01-27,,5000,MIU,['/Month'], , 
4173,2242,Endoxan,2016-06-03,2020-12-14,1000, ,['/Month'],IV,Lack of efficacy
4174,2242,Alemtuzumab (Campath),2016-02-10,2018-05-04,300, ,['3 / Week'],IV,Adverse Event
4175,2242,Tecfidera,2016-05-31,2019-03-02,20,mg,['3 / Week'],IV,Lack of efficacy
4176,2242,Endoxan,2016-05-31,,20,mg,[' '], , 
4177,1882,IVIG,2016-02-08,,20, ,['3 / Week'],IV, 
4178,1882,Tecfidera,2016-05-06,,500, ,['/Month'],Oral, 
4179,558,Mitoxantrone,2016-02-06,,300,mg,['2 / Day'], , 
4180,558,Mitoxantrone,2016-01-10,, , ,['2 / Day'],IV, 
4181,558,Tysabri,2016-05-09,2021-05-26,1000,mcg,['2 / Day'],IV,Patient Choice/Convenience
4182,4117,Rebif [44],2015-12-24,2021-10-13, ,mg,['2 / Day'],Oral,Persisting MRI activity
4183,4117,IVIG,2016-09-01,2019-02-03,20, ,['2 / Day'], ,Lack of efficacy
4184,4117,D-cure (Vitamine D),2016-08-24,2018-08-08,5000,mg,['/Month'], ,Persisting MRI activity
4185,2178,Alemtuzumab (Campath),2016-08-01,2018-07-04, ,mg,['/ Day'], ,Persisting MRI activity
4186,1464,Tysabri,2016-09-04,2019-12-12,500,mg,['/ Week'],IV,Lack of efficacy
4187,1464,Alemtuzumab (Campath),2016-02-13,2020-11-26,300, ,['/Month'],IV,Persistence of relapses
4188,1361,Endoxan,2016-04-17,2018-12-31, , ,['/Month'],IV,Lack of efficacy
4189,1361,Mitoxantrone,2016-03-29,,400, ,['/ Day'],IV, 
4190,4074,Endoxan,2016-02-09,, , ,['/ Day'],Oral, 
4191,333,Methylprednisolone,2016-06-15,, , ,['/ Day'],IV, 
4192,4435,D-cure (Vitamine D),2016-03-07,, ,mg,['3 / Week'],IV, 
4193,4435,Gilenya,2016-06-28,2019-05-06,400, ,['2 / Day'], ,Persisting MRI activity
4194,4435,IVIG,2016-05-02,2018-11-09,20,mg,['/Month'], ,Adverse Event
4195,4435,Betaferon,2016-09-14,2019-01-03,500, ,['/ Day'],IV,Adverse Event
4196,4440,Methylprednisolone,2016-04-04,,1000,mg,['/Month'], , 
4197,4440,D-cure (Vitamine D),2016-03-31,,500, ,[' '],IV, 
4198,3100,Tecfidera,2015-10-29,2019-06-24,1,MIU,['/Month'],Oral,Patient Choice/Convenience
4199,3100,Endoxan,2015-11-14,,20, ,['/ Week'],IV, 
4200,3100,D-cure (Vitamine D),2016-04-24,, ,mg,['/Month'], , 
4201,2006,Tecfidera,2015-11-10,2019-12-01,20,MIU,['3 / Week'],IV,Lack of efficacy
4202,2006,Ledertrexaat,2016-10-12,, ,mg,[' '],Oral, 
4203,2006,Copaxone,2016-03-01,,500,MIU,['/ Week'],Oral, 
4204,2006,Teriflunomide,2016-06-12,, ,mg,['3 / Week'],IV, 
4205,1133,Methylprednisolone,2015-12-26,, ,mcg,['/Month'], , 
4206,1133,Betaferon,2016-01-04,,1,mg,['/Month'],IV, 
4207,4059,Alemtuzumab (Campath),2016-10-02,,5000,mg,['/ Week'], , 
4208,4059,Endoxan,2016-07-04,, ,mg,['/Month'],IV, 
4209,4059,IVIG,2016-05-20,2021-05-24,1000,MIU,['3 / Week'], ,Patient Choice/Convenience
4210,4445,D-cure (Vitamine D),2016-02-09,2017-12-07,5000,mcg,[' '],IV,Persisting MRI activity
4211,4445,IVIG,2016-02-22,2020-06-04,1000, ,[' '], ,Patient Choice/Convenience
4212,3185,Rebif [44],2016-07-06,,1,MIU,['2 / Day'],IV, 
4213,3185,Rebif [22],2016-09-01,2018-02-04, ,MIU,['/Month'],IV,Lack of efficacy
4214,3185,Gilenya,2016-03-01,, ,mg,['/Month'], , 
4215,3185,Tecfidera,2016-08-04,,5000,mg,['2 / Day'],IV, 
4216,128,Betaferon,2016-10-09,2018-09-05,5000, ,['2 / Day'],Oral,Persisting MRI activity
4217,128,Gilenya,2015-12-24,2018-09-12,300,mcg,['/Month'],IV,Persistence of relapses
4218,2315,Gilenya,2016-10-08,2021-06-14,5000,MIU,[' '],IV,Adverse Event
4219,4479,Rebif [44],2016-03-27,, ,mcg,['/Month'], , 
4220,4479,Betaferon,2016-09-11,, ,mg,['/ Week'], , 
4221,4479,IVIG,2016-09-22,,1, ,['2 / Day'],Oral, 
4222,4479,Methylprednisolone,2016-06-09,2019-02-24,500, ,['2 / Day'],IV,Patient Choice/Convenience
4223,2293,IVIG,2015-12-19,,5000,MIU,[' '], , 
4224,2293,Rebif [44],2016-07-27,2018-11-24,400,mg,['2 / Day'], ,Persistence of relapses
4225,2293,Teriflunomide,2016-06-10,,5000, ,['/Month'], , 
4226,1241,Gilenya,2016-05-24,2019-09-03,20,mg,['/Month'], ,Adverse Event
4227,1241,Gilenya,2016-06-01,, ,mg,['3 / Week'],IV, 
4228,1241,Methylprednisolone,2016-06-01,2020-08-12, , ,['3 / Week'],IV,Adverse Event
4229,1241,Gilenya,2016-06-03,,400, ,['/Month'],IV, 
4230,4027,Teriflunomide,2016-09-02,2020-05-14, , ,['/Month'], ,Lack of efficacy
4231,4549,Avonex,2015-12-10,,1, ,['/Month'],IV, 
4232,523,Tysabri,2016-06-30,2019-09-08, ,mg,['/Month'],IV,Patient Choice/Convenience
4233,523,Alemtuzumab (Campath),2016-05-07,2018-02-13,300,mg,['/Month'],IV,Adverse Event
4234,523,Tysabri,2016-07-21,,400,mg,['/Month'],IV, 
4235,523,Methylprednisolone,2015-11-20,,20,mg,['/Month'], , 
4236,3918,Gilenya,2016-03-24,2021-03-15, , ,['/Month'],Oral,Persistence of relapses
4237,3918,Tecfidera,2016-07-07,,1000,mg,['/Month'], , 
4238,3918,Gilenya,2015-10-30,2019-03-08,1,mg,[' '], ,Lack of efficacy
4239,913,Methylprednisolone,2016-09-11,,20,mg,['/Month'],IV, 
4240,913,Tysabri,2016-03-15,2019-03-30,20, ,['/ Week'],Oral,Persisting MRI activity
4241,913,Tysabri,2016-03-28,,1000,MIU,['/Month'],IV, 
4242,913,Tysabri,2015-12-19,2019-05-25,5000, ,['3 / Week'],IV,Persisting MRI activity
4243,4806,Endoxan,2016-01-11,,400,mg,['3 / Week'],IV, 
4244,4806,Rebif [22],2016-02-21,,500,mcg,['/Month'], , 
4245,1244,Gilenya,2016-04-15,,300,mg,['/Month'],IV, 
4246,1244,Tecfidera,2016-10-14,2020-11-06,400,MIU,['/Month'], ,Lack of efficacy
4247,1244,Teriflunomide,2016-04-15,,1000, ,['/Month'],Oral, 
4248,1679,D-cure (Vitamine D),2016-03-27,, ,mg,['/Month'],IV, 
4249,1679,IVIG,2016-07-04,,20,mg,[' '],IV, 
4250,1679,Copaxone,2015-11-22,2021-10-02,500, ,['/ Day'],IV,Persisting MRI activity
4251,1679,IVIG,2016-02-20,,1, ,['/Month'],IV, 
4252,3470,Copaxone,2016-02-03,,5000,mg,['/Month'],IV, 
4253,3470,Gilenya,2016-06-20,2018-08-06, ,mg,['/Month'], ,Lack of efficacy
4254,3856,Methylprednisolone,2016-01-22,,1,mg,[' '], , 
4255,3856,Rebif [44],2016-02-10,, ,mg,['2 / Day'], , 
4256,3856,Endoxan,2015-12-21,2019-06-23, ,mg,['2 / Day'], ,Lack of efficacy
4257,2155,Rebif [22],2016-06-19,, ,mcg,[' '], , 
4258,2155,Copaxone,2016-08-19,,1,mg,['2 / Day'], , 
4259,2155,Rebif [44],2016-05-07,,5000,mg,['2 / Day'],Oral, 
4260,2155,Alemtuzumab (Campath),2016-06-11,2021-08-29,20, ,['3 / Week'],IV,Adverse Event
4261,669,Avonex,2016-09-30,,1,MIU,['2 / Day'],IV, 
4262,2945,Tecfidera,2016-05-13,,300,MIU,['2 / Day'], , 
4263,1281,IVIG,2016-08-18,2019-05-31,1000, ,['/Month'],Oral,Patient Choice/Convenience
4264,1281,D-cure (Vitamine D),2015-12-19,,1000,mg,['/ Day'],IV, 
4265,358,Gilenya,2016-07-22,,5000,MIU,['3 / Week'],IV, 
4266,358,Gilenya,2016-02-17,, ,mg,['3 / Week'],IV, 
4267,358,Alemtuzumab (Campath),2016-07-23,, ,mg,['3 / Week'],Oral, 
4268,358,Methylprednisolone,2016-02-13,2020-07-06,500,MIU,['/Month'], ,Adverse Event
4269,991,Mitoxantrone,2016-09-12,2018-10-29, ,mg,[' '],IV,Lack of efficacy
4270,4542,D-cure (Vitamine D),2016-07-07,, ,mcg,['/Month'],IV, 
4271,4542,Gilenya,2016-02-27,,500,mg,['/ Day'], , 
4272,4542,Mitoxantrone,2016-07-30,, ,mg,['2 / Day'], , 
4273,4542,IVIG,2016-03-24,2018-08-04,1000, ,['3 / Week'],IV,Persisting MRI activity
4274,4225,Endoxan,2016-06-05,2021-02-25, ,mg,['3 / Week'],IV,Patient Choice/Convenience
4275,4842,Mitoxantrone,2016-10-02,2018-09-06, ,mcg,['/Month'], ,Lack of efficacy
4276,4842,Rebif [22],2015-12-20,, ,mg,['3 / Week'],IV, 
4277,2159,Ledertrexaat,2016-05-26,2018-12-08,300,mg,['/Month'], ,Adverse Event
4278,4876,Rebif [44],2016-07-03,,300,mg,['/Month'], , 
4279,4876,Gilenya,2016-04-27,, , ,['/Month'],IV, 
4280,4876,Alemtuzumab (Campath),2016-07-28,2019-07-01,5000,mg,['2 / Day'], ,Adverse Event
4281,4876,Alemtuzumab (Campath),2016-05-06,2020-09-22, ,mg,['/ Day'], ,Lack of efficacy
4282,2185,Rebif [44],2016-07-26,,20, ,['3 / Week'],Oral, 
4283,2185,Tecfidera,2015-11-17,2018-07-02,5000, ,['/Month'],IV,Persisting MRI activity
4284,2185,Endoxan,2016-07-17,2020-09-19,20,mg,['2 / Day'],IV,Adverse Event
4285,3633,IVIG,2016-03-21,, ,mg,['/Month'],IV, 
4286,3633,D-cure (Vitamine D),2016-04-29,, , ,[' '], , 
4287,3633,Alemtuzumab (Campath),2016-05-06,2021-01-03,500, ,[' '],IV,Persisting MRI activity
4288,305,Gilenya,2016-03-19,,300, ,['2 / Day'],IV, 
4289,3577,Copaxone,2016-09-18,,1000, ,['/Month'],IV, 
4290,4462,Betaferon,2015-12-11,, ,mg,['/Month'],IV, 
4291,4462,Tysabri,2015-10-30,2017-12-28, , ,['2 / Day'],Oral,Adverse Event
4292,4462,D-cure (Vitamine D),2016-08-16,2020-08-26, , ,['3 / Week'],IV,Persisting MRI activity
4293,4462,Rebif [44],2016-03-25,2018-03-01,1000,mg,['/Month'], ,Persistence of relapses
4294,1082,Alemtuzumab (Campath),2016-07-09,2021-01-21,20, ,['/Month'], ,Adverse Event
4295,1082,Betaferon,2016-06-06,2021-01-27,5000,mg,['/Month'], ,Patient Choice/Convenience
4296,1287,IVIG,2016-01-13,,300, ,['2 / Day'],IV, 
4297,1287,Endoxan,2016-05-14,, ,mcg,['/ Day'],Oral, 
4298,162,Rebif [44],2015-12-04,2019-06-17, ,mg,['/ Week'], ,Persisting MRI activity
4299,162,Methylprednisolone,2016-10-21,,20, ,['/Month'], , 
4300,162,Tysabri,2016-05-13,2021-01-09, ,mg,['/ Week'],Oral,Adverse Event
4301,2254,Avonex,2016-01-03,2017-11-15,1000,mg,['2 / Day'],Oral,Persistence of relapses
4302,2254,Gilenya,2015-11-11,2021-01-01, ,MIU,['2 / Day'],IV,Lack of efficacy
4303,2254,Avonex,2016-05-28,,20, ,['3 / Week'], , 
4304,301,IVIG,2016-05-06,,1,mg,['/Month'], , 
4305,301,D-cure (Vitamine D),2016-01-06,,300,mg,['/Month'],IV, 
4306,444,Gilenya,2016-07-29,2020-03-26,400, ,[' '], ,Adverse Event
4307,444,Gilenya,2016-06-21,,500, ,[' '],IV, 
4308,444,Alemtuzumab (Campath),2016-03-15,, , ,['/Month'], , 
4309,717,IVIG,2016-04-23,, ,MIU,['/Month'],Oral, 
4310,717,Rebif [44],2016-08-31,,5000,mg,[' '], , 
4311,4743,Tysabri,2016-08-30,2021-07-28,1,MIU,['/Month'], ,Persisting MRI activity
4312,4743,Copaxone,2016-03-27,, ,mg,['/ Day'],IV, 
4313,716,Rebif [22],2016-06-10,, ,mg,['/ Day'],IV, 
4314,716,Tecfidera,2015-11-24,2019-09-06, ,MIU,['/Month'],IV,Patient Choice/Convenience
4315,1508,Endoxan,2015-12-26,,20,mcg,['/Month'],IV, 
4316,1508,Mitoxantrone,2016-07-08,,300, ,[' '],Oral, 
4317,3901,Mitoxantrone,2016-09-08,, ,mg,['/ Week'],IV, 
4318,2270,D-cure (Vitamine D),2016-02-02,2019-08-09,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
4319,2270,Tecfidera,2016-02-27,,1,mg,['2 / Day'], , 
4320,2270,Rebif [44],2016-09-16,2019-02-11,300,MIU,['2 / Day'], ,Persistence of relapses
4321,2027,Alemtuzumab (Campath),2016-02-23,,400,MIU,['2 / Day'],Oral, 
4322,1401,Copaxone,2015-12-30,,500,mcg,['/Month'],IV, 
4323,1477,Methylprednisolone,2016-10-04,, , ,['2 / Day'], , 
4324,1477,Rebif [22],2016-10-04,,1,mg,['/Month'], , 
4325,1477,Methylprednisolone,2016-05-30,,5000, ,['2 / Day'],IV, 
4326,1477,Rebif [22],2015-12-26,,300,mg,['/Month'], , 
4327,4795,Tysabri,2015-11-15,, , ,['2 / Day'],Oral, 
4328,1168,Tysabri,2016-07-28,, ,mg,['2 / Day'],Oral, 
4329,225,Avonex,2016-01-14,2018-03-12,5000, ,['/ Day'], ,Patient Choice/Convenience
4330,225,Betaferon,2016-08-16,2019-01-27,5000, ,['/Month'], ,Lack of efficacy
4331,225,D-cure (Vitamine D),2016-09-14,,5000, ,['/Month'],Oral, 
4332,225,Tysabri,2015-11-16,,500,mg,['2 / Day'],IV, 
4333,4944,IVIG,2016-03-24,2021-01-30, , ,['/ Day'],IV,Persisting MRI activity
4334,3938,Teriflunomide,2016-07-13,2020-10-28,300, ,['2 / Day'],IV,Persisting MRI activity
4335,3938,Alemtuzumab (Campath),2016-09-21,, ,mg,['2 / Day'], , 
4336,4529,IVIG,2016-05-22,, , ,['2 / Day'], , 
4337,4529,D-cure (Vitamine D),2016-01-02,, , ,['/ Week'],IV, 
4338,1581,D-cure (Vitamine D),2016-07-03,,300,mg,['3 / Week'], , 
4339,1581,Gilenya,2016-08-30,2019-10-11,5000, ,[' '],IV,Patient Choice/Convenience
4340,1581,Ledertrexaat,2015-11-19,2017-12-24,1000, ,['2 / Day'],IV,Persisting MRI activity
4341,2101,Rebif [22],2016-09-25,2021-09-18,300, ,['2 / Day'],Oral,Adverse Event
4342,4064,Betaferon,2016-01-16,,5000, ,['/Month'],IV, 
4343,719,Copaxone,2016-03-25,, ,mg,['/ Day'], , 
4344,719,Tecfidera,2016-04-02,,400,mg,['2 / Day'],Oral, 
4345,719,Copaxone,2016-08-30,, ,mg,['/ Week'],IV, 
4346,719,Tysabri,2016-05-09,2020-12-28,300,mg,['/ Day'],Oral,Patient Choice/Convenience
4347,3703,IVIG,2015-11-16,,500, ,[' '], , 
4348,2073,Tecfidera,2016-06-25,2019-09-04,5000, ,['2 / Day'],Oral,Persistence of relapses
4349,2073,Copaxone,2016-02-20,2019-05-28, ,mg,[' '],Oral,Persisting MRI activity
4350,2073,Avonex,2016-07-26,2018-10-18,300,mcg,['3 / Week'], ,Lack of efficacy
4351,2073,D-cure (Vitamine D),2016-07-27,, , ,['2 / Day'],IV, 
4352,4339,Tecfidera,2016-05-05,2019-01-25,400,mg,['/Month'], ,Persisting MRI activity
4353,4339,Methylprednisolone,2016-05-18,,400,mg,[' '], , 
4354,4339,Alemtuzumab (Campath),2015-12-02,2018-12-11,1000, ,['/Month'], ,Persistence of relapses
4355,2054,Alemtuzumab (Campath),2016-03-28,2018-11-04,500, ,['3 / Week'], ,Lack of efficacy
4356,2054,Methylprednisolone,2016-03-29,2018-07-04,500, ,['/ Week'],IV,Patient Choice/Convenience
4357,2054,Avonex,2016-06-09,2018-08-24, , ,['/Month'],IV,Persisting MRI activity
4358,2054,Mitoxantrone,2016-01-08,, ,MIU,['/Month'], , 
4359,3274,Gilenya,2016-06-24,2019-01-17,400, ,['3 / Week'],Oral,Adverse Event
4360,3274,Mitoxantrone,2016-10-18,, ,mg,['2 / Day'],IV, 
4361,3274,D-cure (Vitamine D),2016-03-01,, ,mg,['/Month'], , 
4362,3274,Gilenya,2016-07-02,2021-07-14, ,MIU,['2 / Day'],IV,Adverse Event
4363,3109,Endoxan,2016-02-28,, ,mg,['/Month'], , 
4364,3109,Tysabri,2016-02-29,, , ,[' '],IV, 
4365,3109,Rebif [22],2015-12-14,, , ,['2 / Day'], , 
4366,4959,Gilenya,2016-07-06,,5000, ,['/ Day'], , 
4367,3752,Tecfidera,2016-01-02,,1,mg,['3 / Week'],IV, 
4368,3752,Copaxone,2016-03-16,, , ,['/ Day'],IV, 
4369,564,Methylprednisolone,2016-02-25,,400,mg,['2 / Day'], , 
4370,564,D-cure (Vitamine D),2016-10-08,,5000,mg,['/Month'],IV, 
4371,2209,Betaferon,2016-06-30,2020-03-10,400, ,['2 / Day'],Oral,Patient Choice/Convenience
4372,4686,Gilenya,2016-03-04,, ,mg,['2 / Day'], , 
4373,3181,Teriflunomide,2016-09-08,,300,mcg,['3 / Week'],IV, 
4374,3181,Rebif [22],2016-03-23,2021-01-17,20, ,['/ Week'],IV,Persistence of relapses
4375,4605,Copaxone,2016-09-20,2019-08-19,1,mg,['/ Week'],IV,Adverse Event
4376,4605,Methylprednisolone,2016-03-04,,1,mcg,['2 / Day'], , 
4377,4605,Endoxan,2016-06-17,,500,MIU,['2 / Day'],IV, 
4378,4605,Methylprednisolone,2015-11-30,,500,MIU,['/Month'], , 
4379,670,Gilenya,2016-02-16,2020-06-24,300,mg,['/ Day'],IV,Patient Choice/Convenience
4380,670,Tecfidera,2016-05-28,2021-01-11,500,mg,['3 / Week'], ,Adverse Event
4381,3614,Alemtuzumab (Campath),2016-04-29,2019-08-08,400, ,['/ Day'],IV,Adverse Event
4382,3614,Tecfidera,2015-11-27,2020-11-21, ,mg,['/Month'],IV,Patient Choice/Convenience
4383,3614,Methylprednisolone,2015-11-15,2020-05-17,20,mg,['/ Week'],IV,Lack of efficacy
4384,2112,Endoxan,2015-12-07,,500,mg,['/Month'], , 
4385,2112,Rebif [22],2016-03-03,,1,mg,['/ Day'], , 
4386,132,Gilenya,2016-03-25,,5000,mg,['/ Week'],Oral, 
4387,2274,Copaxone,2016-08-28,,300,mcg,['3 / Week'],IV, 
4388,2274,Rebif [22],2016-10-22,2019-06-27, ,mg,['/ Day'],IV,Adverse Event
4389,2676,D-cure (Vitamine D),2016-03-04,2020-12-19, ,mg,['/ Week'], ,Adverse Event
4390,2676,Avonex,2016-02-14,2019-05-18,1, ,['2 / Day'],Oral,Persisting MRI activity
4391,1959,Gilenya,2016-01-10,,5000, ,['/ Day'],IV, 
4392,1959,IVIG,2015-11-26,2020-01-06,1000,mg,['2 / Day'],IV,Lack of efficacy
4393,1959,Betaferon,2015-12-05,,1, ,['/Month'],IV, 
4394,1959,Tysabri,2016-01-22,,20, ,['/Month'],IV, 
4395,3994,Teriflunomide,2016-08-27,,500,mg,['/Month'], , 
4396,3994,Rebif [44],2016-03-23,,300,mg,['/ Day'], , 
4397,4542,Gilenya,2015-12-01,2021-05-31,500,mcg,['3 / Week'], ,Lack of efficacy
4398,4542,Betaferon,2016-04-05,,500,mg,['/ Day'], , 
4399,4542,Alemtuzumab (Campath),2016-06-21,2020-09-04, , ,['2 / Day'],Oral,Persistence of relapses
4400,2084,Copaxone,2016-04-08,, , ,['2 / Day'],IV, 
4401,2084,Tecfidera,2016-09-04,,500,mg,[' '],IV, 
4402,2084,Gilenya,2016-08-16,,300,mg,['2 / Day'],IV, 
4403,3998,Rebif [22],2016-02-03,2018-03-28,1, ,['/ Week'],IV,Patient Choice/Convenience
4404,1665,Endoxan,2016-07-23,, ,MIU,['/ Week'],Oral, 
4405,1665,Alemtuzumab (Campath),2016-06-10,,5000,mg,['2 / Day'], , 
4406,1665,Teriflunomide,2016-01-20,,5000,mg,['2 / Day'],IV, 
4407,2932,Ledertrexaat,2016-01-10,,500,mg,['2 / Day'],IV, 
4408,3355,Rebif [44],2016-09-10,,500,MIU,['2 / Day'], , 
4409,3355,D-cure (Vitamine D),2016-02-01,2019-03-18,20, ,['2 / Day'],IV,Persisting MRI activity
4410,3355,Endoxan,2016-02-17,2021-10-08,400, ,['2 / Day'], ,Adverse Event
4411,2796,Gilenya,2016-10-17,, , ,['/Month'], , 
4412,2796,Tecfidera,2016-02-12,2020-01-19,500,mg,['2 / Day'],IV,Patient Choice/Convenience
4413,453,Methylprednisolone,2015-11-11,,500, ,['/ Week'],IV, 
4414,453,Alemtuzumab (Campath),2016-05-11,,400,mg,['/ Day'], , 
4415,453,IVIG,2016-04-26,,500,mg,['3 / Week'],IV, 
4416,4773,IVIG,2015-12-14,,20, ,['/Month'], , 
4417,3354,Rebif [22],2016-07-22,,500,MIU,['3 / Week'], , 
4418,3354,Copaxone,2016-05-21,, ,mg,['2 / Day'],IV, 
4419,3354,Avonex,2016-05-23,, ,mg,[' '],IV, 
4420,3354,Endoxan,2016-05-06,,5000,MIU,['/ Week'], , 
4421,4012,Rebif [44],2016-09-29,, ,mg,['2 / Day'],IV, 
4422,4012,Betaferon,2015-12-13,,1, ,['2 / Day'],IV, 
4423,4012,Copaxone,2016-04-07,,1, ,['/Month'],Oral, 
4424,3802,Gilenya,2016-01-03,, , ,['2 / Day'],Oral, 
4425,1118,Tecfidera,2016-03-22,2018-10-24, ,mg,['2 / Day'],IV,Persistence of relapses
4426,1118,D-cure (Vitamine D),2016-03-21,2021-04-11,1000,MIU,['2 / Day'],IV,Adverse Event
4427,1118,IVIG,2016-05-14,2018-08-05,1000,mg,[' '],IV,Persistence of relapses
4428,2568,Methylprednisolone,2015-12-12,, ,mg,[' '], , 
4429,2568,Methylprednisolone,2016-02-13,, ,mg,['2 / Day'],IV, 
4430,2568,Endoxan,2016-07-29,2020-01-01,20,mg,['/Month'], ,Lack of efficacy
4431,4143,Tysabri,2016-03-24,2018-03-21,500,mg,['3 / Week'],IV,Persisting MRI activity
4432,4143,D-cure (Vitamine D),2016-03-24,2018-01-15, ,mg,['3 / Week'],IV,Lack of efficacy
4433,4143,Tysabri,2016-05-11,, , ,['/Month'], , 
4434,4143,Gilenya,2016-07-10,2020-08-17, ,MIU,['/Month'], ,Patient Choice/Convenience
4435,1514,Tecfidera,2016-08-19,2020-01-17, ,mg,['2 / Day'],IV,Patient Choice/Convenience
4436,1514,Copaxone,2016-05-20,2021-05-19,500,mg,[' '],IV,Persisting MRI activity
4437,700,Gilenya,2015-10-30,, ,mg,['/Month'],IV, 
4438,700,IVIG,2016-09-28,,1000,mcg,['2 / Day'],Oral, 
4439,700,Mitoxantrone,2016-09-27,, , ,['/ Day'],IV, 
4440,1368,Tecfidera,2016-10-21,,20,mg,['/ Day'], , 
4441,1368,Tysabri,2016-06-12,, ,mg,['/Month'], , 
4442,1368,IVIG,2016-07-06,2019-12-23,500, ,[' '],IV,Persisting MRI activity
4443,1368,Gilenya,2016-03-10,,300,MIU,['3 / Week'],Oral, 
4444,784,Gilenya,2016-07-31,2020-07-29,5000,mcg,['2 / Day'], ,Adverse Event
4445,784,IVIG,2016-09-23,,300, ,['/ Day'],IV, 
4446,808,Rebif [44],2015-10-29,2019-06-30,1, ,['/ Day'],IV,Persisting MRI activity
4447,808,Teriflunomide,2016-04-02,,5000,mg,['/Month'],IV, 
4448,808,Betaferon,2015-11-02,,20,MIU,['2 / Day'],IV, 
4449,307,Rebif [44],2015-11-10,2021-01-05,1000,mcg,['2 / Day'],IV,Lack of efficacy
4450,4931,Gilenya,2015-10-27,2020-04-14,1, ,['/ Day'],IV,Adverse Event
4451,4931,Tecfidera,2016-06-22,2018-11-14,300, ,['2 / Day'],Oral,Persistence of relapses
4452,4931,Avonex,2015-11-07,,400,mg,['/Month'],IV, 
4453,4931,D-cure (Vitamine D),2016-01-04,,20,MIU,[' '],IV, 
4454,3128,Endoxan,2016-03-30,,300,mg,['/Month'], , 
4455,3128,Betaferon,2016-05-17,2021-10-10, , ,['/Month'], ,Patient Choice/Convenience
4456,3128,Ledertrexaat,2016-08-10,, , ,['3 / Week'], , 
4457,2661,Rebif [44],2016-07-04,2020-11-21, , ,['/Month'],Oral,Adverse Event
4458,2661,D-cure (Vitamine D),2016-07-10,,500,MIU,['2 / Day'], , 
4459,2661,Endoxan,2016-08-03,,20,MIU,[' '], , 
4460,3209,Methylprednisolone,2015-11-25,2019-03-08,20, ,[' '], ,Patient Choice/Convenience
4461,3209,Gilenya,2016-09-03,2019-04-10,5000, ,['/Month'],IV,Persistence of relapses
4462,3209,Copaxone,2016-10-01,2017-12-17,20,mcg,['/ Day'],IV,Patient Choice/Convenience
4463,3209,Rebif [44],2016-09-29,2021-10-11, ,mg,['3 / Week'], ,Persistence of relapses
4464,4068,Methylprednisolone,2016-03-30,2019-06-03,500,MIU,['/Month'],Oral,Adverse Event
4465,4068,IVIG,2015-11-08,,500,mg,[' '],IV, 
4466,4068,Ledertrexaat,2016-07-12,2021-03-15,20,mg,['/Month'], ,Persisting MRI activity
4467,3555,D-cure (Vitamine D),2016-02-17,,300,mg,['/ Day'], , 
4468,3555,Tecfidera,2016-04-26,,20, ,['3 / Week'],IV, 
4469,3555,Betaferon,2015-10-25,,1000,mg,['2 / Day'],Oral, 
4470,3555,Methylprednisolone,2016-10-16,,500,mg,['3 / Week'], , 
4471,394,IVIG,2016-09-03,, ,mg,['/Month'],Oral, 
4472,394,Methylprednisolone,2016-03-15,, ,MIU,['/Month'], , 
4473,394,Ledertrexaat,2016-03-12,2019-03-26,5000,mg,['/Month'],Oral,Persisting MRI activity
4474,394,Methylprednisolone,2015-12-20,2020-09-12,1000,MIU,['/Month'],IV,Lack of efficacy
4475,212,Avonex,2016-07-31,2019-03-29, ,MIU,['/Month'],IV,Persisting MRI activity
4476,212,Alemtuzumab (Campath),2016-02-21,,500,mg,['/Month'],Oral, 
4477,212,Alemtuzumab (Campath),2016-03-24,, , ,['2 / Day'], , 
4478,212,Ledertrexaat,2016-03-19,,300,mg,['2 / Day'],IV, 
4479,2992,IVIG,2015-11-20,2020-07-31,500,mg,['2 / Day'],IV,Adverse Event
4480,2992,D-cure (Vitamine D),2016-04-26,,1000,mg,['/ Week'], , 
4481,2992,Copaxone,2016-06-01,2020-12-30, ,mg,['2 / Day'], ,Persistence of relapses
4482,1936,Alemtuzumab (Campath),2016-03-18,2018-05-11,500, ,['/ Day'], ,Persisting MRI activity
4483,1936,Gilenya,2016-03-24,2017-10-31,500,mg,['2 / Day'], ,Adverse Event
4484,1936,Rebif [22],2016-01-19,,400,mg,['3 / Week'],IV, 
4485,1936,Tecfidera,2016-06-05,2018-08-24,5000, ,['2 / Day'],IV,Persistence of relapses
4486,1515,Tysabri,2015-12-19,2021-01-24,300,mg,['2 / Day'],Oral,Persisting MRI activity
4487,1515,Avonex,2015-11-11,,20, ,['3 / Week'],IV, 
4488,3299,D-cure (Vitamine D),2016-01-11,2020-12-10,400, ,['2 / Day'], ,Lack of efficacy
4489,3770,Copaxone,2015-12-05,2018-09-25,1,MIU,['/Month'], ,Adverse Event
4490,3770,Avonex,2016-08-30,2018-06-23,1,mg,['/ Day'], ,Adverse Event
4491,2286,IVIG,2015-12-28,,20, ,['/ Day'],IV, 
4492,2139,Betaferon,2016-06-22,, ,MIU,['/ Day'],IV, 
4493,2139,Endoxan,2016-02-22,,20,mg,[' '],IV, 
4494,2139,Tysabri,2016-04-26,,500, ,['2 / Day'],IV, 
4495,2139,Rebif [44],2016-04-17,, ,MIU,[' '],IV, 
4496,4592,Betaferon,2016-03-30,2019-04-09,1, ,['2 / Day'], ,Persistence of relapses
4497,4592,Avonex,2015-11-14,,400,mcg,[' '],IV, 
4498,4592,Tysabri,2016-02-20,, , ,['3 / Week'], , 
4499,4592,Tysabri,2015-12-13,, , ,[' '],IV, 
4500,1421,Copaxone,2016-07-04,2018-06-19,300,mg,['2 / Day'], ,Adverse Event
4501,1421,Endoxan,2016-08-08,, ,mg,['2 / Day'],Oral, 
4502,882,Rebif [22],2016-03-27,2020-03-31, , ,['2 / Day'],IV,Lack of efficacy
4503,1455,Gilenya,2016-07-14,,20, ,['/ Day'], , 
4504,1455,D-cure (Vitamine D),2015-12-29,2019-01-02,1000,mg,['2 / Day'],IV,Lack of efficacy
4505,1455,Rebif [22],2016-07-04,2021-09-08,1000,mg,['/Month'],IV,Persistence of relapses
4506,1455,Rebif [44],2016-08-21,,500, ,['/Month'],IV, 
4507,2617,D-cure (Vitamine D),2016-02-20,2020-01-06,1, ,['2 / Day'],IV,Adverse Event
4508,2617,Rebif [44],2016-08-25,,20,mg,['2 / Day'],IV, 
4509,2617,Methylprednisolone,2016-07-08,,1000, ,['/Month'],IV, 
4510,4166,Teriflunomide,2016-04-02,, ,mg,['3 / Week'], , 
4511,4166,Copaxone,2015-12-23,2021-09-15,5000,mcg,[' '],IV,Persisting MRI activity
4512,4166,Teriflunomide,2016-06-24,2020-07-21, ,mg,['3 / Week'],IV,Persisting MRI activity
4513,4166,Gilenya,2016-07-30,2018-12-04,500,mg,[' '],IV,Persisting MRI activity
4514,3157,Copaxone,2016-05-24,,500, ,['2 / Day'], , 
4515,3157,Copaxone,2016-04-09,,20,mg,['/Month'],IV, 
4516,3157,IVIG,2016-02-04,, ,mg,['/ Day'], , 
4517,3157,Teriflunomide,2015-11-08,, , ,['/Month'],IV, 
4518,949,Ledertrexaat,2016-03-12,2018-06-19,500,mg,['/ Day'],IV,Adverse Event
4519,949,Rebif [22],2016-06-10,, ,MIU,['2 / Day'],IV, 
4520,949,Rebif [22],2016-02-06,,500, ,['2 / Day'], , 
4521,757,Alemtuzumab (Campath),2016-09-04,,1000, ,['3 / Week'],IV, 
4522,757,Rebif [44],2015-11-13,,5000,mg,['3 / Week'], , 
4523,757,Tecfidera,2016-04-20,,1, ,['/Month'], , 
4524,757,Methylprednisolone,2016-07-09,2019-06-26,5000,MIU,['2 / Day'],IV,Adverse Event
4525,3451,D-cure (Vitamine D),2016-03-31,,400,mg,['2 / Day'],IV, 
4526,3451,Tysabri,2016-09-23,, ,mg,['/Month'], , 
4527,3451,Tecfidera,2015-12-02,,300,mg,['/Month'],IV, 
4528,3031,Copaxone,2016-09-21,2020-09-21,500, ,['3 / Week'], ,Patient Choice/Convenience
4529,3031,IVIG,2016-06-23,,500,mg,['3 / Week'],IV, 
4530,3031,Gilenya,2016-04-07,2018-10-21,20, ,['/Month'],IV,Adverse Event
4531,3633,Tecfidera,2016-01-13,2019-08-13, ,mcg,['3 / Week'],IV,Patient Choice/Convenience
4532,3633,Tysabri,2016-10-07,,400, ,['/Month'], , 
4533,979,Tecfidera,2015-11-18,2021-02-06, ,mg,['/ Week'],IV,Persisting MRI activity
4534,979,Tecfidera,2016-01-05,2019-12-19, ,mg,[' '], ,Persistence of relapses
4535,979,Rebif [22],2016-10-01,, , ,['2 / Day'], , 
4536,3808,Tecfidera,2016-06-26,, ,mg,['/ Day'],IV, 
4537,3530,Avonex,2015-11-14,,1000,mg,['/ Week'],IV, 
4538,3530,IVIG,2016-05-13,,1, ,['/ Day'],IV, 
4539,3530,Copaxone,2016-01-04,,500,mg,['/Month'],IV, 
4540,3530,Betaferon,2016-03-14,,1000,mg,['/ Day'], , 
4541,4069,Tysabri,2016-08-19,,1,mg,['/ Day'], , 
4542,4069,Tecfidera,2016-06-12,,1000,mg,['2 / Day'],IV, 
4543,4069,Copaxone,2016-10-10,,5000,MIU,['2 / Day'],IV, 
4544,4069,Methylprednisolone,2016-04-12,2018-02-06,20,mg,[' '], ,Persisting MRI activity
4545,224,Ledertrexaat,2016-07-04,2020-04-11,400, ,[' '], ,Adverse Event
4546,224,Avonex,2016-04-24,, ,mcg,['/Month'], , 
4547,224,D-cure (Vitamine D),2016-05-06,, ,mg,['2 / Day'],Oral, 
4548,2165,Avonex,2016-06-03,,5000,MIU,[' '],IV, 
4549,1656,Methylprednisolone,2016-05-28,,300,mg,['/Month'], , 
4550,2198,IVIG,2016-01-11,, ,MIU,['/Month'], , 
4551,2549,D-cure (Vitamine D),2016-09-02,,1000,mcg,['/ Week'],IV, 
4552,2549,Methylprednisolone,2016-09-04,2021-06-15,300,mg,['/ Day'], ,Lack of efficacy
4553,3392,Ledertrexaat,2016-02-29,2018-06-28,500, ,['/Month'], ,Lack of efficacy
4554,3392,Endoxan,2016-06-23,,1,mg,['/Month'], , 
4555,3392,Avonex,2016-04-09,,5000, ,['2 / Day'], , 
4556,3392,Methylprednisolone,2015-11-09,,5000,mg,[' '],IV, 
4557,1491,IVIG,2016-01-28,,400, ,['2 / Day'], , 
4558,1491,Tysabri,2016-06-19,,5000,mg,['/ Week'],IV, 
4559,1760,Teriflunomide,2016-08-30,2019-02-12, , ,['/Month'], ,Lack of efficacy
4560,1760,Mitoxantrone,2016-03-01,,5000, ,['/Month'],IV, 
4561,1372,Methylprednisolone,2016-06-12,2021-02-22,400,mg,['2 / Day'], ,Adverse Event
4562,1372,Tecfidera,2015-11-26,2019-02-05,1,mcg,['2 / Day'], ,Patient Choice/Convenience
4563,4380,D-cure (Vitamine D),2016-09-05,,300, ,['2 / Day'], , 
4564,4380,Ledertrexaat,2016-03-15,,20, ,['2 / Day'], , 
4565,4380,Rebif [22],2016-01-30,2018-06-17,20,mcg,['2 / Day'], ,Patient Choice/Convenience
4566,4380,Copaxone,2016-09-02,,500,mg,['2 / Day'], , 
4567,1317,Teriflunomide,2016-01-20,, , ,['/Month'],IV, 
4568,295,Endoxan,2016-07-28,,1, ,['2 / Day'],IV, 
4569,295,Copaxone,2015-12-21,, ,MIU,['2 / Day'], , 
4570,2063,IVIG,2015-12-01,, , ,['3 / Week'],IV, 
4571,2698,Teriflunomide,2016-01-14,2021-03-11,300,mg,['/Month'],IV,Adverse Event
4572,2698,Tecfidera,2016-05-10,, , ,[' '],Oral, 
4573,2698,Avonex,2016-04-09,, , ,['2 / Day'],IV, 
4574,2698,Rebif [44],2016-04-02,2019-11-06,400,mcg,[' '],Oral,Persisting MRI activity
4575,2874,Ledertrexaat,2016-05-08,2021-03-09, ,mg,[' '], ,Patient Choice/Convenience
4576,4148,Methylprednisolone,2016-09-23,,1000, ,['2 / Day'],IV, 
4577,4148,Tecfidera,2015-12-15,, ,mg,['/ Week'],Oral, 
4578,4148,Mitoxantrone,2016-02-12,, ,mg,['/Month'],IV, 
4579,4148,Gilenya,2016-06-15,2019-05-15, ,mg,['2 / Day'],IV,Adverse Event
4580,175,Methylprednisolone,2016-01-17,,500, ,['3 / Week'], , 
4581,3048,Methylprednisolone,2016-03-03,, ,mg,['/Month'],IV, 
4582,3470,Tysabri,2016-08-15,, ,mg,['3 / Week'],IV, 
4583,3470,D-cure (Vitamine D),2016-03-09,,5000, ,[' '],Oral, 
4584,3185,Rebif [44],2016-05-10,2020-06-24,500,mg,['/Month'],IV,Adverse Event
4585,2473,D-cure (Vitamine D),2016-04-16,, , ,['/Month'], , 
4586,2293,Tysabri,2016-05-26,, , ,[' '],IV, 
4587,626,IVIG,2016-02-24,,1, ,['/ Day'], , 
4588,626,Avonex,2016-06-02,,1, ,['/ Day'],IV, 
4589,4174,Tysabri,2016-06-03,2019-02-21,300,mg,['2 / Day'],IV,Persisting MRI activity
4590,4174,D-cure (Vitamine D),2015-12-11,,1000, ,['/Month'],IV, 
4591,4174,Betaferon,2016-08-26,2017-12-30, , ,['/ Day'], ,Adverse Event
4592,2687,Endoxan,2016-05-13,,500,mg,['/ Day'],Oral, 
4593,2687,Gilenya,2016-06-01,2019-06-06, ,mg,['3 / Week'], ,Patient Choice/Convenience
4594,2687,Tysabri,2015-11-04,2018-04-19,500,mg,['2 / Day'], ,Lack of efficacy
4595,3169,D-cure (Vitamine D),2015-11-08,,1, ,['/ Week'], , 
4596,3169,Gilenya,2015-11-11,2021-07-12,400,mg,['2 / Day'],IV,Adverse Event
4597,3169,Tysabri,2016-10-12,2019-02-11,5000,mg,['3 / Week'],Oral,Lack of efficacy
4598,3671,Copaxone,2016-02-12,,1, ,['/Month'],IV, 
4599,3218,Methylprednisolone,2016-09-20,,500,mg,['3 / Week'],IV, 
4600,198,Gilenya,2016-06-05,,1000, ,['2 / Day'],Oral, 
4601,198,Endoxan,2016-03-29,, , ,['/Month'],IV, 
4602,1784,Rebif [44],2016-01-07,,5000,mg,['2 / Day'],IV, 
4603,1784,D-cure (Vitamine D),2016-01-21,2021-06-26,1000, ,['/Month'],IV,Persisting MRI activity
4604,4657,Tysabri,2016-04-25,,1000, ,[' '], , 
4605,4657,Endoxan,2016-07-02,2021-01-05,500,mg,['/Month'],IV,Adverse Event
4606,4657,Tecfidera,2016-08-18,2018-11-22, , ,['2 / Day'],IV,Adverse Event
4607,4657,Methylprednisolone,2016-02-12,, ,MIU,['/ Week'],IV, 
4608,4854,Tecfidera,2016-02-08,,1,mg,['2 / Day'], , 
4609,4854,D-cure (Vitamine D),2016-06-21,2020-05-06, , ,['2 / Day'],IV,Adverse Event
4610,4854,Alemtuzumab (Campath),2015-11-29,2018-09-27, , ,['/Month'], ,Lack of efficacy
4611,4854,Tecfidera,2016-04-06,2019-04-01, ,MIU,['3 / Week'], ,Patient Choice/Convenience
4612,4972,Methylprednisolone,2016-05-30,, ,mg,['2 / Day'],IV, 
4613,4972,IVIG,2016-06-20,2018-10-13,400,mg,['/Month'], ,Patient Choice/Convenience
4614,1566,Teriflunomide,2016-05-14,2019-10-15, ,mg,['/Month'], ,Patient Choice/Convenience
4615,1566,Tecfidera,2016-08-27,,20, ,['/ Day'], , 
4616,1566,D-cure (Vitamine D),2016-07-29,, , ,['2 / Day'],Oral, 
4617,1566,Gilenya,2016-07-04,,300, ,['2 / Day'],IV, 
4618,1807,D-cure (Vitamine D),2016-03-30,,1,mg,['2 / Day'],IV, 
4619,296,Endoxan,2016-02-10,2019-03-07,20, ,['/ Day'],IV,Patient Choice/Convenience
4620,296,Rebif [44],2016-07-31,,500,mg,['2 / Day'],IV, 
4621,296,Betaferon,2016-02-20,, ,MIU,['/Month'],IV, 
4622,4767,D-cure (Vitamine D),2016-01-14,2021-08-30,500,MIU,['3 / Week'],IV,Patient Choice/Convenience
4623,4767,Tysabri,2015-12-22,, ,mg,['2 / Day'],IV, 
4624,701,Copaxone,2016-05-23,2019-05-17,500, ,['/Month'],IV,Lack of efficacy
4625,4505,Endoxan,2015-12-25,2019-01-12,300,mg,['2 / Day'],IV,Persisting MRI activity
4626,4505,Tysabri,2016-01-28,2020-07-07,300,mg,[' '], ,Lack of efficacy
4627,4505,Endoxan,2015-10-24,2021-02-07,5000, ,['/Month'], ,Persistence of relapses
4628,4505,D-cure (Vitamine D),2015-11-03,2020-08-06,1000,mg,[' '], ,Persisting MRI activity
4629,1874,D-cure (Vitamine D),2016-06-02,, , ,['2 / Day'],IV, 
4630,1874,Alemtuzumab (Campath),2016-09-01,,20, ,['/Month'],IV, 
4631,1874,Mitoxantrone,2016-04-04,, ,mg,[' '], , 
4632,4376,Tysabri,2016-05-21,, ,mg,['/Month'], , 
4633,1831,IVIG,2016-05-24,2021-10-03, , ,['/Month'], ,Adverse Event
4634,1831,Mitoxantrone,2016-05-26,,5000, ,['2 / Day'],IV, 
4635,1831,Methylprednisolone,2016-07-12,,1,mg,['2 / Day'], , 
4636,4994,Copaxone,2015-12-15,,500,mg,['2 / Day'],IV, 
4637,4994,D-cure (Vitamine D),2016-10-20,,1000,mg,[' '],Oral, 
4638,3039,Copaxone,2016-05-23,,400, ,['2 / Day'], , 
4639,3039,D-cure (Vitamine D),2016-05-29,,5000, ,['2 / Day'], , 
4640,2045,IVIG,2015-10-24,,1,mg,['/Month'],IV, 
4641,2045,Gilenya,2016-01-07,2020-02-15, , ,['2 / Day'], ,Persistence of relapses
4642,2045,Copaxone,2016-08-21,,5000,mg,['2 / Day'],IV, 
4643,2045,IVIG,2016-09-19,,20, ,['/Month'], , 
4644,195,Rebif [22],2015-11-07,,5000, ,['/Month'],IV, 
4645,2915,Alemtuzumab (Campath),2016-07-21,2019-02-28,500, ,['2 / Day'],IV,Persisting MRI activity
4646,3263,IVIG,2016-10-06,, ,mg,['2 / Day'],IV, 
4647,3263,Tysabri,2016-03-11,,5000,mg,['2 / Day'],IV, 
4648,3263,D-cure (Vitamine D),2015-11-15,,400, ,['2 / Day'],IV, 
4649,4386,D-cure (Vitamine D),2016-04-30,, ,mg,['/ Week'], , 
4650,4386,Alemtuzumab (Campath),2015-11-14,,20, ,['2 / Day'],IV, 
4651,4386,Rebif [44],2016-08-07,2021-04-19,500,mcg,['2 / Day'],IV,Patient Choice/Convenience
4652,4386,Methylprednisolone,2016-10-06,2021-08-02,1,MIU,['/Month'], ,Patient Choice/Convenience
4653,2719,Tysabri,2016-06-27,, ,mg,['2 / Day'], , 
4654,2719,Endoxan,2016-10-16,2021-03-13,20, ,['2 / Day'],IV,Lack of efficacy
4655,743,Avonex,2016-08-21,,5000,mcg,['/Month'],IV, 
4656,743,Mitoxantrone,2016-05-03,,5000,mcg,['2 / Day'],Oral, 
4657,3454,Gilenya,2016-03-25,,500,mg,['/ Week'],IV, 
4658,3454,Copaxone,2016-06-13,,1000,mg,[' '],Oral, 
4659,3677,Teriflunomide,2016-09-21,,300,mg,['/Month'], , 
4660,3677,Tysabri,2015-11-18,,1,mcg,[' '],IV, 
4661,3677,Tecfidera,2016-01-09,2017-12-13,500,mg,['3 / Week'],IV,Patient Choice/Convenience
4662,1272,Tysabri,2016-09-14,2021-09-27, ,mg,['2 / Day'], ,Persistence of relapses
4663,1272,Tecfidera,2016-01-23,,500,mg,['/Month'], , 
4664,1272,Avonex,2016-06-23,, ,mg,['/ Day'], , 
4665,3518,Alemtuzumab (Campath),2016-01-22,,20,mcg,['3 / Week'],IV, 
4666,3518,Gilenya,2016-04-20,, , ,['2 / Day'],IV, 
4667,3518,Tysabri,2015-12-09,,20, ,['/Month'],IV, 
4668,3518,Endoxan,2016-03-29,,5000, ,['3 / Week'],IV, 
4669,1206,Rebif [44],2015-10-29,2019-04-01,300,mg,['2 / Day'],IV,Adverse Event
4670,1206,D-cure (Vitamine D),2016-01-27,2021-08-01, , ,['2 / Day'],IV,Persisting MRI activity
4671,1413,Avonex,2016-04-10,, ,MIU,[' '],IV, 
4672,1413,Tecfidera,2015-11-21,,300,MIU,['/ Week'],IV, 
4673,1413,Betaferon,2015-12-05,, ,mg,['/Month'],Oral, 
4674,443,IVIG,2016-04-06,,1000,mg,['3 / Week'], , 
4675,443,Tysabri,2016-02-22,2019-07-20,400, ,['/Month'],IV,Adverse Event
4676,119,Copaxone,2016-10-17,,5000,mg,['2 / Day'],IV, 
4677,119,Methylprednisolone,2016-01-12,2019-03-21,1000,MIU,['2 / Day'], ,Patient Choice/Convenience
4678,2016,D-cure (Vitamine D),2016-07-11,,5000,mg,['2 / Day'],IV, 
4679,885,Mitoxantrone,2016-02-24,2019-09-30,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
4680,885,Tysabri,2016-03-15,2019-02-28, ,mg,['/Month'],IV,Persisting MRI activity
4681,885,Betaferon,2016-10-17,, , ,['2 / Day'], , 
4682,885,Alemtuzumab (Campath),2015-12-17,2018-02-05,300, ,['2 / Day'], ,Adverse Event
4683,4386,Teriflunomide,2016-03-12,,400, ,['/Month'],IV, 
4684,279,Avonex,2015-11-26,, ,mg,['/ Day'],Oral, 
4685,279,Alemtuzumab (Campath),2015-11-04,2018-03-04,300, ,['/ Day'],IV,Persistence of relapses
4686,279,Tysabri,2016-03-05,2019-11-04, ,MIU,['2 / Day'], ,Patient Choice/Convenience
4687,3437,IVIG,2015-11-08,, ,mg,['/ Week'],IV, 
4688,3437,Betaferon,2016-07-18,, ,mg,['3 / Week'],Oral, 
4689,3437,Methylprednisolone,2016-05-21,2021-09-11,1,MIU,['/Month'],IV,Adverse Event
4690,3437,Endoxan,2016-09-18,2020-03-31,400,mg,['/ Day'],IV,Patient Choice/Convenience
4691,2248,IVIG,2015-12-21,2018-06-27, , ,['2 / Day'],IV,Adverse Event
4692,2248,Gilenya,2015-12-27,2019-07-30,5000, ,['3 / Week'], ,Persistence of relapses
4693,2248,Gilenya,2016-05-20,,500,mg,['2 / Day'],IV, 
4694,2248,Copaxone,2015-11-30,2019-04-05,1000,MIU,['/ Week'], ,Adverse Event
4695,3959,Tecfidera,2016-09-11,2019-09-30,5000, ,['3 / Week'], ,Patient Choice/Convenience
4696,3959,D-cure (Vitamine D),2015-11-23,,5000, ,['/Month'],IV, 
4697,3959,D-cure (Vitamine D),2016-10-15,, ,mcg,['/ Day'],IV, 
4698,3959,Betaferon,2016-05-20,,300,mg,[' '],IV, 
4699,1447,IVIG,2016-06-14,2018-07-21,20,mcg,[' '],IV,Patient Choice/Convenience
4700,1447,Betaferon,2016-09-16,,500,mg,['/ Week'],IV, 
4701,1447,Ledertrexaat,2015-12-20,,20, ,['/Month'],IV, 
4702,1447,Copaxone,2015-11-11,,300,mg,['2 / Day'],IV, 
4703,1062,Avonex,2016-02-02,,1000,mg,['2 / Day'], , 
4704,4152,Alemtuzumab (Campath),2016-05-30,,300, ,['/Month'],IV, 
4705,4152,Tysabri,2016-06-21,2019-03-12,5000, ,['3 / Week'],IV,Persisting MRI activity
4706,4152,Endoxan,2016-02-17,2021-04-29,500, ,['/ Day'],Oral,Lack of efficacy
4707,4152,Gilenya,2016-01-25,2021-01-05, , ,['2 / Day'], ,Adverse Event
4708,1787,Endoxan,2016-08-03,2019-04-18,500,mg,['/Month'], ,Persistence of relapses
4709,1787,Tysabri,2015-12-03,,1000,MIU,['/Month'],IV, 
4710,1787,Rebif [22],2016-03-26,, ,mg,[' '],Oral, 
4711,3438,Betaferon,2016-06-24,2020-09-29,500,mg,['/Month'],IV,Lack of efficacy
4712,3438,Alemtuzumab (Campath),2015-12-12,2019-06-26,500,mg,['/ Day'],IV,Patient Choice/Convenience
4713,3438,Avonex,2016-10-18,2018-05-10,300, ,['2 / Day'], ,Lack of efficacy
4714,3438,Betaferon,2015-11-19,,500,MIU,['2 / Day'],IV, 
4715,4191,IVIG,2016-02-22,2021-01-15,500,mg,['2 / Day'], ,Lack of efficacy
4716,4191,Rebif [22],2016-03-28,,20,mg,['2 / Day'],IV, 
4717,1136,Mitoxantrone,2016-05-11,,1000,mg,['/ Day'], , 
4718,1136,Alemtuzumab (Campath),2016-09-20,,400, ,['/Month'],IV, 
4719,1136,Endoxan,2016-08-26,2021-05-23, ,mcg,['/Month'], ,Lack of efficacy
4720,4734,D-cure (Vitamine D),2015-12-16,2020-12-16,5000,mcg,[' '], ,Adverse Event
4721,4734,Copaxone,2016-01-04,, ,mcg,['/Month'], , 
4722,4734,Betaferon,2016-02-13,2018-05-17, ,mg,['/Month'],IV,Lack of efficacy
4723,4734,Methylprednisolone,2015-10-28,2019-03-20,20,mg,[' '],IV,Persisting MRI activity
4724,2647,Betaferon,2016-09-04,,500, ,['/Month'],IV, 
4725,2647,Alemtuzumab (Campath),2015-11-25,,5000,MIU,['/Month'], , 
4726,2647,Mitoxantrone,2016-08-22,2020-05-01,5000, ,['/Month'],IV,Persistence of relapses
4727,2647,Methylprednisolone,2015-12-14,, ,mcg,['/ Day'], , 
4728,4634,Tysabri,2016-08-10,,400,mg,['/ Week'], , 
4729,639,Rebif [44],2016-08-29,, ,mg,['/Month'],IV, 
4730,639,Methylprednisolone,2016-07-22,, ,MIU,['/ Week'],IV, 
4731,639,Alemtuzumab (Campath),2015-12-01,2020-11-30,400,mg,['/ Week'],IV,Persisting MRI activity
4732,515,Mitoxantrone,2016-06-13,2018-06-26,500,mg,[' '],Oral,Persisting MRI activity
4733,515,Rebif [22],2016-01-01,, , ,['2 / Day'],IV, 
4734,515,Betaferon,2016-05-27,,400,mg,['2 / Day'],IV, 
4735,1087,Gilenya,2016-05-20,, ,mg,['3 / Week'],IV, 
4736,1087,Alemtuzumab (Campath),2016-09-28,,400,mg,['2 / Day'],IV, 
4737,1087,Tecfidera,2016-10-02,2018-05-04, ,mg,['/ Week'],IV,Persistence of relapses
4738,594,Tecfidera,2016-04-24,,300,mg,['/ Day'], , 
4739,981,Endoxan,2015-12-04,, ,MIU,['2 / Day'],IV, 
4740,981,Teriflunomide,2016-07-07,, ,MIU,['2 / Day'], , 
4741,981,Endoxan,2016-07-07,,5000, ,['3 / Week'],IV, 
4742,981,Methylprednisolone,2016-07-06,,1000,MIU,['2 / Day'], , 
4743,1344,Rebif [22],2016-04-13,, , ,[' '], , 
4744,1344,Endoxan,2016-07-18,2018-09-25,500,mg,['3 / Week'], ,Persisting MRI activity
4745,3999,D-cure (Vitamine D),2016-02-03,2021-06-11,400, ,['2 / Day'],IV,Patient Choice/Convenience
4746,3999,Rebif [44],2016-02-26,, , ,['3 / Week'], , 
4747,190,Tecfidera,2016-07-02,2020-01-07,500, ,['3 / Week'], ,Lack of efficacy
4748,190,Gilenya,2016-10-14,,1,mg,['/Month'],Oral, 
4749,190,Gilenya,2016-02-19,2020-01-22, ,mg,['2 / Day'], ,Patient Choice/Convenience
4750,4858,D-cure (Vitamine D),2016-09-25,2019-09-24,1,mg,['2 / Day'],IV,Adverse Event
4751,4858,Teriflunomide,2016-03-01,2021-04-08,5000,mg,['2 / Day'], ,Lack of efficacy
4752,4858,Alemtuzumab (Campath),2015-11-22,,300,MIU,[' '],Oral, 
4753,4858,Ledertrexaat,2016-01-12,, ,mg,['/ Day'],IV, 
4754,323,Rebif [22],2015-11-08,,5000,MIU,['/Month'],IV, 
4755,323,Avonex,2016-07-24,,1,MIU,['2 / Day'], , 
4756,323,Tecfidera,2016-04-29,,5000, ,['/Month'],IV, 
4757,2439,Copaxone,2015-12-07,2021-05-01, , ,[' '], ,Patient Choice/Convenience
4758,4218,Rebif [22],2016-07-25,2021-08-19, , ,['2 / Day'], ,Adverse Event
4759,4218,Rebif [22],2016-02-24,2018-05-26,1000, ,['/Month'],Oral,Lack of efficacy
4760,3871,Endoxan,2016-08-24,,500,mcg,['2 / Day'],IV, 
4761,2329,Mitoxantrone,2016-07-18,,20,mg,['2 / Day'],IV, 
4762,2329,Endoxan,2016-02-01,, ,mg,['3 / Week'],IV, 
4763,1409,D-cure (Vitamine D),2016-10-17,2019-11-19,300,MIU,['/Month'],IV,Lack of efficacy
4764,3195,Gilenya,2015-11-08,2019-08-17, , ,['/Month'],IV,Persistence of relapses
4765,3195,Tecfidera,2016-03-27,,5000, ,['2 / Day'],IV, 
4766,3195,Betaferon,2016-10-14,2017-12-08,1, ,['/ Day'], ,Patient Choice/Convenience
4767,3195,Avonex,2016-09-30,,5000,mg,['3 / Week'], , 
4768,2392,Gilenya,2015-11-29,,5000, ,['3 / Week'],IV, 
4769,2392,IVIG,2016-05-26,,500, ,['2 / Day'],IV, 
4770,2392,IVIG,2016-10-10,2020-07-29,1000, ,['/ Week'], ,Persisting MRI activity
4771,2392,D-cure (Vitamine D),2015-10-24,2018-05-31, , ,['2 / Day'],IV,Patient Choice/Convenience
4772,1185,Endoxan,2016-04-14,,20,MIU,['3 / Week'], , 
4773,4370,Tysabri,2016-04-16,2018-07-02,500, ,['/Month'],IV,Persisting MRI activity
4774,4370,D-cure (Vitamine D),2016-03-01,2019-01-02,1000, ,['2 / Day'],IV,Patient Choice/Convenience
4775,4370,Rebif [44],2016-09-22,, , ,['2 / Day'], , 
4776,4370,Tysabri,2016-07-08,2019-12-20, , ,[' '],Oral,Persistence of relapses
4777,4412,IVIG,2015-12-26,2020-10-29, , ,['/Month'], ,Persisting MRI activity
4778,4412,Endoxan,2016-02-12,,20, ,['3 / Week'], , 
4779,150,IVIG,2016-03-03,,500,mg,['3 / Week'], , 
4780,150,Rebif [44],2016-05-29,,300, ,['/Month'],IV, 
4781,3703,Endoxan,2016-08-05,,20,mg,['2 / Day'],IV, 
4782,3703,Avonex,2015-12-31,2021-08-01,20,mg,['2 / Day'],IV,Patient Choice/Convenience
4783,3703,Teriflunomide,2016-03-17,2020-09-17,300,mg,['2 / Day'],IV,Adverse Event
4784,3703,Gilenya,2015-11-10,,400,MIU,['/Month'],IV, 
4785,4365,Rebif [22],2016-03-08,, , ,['3 / Week'], , 
4786,4365,Mitoxantrone,2016-04-07,, ,mg,['/Month'], , 
4787,4365,Avonex,2016-02-27,2018-09-16,500, ,['/ Week'],IV,Patient Choice/Convenience
4788,4891,Alemtuzumab (Campath),2016-03-12,, ,mg,['/ Day'],Oral, 
4789,2902,D-cure (Vitamine D),2016-05-17,2018-05-29, ,MIU,['2 / Day'], ,Persistence of relapses
4790,344,Avonex,2015-11-14,,500,mg,['/ Day'],IV, 
4791,4897,Tysabri,2016-08-03,,20, ,['/Month'], , 
4792,4897,Teriflunomide,2016-01-03,2021-07-12,300,MIU,['2 / Day'], ,Adverse Event
4793,4897,Alemtuzumab (Campath),2016-10-18,, , ,['2 / Day'],IV, 
4794,1721,Tysabri,2016-06-07,,300, ,['3 / Week'],IV, 
4795,1721,Tecfidera,2016-09-19,,500,mg,['3 / Week'], , 
4796,700,Copaxone,2015-11-04,2020-01-28,500, ,['2 / Day'],IV,Persistence of relapses
4797,700,IVIG,2016-08-25,2019-05-19,500, ,['3 / Week'], ,Patient Choice/Convenience
4798,700,IVIG,2016-03-21,2020-08-01, , ,['/Month'], ,Lack of efficacy
4799,3856,Methylprednisolone,2016-06-02,,1000,mg,['/ Day'],Oral, 
4800,2102,Alemtuzumab (Campath),2016-04-22,,20, ,['2 / Day'],Oral, 
4801,1096,Avonex,2016-01-10,,20,mg,['/Month'], , 
4802,1096,Tysabri,2016-01-15,,20,mg,['2 / Day'], , 
4803,4672,Ledertrexaat,2015-12-20,,500, ,[' '], , 
4804,4672,Alemtuzumab (Campath),2015-12-10,2020-11-19,1, ,['/Month'],IV,Adverse Event
4805,4672,Methylprednisolone,2016-04-13,2020-10-20,300, ,['3 / Week'],IV,Adverse Event
4806,596,D-cure (Vitamine D),2016-01-23,2020-09-21,20,mcg,['2 / Day'], ,Persisting MRI activity
4807,596,Gilenya,2016-06-15,2019-06-14, ,mg,['2 / Day'], ,Adverse Event
4808,596,IVIG,2016-08-15,2021-06-04,300,MIU,['/Month'],IV,Adverse Event
4809,596,Gilenya,2015-12-20,,1000, ,['2 / Day'],IV, 
4810,1788,Alemtuzumab (Campath),2016-04-07,2017-12-05,500,mg,['3 / Week'],IV,Patient Choice/Convenience
4811,1788,Ledertrexaat,2016-02-04,,300,mcg,[' '], , 
4812,1788,D-cure (Vitamine D),2016-08-22,, ,mg,['/Month'],Oral, 
4813,1788,Methylprednisolone,2016-07-30,,1000,mg,['2 / Day'],Oral, 
4814,4959,Tysabri,2016-01-21,2019-08-23,400,mg,['2 / Day'],IV,Lack of efficacy
4815,4959,Alemtuzumab (Campath),2015-12-05,2021-04-17,1,mg,[' '],Oral,Adverse Event
4816,2671,Ledertrexaat,2015-12-19,2017-10-27,1000, ,['/Month'],IV,Persistence of relapses
4817,2671,Gilenya,2016-08-15,, , ,['3 / Week'], , 
4818,2671,Gilenya,2016-05-15,, ,mcg,['2 / Day'],IV, 
4819,4431,Gilenya,2016-08-01,2021-07-21,20,mg,['/ Week'],IV,Persistence of relapses
4820,4431,Tecfidera,2016-05-17,,5000,mg,['3 / Week'],IV, 
4821,4911,IVIG,2016-03-31,,500,mg,['2 / Day'], , 
4822,4911,Rebif [22],2016-03-17,,20, ,['/ Day'],IV, 
4823,4911,Endoxan,2015-11-29,,400, ,['/Month'],IV, 
4824,4911,Gilenya,2015-11-07,2020-06-28, , ,['2 / Day'],IV,Persistence of relapses
4825,1979,Rebif [22],2016-04-02,, ,mcg,['/Month'],IV, 
4826,1979,Tecfidera,2016-08-07,,20, ,['2 / Day'],IV, 
4827,551,Gilenya,2015-11-06,2020-08-13, ,mg,['/Month'],Oral,Persisting MRI activity
4828,551,IVIG,2016-05-06,, ,mg,['2 / Day'],IV, 
4829,551,Gilenya,2016-02-02,, , ,['2 / Day'], , 
4830,3355,Rebif [44],2015-10-31,2021-09-28,400, ,['3 / Week'],IV,Adverse Event
4831,3355,D-cure (Vitamine D),2016-01-08,,300, ,[' '],IV, 
4832,2979,Avonex,2016-02-16,,5000,MIU,['2 / Day'], , 
4833,2979,Betaferon,2016-01-07,, , ,['/Month'],IV, 
4834,2979,Endoxan,2016-06-25,2021-08-30, ,mg,['/Month'],Oral,Adverse Event
4835,3698,Endoxan,2016-02-17,, , ,['2 / Day'], , 
4836,3698,Teriflunomide,2016-06-29,,500,mg,['3 / Week'], , 
4837,3698,Teriflunomide,2016-05-24,,1, ,['/ Week'],IV, 
4838,3698,D-cure (Vitamine D),2016-06-30,,1000,mg,['/Month'],IV, 
4839,1568,Endoxan,2016-09-22,,1000,MIU,['2 / Day'],Oral, 
4840,1568,Tecfidera,2015-12-04,2018-02-09,500,mg,['/ Week'],IV,Adverse Event
4841,620,Copaxone,2016-05-11,, ,MIU,['2 / Day'],IV, 
4842,620,Rebif [44],2016-02-16,,300, ,['3 / Week'],Oral, 
4843,620,Alemtuzumab (Campath),2016-05-20,,1000, ,['/ Day'], , 
4844,3889,Methylprednisolone,2016-07-18,, ,MIU,['2 / Day'], , 
4845,3889,Endoxan,2016-01-26,, ,mg,['/Month'], , 
4846,3889,Rebif [44],2015-10-26,,20,mg,['/Month'],IV, 
4847,3889,D-cure (Vitamine D),2016-04-12,2020-07-17,400,mg,['3 / Week'],Oral,Persisting MRI activity
4848,3946,Rebif [44],2015-11-16,,400,mcg,['/Month'], , 
4849,3946,IVIG,2016-02-06,,500, ,['/Month'], , 
4850,3946,D-cure (Vitamine D),2016-07-22,2021-06-10,20,mcg,['/Month'],IV,Lack of efficacy
4851,2991,D-cure (Vitamine D),2016-03-12,, ,mg,['/Month'],IV, 
4852,2191,Copaxone,2016-07-23,2020-06-16,300, ,['3 / Week'],IV,Patient Choice/Convenience
4853,1442,Teriflunomide,2016-09-19,,500,MIU,['/Month'],IV, 
4854,1442,Copaxone,2016-07-23,,1,mg,['/Month'],Oral, 
4855,1442,Alemtuzumab (Campath),2016-05-25,2017-12-29, ,mcg,['/ Day'],IV,Adverse Event
4856,4564,Tysabri,2016-02-20,2019-03-28, ,mg,['2 / Day'], ,Patient Choice/Convenience
4857,4564,D-cure (Vitamine D),2016-09-20,,500,mcg,['2 / Day'],Oral, 
4858,4564,D-cure (Vitamine D),2016-07-24,2019-01-02,1000,mcg,['2 / Day'], ,Adverse Event
4859,3646,Tecfidera,2016-05-06,,1,MIU,['2 / Day'], , 
4860,3646,Alemtuzumab (Campath),2016-08-31,,400,mg,['2 / Day'], , 
4861,3646,Gilenya,2016-06-05,,1000,mg,['2 / Day'],Oral, 
4862,1006,Mitoxantrone,2016-10-17,2018-08-16,1000,MIU,['/Month'],IV,Patient Choice/Convenience
4863,1006,IVIG,2016-07-04,,400,mg,['2 / Day'],IV, 
4864,1006,Methylprednisolone,2016-01-15,2019-12-30,1000, ,['3 / Week'],IV,Persisting MRI activity
4865,1006,Betaferon,2016-07-09,2020-11-22, ,mcg,['/ Day'], ,Lack of efficacy
4866,3262,Rebif [22],2016-10-17,2018-09-11, , ,['/ Day'],IV,Patient Choice/Convenience
4867,4487,IVIG,2016-03-08,,400,mg,['3 / Week'],IV, 
4868,4487,Gilenya,2015-11-19,2019-05-01,400,mg,['2 / Day'],IV,Persistence of relapses
4869,4487,Methylprednisolone,2016-09-11,,1,mg,['2 / Day'],IV, 
4870,3977,Ledertrexaat,2016-09-30,,5000, ,['/Month'], , 
4871,3977,Gilenya,2016-01-24,2017-11-13, , ,['/Month'],Oral,Patient Choice/Convenience
4872,3977,D-cure (Vitamine D),2016-06-08,2020-08-18,1,mg,[' '],IV,Patient Choice/Convenience
4873,279,Endoxan,2016-04-10,, ,mg,['/ Day'],IV, 
4874,279,Rebif [22],2016-03-27,,1000,mg,['/ Day'],IV, 
4875,3846,Tysabri,2015-12-02,2019-10-10,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
4876,3846,Ledertrexaat,2016-08-29,,300, ,['2 / Day'], , 
4877,3846,D-cure (Vitamine D),2016-05-16,, , ,['2 / Day'], , 
4878,3846,Gilenya,2015-11-15,,500,mg,['/ Week'], , 
4879,3984,Tecfidera,2016-07-19,2020-08-03, , ,['/Month'], ,Persisting MRI activity
4880,3984,IVIG,2016-09-04,,400, ,['/Month'],IV, 
4881,3984,Avonex,2016-08-04,2019-03-26,5000,MIU,['/Month'],IV,Lack of efficacy
4882,944,Alemtuzumab (Campath),2016-03-09,,1, ,['/ Week'], , 
4883,944,Tecfidera,2016-02-24,,400,mg,['2 / Day'],IV, 
4884,944,Gilenya,2016-03-07,,1000,mcg,['3 / Week'], , 
4885,1674,Ledertrexaat,2016-06-15,,400, ,['3 / Week'],IV, 
4886,3429,Rebif [44],2016-10-16,,1, ,['/Month'],IV, 
4887,3429,Avonex,2016-03-03,2021-08-13,300,mg,['/Month'],IV,Adverse Event
4888,3429,Rebif [44],2016-06-05,,20, ,['2 / Day'], , 
4889,3429,Copaxone,2016-02-19,2018-01-12,500,mg,['/ Day'], ,Patient Choice/Convenience
4890,882,Betaferon,2016-04-12,, , ,['2 / Day'],IV, 
4891,4628,Gilenya,2016-03-31,2019-07-18,1, ,[' '],IV,Patient Choice/Convenience
4892,4628,Alemtuzumab (Campath),2016-08-17,, , ,[' '], , 
4893,4628,Ledertrexaat,2016-02-16,,400, ,['/Month'],IV, 
4894,4628,Betaferon,2016-01-05,,5000, ,['2 / Day'],IV, 
4895,3659,Betaferon,2016-02-23,,300, ,[' '],IV, 
4896,3659,Teriflunomide,2016-04-06,2018-04-23,5000,mg,['3 / Week'],IV,Persisting MRI activity
4897,3659,Rebif [22],2016-04-06,2020-02-26, ,MIU,['/ Day'], ,Lack of efficacy
4898,3659,Mitoxantrone,2016-02-02,, , ,['2 / Day'],IV, 
4899,4200,Tecfidera,2016-10-07,,20, ,['2 / Day'],Oral, 
4900,2562,IVIG,2016-06-15,, , ,['2 / Day'], , 
4901,2562,Mitoxantrone,2016-01-21,,20, ,['2 / Day'],IV, 
4902,3237,Copaxone,2016-05-13,,5000, ,[' '],IV, 
4903,3237,IVIG,2016-05-26,2021-09-18, , ,['3 / Week'],Oral,Patient Choice/Convenience
4904,4934,Mitoxantrone,2016-09-03,2021-07-04,1000, ,['3 / Week'],IV,Persisting MRI activity
4905,4934,D-cure (Vitamine D),2016-06-28,2021-07-19,5000,mg,['2 / Day'], ,Adverse Event
4906,4934,Teriflunomide,2016-02-22,,20, ,['/ Day'],IV, 
4907,4934,Methylprednisolone,2016-07-12,2019-11-03,300, ,['2 / Day'],Oral,Adverse Event
4908,1956,Alemtuzumab (Campath),2015-11-13,2021-07-26, , ,[' '], ,Lack of efficacy
4909,1956,IVIG,2016-05-19,,400,mcg,['3 / Week'], , 
4910,1956,Rebif [44],2016-06-29,2020-12-03,1000, ,['/Month'],IV,Patient Choice/Convenience
4911,1971,Endoxan,2016-02-26,,5000, ,['/ Week'], , 
4912,4599,Rebif [22],2016-02-06,, , ,['/Month'], , 
4913,4599,Betaferon,2016-08-06,,1000, ,['/Month'], , 
4914,4599,Endoxan,2015-12-20,,20,mg,['2 / Day'], , 
4915,4599,Tysabri,2016-05-01,2020-02-01,5000,mg,['3 / Week'],IV,Adverse Event
4916,4592,Mitoxantrone,2016-02-25,2019-06-30,500,MIU,['/Month'],IV,Persisting MRI activity
4917,4592,Mitoxantrone,2016-09-27,,20, ,['3 / Week'], , 
4918,2301,Methylprednisolone,2016-10-03,2019-10-30, , ,['/Month'],Oral,Persistence of relapses
4919,2301,Endoxan,2015-11-29,2019-02-15,500, ,['/ Day'], ,Adverse Event
4920,2301,Ledertrexaat,2016-05-04,2020-12-20,300, ,['/Month'],Oral,Patient Choice/Convenience
4921,2754,Betaferon,2015-12-27,2020-12-28, , ,['2 / Day'],Oral,Adverse Event
4922,2754,Tecfidera,2016-01-04,2020-10-22,500,mg,['3 / Week'],IV,Persisting MRI activity
4923,2241,Teriflunomide,2016-03-29,2018-07-31, ,mg,['2 / Day'], ,Patient Choice/Convenience
4924,483,Ledertrexaat,2015-11-02,,1000,mcg,['/Month'], , 
4925,4781,Copaxone,2015-12-03,2020-07-25,1, ,['/Month'], ,Lack of efficacy
4926,4781,IVIG,2016-06-15,,400, ,['3 / Week'],IV, 
4927,3027,IVIG,2016-06-09,, ,MIU,['2 / Day'], , 
4928,3027,Methylprednisolone,2016-01-16,,300,mg,['/Month'],IV, 
4929,3027,Alemtuzumab (Campath),2016-09-15,2017-12-28,5000,mcg,['2 / Day'],IV,Adverse Event
4930,4243,Alemtuzumab (Campath),2016-01-15,2019-06-26, ,MIU,['/Month'],IV,Persisting MRI activity
4931,4243,Tecfidera,2016-02-14,2020-11-20, ,mg,['3 / Week'],Oral,Adverse Event
4932,4243,D-cure (Vitamine D),2015-10-28,,20,mg,['/Month'], , 
4933,1098,Rebif [44],2016-08-25,2020-06-25,1,mg,['/ Day'], ,Persisting MRI activity
4934,1098,Copaxone,2016-02-08,2021-08-25, ,mcg,['2 / Day'],IV,Persisting MRI activity
4935,4468,Methylprednisolone,2016-04-11,, ,mg,['3 / Week'],IV, 
4936,4468,Betaferon,2016-05-27,,1, ,['/ Week'],IV, 
4937,4468,Avonex,2016-05-06,,5000, ,['2 / Day'],IV, 
4938,4468,D-cure (Vitamine D),2016-07-21,2018-02-03,20,MIU,['2 / Day'],IV,Adverse Event
4939,535,Gilenya,2016-01-09,2020-11-10,20, ,['2 / Day'],IV,Adverse Event
4940,535,Gilenya,2016-01-28,,400,mg,[' '],IV, 
4941,1596,Betaferon,2015-10-24,, , ,['3 / Week'], , 
4942,1596,D-cure (Vitamine D),2016-06-30,2017-12-31,300,mcg,['/Month'],IV,Patient Choice/Convenience
4943,1596,Tysabri,2016-03-12,, ,mg,['/Month'],IV, 
4944,1504,Endoxan,2016-07-19,,20, ,['2 / Day'],IV, 
4945,2944,Rebif [22],2016-06-06,2017-11-13,5000,mcg,['/Month'], ,Persisting MRI activity
4946,2944,Avonex,2016-05-12,, , ,['/Month'],IV, 
4947,2944,IVIG,2016-07-19,, ,mg,['/Month'],IV, 
4948,4728,Gilenya,2016-08-02,,20,mcg,['/Month'],IV, 
4949,4728,Avonex,2016-04-15,,300,mg,[' '],IV, 
4950,4421,Betaferon,2016-04-28,2017-12-28,20,mcg,['2 / Day'], ,Patient Choice/Convenience
4951,2741,D-cure (Vitamine D),2016-06-05,,1,mg,['/Month'],Oral, 
4952,2741,Teriflunomide,2015-11-07,,1, ,['2 / Day'],Oral, 
4953,2741,Teriflunomide,2016-02-20,2018-02-28,5000,mg,['2 / Day'],IV,Adverse Event
4954,2741,Rebif [22],2016-03-23,2020-12-20,400,mg,['3 / Week'],IV,Adverse Event
4955,2729,D-cure (Vitamine D),2016-03-04,2020-02-24, ,mg,['2 / Day'], ,Patient Choice/Convenience
4956,2729,D-cure (Vitamine D),2016-06-14,, , ,['/ Day'],IV, 
4957,2729,IVIG,2016-06-12,2020-07-04, ,mcg,['2 / Day'], ,Persisting MRI activity
4958,2729,Tysabri,2016-05-05,,300,mg,['2 / Day'],IV, 
4959,1193,Teriflunomide,2016-05-10,,20, ,['2 / Day'],Oral, 
4960,1193,IVIG,2015-11-23,2021-03-10, , ,['3 / Week'], ,Patient Choice/Convenience
4961,1193,Methylprednisolone,2016-06-07,2019-04-12,1000,MIU,['/ Day'], ,Persistence of relapses
4962,1193,Copaxone,2016-02-19,2020-05-10, , ,[' '],IV,Patient Choice/Convenience
4963,1256,Betaferon,2016-02-08,2018-05-03, ,mg,['2 / Day'], ,Patient Choice/Convenience
4964,1256,Ledertrexaat,2016-09-10,,1000,mg,['/Month'],IV, 
4965,1008,Copaxone,2016-06-12,,500, ,['3 / Week'], , 
4966,1008,D-cure (Vitamine D),2016-08-18,,300,MIU,['2 / Day'],IV, 
4967,1774,Avonex,2016-09-24,2021-07-27, ,mg,['/Month'], ,Persisting MRI activity
4968,1774,Teriflunomide,2016-04-16,2021-01-20,1000,mg,[' '],IV,Patient Choice/Convenience
4969,1774,Betaferon,2016-04-15,2019-11-05,1,mg,['3 / Week'], ,Adverse Event
4970,1774,Avonex,2015-11-11,2020-08-05,300, ,['3 / Week'],IV,Persistence of relapses
4971,2186,Gilenya,2015-12-13,, , ,['2 / Day'],IV, 
4972,2186,Methylprednisolone,2016-03-27,,20, ,[' '], , 
4973,2186,Tysabri,2016-07-13,,400,mg,['2 / Day'],IV, 
4974,172,Rebif [44],2016-02-11,,400, ,['/Month'],IV, 
4975,172,Rebif [44],2016-01-19,, ,mg,['/Month'], , 
4976,4494,Alemtuzumab (Campath),2015-11-21,2020-03-09,300,mg,['/Month'],IV,Patient Choice/Convenience
4977,4494,D-cure (Vitamine D),2016-06-18,,20,mg,['3 / Week'],Oral, 
4978,4494,Tecfidera,2016-06-08,,400,mg,['/ Week'],IV, 
4979,4494,IVIG,2016-07-08,,1000,mg,['3 / Week'],IV, 
4980,1813,Tysabri,2016-03-25,2021-03-15,300,mg,[' '], ,Persistence of relapses
4981,1813,Rebif [44],2015-11-25,2020-11-24, ,mg,['/Month'],IV,Patient Choice/Convenience
4982,1813,Avonex,2016-03-02,, ,mg,['/ Day'],IV, 
4983,1444,Gilenya,2016-04-10,,400,mg,['/Month'],IV, 
4984,1444,D-cure (Vitamine D),2016-03-21,2019-11-16,300,mg,['3 / Week'],IV,Lack of efficacy
4985,2048,Gilenya,2015-11-13,,1000,MIU,['/Month'], , 
4986,1513,Teriflunomide,2015-11-09,,400, ,['/Month'], , 
4987,1513,Alemtuzumab (Campath),2016-10-11,,1000,mg,[' '], , 
4988,1513,D-cure (Vitamine D),2016-09-23,, ,mg,['2 / Day'],IV, 
4989,1513,IVIG,2016-10-19,2020-04-13,5000,MIU,['/Month'], ,Adverse Event
4990,3195,Alemtuzumab (Campath),2016-10-03,,500, ,['2 / Day'], , 
4991,3195,D-cure (Vitamine D),2016-09-26,2018-11-20,500,mcg,['3 / Week'],IV,Lack of efficacy
4992,3195,Ledertrexaat,2016-10-05,,1000, ,[' '],IV, 
4993,4015,IVIG,2016-09-12,2020-12-07,1000,MIU,['2 / Day'],IV,Persistence of relapses
4994,4015,D-cure (Vitamine D),2016-03-04,,5000, ,['/ Day'], , 
4995,4015,IVIG,2016-08-29,,1,mg,['3 / Week'],IV, 
4996,1301,Gilenya,2015-11-09,2021-08-11,300, ,['3 / Week'],Oral,Adverse Event
4997,1784,Alemtuzumab (Campath),2016-04-20,2021-01-24,5000,MIU,['2 / Day'], ,Lack of efficacy
4998,4671,Teriflunomide,2016-02-28,,1,mg,[' '],Oral, 
4999,4671,Endoxan,2016-05-11,, ,mg,['2 / Day'], , 
5000,4331,Mitoxantrone,2016-05-11,2019-01-09,20,MIU,['/ Week'],IV,Adverse Event
5001,4331,Mitoxantrone,2016-06-30,2018-04-07,20, ,['/Month'], ,Adverse Event
5002,4441,Endoxan,2015-12-03,2020-11-10,5000,mg,['/Month'],IV,Lack of efficacy
5003,4441,Rebif [44],2016-09-02,,300, ,['3 / Week'], , 
5004,4441,Gilenya,2016-10-20,,400, ,['3 / Week'], , 
5005,4441,Tecfidera,2015-12-21,2021-04-15,300,mcg,['/ Day'],IV,Persisting MRI activity
5006,4529,Methylprednisolone,2016-07-12,,400, ,['2 / Day'],IV, 
5007,4529,Endoxan,2015-11-22,,500,mg,['2 / Day'],IV, 
5008,3313,Tecfidera,2016-03-31,,500, ,['/ Week'], , 
5009,3313,Gilenya,2016-04-16,2020-03-16,400,mg,['3 / Week'], ,Lack of efficacy
5010,3313,Tecfidera,2016-06-17,,1000,mg,['2 / Day'],IV, 
5011,3402,Teriflunomide,2015-11-11,2020-06-28,300,MIU,['/Month'],Oral,Adverse Event
5012,4737,Tysabri,2016-09-24,,20,MIU,['/Month'],IV, 
5013,2535,D-cure (Vitamine D),2016-10-10,,300,mg,['2 / Day'], , 
5014,2535,IVIG,2016-04-05,2020-10-25,500, ,[' '], ,Persisting MRI activity
5015,2535,D-cure (Vitamine D),2016-08-24,,5000, ,['/Month'],IV, 
5016,2535,Teriflunomide,2016-01-25,2018-04-10,20,mg,['2 / Day'],IV,Patient Choice/Convenience
5017,3560,Avonex,2016-08-26,2020-11-23,1,mg,['3 / Week'],IV,Adverse Event
5018,3560,Tecfidera,2016-01-23,2019-05-30,400,mg,['2 / Day'], ,Patient Choice/Convenience
5019,3560,Rebif [22],2016-09-28,2020-08-09,500,mg,['/ Week'],Oral,Patient Choice/Convenience
5020,104,IVIG,2016-01-06,, ,mg,['/Month'], , 
5021,104,Tecfidera,2016-02-10,, ,mg,['/Month'],Oral, 
5022,104,Rebif [22],2016-07-25,2020-10-02,300,mg,['/Month'],IV,Adverse Event
5023,104,Ledertrexaat,2016-04-24,2018-12-14, ,MIU,['3 / Week'], ,Lack of efficacy
5024,4429,Gilenya,2016-10-17,,400,mg,['2 / Day'], , 
5025,4429,Methylprednisolone,2016-06-09,2018-09-14, ,mg,['/ Week'],IV,Lack of efficacy
5026,4429,D-cure (Vitamine D),2016-07-02,2018-08-02, ,mg,['/Month'], ,Adverse Event
5027,3824,Copaxone,2016-01-01,,500,mg,[' '],IV, 
5028,3824,D-cure (Vitamine D),2016-07-30,2020-02-19,1000,mg,['2 / Day'], ,Persistence of relapses
5029,2431,Rebif [44],2016-02-02,2020-10-13, , ,['/ Day'],IV,Adverse Event
5030,4520,IVIG,2016-05-21,2020-08-05,400,MIU,['/Month'],IV,Persisting MRI activity
5031,4520,Alemtuzumab (Campath),2016-03-30,2020-10-31, ,mg,['2 / Day'], ,Persisting MRI activity
5032,855,D-cure (Vitamine D),2016-03-23,2019-02-08,500,mg,['/Month'],IV,Lack of efficacy
5033,855,IVIG,2016-07-31,2021-09-07, , ,[' '],Oral,Adverse Event
5034,4789,Gilenya,2016-01-13,,500,MIU,[' '],IV, 
5035,1537,Methylprednisolone,2016-05-28,,400,mcg,['/Month'], , 
5036,1537,Endoxan,2016-04-23,,20,MIU,['/Month'],IV, 
5037,1953,Endoxan,2016-08-21,, ,mg,['/Month'],Oral, 
5038,1953,Methylprednisolone,2016-10-07,2020-11-26,20,MIU,[' '], ,Persistence of relapses
5039,1953,Tysabri,2016-07-28,2018-09-15,400, ,['3 / Week'], ,Adverse Event
5040,1418,Avonex,2016-04-30,,400,mg,['/Month'], , 
5041,1418,Ledertrexaat,2015-11-23,, ,MIU,['/Month'],IV, 
5042,3726,Methylprednisolone,2016-10-14,, ,MIU,[' '],IV, 
5043,4135,Avonex,2015-12-19,,5000,MIU,['/Month'],Oral, 
5044,4135,D-cure (Vitamine D),2016-02-25,, ,MIU,['/Month'], , 
5045,4135,Methylprednisolone,2015-12-28,,300,mg,['/Month'],Oral, 
5046,4135,Tecfidera,2016-03-05,2021-03-08,20, ,[' '],IV,Patient Choice/Convenience
5047,1855,Rebif [44],2016-01-08,,1,MIU,['2 / Day'],IV, 
5048,1855,Alemtuzumab (Campath),2016-05-08,,400,mcg,['/Month'], , 
5049,1855,Teriflunomide,2016-06-05,,300,mg,['2 / Day'],Oral, 
5050,776,D-cure (Vitamine D),2016-01-31,,1000,mg,['2 / Day'],IV, 
5051,776,Tysabri,2016-08-16,2018-08-07,1,mg,['2 / Day'],IV,Adverse Event
5052,776,Tecfidera,2015-12-18,,1000, ,['/Month'],IV, 
5053,776,IVIG,2016-01-22,,20,MIU,['2 / Day'], , 
5054,1372,Rebif [22],2016-07-19,2019-09-05,5000, ,['/Month'], ,Lack of efficacy
5055,1372,Alemtuzumab (Campath),2016-04-14,,500,mg,[' '],IV, 
5056,1372,Gilenya,2015-10-31,,500,mg,['2 / Day'],IV, 
5057,1372,Methylprednisolone,2016-06-08,2019-03-28,300,MIU,['/Month'],IV,Patient Choice/Convenience
5058,563,Tysabri,2016-01-29,,20, ,['/Month'],IV, 
5059,563,Alemtuzumab (Campath),2016-07-25,2018-02-21, ,mg,['/Month'], ,Lack of efficacy
5060,563,IVIG,2016-05-18,,1000,mg,['2 / Day'], , 
5061,1328,Rebif [44],2015-11-22,2018-03-01,1,MIU,['/ Week'], ,Lack of efficacy
5062,1328,Copaxone,2015-10-25,,1000,mg,['/ Day'],IV, 
5063,1328,Tysabri,2016-03-10,2018-12-18, ,mg,['2 / Day'],IV,Lack of efficacy
5064,3467,Rebif [44],2016-09-28,, , ,['2 / Day'], , 
5065,3467,Copaxone,2016-06-16,,1,mcg,['/Month'], , 
5066,3708,Rebif [44],2016-04-04,,5000,mg,['/Month'],IV, 
5067,888,Copaxone,2016-04-15,, ,mg,['/Month'], , 
5068,888,Betaferon,2016-03-02,, ,mg,['2 / Day'], , 
5069,888,Rebif [22],2016-05-30,,20,mcg,['2 / Day'],IV, 
5070,888,IVIG,2016-09-25,2021-02-16,500,mg,['2 / Day'],IV,Adverse Event
5071,4024,Endoxan,2016-10-11,2021-10-13, ,mg,['/ Day'], ,Persisting MRI activity
5072,4114,Tysabri,2016-02-12,, ,mg,['2 / Day'], , 
5073,3381,IVIG,2015-11-17,,20,mg,['2 / Day'], , 
5074,3381,D-cure (Vitamine D),2016-08-13,2020-02-23, ,mcg,['/Month'],IV,Adverse Event
5075,3381,Ledertrexaat,2016-07-06,2020-03-14,1000,mg,['2 / Day'],Oral,Adverse Event
5076,1119,IVIG,2016-06-02,,1000,MIU,['/ Day'], , 
5077,1119,IVIG,2016-09-04,,5000, ,['/Month'],Oral, 
5078,1119,Avonex,2015-12-20,,5000, ,['/Month'],Oral, 
5079,4485,Gilenya,2016-09-07,2019-04-13,20, ,['/ Day'],Oral,Adverse Event
5080,4485,Alemtuzumab (Campath),2016-05-28,, ,mg,['/Month'], , 
5081,4485,Copaxone,2016-01-06,2021-07-14, ,mg,['2 / Day'], ,Adverse Event
5082,1213,Teriflunomide,2015-12-23,,300,mg,['2 / Day'],IV, 
5083,1213,Gilenya,2015-12-20,2020-05-06,1,mg,['/Month'],IV,Persisting MRI activity
5084,1213,Tysabri,2015-12-11,2019-01-09,400, ,['/Month'], ,Lack of efficacy
5085,1213,Tecfidera,2016-03-31,2019-02-14, , ,['3 / Week'], ,Persisting MRI activity
5086,2523,Gilenya,2016-04-22,,1,mg,['/ Day'], , 
5087,2523,IVIG,2016-04-20,,5000, ,['/Month'], , 
5088,2523,IVIG,2016-07-18,2019-07-15,20, ,['/Month'],Oral,Adverse Event
5089,3684,Tysabri,2016-04-08,2021-06-04,1000, ,[' '], ,Persistence of relapses
5090,3684,D-cure (Vitamine D),2016-10-18,,5000,mg,[' '],IV, 
5091,3684,Tecfidera,2016-07-19,, , ,['/Month'],IV, 
5092,3684,Alemtuzumab (Campath),2016-06-03,2021-02-25,20,mcg,['/Month'], ,Persisting MRI activity
5093,2082,Mitoxantrone,2016-06-18,,5000, ,['3 / Week'],IV, 
5094,2082,Endoxan,2015-11-20,,400,mg,['/ Day'], , 
5095,4207,D-cure (Vitamine D),2016-01-21,2020-05-08,1,mg,[' '],IV,Adverse Event
5096,4207,Mitoxantrone,2015-11-29,2018-07-22,500,mg,['/Month'], ,Adverse Event
5097,1637,IVIG,2015-12-14,2018-04-22,300,mg,['/ Day'], ,Patient Choice/Convenience
5098,4732,Endoxan,2016-01-16,2017-11-18,500, ,['2 / Day'],IV,Persisting MRI activity
5099,4732,Alemtuzumab (Campath),2015-10-27,,500,mg,['2 / Day'], , 
5100,2183,Teriflunomide,2016-06-26,, ,mg,['/Month'],Oral, 
5101,653,Tysabri,2016-07-14,2021-09-25, ,mg,['/ Day'],Oral,Adverse Event
5102,653,Tecfidera,2015-10-27,,500,mg,[' '], , 
5103,653,D-cure (Vitamine D),2016-09-15,,5000, ,['2 / Day'],IV, 
5104,653,Alemtuzumab (Campath),2016-02-26,,500,mcg,['2 / Day'], , 
5105,2264,D-cure (Vitamine D),2016-01-03,,1000,MIU,['3 / Week'],IV, 
5106,4235,IVIG,2016-08-31,,1, ,['2 / Day'],IV, 
5107,4235,IVIG,2016-07-02,2018-03-26, ,MIU,['3 / Week'],IV,Persisting MRI activity
5108,3719,Rebif [44],2015-12-24,,20,mg,['2 / Day'],IV, 
5109,4006,Tecfidera,2016-02-03,2021-04-07, ,mg,['3 / Week'],Oral,Patient Choice/Convenience
5110,4006,Tysabri,2016-04-17,,300,mg,['/Month'], , 
5111,906,Rebif [22],2015-10-24,,5000,mg,['/ Week'], , 
5112,906,Tysabri,2015-10-24,2017-12-01,400, ,['2 / Day'], ,Patient Choice/Convenience
5113,906,Copaxone,2016-01-05,2021-04-09,500, ,['/ Day'],IV,Patient Choice/Convenience
5114,2481,Alemtuzumab (Campath),2016-03-29,2018-06-03,20,mg,['/Month'], ,Persisting MRI activity
5115,2481,Alemtuzumab (Campath),2016-10-06,2021-04-23, , ,['/Month'], ,Patient Choice/Convenience
5116,4135,Methylprednisolone,2016-02-18,2017-12-07,1000,mg,['3 / Week'], ,Adverse Event
5117,4135,Tecfidera,2016-09-12,, ,MIU,['/Month'],IV, 
5118,4135,Methylprednisolone,2016-04-09,2018-02-22,400, ,['/Month'], ,Persistence of relapses
5119,659,D-cure (Vitamine D),2016-05-22,,20,mcg,[' '],IV, 
5120,659,Alemtuzumab (Campath),2015-12-08,, ,mg,['2 / Day'],IV, 
5121,659,Copaxone,2016-06-28,,300,MIU,['/ Week'],IV, 
5122,4975,Copaxone,2016-01-08,,500,mcg,[' '],IV, 
5123,3478,Rebif [44],2015-12-07,2021-03-01,5000,mg,['2 / Day'], ,Persisting MRI activity
5124,2269,Rebif [44],2016-03-25,2021-04-26, ,mg,['/Month'], ,Adverse Event
5125,2269,IVIG,2016-04-02,2021-10-14,300, ,['2 / Day'],IV,Persistence of relapses
5126,479,Gilenya,2016-07-04,,1000,mcg,['/Month'],IV, 
5127,479,Ledertrexaat,2016-01-15,,1000, ,['2 / Day'], , 
5128,479,Tysabri,2015-11-11,2018-12-21, , ,['2 / Day'],IV,Patient Choice/Convenience
5129,479,Methylprednisolone,2016-02-03,,300,MIU,['2 / Day'], , 
5130,3189,Methylprednisolone,2016-03-26,2018-10-05, , ,['/Month'],IV,Persisting MRI activity
5131,3189,Avonex,2016-09-29,,1000,mg,['/ Day'],Oral, 
5132,3189,Avonex,2015-11-07,, , ,[' '],Oral, 
5133,3189,Alemtuzumab (Campath),2016-05-22,2018-12-05, ,mg,['/ Day'],IV,Lack of efficacy
5134,1512,Gilenya,2016-04-02,,20, ,['2 / Day'],IV, 
5135,1512,Endoxan,2016-09-18,,20, ,['/Month'],IV, 
5136,1469,Tysabri,2016-01-12,2021-06-17,1000, ,['/Month'], ,Persisting MRI activity
5137,351,D-cure (Vitamine D),2016-06-13,,5000,mg,['2 / Day'],IV, 
5138,351,Alemtuzumab (Campath),2015-12-28,2019-07-18, ,mg,['/Month'],IV,Adverse Event
5139,1304,Rebif [44],2016-08-18,, , ,['2 / Day'],Oral, 
5140,1304,Copaxone,2016-05-05,,300,MIU,['/ Week'],IV, 
5141,2479,Teriflunomide,2016-06-06,2021-09-16,400,mg,['/Month'],Oral,Lack of efficacy
5142,2479,Teriflunomide,2016-01-27,, ,mg,['/Month'], , 
5143,2479,Tecfidera,2016-02-15,,300, ,['2 / Day'],IV, 
5144,1292,Betaferon,2016-05-31,2020-02-27,1,mg,['3 / Week'],IV,Patient Choice/Convenience
5145,811,Tysabri,2016-04-28,2020-08-29,20,mg,[' '],IV,Adverse Event
5146,2923,D-cure (Vitamine D),2016-02-11,,300, ,['/ Day'],Oral, 
5147,4664,Gilenya,2016-03-02,2020-11-04,5000,mg,['/ Day'],IV,Adverse Event
5148,4664,Endoxan,2016-04-08,2021-04-20,500, ,['/Month'],Oral,Adverse Event
5149,4664,Copaxone,2016-09-19,2019-05-21, ,mcg,['2 / Day'], ,Persisting MRI activity
5150,4664,IVIG,2016-09-28,2017-12-31, , ,['/ Day'],IV,Persisting MRI activity
5151,4643,Alemtuzumab (Campath),2016-05-30,2020-12-26,300, ,['/ Day'],IV,Persistence of relapses
5152,4643,IVIG,2016-09-03,2019-11-19,1,mg,['2 / Day'], ,Adverse Event
5153,4643,D-cure (Vitamine D),2016-09-21,,1000,mg,['/ Week'],IV, 
5154,4643,Endoxan,2015-12-20,2018-08-07,20,mg,['/Month'],IV,Lack of efficacy
5155,4658,Tysabri,2016-06-17,2020-11-30, , ,['2 / Day'], ,Persisting MRI activity
5156,4658,Methylprednisolone,2016-03-29,,20, ,['2 / Day'],IV, 
5157,4658,Rebif [22],2016-07-29,,20,MIU,['/ Week'], , 
5158,4658,Endoxan,2016-07-08,,1,MIU,['2 / Day'], , 
5159,3424,Gilenya,2016-05-15,,300, ,['2 / Day'], , 
5160,3424,D-cure (Vitamine D),2016-07-12,2021-01-27,1,mcg,['/Month'],IV,Patient Choice/Convenience
5161,3424,Rebif [44],2016-01-28,,300, ,['/Month'],Oral, 
5162,3953,Rebif [22],2016-09-15,2019-05-24,1, ,['/ Day'],IV,Lack of efficacy
5163,3953,Copaxone,2016-03-18,,20, ,[' '], , 
5164,3760,Methylprednisolone,2016-10-11,,1,mcg,['/Month'], , 
5165,3760,Ledertrexaat,2016-08-30,2018-12-31, , ,['2 / Day'], ,Persisting MRI activity
5166,3760,Tysabri,2016-02-01,2018-03-25,1000,MIU,['/ Week'],Oral,Adverse Event
5167,827,Teriflunomide,2016-09-17,,500,mg,['2 / Day'],Oral, 
5168,827,Endoxan,2016-01-12,, , ,['/Month'],IV, 
5169,827,Betaferon,2015-11-27,,20,mg,['3 / Week'],IV, 
5170,1688,Gilenya,2016-08-17,,20,mcg,['/Month'], , 
5171,1688,Avonex,2015-12-20,, , ,['2 / Day'],IV, 
5172,4971,Methylprednisolone,2016-02-23,, ,MIU,['/Month'],IV, 
5173,2771,Endoxan,2016-01-27,,1000, ,['2 / Day'], , 
5174,2872,Rebif [44],2016-06-08,2019-07-31, ,mg,['/Month'],Oral,Patient Choice/Convenience
5175,4787,Methylprednisolone,2016-03-14,, , ,['/ Day'], , 
5176,4787,Ledertrexaat,2016-05-19,,500,mcg,['/Month'],Oral, 
5177,4787,Tecfidera,2016-03-31,2020-03-19,300,mcg,['/Month'],IV,Adverse Event
5178,1716,Teriflunomide,2016-01-30,2019-02-03,20,mg,['/ Day'],IV,Adverse Event
5179,1716,Tysabri,2016-08-18,,300,mg,['/Month'], , 
5180,1716,Tysabri,2015-12-09,,1000,mg,['/ Day'],IV, 
5181,1716,Endoxan,2016-03-17,2021-05-24, ,mcg,['3 / Week'],IV,Lack of efficacy
5182,924,Endoxan,2015-11-10,2017-12-29,20, ,[' '],IV,Adverse Event
5183,3859,Endoxan,2016-09-01,,300,mcg,['2 / Day'],IV, 
5184,3285,Rebif [44],2015-11-26,, ,MIU,['3 / Week'], , 
5185,3285,Gilenya,2016-09-23,2021-07-15, , ,['2 / Day'], ,Patient Choice/Convenience
5186,3285,Ledertrexaat,2016-10-19,,500,mcg,['/Month'],Oral, 
5187,3285,Avonex,2016-06-01,2020-07-10, ,mg,['2 / Day'], ,Patient Choice/Convenience
5188,4669,Tysabri,2016-03-31,, , ,[' '],IV, 
5189,789,Ledertrexaat,2016-02-07,,500, ,['2 / Day'],IV, 
5190,448,Tecfidera,2016-03-29,2018-12-24, ,mg,[' '], ,Lack of efficacy
5191,448,Endoxan,2016-05-04,2018-12-09, ,mg,['2 / Day'],Oral,Lack of efficacy
5192,4892,Avonex,2015-11-10,,500,mg,['2 / Day'],IV, 
5193,4892,Gilenya,2016-10-07,,1,mcg,['/Month'],IV, 
5194,4892,Ledertrexaat,2016-08-18,,1000, ,['/Month'],IV, 
5195,4892,Alemtuzumab (Campath),2016-02-27,2018-04-23,300, ,[' '], ,Persisting MRI activity
5196,1216,Rebif [22],2016-06-15,,400,mg,[' '], , 
5197,1216,Teriflunomide,2016-06-16,2019-07-08,20, ,['3 / Week'], ,Persisting MRI activity
5198,1319,D-cure (Vitamine D),2016-09-27,2019-12-17, , ,['/Month'],IV,Lack of efficacy
5199,1319,Mitoxantrone,2016-03-04,2018-03-14,5000,mg,['3 / Week'], ,Lack of efficacy
5200,1319,Rebif [22],2016-02-04,,1,mg,['3 / Week'],IV, 
5201,1319,D-cure (Vitamine D),2016-06-22,2021-06-29, ,mg,['3 / Week'],IV,Adverse Event
5202,3776,Endoxan,2016-04-02,,5000, ,[' '],IV, 
5203,3776,Methylprednisolone,2016-08-26,2021-04-11, ,mg,['2 / Day'],IV,Persisting MRI activity
5204,651,Avonex,2015-11-27,2017-11-09, , ,['2 / Day'], ,Patient Choice/Convenience
5205,651,D-cure (Vitamine D),2016-07-28,,20,mg,['2 / Day'],Oral, 
5206,651,Betaferon,2016-10-21,2021-03-30, , ,['2 / Day'],IV,Adverse Event
5207,651,Gilenya,2016-07-31,, ,mg,['/Month'],IV, 
5208,1794,Tecfidera,2015-12-06,, , ,['/Month'], , 
5209,1794,Avonex,2016-01-17,2019-12-16,1000, ,['/Month'], ,Persisting MRI activity
5210,1794,IVIG,2016-02-29,,500,mg,['3 / Week'],IV, 
5211,4012,D-cure (Vitamine D),2016-09-12,,400, ,['/Month'], , 
5212,2045,Tysabri,2015-11-22,2018-11-17,1, ,['3 / Week'], ,Patient Choice/Convenience
5213,2045,IVIG,2015-11-17,, ,mg,['/Month'], , 
5214,2045,Teriflunomide,2016-02-21,,400, ,['/Month'],Oral, 
5215,2045,D-cure (Vitamine D),2016-06-02,,1000, ,['/Month'],IV, 
5216,4067,IVIG,2016-02-15,,20, ,['3 / Week'],Oral, 
5217,4925,Methylprednisolone,2016-07-25,2018-06-28,500,mg,['2 / Day'], ,Lack of efficacy
5218,780,IVIG,2015-12-05,,300,mcg,['2 / Day'], , 
5219,780,Gilenya,2016-05-09,, ,mg,['/Month'],IV, 
5220,780,D-cure (Vitamine D),2016-03-09,, , ,['2 / Day'],IV, 
5221,780,IVIG,2015-12-29,2020-04-07,1000,mg,['/Month'],IV,Persisting MRI activity
5222,3143,Alemtuzumab (Campath),2016-03-21,, ,mg,['3 / Week'],IV, 
5223,3143,Gilenya,2015-11-02,2020-02-11, ,mcg,['3 / Week'],IV,Adverse Event
5224,749,Rebif [44],2016-01-26,, ,mcg,['/ Week'],IV, 
5225,749,Rebif [44],2015-12-03,,1000, ,['2 / Day'],Oral, 
5226,749,Ledertrexaat,2016-05-29,,300, ,['3 / Week'], , 
5227,2134,D-cure (Vitamine D),2016-04-24,2018-05-31,5000,mg,['2 / Day'], ,Adverse Event
5228,2134,Methylprednisolone,2016-07-12,,20,MIU,['/ Day'], , 
5229,2134,Rebif [44],2015-12-21,2019-02-05,1000,mg,['/Month'],IV,Persistence of relapses
5230,2134,Rebif [44],2016-01-11,,1, ,['/ Day'],IV, 
5231,766,Tecfidera,2016-07-04,,1000, ,['2 / Day'],Oral, 
5232,766,D-cure (Vitamine D),2016-06-20,2018-05-22,1,MIU,['/Month'], ,Lack of efficacy
5233,766,Avonex,2016-06-22,, ,MIU,['2 / Day'],IV, 
5234,766,Teriflunomide,2016-08-23,, , ,['2 / Day'], , 
5235,3859,Teriflunomide,2016-07-17,2021-04-21, , ,['2 / Day'],IV,Patient Choice/Convenience
5236,4882,Tecfidera,2015-12-31,2018-09-01, ,mcg,['3 / Week'], ,Adverse Event
5237,882,Copaxone,2016-10-15,2019-12-18,5000,mg,['/Month'], ,Adverse Event
5238,882,Avonex,2016-09-18,2021-07-11, ,mcg,['2 / Day'],IV,Adverse Event
5239,882,Copaxone,2016-09-30,2020-08-19,400, ,['/Month'],IV,Adverse Event
5240,882,Teriflunomide,2016-02-10,,1, ,['/Month'], , 
5241,371,Tecfidera,2015-12-17,, ,mg,['/Month'],IV, 
5242,371,Gilenya,2016-05-28,2018-08-18,20,MIU,['3 / Week'],IV,Patient Choice/Convenience
5243,371,Teriflunomide,2016-02-09,2020-10-23, ,mg,[' '],Oral,Adverse Event
5244,371,Rebif [44],2016-03-10,2019-03-05,1000,mcg,['2 / Day'],IV,Persisting MRI activity
5245,994,Methylprednisolone,2015-11-27,, , ,['3 / Week'],Oral, 
5246,994,Betaferon,2016-04-11,2018-06-17,5000,mg,['/ Week'], ,Adverse Event
5247,994,Rebif [44],2016-10-14,,1000, ,['/ Week'],IV, 
5248,4454,Copaxone,2016-08-04,, ,mg,['2 / Day'], , 
5249,4454,Tysabri,2016-04-29,2020-06-23,300,MIU,['3 / Week'],IV,Persisting MRI activity
5250,4454,IVIG,2016-04-12,,500,mg,[' '],IV, 
5251,3306,Tecfidera,2016-02-18,2019-12-23, ,MIU,['/Month'], ,Patient Choice/Convenience
5252,3306,Tecfidera,2016-01-24,2018-09-26,5000,mg,['/Month'],IV,Adverse Event
5253,3306,Gilenya,2016-01-16,2017-12-11, , ,['/Month'],IV,Persisting MRI activity
5254,3306,Tysabri,2016-07-16,2021-06-29,1000,mg,['2 / Day'],IV,Adverse Event
5255,547,Betaferon,2016-09-10,,1000,mg,['/Month'], , 
5256,547,Mitoxantrone,2016-06-28,2021-04-04,500, ,['3 / Week'],Oral,Persisting MRI activity
5257,1220,Tecfidera,2016-06-14,, ,mcg,['/ Day'],IV, 
5258,1220,Ledertrexaat,2016-07-01,, ,mg,['2 / Day'],Oral, 
5259,1220,Betaferon,2016-09-13,,1000,mg,['2 / Day'],IV, 
5260,4727,Gilenya,2016-07-07,,1,mg,['/Month'],IV, 
5261,4727,Alemtuzumab (Campath),2016-07-20,2019-06-10, ,mcg,['2 / Day'], ,Lack of efficacy
5262,878,Methylprednisolone,2016-10-15,2021-03-02,300, ,['2 / Day'], ,Persisting MRI activity
5263,878,Copaxone,2015-11-06,2020-12-12, , ,[' '], ,Lack of efficacy
5264,878,Rebif [44],2016-10-19,2017-11-22,300,mg,['2 / Day'],IV,Persistence of relapses
5265,878,Tysabri,2016-10-14,,400,MIU,['/ Week'],Oral, 
5266,3812,D-cure (Vitamine D),2016-02-04,,500, ,['2 / Day'],IV, 
5267,3812,Methylprednisolone,2016-06-07,,500,mg,['2 / Day'], , 
5268,2780,Methylprednisolone,2016-08-15,2020-10-25, ,mg,['/ Week'],Oral,Patient Choice/Convenience
5269,2780,Tecfidera,2016-07-05,,300,mg,['/Month'],Oral, 
5270,2780,Tysabri,2015-12-02,2020-12-13, ,mg,['3 / Week'],IV,Adverse Event
5271,1030,Gilenya,2016-04-14,, ,MIU,['/ Day'], , 
5272,1030,Rebif [22],2016-02-15,2018-05-09,20, ,['3 / Week'], ,Persisting MRI activity
5273,1030,Ledertrexaat,2016-07-27,,500, ,['/Month'],IV, 
5274,1030,Teriflunomide,2016-09-24,2020-11-23,1000,MIU,['/Month'],IV,Persisting MRI activity
5275,3659,Betaferon,2016-03-09,2020-03-27, ,mg,['2 / Day'],IV,Persisting MRI activity
5276,3659,Methylprednisolone,2016-05-08,2021-03-25, ,mg,['2 / Day'], ,Persistence of relapses
5277,2433,Betaferon,2015-12-05,2020-12-12, , ,['2 / Day'], ,Patient Choice/Convenience
5278,2433,Tecfidera,2016-04-25,2018-04-16, , ,['/Month'], ,Adverse Event
5279,4352,Endoxan,2016-08-17,,500,mg,['2 / Day'],IV, 
5280,1184,Tecfidera,2015-11-15,,1,MIU,[' '], , 
5281,1184,Rebif [22],2016-09-30,2017-11-04,400, ,['3 / Week'],IV,Persistence of relapses
5282,2018,Gilenya,2016-09-02,,20,mg,['/Month'],IV, 
5283,2018,Rebif [44],2016-09-10,2018-02-01,1,mg,['2 / Day'], ,Patient Choice/Convenience
5284,2018,Gilenya,2016-03-10,,1000,mg,['/ Week'], , 
5285,3621,Alemtuzumab (Campath),2016-09-29,, ,mg,['/Month'], , 
5286,3621,Betaferon,2016-02-07,,20,MIU,['3 / Week'],IV, 
5287,4629,Betaferon,2015-11-08,2020-05-20,1000, ,['2 / Day'], ,Adverse Event
5288,4629,Gilenya,2016-06-22,,5000,MIU,['2 / Day'],IV, 
5289,4629,Betaferon,2016-03-28,,300,MIU,['/Month'], , 
5290,4629,Rebif [44],2015-11-01,,5000,mg,['/Month'], , 
5291,3110,Gilenya,2015-12-03,, ,MIU,['/ Day'],IV, 
5292,3110,Methylprednisolone,2016-10-02,2018-09-22,5000, ,['/Month'],IV,Patient Choice/Convenience
5293,4126,Ledertrexaat,2016-04-21,2018-12-01, ,mg,['/Month'], ,Lack of efficacy
5294,4784,Rebif [44],2016-04-26,,5000, ,['/ Day'], , 
5295,4395,D-cure (Vitamine D),2016-04-05,,400,MIU,['3 / Week'], , 
5296,4395,Avonex,2016-10-12,,1000,mcg,['/Month'], , 
5297,4395,Avonex,2016-07-18,2019-08-12,1,MIU,['2 / Day'],IV,Adverse Event
5298,660,Alemtuzumab (Campath),2016-04-24,2021-05-26, ,mg,['2 / Day'],IV,Lack of efficacy
5299,660,D-cure (Vitamine D),2016-04-11,,20,mg,['/Month'],IV, 
5300,660,D-cure (Vitamine D),2016-06-29,,1000,mg,['/Month'],IV, 
5301,4188,Tysabri,2016-10-16,, , ,['/Month'],IV, 
5302,4188,Rebif [22],2015-11-20,,5000,mg,['/Month'],IV, 
5303,4188,Copaxone,2015-12-27,,500,mg,['/ Day'], , 
5304,372,Copaxone,2016-09-19,,5000,mg,['/Month'],IV, 
5305,372,Gilenya,2016-05-27,,1000, ,['/Month'],Oral, 
5306,372,Avonex,2015-11-01,2021-01-04,500, ,['/Month'],IV,Persistence of relapses
5307,2755,Teriflunomide,2016-09-17,2018-10-19,500,mg,['/Month'], ,Persistence of relapses
5308,2755,Methylprednisolone,2016-06-30,2019-11-04,1000,mg,['/ Week'], ,Adverse Event
5309,2652,Rebif [44],2015-12-27,2021-09-10,400,mg,['2 / Day'], ,Lack of efficacy
5310,2652,Rebif [44],2016-03-11,2018-08-09,400,mg,['3 / Week'],IV,Persisting MRI activity
5311,2652,Ledertrexaat,2016-02-08,2020-02-03,5000,MIU,['3 / Week'], ,Adverse Event
5312,2652,Alemtuzumab (Campath),2016-02-03,2019-03-13,400, ,[' '], ,Patient Choice/Convenience
5313,4137,D-cure (Vitamine D),2016-04-30,2020-04-30, ,mg,['3 / Week'],Oral,Patient Choice/Convenience
5314,4137,Methylprednisolone,2016-03-29,2019-07-15, , ,['2 / Day'],IV,Adverse Event
5315,4137,Teriflunomide,2016-02-10,2021-04-12,1, ,['/Month'],IV,Adverse Event
5316,4137,IVIG,2016-05-04,2018-10-06, ,MIU,['2 / Day'], ,Adverse Event
5317,2712,Betaferon,2016-01-17,2018-10-25,5000, ,['2 / Day'],IV,Adverse Event
5318,2712,Avonex,2016-04-23,2018-10-22,500,mg,['2 / Day'], ,Persisting MRI activity
5319,123,Tecfidera,2016-02-17,,5000,MIU,['/ Week'], , 
5320,1817,Tysabri,2016-03-13,,500, ,['/ Week'], , 
5321,1817,Avonex,2016-03-29,2019-08-31, , ,['3 / Week'], ,Patient Choice/Convenience
5322,2155,IVIG,2016-05-20,,20,mg,['2 / Day'], , 
5323,3693,Tysabri,2015-11-24,, , ,['/Month'],IV, 
5324,1296,Tysabri,2015-11-29,2021-07-20,5000, ,['/Month'], ,Persistence of relapses
5325,1296,Methylprednisolone,2016-06-24,,500, ,['/ Day'],IV, 
5326,1296,Methylprednisolone,2016-09-30,,5000, ,['/Month'], , 
5327,4499,Gilenya,2016-08-06,2018-10-27,400, ,['/ Week'],Oral,Patient Choice/Convenience
5328,4499,Endoxan,2015-12-03,2020-04-27,500,MIU,['3 / Week'],Oral,Lack of efficacy
5329,4499,Copaxone,2016-01-03,,1000, ,['3 / Week'], , 
5330,249,Tecfidera,2016-04-18,2019-08-26,5000, ,['/Month'],IV,Persistence of relapses
5331,3457,Copaxone,2016-02-14,2019-12-27,300,mcg,['2 / Day'], ,Lack of efficacy
5332,3457,D-cure (Vitamine D),2016-01-02,2020-05-28,400, ,['2 / Day'],Oral,Persistence of relapses
5333,3457,Copaxone,2016-06-23,,5000,mg,['/Month'],IV, 
5334,3227,Gilenya,2015-11-10,,1, ,['2 / Day'],IV, 
5335,4629,Tecfidera,2016-04-27,, ,MIU,['/ Day'],IV, 
5336,4629,Copaxone,2016-03-05,, , ,['/ Week'],IV, 
5337,4629,Tecfidera,2016-03-24,2020-10-28,5000, ,['2 / Day'], ,Adverse Event
5338,1693,Tysabri,2016-04-20,, ,mg,['/Month'],IV, 
5339,1693,Rebif [44],2016-07-08,2020-10-07,1,mg,['2 / Day'],IV,Adverse Event
5340,1265,Tysabri,2016-08-26,, ,mg,['2 / Day'],IV, 
5341,1265,Methylprednisolone,2016-04-14,2018-09-13,5000,mg,['/Month'],Oral,Adverse Event
5342,1265,Avonex,2016-09-07,2021-02-16,500,mg,['/Month'],IV,Adverse Event
5343,2426,Endoxan,2016-06-04,,1,MIU,['/Month'], , 
5344,2426,Mitoxantrone,2016-06-06,2021-09-03,20,mg,['/Month'], ,Adverse Event
5345,2426,Ledertrexaat,2016-05-25,2018-07-08,1000,mg,['/Month'], ,Persisting MRI activity
5346,2426,Avonex,2016-04-23,2020-01-18,1000, ,['2 / Day'],IV,Adverse Event
5347,2702,D-cure (Vitamine D),2016-05-06,,500,mg,['/Month'],IV, 
5348,2702,Copaxone,2016-06-28,, ,mg,['/Month'], , 
5349,4011,Rebif [22],2016-07-03,2018-12-24,1000,mg,['/Month'],IV,Adverse Event
5350,4011,Betaferon,2015-12-13,2018-10-07, ,MIU,['/ Day'], ,Patient Choice/Convenience
5351,4011,Rebif [22],2016-09-09,, ,MIU,[' '],IV, 
5352,4011,Rebif [22],2016-01-04,2021-09-05,1000, ,['/ Week'], ,Adverse Event
5353,3544,Tysabri,2016-07-07,,400,mg,['/Month'], , 
5354,3544,Tecfidera,2016-02-15,,1000, ,[' '],IV, 
5355,3544,Rebif [22],2016-03-09,2021-04-23,500,MIU,['/ Week'], ,Adverse Event
5356,3544,IVIG,2016-08-24,2018-06-21,1, ,['/ Week'],IV,Patient Choice/Convenience
5357,3659,IVIG,2016-03-09,2020-01-20,300, ,['/ Day'],IV,Patient Choice/Convenience
5358,2857,D-cure (Vitamine D),2016-04-06,,500,mg,['/Month'],IV, 
5359,2857,Tysabri,2015-11-22,,5000,mcg,['/ Day'],IV, 
5360,2857,Endoxan,2015-12-02,, ,mg,['3 / Week'],Oral, 
5361,2857,Betaferon,2016-06-27,2018-04-22,20, ,[' '], ,Adverse Event
5362,232,D-cure (Vitamine D),2016-03-23,2020-08-17,20,mg,['3 / Week'],IV,Persistence of relapses
5363,232,Rebif [22],2016-02-29,,500, ,['3 / Week'],Oral, 
5364,232,Tecfidera,2016-07-06,, , ,['3 / Week'],IV, 
5365,4679,IVIG,2016-10-16,2020-03-27,1000,mg,['2 / Day'], ,Adverse Event
5366,4679,Betaferon,2016-07-24,2021-08-09,500, ,['/Month'], ,Patient Choice/Convenience
5367,4679,Gilenya,2016-08-09,,1,mg,['/Month'],IV, 
5368,3851,Alemtuzumab (Campath),2016-10-06,2020-02-05,5000,mg,['2 / Day'], ,Patient Choice/Convenience
5369,4029,Tecfidera,2016-01-23,2018-03-22,300,mg,['2 / Day'],IV,Persisting MRI activity
5370,4029,IVIG,2015-12-25,,1,MIU,['/ Day'], , 
5371,4029,Rebif [22],2016-03-07,, ,mg,[' '],IV, 
5372,3312,D-cure (Vitamine D),2015-11-14,,5000, ,['3 / Week'],IV, 
5373,2171,Tecfidera,2015-11-14,, ,mg,['2 / Day'],IV, 
5374,4957,Endoxan,2016-05-14,2020-11-23,20,mg,[' '], ,Adverse Event
5375,4957,Methylprednisolone,2015-11-19,, , ,['2 / Day'], , 
5376,4163,Teriflunomide,2016-05-15,,5000,mg,['/Month'], , 
5377,4163,D-cure (Vitamine D),2016-03-07,2018-08-04, ,mg,['/Month'],Oral,Lack of efficacy
5378,4163,Tecfidera,2016-07-16,2021-01-19,20,mg,['/Month'],IV,Persistence of relapses
5379,4704,Methylprednisolone,2016-02-02,2017-10-25, ,mg,['/Month'],IV,Persisting MRI activity
5380,4704,IVIG,2016-05-02,2020-01-14, , ,['2 / Day'], ,Adverse Event
5381,4704,Methylprednisolone,2016-06-24,,300, ,['2 / Day'], , 
5382,4704,D-cure (Vitamine D),2016-07-05,,5000, ,['/Month'], , 
5383,672,Mitoxantrone,2016-02-27,,300, ,['/ Week'],IV, 
5384,672,Ledertrexaat,2016-09-06,2018-07-17, ,MIU,['3 / Week'],IV,Persisting MRI activity
5385,672,Rebif [22],2016-08-03,,500, ,['/ Week'],IV, 
5386,672,Rebif [22],2016-04-09,2021-06-10,300,mg,['/Month'], ,Persisting MRI activity
5387,3083,Mitoxantrone,2015-10-24,,500,mg,['/Month'],IV, 
5388,3083,Avonex,2016-07-05,2018-09-17,20, ,['3 / Week'], ,Adverse Event
5389,3083,IVIG,2016-05-27,,300,mg,['/Month'], , 
5390,4508,D-cure (Vitamine D),2016-02-18,2017-12-10,1000,mg,['/Month'],IV,Lack of efficacy
5391,4508,D-cure (Vitamine D),2015-11-06,,300, ,['/Month'], , 
5392,1463,Alemtuzumab (Campath),2016-09-23,,1000,mg,['2 / Day'], , 
5393,1406,Rebif [22],2016-10-18,,20,MIU,['2 / Day'],IV, 
5394,1406,Tecfidera,2016-08-15,,1000,MIU,['/Month'],IV, 
5395,1406,Rebif [44],2016-10-19,,1000,mg,[' '],IV, 
5396,3199,Gilenya,2016-01-19,,1, ,['3 / Week'], , 
5397,3199,Rebif [44],2015-11-12,,1000,mg,['/Month'],Oral, 
5398,3199,Alemtuzumab (Campath),2016-02-27,2019-06-22,500, ,['2 / Day'],Oral,Persisting MRI activity
5399,3199,Methylprednisolone,2016-01-20,2019-04-22,20,MIU,['2 / Day'],IV,Lack of efficacy
5400,4272,Rebif [44],2016-01-03,2021-06-02,300,mg,['2 / Day'],IV,Persisting MRI activity
5401,4272,Betaferon,2016-03-30,,1,mg,[' '], , 
5402,177,Endoxan,2016-08-26,, ,MIU,['3 / Week'], , 
5403,177,Copaxone,2016-01-17,,20,mg,['/ Day'],IV, 
5404,177,IVIG,2015-11-20,,300,mg,['2 / Day'],IV, 
5405,177,IVIG,2015-11-13,, ,mg,['2 / Day'],IV, 
5406,1438,Rebif [22],2016-10-06,,500,mg,['/Month'], , 
5407,1438,Tysabri,2016-01-12,, ,mg,['/ Week'], , 
5408,1438,Betaferon,2016-09-09,2020-03-09,400, ,['3 / Week'], ,Lack of efficacy
5409,1783,Endoxan,2016-06-03,,5000, ,['3 / Week'],IV, 
5410,1783,Methylprednisolone,2015-11-09,, , ,['2 / Day'],IV, 
5411,2152,Alemtuzumab (Campath),2015-11-24,, ,mg,['2 / Day'],Oral, 
5412,2152,Avonex,2015-12-24,2019-06-08, ,mg,['/Month'],IV,Persistence of relapses
5413,493,IVIG,2016-08-23,2019-11-22,300, ,['2 / Day'], ,Patient Choice/Convenience
5414,493,Alemtuzumab (Campath),2016-02-27,, ,mg,['/ Day'],Oral, 
5415,1480,Rebif [44],2016-10-06,2019-02-05, , ,['/Month'], ,Adverse Event
5416,1480,Rebif [44],2015-12-14,, ,mg,['/Month'],IV, 
5417,1480,D-cure (Vitamine D),2016-10-19,2018-03-20, , ,['/ Week'], ,Persisting MRI activity
5418,1773,Avonex,2015-12-08,,500, ,['/Month'],IV, 
5419,1773,D-cure (Vitamine D),2016-10-13,,20,mg,['3 / Week'],Oral, 
5420,1773,Tysabri,2016-04-23,2021-02-04,1,mg,['2 / Day'],IV,Persisting MRI activity
5421,1401,Copaxone,2015-11-05,,500, ,['/Month'],Oral, 
5422,1401,Gilenya,2016-02-16,2020-11-25, ,MIU,['2 / Day'],IV,Adverse Event
5423,1401,Endoxan,2016-03-04,,1000,mg,['/ Week'],IV, 
5424,2777,Rebif [22],2016-05-09,,5000,mg,['2 / Day'], , 
5425,2248,Endoxan,2015-11-15,,400,mg,['/Month'],Oral, 
5426,2248,Betaferon,2016-09-10,2019-05-31,400,mg,['/Month'],IV,Patient Choice/Convenience
5427,2248,Gilenya,2016-01-12,,5000,mcg,['2 / Day'],Oral, 
5428,2248,Tysabri,2016-01-11,2020-12-09,1,mg,['3 / Week'],IV,Lack of efficacy
5429,4232,Endoxan,2016-04-11,,500,MIU,['2 / Day'],IV, 
5430,4679,Tecfidera,2016-06-22,,400,mg,['2 / Day'],IV, 
5431,4679,Avonex,2016-01-15,2019-06-05,1, ,['/Month'],IV,Adverse Event
5432,4679,Copaxone,2016-07-05,2019-03-28,1000,mg,['3 / Week'],IV,Lack of efficacy
5433,2454,Methylprednisolone,2016-07-30,2019-01-18,400,MIU,['/Month'],Oral,Persisting MRI activity
5434,4939,Gilenya,2015-11-03,2020-04-23,20, ,['3 / Week'], ,Persistence of relapses
5435,4939,Methylprednisolone,2016-07-01,2019-06-08,1, ,['/Month'], ,Patient Choice/Convenience
5436,4939,D-cure (Vitamine D),2015-11-15,2018-12-31,20,mg,['/Month'], ,Adverse Event
5437,4939,Tysabri,2016-06-28,,1,mg,['/ Week'], , 
5438,1647,Mitoxantrone,2016-06-05,2017-12-04,20,mg,['2 / Day'], ,Patient Choice/Convenience
5439,1647,Endoxan,2016-07-14,2019-12-05,20, ,['2 / Day'],IV,Patient Choice/Convenience
5440,1647,Ledertrexaat,2015-12-08,,5000,mg,['/ Day'],IV, 
5441,1647,Gilenya,2016-02-03,,500,MIU,['3 / Week'],IV, 
5442,2139,D-cure (Vitamine D),2016-08-03,,1000,mg,['2 / Day'],IV, 
5443,3480,IVIG,2015-12-03,,20,mg,['/ Day'],IV, 
5444,3480,Endoxan,2016-07-25,,1, ,['2 / Day'],IV, 
5445,3480,Copaxone,2016-08-20,,500,MIU,['/ Week'], , 
5446,3480,Alemtuzumab (Campath),2016-09-10,,20,mg,['3 / Week'],IV, 
5447,968,Alemtuzumab (Campath),2015-12-09,,500, ,['3 / Week'], , 
5448,3613,Betaferon,2016-05-14,,5000, ,['/ Week'], , 
5449,912,Ledertrexaat,2016-01-25,,500, ,['/Month'], , 
5450,912,Teriflunomide,2016-07-04,,20,mg,['/ Week'],Oral, 
5451,912,Alemtuzumab (Campath),2016-03-10,,20, ,['2 / Day'], , 
5452,4166,Tecfidera,2016-01-03,,5000,mg,['/ Day'],IV, 
5453,4166,Rebif [44],2016-01-03,,1, ,['/Month'],IV, 
5454,4166,Alemtuzumab (Campath),2016-09-26,,500, ,['2 / Day'],IV, 
5455,2185,Copaxone,2016-05-09,,1000,mg,['2 / Day'], , 
5456,2185,Endoxan,2016-09-07,2021-01-13,1000,mcg,['/Month'], ,Persisting MRI activity
5457,2185,Tecfidera,2015-12-14,,1, ,['/Month'],Oral, 
5458,2185,Ledertrexaat,2016-06-28,,1000,mcg,[' '], , 
5459,2412,Endoxan,2016-03-31,,400, ,['2 / Day'],IV, 
5460,2412,IVIG,2016-08-29,2018-09-24,500,mg,['/Month'], ,Lack of efficacy
5461,3229,IVIG,2016-09-28,2021-09-05,400, ,['/Month'], ,Persisting MRI activity
5462,3229,Rebif [44],2016-04-28,,500, ,['/Month'],IV, 
5463,3229,Copaxone,2015-11-23,,400,mg,['2 / Day'], , 
5464,3229,Alemtuzumab (Campath),2016-01-25,2018-10-13,1,MIU,['/Month'], ,Persisting MRI activity
5465,1312,Methylprednisolone,2016-02-06,2017-12-31,1,mg,['/Month'],IV,Persistence of relapses
5466,4362,IVIG,2016-04-13,2018-02-28,5000,MIU,['2 / Day'],IV,Persistence of relapses
5467,4362,Teriflunomide,2016-05-31,,5000,MIU,['/Month'], , 
5468,4362,Endoxan,2016-06-28,,300,mg,['2 / Day'], , 
5469,4362,Betaferon,2016-02-13,2020-11-02,300, ,['2 / Day'], ,Lack of efficacy
5470,3853,Methylprednisolone,2016-02-27,,300, ,['2 / Day'],Oral, 
5471,4071,Tecfidera,2015-11-03,2018-07-27,300,mg,['3 / Week'],IV,Persistence of relapses
5472,4071,Copaxone,2015-12-01,,1,mg,['2 / Day'],IV, 
5473,4847,Mitoxantrone,2015-11-16,, ,mg,['/Month'],IV, 
5474,4847,Gilenya,2016-06-19,, ,mg,['/ Week'], , 
5475,4381,Gilenya,2015-12-19,2021-06-17, , ,['/ Day'],IV,Persisting MRI activity
5476,4381,Endoxan,2015-12-07,, ,mg,['2 / Day'],IV, 
5477,1762,Copaxone,2016-06-14,, ,mg,['2 / Day'],IV, 
5478,2746,D-cure (Vitamine D),2015-11-10,, , ,['2 / Day'], , 
5479,2746,Mitoxantrone,2016-06-25,,500,mg,['/Month'], , 
5480,3599,Endoxan,2015-12-21,,1,mg,['/Month'],IV, 
5481,3599,Tecfidera,2016-04-15,,300, ,['/ Day'],IV, 
5482,3158,Methylprednisolone,2016-09-14,2020-05-08,300,mg,['2 / Day'],Oral,Persisting MRI activity
5483,3158,IVIG,2015-12-28,2018-09-24, ,mg,['/Month'], ,Patient Choice/Convenience
5484,3158,Tecfidera,2016-08-04,, ,mg,['2 / Day'], , 
5485,3158,D-cure (Vitamine D),2015-12-04,, ,mg,['2 / Day'], , 
5486,1350,Alemtuzumab (Campath),2015-12-26,2021-04-30, , ,['/Month'],IV,Persisting MRI activity
5487,1350,Ledertrexaat,2016-01-27,2020-10-17,300,mg,['3 / Week'],IV,Persistence of relapses
5488,3387,Tecfidera,2016-01-16,2019-10-03, , ,['3 / Week'], ,Persisting MRI activity
5489,3387,Rebif [22],2015-12-23,,500, ,['/ Day'],Oral, 
5490,1357,Mitoxantrone,2016-02-04,,300,mg,['2 / Day'],IV, 
5491,1357,Copaxone,2016-03-21,, , ,['2 / Day'],IV, 
5492,1357,Rebif [44],2016-04-06,2019-01-23,300, ,['/ Day'],IV,Persisting MRI activity
5493,1357,Avonex,2016-06-28,, , ,['/ Day'],IV, 
5494,963,Rebif [44],2016-01-11,, ,MIU,['3 / Week'],Oral, 
5495,963,Tecfidera,2016-04-13,2020-09-10,5000,MIU,['2 / Day'],IV,Lack of efficacy
5496,963,Tecfidera,2015-12-08,2018-09-13, ,mcg,['3 / Week'], ,Adverse Event
5497,153,D-cure (Vitamine D),2016-09-20,, , ,['2 / Day'], , 
5498,1944,D-cure (Vitamine D),2016-03-05,2020-04-20,300,mg,['2 / Day'],IV,Patient Choice/Convenience
5499,556,Gilenya,2016-01-24,,400,mg,['/Month'],IV, 
5500,556,D-cure (Vitamine D),2016-07-01,2020-07-23,20, ,['2 / Day'], ,Patient Choice/Convenience
5501,556,Gilenya,2016-10-20,2021-10-20,400,mg,['/Month'], ,Lack of efficacy
5502,556,Avonex,2016-08-26,2018-12-06, ,mg,['3 / Week'], ,Adverse Event
5503,2526,Avonex,2015-12-19,2018-06-13,300, ,['3 / Week'],IV,Adverse Event
5504,325,Gilenya,2015-12-22,,1,mg,['/Month'],IV, 
5505,325,Copaxone,2016-09-13,,5000, ,['2 / Day'],IV, 
5506,325,Gilenya,2016-03-28,,300,mg,['/ Day'],IV, 
5507,2204,Gilenya,2016-01-09,,1000, ,['3 / Week'], , 
5508,2204,Rebif [44],2016-08-30,2018-08-20,500,mg,['/Month'],IV,Adverse Event
5509,2204,Mitoxantrone,2015-11-20,2020-03-28, ,mg,['/Month'],IV,Persisting MRI activity
5510,937,D-cure (Vitamine D),2016-04-27,2020-05-05,1000,mg,['/Month'],Oral,Lack of efficacy
5511,937,D-cure (Vitamine D),2016-09-26,,1,MIU,['3 / Week'], , 
5512,937,Copaxone,2016-06-21,2021-10-03,300, ,['/ Week'], ,Adverse Event
5513,857,Alemtuzumab (Campath),2016-01-17,2018-10-31,500, ,['/Month'],IV,Adverse Event
5514,857,Avonex,2016-06-22,,1, ,[' '],Oral, 
5515,857,Teriflunomide,2015-11-17,2019-02-11, , ,[' '],Oral,Lack of efficacy
5516,857,Copaxone,2016-06-06,2018-05-17, ,mg,['2 / Day'],IV,Adverse Event
5517,2838,Methylprednisolone,2016-05-10,, ,MIU,['/Month'], , 
5518,2838,Ledertrexaat,2016-06-18,2021-06-25, ,mcg,['2 / Day'], ,Adverse Event
5519,3117,Alemtuzumab (Campath),2016-04-24,,500, ,['2 / Day'],IV, 
5520,2235,Tecfidera,2016-04-28,,400, ,['/Month'], , 
5521,2235,Tecfidera,2016-03-16,, ,mg,['/ Day'], , 
5522,2235,Alemtuzumab (Campath),2016-07-18,2019-11-09,1000, ,['2 / Day'],IV,Patient Choice/Convenience
5523,2235,Rebif [22],2015-11-06,2019-10-10,300,mg,['3 / Week'],IV,Patient Choice/Convenience
5524,3342,Tecfidera,2016-03-14,, ,mg,[' '],IV, 
5525,3342,Tecfidera,2016-06-02,2019-01-30, ,mcg,['2 / Day'],IV,Lack of efficacy
5526,3342,Rebif [22],2016-04-30,2020-07-10, ,MIU,['3 / Week'],IV,Lack of efficacy
5527,1085,Tecfidera,2016-04-01,,400,mcg,['3 / Week'], , 
5528,1085,Gilenya,2016-07-25,2019-05-28,1,mg,['/Month'], ,Lack of efficacy
5529,4814,Rebif [44],2016-08-23,,20,mg,['2 / Day'],IV, 
5530,4814,Gilenya,2016-06-07,2018-09-04,20,mg,['/Month'],Oral,Persisting MRI activity
5531,4664,Rebif [22],2016-07-28,, ,mg,['/Month'],IV, 
5532,4664,Rebif [22],2016-06-04,2020-10-28, ,mg,['/Month'], ,Persisting MRI activity
5533,2037,Avonex,2016-09-25,,1,mg,['/ Day'], , 
5534,143,IVIG,2016-04-03,, ,mg,['2 / Day'],Oral, 
5535,1855,Ledertrexaat,2016-09-09,, ,mg,['2 / Day'], , 
5536,1855,Avonex,2016-07-01,, ,mg,['2 / Day'],IV, 
5537,1855,D-cure (Vitamine D),2016-08-04,,1000,mg,[' '], , 
5538,2793,Tecfidera,2016-01-05,2019-01-06,20, ,['3 / Week'], ,Adverse Event
5539,2793,Endoxan,2016-10-04,2018-04-23,1,mg,['/Month'],IV,Lack of efficacy
5540,2793,Alemtuzumab (Campath),2015-11-26,, ,MIU,['/Month'],IV, 
5541,2793,Alemtuzumab (Campath),2015-12-15,, ,mg,['/ Week'],IV, 
5542,913,Ledertrexaat,2015-12-02,, , ,['3 / Week'], , 
5543,913,Betaferon,2016-09-11,2018-09-28,1000, ,['2 / Day'],Oral,Patient Choice/Convenience
5544,913,Rebif [44],2016-06-28,,500,mg,['/Month'], , 
5545,913,Gilenya,2016-08-07,,1, ,['3 / Week'],IV, 
5546,4377,Copaxone,2016-08-20,,1000,mg,['2 / Day'], , 
5547,4377,Ledertrexaat,2016-04-14,,1000,mg,['/Month'],IV, 
5548,4377,Rebif [44],2016-04-02,2020-05-01,400,mg,[' '],Oral,Persisting MRI activity
5549,4377,Alemtuzumab (Campath),2015-11-28,2021-09-29, ,mg,['2 / Day'],IV,Patient Choice/Convenience
5550,1758,Tecfidera,2016-10-03,2019-01-30,300, ,['2 / Day'],IV,Lack of efficacy
5551,1758,Alemtuzumab (Campath),2016-04-28,2021-01-10, ,MIU,['/ Week'],Oral,Patient Choice/Convenience
5552,2273,Teriflunomide,2016-10-03,, ,mg,['2 / Day'],IV, 
5553,2273,Methylprednisolone,2016-01-16,2018-09-29, , ,['2 / Day'],Oral,Persistence of relapses
5554,1352,Gilenya,2016-05-24,, , ,[' '], , 
5555,1352,D-cure (Vitamine D),2016-03-09,2018-10-16, ,mg,['/ Week'],IV,Adverse Event
5556,1352,Alemtuzumab (Campath),2016-09-04,2019-04-01,500,mg,['/Month'], ,Adverse Event
5557,1352,Rebif [44],2016-03-11,,400,MIU,['/Month'],Oral, 
5558,1693,Methylprednisolone,2015-12-07,,400,mg,['/Month'],Oral, 
5559,3560,Tysabri,2016-09-09,2018-03-21,20, ,['/ Day'], ,Persistence of relapses
5560,752,IVIG,2015-11-15,,1,mg,['2 / Day'],IV, 
5561,752,Rebif [22],2016-01-17,,300, ,['2 / Day'], , 
5562,752,Rebif [44],2016-08-16,,400,mg,['/ Day'], , 
5563,752,IVIG,2016-08-07,2020-10-07,5000,mcg,['3 / Week'], ,Lack of efficacy
5564,1434,IVIG,2016-01-19,2021-06-03,500,mg,['3 / Week'], ,Patient Choice/Convenience
5565,1434,Gilenya,2016-02-25,2019-04-19, ,mg,['2 / Day'], ,Patient Choice/Convenience
5566,1434,Alemtuzumab (Campath),2016-07-13,2020-06-08,400,mg,['/Month'], ,Persisting MRI activity
5567,1434,Ledertrexaat,2015-11-23,,400,mg,['/ Day'], , 
5568,3467,Gilenya,2016-01-07,,20,mg,['/ Week'], , 
5569,3467,Avonex,2016-03-30,,300,mg,[' '],IV, 
5570,3467,Betaferon,2016-06-09,2020-08-24,500,mcg,['/ Day'], ,Adverse Event
5571,3467,Rebif [44],2016-06-02,,400, ,[' '],IV, 
5572,3855,Endoxan,2015-12-04,,500,mg,['2 / Day'],IV, 
5573,3855,Alemtuzumab (Campath),2016-07-13,,5000,mcg,['3 / Week'],IV, 
5574,3855,Rebif [22],2016-09-26,2018-06-04,1000, ,['3 / Week'], ,Lack of efficacy
5575,3855,Tysabri,2016-03-21,,500,mg,['2 / Day'],IV, 
5576,148,Rebif [22],2016-07-06,,500, ,['2 / Day'],IV, 
5577,2850,Methylprednisolone,2016-06-11,2017-11-24,300, ,['/Month'], ,Lack of efficacy
5578,2850,Rebif [44],2016-08-28,, , ,['/Month'], , 
5579,2850,Alemtuzumab (Campath),2016-07-02,2020-10-29, , ,['2 / Day'], ,Patient Choice/Convenience
5580,2850,Rebif [44],2016-07-06,2018-01-30, ,MIU,[' '], ,Patient Choice/Convenience
5581,2123,D-cure (Vitamine D),2016-10-21,,5000,mg,['/Month'], , 
5582,2123,IVIG,2016-10-16,2018-02-02,20,MIU,['/ Day'],IV,Persistence of relapses
5583,2059,Gilenya,2016-03-05,, , ,['/Month'],IV, 
5584,2059,Methylprednisolone,2016-10-13,,1000,MIU,['/Month'],IV, 
5585,2059,Rebif [22],2016-02-19,,5000, ,[' '], , 
5586,2059,Copaxone,2016-02-10,,1,MIU,['2 / Day'], , 
5587,2288,D-cure (Vitamine D),2016-07-07,2019-05-28,5000, ,[' '],IV,Persistence of relapses
5588,2288,Rebif [22],2016-07-07,2019-08-26, ,mg,['3 / Week'],IV,Patient Choice/Convenience
5589,2288,Tecfidera,2015-12-12,2020-06-16, ,mg,['3 / Week'],IV,Persisting MRI activity
5590,2288,Endoxan,2016-06-26,2020-03-13, ,mg,['/Month'],IV,Adverse Event
5591,3084,Rebif [22],2016-08-30,, ,mg,['/Month'],Oral, 
5592,3084,IVIG,2016-08-24,2017-11-26,20, ,['2 / Day'],IV,Patient Choice/Convenience
5593,3550,Rebif [44],2016-08-22,, , ,['/Month'], , 
5594,3550,Avonex,2016-06-11,2018-08-25,500,mg,['/Month'],IV,Persisting MRI activity
5595,2745,Tecfidera,2016-03-11,,500,mcg,['2 / Day'], , 
5596,1131,Tysabri,2015-12-02,2020-01-24,5000, ,['2 / Day'],Oral,Persistence of relapses
5597,1131,Tysabri,2015-12-20,,500,mg,['/Month'], , 
5598,3619,Endoxan,2015-11-17,,1000,mg,['/ Day'],IV, 
5599,3619,Alemtuzumab (Campath),2016-04-16,,1000, ,['2 / Day'],IV, 
5600,3619,Tysabri,2015-11-02,,500,mg,['/ Week'],Oral, 
5601,3619,Tecfidera,2015-12-19,,1,mcg,['2 / Day'],IV, 
5602,861,Rebif [44],2016-07-23,,500,MIU,['2 / Day'],Oral, 
5603,861,Rebif [44],2016-09-04,, ,mg,[' '], , 
5604,861,IVIG,2016-07-14,2021-09-22,500,mg,['3 / Week'],IV,Patient Choice/Convenience
5605,861,Rebif [44],2016-05-16,, ,mg,['2 / Day'], , 
5606,2731,Rebif [44],2016-05-26,,20,mg,[' '],IV, 
5607,1295,Endoxan,2016-04-18,2021-06-03,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
5608,1295,Ledertrexaat,2016-06-13,2021-03-10,500, ,['2 / Day'],IV,Persisting MRI activity
5609,4308,Tecfidera,2015-12-25,2019-09-07,500,mg,['/ Week'],Oral,Persisting MRI activity
5610,4308,D-cure (Vitamine D),2016-10-21,2018-04-29,1000, ,[' '],Oral,Lack of efficacy
5611,4308,Alemtuzumab (Campath),2016-03-31,,400, ,['/Month'], , 
5612,3352,D-cure (Vitamine D),2016-04-10,2021-08-11,1000,mg,['2 / Day'],Oral,Persistence of relapses
5613,3352,Tecfidera,2015-12-08,2018-11-26, , ,['/Month'],IV,Patient Choice/Convenience
5614,814,Rebif [44],2016-02-10,2019-08-27,500,mg,['2 / Day'], ,Persisting MRI activity
5615,1089,Teriflunomide,2016-07-07,,300,mg,['/ Day'], , 
5616,2531,D-cure (Vitamine D),2016-03-03,2018-11-08,1000, ,['2 / Day'], ,Persistence of relapses
5617,2531,Rebif [22],2016-07-01,, ,mg,['3 / Week'],Oral, 
5618,541,Rebif [44],2015-11-23,, ,mg,['/Month'], , 
5619,541,Avonex,2016-09-09,2020-12-09,20, ,['/Month'],IV,Adverse Event
5620,541,Teriflunomide,2016-03-03,, ,mg,['2 / Day'],IV, 
5621,541,Gilenya,2015-12-09,,400,MIU,['2 / Day'],IV, 
5622,632,Gilenya,2015-12-26,,500,mg,['/Month'], , 
5623,632,IVIG,2016-06-05,2020-08-05,20, ,['2 / Day'],IV,Lack of efficacy
5624,3301,Rebif [22],2016-06-10,, , ,['/Month'],IV, 
5625,3301,Tecfidera,2016-01-19,,300, ,['/ Day'],IV, 
5626,1756,D-cure (Vitamine D),2016-04-13,2018-04-05,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
5627,1060,Teriflunomide,2016-09-27,, ,mcg,['/ Day'],IV, 
5628,1060,Alemtuzumab (Campath),2015-11-12,,300,mcg,['/Month'],Oral, 
5629,1060,Tecfidera,2016-01-30,,1000,mg,[' '],IV, 
5630,2388,Methylprednisolone,2016-08-08,2020-08-08,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
5631,4362,Teriflunomide,2016-06-29,, , ,[' '], , 
5632,4362,Methylprednisolone,2016-05-24,,1000,mcg,['/Month'],IV, 
5633,1472,Alemtuzumab (Campath),2016-09-20,, , ,['/ Day'], , 
5634,1472,Gilenya,2016-01-18,2021-08-21,300,mg,['/Month'], ,Persistence of relapses
5635,1472,Gilenya,2015-11-21,, , ,['3 / Week'],IV, 
5636,1472,Copaxone,2016-03-19,,300, ,['/ Day'], , 
5637,2173,IVIG,2016-09-03,,1,mg,['3 / Week'],IV, 
5638,2173,Betaferon,2016-03-08,2018-10-27,20,mg,[' '],Oral,Persisting MRI activity
5639,2173,Methylprednisolone,2015-12-30,2021-06-05, ,mg,['/ Day'],IV,Adverse Event
5640,4332,Ledertrexaat,2015-12-26,2019-09-08,1000, ,['2 / Day'],IV,Patient Choice/Convenience
5641,4332,Methylprednisolone,2016-07-28,2019-01-13,20,mg,['2 / Day'],IV,Persisting MRI activity
5642,4332,Teriflunomide,2016-03-26,2020-04-28,400,mg,['2 / Day'], ,Patient Choice/Convenience
5643,208,D-cure (Vitamine D),2016-08-06,2019-11-21,300,mg,['3 / Week'],IV,Lack of efficacy
5644,208,Methylprednisolone,2016-03-01,,5000,mg,['3 / Week'], , 
5645,208,Rebif [44],2016-07-15,2020-11-05, ,mcg,['2 / Day'],IV,Persisting MRI activity
5646,208,Tecfidera,2016-04-08,2019-05-24,5000, ,['/Month'],IV,Patient Choice/Convenience
5647,2248,Rebif [22],2016-04-18,2020-01-26,500, ,['3 / Week'],Oral,Adverse Event
5648,2248,Methylprednisolone,2016-08-19,,1,mg,['2 / Day'],IV, 
5649,2248,Tysabri,2016-09-11,2021-07-19, , ,['3 / Week'], ,Adverse Event
5650,2248,Rebif [44],2016-05-27,2017-11-11,1000,MIU,['/Month'], ,Persistence of relapses
5651,4298,Tysabri,2016-09-06,2020-09-23,400, ,['/ Day'],IV,Adverse Event
5652,4298,Mitoxantrone,2016-03-03,,1, ,['/Month'],IV, 
5653,369,Rebif [44],2016-03-27,, ,mg,['/Month'],IV, 
5654,369,Gilenya,2016-07-28,2019-07-03,1000,mg,[' '],IV,Lack of efficacy
5655,1659,Tysabri,2016-03-09,, , ,['2 / Day'],Oral, 
5656,1659,Copaxone,2015-11-24,2021-04-16,500,MIU,[' '],IV,Adverse Event
5657,3693,Mitoxantrone,2016-01-14,,300,mg,['3 / Week'], , 
5658,3693,Methylprednisolone,2016-03-06,,1000, ,['/Month'],IV, 
5659,3693,Tysabri,2015-12-05,,5000, ,[' '],IV, 
5660,2540,Rebif [22],2016-04-06,, ,mg,['3 / Week'],Oral, 
5661,2540,Alemtuzumab (Campath),2016-07-29,,400,mg,['2 / Day'],IV, 
5662,2540,Avonex,2015-12-27,2020-09-09,20,mcg,['/Month'],IV,Adverse Event
5663,2540,Tysabri,2016-04-25,, , ,['/Month'], , 
5664,1979,Gilenya,2016-02-26,, ,mg,['3 / Week'],Oral, 
5665,1979,Teriflunomide,2016-05-12,,1000, ,['/Month'],Oral, 
5666,2111,IVIG,2016-10-03,,300,mg,[' '], , 
5667,2111,Tecfidera,2016-10-10,2017-12-16,1,mg,['2 / Day'], ,Adverse Event
5668,2111,Tysabri,2016-09-11,2021-04-02, ,mg,['/Month'], ,Adverse Event
5669,1377,IVIG,2015-12-08,,500, ,['2 / Day'], , 
5670,1377,Rebif [44],2015-11-15,2021-06-04,300,mg,['2 / Day'],IV,Persistence of relapses
5671,1377,D-cure (Vitamine D),2016-01-29,,400, ,['/Month'], , 
5672,3485,Teriflunomide,2016-06-20,2020-04-25,500,MIU,['2 / Day'],IV,Lack of efficacy
5673,3485,IVIG,2016-03-24,2020-01-23,1000,mg,['/Month'], ,Persistence of relapses
5674,3485,Alemtuzumab (Campath),2015-12-21,, , ,['/ Week'], , 
5675,1608,D-cure (Vitamine D),2016-05-29,, , ,['/Month'],Oral, 
5676,1608,Alemtuzumab (Campath),2016-01-08,,5000,mg,['3 / Week'],IV, 
5677,2629,Avonex,2016-01-23,,300, ,['/ Week'],IV, 
5678,2629,IVIG,2016-04-12,, , ,['/ Day'], , 
5679,2629,Avonex,2016-08-08,, ,mcg,['2 / Day'],IV, 
5680,2629,IVIG,2016-01-14,, ,MIU,[' '],IV, 
5681,3918,Tecfidera,2016-03-30,2018-06-28,300, ,['/ Day'],Oral,Adverse Event
5682,3918,Betaferon,2016-08-29,, , ,['/ Week'],IV, 
5683,563,Avonex,2016-02-01,,1000, ,['/Month'],IV, 
5684,563,Copaxone,2016-07-11,2019-05-24,400,mg,['/ Day'], ,Adverse Event
5685,563,Betaferon,2016-07-18,2021-01-07,1, ,['/Month'],Oral,Lack of efficacy
5686,3113,Rebif [44],2016-05-02,, , ,['/Month'],IV, 
5687,4650,Tecfidera,2016-01-29,,20,mg,['3 / Week'],IV, 
5688,4650,Tecfidera,2016-09-09,2019-05-02,300,mcg,['/Month'], ,Persisting MRI activity
5689,1010,Teriflunomide,2016-01-26,2018-07-06,500,mg,['/ Day'],IV,Patient Choice/Convenience
5690,1010,Alemtuzumab (Campath),2016-07-30,, ,mg,['3 / Week'],IV, 
5691,1010,Avonex,2015-11-28,, , ,[' '],IV, 
5692,1010,Copaxone,2016-08-05,,400,mg,['/Month'], , 
5693,2747,Rebif [22],2016-05-13,2019-03-18, ,mg,['3 / Week'], ,Persistence of relapses
5694,2747,Copaxone,2016-02-18,2020-11-12,5000,mg,['/Month'],IV,Adverse Event
5695,2747,Gilenya,2016-10-09,2020-06-04,5000, ,['/Month'],IV,Lack of efficacy
5696,3032,Tecfidera,2016-04-11,,1000,mg,[' '], , 
5697,3828,D-cure (Vitamine D),2016-07-09,2017-11-06,5000,mg,['2 / Day'],IV,Persistence of relapses
5698,3897,Rebif [22],2016-06-15,,300,mg,['/Month'], , 
5699,1245,Rebif [44],2016-05-11,, ,mcg,[' '],IV, 
5700,1245,Mitoxantrone,2016-01-05,,1000,mg,['2 / Day'],Oral, 
5701,1245,Endoxan,2015-12-10,2021-05-12, ,mcg,['/Month'],IV,Persistence of relapses
5702,1245,Alemtuzumab (Campath),2016-01-14,2018-03-06,400,mg,['2 / Day'],IV,Patient Choice/Convenience
5703,4167,Avonex,2016-02-02,2019-04-22,20, ,['/ Day'],Oral,Patient Choice/Convenience
5704,768,Mitoxantrone,2016-08-07,2018-04-22,5000,MIU,['2 / Day'], ,Persisting MRI activity
5705,768,Avonex,2016-08-29,2020-08-11,1000,mg,['/Month'], ,Patient Choice/Convenience
5706,271,Endoxan,2016-03-17,,300,mcg,['2 / Day'], , 
5707,271,Tecfidera,2016-01-16,,5000,mg,[' '], , 
5708,271,Endoxan,2016-05-18,2021-03-10, ,mg,['3 / Week'], ,Lack of efficacy
5709,4735,Rebif [22],2016-03-13,2018-10-30, ,mg,['2 / Day'], ,Adverse Event
5710,4735,Tecfidera,2016-01-01,, ,mg,['2 / Day'], , 
5711,4735,Tecfidera,2016-06-28,2019-10-12,1000, ,['2 / Day'],Oral,Patient Choice/Convenience
5712,4735,IVIG,2016-08-17,2018-01-13,1000, ,['/ Day'], ,Persisting MRI activity
5713,996,IVIG,2016-05-01,2019-11-06,20,mcg,['/Month'],IV,Adverse Event
5714,768,Mitoxantrone,2016-04-12,2020-05-24, , ,['/Month'],IV,Adverse Event
5715,768,Teriflunomide,2016-01-02,,500,MIU,['2 / Day'],IV, 
5716,768,Mitoxantrone,2016-03-24,, ,MIU,['3 / Week'],IV, 
5717,768,IVIG,2016-01-15,2018-09-08,5000,mg,['/ Week'], ,Patient Choice/Convenience
5718,1584,Teriflunomide,2016-02-09,2019-01-11,300, ,['2 / Day'],Oral,Persistence of relapses
5719,1584,Rebif [44],2015-11-21,2018-06-13, ,mg,['2 / Day'], ,Adverse Event
5720,1556,D-cure (Vitamine D),2016-06-15,,300, ,[' '],IV, 
5721,1556,IVIG,2016-05-28,, ,mg,['2 / Day'],IV, 
5722,1556,IVIG,2016-01-21,,20, ,[' '],IV, 
5723,1556,Copaxone,2016-09-15,,300, ,[' '],IV, 
5724,1116,Tecfidera,2016-01-18,,500,mg,[' '],IV, 
5725,1116,IVIG,2016-05-04,, ,MIU,['3 / Week'], , 
5726,1781,Ledertrexaat,2015-11-19,2018-04-26,1000,mg,['/Month'], ,Adverse Event
5727,1781,Alemtuzumab (Campath),2015-12-26,2018-10-13,500,mg,[' '],IV,Persistence of relapses
5728,3291,Copaxone,2016-08-14,2021-06-29,300,mg,['2 / Day'], ,Lack of efficacy
5729,3492,Teriflunomide,2016-09-17,,5000,mcg,['2 / Day'],IV, 
5730,3492,Endoxan,2016-08-19,2020-11-27, ,MIU,['/ Week'], ,Lack of efficacy
5731,3492,Tysabri,2015-12-28,,500, ,['2 / Day'],IV, 
5732,3492,Betaferon,2016-08-21,,500,mg,['3 / Week'], , 
5733,427,Mitoxantrone,2016-01-29,,500, ,['/Month'], , 
5734,427,Avonex,2016-07-15,,1000,MIU,['2 / Day'], , 
5735,4267,Gilenya,2016-05-19,, ,MIU,['3 / Week'],IV, 
5736,4267,Tysabri,2015-12-25,, , ,['2 / Day'],Oral, 
5737,1487,Betaferon,2015-11-15,,400,mg,[' '],IV, 
5738,1487,Rebif [44],2016-07-23,, ,mg,['/Month'], , 
5739,1487,D-cure (Vitamine D),2016-07-03,2019-02-06,500,mg,['/Month'], ,Adverse Event
5740,3083,Alemtuzumab (Campath),2015-11-24,,5000,MIU,['/Month'], , 
5741,4311,Rebif [44],2016-05-06,,500,mg,['/Month'],Oral, 
5742,4311,Gilenya,2016-04-09,2021-02-06,400,mg,['/Month'], ,Adverse Event
5743,1358,D-cure (Vitamine D),2016-01-04,,400,MIU,[' '],IV, 
5744,2609,Endoxan,2016-09-24,2019-10-26,5000, ,['2 / Day'], ,Adverse Event
5745,2609,Tysabri,2016-03-01,2017-11-29,300, ,['2 / Day'], ,Patient Choice/Convenience
5746,2609,Copaxone,2016-08-12,2020-01-22,20,mg,['/ Week'], ,Patient Choice/Convenience
5747,2609,D-cure (Vitamine D),2016-08-20,,500,mg,[' '], , 
5748,2351,Teriflunomide,2016-07-27,,500,mg,['/Month'],IV, 
5749,3205,Ledertrexaat,2016-05-05,2018-10-06,300,mg,['/Month'], ,Lack of efficacy
5750,3205,Copaxone,2016-09-07,,500,mg,['2 / Day'], , 
5751,3205,Copaxone,2016-04-05,, ,MIU,[' '],IV, 
5752,3205,Teriflunomide,2016-08-12,, ,mg,['2 / Day'],Oral, 
5753,3018,Mitoxantrone,2016-07-22,2019-02-26,1, ,['/ Day'],IV,Adverse Event
5754,3018,D-cure (Vitamine D),2016-02-16,2019-05-31, ,mg,['/ Day'], ,Patient Choice/Convenience
5755,3018,Methylprednisolone,2015-12-01,2020-04-08,20,mg,['2 / Day'], ,Patient Choice/Convenience
5756,3018,IVIG,2016-07-01,, , ,['/Month'],IV, 
5757,3266,Ledertrexaat,2015-12-14,,1, ,['2 / Day'], , 
5758,626,Gilenya,2015-11-08,2020-08-04,20,mg,['3 / Week'],IV,Adverse Event
5759,626,Methylprednisolone,2016-03-01,,5000,mg,['/Month'],IV, 
5760,626,Rebif [44],2016-09-02,2020-12-03, ,mg,[' '], ,Adverse Event
5761,626,Alemtuzumab (Campath),2015-11-12,2021-02-07, , ,['/Month'],IV,Adverse Event
5762,1585,Gilenya,2016-06-09,2019-05-20, , ,['2 / Day'], ,Lack of efficacy
5763,1585,Endoxan,2016-03-20,, , ,['3 / Week'],IV, 
5764,1585,Rebif [44],2016-02-27,2018-06-12, ,mcg,['/ Day'],IV,Persisting MRI activity
5765,1085,Teriflunomide,2016-07-29,2020-12-23, , ,['/Month'], ,Lack of efficacy
5766,3650,Ledertrexaat,2016-03-19,,500, ,['3 / Week'], , 
5767,2744,IVIG,2016-04-11,,1000,MIU,['2 / Day'],IV, 
5768,4214,D-cure (Vitamine D),2016-09-19,2020-09-04,400,mg,['/Month'],Oral,Persistence of relapses
5769,4214,D-cure (Vitamine D),2016-01-07,2018-08-21,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
5770,4214,Methylprednisolone,2016-09-04,2020-05-23,20, ,['3 / Week'],IV,Persistence of relapses
5771,4214,D-cure (Vitamine D),2016-09-24,,500,mg,['/Month'], , 
5772,1575,Ledertrexaat,2016-06-04,,300, ,['2 / Day'],IV, 
5773,1575,Alemtuzumab (Campath),2016-05-16,2019-05-07,1000,MIU,['/ Week'], ,Adverse Event
5774,1575,Betaferon,2016-07-22,2021-05-06,1000,mg,['/Month'], ,Adverse Event
5775,3060,Tysabri,2016-08-23,,300,mg,['/Month'], , 
5776,3060,D-cure (Vitamine D),2015-12-29,2020-10-03, ,mg,['/ Day'], ,Persisting MRI activity
5777,3060,Mitoxantrone,2016-07-24,, ,mg,['3 / Week'],IV, 
5778,3060,Methylprednisolone,2016-03-11,,500,mg,['/ Day'],IV, 
5779,672,Betaferon,2015-12-16,, ,mcg,['2 / Day'],IV, 
5780,4534,Rebif [44],2016-03-28,2018-04-06,1,mg,['/Month'],IV,Lack of efficacy
5781,4534,Alemtuzumab (Campath),2016-03-17,2018-10-25,20, ,['2 / Day'],IV,Lack of efficacy
5782,4534,Rebif [22],2015-12-06,,500,mg,['3 / Week'],IV, 
5783,2978,Gilenya,2016-03-09,, , ,['2 / Day'],IV, 
5784,3050,Alemtuzumab (Campath),2016-04-07,,500, ,['/Month'],IV, 
5785,811,Tecfidera,2015-12-29,,400, ,[' '], , 
5786,811,Gilenya,2016-02-07,2020-01-26,400, ,['/Month'], ,Adverse Event
5787,811,IVIG,2016-02-15,,5000,mcg,['/Month'], , 
5788,965,Endoxan,2016-07-01,2020-02-16,1000, ,[' '], ,Adverse Event
5789,965,Rebif [44],2016-05-10,,20, ,['/Month'],IV, 
5790,965,D-cure (Vitamine D),2016-06-12,,300,MIU,['2 / Day'], , 
5791,965,Copaxone,2016-01-22,,500,MIU,['2 / Day'],IV, 
5792,239,Methylprednisolone,2016-03-16,, , ,['/ Day'],IV, 
5793,239,Rebif [44],2016-08-04,,500,mg,['2 / Day'],IV, 
5794,239,Rebif [44],2016-01-10,, , ,['/Month'],IV, 
5795,4787,IVIG,2016-08-16,2020-08-29, , ,['3 / Week'],IV,Lack of efficacy
5796,4154,Avonex,2016-02-21,2020-03-02,20,MIU,['2 / Day'],IV,Lack of efficacy
5797,4154,Endoxan,2016-08-16,2018-03-29,500,mg,['/Month'],IV,Persisting MRI activity
5798,4154,Endoxan,2016-05-02,2018-06-10,300,mg,['3 / Week'], ,Persisting MRI activity
5799,4154,Tecfidera,2016-05-06,2020-07-24,1000,mg,['/Month'], ,Patient Choice/Convenience
5800,3980,Avonex,2016-06-09,2018-08-03, , ,['/Month'],IV,Persisting MRI activity
5801,3980,Methylprednisolone,2016-07-18,,1,mcg,['/Month'],IV, 
5802,1822,Gilenya,2015-11-21,2019-06-29,20,MIU,['3 / Week'], ,Adverse Event
5803,2396,Rebif [44],2016-07-17,,400, ,['2 / Day'],Oral, 
5804,2396,Tecfidera,2015-12-13,2018-08-24,1,MIU,['/Month'],IV,Adverse Event
5805,2396,Alemtuzumab (Campath),2016-09-21,, ,MIU,['/Month'], , 
5806,3070,Methylprednisolone,2016-05-13,2017-11-17,20,MIU,[' '],Oral,Lack of efficacy
5807,2968,Gilenya,2015-11-11,2017-10-30, ,mcg,['/Month'],IV,Persisting MRI activity
5808,1762,Gilenya,2016-04-24,2018-03-28,20,MIU,['/ Week'], ,Persisting MRI activity
5809,1762,D-cure (Vitamine D),2016-03-13,, , ,['3 / Week'],IV, 
5810,1762,Tecfidera,2016-04-27,2020-05-11, , ,[' '],IV,Adverse Event
5811,1170,Rebif [22],2016-06-30,2021-04-12,400, ,['/Month'], ,Lack of efficacy
5812,1170,Rebif [44],2015-12-04,,300,mg,['/ Day'],IV, 
5813,1170,Tysabri,2016-08-27,2019-02-07,20, ,['2 / Day'],IV,Adverse Event
5814,4797,Copaxone,2016-05-16,,5000,mg,['/Month'], , 
5815,3318,Gilenya,2016-01-04,,20, ,[' '],Oral, 
5816,3218,Avonex,2016-06-30,,20, ,['2 / Day'],IV, 
5817,3218,Tecfidera,2015-11-23,,1000, ,['/ Day'],IV, 
5818,4197,D-cure (Vitamine D),2016-07-08,,5000,mg,['3 / Week'],Oral, 
5819,4197,Endoxan,2016-09-01,2020-10-25, , ,[' '],IV,Lack of efficacy
5820,3962,Rebif [22],2016-08-26,, ,mg,['/ Day'],IV, 
5821,3962,Tysabri,2015-12-29,2021-05-04,5000,mg,['/Month'],IV,Patient Choice/Convenience
5822,3962,Methylprednisolone,2016-09-23,,5000,MIU,['3 / Week'],IV, 
5823,2369,Teriflunomide,2016-02-01,2021-06-25, , ,[' '],IV,Lack of efficacy
5824,2369,Gilenya,2016-02-03,,300,mg,['/ Day'], , 
5825,2369,Gilenya,2016-03-30,,500,MIU,['2 / Day'], , 
5826,2369,Gilenya,2016-08-11,,300,MIU,[' '], , 
5827,2121,Endoxan,2016-05-10,,400,MIU,['/Month'], , 
5828,2217,Rebif [22],2015-12-15,,1000,mg,['/Month'],IV, 
5829,3944,Betaferon,2016-07-11,, ,mg,['2 / Day'],IV, 
5830,3944,Methylprednisolone,2016-03-04,,1000, ,['2 / Day'],IV, 
5831,3567,Tecfidera,2016-09-13,,1000,MIU,['/Month'], , 
5832,4653,Tecfidera,2016-01-06,, ,MIU,['2 / Day'],Oral, 
5833,1059,Mitoxantrone,2016-03-30,,20,mg,['2 / Day'],IV, 
5834,968,D-cure (Vitamine D),2016-03-08,, ,mg,[' '],IV, 
5835,968,D-cure (Vitamine D),2016-02-14,2018-12-08,20,mg,['/Month'],Oral,Adverse Event
5836,4890,Rebif [44],2016-05-22,,1,MIU,['2 / Day'], , 
5837,4890,Teriflunomide,2016-08-18,,20, ,['/ Day'],IV, 
5838,2885,Gilenya,2016-03-27,, ,mg,['/Month'], , 
5839,2885,Tecfidera,2015-12-04,2019-11-27,5000, ,['2 / Day'],IV,Persistence of relapses
5840,1206,D-cure (Vitamine D),2016-01-04,, ,mg,['/ Day'], , 
5841,1206,Tecfidera,2015-11-28,, ,mg,['/Month'],IV, 
5842,1206,Ledertrexaat,2016-03-21,, ,mg,['2 / Day'],IV, 
5843,3334,Gilenya,2016-06-07,,5000, ,['/Month'], , 
5844,3431,Betaferon,2016-06-23,,5000, ,[' '],IV, 
5845,3431,Ledertrexaat,2016-05-27,,1,MIU,[' '],IV, 
5846,3431,Endoxan,2016-07-02,, ,mg,['2 / Day'],IV, 
5847,3431,Teriflunomide,2015-11-12,, , ,['2 / Day'], , 
5848,3049,Methylprednisolone,2015-11-19,2019-11-07, ,mg,['2 / Day'],IV,Adverse Event
5849,1853,Methylprednisolone,2016-06-02,2019-03-03,20,mg,['/Month'],Oral,Patient Choice/Convenience
5850,1853,Gilenya,2016-10-11,2020-12-29,5000,MIU,['3 / Week'],IV,Persistence of relapses
5851,1853,Teriflunomide,2016-08-20,2018-08-08,20, ,['/Month'],IV,Lack of efficacy
5852,1853,D-cure (Vitamine D),2016-04-08,,1000,MIU,['2 / Day'],IV, 
5853,225,Tysabri,2016-05-27,,5000,mg,['/ Day'],IV, 
5854,225,D-cure (Vitamine D),2016-01-04,,300, ,['2 / Day'],IV, 
5855,2237,Mitoxantrone,2016-08-14,,500,mg,['3 / Week'],IV, 
5856,4033,Tecfidera,2016-01-26,,1, ,['/Month'],Oral, 
5857,4033,Betaferon,2016-08-03,2019-08-31,500, ,['/Month'], ,Adverse Event
5858,1102,IVIG,2016-04-26,,1,mg,['3 / Week'], , 
5859,1102,Rebif [22],2016-10-12,2019-10-17, ,mg,['/Month'],IV,Persisting MRI activity
5860,1102,Mitoxantrone,2016-05-24,2021-02-14, ,mg,['/Month'], ,Persisting MRI activity
5861,4675,Tysabri,2016-05-04,,1,mg,['2 / Day'],IV, 
5862,4675,Copaxone,2016-08-04,, ,mg,['3 / Week'],IV, 
5863,4173,Tysabri,2016-06-14,,300, ,['/Month'],IV, 
5864,4173,Ledertrexaat,2016-08-27,2019-12-19, ,mg,['2 / Day'],IV,Adverse Event
5865,4173,D-cure (Vitamine D),2016-03-27,, , ,['2 / Day'], , 
5866,4173,Tysabri,2015-11-26,,5000,MIU,['3 / Week'],IV, 
5867,1639,Gilenya,2016-04-11,2018-08-08, , ,['/ Day'], ,Patient Choice/Convenience
5868,1639,Copaxone,2015-11-18,2018-09-11,300, ,[' '],IV,Patient Choice/Convenience
5869,1639,Alemtuzumab (Campath),2016-10-09,2021-07-09, , ,['/ Week'],IV,Adverse Event
5870,824,Tysabri,2016-02-06,2021-06-09, ,mg,[' '], ,Persistence of relapses
5871,824,Ledertrexaat,2016-02-22,,1,mg,['2 / Day'], , 
5872,824,D-cure (Vitamine D),2015-11-02,2019-09-30,500,mg,['2 / Day'],IV,Patient Choice/Convenience
5873,3639,Gilenya,2016-05-02,, ,mg,['2 / Day'],IV, 
5874,3639,Betaferon,2016-04-21,,5000,mg,['/Month'],IV, 
5875,3639,Tecfidera,2016-08-27,, ,MIU,['/ Week'],IV, 
5876,3022,IVIG,2016-03-09,, ,mg,[' '],IV, 
5877,3022,Rebif [44],2016-02-19,,20,mg,['/ Week'],IV, 
5878,3656,Endoxan,2016-10-01,2018-03-19,500,mg,['/Month'],Oral,Adverse Event
5879,3656,Rebif [44],2016-01-09,,20, ,[' '],IV, 
5880,1592,Endoxan,2015-11-04,2019-10-03, ,mg,['2 / Day'], ,Persistence of relapses
5881,1592,Betaferon,2016-08-13,2020-07-15,1, ,['2 / Day'],IV,Patient Choice/Convenience
5882,1715,Tecfidera,2016-09-06,,20,mg,['/Month'],IV, 
5883,1715,Alemtuzumab (Campath),2016-01-13,, ,mg,['2 / Day'],IV, 
5884,1715,Mitoxantrone,2016-01-03,2020-10-08, , ,['/ Week'],IV,Adverse Event
5885,1715,Rebif [44],2015-12-01,,5000,MIU,['/ Day'],IV, 
5886,775,Alemtuzumab (Campath),2016-06-27,2020-06-12,20,mg,['/Month'],IV,Persisting MRI activity
5887,775,Gilenya,2016-05-26,2018-12-06, ,mg,['2 / Day'], ,Lack of efficacy
5888,351,Tysabri,2016-01-17,,1000,mg,['/Month'],IV, 
5889,351,Tecfidera,2016-08-16,2020-02-01,400,mg,[' '],IV,Adverse Event
5890,4799,D-cure (Vitamine D),2015-11-25,2018-04-03,20,mg,['2 / Day'],IV,Lack of efficacy
5891,4799,IVIG,2016-07-11,, ,mg,['2 / Day'], , 
5892,4799,Gilenya,2015-11-27,,500,MIU,[' '],IV, 
5893,247,Tysabri,2016-03-20,,1000,mg,['/Month'],Oral, 
5894,597,IVIG,2016-03-03,2019-10-24, ,mg,['2 / Day'], ,Adverse Event
5895,597,Betaferon,2016-02-28,2019-07-14,1000,mg,['/Month'],IV,Patient Choice/Convenience
5896,2286,Endoxan,2015-10-25,, , ,['3 / Week'],IV, 
5897,2286,Ledertrexaat,2016-07-17,,5000,mcg,['2 / Day'], , 
5898,2286,D-cure (Vitamine D),2016-01-20,2018-10-03,20,mg,[' '], ,Persistence of relapses
5899,2777,IVIG,2015-12-20,2019-05-12,1000, ,['2 / Day'],IV,Lack of efficacy
5900,1345,Endoxan,2016-06-21,,1, ,['/ Day'], , 
5901,1345,Mitoxantrone,2015-12-23,, ,mg,[' '],IV, 
5902,2517,D-cure (Vitamine D),2016-01-09,, ,mg,['2 / Day'], , 
5903,2517,Teriflunomide,2016-06-22,2019-03-23,1000,mg,['/Month'],IV,Lack of efficacy
5904,2517,Gilenya,2016-01-19,, ,MIU,['2 / Day'], , 
5905,2517,Rebif [22],2015-12-25,2020-11-03,300,mg,['/Month'],IV,Lack of efficacy
5906,1699,Teriflunomide,2016-01-29,2019-02-28,500, ,['/Month'], ,Lack of efficacy
5907,3782,D-cure (Vitamine D),2016-05-24,,500, ,['2 / Day'],Oral, 
5908,3782,Methylprednisolone,2015-12-28,, ,mcg,['2 / Day'],IV, 
5909,3561,D-cure (Vitamine D),2016-08-04,, ,mg,['/ Week'], , 
5910,3561,Tysabri,2016-08-24,,400,mcg,['/Month'],IV, 
5911,4527,Gilenya,2016-05-16,,1000,mg,['/ Week'], , 
5912,592,IVIG,2016-08-18,2019-01-08,20, ,[' '],IV,Patient Choice/Convenience
5913,592,Gilenya,2016-04-23,,5000,mg,['3 / Week'],IV, 
5914,592,D-cure (Vitamine D),2016-01-25,2021-06-01, ,mg,['/ Day'], ,Patient Choice/Convenience
5915,851,Alemtuzumab (Campath),2016-06-13,,400,mg,['2 / Day'],IV, 
5916,851,IVIG,2016-02-22,,500,mg,[' '], , 
5917,1305,Tecfidera,2016-02-04,2018-11-19,500,mg,['3 / Week'],IV,Patient Choice/Convenience
5918,1305,Methylprednisolone,2016-03-15,,1,mg,['/Month'],IV, 
5919,1305,D-cure (Vitamine D),2016-02-11,, , ,['/Month'], , 
5920,3422,D-cure (Vitamine D),2016-10-15,, ,mg,['/Month'], , 
5921,3422,Gilenya,2016-10-07,2020-02-01,500,mg,[' '],IV,Adverse Event
5922,3422,Betaferon,2016-08-09,,400, ,['/Month'],IV, 
5923,444,IVIG,2016-02-24,2018-09-01, ,mg,['/ Week'], ,Lack of efficacy
5924,1211,Rebif [22],2016-06-24,,300, ,['/ Day'], , 
5925,1211,Betaferon,2016-07-19,2021-09-30,300, ,['/ Day'], ,Persisting MRI activity
5926,1211,Avonex,2015-10-30,, , ,['2 / Day'],IV, 
5927,4614,Betaferon,2016-10-09,2019-08-01, , ,['2 / Day'],Oral,Adverse Event
5928,4614,Tysabri,2016-02-13,2019-05-07, , ,['/Month'],IV,Patient Choice/Convenience
5929,4862,D-cure (Vitamine D),2016-05-19,,5000, ,['2 / Day'], , 
5930,4862,Rebif [22],2016-03-24,2018-10-17,5000, ,['2 / Day'],IV,Adverse Event
5931,1908,IVIG,2016-06-21,,5000, ,[' '],Oral, 
5932,1908,Endoxan,2016-03-09,2020-12-05,1000,mg,[' '],Oral,Lack of efficacy
5933,1908,IVIG,2016-06-05,2021-07-10,5000,mg,[' '],IV,Patient Choice/Convenience
5934,1908,D-cure (Vitamine D),2015-12-16,2019-04-27,1,mcg,['/ Day'],IV,Lack of efficacy
5935,2575,Tecfidera,2015-10-29,2019-08-17, , ,[' '], ,Patient Choice/Convenience
5936,2575,Betaferon,2015-11-29,2018-09-09,1000, ,['/Month'],IV,Lack of efficacy
5937,2575,D-cure (Vitamine D),2016-09-28,,5000,mg,['/ Day'], , 
5938,4977,Tysabri,2016-08-14,2020-10-23,1,mg,['2 / Day'],Oral,Persisting MRI activity
5939,4977,Tysabri,2016-10-21,,1000,mcg,['2 / Day'],Oral, 
5940,4977,Alemtuzumab (Campath),2015-12-01,, , ,['2 / Day'],Oral, 
5941,3863,Rebif [22],2016-09-03,2021-09-17, , ,['/ Day'], ,Persistence of relapses
5942,3863,Copaxone,2016-05-20,, ,mg,['2 / Day'], , 
5943,3863,Gilenya,2016-04-20,,300,MIU,[' '],IV, 
5944,3863,Tecfidera,2016-01-21,2021-06-13, , ,['3 / Week'], ,Persisting MRI activity
5945,1992,Ledertrexaat,2015-11-01,2018-05-23,300,MIU,['3 / Week'],Oral,Adverse Event
5946,1992,Gilenya,2016-04-04,, , ,['2 / Day'],IV, 
5947,1992,Ledertrexaat,2016-10-21,,500,mg,['2 / Day'],Oral, 
5948,1992,IVIG,2016-01-28,2020-02-08,400,mg,['/ Day'],IV,Adverse Event
5949,343,Gilenya,2016-02-01,2021-06-11, , ,[' '], ,Lack of efficacy
5950,2859,Copaxone,2016-02-08,2020-09-30, ,mg,[' '], ,Persisting MRI activity
5951,2004,Tysabri,2015-11-01,, ,mg,['/Month'],IV, 
5952,2004,Betaferon,2016-08-14,2021-10-08, , ,['2 / Day'],Oral,Adverse Event
5953,2004,Betaferon,2016-06-01,,400,mg,['2 / Day'],Oral, 
5954,2004,Tecfidera,2016-10-16,,500,MIU,['2 / Day'], , 
5955,2130,Copaxone,2016-07-18,,1,mg,['/Month'],IV, 
5956,2130,D-cure (Vitamine D),2016-10-06,,20,mg,['2 / Day'],Oral, 
5957,2130,IVIG,2015-10-28,,300,mg,['3 / Week'],IV, 
5958,1484,Ledertrexaat,2016-03-08,,1, ,[' '],Oral, 
5959,1484,Teriflunomide,2016-09-02,,300, ,[' '],IV, 
5960,1484,Teriflunomide,2016-03-29,, ,mg,['2 / Day'],IV, 
5961,4692,Tecfidera,2016-09-28,2021-08-01,1,mg,['/Month'],IV,Lack of efficacy
5962,4692,Tysabri,2016-01-14,2017-11-02,1000, ,['/Month'],IV,Lack of efficacy
5963,2073,Teriflunomide,2015-12-26,2018-11-14,500, ,['2 / Day'], ,Lack of efficacy
5964,2073,IVIG,2016-09-18,,300,MIU,['/Month'], , 
5965,1853,Betaferon,2016-08-30,,1,mg,['2 / Day'], , 
5966,1853,IVIG,2016-09-22,2020-05-03, , ,[' '],IV,Persistence of relapses
5967,1853,IVIG,2016-01-28,,300, ,['/ Week'],IV, 
5968,1853,Copaxone,2016-06-13,,500,mg,['/ Week'],Oral, 
5969,4308,Tecfidera,2016-06-09,,500,mg,['/Month'], , 
5970,4308,Avonex,2016-06-12,2020-10-07,1, ,['/Month'],IV,Patient Choice/Convenience
5971,4308,Betaferon,2016-02-22,2019-06-05, ,mg,['2 / Day'],IV,Patient Choice/Convenience
5972,4308,Betaferon,2016-07-21,2021-02-20,500, ,['/Month'],IV,Patient Choice/Convenience
5973,945,Endoxan,2016-09-15,,1,mg,['/ Day'],IV, 
5974,945,Ledertrexaat,2016-05-30,, ,mcg,['3 / Week'],Oral, 
5975,945,Avonex,2016-06-26,2018-01-12, , ,['/Month'], ,Lack of efficacy
5976,4004,Mitoxantrone,2016-10-11,2019-07-21,1,mg,[' '], ,Persisting MRI activity
5977,4004,Tysabri,2016-10-01,, ,mg,['/ Day'],IV, 
5978,4004,Gilenya,2015-11-21,,20,mg,['3 / Week'],IV, 
5979,1065,Copaxone,2015-11-06,2021-10-20,300,MIU,['3 / Week'], ,Lack of efficacy
5980,1196,Rebif [22],2015-11-09,,400,mg,['/Month'],IV, 
5981,1196,Methylprednisolone,2016-06-03,,1000,mg,['/ Week'],IV, 
5982,1016,Ledertrexaat,2015-11-01,2020-01-06,20,mg,['/Month'],Oral,Lack of efficacy
5983,1016,Mitoxantrone,2016-04-03,, , ,['2 / Day'], , 
5984,1016,Gilenya,2016-06-12,2019-10-03,1, ,['/ Day'],IV,Adverse Event
5985,1924,Mitoxantrone,2016-03-30,2021-04-11,1, ,['2 / Day'], ,Adverse Event
5986,1924,Gilenya,2016-09-23,2020-07-05,5000, ,['/ Week'],IV,Persistence of relapses
5987,1924,Endoxan,2016-01-02,,20, ,['/ Day'],IV, 
5988,4150,IVIG,2016-07-03,,20,mg,['2 / Day'],Oral, 
5989,4677,Betaferon,2015-11-02,,20,mg,['2 / Day'],Oral, 
5990,4677,Tysabri,2016-06-25,2019-12-02,5000,mg,['/Month'], ,Adverse Event
5991,3501,Gilenya,2016-03-27,2020-10-27,1000,mg,['2 / Day'], ,Persisting MRI activity
5992,3501,Copaxone,2015-12-28,2020-05-10,500,mg,['/Month'],IV,Adverse Event
5993,3501,Ledertrexaat,2016-08-02,2019-02-02,500, ,['/ Day'],IV,Persistence of relapses
5994,3501,Alemtuzumab (Campath),2016-10-06,2020-12-19,500, ,['3 / Week'],IV,Adverse Event
5995,3623,Gilenya,2016-05-14,, ,mg,['/Month'],IV, 
5996,3623,Rebif [44],2016-05-28,,1000, ,['/Month'], , 
5997,4927,D-cure (Vitamine D),2016-07-08,2021-03-17,500,mg,['/ Day'],IV,Patient Choice/Convenience
5998,2799,D-cure (Vitamine D),2016-03-27,,500,MIU,['2 / Day'], , 
5999,2799,Ledertrexaat,2015-11-03,2019-04-16,500,mg,['2 / Day'],IV,Adverse Event
6000,2799,Tecfidera,2016-05-16,,500,mcg,['2 / Day'], , 
6001,2717,Rebif [22],2015-12-16,2019-02-24, , ,[' '],Oral,Adverse Event
6002,3790,IVIG,2016-02-08,,1000,mcg,['/ Day'],Oral, 
6003,3790,Gilenya,2015-12-09,,1000,MIU,['/ Week'], , 
6004,3790,D-cure (Vitamine D),2016-05-24,2020-07-09,300, ,['3 / Week'],IV,Adverse Event
6005,2400,Alemtuzumab (Campath),2016-04-01,2021-04-17,5000,MIU,['/Month'],IV,Persisting MRI activity
6006,624,D-cure (Vitamine D),2016-10-21,2021-07-14,300,mcg,[' '],IV,Patient Choice/Convenience
6007,624,Mitoxantrone,2016-04-22,, , ,['/Month'],IV, 
6008,624,Rebif [22],2016-08-05,, ,mg,['3 / Week'],IV, 
6009,2117,Tysabri,2016-07-05,, , ,['/Month'], , 
6010,3152,Gilenya,2016-05-31,,1, ,['/ Day'],IV, 
6011,3152,Methylprednisolone,2015-12-20,,400,MIU,['2 / Day'],IV, 
6012,3152,Avonex,2016-08-24,,5000,mg,['/Month'], , 
6013,2259,D-cure (Vitamine D),2016-09-24,2018-04-04, ,mg,['/Month'],IV,Adverse Event
6014,4093,Avonex,2015-12-04,,300, ,['2 / Day'], , 
6015,4093,Methylprednisolone,2016-04-17,2018-04-04, , ,['3 / Week'], ,Adverse Event
6016,4093,IVIG,2016-01-30,2021-01-11,500, ,['3 / Week'], ,Adverse Event
6017,4093,D-cure (Vitamine D),2016-05-17,2019-02-20,1000,MIU,['/ Day'],IV,Persisting MRI activity
6018,789,Methylprednisolone,2016-09-06,2019-04-11, , ,['2 / Day'],IV,Adverse Event
6019,789,Rebif [22],2016-07-26,,20, ,['/ Week'], , 
6020,789,Gilenya,2016-09-12,2021-07-19,1000,mg,['/ Day'],IV,Persistence of relapses
6021,3043,Methylprednisolone,2015-10-25,, ,mg,['/ Day'], , 
6022,2452,D-cure (Vitamine D),2016-07-08,, , ,['/Month'], , 
6023,2452,Tysabri,2015-11-14,,5000,mg,[' '],IV, 
6024,2452,D-cure (Vitamine D),2016-10-08,2021-05-18,300,mg,['/Month'], ,Adverse Event
6025,2452,Gilenya,2016-08-24,2019-07-14,5000,MIU,['2 / Day'], ,Lack of efficacy
6026,4070,IVIG,2015-11-17,2020-05-28,1, ,['/ Week'],IV,Patient Choice/Convenience
6027,3304,Betaferon,2016-07-27,2019-11-26,400,MIU,['/Month'],IV,Persisting MRI activity
6028,3304,Rebif [22],2016-07-08,2019-04-13,1, ,[' '], ,Adverse Event
6029,3304,IVIG,2016-05-04,,1,mg,['/Month'],IV, 
6030,520,Copaxone,2016-03-03,2019-03-02, ,mcg,['/ Day'],IV,Persisting MRI activity
6031,3895,D-cure (Vitamine D),2016-04-15,2018-11-20,500, ,['/Month'], ,Persisting MRI activity
6032,4559,IVIG,2016-03-06,2018-08-12,300,MIU,['3 / Week'], ,Adverse Event
6033,4559,Mitoxantrone,2016-02-20,, , ,['/Month'],IV, 
6034,2205,Ledertrexaat,2016-08-31,2018-05-28, ,mg,['/Month'],IV,Persisting MRI activity
6035,1863,D-cure (Vitamine D),2016-03-25,, ,mg,['/Month'],IV, 
6036,2789,D-cure (Vitamine D),2016-03-01,, ,MIU,[' '], , 
6037,2789,Mitoxantrone,2016-01-18,2018-03-18,400,mg,['2 / Day'],IV,Adverse Event
6038,4168,Copaxone,2015-11-27,,5000,mcg,['2 / Day'], , 
6039,4168,Avonex,2016-07-09,, , ,['2 / Day'],IV, 
6040,4168,IVIG,2016-07-12,,1000, ,['/ Day'], , 
6041,4168,Tysabri,2016-02-20,,20,MIU,['/Month'],IV, 
6042,860,Rebif [22],2015-12-23,2019-10-05, ,mg,['/Month'],IV,Adverse Event
6043,860,Alemtuzumab (Campath),2016-10-17,,1000,MIU,['/Month'],IV, 
6044,860,Tysabri,2016-06-05,2018-03-25,500, ,['/Month'],IV,Patient Choice/Convenience
6045,860,Methylprednisolone,2016-07-25,2018-10-23, , ,['2 / Day'], ,Patient Choice/Convenience
6046,1486,Avonex,2016-01-15,2019-05-11,300,MIU,['/ Week'],IV,Adverse Event
6047,1486,Alemtuzumab (Campath),2016-09-02,2021-03-27, ,mg,['/ Day'], ,Adverse Event
6048,1486,Methylprednisolone,2016-09-07,,1,MIU,['2 / Day'], , 
6049,2382,Methylprednisolone,2015-12-24,, , ,['/ Day'], , 
6050,2382,Gilenya,2016-07-28,2020-07-08,5000, ,['2 / Day'], ,Lack of efficacy
6051,2382,Betaferon,2016-04-25,2019-06-22,1,mg,['/ Day'],Oral,Patient Choice/Convenience
6052,2055,Gilenya,2016-10-10,2020-12-03, ,mg,['/ Day'], ,Lack of efficacy
6053,2055,Alemtuzumab (Campath),2016-07-29,,20, ,['/Month'],IV, 
6054,205,Rebif [44],2015-11-12,2021-06-05,1000,mcg,['/Month'],IV,Lack of efficacy
6055,4057,Ledertrexaat,2016-01-28,2020-03-17,300,mg,['3 / Week'], ,Adverse Event
6056,4057,Gilenya,2016-01-27,2018-09-15, , ,['2 / Day'],IV,Adverse Event
6057,2361,Tecfidera,2016-02-01,2020-10-22, ,mcg,['/ Day'],Oral,Patient Choice/Convenience
6058,2361,Avonex,2016-08-03,2020-02-09,400, ,['/Month'], ,Patient Choice/Convenience
6059,1020,Gilenya,2016-06-06,2018-08-24, ,mg,['/ Week'],Oral,Adverse Event
6060,2255,Endoxan,2016-04-26,,400,mg,['/Month'],IV, 
6061,2255,Teriflunomide,2015-11-28,,1000, ,['/Month'],IV, 
6062,2255,Teriflunomide,2016-09-10,2019-07-14, , ,['/Month'],Oral,Patient Choice/Convenience
6063,3144,Betaferon,2016-07-15,2019-08-21,500,mg,['3 / Week'], ,Patient Choice/Convenience
6064,1557,Alemtuzumab (Campath),2015-11-25,,20,MIU,['3 / Week'],IV, 
6065,1880,Endoxan,2016-05-03,2021-02-23, , ,[' '],IV,Persisting MRI activity
6066,1880,Copaxone,2016-10-05,2020-08-28,1000,mcg,['2 / Day'],IV,Adverse Event
6067,1880,Endoxan,2016-07-15,,400,mg,['/ Day'], , 
6068,1880,Ledertrexaat,2016-01-12,,300, ,['/Month'], , 
6069,761,Teriflunomide,2016-02-12,2019-12-23,1, ,['2 / Day'],IV,Adverse Event
6070,761,Betaferon,2016-06-19,2019-10-07, ,MIU,[' '], ,Persisting MRI activity
6071,584,Tecfidera,2016-06-17,,300,mg,['2 / Day'],IV, 
6072,2672,Betaferon,2016-09-16,,400,mg,['3 / Week'],IV, 
6073,290,Rebif [44],2016-06-28,2018-11-05,5000,mg,['/Month'],IV,Persisting MRI activity
6074,290,Endoxan,2015-11-14,,5000,mg,['2 / Day'],IV, 
6075,2121,IVIG,2016-07-04,2019-12-24,400,mg,['2 / Day'],IV,Lack of efficacy
6076,3010,Avonex,2016-02-16,2020-05-31, , ,['/Month'], ,Patient Choice/Convenience
6077,3010,Ledertrexaat,2016-09-23,2020-04-24,400, ,['2 / Day'],IV,Persistence of relapses
6078,3010,Avonex,2016-06-03,, ,mg,['/Month'],Oral, 
6079,3010,Tecfidera,2015-12-07,2018-04-19,1000,mg,[' '],IV,Adverse Event
6080,4389,Tysabri,2016-09-13,, ,mg,[' '], , 
6081,4389,Tysabri,2015-12-22,,5000,mg,['2 / Day'],Oral, 
6082,4615,Avonex,2016-06-15,, ,mg,['/Month'],IV, 
6083,4615,Rebif [44],2016-04-04,2020-11-03, , ,['/Month'], ,Adverse Event
6084,570,Betaferon,2016-07-04,,400,mcg,['2 / Day'],Oral, 
6085,4490,Endoxan,2016-04-16,,500, ,['/Month'], , 
6086,1295,Copaxone,2016-05-27,, , ,['3 / Week'],IV, 
6087,1295,Rebif [44],2016-06-11,,1000,mg,[' '],IV, 
6088,1295,Ledertrexaat,2016-07-14,, ,mg,[' '],IV, 
6089,1295,Rebif [22],2016-07-18,2018-03-27, , ,['/ Day'],IV,Persistence of relapses
6090,2124,Methylprednisolone,2016-07-22,2018-09-11,20,MIU,[' '],IV,Persisting MRI activity
6091,2124,Gilenya,2016-05-22,2020-01-31,1000, ,['3 / Week'],IV,Persisting MRI activity
6092,2124,Methylprednisolone,2016-02-24,, ,mg,['/ Week'],IV, 
6093,3183,IVIG,2016-02-26,2017-12-09, ,mg,['2 / Day'], ,Adverse Event
6094,3183,Methylprednisolone,2016-02-12,,400,mg,['/Month'],Oral, 
6095,2632,Endoxan,2016-06-11,2019-02-23,500, ,['/Month'],IV,Persisting MRI activity
6096,2632,Tecfidera,2016-04-18,, , ,['/ Day'], , 
6097,2632,Rebif [44],2016-06-11,,1000, ,['3 / Week'],IV, 
6098,1736,Tysabri,2016-08-27,2019-02-13,20, ,['2 / Day'],IV,Adverse Event
6099,1736,Rebif [44],2016-02-19,2019-01-20,1,mg,['2 / Day'], ,Patient Choice/Convenience
6100,175,Endoxan,2016-03-02,2020-09-16,300, ,['/ Day'],IV,Persisting MRI activity
6101,1420,Teriflunomide,2016-03-20,2018-07-16,1000, ,['2 / Day'],IV,Lack of efficacy
6102,1420,Alemtuzumab (Campath),2015-11-05,2018-04-29,300,mg,['/Month'], ,Lack of efficacy
6103,1420,Tecfidera,2015-10-28,2020-12-23,5000, ,['2 / Day'],IV,Lack of efficacy
6104,2789,Endoxan,2016-02-17,2020-12-07,20,mg,['/Month'], ,Adverse Event
6105,2789,Rebif [44],2016-03-19,2019-02-25, , ,['2 / Day'], ,Patient Choice/Convenience
6106,2789,Rebif [22],2016-05-25,2017-12-13, ,mg,['/Month'],IV,Patient Choice/Convenience
6107,3155,Endoxan,2016-07-23,2019-01-15,1000, ,['2 / Day'], ,Adverse Event
6108,3155,Tecfidera,2016-02-02,2020-01-10,1000, ,['3 / Week'],IV,Patient Choice/Convenience
6109,4079,Methylprednisolone,2016-10-17,2020-08-19, ,MIU,['2 / Day'],Oral,Lack of efficacy
6110,4079,Methylprednisolone,2016-04-25,, ,mcg,['2 / Day'],IV, 
6111,4079,Betaferon,2016-04-21,,5000,mg,['/Month'], , 
6112,4079,Copaxone,2016-02-28,,20,MIU,['2 / Day'],IV, 
6113,512,Gilenya,2016-07-05,2018-01-06,1000, ,['2 / Day'],IV,Persistence of relapses
6114,2894,Rebif [44],2016-09-06,,400,mg,['3 / Week'], , 
6115,2894,Gilenya,2016-01-28,,20, ,['2 / Day'], , 
6116,2955,Tecfidera,2016-08-27,,1000, ,['/Month'],IV, 
6117,2955,IVIG,2016-09-01,,500,mg,['/Month'],IV, 
6118,2955,Alemtuzumab (Campath),2016-08-10,,400,mg,['/ Day'],IV, 
6119,2955,Gilenya,2015-12-07,, ,mg,[' '], , 
6120,3082,Alemtuzumab (Campath),2016-05-01,, ,mg,['/Month'],IV, 
6121,4160,Methylprednisolone,2016-06-12,,400,mg,['3 / Week'],IV, 
6122,4160,Avonex,2016-10-15,,1,mg,['2 / Day'],IV, 
6123,3747,Tecfidera,2016-04-21,, , ,['2 / Day'],Oral, 
6124,2722,Tysabri,2015-11-26,2021-08-14, , ,['2 / Day'],IV,Adverse Event
6125,2722,IVIG,2016-10-16,2021-06-09, ,mg,['/Month'], ,Persistence of relapses
6126,2722,Rebif [22],2016-03-30,2020-04-20,300,mg,['2 / Day'],IV,Persisting MRI activity
6127,2722,Alemtuzumab (Campath),2016-04-09,, , ,['3 / Week'], , 
6128,407,Copaxone,2015-12-16,, , ,['/Month'],IV, 
6129,1353,Gilenya,2016-01-23,,1, ,['2 / Day'], , 
6130,4949,Rebif [44],2016-05-20,2020-03-21,1,mg,[' '],IV,Lack of efficacy
6131,4949,D-cure (Vitamine D),2016-05-07,,1,mg,['/Month'],IV, 
6132,4949,Methylprednisolone,2016-06-05,, ,mg,[' '],IV, 
6133,4949,Gilenya,2016-06-12,, , ,['3 / Week'],IV, 
6134,1214,Copaxone,2016-01-09,2018-05-19,1,mg,['/Month'], ,Persistence of relapses
6135,4710,Rebif [22],2016-02-12,2020-06-03, ,mg,['3 / Week'],Oral,Adverse Event
6136,4710,Teriflunomide,2016-07-11,2018-03-31,5000, ,['/ Day'], ,Persisting MRI activity
6137,162,Gilenya,2015-11-06,, , ,['/Month'],IV, 
6138,162,Endoxan,2016-03-01,2017-11-02,5000, ,['/Month'], ,Persistence of relapses
6139,162,Copaxone,2015-12-16,2020-04-30,1000, ,['2 / Day'], ,Patient Choice/Convenience
6140,162,D-cure (Vitamine D),2016-03-05,, , ,['3 / Week'],Oral, 
6141,4119,Methylprednisolone,2016-08-06,2019-10-13, , ,['/Month'], ,Adverse Event
6142,4119,D-cure (Vitamine D),2016-09-24,2020-03-06,20,mg,['3 / Week'],IV,Adverse Event
6143,3972,IVIG,2016-01-30,2018-06-25,5000,mg,['2 / Day'],IV,Persisting MRI activity
6144,3972,Methylprednisolone,2016-08-23,, , ,['2 / Day'],IV, 
6145,3972,Rebif [44],2016-02-20,2018-02-01,20, ,['/Month'],IV,Patient Choice/Convenience
6146,3972,Tecfidera,2016-09-26,2020-07-02,400,MIU,['/Month'],IV,Persistence of relapses
6147,1317,Rebif [22],2016-09-04,2019-12-12, ,mg,['2 / Day'],IV,Patient Choice/Convenience
6148,1559,Alemtuzumab (Campath),2016-02-20,2020-06-19,5000, ,['/ Week'],IV,Lack of efficacy
6149,4336,Methylprednisolone,2016-07-29,, ,mcg,['3 / Week'],IV, 
6150,3116,D-cure (Vitamine D),2016-01-04,2018-06-17,1,mg,['2 / Day'], ,Lack of efficacy
6151,3116,Rebif [22],2016-09-14,2017-12-13, , ,['2 / Day'],Oral,Lack of efficacy
6152,3116,Teriflunomide,2016-01-28,, , ,['/Month'],IV, 
6153,3116,Tecfidera,2015-12-22,2018-01-02,300, ,[' '], ,Persistence of relapses
6154,3370,Gilenya,2015-12-15,,1, ,['/Month'], , 
6155,3370,D-cure (Vitamine D),2016-01-14,2021-06-14,20,mg,[' '],IV,Adverse Event
6156,3370,Rebif [44],2016-04-22,2020-05-28,400, ,['/Month'], ,Lack of efficacy
6157,4321,Rebif [44],2016-06-09,,5000,mg,['2 / Day'],Oral, 
6158,4321,Endoxan,2016-06-17,,5000, ,['/Month'],IV, 
6159,4856,Endoxan,2016-04-07,,20,MIU,['/ Week'],IV, 
6160,4856,Rebif [22],2016-08-01,2020-08-04, ,mg,['/Month'],IV,Adverse Event
6161,4856,IVIG,2016-01-30,, , ,['3 / Week'], , 
6162,4856,Methylprednisolone,2016-02-07,2021-02-23,300, ,['3 / Week'], ,Persistence of relapses
6163,3571,Methylprednisolone,2016-04-24,,1,mg,['2 / Day'],Oral, 
6164,3571,IVIG,2015-12-05,2020-01-13,20, ,['/Month'],IV,Adverse Event
6165,3571,Ledertrexaat,2016-02-27,, , ,['2 / Day'],IV, 
6166,2585,Ledertrexaat,2016-04-01,,5000, ,['2 / Day'], , 
6167,1839,IVIG,2016-06-21,,1000,mg,[' '],IV, 
6168,1839,Alemtuzumab (Campath),2015-12-15,2018-08-24,400,mg,['/Month'],Oral,Persisting MRI activity
6169,4563,Teriflunomide,2016-06-18,,1,MIU,['/Month'], , 
6170,4563,Methylprednisolone,2016-06-17,2020-02-13,1000,mg,['2 / Day'],IV,Lack of efficacy
6171,4563,IVIG,2016-02-17,2020-07-17,1000,MIU,['/Month'], ,Adverse Event
6172,4563,Rebif [44],2016-07-28,,500,MIU,[' '],Oral, 
6173,2316,Alemtuzumab (Campath),2016-03-31,2018-10-17, , ,['2 / Day'],IV,Patient Choice/Convenience
6174,2316,Betaferon,2016-03-09,,300, ,['/Month'],IV, 
6175,1484,Ledertrexaat,2016-07-07,,5000, ,['/ Day'],Oral, 
6176,1484,Teriflunomide,2016-04-22,,300,mg,['2 / Day'],Oral, 
6177,4919,Copaxone,2016-06-09,,5000,MIU,['2 / Day'],IV, 
6178,4919,Copaxone,2016-08-16,,500,mcg,[' '], , 
6179,4919,Ledertrexaat,2016-01-25,, , ,['2 / Day'],IV, 
6180,4919,Methylprednisolone,2016-01-21,2019-08-10,1,MIU,['/Month'],Oral,Adverse Event
6181,2228,Methylprednisolone,2015-12-06,,300, ,['/Month'], , 
6182,2228,Mitoxantrone,2015-11-02,2019-07-07, ,mg,['3 / Week'],IV,Patient Choice/Convenience
6183,1925,Avonex,2016-05-19,, ,mg,['2 / Day'],IV, 
6184,2713,Rebif [44],2016-06-17,,1000,mcg,['2 / Day'],Oral, 
6185,2713,Ledertrexaat,2016-05-17,2020-12-18, ,mcg,['2 / Day'], ,Persisting MRI activity
6186,659,Tecfidera,2016-08-05,2021-05-18,1000,mg,['/ Day'],IV,Lack of efficacy
6187,659,Tysabri,2016-07-23,2021-06-01,300,mg,['/Month'], ,Lack of efficacy
6188,659,Tecfidera,2016-09-29,2021-06-10,20, ,['/Month'], ,Adverse Event
6189,659,Gilenya,2016-09-20,,1000,mg,['2 / Day'],Oral, 
6190,3258,D-cure (Vitamine D),2016-09-19,, , ,['2 / Day'],Oral, 
6191,3258,D-cure (Vitamine D),2016-04-28,2021-03-17, ,mg,['2 / Day'],IV,Persistence of relapses
6192,3961,Ledertrexaat,2015-11-29,2018-01-07,1000,mg,['/ Day'],IV,Adverse Event
6193,3961,Betaferon,2016-09-16,, ,mg,['/Month'], , 
6194,3961,Betaferon,2016-07-05,2017-12-18,20, ,['2 / Day'],IV,Adverse Event
6195,1587,Rebif [22],2016-04-25,2019-04-13, , ,['2 / Day'],IV,Persistence of relapses
6196,1587,IVIG,2015-12-08,,400, ,['2 / Day'],IV, 
6197,763,Betaferon,2016-08-28,2019-05-08,400,mcg,['/ Day'],IV,Patient Choice/Convenience
6198,763,Tysabri,2015-11-07,,1, ,['2 / Day'],IV, 
6199,763,Avonex,2016-05-07,2019-07-23, ,mg,['/ Day'], ,Persistence of relapses
6200,763,Alemtuzumab (Campath),2016-01-03,,1000, ,['/Month'],IV, 
6201,1231,Endoxan,2016-02-13,,500, ,['/ Day'],IV, 
6202,1231,Rebif [44],2016-09-19,2019-11-26,400,mg,['/Month'], ,Lack of efficacy
6203,1231,Rebif [22],2015-10-29,2020-07-05,20, ,['/Month'], ,Lack of efficacy
6204,1231,Ledertrexaat,2016-08-28,,300, ,['/Month'], , 
6205,975,Methylprednisolone,2016-01-05,, ,mcg,[' '], , 
6206,975,Endoxan,2015-10-25,2019-11-28,1,MIU,['3 / Week'],IV,Adverse Event
6207,975,IVIG,2016-09-18,2019-09-21,500, ,['/Month'], ,Adverse Event
6208,975,Gilenya,2015-12-07,2018-04-07,20,MIU,['/Month'], ,Adverse Event
6209,113,Rebif [44],2016-02-10,2018-10-28,1, ,['/ Day'],IV,Adverse Event
6210,113,Copaxone,2016-07-23,2021-01-26, ,MIU,['/Month'],IV,Persistence of relapses
6211,113,D-cure (Vitamine D),2016-07-05,, ,mg,['/Month'], , 
6212,113,Tysabri,2016-08-25,2021-08-17,1,mg,['/Month'],Oral,Adverse Event
6213,1758,Mitoxantrone,2016-08-14,,20, ,['2 / Day'], , 
6214,1758,Endoxan,2015-11-05,,1000,mg,['/Month'],Oral, 
6215,2390,Avonex,2015-12-28,2018-05-30,5000, ,[' '],IV,Lack of efficacy
6216,2390,Methylprednisolone,2016-10-20,,1,mg,['2 / Day'],IV, 
6217,379,Copaxone,2015-12-27,, ,mg,['/Month'],Oral, 
6218,1262,Ledertrexaat,2016-01-23,2020-04-01,400, ,['/Month'], ,Lack of efficacy
6219,1974,Mitoxantrone,2016-04-28,,300,MIU,['/Month'],IV, 
6220,2851,Avonex,2016-03-20,2020-05-20,400,MIU,['/Month'], ,Patient Choice/Convenience
6221,2851,Avonex,2016-06-16,2020-08-01, ,mg,[' '],IV,Patient Choice/Convenience
6222,1711,IVIG,2016-03-11,2020-06-03,20,MIU,['2 / Day'], ,Adverse Event
6223,1711,Tecfidera,2016-01-05,, , ,[' '], , 
6224,1435,Betaferon,2016-08-17,,300, ,['2 / Day'],IV, 
6225,1435,Avonex,2016-03-31,2020-11-10,500,mg,['/Month'], ,Patient Choice/Convenience
6226,1305,Avonex,2016-07-31,,500,mcg,['/Month'], , 
6227,808,Ledertrexaat,2016-09-27,2018-01-05, ,mg,['/Month'],IV,Lack of efficacy
6228,1302,Teriflunomide,2016-05-03,2020-04-06,20,mg,['2 / Day'],IV,Persisting MRI activity
6229,1302,D-cure (Vitamine D),2016-03-21,,300, ,['2 / Day'],IV, 
6230,1302,Tysabri,2015-11-11,,500, ,['/Month'], , 
6231,2587,Copaxone,2016-03-01,, ,MIU,['/ Day'],IV, 
6232,4053,Tecfidera,2016-01-20,2020-11-25, ,mcg,['/Month'], ,Adverse Event
6233,4053,IVIG,2016-06-12,,400, ,['2 / Day'],IV, 
6234,4053,Tecfidera,2016-03-27,,5000, ,['/Month'],IV, 
6235,4053,Tecfidera,2016-08-02,, ,MIU,['3 / Week'],IV, 
6236,2365,Methylprednisolone,2016-01-13,2020-08-27,500, ,['3 / Week'], ,Patient Choice/Convenience
6237,2365,Alemtuzumab (Campath),2016-06-04,2021-07-04, , ,['/Month'],Oral,Patient Choice/Convenience
6238,2084,D-cure (Vitamine D),2016-09-21,2018-05-07,1000, ,['2 / Day'], ,Persisting MRI activity
6239,2084,Endoxan,2015-11-17,, ,mg,['/Month'],Oral, 
6240,2084,Methylprednisolone,2016-04-27,,400,mg,[' '], , 
6241,3165,Rebif [22],2016-05-04,,1000,mg,['/Month'], , 
6242,3165,IVIG,2016-04-10,2020-11-11,20, ,['/Month'],IV,Patient Choice/Convenience
6243,3165,D-cure (Vitamine D),2016-08-19,2017-12-28,300,MIU,['3 / Week'],IV,Lack of efficacy
6244,852,Rebif [22],2016-06-19,, , ,['2 / Day'], , 
6245,2049,Tecfidera,2016-03-22,, ,mg,['/ Week'],IV, 
6246,2049,D-cure (Vitamine D),2016-07-27,,5000,MIU,['2 / Day'], , 
6247,2049,Gilenya,2016-02-28,,1000, ,['/Month'], , 
6248,3934,D-cure (Vitamine D),2016-06-03,2020-08-16, ,mg,['/Month'],IV,Persisting MRI activity
6249,308,Alemtuzumab (Campath),2016-05-02,,1000,MIU,['2 / Day'], , 
6250,308,Tecfidera,2016-08-25,2020-02-02,500,mg,['/Month'], ,Lack of efficacy
6251,2379,Methylprednisolone,2016-10-05,2021-08-04,5000, ,['2 / Day'],Oral,Persisting MRI activity
6252,882,Tysabri,2015-12-26,2019-08-11, ,MIU,[' '],IV,Adverse Event
6253,882,Gilenya,2016-06-12,2018-01-01,1, ,[' '],IV,Persistence of relapses
6254,882,Alemtuzumab (Campath),2016-10-02,2020-07-22, ,mg,['/Month'], ,Adverse Event
6255,882,Copaxone,2015-12-22,,1, ,['3 / Week'],IV, 
6256,411,Tysabri,2016-06-01,2021-04-08,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
6257,411,Rebif [44],2016-09-30,2018-09-29, , ,['/Month'], ,Adverse Event
6258,411,Methylprednisolone,2016-07-07,2018-10-05,500, ,['/ Day'],IV,Patient Choice/Convenience
6259,4324,Endoxan,2015-10-29,, ,mg,['3 / Week'], , 
6260,4324,Endoxan,2016-06-26,,300,mg,['3 / Week'],IV, 
6261,4324,Methylprednisolone,2015-11-29,2018-02-27, ,mg,['/Month'], ,Adverse Event
6262,4324,D-cure (Vitamine D),2016-08-01,2019-11-28, ,mg,['/ Day'],IV,Patient Choice/Convenience
6263,2901,Rebif [22],2016-04-25,,1000, ,['3 / Week'],IV, 
6264,1096,D-cure (Vitamine D),2016-01-06,,500,mcg,['2 / Day'],IV, 
6265,3080,Betaferon,2016-09-10,,5000, ,['3 / Week'], , 
6266,3702,Mitoxantrone,2016-05-31,, ,mcg,['/Month'], , 
6267,3702,Rebif [44],2016-04-11,2019-04-04,500, ,['/ Week'], ,Adverse Event
6268,1813,Tecfidera,2016-05-20,,500,mg,['2 / Day'], , 
6269,1813,Alemtuzumab (Campath),2016-06-27,,20,mg,['/Month'],IV, 
6270,1813,Avonex,2016-06-17,2019-02-10, , ,['2 / Day'],IV,Persisting MRI activity
6271,1813,Teriflunomide,2016-04-08,, , ,['/Month'],IV, 
6272,1858,Tysabri,2015-12-18,, , ,[' '], , 
6273,1858,Avonex,2016-03-08,2020-12-23,20,mg,[' '], ,Patient Choice/Convenience
6274,1858,Teriflunomide,2016-02-26,,1000, ,['/Month'],IV, 
6275,1858,Endoxan,2016-06-23,,20,mg,[' '],IV, 
6276,338,IVIG,2016-08-14,2018-08-10,1000,mg,['3 / Week'],Oral,Persisting MRI activity
6277,338,D-cure (Vitamine D),2016-07-17,,1,mg,['/Month'], , 
6278,4792,Betaferon,2016-01-08,,400, ,['/Month'],IV, 
6279,4792,Avonex,2016-05-28,,300,mg,['2 / Day'], , 
6280,4792,Alemtuzumab (Campath),2016-02-10,2020-12-11,1, ,['2 / Day'],IV,Persisting MRI activity
6281,4792,Rebif [44],2016-06-05,2020-05-10,20,mg,['3 / Week'],IV,Persisting MRI activity
6282,4261,Rebif [22],2016-08-20,, , ,['/ Day'],Oral, 
6283,4261,Tysabri,2016-03-29,2020-04-03, , ,['/Month'],IV,Patient Choice/Convenience
6284,671,Endoxan,2016-04-12,2020-12-22, ,mg,['2 / Day'],IV,Adverse Event
6285,671,Tecfidera,2016-02-03,, , ,['/Month'],IV, 
6286,671,Tecfidera,2016-10-13,2021-08-05,20, ,['3 / Week'],Oral,Lack of efficacy
6287,671,Rebif [22],2016-03-23,, , ,['2 / Day'],IV, 
6288,1921,Gilenya,2015-11-18,,1000, ,[' '], , 
6289,1972,Ledertrexaat,2016-09-11,,300, ,['2 / Day'],IV, 
6290,1972,Tecfidera,2016-06-15,, ,mg,['2 / Day'],IV, 
6291,1972,Ledertrexaat,2016-03-18,,300,MIU,['/Month'], , 
6292,1972,Rebif [22],2016-09-26,, ,mg,['/Month'],Oral, 
6293,3104,D-cure (Vitamine D),2016-08-29,2021-07-28, , ,['/ Week'],IV,Lack of efficacy
6294,3104,Alemtuzumab (Campath),2016-09-23,,20,mg,['/ Week'],IV, 
6295,3104,Rebif [22],2015-12-27,,1, ,['2 / Day'],IV, 
6296,3562,Betaferon,2016-02-06,,500, ,['/ Week'],IV, 
6297,3562,Endoxan,2016-05-29,2018-04-29,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
6298,3562,Tecfidera,2016-02-15,2018-05-31,1000,mg,['/Month'], ,Lack of efficacy
6299,3562,Rebif [22],2016-10-10,2019-10-11,1, ,['3 / Week'],Oral,Persistence of relapses
6300,3087,IVIG,2016-03-08,2019-06-06,5000, ,['/Month'],Oral,Adverse Event
6301,3087,D-cure (Vitamine D),2016-06-03,2019-01-21,500,mg,['/Month'], ,Patient Choice/Convenience
6302,3087,D-cure (Vitamine D),2015-12-15,,300, ,['/Month'], , 
6303,3993,D-cure (Vitamine D),2016-04-19,2018-05-26, , ,['/Month'],Oral,Patient Choice/Convenience
6304,3993,Rebif [44],2016-10-21,,1000,MIU,['/Month'],IV, 
6305,3993,Teriflunomide,2016-02-08,,500,mg,[' '],IV, 
6306,3993,Avonex,2016-03-13,2019-10-30,1000,MIU,['/ Day'], ,Persisting MRI activity
6307,394,Betaferon,2016-05-01,, , ,['2 / Day'], , 
6308,394,Gilenya,2016-10-09,2018-01-06,300, ,['2 / Day'],IV,Persistence of relapses
6309,2977,Alemtuzumab (Campath),2016-09-19,2019-07-25,5000,mg,['2 / Day'],IV,Persisting MRI activity
6310,2977,Alemtuzumab (Campath),2016-02-16,2020-02-16,500,mg,[' '], ,Adverse Event
6311,1931,D-cure (Vitamine D),2016-03-28,,20,mg,['/Month'],IV, 
6312,1000,Endoxan,2016-10-05,,300,mg,['/Month'],Oral, 
6313,1000,Alemtuzumab (Campath),2016-09-19,2018-12-01,1000,MIU,['2 / Day'], ,Persisting MRI activity
6314,1000,IVIG,2015-12-12,, ,mg,[' '],IV, 
6315,1000,Gilenya,2016-03-07,,300,mg,[' '],IV, 
6316,3544,Tecfidera,2016-06-18,,20,mg,['/ Day'],IV, 
6317,3544,Alemtuzumab (Campath),2016-08-29,2020-12-11, ,mcg,['2 / Day'],Oral,Persistence of relapses
6318,900,Teriflunomide,2016-08-05,,500, ,['2 / Day'], , 
6319,1649,Tecfidera,2015-12-08,,1, ,['2 / Day'], , 
6320,2648,Copaxone,2016-09-04,2019-09-28,1, ,['/Month'],IV,Adverse Event
6321,2648,Copaxone,2016-02-19,2019-08-26,5000,MIU,['2 / Day'],IV,Adverse Event
6322,2648,Copaxone,2016-02-05,2021-08-25,400,MIU,['2 / Day'],IV,Patient Choice/Convenience
6323,2648,Alemtuzumab (Campath),2016-04-13,,300, ,['2 / Day'], , 
6324,1106,Mitoxantrone,2016-01-18,,20,mcg,['/Month'],IV, 
6325,1106,Endoxan,2015-10-25,, , ,['3 / Week'],IV, 
6326,2398,Endoxan,2015-11-02,,20, ,['2 / Day'],Oral, 
6327,2398,Endoxan,2016-09-12,, , ,['2 / Day'], , 
6328,2398,Alemtuzumab (Campath),2015-10-28,2018-04-20, ,mg,['/Month'],IV,Lack of efficacy
6329,2398,Teriflunomide,2016-05-24,2020-06-29, ,MIU,['2 / Day'], ,Patient Choice/Convenience
6330,3256,D-cure (Vitamine D),2016-09-03,,1000,mg,['/Month'],IV, 
6331,3256,Endoxan,2016-08-15,2018-07-12, ,mg,['/Month'],IV,Adverse Event
6332,3256,Rebif [44],2016-06-07,,400,mg,['3 / Week'],Oral, 
6333,3256,Endoxan,2016-08-09,,500,MIU,['2 / Day'],IV, 
6334,664,Rebif [44],2016-10-05,, ,mcg,['/Month'],Oral, 
6335,1098,Rebif [22],2016-06-18,2021-09-11,20, ,['/Month'],IV,Adverse Event
6336,1098,Ledertrexaat,2016-04-13,,20, ,['/ Day'],IV, 
6337,1098,Tysabri,2015-10-31,,20,mg,['2 / Day'],IV, 
6338,1098,IVIG,2015-10-24,,5000,mg,['/Month'], , 
6339,3813,Rebif [44],2016-01-12,,1,mg,['/Month'], , 
6340,3813,Rebif [44],2016-05-13,2019-10-14, , ,['3 / Week'], ,Persistence of relapses
6341,3813,Alemtuzumab (Campath),2016-06-07,,5000, ,['/Month'], , 
6342,1481,Teriflunomide,2015-12-05,,300,mg,['3 / Week'], , 
6343,632,Mitoxantrone,2016-07-06,2018-08-17,20,mg,['/Month'],Oral,Patient Choice/Convenience
6344,632,Teriflunomide,2016-05-10,2020-02-26,1000, ,['2 / Day'],IV,Adverse Event
6345,632,Mitoxantrone,2015-12-26,,500, ,['/ Day'],IV, 
6346,632,Tysabri,2016-04-08,,500,mg,['/ Week'], , 
6347,4094,Tecfidera,2016-07-25,, , ,['/ Day'],IV, 
6348,4094,Alemtuzumab (Campath),2015-11-10,, , ,['/Month'], , 
6349,2125,Mitoxantrone,2016-05-26,2019-11-18,20, ,['2 / Day'],Oral,Persisting MRI activity
6350,2125,Methylprednisolone,2016-04-30,2018-11-16,500, ,['/Month'],IV,Persisting MRI activity
6351,2125,Tysabri,2015-12-11,,300,mg,['/Month'],IV, 
6352,2832,Tysabri,2016-08-28,,1, ,['3 / Week'],IV, 
6353,4819,Endoxan,2016-01-04,,300,mg,['/Month'],IV, 
6354,329,Copaxone,2016-07-20,,300,mcg,['3 / Week'], , 
6355,329,Teriflunomide,2015-12-19,2018-11-04,1000, ,['2 / Day'], ,Lack of efficacy
6356,329,Betaferon,2016-06-25,, , ,['/ Week'],IV, 
6357,329,Gilenya,2016-05-20,2018-09-15,5000,mg,['/Month'], ,Persisting MRI activity
6358,3833,Endoxan,2015-11-22,2019-06-11,300,mg,[' '],Oral,Lack of efficacy
6359,3833,Tysabri,2016-02-04,,300,mg,[' '],IV, 
6360,3904,Avonex,2016-07-18,,5000,mg,['2 / Day'],IV, 
6361,3904,Methylprednisolone,2016-02-04,2020-02-03,20, ,['/ Day'], ,Patient Choice/Convenience
6362,3904,Tecfidera,2015-11-16,2018-02-16,1000,mg,['/Month'],IV,Persisting MRI activity
6363,3904,Tysabri,2016-09-24,,5000,mg,['3 / Week'], , 
6364,3392,Rebif [22],2016-10-05,2020-11-09,500, ,['/Month'],Oral,Patient Choice/Convenience
6365,4018,Tecfidera,2015-11-22,2018-04-01,20, ,['3 / Week'], ,Lack of efficacy
6366,4018,Gilenya,2016-09-20,2018-06-22,300,mg,['/ Day'], ,Lack of efficacy
6367,4018,Teriflunomide,2016-02-28,,1000,mg,['/ Day'], , 
6368,277,D-cure (Vitamine D),2016-01-31,2018-03-29,5000,mg,[' '],Oral,Adverse Event
6369,277,IVIG,2016-10-08,, ,mg,['/Month'], , 
6370,3398,Mitoxantrone,2016-03-15,2021-02-14,300,mg,[' '], ,Patient Choice/Convenience
6371,3398,D-cure (Vitamine D),2016-07-19,,5000,mcg,['2 / Day'],Oral, 
6372,620,Rebif [22],2016-02-22,, ,mg,['/ Week'],Oral, 
6373,620,Betaferon,2016-02-17,, ,mg,['/Month'],IV, 
6374,620,Alemtuzumab (Campath),2016-10-05,,5000,mg,['2 / Day'],Oral, 
6375,2402,Tysabri,2016-04-26,2018-11-22,20,mg,['2 / Day'], ,Adverse Event
6376,263,Mitoxantrone,2015-11-25,,500,mg,['2 / Day'], , 
6377,263,Methylprednisolone,2015-11-15,2021-06-10,1, ,['2 / Day'], ,Patient Choice/Convenience
6378,2483,Teriflunomide,2016-06-11,2018-07-13, , ,['2 / Day'],IV,Adverse Event
6379,4025,Tysabri,2016-10-16,2018-06-27,1000,mcg,['/Month'], ,Adverse Event
6380,4025,Gilenya,2016-07-02,, ,mg,['2 / Day'],Oral, 
6381,4025,Endoxan,2016-08-15,2018-06-27, , ,['3 / Week'], ,Persistence of relapses
6382,4025,Avonex,2016-04-21,, ,mg,['/Month'], , 
6383,2291,Tecfidera,2016-08-25,2018-11-30, , ,['/ Week'], ,Patient Choice/Convenience
6384,2291,Tysabri,2016-01-29,2018-01-28, ,MIU,['/ Day'],IV,Patient Choice/Convenience
6385,1630,D-cure (Vitamine D),2016-06-07,, ,mg,['/Month'],Oral, 
6386,1630,Rebif [44],2016-03-30,2019-07-09, ,mg,['/Month'],IV,Lack of efficacy
6387,3248,D-cure (Vitamine D),2015-10-24,2019-09-07,1,mg,['/Month'],IV,Persisting MRI activity
6388,3248,Tysabri,2016-07-25,2019-06-20, ,mg,[' '],IV,Lack of efficacy
6389,3248,Avonex,2016-07-30,, ,mg,['/Month'],IV, 
6390,3067,Tecfidera,2015-12-23,, ,mcg,[' '],IV, 
6391,3466,IVIG,2016-07-29,2021-09-18,300,mg,['3 / Week'], ,Persistence of relapses
6392,3466,Rebif [22],2016-04-21,2019-06-07,1000, ,['/Month'],IV,Adverse Event
6393,3466,Rebif [22],2016-04-15,2018-09-25,20,MIU,['2 / Day'],IV,Patient Choice/Convenience
6394,3466,Endoxan,2016-07-07,2019-03-07,5000,mg,[' '],Oral,Patient Choice/Convenience
6395,3529,Mitoxantrone,2016-02-09,,20, ,['/ Week'], , 
6396,788,Rebif [22],2016-06-25,,500,mg,['/ Week'],IV, 
6397,788,Mitoxantrone,2015-11-04,2018-07-20,500,mg,['2 / Day'],IV,Patient Choice/Convenience
6398,788,Alemtuzumab (Campath),2016-02-02,2021-08-02,20, ,[' '], ,Adverse Event
6399,788,Copaxone,2016-08-26,,1,MIU,['2 / Day'],IV, 
6400,3620,Endoxan,2016-01-27,2018-09-08, , ,['/Month'],IV,Persisting MRI activity
6401,3620,Mitoxantrone,2015-12-12,2019-04-29,400,mg,['/Month'],Oral,Persistence of relapses
6402,3620,Copaxone,2016-03-20,,500, ,['/ Day'], , 
6403,2140,Teriflunomide,2016-09-01,,1000,MIU,[' '], , 
6404,4289,Rebif [22],2016-07-22,2017-12-21,5000,mg,['/ Day'],IV,Persisting MRI activity
6405,4289,Avonex,2015-12-31,, , ,['/Month'],IV, 
6406,4289,Methylprednisolone,2016-07-26,2018-06-12,1000,mg,['3 / Week'], ,Lack of efficacy
6407,441,Rebif [22],2016-05-18,2019-10-24,1, ,['/Month'],IV,Persisting MRI activity
6408,441,Tecfidera,2016-06-30,,500, ,['/Month'],IV, 
6409,2982,Betaferon,2016-01-13,, , ,['2 / Day'],IV, 
6410,744,Betaferon,2016-05-23,,300,mg,['2 / Day'],IV, 
6411,2964,Tysabri,2015-12-15,2019-04-16,400, ,['/Month'],IV,Patient Choice/Convenience
6412,2964,Avonex,2016-07-09,,400, ,['/Month'],IV, 
6413,2964,IVIG,2015-11-07,2021-02-01,300,MIU,['/Month'], ,Patient Choice/Convenience
6414,2783,Tecfidera,2016-08-07,, ,mg,[' '], , 
6415,2783,Tysabri,2016-04-28,,500,mg,['/Month'],IV, 
6416,2783,Rebif [22],2016-08-24,,5000,mg,['/ Day'],IV, 
6417,1195,IVIG,2016-04-25,,400,mg,['/ Week'],IV, 
6418,1195,Avonex,2016-06-27,,1,mg,['2 / Day'], , 
6419,1195,Copaxone,2016-04-26,2020-03-04, ,mcg,['2 / Day'], ,Lack of efficacy
6420,865,Copaxone,2016-07-24,2018-03-17, , ,['3 / Week'],IV,Adverse Event
6421,865,Gilenya,2016-04-11,2021-01-15, ,MIU,['2 / Day'], ,Lack of efficacy
6422,865,Methylprednisolone,2015-12-18,,5000,mg,[' '],IV, 
6423,865,Gilenya,2016-02-15,,20,mg,['/ Day'], , 
6424,2548,Gilenya,2016-04-21,2021-03-15,500,mg,['/Month'],IV,Patient Choice/Convenience
6425,1577,Tecfidera,2016-07-25,,500,mcg,['2 / Day'],IV, 
6426,1577,Tecfidera,2016-04-27,, , ,['/ Week'],IV, 
6427,1577,Methylprednisolone,2016-02-03,, ,mg,['2 / Day'],Oral, 
6428,1383,Rebif [22],2015-11-30,,400, ,['/Month'],IV, 
6429,377,Copaxone,2016-01-17,,20, ,['3 / Week'], , 
6430,4736,Rebif [44],2015-12-30,,1,mg,['/ Day'],IV, 
6431,4736,Methylprednisolone,2016-04-23,,500,mg,['3 / Week'], , 
6432,4736,Methylprednisolone,2016-01-10,,5000,mg,['/Month'],IV, 
6433,4736,Alemtuzumab (Campath),2016-04-21,, , ,['/Month'],IV, 
6434,1391,Methylprednisolone,2016-07-01,2018-09-14, ,mg,['2 / Day'],IV,Patient Choice/Convenience
6435,1391,IVIG,2016-04-25,2021-08-07,1000, ,['/ Week'],IV,Persisting MRI activity
6436,1391,Betaferon,2015-10-26,,300,mg,['/Month'], , 
6437,1391,Gilenya,2016-06-20,2019-07-11, , ,['/Month'],IV,Persisting MRI activity
6438,2240,Betaferon,2016-02-26,,20, ,['/ Week'],Oral, 
6439,2240,Betaferon,2016-09-23,2019-07-29,300, ,['2 / Day'], ,Adverse Event
6440,2351,Tecfidera,2016-05-20,,20, ,['2 / Day'],IV, 
6441,2351,Tysabri,2016-08-24,2020-10-15,1,mg,[' '], ,Patient Choice/Convenience
6442,4843,Rebif [22],2016-08-22,2018-07-08,20, ,['3 / Week'],IV,Persisting MRI activity
6443,4843,Betaferon,2016-01-11,, ,mcg,['3 / Week'],IV, 
6444,107,D-cure (Vitamine D),2016-07-12,,5000,mg,[' '],IV, 
6445,107,Ledertrexaat,2016-05-13,,500,mg,['/Month'],IV, 
6446,2717,Ledertrexaat,2016-08-29,,500, ,['2 / Day'],IV, 
6447,2717,Copaxone,2016-04-07,2018-10-28, ,mg,['2 / Day'],IV,Patient Choice/Convenience
6448,1606,Gilenya,2016-03-23,,20, ,['2 / Day'],Oral, 
6449,1813,Copaxone,2016-09-20,2019-02-01,5000, ,['2 / Day'], ,Adverse Event
6450,3261,Tecfidera,2015-11-16,,1000,mg,['2 / Day'],IV, 
6451,4993,Gilenya,2015-11-19,, , ,[' '], , 
6452,4993,Mitoxantrone,2015-12-30,2021-06-18,5000,mg,['/Month'],IV,Adverse Event
6453,4196,Tysabri,2016-05-12,,20, ,['/Month'],Oral, 
6454,4196,Gilenya,2016-09-27,, , ,['/ Day'],Oral, 
6455,4196,Rebif [44],2016-10-21,2019-11-06,500,mg,['/ Week'],IV,Adverse Event
6456,4196,IVIG,2016-01-18,2020-01-05,20,mg,['/ Week'],Oral,Patient Choice/Convenience
6457,3777,Tysabri,2015-12-09,,20, ,['/ Day'],IV, 
6458,3777,Copaxone,2016-10-21,,1000,mg,[' '],Oral, 
6459,3777,Copaxone,2016-10-07,2020-03-19,20,MIU,['2 / Day'],Oral,Patient Choice/Convenience
6460,1949,Betaferon,2015-10-29,2021-07-03, ,mg,['2 / Day'], ,Adverse Event
6461,1949,Tysabri,2016-07-02,2019-04-02,20,mg,['2 / Day'],IV,Adverse Event
6462,4455,D-cure (Vitamine D),2016-05-06,,1,mg,['2 / Day'], , 
6463,3611,Tecfidera,2016-09-30,,5000,MIU,['/ Day'],Oral, 
6464,3611,Ledertrexaat,2016-02-12,, ,mg,[' '], , 
6465,4288,Rebif [44],2016-08-20,2020-06-25, ,mg,['/Month'],IV,Patient Choice/Convenience
6466,4288,Alemtuzumab (Campath),2015-12-31,,500, ,['/ Week'], , 
6467,4288,Avonex,2016-10-21,, ,mcg,['/Month'], , 
6468,4288,Tysabri,2016-01-30,, ,mcg,['3 / Week'],Oral, 
6469,2558,D-cure (Vitamine D),2015-11-23,,300,mg,['2 / Day'], , 
6470,2558,Avonex,2015-12-26,,1, ,['2 / Day'],IV, 
6471,3235,Endoxan,2016-07-04,,20,mg,[' '], , 
6472,1010,Rebif [22],2016-10-05,, , ,['/ Day'],IV, 
6473,3143,Methylprednisolone,2016-07-16,2019-12-10,500, ,['/ Day'],IV,Adverse Event
6474,3143,Tecfidera,2016-08-22,,500,mg,['/Month'],IV, 
6475,3143,Methylprednisolone,2016-08-05,, ,mg,[' '], , 
6476,3143,Gilenya,2015-12-18,2020-01-05, ,mg,['3 / Week'],IV,Persistence of relapses
6477,2396,Tecfidera,2016-09-10,, , ,['/ Week'],IV, 
6478,2919,Copaxone,2015-12-26,,300, ,['/ Week'],IV, 
6479,2919,Alemtuzumab (Campath),2016-06-25,, , ,['/ Day'],IV, 
6480,2919,Methylprednisolone,2015-12-26,,5000,mg,['/Month'],IV, 
6481,2919,IVIG,2016-01-30,2019-08-27, ,mg,['/Month'],IV,Adverse Event
6482,1984,Endoxan,2016-10-22,,400, ,['/Month'],IV, 
6483,1984,Alemtuzumab (Campath),2016-06-06,,5000, ,['3 / Week'],IV, 
6484,3873,D-cure (Vitamine D),2016-06-06,,1000,mg,['/Month'], , 
6485,3873,Rebif [44],2015-11-09,,300, ,['2 / Day'], , 
6486,1245,Tysabri,2016-03-04,,20, ,['/ Day'], , 
6487,1245,Alemtuzumab (Campath),2016-05-29,,500,mg,[' '],Oral, 
6488,667,Alemtuzumab (Campath),2016-02-27,2021-01-18,500,mg,['2 / Day'], ,Adverse Event
6489,667,Endoxan,2016-08-12,,5000,mg,['2 / Day'],IV, 
6490,667,Methylprednisolone,2016-09-05,,400, ,['2 / Day'], , 
6491,667,Tecfidera,2016-07-20,,1,mg,['/ Day'],IV, 
6492,4066,Ledertrexaat,2016-02-09,,300, ,['/Month'], , 
6493,3799,Alemtuzumab (Campath),2016-04-02,,300, ,['2 / Day'],IV, 
6494,3447,D-cure (Vitamine D),2015-12-20,, ,mg,[' '],IV, 
6495,3627,Tecfidera,2016-04-28,,20,mg,['2 / Day'], , 
6496,2071,Tysabri,2016-09-03,2019-08-30,1, ,['3 / Week'],IV,Patient Choice/Convenience
6497,2071,Teriflunomide,2016-01-05,,20, ,['/ Day'], , 
6498,2071,Rebif [44],2016-06-27,2020-10-25,1000, ,['/ Day'],IV,Patient Choice/Convenience
6499,853,Endoxan,2016-01-20,,500,mg,['/Month'],IV, 
6500,853,Gilenya,2015-10-24,,400,MIU,['/Month'],IV, 
6501,853,Endoxan,2016-08-01,,300, ,['2 / Day'],IV, 
6502,786,Rebif [44],2016-01-18,,1000,mg,['3 / Week'],IV, 
6503,786,D-cure (Vitamine D),2016-06-08,2019-03-11,500, ,['2 / Day'],IV,Adverse Event
6504,786,Endoxan,2016-08-31,2017-10-30,5000, ,['/ Day'],IV,Patient Choice/Convenience
6505,1325,Betaferon,2016-09-07,,20,mg,['/ Day'], , 
6506,1325,Tysabri,2016-08-21,2018-04-08,20, ,['3 / Week'], ,Patient Choice/Convenience
6507,1325,D-cure (Vitamine D),2015-12-12,2020-08-14,500, ,['2 / Day'],IV,Persisting MRI activity
6508,4532,Tecfidera,2016-03-23,2018-07-02,400,mg,[' '], ,Persisting MRI activity
6509,4532,Gilenya,2015-11-11,2020-03-28,20,mg,['3 / Week'],IV,Patient Choice/Convenience
6510,4532,Rebif [44],2016-10-06,2021-07-31,20, ,['2 / Day'],Oral,Patient Choice/Convenience
6511,4532,Rebif [44],2016-09-16,2018-06-11, , ,['/Month'],IV,Persisting MRI activity
6512,2502,D-cure (Vitamine D),2016-01-14,2018-04-30, ,MIU,['/Month'],IV,Adverse Event
6513,2502,IVIG,2015-12-26,2017-12-25,400, ,[' '], ,Patient Choice/Convenience
6514,2502,Tecfidera,2016-08-15,,500, ,['/ Day'],IV, 
6515,2502,Methylprednisolone,2016-05-12,, , ,['3 / Week'],Oral, 
6516,945,Gilenya,2015-12-17,2020-12-26,300,MIU,['/Month'], ,Patient Choice/Convenience
6517,320,D-cure (Vitamine D),2016-04-19,, ,mg,['2 / Day'],IV, 
6518,320,Avonex,2016-04-08,2019-05-13,1, ,['/Month'], ,Adverse Event
6519,1305,Endoxan,2016-07-29,, , ,['2 / Day'], , 
6520,1305,Copaxone,2016-09-23,,5000, ,['3 / Week'], , 
6521,1997,D-cure (Vitamine D),2015-10-27,, ,mg,['2 / Day'],IV, 
6522,1997,Betaferon,2015-11-09,,300, ,[' '], , 
6523,2194,Tecfidera,2016-10-17,2020-09-17,1000,mg,['2 / Day'], ,Lack of efficacy
6524,598,Betaferon,2016-08-13,2020-07-14,400,MIU,['/ Day'],IV,Persisting MRI activity
6525,1195,Ledertrexaat,2016-08-16,2021-06-13, , ,['2 / Day'],IV,Persistence of relapses
6526,1195,Tecfidera,2016-07-29,,5000,mcg,['2 / Day'], , 
6527,1195,Ledertrexaat,2015-12-08,, , ,['3 / Week'],IV, 
6528,3764,Ledertrexaat,2016-08-13,2021-08-21,20, ,['/ Day'],Oral,Adverse Event
6529,3764,Teriflunomide,2016-09-07,2021-09-13,500,MIU,['3 / Week'], ,Persisting MRI activity
6530,3985,Avonex,2016-07-25,2019-03-24,1000, ,['3 / Week'],IV,Adverse Event
6531,3985,D-cure (Vitamine D),2016-03-03,,400, ,['2 / Day'],IV, 
6532,3652,Ledertrexaat,2015-11-08,2019-06-19,1000, ,['/ Week'],IV,Adverse Event
6533,3652,Tysabri,2015-11-09,, ,mg,['/ Week'],IV, 
6534,3652,Mitoxantrone,2015-12-24,,20, ,[' '],IV, 
6535,3652,Rebif [44],2016-05-05,, , ,['/ Week'],IV, 
6536,1541,Endoxan,2016-01-29,,1,mg,['/Month'],IV, 
6537,1541,Tysabri,2016-03-21,,1000,MIU,['2 / Day'],Oral, 
6538,1541,D-cure (Vitamine D),2016-09-11,2020-04-25,20,mg,['2 / Day'], ,Lack of efficacy
6539,1541,D-cure (Vitamine D),2016-01-16,,300, ,['/Month'],Oral, 
6540,3011,Endoxan,2016-02-09,,500, ,['2 / Day'],IV, 
6541,3011,Copaxone,2016-10-07,,300,mg,['2 / Day'],IV, 
6542,3555,Rebif [44],2015-12-13,,500,mg,['3 / Week'],IV, 
6543,2387,Endoxan,2016-03-07,2021-10-10, , ,['/Month'],IV,Lack of efficacy
6544,2387,D-cure (Vitamine D),2016-06-06,2018-10-25,1000,mg,[' '],IV,Persisting MRI activity
6545,2387,IVIG,2016-03-02,2018-10-09,1,mg,['2 / Day'],IV,Adverse Event
6546,3439,IVIG,2016-03-13,, ,mg,['/Month'],Oral, 
6547,3439,Ledertrexaat,2016-02-04,,5000,mg,['2 / Day'], , 
6548,3439,Copaxone,2016-08-06,, ,MIU,['3 / Week'],IV, 
6549,3439,D-cure (Vitamine D),2016-05-24,,1,mg,['/Month'],IV, 
6550,3980,Ledertrexaat,2016-05-11,2018-09-25,20,mg,['/ Week'],IV,Persisting MRI activity
6551,3640,IVIG,2016-08-25,2018-09-05,5000, ,['2 / Day'], ,Adverse Event
6552,4247,Copaxone,2016-08-20,,400, ,['/Month'],Oral, 
6553,4247,Alemtuzumab (Campath),2015-12-05,2018-11-27,5000,mg,['2 / Day'], ,Lack of efficacy
6554,3797,IVIG,2016-02-10,2018-02-04,500,mg,['2 / Day'],IV,Persisting MRI activity
6555,3797,Ledertrexaat,2016-08-10,,20,mg,['2 / Day'],IV, 
6556,3797,Rebif [22],2015-11-08,, ,mg,['2 / Day'],IV, 
6557,3797,Rebif [22],2016-05-22,,1000,mcg,['3 / Week'], , 
6558,1942,Betaferon,2016-07-10,,5000,mg,['/ Day'], , 
6559,1942,Rebif [44],2016-07-16,,5000,mg,['/Month'],IV, 
6560,1942,Tysabri,2016-01-29,, , ,['/ Day'],IV, 
6561,3866,Alemtuzumab (Campath),2016-02-14,,1,mcg,['/Month'], , 
6562,3866,Gilenya,2016-07-13,,1, ,['3 / Week'], , 
6563,3866,Tecfidera,2016-06-22,2019-12-16, , ,['3 / Week'],IV,Lack of efficacy
6564,3866,Rebif [44],2016-05-13,,1,mg,['/ Day'],IV, 
6565,2864,Tecfidera,2016-06-19,2019-01-04,500,mg,['/ Week'],IV,Persisting MRI activity
6566,2864,IVIG,2016-06-28,2020-10-11,500,mg,['/ Day'],IV,Patient Choice/Convenience
6567,2864,Gilenya,2015-12-29,2020-10-08, ,mg,['/Month'], ,Adverse Event
6568,3007,Avonex,2016-07-02,,400, ,['3 / Week'], , 
6569,3007,Tecfidera,2016-10-15,2021-08-05, , ,['2 / Day'],IV,Adverse Event
6570,3007,Alemtuzumab (Campath),2016-08-21,,1000,mcg,['2 / Day'],IV, 
6571,3007,Endoxan,2016-04-14,2019-06-15, ,mg,['/ Week'],IV,Lack of efficacy
6572,3462,Tecfidera,2016-08-14,,1000,mcg,['3 / Week'], , 
6573,3462,IVIG,2015-11-20,2021-10-05, , ,['/Month'],IV,Patient Choice/Convenience
6574,2991,Alemtuzumab (Campath),2016-01-18,,300, ,['2 / Day'],IV, 
6575,2991,Rebif [22],2016-04-26,2020-01-23,1000,mg,['2 / Day'], ,Adverse Event
6576,2991,Copaxone,2016-05-18,, , ,[' '],Oral, 
6577,2991,Gilenya,2016-09-23,,400,mg,['2 / Day'],IV, 
6578,1352,Rebif [22],2016-04-22,2021-10-17,500,mg,['3 / Week'],IV,Patient Choice/Convenience
6579,1352,IVIG,2016-06-17,, , ,['2 / Day'], , 
6580,2008,IVIG,2016-04-05,, ,MIU,['/Month'],IV, 
6581,3477,Avonex,2016-03-11,2021-08-11,500, ,['/ Day'],IV,Persistence of relapses
6582,2333,Teriflunomide,2016-10-03,, , ,['3 / Week'],IV, 
6583,3278,Gilenya,2016-07-29,2019-12-22,1000,mg,['/Month'],Oral,Patient Choice/Convenience
6584,3278,Gilenya,2016-04-02,,20,mcg,['2 / Day'], , 
6585,3278,Methylprednisolone,2015-12-19,, , ,['/Month'],Oral, 
6586,3278,Tysabri,2016-09-25,2021-05-09,1000,mg,['/ Day'],IV,Adverse Event
6587,3386,Tysabri,2016-01-29,2020-03-10,400,mg,['/Month'], ,Persisting MRI activity
6588,1776,Rebif [22],2016-03-26,, ,mg,['2 / Day'],IV, 
6589,1776,Betaferon,2016-09-09,2018-10-15,300, ,['/Month'], ,Persisting MRI activity
6590,1776,Gilenya,2016-01-07,2019-12-26,5000,mg,['/Month'], ,Adverse Event
6591,1776,Copaxone,2016-02-28,2019-05-14,500, ,['2 / Day'],IV,Adverse Event
6592,2640,Methylprednisolone,2015-11-25,2020-01-09,500,mg,['2 / Day'],IV,Patient Choice/Convenience
6593,171,Avonex,2016-08-30,,1000,mg,[' '], , 
6594,171,Mitoxantrone,2016-01-05,,400, ,['2 / Day'],Oral, 
6595,171,Copaxone,2016-06-24,, , ,['/Month'],Oral, 
6596,171,Rebif [22],2016-09-29,,400,mg,['3 / Week'],IV, 
6597,1641,Rebif [44],2016-08-21,2019-06-27,1000, ,['2 / Day'], ,Persisting MRI activity
6598,1297,Endoxan,2016-02-13,,500,mg,['2 / Day'], , 
6599,1297,Endoxan,2016-02-29,2018-02-02, , ,['/Month'],IV,Persisting MRI activity
6600,1297,Methylprednisolone,2016-01-24,,5000, ,['3 / Week'],IV, 
6601,1297,Gilenya,2015-11-28,2020-02-19, , ,['/ Day'],IV,Lack of efficacy
6602,2223,Copaxone,2015-10-31,2021-02-03, ,mcg,['/Month'],IV,Lack of efficacy
6603,2207,Tecfidera,2015-12-08,2019-04-21,500, ,['/Month'],Oral,Patient Choice/Convenience
6604,4032,Rebif [44],2015-12-15,2019-10-08,300,MIU,['/Month'], ,Patient Choice/Convenience
6605,4032,Tecfidera,2015-12-23,, , ,['/ Day'],Oral, 
6606,4032,Tecfidera,2015-11-09,2019-02-09,1000,mg,['/ Day'],IV,Adverse Event
6607,1814,Methylprednisolone,2016-07-07,2017-12-14,20, ,['/ Week'],IV,Adverse Event
6608,1814,IVIG,2016-01-22,2018-06-04,5000, ,['/Month'],IV,Persistence of relapses
6609,1814,Tecfidera,2016-04-08,2020-10-06, , ,['/Month'],IV,Lack of efficacy
6610,4365,Betaferon,2016-09-16,,1000,mg,['/Month'],IV, 
6611,4365,Methylprednisolone,2015-11-12,2018-05-10,300, ,[' '],IV,Adverse Event
6612,4365,Alemtuzumab (Campath),2016-09-28,2020-11-16,1, ,['2 / Day'],IV,Lack of efficacy
6613,3290,Endoxan,2016-10-09,,500,mg,['/Month'],Oral, 
6614,3290,Avonex,2016-06-01,, ,mg,['2 / Day'], , 
6615,3290,D-cure (Vitamine D),2015-12-10,2018-07-03, ,mg,['3 / Week'], ,Lack of efficacy
6616,3290,Methylprednisolone,2016-05-15,,1000,mg,['/Month'],IV, 
6617,246,Betaferon,2015-11-29,, ,mcg,['2 / Day'], , 
6618,246,Teriflunomide,2016-03-28,,500,MIU,['/Month'], , 
6619,4129,D-cure (Vitamine D),2016-08-19,2019-05-17, , ,['2 / Day'],IV,Adverse Event
6620,489,IVIG,2016-08-25,,300,mg,['/Month'], , 
6621,489,Avonex,2016-10-13,2021-06-11,1,MIU,['2 / Day'], ,Patient Choice/Convenience
6622,451,Rebif [44],2016-07-13,2018-09-03,20, ,['2 / Day'], ,Patient Choice/Convenience
6623,451,Tecfidera,2016-05-07,,20,MIU,['2 / Day'], , 
6624,451,Methylprednisolone,2015-11-16,,1,mg,['/ Day'],IV, 
6625,2024,Ledertrexaat,2016-04-23,,20,mg,['3 / Week'], , 
6626,3061,Tysabri,2016-08-23,,400, ,['2 / Day'], , 
6627,578,Alemtuzumab (Campath),2016-05-05,,500,mg,['2 / Day'],IV, 
6628,578,Rebif [22],2016-04-30,,300,mg,['2 / Day'],IV, 
6629,4691,Teriflunomide,2016-04-21,2019-03-13,1, ,['2 / Day'],IV,Lack of efficacy
6630,4691,Methylprednisolone,2016-08-23,,5000, ,['/Month'], , 
6631,4691,Endoxan,2015-11-03,2017-11-27, ,mg,[' '],IV,Lack of efficacy
6632,4691,Tecfidera,2016-07-28,,500,MIU,['3 / Week'],IV, 
6633,970,Ledertrexaat,2016-06-14,2020-07-08,500,mcg,[' '],IV,Patient Choice/Convenience
6634,970,Teriflunomide,2016-09-27,, , ,['/Month'],IV, 
6635,2098,Betaferon,2016-10-18,,500, ,['/ Week'],Oral, 
6636,1064,Tysabri,2015-11-29,, ,mg,['2 / Day'],IV, 
6637,1064,Gilenya,2016-01-23,2020-01-11,1, ,['/Month'],IV,Persisting MRI activity
6638,1064,Tecfidera,2016-01-03,,20,mcg,['/Month'], , 
6639,1064,IVIG,2016-08-09,2021-01-17, ,mg,['2 / Day'],IV,Adverse Event
6640,1475,Methylprednisolone,2016-07-05,2018-10-03, ,mg,['2 / Day'],Oral,Persistence of relapses
6641,1475,Tysabri,2016-08-10,,300,mg,['2 / Day'],IV, 
6642,1475,Methylprednisolone,2016-04-14,,20,mg,['/ Day'],IV, 
6643,1475,IVIG,2016-04-23,,500,mg,['3 / Week'],IV, 
6644,4037,Copaxone,2015-11-04,, ,mg,['/ Day'],IV, 
6645,3264,Copaxone,2016-09-22,2020-02-26,1000,MIU,['/Month'], ,Patient Choice/Convenience
6646,3264,IVIG,2016-05-25,,400,mg,['2 / Day'], , 
6647,4253,Methylprednisolone,2016-02-11,2018-10-16,1000,mg,['2 / Day'], ,Persistence of relapses
6648,4253,IVIG,2015-12-28,, ,mg,[' '], , 
6649,4253,Betaferon,2015-11-20,, ,mcg,['/Month'],IV, 
6650,4123,D-cure (Vitamine D),2016-09-05,,20,mg,['/Month'],Oral, 
6651,4123,Tysabri,2015-11-10,2020-10-18, ,mg,['/Month'], ,Patient Choice/Convenience
6652,4123,Methylprednisolone,2015-12-22,2020-09-06,500, ,['/Month'],IV,Adverse Event
6653,4123,Endoxan,2016-06-26,,1, ,['2 / Day'], , 
6654,4245,D-cure (Vitamine D),2016-01-13,,5000, ,['2 / Day'],IV, 
6655,4245,Gilenya,2016-02-11,,1000,mg,['/Month'], , 
6656,4245,Mitoxantrone,2016-01-19,, ,mg,['/ Week'],IV, 
6657,4234,D-cure (Vitamine D),2016-03-23,, ,mg,['2 / Day'],IV, 
6658,4234,Avonex,2015-12-11,2020-09-14,400,mg,['/ Day'], ,Persistence of relapses
6659,4234,Mitoxantrone,2015-11-03,2018-05-21,400, ,['3 / Week'], ,Lack of efficacy
6660,4234,Endoxan,2015-11-10,, ,mg,['/ Day'],IV, 
6661,220,Rebif [44],2016-03-16,,1, ,['2 / Day'], , 
6662,220,Rebif [44],2015-11-28,2020-03-28,300,mg,['/Month'],Oral,Persisting MRI activity
6663,2278,Alemtuzumab (Campath),2016-08-17,2020-12-08,20,mg,['3 / Week'],IV,Patient Choice/Convenience
6664,2278,Avonex,2016-09-06,,300,mg,['3 / Week'], , 
6665,2278,Rebif [22],2016-02-28,,500,mg,['/Month'],IV, 
6666,3022,Betaferon,2016-04-09,2020-04-04, ,MIU,[' '],IV,Adverse Event
6667,3022,Methylprednisolone,2016-07-27,,1,mg,['/ Day'], , 
6668,3022,Rebif [44],2016-07-01,, , ,['/Month'],IV, 
6669,3022,Rebif [22],2016-03-20,, ,mcg,['3 / Week'],IV, 
6670,701,Tecfidera,2016-05-07,2021-08-30, ,mg,['2 / Day'],IV,Persisting MRI activity
6671,2800,Rebif [44],2016-09-10,2018-03-04,300, ,['/Month'],IV,Lack of efficacy
6672,2800,D-cure (Vitamine D),2016-08-26,,400,MIU,['/Month'],IV, 
6673,2800,Methylprednisolone,2016-04-10,,300,mg,['/Month'],Oral, 
6674,3620,Gilenya,2016-05-26,2017-10-28, ,MIU,[' '], ,Persisting MRI activity
6675,3620,Endoxan,2016-03-05,,1000,mg,['2 / Day'],IV, 
6676,3620,D-cure (Vitamine D),2016-05-20,,5000,mg,['/Month'],Oral, 
6677,1282,Alemtuzumab (Campath),2015-11-21,,1000,MIU,['2 / Day'],IV, 
6678,2871,Methylprednisolone,2016-04-09,,500,MIU,['2 / Day'], , 
6679,2871,Tecfidera,2016-07-12,,5000,MIU,['/Month'],IV, 
6680,2581,D-cure (Vitamine D),2016-09-18,2019-02-19,1,mg,[' '], ,Patient Choice/Convenience
6681,2581,Tecfidera,2015-12-17,,300,MIU,['/ Day'], , 
6682,2581,Copaxone,2016-05-29,2020-01-05, , ,['/Month'],IV,Persistence of relapses
6683,1389,Betaferon,2016-07-07,,1,mcg,[' '],IV, 
6684,1389,D-cure (Vitamine D),2016-07-09,,500,mg,['2 / Day'], , 
6685,2117,Tecfidera,2016-01-12,2020-06-01,5000,mg,['2 / Day'], ,Persistence of relapses
6686,2117,Copaxone,2016-05-22,,300, ,['2 / Day'], , 
6687,2117,Tecfidera,2016-06-09,,1, ,['2 / Day'], , 
6688,2117,Rebif [44],2016-09-07,2020-01-13,1000, ,['/Month'],Oral,Patient Choice/Convenience
6689,2716,Methylprednisolone,2016-02-15,2017-11-24, , ,['2 / Day'], ,Persisting MRI activity
6690,2716,D-cure (Vitamine D),2016-09-11,,1000,mg,['/Month'], , 
6691,2716,IVIG,2016-01-10,2021-01-05,1000,mg,['/Month'],Oral,Adverse Event
6692,2739,Rebif [44],2016-07-21,,5000,mg,['/ Week'],IV, 
6693,2739,Ledertrexaat,2015-12-23,,500,mg,['2 / Day'],IV, 
6694,3637,Tecfidera,2016-01-15,,20,mg,['/Month'],IV, 
6695,3637,Methylprednisolone,2015-10-31,2018-01-29,1000,mg,['/Month'],IV,Adverse Event
6696,3637,Tysabri,2016-04-05,2019-10-03,1, ,['/Month'],IV,Persistence of relapses
6697,3637,Alemtuzumab (Campath),2016-10-17,2019-01-28, ,mg,['3 / Week'],IV,Lack of efficacy
6698,2802,Ledertrexaat,2016-06-26,,20, ,['/Month'],IV, 
6699,2802,Gilenya,2016-10-21,,300, ,['/Month'],IV, 
6700,2802,Copaxone,2015-11-14,2019-06-27,1000, ,['/ Week'], ,Adverse Event
6701,2802,D-cure (Vitamine D),2016-03-24,,20, ,[' '],IV, 
6702,3619,Gilenya,2016-08-08,,1,mg,['3 / Week'], , 
6703,3619,Rebif [44],2016-03-26,2019-09-05,500,MIU,['2 / Day'], ,Persisting MRI activity
6704,3619,Gilenya,2016-03-19,2018-12-15,500,mg,['2 / Day'], ,Persistence of relapses
6705,1755,Rebif [44],2016-10-22,2017-12-10, , ,['/Month'],IV,Adverse Event
6706,546,D-cure (Vitamine D),2015-11-23,2020-09-19,1,mg,['/Month'], ,Patient Choice/Convenience
6707,546,Copaxone,2015-12-07,2019-02-06,1000, ,['/ Week'],Oral,Adverse Event
6708,4437,D-cure (Vitamine D),2016-02-01,2021-07-23,5000,MIU,['/ Day'],IV,Persisting MRI activity
6709,4437,Tysabri,2016-01-24,2019-06-16, ,MIU,['/Month'], ,Persisting MRI activity
6710,4437,Tysabri,2016-03-28,2019-08-31,5000,mg,['2 / Day'],IV,Persistence of relapses
6711,3950,Alemtuzumab (Campath),2016-03-13,,500,mcg,['/Month'],IV, 
6712,3950,IVIG,2015-11-23,2019-03-03,400,mg,['/Month'],Oral,Patient Choice/Convenience
6713,3950,D-cure (Vitamine D),2016-03-15,,300, ,['/Month'], , 
6714,3950,Alemtuzumab (Campath),2016-05-02,2018-09-15, , ,['/Month'],Oral,Adverse Event
6715,2655,D-cure (Vitamine D),2016-05-10,, , ,['3 / Week'],IV, 
6716,2655,Rebif [44],2015-11-28,2021-03-03,5000,mg,['/Month'], ,Persisting MRI activity
6717,2655,Copaxone,2016-06-15,,5000,mg,['2 / Day'],Oral, 
6718,4126,Copaxone,2016-04-14,,20, ,['3 / Week'],IV, 
6719,4126,Rebif [22],2016-07-21,2021-08-25,20, ,['2 / Day'],IV,Persistence of relapses
6720,782,Rebif [22],2016-04-18,2021-04-16, , ,[' '],IV,Lack of efficacy
6721,782,Teriflunomide,2015-12-02,, ,mg,['2 / Day'],IV, 
6722,4270,Teriflunomide,2016-05-01,2020-02-10,1, ,['3 / Week'],Oral,Patient Choice/Convenience
6723,4270,Rebif [22],2016-02-01,2019-08-19,20, ,['3 / Week'], ,Patient Choice/Convenience
6724,4270,IVIG,2016-10-01,2019-10-08,20,mg,['2 / Day'], ,Persisting MRI activity
6725,1795,Endoxan,2016-05-25,2021-04-14,500, ,['3 / Week'],IV,Patient Choice/Convenience
6726,1795,Gilenya,2016-07-21,, ,mg,['2 / Day'], , 
6727,3307,Methylprednisolone,2016-03-08,2018-07-27,20, ,['3 / Week'],IV,Patient Choice/Convenience
6728,3307,D-cure (Vitamine D),2016-07-24,,500,mg,['2 / Day'],Oral, 
6729,4153,Betaferon,2016-04-30,,400,mg,['/ Day'], , 
6730,4153,Gilenya,2016-08-10,, , ,['/ Week'], , 
6731,1710,IVIG,2015-12-21,2021-10-16,1000,mg,['3 / Week'],IV,Persisting MRI activity
6732,796,Rebif [22],2016-05-28,2020-03-26, ,MIU,['/ Day'],IV,Patient Choice/Convenience
6733,796,Gilenya,2016-06-16,, ,mg,['2 / Day'],IV, 
6734,796,Copaxone,2015-10-24,2018-09-20, , ,['2 / Day'], ,Lack of efficacy
6735,796,Rebif [44],2016-10-04,,500,mg,['/Month'],IV, 
6736,1244,IVIG,2016-03-11,2020-09-04,20, ,['/Month'], ,Adverse Event
6737,4261,Tysabri,2015-12-26,,300,mg,['3 / Week'],IV, 
6738,4261,Gilenya,2015-11-06,2018-03-29,1,mg,['/Month'],IV,Adverse Event
6739,4811,Endoxan,2016-05-22,, ,mg,['/Month'], , 
6740,4811,D-cure (Vitamine D),2016-02-22,2019-12-08,300, ,['2 / Day'], ,Lack of efficacy
6741,4811,Rebif [44],2016-09-24,,5000,mg,['3 / Week'],IV, 
6742,4811,Betaferon,2016-01-04,2020-11-03,1000,mg,['/Month'],IV,Lack of efficacy
6743,3196,Alemtuzumab (Campath),2015-11-11,,1000, ,['/Month'],IV, 
6744,3196,Avonex,2016-05-09,2020-10-11,1, ,['/Month'],IV,Patient Choice/Convenience
6745,3196,Betaferon,2016-06-05,2020-03-28,400, ,['2 / Day'],IV,Patient Choice/Convenience
6746,4422,D-cure (Vitamine D),2016-08-27,, , ,['/ Day'],Oral, 
6747,4422,D-cure (Vitamine D),2016-07-11,2019-07-06,300, ,['/ Day'],IV,Persistence of relapses
6748,4422,Mitoxantrone,2016-07-23,, , ,['2 / Day'], , 
6749,4422,IVIG,2016-01-17,, , ,['/Month'], , 
6750,2692,Rebif [44],2016-06-30,2017-12-31,20, ,[' '],IV,Lack of efficacy
6751,2692,Methylprednisolone,2016-10-11,,1000,mcg,['/Month'],Oral, 
6752,3753,Copaxone,2015-10-31,,500,mg,['2 / Day'],IV, 
6753,3753,Tysabri,2016-03-05,2021-04-01, ,mcg,['/Month'],IV,Persistence of relapses
6754,4613,Tysabri,2016-02-01,2021-08-18,400,mg,['/Month'], ,Lack of efficacy
6755,2953,Gilenya,2016-06-09,2017-11-03, ,mcg,['2 / Day'],IV,Lack of efficacy
6756,2953,D-cure (Vitamine D),2016-10-15,, ,mg,['/Month'], , 
6757,1108,IVIG,2016-04-10,2018-06-19,1000,MIU,['2 / Day'], ,Lack of efficacy
6758,1108,Tecfidera,2016-07-18,,300, ,['2 / Day'], , 
6759,929,Teriflunomide,2016-09-11,, ,mg,['2 / Day'],IV, 
6760,929,Methylprednisolone,2016-02-02,, , ,['/ Week'], , 
6761,929,Ledertrexaat,2016-10-21,,500,MIU,['/ Week'],IV, 
6762,371,IVIG,2016-02-18,,1000, ,['/Month'], , 
6763,371,Rebif [44],2016-04-23,, ,mg,['3 / Week'], , 
6764,677,Mitoxantrone,2016-03-17,,500,mg,['/ Day'],IV, 
6765,677,IVIG,2016-04-01,,1000, ,['/ Day'],IV, 
6766,677,D-cure (Vitamine D),2016-05-25,,1,mcg,['/ Day'],Oral, 
6767,677,Endoxan,2015-11-22,2019-08-29,1,mg,['/Month'], ,Adverse Event
6768,198,Methylprednisolone,2016-06-07,, ,mcg,[' '],IV, 
6769,3264,D-cure (Vitamine D),2016-09-02,,400,mg,['/Month'], , 
6770,3264,Tysabri,2016-01-29,,1,mg,['/ Day'],IV, 
6771,4780,IVIG,2015-11-15,, ,mcg,['/Month'], , 
6772,4780,Alemtuzumab (Campath),2016-05-27,2021-06-06, ,mg,['/Month'],Oral,Patient Choice/Convenience
6773,4780,D-cure (Vitamine D),2015-11-29,,1000,mg,['2 / Day'],IV, 
6774,1206,IVIG,2016-10-09,,20,mg,['3 / Week'], , 
6775,1206,Ledertrexaat,2016-03-25,,400, ,[' '],IV, 
6776,981,D-cure (Vitamine D),2015-11-13,2020-11-14, ,mg,['/Month'],IV,Lack of efficacy
6777,981,Alemtuzumab (Campath),2016-01-02,2019-01-01, ,MIU,['/ Day'], ,Adverse Event
6778,1718,Teriflunomide,2016-06-29,2020-05-27,400,mg,['/Month'], ,Lack of efficacy
6779,1322,Rebif [44],2015-12-24,, , ,['/Month'],Oral, 
6780,1322,Avonex,2016-02-19,,5000,mg,['2 / Day'],IV, 
6781,1367,IVIG,2015-11-04,2019-01-19,500, ,['/Month'],Oral,Patient Choice/Convenience
6782,4957,Tecfidera,2016-02-13,,1,mg,[' '],Oral, 
6783,4957,Rebif [22],2016-02-20,2017-12-13, , ,[' '], ,Patient Choice/Convenience
6784,4957,Teriflunomide,2016-08-27,,300, ,['2 / Day'],IV, 
6785,4957,Tysabri,2016-05-18,,5000,mg,['2 / Day'],IV, 
6786,4835,Gilenya,2016-07-08,2019-10-16, ,mg,['/Month'], ,Persistence of relapses
6787,4835,Betaferon,2015-11-29,,400, ,['/Month'], , 
6788,4835,Methylprednisolone,2016-04-24,2021-05-19, , ,['2 / Day'],IV,Adverse Event
6789,4790,Endoxan,2015-12-22,,1, ,['/ Day'], , 
6790,3809,Gilenya,2016-10-15,2020-06-23, , ,['/Month'], ,Adverse Event
6791,3809,Tecfidera,2016-02-22,, ,mcg,['2 / Day'], , 
6792,401,Rebif [22],2016-07-22,2020-08-23,1000,mcg,[' '],IV,Adverse Event
6793,401,IVIG,2016-05-20,2017-12-20,1000, ,[' '], ,Adverse Event
6794,4755,Gilenya,2016-09-03,,300, ,['/ Week'], , 
6795,4755,Endoxan,2016-08-13,, , ,['3 / Week'],IV, 
6796,4755,IVIG,2016-09-07,2018-03-20, ,mg,['2 / Day'], ,Patient Choice/Convenience
6797,4499,Endoxan,2016-08-19,2019-10-10,20,mg,[' '],IV,Persistence of relapses
6798,4499,D-cure (Vitamine D),2016-08-05,2021-10-03,5000, ,['2 / Day'],IV,Adverse Event
6799,4499,Tysabri,2016-01-29,,1000,MIU,['/Month'],IV, 
6800,1242,Endoxan,2016-08-19,, , ,['/Month'],Oral, 
6801,1242,Tecfidera,2016-03-05,,5000, ,['3 / Week'],IV, 
6802,1242,Tecfidera,2016-09-17,2020-09-21,500,mg,['2 / Day'],Oral,Lack of efficacy
6803,1242,Rebif [44],2015-12-01,2021-01-10,1000,MIU,['3 / Week'], ,Persistence of relapses
6804,634,D-cure (Vitamine D),2015-12-02,,300,MIU,['3 / Week'], , 
6805,634,Avonex,2016-07-02,,1000, ,['2 / Day'],IV, 
6806,2259,Betaferon,2016-05-13,2019-02-19, , ,['/ Day'],IV,Patient Choice/Convenience
6807,2751,D-cure (Vitamine D),2015-11-07,,20, ,['/Month'], , 
6808,2751,Copaxone,2016-09-27,,400,mg,['2 / Day'], , 
6809,4880,Gilenya,2016-08-22,, ,mg,['/Month'],IV, 
6810,1026,Tecfidera,2016-03-18,2020-03-11,1,mg,['/Month'],IV,Patient Choice/Convenience
6811,1026,Rebif [44],2016-10-17,2019-12-28,400,mg,['2 / Day'],IV,Adverse Event
6812,1026,Tecfidera,2016-01-07,,500,MIU,['/ Day'],IV, 
6813,3616,IVIG,2015-12-12,, , ,['2 / Day'],IV, 
6814,3616,D-cure (Vitamine D),2015-11-18,, , ,['2 / Day'],Oral, 
6815,4421,D-cure (Vitamine D),2016-02-14,2018-10-31,1000,mg,['/ Day'], ,Adverse Event
6816,2485,IVIG,2016-01-17,2018-05-05,1000,MIU,['/Month'], ,Adverse Event
6817,2485,Avonex,2016-07-18,2018-04-03, ,MIU,['/Month'],IV,Patient Choice/Convenience
6818,2485,Rebif [44],2016-02-23,2017-12-02,1,mg,[' '], ,Patient Choice/Convenience
6819,3039,Tecfidera,2015-12-18,,20, ,['3 / Week'],Oral, 
6820,2829,Tysabri,2015-10-31,2018-11-19,400, ,[' '],IV,Patient Choice/Convenience
6821,2745,IVIG,2015-11-30,,5000,MIU,['3 / Week'],Oral, 
6822,2745,Rebif [44],2016-09-08,,20, ,['/Month'], , 
6823,3240,Rebif [44],2016-02-28,, ,mcg,['/ Day'],IV, 
6824,3545,Copaxone,2015-11-19,,500, ,['/ Day'],IV, 
6825,3545,D-cure (Vitamine D),2016-09-05,2019-08-18, ,mcg,['2 / Day'],IV,Adverse Event
6826,3545,Betaferon,2016-06-26,2021-03-17,1000,mg,['/Month'], ,Patient Choice/Convenience
6827,3545,Endoxan,2015-11-28,2019-10-03,500, ,['2 / Day'], ,Adverse Event
6828,449,D-cure (Vitamine D),2016-03-28,,400,mg,['/Month'],Oral, 
6829,449,Rebif [22],2016-03-15,2018-06-15,1000, ,['/Month'],Oral,Adverse Event
6830,449,Rebif [22],2015-12-04,, ,mg,['/Month'], , 
6831,2534,Tysabri,2016-02-05,2021-10-09,1000, ,['3 / Week'], ,Lack of efficacy
6832,2744,Copaxone,2015-11-29,, , ,['/Month'],Oral, 
6833,2744,Ledertrexaat,2016-10-15,,500,MIU,['/ Day'], , 
6834,2744,Avonex,2015-11-21,,1, ,['2 / Day'], , 
6835,2685,Tecfidera,2016-10-04,,20, ,['/ Week'],IV, 
6836,2685,Copaxone,2016-07-16,2020-06-27,1000,mcg,['/ Day'], ,Persistence of relapses
6837,2685,Rebif [44],2016-02-19,, , ,['2 / Day'], , 
6838,4874,Endoxan,2015-12-24,,5000, ,['/Month'], , 
6839,4874,Tysabri,2016-09-19,2018-08-14,20,mg,['/Month'],IV,Patient Choice/Convenience
6840,2105,Betaferon,2016-07-14,2021-04-20, ,mg,['3 / Week'],Oral,Lack of efficacy
6841,2948,Avonex,2016-01-16,,1000,mg,['/Month'],IV, 
6842,2948,Methylprednisolone,2016-03-26,2018-11-24,300, ,['/ Week'], ,Lack of efficacy
6843,494,Teriflunomide,2016-01-12,,1,mg,['3 / Week'],IV, 
6844,494,Teriflunomide,2016-05-07,2021-06-13,1,mg,['2 / Day'],IV,Patient Choice/Convenience
6845,494,Copaxone,2016-09-07,,400,MIU,['/Month'],IV, 
6846,390,Endoxan,2016-06-28,,20, ,['/Month'], , 
6847,787,Gilenya,2016-03-01,2020-01-31, ,mg,['/ Week'], ,Lack of efficacy
6848,787,Ledertrexaat,2016-08-05,, , ,['/Month'],IV, 
6849,3905,Methylprednisolone,2016-04-26,2019-06-09,1,mg,['2 / Day'],IV,Patient Choice/Convenience
6850,3905,Avonex,2016-04-10,2021-03-26,1,mcg,['/Month'], ,Lack of efficacy
6851,1364,Alemtuzumab (Campath),2016-01-19,,400, ,['2 / Day'], , 
6852,332,Mitoxantrone,2016-02-15,2020-07-24,300,mg,['2 / Day'], ,Lack of efficacy
6853,332,Tecfidera,2016-07-22,2017-12-25, , ,['2 / Day'],IV,Persisting MRI activity
6854,332,IVIG,2016-07-29,,1,mg,[' '],Oral, 
6855,332,Avonex,2016-07-10,,1000, ,['/Month'],IV, 
6856,155,Copaxone,2016-04-17,, , ,['/Month'], , 
6857,155,D-cure (Vitamine D),2016-05-09,,500,mg,['/ Week'], , 
6858,155,Ledertrexaat,2016-04-28,2018-06-30,1000, ,['2 / Day'],IV,Persisting MRI activity
6859,155,Rebif [22],2016-01-29,2017-10-28,300, ,['/ Week'],IV,Patient Choice/Convenience
6860,3256,Ledertrexaat,2016-05-26,2018-06-30,400, ,['/ Day'],IV,Adverse Event
6861,3256,D-cure (Vitamine D),2016-06-03,2018-12-30, ,mg,['2 / Day'],IV,Adverse Event
6862,3256,Teriflunomide,2016-06-13,,400,mcg,['3 / Week'], , 
6863,3256,Avonex,2016-04-13,,500,mg,['/ Day'],Oral, 
6864,728,Ledertrexaat,2015-11-20,2020-01-15,300,mg,['/Month'],IV,Patient Choice/Convenience
6865,728,Alemtuzumab (Campath),2016-04-05,,20, ,['2 / Day'],Oral, 
6866,1851,Gilenya,2016-08-02,,400, ,['/Month'],IV, 
6867,1851,IVIG,2016-01-20,, ,mg,['2 / Day'],IV, 
6868,1851,D-cure (Vitamine D),2016-01-19,2021-09-15,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
6869,1879,Copaxone,2016-09-21,2021-06-29, , ,[' '],Oral,Patient Choice/Convenience
6870,1879,Gilenya,2016-01-05,2020-08-06, ,mg,['3 / Week'],IV,Adverse Event
6871,1879,Gilenya,2016-08-05,,400,mg,['2 / Day'],IV, 
6872,1879,Rebif [22],2016-01-31,2019-11-06,300, ,['3 / Week'],Oral,Lack of efficacy
6873,4252,Avonex,2016-06-18,2019-01-16,5000,mg,['2 / Day'],IV,Lack of efficacy
6874,2682,Avonex,2016-03-21,2019-04-27, ,mg,['/Month'], ,Patient Choice/Convenience
6875,2682,Tysabri,2016-02-29,, , ,['2 / Day'],IV, 
6876,2682,Rebif [44],2016-05-15,,300,mg,['3 / Week'], , 
6877,2682,IVIG,2016-06-29,, , ,['3 / Week'],IV, 
6878,2543,Gilenya,2016-08-12,2020-01-05,500,MIU,['3 / Week'], ,Adverse Event
6879,4198,IVIG,2015-11-09,,20,mg,['3 / Week'],IV, 
6880,4198,Teriflunomide,2016-08-06,2017-11-10,1000, ,['2 / Day'],IV,Patient Choice/Convenience
6881,4198,Gilenya,2016-09-25,2020-07-22,1000,mg,['/Month'], ,Patient Choice/Convenience
6882,4198,Rebif [22],2016-01-21,,1,mg,[' '], , 
6883,2669,Mitoxantrone,2016-03-25,,400, ,['3 / Week'], , 
6884,2669,Tysabri,2016-10-14,, ,mg,['2 / Day'],IV, 
6885,4927,Methylprednisolone,2016-09-06,2020-01-07, , ,['/ Day'],Oral,Lack of efficacy
6886,4927,Ledertrexaat,2016-04-18,,300,MIU,['/ Day'], , 
6887,4927,Betaferon,2015-12-27,2020-08-12,20, ,['/Month'],IV,Persistence of relapses
6888,1374,Methylprednisolone,2016-01-02,2020-12-15,1000,MIU,['/Month'],Oral,Adverse Event
6889,1374,Betaferon,2016-04-01,,20,mg,['/Month'],IV, 
6890,1374,Methylprednisolone,2016-09-25,,1000,mg,['2 / Day'], , 
6891,4545,Methylprednisolone,2015-12-12,,400, ,['2 / Day'],Oral, 
6892,4545,Alemtuzumab (Campath),2015-10-30,,20, ,[' '],Oral, 
6893,4545,IVIG,2016-02-11,2021-01-27,1,mg,['/Month'], ,Persisting MRI activity
6894,4545,Betaferon,2016-07-09,,1000,mg,['/Month'],IV, 
6895,3031,Methylprednisolone,2016-03-21,,400, ,['/Month'], , 
6896,3031,Mitoxantrone,2016-05-24,2018-09-19,500, ,['/ Day'], ,Patient Choice/Convenience
6897,3031,D-cure (Vitamine D),2015-11-14,,500,mg,[' '],IV, 
6898,3680,Tecfidera,2016-09-26,2021-06-16,20,MIU,['2 / Day'],IV,Adverse Event
6899,3680,Tecfidera,2016-06-04,,5000,MIU,['/Month'],IV, 
6900,3680,Teriflunomide,2016-06-20,2021-05-16,500, ,['2 / Day'], ,Persistence of relapses
6901,4385,D-cure (Vitamine D),2016-04-12,,500,mg,[' '],Oral, 
6902,4385,IVIG,2016-02-20,,400,mg,['/Month'],Oral, 
6903,4385,Methylprednisolone,2016-10-02,2018-06-28,300, ,['3 / Week'], ,Lack of efficacy
6904,4385,Methylprednisolone,2016-10-13,2018-02-17,1,mg,['2 / Day'],IV,Adverse Event
6905,3656,D-cure (Vitamine D),2016-06-24,2017-11-24, ,mg,[' '],Oral,Patient Choice/Convenience
6906,3656,Gilenya,2015-11-07,,300,mg,['/ Day'],IV, 
6907,4095,Copaxone,2016-06-21,2018-01-30,300,mcg,['/Month'],IV,Patient Choice/Convenience
6908,4095,Rebif [44],2016-04-01,2020-05-28,500,mg,['2 / Day'], ,Persisting MRI activity
6909,4095,Methylprednisolone,2016-10-06,2019-07-26, ,mg,['2 / Day'],IV,Persisting MRI activity
6910,2828,Gilenya,2016-03-06,,500, ,['/Month'], , 
6911,2828,Endoxan,2016-09-03,,500,MIU,['3 / Week'],IV, 
6912,2828,Tecfidera,2016-07-30,,500,mg,['2 / Day'], , 
6913,2828,D-cure (Vitamine D),2016-07-21,2018-12-09,5000,mg,['2 / Day'],IV,Persisting MRI activity
6914,2521,IVIG,2016-04-16,, , ,['2 / Day'],IV, 
6915,2521,IVIG,2016-01-17,, , ,['2 / Day'],IV, 
6916,2521,Teriflunomide,2016-02-01,2021-05-17,5000,mg,['3 / Week'],IV,Persisting MRI activity
6917,656,Copaxone,2016-01-31,,5000,mg,['2 / Day'], , 
6918,656,Tecfidera,2016-03-30,2020-09-28,1,mg,['2 / Day'], ,Persisting MRI activity
6919,656,Tecfidera,2016-01-14,,1000, ,['2 / Day'],IV, 
6920,656,Alemtuzumab (Campath),2016-04-22,,500,mg,['3 / Week'],IV, 
6921,4326,Copaxone,2016-10-12,2017-11-25,20,mg,[' '],IV,Lack of efficacy
6922,4326,Betaferon,2016-04-05,,500,MIU,[' '], , 
6923,4326,D-cure (Vitamine D),2015-11-06,, , ,[' '],IV, 
6924,4326,Tysabri,2016-08-25,2018-10-17,400,mg,['2 / Day'], ,Persisting MRI activity
6925,243,Gilenya,2016-02-25,2019-08-02,400,mg,['3 / Week'],Oral,Adverse Event
6926,243,Alemtuzumab (Campath),2016-04-04,,300, ,['/Month'],Oral, 
6927,243,Rebif [44],2016-06-27,2020-10-14, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
6928,1086,Mitoxantrone,2016-09-29,,1000,mg,['/Month'],IV, 
6929,3974,Endoxan,2016-09-16,2020-02-15, , ,['/Month'],Oral,Persisting MRI activity
6930,1249,Rebif [44],2015-12-31,2020-06-12,300,mcg,['2 / Day'], ,Patient Choice/Convenience
6931,1249,Rebif [44],2016-05-24,2020-02-21, , ,['/ Day'],IV,Persisting MRI activity
6932,1249,Alemtuzumab (Campath),2016-09-11,2020-11-11, , ,['2 / Day'],IV,Adverse Event
6933,2373,Rebif [22],2016-03-08,, ,MIU,['/Month'], , 
6934,2373,Tysabri,2016-08-05,2019-01-11, ,mg,['/Month'], ,Adverse Event
6935,727,D-cure (Vitamine D),2016-04-22,,500, ,['3 / Week'],IV, 
6936,727,IVIG,2015-12-03,,20,MIU,['/Month'],Oral, 
6937,4839,D-cure (Vitamine D),2016-07-18,, , ,['3 / Week'], , 
6938,4839,Gilenya,2016-08-19,,1,mg,['/ Week'], , 
6939,4839,D-cure (Vitamine D),2016-09-20,,1000, ,['/Month'],Oral, 
6940,4839,Ledertrexaat,2016-09-12,, , ,['3 / Week'],Oral, 
6941,727,Endoxan,2016-10-05,2020-12-30, ,MIU,['/Month'], ,Lack of efficacy
6942,727,Avonex,2016-10-15,2018-10-25,300,MIU,['/Month'], ,Patient Choice/Convenience
6943,3874,Rebif [44],2016-07-10,,400, ,['3 / Week'],IV, 
6944,3874,D-cure (Vitamine D),2015-12-16,,1000, ,['3 / Week'], , 
6945,3874,Methylprednisolone,2016-04-20,2021-04-05,1000, ,['/Month'],IV,Patient Choice/Convenience
6946,3874,Mitoxantrone,2016-02-07,2019-02-10,1000, ,['2 / Day'],IV,Persistence of relapses
6947,2844,IVIG,2016-04-08,2021-05-23,5000,mg,['2 / Day'],IV,Adverse Event
6948,2844,Gilenya,2016-08-09,2020-05-10,400, ,['3 / Week'],IV,Lack of efficacy
6949,2844,D-cure (Vitamine D),2016-10-10,2018-09-13, ,mg,['/Month'], ,Lack of efficacy
6950,2034,Methylprednisolone,2016-08-02,,1000,mg,['3 / Week'],IV, 
6951,2034,Gilenya,2015-11-04,, ,mg,['/Month'], , 
6952,2034,Endoxan,2015-11-23,2019-01-25, ,MIU,['/Month'],IV,Adverse Event
6953,2068,Gilenya,2016-09-07,,500,MIU,['/Month'], , 
6954,2068,D-cure (Vitamine D),2016-03-23,2017-12-08,500, ,[' '],IV,Persisting MRI activity
6955,2068,Avonex,2015-10-27,2018-07-19,1,mg,['/ Day'], ,Adverse Event
6956,2068,Tysabri,2016-04-11,,5000, ,['2 / Day'], , 
6957,3166,Rebif [44],2016-07-10,2020-08-07,400, ,['2 / Day'], ,Adverse Event
6958,3166,Avonex,2015-12-10,,5000,mg,['/Month'], , 
6959,3166,Rebif [44],2016-03-15,2019-12-17,500,mcg,[' '],IV,Patient Choice/Convenience
6960,4874,Ledertrexaat,2016-04-30,2019-09-06,1000, ,['2 / Day'],IV,Adverse Event
6961,1853,Rebif [44],2016-10-01,2020-10-26,20,MIU,['/Month'],IV,Persisting MRI activity
6962,1853,Avonex,2016-01-18,,20, ,['2 / Day'], , 
6963,1853,Teriflunomide,2016-10-21,, ,mg,['2 / Day'], , 
6964,1853,Avonex,2016-06-20,, ,mg,['/ Week'], , 
6965,853,Gilenya,2016-07-02,, ,mg,['2 / Day'],IV, 
6966,853,Gilenya,2016-10-03,,1,mg,['/Month'],Oral, 
6967,853,Endoxan,2016-04-03,,300,mg,['2 / Day'],Oral, 
6968,2905,Endoxan,2015-12-17,, , ,['2 / Day'], , 
6969,2905,Betaferon,2016-01-11,,1000,MIU,['/Month'], , 
6970,2905,Methylprednisolone,2016-07-20,, ,mg,['/ Day'],IV, 
6971,1410,Rebif [44],2016-06-26,2020-12-19,400, ,['/Month'],IV,Adverse Event
6972,3774,Ledertrexaat,2016-01-15,2017-12-03,1000,mg,['2 / Day'], ,Adverse Event
6973,3774,Endoxan,2016-09-24,2020-03-08, ,mg,['/Month'],IV,Lack of efficacy
6974,3774,Tecfidera,2015-10-25,2019-06-16,1000, ,['/Month'], ,Persisting MRI activity
6975,3774,Teriflunomide,2016-09-19,2019-09-30, ,mg,['2 / Day'],Oral,Persisting MRI activity
6976,4725,D-cure (Vitamine D),2016-08-09,2019-08-25, ,mg,['/ Week'],Oral,Lack of efficacy
6977,4725,IVIG,2016-02-16,,500, ,['2 / Day'], , 
6978,4725,IVIG,2016-04-09,,500,mg,['/Month'],IV, 
6979,4725,Mitoxantrone,2016-02-08,,300,mcg,[' '], , 
6980,2560,Gilenya,2015-12-25,2018-02-21,1,mg,['/Month'],IV,Persisting MRI activity
6981,1609,Betaferon,2015-11-23,,1000, ,['/ Week'],IV, 
6982,1609,Tecfidera,2016-03-16,,400,mg,['/ Day'],IV, 
6983,1609,IVIG,2016-07-28,2018-02-25,300,mg,['3 / Week'], ,Persistence of relapses
6984,1609,Methylprednisolone,2016-08-11,2021-04-05,300,mg,['2 / Day'], ,Patient Choice/Convenience
6985,2204,Alemtuzumab (Campath),2016-02-20,2018-02-19,500,mg,['/Month'],IV,Persistence of relapses
6986,3336,Endoxan,2015-11-16,,1000, ,['2 / Day'],IV, 
6987,3336,IVIG,2016-02-27,,20,mg,['/ Day'],IV, 
6988,3336,Gilenya,2015-11-02,,20,mg,['3 / Week'], , 
6989,3336,Alemtuzumab (Campath),2016-06-30,2021-10-01, ,mg,['2 / Day'],IV,Persisting MRI activity
6990,3942,Gilenya,2016-10-17,, , ,['/Month'],IV, 
6991,3942,Alemtuzumab (Campath),2016-03-25,,400,mg,['/ Day'], , 
6992,3942,Copaxone,2016-10-09,,1000, ,['/Month'],Oral, 
6993,3942,Alemtuzumab (Campath),2016-09-01,,20, ,['/Month'],IV, 
6994,4029,D-cure (Vitamine D),2016-07-28,2021-09-19,1000, ,['3 / Week'],IV,Adverse Event
6995,1033,Mitoxantrone,2015-11-23,,20,mg,['2 / Day'],IV, 
6996,1033,Betaferon,2016-10-05,2020-02-05,500, ,['/Month'],IV,Persistence of relapses
6997,1033,Rebif [22],2016-03-11,2020-02-23,1000,mg,[' '], ,Patient Choice/Convenience
6998,3338,Tysabri,2016-02-16,2020-04-13,1, ,['/Month'],IV,Lack of efficacy
6999,3338,Teriflunomide,2016-05-19,2018-05-20,300,mg,['3 / Week'],IV,Persistence of relapses
7000,3338,Copaxone,2016-01-26,,1000, ,['2 / Day'],Oral, 
7001,2394,Methylprednisolone,2016-03-24,2020-04-13,20,MIU,['3 / Week'],IV,Persisting MRI activity
7002,2394,Tecfidera,2016-09-10,2021-02-04, ,MIU,['2 / Day'], ,Persisting MRI activity
7003,2394,Tecfidera,2015-12-25,,20,mg,['/ Week'],IV, 
7004,2394,Betaferon,2016-03-15,2018-12-28,300,mg,['/Month'],IV,Persistence of relapses
7005,3910,Copaxone,2016-03-11,,300,MIU,['/Month'],IV, 
7006,4547,Tecfidera,2016-09-09,,20,mg,[' '], , 
7007,563,Methylprednisolone,2015-12-31,2018-11-02,1000, ,[' '],IV,Persistence of relapses
7008,3841,IVIG,2016-05-04,2018-01-17,300,mg,['2 / Day'],IV,Patient Choice/Convenience
7009,3841,Tecfidera,2016-10-05,2018-09-19, ,MIU,['2 / Day'],IV,Adverse Event
7010,3841,Rebif [22],2015-11-11,2018-06-23,500,mg,['2 / Day'], ,Persisting MRI activity
7011,4916,Avonex,2015-11-14,,1, ,['/ Week'],IV, 
7012,4916,Tecfidera,2016-02-27,2020-08-16,20,mcg,['2 / Day'],IV,Persisting MRI activity
7013,320,Rebif [22],2016-01-30,2020-09-25,5000, ,['2 / Day'], ,Adverse Event
7014,320,Endoxan,2016-03-22,, , ,['3 / Week'],IV, 
7015,3994,D-cure (Vitamine D),2016-07-18,,1000,mg,['/Month'], , 
7016,3994,D-cure (Vitamine D),2015-12-27,,20,mg,['/Month'],Oral, 
7017,3994,Gilenya,2016-05-06,, ,mg,['2 / Day'], , 
7018,3994,Tecfidera,2016-02-04,, ,mg,['3 / Week'],IV, 
7019,4881,D-cure (Vitamine D),2016-08-16,2020-07-10, , ,['/Month'],IV,Adverse Event
7020,4881,IVIG,2015-11-18,2020-10-13, , ,['/Month'], ,Adverse Event
7021,4881,Avonex,2016-06-02,, ,MIU,[' '],Oral, 
7022,2005,IVIG,2015-12-25,2019-07-27,20, ,['2 / Day'], ,Persisting MRI activity
7023,2005,Tecfidera,2016-05-31,, ,mg,['/Month'],IV, 
7024,2864,Betaferon,2016-07-12,2021-04-15,1,mg,['/Month'], ,Adverse Event
7025,4859,Avonex,2016-03-26,,1000,mg,['/Month'], , 
7026,4859,Rebif [44],2016-05-16,,5000,mg,['/ Day'],IV, 
7027,4859,IVIG,2016-09-10,2020-05-23,1000,mg,['2 / Day'], ,Adverse Event
7028,4859,Rebif [44],2016-09-25,,1, ,[' '],IV, 
7029,3509,Tecfidera,2016-04-26,, , ,['3 / Week'],IV, 
7030,3509,Mitoxantrone,2016-09-25,2020-06-22, ,mg,['2 / Day'], ,Patient Choice/Convenience
7031,3509,Tysabri,2016-09-27,,20,MIU,['/ Day'],IV, 
7032,4688,IVIG,2016-07-03,, ,mg,['/Month'],Oral, 
7033,731,Gilenya,2016-07-26,,1, ,['2 / Day'],IV, 
7034,731,Endoxan,2016-07-08,,400, ,['/Month'],IV, 
7035,731,Gilenya,2015-12-20,2020-11-19,1000, ,[' '],IV,Adverse Event
7036,2618,Alemtuzumab (Campath),2016-10-18,2019-11-28,300, ,['2 / Day'],IV,Persisting MRI activity
7037,2069,Rebif [22],2016-08-06,2018-06-30,5000,mg,['/Month'], ,Patient Choice/Convenience
7038,2069,Rebif [44],2015-11-05,,20, ,['2 / Day'],IV, 
7039,2069,Methylprednisolone,2016-02-28,,5000,MIU,[' '],IV, 
7040,2069,Rebif [44],2016-09-30,2018-04-06,300,mg,['2 / Day'],IV,Lack of efficacy
7041,719,Avonex,2015-11-30,2018-11-14, ,mg,['3 / Week'],IV,Patient Choice/Convenience
7042,4094,Alemtuzumab (Campath),2016-10-17,2020-01-11,300, ,['2 / Day'],IV,Adverse Event
7043,4094,Alemtuzumab (Campath),2016-08-12,2019-07-08,1, ,[' '],IV,Lack of efficacy
7044,4094,Tecfidera,2016-03-21,,500,mg,['/Month'], , 
7045,3242,Rebif [44],2016-01-29,,20,MIU,['2 / Day'], , 
7046,3242,Methylprednisolone,2016-02-29,,500,mg,['/Month'],IV, 
7047,4807,Ledertrexaat,2016-02-12,,5000,mg,['/ Week'], , 
7048,4807,Alemtuzumab (Campath),2015-12-15,2021-05-23, ,mg,['/Month'],IV,Lack of efficacy
7049,3301,Tysabri,2016-07-06,, ,MIU,[' '],Oral, 
7050,3301,Rebif [44],2016-07-11,2019-04-21,300,mg,['2 / Day'],IV,Adverse Event
7051,2025,D-cure (Vitamine D),2016-06-16,,1,mg,['/Month'],IV, 
7052,2025,D-cure (Vitamine D),2016-04-12,,500, ,['/Month'], , 
7053,2025,Teriflunomide,2016-07-01,2020-01-01,300, ,[' '],IV,Persistence of relapses
7054,2025,Methylprednisolone,2016-03-05,, , ,['3 / Week'],IV, 
7055,3146,Copaxone,2015-11-26,,20, ,['2 / Day'], , 
7056,1788,Tecfidera,2016-06-18,2019-01-07,20,mg,['/Month'],Oral,Adverse Event
7057,1788,IVIG,2016-05-27,,500, ,['/ Day'], , 
7058,3098,Tecfidera,2016-07-25,,300, ,['/ Day'],IV, 
7059,3098,Tysabri,2016-08-17,, , ,['2 / Day'], , 
7060,3098,Betaferon,2016-03-12,, , ,['/ Week'], , 
7061,3098,Tysabri,2016-06-25,, , ,['2 / Day'],IV, 
7062,2290,Gilenya,2016-07-04,, , ,['3 / Week'],Oral, 
7063,2290,Avonex,2016-09-18,2019-07-18, ,mg,['/Month'],IV,Patient Choice/Convenience
7064,2144,Ledertrexaat,2016-02-14,,5000, ,['/Month'],Oral, 
7065,2144,Tecfidera,2015-11-19,, ,mg,[' '],IV, 
7066,2683,Tysabri,2016-07-09,2021-02-22,1000, ,['2 / Day'],Oral,Lack of efficacy
7067,2683,Rebif [44],2016-03-27,,500,mcg,['/Month'],IV, 
7068,2683,IVIG,2016-08-25,2020-08-21,300,mg,['/ Week'], ,Persisting MRI activity
7069,2921,Rebif [22],2016-05-08,,500, ,['2 / Day'],IV, 
7070,2921,D-cure (Vitamine D),2016-10-17,,5000,MIU,['/Month'],IV, 
7071,2921,Endoxan,2016-03-09,2020-09-06,300, ,['2 / Day'], ,Persisting MRI activity
7072,3542,Alemtuzumab (Campath),2015-11-27,,300, ,['/Month'],IV, 
7073,502,Endoxan,2016-05-27,,500,mg,['2 / Day'],IV, 
7074,502,Copaxone,2016-09-12,,1000,mg,[' '],IV, 
7075,502,Rebif [44],2016-09-23,,1,mcg,['2 / Day'],IV, 
7076,502,Betaferon,2016-10-14,2019-05-04, , ,[' '],IV,Lack of efficacy
7077,3124,Rebif [22],2016-05-30,2019-04-10, , ,[' '],Oral,Patient Choice/Convenience
7078,763,Tecfidera,2015-11-04,,5000,mg,[' '],IV, 
7079,763,Rebif [44],2016-06-01,,1, ,['/Month'], , 
7080,104,Teriflunomide,2016-06-09,,500,mg,['2 / Day'],IV, 
7081,104,Betaferon,2015-12-23,,5000, ,['/Month'],IV, 
7082,104,Betaferon,2016-09-13,,5000, ,['2 / Day'],IV, 
7083,2431,Copaxone,2016-09-16,, , ,['3 / Week'],Oral, 
7084,2431,Betaferon,2016-07-14,,1, ,['2 / Day'],IV, 
7085,3882,Endoxan,2016-01-20,2020-10-17,300, ,['/Month'], ,Persistence of relapses
7086,3882,Endoxan,2016-06-06,2019-02-08,400, ,['/Month'],IV,Adverse Event
7087,3882,Rebif [22],2016-06-23,,1000, ,['2 / Day'],IV, 
7088,3882,Copaxone,2016-09-10,,1000,mg,['/Month'], , 
7089,2920,Tecfidera,2016-05-07,2018-03-18,1,mg,['/Month'],IV,Lack of efficacy
7090,2331,Tecfidera,2015-12-04,2021-06-25,5000, ,['/Month'],IV,Lack of efficacy
7091,574,Alemtuzumab (Campath),2016-05-07,2018-12-24,20, ,['3 / Week'],IV,Lack of efficacy
7092,574,Tysabri,2015-12-09,,20, ,['2 / Day'],IV, 
7093,1516,Betaferon,2016-07-20,2019-12-19,1000,MIU,['/Month'], ,Patient Choice/Convenience
7094,943,Methylprednisolone,2016-07-20,2018-05-01,5000, ,['2 / Day'],IV,Lack of efficacy
7095,943,Tysabri,2016-05-03,, , ,['3 / Week'],IV, 
7096,943,Tecfidera,2016-04-01,,500, ,['3 / Week'],IV, 
7097,607,Endoxan,2016-01-26,,5000,mcg,['/Month'],IV, 
7098,607,D-cure (Vitamine D),2015-11-10,,1,mg,['2 / Day'],IV, 
7099,607,Rebif [22],2016-07-05,2018-01-06, ,mcg,[' '],IV,Persistence of relapses
7100,3655,Alemtuzumab (Campath),2016-02-25,,1000, ,['/Month'],IV, 
7101,3655,Ledertrexaat,2016-07-11,2021-05-09,400, ,['/Month'], ,Adverse Event
7102,3655,D-cure (Vitamine D),2016-07-25,2021-01-24,20,mg,['3 / Week'],IV,Lack of efficacy
7103,3655,Tysabri,2016-10-19,2018-07-09,5000,MIU,['/Month'],IV,Lack of efficacy
7104,4474,Alemtuzumab (Campath),2016-09-03,,300,mg,['/ Day'], , 
7105,4474,Tysabri,2016-03-30,2021-02-14,20,mg,['/ Day'],Oral,Persisting MRI activity
7106,1846,Ledertrexaat,2016-09-06,, ,mg,['/Month'],IV, 
7107,1846,Endoxan,2016-08-06,,1000,mg,['3 / Week'],IV, 
7108,1846,Endoxan,2015-12-17,,300,mg,['2 / Day'], , 
7109,4212,Tecfidera,2016-02-16,,1000,MIU,[' '], , 
7110,4212,Rebif [22],2016-08-20,, ,mg,[' '], , 
7111,4212,Endoxan,2016-09-29,, , ,['/ Day'],IV, 
7112,4212,Rebif [22],2016-03-06,,500, ,[' '],Oral, 
7113,3004,Avonex,2016-01-27,, , ,[' '],IV, 
7114,3004,Tysabri,2015-12-09,2018-06-04,500,mg,['/ Day'], ,Patient Choice/Convenience
7115,3004,Ledertrexaat,2016-01-22,,400, ,['2 / Day'],IV, 
7116,3004,D-cure (Vitamine D),2015-11-28,, , ,['2 / Day'],IV, 
7117,3962,Teriflunomide,2015-11-07,2018-05-19, , ,['2 / Day'],Oral,Persistence of relapses
7118,2132,Methylprednisolone,2016-09-03,,5000, ,['2 / Day'],IV, 
7119,2132,Teriflunomide,2016-05-18,2018-06-25, ,mg,[' '],IV,Persistence of relapses
7120,2132,Alemtuzumab (Campath),2016-09-24,,300, ,['/Month'], , 
7121,4393,Tysabri,2016-07-12,,300,MIU,['2 / Day'], , 
7122,837,Rebif [22],2016-06-01,,500,mg,['2 / Day'], , 
7123,837,Tysabri,2016-04-09,2020-02-23,300, ,['3 / Week'], ,Lack of efficacy
7124,837,Gilenya,2016-09-10,,500,mcg,['/ Day'], , 
7125,837,Rebif [44],2016-04-18,2021-05-20, , ,['2 / Day'],IV,Adverse Event
7126,2372,Ledertrexaat,2015-12-26,,5000, ,['/Month'], , 
7127,2372,Tecfidera,2016-06-04,,1, ,['/Month'],IV, 
7128,2372,D-cure (Vitamine D),2016-09-05,, , ,['/Month'],Oral, 
7129,1657,Alemtuzumab (Campath),2016-01-09,, ,MIU,['2 / Day'],IV, 
7130,1657,Copaxone,2016-01-19,,500,mg,['/Month'],IV, 
7131,1657,Ledertrexaat,2016-03-08,, ,mg,['2 / Day'],IV, 
7132,3269,D-cure (Vitamine D),2016-05-08,,1, ,[' '],Oral, 
7133,3269,Copaxone,2016-06-10,2020-08-12,500, ,['3 / Week'],IV,Adverse Event
7134,2663,Rebif [44],2016-07-22,, , ,['/ Day'],IV, 
7135,2663,Alemtuzumab (Campath),2016-01-04,2020-09-16, , ,['/ Day'], ,Adverse Event
7136,2663,Methylprednisolone,2016-08-21,2018-04-05,1, ,['2 / Day'], ,Persisting MRI activity
7137,2663,IVIG,2015-12-15,2020-03-03,5000,mg,[' '], ,Adverse Event
7138,3571,Avonex,2016-09-21,2020-12-25,1000,mg,['/ Day'],IV,Persisting MRI activity
7139,873,Rebif [44],2016-09-03,,300, ,['/ Day'],Oral, 
7140,873,IVIG,2015-12-11,2021-08-08, ,mg,[' '],IV,Patient Choice/Convenience
7141,873,Endoxan,2016-10-08,2018-09-04,1000,MIU,['3 / Week'],IV,Persisting MRI activity
7142,1641,Gilenya,2015-10-30,2021-06-27,5000,MIU,['/Month'], ,Persisting MRI activity
7143,1641,Rebif [22],2016-01-19,,500,mg,['2 / Day'],IV, 
7144,1641,Methylprednisolone,2015-12-27,2017-10-25,5000, ,['2 / Day'], ,Persisting MRI activity
7145,1641,Mitoxantrone,2016-04-08,,1,mg,['/Month'], , 
7146,2838,Tysabri,2016-02-05,, , ,['2 / Day'],IV, 
7147,2838,Methylprednisolone,2016-06-12,2019-07-24, , ,[' '],IV,Persistence of relapses
7148,2838,Copaxone,2016-06-29,,20,MIU,['/ Day'],IV, 
7149,3361,IVIG,2016-05-01,,1000, ,['2 / Day'],Oral, 
7150,2394,D-cure (Vitamine D),2016-05-10,2020-10-29,500,mg,['2 / Day'],IV,Patient Choice/Convenience
7151,2394,D-cure (Vitamine D),2015-11-24,,400, ,['2 / Day'],IV, 
7152,2394,Teriflunomide,2016-04-15,,1000,mg,['2 / Day'], , 
7153,2045,Mitoxantrone,2016-04-29,, , ,['2 / Day'],Oral, 
7154,2045,Alemtuzumab (Campath),2016-05-29,, ,MIU,['2 / Day'], , 
7155,2045,IVIG,2016-09-29,2018-01-07, , ,['/ Day'], ,Adverse Event
7156,4423,Alemtuzumab (Campath),2016-06-21,,20, ,['/Month'], , 
7157,240,Copaxone,2015-12-18,,20,mg,['/ Day'],Oral, 
7158,691,Rebif [44],2016-03-09,,1000,mcg,[' '], , 
7159,974,Methylprednisolone,2016-08-27,,20,mg,['2 / Day'], , 
7160,2355,D-cure (Vitamine D),2015-11-17,2018-06-23,300,mcg,['/Month'],IV,Patient Choice/Convenience
7161,2355,D-cure (Vitamine D),2015-11-10,, ,mg,['2 / Day'],IV, 
7162,1818,Ledertrexaat,2016-02-22,2018-07-19,1,MIU,['3 / Week'],IV,Patient Choice/Convenience
7163,2483,D-cure (Vitamine D),2016-01-20,2019-03-12, ,mg,['/ Day'],IV,Adverse Event
7164,2483,Alemtuzumab (Campath),2016-08-19,, ,MIU,['2 / Day'],IV, 
7165,2483,Ledertrexaat,2015-12-27,2018-10-21, ,mg,['/Month'], ,Adverse Event
7166,4345,Teriflunomide,2015-12-06,, ,mg,['3 / Week'],IV, 
7167,4345,D-cure (Vitamine D),2015-10-26,2019-12-07,1000,mcg,[' '],IV,Patient Choice/Convenience
7168,1810,Tecfidera,2016-08-03,2017-11-21, ,mcg,[' '],IV,Patient Choice/Convenience
7169,1810,Tecfidera,2016-09-13,, ,mg,[' '], , 
7170,1810,Ledertrexaat,2016-06-26,, ,mg,['/Month'], , 
7171,1810,Gilenya,2016-10-10,,300,mg,['/Month'], , 
7172,2433,Betaferon,2016-08-08,,300,mg,['/ Day'],IV, 
7173,2433,Copaxone,2015-11-15,2019-07-09, ,MIU,['/ Day'],Oral,Patient Choice/Convenience
7174,2433,Mitoxantrone,2016-02-14,,500, ,[' '],Oral, 
7175,4463,Ledertrexaat,2015-11-01,,5000,mg,['3 / Week'],Oral, 
7176,4463,Mitoxantrone,2016-10-10,,500,mg,['/Month'], , 
7177,649,Rebif [44],2016-07-06,2018-03-04,1000,mg,['2 / Day'], ,Patient Choice/Convenience
7178,649,Tysabri,2016-10-14,,500, ,['3 / Week'],IV, 
7179,4724,Rebif [22],2016-03-14,2021-05-19,1,mg,['/Month'],IV,Adverse Event
7180,4724,IVIG,2016-03-01,, , ,[' '],IV, 
7181,4724,IVIG,2016-01-06,2019-05-27,400, ,[' '], ,Adverse Event
7182,4724,Methylprednisolone,2016-02-18,, , ,['3 / Week'],IV, 
7183,1486,Methylprednisolone,2015-12-29,,20,mcg,['/Month'], , 
7184,1486,Rebif [44],2016-08-02,,5000,mg,['2 / Day'],Oral, 
7185,1486,D-cure (Vitamine D),2016-08-19,,20, ,['/ Day'],IV, 
7186,1486,Tecfidera,2016-06-20,,1, ,['2 / Day'],IV, 
7187,3115,Ledertrexaat,2016-09-11,2020-02-05,1,mg,['/Month'],IV,Persisting MRI activity
7188,3115,Rebif [44],2015-11-27,,20, ,['/ Week'], , 
7189,3115,IVIG,2016-09-27,2019-06-25,400, ,['2 / Day'],IV,Patient Choice/Convenience
7190,2950,Alemtuzumab (Campath),2016-08-21,,20, ,['3 / Week'], , 
7191,4738,Betaferon,2016-04-06,2018-07-31,5000,mg,['2 / Day'],Oral,Adverse Event
7192,4738,Rebif [44],2016-07-20,2020-01-05, ,mg,['/ Week'],Oral,Persisting MRI activity
7193,4738,Endoxan,2016-03-24,2018-01-30, , ,[' '], ,Persisting MRI activity
7194,4738,Teriflunomide,2016-07-03,,20,MIU,['2 / Day'],IV, 
7195,689,D-cure (Vitamine D),2016-07-12,2021-08-20,20,mg,['/ Day'],Oral,Lack of efficacy
7196,689,Tecfidera,2016-06-12,,300, ,['2 / Day'],IV, 
7197,689,Tysabri,2016-06-07,,300,mg,['/Month'],IV, 
7198,4515,Methylprednisolone,2016-10-21,,5000,mg,['/Month'], , 
7199,2985,Tysabri,2016-04-15,,500,mg,[' '],IV, 
7200,2985,Ledertrexaat,2016-08-30,, ,mg,['/Month'], , 
7201,2985,Tecfidera,2016-02-02,, ,mcg,['/Month'],Oral, 
7202,2985,Copaxone,2016-04-09,2019-02-06, ,mg,['/ Day'],IV,Lack of efficacy
7203,4236,Rebif [44],2015-12-10,,1,mcg,[' '],IV, 
7204,4236,Tysabri,2016-07-12,,5000,mg,['/ Day'], , 
7205,1654,Tecfidera,2016-04-11,2018-06-20,5000,mcg,['/Month'],Oral,Lack of efficacy
7206,1654,Rebif [44],2016-04-16,2020-08-30,1,mg,['2 / Day'],IV,Lack of efficacy
7207,2425,Rebif [44],2016-09-11,2019-08-13,5000,mg,['2 / Day'],Oral,Persistence of relapses
7208,633,Betaferon,2016-09-05,,500,mg,['2 / Day'],IV, 
7209,633,Copaxone,2016-03-06,2021-03-15,500,mcg,['2 / Day'],Oral,Lack of efficacy
7210,633,Methylprednisolone,2016-09-13,,1000,mg,['2 / Day'],IV, 
7211,2171,Betaferon,2016-02-24,,500,MIU,['/Month'], , 
7212,2171,Methylprednisolone,2016-05-26,2018-02-03,1, ,['2 / Day'], ,Adverse Event
7213,2477,Gilenya,2016-02-03,,5000,mg,['/Month'],IV, 
7214,3654,Methylprednisolone,2016-03-18,,400,mg,['/ Week'], , 
7215,3024,Methylprednisolone,2016-08-20,2021-05-04,1000, ,['3 / Week'], ,Persisting MRI activity
7216,3024,IVIG,2016-01-27,2019-08-26,400,MIU,['2 / Day'], ,Patient Choice/Convenience
7217,3024,Endoxan,2016-02-02,, , ,['2 / Day'], , 
7218,3024,Rebif [44],2015-12-11,2020-04-24,500,mcg,['2 / Day'],IV,Persisting MRI activity
7219,1253,D-cure (Vitamine D),2016-01-03,,500,mg,[' '], , 
7220,1253,Endoxan,2015-12-10,,500,mg,[' '],IV, 
7221,4649,Tysabri,2016-03-09,, , ,['/ Week'],IV, 
7222,4649,Mitoxantrone,2016-03-27,,1000, ,['3 / Week'],IV, 
7223,4649,Alemtuzumab (Campath),2016-01-05,, , ,['3 / Week'], , 
7224,4649,Rebif [22],2015-12-01,2020-01-09,20,mg,['2 / Day'], ,Persisting MRI activity
7225,3510,Endoxan,2016-09-28,2019-04-13, , ,[' '],Oral,Lack of efficacy
7226,3510,Rebif [44],2016-07-31,,1,MIU,['2 / Day'], , 
7227,3510,Gilenya,2016-04-15,2018-06-26, , ,['/ Day'],IV,Lack of efficacy
7228,1561,Rebif [22],2016-03-30,, ,mg,['/Month'], , 
7229,2146,IVIG,2016-03-18,, ,mg,['3 / Week'], , 
7230,2707,Rebif [44],2016-05-28,2019-10-10,1000, ,['2 / Day'],IV,Patient Choice/Convenience
7231,2917,Alemtuzumab (Campath),2016-08-04,2021-07-23,300, ,['2 / Day'], ,Patient Choice/Convenience
7232,2917,Methylprednisolone,2016-02-11,,300,MIU,['3 / Week'], , 
7233,2917,Endoxan,2016-06-28,2018-05-10,20,mcg,['2 / Day'], ,Adverse Event
7234,3994,Rebif [44],2016-03-21,2021-06-17,500,mg,['/ Day'], ,Persistence of relapses
7235,3994,Tecfidera,2016-03-04,,1000,mg,[' '],IV, 
7236,3994,Methylprednisolone,2016-05-14,2019-08-30,1000,MIU,['/Month'],IV,Adverse Event
7237,3994,Rebif [44],2015-12-28,2019-07-15,5000, ,['2 / Day'],Oral,Patient Choice/Convenience
7238,1627,Endoxan,2016-03-26,,300, ,['3 / Week'], , 
7239,1627,D-cure (Vitamine D),2016-03-30,,20,mg,[' '], , 
7240,1627,Rebif [44],2016-10-17,,1000,mg,['3 / Week'], , 
7241,2667,Endoxan,2016-04-17,,500,mg,['/ Day'],IV, 
7242,2667,Gilenya,2016-02-26,, , ,['/Month'], , 
7243,2667,Gilenya,2016-01-28,,500,mcg,['2 / Day'],IV, 
7244,2667,Rebif [44],2016-01-04,, , ,['/Month'], , 
7245,2202,Avonex,2015-11-25,2021-04-01,300,mg,[' '],IV,Lack of efficacy
7246,2202,Methylprednisolone,2016-06-27,,500, ,['/ Week'],IV, 
7247,2202,Ledertrexaat,2015-11-28,,400,mcg,['3 / Week'], , 
7248,2202,Endoxan,2015-12-23,2021-03-17,500,mg,['/Month'], ,Adverse Event
7249,4760,Methylprednisolone,2016-03-08,,300, ,['2 / Day'], , 
7250,4760,Avonex,2016-03-19,2018-02-16,5000,mg,['/ Day'], ,Lack of efficacy
7251,4760,IVIG,2016-02-28,2020-05-26,300,mg,['2 / Day'],Oral,Adverse Event
7252,4760,Methylprednisolone,2015-10-29,, ,mg,['/ Day'], , 
7253,1825,Methylprednisolone,2015-11-25,2021-04-23, ,mg,['/Month'],IV,Patient Choice/Convenience
7254,1825,Tysabri,2016-10-02,2018-03-22,1,mg,[' '], ,Persisting MRI activity
7255,1825,Endoxan,2016-02-16,,1000, ,['/Month'],IV, 
7256,1825,Copaxone,2016-05-12,2021-01-27, ,mg,['/ Week'],Oral,Persisting MRI activity
7257,4871,Mitoxantrone,2016-09-12,, , ,['/Month'],IV, 
7258,1442,Tecfidera,2016-02-16,, ,mg,['2 / Day'],IV, 
7259,1103,Copaxone,2016-10-16,2019-06-16,5000, ,['3 / Week'],IV,Persistence of relapses
7260,1103,Rebif [44],2015-11-15,,400, ,['/Month'],IV, 
7261,1103,IVIG,2016-02-11,, ,mg,['2 / Day'],IV, 
7262,3645,Gilenya,2016-08-05,, ,mg,[' '], , 
7263,1281,IVIG,2016-05-26,,300,mg,['/Month'], , 
7264,1281,Rebif [44],2016-04-06,2018-02-08,5000, ,['/Month'],IV,Adverse Event
7265,1281,Endoxan,2016-04-24,2020-09-06,1,mg,['3 / Week'],IV,Adverse Event
7266,1281,IVIG,2016-02-25,,1, ,[' '],IV, 
7267,4152,Tecfidera,2015-11-19,, ,mcg,['3 / Week'],IV, 
7268,4152,Tecfidera,2016-06-14,2018-08-14, ,mg,[' '],IV,Patient Choice/Convenience
7269,4152,IVIG,2016-05-31,2021-04-07, ,mg,[' '],IV,Adverse Event
7270,4277,Methylprednisolone,2015-11-05,2020-05-22,500, ,['/Month'],Oral,Adverse Event
7271,4277,IVIG,2016-08-09,2021-06-20,1000, ,['/Month'], ,Lack of efficacy
7272,4277,IVIG,2016-01-05,2021-06-22,20,mg,['/ Week'],IV,Persisting MRI activity
7273,4277,Betaferon,2015-10-29,, , ,[' '], , 
7274,3616,Teriflunomide,2016-01-03,, , ,['/Month'], , 
7275,3616,Tysabri,2015-12-23,2020-01-25,5000,mcg,['2 / Day'], ,Adverse Event
7276,3616,Gilenya,2016-03-28,2019-03-19, ,mg,['3 / Week'],IV,Persisting MRI activity
7277,3616,IVIG,2016-07-08,,1,mg,['/ Day'],Oral, 
7278,1328,IVIG,2016-10-16,,1000, ,['/Month'], , 
7279,1328,Rebif [44],2016-08-06,,5000, ,[' '], , 
7280,1328,Ledertrexaat,2016-03-08,,1,mg,['2 / Day'],IV, 
7281,2006,Avonex,2016-09-15,,20,MIU,['/Month'], , 
7282,2006,Rebif [44],2016-08-04,2020-03-09,300,mcg,['/ Week'],IV,Adverse Event
7283,2006,Alemtuzumab (Campath),2016-04-26,,5000, ,['3 / Week'],IV, 
7284,2006,Tecfidera,2016-07-08,, ,mg,[' '],Oral, 
7285,1551,Avonex,2016-04-10,2017-12-11, ,mg,['/Month'],Oral,Patient Choice/Convenience
7286,1832,Alemtuzumab (Campath),2016-05-28,,300,mg,['/ Week'],Oral, 
7287,1832,IVIG,2016-03-31,,1000, ,['2 / Day'], , 
7288,306,Ledertrexaat,2016-06-03,,1000,mg,[' '],IV, 
7289,306,Rebif [44],2016-08-04,2019-02-01, , ,['2 / Day'],Oral,Patient Choice/Convenience
7290,2760,Alemtuzumab (Campath),2015-12-15,,5000,mg,['/ Day'],IV, 
7291,2760,Rebif [44],2016-09-13,2020-11-23, ,mg,['/Month'],IV,Adverse Event
7292,2925,Copaxone,2016-08-24,, ,mg,['/Month'],Oral, 
7293,2925,Methylprednisolone,2016-03-14,,400,mcg,['/Month'], , 
7294,4223,IVIG,2016-02-12,,5000,mg,['/Month'],IV, 
7295,4223,IVIG,2016-02-22,,400, ,[' '],IV, 
7296,4223,IVIG,2016-01-18,2021-04-12,300,mg,['/Month'],IV,Lack of efficacy
7297,4223,IVIG,2016-07-21,,1, ,['2 / Day'],IV, 
7298,233,Tecfidera,2016-08-19,,1000,MIU,['2 / Day'],IV, 
7299,2442,IVIG,2016-01-16,2021-09-05,400, ,['/Month'], ,Persisting MRI activity
7300,2442,Ledertrexaat,2016-05-26,, , ,['/Month'],IV, 
7301,2442,Betaferon,2016-09-21,,1,mg,['/ Day'],IV, 
7302,2442,Mitoxantrone,2016-05-29,2018-09-08, , ,['/Month'],IV,Lack of efficacy
7303,4924,Rebif [22],2016-01-27,,1, ,['/Month'],IV, 
7304,4924,D-cure (Vitamine D),2016-03-10,,20, ,['/Month'], , 
7305,4924,Endoxan,2015-12-20,,500,mg,['3 / Week'], , 
7306,4924,D-cure (Vitamine D),2016-05-22,,20, ,['2 / Day'],IV, 
7307,1241,D-cure (Vitamine D),2016-05-19,2021-04-13, , ,['2 / Day'], ,Adverse Event
7308,1241,D-cure (Vitamine D),2016-01-09,2020-05-27,300, ,['2 / Day'], ,Persistence of relapses
7309,1241,Alemtuzumab (Campath),2016-07-18,2019-10-28,5000,MIU,['3 / Week'], ,Patient Choice/Convenience
7310,1241,Methylprednisolone,2016-04-20,2020-05-16,500,MIU,['/Month'], ,Patient Choice/Convenience
7311,1929,Alemtuzumab (Campath),2016-02-01,,5000,mcg,['/ Day'], , 
7312,1929,Tysabri,2015-12-26,2018-08-09,1000,mg,['2 / Day'],Oral,Adverse Event
7313,1929,Copaxone,2016-05-17,,1, ,['/Month'],IV, 
7314,3214,Gilenya,2016-08-08,, ,mg,['/Month'],IV, 
7315,3214,Rebif [22],2016-02-08,,1000,mg,['2 / Day'],IV, 
7316,1633,Alemtuzumab (Campath),2016-10-03,2019-07-12,500, ,['2 / Day'],IV,Adverse Event
7317,1633,Rebif [22],2016-06-30,2019-09-29, ,MIU,['2 / Day'], ,Patient Choice/Convenience
7318,1633,Alemtuzumab (Campath),2016-03-18,,5000, ,['2 / Day'],Oral, 
7319,4410,Rebif [44],2016-01-08,,1, ,['/Month'],IV, 
7320,4410,Gilenya,2016-08-12,,1000,mg,['2 / Day'], , 
7321,4410,Rebif [44],2016-04-14,2018-05-05,400, ,['/Month'], ,Patient Choice/Convenience
7322,4410,Endoxan,2016-04-19,,500,MIU,['/ Day'], , 
7323,371,Avonex,2016-03-21,2020-09-24,20,mg,['/ Week'], ,Lack of efficacy
7324,371,Methylprednisolone,2016-08-05,,400,mg,['2 / Day'],IV, 
7325,371,IVIG,2016-04-25,, ,MIU,['/Month'],IV, 
7326,371,D-cure (Vitamine D),2016-04-11,2020-12-03,500,MIU,['3 / Week'],IV,Persistence of relapses
7327,842,Gilenya,2016-10-20,2020-05-08,1000,MIU,['2 / Day'],IV,Persisting MRI activity
7328,842,Tysabri,2015-11-29,2017-12-27, ,mg,['/Month'],Oral,Adverse Event
7329,4842,Betaferon,2016-05-12,2021-08-12, , ,['2 / Day'],Oral,Persisting MRI activity
7330,4842,Betaferon,2016-08-23,2021-09-16, ,MIU,['/ Day'],Oral,Adverse Event
7331,4842,Rebif [22],2016-04-09,2021-06-13, ,MIU,['/ Day'],IV,Patient Choice/Convenience
7332,4842,Rebif [44],2016-02-01,2020-12-08, , ,['3 / Week'], ,Persisting MRI activity
7333,3495,D-cure (Vitamine D),2016-02-11,,500,MIU,['/Month'],IV, 
7334,2700,Tysabri,2015-11-28,,1000,mg,['2 / Day'], , 
7335,300,Methylprednisolone,2016-03-16,2021-09-23, ,mg,['/Month'], ,Patient Choice/Convenience
7336,1779,Rebif [22],2016-04-16,2018-11-12,5000, ,[' '],IV,Adverse Event
7337,1779,Methylprednisolone,2016-03-01,,500,MIU,['/Month'],IV, 
7338,1779,Rebif [22],2015-11-13,, , ,['/Month'],IV, 
7339,1779,Avonex,2016-02-17,,300,mg,['3 / Week'], , 
7340,1762,Mitoxantrone,2016-07-21,2020-09-14,5000,mg,['/ Week'], ,Adverse Event
7341,1762,D-cure (Vitamine D),2016-08-29,, ,mg,['/Month'],IV, 
7342,1762,Alemtuzumab (Campath),2016-06-25,2020-12-03, ,mg,[' '],IV,Adverse Event
7343,4363,D-cure (Vitamine D),2016-01-25,,5000, ,['2 / Day'],IV, 
7344,4363,IVIG,2015-11-04,,300,mg,[' '], , 
7345,4696,Rebif [22],2016-06-08,, ,MIU,['/Month'],IV, 
7346,4696,Tecfidera,2016-08-17,2019-12-28, , ,['2 / Day'],IV,Persistence of relapses
7347,4696,D-cure (Vitamine D),2016-09-12,2019-06-29,1, ,['2 / Day'],IV,Adverse Event
7348,1257,Betaferon,2015-11-19,2018-01-16,1000, ,['/Month'], ,Lack of efficacy
7349,1257,Tecfidera,2016-05-29,2020-11-13,1000, ,['/ Week'],IV,Adverse Event
7350,4754,Methylprednisolone,2016-09-24,, ,mg,['/Month'],IV, 
7351,4754,Copaxone,2016-01-26,2021-03-09, ,mcg,['/Month'],IV,Patient Choice/Convenience
7352,3145,Tecfidera,2016-07-16,2021-07-11,1000, ,[' '], ,Patient Choice/Convenience
7353,3145,Rebif [44],2016-10-14,,1,mcg,['/Month'], , 
7354,3145,Alemtuzumab (Campath),2016-01-01,2021-03-13,1000, ,['3 / Week'], ,Adverse Event
7355,4197,Tecfidera,2015-12-24,,500, ,['/Month'],IV, 
7356,4233,IVIG,2016-09-24,2020-12-03,500, ,['2 / Day'],IV,Persisting MRI activity
7357,4233,Ledertrexaat,2016-06-30,,300,mg,[' '],IV, 
7358,4233,Mitoxantrone,2016-01-14,,5000,mg,['2 / Day'],IV, 
7359,2822,D-cure (Vitamine D),2016-02-28,,300,mg,['2 / Day'], , 
7360,2822,Methylprednisolone,2016-04-06,, ,mg,['2 / Day'],IV, 
7361,2822,Methylprednisolone,2016-06-23,2020-09-03, , ,['/Month'],IV,Lack of efficacy
7362,2822,Rebif [22],2016-03-17,2019-02-23,500,mg,['/Month'], ,Persisting MRI activity
7363,3591,D-cure (Vitamine D),2016-09-02,,1000,mg,['/ Week'],IV, 
7364,3591,Methylprednisolone,2016-01-20,2021-04-16, ,mg,['/ Week'],IV,Adverse Event
7365,3591,Tysabri,2015-11-21,,1, ,['/Month'], , 
7366,4649,Tysabri,2016-05-11,,300, ,['/Month'],IV, 
7367,4649,Endoxan,2016-04-03,,1, ,['/ Day'],Oral, 
7368,4718,Mitoxantrone,2016-02-13,2019-10-30,500, ,['2 / Day'], ,Lack of efficacy
7369,1184,Gilenya,2016-08-31,2017-12-31, ,mcg,['3 / Week'],IV,Persisting MRI activity
7370,1184,Endoxan,2016-06-12,2018-08-29,500,mg,['2 / Day'],IV,Lack of efficacy
7371,1184,D-cure (Vitamine D),2015-11-02,2018-12-08,500,mcg,['/Month'], ,Adverse Event
7372,1184,Ledertrexaat,2016-05-25,, ,MIU,['3 / Week'],Oral, 
7373,1224,Tecfidera,2016-02-08,2020-10-02,20,mcg,['2 / Day'], ,Persistence of relapses
7374,1224,Alemtuzumab (Campath),2015-11-06,2017-11-28,1, ,['3 / Week'], ,Lack of efficacy
7375,1224,Copaxone,2016-10-12,,1,mg,['3 / Week'], , 
7376,1224,D-cure (Vitamine D),2016-06-07,2021-09-19,5000,mcg,['2 / Day'],IV,Persisting MRI activity
7377,3402,Teriflunomide,2016-05-31,,1000,mg,['/ Week'], , 
7378,3402,Endoxan,2015-11-24,2021-07-05,1000, ,['/ Day'],IV,Persisting MRI activity
7379,1255,Tecfidera,2015-12-04,,500,mg,['2 / Day'], , 
7380,1255,Rebif [44],2016-05-19,2018-03-15, , ,['/Month'],IV,Persisting MRI activity
7381,1255,Copaxone,2015-12-15,2018-02-13,1, ,['/Month'], ,Adverse Event
7382,1255,Avonex,2016-02-28,,1000,mg,['2 / Day'],IV, 
7383,1905,IVIG,2015-11-18,2021-01-29, , ,['3 / Week'],IV,Persisting MRI activity
7384,1905,Gilenya,2016-07-01,2021-06-17, ,mg,['/Month'], ,Patient Choice/Convenience
7385,516,IVIG,2016-03-14,2019-03-30,500, ,['/Month'], ,Adverse Event
7386,516,Rebif [44],2016-01-22,,1,mcg,['/Month'], , 
7387,516,Alemtuzumab (Campath),2016-06-30,2018-02-20,20,mcg,['/Month'],IV,Patient Choice/Convenience
7388,1809,Rebif [44],2016-05-02,2018-01-29, ,MIU,['2 / Day'], ,Persistence of relapses
7389,1408,Avonex,2015-11-07,2021-04-28,5000,mg,['3 / Week'],IV,Patient Choice/Convenience
7390,1408,IVIG,2016-08-21,, , ,['2 / Day'], , 
7391,1408,IVIG,2016-05-14,2020-05-05,300, ,['/ Week'], ,Persisting MRI activity
7392,3346,Gilenya,2016-05-26,, , ,['3 / Week'], , 
7393,3346,Endoxan,2016-08-11,2021-05-23,500,mcg,['/Month'],IV,Lack of efficacy
7394,3346,Ledertrexaat,2016-02-25,2019-08-10,1000, ,[' '],IV,Adverse Event
7395,3346,Rebif [22],2016-01-26,,300, ,['/ Week'],IV, 
7396,2171,Methylprednisolone,2015-12-19,,5000,mcg,['/Month'],IV, 
7397,2171,Rebif [44],2016-01-20,2019-06-10, ,mg,['/Month'],IV,Patient Choice/Convenience
7398,2171,Alemtuzumab (Campath),2015-10-26,2020-08-10, ,MIU,['/Month'], ,Persisting MRI activity
7399,2171,Gilenya,2016-02-06,2021-06-09,1000,MIU,['/Month'], ,Adverse Event
7400,685,Tysabri,2016-05-18,, , ,['3 / Week'],IV, 
7401,851,Alemtuzumab (Campath),2015-10-29,2021-05-23,500, ,['2 / Day'],Oral,Persisting MRI activity
7402,851,Methylprednisolone,2016-02-17,,500,mg,['/Month'], , 
7403,851,Endoxan,2016-02-03,2020-05-18, ,MIU,['2 / Day'],IV,Adverse Event
7404,851,D-cure (Vitamine D),2015-11-11,, ,mg,['/Month'],IV, 
7405,3710,Methylprednisolone,2016-03-09,,300, ,['2 / Day'],Oral, 
7406,3710,Teriflunomide,2016-03-10,2020-12-25,1000,mg,['/Month'],IV,Persistence of relapses
7407,3710,IVIG,2016-05-02,,20,mg,[' '],IV, 
7408,3710,IVIG,2016-02-04,, , ,['3 / Week'],IV, 
7409,676,Ledertrexaat,2016-07-28,2020-09-08,400,mg,['/Month'],IV,Adverse Event
7410,676,Mitoxantrone,2015-12-06,2020-07-26, ,mg,[' '],Oral,Adverse Event
7411,4065,Copaxone,2016-06-21,2021-05-18,5000,mg,[' '],Oral,Patient Choice/Convenience
7412,2394,Rebif [22],2015-11-06,2020-01-05,500,mg,['2 / Day'], ,Persistence of relapses
7413,3498,Ledertrexaat,2016-01-07,,1, ,['2 / Day'],IV, 
7414,3498,Gilenya,2016-07-15,2020-10-09,1, ,['/Month'], ,Patient Choice/Convenience
7415,3498,Betaferon,2016-09-10,2020-11-26,300, ,['/ Day'], ,Lack of efficacy
7416,3417,Ledertrexaat,2016-05-10,,500,mcg,['/Month'],IV, 
7417,1508,Rebif [44],2016-07-16,2020-08-31, ,mg,['/Month'],IV,Persistence of relapses
7418,1508,Betaferon,2016-03-01,2021-06-19,1000,mcg,['/Month'],Oral,Adverse Event
7419,2876,Endoxan,2016-07-26,, , ,[' '], , 
7420,2876,Methylprednisolone,2016-07-03,,5000, ,['/ Day'], , 
7421,2876,Copaxone,2016-03-25,2020-03-11,5000,mg,['/Month'],IV,Adverse Event
7422,2876,Avonex,2016-09-27,2019-12-28,400, ,['2 / Day'], ,Adverse Event
7423,3248,Betaferon,2016-03-22,2020-03-26,1,mg,['3 / Week'],IV,Lack of efficacy
7424,3248,IVIG,2016-05-22,2019-12-12,400,mg,['/Month'],IV,Adverse Event
7425,3215,Tecfidera,2016-01-10,,20,mg,['2 / Day'],Oral, 
7426,1506,Avonex,2015-12-16,2019-08-09, ,MIU,['2 / Day'], ,Persisting MRI activity
7427,1506,Endoxan,2015-10-24,2018-10-16,1000, ,['2 / Day'],Oral,Adverse Event
7428,1506,Gilenya,2016-03-17,,5000,mcg,['/Month'],IV, 
7429,3348,Avonex,2016-08-27,,500,mg,['2 / Day'],IV, 
7430,3348,D-cure (Vitamine D),2016-03-04,,1000,MIU,['/Month'],IV, 
7431,3020,Gilenya,2016-04-29,,1000, ,[' '],IV, 
7432,3088,Gilenya,2015-10-24,, ,MIU,[' '], , 
7433,3088,Alemtuzumab (Campath),2016-06-13,,1, ,['/Month'],IV, 
7434,3088,IVIG,2016-04-23,,500,MIU,['2 / Day'],IV, 
7435,3088,Tysabri,2016-05-03,2021-07-31,400, ,['/Month'],IV,Patient Choice/Convenience
7436,1820,Methylprednisolone,2016-05-08,,20, ,['2 / Day'],IV, 
7437,1820,Gilenya,2016-09-29,2019-02-23,300, ,['2 / Day'],IV,Adverse Event
7438,2386,Rebif [22],2016-07-25,,300,mg,['2 / Day'],IV, 
7439,3573,IVIG,2016-01-28,,5000,mg,['/Month'], , 
7440,3573,Alemtuzumab (Campath),2016-07-06,,300,mg,['/Month'], , 
7441,3573,Alemtuzumab (Campath),2016-04-16,2019-03-01,20,MIU,['/Month'], ,Persistence of relapses
7442,3573,Tysabri,2016-04-06,2020-05-24, , ,['2 / Day'], ,Patient Choice/Convenience
7443,2279,Mitoxantrone,2016-07-19,2020-11-26,300,mg,[' '], ,Adverse Event
7444,1406,Endoxan,2016-02-08,,1000,mg,['/Month'],IV, 
7445,3930,Gilenya,2016-02-26,,300, ,['2 / Day'], , 
7446,3930,D-cure (Vitamine D),2016-06-20,2019-08-03,1000,mg,['/Month'],IV,Patient Choice/Convenience
7447,350,Betaferon,2016-09-08,2019-01-03,1, ,['/Month'], ,Persisting MRI activity
7448,922,Teriflunomide,2015-12-26,,5000,MIU,['2 / Day'],IV, 
7449,922,Copaxone,2015-10-30,2019-01-16,5000, ,[' '],IV,Adverse Event
7450,3575,Tecfidera,2016-08-06,,500,MIU,['/Month'],IV, 
7451,3879,Ledertrexaat,2016-08-17,2020-09-15,20,mg,['2 / Day'],Oral,Patient Choice/Convenience
7452,3879,Tecfidera,2015-12-23,, , ,['3 / Week'],IV, 
7453,3879,Tecfidera,2016-05-04,, , ,['/ Week'],IV, 
7454,4769,Endoxan,2016-07-06,2020-10-10, ,mg,['/Month'],IV,Persistence of relapses
7455,4769,Avonex,2016-03-21,,1, ,['/ Day'], , 
7456,4769,D-cure (Vitamine D),2016-01-20,,20,mg,[' '], , 
7457,3764,Rebif [22],2016-04-03,2018-09-26,500,mcg,['/ Day'],IV,Patient Choice/Convenience
7458,3764,Methylprednisolone,2016-05-04,2021-01-17,1, ,['3 / Week'], ,Patient Choice/Convenience
7459,3764,Methylprednisolone,2016-07-01,, , ,['2 / Day'],IV, 
7460,3856,Rebif [22],2016-09-18,,1, ,['2 / Day'],IV, 
7461,3856,Alemtuzumab (Campath),2016-07-06,2019-06-13, ,mg,['/Month'], ,Patient Choice/Convenience
7462,3856,Ledertrexaat,2016-01-06,2019-12-24,5000,MIU,['3 / Week'], ,Adverse Event
7463,3329,Tysabri,2016-09-27,, ,mg,['2 / Day'], , 
7464,3329,D-cure (Vitamine D),2016-07-24,, ,mg,['/ Day'], , 
7465,4634,Copaxone,2016-08-02,,1000, ,['/ Day'],Oral, 
7466,4634,D-cure (Vitamine D),2016-04-20,2020-05-22, ,mg,['/Month'],IV,Adverse Event
7467,751,Methylprednisolone,2016-07-29,2021-06-12,1,mg,['/Month'], ,Persisting MRI activity
7468,751,Gilenya,2016-09-30,2021-01-25,1000,mg,[' '],IV,Adverse Event
7469,751,Rebif [44],2016-04-18,,300, ,['2 / Day'], , 
7470,751,Teriflunomide,2016-08-11,2019-02-26,20,mg,[' '],IV,Lack of efficacy
7471,1357,Copaxone,2016-02-05,2021-05-26,300,MIU,['2 / Day'], ,Adverse Event
7472,4356,Teriflunomide,2016-01-02,,400,mg,['/Month'], , 
7473,4356,Endoxan,2016-08-02,2018-12-29,20,mg,['/ Week'],IV,Lack of efficacy
7474,4356,IVIG,2016-06-14,,1000,mg,['2 / Day'],Oral, 
7475,4356,Rebif [44],2015-12-22,,5000, ,['/Month'],IV, 
7476,671,Avonex,2015-12-22,,1, ,['2 / Day'],IV, 
7477,671,Ledertrexaat,2016-01-26,, , ,['3 / Week'],IV, 
7478,671,Teriflunomide,2016-08-02,2019-09-24,1,mg,['/Month'], ,Persisting MRI activity
7479,2762,Rebif [44],2016-09-05,,5000, ,[' '],IV, 
7480,3998,Copaxone,2016-02-15,,5000, ,[' '],IV, 
7481,3998,IVIG,2016-02-11,2020-03-28, , ,['2 / Day'],IV,Adverse Event
7482,4211,Betaferon,2016-02-14,2021-09-16,400,MIU,['/Month'], ,Persisting MRI activity
7483,4211,Alemtuzumab (Campath),2015-11-18,2020-06-23,1,mg,['/Month'],IV,Patient Choice/Convenience
7484,4323,Rebif [22],2016-03-21,,20,mg,['2 / Day'],IV, 
7485,4323,Alemtuzumab (Campath),2016-06-30,,500,MIU,['2 / Day'],IV, 
7486,4323,Tecfidera,2016-01-23,2018-09-02,1000, ,['2 / Day'],IV,Persistence of relapses
7487,3423,Tysabri,2016-01-04,2018-12-11,300,mg,['2 / Day'],IV,Persistence of relapses
7488,3423,Alemtuzumab (Campath),2015-11-13,2019-08-06,500, ,['/Month'], ,Lack of efficacy
7489,2376,Methylprednisolone,2016-06-12,,20, ,['/Month'],IV, 
7490,2284,Copaxone,2016-02-10,2019-05-04,5000,mg,['/Month'],Oral,Patient Choice/Convenience
7491,2284,D-cure (Vitamine D),2016-09-30,,1000,mg,['3 / Week'],IV, 
7492,3268,Betaferon,2016-05-31,2019-11-15,1000, ,['/Month'],IV,Persisting MRI activity
7493,3268,Tysabri,2016-08-05,2019-10-09,1,mg,['/Month'],Oral,Adverse Event
7494,4818,Avonex,2015-12-20,2019-01-19,1000, ,['/Month'],IV,Adverse Event
7495,2202,D-cure (Vitamine D),2016-02-17,2018-05-26,1000,mg,['/ Week'], ,Lack of efficacy
7496,2202,IVIG,2016-08-31,2021-10-12, , ,['/Month'], ,Adverse Event
7497,1315,Rebif [44],2016-06-28,2019-03-14,400, ,['2 / Day'],IV,Lack of efficacy
7498,3382,Rebif [44],2016-06-01,2021-03-21,1000, ,['/Month'],Oral,Patient Choice/Convenience
7499,3382,Copaxone,2016-06-09,,5000,mg,['2 / Day'], , 
7500,1936,Rebif [22],2015-12-02,2019-01-04,300,MIU,['/ Day'],IV,Adverse Event
7501,418,Alemtuzumab (Campath),2015-12-10,,500,MIU,['/Month'],Oral, 
7502,418,Teriflunomide,2016-01-31,,300, ,['2 / Day'],Oral, 
7503,410,Rebif [44],2016-03-26,,1,mg,['/ Day'],IV, 
7504,410,Tecfidera,2015-12-13,,20,mg,['2 / Day'],IV, 
7505,967,Methylprednisolone,2015-11-26,, ,mg,[' '], , 
7506,967,Methylprednisolone,2016-09-07,2020-11-15,20,mg,['3 / Week'],IV,Lack of efficacy
7507,996,Copaxone,2016-01-08,2020-06-28,400, ,['2 / Day'], ,Persistence of relapses
7508,996,Betaferon,2016-03-21,,1,mg,['/Month'],IV, 
7509,996,Tysabri,2016-06-24,, ,mg,['2 / Day'], , 
7510,996,IVIG,2016-06-01,2018-01-26,5000,MIU,['2 / Day'],IV,Lack of efficacy
7511,1824,Gilenya,2016-04-23,, ,mg,['/ Day'], , 
7512,4846,Alemtuzumab (Campath),2015-11-01,,20,MIU,['/Month'], , 
7513,602,Tecfidera,2016-07-18,2018-02-05, , ,['/Month'],Oral,Adverse Event
7514,602,Tysabri,2016-03-15,, , ,['2 / Day'],IV, 
7515,4389,Gilenya,2016-04-19,2020-11-03,1, ,['/ Day'],IV,Patient Choice/Convenience
7516,4389,Avonex,2016-06-19,2017-11-16,300, ,['2 / Day'],Oral,Adverse Event
7517,4389,Methylprednisolone,2015-12-09,,400,mg,['/Month'],IV, 
7518,1881,Methylprednisolone,2016-06-04,2020-12-25,300,mg,['/Month'],IV,Lack of efficacy
7519,1881,Gilenya,2016-01-07,,20,MIU,['2 / Day'],Oral, 
7520,4276,Betaferon,2016-05-28,,300,mg,['/Month'], , 
7521,4276,Rebif [44],2016-05-13,,300, ,['/Month'], , 
7522,4276,Rebif [22],2016-07-21,, ,mg,['/Month'], , 
7523,4276,Avonex,2016-03-20,2020-05-15,5000,mcg,['3 / Week'],IV,Lack of efficacy
7524,3597,Copaxone,2016-02-11,2019-01-27,500, ,['/ Week'], ,Patient Choice/Convenience
7525,3597,Avonex,2016-09-26,2021-08-28, ,mg,['/ Week'],IV,Patient Choice/Convenience
7526,1508,Tysabri,2016-03-08,2018-12-15,400, ,['/Month'],IV,Persisting MRI activity
7527,1508,Methylprednisolone,2016-07-25,,300,mg,['/ Week'],IV, 
7528,1508,Tecfidera,2015-12-25,2020-11-07,1000,mg,['/Month'],IV,Lack of efficacy
7529,1508,Endoxan,2016-01-19,,500,mg,['/Month'],IV, 
7530,805,Mitoxantrone,2016-04-19,, ,mg,['/ Day'],IV, 
7531,805,Betaferon,2016-03-03,, , ,['2 / Day'],IV, 
7532,2418,Rebif [22],2016-07-08,, ,mg,['2 / Day'],IV, 
7533,2418,D-cure (Vitamine D),2016-06-11,2020-05-19,500,MIU,['/Month'], ,Adverse Event
7534,2418,Copaxone,2015-11-07,2019-05-10,400, ,['/ Day'],IV,Lack of efficacy
7535,2418,Betaferon,2016-10-14,,5000, ,['2 / Day'],IV, 
7536,4506,Alemtuzumab (Campath),2015-12-03,, ,mg,['/Month'],IV, 
7537,4506,Ledertrexaat,2016-08-24,2021-02-09, ,MIU,['/Month'],IV,Adverse Event
7538,294,Tysabri,2016-01-25,,500, ,['2 / Day'], , 
7539,294,Methylprednisolone,2015-12-26,2020-01-19, ,MIU,['/Month'], ,Patient Choice/Convenience
7540,2743,Betaferon,2016-07-20,2018-04-03,5000,mg,['/Month'],Oral,Adverse Event
7541,2743,Avonex,2015-11-26,,400, ,['/Month'],IV, 
7542,2743,IVIG,2016-08-26,2020-03-27, , ,['2 / Day'], ,Persisting MRI activity
7543,2743,Copaxone,2015-12-03,,1000,mg,['2 / Day'],IV, 
7544,3466,Tysabri,2015-12-27,2020-06-22, , ,['/Month'],IV,Persisting MRI activity
7545,3466,Endoxan,2015-11-18,2021-01-07,1, ,['/ Day'], ,Adverse Event
7546,3466,Tecfidera,2016-08-13,2020-11-22,1000, ,['3 / Week'], ,Adverse Event
7547,3466,Betaferon,2016-06-02,,400, ,[' '],IV, 
7548,2846,Gilenya,2016-01-28,2020-08-21,400,MIU,['/ Week'], ,Adverse Event
7549,2846,Copaxone,2016-04-23,, ,mg,['/ Day'], , 
7550,2846,Teriflunomide,2016-01-21,2018-08-07,500,mg,[' '], ,Patient Choice/Convenience
7551,2846,Mitoxantrone,2015-12-23,2019-05-31, ,mg,['/ Week'],IV,Lack of efficacy
7552,3449,Betaferon,2016-03-17,2021-01-06,20,MIU,['2 / Day'],IV,Adverse Event
7553,1812,Tysabri,2016-05-24,,1000, ,['/Month'],Oral, 
7554,1812,IVIG,2016-03-27,2020-03-11,300,MIU,[' '],IV,Persisting MRI activity
7555,4782,Copaxone,2016-08-19,, , ,['2 / Day'],IV, 
7556,4782,Betaferon,2016-03-02,2018-05-31,1000,mg,['/Month'],Oral,Patient Choice/Convenience
7557,1994,Avonex,2016-06-06,2017-12-27, , ,['2 / Day'], ,Patient Choice/Convenience
7558,2221,Gilenya,2016-04-03,,5000,mg,['/ Week'],IV, 
7559,2221,Ledertrexaat,2016-10-18,, ,mg,['2 / Day'],Oral, 
7560,2806,Rebif [44],2015-12-20,2020-07-06, ,mg,['2 / Day'],IV,Persistence of relapses
7561,2982,Tecfidera,2016-02-25,2018-10-19,1, ,['/Month'],IV,Persisting MRI activity
7562,2982,Rebif [22],2016-09-18,,500, ,['3 / Week'],IV, 
7563,2982,Tecfidera,2016-04-23,2021-09-24, ,mg,[' '],Oral,Adverse Event
7564,2982,Mitoxantrone,2016-04-25,,20,mg,['/Month'],IV, 
7565,1069,Gilenya,2015-10-29,, ,mg,['3 / Week'],IV, 
7566,1069,Methylprednisolone,2016-07-14,,1000,MIU,['/ Week'],IV, 
7567,1069,Betaferon,2016-01-07,,20,MIU,['/ Day'],IV, 
7568,1069,D-cure (Vitamine D),2016-07-27,, ,mg,['3 / Week'], , 
7569,229,IVIG,2016-04-07,2018-08-26,1,mg,['2 / Day'],Oral,Lack of efficacy
7570,229,Methylprednisolone,2016-07-13,2020-09-14, ,mg,['/Month'], ,Persisting MRI activity
7571,229,Tysabri,2015-11-20,, , ,['/ Week'], , 
7572,229,IVIG,2015-12-31,,400, ,['/ Week'],Oral, 
7573,2387,Avonex,2016-01-21,,400, ,[' '],Oral, 
7574,2387,Tysabri,2016-08-17,,300,MIU,['/ Week'], , 
7575,2387,Copaxone,2016-07-22,, ,mg,['3 / Week'],IV, 
7576,2387,Ledertrexaat,2016-04-16,2019-05-26,1, ,[' '], ,Lack of efficacy
7577,4395,Teriflunomide,2016-02-01,, ,mg,['/Month'],IV, 
7578,2060,Tecfidera,2016-06-26,2018-07-31,1000,mcg,['2 / Day'],IV,Persisting MRI activity
7579,2060,D-cure (Vitamine D),2016-09-01,2021-10-12,1, ,['2 / Day'],IV,Adverse Event
7580,2633,Endoxan,2016-10-13,,1,MIU,['3 / Week'], , 
7581,2633,Avonex,2015-10-27,2021-07-27, ,mg,['/Month'], ,Adverse Event
7582,2633,Tecfidera,2016-04-17,2018-02-10, , ,['/Month'], ,Adverse Event
7583,3301,IVIG,2015-11-21,2019-11-26, ,mg,['/Month'], ,Patient Choice/Convenience
7584,3301,D-cure (Vitamine D),2016-01-16,2021-07-23, ,mg,['/Month'],IV,Patient Choice/Convenience
7585,3564,Ledertrexaat,2016-08-10,2019-07-07,300, ,['3 / Week'], ,Adverse Event
7586,3564,Betaferon,2016-08-30,,500,MIU,['/Month'],IV, 
7587,3564,Copaxone,2016-02-26,,300, ,['2 / Day'],IV, 
7588,3564,Copaxone,2016-03-12,,5000,mg,['/ Day'], , 
7589,3895,Tysabri,2016-03-23,,5000,mg,[' '],IV, 
7590,3895,Rebif [44],2016-03-18,, ,mg,['/Month'],IV, 
7591,3895,Alemtuzumab (Campath),2016-10-22,,20,mg,['/ Day'],IV, 
7592,3895,Tecfidera,2016-04-17,,300,mg,['3 / Week'],IV, 
7593,1111,IVIG,2016-10-21,,1,mg,['/Month'], , 
7594,1111,Rebif [44],2016-05-31,2020-09-23, ,mg,[' '],Oral,Lack of efficacy
7595,368,Gilenya,2015-11-17,2018-03-21,5000,mg,['3 / Week'],IV,Persisting MRI activity
7596,368,Alemtuzumab (Campath),2016-01-01,2018-02-18, , ,['/ Week'],IV,Patient Choice/Convenience
7597,368,Betaferon,2016-04-04,2018-01-17, , ,['/Month'], ,Lack of efficacy
7598,3876,Rebif [22],2016-02-03,,20,mg,[' '],IV, 
7599,3876,IVIG,2016-03-01,,20,mcg,['/ Week'],IV, 
7600,3876,D-cure (Vitamine D),2015-11-01,2018-04-20,1,MIU,['/Month'], ,Persistence of relapses
7601,3876,Alemtuzumab (Campath),2016-02-23,,300, ,['3 / Week'], , 
7602,140,Gilenya,2016-04-29,,500,mg,['2 / Day'], , 
7603,140,Gilenya,2016-05-06,,1, ,['3 / Week'], , 
7604,1966,Avonex,2015-12-20,2018-07-11,500,mg,['/Month'],IV,Persisting MRI activity
7605,1966,Gilenya,2016-04-25,, ,mg,[' '],IV, 
7606,1966,Tysabri,2016-06-30,,500,MIU,['2 / Day'], , 
7607,4270,Avonex,2016-05-03,2018-12-01,500,MIU,['2 / Day'], ,Persisting MRI activity
7608,889,IVIG,2016-06-16,,20,mg,['/Month'],IV, 
7609,889,Gilenya,2016-08-03,2018-07-26, , ,[' '],IV,Adverse Event
7610,889,Tysabri,2016-10-06,,1000,mg,['/Month'], , 
7611,3116,Rebif [22],2015-12-16,2021-10-07,20, ,['/ Day'],IV,Persisting MRI activity
7612,3116,Rebif [22],2016-02-09,,5000,mg,['3 / Week'],IV, 
7613,3116,Rebif [22],2016-01-05,2021-03-30,5000, ,['/ Week'],IV,Patient Choice/Convenience
7614,3116,Methylprednisolone,2016-06-29,,500,mg,['/Month'],IV, 
7615,4434,Teriflunomide,2016-06-27,2019-10-05,1,mg,['/Month'],IV,Patient Choice/Convenience
7616,4434,Gilenya,2016-10-10,,5000, ,['/ Day'], , 
7617,4434,Tecfidera,2016-10-16,2020-08-11,500,mg,['2 / Day'],IV,Lack of efficacy
7618,4434,Alemtuzumab (Campath),2016-04-17,2021-04-08,500, ,['2 / Day'], ,Patient Choice/Convenience
7619,725,D-cure (Vitamine D),2016-07-19,, ,mcg,[' '],IV, 
7620,4520,IVIG,2016-08-14,2018-01-08, ,mg,['/Month'],IV,Persisting MRI activity
7621,4520,Mitoxantrone,2015-11-09,2020-06-12, ,mg,['2 / Day'], ,Patient Choice/Convenience
7622,4520,Alemtuzumab (Campath),2016-04-21,,500, ,['/ Week'], , 
7623,1113,Methylprednisolone,2016-06-13,2020-08-16, ,mcg,['2 / Day'], ,Patient Choice/Convenience
7624,1113,IVIG,2016-06-22,2019-10-04, , ,['2 / Day'],IV,Persistence of relapses
7625,1113,Methylprednisolone,2016-01-27,2021-07-24,500, ,['/Month'],IV,Lack of efficacy
7626,1113,Endoxan,2016-10-16,, ,mg,['/ Day'], , 
7627,1418,Tysabri,2016-05-27,,1000,MIU,[' '],Oral, 
7628,1418,Copaxone,2016-05-22,, ,mg,['2 / Day'],Oral, 
7629,1418,Rebif [44],2016-06-14,,5000,mg,['3 / Week'],IV, 
7630,1418,Betaferon,2016-09-27,2018-02-03,1000,mg,['/Month'],IV,Adverse Event
7631,4894,Alemtuzumab (Campath),2015-11-15,2019-11-08,1, ,['2 / Day'],IV,Adverse Event
7632,4894,Alemtuzumab (Campath),2016-01-22,2021-07-05,5000, ,['/Month'],IV,Adverse Event
7633,4894,Rebif [22],2016-09-16,,5000,mg,['2 / Day'], , 
7634,1695,Avonex,2016-05-18,, , ,['/Month'],IV, 
7635,1695,Rebif [22],2016-08-04,,20, ,[' '], , 
7636,1695,Avonex,2016-08-13,2018-01-08,1000, ,['/Month'],Oral,Lack of efficacy
7637,3015,Alemtuzumab (Campath),2016-05-18,, ,mg,[' '],IV, 
7638,3015,Gilenya,2016-09-16,,300, ,['/ Day'],Oral, 
7639,3015,Gilenya,2016-03-22,, , ,['/Month'],IV, 
7640,3987,D-cure (Vitamine D),2016-03-31,2020-07-29,20,MIU,['/Month'], ,Patient Choice/Convenience
7641,4190,Gilenya,2016-07-06,2017-11-21, ,mg,['/ Day'], ,Lack of efficacy
7642,4190,Gilenya,2016-01-28,,20, ,[' '], , 
7643,4190,Tecfidera,2015-11-12,, ,MIU,['2 / Day'],IV, 
7644,224,IVIG,2016-03-08,,1000,mg,[' '],IV, 
7645,224,Alemtuzumab (Campath),2016-07-10,,1000,mcg,['/ Day'],IV, 
7646,224,Alemtuzumab (Campath),2016-08-06,, , ,['/Month'],IV, 
7647,1760,Endoxan,2016-01-27,, ,mg,['2 / Day'],IV, 
7648,1760,Rebif [22],2016-09-08,,300,mg,['/Month'],IV, 
7649,2722,Alemtuzumab (Campath),2016-03-17,2020-11-01, , ,['/Month'], ,Persisting MRI activity
7650,2722,Rebif [44],2016-06-05,, , ,['2 / Day'],IV, 
7651,2722,Tecfidera,2015-12-28,2020-08-20,1,MIU,['/ Day'], ,Persisting MRI activity
7652,4849,Avonex,2015-11-07,, , ,['/ Week'],IV, 
7653,4849,D-cure (Vitamine D),2016-08-26,, ,mg,['/Month'],IV, 
7654,2930,IVIG,2016-08-26,,1000, ,[' '], , 
7655,2930,Rebif [44],2016-03-07,2020-05-12,1,mg,['/ Week'],IV,Patient Choice/Convenience
7656,1449,Teriflunomide,2016-10-17,2021-05-14, , ,['3 / Week'],IV,Adverse Event
7657,1449,Alemtuzumab (Campath),2016-01-02,2018-06-10,1,MIU,['/Month'], ,Persistence of relapses
7658,1092,Copaxone,2015-10-26,, ,mg,['/Month'], , 
7659,1092,Endoxan,2016-01-22,,5000,mg,['/Month'],IV, 
7660,1092,Methylprednisolone,2015-10-25,,1000, ,['2 / Day'],Oral, 
7661,3640,IVIG,2015-12-18,2021-03-30,1000,MIU,['3 / Week'],IV,Lack of efficacy
7662,3640,Methylprednisolone,2016-09-19,,20,mcg,['3 / Week'],IV, 
7663,4889,Methylprednisolone,2016-03-05,, ,mg,['/Month'],IV, 
7664,4889,D-cure (Vitamine D),2016-04-07,,20,mg,['/ Day'],Oral, 
7665,4889,Tysabri,2016-08-04,,300,MIU,[' '],IV, 
7666,4889,Ledertrexaat,2016-03-13,2020-10-30, , ,['/ Week'], ,Persisting MRI activity
7667,4407,D-cure (Vitamine D),2016-09-08,, , ,['2 / Day'],IV, 
7668,4125,Gilenya,2016-01-23,2020-10-02, ,MIU,['/Month'],IV,Patient Choice/Convenience
7669,462,Tecfidera,2016-07-10,,5000, ,['2 / Day'],Oral, 
7670,462,Ledertrexaat,2016-08-05,, ,mcg,['3 / Week'],Oral, 
7671,462,Betaferon,2016-01-11,,300, ,['2 / Day'], , 
7672,4487,Rebif [44],2015-12-20,2018-05-03, ,mcg,['/Month'], ,Patient Choice/Convenience
7673,2439,Alemtuzumab (Campath),2016-02-15,, , ,['2 / Day'],Oral, 
7674,2439,Alemtuzumab (Campath),2016-05-03,, ,mg,['/Month'],IV, 
7675,2439,Rebif [44],2016-09-05,,1000,mg,['/Month'],IV, 
7676,2439,Rebif [22],2016-06-23,2019-08-08,1000, ,['2 / Day'],IV,Patient Choice/Convenience
7677,1727,Rebif [44],2016-08-17,,500,mg,['2 / Day'],IV, 
7678,1498,Avonex,2016-08-19,,500,MIU,['/ Day'], , 
7679,2029,Copaxone,2015-10-30,,1000,mg,['2 / Day'],IV, 
7680,3422,Tecfidera,2016-04-04,,500,mg,['2 / Day'],IV, 
7681,3422,Methylprednisolone,2016-02-06,,20, ,['3 / Week'], , 
7682,3422,Tecfidera,2016-01-30,2017-11-16,400, ,['2 / Day'],Oral,Persistence of relapses
7683,1837,Copaxone,2016-01-13,,20,mg,['2 / Day'],IV, 
7684,1837,Endoxan,2015-11-06,2021-09-05, ,mg,['/Month'], ,Persisting MRI activity
7685,3360,Alemtuzumab (Campath),2016-01-13,,300, ,[' '],Oral, 
7686,3360,Avonex,2015-10-24,,500,mg,['/Month'],Oral, 
7687,3360,IVIG,2016-05-15,2018-07-05, , ,['/Month'], ,Adverse Event
7688,3360,Tysabri,2016-03-30,, ,mcg,['/ Week'], , 
7689,4474,Ledertrexaat,2016-03-07,, ,mg,[' '], , 
7690,4474,Rebif [44],2015-11-16,,20,mg,['3 / Week'],IV, 
7691,4474,D-cure (Vitamine D),2016-03-04,2020-08-05,1000, ,['2 / Day'],Oral,Persisting MRI activity
7692,3723,Rebif [22],2016-10-17,2020-08-11, ,mg,['2 / Day'], ,Persisting MRI activity
7693,399,Methylprednisolone,2016-01-19,2018-11-04, ,mg,['/Month'],IV,Lack of efficacy
7694,4862,Mitoxantrone,2016-05-27,2018-06-13,500,mg,['2 / Day'],IV,Adverse Event
7695,4862,Endoxan,2015-10-24,,1,mcg,['2 / Day'],Oral, 
7696,3908,Betaferon,2016-07-05,2018-07-25,20, ,['/Month'], ,Patient Choice/Convenience
7697,3908,Gilenya,2016-07-06,, ,MIU,['/Month'],IV, 
7698,3908,Endoxan,2016-09-19,2018-05-04,1000,mcg,['/ Day'],Oral,Adverse Event
7699,1738,Rebif [44],2016-04-15,,1,mg,['/Month'],IV, 
7700,1486,IVIG,2015-10-25,,400,mcg,['/ Week'],IV, 
7701,1486,Endoxan,2016-06-17,, , ,['2 / Day'],IV, 
7702,2361,Rebif [22],2016-03-03,, ,mg,['2 / Day'],Oral, 
7703,2361,Endoxan,2016-03-21,2018-07-04, ,mg,['/Month'],IV,Adverse Event
7704,2361,Gilenya,2016-01-17,2020-02-11, ,MIU,['/Month'],IV,Lack of efficacy
7705,2361,D-cure (Vitamine D),2016-07-18,2020-03-06,1,mg,['/Month'],IV,Patient Choice/Convenience
7706,4649,Rebif [44],2015-12-06,,20,mg,[' '],IV, 
7707,4649,D-cure (Vitamine D),2016-06-21,, ,mg,['2 / Day'],IV, 
7708,2257,Copaxone,2016-09-08,2020-02-24,300,mg,['/Month'],IV,Patient Choice/Convenience
7709,2257,Rebif [22],2016-10-17,2020-04-15,500,mg,['/Month'],IV,Adverse Event
7710,2257,Methylprednisolone,2016-07-20,2021-02-05, ,mg,['/ Day'], ,Persisting MRI activity
7711,2257,Avonex,2015-12-02,, ,mg,['/ Day'],IV, 
7712,2710,Tysabri,2016-10-12,2019-10-28,5000,mcg,['3 / Week'],IV,Adverse Event
7713,2710,Gilenya,2016-03-10,,1000,mg,['2 / Day'],Oral, 
7714,2710,Tecfidera,2015-10-25,, ,mg,['3 / Week'],IV, 
7715,1494,Tecfidera,2016-03-04,2020-02-10,300,MIU,['/Month'], ,Patient Choice/Convenience
7716,1494,Methylprednisolone,2016-05-20,, , ,['3 / Week'], , 
7717,1494,IVIG,2016-06-01,,500, ,['/ Week'],IV, 
7718,1494,D-cure (Vitamine D),2015-11-09,2020-10-13, , ,['2 / Day'],IV,Lack of efficacy
7719,4909,Methylprednisolone,2016-01-12,,5000,mg,['2 / Day'],IV, 
7720,4909,Rebif [44],2016-08-29,,20,mg,['/Month'],IV, 
7721,4909,Methylprednisolone,2016-06-16,2020-10-10, , ,['/Month'], ,Persisting MRI activity
7722,4909,Teriflunomide,2016-08-14,,20, ,['2 / Day'],IV, 
7723,4711,Gilenya,2016-02-24,2021-05-08,1000,MIU,['/ Day'], ,Lack of efficacy
7724,4711,Gilenya,2016-06-09,2018-05-10,5000,mg,['/ Day'],IV,Persistence of relapses
7725,4711,Gilenya,2016-06-07,,300,mg,[' '], , 
7726,4711,Gilenya,2015-10-29,,300,mg,['2 / Day'],IV, 
7727,4133,Tecfidera,2016-06-08,2019-10-21,400, ,['3 / Week'],IV,Persisting MRI activity
7728,2599,Rebif [22],2016-07-11,, ,mg,['2 / Day'],IV, 
7729,2461,Rebif [44],2016-02-17,, , ,['2 / Day'], , 
7730,2461,Mitoxantrone,2016-05-01,, , ,['2 / Day'],IV, 
7731,2461,Tecfidera,2016-03-02,2021-07-13,500,mg,['3 / Week'],Oral,Patient Choice/Convenience
7732,2461,Endoxan,2016-09-05,,400,mg,['2 / Day'], , 
7733,2396,Gilenya,2016-10-13,,20,mg,['2 / Day'], , 
7734,2396,Endoxan,2015-12-05,2019-10-07,1000, ,['2 / Day'],IV,Persisting MRI activity
7735,2396,Methylprednisolone,2015-12-19,, ,mg,[' '],IV, 
7736,2818,Gilenya,2016-01-05,2020-05-30,300, ,[' '], ,Patient Choice/Convenience
7737,2818,IVIG,2016-03-21,2020-08-19,1, ,['3 / Week'],IV,Lack of efficacy
7738,1115,Mitoxantrone,2016-05-25,2021-02-04,20, ,['2 / Day'],IV,Adverse Event
7739,1115,Betaferon,2016-04-24,,1000,mg,['/Month'],IV, 
7740,1115,Rebif [44],2016-08-13,, ,mg,['2 / Day'],IV, 
7741,2518,Avonex,2016-08-02,2021-01-28,500,mg,['2 / Day'],IV,Lack of efficacy
7742,2518,D-cure (Vitamine D),2016-05-25,,500, ,['3 / Week'],Oral, 
7743,2518,Mitoxantrone,2016-03-26,2021-04-26,1000,mcg,['2 / Day'], ,Patient Choice/Convenience
7744,2518,Methylprednisolone,2016-09-29,,20, ,['/Month'], , 
7745,363,Tysabri,2015-11-26,2017-11-06, , ,[' '],IV,Patient Choice/Convenience
7746,363,Avonex,2016-09-08,2021-06-12,20, ,['/Month'],IV,Patient Choice/Convenience
7747,4536,Copaxone,2016-07-03,2017-10-24,20,mg,['/Month'],IV,Adverse Event
7748,4536,Ledertrexaat,2016-04-26,2020-05-12,1,mg,['/ Day'],IV,Patient Choice/Convenience
7749,2519,D-cure (Vitamine D),2016-06-09,2019-06-12, ,mg,['/Month'],IV,Patient Choice/Convenience
7750,2519,IVIG,2016-04-27,2019-02-21,1000,mg,['2 / Day'],Oral,Lack of efficacy
7751,2519,Rebif [22],2016-04-02,, ,mg,['3 / Week'],Oral, 
7752,2519,IVIG,2016-10-14,,20, ,['2 / Day'], , 
7753,3200,Copaxone,2016-05-22,2019-02-14,300,mcg,['2 / Day'],IV,Persisting MRI activity
7754,3200,Tysabri,2016-01-21,2018-03-17,1000,mg,['/Month'],IV,Adverse Event
7755,1269,Rebif [22],2016-01-16,2021-01-23,500, ,['3 / Week'],Oral,Persisting MRI activity
7756,1269,Tysabri,2016-03-07,2020-05-06,300,mg,['2 / Day'],IV,Persisting MRI activity
7757,1269,Gilenya,2016-08-23,,300, ,['/Month'], , 
7758,676,Methylprednisolone,2016-07-15,,500,mg,['/Month'], , 
7759,676,Rebif [44],2016-03-13,2021-05-29,1, ,['2 / Day'],IV,Adverse Event
7760,1432,Betaferon,2016-07-07,,500, ,['/Month'],IV, 
7761,1432,Tysabri,2016-10-14,,500,mg,['/Month'],IV, 
7762,1432,Avonex,2015-12-07,,400,mg,['/Month'],Oral, 
7763,1432,Methylprednisolone,2016-09-26,,20,mg,['/Month'],IV, 
7764,3815,Mitoxantrone,2016-06-07,,300, ,['2 / Day'], , 
7765,2591,Endoxan,2016-07-06,2018-06-27,1000,mg,['/ Week'],IV,Lack of efficacy
7766,2591,Tecfidera,2016-07-07,,500,MIU,['2 / Day'],Oral, 
7767,2591,Rebif [22],2015-10-25,,1, ,['/Month'],IV, 
7768,4167,Rebif [22],2015-11-12,, ,mg,['2 / Day'],IV, 
7769,3308,Methylprednisolone,2016-05-18,2018-09-20, , ,['3 / Week'],IV,Adverse Event
7770,3308,Alemtuzumab (Campath),2016-01-29,2019-01-26,400,mcg,['2 / Day'], ,Lack of efficacy
7771,4763,Betaferon,2016-01-24,,5000,mg,['/ Day'],IV, 
7772,4763,Methylprednisolone,2016-09-24,2018-11-19,5000, ,['2 / Day'], ,Patient Choice/Convenience
7773,4763,Tysabri,2016-01-23,,500,mg,['2 / Day'],IV, 
7774,1053,Tysabri,2016-04-13,2020-08-07, , ,['2 / Day'],Oral,Lack of efficacy
7775,1053,Methylprednisolone,2016-03-12,,1, ,['/Month'], , 
7776,4972,IVIG,2016-02-21,2018-02-21,400,mg,['3 / Week'],IV,Adverse Event
7777,4972,IVIG,2015-12-12,2019-10-03,1, ,[' '],IV,Adverse Event
7778,2755,Rebif [44],2015-11-13,2019-06-02,300,mg,['/Month'],IV,Adverse Event
7779,2755,Tecfidera,2016-01-31,2019-08-24, , ,[' '], ,Persisting MRI activity
7780,3151,Methylprednisolone,2015-11-12,,1,mg,['/Month'], , 
7781,3151,Rebif [22],2016-02-16,,1, ,['/Month'],Oral, 
7782,3151,Tysabri,2016-10-02,, , ,['/Month'],Oral, 
7783,3747,Gilenya,2015-12-31,,1, ,[' '],IV, 
7784,3747,IVIG,2015-12-07,,1,MIU,['2 / Day'],Oral, 
7785,3747,Gilenya,2016-08-05,2021-10-22,300, ,['/ Day'], ,Lack of efficacy
7786,4641,D-cure (Vitamine D),2016-07-25,, ,mg,['/Month'],IV, 
7787,4641,Tecfidera,2015-12-04,2020-07-28, ,mg,['2 / Day'],IV,Persisting MRI activity
7788,1585,Gilenya,2016-06-07,2018-11-24, ,MIU,['3 / Week'],IV,Persisting MRI activity
7789,1585,Rebif [44],2016-07-25,2020-07-13, ,mg,[' '], ,Adverse Event
7790,447,D-cure (Vitamine D),2016-07-29,2020-07-08, ,mg,['/ Week'],IV,Persisting MRI activity
7791,447,Endoxan,2016-04-27,2021-01-29,1000, ,['2 / Day'],Oral,Adverse Event
7792,447,Tecfidera,2016-07-06,, , ,[' '],Oral, 
7793,447,Methylprednisolone,2015-12-31,, ,mg,['2 / Day'],IV, 
7794,1621,Tysabri,2016-02-10,, ,mcg,['3 / Week'],IV, 
7795,1621,Gilenya,2016-04-22,, ,mg,['/ Day'],IV, 
7796,1621,IVIG,2016-06-15,2020-11-24,5000,mg,[' '],IV,Persistence of relapses
7797,1621,Tecfidera,2016-07-07,,500, ,['2 / Day'],IV, 
7798,1065,Alemtuzumab (Campath),2016-02-24,2019-02-24,5000, ,['/ Day'],IV,Adverse Event
7799,1065,IVIG,2015-11-08,2021-03-31,20,MIU,['2 / Day'],IV,Persistence of relapses
7800,1065,Alemtuzumab (Campath),2016-07-03,,400,mg,['2 / Day'], , 
7801,1065,Copaxone,2016-01-28,,500,mg,['/ Day'], , 
7802,2991,Mitoxantrone,2016-02-02,,1,MIU,['/Month'],IV, 
7803,2991,Alemtuzumab (Campath),2016-02-18,2020-02-06,1, ,['/Month'],IV,Patient Choice/Convenience
7804,2991,Avonex,2015-12-16,2019-04-23,20,mg,['/Month'], ,Patient Choice/Convenience
7805,2991,Mitoxantrone,2016-06-19,,1,mg,['2 / Day'],IV, 
7806,2543,Avonex,2015-12-18,2018-04-06,400, ,['3 / Week'],IV,Adverse Event
7807,2543,Tysabri,2016-10-14,2020-05-17,5000,mcg,['/Month'],Oral,Persistence of relapses
7808,2543,Gilenya,2016-04-17,2018-11-19,1,mg,['2 / Day'], ,Patient Choice/Convenience
7809,2543,Mitoxantrone,2016-03-23,2018-09-14, ,mg,['2 / Day'],IV,Patient Choice/Convenience
7810,3743,Gilenya,2016-04-24,,300,mg,['/Month'],IV, 
7811,3743,IVIG,2016-01-20,2021-01-26,500, ,['2 / Day'],Oral,Lack of efficacy
7812,3743,Methylprednisolone,2016-06-29,,5000,mg,['/Month'], , 
7813,3743,D-cure (Vitamine D),2016-04-16,2021-01-09,1000,mg,['3 / Week'],IV,Lack of efficacy
7814,1746,Mitoxantrone,2016-10-15,, , ,['2 / Day'],IV, 
7815,1746,Gilenya,2016-03-01,2019-03-19, ,mg,['/Month'],IV,Lack of efficacy
7816,1746,Betaferon,2016-04-13,2018-05-12,20, ,['2 / Day'], ,Persistence of relapses
7817,4563,Alemtuzumab (Campath),2016-09-21,,1000, ,['2 / Day'],Oral, 
7818,4563,Betaferon,2016-07-19,2018-03-04, ,mg,['/Month'],IV,Patient Choice/Convenience
7819,1226,IVIG,2016-10-20,,500, ,[' '], , 
7820,1226,Tysabri,2016-06-04,,20,mg,['/Month'], , 
7821,1226,Tysabri,2016-10-02,,1000, ,[' '],IV, 
7822,1226,Tecfidera,2016-04-26,, ,mg,['2 / Day'], , 
7823,4868,Alemtuzumab (Campath),2016-10-17,2021-05-06, , ,['2 / Day'], ,Persisting MRI activity
7824,4868,Alemtuzumab (Campath),2016-06-05,2020-08-26,20, ,['3 / Week'],Oral,Adverse Event
7825,4868,Methylprednisolone,2015-11-06,2019-10-01,20,mg,['2 / Day'], ,Patient Choice/Convenience
7826,4868,Tecfidera,2016-06-03,, , ,['/Month'],Oral, 
7827,3508,Avonex,2016-08-15,, , ,['/Month'],IV, 
7828,3508,Betaferon,2016-07-25,2019-12-13,500,mg,['2 / Day'], ,Persisting MRI activity
7829,3508,Teriflunomide,2016-05-19,2018-10-14,20,mg,['/Month'], ,Lack of efficacy
7830,584,Tysabri,2016-07-21,, ,mg,['2 / Day'],IV, 
7831,584,Copaxone,2016-04-06,, ,mg,['3 / Week'],IV, 
7832,541,Rebif [44],2015-12-13,2021-01-09, ,mg,['/ Day'],IV,Lack of efficacy
7833,541,IVIG,2016-03-26,, , ,['/ Day'],IV, 
7834,3078,Teriflunomide,2016-09-13,2019-03-14,1,mg,['/Month'],IV,Lack of efficacy
7835,3078,Tecfidera,2015-12-06,2018-02-12,1,mg,['3 / Week'],IV,Adverse Event
7836,4226,D-cure (Vitamine D),2016-10-18,,5000,mcg,['/Month'],Oral, 
7837,2066,Betaferon,2016-10-21,,20, ,['3 / Week'],IV, 
7838,2066,Rebif [22],2016-10-13,,500,mg,['/ Week'],IV, 
7839,2066,D-cure (Vitamine D),2016-01-01,,500, ,['3 / Week'],IV, 
7840,2066,IVIG,2016-08-06,2020-03-08,20,mg,['3 / Week'],Oral,Lack of efficacy
7841,729,Ledertrexaat,2016-08-14,2021-06-13,1, ,['/Month'],IV,Lack of efficacy
7842,729,Betaferon,2016-09-10,,1000,mcg,['/Month'],IV, 
7843,729,Tecfidera,2016-02-21,2018-06-16,1, ,['2 / Day'],Oral,Lack of efficacy
7844,729,Ledertrexaat,2016-01-13,, , ,['/Month'],Oral, 
7845,1461,Alemtuzumab (Campath),2016-04-03,2018-01-28,500,mg,['/ Day'],Oral,Patient Choice/Convenience
7846,1461,D-cure (Vitamine D),2016-09-27,,500, ,['/ Day'],IV, 
7847,4565,Tysabri,2016-02-09,2021-05-25,300,mg,['/Month'],Oral,Persistence of relapses
7848,1949,Tecfidera,2016-04-06,, , ,['2 / Day'], , 
7849,1949,Gilenya,2016-05-09,,5000,mg,[' '],IV, 
7850,1709,Betaferon,2016-01-08,,20,mg,['/ Week'],IV, 
7851,1709,Gilenya,2016-07-02,,1, ,['/Month'],IV, 
7852,2260,Betaferon,2016-10-01,,500,MIU,['2 / Day'],IV, 
7853,2260,Alemtuzumab (Campath),2015-12-15,,300,mg,['/Month'],IV, 
7854,2592,Gilenya,2015-12-21,2020-09-10, , ,['/Month'], ,Persistence of relapses
7855,2592,D-cure (Vitamine D),2016-07-12,2019-11-30,20,mg,['2 / Day'],IV,Adverse Event
7856,2592,Ledertrexaat,2016-02-29,,1, ,['/Month'],IV, 
7857,2592,D-cure (Vitamine D),2016-05-28,2020-11-04,20,mcg,['/Month'], ,Persisting MRI activity
7858,3000,Rebif [22],2016-05-12,,20,mg,['/ Week'],IV, 
7859,4050,Avonex,2016-03-04,, ,mcg,['2 / Day'],Oral, 
7860,4050,Teriflunomide,2016-04-23,2018-07-24, , ,['3 / Week'],IV,Persisting MRI activity
7861,4050,Gilenya,2016-09-12,,1,mg,['2 / Day'],IV, 
7862,4933,Tecfidera,2016-08-09,2020-11-17, ,mg,['2 / Day'],IV,Persistence of relapses
7863,4933,Alemtuzumab (Campath),2016-03-25,2019-08-03, , ,['2 / Day'],IV,Adverse Event
7864,4933,Ledertrexaat,2016-08-09,, ,mg,['/Month'], , 
7865,4933,Gilenya,2016-03-23,, ,mg,[' '],IV, 
7866,4841,Gilenya,2015-11-10,, ,mg,['/Month'],IV, 
7867,4841,D-cure (Vitamine D),2016-09-04,, , ,['/Month'],Oral, 
7868,4841,Gilenya,2016-03-15,2018-10-02, ,mg,['/Month'],Oral,Lack of efficacy
7869,3623,Ledertrexaat,2016-02-24,2019-03-05, ,mg,['/Month'], ,Patient Choice/Convenience
7870,3623,Copaxone,2016-04-20,,5000, ,['2 / Day'],IV, 
7871,3623,Gilenya,2016-04-14,, ,mg,['/ Week'], , 
7872,3028,IVIG,2016-02-02,2019-10-04,1000, ,['3 / Week'], ,Persisting MRI activity
7873,3685,Copaxone,2016-05-20,2020-06-02,500,mg,['2 / Day'], ,Persistence of relapses
7874,3685,Tysabri,2016-01-05,,5000,mg,['2 / Day'],Oral, 
7875,3685,Gilenya,2016-04-05,,20,mg,['2 / Day'],IV, 
7876,3685,Teriflunomide,2016-01-11,,1000,mg,['2 / Day'],IV, 
7877,1923,Ledertrexaat,2016-10-20,2020-04-03, ,MIU,['2 / Day'],IV,Persisting MRI activity
7878,1923,Gilenya,2016-09-02,,5000,mg,['/Month'],Oral, 
7879,3676,Tecfidera,2016-05-03,,20,mg,[' '], , 
7880,3676,Rebif [22],2016-06-06,2019-08-12,5000, ,['3 / Week'],IV,Adverse Event
7881,3676,Ledertrexaat,2016-08-09,,500, ,['/Month'], , 
7882,3676,IVIG,2016-08-06,2021-04-08,500, ,['/ Day'],IV,Persisting MRI activity
7883,4755,Avonex,2016-10-04,2020-03-25, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
7884,4755,Alemtuzumab (Campath),2016-10-09,,300, ,['/Month'],IV, 
7885,1028,Endoxan,2016-02-12,,300,MIU,['/Month'],Oral, 
7886,1028,Rebif [22],2016-01-15,2018-09-25, ,mg,['/Month'],IV,Persisting MRI activity
7887,1028,Avonex,2016-09-09,, ,MIU,['/ Day'],IV, 
7888,2205,D-cure (Vitamine D),2016-09-07,2019-10-22,1000, ,['3 / Week'], ,Persisting MRI activity
7889,2205,Ledertrexaat,2016-07-07,2020-03-09,1, ,['/Month'], ,Persisting MRI activity
7890,2205,Tecfidera,2016-05-25,,1,mg,['/Month'],IV, 
7891,2205,D-cure (Vitamine D),2016-05-17,,20, ,['/Month'],IV, 
7892,2241,Endoxan,2016-05-13,2021-01-26,20, ,['/ Day'],IV,Persisting MRI activity
7893,2241,Alemtuzumab (Campath),2016-03-26,,300, ,[' '],IV, 
7894,2241,Methylprednisolone,2016-07-18,2018-07-16,500,mcg,['2 / Day'],IV,Adverse Event
7895,2241,Teriflunomide,2016-08-07,2018-10-18,20,mcg,['2 / Day'],Oral,Patient Choice/Convenience
7896,790,Gilenya,2016-03-23,,1,mg,['2 / Day'],IV, 
7897,790,Mitoxantrone,2016-10-09,,1000, ,['3 / Week'],IV, 
7898,790,Alemtuzumab (Campath),2016-01-02,, , ,['/Month'], , 
7899,790,D-cure (Vitamine D),2016-04-19,2018-11-29, ,mg,['/Month'],IV,Persisting MRI activity
7900,4471,Teriflunomide,2016-03-09,2019-12-11,5000, ,['/Month'],IV,Persistence of relapses
7901,4471,Mitoxantrone,2016-03-05,,500,mg,['/Month'], , 
7902,4471,Copaxone,2016-01-29,2021-05-07,20, ,['/Month'],IV,Patient Choice/Convenience
7903,4471,Rebif [22],2016-10-19,,5000,MIU,['2 / Day'],Oral, 
7904,1671,Ledertrexaat,2016-09-08,, ,mcg,['2 / Day'],IV, 
7905,1671,Gilenya,2015-12-16,2019-07-27,5000,mg,[' '],IV,Adverse Event
7906,1671,Rebif [44],2016-04-22,,500, ,['/Month'], , 
7907,4040,Tysabri,2015-10-29,,400,mg,['/Month'],IV, 
7908,4040,Tecfidera,2016-01-21,2017-11-30,1000,MIU,['/ Day'],IV,Persisting MRI activity
7909,4040,Alemtuzumab (Campath),2016-06-04,2020-12-21,20, ,[' '],IV,Persistence of relapses
7910,3491,D-cure (Vitamine D),2015-11-25,2020-06-23, , ,['/Month'],IV,Persisting MRI activity
7911,3491,IVIG,2016-02-21,2017-12-02,300, ,[' '], ,Patient Choice/Convenience
7912,3491,Gilenya,2016-07-29,,1000, ,['2 / Day'],IV, 
7913,3491,D-cure (Vitamine D),2015-11-16,2019-12-15, ,MIU,[' '],IV,Adverse Event
7914,1414,Endoxan,2016-03-18,2020-04-17,1000,mg,['/ Week'],IV,Patient Choice/Convenience
7915,1414,Methylprednisolone,2016-01-30,,20, ,['2 / Day'],Oral, 
7916,1414,Endoxan,2016-06-26,2020-01-31,500,mg,['2 / Day'],IV,Persisting MRI activity
7917,2386,Avonex,2016-08-28,2019-03-11,300,MIU,['/Month'],IV,Patient Choice/Convenience
7918,1750,D-cure (Vitamine D),2016-03-29,2018-10-27,500, ,['2 / Day'],IV,Patient Choice/Convenience
7919,1750,Alemtuzumab (Campath),2015-11-26,2021-02-02,5000, ,['2 / Day'],Oral,Lack of efficacy
7920,3798,Tecfidera,2016-08-24,2020-06-20,400, ,['2 / Day'], ,Persisting MRI activity
7921,1466,Gilenya,2015-12-10,2018-06-15, ,mg,['/Month'],IV,Adverse Event
7922,1466,Betaferon,2016-10-17,2018-11-25,20,mg,['2 / Day'],Oral,Persisting MRI activity
7923,2524,Avonex,2016-10-07,,1000, ,['/ Week'], , 
7924,2524,Rebif [44],2016-01-06,,20,mg,['2 / Day'],IV, 
7925,1903,D-cure (Vitamine D),2016-09-11,2018-03-07,1000, ,['2 / Day'],Oral,Lack of efficacy
7926,3900,Rebif [44],2016-08-01,,1,mg,['/Month'],IV, 
7927,3900,IVIG,2016-02-14,2018-07-07,300,mg,['2 / Day'],IV,Patient Choice/Convenience
7928,1186,Alemtuzumab (Campath),2016-07-15,2020-03-06,5000, ,['/Month'],IV,Patient Choice/Convenience
7929,528,Mitoxantrone,2016-07-15,2018-08-21,500, ,['/Month'], ,Patient Choice/Convenience
7930,705,Endoxan,2016-06-21,2017-12-14, ,mcg,['/Month'],IV,Persisting MRI activity
7931,705,Tecfidera,2016-07-06,,5000,mg,['/Month'],Oral, 
7932,705,Avonex,2015-11-23,,1000,MIU,['/Month'],IV, 
7933,4614,Methylprednisolone,2016-05-05,,1000,mcg,['3 / Week'], , 
7934,4614,Betaferon,2015-11-05,2018-06-02,20,mg,['/ Day'], ,Adverse Event
7935,4614,Tysabri,2015-12-01,,20,mg,['2 / Day'],IV, 
7936,4614,Betaferon,2016-10-01,, ,mg,['/Month'], , 
7937,3631,D-cure (Vitamine D),2016-06-01,2020-01-28,300,mg,['/Month'],IV,Lack of efficacy
7938,3631,Rebif [44],2016-06-07,2019-10-22,5000, ,['/Month'],IV,Adverse Event
7939,3631,Betaferon,2016-06-15,,300,mg,['2 / Day'],IV, 
7940,561,Rebif [44],2015-10-29,, ,mg,['3 / Week'],IV, 
7941,561,Tecfidera,2016-01-10,2019-06-03,400,mcg,['/ Week'], ,Persistence of relapses
7942,561,Ledertrexaat,2016-05-27,2018-06-17,20, ,['/Month'],IV,Patient Choice/Convenience
7943,561,D-cure (Vitamine D),2016-07-19,, ,mg,['2 / Day'], , 
7944,3563,Endoxan,2016-01-10,,20,mg,['/Month'],IV, 
7945,3563,Gilenya,2015-12-14,2020-03-15,300, ,['/Month'],IV,Persisting MRI activity
7946,957,D-cure (Vitamine D),2016-08-18,2018-12-23,300,mg,['/Month'],IV,Adverse Event
7947,4399,Tecfidera,2016-05-29,2019-12-26,1, ,['/Month'],Oral,Persisting MRI activity
7948,4399,Rebif [44],2016-08-13,2018-09-21,1,MIU,['/ Week'],IV,Adverse Event
7949,4399,IVIG,2016-08-25,2021-07-28, ,MIU,['3 / Week'],IV,Adverse Event
7950,3003,Rebif [44],2016-08-04,, ,mg,['2 / Day'],IV, 
7951,3003,D-cure (Vitamine D),2015-10-28,,1000,mcg,['2 / Day'], , 
7952,3003,Methylprednisolone,2016-09-23,, , ,['2 / Day'],IV, 
7953,440,Gilenya,2016-06-04,,1000,mg,[' '], , 
7954,1630,Mitoxantrone,2016-06-06,,500, ,['/ Day'],IV, 
7955,1630,D-cure (Vitamine D),2015-12-14,2021-03-06, ,mg,['/Month'], ,Persisting MRI activity
7956,954,IVIG,2015-11-26,,1000, ,['/Month'], , 
7957,954,Copaxone,2016-07-31,,20,mg,[' '], , 
7958,954,IVIG,2016-05-18,,500, ,['/ Day'], , 
7959,954,Tecfidera,2016-06-17,, ,MIU,['/ Day'],IV, 
7960,714,Tysabri,2016-05-27,,20,mg,['/ Day'], , 
7961,3602,Betaferon,2015-10-29,, ,MIU,['3 / Week'], , 
7962,3602,Endoxan,2016-02-16,,300,mg,['/ Week'],IV, 
7963,3602,IVIG,2016-09-15,,1000,MIU,['3 / Week'],Oral, 
7964,515,Methylprednisolone,2016-10-05,2018-10-28, ,mg,['/ Day'], ,Lack of efficacy
7965,515,Gilenya,2016-02-01,2020-10-06,1000,mg,[' '], ,Persistence of relapses
7966,515,Rebif [44],2015-12-27,, ,MIU,['2 / Day'], , 
7967,4876,Tysabri,2016-07-30,,500,mcg,['2 / Day'],IV, 
7968,4876,Rebif [44],2016-06-09,2020-08-12, , ,['2 / Day'], ,Patient Choice/Convenience
7969,4763,Alemtuzumab (Campath),2016-02-27,2019-05-25,20, ,['/Month'],Oral,Adverse Event
7970,4763,Endoxan,2016-10-13,,1000, ,['3 / Week'],IV, 
7971,3448,Alemtuzumab (Campath),2016-07-10,2019-04-06, ,mg,['/Month'], ,Persisting MRI activity
7972,3448,Endoxan,2016-07-15,,20, ,['2 / Day'], , 
7973,3448,Rebif [44],2015-12-13,,1,mg,['2 / Day'], , 
7974,3682,Tysabri,2015-11-30,,300,mg,['2 / Day'],IV, 
7975,3682,Rebif [44],2016-10-05,2021-04-29,500, ,['3 / Week'],Oral,Adverse Event
7976,3682,Rebif [22],2015-11-07,, , ,['/Month'], , 
7977,3682,IVIG,2016-02-14,2018-01-25,500, ,['/Month'],IV,Adverse Event
7978,381,Ledertrexaat,2016-04-04,2020-10-24,500, ,['/Month'], ,Adverse Event
7979,381,Copaxone,2015-10-26,2018-01-16, , ,['2 / Day'],IV,Persistence of relapses
7980,381,Endoxan,2016-10-06,,20,mcg,['/Month'],IV, 
7981,381,Gilenya,2015-12-23,,1000,mcg,[' '], , 
7982,3098,Alemtuzumab (Campath),2016-05-13,, ,mcg,['/ Day'],Oral, 
7983,1749,D-cure (Vitamine D),2016-02-13,, ,mcg,[' '], , 
7984,1749,Tecfidera,2016-10-14,2021-10-03, , ,['/ Day'],Oral,Lack of efficacy
7985,4975,Endoxan,2016-03-09,2018-09-30,1000,mg,['3 / Week'], ,Patient Choice/Convenience
7986,4975,Rebif [44],2016-01-11,,1000,mg,['/ Week'], , 
7987,4715,Tecfidera,2016-04-03,, ,MIU,['/ Day'],IV, 
7988,4715,Rebif [44],2016-04-05,2021-05-01,400,mg,[' '],Oral,Persistence of relapses
7989,4715,Rebif [22],2016-02-02,, , ,['/Month'], , 
7990,4715,Ledertrexaat,2016-06-08,2019-04-23,500,mg,[' '],IV,Patient Choice/Convenience
7991,2115,Avonex,2015-10-27,2020-03-23,5000, ,['2 / Day'],IV,Adverse Event
7992,2115,Rebif [44],2016-02-03,2018-11-08,400,mg,['2 / Day'], ,Persistence of relapses
7993,2115,Endoxan,2015-11-10,,5000, ,['/ Week'], , 
7994,2115,IVIG,2016-04-20,2018-05-19, , ,['3 / Week'],IV,Persisting MRI activity
7995,4201,Avonex,2016-09-18,2019-07-29,5000, ,['2 / Day'], ,Persistence of relapses
7996,4201,IVIG,2015-12-16,, ,mg,['2 / Day'], , 
7997,3945,D-cure (Vitamine D),2016-10-16,2019-07-09, , ,['2 / Day'], ,Persistence of relapses
7998,4135,Teriflunomide,2016-04-18,,300, ,['/Month'],IV, 
7999,4135,IVIG,2016-08-02,,1,mg,['/Month'],Oral, 
8000,4135,IVIG,2016-05-24,,20,mg,['2 / Day'],IV, 
8001,4135,Methylprednisolone,2016-07-13,,20,mg,['/ Week'],Oral, 
8002,3085,Alemtuzumab (Campath),2015-12-03,,20,mg,['/Month'],IV, 
8003,3085,Endoxan,2016-05-27,,400, ,['/Month'], , 
8004,3085,Avonex,2016-09-12,, ,mg,['2 / Day'],IV, 
8005,4574,Rebif [22],2015-12-15,2018-11-28,300,mg,['/Month'],IV,Adverse Event
8006,4574,Endoxan,2016-10-07,, , ,[' '],IV, 
8007,4574,Betaferon,2016-07-07,,5000, ,['3 / Week'],IV, 
8008,4574,IVIG,2016-08-27,2020-10-19,500,mg,['/Month'],Oral,Persisting MRI activity
8009,2918,Rebif [22],2016-03-13,2019-10-06, ,MIU,['3 / Week'],Oral,Adverse Event
8010,2918,Copaxone,2016-08-24,, ,MIU,[' '], , 
8011,2918,Copaxone,2016-04-05,,5000,mg,['2 / Day'], , 
8012,2918,Endoxan,2016-07-22,,1000, ,['3 / Week'],IV, 
8013,2855,Rebif [22],2016-01-16,, ,mcg,[' '],IV, 
8014,2855,Endoxan,2016-05-28,, ,mg,['/Month'],Oral, 
8015,2855,Rebif [44],2016-04-22,2021-10-03, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
8016,2855,D-cure (Vitamine D),2016-03-26,, , ,['2 / Day'],IV, 
8017,633,Gilenya,2016-04-29,2017-11-09,500, ,[' '],IV,Patient Choice/Convenience
8018,633,Ledertrexaat,2016-02-18,, ,mg,['3 / Week'],IV, 
8019,633,Rebif [44],2015-12-20,,300, ,['/Month'], , 
8020,633,Tysabri,2016-06-25,2020-10-01,20, ,[' '], ,Adverse Event
8021,3410,Teriflunomide,2016-09-20,, , ,['3 / Week'], , 
8022,3410,Gilenya,2016-10-16,, ,mcg,['3 / Week'], , 
8023,3410,Gilenya,2016-04-03,2018-06-04,1000,MIU,['2 / Day'],Oral,Adverse Event
8024,3410,Alemtuzumab (Campath),2016-07-28,2020-04-09,5000,mg,['2 / Day'],IV,Adverse Event
8025,2595,Tecfidera,2016-08-31,,5000, ,['/ Day'], , 
8026,2595,Copaxone,2015-10-28,2019-12-14,1000, ,['/ Day'],IV,Persistence of relapses
8027,2595,D-cure (Vitamine D),2016-06-28,2018-11-19,500,mg,['3 / Week'], ,Lack of efficacy
8028,1421,Gilenya,2016-01-11,,1000, ,['/ Week'], , 
8029,3508,Methylprednisolone,2015-11-09,, ,mg,['2 / Day'],IV, 
8030,3508,Tecfidera,2016-08-09,2020-04-13,500,mg,['3 / Week'],IV,Persistence of relapses
8031,3508,Tysabri,2016-04-25,2019-11-05, , ,['/Month'],Oral,Persisting MRI activity
8032,3508,IVIG,2015-12-08,,500,mg,['2 / Day'],IV, 
8033,3463,Methylprednisolone,2015-10-25,,1000,mg,['3 / Week'], , 
8034,3653,Methylprednisolone,2016-05-02,2018-11-19,5000, ,['2 / Day'], ,Lack of efficacy
8035,3653,Endoxan,2016-03-17,,20, ,['/Month'], , 
8036,3653,Methylprednisolone,2016-07-07,,1,mg,['/ Day'],IV, 
8037,3653,Rebif [44],2016-08-19,,300, ,[' '], , 
8038,2603,Rebif [44],2016-03-05,2021-09-06,1000,mcg,['/Month'],IV,Patient Choice/Convenience
8039,2603,D-cure (Vitamine D),2016-03-10,2019-02-22, ,mg,['/Month'],IV,Adverse Event
8040,2603,Teriflunomide,2016-10-20,,1, ,['/ Week'],IV, 
8041,2603,Tysabri,2015-11-28,2019-12-03,20,mcg,['2 / Day'], ,Persistence of relapses
8042,3312,Rebif [44],2016-05-28,2021-10-13, , ,['/Month'],IV,Adverse Event
8043,3312,Avonex,2016-09-16,,1000,MIU,['/Month'], , 
8044,3312,IVIG,2016-02-25,2020-04-23, , ,['/ Week'], ,Persisting MRI activity
8045,3312,Rebif [22],2016-06-21,, ,mcg,['2 / Day'],Oral, 
8046,3525,Rebif [44],2016-08-17,2019-07-15, , ,['/Month'],IV,Persisting MRI activity
8047,3525,Rebif [22],2015-12-30,,20,mg,['/Month'],IV, 
8048,1075,Endoxan,2016-06-04,, ,mg,['2 / Day'], , 
8049,2071,Alemtuzumab (Campath),2016-02-13,,5000,mg,['/Month'], , 
8050,2071,D-cure (Vitamine D),2016-05-19,,5000,mg,['/Month'],IV, 
8051,2071,Gilenya,2015-11-19,2019-09-23,1000,mg,['2 / Day'],IV,Lack of efficacy
8052,3528,Methylprednisolone,2016-02-17,,5000,mcg,['3 / Week'], , 
8053,481,Tysabri,2016-10-09,2018-09-01,5000,mg,['/Month'],IV,Adverse Event
8054,481,Tysabri,2016-06-02,2020-12-27,1,mg,['/Month'], ,Patient Choice/Convenience
8055,481,Alemtuzumab (Campath),2016-08-21,2018-08-22,1000,mg,[' '],IV,Persistence of relapses
8056,870,IVIG,2016-04-21,2019-05-08,5000,MIU,['2 / Day'], ,Adverse Event
8057,870,Rebif [44],2015-12-10,, ,mg,['/Month'],IV, 
8058,870,Alemtuzumab (Campath),2016-08-02,,400, ,['/Month'],Oral, 
8059,870,Gilenya,2016-06-01,,20, ,['/Month'],IV, 
8060,1682,Gilenya,2015-11-11,, , ,['/Month'],IV, 
8061,1682,Tecfidera,2016-07-12,2020-04-29,1,mg,['/Month'],IV,Adverse Event
8062,1682,Teriflunomide,2016-10-08,,1000,mg,['2 / Day'],IV, 
8063,2981,Copaxone,2015-11-02,2018-12-19,300,MIU,['2 / Day'], ,Adverse Event
8064,2981,Avonex,2015-10-24,, ,mg,['3 / Week'],IV, 
8065,2981,D-cure (Vitamine D),2015-11-11,,1000, ,['/Month'],IV, 
8066,130,Mitoxantrone,2016-04-22,, , ,['2 / Day'],IV, 
8067,2573,Ledertrexaat,2016-05-15,, , ,['2 / Day'],Oral, 
8068,3380,Rebif [44],2016-01-28,2020-01-13,1000, ,['/Month'], ,Persisting MRI activity
8069,1796,Copaxone,2016-04-25,2019-11-17,300,mg,['/ Day'],IV,Patient Choice/Convenience
8070,1796,Tecfidera,2016-09-29,,1000,MIU,['/Month'],IV, 
8071,1796,Rebif [44],2016-05-29,2020-08-16,500, ,['2 / Day'], ,Lack of efficacy
8072,1796,Mitoxantrone,2016-01-27,2020-08-21, , ,[' '],Oral,Patient Choice/Convenience
8073,2449,Teriflunomide,2016-01-03,, , ,['2 / Day'],IV, 
8074,2449,Betaferon,2016-01-18,, , ,['/Month'],Oral, 
8075,2449,Copaxone,2016-01-27,2021-06-25,20, ,['/Month'],IV,Persisting MRI activity
8076,2449,Tysabri,2016-06-25,,500,mg,['/ Week'],IV, 
8077,3235,Tecfidera,2015-11-20,2019-02-25,500,mg,['2 / Day'],IV,Lack of efficacy
8078,3235,Betaferon,2016-10-16,2019-02-08, , ,['3 / Week'], ,Persistence of relapses
8079,4326,Rebif [44],2016-07-29,,1, ,['2 / Day'],IV, 
8080,4326,Mitoxantrone,2016-04-30,,20,mg,['/Month'],IV, 
8081,4326,D-cure (Vitamine D),2016-01-20,2018-10-21,400,mg,['/Month'],IV,Patient Choice/Convenience
8082,4326,Rebif [22],2016-08-05,,5000,mcg,['/ Week'],Oral, 
8083,2849,Tysabri,2016-04-02,, ,mg,['3 / Week'],IV, 
8084,2849,D-cure (Vitamine D),2016-05-27,2018-03-21,1000, ,[' '],IV,Adverse Event
8085,1023,IVIG,2016-02-24,,1,mg,['3 / Week'],IV, 
8086,1023,Copaxone,2016-02-24,,20,MIU,['/Month'],IV, 
8087,1023,Methylprednisolone,2016-09-01,2018-02-24,500, ,['2 / Day'],IV,Adverse Event
8088,1023,Endoxan,2016-05-06,,20, ,['3 / Week'], , 
8089,3071,Rebif [22],2016-07-10,,1000,mg,['/Month'], , 
8090,3071,Copaxone,2016-08-21,,500,MIU,[' '], , 
8091,3071,Alemtuzumab (Campath),2015-11-25,2020-04-02, ,mg,[' '],Oral,Patient Choice/Convenience
8092,3071,Copaxone,2016-07-20,2020-04-07,20,mcg,['2 / Day'],IV,Adverse Event
8093,4251,Copaxone,2016-08-03,, ,mg,['2 / Day'],IV, 
8094,4251,Tecfidera,2016-09-11,, ,mg,['/ Week'],Oral, 
8095,4251,Betaferon,2016-02-17,2018-02-17, ,mcg,['3 / Week'],Oral,Persisting MRI activity
8096,4251,Gilenya,2016-01-30,,1000,MIU,[' '], , 
8097,2075,Gilenya,2015-12-22,2017-12-26,500, ,['3 / Week'],Oral,Patient Choice/Convenience
8098,2075,D-cure (Vitamine D),2016-02-04,, , ,['2 / Day'],IV, 
8099,2075,Avonex,2015-12-25,2020-10-27,1,mg,['2 / Day'],IV,Adverse Event
8100,2075,Tecfidera,2016-08-02,,500,mg,['/Month'],IV, 
8101,3178,Rebif [44],2016-01-16,,500,mg,['/ Day'],IV, 
8102,3178,Rebif [44],2015-12-19,2021-04-04,1000, ,['/ Day'],IV,Persisting MRI activity
8103,3178,IVIG,2016-02-15,,1000, ,['/Month'], , 
8104,3178,Endoxan,2016-06-23,,1000, ,['2 / Day'], , 
8105,854,Methylprednisolone,2016-05-29,, ,MIU,['3 / Week'], , 
8106,854,Gilenya,2016-03-12,, , ,['/ Week'], , 
8107,3459,Betaferon,2016-03-07,,1000,MIU,['2 / Day'], , 
8108,3459,Endoxan,2016-03-28,,300,mg,['/ Day'],IV, 
8109,1549,Alemtuzumab (Campath),2015-12-14,,300, ,[' '], , 
8110,1549,IVIG,2016-10-09,2020-03-31,400, ,['2 / Day'],IV,Lack of efficacy
8111,1549,Alemtuzumab (Campath),2016-01-04,2019-07-28,5000, ,['3 / Week'],IV,Adverse Event
8112,988,Rebif [44],2016-09-25,, , ,[' '], , 
8113,988,Tecfidera,2016-04-09,2020-02-04,1000,mg,['3 / Week'],IV,Adverse Event
8114,988,Rebif [22],2016-08-31,,500, ,['2 / Day'], , 
8115,3774,Rebif [44],2015-12-29,2020-07-19, ,mg,[' '],IV,Patient Choice/Convenience
8116,3774,Teriflunomide,2016-04-07,2019-08-23, , ,['/ Day'],IV,Patient Choice/Convenience
8117,2575,Betaferon,2016-04-29,,400, ,['/Month'],Oral, 
8118,2575,Tysabri,2016-04-21,,300, ,['3 / Week'],IV, 
8119,2575,Alemtuzumab (Campath),2016-03-26,, ,mg,['2 / Day'],IV, 
8120,4988,Endoxan,2016-02-13,2020-09-01,300,mg,['3 / Week'], ,Patient Choice/Convenience
8121,4988,D-cure (Vitamine D),2016-02-29,,5000,mg,['/Month'], , 
8122,4988,Alemtuzumab (Campath),2016-04-21,2019-07-29,5000, ,['2 / Day'],IV,Adverse Event
8123,202,Tecfidera,2016-03-09,,5000,mcg,['2 / Day'], , 
8124,202,Betaferon,2016-08-05,, ,mg,['/Month'], , 
8125,202,Rebif [22],2016-03-30,2020-08-11,5000,mg,['/Month'],IV,Patient Choice/Convenience
8126,202,Tysabri,2015-11-15,,300, ,['/ Week'],Oral, 
8127,1175,Alemtuzumab (Campath),2016-06-23,2018-09-24,20, ,['/ Day'],IV,Patient Choice/Convenience
8128,1175,Rebif [22],2016-07-24,,5000, ,['2 / Day'],IV, 
8129,1175,Tysabri,2016-03-04,2019-11-21, ,MIU,['2 / Day'],Oral,Persistence of relapses
8130,2750,Methylprednisolone,2016-06-04,,1000, ,['2 / Day'],IV, 
8131,2750,IVIG,2016-10-19,,500, ,['2 / Day'], , 
8132,2750,Alemtuzumab (Campath),2016-03-16,,5000, ,['3 / Week'],Oral, 
8133,2790,Tysabri,2016-01-15,, ,mg,['/Month'], , 
8134,2790,Mitoxantrone,2016-10-21,,400,mcg,['/Month'],IV, 
8135,177,Alemtuzumab (Campath),2016-03-02,, , ,['/ Day'],IV, 
8136,1022,Tysabri,2016-02-01,,20,mg,[' '],Oral, 
8137,1022,IVIG,2016-09-15,,1000, ,['2 / Day'], , 
8138,1978,Endoxan,2016-02-10,2019-08-28,20, ,['/ Day'],IV,Persisting MRI activity
8139,1978,Rebif [22],2016-02-16,2019-05-15,400,mg,['2 / Day'],IV,Adverse Event
8140,1978,Tysabri,2015-11-25,2019-05-23,400,mg,['/Month'],IV,Adverse Event
8141,1978,Copaxone,2016-07-01,2019-04-18,400,mg,['/Month'],IV,Adverse Event
8142,3133,Mitoxantrone,2015-12-11,2019-01-28,300,mg,['3 / Week'],IV,Lack of efficacy
8143,3133,D-cure (Vitamine D),2015-11-22,,500,mg,['/ Day'],IV, 
8144,3893,Alemtuzumab (Campath),2016-02-03,2021-05-03, ,mcg,[' '],IV,Persisting MRI activity
8145,3893,Endoxan,2016-10-13,, ,mg,['2 / Day'],IV, 
8146,1665,D-cure (Vitamine D),2016-02-21,, ,mg,['/Month'],IV, 
8147,1665,D-cure (Vitamine D),2016-04-02,2017-12-10,300,mg,[' '],IV,Adverse Event
8148,1665,Rebif [44],2016-05-30,, , ,['2 / Day'],IV, 
8149,1665,Gilenya,2016-07-28,, ,mg,[' '], , 
8150,2050,Tysabri,2015-11-16,2019-03-11,20,mg,['3 / Week'], ,Lack of efficacy
8151,2050,Rebif [44],2016-04-20,,1000,MIU,['/Month'],IV, 
8152,3938,D-cure (Vitamine D),2016-01-22,,1000,mcg,['/Month'],IV, 
8153,1680,Avonex,2016-05-29,2020-09-06,1000, ,['2 / Day'],IV,Lack of efficacy
8154,1680,Rebif [22],2016-10-06,2019-03-23,20,mg,['2 / Day'], ,Adverse Event
8155,746,Gilenya,2016-06-24,, ,mg,['2 / Day'],Oral, 
8156,1292,Gilenya,2016-05-12,2019-07-04,400,mg,['3 / Week'],IV,Adverse Event
8157,1292,Methylprednisolone,2016-07-05,, ,mg,['3 / Week'],Oral, 
8158,1292,Rebif [44],2016-08-21,,500,mg,['3 / Week'], , 
8159,1563,Tysabri,2016-04-08,, ,mg,['/Month'],IV, 
8160,1563,Methylprednisolone,2016-02-19,, , ,['2 / Day'], , 
8161,1563,Endoxan,2016-02-20,, , ,['/Month'],IV, 
8162,3492,IVIG,2016-03-27,, , ,['3 / Week'],IV, 
8163,773,Endoxan,2016-05-22,,20,mcg,['/Month'], , 
8164,773,Endoxan,2016-09-14,,1, ,['3 / Week'],Oral, 
8165,773,Gilenya,2016-09-22,,20, ,['2 / Day'],IV, 
8166,2255,Gilenya,2016-05-23,2021-05-01, ,mcg,['/ Day'], ,Lack of efficacy
8167,2255,Ledertrexaat,2016-04-03,, ,mcg,['/Month'], , 
8168,2255,D-cure (Vitamine D),2015-11-10,2020-12-17, ,mcg,['/Month'],Oral,Lack of efficacy
8169,4043,Gilenya,2015-11-16,2021-02-16, ,MIU,['2 / Day'], ,Adverse Event
8170,4043,Teriflunomide,2016-08-09,2020-12-08,5000, ,['3 / Week'], ,Adverse Event
8171,4043,Tysabri,2016-04-26,, ,MIU,['3 / Week'],IV, 
8172,4043,Rebif [44],2016-06-03,, , ,['/Month'],IV, 
8173,930,Rebif [22],2016-01-05,2020-01-15, ,MIU,['/Month'],IV,Persisting MRI activity
8174,3371,Tysabri,2016-02-12,,300, ,['/Month'], , 
8175,3371,Tysabri,2016-01-03,,400, ,['/Month'], , 
8176,3371,Endoxan,2016-06-04,,300, ,['/Month'],IV, 
8177,2545,IVIG,2016-09-01,,300,mg,['/Month'], , 
8178,2545,Copaxone,2016-08-31,, ,mg,[' '],IV, 
8179,2545,Alemtuzumab (Campath),2015-12-24,, ,mg,['2 / Day'],IV, 
8180,2545,Ledertrexaat,2016-04-13,2019-02-24,20,mcg,['/ Day'],IV,Adverse Event
8181,1716,D-cure (Vitamine D),2016-06-02,2018-10-18,500, ,['/Month'],Oral,Patient Choice/Convenience
8182,322,Methylprednisolone,2015-12-27,,500, ,['/Month'], , 
8183,322,Gilenya,2016-08-05,2020-06-30,1, ,['/Month'],IV,Persistence of relapses
8184,3544,Ledertrexaat,2016-09-27,, ,mg,['2 / Day'],IV, 
8185,3544,Endoxan,2016-04-16,2019-07-22, , ,['2 / Day'],IV,Lack of efficacy
8186,2158,Alemtuzumab (Campath),2016-08-21,,1, ,[' '], , 
8187,2158,Copaxone,2016-08-20,2020-07-04, , ,['/ Day'],IV,Patient Choice/Convenience
8188,2158,Tysabri,2016-08-20,2019-12-03,5000, ,['3 / Week'], ,Patient Choice/Convenience
8189,2158,Endoxan,2015-10-24,2020-04-17,500, ,[' '], ,Lack of efficacy
8190,383,Tecfidera,2016-08-21,, , ,['/ Week'],IV, 
8191,383,Rebif [22],2016-08-16,2019-10-09,300,mg,['2 / Day'],IV,Persisting MRI activity
8192,931,Alemtuzumab (Campath),2016-08-02,,1000,mg,['3 / Week'],IV, 
8193,1895,Tysabri,2016-07-25,,1, ,['/ Day'], , 
8194,2689,Copaxone,2015-12-24,,20,mg,['/ Week'],IV, 
8195,2689,Tecfidera,2016-05-04,, ,mg,['/ Day'],IV, 
8196,3366,Tecfidera,2016-04-16,2019-07-05, ,mg,['3 / Week'], ,Lack of efficacy
8197,3366,Methylprednisolone,2016-09-28,2021-10-04,500,mg,['2 / Day'],IV,Lack of efficacy
8198,1303,Tecfidera,2016-03-04,, ,MIU,['/Month'],IV, 
8199,1303,Methylprednisolone,2015-11-12,2021-10-10, ,mcg,['2 / Day'], ,Patient Choice/Convenience
8200,1303,Rebif [22],2016-10-21,, , ,['2 / Day'],Oral, 
8201,1303,Tysabri,2016-09-27,, ,mg,['2 / Day'], , 
8202,969,Gilenya,2016-09-24,,500, ,['3 / Week'],IV, 
8203,969,Methylprednisolone,2016-04-04,, ,mg,['/ Day'], , 
8204,1275,Tysabri,2015-11-09,2020-05-11,1000,mg,['2 / Day'],IV,Adverse Event
8205,1275,Tysabri,2016-04-24,2021-05-05, ,MIU,['/ Week'],IV,Patient Choice/Convenience
8206,811,Ledertrexaat,2016-07-24,2019-03-30,500, ,['/Month'],IV,Persistence of relapses
8207,2570,Ledertrexaat,2016-09-13,,5000, ,['2 / Day'],IV, 
8208,2570,Teriflunomide,2016-07-06,, , ,['2 / Day'],IV, 
8209,2570,Teriflunomide,2016-02-16,2018-11-11,5000,MIU,['2 / Day'], ,Lack of efficacy
8210,2570,Tysabri,2016-05-01,2019-03-08,5000,mg,[' '],IV,Persistence of relapses
8211,2584,D-cure (Vitamine D),2016-09-14,,300,mg,['3 / Week'], , 
8212,2584,Alemtuzumab (Campath),2016-03-20,, ,mg,['2 / Day'],IV, 
8213,4689,IVIG,2015-11-12,2018-04-29,300,mg,['2 / Day'],IV,Persisting MRI activity
8214,4689,Tysabri,2016-06-09,,1000,mg,['/Month'],IV, 
8215,4689,Rebif [22],2016-07-07,, , ,[' '],IV, 
8216,3980,Avonex,2015-10-27,,500,mg,['2 / Day'], , 
8217,3980,Rebif [22],2016-07-24,2019-07-28,500, ,['2 / Day'], ,Patient Choice/Convenience
8218,3980,Mitoxantrone,2016-02-06,,1,MIU,['/Month'], , 
8219,4261,D-cure (Vitamine D),2015-11-20,2019-01-13,1000,mg,['/ Day'],IV,Persisting MRI activity
8220,4261,Tysabri,2015-11-30,2021-01-14,1000,mg,['2 / Day'], ,Patient Choice/Convenience
8221,4261,Tecfidera,2016-09-09,, ,mg,['2 / Day'],IV, 
8222,4261,Ledertrexaat,2016-07-20,2019-09-07, , ,['2 / Day'],IV,Adverse Event
8223,3281,Methylprednisolone,2015-12-24,,300,MIU,['/Month'], , 
8224,3281,Avonex,2016-10-18,,400,mg,['/Month'],IV, 
8225,3281,Methylprednisolone,2016-01-02,2021-06-03,1000,mg,['/Month'],IV,Adverse Event
8226,3281,Avonex,2015-11-13,,5000,MIU,['/Month'],IV, 
8227,2772,Betaferon,2016-01-28,2021-09-22, ,mg,['/Month'],IV,Adverse Event
8228,2772,Tecfidera,2016-10-11,,1000,MIU,['3 / Week'],Oral, 
8229,2772,Methylprednisolone,2016-03-02,2021-09-06,1,mg,['/Month'],Oral,Adverse Event
8230,2772,Tecfidera,2016-01-10,,500, ,['/ Week'],Oral, 
8231,4951,Rebif [22],2016-08-10,, , ,['/Month'],IV, 
8232,4951,Ledertrexaat,2015-12-18,2019-02-12, ,mg,['/ Day'], ,Adverse Event
8233,4951,Rebif [44],2016-08-31,,20,mg,['/Month'], , 
8234,4951,Avonex,2016-01-07,2021-04-04,1, ,['3 / Week'],IV,Adverse Event
8235,4498,Tecfidera,2015-12-11,,1,MIU,['/ Day'], , 
8236,2279,IVIG,2016-04-09,2018-02-24,1000,mg,['/Month'],Oral,Adverse Event
8237,2279,Mitoxantrone,2016-07-07,, , ,['/Month'],Oral, 
8238,2279,Methylprednisolone,2016-02-29,2020-07-03,1,mg,['/Month'],IV,Persisting MRI activity
8239,3149,Betaferon,2016-07-29,,20,mg,['/Month'], , 
8240,3149,Alemtuzumab (Campath),2016-09-19,,1,mcg,['/Month'], , 
8241,3011,Endoxan,2016-01-27,2019-05-12,20,mg,['2 / Day'],IV,Patient Choice/Convenience
8242,3011,Gilenya,2016-04-19,,300,MIU,['3 / Week'], , 
8243,4682,Rebif [22],2015-12-05,, , ,['/ Week'],Oral, 
8244,4682,Tecfidera,2016-04-20,, , ,['2 / Day'],Oral, 
8245,4682,Alemtuzumab (Campath),2016-08-30,,1, ,[' '],IV, 
8246,4682,Methylprednisolone,2016-01-08,, ,mg,['2 / Day'], , 
8247,3809,Tysabri,2016-03-10,,1,mcg,['2 / Day'],IV, 
8248,3809,Avonex,2016-08-19,2021-07-15,300,mg,['2 / Day'],Oral,Patient Choice/Convenience
8249,4425,Gilenya,2016-07-24,2019-04-03,1000,mg,['3 / Week'], ,Patient Choice/Convenience
8250,4425,Tysabri,2016-05-14,,400, ,[' '], , 
8251,3982,Ledertrexaat,2016-10-12,,20,mg,['/Month'],IV, 
8252,3982,D-cure (Vitamine D),2016-09-21,, ,mg,['/Month'],IV, 
8253,3982,D-cure (Vitamine D),2016-09-30,2021-08-16,500, ,['2 / Day'], ,Patient Choice/Convenience
8254,1412,Alemtuzumab (Campath),2015-11-07,2020-10-10, , ,['2 / Day'], ,Adverse Event
8255,1412,Endoxan,2016-01-17,2019-05-27,1000, ,['2 / Day'],IV,Adverse Event
8256,1412,Rebif [44],2016-07-04,, ,mg,[' '],IV, 
8257,944,Endoxan,2016-08-18,,5000,mcg,['3 / Week'],Oral, 
8258,944,D-cure (Vitamine D),2016-03-24,2019-12-30,300,mg,['3 / Week'], ,Adverse Event
8259,944,Rebif [44],2016-09-08,,300,mg,['/ Week'],IV, 
8260,1299,Gilenya,2016-07-04,2018-06-17,300, ,['/Month'],IV,Adverse Event
8261,1299,Copaxone,2015-12-11,, , ,['3 / Week'], , 
8262,1299,Tecfidera,2016-03-26,,300, ,['/ Week'], , 
8263,1299,Ledertrexaat,2016-04-28,2018-04-19,400, ,['/ Week'], ,Persisting MRI activity
8264,4238,Endoxan,2016-02-17,,400,MIU,['2 / Day'], , 
8265,4238,Endoxan,2015-10-30,2021-02-17,300,MIU,['2 / Day'],IV,Adverse Event
8266,4238,Betaferon,2016-04-07,,1000,MIU,['2 / Day'],IV, 
8267,4238,Gilenya,2016-03-21,2021-03-09,20,MIU,['3 / Week'], ,Persistence of relapses
8268,307,Methylprednisolone,2015-10-28,2020-08-24,500, ,[' '], ,Patient Choice/Convenience
8269,4706,Avonex,2016-03-26,2020-01-31,300,mg,['/Month'],Oral,Persisting MRI activity
8270,4706,Tysabri,2015-12-26,, , ,['2 / Day'],IV, 
8271,4706,Betaferon,2016-08-18,2021-09-18,500,MIU,['/Month'], ,Patient Choice/Convenience
8272,2258,Methylprednisolone,2016-06-07,, ,mg,['3 / Week'],Oral, 
8273,2258,Copaxone,2016-01-27,2019-08-14,400,mg,['/ Week'],Oral,Adverse Event
8274,2258,Methylprednisolone,2016-06-15,, ,mg,['/Month'],IV, 
8275,2258,Endoxan,2015-12-02,2019-12-19,400,mg,['3 / Week'], ,Patient Choice/Convenience
8276,4896,Ledertrexaat,2016-02-25,,400, ,['/ Week'],Oral, 
8277,4896,Tecfidera,2016-02-07,, , ,['2 / Day'], , 
8278,565,Methylprednisolone,2016-09-21,2018-07-10,1,mg,['/ Day'], ,Adverse Event
8279,565,Alemtuzumab (Campath),2016-06-02,2021-05-06, ,MIU,['/Month'], ,Patient Choice/Convenience
8280,3481,Methylprednisolone,2016-03-28,, ,MIU,['/ Day'],IV, 
8281,2338,Tysabri,2016-05-27,,20,mg,['/ Day'],IV, 
8282,2338,D-cure (Vitamine D),2015-12-15,2020-05-04,1000, ,['2 / Day'], ,Lack of efficacy
8283,2338,Betaferon,2016-08-16,2021-03-30,20, ,['/ Day'],Oral,Persisting MRI activity
8284,2338,Endoxan,2016-10-19,2019-01-30, ,mg,['/Month'],IV,Lack of efficacy
8285,1371,Rebif [44],2016-04-03,, , ,['/ Week'], , 
8286,1371,D-cure (Vitamine D),2016-08-27,, ,mg,['/Month'],IV, 
8287,2507,Rebif [22],2016-03-06,2021-05-11,1, ,['2 / Day'], ,Patient Choice/Convenience
8288,703,IVIG,2016-06-30,, ,mg,['/ Week'],IV, 
8289,703,Copaxone,2016-07-11,2020-12-28,500, ,['/ Week'],IV,Persistence of relapses
8290,703,D-cure (Vitamine D),2015-11-19,, ,mg,['2 / Day'], , 
8291,703,Teriflunomide,2016-05-11,,5000,mcg,['/Month'],IV, 
8292,435,Ledertrexaat,2015-12-08,2021-02-15, , ,['/Month'],IV,Persisting MRI activity
8293,1874,D-cure (Vitamine D),2015-11-11,2021-03-25,400, ,['/Month'],IV,Adverse Event
8294,1453,Copaxone,2016-09-08,2020-06-30, , ,['/Month'],Oral,Patient Choice/Convenience
8295,1192,Alemtuzumab (Campath),2016-03-17,2020-11-29,1000,mg,[' '],IV,Persistence of relapses
8296,4061,IVIG,2016-09-07,,1000, ,['/Month'],IV, 
8297,4061,Ledertrexaat,2016-03-17,, ,MIU,['2 / Day'], , 
8298,1163,D-cure (Vitamine D),2016-03-19,2020-06-26,5000,mg,['2 / Day'],IV,Persisting MRI activity
8299,1163,Copaxone,2015-12-08,2018-11-03,1000, ,['3 / Week'], ,Adverse Event
8300,1163,Alemtuzumab (Campath),2016-03-16,,1000, ,['3 / Week'], , 
8301,4123,Tysabri,2016-02-21,, ,mg,['2 / Day'], , 
8302,4123,Methylprednisolone,2016-08-05,,20,mg,['/Month'],IV, 
8303,4123,IVIG,2016-10-03,,400, ,['2 / Day'], , 
8304,4026,Tecfidera,2016-04-14,,1000, ,['/Month'],IV, 
8305,4026,Tysabri,2016-03-27,, , ,['/ Week'],Oral, 
8306,4026,Tysabri,2016-09-21,,500,mcg,['2 / Day'],IV, 
8307,3990,Betaferon,2016-04-05,,20,mcg,[' '],Oral, 
8308,3990,Endoxan,2015-11-21,,1000, ,[' '],Oral, 
8309,3990,Rebif [22],2015-12-28,2018-05-29, ,mg,['3 / Week'],IV,Adverse Event
8310,2094,Endoxan,2016-07-24,2019-06-16,1, ,['/ Day'],IV,Persisting MRI activity
8311,3439,Copaxone,2016-07-07,2018-11-12, ,mg,['/Month'],IV,Persistence of relapses
8312,3439,IVIG,2015-10-26,2019-03-07,20,mg,['2 / Day'],IV,Adverse Event
8313,3720,D-cure (Vitamine D),2016-07-19,,300,MIU,['/ Week'],Oral, 
8314,3542,Tecfidera,2016-08-21,,1000,mg,[' '], , 
8315,3542,Teriflunomide,2016-09-23,2017-12-21,300, ,['3 / Week'], ,Patient Choice/Convenience
8316,3542,IVIG,2016-02-06,,5000,MIU,['/Month'], , 
8317,260,Ledertrexaat,2016-08-03,2018-09-20, ,mg,['2 / Day'], ,Patient Choice/Convenience
8318,260,Avonex,2016-03-30,, ,mcg,['/Month'], , 
8319,2557,Alemtuzumab (Campath),2016-07-28,, , ,['/Month'], , 
8320,2557,Ledertrexaat,2016-04-02,2021-02-19, ,mcg,['/Month'], ,Persisting MRI activity
8321,2557,D-cure (Vitamine D),2015-12-10,2021-01-13, , ,['/ Week'],IV,Patient Choice/Convenience
8322,2660,Alemtuzumab (Campath),2016-09-19,,20,mg,['/ Day'], , 
8323,2660,Tysabri,2016-09-22,,5000, ,['2 / Day'], , 
8324,2660,Rebif [44],2016-01-04,,300, ,['/Month'],IV, 
8325,4604,Tecfidera,2016-06-16,2018-10-27, ,mg,['2 / Day'],IV,Persisting MRI activity
8326,4604,Rebif [44],2016-06-02,,400, ,['2 / Day'],IV, 
8327,3436,Betaferon,2016-03-25,, , ,['/ Week'], , 
8328,3436,Betaferon,2015-11-21,,20,mg,['/Month'],IV, 
8329,590,Mitoxantrone,2015-11-14,,1000, ,['/Month'], , 
8330,590,Gilenya,2016-05-12,2019-10-20, , ,['/Month'], ,Persistence of relapses
8331,590,Rebif [44],2016-01-26,2021-04-03,20,mg,['2 / Day'], ,Persistence of relapses
8332,3050,Alemtuzumab (Campath),2016-01-05,,500, ,['2 / Day'], , 
8333,3050,Tecfidera,2016-04-19,2020-10-05,1, ,['/Month'],Oral,Adverse Event
8334,3050,Gilenya,2016-05-06,,5000, ,['2 / Day'],Oral, 
8335,1726,Endoxan,2016-08-02,,20,mg,['2 / Day'],IV, 
8336,1196,Alemtuzumab (Campath),2016-03-02,,1000, ,['/ Week'],IV, 
8337,1797,IVIG,2015-11-02,2021-05-18,500,mg,['/Month'], ,Persisting MRI activity
8338,1797,Tecfidera,2015-11-03,, ,mg,['2 / Day'],Oral, 
8339,1797,Rebif [44],2016-01-06,2020-11-06,1, ,['/Month'], ,Adverse Event
8340,4188,Tysabri,2015-10-31,2021-06-21, , ,['2 / Day'],IV,Adverse Event
8341,4188,Endoxan,2016-10-15,2021-08-11,5000, ,['/Month'], ,Adverse Event
8342,492,Mitoxantrone,2015-11-29,,20,mg,['/Month'], , 
8343,492,Rebif [22],2016-07-25,,500, ,['/Month'],IV, 
8344,492,Gilenya,2015-12-17,,20,mg,['/Month'], , 
8345,492,Endoxan,2016-06-25,, ,mcg,['/Month'],IV, 
8346,863,Avonex,2016-03-04,,300,mg,['2 / Day'],Oral, 
8347,863,Rebif [22],2015-12-12,,500, ,['/Month'],Oral, 
8348,3646,Tecfidera,2016-06-26,,500, ,['/Month'], , 
8349,3646,Tysabri,2016-07-09,,20, ,['2 / Day'], , 
8350,3516,Methylprednisolone,2016-03-11,2019-11-09,1000, ,['3 / Week'],Oral,Adverse Event
8351,3516,Tysabri,2016-09-22,2018-10-30,400,mg,['2 / Day'], ,Patient Choice/Convenience
8352,3516,Tysabri,2016-04-03,2019-03-31,1000, ,['/ Day'],Oral,Lack of efficacy
8353,3516,Alemtuzumab (Campath),2016-08-08,2021-04-25, ,MIU,['/ Day'],IV,Adverse Event
8354,1785,D-cure (Vitamine D),2016-03-04,2018-02-21,500, ,['/Month'], ,Adverse Event
8355,1785,Gilenya,2016-03-09,,20, ,['/Month'],IV, 
8356,4518,Tecfidera,2016-10-08,2018-04-06,500,mcg,['/ Week'],Oral,Persisting MRI activity
8357,1347,Avonex,2015-12-12,2018-02-28,500,MIU,['/Month'], ,Lack of efficacy
8358,938,Gilenya,2016-07-16,, ,mg,[' '],IV, 
8359,938,Ledertrexaat,2016-09-01,2020-07-29,500,mg,['2 / Day'], ,Persisting MRI activity
8360,2500,D-cure (Vitamine D),2016-02-08,,400, ,['/Month'],IV, 
8361,2500,Endoxan,2016-01-06,,20, ,['3 / Week'],IV, 
8362,3639,Alemtuzumab (Campath),2016-05-06,,20,mcg,['/Month'],IV, 
8363,3639,Endoxan,2016-04-21,,20,mg,['2 / Day'],IV, 
8364,3639,D-cure (Vitamine D),2015-10-27,2018-04-05,400,mg,['2 / Day'],Oral,Adverse Event
8365,945,Mitoxantrone,2016-01-12,2019-10-30, , ,[' '],IV,Lack of efficacy
8366,945,Rebif [22],2016-08-24,,400,mcg,['/Month'], , 
8367,945,Mitoxantrone,2016-01-01,,5000,mg,['/ Week'],IV, 
8368,945,Gilenya,2016-08-21,,500,mg,['2 / Day'],IV, 
8369,2137,Tysabri,2016-06-18,2019-04-11,1000, ,['/Month'], ,Persisting MRI activity
8370,2137,Rebif [44],2016-08-16,, , ,['/Month'],Oral, 
8371,1451,Alemtuzumab (Campath),2016-07-24,,500,mg,['2 / Day'],IV, 
8372,1709,Endoxan,2016-09-15,,1000,mg,['/Month'],Oral, 
8373,1709,Gilenya,2016-08-10,2020-11-23,300,mg,['3 / Week'], ,Patient Choice/Convenience
8374,4534,D-cure (Vitamine D),2016-09-15,2020-06-27, ,MIU,['2 / Day'],Oral,Patient Choice/Convenience
8375,4314,Rebif [44],2016-05-24,, ,mg,['/Month'], , 
8376,4314,Avonex,2016-02-24,2020-11-06,1000,mg,[' '],IV,Adverse Event
8377,4314,Avonex,2015-12-31,,300,mg,[' '],IV, 
8378,1639,Rebif [44],2016-08-17,,500, ,['2 / Day'],Oral, 
8379,1639,Ledertrexaat,2016-04-14,2020-04-06,5000,mg,['/Month'],IV,Adverse Event
8380,1639,Rebif [44],2016-07-13,,500,mg,['/Month'], , 
8381,1639,Teriflunomide,2016-07-03,,1, ,['/ Day'],IV, 
8382,4858,Methylprednisolone,2016-03-14,,400, ,['2 / Day'],IV, 
8383,1462,Methylprednisolone,2016-09-07,2018-03-23,20,mg,['3 / Week'],IV,Persistence of relapses
8384,921,Copaxone,2016-08-02,,400,mg,['2 / Day'],IV, 
8385,921,Teriflunomide,2016-03-28,2021-03-18, , ,['/Month'], ,Lack of efficacy
8386,2909,Endoxan,2015-12-10,,300,mg,['2 / Day'],IV, 
8387,3991,Rebif [44],2016-08-12,,300, ,['2 / Day'],IV, 
8388,3991,Alemtuzumab (Campath),2016-09-30,,500,mg,['/Month'],IV, 
8389,3991,Ledertrexaat,2016-05-05,, , ,['/ Day'],Oral, 
8390,695,Avonex,2016-02-26,,1000,mg,['3 / Week'], , 
8391,695,IVIG,2016-04-15,,1000,mcg,['/Month'],IV, 
8392,695,Alemtuzumab (Campath),2016-09-29,,1, ,['/Month'],IV, 
8393,751,D-cure (Vitamine D),2016-08-25,2021-08-05,300,mg,['2 / Day'], ,Adverse Event
8394,2846,Teriflunomide,2016-09-25,, ,mg,['/Month'],IV, 
8395,2846,Tecfidera,2015-12-24,,300,mg,['/ Week'],IV, 
8396,2846,Rebif [44],2016-07-26,2019-02-20, , ,['2 / Day'], ,Patient Choice/Convenience
8397,242,Avonex,2016-03-03,,5000, ,['/ Day'], , 
8398,242,Copaxone,2016-06-29,2019-05-12, ,MIU,['/ Day'], ,Patient Choice/Convenience
8399,242,Copaxone,2016-10-01,, ,mg,['/Month'],Oral, 
8400,3392,Rebif [22],2015-12-08,2020-11-19, ,mg,['3 / Week'],IV,Persisting MRI activity
8401,3392,D-cure (Vitamine D),2015-12-03,,400,mg,['2 / Day'],IV, 
8402,3527,IVIG,2015-11-14,2021-05-14,1000,mcg,['/Month'],IV,Adverse Event
8403,3527,D-cure (Vitamine D),2016-10-07,2020-08-17,400, ,['2 / Day'], ,Adverse Event
8404,3527,Gilenya,2016-07-09,,20,mg,[' '],IV, 
8405,3527,Rebif [22],2015-11-08,, ,mg,['2 / Day'],IV, 
8406,3046,Tecfidera,2015-12-30,,400, ,['2 / Day'], , 
8407,3046,Methylprednisolone,2015-11-11,2017-11-25, ,mg,['/Month'], ,Adverse Event
8408,4613,Tecfidera,2016-05-19,2019-05-05,1,mg,['3 / Week'],IV,Persisting MRI activity
8409,4136,Rebif [22],2016-04-16,, ,MIU,['/Month'],IV, 
8410,4136,Rebif [44],2015-11-30,2020-03-03,1000, ,['/Month'], ,Adverse Event
8411,4136,Methylprednisolone,2016-01-05,,1,MIU,['2 / Day'],IV, 
8412,4136,Endoxan,2015-10-28,,500,mg,['/Month'],IV, 
8413,746,Gilenya,2016-07-05,2020-08-03,20,mg,['2 / Day'],Oral,Patient Choice/Convenience
8414,746,D-cure (Vitamine D),2016-09-10,,5000,MIU,['2 / Day'],Oral, 
8415,746,Endoxan,2015-11-18,, , ,['2 / Day'],IV, 
8416,4527,Alemtuzumab (Campath),2016-04-05,,500,mg,['2 / Day'],IV, 
8417,4527,Endoxan,2015-11-06,,1000,mcg,['/ Day'], , 
8418,2497,Tecfidera,2016-09-05,,1000,mg,['/Month'],IV, 
8419,2497,Mitoxantrone,2016-06-25,, ,mg,['/Month'], , 
8420,2497,Avonex,2016-05-24,,400,mg,[' '],IV, 
8421,2497,Tecfidera,2016-07-12,,400,mcg,['2 / Day'],IV, 
8422,463,IVIG,2016-10-20,,500, ,['/Month'],IV, 
8423,3911,Endoxan,2016-09-30,,300,mg,['/ Day'], , 
8424,3911,IVIG,2016-03-11,,1000,MIU,['/Month'], , 
8425,3911,D-cure (Vitamine D),2016-08-25,2021-06-25,400,mg,['2 / Day'],IV,Persisting MRI activity
8426,3911,Tecfidera,2016-03-13,2018-03-02, ,mg,['3 / Week'],IV,Lack of efficacy
8427,161,D-cure (Vitamine D),2016-01-12,, ,MIU,['2 / Day'], , 
8428,161,Methylprednisolone,2016-04-24,,5000,mg,['3 / Week'], , 
8429,161,D-cure (Vitamine D),2016-05-15,,5000, ,['/Month'],Oral, 
8430,3038,Endoxan,2016-07-27,,300, ,['/ Day'], , 
8431,865,IVIG,2016-09-16,,20, ,['3 / Week'],Oral, 
8432,2862,IVIG,2016-06-13,2019-10-26,1,mg,['2 / Day'],IV,Lack of efficacy
8433,1292,Rebif [22],2016-09-21,2020-11-17, ,mg,['/Month'],IV,Patient Choice/Convenience
8434,1292,Rebif [44],2016-10-11,, ,mg,['2 / Day'],IV, 
8435,4134,Ledertrexaat,2016-10-18,,500,mcg,['/ Week'], , 
8436,4134,Tecfidera,2016-04-02,,20,mg,['2 / Day'],Oral, 
8437,4134,Endoxan,2016-09-30,, ,mg,['2 / Day'],IV, 
8438,4134,Endoxan,2015-11-23,2021-03-22,5000,mg,['/ Week'], ,Persisting MRI activity
8439,958,Methylprednisolone,2016-09-06,2017-12-12,1000,mg,['/Month'], ,Adverse Event
8440,958,D-cure (Vitamine D),2016-07-07,,500,mg,['/ Week'], , 
8441,958,Mitoxantrone,2016-06-20,,20, ,['/Month'],IV, 
8442,2507,Tecfidera,2016-03-15,,500, ,['/ Week'], , 
8443,1431,Avonex,2016-04-25,, ,mg,['/Month'], , 
8444,1431,Tecfidera,2015-11-12,,5000, ,['/ Day'],IV, 
8445,1431,IVIG,2016-04-10,2019-08-04,1,MIU,['/Month'], ,Persisting MRI activity
8446,1431,Rebif [44],2015-11-09,,20,MIU,[' '], , 
8447,629,Tecfidera,2016-04-20,2019-09-17, , ,['/Month'],IV,Patient Choice/Convenience
8448,3118,IVIG,2016-01-31,,1000,mg,['2 / Day'], , 
8449,2090,Tecfidera,2016-10-11,,400,mg,['/Month'],IV, 
8450,2090,Ledertrexaat,2016-07-25,2017-11-09, , ,['2 / Day'], ,Adverse Event
8451,2090,Tecfidera,2016-05-04,,500,MIU,['2 / Day'],IV, 
8452,2090,Rebif [22],2016-02-24,,5000, ,['/ Day'], , 
8453,2860,Endoxan,2016-06-02,,20, ,[' '], , 
8454,2860,IVIG,2015-11-13,,400,mcg,['2 / Day'], , 
8455,2860,Mitoxantrone,2016-02-17,2019-09-18, ,mg,['/Month'],IV,Adverse Event
8456,2860,Teriflunomide,2016-04-26,2020-10-12,400,mg,['/Month'], ,Persistence of relapses
8457,2344,Copaxone,2016-04-01,,300, ,[' '], , 
8458,2344,D-cure (Vitamine D),2016-04-06,,500,MIU,['3 / Week'],IV, 
8459,4903,Betaferon,2016-08-27,2020-03-21,500,mg,['/Month'],IV,Adverse Event
8460,2703,IVIG,2016-10-04,2020-02-04,5000,mg,['2 / Day'],Oral,Adverse Event
8461,2703,Rebif [44],2016-10-15,2018-03-09,300,mg,['/ Week'], ,Lack of efficacy
8462,3880,Betaferon,2015-11-08,2019-06-07,5000, ,['/ Day'], ,Adverse Event
8463,813,Betaferon,2015-12-07,2020-10-22, , ,['2 / Day'], ,Patient Choice/Convenience
8464,813,Rebif [22],2016-01-04,2021-04-04, , ,['/Month'],Oral,Adverse Event
8465,813,Ledertrexaat,2016-01-16,,1000,mg,['/Month'], , 
8466,813,Endoxan,2016-01-15,2018-12-29, ,mcg,['2 / Day'],Oral,Lack of efficacy
8467,4974,Copaxone,2016-02-03,2020-12-08,500,mg,['3 / Week'],IV,Adverse Event
8468,4315,Endoxan,2016-02-16,,500,mcg,['/Month'], , 
8469,4315,Tysabri,2016-01-07,, ,mg,['2 / Day'],IV, 
8470,4315,Mitoxantrone,2016-09-03,, ,mcg,['/Month'], , 
8471,4315,Avonex,2016-01-16,, ,mg,['/Month'],IV, 
8472,208,IVIG,2016-05-30,,1,mcg,['2 / Day'],IV, 
8473,208,Ledertrexaat,2015-12-07,, , ,['/Month'],IV, 
8474,208,Rebif [22],2016-08-18,,20,MIU,['2 / Day'],IV, 
8475,2717,Tysabri,2016-05-19,2017-11-14,500, ,['/Month'], ,Patient Choice/Convenience
8476,2717,Endoxan,2015-11-10,, , ,[' '], , 
8477,2717,D-cure (Vitamine D),2016-01-10,, , ,['/Month'], , 
8478,2717,Betaferon,2015-12-20,,300,MIU,['/Month'],IV, 
8479,3995,Gilenya,2016-06-29,, ,mcg,['3 / Week'],IV, 
8480,3995,Endoxan,2016-02-11,, ,mg,['2 / Day'], , 
8481,3995,IVIG,2016-06-07,2018-06-25,20,MIU,['/ Day'],Oral,Lack of efficacy
8482,3995,Endoxan,2016-01-30,2019-08-10,1000,mg,['/ Week'], ,Adverse Event
8483,1901,Rebif [22],2016-04-29,,300,mcg,['2 / Day'],IV, 
8484,1901,Alemtuzumab (Campath),2016-07-13,,5000,mg,['/Month'], , 
8485,1901,IVIG,2015-11-11,, ,mcg,['3 / Week'],IV, 
8486,1901,Tysabri,2016-06-29,2019-12-07,400,mcg,['3 / Week'],IV,Lack of efficacy
8487,1684,Gilenya,2015-12-23,,5000,mg,['/ Day'],IV, 
8488,1684,Tysabri,2016-04-22,,300, ,['2 / Day'],IV, 
8489,1684,Tecfidera,2016-06-04,,500,mg,['/ Day'],IV, 
8490,1447,Teriflunomide,2016-03-06,, , ,['/Month'],IV, 
8491,1447,Copaxone,2015-12-16,2019-07-05,1000,MIU,[' '], ,Adverse Event
8492,1447,Tysabri,2016-01-19,, ,mg,['/Month'],IV, 
8493,1447,Alemtuzumab (Campath),2016-05-02,,500,mg,[' '], , 
8494,670,Tecfidera,2016-10-08,2017-11-14,20,mg,['/Month'],IV,Patient Choice/Convenience
8495,1245,D-cure (Vitamine D),2016-05-20,2021-04-22,1,mg,['/Month'],IV,Patient Choice/Convenience
8496,1245,Rebif [44],2016-08-12,,400, ,['3 / Week'], , 
8497,1245,D-cure (Vitamine D),2015-11-27,2017-12-16,300,mg,['3 / Week'], ,Adverse Event
8498,1133,Gilenya,2016-09-20,, , ,['/Month'], , 
8499,1133,Avonex,2016-08-16,2020-09-12,1, ,[' '],Oral,Patient Choice/Convenience
8500,3702,D-cure (Vitamine D),2016-10-18,,20,mcg,['/ Week'], , 
8501,3702,Alemtuzumab (Campath),2016-02-26,,5000,mg,['2 / Day'],IV, 
8502,754,IVIG,2016-05-17,2019-11-10, ,mg,['2 / Day'], ,Persistence of relapses
8503,3010,Endoxan,2016-02-26,2018-10-13,20,mg,['/Month'], ,Lack of efficacy
8504,3010,Tecfidera,2016-08-21,,500,mg,['/Month'],Oral, 
8505,1937,Tecfidera,2016-04-25,,300, ,['/Month'],IV, 
8506,1937,Endoxan,2016-05-31,, ,mg,['/Month'],IV, 
8507,1937,Rebif [22],2016-07-30,,500,mg,['/ Day'],Oral, 
8508,539,Tysabri,2016-04-24,, , ,[' '], , 
8509,3039,Avonex,2016-06-18,, ,mg,['2 / Day'],IV, 
8510,3039,Endoxan,2015-11-28,2020-06-09,300,mg,['/Month'],IV,Persisting MRI activity
8511,3039,Rebif [22],2016-04-04,, ,mg,[' '],IV, 
8512,3039,Tecfidera,2015-11-29,, ,mg,[' '],IV, 
8513,3131,Endoxan,2016-06-25,, , ,['2 / Day'], , 
8514,3131,Rebif [44],2015-10-30,2019-11-15,300,mg,['/Month'],IV,Persisting MRI activity
8515,1651,Tecfidera,2016-09-30,,5000,mg,[' '], , 
8516,1651,Endoxan,2015-12-31,,20, ,[' '], , 
8517,1651,Copaxone,2016-04-10,,5000, ,['3 / Week'],IV, 
8518,1651,Gilenya,2016-06-17,2020-10-14,500,mcg,['2 / Day'],Oral,Adverse Event
8519,2771,Gilenya,2015-11-18,2021-06-07,5000, ,['/ Day'], ,Patient Choice/Convenience
8520,2771,Tysabri,2016-07-28,2020-12-28,1000,MIU,['3 / Week'], ,Adverse Event
8521,4150,Rebif [44],2016-08-14,2021-06-22, ,mg,['3 / Week'],IV,Patient Choice/Convenience
8522,4150,D-cure (Vitamine D),2016-08-25,, ,mg,[' '], , 
8523,139,Avonex,2016-05-28,2020-10-11,1,mg,['/ Day'], ,Persisting MRI activity
8524,139,Tecfidera,2015-12-19,2020-04-29,5000,mcg,[' '],IV,Adverse Event
8525,139,Endoxan,2016-09-10,, ,mg,['2 / Day'],IV, 
8526,139,Teriflunomide,2015-12-23,,300,mg,[' '],IV, 
8527,4289,IVIG,2015-11-29,,20,mg,['/ Week'], , 
8528,4289,Betaferon,2016-04-08,2018-01-05,20, ,['/Month'],Oral,Lack of efficacy
8529,4289,Alemtuzumab (Campath),2016-05-29,,500, ,['/ Day'],IV, 
8530,3941,Copaxone,2016-03-19,2020-01-22,1, ,['/Month'], ,Persisting MRI activity
8531,3419,Tecfidera,2016-08-01,2021-07-05, , ,['3 / Week'], ,Persisting MRI activity
8532,3419,Mitoxantrone,2016-05-15,2021-03-30, , ,['/Month'], ,Persisting MRI activity
8533,3419,IVIG,2016-09-15,,5000,mg,['3 / Week'], , 
8534,2232,Betaferon,2016-05-08,,20, ,['/ Week'], , 
8535,432,Gilenya,2015-11-01,,5000, ,[' '],Oral, 
8536,3914,Methylprednisolone,2015-12-05,2021-07-21, ,mcg,[' '], ,Patient Choice/Convenience
8537,3914,Tysabri,2016-10-04,2021-10-10,300, ,['3 / Week'], ,Adverse Event
8538,747,Rebif [22],2016-03-25,2021-09-27, , ,['2 / Day'],IV,Persistence of relapses
8539,747,Tysabri,2016-04-25,, , ,['2 / Day'], , 
8540,747,Tysabri,2015-11-13,2021-07-20,400, ,['2 / Day'],Oral,Adverse Event
8541,747,IVIG,2016-03-02,,300,mcg,['3 / Week'], , 
8542,2701,Copaxone,2016-01-28,,1000,mg,['/Month'],IV, 
8543,3620,Rebif [44],2016-06-25,,20, ,['/Month'],IV, 
8544,3620,Alemtuzumab (Campath),2016-10-01,2017-12-22,500, ,['2 / Day'],IV,Lack of efficacy
8545,3620,D-cure (Vitamine D),2016-07-27,,500,MIU,['2 / Day'], , 
8546,3620,Rebif [22],2016-08-24,,300, ,['3 / Week'],IV, 
8547,1979,Teriflunomide,2016-08-11,, , ,['/Month'],Oral, 
8548,1979,Methylprednisolone,2016-06-03,2020-06-10,400,MIU,['3 / Week'],IV,Adverse Event
8549,1979,Endoxan,2016-06-20,, ,MIU,['2 / Day'],IV, 
8550,1979,Teriflunomide,2016-09-15,2019-06-29,1,mcg,['/ Day'],IV,Persisting MRI activity
8551,1105,D-cure (Vitamine D),2016-09-07,,500, ,['/Month'],Oral, 
8552,2180,Gilenya,2016-02-26,, ,mg,['2 / Day'], , 
8553,2180,Betaferon,2016-09-16,2018-10-12,20,mg,['/Month'],IV,Patient Choice/Convenience
8554,235,Methylprednisolone,2016-07-30,2017-10-24,400, ,[' '],IV,Adverse Event
8555,235,Betaferon,2016-03-29,2018-03-17,5000, ,['2 / Day'],IV,Persisting MRI activity
8556,235,Ledertrexaat,2016-08-06,,300,mg,[' '], , 
8557,4966,Alemtuzumab (Campath),2016-08-26,, , ,['2 / Day'],IV, 
8558,3746,IVIG,2016-08-05,,1,mg,['2 / Day'],IV, 
8559,3746,Methylprednisolone,2015-12-20,,5000,mg,['/ Day'],IV, 
8560,3746,Endoxan,2015-12-11,2020-08-25,500,mg,[' '], ,Patient Choice/Convenience
8561,3746,Rebif [22],2016-03-17,2018-07-06,1, ,['/Month'],IV,Lack of efficacy
8562,4503,Tecfidera,2016-03-16,2019-08-15, ,MIU,['2 / Day'], ,Adverse Event
8563,4503,Ledertrexaat,2016-10-05,2019-05-09,400,mcg,['2 / Day'],IV,Adverse Event
8564,4503,Ledertrexaat,2016-02-08,,5000,mg,['/Month'],IV, 
8565,4503,Teriflunomide,2016-04-26,2018-11-28,5000,mg,['2 / Day'], ,Lack of efficacy
8566,3879,Betaferon,2015-11-23,2021-05-02,300,mg,['2 / Day'], ,Persisting MRI activity
8567,4176,Rebif [44],2016-07-19,2020-07-05,1000,mcg,['/ Week'], ,Patient Choice/Convenience
8568,3341,Alemtuzumab (Campath),2016-02-20,,20,mg,['/Month'], , 
8569,3341,Rebif [44],2016-01-07,, ,mg,['/Month'], , 
8570,3341,Copaxone,2016-05-15,,20, ,['3 / Week'],Oral, 
8571,3341,Avonex,2016-08-21,,300,mg,['/Month'], , 
8572,929,Rebif [22],2015-12-14,,1000,MIU,['/Month'], , 
8573,929,Gilenya,2016-10-12,,1000, ,['2 / Day'],IV, 
8574,929,Tysabri,2015-11-03,2021-08-08,5000,mg,['/Month'], ,Patient Choice/Convenience
8575,929,Avonex,2015-11-13,, ,mg,[' '],Oral, 
8576,3250,Teriflunomide,2016-01-21,,500,mg,['/Month'],IV, 
8577,3250,Gilenya,2015-11-13,2020-02-25, ,mcg,['3 / Week'], ,Lack of efficacy
8578,2909,D-cure (Vitamine D),2016-07-02,, ,mg,['/ Day'],IV, 
8579,3185,Ledertrexaat,2016-06-30,, ,mg,['3 / Week'],IV, 
8580,3185,Tecfidera,2016-01-04,,20, ,['/Month'],IV, 
8581,3185,Rebif [22],2016-03-25,2018-03-01,1, ,['/Month'],IV,Persistence of relapses
8582,3185,Gilenya,2016-10-07,2021-01-20,500,MIU,['/Month'], ,Persisting MRI activity
8583,904,Mitoxantrone,2016-05-12,2019-04-01, , ,['3 / Week'],IV,Patient Choice/Convenience
8584,2135,Tysabri,2016-02-08,, ,mg,['3 / Week'],Oral, 
8585,2135,Teriflunomide,2016-04-28,,5000,mg,['3 / Week'],IV, 
8586,2135,Tysabri,2016-01-16,,1000, ,['2 / Day'], , 
8587,4079,Endoxan,2016-08-28,2020-02-27,20,mg,['/ Week'],IV,Patient Choice/Convenience
8588,4079,IVIG,2016-01-03,2019-05-10,1,MIU,['2 / Day'], ,Adverse Event
8589,4079,Tysabri,2016-03-16,2019-12-12, , ,['/Month'],Oral,Adverse Event
8590,2942,Betaferon,2016-08-06,,1000, ,['/ Day'],IV, 
8591,2942,Ledertrexaat,2016-06-27,2019-07-23,20, ,['2 / Day'], ,Adverse Event
8592,2942,Tecfidera,2016-08-24,,1000, ,['/ Day'],IV, 
8593,2942,D-cure (Vitamine D),2015-11-03,, ,mg,['3 / Week'], , 
8594,2433,Avonex,2015-11-22,2019-07-24,1,mg,[' '],Oral,Persistence of relapses
8595,4491,Endoxan,2015-12-03,2018-03-26,20, ,['/ Week'],IV,Patient Choice/Convenience
8596,4491,Alemtuzumab (Campath),2015-12-18,2018-04-20,300,mg,['/Month'],IV,Persistence of relapses
8597,4491,Avonex,2016-03-24,2018-08-08, , ,['/Month'],IV,Adverse Event
8598,4491,IVIG,2016-07-01,2021-09-19,500, ,['/ Day'],Oral,Adverse Event
8599,1310,Methylprednisolone,2016-09-11,,500, ,['/Month'],Oral, 
8600,1310,Avonex,2016-06-21,,1000, ,['/Month'], , 
8601,1310,Rebif [22],2016-02-11,, ,mg,['3 / Week'],IV, 
8602,3929,Methylprednisolone,2016-01-25,,300,mg,['/ Week'], , 
8603,3929,Teriflunomide,2015-11-02,2018-08-19, , ,['/ Day'],IV,Persistence of relapses
8604,3929,Tecfidera,2016-08-30,,5000,mcg,['2 / Day'],IV, 
8605,3929,Tysabri,2016-05-27,,1000,mg,['3 / Week'],IV, 
8606,3003,Tysabri,2016-07-21,2018-02-14,1, ,[' '],IV,Lack of efficacy
8607,3003,Ledertrexaat,2016-02-18,,5000, ,['/Month'], , 
8608,3003,Rebif [44],2016-05-19,,500,mcg,['/Month'], , 
8609,3003,Gilenya,2016-08-11,2021-05-18, , ,['/Month'],Oral,Lack of efficacy
8610,1435,Endoxan,2016-09-13,2020-10-08, , ,[' '],IV,Persistence of relapses
8611,1435,Mitoxantrone,2016-01-04,, , ,['2 / Day'],IV, 
8612,2928,Copaxone,2016-04-12,,1,mg,['/ Week'], , 
8613,2928,Rebif [22],2016-01-19,, ,mg,['2 / Day'], , 
8614,2928,Ledertrexaat,2016-06-18,2018-04-08, ,mg,['3 / Week'], ,Adverse Event
8615,2928,Tysabri,2016-03-27,,1,MIU,['2 / Day'], , 
8616,428,Tysabri,2016-05-09,,5000,mg,['/ Week'],IV, 
8617,3924,Mitoxantrone,2016-05-07,,20,mcg,['3 / Week'],IV, 
8618,2559,Mitoxantrone,2016-04-27,2019-11-10,400, ,['2 / Day'],IV,Patient Choice/Convenience
8619,2559,Tecfidera,2016-05-26,,300,mg,['2 / Day'], , 
8620,3068,D-cure (Vitamine D),2016-02-19,,20,mcg,['/ Day'], , 
8621,3197,Tysabri,2015-12-15,,500, ,['/Month'], , 
8622,1599,Tecfidera,2016-07-18,2021-05-23,5000,mg,['3 / Week'],IV,Adverse Event
8623,1511,Rebif [44],2016-06-27,, ,mg,['/Month'], , 
8624,587,IVIG,2016-10-19,,20, ,['3 / Week'],Oral, 
8625,587,D-cure (Vitamine D),2015-12-11,,1000,mg,['/Month'], , 
8626,747,Gilenya,2016-02-17,, , ,['2 / Day'],IV, 
8627,747,Tysabri,2016-01-18,2020-08-23, ,mg,['/Month'],IV,Lack of efficacy
8628,747,Rebif [44],2016-04-23,,500,MIU,['3 / Week'], , 
8629,747,Endoxan,2015-12-16,,20,MIU,['3 / Week'],IV, 
8630,4372,Methylprednisolone,2016-09-14,2021-08-15,400,mg,['/Month'],IV,Lack of efficacy
8631,2514,Betaferon,2016-08-20,2019-11-24, ,mcg,['/Month'],IV,Adverse Event
8632,2514,Tysabri,2016-01-24,,1000,mg,['/ Day'],Oral, 
8633,2514,Tecfidera,2016-01-22,, ,mg,['2 / Day'],Oral, 
8634,676,Tecfidera,2015-12-09,,300,mcg,['3 / Week'], , 
8635,1858,Avonex,2016-06-03,,300,mg,[' '],IV, 
8636,1858,Gilenya,2016-09-18,2021-06-28, ,mg,['/Month'],Oral,Persistence of relapses
8637,1858,Teriflunomide,2016-08-28,,20,mg,['/Month'],IV, 
8638,1858,Teriflunomide,2016-07-30,,300,mg,['2 / Day'],Oral, 
8639,3057,IVIG,2015-12-29,2021-01-09, ,mcg,['/ Week'], ,Persistence of relapses
8640,3057,Methylprednisolone,2016-02-13,2017-11-25,5000, ,[' '],IV,Adverse Event
8641,1461,Mitoxantrone,2015-11-17,, , ,['/ Day'], , 
8642,1461,Methylprednisolone,2016-01-04,, ,mg,['/Month'], , 
8643,1461,Methylprednisolone,2016-09-09,2019-05-29, ,mg,['/ Day'], ,Persisting MRI activity
8644,4840,Rebif [22],2016-07-14,2020-09-04, ,MIU,['2 / Day'],IV,Lack of efficacy
8645,4840,Avonex,2015-11-24,,1,mg,['/Month'],IV, 
8646,4840,Gilenya,2016-09-20,,20,MIU,['2 / Day'],IV, 
8647,1571,Copaxone,2015-11-08,2019-06-12,5000,mcg,['/ Day'],IV,Adverse Event
8648,1571,Betaferon,2015-12-10,,1000,mg,['2 / Day'],IV, 
8649,1571,IVIG,2016-07-10,,1000,MIU,['/Month'],Oral, 
8650,4598,Tecfidera,2015-11-19,,400,mg,['3 / Week'],IV, 
8651,4598,Methylprednisolone,2016-05-24,, ,mg,['/Month'],IV, 
8652,4598,Rebif [44],2016-01-20,, ,mg,['2 / Day'], , 
8653,4598,Copaxone,2016-05-10,2021-08-16,300, ,['2 / Day'],Oral,Persistence of relapses
8654,3133,Tysabri,2016-05-14,2021-07-07,500, ,['/ Week'],IV,Lack of efficacy
8655,3133,D-cure (Vitamine D),2016-10-03,,20,mg,[' '],IV, 
8656,3133,Copaxone,2016-06-24,2020-07-15,500,mg,['2 / Day'],IV,Lack of efficacy
8657,4216,Copaxone,2016-10-13,,5000, ,['/ Week'],Oral, 
8658,4216,Tecfidera,2015-11-19,2020-06-14,500,mg,['/Month'],IV,Adverse Event
8659,4216,IVIG,2016-10-17,,500, ,['/Month'],IV, 
8660,4705,Avonex,2015-11-01,,5000, ,['/ Day'], , 
8661,4705,Rebif [44],2016-03-30,,1,MIU,['2 / Day'],IV, 
8662,837,Tecfidera,2016-08-20,,1,mg,['2 / Day'], , 
8663,837,Methylprednisolone,2016-06-11,,20, ,['/Month'],Oral, 
8664,837,D-cure (Vitamine D),2016-08-17,2019-07-12,1,mg,[' '],IV,Adverse Event
8665,837,Rebif [22],2016-07-12,2018-12-10, , ,['/Month'], ,Lack of efficacy
8666,547,Betaferon,2016-01-14,2021-08-11, , ,['2 / Day'], ,Persisting MRI activity
8667,3519,Rebif [22],2016-01-12,2018-05-29,400,MIU,['/ Week'],IV,Patient Choice/Convenience
8668,3519,Tecfidera,2015-11-07,,1, ,['3 / Week'],Oral, 
8669,2954,IVIG,2016-05-28,,500,mg,['/ Day'],IV, 
8670,2954,Betaferon,2016-05-24,,1,mg,['/Month'], , 
8671,3318,D-cure (Vitamine D),2016-05-05,2020-05-03, ,mg,['/ Day'],IV,Persistence of relapses
8672,3318,Tysabri,2016-08-08,, ,mg,['2 / Day'],IV, 
8673,3318,Methylprednisolone,2016-02-20,,1000,mcg,['/ Day'],IV, 
8674,3318,Copaxone,2016-05-20,,1000, ,['/Month'],Oral, 
8675,1977,Tysabri,2016-09-04,2018-01-29, ,mg,[' '],Oral,Adverse Event
8676,1977,Tecfidera,2016-08-10,, ,MIU,['2 / Day'], , 
8677,2024,Methylprednisolone,2016-07-08,,500, ,['/Month'],IV, 
8678,2024,Methylprednisolone,2016-01-16,2021-08-13,1,mg,['/Month'],IV,Persistence of relapses
8679,2024,Gilenya,2016-09-20,,1, ,['2 / Day'],IV, 
8680,2088,Rebif [22],2016-06-16,2018-08-04,1000, ,[' '],IV,Persisting MRI activity
8681,2088,Gilenya,2016-09-23,, , ,['2 / Day'],IV, 
8682,2088,Teriflunomide,2016-06-14,,1000,MIU,['/Month'], , 
8683,2088,Tecfidera,2016-10-15,,500, ,['/Month'],IV, 
8684,698,Avonex,2016-02-13,,1,mg,[' '],IV, 
8685,2093,Avonex,2016-07-27,2021-02-01,1000,mg,['2 / Day'],IV,Lack of efficacy
8686,2093,Betaferon,2016-10-10,, ,MIU,['2 / Day'], , 
8687,557,D-cure (Vitamine D),2015-11-13,, , ,['/ Day'],IV, 
8688,557,IVIG,2016-04-07,, ,mg,[' '],IV, 
8689,2342,D-cure (Vitamine D),2016-05-24,,1, ,[' '],IV, 
8690,2342,Avonex,2016-05-01,2021-08-15, , ,['/ Week'], ,Lack of efficacy
8691,2342,Gilenya,2015-10-24,,500,MIU,['2 / Day'],IV, 
8692,955,D-cure (Vitamine D),2016-09-06,, , ,['/Month'],IV, 
8693,4858,Copaxone,2016-02-11,, ,mg,['/ Week'], , 
8694,1407,Methylprednisolone,2015-11-10,,20,mg,['2 / Day'],IV, 
8695,1407,Gilenya,2016-02-02,, , ,['2 / Day'],IV, 
8696,1407,D-cure (Vitamine D),2016-03-12,,5000, ,['/Month'],Oral, 
8697,1407,Avonex,2015-12-01,2018-10-23, ,mg,[' '], ,Adverse Event
8698,4952,Gilenya,2016-04-30,,300, ,['3 / Week'], , 
8699,4952,Alemtuzumab (Campath),2016-04-30,,300,mg,['/Month'], , 
8700,813,Teriflunomide,2016-04-27,,5000, ,[' '],IV, 
8701,813,IVIG,2016-07-25,,300,mg,['3 / Week'],IV, 
8702,2336,Mitoxantrone,2016-03-14,2021-10-10,1000, ,['/Month'], ,Lack of efficacy
8703,2336,Copaxone,2016-04-07,, , ,['/Month'],IV, 
8704,2336,Rebif [22],2016-01-04,,5000, ,['/Month'],IV, 
8705,2336,Rebif [44],2016-04-05,2018-01-29, ,MIU,['2 / Day'], ,Persisting MRI activity
8706,2167,Betaferon,2016-10-08,2020-02-10,300,mcg,['/Month'],IV,Patient Choice/Convenience
8707,2167,Gilenya,2016-10-13,, , ,['3 / Week'], , 
8708,1913,IVIG,2016-05-23,2020-04-24,300, ,['2 / Day'],IV,Persistence of relapses
8709,1913,D-cure (Vitamine D),2016-02-10,, ,mg,[' '],Oral, 
8710,1913,Alemtuzumab (Campath),2016-08-14,2018-12-13,5000,mg,['2 / Day'], ,Lack of efficacy
8711,1913,Tecfidera,2016-06-04,,20,mg,['3 / Week'], , 
8712,4086,Copaxone,2015-12-10,,20,mg,['/ Day'],IV, 
8713,4086,Rebif [44],2015-11-02,, ,MIU,['2 / Day'],IV, 
8714,4086,Rebif [44],2016-03-22,2019-10-17,1, ,['3 / Week'],IV,Adverse Event
8715,767,D-cure (Vitamine D),2015-10-31,2019-10-10, , ,['/Month'],IV,Adverse Event
8716,936,Tecfidera,2015-12-12,2020-07-08,1000, ,['/ Week'],IV,Adverse Event
8717,936,Tecfidera,2016-01-07,,1, ,['/Month'], , 
8718,936,Gilenya,2016-07-06,2019-10-28,300, ,['/ Day'], ,Adverse Event
8719,4549,Avonex,2016-05-28,,5000,mg,[' '],IV, 
8720,4549,IVIG,2016-07-10,, ,mg,['2 / Day'], , 
8721,4549,Endoxan,2015-10-29,,1,mg,['/Month'],IV, 
8722,4549,D-cure (Vitamine D),2016-08-24,,300, ,['/ Week'],IV, 
8723,2663,IVIG,2016-01-08,,5000, ,['/Month'], , 
8724,3894,Alemtuzumab (Campath),2015-11-24,2020-03-17, ,mg,['3 / Week'],IV,Persistence of relapses
8725,3894,Tecfidera,2016-06-21,,500,mg,['2 / Day'],IV, 
8726,3894,Avonex,2016-04-23,2020-09-11,5000,MIU,['/ Day'],Oral,Lack of efficacy
8727,1775,Tysabri,2016-05-06,,1000,MIU,[' '],IV, 
8728,1775,Teriflunomide,2015-10-26,,1, ,['2 / Day'],IV, 
8729,1775,Tecfidera,2016-05-03,, ,mg,['3 / Week'],IV, 
8730,1775,Alemtuzumab (Campath),2016-07-01,2019-10-13, , ,['/Month'],Oral,Adverse Event
8731,3431,Gilenya,2016-06-18,,1000,MIU,['/Month'],Oral, 
8732,3431,Tecfidera,2016-05-17,,5000,mg,['3 / Week'],IV, 
8733,4546,Betaferon,2016-04-24,2019-02-23, ,mg,['2 / Day'],Oral,Adverse Event
8734,4546,IVIG,2016-08-16,,1000,mg,['3 / Week'],IV, 
8735,3502,Betaferon,2016-02-29,2019-02-17,5000, ,['2 / Day'], ,Adverse Event
8736,3502,Betaferon,2016-02-28,,5000, ,[' '], , 
8737,3502,D-cure (Vitamine D),2016-01-08,2021-09-20,500, ,['/Month'],IV,Patient Choice/Convenience
8738,3502,Methylprednisolone,2016-01-29,,5000,mg,['2 / Day'],Oral, 
8739,3091,IVIG,2016-01-26,,1,MIU,['2 / Day'], , 
8740,3091,Copaxone,2016-10-02,2019-07-04, ,MIU,['/Month'], ,Persisting MRI activity
8741,3677,Alemtuzumab (Campath),2016-09-02,,500, ,['3 / Week'],IV, 
8742,1906,Ledertrexaat,2016-04-29,,1000,mg,['/Month'], , 
8743,2911,Mitoxantrone,2015-12-18,2019-09-17, ,mg,['/ Day'],IV,Patient Choice/Convenience
8744,2911,Alemtuzumab (Campath),2016-06-04,2021-01-14,500,mg,['3 / Week'],Oral,Adverse Event
8745,2911,D-cure (Vitamine D),2016-04-25,, , ,[' '],IV, 
8746,2911,Rebif [44],2016-03-15,2018-11-16, ,mg,['/Month'],IV,Persisting MRI activity
8747,992,Tecfidera,2016-09-22,2019-04-29, ,mg,['/ Day'],Oral,Persisting MRI activity
8748,992,Betaferon,2015-10-30,2018-03-20,5000,MIU,['2 / Day'],IV,Lack of efficacy
8749,186,Tysabri,2016-02-02,2020-09-18, ,MIU,['/Month'],Oral,Adverse Event
8750,186,Alemtuzumab (Campath),2016-09-15,, , ,['/Month'],IV, 
8751,2452,Endoxan,2015-11-23,,20,mg,['2 / Day'],IV, 
8752,1485,Tecfidera,2016-03-06,,1000,mg,[' '], , 
8753,1485,Avonex,2016-05-20,2019-01-25, , ,['3 / Week'], ,Persisting MRI activity
8754,1485,Rebif [44],2016-03-18,2021-09-12,5000, ,['/Month'],IV,Persistence of relapses
8755,1485,Rebif [44],2016-08-14,,500, ,['3 / Week'],IV, 
8756,4040,D-cure (Vitamine D),2015-12-18,,300, ,['2 / Day'],IV, 
8757,4040,Mitoxantrone,2016-08-30,,500,mg,['/Month'],Oral, 
8758,4040,Avonex,2016-09-13,,300,mg,[' '],IV, 
8759,488,Gilenya,2015-11-12,,20, ,['/Month'],Oral, 
8760,488,Copaxone,2016-09-17,, ,mg,['3 / Week'],Oral, 
8761,488,Avonex,2015-12-04,,5000,mg,['/Month'],Oral, 
8762,3682,Mitoxantrone,2016-02-29,,300,mcg,['2 / Day'],Oral, 
8763,1834,Rebif [22],2015-12-19,2019-10-08,5000, ,['3 / Week'],Oral,Persistence of relapses
8764,1834,Rebif [44],2016-10-09,, ,mg,['/Month'], , 
8765,1834,Ledertrexaat,2016-09-16,,20,mg,[' '],IV, 
8766,3184,Rebif [44],2015-12-19,2020-08-29,20, ,['/Month'], ,Lack of efficacy
8767,2144,Copaxone,2015-12-13,2020-02-01, ,MIU,['/Month'], ,Adverse Event
8768,2546,Avonex,2016-03-16,,400,MIU,['2 / Day'], , 
8769,2849,Mitoxantrone,2016-07-25,,500,mcg,['/Month'],IV, 
8770,2849,IVIG,2015-12-17,2021-06-02,20, ,['2 / Day'],IV,Lack of efficacy
8771,1147,IVIG,2016-02-13,2021-02-25, , ,['3 / Week'],IV,Adverse Event
8772,1147,Tecfidera,2016-08-22,,5000,mg,[' '],IV, 
8773,1976,Copaxone,2016-05-29,,20, ,['3 / Week'],IV, 
8774,4817,Teriflunomide,2016-06-01,2018-05-11,20,mg,['/ Week'], ,Lack of efficacy
8775,3831,Copaxone,2016-06-05,,500, ,['/Month'],IV, 
8776,3831,Copaxone,2016-08-23,,500, ,['2 / Day'],IV, 
8777,3831,Methylprednisolone,2016-10-05,,1000,mg,['2 / Day'],Oral, 
8778,3831,Ledertrexaat,2016-08-16,2019-08-12,1000, ,[' '], ,Patient Choice/Convenience
8779,1700,Teriflunomide,2016-02-20,2018-06-02,20,MIU,['2 / Day'], ,Persistence of relapses
8780,2249,Alemtuzumab (Campath),2016-01-29,2018-11-21,1000, ,['2 / Day'],IV,Persistence of relapses
8781,2249,Rebif [44],2016-09-25,2018-10-17,1000,MIU,['/Month'],IV,Persisting MRI activity
8782,2249,Copaxone,2016-03-10,2018-12-14, ,mg,['2 / Day'],Oral,Persisting MRI activity
8783,2249,Avonex,2016-01-29,,1,mcg,['/Month'],IV, 
8784,555,Endoxan,2016-03-10,, , ,['2 / Day'],IV, 
8785,555,Betaferon,2016-10-20,2020-10-30, ,mg,['2 / Day'],IV,Persistence of relapses
8786,4973,Methylprednisolone,2016-07-14,,1000, ,['/ Week'],IV, 
8787,4973,Endoxan,2016-05-02,,300,mg,['2 / Day'], , 
8788,4973,D-cure (Vitamine D),2016-10-07,2018-05-10,20,MIU,['3 / Week'], ,Lack of efficacy
8789,2591,Tecfidera,2015-11-03,,500, ,['2 / Day'], , 
8790,1003,D-cure (Vitamine D),2016-06-17,2020-09-30,400, ,['/ Week'], ,Adverse Event
8791,1003,Tysabri,2015-11-07,,300, ,['2 / Day'],IV, 
8792,2138,D-cure (Vitamine D),2016-01-20,2021-09-03,20, ,['/Month'], ,Patient Choice/Convenience
8793,2138,Rebif [22],2016-01-18,2018-07-07, , ,['3 / Week'],IV,Persisting MRI activity
8794,2724,Endoxan,2016-08-30,2017-12-04,300, ,['3 / Week'],IV,Adverse Event
8795,2724,Tecfidera,2016-04-27,,300,mg,['2 / Day'], , 
8796,1675,Tecfidera,2016-09-15,,500, ,['/ Day'], , 
8797,1675,Mitoxantrone,2016-02-29,, ,mg,['/ Week'],IV, 
8798,1675,Rebif [44],2016-06-03,2019-10-25,1000,mg,['2 / Day'], ,Persisting MRI activity
8799,3379,Tysabri,2016-10-13,2020-11-28,1000,MIU,['/Month'], ,Adverse Event
8800,2568,Alemtuzumab (Campath),2015-11-20,, ,mg,['/Month'],IV, 
8801,2568,Rebif [22],2016-06-21,,400,MIU,['2 / Day'], , 
8802,2568,Gilenya,2016-04-07,,5000,MIU,['2 / Day'],Oral, 
8803,2568,Betaferon,2016-05-02,, ,mg,[' '],IV, 
8804,2537,Rebif [22],2016-09-10,,1000, ,['3 / Week'],IV, 
8805,2537,Alemtuzumab (Campath),2016-03-27,, , ,['/Month'], , 
8806,2537,D-cure (Vitamine D),2015-11-21,2020-03-26,20,mg,['2 / Day'],IV,Patient Choice/Convenience
8807,2537,Gilenya,2016-02-13,2018-11-01, ,mg,['2 / Day'],IV,Persistence of relapses
8808,2009,Methylprednisolone,2015-12-06,,1000, ,['/Month'],Oral, 
8809,2009,Endoxan,2016-09-12,,400,mg,['/Month'],IV, 
8810,4641,Tecfidera,2016-07-30,,1,mg,['/Month'],IV, 
8811,3199,Tecfidera,2016-09-11,,1, ,['2 / Day'],IV, 
8812,3199,Teriflunomide,2015-11-07,,500, ,['2 / Day'], , 
8813,3199,Copaxone,2015-12-02,2019-07-18,500, ,['2 / Day'],IV,Persisting MRI activity
8814,1912,Teriflunomide,2016-02-23,2018-11-26,500,MIU,['/Month'],IV,Patient Choice/Convenience
8815,1912,Tysabri,2015-11-11,2021-06-06,500, ,['/ Day'], ,Patient Choice/Convenience
8816,3944,Rebif [44],2016-09-26,2018-01-03,1000, ,['3 / Week'],IV,Persisting MRI activity
8817,3944,Methylprednisolone,2016-03-17,2018-11-25,1000,mg,[' '], ,Persistence of relapses
8818,3944,Tecfidera,2016-02-06,,1,mg,['/Month'],IV, 
8819,4513,Avonex,2016-02-23,2019-07-20, , ,['/Month'], ,Persisting MRI activity
8820,4513,Copaxone,2016-09-12,,20, ,['2 / Day'],IV, 
8821,1702,Copaxone,2016-04-06,2019-11-15, ,mg,[' '], ,Adverse Event
8822,1702,D-cure (Vitamine D),2016-05-18,2019-12-26,20,mg,['/Month'],IV,Lack of efficacy
8823,1702,Gilenya,2016-09-10,, ,mg,['2 / Day'],IV, 
8824,3622,IVIG,2016-01-10,,300,mcg,['/Month'], , 
8825,3622,Alemtuzumab (Campath),2016-01-21,,500, ,['2 / Day'], , 
8826,3622,Methylprednisolone,2016-08-05,2019-07-02, ,mg,['/Month'],IV,Persistence of relapses
8827,4692,Tysabri,2016-02-13,2020-06-19, ,mg,['3 / Week'], ,Adverse Event
8828,4692,Rebif [44],2016-02-01,2019-08-14, , ,['3 / Week'],IV,Adverse Event
8829,4692,Tecfidera,2016-05-01,2021-03-12,20,mg,['3 / Week'],IV,Patient Choice/Convenience
8830,4692,Tysabri,2016-07-16,2020-01-05,1, ,['/ Week'],IV,Lack of efficacy
8831,1292,D-cure (Vitamine D),2016-04-25,2020-11-07,1000, ,['/ Day'],Oral,Adverse Event
8832,1292,Tecfidera,2016-06-05,, , ,['/ Day'], , 
8833,1292,Tecfidera,2016-06-24,2019-05-13, ,mg,['/ Day'],IV,Lack of efficacy
8834,1292,Alemtuzumab (Campath),2016-06-18,, ,MIU,['/Month'],IV, 
8835,3274,Tecfidera,2016-01-21,,1,mg,['3 / Week'], , 
8836,3274,Teriflunomide,2015-12-06,,1000,MIU,['/Month'],Oral, 
8837,3274,Ledertrexaat,2015-10-24,, ,mcg,['2 / Day'],IV, 
8838,2163,Alemtuzumab (Campath),2016-08-23,2019-01-17,20, ,['/Month'],IV,Patient Choice/Convenience
8839,2163,Tecfidera,2016-09-18,2021-10-09,1, ,['/ Week'],IV,Persisting MRI activity
8840,2163,Gilenya,2016-03-07,, , ,['2 / Day'], , 
8841,2163,Alemtuzumab (Campath),2015-12-24,,500, ,['3 / Week'],Oral, 
8842,4673,Alemtuzumab (Campath),2016-02-26,2018-03-12,400,mg,['/Month'],IV,Adverse Event
8843,215,Tecfidera,2016-09-27,,1000,MIU,['/ Week'], , 
8844,215,Methylprednisolone,2016-08-20,2020-10-26,1000,mg,['3 / Week'],Oral,Adverse Event
8845,215,IVIG,2016-05-17,2018-07-11,500,mcg,['3 / Week'],Oral,Lack of efficacy
8846,2370,Ledertrexaat,2016-10-09,, ,MIU,['3 / Week'],IV, 
8847,2370,D-cure (Vitamine D),2016-02-08,,1,MIU,['2 / Day'],Oral, 
8848,3937,Ledertrexaat,2016-02-06,,1000,mg,['3 / Week'], , 
8849,3937,IVIG,2016-08-01,2018-01-09,300,mg,['/Month'], ,Patient Choice/Convenience
8850,3937,Tysabri,2016-09-11,,500,MIU,['2 / Day'],Oral, 
8851,1261,Betaferon,2016-07-23,2020-08-22,1000,mg,['2 / Day'], ,Adverse Event
8852,1261,Ledertrexaat,2015-12-02,, ,mg,['/ Day'],IV, 
8853,1261,Copaxone,2016-05-24,2020-01-16, , ,['/Month'],IV,Patient Choice/Convenience
8854,3479,D-cure (Vitamine D),2016-03-15,,1000,mg,['/Month'], , 
8855,3382,Copaxone,2015-11-22,,500, ,['3 / Week'],IV, 
8856,3382,Avonex,2016-08-13,, , ,['3 / Week'],IV, 
8857,3382,D-cure (Vitamine D),2015-12-20,,1,mg,['2 / Day'],IV, 
8858,2567,Tysabri,2016-01-17,,300, ,['/ Week'],IV, 
8859,2567,Endoxan,2016-02-23,,1,MIU,['3 / Week'], , 
8860,3713,Tecfidera,2016-10-18,,300,MIU,['2 / Day'],IV, 
8861,3713,Tecfidera,2016-10-14,,20, ,['/ Day'], , 
8862,3713,Methylprednisolone,2016-01-13,,1000,mg,[' '],IV, 
8863,3713,Teriflunomide,2016-09-07,2018-02-08, , ,[' '],IV,Patient Choice/Convenience
8864,2509,IVIG,2016-10-22,,300, ,[' '],IV, 
8865,2509,Betaferon,2016-04-04,,300,mg,['/ Day'],IV, 
8866,2509,Rebif [44],2016-09-17,, ,mg,['/Month'], , 
8867,3502,Tecfidera,2016-09-18,,1000,mg,['/Month'],Oral, 
8868,3502,Avonex,2015-12-27,,5000,MIU,['/ Week'], , 
8869,3502,Rebif [44],2016-03-30,2021-10-08,1000,mg,['2 / Day'],Oral,Lack of efficacy
8870,922,Teriflunomide,2016-03-02,2021-06-02,1,MIU,['2 / Day'], ,Adverse Event
8871,1594,Rebif [22],2016-08-06,2019-01-19,1000,mg,['2 / Day'],Oral,Patient Choice/Convenience
8872,1594,IVIG,2016-05-16,,500,mg,['/Month'], , 
8873,1594,Betaferon,2016-02-20,, ,mcg,['/Month'],Oral, 
8874,3042,Gilenya,2016-01-14,2020-05-24,5000,MIU,['2 / Day'],IV,Adverse Event
8875,3042,Rebif [22],2016-08-05,2019-09-20,5000,MIU,['2 / Day'], ,Patient Choice/Convenience
8876,3042,Ledertrexaat,2016-07-09,,5000, ,['/Month'], , 
8877,3042,Betaferon,2016-02-02,2020-06-04, ,mg,['2 / Day'],IV,Adverse Event
8878,589,Rebif [22],2016-07-12,2018-04-03,1,mg,['2 / Day'],IV,Patient Choice/Convenience
8879,589,Methylprednisolone,2015-11-29,,1000, ,['2 / Day'], , 
8880,589,Alemtuzumab (Campath),2016-04-20,,1000,mg,[' '],Oral, 
8881,2744,Teriflunomide,2016-09-06,,500,mg,['/ Day'],IV, 
8882,4554,Methylprednisolone,2016-03-12,,5000,mg,['/ Day'],IV, 
8883,1798,Copaxone,2016-07-25,2020-08-23, ,MIU,['/Month'],Oral,Lack of efficacy
8884,1798,Avonex,2016-06-12,,1000,mcg,[' '], , 
8885,1798,Tecfidera,2015-12-05,,300,MIU,['2 / Day'], , 
8886,1798,Methylprednisolone,2016-01-05,2019-11-16,500,mg,['2 / Day'],IV,Persistence of relapses
8887,3122,IVIG,2016-03-23,,500, ,[' '],Oral, 
8888,3122,Teriflunomide,2016-07-06,2020-12-04,20, ,['2 / Day'],IV,Patient Choice/Convenience
8889,3122,IVIG,2016-10-10,, , ,['/ Week'],IV, 
8890,3714,Rebif [44],2015-11-13,, , ,['/Month'],IV, 
8891,3518,Gilenya,2016-06-01,2017-12-24,5000,mg,['2 / Day'],Oral,Patient Choice/Convenience
8892,3518,Copaxone,2016-08-09,2018-01-06, , ,['/Month'],IV,Adverse Event
8893,4353,Copaxone,2016-02-18,2020-11-16,20,mg,['3 / Week'],IV,Patient Choice/Convenience
8894,4353,Methylprednisolone,2016-04-20,,20,MIU,[' '],Oral, 
8895,3330,Alemtuzumab (Campath),2016-06-13,2021-05-08,500,mg,['/Month'],IV,Patient Choice/Convenience
8896,2779,Rebif [22],2016-01-18,,300, ,['2 / Day'],IV, 
8897,3261,Tysabri,2015-10-27,2021-03-16, ,mg,['2 / Day'],IV,Persisting MRI activity
8898,3261,Tecfidera,2015-11-22,2018-05-11,300,MIU,['2 / Day'], ,Patient Choice/Convenience
8899,3261,Copaxone,2016-02-22,,5000,MIU,['/Month'], , 
8900,4348,Mitoxantrone,2016-06-06,2018-01-11,300,mg,['2 / Day'],IV,Persisting MRI activity
8901,4348,Mitoxantrone,2015-11-26,2021-02-20,500, ,['2 / Day'],IV,Patient Choice/Convenience
8902,4348,Tysabri,2016-05-02,2021-02-07,300,mg,['3 / Week'],Oral,Patient Choice/Convenience
8903,3904,Rebif [44],2016-09-08,2018-04-26,20,mg,['/ Week'], ,Adverse Event
8904,3904,Rebif [22],2016-09-26,2020-02-27,5000, ,['/Month'], ,Adverse Event
8905,3904,Tecfidera,2016-05-14,2019-10-08, , ,['/Month'], ,Patient Choice/Convenience
8906,4866,Rebif [22],2016-10-21,,300,mg,['2 / Day'],Oral, 
8907,1529,Alemtuzumab (Campath),2016-07-08,, ,mg,['/ Day'],IV, 
8908,2033,Rebif [44],2016-09-01,, ,mg,['2 / Day'],IV, 
8909,2033,D-cure (Vitamine D),2015-12-07,, ,mg,['/Month'],IV, 
8910,2349,Methylprednisolone,2016-03-06,2018-05-06,300,mg,['/ Day'],IV,Adverse Event
8911,2349,Tysabri,2016-04-10,,1000,mg,['3 / Week'], , 
8912,2333,Methylprednisolone,2016-02-23,,500,mg,['/Month'], , 
8913,2101,Endoxan,2016-07-20,,500, ,['2 / Day'],Oral, 
8914,2101,Tysabri,2016-06-09,2019-01-04, , ,['/ Day'], ,Persisting MRI activity
8915,1317,Avonex,2016-04-13,2019-08-15, , ,['/ Day'], ,Patient Choice/Convenience
8916,1317,D-cure (Vitamine D),2016-04-30,2021-07-26,1000,mg,['/Month'],Oral,Adverse Event
8917,2077,Tecfidera,2016-10-17,,300,mg,['2 / Day'],IV, 
8918,2077,Methylprednisolone,2016-01-05,2019-12-11, , ,['2 / Day'],IV,Adverse Event
8919,2077,Copaxone,2016-01-27,2020-04-07,20,mg,['/Month'],IV,Persistence of relapses
8920,2077,Gilenya,2015-10-30,2020-05-21,400, ,['2 / Day'],IV,Lack of efficacy
8921,4198,Tysabri,2016-08-01,, ,mg,[' '],IV, 
8922,4198,Ledertrexaat,2016-03-08,,1000, ,['/ Week'],Oral, 
8923,1429,Ledertrexaat,2015-12-04,2019-02-23, ,mg,['3 / Week'], ,Lack of efficacy
8924,1429,IVIG,2015-12-07,,300, ,['/Month'], , 
8925,1429,Betaferon,2016-03-06,2018-09-29,500,mg,['2 / Day'],IV,Lack of efficacy
8926,1429,Methylprednisolone,2016-07-07,,20, ,['/Month'],IV, 
8927,2802,Avonex,2015-11-22,, , ,['/Month'], , 
8928,2802,Rebif [44],2016-04-01,,300,mg,['/ Day'], , 
8929,2802,D-cure (Vitamine D),2016-03-29,,500,mg,['/Month'],IV, 
8930,4597,Gilenya,2016-01-22,,1,mg,['2 / Day'],IV, 
8931,4597,Rebif [44],2016-08-18,2020-01-01, , ,['/Month'],IV,Adverse Event
8932,4597,Rebif [22],2016-05-17,, , ,['/Month'], , 
8933,4597,IVIG,2016-05-19,2017-12-09, , ,['3 / Week'],IV,Adverse Event
8934,4257,IVIG,2016-05-10,, , ,['/ Day'],IV, 
8935,4257,Endoxan,2016-02-08,2017-11-14, , ,['3 / Week'],Oral,Lack of efficacy
8936,3959,Rebif [44],2015-11-29,,1,mg,['/Month'],Oral, 
8937,205,Alemtuzumab (Campath),2016-01-22,,5000,mg,['/ Day'],Oral, 
8938,987,D-cure (Vitamine D),2016-09-17,2019-01-16,300, ,['/Month'], ,Persistence of relapses
8939,987,IVIG,2016-08-21,,5000,mg,[' '], , 
8940,987,Alemtuzumab (Campath),2015-11-27,, ,mg,['2 / Day'],IV, 
8941,1877,Alemtuzumab (Campath),2016-07-20,,1000,mg,['/Month'], , 
8942,1771,Gilenya,2016-04-14,2019-09-10,20, ,['/Month'], ,Adverse Event
8943,1771,Methylprednisolone,2016-10-09,2018-05-18,5000,mg,['2 / Day'], ,Patient Choice/Convenience
8944,1771,Mitoxantrone,2016-02-21,,300,mg,['/Month'],IV, 
8945,1771,Endoxan,2016-04-14,, ,mg,['3 / Week'], , 
8946,1452,Tysabri,2016-01-27,,1000, ,['/Month'],IV, 
8947,1452,IVIG,2016-06-02,2021-03-29,1000, ,['2 / Day'],IV,Adverse Event
8948,666,Mitoxantrone,2016-06-21,, ,MIU,['2 / Day'], , 
8949,666,Avonex,2016-05-06,2020-02-06,1, ,['3 / Week'],IV,Persisting MRI activity
8950,666,Ledertrexaat,2016-06-05,2018-12-27,300,mg,['2 / Day'], ,Patient Choice/Convenience
8951,373,Gilenya,2016-08-17,, ,mcg,['2 / Day'],IV, 
8952,373,IVIG,2016-02-23,2018-01-25,1,mg,[' '], ,Adverse Event
8953,2209,Copaxone,2016-01-10,2019-08-03,5000,mg,['2 / Day'], ,Persistence of relapses
8954,4905,Gilenya,2015-11-20,2018-07-03,1000,mg,['/Month'],IV,Persistence of relapses
8955,4905,Copaxone,2016-01-24,2019-07-25,1, ,['/Month'],IV,Persistence of relapses
8956,4905,Alemtuzumab (Campath),2016-04-13,,1, ,[' '],IV, 
8957,4905,D-cure (Vitamine D),2015-11-18,2019-11-23, , ,['2 / Day'],Oral,Patient Choice/Convenience
8958,1420,Betaferon,2016-08-05,, ,mg,['2 / Day'], , 
8959,1420,Alemtuzumab (Campath),2016-10-08,,300,mg,['/Month'], , 
8960,4756,D-cure (Vitamine D),2016-01-10,2019-03-19,500,mg,[' '], ,Persisting MRI activity
8961,3870,D-cure (Vitamine D),2016-09-18,,20,MIU,[' '], , 
8962,3870,Endoxan,2016-09-18,2020-07-23,5000,MIU,['3 / Week'],IV,Adverse Event
8963,3870,IVIG,2016-10-01,, , ,['/Month'],IV, 
8964,3870,Tecfidera,2016-07-04,2020-04-04,300, ,['/ Day'],IV,Patient Choice/Convenience
8965,4479,Endoxan,2015-12-02,2019-07-08,5000, ,['/Month'], ,Lack of efficacy
8966,2089,Ledertrexaat,2016-10-20,,300, ,['/Month'],IV, 
8967,2089,Teriflunomide,2016-08-24,,400,mg,['/ Day'], , 
8968,2089,Methylprednisolone,2016-05-18,2021-06-25,300, ,['3 / Week'],Oral,Adverse Event
8969,3713,Gilenya,2015-12-29,,1000,mg,['/Month'],IV, 
8970,3713,Teriflunomide,2016-07-05,,1, ,['3 / Week'], , 
8971,554,Copaxone,2016-02-01,2021-06-25, ,mcg,['/ Week'], ,Adverse Event
8972,554,Avonex,2015-11-15,, ,mg,['/ Week'],IV, 
8973,3801,Tecfidera,2015-11-13,,500,mg,['/ Day'], , 
8974,3801,Tecfidera,2015-11-20,,1,mg,['/ Day'], , 
8975,3801,Rebif [22],2016-04-30,2020-12-23,20, ,[' '],IV,Patient Choice/Convenience
8976,3801,Betaferon,2016-02-16,,1, ,['2 / Day'],IV, 
8977,4726,Tysabri,2016-07-24,,500,mg,['/ Week'],IV, 
8978,4726,Tysabri,2015-12-11,,400,mcg,['2 / Day'], , 
8979,4726,Gilenya,2016-08-25,2021-10-03,1,mg,['/Month'],Oral,Patient Choice/Convenience
8980,4726,Alemtuzumab (Campath),2016-01-22,, , ,['2 / Day'],IV, 
8981,1490,Rebif [22],2016-01-24,2021-02-26,1,MIU,['2 / Day'], ,Lack of efficacy
8982,3148,Rebif [22],2015-12-24,,300, ,['2 / Day'],IV, 
8983,3148,Rebif [22],2016-06-25,, ,mg,[' '],IV, 
8984,1410,Methylprednisolone,2015-12-23,,500,mg,['2 / Day'], , 
8985,1410,Mitoxantrone,2016-08-04,,300,mg,['/ Day'], , 
8986,1410,Betaferon,2016-09-20,,300,MIU,['/ Week'],Oral, 
8987,1410,Gilenya,2016-06-12,,400, ,[' '], , 
8988,4352,IVIG,2016-09-03,,20,MIU,['/ Week'],IV, 
8989,4352,Endoxan,2015-11-18,2018-04-12,500,mg,[' '],Oral,Adverse Event
8990,3111,Tysabri,2016-07-13,,1000, ,['/Month'],IV, 
8991,3111,Tecfidera,2016-06-08,2018-11-01,1000,mg,['/Month'],Oral,Persisting MRI activity
8992,3111,Betaferon,2016-03-01,, ,mg,['/ Day'],Oral, 
8993,3361,D-cure (Vitamine D),2016-02-25,2019-01-10,300, ,['/ Day'], ,Patient Choice/Convenience
8994,3361,Ledertrexaat,2016-02-23,,300,mg,[' '],IV, 
8995,3361,Gilenya,2015-11-06,, ,mg,['/Month'], , 
8996,1878,Betaferon,2016-09-07,,5000,mcg,['/ Day'],IV, 
8997,1878,Tecfidera,2015-11-20,, , ,['/Month'], , 
8998,1878,Avonex,2016-02-17,,5000, ,['3 / Week'],IV, 
8999,1878,Tecfidera,2016-07-31,,500, ,['/Month'], , 
9000,2366,Tecfidera,2016-04-22,, ,mg,['/Month'],Oral, 
9001,2366,Methylprednisolone,2015-11-05,,5000,mg,[' '], , 
9002,4479,Methylprednisolone,2015-12-11,,400,mcg,['2 / Day'],IV, 
9003,4479,D-cure (Vitamine D),2016-09-06,2021-07-17,1, ,['2 / Day'],IV,Patient Choice/Convenience
9004,2741,IVIG,2015-11-05,, ,mg,['2 / Day'], , 
9005,4839,Rebif [22],2015-12-22,2018-02-28, , ,[' '], ,Adverse Event
9006,4345,Endoxan,2016-06-28,2020-05-27,500,mg,['2 / Day'],IV,Patient Choice/Convenience
9007,4345,Avonex,2016-05-16,2019-06-02, ,mcg,['/Month'],IV,Adverse Event
9008,1731,Teriflunomide,2016-03-28,,1,mg,['2 / Day'],IV, 
9009,1731,Copaxone,2016-09-11,, , ,['2 / Day'], , 
9010,2006,Betaferon,2015-11-30,, , ,['/Month'], , 
9011,2006,Rebif [22],2016-06-15,2018-08-06, , ,['/Month'],IV,Patient Choice/Convenience
9012,2006,Rebif [44],2016-07-09,, , ,['/ Week'], , 
9013,2143,Rebif [22],2016-03-17,,300,mg,['3 / Week'],IV, 
9014,2143,Avonex,2016-03-23,2020-01-08, ,mg,['/Month'], ,Lack of efficacy
9015,2905,Rebif [22],2015-10-26,2020-06-21,1, ,['2 / Day'], ,Persisting MRI activity
9016,2905,Rebif [44],2015-12-25,,20, ,['/Month'], , 
9017,687,Betaferon,2015-12-04,, ,MIU,['/Month'],IV, 
9018,687,Rebif [44],2015-11-09,, ,mg,['2 / Day'],IV, 
9019,687,Methylprednisolone,2016-06-11,, , ,['/Month'],IV, 
9020,687,Copaxone,2016-07-19,, ,mcg,['/Month'],IV, 
9021,268,IVIG,2016-08-23,, , ,['3 / Week'], , 
9022,268,D-cure (Vitamine D),2016-09-08,2021-02-02,20,mg,['3 / Week'],Oral,Adverse Event
9023,268,IVIG,2016-05-01,,500, ,['/Month'],IV, 
9024,2655,Rebif [44],2015-11-17,,1,mg,['/Month'],IV, 
9025,4175,Tecfidera,2016-04-13,, ,mg,[' '], , 
9026,4175,IVIG,2016-07-09,,500, ,['/Month'],Oral, 
9027,4175,Rebif [22],2016-07-14,2018-10-25,1,mg,[' '], ,Adverse Event
9028,4175,Betaferon,2016-02-11,,5000,mg,['3 / Week'],IV, 
9029,3289,Alemtuzumab (Campath),2016-03-05,2020-07-26,5000, ,['3 / Week'], ,Lack of efficacy
9030,3289,Alemtuzumab (Campath),2015-12-19,2019-05-15,1000, ,['/Month'],IV,Adverse Event
9031,3289,Mitoxantrone,2016-04-12,2021-04-02,300,mcg,['/Month'], ,Patient Choice/Convenience
9032,3289,Tecfidera,2015-11-09,2020-12-19, ,mcg,['2 / Day'],IV,Lack of efficacy
9033,3064,Betaferon,2016-03-28,,400,mg,['/Month'],IV, 
9034,3064,Teriflunomide,2016-07-04,2019-06-21,500, ,['/Month'],IV,Adverse Event
9035,3064,Betaferon,2016-05-24,2018-05-08,400,mg,[' '],IV,Adverse Event
9036,4991,Tecfidera,2016-04-15,,1000, ,['2 / Day'],IV, 
9037,4991,Alemtuzumab (Campath),2016-10-16,,400, ,['/Month'],IV, 
9038,4991,D-cure (Vitamine D),2015-10-29,2018-08-06, ,mg,['/ Day'], ,Patient Choice/Convenience
9039,4991,D-cure (Vitamine D),2016-06-15,2018-04-15, ,mg,['2 / Day'],IV,Adverse Event
9040,1921,Copaxone,2015-12-08,,400,mg,[' '],Oral, 
9041,1921,Copaxone,2016-06-20,,500,mcg,['3 / Week'],IV, 
9042,4149,Ledertrexaat,2016-01-27,2019-04-30, ,mg,['/ Week'],IV,Patient Choice/Convenience
9043,1964,Avonex,2016-07-31,2020-10-24,1000,mcg,['/Month'], ,Adverse Event
9044,1964,Tecfidera,2016-08-11,2021-06-30,500,MIU,['/Month'],IV,Persisting MRI activity
9045,1817,IVIG,2016-05-28,2021-02-09,400,mcg,['/Month'], ,Adverse Event
9046,1817,Rebif [44],2016-04-03,2018-10-01,5000,mg,['2 / Day'],IV,Lack of efficacy
9047,1817,Gilenya,2015-12-27,2020-04-14,1,mg,[' '],IV,Persisting MRI activity
9048,1817,Tysabri,2015-11-27,,20, ,['2 / Day'],IV, 
9049,2406,Tysabri,2015-12-30,2019-01-17, ,mcg,['2 / Day'], ,Patient Choice/Convenience
9050,2406,Gilenya,2016-09-08,,300, ,['/Month'],IV, 
9051,2406,Gilenya,2016-07-21,,500, ,['/Month'],Oral, 
9052,3407,Betaferon,2016-06-03,,1000, ,[' '],IV, 
9053,3407,Endoxan,2016-05-09,2021-06-07,5000,MIU,['/Month'],Oral,Patient Choice/Convenience
9054,3407,Gilenya,2015-11-23,, ,mg,[' '],IV, 
9055,275,Gilenya,2016-07-01,2019-12-01,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
9056,275,D-cure (Vitamine D),2015-11-09,, ,mg,['2 / Day'],IV, 
9057,347,Endoxan,2016-08-29,2018-05-30,1000,mg,['/Month'],Oral,Adverse Event
9058,347,Rebif [44],2015-11-14,,1,mg,['2 / Day'], , 
9059,347,Teriflunomide,2016-07-25,, , ,['/Month'],IV, 
9060,347,Ledertrexaat,2016-02-28,,1000,MIU,['2 / Day'],IV, 
9061,820,Alemtuzumab (Campath),2016-02-11,2018-08-08,1000,mg,['/Month'],Oral,Adverse Event
9062,820,Tysabri,2015-10-28,2020-12-09, , ,['3 / Week'],IV,Persisting MRI activity
9063,4759,Ledertrexaat,2016-09-12,,5000,mcg,['/Month'],IV, 
9064,4759,Rebif [22],2015-12-13,2018-08-05,500, ,['2 / Day'],Oral,Persistence of relapses
9065,4759,Methylprednisolone,2015-11-24,2018-12-11, ,mg,['2 / Day'],IV,Adverse Event
9066,4567,Ledertrexaat,2016-10-11,2021-05-07, ,mg,['3 / Week'], ,Adverse Event
9067,4567,Rebif [22],2015-11-24,2018-04-16,400,mg,['/Month'],IV,Adverse Event
9068,1008,Methylprednisolone,2016-05-04,2018-06-23,20,MIU,[' '],IV,Persisting MRI activity
9069,1008,Tysabri,2016-05-21,2019-05-22,500, ,['/Month'],IV,Patient Choice/Convenience
9070,1008,Ledertrexaat,2016-08-29,,500,mcg,['/Month'],IV, 
9071,3855,Ledertrexaat,2016-06-28,, ,MIU,['3 / Week'], , 
9072,3855,Methylprednisolone,2016-10-11,,300,mg,['2 / Day'],IV, 
9073,3855,Rebif [22],2015-10-29,2021-08-19, ,mg,['/Month'], ,Adverse Event
9074,3855,Endoxan,2016-03-01,2019-11-11,500,MIU,[' '],IV,Adverse Event
9075,1275,Tecfidera,2015-10-31,, , ,['2 / Day'],IV, 
9076,1275,Avonex,2016-06-28,,500,mg,['/ Day'],IV, 
9077,844,Copaxone,2016-03-10,2018-06-10,500,mg,['2 / Day'],IV,Adverse Event
9078,844,D-cure (Vitamine D),2016-07-17,,20,MIU,['/Month'], , 
9079,3644,Tecfidera,2015-12-02,2018-09-19,5000,mcg,['3 / Week'], ,Persisting MRI activity
9080,4671,Ledertrexaat,2016-05-02,,1000,mg,['3 / Week'],IV, 
9081,4214,Alemtuzumab (Campath),2016-04-17,2017-12-28,20, ,['2 / Day'],Oral,Lack of efficacy
9082,4214,D-cure (Vitamine D),2015-11-18,, ,mg,['/ Day'], , 
9083,4214,D-cure (Vitamine D),2015-12-14,, ,mg,['/Month'], , 
9084,4214,Rebif [22],2016-01-04,,1,mg,['2 / Day'], , 
9085,1644,D-cure (Vitamine D),2016-05-14,,300, ,['/Month'], , 
9086,4760,Avonex,2016-09-22,2019-03-25,1000, ,['/Month'],IV,Lack of efficacy
9087,4760,Methylprednisolone,2016-03-30,2020-10-08,1, ,['2 / Day'], ,Persisting MRI activity
9088,1871,Methylprednisolone,2016-08-29,,500, ,['/Month'],IV, 
9089,1871,D-cure (Vitamine D),2016-10-02,,500,mg,['2 / Day'],IV, 
9090,2009,Gilenya,2016-08-16,,1000,mg,['2 / Day'],IV, 
9091,2009,Mitoxantrone,2016-08-04,,1,mg,['2 / Day'], , 
9092,2009,D-cure (Vitamine D),2016-08-22,2021-02-10, , ,['3 / Week'],IV,Adverse Event
9093,2009,Avonex,2015-12-30,2019-06-16, ,MIU,['3 / Week'], ,Lack of efficacy
9094,3981,Mitoxantrone,2016-02-29,2018-09-29,400,mg,['2 / Day'], ,Adverse Event
9095,1960,Avonex,2016-04-25,2020-03-12,300,mg,['/Month'],IV,Adverse Event
9096,1960,Rebif [22],2016-01-16,2019-10-12,1000, ,[' '],IV,Adverse Event
9097,1960,Methylprednisolone,2015-11-26,,5000, ,['/Month'],IV, 
9098,1960,Betaferon,2016-05-22,2021-06-25,5000,MIU,['/Month'],Oral,Lack of efficacy
9099,3766,D-cure (Vitamine D),2015-10-24,,5000,mg,['/Month'],IV, 
9100,3766,Endoxan,2015-12-03,,300, ,['/ Week'],Oral, 
9101,3766,Tysabri,2016-04-16,, ,mg,['3 / Week'], , 
9102,3766,D-cure (Vitamine D),2015-11-16,2020-04-14,20,MIU,['3 / Week'],IV,Adverse Event
9103,1079,Betaferon,2016-06-30,2018-12-02,1,MIU,['2 / Day'], ,Adverse Event
9104,1079,Rebif [44],2015-12-08,2019-10-09, ,MIU,['/Month'],IV,Persisting MRI activity
9105,4293,Endoxan,2016-05-22,2018-10-19,500, ,['/ Day'],IV,Persisting MRI activity
9106,4293,Methylprednisolone,2016-09-02,2020-05-29, ,MIU,[' '],IV,Lack of efficacy
9107,4293,Rebif [22],2016-08-08,2021-07-27, ,mg,['/ Day'], ,Persistence of relapses
9108,4351,Endoxan,2016-07-04,, ,mg,['/Month'], , 
9109,4351,Ledertrexaat,2016-09-29,2018-10-16, ,mg,['2 / Day'], ,Adverse Event
9110,4351,Tysabri,2015-12-28,2020-12-12,5000,mg,['/ Day'],IV,Persisting MRI activity
9111,4351,Ledertrexaat,2016-08-03,,20,mg,['2 / Day'],IV, 
9112,4482,Betaferon,2016-04-11,, ,MIU,[' '],IV, 
9113,4482,Alemtuzumab (Campath),2016-05-19,2020-02-12,1000, ,['3 / Week'], ,Adverse Event
9114,4482,Tecfidera,2016-10-11,,5000,mg,['/ Day'], , 
9115,2951,Alemtuzumab (Campath),2016-04-22,2020-10-07,1000, ,['2 / Day'], ,Persisting MRI activity
9116,2336,D-cure (Vitamine D),2016-06-09,,1, ,['/ Day'],Oral, 
9117,2119,Endoxan,2016-08-02,2020-03-01,5000, ,['/ Week'],IV,Adverse Event
9118,610,Ledertrexaat,2016-04-10,2018-05-12,1,MIU,['/Month'], ,Persisting MRI activity
9119,610,D-cure (Vitamine D),2016-10-11,2021-05-30, ,mg,['/Month'],IV,Adverse Event
9120,3927,Tysabri,2016-10-17,2018-11-09,1,MIU,['2 / Day'], ,Lack of efficacy
9121,581,IVIG,2015-11-13,2019-08-18,500,mcg,['2 / Day'], ,Patient Choice/Convenience
9122,581,Teriflunomide,2016-07-11,,5000,mg,['/Month'],Oral, 
9123,581,Copaxone,2016-08-13,2018-10-14,400, ,['/Month'],Oral,Lack of efficacy
9124,3102,Rebif [44],2016-08-04,,1000,mg,['2 / Day'],IV, 
9125,3102,Tysabri,2015-12-23,,1000,mg,['3 / Week'],IV, 
9126,3102,Betaferon,2016-03-09,,20,mcg,[' '], , 
9127,3102,Betaferon,2015-11-16,2018-10-29,1000, ,['2 / Day'],IV,Patient Choice/Convenience
9128,1040,Tysabri,2016-04-26,2018-12-26,20,mg,['/Month'],IV,Persisting MRI activity
9129,1040,Betaferon,2016-03-10,,5000,mg,[' '],Oral, 
9130,1040,Methylprednisolone,2016-04-24,2021-05-27,300, ,['/Month'],Oral,Persisting MRI activity
9131,2744,Tysabri,2015-11-06,,20,MIU,[' '],IV, 
9132,3740,IVIG,2016-02-19,2019-01-31,500,mcg,['2 / Day'],IV,Adverse Event
9133,3740,Endoxan,2016-10-17,2018-01-03,300,mg,['2 / Day'], ,Lack of efficacy
9134,201,Tysabri,2016-06-11,, ,mg,['3 / Week'], , 
9135,201,Endoxan,2016-01-13,,500,mg,['/ Week'], , 
9136,4564,D-cure (Vitamine D),2016-04-06,2020-07-31,300,MIU,['2 / Day'],Oral,Persisting MRI activity
9137,135,Tecfidera,2016-04-29,,20,MIU,['/ Day'],Oral, 
9138,1915,Avonex,2016-01-04,,5000,mg,['/Month'],IV, 
9139,1915,Rebif [44],2016-06-02,, , ,['3 / Week'], , 
9140,1915,Avonex,2016-02-01,2018-07-18, ,mg,['/Month'], ,Adverse Event
9141,4422,Alemtuzumab (Campath),2015-10-24,,300, ,['/Month'], , 
9142,4422,Teriflunomide,2016-08-26,, ,mg,['/Month'], , 
9143,4422,Rebif [44],2015-12-22,2018-02-28, , ,['/ Day'], ,Patient Choice/Convenience
9144,4422,Endoxan,2015-10-31,,300,mg,['2 / Day'],IV, 
9145,1193,D-cure (Vitamine D),2016-08-01,2019-10-24,400,mg,['2 / Day'],IV,Patient Choice/Convenience
9146,1193,Endoxan,2015-12-30,2020-02-26, ,mg,['/Month'], ,Lack of efficacy
9147,1193,Mitoxantrone,2016-07-16,2020-03-31,1000,mg,['2 / Day'], ,Persisting MRI activity
9148,4967,Methylprednisolone,2016-04-01,,20, ,['2 / Day'], , 
9149,4967,Teriflunomide,2015-12-19,2018-12-31, ,mg,['/Month'],IV,Adverse Event
9150,4967,IVIG,2016-09-07,2017-12-22,500, ,[' '], ,Patient Choice/Convenience
9151,3842,Mitoxantrone,2016-03-26,,20,mg,[' '],Oral, 
9152,3842,Avonex,2016-03-23,2021-07-16,20, ,[' '],IV,Lack of efficacy
9153,3842,Rebif [22],2015-11-19,,20, ,['/ Week'], , 
9154,3346,Tysabri,2016-08-06,, , ,['3 / Week'],IV, 
9155,3346,IVIG,2016-01-19,,5000,mg,['/ Week'],IV, 
9156,3346,Endoxan,2016-02-24,,300,MIU,['2 / Day'],IV, 
9157,3346,D-cure (Vitamine D),2016-10-15,,5000,mg,['2 / Day'], , 
9158,2372,Copaxone,2016-03-11,,500,mg,['2 / Day'],IV, 
9159,2372,Ledertrexaat,2016-02-04,,5000,mg,['/ Week'],IV, 
9160,2372,Endoxan,2016-08-02,,5000,MIU,['2 / Day'], , 
9161,2372,D-cure (Vitamine D),2016-04-11,, , ,['/ Week'],Oral, 
9162,189,Gilenya,2016-04-04,,1,mg,['/Month'],IV, 
9163,4425,IVIG,2016-04-07,2021-01-31, , ,['/Month'], ,Persisting MRI activity
9164,3424,Teriflunomide,2016-02-11,,1, ,[' '], , 
9165,3424,Rebif [44],2015-12-27,2018-03-15,1000,mg,['/Month'],Oral,Patient Choice/Convenience
9166,3424,Rebif [44],2016-03-30,,20, ,['/ Day'], , 
9167,3875,Methylprednisolone,2016-10-16,2021-07-02, , ,['/Month'], ,Persistence of relapses
9168,3875,Gilenya,2016-07-18,,500, ,['/Month'], , 
9169,369,D-cure (Vitamine D),2016-06-07,2020-03-15, , ,[' '],Oral,Persistence of relapses
9170,369,Endoxan,2016-05-25,,5000,mg,['/Month'],Oral, 
9171,4968,Gilenya,2016-05-18,2019-11-28,300,mcg,['/Month'],IV,Persisting MRI activity
9172,4968,Tysabri,2015-10-29,2020-08-07, , ,['/Month'],IV,Adverse Event
9173,4968,Betaferon,2016-06-13,, , ,['/Month'],IV, 
9174,4141,D-cure (Vitamine D),2016-09-04,,1,mcg,['2 / Day'],IV, 
9175,4141,Alemtuzumab (Campath),2016-10-18,2020-03-18,400, ,['/Month'],Oral,Persisting MRI activity
9176,4141,IVIG,2015-11-17,, ,mg,[' '],IV, 
9177,431,Alemtuzumab (Campath),2016-01-07,2020-10-18,500, ,['/Month'], ,Patient Choice/Convenience
9178,431,Rebif [22],2016-03-07,2018-09-27,1,mg,['/ Day'],IV,Adverse Event
9179,431,Tysabri,2016-01-01,2017-12-11,5000, ,['2 / Day'], ,Lack of efficacy
9180,4573,D-cure (Vitamine D),2016-06-17,2018-04-06,20,MIU,['/Month'],IV,Lack of efficacy
9181,4573,Teriflunomide,2016-08-25,,1, ,['/Month'], , 
9182,4628,Rebif [22],2016-03-26,2018-06-27, , ,['/Month'],IV,Persistence of relapses
9183,4628,Teriflunomide,2016-08-20,, ,mg,['/Month'],IV, 
9184,2951,Mitoxantrone,2016-01-06,2021-09-10,1,MIU,['/Month'],Oral,Lack of efficacy
9185,2951,D-cure (Vitamine D),2016-10-11,2020-05-25,1000, ,[' '],IV,Persisting MRI activity
9186,2951,Betaferon,2016-02-05,,500,mg,['2 / Day'],IV, 
9187,3406,Gilenya,2016-08-18,2019-09-12,500, ,['2 / Day'],IV,Persisting MRI activity
9188,2599,Rebif [22],2016-04-12,2020-02-16,20,MIU,['3 / Week'], ,Persisting MRI activity
9189,2599,Rebif [44],2016-04-23,, ,mg,['/ Day'],IV, 
9190,2599,Rebif [44],2016-08-16,2021-09-24,20,mg,['2 / Day'], ,Persisting MRI activity
9191,1922,Avonex,2016-04-09,2020-05-04, ,mg,['2 / Day'],IV,Patient Choice/Convenience
9192,630,Copaxone,2015-11-22,,1000, ,['/Month'],IV, 
9193,3796,Gilenya,2016-05-28,2018-04-05,1,mg,['2 / Day'],Oral,Persistence of relapses
9194,3796,Betaferon,2016-01-02,,300,mg,['/Month'],IV, 
9195,1204,Avonex,2016-07-30,, ,mg,['3 / Week'], , 
9196,1204,Gilenya,2015-11-05,, , ,['/Month'],Oral, 
9197,1718,Betaferon,2016-03-15,2018-01-07,300,mg,['2 / Day'],IV,Patient Choice/Convenience
9198,410,Avonex,2016-10-10,,20, ,['2 / Day'],IV, 
9199,410,Gilenya,2015-11-23,, ,mg,['3 / Week'], , 
9200,410,Rebif [22],2016-09-02,2021-07-09,20,mg,[' '], ,Patient Choice/Convenience
9201,410,Teriflunomide,2016-08-10,2018-05-29,1,mcg,['3 / Week'], ,Persisting MRI activity
9202,604,Alemtuzumab (Campath),2016-04-14,,1000, ,['2 / Day'],IV, 
9203,604,Rebif [44],2015-10-26,,20,MIU,[' '], , 
9204,4476,IVIG,2016-08-19,2017-11-22,1000, ,['3 / Week'],IV,Patient Choice/Convenience
9205,4476,Rebif [44],2016-08-29,2020-06-21,500, ,['/Month'],IV,Adverse Event
9206,4476,IVIG,2016-09-27,2020-05-02,20, ,['/Month'],Oral,Patient Choice/Convenience
9207,3654,Rebif [22],2016-07-18,,300,mg,['/Month'],IV, 
9208,3654,Alemtuzumab (Campath),2016-07-25,,20, ,['2 / Day'],Oral, 
9209,3654,Tecfidera,2015-11-21,,400, ,['2 / Day'],IV, 
9210,3654,Tysabri,2016-04-14,2019-07-11,1,mcg,['/Month'],IV,Patient Choice/Convenience
9211,1916,Gilenya,2016-03-06,2019-05-23,500, ,['2 / Day'], ,Persisting MRI activity
9212,1916,Rebif [22],2015-10-30,,1000, ,['/Month'], , 
9213,1916,Rebif [22],2016-01-07,,1, ,['/Month'],IV, 
9214,1916,Avonex,2015-11-23,,1000,mg,['/Month'],IV, 
9215,2712,IVIG,2016-08-23,2021-05-04, ,mg,['/Month'], ,Adverse Event
9216,1375,Gilenya,2015-11-15,2018-09-25,20,mg,['2 / Day'], ,Lack of efficacy
9217,1375,Ledertrexaat,2015-11-29,2020-07-15, , ,['3 / Week'],IV,Patient Choice/Convenience
9218,1375,Tecfidera,2016-02-20,2018-08-02, ,mcg,['/Month'], ,Patient Choice/Convenience
9219,1492,Tecfidera,2016-06-09,,500,mcg,['/ Day'], , 
9220,1492,Rebif [44],2016-04-09,2021-08-07,1, ,['/ Day'],IV,Adverse Event
9221,2690,Avonex,2016-02-23,2019-11-08,20,MIU,['/Month'], ,Persisting MRI activity
9222,2690,Gilenya,2016-01-14,,500, ,['/Month'],IV, 
9223,2690,Tysabri,2016-04-03,2021-05-17,1000,mg,['/Month'],IV,Adverse Event
9224,811,Rebif [22],2015-11-05,, ,mg,['2 / Day'],IV, 
9225,1890,Methylprednisolone,2015-12-28,,300, ,['2 / Day'], , 
9226,1890,D-cure (Vitamine D),2016-07-20,2021-10-03,20,mcg,[' '],IV,Lack of efficacy
9227,1890,Rebif [22],2016-05-08,,300, ,['2 / Day'],IV, 
9228,1890,Copaxone,2016-09-02,2021-03-17,500,mg,['3 / Week'],IV,Patient Choice/Convenience
9229,357,Rebif [22],2016-04-16,2020-06-10, , ,['2 / Day'], ,Lack of efficacy
9230,357,Tysabri,2016-06-28,,1000,mg,['/ Week'], , 
9231,357,Rebif [22],2016-08-29,, , ,['2 / Day'],Oral, 
9232,357,Mitoxantrone,2016-09-04,2021-10-17,1000,mcg,['/Month'], ,Lack of efficacy
9233,4339,Rebif [22],2016-04-08,,1000,mg,['2 / Day'],IV, 
9234,698,IVIG,2016-05-31,2020-09-25,500,MIU,['/ Week'],IV,Adverse Event
9235,698,D-cure (Vitamine D),2016-05-09,2019-11-28,1000, ,['/ Day'],IV,Adverse Event
9236,698,Copaxone,2016-09-13,,300,mg,['2 / Day'],IV, 
9237,698,Ledertrexaat,2016-07-05,,1, ,[' '], , 
9238,1417,D-cure (Vitamine D),2016-03-13,2019-01-29, ,MIU,[' '],IV,Patient Choice/Convenience
9239,1417,Alemtuzumab (Campath),2016-08-08,2019-12-20,300,mg,['3 / Week'],Oral,Lack of efficacy
9240,1417,D-cure (Vitamine D),2016-02-02,,20, ,['2 / Day'],IV, 
9241,1417,Copaxone,2016-06-06,,1,mcg,['2 / Day'],Oral, 
9242,4089,Alemtuzumab (Campath),2016-09-21,2018-07-11, ,mg,[' '],IV,Patient Choice/Convenience
9243,4089,IVIG,2015-12-12,2018-10-05,1000,MIU,['3 / Week'], ,Adverse Event
9244,4089,Methylprednisolone,2016-01-15,2020-11-19,1000,mg,['/ Week'], ,Persisting MRI activity
9245,4905,Tysabri,2016-03-20,, ,mg,['2 / Day'],IV, 
9246,2773,Teriflunomide,2016-06-10,2019-08-27, ,MIU,[' '],IV,Persisting MRI activity
9247,2773,Rebif [44],2015-12-08,2019-01-13,300,mg,['2 / Day'],IV,Lack of efficacy
9248,2773,Tecfidera,2016-01-02,,300,MIU,['3 / Week'],IV, 
9249,2773,Alemtuzumab (Campath),2015-10-28,,5000,mg,['3 / Week'],Oral, 
9250,4169,Ledertrexaat,2016-05-10,,400,mg,['3 / Week'], , 
9251,4169,Mitoxantrone,2016-09-27,2019-12-19,500,MIU,[' '],IV,Lack of efficacy
9252,2376,IVIG,2016-03-15,, , ,[' '],IV, 
9253,2376,D-cure (Vitamine D),2016-02-08,,20,mg,[' '],IV, 
9254,1043,Tecfidera,2016-07-15,2021-05-23,5000,mg,['/Month'],IV,Patient Choice/Convenience
9255,1043,Rebif [22],2016-02-18,2019-03-13,1000,mg,['3 / Week'], ,Lack of efficacy
9256,2199,Methylprednisolone,2015-11-20,, ,MIU,['2 / Day'], , 
9257,3843,D-cure (Vitamine D),2016-05-11,2019-08-15,300, ,['/Month'],IV,Lack of efficacy
9258,2835,Tecfidera,2016-09-22,, , ,['3 / Week'], , 
9259,2835,Ledertrexaat,2016-03-17,2020-01-05,300, ,['3 / Week'], ,Adverse Event
9260,2835,Rebif [44],2016-02-07,, ,MIU,['2 / Day'],IV, 
9261,969,Rebif [44],2016-03-26,2018-07-11,400,MIU,['/Month'], ,Adverse Event
9262,3776,Rebif [44],2016-02-26,2017-12-09, , ,['/Month'],Oral,Lack of efficacy
9263,3776,Tysabri,2016-02-19,,500, ,['2 / Day'],IV, 
9264,1749,Endoxan,2015-11-19,, ,mg,[' '], , 
9265,1749,Gilenya,2016-08-25,2021-08-09, , ,['3 / Week'], ,Persisting MRI activity
9266,2011,Tecfidera,2016-04-12,,500,mg,['/Month'],IV, 
9267,2011,Copaxone,2016-10-16,2021-02-04,20,mg,['/Month'],IV,Persisting MRI activity
9268,2011,Tysabri,2016-09-02,2020-03-22, ,MIU,['/Month'], ,Adverse Event
9269,2011,D-cure (Vitamine D),2016-09-06,2019-08-30,500, ,['/ Day'], ,Persisting MRI activity
9270,2872,Alemtuzumab (Campath),2016-10-06,2019-08-30, ,mg,['3 / Week'], ,Adverse Event
9271,2872,IVIG,2016-05-09,2019-12-21,400,mg,['3 / Week'],IV,Patient Choice/Convenience
9272,2872,IVIG,2016-09-04,,20, ,[' '], , 
9273,2872,Gilenya,2016-07-16,,300,mcg,['2 / Day'],Oral, 
9274,3691,Endoxan,2016-10-10,,5000,MIU,['2 / Day'],IV, 
9275,3691,Betaferon,2016-03-26,,1000,mg,['2 / Day'], , 
9276,1748,Endoxan,2016-10-01,,5000,MIU,['2 / Day'],IV, 
9277,1748,Endoxan,2016-04-26,,300, ,['/Month'],Oral, 
9278,1748,Methylprednisolone,2016-10-17,2019-09-23,300,MIU,[' '],Oral,Adverse Event
9279,1748,Tysabri,2016-01-28,2020-01-31,300,mg,['/Month'], ,Adverse Event
9280,947,Teriflunomide,2015-10-30,, ,mg,[' '],IV, 
9281,2782,Methylprednisolone,2016-09-10,, ,MIU,['/Month'], , 
9282,4343,Mitoxantrone,2016-08-19,,500, ,['2 / Day'], , 
9283,4343,Methylprednisolone,2015-12-27,2018-02-14,500,mg,['/Month'],Oral,Adverse Event
9284,4343,Endoxan,2016-09-26,,1000,mg,[' '],IV, 
9285,4343,Rebif [44],2016-06-26,, ,mg,[' '],IV, 
9286,3825,Tysabri,2016-10-08,2021-04-25,20,mg,['/ Day'], ,Persisting MRI activity
9287,491,IVIG,2016-06-04,2021-09-09,1,mg,['/Month'],IV,Adverse Event
9288,491,Ledertrexaat,2015-11-01,2021-08-07,300,MIU,['3 / Week'],IV,Persistence of relapses
9289,491,IVIG,2016-02-11,, ,mg,['2 / Day'],IV, 
9290,4851,Gilenya,2015-12-17,,5000, ,['2 / Day'],IV, 
9291,309,Avonex,2016-07-28,,20, ,['2 / Day'],IV, 
9292,309,Gilenya,2015-11-25,,20,mg,['3 / Week'],IV, 
9293,309,Alemtuzumab (Campath),2016-02-09,2021-09-04,20, ,['/Month'], ,Patient Choice/Convenience
9294,309,Copaxone,2016-04-25,, , ,['2 / Day'],Oral, 
9295,1444,Copaxone,2016-01-01,, ,mg,['2 / Day'],IV, 
9296,1444,Tysabri,2016-05-01,, ,mg,['2 / Day'], , 
9297,1444,Mitoxantrone,2015-12-28,2019-03-30,20,MIU,['3 / Week'],Oral,Persistence of relapses
9298,4366,Tysabri,2016-07-21,,300,mcg,['/ Day'],Oral, 
9299,4366,Gilenya,2016-04-20,,5000, ,['/Month'], , 
9300,3883,D-cure (Vitamine D),2015-12-13,2021-04-03,20,mg,['2 / Day'],Oral,Adverse Event
9301,3883,Methylprednisolone,2016-07-07,,1000, ,['3 / Week'],IV, 
9302,3883,Methylprednisolone,2016-08-31,2017-12-21,20, ,['2 / Day'], ,Patient Choice/Convenience
9303,3883,Copaxone,2016-09-10,, ,mg,['2 / Day'], , 
9304,825,Tecfidera,2016-03-17,, ,mg,['/Month'], , 
9305,825,Betaferon,2016-01-21,2020-05-04, , ,['/Month'],IV,Persistence of relapses
9306,825,Rebif [44],2016-10-16,2020-02-04,1000,mcg,['2 / Day'], ,Adverse Event
9307,495,Alemtuzumab (Campath),2016-09-23,,1000,mg,['2 / Day'],IV, 
9308,4963,Rebif [22],2016-09-20,2019-11-05,500,mg,['/ Week'],IV,Adverse Event
9309,4963,Tysabri,2016-01-12,2018-03-20,1,mg,['2 / Day'], ,Lack of efficacy
9310,4963,Alemtuzumab (Campath),2016-07-07,,1000, ,['2 / Day'], , 
9311,1529,Endoxan,2016-07-13,,1000,mg,['/Month'], , 
9312,1529,Methylprednisolone,2016-03-18,, ,mcg,['/ Week'], , 
9313,3213,Betaferon,2015-11-13,2021-07-09,5000,mg,['2 / Day'],Oral,Persisting MRI activity
9314,3213,Alemtuzumab (Campath),2016-05-23,,5000, ,['2 / Day'],IV, 
9315,4565,Gilenya,2015-11-30,2021-06-24,1, ,['/ Day'], ,Patient Choice/Convenience
9316,4565,Alemtuzumab (Campath),2016-09-23,2020-03-26,20,mcg,['/Month'], ,Patient Choice/Convenience
9317,3855,Gilenya,2016-01-01,,5000, ,['2 / Day'],IV, 
9318,3630,Tysabri,2016-02-13,,500,mg,['2 / Day'],IV, 
9319,3630,Tecfidera,2016-04-19,2018-12-22, ,mg,['2 / Day'],IV,Adverse Event
9320,3630,Avonex,2016-08-24,2019-04-03,5000,mg,['/Month'],IV,Lack of efficacy
9321,444,Ledertrexaat,2016-09-01,,20,mcg,['/Month'],IV, 
9322,4858,Methylprednisolone,2016-01-25,2019-10-31,5000,mg,['/ Day'],IV,Adverse Event
9323,4858,Rebif [44],2016-08-12,, ,mg,['/Month'],IV, 
9324,4858,IVIG,2016-02-19,,300, ,[' '],IV, 
9325,4858,Rebif [22],2016-05-06,,1000,mg,['/Month'], , 
9326,745,Teriflunomide,2016-09-01,2018-01-12, , ,['/Month'],IV,Adverse Event
9327,745,Avonex,2016-03-23,2019-04-24, ,mg,['2 / Day'],IV,Lack of efficacy
9328,745,Teriflunomide,2016-05-10,2019-08-15,1,mg,['3 / Week'],IV,Lack of efficacy
9329,745,Methylprednisolone,2016-08-14,, ,mg,['/ Week'], , 
9330,3453,Mitoxantrone,2016-08-29,,5000,mg,['2 / Day'],IV, 
9331,1358,Methylprednisolone,2016-04-21,, ,mg,['/Month'],IV, 
9332,1491,Teriflunomide,2015-10-29,,20, ,['/Month'],IV, 
9333,1872,Copaxone,2016-03-31,2018-09-11,1000,mcg,['/Month'], ,Adverse Event
9334,1872,Rebif [22],2016-10-17,,300,MIU,['3 / Week'], , 
9335,1872,Rebif [44],2016-01-10,2018-12-27,5000, ,['/Month'], ,Patient Choice/Convenience
9336,1872,Tysabri,2016-01-18,2020-11-09,1,mg,['/ Week'],IV,Lack of efficacy
9337,305,Tecfidera,2016-10-15,, , ,['/Month'],IV, 
9338,305,Tysabri,2016-01-18,,1000,mg,['/Month'],IV, 
9339,1701,Methylprednisolone,2016-10-02,2019-10-05,500, ,['/Month'], ,Adverse Event
9340,1701,Tysabri,2016-03-29,,20,mg,[' '],Oral, 
9341,1701,Tecfidera,2015-12-16,,300, ,['2 / Day'],IV, 
9342,1701,IVIG,2016-05-30,,5000,mg,['/ Week'], , 
9343,2952,IVIG,2016-05-11,,20,mg,['/Month'],IV, 
9344,2952,Avonex,2016-09-12,,1000,mg,['2 / Day'],IV, 
9345,2952,Avonex,2016-09-10,, , ,['/Month'],IV, 
9346,2952,Rebif [22],2015-12-03,2019-03-18, ,mg,['/Month'], ,Patient Choice/Convenience
9347,1081,Methylprednisolone,2016-01-16,2019-09-26,1000,mg,['/Month'],IV,Persistence of relapses
9348,1081,D-cure (Vitamine D),2016-05-03,,400,mg,['/Month'],IV, 
9349,1081,Methylprednisolone,2016-01-01,2019-02-14, ,mg,[' '],IV,Adverse Event
9350,1081,Tecfidera,2016-04-30,,400,mcg,['/Month'], , 
9351,4807,Avonex,2015-11-09,, ,mg,[' '], , 
9352,4807,Rebif [44],2016-08-16,2018-05-31,20,mg,[' '], ,Adverse Event
9353,4807,Gilenya,2015-11-25,, ,mg,['2 / Day'], , 
9354,4807,Teriflunomide,2016-09-09,, ,MIU,['/ Week'],IV, 
9355,2387,Copaxone,2016-01-05,,500,MIU,['/Month'],IV, 
9356,2387,Avonex,2016-05-26,2020-10-10,400,MIU,['/Month'],IV,Persisting MRI activity
9357,2387,Mitoxantrone,2015-11-16,2021-03-13,1, ,['2 / Day'],IV,Lack of efficacy
9358,2387,Copaxone,2016-03-23,,500,mg,['2 / Day'],IV, 
9359,3364,Betaferon,2016-01-09,,5000, ,['2 / Day'],IV, 
9360,3364,Ledertrexaat,2016-03-27,, , ,['/ Day'], , 
9361,3364,Copaxone,2016-02-06,, ,mg,['/ Day'],IV, 
9362,2300,Betaferon,2016-01-27,, ,mg,[' '],IV, 
9363,2300,Tysabri,2016-04-08,, ,mg,['/Month'],Oral, 
9364,978,IVIG,2016-03-06,2020-11-05,1000,mcg,['3 / Week'],IV,Patient Choice/Convenience
9365,4213,Rebif [22],2016-05-18,2020-07-13, , ,['2 / Day'],Oral,Adverse Event
9366,4213,Methylprednisolone,2016-04-29,,1000,mg,[' '],IV, 
9367,1724,D-cure (Vitamine D),2016-02-06,,20,mg,['/Month'],IV, 
9368,1724,Rebif [44],2016-07-02,,1000,MIU,['3 / Week'], , 
9369,1724,Betaferon,2015-12-08,,500,mcg,['/Month'],IV, 
9370,170,IVIG,2016-03-14,2021-08-18,5000,MIU,['/Month'], ,Persisting MRI activity
9371,4937,IVIG,2015-12-03,, ,mg,['3 / Week'], , 
9372,1633,Alemtuzumab (Campath),2016-01-31,,20,mg,['/Month'], , 
9373,1633,Tecfidera,2016-08-27,2019-11-22, ,mg,['/Month'],IV,Persistence of relapses
9374,3957,D-cure (Vitamine D),2016-06-08,2020-07-15,20, ,['3 / Week'],IV,Persisting MRI activity
9375,3957,D-cure (Vitamine D),2016-01-31,,5000, ,['/Month'],IV, 
9376,3957,Rebif [22],2016-09-08,, ,mg,['/Month'], , 
9377,4527,Mitoxantrone,2016-09-28,,1,mg,['/Month'],IV, 
9378,1188,Gilenya,2016-10-05,2021-10-23,300,mg,['2 / Day'], ,Patient Choice/Convenience
9379,1188,Avonex,2016-06-30,,1000, ,['/Month'], , 
9380,1188,Endoxan,2016-10-11,, ,mcg,['/Month'],IV, 
9381,1325,Gilenya,2016-02-21,2021-01-18,300,mg,['/Month'],IV,Persisting MRI activity
9382,1325,D-cure (Vitamine D),2016-06-13,2019-05-26,300,mg,['/ Week'], ,Persisting MRI activity
9383,1325,Methylprednisolone,2016-10-20,2021-02-05,20,mg,['2 / Day'],IV,Persistence of relapses
9384,1865,Tysabri,2015-12-09,, ,mg,['/ Day'],Oral, 
9385,4607,Methylprednisolone,2016-06-02,, ,mg,['/Month'], , 
9386,4607,Endoxan,2015-11-04,,300,mcg,['2 / Day'],Oral, 
9387,4607,Betaferon,2016-01-02,2020-11-10,1,mg,['3 / Week'],IV,Persisting MRI activity
9388,3717,Tysabri,2016-02-12,, ,mg,['2 / Day'], , 
9389,3717,Copaxone,2015-11-04,2021-03-13,1,mg,['/Month'], ,Patient Choice/Convenience
9390,3717,Tysabri,2016-02-16,2018-08-09,1,MIU,['/Month'],IV,Adverse Event
9391,3717,Mitoxantrone,2016-07-10,, , ,['3 / Week'],IV, 
9392,1320,Rebif [22],2015-11-04,, , ,['/ Day'], , 
9393,1760,Mitoxantrone,2016-04-20,,400,mcg,['2 / Day'],IV, 
9394,1760,Methylprednisolone,2016-01-12,,300, ,['3 / Week'],IV, 
9395,1760,Alemtuzumab (Campath),2016-07-31,, ,mg,['3 / Week'], , 
9396,1760,Copaxone,2015-12-26,2018-03-18, , ,['2 / Day'],IV,Lack of efficacy
9397,2186,Alemtuzumab (Campath),2015-10-28,2018-01-11,1, ,['3 / Week'],IV,Adverse Event
9398,3553,Methylprednisolone,2016-02-12,, ,mcg,['/Month'],IV, 
9399,3553,Gilenya,2016-05-09,, , ,['2 / Day'],IV, 
9400,3544,Copaxone,2015-10-30,2018-08-22, , ,['/Month'], ,Persisting MRI activity
9401,3544,Alemtuzumab (Campath),2016-01-01,2020-12-24,20,mg,['2 / Day'], ,Patient Choice/Convenience
9402,3544,Ledertrexaat,2016-01-20,,300, ,['/ Day'], , 
9403,2183,IVIG,2016-09-21,,5000, ,['3 / Week'], , 
9404,2183,Tecfidera,2016-08-11,,20, ,['/Month'], , 
9405,2183,Tysabri,2016-03-06,2018-07-05, , ,['2 / Day'], ,Adverse Event
9406,1449,Endoxan,2016-09-06,,500,mg,['3 / Week'],IV, 
9407,3378,Ledertrexaat,2016-05-16,, , ,['2 / Day'],Oral, 
9408,3378,Gilenya,2016-01-13,,1, ,['/Month'],IV, 
9409,3378,Copaxone,2016-07-16,2020-07-11,20,mg,['/Month'], ,Patient Choice/Convenience
9410,1964,Tysabri,2016-06-01,2019-11-11,20,mg,['3 / Week'],Oral,Adverse Event
9411,295,Alemtuzumab (Campath),2016-10-18,2018-05-26,400, ,['/Month'],IV,Adverse Event
9412,3594,IVIG,2016-06-19,,5000, ,['/ Day'],IV, 
9413,559,Tecfidera,2016-03-21,, ,mg,['3 / Week'],IV, 
9414,559,Methylprednisolone,2015-10-27,, ,mg,['2 / Day'], , 
9415,559,Endoxan,2016-01-23,2019-08-11, , ,[' '], ,Patient Choice/Convenience
9416,559,Avonex,2016-01-08,2019-12-25,300, ,['/Month'],Oral,Persisting MRI activity
9417,3666,Mitoxantrone,2015-12-25,,300,mg,['2 / Day'],IV, 
9418,4818,Tecfidera,2016-07-06,,300, ,['2 / Day'],IV, 
9419,276,Rebif [22],2016-01-23,2018-02-08,1,mg,['/Month'],Oral,Patient Choice/Convenience
9420,2713,D-cure (Vitamine D),2015-12-28,, , ,['2 / Day'],IV, 
9421,2713,Tysabri,2016-05-01,,500,mg,[' '],IV, 
9422,2713,Tecfidera,2016-09-10,2020-08-24, ,MIU,['/Month'],IV,Patient Choice/Convenience
9423,1909,IVIG,2015-12-02,,300, ,['/Month'],Oral, 
9424,1909,Alemtuzumab (Campath),2016-06-06,2021-04-20,400,mg,['/Month'], ,Lack of efficacy
9425,1909,Methylprednisolone,2016-06-09,, ,mg,['3 / Week'],Oral, 
9426,1909,Tecfidera,2016-09-02,,500,mcg,['/Month'],IV, 
9427,2322,Alemtuzumab (Campath),2016-04-18,2018-10-07,20, ,['2 / Day'],IV,Persisting MRI activity
9428,2322,IVIG,2016-05-03,,1,mg,[' '],IV, 
9429,2322,Avonex,2016-04-21,,1, ,['/Month'], , 
9430,2322,Rebif [44],2016-02-08,,400, ,['/Month'],Oral, 
9431,958,Ledertrexaat,2015-11-01,2018-04-29, , ,['/Month'],IV,Patient Choice/Convenience
9432,958,Copaxone,2015-12-07,2019-08-04,500, ,[' '],IV,Lack of efficacy
9433,792,Tysabri,2016-04-27,,400,MIU,[' '],Oral, 
9434,792,Mitoxantrone,2016-10-16,,20, ,['2 / Day'],IV, 
9435,792,Endoxan,2016-07-10,,300,mg,['/ Week'], , 
9436,792,Tysabri,2016-03-20,2018-11-04, , ,['2 / Day'],IV,Persisting MRI activity
9437,519,Endoxan,2016-07-08,, ,mg,['2 / Day'], , 
9438,519,IVIG,2015-10-30,,1, ,['2 / Day'],IV, 
9439,519,Methylprednisolone,2016-04-18,, , ,['2 / Day'], , 
9440,519,Methylprednisolone,2016-07-15,2021-05-25,500, ,['/Month'], ,Adverse Event
9441,1431,Tecfidera,2015-12-04,,20,mg,['/Month'], , 
9442,1431,Copaxone,2016-01-12,2017-12-19,5000,mg,['2 / Day'],IV,Adverse Event
9443,1431,Mitoxantrone,2016-10-19,2020-05-04,5000,mg,['/ Week'], ,Patient Choice/Convenience
9444,4231,Rebif [44],2016-07-10,, , ,['2 / Day'],Oral, 
9445,4231,Copaxone,2016-01-09,, , ,['2 / Day'],IV, 
9446,4231,Betaferon,2015-12-01,, , ,['/ Week'],IV, 
9447,1619,Tysabri,2016-09-09,, , ,['/Month'], , 
9448,1865,Copaxone,2016-10-07,,400,MIU,['/Month'],IV, 
9449,1865,Betaferon,2016-06-13,2018-08-16, ,mg,['2 / Day'],IV,Persisting MRI activity
9450,4611,Ledertrexaat,2016-07-30,,500,mg,['2 / Day'], , 
9451,4611,Mitoxantrone,2016-09-16,2019-08-01,1000, ,['/Month'],IV,Patient Choice/Convenience
9452,4611,Gilenya,2016-02-19,2019-08-28, ,mg,['/ Day'],IV,Patient Choice/Convenience
9453,733,Alemtuzumab (Campath),2016-07-14,2018-05-16,500, ,['2 / Day'],IV,Persistence of relapses
9454,733,Alemtuzumab (Campath),2016-04-25,, ,mg,['2 / Day'], , 
9455,733,Gilenya,2016-08-02,,500,mg,['/ Day'],IV, 
9456,733,Tysabri,2016-08-26,, , ,['/Month'],IV, 
9457,3307,Betaferon,2016-05-05,, , ,['/Month'],IV, 
9458,3307,IVIG,2016-08-10,,1,MIU,['3 / Week'], , 
9459,3307,IVIG,2016-07-17,2018-06-28, ,MIU,[' '],Oral,Persisting MRI activity
9460,2095,Rebif [44],2016-02-24,2020-10-24, , ,['2 / Day'], ,Patient Choice/Convenience
9461,1248,Copaxone,2016-05-07,, ,mg,['2 / Day'], , 
9462,1248,Gilenya,2016-02-13,,400,mcg,['/Month'],IV, 
9463,1248,Alemtuzumab (Campath),2016-01-16,,1000,mg,['/Month'],Oral, 
9464,1248,Tecfidera,2015-12-10,,5000,mcg,['3 / Week'],IV, 
9465,4190,Methylprednisolone,2016-10-15,,5000,mg,['/Month'], , 
9466,4190,Tysabri,2015-12-16,2018-10-17,20,mg,['2 / Day'], ,Lack of efficacy
9467,2697,IVIG,2016-03-03,, , ,['2 / Day'], , 
9468,2697,Tysabri,2016-10-03,2017-12-09, ,mg,['/ Day'], ,Lack of efficacy
9469,2697,Rebif [44],2015-12-08,2020-02-24,300,mg,['/Month'],IV,Patient Choice/Convenience
9470,2697,Betaferon,2016-07-17,2019-12-20, ,mg,['2 / Day'],IV,Adverse Event
9471,2440,Rebif [22],2016-01-07,2020-01-01, , ,['2 / Day'],Oral,Lack of efficacy
9472,2440,Rebif [22],2016-10-13,,20,mcg,['3 / Week'], , 
9473,3099,Gilenya,2016-07-06,2018-02-19,500,mg,['3 / Week'], ,Persisting MRI activity
9474,3099,Rebif [22],2015-11-02,,20,MIU,['/ Day'],IV, 
9475,2006,IVIG,2016-01-07,,400, ,['/ Day'],IV, 
9476,2006,Ledertrexaat,2016-03-16,, , ,['/Month'],IV, 
9477,2006,Mitoxantrone,2015-12-26,,5000,mg,['/ Day'],IV, 
9478,2006,IVIG,2016-09-27,, , ,['2 / Day'],IV, 
9479,1117,IVIG,2016-08-16,, , ,['/Month'], , 
9480,1117,D-cure (Vitamine D),2016-10-13,, ,MIU,[' '],Oral, 
9481,1117,Tecfidera,2016-07-09,,500,mg,['2 / Day'],Oral, 
9482,4398,D-cure (Vitamine D),2016-04-01,,1,MIU,['3 / Week'], , 
9483,4398,Alemtuzumab (Campath),2016-03-24,,1000, ,['/ Week'],IV, 
9484,4398,Alemtuzumab (Campath),2016-05-30,,500,mg,['/Month'], , 
9485,4398,Teriflunomide,2016-01-23,2018-05-26, ,mcg,['3 / Week'],IV,Lack of efficacy
9486,4522,Gilenya,2015-11-26,2020-02-28,1000, ,['3 / Week'],IV,Persisting MRI activity
9487,4522,Tysabri,2016-09-03,, ,MIU,['/Month'],Oral, 
9488,4522,Betaferon,2016-10-05,2017-12-05, ,mg,['/ Day'],Oral,Adverse Event
9489,3217,Teriflunomide,2016-08-05,, ,mg,['2 / Day'],IV, 
9490,3217,Rebif [22],2016-05-06,2020-07-30,500,mg,['/Month'], ,Lack of efficacy
9491,3550,Alemtuzumab (Campath),2015-11-13,, , ,['2 / Day'],Oral, 
9492,3753,Methylprednisolone,2016-02-22,2021-02-08,300,mg,['/ Day'], ,Adverse Event
9493,3753,Endoxan,2016-09-13,2021-03-02,5000,mg,['2 / Day'], ,Persisting MRI activity
9494,3753,Mitoxantrone,2016-09-30,2018-01-04, , ,['2 / Day'],Oral,Patient Choice/Convenience
9495,3753,Copaxone,2015-11-14,2020-10-02,1,mg,[' '], ,Lack of efficacy
9496,3465,Endoxan,2016-09-27,,500,mg,['2 / Day'], , 
9497,3465,Tecfidera,2016-06-16,2019-09-05, ,mg,['2 / Day'], ,Persistence of relapses
9498,3465,Gilenya,2015-11-27,2018-05-07,300,mg,['/ Day'],IV,Patient Choice/Convenience
9499,2038,Gilenya,2015-11-27,2017-10-26,300,mg,['2 / Day'], ,Lack of efficacy
9500,2038,Copaxone,2016-05-30,,1000,MIU,['2 / Day'], , 
9501,2038,IVIG,2016-02-26,, ,mg,[' '], , 
9502,2170,IVIG,2016-07-08,,20, ,['/Month'],Oral, 
9503,2170,Methylprednisolone,2016-06-20,2018-08-02,20,mg,['/Month'], ,Persistence of relapses
9504,2170,Tecfidera,2016-05-17,2021-04-09,1,mcg,['/ Day'], ,Patient Choice/Convenience
9505,2170,Tecfidera,2015-11-06,,500,mg,['/Month'], , 
9506,414,Tecfidera,2016-04-01,,5000,mcg,['/Month'],IV, 
9507,414,Rebif [22],2015-11-03,,300,MIU,['/Month'], , 
9508,414,Methylprednisolone,2016-10-03,2021-04-08,1, ,[' '],Oral,Patient Choice/Convenience
9509,1814,Betaferon,2015-11-05,2020-04-19, , ,['/Month'], ,Lack of efficacy
9510,290,D-cure (Vitamine D),2016-02-25,,300,mg,['2 / Day'],IV, 
9511,2114,Methylprednisolone,2016-05-18,2021-03-14, ,MIU,['/ Day'], ,Lack of efficacy
9512,2114,Alemtuzumab (Campath),2016-05-28,2021-08-19,500, ,['/Month'],IV,Adverse Event
9513,2114,Copaxone,2016-07-30,2021-05-24, ,mg,['2 / Day'],IV,Persistence of relapses
9514,251,Tysabri,2015-10-30,,300, ,['3 / Week'],IV, 
9515,3013,IVIG,2016-10-18,,300,MIU,['/Month'],Oral, 
9516,3013,D-cure (Vitamine D),2015-11-04,2019-05-09,5000,mg,['/Month'],IV,Adverse Event
9517,4665,Copaxone,2016-04-21,,500,mg,[' '], , 
9518,4665,Teriflunomide,2016-05-26,2021-05-19, ,mg,['2 / Day'], ,Patient Choice/Convenience
9519,4223,Mitoxantrone,2016-02-18,,5000,mg,['/Month'], , 
9520,4223,Copaxone,2016-08-13,2017-12-31, ,mg,['2 / Day'],IV,Patient Choice/Convenience
9521,751,Betaferon,2016-05-25,,1, ,[' '],IV, 
9522,751,Tecfidera,2016-04-16,2019-09-20,5000, ,['/Month'],Oral,Patient Choice/Convenience
9523,751,Tecfidera,2016-09-18,2020-06-11,20,mg,[' '],IV,Lack of efficacy
9524,1273,D-cure (Vitamine D),2015-11-24,,500,mg,['3 / Week'],Oral, 
9525,3726,Gilenya,2016-09-07,,20, ,['2 / Day'], , 
9526,3726,Copaxone,2016-10-17,,1000, ,['/ Week'], , 
9527,3726,Tecfidera,2015-10-26,2020-11-09,400,mg,['/Month'], ,Adverse Event
9528,2421,Tecfidera,2016-03-19,2020-07-21,500,mg,['/Month'], ,Patient Choice/Convenience
9529,589,Endoxan,2016-03-28,2021-07-23,1000,mg,['3 / Week'],IV,Adverse Event
9530,589,Copaxone,2016-10-02,, ,mg,['/ Week'],IV, 
9531,589,Copaxone,2016-02-23,2020-11-22, ,mg,['/ Week'], ,Persistence of relapses
9532,589,Avonex,2016-07-28,, , ,['3 / Week'],IV, 
9533,1982,IVIG,2016-05-20,,20,mcg,['2 / Day'], , 
9534,1982,Avonex,2016-09-24,,1000, ,['2 / Day'],Oral, 
9535,1982,Teriflunomide,2016-08-09,,5000, ,['/Month'], , 
9536,4670,Methylprednisolone,2016-01-11,,5000,mg,['3 / Week'],IV, 
9537,2860,Rebif [22],2016-01-17,2018-12-16,300, ,['2 / Day'], ,Patient Choice/Convenience
9538,2860,Methylprednisolone,2015-11-12,2018-08-10,20,mg,['2 / Day'],IV,Adverse Event
9539,2860,IVIG,2015-11-18,,500, ,[' '], , 
9540,2860,Methylprednisolone,2016-03-01,,5000, ,['3 / Week'], , 
9541,4254,D-cure (Vitamine D),2016-07-12,,1000, ,['/ Day'],IV, 
9542,4254,Rebif [22],2016-04-10,2021-06-23,400, ,['/Month'],IV,Persistence of relapses
9543,2778,Rebif [44],2016-06-19,2020-10-05, , ,['/ Day'],IV,Persisting MRI activity
9544,2778,Rebif [22],2015-12-29,2019-11-25,300, ,['2 / Day'], ,Patient Choice/Convenience
9545,2778,Rebif [22],2016-06-12,2018-08-03,300, ,['/Month'],IV,Persistence of relapses
9546,758,Tecfidera,2016-01-06,,20,MIU,['/Month'],Oral, 
9547,758,Rebif [44],2016-05-19,, , ,['2 / Day'],IV, 
9548,758,Gilenya,2016-06-17,, ,mg,['/Month'], , 
9549,1587,Endoxan,2016-04-21,, ,mg,[' '],IV, 
9550,1587,Tysabri,2016-02-16,2018-06-23,1,mg,['/Month'],IV,Lack of efficacy
9551,1019,Alemtuzumab (Campath),2016-01-05,,300,MIU,['2 / Day'],IV, 
9552,1156,Rebif [44],2016-01-22,, ,MIU,['/ Week'],IV, 
9553,1973,Tysabri,2016-05-30,, ,MIU,['/Month'],IV, 
9554,1973,Teriflunomide,2016-04-12,,20, ,['/Month'],Oral, 
9555,659,Mitoxantrone,2016-06-18,2020-02-28,500, ,['2 / Day'], ,Persistence of relapses
9556,659,Alemtuzumab (Campath),2016-09-01,,300,mg,['/Month'],IV, 
9557,659,Rebif [22],2016-07-09,, ,mg,['/Month'],Oral, 
9558,1070,Gilenya,2016-03-21,,20,mg,['/Month'], , 
9559,1070,Endoxan,2016-04-18,, ,MIU,['2 / Day'],Oral, 
9560,1070,IVIG,2015-11-15,,1000,mcg,[' '],Oral, 
9561,1449,Tysabri,2016-07-31,2020-07-07, , ,['/Month'],IV,Patient Choice/Convenience
9562,1449,IVIG,2016-09-21,2021-10-18,1000,mg,['/Month'], ,Patient Choice/Convenience
9563,1449,Gilenya,2016-05-26,2019-07-29, , ,['/Month'],IV,Adverse Event
9564,962,Rebif [44],2016-07-11,,1, ,['2 / Day'], , 
9565,962,Avonex,2016-09-18,2019-04-03,400,mg,[' '],IV,Adverse Event
9566,962,Tysabri,2016-05-04,2020-02-04,1,mg,['/Month'], ,Adverse Event
9567,962,Avonex,2016-03-21,2021-03-02,1,mg,['3 / Week'], ,Persisting MRI activity
9568,3209,Rebif [22],2016-05-17,2021-02-25,300,mg,['/Month'],IV,Adverse Event
9569,3906,IVIG,2016-03-23,, ,mg,['3 / Week'],IV, 
9570,3906,Betaferon,2016-09-27,,500, ,['2 / Day'],IV, 
9571,4478,Avonex,2016-09-14,2020-09-30, , ,['3 / Week'],Oral,Patient Choice/Convenience
9572,4478,Tecfidera,2016-04-16,2021-04-30,300, ,['2 / Day'],IV,Patient Choice/Convenience
9573,2845,IVIG,2016-01-14,2021-03-17,1000, ,['/ Day'],IV,Adverse Event
9574,2845,Alemtuzumab (Campath),2016-06-27,, , ,['/Month'],IV, 
9575,2845,Methylprednisolone,2016-04-26,, ,mcg,['/Month'], , 
9576,4124,Ledertrexaat,2015-12-30,2019-12-21,1000,mg,['/Month'],IV,Lack of efficacy
9577,4124,Rebif [44],2016-07-09,2020-12-15, , ,['3 / Week'],IV,Adverse Event
9578,4124,Endoxan,2015-11-10,2020-08-26,1000, ,['/ Day'],IV,Patient Choice/Convenience
9579,467,Gilenya,2016-03-17,2020-05-28, , ,['2 / Day'], ,Adverse Event
9580,467,Avonex,2016-02-29,2018-12-29,1000,mg,['/Month'], ,Patient Choice/Convenience
9581,467,Endoxan,2016-10-22,2019-04-09,1, ,['/ Week'],IV,Adverse Event
9582,467,Rebif [44],2016-04-29,2018-07-26,1000, ,['/Month'],IV,Adverse Event
9583,4053,Avonex,2016-04-12,, ,mg,['3 / Week'],IV, 
9584,4053,Betaferon,2016-05-06,,1, ,['/Month'], , 
9585,4053,Betaferon,2015-12-31,2021-03-10,300,mg,['3 / Week'],IV,Persisting MRI activity
9586,125,Ledertrexaat,2016-06-15,,1, ,['/ Week'], , 
9587,125,IVIG,2015-12-02,2019-01-02,20, ,['/Month'], ,Lack of efficacy
9588,1677,Copaxone,2015-11-20,2018-05-17, , ,['/ Day'],IV,Persisting MRI activity
9589,1677,D-cure (Vitamine D),2016-06-30,,20, ,['/Month'],IV, 
9590,1677,IVIG,2016-10-03,, , ,['/Month'],IV, 
9591,2145,Copaxone,2015-10-26,2020-02-08,20, ,['2 / Day'],IV,Adverse Event
9592,2145,Alemtuzumab (Campath),2016-07-30,, ,mg,['2 / Day'],IV, 
9593,3861,Copaxone,2015-12-10,2019-03-26,5000,MIU,['/Month'],IV,Lack of efficacy
9594,3861,Gilenya,2016-09-09,,5000,mg,[' '],Oral, 
9595,3861,Betaferon,2016-03-08,,1,mg,['/Month'], , 
9596,2636,Rebif [22],2016-02-10,,5000,mg,['2 / Day'],IV, 
9597,2636,Gilenya,2015-12-04,,5000,mg,['2 / Day'],Oral, 
9598,2636,Rebif [44],2016-03-27,,20,mg,['3 / Week'],Oral, 
9599,279,Avonex,2015-12-06,,1,mg,['2 / Day'],IV, 
9600,279,Endoxan,2016-07-11,2019-10-26,300, ,['2 / Day'], ,Lack of efficacy
9601,279,Alemtuzumab (Campath),2015-11-22,2020-12-08, ,mg,['/Month'],IV,Patient Choice/Convenience
9602,279,Mitoxantrone,2016-08-06,,20,mg,['2 / Day'],IV, 
9603,3091,Betaferon,2016-05-17,, ,mg,['/Month'],Oral, 
9604,3091,Methylprednisolone,2016-01-15,2020-11-26,400, ,['2 / Day'],Oral,Patient Choice/Convenience
9605,391,Copaxone,2015-11-20,2018-12-30,500,MIU,[' '],IV,Adverse Event
9606,391,Tysabri,2016-06-22,2018-05-10,1,mg,['/ Week'],IV,Patient Choice/Convenience
9607,391,Teriflunomide,2016-04-20,,500, ,['3 / Week'],IV, 
9608,3776,Endoxan,2016-03-17,2020-05-12,400, ,['2 / Day'], ,Adverse Event
9609,1702,Endoxan,2016-06-15,2019-05-13, ,mg,['/ Week'],IV,Adverse Event
9610,1702,Tysabri,2016-07-31,, ,mg,[' '],IV, 
9611,4416,D-cure (Vitamine D),2016-08-24,, , ,['/Month'],Oral, 
9612,4657,Betaferon,2016-09-15,,1, ,['/Month'],Oral, 
9613,718,IVIG,2016-01-22,,1,mg,['/Month'], , 
9614,2887,IVIG,2016-06-03,, ,mg,['2 / Day'], , 
9615,2887,IVIG,2016-04-23,, , ,['/ Day'], , 
9616,2724,D-cure (Vitamine D),2016-02-28,,300, ,['/ Day'], , 
9617,2724,Rebif [22],2016-09-24,, , ,['/Month'],IV, 
9618,787,Avonex,2016-10-06,2018-10-23,20,mg,['/Month'],Oral,Persisting MRI activity
9619,787,Avonex,2016-07-25,2020-06-25,20, ,['/ Day'],Oral,Persisting MRI activity
9620,4845,Rebif [22],2016-07-20,, ,mg,['/Month'],IV, 
9621,4845,IVIG,2016-02-28,2018-05-04, ,mg,['3 / Week'],IV,Adverse Event
9622,134,Teriflunomide,2016-05-28,,500,mg,['2 / Day'], , 
9623,134,Gilenya,2016-10-18,, ,mg,['/Month'],IV, 
9624,564,Alemtuzumab (Campath),2016-04-03,,1000,mg,['/ Day'],IV, 
9625,388,Methylprednisolone,2016-04-18,,1000, ,['/Month'],IV, 
9626,388,Alemtuzumab (Campath),2016-01-14,, ,MIU,['3 / Week'], , 
9627,2922,Alemtuzumab (Campath),2015-10-25,,300,MIU,['/Month'],IV, 
9628,2922,IVIG,2016-08-23,, ,mg,['/Month'], , 
9629,2922,Gilenya,2016-07-23,, ,mg,['/ Week'], , 
9630,2922,Copaxone,2016-02-01,2018-01-17,1,mg,['2 / Day'], ,Adverse Event
9631,4769,D-cure (Vitamine D),2015-12-19,,1000,mcg,['/Month'],IV, 
9632,1826,IVIG,2016-06-26,, ,mg,['/Month'],IV, 
9633,1826,Copaxone,2016-04-20,,400,mg,['/Month'],IV, 
9634,1826,IVIG,2016-01-05,, , ,['3 / Week'],IV, 
9635,1826,Tecfidera,2016-10-20,,5000, ,['2 / Day'], , 
9636,163,Tecfidera,2016-01-27,2021-09-19,400, ,[' '], ,Adverse Event
9637,163,Tysabri,2016-03-11,, , ,[' '],Oral, 
9638,3667,Ledertrexaat,2016-09-22,,500,MIU,['2 / Day'],IV, 
9639,1740,IVIG,2016-01-08,2020-09-08,500, ,['3 / Week'],IV,Lack of efficacy
9640,1240,Methylprednisolone,2016-04-08,,400, ,[' '],IV, 
9641,1240,Teriflunomide,2016-01-08,, ,mg,['/Month'],IV, 
9642,1240,Rebif [44],2016-08-06,2020-05-23,400,mg,['3 / Week'],Oral,Adverse Event
9643,1240,Endoxan,2016-07-01,,20,MIU,['2 / Day'],IV, 
9644,3701,Avonex,2016-04-28,, , ,['2 / Day'], , 
9645,3701,Alemtuzumab (Campath),2016-06-26,, ,mg,['/Month'], , 
9646,500,Alemtuzumab (Campath),2016-01-11,,500,mg,['/Month'], , 
9647,1337,Methylprednisolone,2016-05-30,, ,mg,['/Month'], , 
9648,1337,Endoxan,2016-06-22,,20, ,['2 / Day'],Oral, 
9649,1337,Methylprednisolone,2016-05-03,,1000,mg,['/Month'], , 
9650,1337,D-cure (Vitamine D),2016-06-17,2019-01-05, ,MIU,['2 / Day'],IV,Adverse Event
9651,4261,Rebif [44],2016-07-12,2020-12-24,20, ,['/ Week'],IV,Persisting MRI activity
9652,4261,Ledertrexaat,2016-07-16,, ,mg,['/Month'],Oral, 
9653,4261,Tecfidera,2015-11-29,2018-11-26,300, ,['2 / Day'],Oral,Patient Choice/Convenience
9654,4261,Betaferon,2016-10-06,2019-04-16,400,MIU,['/ Day'], ,Adverse Event
9655,2094,IVIG,2016-10-01,2020-09-25,5000, ,['2 / Day'],Oral,Adverse Event
9656,2094,Rebif [22],2016-01-07,, , ,['2 / Day'],Oral, 
9657,2094,IVIG,2015-12-14,2018-01-09, , ,['2 / Day'], ,Persisting MRI activity
9658,1233,Tecfidera,2016-07-18,, ,mcg,['3 / Week'], , 
9659,1233,Tecfidera,2015-12-09,2018-05-22,20, ,['2 / Day'],Oral,Persisting MRI activity
9660,566,Betaferon,2016-08-12,,5000,mg,[' '],IV, 
9661,1699,Betaferon,2015-12-24,,500, ,['2 / Day'],IV, 
9662,1699,IVIG,2016-07-06,, ,mg,['/ Week'],IV, 
9663,1699,Alemtuzumab (Campath),2016-07-08,,1000,mg,['2 / Day'],IV, 
9664,1699,D-cure (Vitamine D),2016-10-15,,300,mg,['2 / Day'],IV, 
9665,4322,Endoxan,2016-06-13,, ,MIU,['2 / Day'],IV, 
9666,4322,Rebif [22],2016-07-12,, ,mg,['/ Week'], , 
9667,4322,IVIG,2016-01-29,, , ,['/Month'], , 
9668,4322,Endoxan,2015-11-06,,1,MIU,['2 / Day'], , 
9669,4863,Tysabri,2015-12-24,, ,mg,['2 / Day'], , 
9670,4863,Tecfidera,2016-04-09,2020-07-20, ,mg,['2 / Day'],IV,Adverse Event
9671,4863,D-cure (Vitamine D),2015-10-24,,500,mg,['/Month'],IV, 
9672,4863,D-cure (Vitamine D),2016-07-22,2018-12-19,500, ,['/ Week'],IV,Adverse Event
9673,2481,Avonex,2016-03-01,, , ,['/Month'],IV, 
9674,2883,Avonex,2016-04-03,,1000,MIU,['/Month'], , 
9675,2883,Gilenya,2016-08-09,2019-04-28,500,MIU,['/ Day'],IV,Persistence of relapses
9676,2883,IVIG,2015-11-10,, ,MIU,['/Month'],IV, 
9677,2883,Tecfidera,2016-02-20,,20,mg,['2 / Day'],IV, 
9678,1030,Endoxan,2016-09-02,2018-05-17,5000, ,['/Month'],IV,Lack of efficacy
9679,1030,IVIG,2016-07-25,, , ,['2 / Day'],Oral, 
9680,432,Betaferon,2015-11-21,2019-07-28,1, ,['/Month'],IV,Persisting MRI activity
9681,432,Copaxone,2016-05-20,2021-07-07,5000,mg,[' '],Oral,Adverse Event
9682,432,Mitoxantrone,2015-12-04,2021-04-25,5000,MIU,['/ Day'],IV,Adverse Event
9683,4195,Tecfidera,2016-06-14,2021-07-12, ,mg,[' '], ,Adverse Event
9684,4195,Avonex,2016-08-02,2018-12-28,1,mcg,['/Month'], ,Adverse Event
9685,4294,Rebif [22],2016-04-21,2018-01-21,1,mg,['2 / Day'],IV,Patient Choice/Convenience
9686,4935,Endoxan,2016-01-16,,500, ,['/ Day'], , 
9687,4935,Teriflunomide,2016-08-09,,5000, ,['/Month'], , 
9688,4935,Teriflunomide,2016-07-06,, , ,['3 / Week'],Oral, 
9689,4935,Tysabri,2016-07-18,,5000, ,['3 / Week'],IV, 
9690,1094,Endoxan,2015-12-18,,500,mg,['/ Week'], , 
9691,1094,Tysabri,2016-01-15,, , ,['3 / Week'], , 
9692,1094,D-cure (Vitamine D),2016-07-20,,1, ,['/Month'],IV, 
9693,1094,Teriflunomide,2016-10-04,2021-06-10, ,mg,['/Month'],Oral,Persisting MRI activity
9694,1188,Gilenya,2016-10-19,, , ,['/Month'],Oral, 
9695,1188,Alemtuzumab (Campath),2016-01-13,,5000, ,['/ Week'],IV, 
9696,1188,IVIG,2016-09-15,,5000,mg,['/ Day'], , 
9697,1188,Betaferon,2016-07-30,,1,MIU,['/Month'], , 
9698,1725,Ledertrexaat,2016-02-27,, ,mg,['3 / Week'],IV, 
9699,3345,Avonex,2016-06-16,,20,mg,[' '],IV, 
9700,3345,Betaferon,2016-07-17,2019-02-16,1, ,[' '], ,Persisting MRI activity
9701,3660,Rebif [44],2016-06-11,,1,mcg,['/Month'], , 
9702,3660,Gilenya,2016-08-12,2020-03-25, , ,['/ Week'], ,Persistence of relapses
9703,3660,Gilenya,2016-06-16,, ,mg,[' '], , 
9704,4443,Copaxone,2015-11-17,,20, ,['/ Week'], , 
9705,3850,Alemtuzumab (Campath),2015-12-28,2018-08-21,1,mg,['2 / Day'],IV,Persisting MRI activity
9706,3260,Copaxone,2016-01-13,,500, ,['/Month'],IV, 
9707,3913,Tecfidera,2016-02-21,, ,MIU,['/ Week'], , 
9708,3913,Rebif [44],2016-04-28,, ,mcg,['2 / Day'], , 
9709,3913,Methylprednisolone,2016-06-05,2019-05-30, ,mg,['/ Week'],Oral,Persistence of relapses
9710,3913,Avonex,2016-06-21,,20,mg,['2 / Day'],IV, 
9711,840,IVIG,2016-01-09,, , ,['2 / Day'], , 
9712,840,IVIG,2015-11-14,2018-09-27,500, ,['2 / Day'],Oral,Persisting MRI activity
9713,840,Endoxan,2016-07-30,2020-05-22,500, ,['2 / Day'],IV,Lack of efficacy
9714,840,Tecfidera,2016-08-25,,5000, ,['3 / Week'], , 
9715,3125,Avonex,2016-02-09,, ,mcg,['/Month'],IV, 
9716,3125,D-cure (Vitamine D),2015-12-10,,5000,mg,['3 / Week'],IV, 
9717,4251,Tecfidera,2015-11-07,2019-08-28, , ,['/ Day'],IV,Patient Choice/Convenience
9718,2200,Methylprednisolone,2016-09-26,,500,mg,['/Month'],IV, 
9719,200,Betaferon,2016-09-21,2021-09-28,1000, ,['3 / Week'],IV,Adverse Event
9720,200,Avonex,2016-07-06,, ,MIU,['/Month'],Oral, 
9721,200,Alemtuzumab (Campath),2016-09-16,,1000,mcg,['/Month'],Oral, 
9722,200,Tysabri,2016-10-18,, ,mg,['2 / Day'],IV, 
9723,2318,Tecfidera,2016-08-18,2020-09-18, ,mg,['/Month'],IV,Lack of efficacy
9724,3870,Tysabri,2016-04-17,2020-04-20,20, ,['/Month'],IV,Lack of efficacy
9725,3870,Copaxone,2016-05-19,,1000,mg,['3 / Week'],IV, 
9726,3870,Methylprednisolone,2015-11-14,2018-11-30,1,mg,['/ Day'],IV,Persistence of relapses
9727,3870,Alemtuzumab (Campath),2016-05-27,,500,mcg,['/Month'], , 
9728,109,Tecfidera,2016-08-22,2021-06-27, , ,[' '], ,Lack of efficacy
9729,4947,Tecfidera,2015-11-26,,1, ,['/ Week'], , 
9730,4947,IVIG,2016-02-20,,20,mg,['2 / Day'],IV, 
9731,4947,D-cure (Vitamine D),2016-09-14,2020-08-02, , ,['/Month'],IV,Lack of efficacy
9732,3390,Tysabri,2015-11-26,2018-08-10, , ,['/Month'],IV,Patient Choice/Convenience
9733,3390,Copaxone,2016-10-04,,1000, ,['3 / Week'], , 
9734,2571,Avonex,2016-09-15,2021-05-19,1000,mg,['2 / Day'],Oral,Patient Choice/Convenience
9735,2571,Alemtuzumab (Campath),2016-02-13,,20, ,['/ Day'],IV, 
9736,2571,IVIG,2015-12-17,,1,mg,['2 / Day'],IV, 
9737,864,Betaferon,2016-03-17,,1,MIU,['3 / Week'],IV, 
9738,864,Mitoxantrone,2015-11-02,2018-05-13,300,mg,['2 / Day'],IV,Adverse Event
9739,864,Avonex,2016-03-27,,1, ,['/ Day'], , 
9740,4855,Tecfidera,2015-12-20,,1000, ,[' '], , 
9741,4855,Ledertrexaat,2016-01-24,2019-01-16, , ,[' '],IV,Persisting MRI activity
9742,4855,Teriflunomide,2016-08-26,,500, ,['2 / Day'], , 
9743,4855,Rebif [44],2016-02-20,,5000,mg,['2 / Day'],Oral, 
9744,1285,Rebif [22],2016-07-24,2019-06-21,1000,MIU,['/Month'],IV,Patient Choice/Convenience
9745,1285,Tysabri,2015-11-08,2019-02-18,1,mg,['2 / Day'], ,Persistence of relapses
9746,1285,Gilenya,2016-04-09,,1000,mg,['3 / Week'], , 
9747,2579,Rebif [44],2016-05-16,,1, ,['2 / Day'], , 
9748,740,Rebif [22],2016-07-25,, , ,['/Month'],IV, 
9749,740,Ledertrexaat,2015-11-25,,20,mg,['/Month'],IV, 
9750,3219,IVIG,2015-12-08,,20, ,['/ Week'], , 
9751,631,Methylprednisolone,2016-09-21,2018-05-09,5000,mg,['2 / Day'], ,Persisting MRI activity
9752,631,Avonex,2016-06-27,,5000,mg,['/Month'], , 
9753,1709,Methylprednisolone,2015-12-02,2020-05-31,300, ,['3 / Week'],IV,Patient Choice/Convenience
9754,1709,Copaxone,2016-03-03,2021-02-15, ,mg,[' '],Oral,Lack of efficacy
9755,1709,Rebif [22],2015-11-11,,500,mg,[' '], , 
9756,3424,Rebif [44],2015-12-17,2018-02-12,500,mg,['/ Day'], ,Adverse Event
9757,3424,Rebif [44],2016-03-29,2021-04-04,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
9758,3424,Alemtuzumab (Campath),2016-04-05,, ,mg,[' '],Oral, 
9759,472,Rebif [22],2015-12-19,2020-05-10,400,mg,['3 / Week'], ,Patient Choice/Convenience
9760,472,Rebif [22],2016-03-18,2019-06-21,5000, ,['2 / Day'],IV,Persisting MRI activity
9761,472,Mitoxantrone,2016-03-11,,300, ,[' '],IV, 
9762,2018,Tecfidera,2016-09-25,, , ,['3 / Week'],Oral, 
9763,2018,D-cure (Vitamine D),2016-06-12,2019-04-03,5000,mg,['3 / Week'],IV,Adverse Event
9764,2018,Endoxan,2016-08-11,, , ,['2 / Day'],IV, 
9765,2863,Tysabri,2016-08-31,2019-07-12,300,mcg,['/ Week'],Oral,Persisting MRI activity
9766,1599,Gilenya,2016-03-03,, ,mg,['/Month'],IV, 
9767,1599,Methylprednisolone,2016-09-05,, , ,['/ Day'], , 
9768,4436,Alemtuzumab (Campath),2016-04-02,,300,mg,['2 / Day'],IV, 
9769,2967,Alemtuzumab (Campath),2016-02-07,2019-02-05, , ,['3 / Week'],IV,Adverse Event
9770,3208,Ledertrexaat,2016-05-21,,400, ,['3 / Week'],Oral, 
9771,3208,Gilenya,2016-07-26,, , ,[' '],IV, 
9772,1362,IVIG,2016-06-13,2020-10-22, , ,[' '], ,Adverse Event
9773,1362,Mitoxantrone,2016-07-23,,5000,mg,['2 / Day'],IV, 
9774,1362,Tecfidera,2016-07-12,2019-12-02,500, ,['/Month'],IV,Patient Choice/Convenience
9775,1362,Teriflunomide,2015-11-05,2021-03-09,400,mg,['/Month'], ,Lack of efficacy
9776,4137,IVIG,2016-08-20,2021-05-15,5000,mg,['/ Day'],Oral,Lack of efficacy
9777,4137,Rebif [44],2015-12-26,,400,mg,['/Month'],IV, 
9778,4137,Rebif [44],2016-03-08,,20,mg,['/Month'], , 
9779,4829,Betaferon,2016-05-23,, ,mcg,['2 / Day'],Oral, 
9780,4829,Gilenya,2016-01-16,2020-08-25,1,MIU,['/Month'], ,Patient Choice/Convenience
9781,4829,IVIG,2016-05-20,,5000,mg,['/Month'],IV, 
9782,2170,Endoxan,2016-09-30,2021-06-12, ,mg,['/Month'],IV,Adverse Event
9783,2170,Copaxone,2015-12-30,2020-11-02,1000,mcg,['/Month'], ,Patient Choice/Convenience
9784,548,D-cure (Vitamine D),2015-12-06,2020-12-23,1,mg,[' '], ,Adverse Event
9785,548,Tysabri,2015-11-19,2021-01-09,5000,MIU,['/Month'],IV,Persistence of relapses
9786,572,IVIG,2015-11-20,2021-05-26,5000, ,['/Month'],IV,Patient Choice/Convenience
9787,572,Betaferon,2015-11-25,,1, ,['2 / Day'],IV, 
9788,4484,Endoxan,2016-01-08,2019-02-03,500, ,['2 / Day'],IV,Patient Choice/Convenience
9789,4484,IVIG,2016-02-26,, , ,['/ Day'],IV, 
9790,1883,Methylprednisolone,2016-05-03,2019-04-21, ,MIU,[' '], ,Persisting MRI activity
9791,1883,Endoxan,2016-05-01,,500,mg,['/Month'],IV, 
9792,1883,Rebif [44],2016-06-28,,20, ,['2 / Day'], , 
9793,1883,Betaferon,2016-03-17,,500, ,['/ Week'], , 
9794,4957,Tecfidera,2015-11-09,2019-02-23, ,mg,['/Month'], ,Persistence of relapses
9795,4957,D-cure (Vitamine D),2016-02-16,2019-11-06,500,mg,['3 / Week'],IV,Adverse Event
9796,4957,Tysabri,2016-03-23,, ,mg,['3 / Week'],IV, 
9797,826,Alemtuzumab (Campath),2016-09-22,,20, ,['/Month'],IV, 
9798,826,Tecfidera,2016-01-29,,300,MIU,['3 / Week'],Oral, 
9799,826,Endoxan,2016-07-27,2019-09-19,300, ,['2 / Day'],Oral,Adverse Event
9800,826,Gilenya,2016-04-29,,300,mg,['2 / Day'],IV, 
9801,3946,IVIG,2016-05-04,,500,mg,['/ Week'],IV, 
9802,3946,Betaferon,2016-07-26,, ,mg,['/ Week'],IV, 
9803,3946,Endoxan,2016-06-14,,300,mg,['/ Day'],IV, 
9804,491,Copaxone,2015-11-30,,20, ,['2 / Day'],Oral, 
9805,491,Ledertrexaat,2016-05-26,2018-03-28,20,mg,['2 / Day'],IV,Persisting MRI activity
9806,4172,Betaferon,2015-11-12,, ,mg,['/ Day'],Oral, 
9807,2554,Teriflunomide,2015-10-28,, , ,['3 / Week'],IV, 
9808,3693,Rebif [22],2016-03-14,2020-04-17, ,MIU,['/Month'],IV,Patient Choice/Convenience
9809,534,IVIG,2016-04-09,2021-04-02,300, ,['2 / Day'],IV,Adverse Event
9810,534,Tecfidera,2016-10-14,,300, ,['2 / Day'],IV, 
9811,534,Endoxan,2016-04-24,2021-01-11,5000, ,[' '], ,Persistence of relapses
9812,534,Methylprednisolone,2016-05-08,2019-10-01, ,mg,['2 / Day'], ,Persisting MRI activity
9813,4163,Betaferon,2016-04-07,,20,mg,['/Month'], , 
9814,4163,Mitoxantrone,2016-10-13,,400,mg,['/Month'],IV, 
9815,2497,Alemtuzumab (Campath),2015-11-18,2020-04-16, ,mcg,['/Month'],Oral,Lack of efficacy
9816,2497,Endoxan,2016-02-15,2021-03-21,5000,MIU,['/Month'],IV,Patient Choice/Convenience
9817,2497,D-cure (Vitamine D),2016-10-10,2018-02-19, , ,['/ Week'], ,Lack of efficacy
9818,2497,IVIG,2016-01-26,,1000,mg,['3 / Week'],IV, 
9819,2979,D-cure (Vitamine D),2016-02-15,,500,mg,['/ Week'], , 
9820,2409,Ledertrexaat,2016-01-16,2020-08-19,1000, ,['2 / Day'],IV,Adverse Event
9821,2409,Gilenya,2016-04-11,2021-03-12,20,mg,['/Month'],IV,Adverse Event
9822,2409,Avonex,2015-11-13,2020-05-21, ,MIU,['/ Day'],IV,Lack of efficacy
9823,2409,Ledertrexaat,2016-07-15,, , ,['2 / Day'],IV, 
9824,3566,Alemtuzumab (Campath),2016-01-22,2019-12-15,5000,mg,['/Month'], ,Lack of efficacy
9825,3566,Copaxone,2015-12-02,,1,mg,['2 / Day'],Oral, 
9826,3566,Methylprednisolone,2016-04-23,2018-11-20, ,mg,['2 / Day'],Oral,Adverse Event
9827,3566,Tecfidera,2016-06-10,2020-03-18,1,mg,['2 / Day'],Oral,Adverse Event
9828,491,Gilenya,2015-11-06,2019-05-26,400, ,['/Month'], ,Lack of efficacy
9829,491,Copaxone,2015-12-08,2018-06-03,1000,MIU,['2 / Day'],IV,Lack of efficacy
9830,491,D-cure (Vitamine D),2015-12-26,2020-05-18,500,MIU,['2 / Day'],IV,Persistence of relapses
9831,3835,Endoxan,2015-12-23,,1000, ,['2 / Day'],IV, 
9832,3835,Tecfidera,2016-08-20,,300, ,['/ Week'],IV, 
9833,3835,Mitoxantrone,2016-06-20,2021-09-29,400,mg,[' '], ,Persistence of relapses
9834,3835,Rebif [44],2016-09-28,, ,mg,['/Month'],Oral, 
9835,1570,D-cure (Vitamine D),2015-12-22,,1, ,['/Month'],IV, 
9836,1570,Methylprednisolone,2016-04-27,, , ,['2 / Day'],Oral, 
9837,4970,Methylprednisolone,2016-04-11,, , ,['3 / Week'], , 
9838,4384,Endoxan,2015-10-31,,5000, ,['2 / Day'],IV, 
9839,4384,IVIG,2016-07-26,2018-01-11, ,mg,['/Month'],IV,Persisting MRI activity
9840,4178,Gilenya,2016-02-01,,20,mcg,['/Month'],Oral, 
9841,4834,Alemtuzumab (Campath),2016-04-20,,500,mg,['2 / Day'],Oral, 
9842,4834,Ledertrexaat,2016-03-05,2018-11-13,300, ,['/Month'],IV,Patient Choice/Convenience
9843,3273,Alemtuzumab (Campath),2016-05-27,2020-01-23, ,mg,['2 / Day'], ,Persisting MRI activity
9844,3273,Tecfidera,2016-07-01,,5000, ,['3 / Week'], , 
9845,964,Copaxone,2016-02-29,,5000,mg,['/Month'], , 
9846,964,Betaferon,2015-12-20,2020-05-29,500,mg,['/Month'],Oral,Patient Choice/Convenience
9847,409,Tysabri,2016-02-23,2021-03-16, , ,['2 / Day'],IV,Adverse Event
9848,409,Avonex,2015-11-18,,500,MIU,['3 / Week'], , 
9849,409,Avonex,2016-08-24,, ,mg,['3 / Week'], , 
9850,409,Betaferon,2016-05-29,2020-07-12,500,MIU,['/Month'], ,Persisting MRI activity
9851,3106,Methylprednisolone,2016-04-03,,20, ,['/Month'], , 
9852,3106,IVIG,2016-02-15,2020-05-08,400,mg,['/Month'], ,Adverse Event
9853,802,Endoxan,2016-04-28,2021-07-26, , ,['2 / Day'], ,Lack of efficacy
9854,802,Methylprednisolone,2016-01-28,2020-09-11,1000,mg,[' '],IV,Adverse Event
9855,802,Methylprednisolone,2016-02-29,2018-05-18,400, ,['/ Day'],IV,Persistence of relapses
9856,802,Rebif [44],2016-05-16,, ,mg,['/Month'],IV, 
9857,1341,Gilenya,2016-01-29,2018-09-07, , ,['3 / Week'],IV,Patient Choice/Convenience
9858,1341,Copaxone,2016-02-07,,1000, ,['2 / Day'], , 
9859,1341,Rebif [22],2016-08-21,2019-09-14,5000, ,['/Month'],Oral,Lack of efficacy
9860,4680,Rebif [44],2015-12-01,2018-11-07,1000, ,['/Month'],IV,Persisting MRI activity
9861,3423,Alemtuzumab (Campath),2016-01-26,2020-01-26,300,mg,['/Month'],Oral,Patient Choice/Convenience
9862,3423,Copaxone,2016-08-02,2019-12-10, , ,['3 / Week'],Oral,Lack of efficacy
9863,3423,IVIG,2016-09-10,,500,mg,['2 / Day'],IV, 
9864,2947,Endoxan,2015-12-26,2020-01-06, , ,['/Month'],IV,Persistence of relapses
9865,2947,IVIG,2016-02-14,2019-10-15, ,MIU,['2 / Day'],IV,Lack of efficacy
9866,2947,Tecfidera,2016-06-20,, ,MIU,['/Month'],IV, 
9867,2947,Copaxone,2016-09-27,, ,MIU,['/Month'], , 
9868,4418,Gilenya,2016-03-18,2019-11-30, ,mg,['/Month'], ,Lack of efficacy
9869,4418,Avonex,2015-12-21,,500,mg,['/Month'],IV, 
9870,3945,Tecfidera,2016-03-22,,20, ,['2 / Day'], , 
9871,1062,D-cure (Vitamine D),2016-09-09,2020-11-28, ,mcg,['2 / Day'], ,Persistence of relapses
9872,1062,Betaferon,2016-10-09,2018-03-20,5000,mcg,['/Month'],IV,Patient Choice/Convenience
9873,1062,D-cure (Vitamine D),2016-07-25,2018-01-12,500,mg,['/ Week'],Oral,Persisting MRI activity
9874,4444,Endoxan,2016-07-18,,1000,MIU,['/Month'],IV, 
9875,4444,Endoxan,2016-06-08,,300,mg,['3 / Week'],IV, 
9876,3981,Betaferon,2016-04-26,, ,mg,['/Month'], , 
9877,3981,Rebif [44],2016-07-03,,300,MIU,['2 / Day'], , 
9878,497,Teriflunomide,2016-09-08,, , ,['3 / Week'],IV, 
9879,497,Tysabri,2016-04-06,,20,MIU,['2 / Day'],IV, 
9880,497,Avonex,2016-08-17,2020-04-02,1,mg,['2 / Day'], ,Adverse Event
9881,2117,Alemtuzumab (Campath),2016-06-05,,400, ,['2 / Day'],IV, 
9882,2014,Endoxan,2016-08-21,,500, ,['/ Day'], , 
9883,2239,Teriflunomide,2016-04-11,, , ,['2 / Day'],IV, 
9884,2239,Tysabri,2016-02-12,,400,MIU,[' '],IV, 
9885,940,Rebif [22],2016-03-31,, , ,['/Month'],IV, 
9886,940,Rebif [22],2016-03-04,, ,mg,['3 / Week'],Oral, 
9887,940,Gilenya,2016-05-23,, ,mg,['/Month'],IV, 
9888,940,Copaxone,2016-09-15,,1000, ,['/Month'],IV, 
9889,4696,Tecfidera,2015-12-08,,400,mg,[' '], , 
9890,4696,IVIG,2016-06-26,,1000, ,['/Month'],Oral, 
9891,4696,Alemtuzumab (Campath),2016-01-16,2017-12-16,1000, ,['/Month'], ,Lack of efficacy
9892,4696,Tecfidera,2016-03-26,,1000,mg,['2 / Day'], , 
9893,950,Gilenya,2016-04-12,2017-11-21,400, ,['/Month'],IV,Adverse Event
9894,950,D-cure (Vitamine D),2016-07-14,2021-06-22,500,mg,[' '],IV,Patient Choice/Convenience
9895,950,Teriflunomide,2016-07-26,,300, ,['/Month'],Oral, 
9896,950,IVIG,2016-08-20,,300,mg,['2 / Day'], , 
9897,1859,Alemtuzumab (Campath),2016-10-01,,300, ,['/Month'],Oral, 
9898,1859,IVIG,2016-09-13,2021-09-20,20,mg,['/Month'],IV,Lack of efficacy
9899,1859,Rebif [22],2016-07-31,,1,mg,['/Month'], , 
9900,2311,Betaferon,2016-07-16,2020-12-16,400, ,['/Month'],IV,Lack of efficacy
9901,2311,Betaferon,2016-02-11,2017-11-24,1000,mg,['/Month'], ,Persisting MRI activity
9902,2311,Copaxone,2016-01-27,2021-09-13, ,mg,['/Month'],IV,Adverse Event
9903,2311,Mitoxantrone,2016-07-08,2018-06-06,20,mg,['2 / Day'],IV,Lack of efficacy
9904,2845,Rebif [44],2015-12-22,, ,mg,['3 / Week'],IV, 
9905,2845,Alemtuzumab (Campath),2015-12-28,, , ,['/ Week'], , 
9906,2845,Gilenya,2016-01-02,,500, ,['2 / Day'],IV, 
9907,731,Avonex,2016-08-03,2018-06-28, ,mg,['3 / Week'],IV,Adverse Event
9908,731,Rebif [44],2016-04-11,2018-05-17, ,mg,['2 / Day'],IV,Persisting MRI activity
9909,731,Gilenya,2016-07-29,2019-08-14,300,MIU,['/Month'],IV,Lack of efficacy
9910,4507,Mitoxantrone,2016-06-15,, ,mcg,[' '], , 
9911,2989,IVIG,2016-04-03,2020-09-13,400,mg,['/ Week'], ,Lack of efficacy
9912,2989,IVIG,2015-11-03,2020-10-15, ,MIU,[' '], ,Adverse Event
9913,2989,Gilenya,2016-05-01,2020-03-02,500, ,['/Month'], ,Lack of efficacy
9914,2989,Copaxone,2016-05-16,,5000, ,['2 / Day'], , 
9915,2649,Methylprednisolone,2016-09-13,, ,mg,['2 / Day'],IV, 
9916,2649,Tecfidera,2016-02-04,2021-04-07,300,mg,['2 / Day'],IV,Persisting MRI activity
9917,2649,Rebif [44],2016-05-22,,1000,mg,['3 / Week'], , 
9918,4862,Ledertrexaat,2016-05-24,, , ,['/ Day'],IV, 
9919,4862,D-cure (Vitamine D),2015-11-30,2018-12-14,1000,MIU,[' '],IV,Patient Choice/Convenience
9920,4862,IVIG,2015-11-22,,1000,MIU,['2 / Day'],IV, 
9921,4862,Avonex,2016-01-03,2019-11-04,500,mg,['2 / Day'], ,Patient Choice/Convenience
9922,3577,Rebif [44],2016-06-05,,1000,mg,['/Month'],IV, 
9923,3577,Alemtuzumab (Campath),2016-02-19,,1000,MIU,['/ Week'],IV, 
9924,3577,Alemtuzumab (Campath),2016-03-06,,1, ,['/Month'], , 
9925,4190,Methylprednisolone,2016-05-24,2020-05-23,1, ,['2 / Day'],IV,Patient Choice/Convenience
9926,4190,Avonex,2016-02-28,,1000,mg,['2 / Day'],IV, 
9927,4190,Ledertrexaat,2016-06-25,2018-09-01, ,mg,['2 / Day'],IV,Persisting MRI activity
9928,1591,Rebif [44],2015-12-11,2018-03-14,1000, ,['2 / Day'], ,Lack of efficacy
9929,1591,Methylprednisolone,2016-08-29,,500,mcg,['2 / Day'],IV, 
9930,1035,Tysabri,2015-12-17,, , ,['/Month'],IV, 
9931,1035,Gilenya,2016-04-19,2020-07-30,1, ,['/ Week'], ,Patient Choice/Convenience
9932,1035,Gilenya,2016-01-09,2020-09-10,1000,mg,['3 / Week'], ,Adverse Event
9933,1035,Tysabri,2015-12-25,,300, ,['/Month'], , 
9934,332,Endoxan,2016-02-10,,1, ,['2 / Day'],IV, 
9935,3628,Betaferon,2016-03-18,,1, ,['2 / Day'],IV, 
9936,3628,Methylprednisolone,2016-02-11,,20,mcg,['2 / Day'], , 
9937,3628,Tecfidera,2016-06-26,2020-10-30,1000,MIU,[' '],IV,Patient Choice/Convenience
9938,3628,Ledertrexaat,2015-11-16,,5000,mcg,['3 / Week'],IV, 
9939,4005,Rebif [44],2016-05-04,,1,mcg,['2 / Day'], , 
9940,4005,Gilenya,2016-04-04,,20,mg,['/Month'], , 
9941,4005,Ledertrexaat,2016-04-08,, , ,['/Month'],IV, 
9942,4005,Betaferon,2016-10-19,,5000,mg,['2 / Day'], , 
9943,2803,Avonex,2015-12-13,2021-03-02, ,mg,['/ Day'],Oral,Persisting MRI activity
9944,1038,Tecfidera,2016-02-03,2021-10-18, ,MIU,['2 / Day'], ,Patient Choice/Convenience
9945,1038,D-cure (Vitamine D),2016-07-27,,5000,MIU,[' '],IV, 
9946,2212,Tysabri,2016-01-03,,500,mg,['2 / Day'], , 
9947,2212,Tysabri,2015-12-18,,500, ,['2 / Day'], , 
9948,2212,Teriflunomide,2016-10-15,2020-12-24, , ,['/Month'], ,Adverse Event
9949,4754,Ledertrexaat,2016-09-13,,1, ,['2 / Day'], , 
9950,4754,Rebif [44],2016-02-15,,1,mg,['/Month'],IV, 
9951,4754,Teriflunomide,2016-05-20,2021-02-19, ,mg,['2 / Day'],IV,Adverse Event
9952,4405,Betaferon,2016-06-02,,1000, ,['3 / Week'],IV, 
9953,4405,Rebif [44],2016-03-03,2018-02-08,20, ,['/ Week'],Oral,Persisting MRI activity
9954,4405,Gilenya,2016-09-22,, ,MIU,['/ Day'],IV, 
9955,3384,Alemtuzumab (Campath),2016-04-09,2021-06-15,1000, ,['2 / Day'],IV,Persisting MRI activity
9956,3384,Avonex,2016-09-03,2021-07-04,300,mcg,['2 / Day'], ,Adverse Event
9957,3384,Copaxone,2016-01-25,,1, ,['/Month'], , 
9958,3871,Tecfidera,2015-12-25,,1, ,['/Month'],IV, 
9959,3871,Mitoxantrone,2016-06-20,, , ,['3 / Week'],IV, 
9960,3871,Gilenya,2015-12-29,,1000,MIU,['/Month'],IV, 
9961,2515,Copaxone,2015-11-10,, ,MIU,['/Month'], , 
9962,2515,Alemtuzumab (Campath),2016-07-16,,20, ,['3 / Week'],IV, 
9963,2548,Rebif [44],2016-04-29,2018-03-29, ,mg,['2 / Day'], ,Adverse Event
9964,2548,Rebif [22],2015-10-26,2020-07-27,500, ,['/ Week'], ,Adverse Event
9965,2548,Alemtuzumab (Campath),2016-05-11,2018-03-22,5000, ,['2 / Day'],IV,Adverse Event
9966,2548,Tysabri,2015-12-01,,500, ,['2 / Day'],IV, 
9967,4801,Tecfidera,2016-05-22,2021-08-22,1,MIU,['2 / Day'],IV,Adverse Event
9968,4801,Tysabri,2015-12-15,,1000, ,['/Month'],IV, 
9969,4801,IVIG,2016-05-29,2020-03-31,1, ,['2 / Day'],IV,Lack of efficacy
9970,4801,Rebif [22],2016-09-13,,20,MIU,['/Month'], , 
9971,881,Gilenya,2016-01-15,, , ,['2 / Day'],IV, 
9972,757,Rebif [44],2016-08-09,,500,MIU,['2 / Day'], , 
9973,757,Tecfidera,2015-12-18,, ,mg,['3 / Week'],IV, 
9974,757,Alemtuzumab (Campath),2016-06-12,2018-08-29,1000, ,['/Month'], ,Lack of efficacy
9975,757,Tecfidera,2016-07-26,,1000, ,['3 / Week'],IV, 
9976,4316,D-cure (Vitamine D),2015-12-06,2019-10-30,400, ,['/ Week'],IV,Persisting MRI activity
9977,4316,Rebif [44],2016-07-30,,400, ,['/Month'],IV, 
9978,4316,Alemtuzumab (Campath),2016-02-22,, , ,['/ Day'],IV, 
9979,3074,D-cure (Vitamine D),2016-07-14,2020-05-14,5000, ,['/ Day'],IV,Persisting MRI activity
9980,3074,Tecfidera,2016-07-22,, ,mg,['/ Day'], , 
9981,3074,Rebif [44],2016-05-20,2020-12-22,500,mg,['2 / Day'],IV,Persistence of relapses
9982,3074,Tysabri,2015-11-06,,5000, ,['2 / Day'],IV, 
9983,3805,Betaferon,2016-02-05,,400,mg,['2 / Day'],IV, 
9984,3805,Avonex,2015-11-10,,1000, ,['/Month'],Oral, 
9985,3805,Tysabri,2016-05-21,,1000, ,[' '],IV, 
9986,3805,D-cure (Vitamine D),2016-01-20,, ,mg,['/Month'],IV, 
9987,2860,Teriflunomide,2016-10-16,,5000,mcg,['/Month'], , 
9988,2860,Copaxone,2016-07-13,,500, ,['/Month'], , 
9989,3226,D-cure (Vitamine D),2016-01-31,, ,mg,['/Month'], , 
9990,1232,Alemtuzumab (Campath),2016-05-01,2017-11-20,500,MIU,['/ Day'],Oral,Persistence of relapses
9991,1232,Methylprednisolone,2016-09-11,, ,MIU,['2 / Day'],IV, 
9992,4384,Mitoxantrone,2016-03-24,2018-07-08, , ,['/ Week'], ,Patient Choice/Convenience
9993,4384,Teriflunomide,2015-12-12,, ,mg,[' '],IV, 
9994,4384,Gilenya,2016-01-30,, ,mg,['2 / Day'],Oral, 
9995,4384,Gilenya,2016-08-08,, ,mg,['/Month'],IV, 
9996,2886,Alemtuzumab (Campath),2016-09-14,,20, ,['/Month'],IV, 
9997,3487,Rebif [44],2016-10-14,,400,mg,['/Month'],IV, 
9998,3487,Tysabri,2016-10-03,,400, ,['2 / Day'],IV, 
9999,3487,Alemtuzumab (Campath),2016-03-30,,500,mg,['3 / Week'],Oral, 
10000,3644,D-cure (Vitamine D),2016-03-26,,20, ,['2 / Day'],IV, 
10001,2767,Tecfidera,2016-07-02,2020-08-30,300, ,['3 / Week'], ,Persistence of relapses
10002,2331,Copaxone,2016-06-25,,1000, ,['/ Week'], , 
10003,2331,Avonex,2016-09-18,, ,MIU,['2 / Day'], , 
10004,1894,Gilenya,2016-03-11,,300, ,['/Month'], , 
10005,1355,Endoxan,2016-01-20,2020-05-30,300, ,[' '],Oral,Patient Choice/Convenience
10006,2250,Endoxan,2016-08-29,2018-07-10,5000,MIU,['3 / Week'], ,Adverse Event
10007,2250,Endoxan,2016-02-10,, ,mg,['2 / Day'],IV, 
10008,4336,Ledertrexaat,2016-05-22,,20, ,[' '],IV, 
10009,4336,D-cure (Vitamine D),2016-01-15,2019-12-22,1000,MIU,['3 / Week'], ,Adverse Event
10010,4948,Rebif [22],2016-03-08,2019-10-28, , ,['3 / Week'],IV,Adverse Event
10011,2955,Tysabri,2016-01-14,,500, ,['2 / Day'], , 
10012,2955,Tecfidera,2016-08-04,,5000, ,['3 / Week'],Oral, 
10013,2955,Betaferon,2016-07-30,, ,mg,['/Month'], , 
10014,2955,Endoxan,2016-01-31,, , ,['/ Day'],IV, 
10015,3627,Tysabri,2015-11-07,, , ,['2 / Day'], , 
10016,1994,Avonex,2016-10-11,2018-05-06,1000,MIU,['3 / Week'],IV,Adverse Event
10017,1994,Methylprednisolone,2016-02-21,,1000,mg,['2 / Day'],IV, 
10018,1929,Gilenya,2016-10-22,, , ,['2 / Day'],IV, 
10019,2067,Betaferon,2015-12-03,2020-05-27,500,mg,['2 / Day'],IV,Lack of efficacy
10020,2067,IVIG,2016-02-09,, ,mg,[' '],IV, 
10021,1430,Endoxan,2016-10-04,,500, ,['2 / Day'], , 
10022,1430,Tecfidera,2016-03-11,, ,mg,['3 / Week'], , 
10023,1430,Gilenya,2016-10-17,2020-10-09, ,mg,['/ Day'],IV,Adverse Event
10024,1430,Teriflunomide,2016-08-14,,5000, ,['/Month'],Oral, 
10025,4511,Tecfidera,2015-11-12,, ,mg,['/Month'],IV, 
10026,2680,IVIG,2016-08-22,2021-01-11, , ,['2 / Day'],IV,Lack of efficacy
10027,2680,Tecfidera,2016-08-16,2020-07-26,500,mg,['2 / Day'],IV,Patient Choice/Convenience
10028,2680,Rebif [22],2016-04-10,,300,mg,['2 / Day'],IV, 
10029,2680,Tysabri,2016-09-26,2018-03-07,1000, ,['/Month'],IV,Persistence of relapses
10030,2425,Tecfidera,2015-11-01,2018-01-13, ,MIU,['/ Week'], ,Lack of efficacy
10031,2425,Betaferon,2016-08-14,2019-05-04, ,mg,['/Month'], ,Lack of efficacy
10032,2425,Copaxone,2015-11-30,2019-02-08,5000,mg,['2 / Day'], ,Adverse Event
10033,2425,IVIG,2016-05-06,2020-09-18, , ,['3 / Week'], ,Adverse Event
10034,1608,Endoxan,2015-12-19,,1, ,['/Month'],IV, 
10035,1608,Endoxan,2016-04-10,2020-01-20, , ,['/Month'],IV,Persisting MRI activity
10036,1608,D-cure (Vitamine D),2016-10-06,,500, ,['/Month'],IV, 
10037,3663,Betaferon,2016-10-16,2018-05-04,1, ,['3 / Week'],IV,Patient Choice/Convenience
10038,1842,Methylprednisolone,2016-10-22,2020-11-06, ,mg,['/ Day'],IV,Adverse Event
10039,2113,Avonex,2016-08-19,,500,mg,['/Month'], , 
10040,4610,Rebif [22],2016-06-15,2018-01-26,500,mg,['2 / Day'],IV,Persisting MRI activity
10041,4610,Methylprednisolone,2016-03-09,2018-05-26,1, ,['3 / Week'], ,Persisting MRI activity
10042,2567,Methylprednisolone,2016-03-10,,1,mcg,['/ Day'],Oral, 
10043,3255,Mitoxantrone,2015-11-15,2019-07-05,5000,MIU,['/Month'],IV,Patient Choice/Convenience
10044,3255,Rebif [44],2016-06-23,,300,mg,['3 / Week'],IV, 
10045,3255,D-cure (Vitamine D),2016-01-11,, ,mg,['2 / Day'], , 
10046,269,Alemtuzumab (Campath),2015-12-22,,1000,mg,[' '],Oral, 
10047,4746,Tysabri,2016-01-08,,400,mg,['/ Day'], , 
10048,3038,Methylprednisolone,2016-07-13,2020-07-31,300,mg,['/Month'], ,Persistence of relapses
10049,3038,IVIG,2015-10-28,2018-08-13,400,mg,[' '],IV,Persisting MRI activity
10050,3038,Copaxone,2016-10-04,,1000,mg,['3 / Week'],IV, 
10051,333,Methylprednisolone,2016-01-27,2018-03-16,400,MIU,[' '],IV,Adverse Event
10052,333,IVIG,2015-12-01,, , ,['/Month'],IV, 
10053,2720,Alemtuzumab (Campath),2016-10-05,,20,mg,['2 / Day'], , 
10054,2720,Endoxan,2016-07-15,,20,mcg,[' '], , 
10055,2720,Tecfidera,2015-12-05,,20,mg,['3 / Week'],Oral, 
10056,2720,Rebif [22],2016-08-23,2019-09-13, , ,['/Month'],IV,Persisting MRI activity
10057,2149,Gilenya,2016-07-13,, ,mg,['3 / Week'],IV, 
10058,2149,Ledertrexaat,2016-01-10,2018-09-09,500,mcg,['/Month'], ,Adverse Event
10059,2149,D-cure (Vitamine D),2016-03-06,,500, ,['/ Day'], , 
10060,2149,Alemtuzumab (Campath),2016-02-10,, ,MIU,['2 / Day'],IV, 
10061,2923,Ledertrexaat,2016-10-18,,5000, ,['/ Day'],IV, 
10062,2923,Copaxone,2016-10-01,, ,MIU,['2 / Day'],IV, 
10063,4306,Rebif [22],2016-10-17,2018-06-12,500,MIU,['/Month'],Oral,Patient Choice/Convenience
10064,4306,Endoxan,2016-04-15,, , ,['/Month'], , 
10065,4306,Betaferon,2016-02-19,, , ,['/Month'],Oral, 
10066,4306,Avonex,2016-10-19,2018-05-23, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
10067,2724,Alemtuzumab (Campath),2016-02-18,,5000, ,['3 / Week'],IV, 
10068,4423,IVIG,2016-07-23,, , ,['2 / Day'], , 
10069,4423,D-cure (Vitamine D),2015-12-24,,5000,MIU,['/Month'],IV, 
10070,4423,Copaxone,2016-06-09,,20,mcg,['2 / Day'], , 
10071,4423,Methylprednisolone,2016-03-01,2019-02-24,300,mg,['3 / Week'],IV,Patient Choice/Convenience
10072,1567,Rebif [22],2016-03-10,,400,mg,[' '], , 
10073,4202,Ledertrexaat,2015-11-05,2018-09-21,500, ,['/Month'],IV,Persisting MRI activity
10074,4202,Endoxan,2016-06-16,2019-10-24, , ,['3 / Week'],Oral,Lack of efficacy
10075,4202,Rebif [44],2015-12-26,, , ,['2 / Day'],Oral, 
10076,3018,Avonex,2015-11-30,2019-10-14,5000,mcg,['/Month'], ,Adverse Event
10077,2707,Methylprednisolone,2016-01-28,2020-01-05, , ,['3 / Week'],IV,Lack of efficacy
10078,2707,Rebif [44],2016-09-23,,500,mg,['/Month'],IV, 
10079,2161,D-cure (Vitamine D),2016-10-20,2021-08-03, , ,['/Month'],IV,Lack of efficacy
10080,2161,D-cure (Vitamine D),2016-05-30,,5000,mg,['/Month'], , 
10081,3356,Tecfidera,2016-02-28,2019-11-23,1000, ,['/Month'],IV,Lack of efficacy
10082,3356,Tecfidera,2016-03-29,,400,mg,['3 / Week'],IV, 
10083,3356,D-cure (Vitamine D),2016-08-11,,400,MIU,['/Month'], , 
10084,3356,Rebif [44],2016-10-17,,20,mg,['/ Day'], , 
10085,2136,Endoxan,2015-12-05,,500,mg,[' '],IV, 
10086,2101,Tecfidera,2016-07-12,2019-09-27,500, ,['/Month'],Oral,Persisting MRI activity
10087,3462,IVIG,2015-12-12,,5000,mcg,['2 / Day'],IV, 
10088,955,Avonex,2016-02-13,,400, ,['/ Week'],Oral, 
10089,1999,Tecfidera,2016-06-01,,500,mg,['2 / Day'],IV, 
10090,1999,Rebif [44],2015-12-25,,5000, ,['/Month'],IV, 
10091,4524,Gilenya,2016-07-24,,300,mg,['/Month'], , 
10092,4524,Endoxan,2016-09-22,2018-01-12,1,mg,['/Month'], ,Persisting MRI activity
10093,4524,Tecfidera,2016-01-05,,20,mg,[' '],IV, 
10094,4524,Tecfidera,2016-04-08,,1000, ,['/Month'], , 
10095,3870,Avonex,2016-09-13,, ,mg,['2 / Day'], , 
10096,1650,IVIG,2016-08-06,2019-04-29,1000,mg,['/ Day'],IV,Persistence of relapses
10097,1650,Tecfidera,2016-06-15,,20, ,['/Month'],IV, 
10098,3056,Endoxan,2016-10-15,,400,mg,[' '], , 
10099,3056,IVIG,2015-12-29,2019-01-30,1,mcg,['2 / Day'], ,Persisting MRI activity
10100,3056,D-cure (Vitamine D),2016-05-29,2018-09-22, ,mg,['2 / Day'],IV,Patient Choice/Convenience
10101,4466,Tecfidera,2016-07-06,, ,mg,['/Month'],IV, 
10102,4466,Teriflunomide,2016-09-10,,5000, ,['/Month'],Oral, 
10103,4466,Rebif [22],2016-10-05,2019-11-09,500, ,['3 / Week'],Oral,Persistence of relapses
10104,4466,Rebif [44],2016-06-18,2018-05-03,500,mg,['/Month'],Oral,Lack of efficacy
10105,4578,Teriflunomide,2015-12-27,, , ,['2 / Day'], , 
10106,4578,Gilenya,2016-03-06,,400,mg,['/Month'], , 
10107,4161,Tysabri,2016-03-06,2019-11-25,20, ,['/ Week'], ,Adverse Event
10108,4161,Gilenya,2016-08-27,,1000,mcg,['/Month'],IV, 
10109,4161,Methylprednisolone,2015-11-04,2018-10-27, ,mcg,['/ Day'],Oral,Lack of efficacy
10110,666,Betaferon,2016-04-21,2020-08-24,5000, ,[' '], ,Patient Choice/Convenience
10111,1079,D-cure (Vitamine D),2016-09-16,2020-07-23,500,MIU,['/Month'], ,Persisting MRI activity
10112,4162,Ledertrexaat,2016-07-22,,5000,mcg,['3 / Week'],IV, 
10113,4162,Gilenya,2015-12-10,,1000, ,['2 / Day'],Oral, 
10114,4162,IVIG,2016-03-25,,1000,mg,[' '],IV, 
10115,1262,Rebif [22],2016-09-21,2019-05-30, , ,['/ Week'],Oral,Lack of efficacy
10116,1262,Alemtuzumab (Campath),2016-01-28,2018-05-30,5000,mg,['2 / Day'],IV,Persistence of relapses
10117,1262,D-cure (Vitamine D),2016-06-01,2018-05-14,5000, ,['3 / Week'],Oral,Patient Choice/Convenience
10118,4168,Gilenya,2015-12-22,,1, ,['3 / Week'],IV, 
10119,4167,Teriflunomide,2016-01-12,2021-06-23,1000,mg,['2 / Day'], ,Persistence of relapses
10120,1519,Rebif [22],2016-01-10,2019-08-23,500,MIU,['2 / Day'],IV,Lack of efficacy
10121,3405,Mitoxantrone,2016-01-14,2020-12-01, , ,['3 / Week'],IV,Patient Choice/Convenience
10122,3405,Teriflunomide,2016-04-23,,1, ,['/Month'],IV, 
10123,3405,Rebif [22],2016-06-17,2017-11-11,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
10124,1056,Tecfidera,2016-10-05,, ,mg,['3 / Week'],IV, 
10125,1056,Avonex,2016-04-08,2021-01-22,300, ,['/Month'], ,Adverse Event
10126,1056,Gilenya,2016-07-04,2020-09-13, , ,['2 / Day'],IV,Adverse Event
10127,186,D-cure (Vitamine D),2016-05-12,,500, ,['2 / Day'],IV, 
10128,186,Teriflunomide,2016-05-08,2018-05-15,1000, ,['2 / Day'],Oral,Patient Choice/Convenience
10129,186,Copaxone,2016-03-28,,1, ,['3 / Week'],IV, 
10130,186,Endoxan,2015-11-07,, , ,['2 / Day'],IV, 
10131,2691,Ledertrexaat,2016-02-07,,400,mg,['/Month'], , 
10132,4724,Rebif [44],2016-05-05,2021-08-22,300,mg,['/ Day'],IV,Persisting MRI activity
10133,3235,Teriflunomide,2016-01-30,2017-12-25,400,mg,[' '],IV,Persistence of relapses
10134,3235,D-cure (Vitamine D),2016-03-02,,20,mg,[' '],Oral, 
10135,3235,D-cure (Vitamine D),2016-10-05,2020-12-18, , ,['/Month'],IV,Patient Choice/Convenience
10136,3902,Methylprednisolone,2016-03-29,,20,mcg,['2 / Day'],IV, 
10137,3908,Avonex,2016-09-27,, ,mcg,['2 / Day'], , 
10138,3908,Rebif [44],2015-11-04,2017-11-04,300,mg,[' '],IV,Persistence of relapses
10139,3908,IVIG,2016-08-08,2018-01-24,20,MIU,['2 / Day'],IV,Persisting MRI activity
10140,570,Methylprednisolone,2016-02-20,,300, ,['/Month'],IV, 
10141,570,Mitoxantrone,2015-12-01,2021-04-10,1,mg,['/ Day'],IV,Adverse Event
10142,2444,Endoxan,2015-12-09,2021-03-11, ,mg,['3 / Week'],IV,Lack of efficacy
10143,2444,Copaxone,2016-08-04,2019-10-09, ,mg,['2 / Day'],Oral,Persisting MRI activity
10144,4459,Methylprednisolone,2016-04-18,,1, ,['2 / Day'], , 
10145,4459,Betaferon,2016-02-09,2018-12-31,1000,MIU,['3 / Week'],IV,Persisting MRI activity
10146,1953,Rebif [22],2016-03-31,2021-08-30,500, ,['3 / Week'],IV,Persistence of relapses
10147,1953,Tysabri,2016-08-22,2021-02-01,1000,mcg,['/Month'],Oral,Patient Choice/Convenience
10148,1953,Copaxone,2016-03-14,2018-04-30,5000,mg,['/Month'], ,Patient Choice/Convenience
10149,1953,Copaxone,2016-10-11,2019-05-30,5000, ,['/Month'], ,Adverse Event
10150,1682,IVIG,2016-05-05,2018-04-27, ,mg,['/ Day'], ,Lack of efficacy
10151,1682,Tysabri,2015-12-13,,300,mg,['2 / Day'], , 
10152,1682,IVIG,2016-04-13,, ,mg,['/Month'],IV, 
10153,545,Methylprednisolone,2015-11-21,2021-10-04,20,mg,['/Month'], ,Persisting MRI activity
10154,2107,Avonex,2016-05-10,,5000,mg,['2 / Day'],IV, 
10155,2107,Tecfidera,2016-10-04,,300,mg,['/Month'],IV, 
10156,2107,Rebif [44],2016-08-26,2021-06-23,500,mg,['2 / Day'],IV,Adverse Event
10157,2107,Rebif [44],2016-04-02,,1,mcg,['2 / Day'],Oral, 
10158,195,D-cure (Vitamine D),2016-04-09,2020-08-05,1,MIU,['/Month'],Oral,Persisting MRI activity
10159,195,D-cure (Vitamine D),2016-06-18,2019-10-12, ,mg,['3 / Week'],IV,Persisting MRI activity
10160,195,IVIG,2016-01-23,2018-02-23,1,mg,['/Month'], ,Adverse Event
10161,195,Tecfidera,2016-02-29,2020-03-13,500,mg,['/Month'],IV,Persistence of relapses
10162,1975,D-cure (Vitamine D),2016-01-16,2020-07-12, ,mg,['2 / Day'],IV,Persistence of relapses
10163,1975,D-cure (Vitamine D),2016-08-15,,20,mg,['3 / Week'], , 
10164,2001,Avonex,2016-07-22,,1000,MIU,['2 / Day'],IV, 
10165,2001,Alemtuzumab (Campath),2015-10-31,2019-08-28,300,MIU,['3 / Week'],IV,Lack of efficacy
10166,2001,Copaxone,2016-07-02,, ,mg,['/ Day'], , 
10167,2001,Endoxan,2016-03-13,, , ,['/Month'],IV, 
10168,610,Ledertrexaat,2016-09-08,,300,mg,['2 / Day'],IV, 
10169,610,Gilenya,2016-07-01,,1,mg,['/Month'],Oral, 
10170,610,Tecfidera,2016-09-10,2018-11-06,300,mg,[' '], ,Persistence of relapses
10171,610,Ledertrexaat,2016-03-22,2020-11-17,5000,mg,['/Month'], ,Adverse Event
10172,2682,IVIG,2016-03-08,,300,mcg,['/ Week'],IV, 
10173,3555,Rebif [44],2016-09-29,2019-05-26,400,mg,['/ Day'],IV,Patient Choice/Convenience
10174,2305,Alemtuzumab (Campath),2016-10-02,, ,mg,['/Month'],IV, 
10175,2305,IVIG,2016-03-04,2020-05-24, ,MIU,['/Month'], ,Adverse Event
10176,2305,Alemtuzumab (Campath),2016-07-26,2021-07-10,400,mg,['/Month'],IV,Patient Choice/Convenience
10177,2305,Rebif [22],2016-09-11,,500, ,['/Month'],Oral, 
10178,698,Rebif [44],2016-06-01,,1000, ,['2 / Day'], , 
10179,698,D-cure (Vitamine D),2015-12-01,2021-07-12,500,mg,['2 / Day'],IV,Persisting MRI activity
10180,1882,Tecfidera,2015-10-27,, , ,['/Month'], , 
10181,1882,Endoxan,2016-05-25,2021-09-12, , ,['2 / Day'], ,Adverse Event
10182,1882,Endoxan,2016-01-10,,1000,mg,['/Month'],IV, 
10183,1882,Avonex,2016-09-18,2018-11-27,1000,MIU,[' '],Oral,Patient Choice/Convenience
10184,1426,D-cure (Vitamine D),2016-08-26,,300,mg,['/Month'],IV, 
10185,1426,Teriflunomide,2016-04-07,2018-02-21,1000,mg,['/ Week'], ,Patient Choice/Convenience
10186,2232,Gilenya,2015-12-12,,300, ,['/Month'],Oral, 
10187,2232,Teriflunomide,2016-05-24,, ,mcg,['/Month'], , 
10188,2232,Rebif [22],2016-03-12,, ,mg,['/ Day'], , 
10189,2232,Methylprednisolone,2016-06-05,, ,mg,['2 / Day'],Oral, 
10190,4845,Tysabri,2016-05-11,, ,mg,['/Month'], , 
10191,4845,Tecfidera,2016-08-13,2019-01-16,500,mg,['/Month'],IV,Patient Choice/Convenience
10192,4845,Ledertrexaat,2016-04-11,,1,MIU,['3 / Week'], , 
10193,4845,Copaxone,2016-05-07,,1, ,['/Month'],Oral, 
10194,2628,Tecfidera,2016-10-14,2019-12-22,500,mcg,['/ Week'], ,Persistence of relapses
10195,2628,Tecfidera,2015-11-10,2021-01-29, ,mg,['2 / Day'],IV,Adverse Event
10196,2628,Ledertrexaat,2016-03-28,,1,mg,['2 / Day'],Oral, 
10197,2628,Mitoxantrone,2016-02-07,,400, ,[' '],IV, 
10198,2906,D-cure (Vitamine D),2016-08-30,2017-11-06, ,MIU,['/Month'], ,Adverse Event
10199,2906,Methylprednisolone,2015-12-12,2018-11-19, ,mg,['3 / Week'],IV,Lack of efficacy
10200,1806,Betaferon,2015-12-26,,300, ,['/ Day'],IV, 
10201,1806,Endoxan,2016-03-14,,5000,MIU,['/Month'],IV, 
10202,1806,Betaferon,2016-04-17,,20,mg,['/Month'], , 
10203,3596,Methylprednisolone,2015-11-27,2020-06-17,1, ,['3 / Week'], ,Persisting MRI activity
10204,3596,Endoxan,2016-05-29,,20, ,['/ Week'],Oral, 
10205,3432,Methylprednisolone,2016-02-22,,300,mcg,['/Month'],IV, 
10206,969,Endoxan,2016-09-21,2018-08-20,500, ,['/ Day'], ,Lack of efficacy
10207,969,Methylprednisolone,2016-06-05,,5000, ,['2 / Day'],IV, 
10208,969,Rebif [44],2016-03-12,2018-10-03,400,mcg,['/Month'],IV,Adverse Event
10209,808,Rebif [22],2016-09-23,2021-01-06,500, ,['/ Day'],IV,Adverse Event
10210,808,Ledertrexaat,2016-02-20,,20,mg,['/ Day'],IV, 
10211,808,Methylprednisolone,2016-02-23,,20,MIU,[' '],IV, 
10212,3676,Tysabri,2016-05-19,2020-07-15, , ,['/Month'],IV,Patient Choice/Convenience
10213,3676,Rebif [44],2016-03-13,2020-04-07, ,mg,[' '], ,Adverse Event
10214,3676,Copaxone,2016-03-11,2021-05-18,500,MIU,['2 / Day'],IV,Persisting MRI activity
10215,3676,Alemtuzumab (Campath),2015-12-31,,1,mcg,['3 / Week'],IV, 
10216,842,Tysabri,2016-06-07,,1000,mg,['3 / Week'], , 
10217,842,Betaferon,2016-09-20,2018-01-31,300,mcg,['2 / Day'], ,Persisting MRI activity
10218,842,IVIG,2016-08-12,,400,mg,['/Month'],IV, 
10219,842,Endoxan,2016-03-18,2020-06-08,1000,mg,['2 / Day'], ,Adverse Event
10220,4112,Methylprednisolone,2016-05-17,,1,mg,['2 / Day'],IV, 
10221,377,Gilenya,2016-04-10,2021-02-20, , ,['3 / Week'],IV,Patient Choice/Convenience
10222,4199,Methylprednisolone,2015-11-14,2021-02-11,1000,mg,['3 / Week'],Oral,Adverse Event
10223,4199,Tecfidera,2016-01-10,2018-03-22,1,mg,['2 / Day'],IV,Lack of efficacy
10224,4049,Betaferon,2016-04-29,,400, ,[' '], , 
10225,4049,Tecfidera,2016-08-12,2019-05-04,1000, ,['/Month'], ,Adverse Event
10226,1395,Gilenya,2016-07-08,2018-03-21,500,mg,['2 / Day'], ,Patient Choice/Convenience
10227,4233,Avonex,2016-03-09,,300,mg,['/ Day'],Oral, 
10228,590,D-cure (Vitamine D),2016-06-09,2018-12-30,300,mg,['2 / Day'],IV,Adverse Event
10229,590,Rebif [44],2016-06-29,2021-02-27,300,mg,['3 / Week'],IV,Adverse Event
10230,2411,Copaxone,2016-10-02,2018-01-22, , ,['/Month'], ,Persisting MRI activity
10231,209,Tysabri,2016-02-14,2021-10-20, ,mg,[' '], ,Lack of efficacy
10232,209,Copaxone,2016-07-10,, ,mg,['/Month'],IV, 
10233,209,Copaxone,2016-07-07,, ,mg,['/ Day'],Oral, 
10234,209,Methylprednisolone,2016-06-26,, ,mg,['/ Week'],IV, 
10235,672,Mitoxantrone,2016-07-12,,300, ,['2 / Day'], , 
10236,672,Teriflunomide,2016-01-13,2020-05-09,1, ,['2 / Day'],Oral,Adverse Event
10237,4910,Endoxan,2016-02-19,2021-06-04,1000,mcg,['/Month'],Oral,Adverse Event
10238,4197,Rebif [22],2016-04-05,2021-09-06, ,mcg,['2 / Day'],IV,Lack of efficacy
10239,4197,Tysabri,2016-03-23,, , ,['2 / Day'],IV, 
10240,4197,IVIG,2015-12-16,2018-12-30,300, ,['2 / Day'],IV,Persisting MRI activity
10241,4197,Methylprednisolone,2016-09-25,,5000, ,['/Month'],IV, 
10242,3191,D-cure (Vitamine D),2016-05-04,2018-11-14,1, ,[' '], ,Persisting MRI activity
10243,3191,Rebif [22],2016-08-14,, , ,['/Month'], , 
10244,3191,Betaferon,2015-11-12,2018-05-08,5000,mg,['/Month'], ,Adverse Event
10245,854,Alemtuzumab (Campath),2016-01-19,2018-05-13,500,mg,['/ Week'], ,Lack of efficacy
10246,1654,Methylprednisolone,2015-11-05,2020-08-30,5000, ,['3 / Week'], ,Adverse Event
10247,3051,Ledertrexaat,2016-04-25,,5000,mcg,['/Month'],Oral, 
10248,954,Rebif [22],2015-11-14,2020-06-14,500,mg,['/Month'],IV,Patient Choice/Convenience
10249,4945,Avonex,2016-02-07,2019-04-16,20,mg,['/Month'], ,Adverse Event
10250,4945,Alemtuzumab (Campath),2015-11-20,2018-12-28,300, ,['/ Week'],IV,Persisting MRI activity
10251,4945,Avonex,2016-07-18,,20,MIU,['3 / Week'],IV, 
10252,3352,D-cure (Vitamine D),2016-03-29,2017-12-15,500,mg,['2 / Day'], ,Adverse Event
10253,801,Tecfidera,2016-04-05,, , ,['/Month'],IV, 
10254,801,Rebif [22],2016-05-08,2018-10-22,1, ,['3 / Week'],IV,Adverse Event
10255,801,Betaferon,2016-02-03,,5000,mg,['2 / Day'],IV, 
10256,1220,Endoxan,2016-05-02,,5000,MIU,['2 / Day'],IV, 
10257,1220,Tecfidera,2016-08-09,, ,mg,['/Month'], , 
10258,1220,Alemtuzumab (Campath),2016-05-28,2018-01-17,300,mg,[' '],IV,Persisting MRI activity
10259,1220,D-cure (Vitamine D),2016-02-11,,300, ,['/Month'], , 
10260,3244,Gilenya,2015-12-22,2019-05-22,300,mg,['2 / Day'],IV,Patient Choice/Convenience
10261,2951,Mitoxantrone,2015-11-12,,500,mg,['/Month'],IV, 
10262,2951,Methylprednisolone,2016-06-29,, ,mg,['2 / Day'], , 
10263,2458,Methylprednisolone,2016-05-04,,500, ,['/Month'],IV, 
10264,487,Tecfidera,2016-05-31,,20, ,['/Month'], , 
10265,487,Methylprednisolone,2016-03-26,2020-08-22,1,mg,['3 / Week'], ,Persisting MRI activity
10266,4234,Alemtuzumab (Campath),2015-12-27,, ,mg,['2 / Day'],IV, 
10267,4234,D-cure (Vitamine D),2016-07-13,2019-03-16, , ,['/ Day'],IV,Adverse Event
10268,4234,Avonex,2016-03-19,2020-03-09,1,mg,['3 / Week'], ,Adverse Event
10269,3424,D-cure (Vitamine D),2015-12-20,, , ,['/Month'], , 
10270,1998,D-cure (Vitamine D),2016-02-07,2021-06-24, ,MIU,['/Month'], ,Lack of efficacy
10271,1998,Avonex,2016-06-07,,1,mg,['/Month'], , 
10272,4012,Betaferon,2016-10-16,,500,mg,['2 / Day'], , 
10273,3419,Tysabri,2015-11-24,, ,mg,['/Month'],Oral, 
10274,3419,Copaxone,2016-09-19,, , ,['2 / Day'],IV, 
10275,3419,Gilenya,2015-10-29,, , ,[' '], , 
10276,3134,Rebif [22],2016-06-27,,300, ,['/Month'],Oral, 
10277,3134,D-cure (Vitamine D),2016-07-30,2020-05-06,1,MIU,['2 / Day'],IV,Lack of efficacy
10278,4384,Copaxone,2016-04-08,,5000, ,['/Month'],IV, 
10279,1445,IVIG,2016-02-20,2020-10-17, ,mg,['2 / Day'], ,Lack of efficacy
10280,1445,Alemtuzumab (Campath),2016-06-10,2021-04-08,20, ,['2 / Day'],IV,Lack of efficacy
10281,1445,Copaxone,2016-05-17,,20,MIU,['/Month'],Oral, 
10282,1325,Tecfidera,2016-03-03,,20,mg,['3 / Week'], , 
10283,612,Tecfidera,2016-06-04,2018-11-25, , ,['/Month'],IV,Adverse Event
10284,612,Tysabri,2016-01-10,,1000,mg,['/Month'], , 
10285,612,D-cure (Vitamine D),2016-02-03,,300,mg,['2 / Day'], , 
10286,612,Rebif [22],2016-01-01,2020-08-04,1000,mg,['/ Day'],IV,Adverse Event
10287,1671,Teriflunomide,2016-03-03,2019-04-29,1000, ,['3 / Week'],IV,Lack of efficacy
10288,4816,Alemtuzumab (Campath),2016-07-01,, ,mcg,['3 / Week'], , 
10289,4816,Alemtuzumab (Campath),2016-08-31,2021-10-04, , ,['/Month'],Oral,Adverse Event
10290,4816,D-cure (Vitamine D),2016-09-25,,300, ,['/Month'],IV, 
10291,580,Rebif [44],2016-09-23,2021-07-01,300, ,['/Month'], ,Persisting MRI activity
10292,580,Endoxan,2015-12-16,,5000,mg,['/ Week'], , 
10293,580,Rebif [22],2016-07-30,2020-04-25, , ,['/ Day'],IV,Persisting MRI activity
10294,580,Copaxone,2016-02-20,2017-12-19,5000,mg,['2 / Day'], ,Persisting MRI activity
10295,2117,Rebif [44],2016-01-27,,5000,mg,[' '],IV, 
10296,2117,Avonex,2016-09-25,, ,mg,['/ Day'],Oral, 
10297,2117,Copaxone,2016-09-16,2019-05-20, , ,['/Month'],IV,Patient Choice/Convenience
10298,2117,Copaxone,2016-09-10,,1000, ,['2 / Day'],Oral, 
10299,842,Endoxan,2015-12-03,,500, ,['/Month'], , 
10300,842,Alemtuzumab (Campath),2016-05-22,2020-11-11, ,mg,['2 / Day'],Oral,Adverse Event
10301,2371,Gilenya,2016-05-15,2021-03-06, , ,['3 / Week'],IV,Lack of efficacy
10302,2371,Betaferon,2016-10-04,2019-02-21,1000, ,[' '],Oral,Lack of efficacy
10303,2371,Gilenya,2015-12-14,,300,mcg,['/Month'],IV, 
10304,3673,IVIG,2016-04-13,2019-11-07,300,mg,['2 / Day'],IV,Patient Choice/Convenience
10305,3673,Gilenya,2016-05-15,,5000,MIU,['/ Day'],IV, 
10306,980,Copaxone,2015-11-03,, ,mcg,['/Month'], , 
10307,980,Gilenya,2015-12-06,2019-05-14,20, ,['/Month'],IV,Adverse Event
10308,980,Endoxan,2016-06-20,2018-05-01,5000, ,['3 / Week'],IV,Patient Choice/Convenience
10309,980,Rebif [22],2016-07-29,2021-05-15,1000,mg,['3 / Week'],IV,Lack of efficacy
10310,590,Tysabri,2016-06-16,2018-02-07,1000, ,['2 / Day'],IV,Persisting MRI activity
10311,590,Tysabri,2016-02-28,,5000, ,['2 / Day'], , 
10312,373,Endoxan,2016-10-02,2018-11-29,500, ,['3 / Week'], ,Persisting MRI activity
10313,373,Endoxan,2016-04-23,2021-07-01,20, ,['/Month'],Oral,Patient Choice/Convenience
10314,373,Teriflunomide,2016-04-24,, ,mcg,['3 / Week'],IV, 
10315,2536,Rebif [22],2016-09-24,2021-05-26,1,MIU,['/Month'],Oral,Adverse Event
10316,2536,Tecfidera,2016-03-22,,20,mg,['/Month'], , 
10317,2536,D-cure (Vitamine D),2016-08-03,2020-08-28,500, ,['/Month'],IV,Persisting MRI activity
10318,2536,Gilenya,2016-05-01,2021-04-26,1,mg,['/ Day'], ,Patient Choice/Convenience
10319,223,Rebif [22],2016-08-13,, , ,[' '], , 
10320,4724,Gilenya,2016-09-17,,500, ,['/Month'], , 
10321,4724,IVIG,2016-03-30,, ,mg,['/Month'],IV, 
10322,4724,Ledertrexaat,2016-03-04,2019-01-08,500,mg,['/Month'], ,Patient Choice/Convenience
10323,1036,Tecfidera,2016-05-27,,300,MIU,['2 / Day'], , 
10324,1036,IVIG,2015-12-02,2021-07-15, , ,['2 / Day'],IV,Lack of efficacy
10325,3507,Endoxan,2016-03-30,, , ,['/Month'],Oral, 
10326,3507,Betaferon,2015-12-28,2019-07-25,5000,MIU,['/Month'],IV,Adverse Event
10327,3507,Rebif [22],2016-02-15,2021-04-16, ,mg,['/Month'], ,Persisting MRI activity
10328,1097,Tecfidera,2016-07-27,2017-12-25,20, ,['2 / Day'],IV,Patient Choice/Convenience
10329,1097,Alemtuzumab (Campath),2016-01-23,,500, ,['3 / Week'], , 
10330,1097,Alemtuzumab (Campath),2016-09-28,2019-09-25,500,MIU,['/Month'],IV,Adverse Event
10331,855,Rebif [44],2016-03-05,,1, ,['2 / Day'],IV, 
10332,855,Endoxan,2016-01-31,,300,mcg,['/ Week'], , 
10333,855,Rebif [44],2016-02-12,,500,mg,['3 / Week'], , 
10334,4413,Copaxone,2015-12-06,,500, ,['/Month'],Oral, 
10335,1879,Gilenya,2016-07-28,,20, ,['/Month'], , 
10336,1879,Methylprednisolone,2015-11-03,2018-11-09,20, ,['/Month'], ,Lack of efficacy
10337,1879,IVIG,2016-09-03,, ,mg,['2 / Day'], , 
10338,3974,IVIG,2016-04-06,2021-01-08,5000, ,['/Month'], ,Persistence of relapses
10339,3974,Betaferon,2015-12-26,,20,mg,[' '],IV, 
10340,3974,Ledertrexaat,2016-04-04,2020-02-15, ,mg,['2 / Day'], ,Patient Choice/Convenience
10341,1337,Tecfidera,2016-10-05,,5000, ,['/Month'],IV, 
10342,907,D-cure (Vitamine D),2016-02-29,2019-03-30, ,mg,['/Month'],IV,Persistence of relapses
10343,907,Teriflunomide,2016-01-29,,20, ,[' '], , 
10344,907,Alemtuzumab (Campath),2016-09-28,2019-11-15,400,mg,['2 / Day'], ,Adverse Event
10345,1896,Rebif [22],2016-04-20,,500,mcg,[' '],Oral, 
10346,1178,Rebif [44],2015-11-06,2020-01-07,5000,mg,['2 / Day'],IV,Adverse Event
10347,1178,Methylprednisolone,2016-06-23,,400, ,[' '],IV, 
10348,300,Methylprednisolone,2016-10-09,,20, ,['/Month'],IV, 
10349,300,Endoxan,2016-05-14,, ,mg,['3 / Week'],IV, 
10350,3174,Tysabri,2016-04-30,,1000, ,['2 / Day'],IV, 
10351,3174,Rebif [22],2016-02-27,2018-03-04,20,mg,['/Month'], ,Adverse Event
10352,3174,Ledertrexaat,2016-01-13,,300,MIU,['2 / Day'],IV, 
10353,3351,Betaferon,2016-03-09,,400,mg,['/Month'], , 
10354,4594,Endoxan,2016-07-18,, ,mcg,['2 / Day'], , 
10355,4594,IVIG,2016-10-22,2020-06-09,20,mg,['/Month'],IV,Persisting MRI activity
10356,4594,Ledertrexaat,2016-09-07,,1, ,['2 / Day'],IV, 
10357,196,Tecfidera,2016-08-08,2020-05-11,400, ,['/ Week'],IV,Adverse Event
10358,196,D-cure (Vitamine D),2015-11-16,,1000, ,['3 / Week'], , 
10359,481,Rebif [22],2016-08-14,,5000, ,['3 / Week'], , 
10360,481,Rebif [44],2016-06-20,,1000,MIU,['/Month'],IV, 
10361,1340,Gilenya,2016-02-09,,20,MIU,[' '],IV, 
10362,1340,Teriflunomide,2016-04-29,2018-02-11, ,MIU,['2 / Day'],IV,Adverse Event
10363,1340,Tecfidera,2015-11-23,2018-10-23,500,mg,['/Month'], ,Persisting MRI activity
10364,1340,Betaferon,2015-11-06,, , ,[' '], , 
10365,1730,Rebif [44],2016-04-19,2019-04-22,500, ,['/Month'],Oral,Lack of efficacy
10366,1730,Gilenya,2015-12-21,2018-08-05, ,mg,['3 / Week'],IV,Patient Choice/Convenience
10367,371,Copaxone,2016-01-02,,400, ,['/ Day'], , 
10368,371,Gilenya,2016-07-03,2019-04-09,20,MIU,['/Month'], ,Patient Choice/Convenience
10369,371,Rebif [22],2016-07-05,2020-10-26,5000,mg,[' '],IV,Adverse Event
10370,371,Gilenya,2016-08-29,,500, ,['2 / Day'],IV, 
10371,2372,Tysabri,2016-10-21,, ,mg,['2 / Day'],IV, 
10372,2372,Betaferon,2016-10-13,2020-03-12, ,mcg,['2 / Day'],IV,Persisting MRI activity
10373,2995,Avonex,2015-11-12,2018-06-28,5000,mg,['/ Week'],Oral,Persisting MRI activity
10374,2995,Teriflunomide,2016-05-25,2020-09-23, ,mcg,['2 / Day'],IV,Lack of efficacy
10375,2995,Avonex,2016-10-11,,300,MIU,['3 / Week'], , 
10376,2995,Tysabri,2016-08-25,,500, ,['/Month'], , 
10377,1054,Methylprednisolone,2016-04-23,2021-01-31, , ,['2 / Day'],IV,Adverse Event
10378,1901,Ledertrexaat,2016-05-23,2020-09-22,400, ,['/Month'], ,Lack of efficacy
10379,3295,IVIG,2016-09-23,,400,mg,['/ Week'],Oral, 
10380,1194,Rebif [22],2015-12-21,2018-01-04,1, ,['2 / Day'],IV,Patient Choice/Convenience
10381,1194,Ledertrexaat,2016-01-31,, ,MIU,['/ Week'], , 
10382,1194,Mitoxantrone,2016-08-15,2020-10-23, ,mg,['/Month'], ,Patient Choice/Convenience
10383,1194,Tecfidera,2015-11-15,2020-01-28, ,mg,['2 / Day'],IV,Patient Choice/Convenience
10384,499,IVIG,2016-04-13,2020-07-25, , ,['2 / Day'], ,Lack of efficacy
10385,499,Rebif [22],2016-02-01,,400, ,['/Month'],IV, 
10386,499,Methylprednisolone,2016-08-09,,1,mg,['2 / Day'],IV, 
10387,499,Avonex,2016-01-23,2018-10-30,1000, ,['/Month'], ,Lack of efficacy
10388,1816,Tecfidera,2016-04-29,2019-05-11,400, ,['3 / Week'], ,Persistence of relapses
10389,1816,Alemtuzumab (Campath),2016-07-07,2020-06-03, ,mg,['/Month'],Oral,Persistence of relapses
10390,1816,Alemtuzumab (Campath),2016-03-09,2020-12-31,5000,mcg,['2 / Day'],IV,Persisting MRI activity
10391,1816,Tysabri,2016-09-17,,500, ,['/ Day'],Oral, 
10392,3444,Copaxone,2016-04-01,, ,MIU,['2 / Day'],IV, 
10393,3444,Endoxan,2016-10-05,,400, ,['3 / Week'], , 
10394,3444,Copaxone,2016-08-14,2017-11-27, ,mg,['3 / Week'], ,Persisting MRI activity
10395,3444,Tecfidera,2015-11-21,2019-02-21, , ,['2 / Day'],IV,Lack of efficacy
10396,940,Rebif [22],2016-07-21,2021-03-20,1,mg,[' '],IV,Adverse Event
10397,4868,Gilenya,2016-01-23,, ,MIU,['/ Day'],IV, 
10398,1981,Teriflunomide,2016-02-06,,1000, ,['3 / Week'],IV, 
10399,2689,Mitoxantrone,2016-01-12,2018-04-30,1,mg,['2 / Day'],Oral,Adverse Event
10400,2689,Methylprednisolone,2016-05-15,,20, ,['2 / Day'],IV, 
10401,2689,D-cure (Vitamine D),2015-12-31,2021-09-05,20, ,['/Month'],IV,Lack of efficacy
10402,2689,Copaxone,2016-06-26,2021-08-19, , ,['2 / Day'], ,Patient Choice/Convenience
10403,2967,Avonex,2016-04-16,,300, ,['/Month'],Oral, 
10404,2967,D-cure (Vitamine D),2015-12-19,, , ,['/Month'],IV, 
10405,4892,Tecfidera,2016-04-30,2021-05-06,400,mg,['/ Day'],IV,Persistence of relapses
10406,4892,Tecfidera,2016-02-05,,1000,mg,['/Month'],IV, 
10407,3235,Copaxone,2016-09-12,,400,mg,['2 / Day'], , 
10408,3235,D-cure (Vitamine D),2015-11-19,2021-07-23,1000, ,['/ Week'], ,Adverse Event
10409,3235,Copaxone,2016-07-26,,300,mg,['/Month'],IV, 
10410,3235,D-cure (Vitamine D),2016-09-04,,5000,MIU,['/ Week'],IV, 
10411,3975,D-cure (Vitamine D),2016-03-23,,20,mg,['/Month'], , 
10412,3975,Mitoxantrone,2016-02-03,,1000,MIU,['/Month'],IV, 
10413,2742,Rebif [22],2016-05-10,,1000,mcg,['/Month'],IV, 
10414,2742,Betaferon,2016-05-16,2021-03-25, , ,['2 / Day'],IV,Patient Choice/Convenience
10415,2742,Betaferon,2016-05-27,2019-11-21,1000, ,['2 / Day'], ,Lack of efficacy
10416,3987,Mitoxantrone,2015-10-29,2019-07-27,500,mcg,['2 / Day'], ,Patient Choice/Convenience
10417,3987,D-cure (Vitamine D),2016-03-16,, ,mg,[' '],IV, 
10418,3987,Methylprednisolone,2015-11-15,, ,mg,['/ Day'],IV, 
10419,3987,Alemtuzumab (Campath),2016-03-10,2019-08-02, ,mg,['/Month'], ,Patient Choice/Convenience
10420,3008,Gilenya,2016-06-14,,20,mg,['/Month'],IV, 
10421,3597,Rebif [44],2016-06-25,2019-11-09, , ,[' '],IV,Adverse Event
10422,3597,Copaxone,2016-06-24,2021-04-20,20,mg,['2 / Day'], ,Lack of efficacy
10423,3597,Alemtuzumab (Campath),2016-06-05,, ,mg,['/Month'],IV, 
10424,2053,Tecfidera,2016-07-14,2020-08-10,1,mg,['2 / Day'],IV,Patient Choice/Convenience
10425,4094,Betaferon,2016-08-26,,500,mg,['/Month'],Oral, 
10426,4094,Betaferon,2016-05-07,2018-04-20,500,mg,['/ Day'], ,Persistence of relapses
10427,1448,Tysabri,2016-10-04,2019-08-11,400, ,['2 / Day'],IV,Lack of efficacy
10428,1448,Methylprednisolone,2016-01-12,,1000, ,['/Month'], , 
10429,1448,Rebif [44],2016-05-25,2021-01-01,20,mg,['2 / Day'],IV,Patient Choice/Convenience
10430,2240,Tecfidera,2016-01-31,2018-12-12,20,mg,['/ Week'], ,Persisting MRI activity
10431,2240,IVIG,2016-01-20,,1, ,['/Month'],IV, 
10432,2240,Mitoxantrone,2016-08-13,2020-03-13,1,MIU,['/Month'], ,Patient Choice/Convenience
10433,425,Endoxan,2015-12-10,,1000, ,[' '],IV, 
10434,425,Tysabri,2015-12-22,,1000, ,['2 / Day'],IV, 
10435,425,Endoxan,2016-07-04,,5000,mg,['3 / Week'],IV, 
10436,425,D-cure (Vitamine D),2016-08-21,, ,mcg,['2 / Day'], , 
10437,2320,Tecfidera,2016-05-04,, ,mg,['3 / Week'], , 
10438,2320,Copaxone,2016-06-01,2019-03-07,400,mg,[' '], ,Patient Choice/Convenience
10439,2320,Rebif [22],2016-03-30,2018-12-29,1000, ,['2 / Day'], ,Adverse Event
10440,2320,Alemtuzumab (Campath),2016-10-03,, , ,['2 / Day'],IV, 
10441,1277,Teriflunomide,2016-07-29,2020-11-08,500, ,['3 / Week'],IV,Lack of efficacy
10442,1277,Copaxone,2016-10-22,,400,MIU,['/Month'], , 
10443,1277,Endoxan,2015-12-16,2020-02-25, ,mg,['/Month'],IV,Adverse Event
10444,870,Endoxan,2015-11-26,,500, ,['3 / Week'],Oral, 
10445,870,Teriflunomide,2016-04-27,2020-12-31,1000,mg,['/ Day'],IV,Persistence of relapses
10446,870,Rebif [22],2016-05-10,2019-06-25,300,mg,['2 / Day'],IV,Persisting MRI activity
10447,870,Tysabri,2016-10-17,2020-06-29,300,mg,['2 / Day'],IV,Patient Choice/Convenience
10448,1866,D-cure (Vitamine D),2016-05-04,,20,mg,['/ Week'],IV, 
10449,1866,Tysabri,2016-01-21,2019-12-26, ,mg,['2 / Day'],IV,Lack of efficacy
10450,1866,Rebif [22],2015-12-09,2019-08-24,400,MIU,['2 / Day'], ,Lack of efficacy
10451,1866,Endoxan,2016-07-05,,500,mg,['/Month'], , 
10452,2586,Tecfidera,2015-11-16,2021-03-26,20,mg,['/Month'],IV,Persisting MRI activity
10453,1002,Teriflunomide,2015-11-07,2020-02-11, ,mcg,['/Month'],IV,Patient Choice/Convenience
10454,1002,Ledertrexaat,2016-02-04,, ,mcg,['/Month'],IV, 
10455,1002,Rebif [44],2015-10-26,,1,mg,['/Month'], , 
10456,2695,Methylprednisolone,2016-04-14,2019-06-14,1,mg,['3 / Week'],IV,Adverse Event
10457,2462,Copaxone,2016-04-13,,20, ,['3 / Week'],Oral, 
10458,2462,Endoxan,2015-11-19,,5000, ,['/Month'],IV, 
10459,2462,Gilenya,2016-04-22,,500,mg,['/ Day'],Oral, 
10460,2614,Alemtuzumab (Campath),2016-07-19,2018-07-10, ,MIU,['/Month'],IV,Adverse Event
10461,4815,Ledertrexaat,2016-05-07,,1000, ,[' '], , 
10462,4815,Alemtuzumab (Campath),2016-06-02,,500, ,['2 / Day'], , 
10463,4815,D-cure (Vitamine D),2016-04-12,2018-02-15,300, ,['2 / Day'], ,Patient Choice/Convenience
10464,3564,Avonex,2016-07-03,, , ,['/Month'],IV, 
10465,4021,Rebif [22],2016-04-25,2019-08-27,500,MIU,[' '],IV,Adverse Event
10466,4021,Endoxan,2016-01-30,2018-02-26,5000, ,['/Month'],Oral,Patient Choice/Convenience
10467,4021,Rebif [44],2015-12-16,2020-10-29,1000, ,['3 / Week'],IV,Adverse Event
10468,2570,Endoxan,2016-03-28,2020-06-04,1000, ,['/ Day'],IV,Persistence of relapses
10469,2570,Betaferon,2016-01-20,2020-06-12,400,mg,['2 / Day'],IV,Persistence of relapses
10470,2196,Tysabri,2015-11-10,,1000,mcg,['2 / Day'],Oral, 
10471,2196,Betaferon,2016-01-30,2019-02-19, ,mg,['/Month'],IV,Adverse Event
10472,2196,D-cure (Vitamine D),2016-02-08,,1,mcg,['/ Day'], , 
10473,236,Alemtuzumab (Campath),2016-04-17,2019-03-23, , ,['/Month'],IV,Adverse Event
10474,236,Methylprednisolone,2016-07-05,2020-06-11,300, ,['2 / Day'],Oral,Adverse Event
10475,2033,Rebif [22],2016-06-11,, ,mg,['3 / Week'],IV, 
10476,2348,Rebif [22],2016-01-03,2021-10-14,300, ,['/ Day'], ,Lack of efficacy
10477,2348,Mitoxantrone,2016-02-26,2019-02-06, , ,['/ Day'], ,Adverse Event
10478,1804,Tysabri,2016-01-01,,20,MIU,['/Month'],Oral, 
10479,1804,IVIG,2016-01-10,,500,mg,[' '],IV, 
10480,1804,Mitoxantrone,2016-10-13,,1000, ,[' '],IV, 
10481,1804,Gilenya,2016-01-28,2018-04-14, , ,['2 / Day'],IV,Adverse Event
10482,229,D-cure (Vitamine D),2015-11-14,, ,mg,[' '], , 
10483,229,Rebif [44],2016-01-29,,20,mg,['/Month'],IV, 
10484,229,Methylprednisolone,2016-07-03,2021-03-22,1,MIU,['/Month'],IV,Persisting MRI activity
10485,229,IVIG,2016-02-13,,1000,MIU,['/ Week'], , 
10486,2709,Teriflunomide,2016-09-07,,1000,mg,['2 / Day'],IV, 
10487,2709,Betaferon,2016-07-31,2018-07-29,1000,mg,['2 / Day'],IV,Persisting MRI activity
10488,1839,Gilenya,2016-05-12,2018-11-12,1000,mg,['/Month'],IV,Adverse Event
10489,1839,IVIG,2016-10-15,, , ,['3 / Week'],IV, 
10490,2894,Teriflunomide,2016-01-31,2021-02-11,1, ,['3 / Week'], ,Persisting MRI activity
10491,2894,Alemtuzumab (Campath),2016-08-20,2017-11-30, , ,[' '],Oral,Adverse Event
10492,2894,Teriflunomide,2016-01-26,, , ,['/Month'], , 
10493,582,IVIG,2016-02-29,,500, ,['3 / Week'], , 
10494,582,IVIG,2016-04-13,2018-12-16, ,mg,['2 / Day'],IV,Adverse Event
10495,582,D-cure (Vitamine D),2016-09-10,2018-03-24, ,mcg,['/Month'], ,Adverse Event
10496,3069,Betaferon,2015-10-25,,20, ,['/Month'], , 
10497,3069,Ledertrexaat,2015-11-26,, , ,[' '], , 
10498,3069,Betaferon,2016-05-09,,500, ,['2 / Day'],IV, 
10499,3069,Alemtuzumab (Campath),2016-02-26,,300, ,['3 / Week'], , 
10500,1121,D-cure (Vitamine D),2016-01-20,2020-11-07,20,mg,['3 / Week'], ,Adverse Event
10501,3931,Avonex,2016-09-05,, , ,[' '], , 
10502,3931,Tecfidera,2016-08-17,,1,mcg,['3 / Week'], , 
10503,3931,Copaxone,2015-11-22,2020-10-20,1,mg,['/Month'], ,Lack of efficacy
10504,149,Gilenya,2016-07-14,,20,mg,['/ Week'], , 
10505,4084,Tecfidera,2016-02-27,, , ,['/Month'],IV, 
10506,4084,Rebif [44],2016-05-28,, ,MIU,['/Month'], , 
10507,4084,Mitoxantrone,2016-09-17,,1,mg,['2 / Day'],Oral, 
10508,4084,Rebif [22],2016-02-28,,300,mg,['/Month'],Oral, 
10509,2529,IVIG,2015-12-21,2019-12-06,20,MIU,['/Month'],IV,Adverse Event
10510,2529,Gilenya,2016-07-08,,1,mg,['/Month'],IV, 
10511,2529,D-cure (Vitamine D),2016-03-06,2018-06-25,300, ,['/ Week'],IV,Adverse Event
10512,2704,Tecfidera,2016-02-11,,5000, ,['/Month'],IV, 
10513,2704,Rebif [22],2016-04-13,,1,mg,['/Month'],IV, 
10514,2704,Gilenya,2016-04-29,2021-02-06,20,MIU,['3 / Week'], ,Lack of efficacy
10515,2034,Gilenya,2016-06-09,,500, ,['3 / Week'],Oral, 
10516,4031,Copaxone,2016-08-30,, ,mg,['2 / Day'], , 
10517,4031,IVIG,2016-09-01,2019-09-28,400, ,['3 / Week'],IV,Patient Choice/Convenience
10518,4031,Gilenya,2016-10-04,2021-05-10,20, ,[' '],IV,Lack of efficacy
10519,3220,Rebif [22],2016-01-06,,5000, ,['2 / Day'],Oral, 
10520,3220,Methylprednisolone,2016-02-22,,5000,mg,['/ Week'],IV, 
10521,3220,Tysabri,2016-04-13,,20,MIU,['2 / Day'], , 
10522,3220,Rebif [44],2016-01-15,, ,mg,['/Month'], , 
10523,1396,Teriflunomide,2015-12-19,2020-10-29,1,MIU,['/ Day'],IV,Persisting MRI activity
10524,1396,IVIG,2016-01-18,2020-05-03, , ,['/Month'], ,Persistence of relapses
10525,675,Copaxone,2015-11-16,, ,mcg,['/Month'], , 
10526,675,Tecfidera,2016-02-12,,300,mg,['2 / Day'],IV, 
10527,675,Teriflunomide,2015-12-23,,5000, ,['/ Week'],IV, 
10528,871,Gilenya,2015-10-24,,300,mg,['2 / Day'],IV, 
10529,871,D-cure (Vitamine D),2016-02-25,,5000,MIU,['/Month'], , 
10530,871,Gilenya,2016-09-08,2020-05-16,500,mg,['2 / Day'],IV,Persisting MRI activity
10531,871,Teriflunomide,2016-02-28,2021-09-22, ,mg,['2 / Day'],IV,Patient Choice/Convenience
10532,1013,Betaferon,2015-12-24,2018-09-18,20,mg,['2 / Day'],IV,Persistence of relapses
10533,1013,Endoxan,2015-11-02,2020-03-11,1,mg,[' '], ,Adverse Event
10534,1013,Rebif [44],2016-10-09,, ,mg,['/Month'],IV, 
10535,1013,Rebif [44],2016-04-17,2019-07-18,400,mg,['/Month'],IV,Adverse Event
10536,1378,Mitoxantrone,2016-06-29,2019-11-30,1, ,['/Month'],IV,Persisting MRI activity
10537,1378,Tecfidera,2016-08-09,2019-07-09, ,mg,['/ Day'],IV,Persisting MRI activity
10538,1378,Gilenya,2016-06-05,2018-01-12,500,mg,[' '], ,Persisting MRI activity
10539,3891,Copaxone,2016-07-13,2021-02-02,20,MIU,['/Month'],IV,Patient Choice/Convenience
10540,3891,Gilenya,2016-10-17,,5000, ,['/Month'], , 
10541,1154,Tecfidera,2016-05-01,2019-11-08, , ,['2 / Day'],IV,Adverse Event
10542,1154,Rebif [22],2016-08-21,,400,mg,[' '],IV, 
10543,1154,Rebif [44],2016-06-27,,500,mg,['/Month'], , 
10544,1154,Methylprednisolone,2016-03-25,,5000, ,['2 / Day'],IV, 
10545,830,Avonex,2016-04-08,, ,MIU,['3 / Week'], , 
10546,830,Avonex,2015-12-12,,1000,mg,['2 / Day'],IV, 
10547,830,Gilenya,2016-06-15,,20, ,['/Month'],IV, 
10548,256,Rebif [44],2016-01-21,,1,mg,['3 / Week'], , 
10549,2231,Tysabri,2016-01-31,,1000,mg,[' '],Oral, 
10550,2231,IVIG,2016-10-01,2021-05-01, ,mg,['/Month'],IV,Persistence of relapses
10551,898,Tysabri,2016-05-04,2020-04-26, , ,['2 / Day'],IV,Persistence of relapses
10552,898,Copaxone,2015-11-29,,500, ,['2 / Day'],IV, 
10553,898,Alemtuzumab (Campath),2016-10-03,2018-03-12,300, ,['2 / Day'],IV,Patient Choice/Convenience
10554,773,Rebif [44],2016-02-12,2021-03-11, , ,[' '],IV,Lack of efficacy
10555,773,Tecfidera,2016-08-23,2021-09-04,20, ,['/Month'], ,Patient Choice/Convenience
10556,773,Betaferon,2016-09-25,,500,mcg,['/Month'], , 
10557,677,Endoxan,2016-10-04,,5000,mcg,[' '],IV, 
10558,677,Endoxan,2016-10-14,2018-01-26, , ,['/Month'],Oral,Persistence of relapses
10559,677,Tysabri,2016-03-14,, ,mcg,['3 / Week'],IV, 
10560,677,Rebif [44],2016-01-04,,1000,mg,['/ Week'], , 
10561,2296,Endoxan,2015-12-30,2017-12-12,5000,MIU,['/Month'],IV,Adverse Event
10562,1241,Copaxone,2015-12-04,, ,mg,['/ Day'],IV, 
10563,1241,Copaxone,2016-09-27,2019-01-05,20,MIU,['2 / Day'], ,Lack of efficacy
10564,1241,Teriflunomide,2016-02-19,2019-07-22,5000, ,['/Month'], ,Lack of efficacy
10565,1241,Methylprednisolone,2016-05-06,2019-10-19,500, ,['3 / Week'],IV,Patient Choice/Convenience
10566,3361,Copaxone,2015-11-29,,400,mg,['/Month'], , 
10567,3361,Rebif [44],2016-05-27,,300,mcg,['2 / Day'],Oral, 
10568,3361,Mitoxantrone,2016-07-07,2018-01-26,1, ,['2 / Day'], ,Adverse Event
10569,3361,Betaferon,2016-05-11,2021-08-07,400, ,['2 / Day'],Oral,Patient Choice/Convenience
10570,1868,D-cure (Vitamine D),2016-09-08,,300, ,['2 / Day'],IV, 
10571,1868,Rebif [44],2016-01-29,2020-03-26,5000, ,['3 / Week'],IV,Adverse Event
10572,1868,Endoxan,2016-04-16,, , ,['/Month'], , 
10573,1089,Ledertrexaat,2015-11-02,, , ,['2 / Day'],Oral, 
10574,1089,Endoxan,2016-07-08,, , ,['/Month'],IV, 
10575,155,Alemtuzumab (Campath),2015-12-12,,1,mg,['2 / Day'],IV, 
10576,155,D-cure (Vitamine D),2016-09-04,,400, ,['/ Day'],IV, 
10577,155,D-cure (Vitamine D),2016-04-18,2020-01-09, ,MIU,['/ Week'],IV,Persisting MRI activity
10578,600,IVIG,2016-04-05,, ,mcg,['/Month'],IV, 
10579,600,D-cure (Vitamine D),2016-08-02,,1,mg,['/Month'],IV, 
10580,600,Gilenya,2015-12-07,2018-06-20,300,mg,['/Month'], ,Persisting MRI activity
10581,600,Tecfidera,2015-11-04,,300,MIU,['/ Day'], , 
10582,2878,Mitoxantrone,2016-06-06,2019-03-02,1000,mg,['2 / Day'], ,Lack of efficacy
10583,4417,Avonex,2016-04-24,, , ,['/Month'], , 
10584,832,Mitoxantrone,2016-09-13,,20,mg,['2 / Day'],IV, 
10585,832,Endoxan,2016-02-06,2021-03-21, , ,['/Month'],IV,Persisting MRI activity
10586,698,Gilenya,2016-06-29,2020-09-29, ,mg,['/Month'],Oral,Adverse Event
10587,698,Tecfidera,2016-01-12,, ,mg,['2 / Day'],Oral, 
10588,3699,Ledertrexaat,2016-06-02,,300, ,['/Month'],IV, 
10589,3699,IVIG,2016-10-12,2019-04-24,5000, ,['/Month'],IV,Adverse Event
10590,3699,Rebif [22],2016-09-13,,20,mg,['/Month'],IV, 
10591,961,IVIG,2016-07-11,,20,MIU,['2 / Day'], , 
10592,961,Mitoxantrone,2016-06-23,2018-01-06, ,mg,['/ Day'], ,Adverse Event
10593,961,Mitoxantrone,2016-05-28,2021-10-21,1000, ,['/Month'], ,Lack of efficacy
10594,2130,Endoxan,2016-05-19,2020-08-16,5000, ,['2 / Day'],Oral,Lack of efficacy
10595,2130,Tecfidera,2016-10-01,,1000,mg,['2 / Day'],IV, 
10596,2130,Rebif [44],2016-08-23,,300,mg,['2 / Day'],IV, 
10597,2130,Gilenya,2016-08-11,,1, ,['/ Day'],IV, 
10598,3408,D-cure (Vitamine D),2016-01-23,,5000,mg,['/ Week'],IV, 
10599,3408,Avonex,2016-04-21,2020-09-08,500,MIU,['2 / Day'], ,Adverse Event
10600,3408,Tysabri,2015-11-27,2020-02-04,20, ,['/ Day'],IV,Adverse Event
10601,3408,Gilenya,2015-12-20,2019-11-16,1000,mcg,['2 / Day'],IV,Adverse Event
10602,1364,Copaxone,2016-08-24,,20, ,[' '], , 
10603,811,D-cure (Vitamine D),2015-10-26,,300, ,['/Month'], , 
10604,811,IVIG,2016-07-01,2021-01-17,20,mg,['3 / Week'], ,Adverse Event
10605,1558,IVIG,2016-06-23,,300,mcg,['2 / Day'],IV, 
10606,1558,Alemtuzumab (Campath),2016-09-12,2020-04-17,400,MIU,['/ Day'],IV,Persisting MRI activity
10607,439,Teriflunomide,2016-01-25,2018-04-06, ,MIU,['/Month'], ,Persisting MRI activity
10608,439,Alemtuzumab (Campath),2016-06-19,,5000,MIU,['3 / Week'],IV, 
10609,4099,IVIG,2015-12-27,,1000, ,['3 / Week'], , 
10610,729,D-cure (Vitamine D),2016-09-06,, ,mg,['3 / Week'],IV, 
10611,2052,Tysabri,2016-04-06,,300,MIU,['/ Day'],IV, 
10612,660,Alemtuzumab (Campath),2015-11-25,, ,mg,['/Month'], , 
10613,2477,Alemtuzumab (Campath),2015-11-18,2018-04-29, , ,['2 / Day'],IV,Persisting MRI activity
10614,738,Methylprednisolone,2016-01-12,,500,mcg,[' '], , 
10615,738,Rebif [44],2016-08-13,, ,mcg,['/ Week'],IV, 
10616,738,Gilenya,2016-09-12,2020-05-23, ,mg,['/Month'], ,Adverse Event
10617,738,Alemtuzumab (Campath),2016-05-13,2020-03-14,300,mg,['3 / Week'],IV,Persistence of relapses
10618,3144,Tecfidera,2015-11-05,, , ,['/ Day'], , 
10619,3195,Rebif [44],2016-01-15,2018-09-15,400, ,['2 / Day'],IV,Adverse Event
10620,3195,Alemtuzumab (Campath),2016-01-19,, ,mcg,['/Month'], , 
10621,3195,Alemtuzumab (Campath),2015-12-28,, , ,['/Month'],IV, 
10622,888,Betaferon,2016-06-11,2020-03-14,500, ,['/Month'], ,Persisting MRI activity
10623,636,D-cure (Vitamine D),2016-05-18,2019-05-25, , ,[' '], ,Patient Choice/Convenience
10624,636,IVIG,2016-10-13,,1,mg,['/ Day'], , 
10625,636,Teriflunomide,2016-01-10,2021-09-16,500,mg,['/Month'], ,Patient Choice/Convenience
10626,636,Teriflunomide,2016-03-06,, ,MIU,['/Month'],IV, 
10627,3376,Rebif [44],2015-10-27,, , ,['3 / Week'], , 
10628,3376,Methylprednisolone,2016-06-25,2019-03-10, ,mg,['2 / Day'],IV,Patient Choice/Convenience
10629,3376,Tecfidera,2015-12-15,2021-02-22, ,mg,['3 / Week'], ,Lack of efficacy
10630,4516,Rebif [44],2016-01-01,2020-09-09, ,mcg,['3 / Week'],IV,Adverse Event
10631,4516,Avonex,2015-10-28,2019-10-31,1000,MIU,['/Month'],IV,Adverse Event
10632,2573,Tecfidera,2016-02-15,,1000, ,['2 / Day'],IV, 
10633,2573,Gilenya,2016-04-16,2019-11-16, , ,['/Month'],IV,Patient Choice/Convenience
10634,2573,Rebif [44],2015-12-29,2020-11-08,300,mg,['2 / Day'], ,Adverse Event
10635,3012,Gilenya,2016-05-20,,1,mg,['2 / Day'],IV, 
10636,3012,IVIG,2016-09-01,2018-06-27,5000,mg,['2 / Day'], ,Patient Choice/Convenience
10637,3012,Alemtuzumab (Campath),2016-08-16,2021-05-29,400,mcg,['/Month'], ,Patient Choice/Convenience
10638,2416,Rebif [44],2016-01-17,2017-11-15, , ,['3 / Week'],Oral,Patient Choice/Convenience
10639,3600,Rebif [22],2016-04-17,2019-09-29,1000, ,['/Month'],IV,Persisting MRI activity
10640,3924,Endoxan,2016-02-18,,300,mg,['/Month'],Oral, 
10641,3921,Rebif [44],2015-12-06,2018-05-12, , ,['/ Day'],IV,Lack of efficacy
10642,3921,D-cure (Vitamine D),2016-07-28,,1000, ,['3 / Week'], , 
10643,3921,Tysabri,2016-05-06,, , ,['/Month'],Oral, 
10644,1270,Methylprednisolone,2016-10-21,,5000, ,['/Month'],IV, 
10645,1270,D-cure (Vitamine D),2015-11-12,, ,mg,[' '],IV, 
10646,3648,Teriflunomide,2016-08-16,, ,MIU,[' '], , 
10647,1240,Mitoxantrone,2016-08-05,2017-12-02,1000,mg,['/ Day'],IV,Adverse Event
10648,1240,Gilenya,2016-01-29,, ,MIU,['/Month'],Oral, 
10649,1275,Tecfidera,2015-12-31,2020-09-17,300,MIU,['2 / Day'],IV,Lack of efficacy
10650,1275,IVIG,2015-11-14,2017-11-19,20,mg,['/Month'], ,Persisting MRI activity
10651,4323,Alemtuzumab (Campath),2015-12-11,2021-10-23,20, ,['/Month'],IV,Adverse Event
10652,4323,D-cure (Vitamine D),2016-01-15,2017-12-01,400,mg,['/ Week'], ,Patient Choice/Convenience
10653,4323,Tecfidera,2016-01-15,2018-02-19,20,mg,['/Month'], ,Persistence of relapses
10654,1739,Copaxone,2015-11-08,2018-05-12, , ,['/Month'],IV,Adverse Event
10655,2886,Gilenya,2016-09-29,2018-02-06,500, ,[' '],IV,Adverse Event
10656,2886,Alemtuzumab (Campath),2016-04-12,2019-08-30,5000, ,['2 / Day'],IV,Lack of efficacy
10657,2886,IVIG,2016-03-12,, ,MIU,['/Month'],IV, 
10658,2886,Rebif [22],2016-02-17,2020-02-21, ,mg,['2 / Day'],IV,Patient Choice/Convenience
10659,2044,Teriflunomide,2016-02-16,, ,MIU,[' '],IV, 
10660,3407,D-cure (Vitamine D),2016-02-24,2018-01-04,20, ,['/Month'],IV,Patient Choice/Convenience
10661,2032,Avonex,2016-07-24,,300,mg,['2 / Day'],IV, 
10662,2032,Tecfidera,2016-03-15,,500, ,['3 / Week'], , 
10663,2032,Tecfidera,2016-02-01,2018-09-02,5000,mcg,[' '], ,Patient Choice/Convenience
10664,2362,Tecfidera,2016-03-15,, ,mg,['3 / Week'],IV, 
10665,743,Ledertrexaat,2016-06-13,,300,mg,['2 / Day'],IV, 
10666,4036,Rebif [22],2015-10-30,,5000,mcg,['2 / Day'],IV, 
10667,4036,Teriflunomide,2016-04-09,,500, ,['/Month'], , 
10668,4036,Avonex,2016-05-09,2021-10-02,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
10669,1906,Copaxone,2015-11-06,,1000,MIU,['/ Day'],IV, 
10670,1906,Tysabri,2015-12-15,, ,mg,['2 / Day'],IV, 
10671,4923,Betaferon,2016-06-04,,20,mg,['/Month'], , 
10672,4923,Endoxan,2016-07-21,2020-08-28,300,mg,['2 / Day'],IV,Adverse Event
10673,4923,Copaxone,2015-12-18,2019-01-19,1000,MIU,[' '], ,Patient Choice/Convenience
10674,523,Rebif [44],2015-12-24,,20, ,['3 / Week'], , 
10675,523,Avonex,2016-08-25,2021-05-07,5000,mcg,['2 / Day'],IV,Lack of efficacy
10676,523,Tysabri,2016-05-24,2019-09-19,1, ,['3 / Week'],IV,Lack of efficacy
10677,523,Alemtuzumab (Campath),2016-05-15,, , ,['2 / Day'],IV, 
10678,3915,Tysabri,2016-10-21,2020-07-17, , ,[' '],IV,Persisting MRI activity
10679,3915,Avonex,2016-05-07,, ,mg,['/Month'], , 
10680,3915,Endoxan,2016-10-18,2018-12-01,300,mg,['3 / Week'], ,Adverse Event
10681,3915,Tysabri,2016-08-26,2018-12-31, , ,['/ Day'],IV,Adverse Event
10682,2950,Tysabri,2015-11-10,2019-10-24,400,MIU,['2 / Day'],IV,Adverse Event
10683,2950,Tysabri,2016-05-13,, , ,['2 / Day'],IV, 
10684,2950,IVIG,2016-01-08,,500,MIU,['/ Day'],Oral, 
10685,1113,Ledertrexaat,2016-06-12,2019-09-17,300, ,['2 / Day'],IV,Lack of efficacy
10686,3445,Alemtuzumab (Campath),2016-09-27,2020-02-24, , ,['/ Day'],Oral,Lack of efficacy
10687,3445,Mitoxantrone,2016-05-09,,1,mg,['/ Week'], , 
10688,1612,D-cure (Vitamine D),2015-11-14,, ,mg,[' '], , 
10689,1320,D-cure (Vitamine D),2016-06-20,,1,mg,['/ Day'],IV, 
10690,1320,Endoxan,2016-07-11,2018-06-19, ,MIU,['/Month'],IV,Patient Choice/Convenience
10691,1320,Teriflunomide,2016-08-23,,300,mg,[' '],IV, 
10692,1320,Gilenya,2016-08-31,,20,mg,['/Month'], , 
10693,4890,IVIG,2016-04-07,2020-02-28, , ,['2 / Day'],IV,Adverse Event
10694,4890,D-cure (Vitamine D),2016-10-02,2018-12-12,300,mg,['/Month'],Oral,Patient Choice/Convenience
10695,4890,Rebif [44],2016-06-13,,300,mg,['/Month'],IV, 
10696,2972,IVIG,2015-11-02,2019-06-07,300, ,['/Month'],Oral,Patient Choice/Convenience
10697,2972,Gilenya,2016-06-14,2018-12-29,20,mg,['/Month'],IV,Persistence of relapses
10698,2972,IVIG,2016-01-21,,20, ,['2 / Day'],IV, 
10699,2972,Copaxone,2016-05-06,,1000, ,['/Month'],IV, 
10700,4202,Copaxone,2015-11-13,2020-06-01,1, ,['/Month'], ,Patient Choice/Convenience
10701,4202,Tysabri,2015-12-17,,400, ,[' '],IV, 
10702,4202,Gilenya,2016-02-18,,400, ,['/Month'],IV, 
10703,1213,Rebif [44],2016-07-01,,1,mcg,['/Month'],Oral, 
10704,1213,Betaferon,2016-04-19,, , ,['/Month'],IV, 
10705,1213,Copaxone,2016-04-30,2019-12-02, , ,[' '], ,Persistence of relapses
10706,1810,Betaferon,2016-01-10,2019-02-18, , ,['2 / Day'],IV,Patient Choice/Convenience
10707,1810,Rebif [44],2015-11-17,,300,mg,['2 / Day'],IV, 
10708,1810,Tecfidera,2016-10-09,,500,mcg,[' '], , 
10709,1810,D-cure (Vitamine D),2016-10-08,,20,mg,['/Month'],IV, 
10710,2715,Methylprednisolone,2016-05-15,,1000, ,['/Month'],Oral, 
10711,2715,Tecfidera,2016-04-11,2019-08-12,1000, ,['2 / Day'],IV,Lack of efficacy
10712,2715,Avonex,2016-08-04,2020-08-08,500,mg,['2 / Day'], ,Patient Choice/Convenience
10713,2715,Copaxone,2016-10-08,,20,mg,[' '],IV, 
10714,1904,Endoxan,2016-04-09,2021-03-15,5000,mg,[' '],IV,Patient Choice/Convenience
10715,2098,Tecfidera,2015-12-22,,5000, ,['/Month'], , 
10716,2098,Endoxan,2015-11-22,2019-07-10,300,mg,['/Month'],IV,Persisting MRI activity
10717,2098,Mitoxantrone,2016-01-20,,500,MIU,['/ Day'],IV, 
10718,1236,Rebif [22],2016-04-15,,400, ,['/Month'], , 
10719,1677,D-cure (Vitamine D),2015-11-15,2021-08-21, , ,['2 / Day'],Oral,Patient Choice/Convenience
10720,1677,Copaxone,2016-07-11,2019-02-10,500,mg,['2 / Day'],IV,Adverse Event
10721,568,Rebif [22],2016-10-07,,500,mg,['2 / Day'],IV, 
10722,2908,IVIG,2016-03-25,, ,mg,['2 / Day'],IV, 
10723,2908,IVIG,2016-07-19,2020-11-10,5000,mg,[' '],IV,Persisting MRI activity
10724,2908,Betaferon,2016-04-17,,5000, ,['/Month'], , 
10725,4225,Tecfidera,2015-11-10,, ,mg,['/ Day'],IV, 
10726,4225,Tysabri,2016-07-05,2018-01-13,5000, ,['/ Week'], ,Adverse Event
10727,4225,Betaferon,2016-06-05,,5000,mg,['/ Week'],IV, 
10728,4225,Mitoxantrone,2016-03-31,,1, ,['2 / Day'],IV, 
10729,4986,Methylprednisolone,2016-09-21,,300, ,['/Month'],Oral, 
10730,4986,IVIG,2016-09-26,, , ,['/Month'],IV, 
10731,4986,Avonex,2016-09-20,2021-06-13, ,mg,['3 / Week'], ,Adverse Event
10732,4986,Rebif [22],2016-01-14,,500, ,[' '], , 
10733,3838,Methylprednisolone,2016-07-24,,300,mg,['/Month'],Oral, 
10734,3838,Ledertrexaat,2016-08-16,, ,mg,[' '],IV, 
10735,4888,Avonex,2016-07-19,2021-04-18,500,mg,['2 / Day'],IV,Persisting MRI activity
10736,4164,Mitoxantrone,2016-10-16,, ,mcg,['/ Day'],IV, 
10737,4164,Betaferon,2016-04-12,2018-11-24,1000, ,['/Month'],IV,Patient Choice/Convenience
10738,1014,D-cure (Vitamine D),2016-03-29,,400, ,['/Month'], , 
10739,3167,Alemtuzumab (Campath),2016-05-10,2019-05-21, , ,[' '],Oral,Persisting MRI activity
10740,3167,IVIG,2015-12-25,, , ,['2 / Day'],IV, 
10741,3167,Tysabri,2016-03-31,,20,mg,['2 / Day'], , 
10742,4411,Endoxan,2015-11-22,,300,mg,['/Month'],IV, 
10743,4669,Alemtuzumab (Campath),2015-12-30,,500, ,['2 / Day'],IV, 
10744,4669,Tecfidera,2016-07-23,2018-11-13, ,mg,['/ Day'],IV,Persisting MRI activity
10745,3730,Teriflunomide,2016-01-05,2021-07-30,300, ,['2 / Day'],IV,Adverse Event
10746,3730,Avonex,2016-07-05,2018-01-30, ,mg,['2 / Day'],IV,Adverse Event
10747,3730,D-cure (Vitamine D),2016-03-31,, , ,['/Month'],IV, 
10748,3730,Gilenya,2016-08-24,, ,mg,['/Month'],IV, 
10749,2119,Mitoxantrone,2016-09-26,2020-08-28,400,mg,[' '],IV,Adverse Event
10750,2119,Gilenya,2016-02-08,2021-01-26,500, ,[' '], ,Persisting MRI activity
10751,2119,Avonex,2015-12-06,, ,mg,['2 / Day'],IV, 
10752,2751,Tysabri,2016-03-23,,300,mg,['2 / Day'],Oral, 
10753,1097,Ledertrexaat,2016-08-06,2019-06-29,1,MIU,['/ Week'],IV,Adverse Event
10754,1097,Ledertrexaat,2016-08-12,2018-12-19,400,MIU,['3 / Week'], ,Lack of efficacy
10755,1097,IVIG,2016-09-20,2019-10-20,5000,mg,['3 / Week'],Oral,Adverse Event
10756,1963,Rebif [22],2016-08-08,,1,MIU,['/Month'], , 
10757,1963,Copaxone,2015-11-23,, , ,['/Month'], , 
10758,3553,Ledertrexaat,2016-05-21,, ,mg,['2 / Day'],IV, 
10759,3553,Alemtuzumab (Campath),2016-08-01,, , ,['2 / Day'],Oral, 
10760,3553,IVIG,2015-12-15,2020-09-16,300,mcg,['/Month'],IV,Adverse Event
10761,3553,Rebif [22],2016-03-08,,500,mcg,['/Month'],IV, 
10762,2441,Betaferon,2016-03-05,, ,mg,['3 / Week'], , 
10763,2441,Endoxan,2016-09-28,2020-11-28,5000, ,['2 / Day'],Oral,Patient Choice/Convenience
10764,2441,Methylprednisolone,2016-04-10,2020-12-25, , ,['2 / Day'], ,Persisting MRI activity
10765,883,Betaferon,2016-02-23,2021-04-07, , ,[' '], ,Persistence of relapses
10766,3320,Ledertrexaat,2016-07-22,,400,MIU,['2 / Day'],IV, 
10767,3320,D-cure (Vitamine D),2016-09-06,, , ,['2 / Day'],IV, 
10768,4850,Rebif [22],2016-04-10,,20,mg,['3 / Week'],Oral, 
10769,4850,D-cure (Vitamine D),2016-04-21,,1000,MIU,[' '],IV, 
10770,1912,D-cure (Vitamine D),2016-03-14,2019-10-01,400,mg,['2 / Day'],IV,Lack of efficacy
10771,1912,Betaferon,2015-10-24,, , ,['2 / Day'],Oral, 
10772,1912,Alemtuzumab (Campath),2016-03-06,,1,MIU,['2 / Day'],IV, 
10773,1912,IVIG,2015-12-16,2021-01-29,500, ,['2 / Day'],IV,Persisting MRI activity
10774,3053,Betaferon,2016-04-07,,300, ,['/Month'], , 
10775,2403,Copaxone,2016-04-26,2021-01-01,20, ,['/ Day'], ,Persistence of relapses
10776,2621,Gilenya,2016-07-01,,20,MIU,['2 / Day'], , 
10777,2621,Rebif [44],2015-11-21,2019-07-18,500,MIU,['/Month'],IV,Persisting MRI activity
10778,4698,Ledertrexaat,2016-09-24,2020-04-06,1000,mg,['/Month'],Oral,Patient Choice/Convenience
10779,4698,Betaferon,2015-12-26,2020-08-15,5000,mg,['/Month'],Oral,Persistence of relapses
10780,3191,Mitoxantrone,2016-01-18,, ,MIU,['2 / Day'],IV, 
10781,3191,Rebif [22],2016-04-14,2020-11-15,20,mg,['2 / Day'],IV,Persistence of relapses
10782,3191,D-cure (Vitamine D),2016-09-02,2017-11-27,5000,mg,['/Month'],IV,Adverse Event
10783,920,Alemtuzumab (Campath),2015-11-10,,500,mg,['2 / Day'], , 
10784,676,Copaxone,2016-02-10,,300, ,['/ Week'], , 
10785,676,Endoxan,2016-02-10,2021-01-21, , ,['3 / Week'], ,Persisting MRI activity
10786,676,Teriflunomide,2016-02-24,2021-05-24, , ,['/Month'], ,Persisting MRI activity
10787,1782,Avonex,2016-06-30,2019-12-02,20,MIU,['2 / Day'], ,Patient Choice/Convenience
10788,1782,Tecfidera,2016-05-04,, , ,['/Month'], , 
10789,1782,IVIG,2015-10-25,, , ,['/Month'], , 
10790,1782,Alemtuzumab (Campath),2016-04-12,2019-10-27,1,mcg,[' '],IV,Adverse Event
10791,943,Betaferon,2016-09-08,, ,mg,['2 / Day'], , 
10792,2107,Methylprednisolone,2016-09-10,,400,mg,[' '],IV, 
10793,3826,Endoxan,2016-01-25,2020-03-20, , ,[' '], ,Adverse Event
10794,3826,Avonex,2016-03-27,, , ,['/ Day'], , 
10795,3826,Betaferon,2016-09-24,, ,mg,[' '],IV, 
10796,4229,Tysabri,2016-05-12,2021-02-04,20, ,['/Month'], ,Patient Choice/Convenience
10797,4229,Alemtuzumab (Campath),2016-08-14,, ,MIU,[' '], , 
10798,4229,Rebif [22],2016-04-16,, , ,['/Month'],Oral, 
10799,2456,Copaxone,2015-12-22,,1000, ,['2 / Day'], , 
10800,1666,D-cure (Vitamine D),2016-07-21,2018-07-16,20,mg,['3 / Week'],IV,Adverse Event
10801,1666,D-cure (Vitamine D),2016-03-14,2021-07-18, , ,['2 / Day'],IV,Persistence of relapses
10802,2890,Tecfidera,2016-06-05,2021-06-23, , ,['2 / Day'],IV,Patient Choice/Convenience
10803,2890,IVIG,2016-10-03,2019-08-17, ,mg,['/Month'], ,Lack of efficacy
10804,2890,Mitoxantrone,2016-04-05,2018-08-18,5000,mg,['2 / Day'], ,Adverse Event
10805,2890,IVIG,2016-03-10,,5000,mg,['/Month'],Oral, 
10806,931,IVIG,2016-09-24,2020-07-28, ,mg,['2 / Day'],IV,Persisting MRI activity
10807,931,Methylprednisolone,2016-09-10,,20, ,['/Month'],IV, 
10808,931,Alemtuzumab (Campath),2016-06-08,,500,mcg,['2 / Day'], , 
10809,931,Copaxone,2016-03-18,2020-07-09,300, ,['3 / Week'],Oral,Patient Choice/Convenience
10810,228,Rebif [44],2016-02-20,2017-11-02,400,mg,['/ Day'], ,Persisting MRI activity
10811,228,IVIG,2016-05-26,2018-08-16,500,mg,['2 / Day'],IV,Persisting MRI activity
10812,228,Alemtuzumab (Campath),2016-08-17,2021-05-28,1000,mg,['/ Week'], ,Persistence of relapses
10813,4842,D-cure (Vitamine D),2015-12-12,2020-01-11,1,mg,['/Month'],IV,Lack of efficacy
10814,4842,Rebif [22],2015-10-30,2018-12-01, ,mg,['/ Day'],IV,Persistence of relapses
10815,4725,Rebif [22],2015-12-27,,1000,mg,['2 / Day'],IV, 
10816,4725,Alemtuzumab (Campath),2016-09-15,, ,MIU,['/Month'],IV, 
10817,4725,Alemtuzumab (Campath),2016-01-01,2021-07-22,500,mg,[' '],IV,Adverse Event
10818,4725,Copaxone,2016-08-01,, ,mg,['2 / Day'], , 
10819,4814,Endoxan,2016-02-27,,500,mg,['2 / Day'],IV, 
10820,4814,Betaferon,2016-02-22,, ,mg,['2 / Day'],IV, 
10821,4547,Avonex,2016-03-07,,20, ,['2 / Day'], , 
10822,4547,Mitoxantrone,2016-08-15,2020-10-12,1,mg,['2 / Day'],IV,Adverse Event
10823,1376,Teriflunomide,2016-07-02,,400, ,['/Month'], , 
10824,1376,Tysabri,2015-11-29,,400,mg,['/Month'],IV, 
10825,1376,Rebif [22],2016-07-18,,400,mg,['2 / Day'],IV, 
10826,1376,Rebif [44],2016-05-30,2018-10-09,1,mg,['3 / Week'],IV,Persisting MRI activity
10827,2126,Avonex,2016-01-12,,500, ,['2 / Day'],IV, 
10828,2126,Rebif [22],2016-01-03,,20,mg,[' '], , 
10829,4473,Methylprednisolone,2016-08-21,2020-12-20,1000,mcg,['3 / Week'],IV,Lack of efficacy
10830,4473,Alemtuzumab (Campath),2015-11-29,2020-07-22,1000,mg,['3 / Week'],IV,Persistence of relapses
10831,4473,Mitoxantrone,2016-08-20,2018-06-09, ,mg,['/Month'],IV,Persistence of relapses
10832,4473,Rebif [44],2016-05-14,, ,MIU,['/Month'],IV, 
10833,1602,IVIG,2016-04-07,, ,mg,[' '],IV, 
10834,1602,Gilenya,2015-10-24,, ,mg,['3 / Week'],IV, 
10835,2943,Endoxan,2015-12-18,,300,mg,['/ Week'], , 
10836,2943,Rebif [44],2016-10-09,2019-10-25, ,mg,[' '],IV,Patient Choice/Convenience
10837,1066,Avonex,2015-11-24,,1000,mg,['/ Day'], , 
10838,1066,Endoxan,2016-07-29,,500,mcg,['/Month'],Oral, 
10839,1066,Ledertrexaat,2015-12-06,2019-06-18,500,mcg,[' '],IV,Lack of efficacy
10840,1075,Methylprednisolone,2016-08-21,, ,MIU,['2 / Day'],Oral, 
10841,4693,Gilenya,2016-06-24,,500, ,['/Month'],IV, 
10842,4693,Mitoxantrone,2016-06-07,2019-12-26, ,mg,['/Month'], ,Adverse Event
10843,4693,Betaferon,2016-07-17,,20, ,['/ Week'], , 
10844,4693,Alemtuzumab (Campath),2016-03-23,,5000, ,['2 / Day'], , 
10845,1514,Gilenya,2016-08-19,,1, ,[' '], , 
10846,1514,Copaxone,2016-05-11,,20,mg,['/ Week'],IV, 
10847,1514,Avonex,2016-09-15,2017-11-17,500,mg,['2 / Day'],IV,Persistence of relapses
10848,3603,Teriflunomide,2015-11-30,,1,MIU,['3 / Week'],Oral, 
10849,3603,IVIG,2016-01-16,2021-07-24,500,mg,['2 / Day'], ,Adverse Event
10850,4210,D-cure (Vitamine D),2016-05-17,,5000, ,['/Month'], , 
10851,4210,Methylprednisolone,2016-08-08,,1000, ,['2 / Day'], , 
10852,1749,Ledertrexaat,2015-12-01,2018-06-04,400,mg,['2 / Day'],IV,Lack of efficacy
10853,2497,D-cure (Vitamine D),2015-11-21,2019-10-02,1000, ,['2 / Day'],IV,Lack of efficacy
10854,2497,Mitoxantrone,2015-11-12,,5000,MIU,[' '], , 
10855,3929,Teriflunomide,2015-11-04,2018-08-13, , ,['/Month'],IV,Patient Choice/Convenience
10856,3929,D-cure (Vitamine D),2016-04-12,2020-05-18,300, ,['/ Week'], ,Adverse Event
10857,3929,Copaxone,2016-05-11,,500, ,['/Month'], , 
10858,1433,Methylprednisolone,2015-11-27,2020-12-23,1, ,['/Month'], ,Adverse Event
10859,1433,Rebif [44],2016-08-21,, ,mg,[' '],IV, 
10860,2838,Avonex,2016-08-14,,1000, ,['/Month'], , 
10861,1208,Tysabri,2016-07-16,,20, ,['/Month'],IV, 
10862,2817,D-cure (Vitamine D),2016-01-29,2020-06-30, ,MIU,['/Month'], ,Adverse Event
10863,659,Rebif [44],2016-06-25,,500,mg,['2 / Day'],IV, 
10864,659,Tecfidera,2016-07-26,,1000, ,['2 / Day'],IV, 
10865,659,Gilenya,2016-06-26,2021-06-09, , ,[' '], ,Patient Choice/Convenience
10866,400,Methylprednisolone,2016-10-07,2017-10-28, ,mg,['/Month'], ,Persistence of relapses
10867,400,Copaxone,2016-06-04,2021-04-09,20,mg,['2 / Day'],IV,Persistence of relapses
10868,400,D-cure (Vitamine D),2015-11-27,,300,mg,['2 / Day'], , 
10869,400,Tecfidera,2015-10-29,,20,MIU,['/ Week'],Oral, 
10870,733,Alemtuzumab (Campath),2016-04-19,2018-01-24,500,MIU,['3 / Week'],IV,Lack of efficacy
10871,733,Copaxone,2016-09-28,2019-08-28, ,MIU,['2 / Day'],IV,Persisting MRI activity
10872,733,Betaferon,2016-08-04,,20,mcg,['2 / Day'],IV, 
10873,733,Betaferon,2015-10-26,2018-12-17,1000,mg,['2 / Day'],Oral,Persistence of relapses
10874,1410,IVIG,2016-09-25,2020-07-15,300,mg,['/ Day'],IV,Adverse Event
10875,1410,Rebif [44],2016-01-02,,5000,MIU,['/Month'],Oral, 
10876,1410,Rebif [44],2016-08-19,2018-11-16,1000, ,['/ Day'],IV,Adverse Event
10877,299,D-cure (Vitamine D),2016-07-09,2021-06-12,5000,mg,['3 / Week'], ,Persistence of relapses
10878,299,Tysabri,2015-11-15,2018-01-22,1000, ,['2 / Day'],IV,Persisting MRI activity
10879,299,Rebif [22],2016-06-13,,500,mg,[' '],IV, 
10880,4052,Mitoxantrone,2016-03-07,2018-01-29, ,MIU,['/Month'],Oral,Patient Choice/Convenience
10881,4052,D-cure (Vitamine D),2016-08-02,2020-06-01,20,mg,['/Month'],IV,Adverse Event
10882,4484,Tecfidera,2015-11-26,, ,mg,['3 / Week'],Oral, 
10883,4484,Betaferon,2016-07-11,2018-02-03, ,mg,['2 / Day'], ,Persisting MRI activity
10884,4484,Betaferon,2016-08-16,2020-07-03,500, ,['3 / Week'], ,Persistence of relapses
10885,4484,D-cure (Vitamine D),2016-01-31,, , ,['/ Day'],IV, 
10886,4341,Teriflunomide,2016-06-12,2019-07-20, ,MIU,['3 / Week'],IV,Adverse Event
10887,4341,Gilenya,2016-05-19,,300, ,['3 / Week'], , 
10888,4341,D-cure (Vitamine D),2016-10-13,2019-10-17,1, ,['2 / Day'], ,Patient Choice/Convenience
10889,4341,IVIG,2015-10-28,2021-01-11,400,mg,['/Month'], ,Patient Choice/Convenience
10890,545,Endoxan,2016-06-25,, , ,['/Month'],IV, 
10891,545,Methylprednisolone,2016-06-11,, , ,['2 / Day'],IV, 
10892,545,Tecfidera,2016-09-02,2017-12-05, ,mcg,['2 / Day'],IV,Adverse Event
10893,737,Gilenya,2016-09-24,, , ,['/ Day'], , 
10894,1266,Mitoxantrone,2016-01-31,,300, ,[' '], , 
10895,3032,Tecfidera,2015-12-02,2021-03-25,300, ,['3 / Week'],IV,Adverse Event
10896,3032,IVIG,2016-07-16,2018-11-13,300,mcg,['2 / Day'], ,Patient Choice/Convenience
10897,3032,D-cure (Vitamine D),2016-10-10,2019-01-05,300,mg,['/ Day'],IV,Persisting MRI activity
10898,3032,Methylprednisolone,2016-08-13,, ,mg,['/Month'],IV, 
10899,521,Gilenya,2016-01-17,2018-03-26,300, ,['2 / Day'], ,Persisting MRI activity
10900,605,Teriflunomide,2016-06-26,,1000,mg,['2 / Day'],IV, 
10901,605,Mitoxantrone,2016-02-27,2019-09-30,300,MIU,['2 / Day'],IV,Adverse Event
10902,2946,Gilenya,2015-12-05,2019-08-16,300, ,['2 / Day'], ,Patient Choice/Convenience
10903,2946,Rebif [44],2016-05-15,, ,mg,['/Month'],IV, 
10904,2946,Methylprednisolone,2016-04-14,2019-12-18,500,mg,['/Month'], ,Adverse Event
10905,2946,Endoxan,2016-01-07,,1000, ,['2 / Day'],Oral, 
10906,1469,IVIG,2016-07-30,2019-12-13,300,mg,['/ Day'], ,Patient Choice/Convenience
10907,1469,Rebif [44],2016-02-29,,400, ,['/Month'],IV, 
10908,4532,Copaxone,2015-12-23,2019-03-10, ,mg,['2 / Day'],IV,Patient Choice/Convenience
10909,4532,Rebif [22],2015-12-16,, ,MIU,['2 / Day'],IV, 
10910,2760,Betaferon,2016-09-20,2021-07-13,5000,mg,['/Month'],IV,Persistence of relapses
10911,2760,IVIG,2015-12-19,,1000, ,['/Month'], , 
10912,2760,Rebif [22],2016-01-05,2017-11-05, ,mg,['/Month'],Oral,Adverse Event
10913,2760,Avonex,2016-07-11,,20, ,['/Month'],IV, 
10914,832,Avonex,2016-04-14,2021-07-04,5000,mg,['/Month'],IV,Persistence of relapses
10915,491,Methylprednisolone,2016-09-10,,400,mcg,['/Month'],IV, 
10916,491,Tysabri,2016-10-02,2018-06-26,300,MIU,['2 / Day'],Oral,Persisting MRI activity
10917,491,Rebif [44],2016-01-13,2021-03-18,400,mg,['2 / Day'],IV,Patient Choice/Convenience
10918,2069,Ledertrexaat,2016-01-30,, ,mg,['3 / Week'],IV, 
10919,4595,D-cure (Vitamine D),2016-03-29,,300,mcg,['2 / Day'],Oral, 
10920,4595,Betaferon,2016-07-29,2021-07-06,5000,mg,['2 / Day'],IV,Adverse Event
10921,4595,D-cure (Vitamine D),2015-11-21,, , ,['/Month'],Oral, 
10922,724,Rebif [44],2015-11-11,,500,mg,['2 / Day'], , 
10923,3891,Betaferon,2016-08-12,, ,mg,['/Month'], , 
10924,3891,Rebif [44],2016-09-16,, , ,['2 / Day'],IV, 
10925,3891,Gilenya,2016-02-09,,20, ,['2 / Day'],IV, 
10926,3891,Mitoxantrone,2016-08-17,,1000,mg,['2 / Day'],IV, 
10927,4132,Tysabri,2015-12-22,,1,MIU,['2 / Day'], , 
10928,4132,Ledertrexaat,2016-03-14,,400, ,['/Month'], , 
10929,1042,Tecfidera,2016-07-04,,20, ,['/ Week'], , 
10930,1042,Rebif [44],2016-01-05,2019-07-21, ,mg,['/ Day'],Oral,Adverse Event
10931,1042,Rebif [44],2016-07-10,, ,mg,['/ Day'], , 
10932,1042,D-cure (Vitamine D),2016-06-08,2019-06-21,500, ,['/Month'],Oral,Persisting MRI activity
10933,2385,Methylprednisolone,2016-06-11,,20,mg,[' '], , 
10934,3071,Tecfidera,2015-11-07,, , ,['/Month'], , 
10935,1147,Copaxone,2016-07-15,2020-06-07,20,MIU,['3 / Week'],Oral,Patient Choice/Convenience
10936,1147,Endoxan,2016-06-05,,1, ,['2 / Day'], , 
10937,707,Teriflunomide,2016-06-22,2018-10-22, ,MIU,['3 / Week'], ,Adverse Event
10938,2131,Teriflunomide,2016-04-05,2018-10-10,1,mg,['/Month'],IV,Patient Choice/Convenience
10939,1532,Tysabri,2016-05-21,, , ,['2 / Day'], , 
10940,2814,IVIG,2015-11-03,2018-03-05, ,MIU,['/Month'], ,Lack of efficacy
10941,2814,D-cure (Vitamine D),2016-08-31,2021-06-13,1, ,['/ Day'],IV,Adverse Event
10942,1680,Ledertrexaat,2016-07-17,,20,MIU,['/ Week'],Oral, 
10943,1680,D-cure (Vitamine D),2016-06-19,2020-07-22,1000, ,['/Month'],IV,Adverse Event
10944,1680,D-cure (Vitamine D),2016-03-16,2018-01-08, ,mg,['2 / Day'],IV,Lack of efficacy
10945,4217,D-cure (Vitamine D),2015-10-28,, ,mg,['2 / Day'], , 
10946,4217,Copaxone,2016-01-11,2020-02-01,1000, ,['/Month'],IV,Lack of efficacy
10947,1836,Methylprednisolone,2016-09-23,,1,MIU,['/Month'],IV, 
10948,1836,D-cure (Vitamine D),2016-05-02,2021-06-22, ,mg,['/Month'],IV,Patient Choice/Convenience
10949,1836,Rebif [22],2016-02-12,2018-02-02,5000,mcg,['2 / Day'],Oral,Patient Choice/Convenience
10950,1836,IVIG,2016-03-28,2018-09-05, , ,['/Month'], ,Lack of efficacy
10951,4072,Ledertrexaat,2016-10-06,2018-12-11,300, ,['/Month'],IV,Persisting MRI activity
10952,4072,Betaferon,2016-04-11,2018-06-04, ,mg,['3 / Week'],IV,Adverse Event
10953,4886,Mitoxantrone,2016-05-13,,500, ,[' '], , 
10954,4886,Endoxan,2016-10-07,,5000,mcg,['3 / Week'], , 
10955,4886,Gilenya,2016-09-24,2020-07-15,500,mg,['/Month'],IV,Patient Choice/Convenience
10956,4886,D-cure (Vitamine D),2015-12-10,, , ,[' '], , 
10957,3135,Tysabri,2015-12-07,2019-06-30,300,mcg,['2 / Day'], ,Adverse Event
10958,3562,Tysabri,2015-12-20,,20, ,['3 / Week'], , 
10959,3562,Rebif [22],2016-02-16,,1, ,['/Month'], , 
10960,3562,IVIG,2016-01-06,2021-06-13,400,mg,[' '],IV,Adverse Event
10961,3562,Ledertrexaat,2015-12-23,2021-09-05, ,mg,[' '], ,Persistence of relapses
10962,1868,Alemtuzumab (Campath),2016-09-10,2019-01-03,300,mg,[' '], ,Persisting MRI activity
10963,1868,Alemtuzumab (Campath),2015-12-30,,300,mg,['3 / Week'],Oral, 
10964,2936,Alemtuzumab (Campath),2016-01-20,2019-07-22,1,mg,[' '],IV,Adverse Event
10965,2936,Rebif [44],2016-09-13,,300,mg,['2 / Day'], , 
10966,4623,Rebif [22],2016-04-16,2020-11-28,20,mg,['2 / Day'],Oral,Persisting MRI activity
10967,4623,Rebif [44],2016-05-03,2018-07-25,1, ,['/ Day'], ,Patient Choice/Convenience
10968,1807,Methylprednisolone,2015-12-04,2017-11-05,1, ,['/Month'],IV,Patient Choice/Convenience
10969,1807,IVIG,2016-09-06,,500,mg,['/Month'],IV, 
10970,4154,Endoxan,2015-11-14,2018-03-15,500,mg,['/Month'],Oral,Lack of efficacy
10971,4154,Tecfidera,2016-10-01,2021-02-13,1,MIU,['/ Week'],IV,Persisting MRI activity
10972,4154,Rebif [44],2016-10-18,2018-04-24, , ,[' '], ,Persisting MRI activity
10973,2392,IVIG,2016-09-29,2019-07-10, ,mg,['/Month'],Oral,Adverse Event
10974,3323,Teriflunomide,2016-04-26,2020-05-28, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
10975,4488,Mitoxantrone,2016-02-08,,20, ,['/ Day'],IV, 
10976,4488,Avonex,2016-03-01,,1, ,['2 / Day'], , 
10977,4488,D-cure (Vitamine D),2016-09-17,,300,MIU,['/Month'],IV, 
10978,4488,Alemtuzumab (Campath),2016-03-29,2021-07-25,1000, ,[' '],IV,Lack of efficacy
10979,2572,Endoxan,2016-08-27,,400, ,['2 / Day'], , 
10980,2572,Rebif [44],2016-03-12,2019-12-02,400,mg,['3 / Week'],IV,Persisting MRI activity
10981,4777,Avonex,2016-03-15,2019-12-07,1000, ,['/Month'], ,Adverse Event
10982,4777,Alemtuzumab (Campath),2016-02-07,, , ,['/Month'],Oral, 
10983,4777,Betaferon,2016-07-06,2021-05-31,300, ,['3 / Week'],IV,Adverse Event
10984,1319,Ledertrexaat,2016-09-06,,500,mg,['/ Day'], , 
10985,1319,Ledertrexaat,2015-11-08,,1000,mg,[' '],IV, 
10986,1319,Tysabri,2016-09-06,,400, ,['2 / Day'],IV, 
10987,1319,Betaferon,2016-09-03,,1,mg,['2 / Day'], , 
10988,1961,Gilenya,2015-12-11,2018-10-03,5000,mg,['2 / Day'], ,Adverse Event
10989,1528,Endoxan,2016-09-10,2018-08-27, , ,['/Month'],IV,Patient Choice/Convenience
10990,2385,Copaxone,2015-12-04,2021-01-16,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
10991,3135,Endoxan,2015-12-29,2019-07-26,1,mg,['3 / Week'], ,Persisting MRI activity
10992,3135,Alemtuzumab (Campath),2015-12-26,,500,mg,['2 / Day'],IV, 
10993,3135,IVIG,2016-07-05,2021-08-09,1,mg,[' '], ,Lack of efficacy
10994,614,Tysabri,2016-08-07,,400,mg,['2 / Day'], , 
10995,614,Methylprednisolone,2015-12-27,,20,mg,[' '],IV, 
10996,1900,Alemtuzumab (Campath),2016-01-02,,500, ,['2 / Day'], , 
10997,1900,Rebif [44],2015-12-28,,1000,mg,['2 / Day'], , 
10998,1900,Rebif [44],2016-06-15,2019-08-27,1000, ,['/Month'],IV,Adverse Event
10999,1900,Ledertrexaat,2015-11-25,2019-09-05, ,mg,['2 / Day'], ,Adverse Event
11000,4411,IVIG,2015-12-07,2018-12-13,1000,MIU,['/ Week'],IV,Persistence of relapses
11001,4411,D-cure (Vitamine D),2016-07-01,,5000,mg,['/Month'],IV, 
11002,4411,Avonex,2016-03-06,,400,mg,['/ Week'],Oral, 
11003,142,Mitoxantrone,2016-05-02,2019-02-17,1000, ,['/ Day'], ,Persisting MRI activity
11004,142,Ledertrexaat,2016-03-17,2020-08-06,20,mg,['/ Week'],IV,Persistence of relapses
11005,142,Tecfidera,2016-09-09,,300, ,['/Month'], , 
11006,4934,Endoxan,2016-04-07,, , ,['3 / Week'],IV, 
11007,4934,IVIG,2016-10-17,, , ,['/Month'],IV, 
11008,557,IVIG,2016-03-03,2021-10-23, ,mg,['/Month'], ,Adverse Event
11009,557,D-cure (Vitamine D),2016-09-25,,5000,mg,['/ Week'],IV, 
11010,4273,Gilenya,2016-09-05,,400, ,['/Month'],IV, 
11011,4273,Rebif [44],2016-07-01,,5000, ,['/Month'], , 
11012,4273,Rebif [22],2015-11-03,,20,mg,['3 / Week'], , 
11013,1295,Endoxan,2016-06-15,2020-05-19,1000,mg,['3 / Week'], ,Persisting MRI activity
11014,4175,Tecfidera,2016-02-09,,1000,mg,['/Month'], , 
11015,4175,Gilenya,2016-09-23,,500,MIU,['/ Day'],Oral, 
11016,4175,Rebif [22],2016-07-16,2018-04-23, ,mcg,['/Month'],IV,Adverse Event
11017,4175,IVIG,2016-03-06,, ,mg,[' '], , 
11018,606,Rebif [22],2016-03-10,2018-06-10,300, ,['2 / Day'],IV,Persistence of relapses
11019,2090,Gilenya,2016-07-20,2020-11-12,5000, ,[' '], ,Lack of efficacy
11020,2090,Rebif [44],2016-10-11,, ,MIU,['2 / Day'], , 
11021,2090,Alemtuzumab (Campath),2016-02-19,, ,mg,['/Month'], , 
11022,2090,Rebif [22],2016-10-01,2021-06-02, ,mg,['/Month'],IV,Persistence of relapses
11023,3221,Gilenya,2016-09-15,,20,MIU,['/Month'], , 
11024,3221,Betaferon,2016-09-22,, , ,['2 / Day'], , 
11025,3221,Rebif [44],2015-12-12,,500, ,['/Month'], , 
11026,1846,Rebif [44],2016-01-02,,5000,mg,['/Month'], , 
11027,1846,Ledertrexaat,2016-03-11,2019-03-03,400,MIU,['/Month'], ,Persistence of relapses
11028,4431,IVIG,2016-04-07,2018-09-17,500, ,['/Month'],IV,Lack of efficacy
11029,4431,Rebif [44],2016-10-12,2018-08-18,300, ,['/Month'], ,Persisting MRI activity
11030,4431,Gilenya,2015-11-02,,20,mg,['/Month'],IV, 
11031,3284,Tysabri,2015-11-11,,5000, ,['/ Day'],IV, 
11032,3284,D-cure (Vitamine D),2015-12-15,2019-07-29, , ,[' '],IV,Persisting MRI activity
11033,3284,Gilenya,2016-07-11,,500,mg,['/ Week'],Oral, 
11034,3284,Copaxone,2015-10-27,2021-04-13,1, ,['/Month'],Oral,Persisting MRI activity
11035,1686,D-cure (Vitamine D),2016-04-04,,5000,mcg,['/Month'], , 
11036,1686,Avonex,2016-09-16,,1000,mg,['2 / Day'], , 
11037,1686,Ledertrexaat,2015-12-31,, ,mg,['/ Week'],IV, 
11038,991,Mitoxantrone,2016-07-11,2020-12-16,300,mcg,['2 / Day'],Oral,Persistence of relapses
11039,991,Endoxan,2015-11-20,2018-12-12, , ,['/Month'],IV,Patient Choice/Convenience
11040,1852,Tecfidera,2015-10-25,2021-05-25,500, ,['2 / Day'],IV,Adverse Event
11041,1852,Alemtuzumab (Campath),2016-04-21,2021-05-24,1,mg,['2 / Day'],Oral,Patient Choice/Convenience
11042,1852,Avonex,2016-02-10,2021-06-11,400,MIU,['3 / Week'], ,Lack of efficacy
11043,1852,Tecfidera,2016-06-16,2020-07-21, , ,['/Month'],Oral,Lack of efficacy
11044,1798,D-cure (Vitamine D),2016-01-11,2020-11-27,400, ,['3 / Week'],Oral,Patient Choice/Convenience
11045,1798,D-cure (Vitamine D),2016-07-04,2021-10-19, , ,['/Month'],IV,Persistence of relapses
11046,4558,Rebif [44],2016-09-14,,500,MIU,['2 / Day'],IV, 
11047,4558,IVIG,2016-07-11,,20, ,[' '], , 
11048,4558,Alemtuzumab (Campath),2016-04-02,2018-04-13, ,mg,['/ Day'],IV,Adverse Event
11049,4558,Rebif [22],2016-10-06,2020-10-15,20, ,['/Month'],IV,Adverse Event
11050,1313,Methylprednisolone,2016-04-08,,400, ,['2 / Day'],Oral, 
11051,1313,Gilenya,2015-12-26,2021-01-27, ,mg,['2 / Day'], ,Patient Choice/Convenience
11052,1313,Tecfidera,2016-09-23,2018-11-06,20, ,['/Month'],IV,Lack of efficacy
11053,1810,Endoxan,2016-07-02,, ,mg,['/Month'], , 
11054,1810,Tecfidera,2016-03-20,2019-08-27, , ,['/Month'],Oral,Patient Choice/Convenience
11055,1810,Gilenya,2016-05-30,,1000,mg,[' '], , 
11056,4240,Rebif [44],2016-06-28,, ,mg,['3 / Week'],IV, 
11057,3922,Rebif [22],2016-05-06,, , ,['/Month'], , 
11058,3922,Tecfidera,2016-09-22,,20,mcg,['2 / Day'], , 
11059,3922,Tecfidera,2016-07-08,, ,mg,['/ Week'],IV, 
11060,4865,D-cure (Vitamine D),2016-10-01,2018-03-27,5000,mg,['/ Day'],IV,Adverse Event
11061,1798,Tysabri,2016-08-29,2020-10-28, ,mcg,['/Month'],Oral,Patient Choice/Convenience
11062,1798,D-cure (Vitamine D),2016-08-08,2019-01-17, ,mcg,[' '],IV,Lack of efficacy
11063,1798,D-cure (Vitamine D),2015-11-08,2020-04-28,20, ,[' '],IV,Adverse Event
11064,1798,Methylprednisolone,2015-11-22,2018-05-08,5000,mcg,['/ Day'],IV,Persistence of relapses
11065,3379,Betaferon,2016-03-21,, , ,['/Month'],IV, 
11066,3379,Betaferon,2015-12-27,2020-07-20,500, ,['/Month'], ,Lack of efficacy
11067,4794,D-cure (Vitamine D),2016-02-03,2020-07-20,20,mg,['/ Day'], ,Patient Choice/Convenience
11068,286,Endoxan,2016-04-10,2018-10-17,5000,mg,[' '],IV,Persisting MRI activity
11069,286,Copaxone,2016-03-08,,1000, ,[' '],Oral, 
11070,286,Rebif [44],2016-08-12,,5000,MIU,['/ Day'], , 
11071,1846,D-cure (Vitamine D),2015-11-07,2018-09-18,500,MIU,['2 / Day'],IV,Adverse Event
11072,2005,Rebif [44],2015-12-09,, ,mg,['/Month'], , 
11073,2005,Methylprednisolone,2016-10-19,2021-07-16,300,mg,['/Month'],IV,Persistence of relapses
11074,2005,IVIG,2016-02-23,, ,mg,['3 / Week'], , 
11075,653,Gilenya,2016-08-01,2019-10-25,500, ,['2 / Day'],IV,Patient Choice/Convenience
11076,653,D-cure (Vitamine D),2016-06-21,2020-03-14,300,mg,['/ Day'],IV,Patient Choice/Convenience
11077,653,IVIG,2016-02-08,2019-09-15,20,mg,['/ Day'],IV,Patient Choice/Convenience
11078,653,Avonex,2016-06-14,2021-06-22, ,MIU,[' '],IV,Adverse Event
11079,2090,Rebif [44],2016-02-11,2020-10-02, , ,['2 / Day'], ,Adverse Event
11080,2090,D-cure (Vitamine D),2016-03-10,, , ,[' '],IV, 
11081,2090,Methylprednisolone,2015-11-30,,1000,MIU,['2 / Day'],IV, 
11082,2090,Ledertrexaat,2016-01-02,2019-11-02, , ,['2 / Day'],IV,Patient Choice/Convenience
11083,514,Ledertrexaat,2016-07-09,,500, ,['/ Week'],IV, 
11084,514,Endoxan,2015-12-20,2018-12-18,20,mg,['/Month'],IV,Adverse Event
11085,514,Copaxone,2016-07-29,,500, ,['2 / Day'], , 
11086,3829,Gilenya,2016-01-16,2019-03-27,400, ,['2 / Day'], ,Persisting MRI activity
11087,3829,Endoxan,2016-03-30,,300,mg,['2 / Day'],IV, 
11088,3829,Endoxan,2016-03-08,,300, ,['2 / Day'],IV, 
11089,3829,Tysabri,2016-07-04,2020-11-25,500,mcg,['/ Day'],IV,Lack of efficacy
11090,1939,Rebif [44],2016-03-12,,5000, ,['2 / Day'],IV, 
11091,1939,Rebif [22],2016-04-16,,400, ,['/ Day'],Oral, 
11092,1939,Avonex,2016-02-27,, , ,['2 / Day'], , 
11093,1939,Rebif [22],2016-04-16,2021-07-08,20, ,['3 / Week'],IV,Patient Choice/Convenience
11094,4601,Tecfidera,2016-08-07,, ,mg,['/Month'],IV, 
11095,4601,Avonex,2016-04-17,,5000, ,['3 / Week'],Oral, 
11096,886,Alemtuzumab (Campath),2016-04-27,,5000,mg,['/Month'],IV, 
11097,886,Methylprednisolone,2016-04-12,, ,mg,['/Month'], , 
11098,886,Avonex,2016-03-25,,500, ,['/ Week'], , 
11099,2952,Gilenya,2016-01-05,2020-03-16,20,mg,['2 / Day'], ,Persisting MRI activity
11100,2952,Rebif [22],2016-04-29,, ,mg,['/Month'],IV, 
11101,2952,IVIG,2016-05-19,2021-03-02, ,mg,['3 / Week'],Oral,Persisting MRI activity
11102,3309,Endoxan,2016-07-17,, ,mg,['2 / Day'], , 
11103,3309,Copaxone,2016-05-08,2017-11-28,500,mg,[' '],Oral,Adverse Event
11104,3309,Ledertrexaat,2015-12-08,2019-05-15, , ,['2 / Day'],Oral,Adverse Event
11105,1633,IVIG,2016-09-09,,5000,mg,['/Month'],Oral, 
11106,1931,Tecfidera,2016-08-28,2018-02-05, , ,['/Month'],IV,Lack of efficacy
11107,3117,Mitoxantrone,2016-08-04,,500,MIU,[' '], , 
11108,3715,Avonex,2015-11-20,2019-01-03, , ,['3 / Week'],IV,Lack of efficacy
11109,3715,Betaferon,2016-07-25,2018-04-20, , ,['2 / Day'],IV,Adverse Event
11110,3715,Tysabri,2016-08-12,, , ,['2 / Day'], , 
11111,1371,Endoxan,2016-06-04,2021-06-04,1, ,['2 / Day'],Oral,Patient Choice/Convenience
11112,1371,Endoxan,2016-03-20,, ,MIU,['/Month'],IV, 
11113,3672,Gilenya,2016-05-09,2018-08-28,500, ,['2 / Day'], ,Adverse Event
11114,3672,Tecfidera,2016-08-31,,20,mg,['/Month'],IV, 
11115,3672,IVIG,2016-02-15,,20, ,[' '],IV, 
11116,3672,Alemtuzumab (Campath),2016-05-03,,300, ,['/Month'],IV, 
11117,3424,Copaxone,2016-10-13,2020-02-23,400, ,['/ Day'], ,Adverse Event
11118,3424,Endoxan,2016-02-26,2021-05-18, , ,['2 / Day'],IV,Lack of efficacy
11119,3424,Tecfidera,2016-06-30,2019-08-22,500, ,['3 / Week'],IV,Persistence of relapses
11120,3424,Rebif [44],2016-10-13,,1000,mg,['/ Day'], , 
11121,4287,Avonex,2016-07-13,,1,mg,['/Month'],IV, 
11122,4287,Tecfidera,2015-12-22,,500,mg,['/ Week'], , 
11123,4287,Copaxone,2016-06-04,,20, ,['/ Week'],IV, 
11124,4287,Avonex,2016-09-13,2020-05-27,1, ,[' '],IV,Adverse Event
11125,1108,Methylprednisolone,2016-10-04,2021-03-20,20,mg,['/Month'],IV,Persisting MRI activity
11126,3483,Copaxone,2016-10-17,2019-05-19,5000, ,['/Month'], ,Patient Choice/Convenience
11127,3483,Tecfidera,2016-10-03,,300,mg,['2 / Day'],Oral, 
11128,3483,Alemtuzumab (Campath),2016-10-11,,1000,MIU,['2 / Day'], , 
11129,2458,Tecfidera,2016-08-07,2020-11-14,300,mg,[' '],IV,Adverse Event
11130,3588,Betaferon,2016-02-11,,300,mg,['/Month'],IV, 
11131,3588,Rebif [22],2016-07-28,,5000,MIU,['2 / Day'],Oral, 
11132,3588,Avonex,2015-12-03,,1, ,[' '],IV, 
11133,3588,Gilenya,2016-09-25,2019-03-29,400,mg,['/Month'], ,Lack of efficacy
11134,1226,Tecfidera,2016-03-05,2021-09-25,400, ,['/Month'],Oral,Persisting MRI activity
11135,2780,Rebif [22],2016-07-17,,20,mg,['3 / Week'],Oral, 
11136,2780,Teriflunomide,2016-01-11,,1,mg,[' '],IV, 
11137,2384,Methylprednisolone,2016-05-13,,500, ,['2 / Day'], , 
11138,3903,Tecfidera,2016-08-12,2020-08-16,500,mg,['/ Week'],IV,Persisting MRI activity
11139,3271,Rebif [22],2015-11-19,2020-01-10, ,mg,['/Month'],IV,Adverse Event
11140,3271,Methylprednisolone,2016-10-03,2018-10-16,1,mg,['/Month'],IV,Lack of efficacy
11141,4039,Avonex,2016-07-28,2018-01-31,300,mg,['2 / Day'],Oral,Patient Choice/Convenience
11142,4039,Rebif [44],2016-09-27,2020-04-01,1,mg,[' '], ,Persistence of relapses
11143,4039,Methylprednisolone,2016-09-09,, , ,['/Month'],IV, 
11144,4039,Alemtuzumab (Campath),2015-12-26,,500,mg,['/Month'], , 
11145,312,Rebif [44],2016-07-15,, , ,[' '],IV, 
11146,312,IVIG,2015-12-05,,1, ,['/Month'],IV, 
11147,312,IVIG,2016-02-07,2017-10-25,500,mg,['2 / Day'],IV,Adverse Event
11148,2536,D-cure (Vitamine D),2016-07-08,, ,mg,['/Month'], , 
11149,2536,IVIG,2016-10-12,2020-10-30,20, ,['2 / Day'],IV,Patient Choice/Convenience
11150,3038,Methylprednisolone,2016-08-27,,1000, ,['2 / Day'], , 
11151,4821,Copaxone,2015-11-28,, ,mg,[' '],Oral, 
11152,4874,IVIG,2016-08-11,,300, ,['/Month'],Oral, 
11153,4874,Rebif [22],2016-06-04,,20,mg,['3 / Week'],Oral, 
11154,1293,Avonex,2015-12-28,2017-11-04,400, ,['2 / Day'], ,Persisting MRI activity
11155,1293,Ledertrexaat,2016-09-17,,5000, ,['/ Day'], , 
11156,1632,Mitoxantrone,2015-11-20,,400, ,['2 / Day'],IV, 
11157,1632,Ledertrexaat,2016-09-03,,5000, ,['/ Day'],IV, 
11158,1632,IVIG,2015-11-11,2017-12-08, , ,[' '],IV,Persisting MRI activity
11159,1632,IVIG,2016-01-12,2019-10-14,400,mg,['3 / Week'],Oral,Adverse Event
11160,3724,Ledertrexaat,2016-07-26,,20, ,['2 / Day'],IV, 
11161,3724,Endoxan,2015-12-07,2018-02-26,500,mg,['/Month'],IV,Patient Choice/Convenience
11162,3724,Endoxan,2016-02-27,2020-07-10,400, ,['2 / Day'], ,Adverse Event
11163,2833,IVIG,2015-11-07,2018-12-04,20,mg,['/Month'], ,Persisting MRI activity
11164,2833,IVIG,2015-12-24,2018-03-25, , ,['/ Week'], ,Patient Choice/Convenience
11165,2833,Tecfidera,2016-10-17,, , ,['2 / Day'], , 
11166,2833,Rebif [44],2016-03-04,2018-02-08,300, ,['2 / Day'], ,Adverse Event
11167,3109,Mitoxantrone,2015-11-27,,1000,mg,['/Month'],Oral, 
11168,3109,IVIG,2016-03-09,2017-11-20,500, ,['/Month'],Oral,Persistence of relapses
11169,3109,D-cure (Vitamine D),2016-01-10,2018-01-07,500, ,['/Month'],IV,Persisting MRI activity
11170,3109,Rebif [44],2016-03-20,,20,mg,['/ Day'], , 
11171,1780,Methylprednisolone,2015-11-24,,1000,mg,['/Month'], , 
11172,3600,Endoxan,2016-01-04,2020-07-06,1,mg,['3 / Week'],IV,Lack of efficacy
11173,3600,Endoxan,2015-11-04,,1,mg,['2 / Day'], , 
11174,3331,D-cure (Vitamine D),2016-06-13,2020-07-24,20,mcg,['/Month'], ,Persisting MRI activity
11175,3331,Alemtuzumab (Campath),2015-11-18,,400,mg,['3 / Week'], , 
11176,263,Tysabri,2015-10-24,2020-04-28,5000,mg,['/Month'],IV,Lack of efficacy
11177,263,Methylprednisolone,2015-12-16,,400,mg,['/Month'],IV, 
11178,2396,D-cure (Vitamine D),2016-01-19,2018-04-30,300, ,['/ Day'],IV,Adverse Event
11179,2396,Teriflunomide,2016-04-30,2021-05-14,20, ,['2 / Day'],IV,Persistence of relapses
11180,2396,Teriflunomide,2016-07-07,,20,mcg,['2 / Day'],IV, 
11181,2565,Tysabri,2016-04-27,, ,mg,['2 / Day'],IV, 
11182,255,Tysabri,2015-10-27,, , ,['2 / Day'], , 
11183,1762,D-cure (Vitamine D),2016-01-19,2020-02-03, ,mg,['/Month'], ,Persistence of relapses
11184,1762,Tysabri,2015-12-28,2020-09-13,1000,MIU,['/ Day'],Oral,Persistence of relapses
11185,1762,Teriflunomide,2015-12-19,,300, ,['/ Week'], , 
11186,1762,IVIG,2016-01-14,, , ,['3 / Week'],IV, 
11187,4032,Gilenya,2016-02-16,, , ,[' '],Oral, 
11188,4032,Copaxone,2015-10-28,2019-12-29,20,mg,['2 / Day'],IV,Adverse Event
11189,4032,Endoxan,2016-10-16,,1000, ,[' '], , 
11190,4032,Rebif [44],2016-07-12,2021-02-23, ,MIU,['/Month'], ,Persistence of relapses
11191,3930,Rebif [44],2016-10-02,2021-02-02,500, ,['2 / Day'],Oral,Persisting MRI activity
11192,3930,Tysabri,2016-06-02,2019-12-13,300,mg,[' '],Oral,Persisting MRI activity
11193,3930,Rebif [22],2016-08-21,, ,mg,[' '], , 
11194,3881,IVIG,2016-09-14,, ,MIU,['2 / Day'],IV, 
11195,2596,Rebif [22],2016-01-01,2019-12-21, ,mg,['3 / Week'],IV,Adverse Event
11196,2596,D-cure (Vitamine D),2016-06-21,,500,mg,['3 / Week'],IV, 
11197,2596,D-cure (Vitamine D),2016-06-17,2021-05-24,400, ,['/Month'],IV,Lack of efficacy
11198,1966,Endoxan,2015-11-22,,20, ,['/ Week'],IV, 
11199,1966,Ledertrexaat,2016-03-09,, ,MIU,['3 / Week'], , 
11200,4366,Copaxone,2016-04-13,,500,mg,['/ Day'],IV, 
11201,880,D-cure (Vitamine D),2015-12-13,2018-03-05, ,mg,['/ Week'],IV,Persisting MRI activity
11202,880,Betaferon,2015-12-28,2019-01-31,5000,mg,['/ Day'],IV,Lack of efficacy
11203,4951,Betaferon,2016-05-27,, ,mg,['/Month'],IV, 
11204,4951,Rebif [22],2016-09-09,,300, ,['3 / Week'], , 
11205,4951,Gilenya,2015-11-10,, ,mcg,['/Month'], , 
11206,1855,Rebif [44],2016-10-21,, ,mg,['/ Day'], , 
11207,1855,Rebif [44],2016-05-15,,20,MIU,['/Month'], , 
11208,1180,Teriflunomide,2015-10-24,2020-11-16,500, ,['2 / Day'],IV,Lack of efficacy
11209,1180,Methylprednisolone,2016-03-30,2020-09-29,20, ,['2 / Day'],IV,Persistence of relapses
11210,2110,Teriflunomide,2016-01-24,2020-05-15,5000, ,['/ Week'], ,Adverse Event
11211,2110,D-cure (Vitamine D),2016-09-21,,300,mg,['/Month'],IV, 
11212,2110,Gilenya,2016-03-18,2019-04-08,1,mg,['2 / Day'],IV,Patient Choice/Convenience
11213,2110,Mitoxantrone,2016-01-27,2019-01-08,5000,mg,['/Month'], ,Persisting MRI activity
11214,4265,Avonex,2016-04-30,, ,mg,[' '], , 
11215,4265,Mitoxantrone,2015-12-04,2019-08-04,5000, ,['2 / Day'], ,Patient Choice/Convenience
11216,4265,Copaxone,2016-01-20,2018-08-13,1,mg,['2 / Day'],IV,Adverse Event
11217,4037,Gilenya,2015-12-01,2017-10-30, , ,['2 / Day'], ,Adverse Event
11218,4037,Methylprednisolone,2016-10-10,,300, ,['2 / Day'],IV, 
11219,4037,Tysabri,2016-10-15,,5000,mg,['2 / Day'],Oral, 
11220,2635,Tecfidera,2016-03-30,2018-09-07,1000,mg,['/Month'], ,Adverse Event
11221,2635,Tysabri,2015-11-20,, ,mg,['/ Day'],Oral, 
11222,3908,Avonex,2016-06-19,2018-01-10,300,mg,['2 / Day'],Oral,Persistence of relapses
11223,3908,Rebif [22],2015-12-24,,300,mg,['3 / Week'], , 
11224,3908,Betaferon,2015-12-28,2018-05-18,20,mcg,['/Month'], ,Adverse Event
11225,2975,IVIG,2016-01-04,, ,mg,['2 / Day'],IV, 
11226,4415,Rebif [22],2015-12-05,2021-07-11, ,mcg,['/Month'],IV,Patient Choice/Convenience
11227,4415,Rebif [44],2016-10-01,2021-04-29,1000,mg,['/Month'],IV,Patient Choice/Convenience
11228,4415,IVIG,2015-11-14,,500,mg,['/ Week'], , 
11229,4415,Tysabri,2015-12-04,2019-12-01,1000,mg,['2 / Day'], ,Adverse Event
11230,3866,Rebif [44],2016-09-05,, , ,['2 / Day'], , 
11231,3866,D-cure (Vitamine D),2016-05-02,,500,mg,['3 / Week'], , 
11232,3866,IVIG,2016-06-14,, ,mcg,['/Month'],IV, 
11233,3866,Rebif [22],2016-07-12,2018-03-08, , ,['2 / Day'],IV,Lack of efficacy
11234,3573,Methylprednisolone,2016-05-31,2019-02-10,500,mg,['/Month'],IV,Adverse Event
11235,3573,Avonex,2016-05-20,2019-08-30,5000, ,['3 / Week'],IV,Lack of efficacy
11236,3573,D-cure (Vitamine D),2016-05-21,2017-12-18,5000,mg,['3 / Week'], ,Lack of efficacy
11237,3573,Ledertrexaat,2016-10-07,2021-03-31,500, ,['/ Week'], ,Persisting MRI activity
11238,3304,Endoxan,2015-12-26,,5000, ,['/ Day'],IV, 
11239,3304,IVIG,2016-05-10,2019-01-15, ,mg,['/Month'], ,Lack of efficacy
11240,3304,Gilenya,2016-02-16,,300,mg,['2 / Day'], , 
11241,3304,Rebif [44],2015-12-01,2021-07-08, ,mg,['/ Day'],Oral,Adverse Event
11242,1203,Rebif [22],2016-05-03,, ,MIU,['2 / Day'],IV, 
11243,1203,Rebif [44],2016-04-20,2021-07-03, , ,['/ Day'],IV,Adverse Event
11244,2509,D-cure (Vitamine D),2016-04-10,2020-04-13, , ,['2 / Day'],IV,Adverse Event
11245,2509,Rebif [22],2016-03-10,, , ,['/Month'],IV, 
11246,2509,Copaxone,2016-04-05,2018-07-23,5000, ,['/Month'],IV,Lack of efficacy
11247,2509,Endoxan,2016-07-14,2019-08-23,1, ,['/Month'], ,Lack of efficacy
11248,2443,D-cure (Vitamine D),2015-12-24,2018-11-21,1000, ,['/ Day'],Oral,Patient Choice/Convenience
11249,2443,Copaxone,2016-06-18,,1000, ,['2 / Day'],IV, 
11250,1638,Alemtuzumab (Campath),2015-12-20,,500,MIU,['2 / Day'],IV, 
11251,1638,Rebif [44],2016-08-23,,1000,mg,['3 / Week'], , 
11252,1638,Methylprednisolone,2016-05-09,2017-12-31, , ,['2 / Day'],IV,Patient Choice/Convenience
11253,376,Alemtuzumab (Campath),2016-07-27,2019-09-24,400,mg,['2 / Day'], ,Patient Choice/Convenience
11254,376,Mitoxantrone,2015-10-31,,20, ,['2 / Day'],IV, 
11255,376,Copaxone,2016-07-15,2020-08-13,5000,MIU,['/Month'], ,Adverse Event
11256,376,IVIG,2016-08-04,2020-09-10,1000, ,['2 / Day'],Oral,Patient Choice/Convenience
11257,975,IVIG,2015-11-26,2020-07-08,20,mg,['/ Day'],IV,Persistence of relapses
11258,2445,Avonex,2016-08-20,,20, ,['/ Day'],Oral, 
11259,2445,Tysabri,2016-05-09,,300,MIU,['2 / Day'],Oral, 
11260,3424,Tysabri,2016-05-07,2019-03-30, ,mg,['2 / Day'], ,Patient Choice/Convenience
11261,3424,Endoxan,2016-06-20,2021-02-23, ,mcg,['3 / Week'],IV,Lack of efficacy
11262,3424,Gilenya,2016-01-30,,20,mg,['2 / Day'],IV, 
11263,1986,IVIG,2016-01-25,2019-09-17,1000,mg,['/ Week'],Oral,Adverse Event
11264,1986,D-cure (Vitamine D),2016-04-07,2020-07-17,400, ,['2 / Day'],IV,Persisting MRI activity
11265,1986,Rebif [44],2016-07-11,2020-08-28,1000,MIU,[' '],IV,Persistence of relapses
11266,1986,Copaxone,2016-01-10,,20,mg,['2 / Day'], , 
11267,1945,Endoxan,2016-09-29,,20,mg,['/Month'], , 
11268,2672,Tecfidera,2016-06-07,,1, ,['/Month'], , 
11269,2672,D-cure (Vitamine D),2016-07-22,, ,mg,['3 / Week'],IV, 
11270,3375,Tecfidera,2016-07-13,2019-07-11, ,mg,['2 / Day'], ,Patient Choice/Convenience
11271,3375,Betaferon,2016-07-26,2019-06-26,20,MIU,['/ Week'],IV,Patient Choice/Convenience
11272,2325,IVIG,2016-05-24,,500,mg,['2 / Day'], , 
11273,2325,Tecfidera,2016-03-29,2021-06-06,20,mg,['3 / Week'], ,Persistence of relapses
11274,2325,Methylprednisolone,2016-01-28,2018-01-06, , ,['2 / Day'],Oral,Patient Choice/Convenience
11275,2166,Alemtuzumab (Campath),2016-02-27,,1000,mcg,['/ Day'],IV, 
11276,2244,Gilenya,2016-03-24,,400,mg,['/Month'],IV, 
11277,2244,Tecfidera,2016-02-22,2021-06-25, , ,['2 / Day'], ,Patient Choice/Convenience
11278,2244,D-cure (Vitamine D),2016-08-30,,20,mg,['/ Day'], , 
11279,945,Rebif [22],2016-05-30,,1000,mcg,[' '],IV, 
11280,945,Rebif [44],2016-06-16,2018-10-31,400,MIU,['/ Week'],IV,Persisting MRI activity
11281,945,Ledertrexaat,2015-11-13,,20,mg,['3 / Week'],IV, 
11282,945,Methylprednisolone,2016-07-12,, , ,['/Month'],IV, 
11283,4000,Gilenya,2016-04-01,,1,mg,['/Month'],IV, 
11284,4000,IVIG,2016-02-11,2019-12-22,20,mg,[' '],IV,Patient Choice/Convenience
11285,3051,Ledertrexaat,2016-08-23,2018-07-21, , ,['/Month'], ,Adverse Event
11286,1314,Copaxone,2016-06-12,2021-07-30,20,mg,['/Month'],IV,Persistence of relapses
11287,1314,Avonex,2016-05-03,2017-11-24,1000, ,['/ Day'],IV,Persisting MRI activity
11288,3128,Rebif [22],2016-01-19,,300,mg,['3 / Week'],IV, 
11289,1795,Endoxan,2015-12-25,,300,mg,['3 / Week'], , 
11290,1795,Endoxan,2015-12-15,2021-03-18,1,mg,['3 / Week'], ,Adverse Event
11291,1795,Teriflunomide,2016-09-02,2021-10-21,300, ,['/Month'],IV,Adverse Event
11292,246,Rebif [22],2016-08-31,,20, ,['/Month'], , 
11293,4756,Endoxan,2016-03-01,2018-11-05,1000,mg,['/Month'], ,Lack of efficacy
11294,4756,Tecfidera,2016-08-04,2021-09-29, ,mg,['/Month'],IV,Patient Choice/Convenience
11295,4756,D-cure (Vitamine D),2016-01-23,2020-07-28,500,mg,[' '],IV,Adverse Event
11296,4756,Betaferon,2016-08-30,,20,mcg,['/Month'],IV, 
11297,4264,Tysabri,2016-07-28,,300,mg,['3 / Week'],Oral, 
11298,4264,Endoxan,2015-12-29,2020-04-10, ,mg,['/Month'],IV,Lack of efficacy
11299,4264,Avonex,2016-01-12,2019-11-14, , ,[' '], ,Adverse Event
11300,3210,Rebif [44],2016-09-18,,20, ,['/Month'], , 
11301,1344,Avonex,2015-11-20,2021-07-23,400, ,[' '],Oral,Persistence of relapses
11302,1344,IVIG,2016-04-21,,400, ,['/Month'],IV, 
11303,1344,Avonex,2016-07-02,2020-09-10, , ,['/Month'],IV,Persistence of relapses
11304,1344,Tysabri,2016-05-14,2021-04-27, ,mcg,['/Month'],Oral,Lack of efficacy
11305,2866,Avonex,2015-11-29,, ,mg,['2 / Day'],IV, 
11306,1179,D-cure (Vitamine D),2016-01-10,2019-06-12,20, ,['/Month'],IV,Patient Choice/Convenience
11307,1179,IVIG,2016-01-01,,20, ,['/Month'],IV, 
11308,1179,Tysabri,2016-10-10,2018-08-09, , ,['/Month'], ,Persistence of relapses
11309,1179,IVIG,2016-04-14,,500,mg,['/ Day'],IV, 
11310,1684,Endoxan,2016-07-24,, , ,['3 / Week'],IV, 
11311,1684,Methylprednisolone,2016-03-21,, , ,['2 / Day'],IV, 
11312,3578,Alemtuzumab (Campath),2016-04-19,, ,mg,['2 / Day'],Oral, 
11313,3578,Rebif [44],2016-04-05,,20,mg,['/ Day'], , 
11314,3578,Methylprednisolone,2016-05-21,, ,mcg,[' '],IV, 
11315,4764,Mitoxantrone,2016-07-02,2021-09-26,1000,MIU,['/Month'], ,Persistence of relapses
11316,4764,Mitoxantrone,2016-10-02,, , ,['/Month'],IV, 
11317,1702,Copaxone,2016-02-22,, , ,['2 / Day'], , 
11318,4198,Alemtuzumab (Campath),2016-05-01,, , ,[' '],IV, 
11319,4198,Gilenya,2016-07-09,, ,mg,['/Month'],IV, 
11320,1861,Rebif [22],2015-11-07,2020-11-21,1, ,['3 / Week'],IV,Patient Choice/Convenience
11321,4953,IVIG,2016-02-11,2018-04-13,1000,mg,['/Month'], ,Adverse Event
11322,4953,Betaferon,2016-07-03,, ,mg,['2 / Day'],IV, 
11323,4953,Ledertrexaat,2016-04-17,2019-12-19, , ,['/Month'],IV,Persistence of relapses
11324,4953,Ledertrexaat,2016-10-09,2020-12-12, ,mg,['2 / Day'],IV,Lack of efficacy
11325,2442,Ledertrexaat,2016-01-28,2020-09-16,300,mg,['/Month'],Oral,Adverse Event
11326,2442,Ledertrexaat,2016-05-19,,1,mg,['/ Day'], , 
11327,2442,Tysabri,2015-12-03,,1, ,['/ Day'], , 
11328,2426,IVIG,2016-04-22,2021-03-10,1, ,['3 / Week'],Oral,Persistence of relapses
11329,2426,Rebif [44],2016-07-18,2019-07-03, ,MIU,[' '],Oral,Adverse Event
11330,2426,Mitoxantrone,2016-02-07,2020-08-22, , ,['/Month'],IV,Lack of efficacy
11331,4478,Betaferon,2016-03-13,,500,MIU,['2 / Day'],IV, 
11332,4478,Betaferon,2016-01-01,,20,mg,['/Month'],IV, 
11333,4478,D-cure (Vitamine D),2016-08-18,, , ,['3 / Week'], , 
11334,1655,Copaxone,2016-03-24,, , ,[' '], , 
11335,1041,IVIG,2016-08-05,,400,mg,['/ Day'], , 
11336,1041,IVIG,2016-02-02,, ,mg,['/Month'],IV, 
11337,1674,Gilenya,2016-08-02,2018-07-06,20,mg,['/Month'],IV,Patient Choice/Convenience
11338,1674,Mitoxantrone,2015-12-28,,20,mg,['2 / Day'],Oral, 
11339,2630,Gilenya,2016-10-05,,5000, ,[' '],IV, 
11340,2630,IVIG,2016-01-02,, , ,['/ Day'], , 
11341,2630,Copaxone,2016-01-21,,1000, ,['/Month'],IV, 
11342,457,Gilenya,2016-10-07,,20, ,['/Month'],IV, 
11343,457,IVIG,2016-02-19,2021-02-05,1000,mg,['/ Week'],IV,Lack of efficacy
11344,457,Mitoxantrone,2015-11-23,,1000, ,['2 / Day'],Oral, 
11345,457,Teriflunomide,2016-09-02,2020-04-17,500,mg,['2 / Day'],IV,Patient Choice/Convenience
11346,3302,IVIG,2016-08-16,, , ,[' '],IV, 
11347,4038,Rebif [22],2016-10-20,,5000,mg,['2 / Day'], , 
11348,1871,Mitoxantrone,2016-07-17,,500,mcg,['2 / Day'],IV, 
11349,955,Tecfidera,2015-12-20,,500, ,['2 / Day'], , 
11350,839,Methylprednisolone,2016-03-15,,1, ,['2 / Day'],IV, 
11351,839,Tecfidera,2016-07-23,,20, ,['/Month'],IV, 
11352,839,Mitoxantrone,2016-10-11,2019-09-09, , ,['2 / Day'],IV,Persistence of relapses
11353,839,Endoxan,2016-03-26,2020-08-25,20,mg,['/Month'],IV,Adverse Event
11354,3321,Mitoxantrone,2016-04-10,, , ,['3 / Week'],IV, 
11355,3321,Gilenya,2016-02-12,2021-06-09,500,MIU,['/Month'], ,Patient Choice/Convenience
11356,3650,Alemtuzumab (Campath),2016-07-18,,300,mg,['/ Day'],IV, 
11357,3650,Tysabri,2015-10-26,, , ,[' '],IV, 
11358,3650,Tecfidera,2016-08-04,, ,MIU,['3 / Week'],Oral, 
11359,1381,Tecfidera,2015-12-01,2018-07-01, ,MIU,['/Month'],IV,Persisting MRI activity
11360,1381,Gilenya,2016-02-06,, , ,['/Month'],Oral, 
11361,1381,Tecfidera,2016-08-02,2018-08-08, ,MIU,['3 / Week'],IV,Persistence of relapses
11362,4862,IVIG,2016-04-09,2021-03-10,20,mcg,['/Month'],IV,Lack of efficacy
11363,4862,D-cure (Vitamine D),2016-08-12,,300,MIU,['/ Day'],IV, 
11364,3526,Methylprednisolone,2016-05-26,,20,mg,['3 / Week'],IV, 
11365,3526,Tecfidera,2016-05-31,, ,MIU,['/Month'], , 
11366,3526,Teriflunomide,2016-02-20,,1000, ,[' '], , 
11367,1824,Gilenya,2016-08-15,,1000, ,['/ Week'],IV, 
11368,1824,Alemtuzumab (Campath),2015-10-31,,1000,MIU,['/Month'], , 
11369,1824,Alemtuzumab (Campath),2016-02-10,, ,MIU,['2 / Day'], , 
11370,1986,D-cure (Vitamine D),2016-03-04,2018-12-10,300, ,['/ Day'],IV,Persisting MRI activity
11371,1986,Ledertrexaat,2016-10-21,, ,mg,['/ Day'], , 
11372,1986,Mitoxantrone,2016-07-12,,20,mg,[' '],IV, 
11373,3165,D-cure (Vitamine D),2016-04-08,,400,mg,[' '],IV, 
11374,3165,Tecfidera,2016-01-16,, ,MIU,['/Month'],IV, 
11375,3165,IVIG,2016-04-19,2021-07-30,500,mg,[' '],IV,Lack of efficacy
11376,4830,Tysabri,2015-11-06,2021-07-11,500,mg,['2 / Day'], ,Adverse Event
11377,2047,Tysabri,2016-05-19,,500, ,['3 / Week'], , 
11378,2047,Rebif [44],2016-02-10,,300,mg,['3 / Week'],IV, 
11379,2047,Avonex,2016-01-24,2020-04-15,1,mg,['3 / Week'], ,Lack of efficacy
11380,2047,Endoxan,2016-09-22,2021-08-10,5000,mg,[' '],IV,Adverse Event
11381,437,Copaxone,2016-03-22,2019-09-09,20,mg,['/Month'], ,Patient Choice/Convenience
11382,437,IVIG,2016-05-07,, ,mg,[' '],IV, 
11383,437,Methylprednisolone,2016-05-28,, ,MIU,['3 / Week'], , 
11384,437,Avonex,2015-10-30,,300,mg,['/ Day'],Oral, 
11385,4750,Tysabri,2016-09-20,, ,MIU,[' '],IV, 
11386,4750,Rebif [22],2016-06-10,,20, ,['3 / Week'],IV, 
11387,4750,Mitoxantrone,2015-12-10,,500, ,['/ Week'], , 
11388,4750,Tysabri,2016-06-18,, ,MIU,['/Month'],IV, 
11389,4773,Endoxan,2016-01-02,,1, ,['/Month'],IV, 
11390,4773,Avonex,2016-08-29,, ,mg,['/Month'],Oral, 
11391,4773,Tecfidera,2016-04-26,2019-04-05,1, ,['/ Day'], ,Persistence of relapses
11392,1765,Endoxan,2016-02-09,2018-02-13, ,mg,['2 / Day'], ,Persistence of relapses
11393,1765,Gilenya,2015-12-02,, , ,[' '], , 
11394,674,Rebif [22],2016-07-26,, , ,['/Month'],IV, 
11395,674,D-cure (Vitamine D),2015-11-08,2019-11-02,20,MIU,['/Month'],IV,Persisting MRI activity
11396,674,Gilenya,2016-06-21,,20, ,['2 / Day'], , 
11397,674,D-cure (Vitamine D),2016-01-04,2020-11-13, , ,['3 / Week'],IV,Patient Choice/Convenience
11398,4862,IVIG,2016-07-12,2020-06-26,500,mg,['2 / Day'],IV,Persisting MRI activity
11399,4862,Rebif [22],2016-03-14,2018-06-02,1, ,['/ Day'],IV,Persisting MRI activity
11400,4862,Rebif [44],2015-11-23,2019-12-17,1,mg,['2 / Day'],IV,Adverse Event
11401,4862,D-cure (Vitamine D),2016-08-31,,300, ,['/Month'], , 
11402,4718,Methylprednisolone,2016-04-08,2021-08-18,300, ,['/Month'],Oral,Lack of efficacy
11403,1855,D-cure (Vitamine D),2016-09-19,,500,mg,[' '], , 
11404,562,Rebif [44],2015-12-16,,1000, ,['2 / Day'], , 
11405,562,Rebif [44],2016-09-06,2017-11-19,500,mg,['/Month'],Oral,Persisting MRI activity
11406,3600,Gilenya,2016-03-25,2020-05-06,5000,mg,['2 / Day'], ,Persisting MRI activity
11407,3600,Avonex,2016-03-21,,5000, ,['/Month'],IV, 
11408,3600,IVIG,2016-08-18,,400, ,['/Month'], , 
11409,1238,IVIG,2016-08-15,,1000,mg,['/ Day'],IV, 
11410,1238,Gilenya,2016-04-25,, ,mg,['3 / Week'],IV, 
11411,1238,Gilenya,2015-11-02,2019-08-04, ,mg,['/ Day'], ,Persisting MRI activity
11412,1447,D-cure (Vitamine D),2016-08-18,,20, ,['/Month'],IV, 
11413,1447,D-cure (Vitamine D),2015-10-29,2021-06-19,20,mg,['2 / Day'], ,Lack of efficacy
11414,1447,Endoxan,2016-10-03,, ,mg,['2 / Day'], , 
11415,562,Mitoxantrone,2016-09-02,2019-09-21,1,mg,['/Month'], ,Persisting MRI activity
11416,562,Methylprednisolone,2016-04-19,2017-12-03,1000,mg,[' '],IV,Persisting MRI activity
11417,1473,Copaxone,2015-11-21,2021-03-10,1000,mg,['2 / Day'],Oral,Patient Choice/Convenience
11418,1473,Betaferon,2016-06-30,,500,mg,['/Month'],IV, 
11419,1473,Copaxone,2016-03-31,,300,mg,[' '],IV, 
11420,1473,Alemtuzumab (Campath),2016-07-30,2019-03-26,400,mg,['2 / Day'],IV,Adverse Event
11421,2147,IVIG,2016-02-02,,20,mcg,[' '],IV, 
11422,2147,D-cure (Vitamine D),2016-10-21,2021-01-23,300,MIU,['/Month'],Oral,Adverse Event
11423,2147,Avonex,2016-03-02,,300, ,['/ Week'],IV, 
11424,1748,IVIG,2015-12-29,2021-04-28, ,mg,[' '],Oral,Lack of efficacy
11425,1748,Methylprednisolone,2016-02-14,,5000, ,['2 / Day'], , 
11426,1748,Copaxone,2015-12-06,,5000,mg,[' '],IV, 
11427,1748,Endoxan,2016-05-20,2019-07-27,20,MIU,['/ Week'], ,Adverse Event
11428,3691,Methylprednisolone,2016-09-01,, ,mcg,[' '],IV, 
11429,3691,D-cure (Vitamine D),2016-07-04,2018-03-02, ,mg,['/Month'], ,Persistence of relapses
11430,174,IVIG,2016-08-16,, ,mg,['3 / Week'],IV, 
11431,174,Copaxone,2016-10-17,,1,mg,['2 / Day'], , 
11432,174,Ledertrexaat,2016-05-17,2019-02-12, , ,['/ Week'], ,Persisting MRI activity
11433,2335,Betaferon,2016-10-08,2017-12-09,1, ,['/ Week'],IV,Persistence of relapses
11434,2335,Gilenya,2016-03-02,,20, ,['2 / Day'], , 
11435,3053,Endoxan,2016-04-28,,20, ,['/Month'], , 
11436,3053,Tysabri,2015-11-21,,500, ,['/ Week'],Oral, 
11437,3053,Avonex,2016-07-16,,5000, ,['2 / Day'],IV, 
11438,3053,Copaxone,2015-11-01,, , ,['2 / Day'], , 
11439,3331,D-cure (Vitamine D),2016-09-01,2017-12-02, ,MIU,['/Month'], ,Patient Choice/Convenience
11440,3331,Endoxan,2016-08-06,2020-07-23,1000, ,['/Month'],IV,Persistence of relapses
11441,3331,D-cure (Vitamine D),2016-01-21,2020-03-26, ,mcg,['2 / Day'],IV,Persisting MRI activity
11442,3331,Teriflunomide,2016-03-16,,5000,mg,['/Month'],Oral, 
11443,1753,Ledertrexaat,2015-12-18,2018-04-16,400, ,[' '], ,Adverse Event
11444,4799,Tysabri,2016-03-10,,1,mg,['/Month'],IV, 
11445,4497,Rebif [44],2015-10-27,2019-06-26,400,mg,['2 / Day'], ,Patient Choice/Convenience
11446,4497,Endoxan,2016-07-23,2019-10-20,500, ,['/Month'],IV,Adverse Event
11447,4497,Tecfidera,2016-03-17,, , ,['2 / Day'],IV, 
11448,4497,Rebif [44],2016-03-31,2019-06-08,300,mg,['2 / Day'],IV,Adverse Event
11449,2375,Gilenya,2016-04-29,,1000,MIU,[' '],IV, 
11450,3695,Copaxone,2016-05-02,,1000,mg,['/ Day'],IV, 
11451,3695,Tysabri,2016-04-18,2019-01-05,5000,mg,[' '],IV,Persisting MRI activity
11452,3695,Tecfidera,2015-11-24,,20,MIU,['3 / Week'],Oral, 
11453,2515,Tecfidera,2016-01-07,, ,MIU,['3 / Week'],Oral, 
11454,2186,Rebif [44],2016-07-08,2019-11-27,300,MIU,['2 / Day'],IV,Persisting MRI activity
11455,2186,Endoxan,2016-02-12,,500, ,['2 / Day'],IV, 
11456,2673,Rebif [44],2016-09-29,2019-07-12,20,mg,['/Month'], ,Adverse Event
11457,2673,Ledertrexaat,2016-08-31,,20, ,['/Month'],IV, 
11458,2673,Rebif [22],2016-01-02,2018-11-15,20,mg,['/ Day'],IV,Adverse Event
11459,1159,IVIG,2016-04-17,,1000, ,['2 / Day'],IV, 
11460,1159,Copaxone,2016-01-21,2020-08-27,500,mg,['3 / Week'],IV,Persisting MRI activity
11461,356,Mitoxantrone,2015-10-31,2018-08-03,20,mg,[' '],Oral,Patient Choice/Convenience
11462,356,Methylprednisolone,2016-06-12,, ,mg,['2 / Day'],IV, 
11463,356,Rebif [22],2016-03-10,, , ,['/ Day'],Oral, 
11464,3096,IVIG,2016-07-23,,1, ,['2 / Day'],IV, 
11465,3096,Alemtuzumab (Campath),2016-03-17,2017-12-20,1000,mg,['3 / Week'], ,Patient Choice/Convenience
11466,1609,D-cure (Vitamine D),2016-01-02,,20,mcg,['/Month'], , 
11467,1540,Methylprednisolone,2016-02-05,2019-11-03,1,mcg,['/Month'],IV,Adverse Event
11468,1540,Ledertrexaat,2016-08-21,, , ,['/Month'],IV, 
11469,1540,Copaxone,2016-10-02,2018-05-25,400,mcg,['2 / Day'], ,Patient Choice/Convenience
11470,1540,D-cure (Vitamine D),2016-01-10,, ,MIU,[' '],IV, 
11471,4681,Alemtuzumab (Campath),2016-06-06,2020-09-08, , ,[' '],IV,Adverse Event
11472,4681,IVIG,2016-09-04,, ,mg,['/ Day'], , 
11473,4681,Copaxone,2016-09-01,2021-02-01, ,mg,['/Month'],Oral,Adverse Event
11474,915,Ledertrexaat,2016-02-07,2020-06-24,1000,mg,['/ Day'], ,Adverse Event
11475,915,Avonex,2016-01-11,2021-02-08,1,MIU,['/Month'], ,Adverse Event
11476,2004,Gilenya,2016-08-17,2019-05-24,300,mg,[' '],IV,Persistence of relapses
11477,2004,Ledertrexaat,2016-06-14,, ,mg,['2 / Day'],IV, 
11478,2004,IVIG,2016-09-20,2020-09-29,400,mg,['2 / Day'], ,Lack of efficacy
11479,2004,D-cure (Vitamine D),2015-11-14,,300,mcg,['/ Day'], , 
11480,1077,Gilenya,2016-09-13,2019-07-31, , ,['2 / Day'],IV,Persisting MRI activity
11481,1077,Copaxone,2016-03-01,, , ,['2 / Day'], , 
11482,2859,D-cure (Vitamine D),2016-10-01,2021-05-19, , ,['/ Day'], ,Persisting MRI activity
11483,2859,Copaxone,2016-05-23,2019-06-26,5000, ,['/Month'],Oral,Adverse Event
11484,2859,Gilenya,2016-10-16,2019-07-28, , ,['/Month'],IV,Persisting MRI activity
11485,3361,Rebif [22],2016-03-19,,500, ,['/Month'],IV, 
11486,3361,Tecfidera,2015-12-11,,500, ,['2 / Day'], , 
11487,3361,Teriflunomide,2016-07-30,, ,mg,['/Month'],IV, 
11488,3361,Endoxan,2016-05-15,,400, ,['/ Week'],IV, 
11489,1238,Copaxone,2015-12-12,,400, ,['2 / Day'],IV, 
11490,1238,D-cure (Vitamine D),2016-07-15,2021-09-19, , ,['3 / Week'],IV,Patient Choice/Convenience
11491,4798,Teriflunomide,2016-04-28,,1, ,['3 / Week'],IV, 
11492,4798,D-cure (Vitamine D),2016-08-05,,300,mg,['3 / Week'],IV, 
11493,4798,Endoxan,2016-02-03,,500,mg,['3 / Week'], , 
11494,1293,Betaferon,2016-05-23,2018-06-13, ,MIU,['/ Day'], ,Adverse Event
11495,1034,D-cure (Vitamine D),2016-05-11,, , ,[' '],IV, 
11496,2591,Tysabri,2016-05-03,2020-08-04, ,mg,['3 / Week'],Oral,Lack of efficacy
11497,2591,Rebif [44],2016-02-19,,5000, ,['/ Day'], , 
11498,2591,Mitoxantrone,2016-07-15,,300,MIU,['2 / Day'], , 
11499,1616,Ledertrexaat,2015-10-25,, , ,['/Month'],IV, 
11500,1616,Endoxan,2016-08-09,2020-03-19, ,mg,['2 / Day'],IV,Adverse Event
11501,1616,Teriflunomide,2015-11-14,2018-06-22,300, ,['/Month'], ,Persisting MRI activity
11502,1616,Rebif [44],2016-10-07,,500,mcg,['/ Day'], , 
11503,517,Gilenya,2016-01-06,,20, ,[' '],IV, 
11504,517,Methylprednisolone,2016-10-06,,20, ,['2 / Day'],IV, 
11505,4892,D-cure (Vitamine D),2015-12-07,2021-03-18, ,MIU,['2 / Day'], ,Lack of efficacy
11506,4892,Rebif [44],2016-01-17,2021-05-25,300,mg,['/Month'],IV,Persisting MRI activity
11507,4892,Rebif [44],2016-05-21,2019-10-28, ,mg,['2 / Day'], ,Adverse Event
11508,4680,Gilenya,2015-12-11,, ,mcg,['2 / Day'],IV, 
11509,4680,Alemtuzumab (Campath),2015-12-12,,500, ,[' '], , 
11510,4680,D-cure (Vitamine D),2015-12-18,, ,MIU,['/ Week'],Oral, 
11511,4680,Endoxan,2016-05-13,2020-03-26,5000,mg,['3 / Week'], ,Patient Choice/Convenience
11512,3309,Copaxone,2016-10-21,2021-05-22,1, ,['/ Day'],IV,Adverse Event
11513,1230,Ledertrexaat,2016-05-30,,500, ,['/Month'],IV, 
11514,1230,IVIG,2016-02-07,,5000,mg,['3 / Week'],IV, 
11515,1230,Tysabri,2015-12-31,2019-07-12,20, ,['2 / Day'],Oral,Adverse Event
11516,1662,D-cure (Vitamine D),2016-02-23,2019-02-20, ,MIU,['/Month'],IV,Lack of efficacy
11517,1662,IVIG,2016-07-08,2020-09-25,300, ,['/Month'], ,Adverse Event
11518,1662,Methylprednisolone,2015-11-06,, , ,['/Month'], , 
11519,3734,Betaferon,2016-06-25,,1000, ,['/Month'],IV, 
11520,539,Tysabri,2016-07-11,2017-12-27,1000,mg,['/Month'],IV,Patient Choice/Convenience
11521,539,D-cure (Vitamine D),2015-11-23,,5000,mg,['/Month'],Oral, 
11522,539,D-cure (Vitamine D),2016-04-22,, , ,['3 / Week'],IV, 
11523,539,D-cure (Vitamine D),2016-04-03,,400,mg,['/Month'], , 
11524,3490,Alemtuzumab (Campath),2016-08-06,,1, ,['/Month'],IV, 
11525,3081,D-cure (Vitamine D),2015-12-05,, ,mcg,['2 / Day'], , 
11526,3081,Rebif [44],2016-08-15,,1,mg,['3 / Week'], , 
11527,3081,Alemtuzumab (Campath),2016-05-30,2021-05-31,20, ,['2 / Day'], ,Lack of efficacy
11528,236,IVIG,2016-10-03,2020-08-27,500, ,[' '],IV,Persisting MRI activity
11529,236,Mitoxantrone,2015-11-29,, , ,['/ Day'], , 
11530,236,Alemtuzumab (Campath),2016-04-15,,1000, ,[' '], , 
11531,2550,Rebif [44],2016-09-08,, ,mg,['2 / Day'],IV, 
11532,2550,Tysabri,2016-01-12,2017-10-29,1000, ,['/Month'], ,Patient Choice/Convenience
11533,2550,Avonex,2015-11-06,2019-06-14,5000, ,['3 / Week'],IV,Patient Choice/Convenience
11534,1985,IVIG,2016-04-10,,300,mg,['/Month'],IV, 
11535,1985,Tysabri,2015-10-29,,20,mg,[' '],IV, 
11536,1985,Gilenya,2016-01-22,, , ,[' '],IV, 
11537,121,Gilenya,2016-10-10,2020-06-21,20, ,['3 / Week'],IV,Lack of efficacy
11538,3762,Tysabri,2016-05-10,,20,MIU,['2 / Day'], , 
11539,3762,IVIG,2015-11-07,, ,mg,[' '],IV, 
11540,3762,Rebif [22],2015-11-03,,20,MIU,['/Month'], , 
11541,1473,Gilenya,2016-09-19,, , ,['3 / Week'],Oral, 
11542,1473,Mitoxantrone,2015-12-02,, , ,['/Month'], , 
11543,224,Avonex,2016-05-31,2018-04-14,1000,MIU,['2 / Day'], ,Adverse Event
11544,224,Tysabri,2015-11-08,,500,mg,['/Month'],IV, 
11545,224,Methylprednisolone,2016-07-10,2017-11-15,20,mg,['/Month'], ,Lack of efficacy
11546,224,Rebif [44],2016-06-21,2018-12-02,400, ,['2 / Day'],IV,Adverse Event
11547,209,Teriflunomide,2016-09-20,2018-05-18,1000,mg,['2 / Day'],IV,Adverse Event
11548,209,Alemtuzumab (Campath),2016-09-14,,1,MIU,['/ Day'],IV, 
11549,209,D-cure (Vitamine D),2016-08-25,, ,MIU,['/ Day'],IV, 
11550,209,Alemtuzumab (Campath),2016-05-23,,5000, ,['/ Week'],IV, 
11551,3173,Copaxone,2015-11-18,,1,mg,[' '],IV, 
11552,3173,D-cure (Vitamine D),2015-11-29,2021-10-06,1000, ,['2 / Day'],IV,Adverse Event
11553,539,Gilenya,2016-04-07,,300, ,['/ Week'], , 
11554,539,Alemtuzumab (Campath),2016-03-14,,500,mcg,['2 / Day'],IV, 
11555,539,IVIG,2016-08-23,2021-04-25,1000, ,['/Month'], ,Patient Choice/Convenience
11556,539,Alemtuzumab (Campath),2016-10-05,2020-02-12, , ,['/Month'],IV,Patient Choice/Convenience
11557,4134,Rebif [22],2016-03-23,2018-10-27, , ,['/ Day'],IV,Adverse Event
11558,4134,Gilenya,2016-03-21,2021-05-04, ,mg,['2 / Day'], ,Patient Choice/Convenience
11559,4134,Mitoxantrone,2016-05-13,2018-06-10,1000,MIU,['2 / Day'], ,Persisting MRI activity
11560,4134,Mitoxantrone,2016-03-03,, ,mcg,['/Month'],Oral, 
11561,146,Copaxone,2016-05-31,,1000,MIU,['2 / Day'],IV, 
11562,146,Tysabri,2016-05-16,2019-05-31,5000,mg,['/Month'],Oral,Patient Choice/Convenience
11563,146,Methylprednisolone,2016-08-29,, ,mg,['/Month'], , 
11564,1512,Rebif [44],2015-12-15,2020-01-14,20, ,['/Month'], ,Persisting MRI activity
11565,3337,Copaxone,2016-10-08,,300,mg,['/Month'],IV, 
11566,3312,Methylprednisolone,2016-08-18,2019-10-16,500, ,['2 / Day'],IV,Adverse Event
11567,3312,Gilenya,2016-06-14,2018-04-19, ,mg,['/Month'],Oral,Adverse Event
11568,3312,Avonex,2015-12-20,,1,mg,['2 / Day'],IV, 
11569,3312,Rebif [22],2015-11-17,2020-04-19, ,mg,['2 / Day'],IV,Patient Choice/Convenience
11570,502,Alemtuzumab (Campath),2016-01-19,2018-08-02,300, ,['3 / Week'],Oral,Lack of efficacy
11571,502,Rebif [44],2016-10-02,2021-02-02,5000, ,['/Month'],IV,Adverse Event
11572,502,IVIG,2016-10-05,2021-08-16,500,mg,['/ Day'],IV,Persistence of relapses
11573,502,Alemtuzumab (Campath),2015-11-21,2018-02-16,20,mg,['2 / Day'], ,Persisting MRI activity
11574,3919,Methylprednisolone,2016-05-19,,400, ,['/ Week'], , 
11575,2053,Rebif [44],2016-03-28,2020-06-19,1000, ,['3 / Week'],IV,Persistence of relapses
11576,2929,Ledertrexaat,2016-03-16,,1000,MIU,['2 / Day'], , 
11577,2929,Methylprednisolone,2016-03-05,2020-04-02,20,mg,['2 / Day'],Oral,Lack of efficacy
11578,2929,Tecfidera,2016-07-16,2020-09-18, ,mg,['2 / Day'],IV,Adverse Event
11579,2929,Copaxone,2015-11-30,2020-09-08, , ,['3 / Week'],IV,Patient Choice/Convenience
11580,4421,Tysabri,2016-08-08,, ,mg,['2 / Day'], , 
11581,4421,D-cure (Vitamine D),2016-07-03,2019-04-17, ,mg,['/Month'], ,Adverse Event
11582,4421,Copaxone,2016-08-20,2019-03-25, ,mg,['3 / Week'],IV,Persisting MRI activity
11583,4421,Rebif [22],2016-02-28,,300,MIU,['3 / Week'],Oral, 
11584,4747,Rebif [22],2016-05-02,,500, ,['/ Week'], , 
11585,4747,Betaferon,2016-01-21,2018-05-02,20,mg,['3 / Week'],IV,Persistence of relapses
11586,4698,Teriflunomide,2016-04-04,2020-05-27,500,mg,['2 / Day'],IV,Patient Choice/Convenience
11587,4698,Avonex,2015-12-28,, , ,['3 / Week'],IV, 
11588,1376,Teriflunomide,2016-10-18,, ,MIU,['/ Week'], , 
11589,3282,Methylprednisolone,2016-03-29,,300, ,['2 / Day'],Oral, 
11590,3282,Avonex,2016-07-22,2020-03-10,1, ,['2 / Day'],IV,Adverse Event
11591,3282,Tecfidera,2015-11-08,,500,mg,['/ Day'], , 
11592,3971,Methylprednisolone,2016-10-06,,1000, ,['2 / Day'],IV, 
11593,3971,Gilenya,2016-08-14,2019-01-14, ,mg,[' '],IV,Patient Choice/Convenience
11594,3971,Teriflunomide,2015-10-28,,20,MIU,['2 / Day'],IV, 
11595,3971,Ledertrexaat,2016-01-11,,1000,mg,['/Month'], , 
11596,1064,IVIG,2016-07-28,,20,mg,['/ Day'],IV, 
11597,1064,Copaxone,2016-06-18,2018-02-01,500,mg,['/ Day'], ,Patient Choice/Convenience
11598,1064,Avonex,2015-10-27,,500, ,['2 / Day'],IV, 
11599,1064,Alemtuzumab (Campath),2016-05-10,2020-10-30, , ,['2 / Day'],IV,Adverse Event
11600,3998,Tecfidera,2016-09-01,2019-05-10, , ,['2 / Day'], ,Adverse Event
11601,3998,Rebif [22],2016-03-21,,1, ,['2 / Day'], , 
11602,3998,D-cure (Vitamine D),2016-04-10,,1000,mg,['/Month'], , 
11603,3998,Alemtuzumab (Campath),2016-05-21,,20,mg,['2 / Day'], , 
11604,269,Copaxone,2016-07-21,2017-11-23,300,mg,['/Month'], ,Lack of efficacy
11605,269,D-cure (Vitamine D),2016-05-11,2021-07-01,500,mcg,['/ Week'], ,Persistence of relapses
11606,269,D-cure (Vitamine D),2016-08-04,,500, ,['2 / Day'],IV, 
11607,269,Ledertrexaat,2015-12-04,2019-01-13,5000, ,['/ Day'],IV,Adverse Event
11608,4423,D-cure (Vitamine D),2016-03-30,2019-11-22,20, ,[' '],IV,Persistence of relapses
11609,4423,Tecfidera,2016-03-05,,1000,mg,['/Month'],IV, 
11610,4423,Tecfidera,2016-04-26,2020-12-19,1,MIU,[' '],IV,Adverse Event
11611,2356,Rebif [44],2016-03-20,, ,MIU,['3 / Week'],IV, 
11612,2356,D-cure (Vitamine D),2016-05-24,, , ,[' '],Oral, 
11613,2356,Copaxone,2016-03-30,,500,mcg,['/ Week'],Oral, 
11614,2356,Gilenya,2016-07-21,, ,mg,['2 / Day'],Oral, 
11615,1091,Tecfidera,2015-11-22,,5000, ,['3 / Week'], , 
11616,1091,Ledertrexaat,2016-09-04,,1000,mg,['/Month'], , 
11617,653,Tysabri,2016-03-31,, , ,['2 / Day'],IV, 
11618,653,IVIG,2016-06-17,2020-12-06, , ,['3 / Week'], ,Persistence of relapses
11619,653,Methylprednisolone,2016-07-22,,5000,mcg,[' '],IV, 
11620,653,Alemtuzumab (Campath),2016-09-11,, , ,['3 / Week'], , 
11621,913,Tecfidera,2016-07-13,,300,mcg,['2 / Day'],IV, 
11622,913,Gilenya,2016-01-15,,1000,mg,['/Month'],IV, 
11623,913,Copaxone,2016-08-15,2021-07-06,1000, ,['/Month'],IV,Persistence of relapses
11624,3051,Copaxone,2016-02-05,,500,mg,['/Month'],IV, 
11625,3051,Tecfidera,2016-04-22,2017-11-20,300, ,['/ Day'], ,Patient Choice/Convenience
11626,2714,Methylprednisolone,2016-09-17,2020-01-21,500,MIU,['2 / Day'],IV,Adverse Event
11627,2714,Rebif [44],2016-04-23,2018-01-06, , ,['/ Week'], ,Lack of efficacy
11628,2714,Rebif [22],2016-08-15,,1000,mcg,['2 / Day'],IV, 
11629,1446,Endoxan,2015-10-25,2020-05-12,300,mg,[' '],IV,Lack of efficacy
11630,1936,D-cure (Vitamine D),2016-08-23,,20, ,[' '],IV, 
11631,1936,D-cure (Vitamine D),2016-09-14,,400, ,['2 / Day'], , 
11632,1936,Betaferon,2016-02-12,2021-01-20,300, ,['3 / Week'], ,Lack of efficacy
11633,2298,Rebif [44],2016-02-04,,5000,mcg,[' '], , 
11634,2298,Gilenya,2016-10-22,,1, ,['/Month'], , 
11635,2298,Tysabri,2016-04-15,,1000, ,['3 / Week'],IV, 
11636,3926,Tecfidera,2016-01-07,,20,mg,['/Month'],IV, 
11637,256,Gilenya,2016-06-13,,20, ,['3 / Week'],IV, 
11638,256,IVIG,2016-04-23,2019-10-11,500,mg,[' '],IV,Patient Choice/Convenience
11639,256,Betaferon,2016-05-01,,20,mg,['/Month'],Oral, 
11640,256,Endoxan,2016-01-02,,1000, ,['2 / Day'], , 
11641,3652,Tecfidera,2015-11-08,2017-11-19,500,mg,['/ Day'],Oral,Patient Choice/Convenience
11642,3652,Avonex,2015-10-30,2019-02-05,20,mg,['/Month'], ,Persistence of relapses
11643,3652,Tecfidera,2016-02-23,,300, ,['2 / Day'], , 
11644,3045,Gilenya,2016-05-19,2020-04-03,1000,mg,['/Month'],IV,Adverse Event
11645,4219,Copaxone,2016-04-05,2021-05-13,1000, ,['/Month'], ,Patient Choice/Convenience
11646,3368,D-cure (Vitamine D),2016-07-04,,300,MIU,['3 / Week'], , 
11647,3368,D-cure (Vitamine D),2016-02-23,,500, ,[' '], , 
11648,3368,IVIG,2016-01-09,,500, ,['3 / Week'], , 
11649,3368,Tysabri,2015-11-16,, ,MIU,['/Month'], , 
11650,4003,Rebif [44],2016-01-04,2018-02-17, ,mg,['2 / Day'],IV,Patient Choice/Convenience
11651,2141,Teriflunomide,2015-12-20,,400, ,['2 / Day'],IV, 
11652,3506,Teriflunomide,2016-04-27,,1000,mcg,['/ Week'],IV, 
11653,4393,Tecfidera,2016-01-29,, , ,['2 / Day'], , 
11654,4393,IVIG,2015-12-16,,5000,mg,[' '], , 
11655,4393,D-cure (Vitamine D),2016-03-16,, , ,['/ Day'],IV, 
11656,186,IVIG,2016-03-15,,5000, ,['/Month'],Oral, 
11657,186,Alemtuzumab (Campath),2016-06-01,,20, ,[' '],IV, 
11658,4736,Rebif [22],2016-05-16,, ,mg,['/Month'], , 
11659,4736,Mitoxantrone,2016-02-09,,300,mg,['/Month'],IV, 
11660,4736,Ledertrexaat,2016-09-06,,500,mg,[' '],IV, 
11661,4736,Gilenya,2015-11-18,,300,mg,['/Month'],IV, 
11662,1785,Gilenya,2016-04-11,2020-10-28,300, ,['2 / Day'],IV,Lack of efficacy
11663,2446,Ledertrexaat,2016-08-02,2020-08-31,1000,mg,['/Month'], ,Persistence of relapses
11664,2446,Mitoxantrone,2016-03-21,2019-02-01,5000,MIU,['2 / Day'],IV,Persisting MRI activity
11665,2446,IVIG,2016-03-29,,1,MIU,['/Month'], , 
11666,1546,Methylprednisolone,2016-05-06,,1,mg,['3 / Week'],IV, 
11667,1546,Ledertrexaat,2015-12-31,,20, ,['3 / Week'],IV, 
11668,2507,Betaferon,2016-08-10,,5000, ,['2 / Day'],IV, 
11669,2507,Betaferon,2015-12-06,,300, ,['3 / Week'], , 
11670,3710,Mitoxantrone,2016-06-09,, ,mg,['/ Week'], , 
11671,3710,IVIG,2016-10-16,,500, ,['/ Day'],IV, 
11672,3710,Rebif [44],2016-06-08,2021-08-26,20, ,['2 / Day'],IV,Persisting MRI activity
11673,3330,Rebif [22],2015-12-01,,500,mg,['2 / Day'],IV, 
11674,3330,Avonex,2016-06-22,2019-05-16,500,mg,['3 / Week'],IV,Patient Choice/Convenience
11675,2131,Alemtuzumab (Campath),2016-02-08,,5000,MIU,['/Month'],Oral, 
11676,2131,Avonex,2016-09-05,2020-09-26,20, ,['3 / Week'],IV,Persistence of relapses
11677,2088,Rebif [44],2016-04-27,,20,mg,['3 / Week'],IV, 
11678,2088,Rebif [44],2016-07-09,, , ,['2 / Day'], , 
11679,2088,IVIG,2016-02-03,,500,mg,['3 / Week'],IV, 
11680,1424,Endoxan,2016-09-30,, ,mg,['2 / Day'], , 
11681,4871,Ledertrexaat,2016-02-08,, ,MIU,['3 / Week'],IV, 
11682,2302,Betaferon,2015-11-23,2018-08-22,1000,mg,['/Month'],IV,Persistence of relapses
11683,2302,Alemtuzumab (Campath),2016-01-31,,300,MIU,['/Month'],IV, 
11684,2302,Tecfidera,2016-09-25,2020-04-08,300,mg,['2 / Day'], ,Adverse Event
11685,3570,Gilenya,2016-08-21,,500,MIU,['/ Day'],IV, 
11686,3570,Gilenya,2016-07-14,2020-10-27,1000,MIU,['2 / Day'], ,Patient Choice/Convenience
11687,3570,IVIG,2016-08-13,2019-08-05,20,mg,['3 / Week'], ,Lack of efficacy
11688,1182,Gilenya,2016-06-30,, , ,['3 / Week'],IV, 
11689,1182,D-cure (Vitamine D),2016-09-29,2020-10-01,500, ,['/ Week'], ,Adverse Event
11690,1182,Rebif [44],2016-05-03,, , ,['3 / Week'],Oral, 
11691,1182,Rebif [22],2016-05-10,,1000,mg,['2 / Day'], , 
11692,950,Rebif [22],2016-10-01,2020-06-24,300, ,['/Month'],IV,Patient Choice/Convenience
11693,950,Tysabri,2015-11-02,2018-01-30,500, ,['3 / Week'],IV,Lack of efficacy
11694,797,Copaxone,2016-04-26,2019-05-09,20,mg,['/Month'], ,Lack of efficacy
11695,797,Alemtuzumab (Campath),2016-09-28,2021-10-07, ,MIU,['/Month'],Oral,Persisting MRI activity
11696,3444,IVIG,2016-08-06,2021-09-07,300,MIU,['2 / Day'],IV,Persistence of relapses
11697,1756,D-cure (Vitamine D),2016-10-04,, ,mg,['/Month'],IV, 
11698,712,Betaferon,2016-05-19,,5000,MIU,['/Month'],IV, 
11699,712,Ledertrexaat,2016-09-29,,1000, ,['/Month'],IV, 
11700,4255,Methylprednisolone,2016-08-02,2018-04-15, ,mg,['/Month'],IV,Patient Choice/Convenience
11701,4255,Mitoxantrone,2015-11-27,2020-09-01,500,mg,['3 / Week'],IV,Persisting MRI activity
11702,4255,Methylprednisolone,2015-12-20,,500,mg,['/ Week'], , 
11703,4255,Betaferon,2016-01-11,2021-07-24, ,mg,['3 / Week'], ,Persisting MRI activity
11704,3657,Gilenya,2015-11-19,2019-05-04,400,MIU,['2 / Day'],IV,Persisting MRI activity
11705,3657,Methylprednisolone,2016-03-23,,20,mg,['/Month'],Oral, 
11706,3657,D-cure (Vitamine D),2016-05-30,2018-05-11, ,mcg,['2 / Day'],Oral,Adverse Event
11707,328,Gilenya,2015-11-24,, ,mg,['/ Week'],IV, 
11708,328,IVIG,2016-03-05,,5000, ,['3 / Week'], , 
11709,3762,Ledertrexaat,2015-12-25,,400,MIU,['3 / Week'], , 
11710,3762,Gilenya,2016-06-30,2021-10-15,300, ,['2 / Day'],Oral,Adverse Event
11711,3762,D-cure (Vitamine D),2016-09-01,,300,mg,['/Month'],IV, 
11712,117,Methylprednisolone,2015-11-09,,1,MIU,['/Month'],IV, 
11713,117,Copaxone,2015-11-26,,5000, ,['/Month'],IV, 
11714,117,Teriflunomide,2016-08-17,,500, ,['/Month'],IV, 
11715,117,Rebif [44],2016-09-01,2019-05-06,1, ,['3 / Week'],IV,Lack of efficacy
11716,1402,IVIG,2016-03-09,2018-08-24,300,mg,['/Month'],IV,Lack of efficacy
11717,1402,Tysabri,2016-09-29,,20,MIU,['/Month'], , 
11718,3242,IVIG,2016-10-02,,500,MIU,[' '],IV, 
11719,3242,Betaferon,2016-10-03,,400,mg,['2 / Day'],IV, 
11720,3242,Tysabri,2016-09-16,2021-02-16,20,mcg,['2 / Day'],IV,Persistence of relapses
11721,3242,Rebif [22],2016-05-02,2019-02-16, , ,['2 / Day'],IV,Adverse Event
11722,3647,Alemtuzumab (Campath),2016-04-20,2020-08-10,400,MIU,['/ Week'],IV,Adverse Event
11723,3647,IVIG,2016-09-30,2019-01-16,300,mg,['/Month'],IV,Lack of efficacy
11724,356,Rebif [44],2015-11-26,,500,mg,['/Month'],IV, 
11725,356,Ledertrexaat,2016-10-03,,1, ,['2 / Day'], , 
11726,951,Ledertrexaat,2016-09-23,, ,mg,['/ Week'],IV, 
11727,951,Endoxan,2016-03-01,2018-07-21, ,mg,['3 / Week'], ,Persisting MRI activity
11728,951,Copaxone,2016-04-13,2021-02-06,5000,mg,['3 / Week'],IV,Persisting MRI activity
11729,1244,D-cure (Vitamine D),2016-05-29,,400,mg,['2 / Day'],IV, 
11730,1244,D-cure (Vitamine D),2016-06-28,2018-11-07,300,MIU,['3 / Week'],Oral,Patient Choice/Convenience
11731,1244,Gilenya,2016-04-03,,1,mg,['2 / Day'], , 
11732,1244,Tecfidera,2015-11-08,,1000, ,['/Month'],IV, 
11733,4823,Avonex,2016-08-16,2021-06-18,400,mg,['3 / Week'], ,Persisting MRI activity
11734,4823,Rebif [22],2016-01-11,,1,mg,['3 / Week'], , 
11735,4823,Tysabri,2016-09-10,2021-10-04,1000, ,['/Month'],IV,Patient Choice/Convenience
11736,4912,Betaferon,2016-04-19,,1,mg,['/ Day'],IV, 
11737,4912,Avonex,2016-05-20,2018-06-27, ,mg,['/Month'],IV,Persistence of relapses
11738,865,Tysabri,2016-06-29,2020-12-13, , ,['/Month'], ,Adverse Event
11739,2425,Alemtuzumab (Campath),2016-01-28,,1000,mg,['3 / Week'],IV, 
11740,4365,Tecfidera,2016-05-08,2020-12-21,300, ,['3 / Week'],IV,Lack of efficacy
11741,1734,Gilenya,2016-06-30,2021-04-20,1, ,['/Month'],Oral,Adverse Event
11742,2337,Gilenya,2016-08-10,2018-12-06,1000,mg,['/ Day'], ,Persisting MRI activity
11743,2337,Endoxan,2015-12-12,,1000,mcg,['3 / Week'],IV, 
11744,2337,Alemtuzumab (Campath),2016-01-13,,400, ,['2 / Day'],IV, 
11745,184,Avonex,2015-12-29,, , ,['/Month'],IV, 
11746,184,Endoxan,2016-06-02,,400, ,['2 / Day'],IV, 
11747,184,Mitoxantrone,2016-06-07,,20,mg,['/ Day'], , 
11748,184,Ledertrexaat,2016-04-06,,500, ,[' '], , 
11749,357,Tysabri,2015-11-07,2018-07-10, ,mg,['/ Day'],IV,Adverse Event
11750,357,Copaxone,2016-04-13,, ,mg,['2 / Day'],IV, 
11751,357,Tecfidera,2016-05-15,,1,MIU,['/ Week'],Oral, 
11752,659,D-cure (Vitamine D),2016-09-22,2020-12-22,1000, ,['3 / Week'], ,Lack of efficacy
11753,659,Tecfidera,2016-05-11,2018-11-08,1, ,[' '],Oral,Persistence of relapses
11754,659,Tecfidera,2016-05-27,,1000, ,['2 / Day'],Oral, 
11755,1511,Betaferon,2016-08-24,,1000, ,['/ Week'], , 
11756,1511,Betaferon,2016-07-03,,20, ,['/Month'],IV, 
11757,3318,D-cure (Vitamine D),2016-02-22,2019-05-10,500,mg,[' '],IV,Patient Choice/Convenience
11758,2777,Mitoxantrone,2016-06-08,,400,mg,['/ Day'],IV, 
11759,2777,Rebif [22],2015-12-02,,1000, ,['2 / Day'], , 
11760,2777,Endoxan,2016-05-31,2019-08-22,20,mcg,['/Month'],IV,Adverse Event
11761,3449,Alemtuzumab (Campath),2016-04-30,2021-08-19,300,mcg,['/Month'],Oral,Persisting MRI activity
11762,3449,Ledertrexaat,2016-02-06,2017-12-29,20,mcg,['/Month'],IV,Patient Choice/Convenience
11763,4822,D-cure (Vitamine D),2016-02-24,2020-09-11,300,mg,['/Month'], ,Lack of efficacy
11764,4822,Avonex,2015-11-15,, , ,['/ Day'],Oral, 
11765,4822,Gilenya,2016-04-30,,20, ,['/Month'],Oral, 
11766,4822,Tecfidera,2016-09-18,2019-12-31, , ,['/Month'], ,Adverse Event
11767,2027,IVIG,2016-07-17,,300, ,['/Month'], , 
11768,2027,Rebif [22],2015-12-29,2019-03-07,400, ,['/Month'],Oral,Adverse Event
11769,1980,Rebif [44],2015-11-05,,1,mg,['/ Week'],IV, 
11770,1980,Rebif [22],2016-10-21,,20, ,['/ Week'],IV, 
11771,3118,Teriflunomide,2016-05-07,, ,mg,['2 / Day'],IV, 
11772,3118,Gilenya,2016-06-28,2020-12-24,400, ,['2 / Day'], ,Persisting MRI activity
11773,3118,Betaferon,2016-07-04,,500,MIU,['2 / Day'],IV, 
11774,1881,Alemtuzumab (Campath),2016-03-31,,1000, ,['/Month'],IV, 
11775,1881,Endoxan,2015-12-08,,400,mg,[' '], , 
11776,1881,Copaxone,2016-01-07,,500,MIU,['/ Day'],Oral, 
11777,3199,Methylprednisolone,2016-01-09,2018-12-11, ,mg,['2 / Day'], ,Patient Choice/Convenience
11778,3199,Tysabri,2016-06-29,,300,MIU,['/ Week'],IV, 
11779,3199,Endoxan,2016-10-12,2019-06-09,500, ,['2 / Day'],IV,Lack of efficacy
11780,4147,Mitoxantrone,2016-04-05,,1000,mg,['2 / Day'],Oral, 
11781,4147,Gilenya,2016-09-29,2021-04-15,300,mcg,['2 / Day'],IV,Adverse Event
11782,4952,Alemtuzumab (Campath),2016-05-11,2019-08-06, , ,['2 / Day'],IV,Persistence of relapses
11783,4952,D-cure (Vitamine D),2015-12-06,2018-12-15,400, ,['3 / Week'],IV,Patient Choice/Convenience
11784,4952,Rebif [44],2016-08-04,2019-05-22,1000, ,['/Month'], ,Lack of efficacy
11785,4910,Endoxan,2016-09-11,,500,mg,['3 / Week'],IV, 
11786,4910,Rebif [22],2016-07-05,2018-11-01,1, ,['2 / Day'],IV,Persisting MRI activity
11787,2074,Copaxone,2016-10-02,,300,mcg,['/Month'],IV, 
11788,2074,D-cure (Vitamine D),2016-02-18,2019-12-22, ,mg,['2 / Day'],IV,Adverse Event
11789,2074,Endoxan,2016-05-12,2021-07-28, ,MIU,['2 / Day'],Oral,Persisting MRI activity
11790,2074,Copaxone,2015-11-24,,20,mcg,['2 / Day'], , 
11791,3096,Avonex,2016-04-03,2017-12-21,400, ,['/Month'],IV,Persisting MRI activity
11792,3096,D-cure (Vitamine D),2016-03-26,, ,mg,['/Month'], , 
11793,3096,Methylprednisolone,2016-08-21,,300,mg,[' '], , 
11794,3096,Copaxone,2016-02-14,, , ,['/ Week'],IV, 
11795,1329,Avonex,2016-08-03,,20,mg,['/Month'], , 
11796,1329,Alemtuzumab (Campath),2016-10-20,, , ,['3 / Week'],Oral, 
11797,4724,Gilenya,2016-10-13,2020-12-07,5000,mcg,['/Month'],IV,Persistence of relapses
11798,4724,Ledertrexaat,2016-01-02,2020-12-25,20, ,['2 / Day'], ,Adverse Event
11799,4724,Rebif [22],2015-12-23,,500,mg,[' '],IV, 
11800,1876,D-cure (Vitamine D),2016-05-02,, ,mg,['/Month'],Oral, 
11801,1876,D-cure (Vitamine D),2016-03-06,2018-03-12, , ,['2 / Day'],IV,Lack of efficacy
11802,1876,Gilenya,2015-11-10,2021-01-26,5000, ,['2 / Day'],IV,Persisting MRI activity
11803,1021,Tecfidera,2016-01-19,2021-06-24,20, ,['2 / Day'], ,Persisting MRI activity
11804,1260,Rebif [44],2016-02-04,2020-11-24,500,MIU,[' '], ,Adverse Event
11805,1260,Avonex,2016-02-04,2019-12-01,300,mg,['/ Week'],IV,Patient Choice/Convenience
11806,1260,Ledertrexaat,2015-12-04,2019-02-28,400, ,['2 / Day'],IV,Persisting MRI activity
11807,1260,IVIG,2016-03-16,, , ,['2 / Day'],Oral, 
11808,4422,Copaxone,2015-10-28,2020-02-28,300,mg,['/Month'],Oral,Adverse Event
11809,4422,Tysabri,2016-06-14,2017-11-22,300,mg,[' '],Oral,Adverse Event
11810,4422,Copaxone,2015-12-21,, , ,['/Month'],Oral, 
11811,4422,Teriflunomide,2016-08-28,,400,MIU,['/Month'],Oral, 
11812,1295,Teriflunomide,2016-05-04,2019-09-13,1, ,['/ Week'],IV,Patient Choice/Convenience
11813,1440,Tysabri,2015-11-26,, , ,['2 / Day'], , 
11814,2260,Rebif [44],2016-05-17,2021-03-29, , ,[' '],Oral,Adverse Event
11815,2260,Alemtuzumab (Campath),2016-04-19,, ,mg,['/ Day'],IV, 
11816,2260,Endoxan,2016-03-27,, ,MIU,['2 / Day'],IV, 
11817,2260,Ledertrexaat,2016-10-13,,5000,mg,['2 / Day'],Oral, 
11818,1280,Tysabri,2015-11-01,,500,mcg,['2 / Day'], , 
11819,1280,Rebif [44],2016-05-30,, ,mg,['/Month'],Oral, 
11820,1280,Gilenya,2015-12-24,,20,mg,['2 / Day'],IV, 
11821,1280,Tysabri,2016-07-19,,20, ,['/ Week'],IV, 
11822,867,IVIG,2015-11-28,,20,MIU,['/ Day'], , 
11823,867,Tysabri,2016-01-26,,500, ,['2 / Day'],IV, 
11824,867,Tysabri,2016-06-29,2020-10-31, , ,['2 / Day'], ,Adverse Event
11825,4814,Methylprednisolone,2016-10-16,, , ,[' '],IV, 
11826,4814,Alemtuzumab (Campath),2016-01-23,, ,mg,['/ Day'],IV, 
11827,1986,Endoxan,2015-10-31,,500, ,['2 / Day'],IV, 
11828,896,Endoxan,2016-02-10,,5000, ,['/ Week'],IV, 
11829,3191,Copaxone,2016-08-12,2017-11-01,400, ,['/Month'], ,Patient Choice/Convenience
11830,3191,Endoxan,2016-09-17,2020-10-31, ,mg,[' '], ,Adverse Event
11831,3191,Rebif [22],2015-11-07,2021-06-20,300,mg,['2 / Day'], ,Persisting MRI activity
11832,3191,Endoxan,2015-12-11,2018-09-27,300,mg,['/ Day'], ,Adverse Event
11833,980,D-cure (Vitamine D),2015-11-27,, ,mg,['/Month'], , 
11834,1978,Tysabri,2015-12-08,2017-12-23,400,mg,['2 / Day'], ,Patient Choice/Convenience
11835,1978,Mitoxantrone,2016-01-18,, , ,['/ Day'],IV, 
11836,1978,Rebif [44],2016-08-05,2018-02-20,500, ,['/ Week'],IV,Persisting MRI activity
11837,1978,Tysabri,2015-10-27,2021-04-26,500, ,['2 / Day'], ,Persisting MRI activity
11838,2400,Ledertrexaat,2016-09-23,2018-03-23, , ,['2 / Day'], ,Adverse Event
11839,2400,Teriflunomide,2016-01-13,2021-04-25,500,MIU,['3 / Week'], ,Patient Choice/Convenience
11840,2400,Teriflunomide,2016-01-02,,1000,mg,['2 / Day'], , 
11841,3267,Rebif [44],2016-09-11,,1000, ,['/Month'], , 
11842,3452,Tecfidera,2016-05-11,,5000,mg,['/Month'], , 
11843,1564,Mitoxantrone,2016-08-29,2019-11-26, , ,['2 / Day'], ,Lack of efficacy
11844,1564,Ledertrexaat,2016-01-10,,1000,mg,['/Month'],IV, 
11845,1564,D-cure (Vitamine D),2016-05-15,2021-06-22,5000,mg,['/ Day'],IV,Persisting MRI activity
11846,177,Tecfidera,2016-06-29,2018-03-24, ,mg,['3 / Week'],IV,Lack of efficacy
11847,177,Copaxone,2016-05-05,2019-10-01,300, ,['2 / Day'], ,Patient Choice/Convenience
11848,4390,Rebif [22],2016-02-14,, ,mcg,[' '],Oral, 
11849,4390,Endoxan,2016-10-08,,20,mg,['2 / Day'], , 
11850,3644,Methylprednisolone,2015-11-19,2019-02-23, , ,['/Month'],Oral,Persistence of relapses
11851,3644,Copaxone,2016-08-15,2018-06-09,400, ,['/Month'], ,Patient Choice/Convenience
11852,3644,Tysabri,2016-03-05,2018-02-22, ,mg,['2 / Day'],IV,Adverse Event
11853,3644,Avonex,2016-01-08,2019-08-03, , ,['/ Day'],IV,Persisting MRI activity
11854,4863,Tysabri,2016-10-09,2021-09-16, , ,['3 / Week'], ,Patient Choice/Convenience
11855,964,IVIG,2016-09-04,,5000,mg,['2 / Day'], , 
11856,964,Alemtuzumab (Campath),2016-05-13,,400,mcg,['/Month'],Oral, 
11857,964,Copaxone,2016-01-13,2020-06-19,500,mg,['2 / Day'],Oral,Adverse Event
11858,2230,Endoxan,2016-07-01,,1,mg,[' '], , 
11859,2230,Alemtuzumab (Campath),2016-02-19,2020-06-16,5000, ,['/Month'], ,Adverse Event
11860,2230,Copaxone,2016-02-21,,500,mg,['2 / Day'],IV, 
11861,2230,Tysabri,2016-05-10,2021-07-20,1000,mg,['3 / Week'], ,Persisting MRI activity
11862,3935,Teriflunomide,2016-10-01,2021-01-23, ,MIU,['2 / Day'],IV,Persisting MRI activity
11863,3935,Tysabri,2016-09-30,2021-08-06,500,mg,['3 / Week'],IV,Adverse Event
11864,3935,Rebif [44],2016-04-28,, , ,['/Month'], , 
11865,3935,Tecfidera,2016-03-15,,500, ,['/Month'],IV, 
11866,309,IVIG,2016-03-07,, ,mg,['2 / Day'], , 
11867,309,Tecfidera,2016-05-16,,20,mg,['3 / Week'], , 
11868,309,Rebif [44],2015-12-11,2019-01-26,1,MIU,['/Month'],IV,Persisting MRI activity
11869,1824,Gilenya,2016-06-03,2020-03-14, ,mg,['/Month'],Oral,Lack of efficacy
11870,1824,Ledertrexaat,2016-02-21,2021-02-17,5000, ,['/Month'],IV,Adverse Event
11871,1824,Gilenya,2016-07-11,2021-01-19,500, ,['/ Day'], ,Patient Choice/Convenience
11872,1824,Endoxan,2016-02-12,,300,mg,['/Month'],IV, 
11873,4846,Alemtuzumab (Campath),2015-12-11,,400,MIU,[' '],IV, 
11874,4941,Methylprednisolone,2016-08-03,,20,mcg,['/Month'], , 
11875,3530,Rebif [22],2015-11-08,2018-07-04, ,mcg,['2 / Day'], ,Persisting MRI activity
11876,829,IVIG,2015-11-20,,20, ,['3 / Week'], , 
11877,2253,Ledertrexaat,2016-09-26,, , ,['/ Week'],Oral, 
11878,2253,Betaferon,2016-09-02,,5000,mg,['/Month'],Oral, 
11879,2253,Copaxone,2016-06-12,2021-01-28,400, ,['2 / Day'],Oral,Persisting MRI activity
11880,2253,Gilenya,2015-12-17,2021-10-08, ,mg,['2 / Day'], ,Adverse Event
11881,281,D-cure (Vitamine D),2016-03-21,2021-05-22,5000, ,['/ Week'], ,Persisting MRI activity
11882,281,Alemtuzumab (Campath),2016-06-29,,300, ,['/Month'], , 
11883,3709,Copaxone,2016-09-26,2021-04-22,300, ,['/ Week'],IV,Lack of efficacy
11884,3369,IVIG,2016-02-09,,500, ,[' '],IV, 
11885,4200,Rebif [22],2016-04-16,2020-01-16,300, ,['/ Week'],Oral,Persisting MRI activity
11886,4200,Betaferon,2016-08-22,,20,mg,['3 / Week'], , 
11887,4200,Avonex,2016-07-29,,300, ,['/Month'], , 
11888,4200,Methylprednisolone,2015-11-19,2021-01-06, , ,[' '],Oral,Lack of efficacy
11889,2991,Endoxan,2016-03-30,,500,mcg,['2 / Day'],IV, 
11890,2991,Rebif [22],2016-07-06,2019-05-19, , ,['/Month'], ,Patient Choice/Convenience
11891,2226,Mitoxantrone,2015-12-09,2021-01-07,5000, ,['/Month'],Oral,Adverse Event
11892,1090,Gilenya,2016-09-13,2019-12-29,20,mg,['3 / Week'], ,Lack of efficacy
11893,1887,Ledertrexaat,2016-06-23,2018-11-03, ,mg,['/Month'],IV,Adverse Event
11894,4106,Alemtuzumab (Campath),2015-11-21,2017-12-20,300,mcg,['/ Week'],IV,Persisting MRI activity
11895,4106,Endoxan,2015-12-17,, ,mg,['2 / Day'],Oral, 
11896,1000,Tecfidera,2016-09-28,,5000,MIU,['/Month'],IV, 
11897,3496,Tecfidera,2016-07-08,, ,mg,['/Month'],IV, 
11898,3496,Tysabri,2016-09-27,,500,mg,['2 / Day'],IV, 
11899,3496,Ledertrexaat,2016-05-13,,400, ,['3 / Week'],Oral, 
11900,3496,Avonex,2016-10-03,,20,mcg,['/ Day'],IV, 
11901,4218,Tysabri,2016-01-11,2020-03-16, ,mcg,['2 / Day'],IV,Adverse Event
11902,4218,IVIG,2016-01-09,, , ,['3 / Week'],IV, 
11903,4218,D-cure (Vitamine D),2016-08-01,,20,mg,['2 / Day'], , 
11904,1459,Methylprednisolone,2016-02-23,,300, ,['2 / Day'],IV, 
11905,1459,Tecfidera,2016-10-09,,20, ,['2 / Day'], , 
11906,1459,Tysabri,2016-01-16,,300,mg,['2 / Day'],Oral, 
11907,1459,Tysabri,2016-03-21,,300,mg,[' '], , 
11908,2090,Avonex,2015-11-12,,20, ,['/ Week'],IV, 
11909,591,Betaferon,2016-05-08,,20, ,['/Month'],Oral, 
11910,591,Copaxone,2016-02-16,, , ,['3 / Week'], , 
11911,591,Methylprednisolone,2016-09-19,,300,mg,['3 / Week'], , 
11912,3142,Gilenya,2016-09-30,2018-07-13,1,mg,['2 / Day'],IV,Persistence of relapses
11913,3142,Tysabri,2016-04-06,, ,mg,['3 / Week'],IV, 
11914,3142,IVIG,2016-04-21,,300,mg,[' '],Oral, 
11915,3142,Mitoxantrone,2016-08-07,,500,mg,['2 / Day'], , 
11916,4608,D-cure (Vitamine D),2016-06-20,,400, ,['/ Week'], , 
11917,4608,Tysabri,2016-03-20,2019-05-25,20, ,['2 / Day'],Oral,Persistence of relapses
11918,4608,Rebif [44],2016-08-29,,300, ,['3 / Week'],Oral, 
11919,445,Rebif [44],2015-12-01,,300,mg,['2 / Day'],IV, 
11920,445,Copaxone,2015-11-18,,400,MIU,['3 / Week'],IV, 
11921,445,Copaxone,2016-03-14,2020-01-12,500,mg,['/Month'], ,Patient Choice/Convenience
11922,942,Rebif [44],2016-07-27,2021-05-09, , ,['/Month'],IV,Lack of efficacy
11923,942,Gilenya,2015-11-26,2018-07-06,20, ,['2 / Day'],IV,Persisting MRI activity
11924,942,Rebif [44],2015-12-30,2018-03-29,300,MIU,['/ Week'],IV,Adverse Event
11925,1289,Tysabri,2016-01-02,,500,MIU,['3 / Week'],IV, 
11926,1289,Rebif [22],2016-01-20,2018-10-02,1,MIU,['2 / Day'],IV,Patient Choice/Convenience
11927,1289,Avonex,2016-08-25,,1000,mg,['/Month'],IV, 
11928,1289,Tecfidera,2016-08-05,, ,mcg,[' '],IV, 
11929,1207,Betaferon,2016-06-25,2021-06-16,20,mg,['2 / Day'],Oral,Persisting MRI activity
11930,1207,Rebif [22],2016-03-01,2021-01-10, , ,['/Month'],IV,Patient Choice/Convenience
11931,1207,Rebif [44],2016-02-26,, , ,['2 / Day'],IV, 
11932,1207,Betaferon,2016-05-21,2020-03-07,5000,MIU,['3 / Week'], ,Lack of efficacy
11933,209,Rebif [44],2016-06-16,2019-02-11,500, ,['/ Week'],IV,Patient Choice/Convenience
11934,3353,D-cure (Vitamine D),2016-04-16,2020-01-01, ,mg,['/Month'], ,Lack of efficacy
11935,3353,Alemtuzumab (Campath),2016-02-03,,1, ,['2 / Day'],IV, 
11936,3353,Methylprednisolone,2016-05-27,,300, ,['2 / Day'],IV, 
11937,3353,D-cure (Vitamine D),2015-12-22,,5000,mg,['3 / Week'],IV, 
11938,141,D-cure (Vitamine D),2016-04-13,2018-01-17,1000, ,['3 / Week'],IV,Lack of efficacy
11939,141,Copaxone,2016-07-23,2018-07-02, , ,[' '],IV,Adverse Event
11940,3322,Gilenya,2015-12-12,, , ,['/ Day'], , 
11941,3409,Tysabri,2015-11-23,,20,mg,['2 / Day'],IV, 
11942,3409,Avonex,2016-01-14,,300,mg,['/Month'],IV, 
11943,3409,IVIG,2016-01-14,, , ,['/ Week'],IV, 
11944,3409,D-cure (Vitamine D),2015-12-19,,500, ,['2 / Day'],IV, 
11945,156,Endoxan,2015-11-04,2018-09-24,400,mg,['/Month'],IV,Adverse Event
11946,156,Methylprednisolone,2016-06-23,2018-12-03,20, ,['2 / Day'],IV,Adverse Event
11947,2746,Tysabri,2016-04-04,2020-07-18,5000, ,['2 / Day'],IV,Adverse Event
11948,4779,Copaxone,2016-08-31,,5000, ,['/Month'],IV, 
11949,4779,D-cure (Vitamine D),2016-07-02,2018-07-27,5000, ,['/Month'],IV,Persistence of relapses
11950,4779,Rebif [22],2016-10-02,, ,mg,['/ Week'],IV, 
11951,4430,Tecfidera,2016-06-19,2020-06-11,20, ,['2 / Day'], ,Adverse Event
11952,4430,Rebif [44],2016-04-25,,500, ,['2 / Day'],IV, 
11953,3871,IVIG,2016-07-01,, ,mg,['/ Day'], , 
11954,3871,Mitoxantrone,2015-12-19,2019-04-20,300, ,['/ Week'], ,Patient Choice/Convenience
11955,3103,Betaferon,2015-12-21,,1000, ,['2 / Day'],Oral, 
11956,3503,Gilenya,2015-12-11,, ,MIU,['/Month'],Oral, 
11957,3503,D-cure (Vitamine D),2016-06-16,2020-09-27,5000,mg,['3 / Week'],IV,Adverse Event
11958,3652,Rebif [44],2016-02-12,,1000, ,['/ Day'], , 
11959,3969,Copaxone,2016-07-10,2020-03-30,20,mg,[' '],IV,Adverse Event
11960,3969,Tecfidera,2015-12-25,2020-12-03, , ,['3 / Week'], ,Patient Choice/Convenience
11961,214,Gilenya,2016-03-21,2019-11-21,1000, ,['/ Day'],IV,Persisting MRI activity
11962,2885,Rebif [44],2016-09-07,, ,MIU,['/Month'],IV, 
11963,2885,Rebif [44],2016-08-06,2021-10-20, ,MIU,['/Month'],IV,Lack of efficacy
11964,2829,D-cure (Vitamine D),2016-08-08,2018-04-23,20,MIU,['3 / Week'], ,Persisting MRI activity
11965,2829,Tysabri,2015-12-16,2021-05-10,1000, ,['/Month'],Oral,Lack of efficacy
11966,3811,Copaxone,2016-05-13,2020-12-06, ,mg,['/ Week'],Oral,Lack of efficacy
11967,3811,Methylprednisolone,2016-03-29,,20,mg,['/Month'], , 
11968,3811,Betaferon,2016-06-27,,300,mg,['3 / Week'],IV, 
11969,3811,Rebif [44],2016-09-11,2021-08-13,5000,mg,['/ Week'],Oral,Lack of efficacy
11970,4205,IVIG,2016-01-25,2019-11-27, , ,['2 / Day'],IV,Patient Choice/Convenience
11971,1304,Tecfidera,2016-06-01,2019-02-15,5000, ,['/Month'],IV,Patient Choice/Convenience
11972,3130,Alemtuzumab (Campath),2015-12-26,, , ,['/Month'],IV, 
11973,3130,Rebif [44],2016-02-14,2020-01-03,300, ,['/Month'], ,Persisting MRI activity
11974,3130,D-cure (Vitamine D),2016-03-26,,500,mg,['/Month'],Oral, 
11975,1120,D-cure (Vitamine D),2015-11-27,,500, ,['/ Week'],IV, 
11976,1120,Endoxan,2016-09-30,,500,mcg,['/Month'], , 
11977,1120,Alemtuzumab (Campath),2016-03-17,, , ,['/ Day'], , 
11978,1120,Endoxan,2016-10-15,2020-05-28, , ,['3 / Week'],IV,Adverse Event
11979,1359,Rebif [22],2015-11-02,2018-08-04,400,mg,[' '], ,Patient Choice/Convenience
11980,1359,Ledertrexaat,2016-07-23,2017-12-17,400,MIU,['2 / Day'], ,Patient Choice/Convenience
11981,1359,Alemtuzumab (Campath),2016-09-23,2020-10-28,300,mg,['/Month'], ,Persisting MRI activity
11982,1359,Copaxone,2015-11-25,2019-05-14,1000, ,['/ Week'],IV,Persistence of relapses
11983,2697,IVIG,2015-11-24,,20,mg,['/Month'],IV, 
11984,2697,D-cure (Vitamine D),2015-10-30,,1,mg,['/Month'],IV, 
11985,2697,Copaxone,2016-08-06,,1000, ,['/Month'],IV, 
11986,2697,IVIG,2016-08-15,,1000, ,['/ Week'],Oral, 
11987,4473,Avonex,2016-09-04,2020-02-21,1, ,['3 / Week'], ,Patient Choice/Convenience
11988,4473,Gilenya,2016-08-01,,1, ,['/ Day'],IV, 
11989,4473,Endoxan,2016-09-05,, ,mg,[' '],IV, 
11990,4257,Tysabri,2016-01-14,2021-05-16, ,mg,['2 / Day'], ,Adverse Event
11991,4257,Copaxone,2015-12-04,2017-11-19,1000,mg,['/Month'],IV,Patient Choice/Convenience
11992,4257,Endoxan,2015-12-23,,1000,mg,['/ Day'],IV, 
11993,4257,D-cure (Vitamine D),2016-05-30,2021-05-29, , ,['/Month'],Oral,Adverse Event
11994,2321,Copaxone,2016-03-27,2021-02-13,5000,MIU,[' '], ,Patient Choice/Convenience
11995,2321,Teriflunomide,2016-07-25,,20, ,['/Month'], , 
11996,2321,Endoxan,2015-12-28,, ,mg,['/ Day'],IV, 
11997,2321,IVIG,2016-10-16,, , ,['/Month'],IV, 
11998,3828,IVIG,2016-03-14,, , ,['2 / Day'],IV, 
11999,3828,Tysabri,2016-01-25,,300,mg,['/Month'],IV, 
12000,3828,Mitoxantrone,2015-11-11,2018-07-18,1000,mcg,['/ Week'], ,Adverse Event
12001,1790,D-cure (Vitamine D),2016-04-01,, ,mg,['/Month'], , 
12002,1790,Endoxan,2016-09-15,,20,mg,['/Month'], , 
12003,1790,Rebif [22],2016-04-09,,400,MIU,['3 / Week'], , 
12004,1790,Methylprednisolone,2016-02-22,2021-09-25,1000,mg,['/Month'],IV,Adverse Event
12005,370,Ledertrexaat,2016-01-19,,1, ,['/Month'], , 
12006,370,Alemtuzumab (Campath),2016-05-08,,20, ,['/Month'],IV, 
12007,370,Rebif [44],2015-11-29,,5000, ,['3 / Week'],IV, 
12008,370,Endoxan,2016-07-18,,20,mg,['/Month'],IV, 
12009,1637,Tysabri,2016-03-28,,1, ,['/ Day'],IV, 
12010,1637,Teriflunomide,2016-02-05,,500, ,['/Month'], , 
12011,3984,Tysabri,2016-04-30,,20, ,['2 / Day'],Oral, 
12012,915,Avonex,2016-07-09,,400,mg,['/ Day'],IV, 
12013,915,IVIG,2016-08-21,2018-06-12,1000, ,['/Month'],IV,Persisting MRI activity
12014,1430,Tecfidera,2015-12-08,2020-11-02,500, ,['2 / Day'],IV,Patient Choice/Convenience
12015,1430,Avonex,2015-10-26,2020-08-01,500, ,[' '],Oral,Persistence of relapses
12016,1430,Ledertrexaat,2015-12-09,2018-04-03,500, ,['/ Week'], ,Persistence of relapses
12017,1744,Tysabri,2016-08-02,2019-11-18, ,mg,['2 / Day'], ,Persisting MRI activity
12018,4440,Betaferon,2015-12-16,,500, ,['/Month'],IV, 
12019,4440,Methylprednisolone,2015-12-06,2021-05-09,300,mg,['2 / Day'],Oral,Adverse Event
12020,4440,Avonex,2015-12-31,2018-10-02,1, ,['/ Week'],IV,Patient Choice/Convenience
12021,4440,Copaxone,2016-05-20,2020-12-18, , ,['/ Day'], ,Persisting MRI activity
12022,4651,Gilenya,2016-02-24,, ,MIU,['/Month'],Oral, 
12023,3295,D-cure (Vitamine D),2015-11-17,,500,mg,['/Month'],IV, 
12024,3295,Tecfidera,2016-05-05,,1000, ,['/ Week'],IV, 
12025,3295,Copaxone,2016-09-29,,300,mg,['2 / Day'],IV, 
12026,3536,Endoxan,2015-12-11,2018-01-01,20,mg,['2 / Day'],IV,Persisting MRI activity
12027,640,Rebif [22],2016-08-01,2018-08-27,1, ,['/Month'],IV,Patient Choice/Convenience
12028,640,Gilenya,2016-08-24,2018-10-30,20,mg,['/Month'],IV,Lack of efficacy
12029,2066,Rebif [22],2016-03-01,, ,mg,['/Month'], , 
12030,225,Endoxan,2015-11-18,,5000,mg,['/Month'], , 
12031,225,Copaxone,2015-12-06,,300, ,[' '],IV, 
12032,225,Ledertrexaat,2016-07-07,2021-08-02, ,mg,[' '], ,Lack of efficacy
12033,2164,Copaxone,2016-01-10,, , ,['/Month'],IV, 
12034,2164,Avonex,2016-04-17,,1000,MIU,['3 / Week'], , 
12035,2164,Tecfidera,2016-05-25,2019-05-21,5000,mg,[' '], ,Patient Choice/Convenience
12036,1139,Betaferon,2016-06-01,, ,mcg,['2 / Day'],IV, 
12037,1578,Rebif [22],2016-09-15,2021-03-21,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
12038,1578,Gilenya,2016-07-31,2020-08-24, ,mg,['/ Day'],IV,Lack of efficacy
12039,1578,Mitoxantrone,2015-11-15,,500, ,['3 / Week'], , 
12040,2183,Endoxan,2016-07-13,2019-07-13,300,MIU,['2 / Day'], ,Adverse Event
12041,2570,Mitoxantrone,2015-11-23,,20, ,['/ Week'],IV, 
12042,2570,D-cure (Vitamine D),2016-07-25,2020-03-09,1000,mg,[' '],IV,Lack of efficacy
12043,2570,Rebif [22],2016-01-23,,20,MIU,['/Month'], , 
12044,2570,Rebif [22],2016-04-15,,20,mg,['3 / Week'],IV, 
12045,3674,Teriflunomide,2016-07-09,,5000, ,['3 / Week'],IV, 
12046,2247,Avonex,2016-03-25,,1000, ,['2 / Day'], , 
12047,2247,Rebif [44],2015-12-03,,5000, ,['3 / Week'],IV, 
12048,2247,D-cure (Vitamine D),2016-01-30,, ,MIU,['/Month'], , 
12049,2247,D-cure (Vitamine D),2016-08-26,2019-12-21,1000, ,['/Month'],IV,Patient Choice/Convenience
12050,1250,D-cure (Vitamine D),2015-12-13,2021-02-17, , ,['2 / Day'],Oral,Adverse Event
12051,1250,Copaxone,2016-06-27,, , ,['/ Week'],IV, 
12052,1250,Methylprednisolone,2016-09-18,, ,mg,['/Month'],IV, 
12053,1250,Methylprednisolone,2016-07-15,,1000, ,['/ Day'], , 
12054,442,Gilenya,2016-05-28,2019-03-20,5000,mg,['2 / Day'], ,Persistence of relapses
12055,442,D-cure (Vitamine D),2016-09-19,,300,mg,['2 / Day'],IV, 
12056,442,Copaxone,2016-10-16,,5000,mg,['/Month'],IV, 
12057,908,D-cure (Vitamine D),2016-01-12,,5000, ,['/Month'],IV, 
12058,1136,Rebif [22],2016-03-16,,20, ,['/Month'],IV, 
12059,1136,Rebif [22],2016-02-22,,1, ,['2 / Day'],IV, 
12060,1136,Copaxone,2016-02-02,2021-10-18, , ,['/Month'],IV,Adverse Event
12061,1136,Ledertrexaat,2016-01-05,2017-11-30,20,mg,['/Month'],IV,Adverse Event
12062,2697,Ledertrexaat,2016-03-20,, ,MIU,['2 / Day'],IV, 
12063,2697,Betaferon,2016-09-30,2019-10-14,1000,mg,['/Month'],Oral,Patient Choice/Convenience
12064,2697,Rebif [44],2016-06-08,,20, ,['/Month'], , 
12065,2697,IVIG,2015-11-20,2018-03-20,5000, ,['/ Day'], ,Persisting MRI activity
12066,432,D-cure (Vitamine D),2016-04-21,2018-10-01, ,mg,['/Month'],IV,Adverse Event
12067,1546,Avonex,2016-09-16,,500, ,['2 / Day'],IV, 
12068,1508,Methylprednisolone,2015-11-17,,500,mg,[' '],IV, 
12069,3306,Alemtuzumab (Campath),2016-04-04,,300,MIU,['2 / Day'],IV, 
12070,895,Rebif [44],2016-08-27,2021-04-29,300,mg,[' '],Oral,Persisting MRI activity
12071,397,Tecfidera,2016-03-28,, ,mg,['/ Day'], , 
12072,397,Avonex,2016-02-17,2020-05-29,1,mg,['2 / Day'],IV,Patient Choice/Convenience
12073,2122,Avonex,2016-10-14,, , ,['3 / Week'],IV, 
12074,2122,Avonex,2016-02-04,,500, ,['3 / Week'],IV, 
12075,2122,Rebif [44],2016-06-03,2019-11-20,1000, ,['/ Day'],IV,Adverse Event
12076,2122,IVIG,2015-10-24,2019-07-15,500,mg,['3 / Week'],IV,Persisting MRI activity
12077,606,D-cure (Vitamine D),2016-08-19,,300, ,['2 / Day'],IV, 
12078,606,Copaxone,2016-07-08,, ,MIU,['2 / Day'], , 
12079,606,IVIG,2016-06-16,2020-05-11,20,mg,['3 / Week'],Oral,Persistence of relapses
12080,1513,Betaferon,2016-03-24,,300,mcg,['/ Day'], , 
12081,1513,Endoxan,2016-09-19,,1000, ,['/Month'],IV, 
12082,1513,Endoxan,2016-02-11,, ,mg,['2 / Day'], , 
12083,1960,Gilenya,2016-07-18,,20,MIU,[' '], , 
12084,1960,Copaxone,2016-03-11,2020-03-10, ,MIU,['/ Week'],IV,Patient Choice/Convenience
12085,1960,Tysabri,2016-07-17,,400,mg,['/Month'], , 
12086,1960,Avonex,2016-10-18,2018-06-02, , ,['/Month'], ,Lack of efficacy
12087,865,Avonex,2016-06-06,,1000, ,['/Month'], , 
12088,865,Rebif [44],2016-06-07,2021-02-27,300,MIU,['3 / Week'],Oral,Lack of efficacy
12089,865,Betaferon,2016-08-03,,500, ,['2 / Day'], , 
12090,2772,D-cure (Vitamine D),2016-07-07,,20, ,['2 / Day'],IV, 
12091,2772,Betaferon,2016-05-01,,1000,mg,['/ Week'],IV, 
12092,292,Avonex,2016-05-28,2018-07-30, ,mcg,['/ Week'],IV,Persisting MRI activity
12093,229,IVIG,2016-06-11,,500, ,['/Month'], , 
12094,229,Gilenya,2016-08-20,,1,mcg,[' '], , 
12095,3518,D-cure (Vitamine D),2016-04-19,2018-09-27,5000, ,[' '],IV,Persisting MRI activity
12096,3518,Teriflunomide,2016-04-29,2019-12-14,1000,mg,['2 / Day'], ,Patient Choice/Convenience
12097,768,Copaxone,2016-05-26,2021-09-21, , ,['/Month'], ,Patient Choice/Convenience
12098,768,Avonex,2016-04-22,2017-11-12,1000, ,['/Month'],IV,Adverse Event
12099,768,Endoxan,2016-01-25,, , ,['/Month'],IV, 
12100,341,Teriflunomide,2016-08-11,,500,mg,['/ Day'],IV, 
12101,341,Betaferon,2016-05-14,, ,mg,['3 / Week'], , 
12102,341,Rebif [44],2016-04-10,,5000, ,['3 / Week'],IV, 
12103,4175,Methylprednisolone,2015-10-25,2018-11-04, ,mg,[' '], ,Patient Choice/Convenience
12104,4175,Tysabri,2016-02-28,,500, ,['/Month'], , 
12105,4175,Copaxone,2016-08-17,,20,MIU,[' '],Oral, 
12106,4175,Rebif [44],2016-06-11,2020-04-25,1,mg,['/ Day'],IV,Adverse Event
12107,2598,Gilenya,2016-07-13,2020-09-11,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
12108,2598,Avonex,2016-05-06,2018-05-30, , ,['/Month'],IV,Adverse Event
12109,2598,Tysabri,2016-10-09,2021-05-25,20,mg,['2 / Day'],IV,Adverse Event
12110,1700,Betaferon,2016-01-22,,1000, ,[' '], , 
12111,1696,Mitoxantrone,2016-02-02,2020-08-04, ,mg,['/ Day'],IV,Adverse Event
12112,1696,Avonex,2015-12-05,2021-02-28,400, ,['2 / Day'],IV,Persisting MRI activity
12113,2851,Tecfidera,2016-07-17,2019-01-02, ,mcg,['/Month'],IV,Adverse Event
12114,2851,Tysabri,2015-10-26,2019-03-28, , ,['2 / Day'],IV,Patient Choice/Convenience
12115,525,Tecfidera,2016-02-24,,500,mg,['/ Week'], , 
12116,525,Methylprednisolone,2016-07-05,,20, ,['/ Week'], , 
12117,525,Avonex,2016-10-14,2020-06-09,1000,mg,['/Month'],IV,Adverse Event
12118,1879,Methylprednisolone,2016-03-10,, ,mcg,['2 / Day'],IV, 
12119,2489,Rebif [22],2016-02-21,2018-09-06, ,MIU,[' '],IV,Persistence of relapses
12120,2489,Ledertrexaat,2016-06-30,2018-08-25,1000,mg,[' '],IV,Adverse Event
12121,2489,Tysabri,2016-01-08,2018-09-04,1000, ,['2 / Day'], ,Persisting MRI activity
12122,2489,Rebif [22],2015-11-30,,1000, ,['/ Week'],Oral, 
12123,3309,Tecfidera,2016-06-03,, ,mcg,['2 / Day'],IV, 
12124,3309,Gilenya,2016-02-03,,5000,mg,['/Month'],Oral, 
12125,3309,D-cure (Vitamine D),2015-12-29,2021-04-28,300,mg,['/ Day'], ,Persisting MRI activity
12126,3309,Betaferon,2016-05-18,,500, ,[' '],IV, 
12127,841,Copaxone,2016-07-16,, ,MIU,['2 / Day'],Oral, 
12128,841,Rebif [22],2016-09-05,,20,mg,['/ Day'],IV, 
12129,841,Methylprednisolone,2016-05-20,,300,mg,['/Month'],IV, 
12130,841,Gilenya,2016-07-08,2020-04-12, ,mg,['2 / Day'],IV,Persistence of relapses
12131,143,Betaferon,2016-01-06,, ,mcg,['2 / Day'], , 
12132,143,Methylprednisolone,2016-06-28,,400,mg,['3 / Week'],IV, 
12133,143,Mitoxantrone,2016-05-30,2021-09-20, ,mg,['/ Week'], ,Adverse Event
12134,4049,Betaferon,2015-12-04,2019-12-30,300,mg,['/ Day'],IV,Lack of efficacy
12135,4049,Alemtuzumab (Campath),2015-12-20,, , ,['/ Day'],Oral, 
12136,4049,Rebif [44],2016-07-26,,1000,mg,['/ Day'],Oral, 
12137,2376,IVIG,2016-03-09,,5000,MIU,['2 / Day'],Oral, 
12138,2376,Copaxone,2016-04-29,,400,mcg,[' '],IV, 
12139,2376,Rebif [44],2015-10-31,,1000,mg,['2 / Day'],IV, 
12140,4782,Rebif [44],2016-06-22,,500, ,['3 / Week'],Oral, 
12141,4782,Tysabri,2016-06-30,2020-05-17,1000,mg,['/Month'],Oral,Patient Choice/Convenience
12142,4271,Endoxan,2016-05-22,,1000, ,['/Month'], , 
12143,2030,Tysabri,2016-07-24,,5000,mg,[' '],IV, 
12144,2030,Alemtuzumab (Campath),2015-11-25,,1000,mg,['3 / Week'],IV, 
12145,2030,IVIG,2016-09-11,,1000, ,[' '],IV, 
12146,2030,Alemtuzumab (Campath),2016-06-12,2018-11-28, ,mg,['/ Day'], ,Adverse Event
12147,1164,Endoxan,2016-08-08,2019-06-12,500, ,['2 / Day'],IV,Lack of efficacy
12148,1164,Avonex,2016-09-05,2019-03-14,20, ,['/Month'],Oral,Persisting MRI activity
12149,1164,Tecfidera,2016-07-16,2019-06-06, , ,['3 / Week'], ,Persistence of relapses
12150,1164,IVIG,2016-01-23,,500,mg,['/ Week'], , 
12151,3456,Copaxone,2016-09-02,2018-12-04,20,mg,[' '],IV,Patient Choice/Convenience
12152,3910,IVIG,2015-12-06,,400, ,['/Month'],IV, 
12153,3910,IVIG,2015-12-25,2017-12-28,1000,mg,['/Month'],IV,Persisting MRI activity
12154,3910,D-cure (Vitamine D),2016-01-20,,5000,mcg,['/Month'], , 
12155,321,Methylprednisolone,2016-08-27,2020-08-08,300,mg,['3 / Week'],IV,Adverse Event
12156,321,Tecfidera,2016-10-07,2018-12-03,1000,MIU,['/ Week'],Oral,Patient Choice/Convenience
12157,321,Rebif [44],2015-12-21,2018-06-10, ,mg,['/ Week'], ,Adverse Event
12158,321,Methylprednisolone,2016-09-19,,500,mg,['/Month'],IV, 
12159,1799,Tecfidera,2016-04-27,,5000, ,['/Month'],IV, 
12160,1799,Copaxone,2016-06-23,, ,mg,['/Month'],IV, 
12161,1799,IVIG,2016-04-28,2021-10-12,300,mg,['/ Week'],Oral,Patient Choice/Convenience
12162,4308,D-cure (Vitamine D),2016-07-15,2017-10-27, , ,[' '],IV,Patient Choice/Convenience
12163,4308,D-cure (Vitamine D),2016-06-09,,1, ,['3 / Week'], , 
12164,4308,Rebif [44],2016-10-11,2018-01-15,20,MIU,['/Month'], ,Persisting MRI activity
12165,1647,Betaferon,2016-01-25,, , ,['3 / Week'], , 
12166,1647,Gilenya,2016-07-25,,1000, ,['3 / Week'], , 
12167,1647,Rebif [22],2016-02-13,,500, ,[' '],Oral, 
12168,1647,Alemtuzumab (Campath),2016-09-26,2018-10-26,20,mg,['3 / Week'], ,Adverse Event
12169,2528,Teriflunomide,2015-12-31,, ,mg,['3 / Week'],IV, 
12170,2708,IVIG,2016-03-01,2018-04-12,300, ,['/Month'],IV,Lack of efficacy
12171,2708,Gilenya,2016-02-01,,500, ,['/Month'], , 
12172,2708,Alemtuzumab (Campath),2016-01-21,2018-10-01,1000,mg,['/ Day'],IV,Lack of efficacy
12173,2894,IVIG,2016-06-19,2021-02-17,1, ,['3 / Week'], ,Lack of efficacy
12174,2894,Methylprednisolone,2016-03-13,2018-05-22, ,mg,[' '], ,Patient Choice/Convenience
12175,2622,D-cure (Vitamine D),2015-11-19,,20, ,['/Month'],Oral, 
12176,2622,Copaxone,2016-01-27,,20,mg,['2 / Day'],IV, 
12177,2622,Ledertrexaat,2016-09-25,2021-03-17,500, ,['2 / Day'],IV,Lack of efficacy
12178,479,Tecfidera,2016-07-18,2017-11-27,500, ,['2 / Day'],IV,Persistence of relapses
12179,479,Alemtuzumab (Campath),2016-04-09,2019-04-17,1000,mg,['/Month'],IV,Persisting MRI activity
12180,479,Tecfidera,2015-12-08,2018-05-25,20, ,['/Month'],IV,Persisting MRI activity
12181,4150,Gilenya,2016-01-13,, ,mg,['/Month'],IV, 
12182,4150,D-cure (Vitamine D),2016-04-27,2018-04-05,5000, ,['/Month'], ,Adverse Event
12183,4150,Alemtuzumab (Campath),2016-04-28,2020-11-08,500, ,['/ Day'], ,Persisting MRI activity
12184,1366,Methylprednisolone,2016-07-12,2018-07-16,1000,MIU,[' '],IV,Adverse Event
12185,3044,Methylprednisolone,2016-06-12,2019-09-07, ,mg,['3 / Week'],IV,Lack of efficacy
12186,3044,Tecfidera,2016-08-20,2019-05-06,1000, ,[' '],Oral,Persisting MRI activity
12187,3044,Rebif [44],2016-01-18,2018-10-29, ,mg,['2 / Day'],IV,Patient Choice/Convenience
12188,3234,Avonex,2016-04-27,2020-02-18, , ,['2 / Day'], ,Adverse Event
12189,4566,Rebif [44],2016-09-11,, ,mg,['/ Day'],Oral, 
12190,2521,Rebif [44],2016-02-18,,20, ,['2 / Day'],IV, 
12191,2521,Endoxan,2016-08-07,2017-11-06,1, ,['/Month'], ,Patient Choice/Convenience
12192,2521,Alemtuzumab (Campath),2015-12-20,2018-11-26,5000,mg,[' '],Oral,Lack of efficacy
12193,1084,Copaxone,2016-04-01,,1,MIU,['/Month'], , 
12194,1084,Rebif [44],2016-05-17,, ,mg,['/Month'],IV, 
12195,1084,Avonex,2016-08-08,2020-05-14, ,mg,['/Month'], ,Adverse Event
12196,1084,IVIG,2016-03-31,2019-10-24,5000,MIU,['/Month'],IV,Adverse Event
12197,1210,Tecfidera,2015-12-25,2017-12-17,20, ,['/Month'],Oral,Adverse Event
12198,1210,Copaxone,2016-01-09,,500,mg,['2 / Day'], , 
12199,1210,Tysabri,2016-07-23,2020-02-19, ,mg,['/ Day'],IV,Patient Choice/Convenience
12200,1210,Tysabri,2016-03-20,2020-03-01, ,MIU,['/Month'], ,Lack of efficacy
12201,966,Rebif [44],2016-10-04,,1000,mcg,['2 / Day'],IV, 
12202,966,Copaxone,2016-08-04,,20, ,[' '],IV, 
12203,966,Avonex,2015-12-18,2019-01-13,1000, ,['/Month'], ,Patient Choice/Convenience
12204,1713,Betaferon,2016-08-28,,400,mg,['/Month'], , 
12205,1713,Tecfidera,2016-08-02,,1,MIU,['/Month'],IV, 
12206,1716,Endoxan,2016-01-31,,1,mg,[' '],IV, 
12207,1716,Rebif [22],2016-09-09,2018-05-07, ,mg,['/Month'],Oral,Persisting MRI activity
12208,1716,Tecfidera,2016-07-23,,300,mg,['2 / Day'], , 
12209,1052,Copaxone,2016-06-09,,5000,mg,['3 / Week'], , 
12210,1584,Betaferon,2016-03-22,2018-12-28,5000,mcg,['/ Day'],Oral,Lack of efficacy
12211,1584,Tecfidera,2016-09-07,, ,mcg,['/Month'],IV, 
12212,3389,D-cure (Vitamine D),2016-06-01,2020-01-01, , ,['2 / Day'],IV,Persistence of relapses
12213,3389,Tecfidera,2016-09-04,,5000,mg,['/ Week'],IV, 
12214,2909,Tecfidera,2016-02-20,,5000, ,['/Month'],IV, 
12215,2909,Ledertrexaat,2015-11-22,,1000,mg,['/Month'],IV, 
12216,2909,Rebif [22],2015-11-01,2020-10-25,1,mg,['2 / Day'],IV,Lack of efficacy
12217,2909,Gilenya,2015-12-14,,5000, ,['2 / Day'], , 
12218,1909,Alemtuzumab (Campath),2016-08-26,,20, ,['2 / Day'],IV, 
12219,1909,Rebif [22],2015-10-24,2019-06-30, , ,['/Month'], ,Patient Choice/Convenience
12220,1909,Gilenya,2016-04-03,2019-12-07,500,mg,['2 / Day'], ,Persisting MRI activity
12221,2613,Alemtuzumab (Campath),2016-02-23,,1000, ,['/Month'],IV, 
12222,2160,Gilenya,2015-12-12,2021-07-31, , ,[' '],IV,Lack of efficacy
12223,2160,Rebif [22],2016-09-13,2020-04-04, , ,['2 / Day'],IV,Adverse Event
12224,2160,Rebif [22],2015-12-16,2020-03-08, ,mg,['/Month'],IV,Lack of efficacy
12225,2160,Tysabri,2016-04-20,2019-12-08,5000,mg,['/ Day'], ,Adverse Event
12226,1377,IVIG,2016-03-28,,20,mg,['/Month'],IV, 
12227,1377,D-cure (Vitamine D),2016-04-20,,300,MIU,['/Month'], , 
12228,2888,Endoxan,2015-11-07,, , ,['3 / Week'], , 
12229,2888,Alemtuzumab (Campath),2015-12-04,,500, ,['/Month'],Oral, 
12230,2888,Rebif [44],2016-08-31,2019-04-18,300,mg,['3 / Week'], ,Persistence of relapses
12231,4912,Methylprednisolone,2016-10-19,,20, ,['/Month'],IV, 
12232,4912,Alemtuzumab (Campath),2015-12-01,,1, ,['2 / Day'],Oral, 
12233,4912,Copaxone,2016-10-11,,5000, ,['/Month'],IV, 
12234,1221,Tecfidera,2016-10-08,,1, ,['/ Week'], , 
12235,1221,Betaferon,2015-12-30,2019-08-06,5000, ,['2 / Day'],Oral,Adverse Event
12236,1221,Avonex,2016-08-28,,400,mg,['2 / Day'],IV, 
12237,1221,IVIG,2016-06-02,, ,mcg,['/ Day'],IV, 
12238,3804,IVIG,2015-12-07,, , ,['/Month'],Oral, 
12239,528,Ledertrexaat,2016-10-18,2019-10-14, ,mg,[' '], ,Adverse Event
12240,4985,Avonex,2016-04-08,, ,mcg,['/ Day'], , 
12241,4985,IVIG,2016-08-10,, , ,['2 / Day'], , 
12242,4985,Tecfidera,2015-12-04,,1, ,['2 / Day'], , 
12243,4985,Avonex,2016-07-21,, , ,['2 / Day'], , 
12244,358,Tysabri,2016-07-21,2020-06-13, , ,['2 / Day'],IV,Lack of efficacy
12245,358,Tecfidera,2015-12-22,,5000,mg,['2 / Day'],Oral, 
12246,358,Endoxan,2015-12-27,,300, ,['2 / Day'],IV, 
12247,358,Rebif [22],2016-02-22,,5000,mg,['2 / Day'],Oral, 
12248,4626,Tysabri,2016-09-12,, ,mg,['/ Day'],Oral, 
12249,4626,IVIG,2016-05-15,,500,mg,['2 / Day'],IV, 
12250,4626,D-cure (Vitamine D),2016-06-27,2020-11-12,20, ,['2 / Day'],IV,Persisting MRI activity
12251,4077,Alemtuzumab (Campath),2016-03-05,2021-10-09,500, ,['2 / Day'],Oral,Patient Choice/Convenience
12252,4077,Endoxan,2016-01-12,,20,mg,['/Month'],IV, 
12253,4077,Avonex,2016-08-10,,5000, ,[' '], , 
12254,4077,Betaferon,2016-02-16,,5000,MIU,['/Month'], , 
12255,135,Betaferon,2016-09-25,2020-05-02, , ,['/Month'],Oral,Patient Choice/Convenience
12256,135,D-cure (Vitamine D),2016-01-05,2020-10-16, , ,['/Month'],IV,Patient Choice/Convenience
12257,3855,Ledertrexaat,2016-06-02,, ,mcg,[' '],IV, 
12258,2642,Endoxan,2015-12-08,, , ,['/Month'],IV, 
12259,2642,Endoxan,2016-08-29,,500, ,['/Month'],IV, 
12260,2642,Mitoxantrone,2015-11-03,,20,MIU,['2 / Day'],IV, 
12261,2642,D-cure (Vitamine D),2016-07-26,2021-03-13,1, ,['/ Week'],IV,Patient Choice/Convenience
12262,1994,IVIG,2015-12-13,,1,MIU,['/ Week'],Oral, 
12263,948,Copaxone,2016-06-21,2020-04-21, , ,['/Month'],IV,Patient Choice/Convenience
12264,948,Methylprednisolone,2016-07-29,,5000,mg,[' '],IV, 
12265,948,Endoxan,2016-10-17,2021-08-17,1000,mg,['3 / Week'],IV,Lack of efficacy
12266,948,Rebif [22],2016-03-21,, ,mg,['2 / Day'],IV, 
12267,4599,Tecfidera,2016-01-11,,5000,mg,['/Month'], , 
12268,1776,IVIG,2015-12-31,,500,MIU,['3 / Week'], , 
12269,1776,Gilenya,2016-08-14,2020-06-21,1000,mg,['2 / Day'],IV,Adverse Event
12270,1776,Tysabri,2016-02-06,, , ,['/Month'], , 
12271,553,Ledertrexaat,2016-03-09,2018-04-05,500,mg,['/Month'],IV,Persistence of relapses
12272,553,Gilenya,2016-09-18,2019-01-15,300,mg,['3 / Week'],IV,Persistence of relapses
12273,3627,Alemtuzumab (Campath),2016-07-01,,5000,mg,['2 / Day'], , 
12274,3627,IVIG,2016-07-27,2020-12-25, , ,['3 / Week'], ,Patient Choice/Convenience
12275,3627,Endoxan,2016-06-28,2019-09-29,20, ,[' '], ,Lack of efficacy
12276,2688,IVIG,2015-11-04,,5000, ,['2 / Day'],IV, 
12277,4042,Endoxan,2015-10-27,,1000,mcg,['/ Day'],IV, 
12278,4042,Tecfidera,2016-01-27,2018-02-01, ,mg,['/ Day'],IV,Persistence of relapses
12279,4042,D-cure (Vitamine D),2016-05-19,,1000, ,['/ Day'],IV, 
12280,4042,Rebif [44],2016-08-21,,1000, ,[' '],IV, 
12281,856,Tysabri,2015-12-25,,1000, ,['/ Day'],IV, 
12282,856,D-cure (Vitamine D),2016-02-28,2021-05-10,400, ,['/ Week'],IV,Adverse Event
12283,856,Tecfidera,2016-10-02,2019-01-01, ,mg,[' '], ,Persisting MRI activity
12284,856,IVIG,2016-03-01,2019-12-22,1, ,['/ Day'],IV,Lack of efficacy
12285,3378,Rebif [22],2015-11-24,2019-01-17,400,mg,['/ Week'],IV,Patient Choice/Convenience
12286,3378,Avonex,2016-06-08,2018-08-15,500, ,['/Month'],IV,Persisting MRI activity
12287,3378,Mitoxantrone,2016-03-15,,400,mg,['/Month'],IV, 
12288,3378,Teriflunomide,2016-08-29,,5000, ,['/ Day'],Oral, 
12289,3837,Rebif [22],2016-04-04,,5000, ,['/Month'], , 
12290,3837,Endoxan,2015-11-11,,500,mcg,['/Month'],Oral, 
12291,3837,Rebif [22],2015-11-06,2019-01-30,1,mg,['/ Day'],IV,Lack of efficacy
12292,3837,Endoxan,2015-11-16,2018-03-03,1, ,['2 / Day'],IV,Adverse Event
12293,2827,Tecfidera,2016-05-09,2018-07-18,300, ,['2 / Day'],IV,Patient Choice/Convenience
12294,616,Gilenya,2016-10-15,,5000,mcg,['2 / Day'], , 
12295,616,Teriflunomide,2015-11-07,,5000,mg,['2 / Day'],IV, 
12296,616,D-cure (Vitamine D),2016-06-30,2018-12-31, , ,['2 / Day'], ,Lack of efficacy
12297,4617,Alemtuzumab (Campath),2016-09-28,,20, ,['/Month'],IV, 
12298,1697,IVIG,2016-07-18,,1,mcg,['/Month'],IV, 
12299,1697,IVIG,2016-04-23,2018-11-13, , ,['/ Week'], ,Patient Choice/Convenience
12300,1697,D-cure (Vitamine D),2016-08-16,,1000, ,['3 / Week'], , 
12301,375,Rebif [22],2016-02-02,,500, ,['/Month'],Oral, 
12302,375,Rebif [44],2016-09-17,, ,mcg,['3 / Week'], , 
12303,375,Tecfidera,2016-04-25,2020-05-17,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
12304,375,D-cure (Vitamine D),2016-03-12,, ,mcg,['3 / Week'], , 
12305,3371,Alemtuzumab (Campath),2016-06-30,2020-10-19, , ,['/Month'], ,Patient Choice/Convenience
12306,3371,Copaxone,2015-12-20,, ,MIU,['2 / Day'],IV, 
12307,3371,Copaxone,2016-04-17,2019-01-22, ,mcg,['/Month'],IV,Persisting MRI activity
12308,3371,D-cure (Vitamine D),2016-06-17,2019-11-10,1,mg,['/ Day'],Oral,Adverse Event
12309,4463,Rebif [22],2016-01-05,,1000, ,['2 / Day'], , 
12310,4463,Alemtuzumab (Campath),2016-08-26,2021-08-07,400, ,['2 / Day'],Oral,Patient Choice/Convenience
12311,4463,Avonex,2016-04-12,2020-03-24,400, ,['2 / Day'],Oral,Persisting MRI activity
12312,4463,Betaferon,2016-02-04,2021-03-04, ,MIU,['/ Day'],IV,Persisting MRI activity
12313,4012,Tecfidera,2016-10-07,, ,mg,['/Month'], , 
12314,4012,D-cure (Vitamine D),2015-11-02,2019-05-20,500, ,['2 / Day'],Oral,Lack of efficacy
12315,1234,IVIG,2016-05-08,2019-03-15,400, ,['2 / Day'],IV,Persisting MRI activity
12316,1234,Mitoxantrone,2016-01-28,,500, ,['/Month'],IV, 
12317,2026,Rebif [44],2015-10-30,, , ,[' '],Oral, 
12318,1704,Endoxan,2016-03-27,2017-11-10,300,mg,['/Month'],IV,Adverse Event
12319,1704,D-cure (Vitamine D),2016-03-12,, , ,['/Month'],IV, 
12320,1704,Methylprednisolone,2016-03-04,, , ,['/Month'],IV, 
12321,1704,Endoxan,2015-12-07,2021-09-30,400,mg,['/ Week'], ,Adverse Event
12322,2246,D-cure (Vitamine D),2015-12-29,, ,mg,['2 / Day'], , 
12323,2246,Rebif [44],2016-08-29,2019-10-07, , ,['2 / Day'],IV,Persistence of relapses
12324,1281,Rebif [44],2016-07-12,,300, ,['/ Day'],IV, 
12325,1281,Teriflunomide,2016-06-04,,400, ,['2 / Day'], , 
12326,1281,Tysabri,2016-05-24,2020-11-11,300,MIU,['2 / Day'],Oral,Adverse Event
12327,666,IVIG,2016-04-12,, ,mg,['3 / Week'], , 
12328,292,Avonex,2016-08-18,2021-05-16,20,mg,['/Month'],IV,Adverse Event
12329,3362,Copaxone,2016-08-02,2020-09-08,500,MIU,['/Month'], ,Patient Choice/Convenience
12330,3362,Methylprednisolone,2016-10-16,, ,mg,['2 / Day'], , 
12331,3362,D-cure (Vitamine D),2016-03-24,2019-05-12,1000,mg,['2 / Day'],IV,Lack of efficacy
12332,1214,Copaxone,2016-09-28,2017-12-08,1000,mg,['2 / Day'],IV,Adverse Event
12333,1214,Avonex,2016-01-01,2020-10-01,300,mcg,['/Month'], ,Patient Choice/Convenience
12334,1214,Mitoxantrone,2016-05-30,2018-09-13, , ,['2 / Day'],IV,Persisting MRI activity
12335,1590,IVIG,2016-01-06,2018-10-04,500, ,['/Month'],IV,Adverse Event
12336,1590,Rebif [44],2016-03-18,2019-10-05,300,mg,['3 / Week'],IV,Persisting MRI activity
12337,1590,Methylprednisolone,2016-02-14,, , ,['3 / Week'],IV, 
12338,1590,Endoxan,2015-11-26,2021-09-09,20, ,['/Month'],Oral,Persisting MRI activity
12339,1160,Rebif [44],2016-07-05,2020-12-31,20, ,['/Month'], ,Patient Choice/Convenience
12340,1160,D-cure (Vitamine D),2016-01-10,2020-03-15,500,mg,['/Month'], ,Patient Choice/Convenience
12341,486,Methylprednisolone,2016-09-02,,1, ,['2 / Day'],IV, 
12342,486,Avonex,2016-01-07,,400,mg,['2 / Day'],IV, 
12343,486,Copaxone,2016-02-15,2018-11-28,500, ,['2 / Day'],IV,Persisting MRI activity
12344,2944,Teriflunomide,2016-08-28,, ,mg,['/Month'],IV, 
12345,2944,Tecfidera,2016-09-18,, ,mg,['/ Week'], , 
12346,2944,IVIG,2015-12-15,2021-09-22,20,mg,['2 / Day'],IV,Persisting MRI activity
12347,2944,Rebif [44],2015-11-20,,5000, ,['3 / Week'],IV, 
12348,3717,Betaferon,2016-07-22,2020-07-08,300, ,['/ Day'],IV,Persisting MRI activity
12349,3717,Teriflunomide,2016-08-02,,300,mg,['/ Day'],IV, 
12350,345,Avonex,2016-09-06,2019-04-24, ,MIU,['/Month'], ,Persisting MRI activity
12351,1072,Avonex,2016-01-21,, ,mg,['/Month'],IV, 
12352,1072,D-cure (Vitamine D),2016-04-21,2019-09-02,1000,mg,['/Month'],IV,Persistence of relapses
12353,1072,IVIG,2016-05-04,2021-08-20,5000, ,['2 / Day'], ,Persisting MRI activity
12354,4766,IVIG,2016-08-03,, , ,['/ Week'], , 
12355,4766,D-cure (Vitamine D),2016-02-06,,1, ,['2 / Day'], , 
12356,2089,Rebif [44],2016-01-28,, ,mg,['2 / Day'],IV, 
12357,2089,D-cure (Vitamine D),2016-09-07,, ,mg,['2 / Day'], , 
12358,2836,Copaxone,2016-03-23,2018-05-16, , ,['/Month'], ,Adverse Event
12359,3599,Gilenya,2016-04-11,, , ,['/ Day'], , 
12360,3599,Teriflunomide,2016-07-13,, ,mg,['/Month'],IV, 
12361,3599,Methylprednisolone,2016-10-13,2020-02-17, ,mg,[' '],IV,Lack of efficacy
12362,1750,Rebif [44],2016-08-11,, ,mg,['/ Day'],IV, 
12363,1750,Avonex,2016-08-04,2018-02-07, , ,['/Month'],IV,Lack of efficacy
12364,1750,Endoxan,2016-06-19,2020-05-09,300,mg,['2 / Day'],Oral,Patient Choice/Convenience
12365,1750,Tysabri,2016-04-02,2018-11-11,20,mg,['2 / Day'],Oral,Persisting MRI activity
12366,3118,Rebif [44],2016-10-01,2017-11-22,5000,MIU,['3 / Week'],IV,Adverse Event
12367,3118,Tysabri,2016-01-07,,1000,mcg,['2 / Day'],IV, 
12368,3118,Alemtuzumab (Campath),2015-11-07,, ,mg,['2 / Day'],IV, 
12369,2263,Alemtuzumab (Campath),2016-03-29,,500, ,['2 / Day'],Oral, 
12370,2263,Teriflunomide,2015-12-05,2021-01-31,500,mg,['/ Week'],Oral,Persisting MRI activity
12371,2263,Methylprednisolone,2016-08-08,, ,mg,['/Month'],IV, 
12372,4128,Betaferon,2016-04-22,2019-05-26, ,mg,['/Month'], ,Patient Choice/Convenience
12373,1718,Tysabri,2016-09-02,,500,mg,['/Month'], , 
12374,1718,Rebif [44],2015-10-26,, ,mg,['2 / Day'], , 
12375,4038,Tysabri,2015-12-23,2019-06-28,400, ,['3 / Week'], ,Patient Choice/Convenience
12376,4038,Betaferon,2016-02-10,,500,mg,['/Month'],IV, 
12377,4038,Alemtuzumab (Campath),2016-06-24,,5000, ,['/Month'],Oral, 
12378,4038,Rebif [44],2016-08-01,,300,mg,['2 / Day'],Oral, 
12379,1669,Mitoxantrone,2015-12-02,,300,mg,['/ Day'], , 
12380,4441,Endoxan,2016-08-12,2020-03-31,1000, ,['/Month'], ,Lack of efficacy
12381,4441,Endoxan,2016-08-07,,5000,mg,['/ Week'], , 
12382,4441,Avonex,2016-04-09,2019-08-04,500, ,['3 / Week'],IV,Persistence of relapses
12383,4441,Gilenya,2016-07-07,, , ,['2 / Day'],IV, 
12384,2480,Gilenya,2016-09-17,2019-12-11, , ,['2 / Day'],Oral,Persistence of relapses
12385,2480,Gilenya,2016-01-06,,1000, ,['/ Week'],IV, 
12386,2480,Methylprednisolone,2016-08-30,,1000,MIU,['/Month'],Oral, 
12387,1744,D-cure (Vitamine D),2016-07-28,2020-03-31,5000,MIU,['3 / Week'],Oral,Persisting MRI activity
12388,1744,Mitoxantrone,2016-06-26,, , ,['/Month'],IV, 
12389,1744,Endoxan,2016-10-11,, ,mg,['3 / Week'], , 
12390,4118,Rebif [22],2016-03-12,2019-06-23, ,mcg,['/Month'], ,Adverse Event
12391,4118,D-cure (Vitamine D),2016-04-01,,500,MIU,['/Month'],Oral, 
12392,4118,IVIG,2015-10-26,2021-03-22,300,mg,['/Month'],IV,Lack of efficacy
12393,712,Betaferon,2016-03-05,2020-06-23,500, ,['2 / Day'],IV,Patient Choice/Convenience
12394,712,Copaxone,2016-01-11,2018-02-22, , ,['3 / Week'], ,Persistence of relapses
12395,712,D-cure (Vitamine D),2016-02-11,2019-10-16,300, ,['/Month'],IV,Adverse Event
12396,2604,Rebif [22],2015-12-22,, ,MIU,['3 / Week'],IV, 
12397,2604,Tecfidera,2016-03-20,2019-03-19,20,mg,[' '], ,Adverse Event
12398,2604,Methylprednisolone,2016-05-17,,5000,MIU,[' '],IV, 
12399,2658,Rebif [22],2015-12-31,,500, ,['3 / Week'],IV, 
12400,2658,Tecfidera,2015-12-07,2017-12-01,300, ,['/Month'],IV,Adverse Event
12401,2658,Rebif [44],2016-07-28,2020-09-22, ,mg,[' '],IV,Patient Choice/Convenience
12402,2658,Rebif [44],2016-06-05,2020-04-10,1,mcg,['3 / Week'],IV,Adverse Event
12403,3979,Tecfidera,2015-11-16,, ,mg,['2 / Day'],IV, 
12404,4312,D-cure (Vitamine D),2016-06-20,2018-09-06,300,MIU,['2 / Day'],Oral,Persisting MRI activity
12405,4312,Avonex,2016-06-29,,20, ,[' '], , 
12406,4312,Gilenya,2016-04-16,2019-05-16,20, ,['3 / Week'], ,Persistence of relapses
12407,3355,Mitoxantrone,2015-11-20,,500,mg,['/ Day'], , 
12408,3355,Alemtuzumab (Campath),2015-11-25,, ,mg,['2 / Day'], , 
12409,3355,Rebif [44],2015-12-01,,1, ,['3 / Week'], , 
12410,3355,Tysabri,2016-05-23,,20,mg,['2 / Day'],IV, 
12411,2746,Betaferon,2015-12-31,,5000,mg,['2 / Day'],IV, 
12412,2746,Ledertrexaat,2016-05-09,,1000, ,['/Month'], , 
12413,2746,IVIG,2015-12-03,2018-04-09,500,mg,['2 / Day'], ,Adverse Event
12414,2746,Betaferon,2016-06-27,2018-10-11,300,mg,['2 / Day'], ,Persisting MRI activity
12415,4080,D-cure (Vitamine D),2016-08-15,2021-03-07,400,mg,['/ Day'],Oral,Persistence of relapses
12416,3017,Tysabri,2016-08-21,2019-03-20,5000,mg,[' '], ,Adverse Event
12417,3017,IVIG,2016-06-24,,1000,mg,['3 / Week'],IV, 
12418,3017,Methylprednisolone,2016-06-15,, ,MIU,['2 / Day'], , 
12419,4913,Methylprednisolone,2016-05-23,,20,mg,['3 / Week'], , 
12420,4913,Betaferon,2016-04-02,2018-11-06,20, ,['3 / Week'], ,Patient Choice/Convenience
12421,4913,Endoxan,2015-11-26,, ,mg,['2 / Day'], , 
12422,1048,Tysabri,2016-01-03,, ,mg,['2 / Day'],IV, 
12423,1798,Tecfidera,2016-04-20,2018-03-03, , ,['/Month'],Oral,Persisting MRI activity
12424,1798,Betaferon,2016-03-01,2021-07-19,5000,MIU,['/ Day'],Oral,Patient Choice/Convenience
12425,2638,Rebif [22],2015-12-18,, , ,[' '],IV, 
12426,2638,Tysabri,2016-03-15,2017-12-22, ,MIU,['/Month'],IV,Lack of efficacy
12427,1289,Rebif [44],2016-02-10,2019-07-09, ,mcg,['3 / Week'],IV,Adverse Event
12428,1289,Tecfidera,2016-10-22,,1, ,['2 / Day'],IV, 
12429,1289,D-cure (Vitamine D),2016-06-27,2020-07-18,5000,MIU,['/Month'],IV,Persisting MRI activity
12430,1142,Teriflunomide,2015-11-09,,500, ,['/Month'],IV, 
12431,329,Tecfidera,2016-02-07,2019-05-05,1000,mg,['2 / Day'],IV,Lack of efficacy
12432,329,Avonex,2015-12-22,2021-02-19,500,mg,['/Month'], ,Patient Choice/Convenience
12433,329,Mitoxantrone,2016-01-05,,400,mg,['2 / Day'], , 
12434,329,Tysabri,2016-09-28,2018-12-18,20,mcg,['2 / Day'],Oral,Patient Choice/Convenience
12435,668,Rebif [22],2016-02-19,, ,mg,[' '],IV, 
12436,668,Alemtuzumab (Campath),2015-11-06,,300, ,['2 / Day'],IV, 
12437,3443,Rebif [22],2016-05-19,, ,mg,['3 / Week'],IV, 
12438,2903,Mitoxantrone,2016-08-07,,400, ,['3 / Week'], , 
12439,2903,Gilenya,2016-10-12,,1,mg,['2 / Day'], , 
12440,1562,D-cure (Vitamine D),2015-12-23,2021-06-09,300,mg,['2 / Day'],IV,Lack of efficacy
12441,1562,IVIG,2016-01-10,,20, ,['3 / Week'], , 
12442,3359,Rebif [44],2016-01-28,, ,mg,['2 / Day'], , 
12443,3359,Endoxan,2016-09-11,,20,mg,['3 / Week'],IV, 
12444,3359,Tysabri,2016-09-01,,500,mg,['3 / Week'], , 
12445,2542,Rebif [44],2015-12-26,,5000,mg,['3 / Week'], , 
12446,2542,D-cure (Vitamine D),2016-03-20,2020-10-16,20,mg,['3 / Week'],IV,Lack of efficacy
12447,2542,Copaxone,2016-04-01,,500, ,['3 / Week'],IV, 
12448,2542,Betaferon,2016-08-02,, ,mg,['2 / Day'],IV, 
12449,3171,Methylprednisolone,2015-12-19,2021-04-11,500, ,['/Month'], ,Patient Choice/Convenience
12450,3171,Teriflunomide,2016-02-12,,1000, ,['/Month'], , 
12451,3171,Copaxone,2016-07-12,,500,mg,['3 / Week'], , 
12452,3171,Betaferon,2016-06-25,2018-11-29,1, ,['/Month'],Oral,Adverse Event
12453,1680,Betaferon,2016-01-20,, , ,['/Month'], , 
12454,1680,Ledertrexaat,2016-10-21,,1,mg,['/Month'],IV, 
12455,4019,Copaxone,2015-12-19,, ,mg,['2 / Day'],IV, 
12456,4726,Rebif [22],2016-04-28,2017-11-07, ,mg,[' '],IV,Persistence of relapses
12457,2906,Copaxone,2016-06-25,,300,mg,['2 / Day'],IV, 
12458,2906,Tecfidera,2016-01-22,,1000,mg,['/Month'],IV, 
12459,2329,Methylprednisolone,2015-12-04,2020-02-26, , ,['2 / Day'],IV,Persisting MRI activity
12460,2329,D-cure (Vitamine D),2016-01-07,2019-04-06, ,MIU,['2 / Day'],Oral,Adverse Event
12461,2329,Mitoxantrone,2016-09-29,2018-02-24,20,mg,['/ Day'],IV,Patient Choice/Convenience
12462,2329,IVIG,2015-12-28,2019-02-03, ,mg,[' '],IV,Adverse Event
12463,4812,Mitoxantrone,2015-11-10,, , ,['/Month'],IV, 
12464,4812,Alemtuzumab (Campath),2015-11-14,,1000,MIU,['/ Week'],IV, 
12465,4812,Tysabri,2016-02-29,, , ,['/Month'], , 
12466,4812,Endoxan,2016-05-30,,1000, ,['2 / Day'], , 
12467,2204,Rebif [44],2016-06-12,,20,mg,['/ Week'], , 
12468,2204,Mitoxantrone,2016-04-21,,20, ,['/ Week'], , 
12469,1245,Gilenya,2016-04-01,,5000, ,['/Month'], , 
12470,1245,Tysabri,2016-06-21,,1000,MIU,['2 / Day'],IV, 
12471,1245,Rebif [22],2015-11-18,2018-08-20,1, ,['2 / Day'],Oral,Patient Choice/Convenience
12472,2082,Endoxan,2016-04-11,,5000, ,['2 / Day'],Oral, 
12473,2082,Copaxone,2016-07-27,,300,mg,['2 / Day'],IV, 
12474,2082,D-cure (Vitamine D),2016-07-09,,20,mg,['2 / Day'],Oral, 
12475,2082,Methylprednisolone,2016-04-18,2018-06-07, ,mg,['2 / Day'], ,Patient Choice/Convenience
12476,4886,Rebif [44],2016-02-26,,20,MIU,['2 / Day'], , 
12477,4886,Avonex,2016-03-25,2018-05-30, , ,['/ Week'], ,Lack of efficacy
12478,4886,Rebif [22],2016-10-03,,300,MIU,['2 / Day'], , 
12479,4698,Copaxone,2015-12-12,2019-09-09,500,mg,['2 / Day'], ,Patient Choice/Convenience
12480,4698,Teriflunomide,2016-01-03,, ,mg,['2 / Day'],IV, 
12481,1702,Tysabri,2016-09-28,,300,mg,['/Month'], , 
12482,3412,Tysabri,2016-04-27,,300, ,['3 / Week'],IV, 
12483,3412,Rebif [22],2015-12-09,, , ,['/Month'], , 
12484,4468,Gilenya,2016-05-11,,1000, ,['3 / Week'],Oral, 
12485,4468,Tecfidera,2016-06-09,,5000,mcg,['/Month'],IV, 
12486,647,Tysabri,2016-01-03,2019-11-09, ,mg,['2 / Day'],IV,Persistence of relapses
12487,559,D-cure (Vitamine D),2016-05-20,2019-11-27, , ,['/ Day'],IV,Adverse Event
12488,559,Methylprednisolone,2015-12-18,, , ,['2 / Day'],IV, 
12489,2461,Alemtuzumab (Campath),2016-04-04,2019-01-19,1000,MIU,['2 / Day'],IV,Adverse Event
12490,2461,IVIG,2016-07-04,,1000,mg,[' '], , 
12491,2277,Rebif [22],2016-06-11,, ,mg,['/Month'], , 
12492,2277,D-cure (Vitamine D),2016-09-26,,500, ,['2 / Day'], , 
12493,2277,Gilenya,2016-08-18,,500,mg,['2 / Day'],IV, 
12494,2341,Endoxan,2016-07-28,,1000,mg,['/ Day'],IV, 
12495,2341,Methylprednisolone,2016-03-01,2017-11-05,1000,mg,[' '], ,Adverse Event
12496,2341,Rebif [22],2016-02-07,,1,mg,['/Month'],IV, 
12497,2341,Methylprednisolone,2016-02-28,2018-11-03,1000,MIU,['/Month'],IV,Adverse Event
12498,1842,Gilenya,2016-05-21,,20,mcg,['2 / Day'],Oral, 
12499,1842,Teriflunomide,2015-12-02,2019-08-03, ,mg,['2 / Day'],Oral,Persisting MRI activity
12500,1842,Teriflunomide,2015-11-30,,5000, ,['/Month'],Oral, 
12501,735,IVIG,2016-02-28,2019-05-13, ,mg,['/Month'], ,Persisting MRI activity
12502,735,Rebif [22],2015-12-03,,5000,mg,['2 / Day'], , 
12503,735,Endoxan,2016-06-07,, , ,['/Month'],Oral, 
12504,735,Rebif [22],2016-02-08,,300, ,['/Month'], , 
12505,1810,D-cure (Vitamine D),2016-08-19,2021-01-21,1, ,['/Month'],IV,Lack of efficacy
12506,1810,Methylprednisolone,2016-01-19,2019-06-02, ,mg,['3 / Week'],Oral,Lack of efficacy
12507,4944,Methylprednisolone,2015-12-19,2020-05-14, , ,['2 / Day'],IV,Persistence of relapses
12508,4944,Tysabri,2016-02-25,,1, ,[' '],IV, 
12509,4944,D-cure (Vitamine D),2016-07-22,,500,mg,['2 / Day'], , 
12510,4019,Rebif [22],2016-07-22,2020-10-17,400, ,['/Month'],IV,Lack of efficacy
12511,4019,Betaferon,2016-07-16,2019-10-14,1, ,['/ Week'], ,Lack of efficacy
12512,4019,Avonex,2016-04-03,,500,MIU,['2 / Day'],IV, 
12513,4019,Methylprednisolone,2016-03-22,2018-03-15,400, ,['/Month'], ,Persistence of relapses
12514,3947,Ledertrexaat,2016-09-07,2018-10-01,1,mg,['/ Week'],Oral,Lack of efficacy
12515,2008,Tecfidera,2015-11-04,,500,mg,['2 / Day'],IV, 
12516,2008,Betaferon,2016-02-29,2018-06-24,300,mg,['/Month'], ,Patient Choice/Convenience
12517,2008,Rebif [44],2016-07-13,,1000,mg,['/Month'], , 
12518,4018,Alemtuzumab (Campath),2016-09-19,2019-07-16,1000,mg,['3 / Week'], ,Adverse Event
12519,4018,Gilenya,2016-08-02,2019-03-19,5000, ,['2 / Day'], ,Patient Choice/Convenience
12520,4018,Tecfidera,2016-09-26,,5000,mg,['2 / Day'], , 
12521,4018,Gilenya,2015-12-26,2019-11-26,500,mg,['3 / Week'],Oral,Adverse Event
12522,4553,Gilenya,2015-12-27,2021-05-28,20,mg,['/Month'],Oral,Adverse Event
12523,2856,Alemtuzumab (Campath),2016-05-04,2021-02-11, ,mg,['/Month'],IV,Lack of efficacy
12524,2856,Gilenya,2016-01-11,2021-07-26,300,mg,['2 / Day'],IV,Persistence of relapses
12525,2856,Methylprednisolone,2016-02-25,,20,mg,['2 / Day'],IV, 
12526,2856,Avonex,2016-10-16,2019-09-10,300,mg,['/Month'],IV,Persisting MRI activity
12527,3748,Rebif [22],2016-10-20,,300,mg,['2 / Day'],IV, 
12528,3748,IVIG,2016-04-21,2020-06-04,1000,MIU,['/Month'],IV,Adverse Event
12529,3748,Endoxan,2015-12-11,, , ,['/ Week'],IV, 
12530,3748,Betaferon,2016-01-21,2018-12-26,500,mg,['2 / Day'], ,Adverse Event
12531,3192,Rebif [44],2016-07-12,, , ,[' '],IV, 
12532,3192,Tecfidera,2016-08-08,,1000, ,['/Month'],IV, 
12533,799,Methylprednisolone,2015-10-29,,20,MIU,['/Month'],IV, 
12534,799,Tysabri,2016-08-27,2019-06-02,20,mg,['/Month'], ,Persisting MRI activity
12535,799,Alemtuzumab (Campath),2016-08-19,2021-06-08,300, ,['/Month'], ,Lack of efficacy
12536,799,D-cure (Vitamine D),2016-05-23,,300, ,['/ Week'],IV, 
12537,316,Alemtuzumab (Campath),2015-12-06,2019-04-04, ,mcg,['2 / Day'],IV,Persisting MRI activity
12538,316,Endoxan,2015-11-24,,500, ,['2 / Day'],Oral, 
12539,4382,Gilenya,2016-09-16,2021-04-19, ,MIU,['2 / Day'],IV,Adverse Event
12540,3584,Methylprednisolone,2016-06-10,,1000, ,['/Month'],IV, 
12541,3584,Tecfidera,2016-07-31,2020-04-18, ,mg,['/Month'],IV,Patient Choice/Convenience
12542,3584,Methylprednisolone,2016-04-22,,300,mg,['/Month'],IV, 
12543,3584,Endoxan,2016-05-01,2018-10-02, , ,['3 / Week'], ,Adverse Event
12544,790,Tecfidera,2016-04-20,, , ,['2 / Day'], , 
12545,790,Rebif [22],2016-03-16,, ,MIU,['3 / Week'],IV, 
12546,790,D-cure (Vitamine D),2016-06-18,2019-03-20, ,mg,['/Month'], ,Adverse Event
12547,790,Gilenya,2016-02-11,2019-08-30,1, ,['/Month'],IV,Lack of efficacy
12548,4425,Tysabri,2016-05-12,,1000,MIU,[' '], , 
12549,4425,Ledertrexaat,2016-06-02,,500, ,[' '],IV, 
12550,4425,Alemtuzumab (Campath),2016-08-28,2018-08-31,500, ,['2 / Day'],Oral,Lack of efficacy
12551,4425,IVIG,2016-05-17,2020-06-17,5000,mg,['2 / Day'], ,Lack of efficacy
12552,1369,D-cure (Vitamine D),2016-08-22,2020-08-15,1000,MIU,['2 / Day'], ,Adverse Event
12553,1369,IVIG,2015-10-27,, ,mg,['/Month'],Oral, 
12554,1369,Endoxan,2016-03-20,2020-06-28, ,mg,['/Month'], ,Adverse Event
12555,1369,Rebif [22],2016-06-23,,5000, ,['/Month'],Oral, 
12556,3218,Copaxone,2016-08-21,, ,mg,['2 / Day'],IV, 
12557,3218,Betaferon,2016-07-24,2021-10-14,5000, ,['3 / Week'],IV,Persisting MRI activity
12558,2631,D-cure (Vitamine D),2016-06-14,,300,mg,['/ Day'],IV, 
12559,2631,Endoxan,2016-07-19,2019-01-18,1, ,['/Month'],Oral,Persistence of relapses
12560,2631,Tysabri,2016-08-28,2020-09-06,500, ,['/Month'], ,Adverse Event
12561,2631,Rebif [44],2015-11-06,,1000,MIU,['2 / Day'],Oral, 
12562,713,D-cure (Vitamine D),2016-03-25,2021-07-10,500,mg,['/ Day'],IV,Persisting MRI activity
12563,713,Gilenya,2016-08-02,2018-03-14,20, ,['2 / Day'],IV,Persisting MRI activity
12564,4865,Betaferon,2016-03-05,,1000,mg,['3 / Week'], , 
12565,4865,Rebif [44],2016-01-10,,1,mcg,['/Month'], , 
12566,4865,Mitoxantrone,2016-07-27,2021-08-26,500, ,['3 / Week'],IV,Lack of efficacy
12567,2184,Teriflunomide,2015-10-25,2018-08-25,300,mg,['/ Week'],IV,Adverse Event
12568,1497,Gilenya,2016-07-26,, , ,['/Month'], , 
12569,1933,Gilenya,2015-11-17,,20,mg,[' '], , 
12570,1933,IVIG,2015-11-13,,300, ,['2 / Day'], , 
12571,4370,IVIG,2016-09-19,2020-03-16, ,mg,['2 / Day'],Oral,Persisting MRI activity
12572,4370,Avonex,2016-01-24,2020-12-29,300,MIU,['/Month'], ,Adverse Event
12573,4370,D-cure (Vitamine D),2015-12-29,, ,mg,['/ Week'], , 
12574,4424,Rebif [22],2016-09-08,2021-08-16, , ,['/ Day'],IV,Patient Choice/Convenience
12575,4424,Avonex,2016-02-08,2020-07-07, ,mg,['3 / Week'], ,Patient Choice/Convenience
12576,2798,IVIG,2016-10-01,,5000, ,['/ Week'],IV, 
12577,2798,Tysabri,2016-07-24,, ,mg,['3 / Week'],Oral, 
12578,2798,Rebif [22],2016-06-04,,20,MIU,['/Month'], , 
12579,2798,IVIG,2016-04-05,2017-11-10,500,mg,['2 / Day'], ,Adverse Event
12580,4874,IVIG,2015-11-13,, , ,['2 / Day'], , 
12581,4874,Teriflunomide,2016-02-25,2018-12-03, , ,['2 / Day'],Oral,Persistence of relapses
12582,4874,Tecfidera,2016-07-29,2020-06-12,1000, ,['2 / Day'],IV,Adverse Event
12583,4818,Alemtuzumab (Campath),2015-10-29,2018-11-19,400, ,['2 / Day'],Oral,Patient Choice/Convenience
12584,4818,Alemtuzumab (Campath),2015-11-27,,5000,MIU,['2 / Day'],IV, 
12585,4818,IVIG,2016-06-26,,1,mg,['3 / Week'],IV, 
12586,4818,Methylprednisolone,2016-08-03,2018-12-28,500,mcg,['3 / Week'],Oral,Lack of efficacy
12587,535,Avonex,2016-03-13,,400,mg,['2 / Day'], , 
12588,535,D-cure (Vitamine D),2016-03-10,,500,mg,['2 / Day'],Oral, 
12589,535,Teriflunomide,2016-05-03,2018-12-30,5000,mg,['2 / Day'],Oral,Lack of efficacy
12590,535,Avonex,2016-05-16,2020-11-13,5000,MIU,['/ Day'], ,Persistence of relapses
12591,4140,Rebif [44],2016-01-17,, ,mcg,[' '],IV, 
12592,4140,D-cure (Vitamine D),2016-04-30,2018-09-22,20, ,['/Month'], ,Persisting MRI activity
12593,4140,Endoxan,2016-10-13,,500,mg,['2 / Day'], , 
12594,2583,Betaferon,2016-10-15,2019-07-07,5000,mg,['/Month'],Oral,Patient Choice/Convenience
12595,2583,Betaferon,2016-01-19,,400,mcg,[' '],IV, 
12596,2575,Rebif [44],2016-07-28,,300,mg,['/Month'],IV, 
12597,2575,D-cure (Vitamine D),2016-03-26,2018-08-09,300, ,[' '],IV,Patient Choice/Convenience
12598,1158,Gilenya,2016-01-12,, ,mg,['2 / Day'],IV, 
12599,1158,Rebif [22],2016-09-30,2021-03-22,300,mcg,['/Month'],Oral,Persisting MRI activity
12600,1158,Rebif [22],2016-06-27,,300,mg,['2 / Day'],Oral, 
12601,1158,Alemtuzumab (Campath),2016-05-29,2020-07-25, ,mg,['3 / Week'],IV,Lack of efficacy
12602,1403,Teriflunomide,2016-04-30,2017-12-19, ,mg,['/Month'], ,Lack of efficacy
12603,1403,Gilenya,2016-07-22,2021-05-16, , ,['/ Week'],IV,Adverse Event
12604,1403,Ledertrexaat,2016-07-16,,5000,mg,['2 / Day'],IV, 
12605,1403,Gilenya,2016-07-22,2021-06-19,1000,mg,['/Month'], ,Lack of efficacy
12606,3207,IVIG,2016-10-12,,1, ,[' '], , 
12607,2292,Betaferon,2016-02-18,,1000,mg,['/ Week'],Oral, 
12608,2292,IVIG,2016-06-10,,500,mcg,['2 / Day'],IV, 
12609,2292,Teriflunomide,2016-05-22,2020-09-17, ,mg,['/Month'],IV,Patient Choice/Convenience
12610,2292,Avonex,2016-06-22,,300, ,['/Month'], , 
12611,2719,Alemtuzumab (Campath),2016-02-16,,300,mg,[' '],Oral, 
12612,2719,Tysabri,2016-06-20,,400,mg,['2 / Day'],IV, 
12613,2719,Endoxan,2016-06-24,,1,mg,['/Month'],IV, 
12614,2719,D-cure (Vitamine D),2015-12-11,, ,mg,['/Month'],Oral, 
12615,1000,Copaxone,2015-12-21,2020-02-16,20,mcg,['/ Week'], ,Persistence of relapses
12616,1000,Endoxan,2015-10-25,,400, ,['/Month'], , 
12617,1000,Tysabri,2016-05-23,, ,mg,['/ Week'],IV, 
12618,3495,Alemtuzumab (Campath),2016-02-01,2018-10-24, , ,[' '],IV,Adverse Event
12619,4030,D-cure (Vitamine D),2016-10-02,2020-03-16,500, ,['2 / Day'],IV,Lack of efficacy
12620,2454,D-cure (Vitamine D),2015-10-26,,1, ,['/Month'],IV, 
12621,2454,Rebif [22],2015-12-04,,1000, ,[' '], , 
12622,2454,Rebif [22],2016-04-29,2021-04-18,300, ,['2 / Day'],IV,Patient Choice/Convenience
12623,2114,D-cure (Vitamine D),2015-11-14,,1000,mg,['/Month'],IV, 
12624,4887,Mitoxantrone,2016-02-29,2020-10-14, , ,['/Month'], ,Lack of efficacy
12625,4874,Teriflunomide,2016-10-22,,500,mg,['3 / Week'], , 
12626,4874,Avonex,2016-05-28,2021-03-27,20,mg,['2 / Day'],Oral,Adverse Event
12627,478,Tysabri,2016-02-08,2021-09-24,300,mcg,['2 / Day'],IV,Adverse Event
12628,478,Tysabri,2016-03-31,, ,mg,['2 / Day'],IV, 
12629,478,D-cure (Vitamine D),2016-04-11,2018-04-02,20, ,['/Month'],IV,Lack of efficacy
12630,478,D-cure (Vitamine D),2016-10-18,,20,MIU,[' '], , 
12631,3943,Gilenya,2015-12-15,,400,mg,['2 / Day'], , 
12632,3943,Methylprednisolone,2016-03-18,,1000,mg,['/ Day'], , 
12633,3943,Gilenya,2016-01-15,,5000,mg,['/Month'],Oral, 
12634,3943,Teriflunomide,2016-04-29,, ,mg,['/ Day'],IV, 
12635,660,Tysabri,2016-04-17,,20,MIU,[' '], , 
12636,717,Ledertrexaat,2016-01-09,, ,mg,['2 / Day'], , 
12637,720,Tecfidera,2015-12-11,,1000, ,['2 / Day'],Oral, 
12638,720,Methylprednisolone,2016-08-01,2019-05-09,500,mg,['/ Week'],Oral,Persistence of relapses
12639,720,Endoxan,2016-01-18,, ,mg,['2 / Day'],IV, 
12640,3173,Avonex,2016-07-14,,20,mg,['/Month'], , 
12641,3173,Methylprednisolone,2015-11-03,2019-02-16, , ,['/ Week'],IV,Persisting MRI activity
12642,3173,Copaxone,2016-09-22,2020-01-09,1000,mg,['/Month'],IV,Lack of efficacy
12643,2297,Alemtuzumab (Campath),2016-07-11,,300,mg,['2 / Day'], , 
12644,2297,Methylprednisolone,2016-05-26,,5000, ,['/ Week'],IV, 
12645,2297,Ledertrexaat,2016-08-10,2020-08-29, ,mg,['2 / Day'], ,Adverse Event
12646,2125,IVIG,2016-04-09,,300,mg,['/Month'],IV, 
12647,2125,D-cure (Vitamine D),2016-04-26,,1000, ,['/ Week'], , 
12648,1845,Methylprednisolone,2016-09-15,,400, ,['/Month'],Oral, 
12649,875,IVIG,2016-06-20,,1,mg,['3 / Week'],IV, 
12650,875,Tecfidera,2016-10-20,2018-01-29,1000, ,[' '],IV,Patient Choice/Convenience
12651,875,Methylprednisolone,2016-03-05,,1,mg,['2 / Day'],IV, 
12652,875,Methylprednisolone,2016-09-22,2021-04-28, ,mg,['2 / Day'],Oral,Persistence of relapses
12653,2884,Methylprednisolone,2016-07-08,2018-10-02,1000, ,[' '],IV,Patient Choice/Convenience
12654,4244,Alemtuzumab (Campath),2015-12-04,,1000,mg,[' '],IV, 
12655,701,Betaferon,2016-06-18,,20,mg,['/Month'],IV, 
12656,103,Rebif [44],2016-05-20,,20, ,['/Month'], , 
12657,103,D-cure (Vitamine D),2016-02-29,,400,MIU,['2 / Day'],IV, 
12658,893,Tysabri,2016-09-14,2020-06-04,300,mcg,['/Month'], ,Lack of efficacy
12659,893,Rebif [22],2016-07-19,2018-10-08,1000, ,[' '], ,Adverse Event
12660,893,Methylprednisolone,2016-07-24,,20,mg,['2 / Day'],Oral, 
12661,893,Endoxan,2016-01-15,,5000,mg,['2 / Day'],IV, 
12662,4920,Teriflunomide,2016-05-07,,500,mg,['2 / Day'],IV, 
12663,4920,Copaxone,2016-09-15,2020-05-06,500,mcg,['2 / Day'],Oral,Lack of efficacy
12664,4920,Teriflunomide,2016-06-13,, ,MIU,['2 / Day'],IV, 
12665,4920,Gilenya,2016-04-19,,1,mg,['2 / Day'], , 
12666,1571,Alemtuzumab (Campath),2015-11-19,,500,MIU,['/Month'], , 
12667,1571,Tecfidera,2015-12-07,, , ,['2 / Day'],IV, 
12668,1571,Endoxan,2016-05-28,,500, ,['2 / Day'], , 
12669,3006,Rebif [22],2015-10-25,,500, ,['3 / Week'],IV, 
12670,3006,D-cure (Vitamine D),2015-11-06,, ,mg,['2 / Day'],Oral, 
12671,3006,D-cure (Vitamine D),2016-04-30,,20, ,['/ Week'],Oral, 
12672,3006,Tecfidera,2015-10-28,2020-02-10,20,mcg,['/Month'], ,Adverse Event
12673,1134,Rebif [22],2016-01-02,2018-12-01,400,mg,['2 / Day'],IV,Patient Choice/Convenience
12674,1134,IVIG,2015-12-25,, ,mg,['3 / Week'],IV, 
12675,1134,Alemtuzumab (Campath),2016-06-30,,1000, ,['/Month'],IV, 
12676,1134,Methylprednisolone,2016-03-05,,5000, ,['/Month'], , 
12677,2355,Avonex,2016-07-10,,500, ,['/Month'],IV, 
12678,2355,D-cure (Vitamine D),2015-12-26,,500, ,['/Month'],Oral, 
12679,2355,Endoxan,2016-03-12,2017-11-06, ,mcg,['2 / Day'],IV,Lack of efficacy
12680,4618,Copaxone,2016-06-20,,1000,MIU,['/Month'],IV, 
12681,4618,Teriflunomide,2016-02-01,,300,mg,['/Month'], , 
12682,4618,Tysabri,2016-06-22,,500,mg,['2 / Day'], , 
12683,2502,Tysabri,2016-02-25,2018-10-02, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
12684,2502,Ledertrexaat,2016-05-11,,1, ,['/Month'],IV, 
12685,4707,Endoxan,2015-11-05,,20, ,['3 / Week'],Oral, 
12686,4707,Teriflunomide,2016-07-21,2019-10-17,5000,mg,['2 / Day'],Oral,Persisting MRI activity
12687,4707,Teriflunomide,2016-07-18,,1000,mg,['/Month'], , 
12688,4707,Gilenya,2016-03-13,2019-08-01, ,MIU,['/Month'],IV,Persistence of relapses
12689,1403,Copaxone,2016-04-27,,1000,mcg,[' '], , 
12690,1403,Betaferon,2016-04-16,2018-10-01, , ,['3 / Week'],Oral,Persisting MRI activity
12691,1537,Teriflunomide,2016-06-30,,5000,mg,['2 / Day'], , 
12692,1537,D-cure (Vitamine D),2016-02-01,,5000, ,['/Month'], , 
12693,1537,Rebif [22],2016-08-16,2020-07-25,1000,mg,[' '],Oral,Persistence of relapses
12694,2986,Endoxan,2016-09-05,,300,MIU,['/Month'], , 
12695,2986,Copaxone,2015-11-10,, , ,[' '], , 
12696,2986,Rebif [44],2016-05-14,,1000,mg,['/ Week'], , 
12697,2986,D-cure (Vitamine D),2016-10-01,2021-04-14,1,MIU,['/ Day'],IV,Persisting MRI activity
12698,4623,Endoxan,2016-04-28,2020-06-22, ,MIU,[' '],IV,Adverse Event
12699,4623,D-cure (Vitamine D),2015-12-31,2020-09-06,400, ,['3 / Week'], ,Patient Choice/Convenience
12700,4623,Alemtuzumab (Campath),2016-05-17,2019-11-20,5000,mcg,[' '],IV,Patient Choice/Convenience
12701,4623,Teriflunomide,2016-04-30,2019-11-26,500,mg,['/ Day'],IV,Adverse Event
12702,3533,Ledertrexaat,2016-07-30,,20,mg,['2 / Day'], , 
12703,3533,D-cure (Vitamine D),2016-01-25,,500,MIU,[' '],IV, 
12704,3533,Gilenya,2015-12-01,,500, ,['2 / Day'], , 
12705,3533,Mitoxantrone,2016-10-14,,20,mg,['/ Day'],IV, 
12706,4261,IVIG,2015-12-02,2018-09-22, , ,['/Month'], ,Patient Choice/Convenience
12707,4261,Endoxan,2016-06-24,2018-10-24,500, ,['2 / Day'],IV,Lack of efficacy
12708,4261,Copaxone,2016-06-25,2019-07-20, ,mg,['2 / Day'],IV,Patient Choice/Convenience
12709,4261,D-cure (Vitamine D),2016-09-16,, , ,['2 / Day'], , 
12710,3076,IVIG,2015-12-01,,1, ,[' '],IV, 
12711,3773,Ledertrexaat,2016-01-24,,1000,mcg,[' '], , 
12712,3773,D-cure (Vitamine D),2016-04-08,,5000, ,['/ Day'],IV, 
12713,3773,Tysabri,2016-02-21,,300,mg,['3 / Week'], , 
12714,109,Avonex,2016-01-29,,1000,mg,['2 / Day'],IV, 
12715,3943,IVIG,2016-10-18,2019-11-07,20, ,['2 / Day'],IV,Lack of efficacy
12716,3943,Methylprednisolone,2016-09-07,,5000, ,['/Month'],IV, 
12717,3943,Rebif [44],2016-05-10,,300, ,['2 / Day'],IV, 
12718,2383,Tecfidera,2016-08-16,2019-03-01,20,mcg,[' '], ,Persisting MRI activity
12719,2383,IVIG,2016-10-19,2018-08-26, , ,['2 / Day'], ,Patient Choice/Convenience
12720,2383,Alemtuzumab (Campath),2016-10-17,2020-02-13,400,mg,['/ Day'], ,Adverse Event
12721,404,Rebif [44],2016-01-08,2020-08-22,500, ,['2 / Day'],Oral,Patient Choice/Convenience
12722,404,D-cure (Vitamine D),2016-03-19,,5000, ,['2 / Day'],IV, 
12723,404,Avonex,2016-08-11,2021-06-23,500,mcg,['3 / Week'], ,Lack of efficacy
12724,4546,Teriflunomide,2015-12-16,2020-01-24,500, ,['/Month'],Oral,Adverse Event
12725,4546,Tecfidera,2016-06-05,,5000, ,['/Month'],IV, 
12726,4546,Copaxone,2016-03-14,,20,mg,['/Month'],IV, 
12727,3005,IVIG,2015-11-15,, ,mg,['/Month'],IV, 
12728,3005,Gilenya,2016-05-13,, , ,['2 / Day'],Oral, 
12729,2330,Avonex,2015-11-03,2018-03-12, ,mcg,['2 / Day'],Oral,Adverse Event
12730,2330,Rebif [22],2015-12-02,, ,mg,['2 / Day'], , 
12731,4407,IVIG,2015-11-02,,300,mcg,['/Month'], , 
12732,4407,Tecfidera,2016-09-07,2017-11-29,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
12733,4672,D-cure (Vitamine D),2015-12-28,, ,mg,[' '],Oral, 
12734,1396,Betaferon,2015-11-15,,20,mg,['/ Week'],Oral, 
12735,1515,IVIG,2016-04-11,2018-11-11,300,mcg,['/Month'],IV,Persisting MRI activity
12736,1515,Betaferon,2016-07-23,2021-10-13,400,mg,['3 / Week'], ,Persistence of relapses
12737,1515,Tecfidera,2016-01-18,,20, ,['2 / Day'], , 
12738,2673,Gilenya,2015-11-19,2018-05-25, , ,['/ Day'],IV,Adverse Event
12739,2673,Methylprednisolone,2015-12-18,2021-07-29,1000,mcg,['/Month'], ,Adverse Event
12740,4149,IVIG,2015-12-19,,1, ,['3 / Week'],Oral, 
12741,4149,Rebif [44],2016-04-01,2019-10-05, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
12742,4149,Rebif [44],2016-03-06,2021-08-06, ,MIU,['2 / Day'],IV,Adverse Event
12743,4531,Tecfidera,2016-10-22,, , ,['2 / Day'],IV, 
12744,4531,Teriflunomide,2015-10-27,2020-05-08,300, ,['3 / Week'],IV,Persisting MRI activity
12745,4531,Teriflunomide,2016-10-21,2017-11-24,500, ,['2 / Day'],IV,Patient Choice/Convenience
12746,4531,Gilenya,2016-01-27,2018-03-20, ,MIU,['/Month'],IV,Lack of efficacy
12747,4787,Rebif [44],2016-02-24,2021-05-15,5000, ,['/ Week'], ,Persisting MRI activity
12748,4787,Alemtuzumab (Campath),2016-05-14,2018-01-14, ,MIU,['/Month'],IV,Adverse Event
12749,2427,Gilenya,2016-07-09,,5000,mg,['/Month'], , 
12750,2427,Endoxan,2016-06-08,2018-09-10, , ,[' '],IV,Patient Choice/Convenience
12751,4607,Tysabri,2016-04-17,2020-06-30,1000,mg,['2 / Day'],IV,Persisting MRI activity
12752,4607,Avonex,2016-05-14,, ,mg,['/ Week'], , 
12753,4607,D-cure (Vitamine D),2016-10-11,2019-08-19,300,mcg,['/Month'],Oral,Patient Choice/Convenience
12754,4607,IVIG,2016-01-06,, , ,['/ Day'], , 
12755,4886,Mitoxantrone,2016-02-13,2021-09-15,20,mg,[' '],Oral,Persistence of relapses
12756,4886,Endoxan,2016-01-27,2021-07-28,1000,mg,[' '],IV,Lack of efficacy
12757,345,Rebif [22],2016-05-22,, ,MIU,['/Month'],IV, 
12758,345,Alemtuzumab (Campath),2016-07-11,2020-03-22,5000,mg,['/Month'], ,Lack of efficacy
12759,345,Alemtuzumab (Campath),2016-02-11,2020-09-02,1000, ,['2 / Day'],IV,Lack of efficacy
12760,345,Rebif [44],2016-07-03,, , ,[' '], , 
12761,2355,Tecfidera,2016-02-25,, , ,['2 / Day'], , 
12762,4837,Rebif [22],2016-08-12,2019-01-29,500,MIU,['2 / Day'],IV,Persisting MRI activity
12763,4837,Methylprednisolone,2016-04-20,2020-10-26,5000, ,['2 / Day'], ,Lack of efficacy
12764,4837,IVIG,2016-04-23,,1000,mg,['2 / Day'],IV, 
12765,4837,Rebif [44],2016-04-23,,300, ,['/Month'], , 
12766,4826,Tecfidera,2016-06-29,,300,mg,['2 / Day'],IV, 
12767,4826,Rebif [44],2016-01-25,2019-03-06,20,mg,['/Month'],IV,Persisting MRI activity
12768,4220,Methylprednisolone,2016-09-26,,1000,mcg,['/Month'],IV, 
12769,4220,Copaxone,2015-12-01,2018-03-02,1,mg,['/Month'],Oral,Patient Choice/Convenience
12770,476,Methylprednisolone,2016-05-20,2020-08-25, ,mg,['2 / Day'],Oral,Adverse Event
12771,476,Betaferon,2016-10-03,,5000,mcg,[' '],IV, 
12772,476,Gilenya,2016-03-27,,1000, ,['/Month'],IV, 
12773,2232,Alemtuzumab (Campath),2016-03-23,,1000,MIU,['3 / Week'], , 
12774,2232,D-cure (Vitamine D),2016-02-20,, ,mg,['3 / Week'], , 
12775,2232,Tecfidera,2016-01-11,2019-04-17,500,mg,['2 / Day'], ,Lack of efficacy
12776,1781,Rebif [44],2015-12-12,,1000,mg,['2 / Day'], , 
12777,1781,Alemtuzumab (Campath),2016-07-11,,5000,mg,['/ Week'],IV, 
12778,1781,Copaxone,2016-09-07,2019-06-21,5000, ,['2 / Day'],Oral,Adverse Event
12779,1781,Rebif [44],2016-04-29,2019-04-26,1000, ,['/Month'],IV,Lack of efficacy
12780,2485,Betaferon,2015-12-11,2018-11-01,300,mg,['/Month'],IV,Patient Choice/Convenience
12781,2485,Tysabri,2015-11-18,2018-06-11,1000, ,['/Month'], ,Persisting MRI activity
12782,3625,IVIG,2016-04-02,2020-07-17,300,MIU,['3 / Week'],Oral,Adverse Event
12783,3625,Alemtuzumab (Campath),2015-10-29,,1,mg,['/Month'],IV, 
12784,3422,Endoxan,2016-08-04,,20,mg,[' '],Oral, 
12785,340,Avonex,2016-07-22,2020-03-11, , ,['/ Day'],IV,Adverse Event
12786,3483,Teriflunomide,2015-11-06,,1000,mg,['/Month'], , 
12787,3483,Methylprednisolone,2016-01-19,,500,MIU,['2 / Day'], , 
12788,3483,Tecfidera,2016-08-29,,1000,mg,['/Month'], , 
12789,854,Betaferon,2015-12-30,2018-02-22,1,mg,[' '],Oral,Adverse Event
12790,854,Tysabri,2016-05-19,, ,mg,['/ Day'], , 
12791,854,Ledertrexaat,2016-08-24,2019-10-21,1000,mg,['/Month'],IV,Lack of efficacy
12792,337,Rebif [44],2015-12-25,2021-01-22,20, ,['/Month'], ,Adverse Event
12793,337,Gilenya,2016-03-13,2020-12-29,5000,mg,['/ Day'], ,Lack of efficacy
12794,1380,Copaxone,2016-02-03,2021-04-19, , ,['/ Day'],IV,Lack of efficacy
12795,1380,Endoxan,2015-10-25,, ,MIU,['2 / Day'],IV, 
12796,3886,Tecfidera,2016-02-14,,1000, ,['/Month'],IV, 
12797,3886,Methylprednisolone,2016-07-25,,20,mg,['/ Week'], , 
12798,3342,Mitoxantrone,2016-10-08,,400,MIU,[' '], , 
12799,3342,Alemtuzumab (Campath),2016-07-03,2018-07-03,300,mg,['2 / Day'],IV,Patient Choice/Convenience
12800,3342,Ledertrexaat,2016-01-09,2018-07-22,5000, ,['/Month'],Oral,Patient Choice/Convenience
12801,3342,Teriflunomide,2015-11-12,2020-10-13,20,mg,['/Month'], ,Adverse Event
12802,4312,Tecfidera,2016-03-12,,20, ,['/Month'], , 
12803,4312,Endoxan,2015-12-22,,1000, ,['2 / Day'],IV, 
12804,4312,Methylprednisolone,2015-12-06,2021-04-04,500,mg,['2 / Day'],IV,Patient Choice/Convenience
12805,4312,IVIG,2016-10-05,,20, ,['/ Week'], , 
12806,802,Rebif [22],2016-02-16,,1, ,['3 / Week'], , 
12807,802,Methylprednisolone,2016-03-20,2019-08-24,300, ,['/Month'],IV,Adverse Event
12808,802,Ledertrexaat,2016-03-18,2021-10-21,5000,mcg,['3 / Week'],IV,Lack of efficacy
12809,1455,D-cure (Vitamine D),2016-09-15,2020-03-02,400,mg,['/Month'],IV,Persisting MRI activity
12810,1455,Betaferon,2016-07-08,2018-11-29, ,mg,['2 / Day'],IV,Persisting MRI activity
12811,1455,Methylprednisolone,2016-03-12,,400,MIU,['2 / Day'],IV, 
12812,4079,Rebif [22],2015-11-05,,1000, ,['/Month'],IV, 
12813,4079,IVIG,2016-03-06,,1000,mg,[' '],IV, 
12814,4079,Gilenya,2016-09-19,2021-10-13,300,mg,['/Month'],Oral,Persisting MRI activity
12815,3634,Teriflunomide,2016-07-05,,1,mg,['3 / Week'],IV, 
12816,3634,IVIG,2015-10-30,,1000,mg,[' '],IV, 
12817,3634,Tecfidera,2016-03-21,2020-08-11,20, ,['2 / Day'],Oral,Patient Choice/Convenience
12818,3634,Tecfidera,2016-10-18,,500,mg,[' '], , 
12819,1746,Betaferon,2015-11-11,,5000,MIU,['2 / Day'],Oral, 
12820,1746,D-cure (Vitamine D),2016-06-29,2017-12-08,5000, ,['/Month'], ,Adverse Event
12821,1746,Tysabri,2016-02-16,, ,mg,[' '], , 
12822,1516,Alemtuzumab (Campath),2016-08-09,2017-11-29, ,mg,['2 / Day'], ,Lack of efficacy
12823,1516,Rebif [44],2016-04-24,2019-08-10,300,mcg,['2 / Day'],Oral,Patient Choice/Convenience
12824,927,IVIG,2016-08-15,,20,mg,['/Month'],Oral, 
12825,1200,IVIG,2016-02-19,2021-06-26,400,mg,['2 / Day'],IV,Patient Choice/Convenience
12826,1200,Teriflunomide,2016-04-09,2021-10-11, ,mg,['3 / Week'],Oral,Persisting MRI activity
12827,1200,Teriflunomide,2016-01-01,, ,MIU,['/Month'],Oral, 
12828,1200,Tecfidera,2015-12-14,,400, ,['/ Week'], , 
12829,1292,Methylprednisolone,2016-03-28,,1000,mcg,['/Month'],IV, 
12830,1935,Rebif [22],2016-02-15,, , ,['/ Day'], , 
12831,1935,Betaferon,2015-11-13,2019-09-28, , ,['/Month'], ,Persisting MRI activity
12832,3238,Tysabri,2015-12-10,,300, ,['/Month'], , 
12833,3238,Gilenya,2016-01-09,2021-06-15,1,mg,['/Month'],IV,Lack of efficacy
12834,3238,Tysabri,2015-11-16,, , ,['/Month'], , 
12835,2455,Alemtuzumab (Campath),2015-11-02,,300, ,['2 / Day'],IV, 
12836,2079,Betaferon,2016-02-08,2021-04-02,5000,mg,['2 / Day'],IV,Persistence of relapses
12837,2079,Gilenya,2016-04-01,2020-11-19,1, ,['2 / Day'],IV,Patient Choice/Convenience
12838,1478,Teriflunomide,2016-08-05,2017-11-12,300,mg,['/Month'], ,Patient Choice/Convenience
12839,3960,Avonex,2016-08-30,2018-03-29, ,mcg,['/Month'], ,Adverse Event
12840,3960,Methylprednisolone,2016-05-02,,1000,mg,['/Month'], , 
12841,3960,IVIG,2016-03-17,,500, ,[' '],Oral, 
12842,231,Mitoxantrone,2016-05-17,2020-02-07,500,mg,['/ Week'],Oral,Lack of efficacy
12843,231,Tysabri,2016-10-10,, ,mg,['3 / Week'], , 
12844,231,Mitoxantrone,2016-10-14,,400, ,['/ Day'],IV, 
12845,231,Rebif [22],2015-11-23,2019-02-13, ,mg,['/Month'], ,Persistence of relapses
12846,3890,Tysabri,2016-06-26,,1, ,['3 / Week'],IV, 
12847,3890,Endoxan,2016-03-14,, ,mg,['/ Day'],IV, 
12848,2341,Mitoxantrone,2016-01-29,2018-02-10,20,mcg,['2 / Day'],IV,Persisting MRI activity
12849,2341,IVIG,2015-12-11,2020-02-26,500,mg,[' '],IV,Adverse Event
12850,2341,Teriflunomide,2016-04-21,2018-10-30,300,mg,['/ Day'],Oral,Lack of efficacy
12851,4596,Rebif [44],2015-10-25,2019-09-27,400,MIU,['2 / Day'],IV,Persistence of relapses
12852,4596,Endoxan,2016-03-31,, ,mg,['/Month'], , 
12853,4596,IVIG,2016-08-09,,1,MIU,['/ Day'], , 
12854,4254,Teriflunomide,2015-12-26,,20, ,['2 / Day'],IV, 
12855,4254,Rebif [44],2016-08-10,2018-09-10,1000, ,['2 / Day'],IV,Patient Choice/Convenience
12856,4254,Rebif [22],2015-11-15,2019-04-14,5000,mg,['3 / Week'], ,Patient Choice/Convenience
12857,4254,Rebif [22],2016-04-16,,5000,mg,['/Month'],IV, 
12858,4987,Tysabri,2016-10-01,2020-08-17,300,mg,['2 / Day'],IV,Persistence of relapses
12859,4987,D-cure (Vitamine D),2016-09-02,,20,mcg,['2 / Day'], , 
12860,4987,Rebif [44],2015-10-31,2018-01-15,20,mg,['/ Week'], ,Adverse Event
12861,4987,Rebif [44],2016-10-13,,400,mg,['2 / Day'],Oral, 
12862,4166,Copaxone,2016-07-13,,5000,mg,['/Month'], , 
12863,4166,D-cure (Vitamine D),2015-11-03,2020-02-05,300, ,['/ Week'],IV,Adverse Event
12864,4166,Teriflunomide,2016-09-01,,300, ,['2 / Day'], , 
12865,2948,Tecfidera,2016-06-27,2020-04-08,500, ,['2 / Day'], ,Persisting MRI activity
12866,2929,Gilenya,2016-08-19,, , ,['3 / Week'], , 
12867,1185,Alemtuzumab (Campath),2016-04-17,2018-12-13, , ,['/Month'],IV,Lack of efficacy
12868,1185,Copaxone,2016-02-25,,400,mg,['2 / Day'], , 
12869,4884,Rebif [44],2016-10-16,2017-12-11,20, ,['3 / Week'],IV,Persistence of relapses
12870,4884,IVIG,2016-01-17,2020-01-24,20, ,['2 / Day'],IV,Adverse Event
12871,4884,Betaferon,2016-01-05,,1000, ,['2 / Day'],Oral, 
12872,567,Rebif [44],2016-09-11,,5000,mg,[' '],IV, 
12873,567,Alemtuzumab (Campath),2016-06-01,2020-08-10,500, ,['/Month'],Oral,Lack of efficacy
12874,4722,Methylprednisolone,2016-10-21,,300, ,['2 / Day'], , 
12875,4722,Gilenya,2016-04-03,,1000,MIU,['/ Week'],IV, 
12876,4722,Tecfidera,2016-05-20,,300, ,[' '], , 
12877,4892,Gilenya,2016-04-21,2019-05-31,1, ,['2 / Day'], ,Adverse Event
12878,4892,Gilenya,2015-11-28,2021-05-03,20,mg,['3 / Week'], ,Adverse Event
12879,687,D-cure (Vitamine D),2016-01-31,,500, ,['/Month'], , 
12880,4225,Avonex,2016-01-26,2020-01-15, ,mg,['3 / Week'], ,Adverse Event
12881,2359,Copaxone,2016-09-07,2019-05-23,1000, ,[' '],IV,Lack of efficacy
12882,2359,Mitoxantrone,2016-09-30,,300,mcg,['2 / Day'],Oral, 
12883,2359,Methylprednisolone,2016-03-05,2019-03-23,20, ,[' '],IV,Lack of efficacy
12884,1482,Betaferon,2016-10-09,2021-04-06,1000,mg,['2 / Day'],IV,Adverse Event
12885,841,Tysabri,2016-03-25,,1000, ,[' '],Oral, 
12886,4451,IVIG,2015-11-21,, , ,['2 / Day'],IV, 
12887,4451,D-cure (Vitamine D),2016-02-05,2017-11-29,1,mg,['3 / Week'], ,Persisting MRI activity
12888,4451,Endoxan,2016-01-08,2021-08-06,1000,mg,['2 / Day'],Oral,Adverse Event
12889,4451,Mitoxantrone,2015-12-04,2018-03-05,1, ,[' '],IV,Persistence of relapses
12890,1829,Avonex,2016-09-15,,500, ,['/Month'],IV, 
12891,4397,Alemtuzumab (Campath),2015-11-22,, ,mg,['2 / Day'],Oral, 
12892,4857,Copaxone,2016-07-19,2021-10-20,1000,mg,['2 / Day'], ,Lack of efficacy
12893,1219,IVIG,2015-12-11,,20,mg,['2 / Day'],Oral, 
12894,4213,IVIG,2016-09-26,2021-03-31, , ,['/Month'],Oral,Adverse Event
12895,4213,Methylprednisolone,2016-09-15,, ,mg,['/Month'],Oral, 
12896,4213,Mitoxantrone,2016-06-18,2020-12-22,5000,mg,['/ Day'], ,Adverse Event
12897,4213,Alemtuzumab (Campath),2016-06-30,,5000,mg,['/Month'],IV, 
12898,4855,Mitoxantrone,2015-11-18,,1000,mg,['/Month'], , 
12899,2936,Rebif [22],2016-05-18,2018-12-01, , ,['2 / Day'],IV,Adverse Event
12900,1411,Copaxone,2016-09-03,2021-10-20,400,MIU,['2 / Day'],IV,Lack of efficacy
12901,1411,IVIG,2016-03-29,2018-06-07,5000, ,['/Month'],Oral,Adverse Event
12902,1411,Tysabri,2016-03-17,,400,mg,['/ Week'],IV, 
12903,1411,Copaxone,2016-08-14,2018-05-11,20,MIU,['/Month'],IV,Adverse Event
12904,4349,Mitoxantrone,2016-06-16,, , ,['/Month'], , 
12905,873,Rebif [44],2016-05-09,2021-04-13,300, ,['/Month'],IV,Lack of efficacy
12906,2911,Endoxan,2015-12-07,,400,mg,['3 / Week'],Oral, 
12907,2911,Gilenya,2015-11-30,2017-12-09,5000, ,['/Month'], ,Adverse Event
12908,2911,Tecfidera,2016-03-14,, , ,['3 / Week'],IV, 
12909,2827,Ledertrexaat,2015-11-01,, ,mg,['2 / Day'],IV, 
12910,3621,Avonex,2016-02-11,2021-06-15,5000, ,['/ Day'],IV,Persisting MRI activity
12911,3621,Rebif [44],2016-05-09,, ,mg,['2 / Day'], , 
12912,3621,Endoxan,2016-06-23,,20,MIU,['2 / Day'],Oral, 
12913,3621,D-cure (Vitamine D),2016-03-03,2020-05-09, , ,['/Month'],IV,Adverse Event
12914,4902,Ledertrexaat,2016-05-15,2018-03-21, ,mcg,['3 / Week'],IV,Lack of efficacy
12915,4902,Rebif [44],2016-07-04,2020-06-22, ,mg,['/Month'], ,Patient Choice/Convenience
12916,2097,IVIG,2016-06-19,,300,mg,['/Month'], , 
12917,4057,Methylprednisolone,2016-05-18,2020-04-22,400, ,['/Month'], ,Persisting MRI activity
12918,4057,Betaferon,2016-07-20,2017-11-05, , ,['/ Day'],IV,Lack of efficacy
12919,4057,Tysabri,2016-04-05,,300,mg,['/Month'],Oral, 
12920,2809,Betaferon,2016-02-18,,300,mg,['2 / Day'], , 
12921,2809,D-cure (Vitamine D),2016-09-22,,400,mcg,['2 / Day'], , 
12922,2809,Betaferon,2016-06-23,,300,MIU,[' '], , 
12923,984,Gilenya,2016-05-21,, ,mg,['/ Week'], , 
12924,984,Methylprednisolone,2015-11-30,2021-10-04,5000,mcg,['2 / Day'], ,Persisting MRI activity
12925,984,Mitoxantrone,2016-04-11,2021-06-26,1000,MIU,['3 / Week'],IV,Adverse Event
12926,3208,Ledertrexaat,2016-10-22,, ,mg,['2 / Day'],IV, 
12927,3208,Endoxan,2016-10-06,, , ,['3 / Week'],IV, 
12928,3208,Ledertrexaat,2016-02-23,, , ,['/ Day'],IV, 
12929,3208,Alemtuzumab (Campath),2016-05-19,2021-02-05,20, ,['3 / Week'],IV,Patient Choice/Convenience
12930,1171,Teriflunomide,2016-03-13,,5000,mg,['/ Week'],IV, 
12931,1171,Betaferon,2015-11-19,2018-01-12, ,MIU,['2 / Day'],Oral,Lack of efficacy
12932,1171,Avonex,2016-08-03,2019-12-26,400,mg,['2 / Day'],IV,Lack of efficacy
12933,1171,Ledertrexaat,2016-09-23,,1000,MIU,['3 / Week'],IV, 
12934,2004,Gilenya,2016-03-31,,500, ,['3 / Week'],IV, 
12935,2004,Methylprednisolone,2016-06-17,2021-10-07, ,mg,['/Month'],IV,Persistence of relapses
12936,3465,Tecfidera,2015-11-03,, , ,['/Month'],IV, 
12937,3722,IVIG,2016-09-04,,1, ,['2 / Day'], , 
12938,3722,Mitoxantrone,2016-08-17,2019-03-07, , ,['/Month'],IV,Lack of efficacy
12939,3722,Endoxan,2016-02-27,,20, ,['/ Day'],IV, 
12940,166,IVIG,2016-01-17,2019-07-06, ,MIU,['/ Day'],IV,Adverse Event
12941,166,D-cure (Vitamine D),2016-02-01,,300,mg,['/ Day'],Oral, 
12942,166,Betaferon,2016-09-30,,400,MIU,['2 / Day'], , 
12943,1948,Betaferon,2016-02-23,, ,mg,['/Month'],IV, 
12944,2387,Alemtuzumab (Campath),2015-12-14,,5000,mg,['3 / Week'],IV, 
12945,2387,Methylprednisolone,2015-12-13,,1, ,['/Month'],Oral, 
12946,2387,Teriflunomide,2016-06-20,,20,mg,['3 / Week'],IV, 
12947,1915,Tysabri,2016-07-24,,400,mg,['/Month'],IV, 
12948,1915,Gilenya,2016-01-20,2020-05-27, , ,['/Month'],IV,Adverse Event
12949,1915,D-cure (Vitamine D),2016-09-26,,20, ,['3 / Week'],IV, 
12950,1915,Mitoxantrone,2015-11-11,,400,mcg,[' '],IV, 
12951,3156,Tysabri,2016-04-22,,500,MIU,['/Month'],Oral, 
12952,2870,Avonex,2016-09-05,2018-07-22,1000, ,['3 / Week'], ,Adverse Event
12953,216,Betaferon,2015-11-23,,1000,mg,['2 / Day'],IV, 
12954,4197,Endoxan,2016-01-17,2020-07-30, ,mg,['/ Week'], ,Persistence of relapses
12955,2999,Teriflunomide,2016-01-20,,20, ,['/Month'],IV, 
12956,2999,Tecfidera,2016-08-06,2021-07-07, ,mg,['2 / Day'],IV,Patient Choice/Convenience
12957,2999,Rebif [22],2016-08-29,, ,mg,['/Month'],Oral, 
12958,2364,Rebif [44],2016-04-09,2019-01-09, , ,['/Month'],IV,Adverse Event
12959,2364,Teriflunomide,2015-11-24,,500,mg,['/Month'],IV, 
12960,2364,Gilenya,2016-06-26,2021-08-08,400,MIU,['2 / Day'], ,Persistence of relapses
12961,2992,Mitoxantrone,2016-10-02,,300, ,['3 / Week'], , 
12962,1823,Alemtuzumab (Campath),2015-11-15,2021-10-22,300, ,['/Month'], ,Adverse Event
12963,1823,Betaferon,2015-11-28,2021-07-29,1000,mg,['/ Day'],Oral,Lack of efficacy
12964,1823,Methylprednisolone,2016-06-09,2020-02-20,500, ,['/Month'],IV,Lack of efficacy
12965,3611,Avonex,2016-05-23,2019-04-03,300,MIU,['3 / Week'],IV,Adverse Event
12966,3611,Methylprednisolone,2015-11-24,2018-02-17, , ,['2 / Day'], ,Patient Choice/Convenience
12967,3611,Copaxone,2016-02-16,2020-01-03,500, ,['2 / Day'], ,Adverse Event
12968,3434,Tysabri,2016-05-12,2019-01-01,20,MIU,['3 / Week'],IV,Patient Choice/Convenience
12969,3434,Avonex,2016-07-06,2020-12-31,500,mg,['/Month'], ,Patient Choice/Convenience
12970,248,Copaxone,2016-06-27,,1000,mg,['/Month'], , 
12971,248,Mitoxantrone,2015-11-12,2018-01-13, ,MIU,['3 / Week'],IV,Persistence of relapses
12972,2151,Endoxan,2016-04-04,,500, ,['/Month'],IV, 
12973,4574,Methylprednisolone,2016-09-25,2021-09-06,300,MIU,['2 / Day'],IV,Adverse Event
12974,4574,Tecfidera,2015-11-06,2018-01-07, , ,['2 / Day'],IV,Patient Choice/Convenience
12975,4574,Rebif [22],2015-10-28,, , ,['3 / Week'], , 
12976,2907,Alemtuzumab (Campath),2016-02-19,2020-03-24,300,mg,['/ Week'],IV,Adverse Event
12977,2907,IVIG,2016-04-26,,1000, ,['/Month'],IV, 
12978,2907,Betaferon,2016-08-27,,300,mg,['2 / Day'],IV, 
12979,2907,D-cure (Vitamine D),2016-09-18,2019-06-29,20, ,['/ Day'], ,Patient Choice/Convenience
12980,1012,Tysabri,2016-03-21,2018-01-20,1,MIU,['/Month'], ,Adverse Event
12981,1012,Ledertrexaat,2016-09-03,2020-08-08,300,mg,['3 / Week'], ,Persisting MRI activity
12982,1012,Endoxan,2016-10-08,,20, ,['2 / Day'],IV, 
12983,2829,IVIG,2016-01-21,2020-03-04,500,mg,['2 / Day'], ,Patient Choice/Convenience
12984,2829,Rebif [44],2015-12-16,2018-03-29,1000, ,['2 / Day'],IV,Persistence of relapses
12985,4698,Endoxan,2016-09-10,,1,mcg,['/Month'],IV, 
12986,4698,D-cure (Vitamine D),2016-03-15,,1,mg,['/Month'], , 
12987,653,D-cure (Vitamine D),2016-09-12,,1000,mg,['2 / Day'],IV, 
12988,653,Rebif [44],2015-11-27,2021-10-02, ,MIU,['/Month'],IV,Adverse Event
12989,653,Ledertrexaat,2016-02-07,2020-06-28, ,MIU,['2 / Day'], ,Adverse Event
12990,3643,IVIG,2015-12-02,2019-04-10, ,mg,['2 / Day'],IV,Adverse Event
12991,3643,Alemtuzumab (Campath),2015-10-31,,1,MIU,['/Month'],IV, 
12992,3643,Teriflunomide,2016-08-26,, , ,[' '],IV, 
12993,3643,D-cure (Vitamine D),2016-04-22,2019-10-14, , ,['/Month'],Oral,Persisting MRI activity
12994,4665,Tysabri,2016-06-10,,5000,mg,['/Month'],IV, 
12995,4665,D-cure (Vitamine D),2015-12-31,2021-09-03,500,mcg,['/Month'], ,Adverse Event
12996,4665,Endoxan,2016-02-09,2021-04-01, , ,['3 / Week'], ,Adverse Event
12997,1160,Methylprednisolone,2016-03-03,2019-03-05,1000,mg,['3 / Week'],IV,Persisting MRI activity
12998,1160,Tysabri,2015-11-09,,1,mg,['3 / Week'],IV, 
12999,1160,Copaxone,2016-10-19,,500,mg,['/Month'], , 
13000,1160,Gilenya,2016-08-24,,20,mg,[' '],Oral, 
13001,4918,Copaxone,2015-11-02,, , ,['/ Day'],IV, 
13002,4918,Avonex,2016-06-30,,400, ,['/Month'], , 
13003,4918,Avonex,2016-09-05,2018-01-09,5000,mg,[' '],IV,Persisting MRI activity
13004,4256,Rebif [22],2016-08-25,2021-09-27,300,mg,['/Month'],IV,Persisting MRI activity
13005,4256,Methylprednisolone,2016-03-08,2020-04-23,400,mg,['2 / Day'], ,Adverse Event
13006,4256,Endoxan,2016-07-29,2021-04-26, , ,['/Month'],Oral,Persisting MRI activity
13007,4256,Rebif [44],2016-05-07,2020-02-16,20,mg,['2 / Day'],IV,Persisting MRI activity
13008,674,D-cure (Vitamine D),2016-08-10,2019-04-22, , ,['2 / Day'],IV,Persistence of relapses
13009,674,Tysabri,2016-01-24,2020-10-09,1000, ,['2 / Day'],IV,Patient Choice/Convenience
13010,674,Methylprednisolone,2016-01-23,2018-02-10,1000, ,['2 / Day'], ,Lack of efficacy
13011,989,Tecfidera,2016-02-28,,300, ,['3 / Week'], , 
13012,989,Rebif [44],2015-11-12,2021-03-10, ,mg,['2 / Day'],IV,Patient Choice/Convenience
13013,3896,Betaferon,2015-11-09,2020-06-19,20, ,['2 / Day'], ,Lack of efficacy
13014,3896,Avonex,2016-06-27,,1,mg,['2 / Day'],IV, 
13015,1796,D-cure (Vitamine D),2016-02-29,,300,mg,['/Month'], , 
13016,1796,Methylprednisolone,2015-12-01,,20,mg,['/ Day'],IV, 
13017,928,Tecfidera,2016-09-19,2019-05-27,300, ,['3 / Week'],Oral,Patient Choice/Convenience
13018,928,IVIG,2016-01-15,,300, ,['/Month'],IV, 
13019,240,Mitoxantrone,2016-01-18,2018-05-31,20,mg,['2 / Day'], ,Patient Choice/Convenience
13020,1630,Endoxan,2015-12-10,2019-06-02,500,mg,['/ Day'],Oral,Persisting MRI activity
13021,1018,Alemtuzumab (Campath),2016-07-03,,20, ,['3 / Week'],IV, 
13022,1018,IVIG,2016-02-18,,500,mg,['3 / Week'],Oral, 
13023,1018,Alemtuzumab (Campath),2015-12-10,,20,MIU,[' '], , 
13024,4856,Rebif [44],2015-12-27,,500,MIU,['2 / Day'],Oral, 
13025,863,Ledertrexaat,2016-07-11,2021-03-07,400,mcg,['/Month'],IV,Lack of efficacy
13026,863,Rebif [44],2016-08-26,2018-06-30,20,mg,['2 / Day'],IV,Lack of efficacy
13027,4795,D-cure (Vitamine D),2015-10-28,, ,MIU,['2 / Day'], , 
13028,4795,Endoxan,2016-04-08,,300,mg,['2 / Day'], , 
13029,2445,Tecfidera,2015-11-19,, , ,['/Month'], , 
13030,2445,Ledertrexaat,2015-12-22,2019-01-03, , ,['3 / Week'], ,Adverse Event
13031,2445,IVIG,2016-06-08,,1000,mg,['3 / Week'],IV, 
13032,2445,IVIG,2016-05-04,,1000, ,['/Month'],IV, 
13033,3097,Gilenya,2016-05-26,, ,mg,['3 / Week'],IV, 
13034,3097,Rebif [22],2016-02-11,,5000,mg,['/Month'],IV, 
13035,997,Alemtuzumab (Campath),2016-03-10,2019-10-09,500,mg,['3 / Week'], ,Lack of efficacy
13036,997,IVIG,2016-05-02,,1000, ,['2 / Day'],IV, 
13037,4522,Rebif [44],2015-12-13,2021-02-13,20,mg,[' '],Oral,Adverse Event
13038,4522,Methylprednisolone,2016-08-13,,1000, ,['/ Week'],IV, 
13039,4522,Alemtuzumab (Campath),2016-05-05,2020-10-13, ,mg,['2 / Day'],IV,Adverse Event
13040,4522,Rebif [22],2015-10-27,,300, ,['2 / Day'],IV, 
13041,3478,Ledertrexaat,2015-11-15,, ,MIU,[' '],IV, 
13042,3478,Tysabri,2016-03-30,,500,mg,['/Month'], , 
13043,3478,D-cure (Vitamine D),2016-08-07,,20, ,['/Month'],IV, 
13044,2492,Gilenya,2016-07-28,,300,mg,['2 / Day'], , 
13045,2492,Tecfidera,2016-04-29,,300,mg,['3 / Week'], , 
13046,1431,Methylprednisolone,2016-02-26,2021-02-26, , ,['2 / Day'], ,Lack of efficacy
13047,1431,Avonex,2016-02-22,, ,mg,['2 / Day'],IV, 
13048,517,Endoxan,2016-04-08,,500,mg,['2 / Day'],IV, 
13049,517,Betaferon,2016-03-05,,300, ,['2 / Day'],Oral, 
13050,1930,Betaferon,2016-08-31,2018-02-02,500,mg,['/Month'], ,Adverse Event
13051,1930,Rebif [22],2016-10-12,2018-03-25,400, ,['2 / Day'], ,Adverse Event
13052,1930,Rebif [44],2016-03-30,2020-05-24,5000, ,['/ Day'],IV,Persisting MRI activity
13053,1930,Copaxone,2016-03-13,, ,MIU,['/Month'], , 
13054,1629,Rebif [44],2016-07-17,2019-02-23, ,mg,['2 / Day'], ,Persistence of relapses
13055,1629,Alemtuzumab (Campath),2015-10-27,,500,mg,['2 / Day'],IV, 
13056,1629,Gilenya,2015-11-27,2020-09-13,300, ,['/ Day'],IV,Lack of efficacy
13057,1629,Tysabri,2016-08-30,, ,mg,['2 / Day'], , 
13058,3894,Copaxone,2016-09-26,2020-11-28,500,mg,['2 / Day'], ,Lack of efficacy
13059,3894,Rebif [22],2015-10-29,2018-02-08,300,MIU,['2 / Day'],IV,Adverse Event
13060,3894,Tecfidera,2016-09-21,2018-11-03, ,mg,['/Month'], ,Adverse Event
13061,1445,Betaferon,2016-06-16,2021-08-25,300, ,['/Month'], ,Adverse Event
13062,2241,Copaxone,2016-02-25,2020-08-19,20, ,[' '],Oral,Adverse Event
13063,2241,D-cure (Vitamine D),2016-03-26,,500, ,['/ Day'],IV, 
13064,3038,Betaferon,2015-11-14,2019-06-09, ,mg,['3 / Week'], ,Adverse Event
13065,3038,IVIG,2015-12-21,2018-09-01, ,mg,['/Month'],IV,Adverse Event
13066,3038,Endoxan,2015-10-26,2020-02-21, , ,['3 / Week'],IV,Patient Choice/Convenience
13067,3038,D-cure (Vitamine D),2015-11-23,,300,mg,['3 / Week'],IV, 
13068,2819,D-cure (Vitamine D),2016-05-11,,1,mg,['/ Day'], , 
13069,716,Teriflunomide,2016-10-21,,500,MIU,['/Month'], , 
13070,716,D-cure (Vitamine D),2015-12-14,,20,mg,['2 / Day'], , 
13071,716,Copaxone,2016-04-03,,500,mg,['/Month'],IV, 
13072,716,Alemtuzumab (Campath),2016-10-18,2020-01-05,500,mcg,['2 / Day'],Oral,Patient Choice/Convenience
13073,1659,Teriflunomide,2016-03-02,2019-01-29, , ,['/Month'], ,Lack of efficacy
13074,2118,Copaxone,2016-08-17,2017-11-27,300,mg,['/ Day'], ,Adverse Event
13075,2063,Gilenya,2016-08-18,2018-06-05,300,mg,['2 / Day'],IV,Patient Choice/Convenience
13076,2063,Avonex,2016-09-09,, ,mg,[' '], , 
13077,2063,D-cure (Vitamine D),2015-12-22,2017-12-08,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
13078,2063,Methylprednisolone,2016-05-10,2018-11-16,400, ,['/Month'], ,Patient Choice/Convenience
13079,2516,Teriflunomide,2015-11-06,2019-09-10,1000,mcg,['2 / Day'],IV,Persistence of relapses
13080,1386,Alemtuzumab (Campath),2016-04-18,,1000, ,['2 / Day'],IV, 
13081,1386,Gilenya,2016-08-11,2018-03-12,1000,mg,['/Month'], ,Adverse Event
13082,1386,IVIG,2016-10-06,, ,MIU,['2 / Day'], , 
13083,4323,Rebif [22],2016-04-19,,5000,mg,['/Month'], , 
13084,2189,Copaxone,2016-09-08,,300, ,['2 / Day'],IV, 
13085,2189,Alemtuzumab (Campath),2016-07-23,2019-02-15,400,mg,['/Month'],Oral,Adverse Event
13086,2189,Tysabri,2016-04-09,,20,mcg,['/ Week'],Oral, 
13087,2189,Teriflunomide,2015-10-28,,300, ,[' '],IV, 
13088,3716,Tysabri,2015-11-27,2021-07-01,5000, ,['3 / Week'],Oral,Persisting MRI activity
13089,3716,Alemtuzumab (Campath),2016-05-03,,20,MIU,['/ Week'], , 
13090,1644,IVIG,2016-09-25,,400, ,['/Month'], , 
13091,1644,Endoxan,2016-09-07,, , ,['/ Week'],Oral, 
13092,1644,Tecfidera,2015-12-03,,500,MIU,['2 / Day'],Oral, 
13093,447,Betaferon,2016-04-03,2019-05-31,1000,mg,['/Month'], ,Persisting MRI activity
13094,447,Alemtuzumab (Campath),2016-04-29,, ,mg,['/Month'],IV, 
13095,447,Betaferon,2016-10-11,2018-12-29, ,mg,['3 / Week'],IV,Lack of efficacy
13096,447,Avonex,2016-07-15,, , ,['/ Week'],IV, 
13097,4215,Ledertrexaat,2016-04-18,2018-10-05,20, ,['2 / Day'],IV,Lack of efficacy
13098,4215,Rebif [44],2016-08-07,,20,mg,['/Month'],IV, 
13099,4215,Rebif [44],2016-08-14,,400,MIU,[' '],Oral, 
13100,2783,Gilenya,2016-03-07,,1000,mg,[' '], , 
13101,2783,Betaferon,2016-07-21,2019-05-13,500,mg,['3 / Week'],IV,Lack of efficacy
13102,2783,Betaferon,2016-01-21,,500,MIU,[' '],IV, 
13103,4181,Alemtuzumab (Campath),2016-09-24,2019-06-20,400,mg,['/Month'], ,Persisting MRI activity
13104,4343,Tecfidera,2015-11-09,,1000,mg,[' '],IV, 
13105,4343,Betaferon,2016-07-20,2018-03-07,20,mg,['2 / Day'],IV,Adverse Event
13106,4343,Gilenya,2016-07-26,,1000,MIU,['/ Day'], , 
13107,1717,Rebif [22],2016-03-27,,1,mg,['2 / Day'], , 
13108,1717,Avonex,2016-07-11,, ,mg,['/Month'],Oral, 
13109,3826,Rebif [44],2015-12-08,2018-02-18,300, ,[' '], ,Persistence of relapses
13110,3826,Ledertrexaat,2015-10-31,,1000, ,['/ Week'], , 
13111,2164,Mitoxantrone,2016-04-26,2017-12-17,300, ,['/Month'],IV,Persisting MRI activity
13112,2164,Rebif [44],2016-01-03,2019-05-22, , ,[' '],IV,Adverse Event
13113,2164,Rebif [44],2016-02-18,,5000, ,[' '], , 
13114,1251,Mitoxantrone,2016-09-10,2021-09-04,1,mg,['3 / Week'],Oral,Adverse Event
13115,1251,Alemtuzumab (Campath),2016-05-30,2018-04-16,1, ,['2 / Day'],IV,Persistence of relapses
13116,1251,Avonex,2016-09-14,2018-07-16,5000, ,['2 / Day'],Oral,Patient Choice/Convenience
13117,1251,Methylprednisolone,2016-02-05,2019-08-08,400,MIU,['2 / Day'],IV,Persisting MRI activity
13118,3085,Methylprednisolone,2016-01-13,, ,mg,['/Month'], , 
13119,4932,Rebif [22],2016-09-08,,400,MIU,['3 / Week'],IV, 
13120,4932,Methylprednisolone,2015-11-08,,1, ,['3 / Week'], , 
13121,4932,Betaferon,2016-01-27,,5000, ,['/Month'],Oral, 
13122,4932,Gilenya,2016-01-26,, , ,['/Month'],IV, 
13123,2470,Gilenya,2015-11-07,,1000,MIU,['/ Day'],IV, 
13124,2470,IVIG,2016-09-07,2019-03-11, ,mg,['2 / Day'],IV,Adverse Event
13125,2470,Alemtuzumab (Campath),2016-04-29,, ,mg,['/Month'],IV, 
13126,1022,Alemtuzumab (Campath),2016-07-23,,1000, ,['3 / Week'],IV, 
13127,1022,Rebif [22],2016-03-16,2021-04-05,20,MIU,['2 / Day'],IV,Persisting MRI activity
13128,1022,Copaxone,2016-08-08,,500, ,[' '], , 
13129,4635,Methylprednisolone,2016-04-29,2018-12-07,5000, ,['/Month'], ,Persisting MRI activity
13130,4458,D-cure (Vitamine D),2016-09-19,,500, ,['2 / Day'],IV, 
13131,4458,Alemtuzumab (Campath),2015-12-26,,300,MIU,[' '],Oral, 
13132,3665,Rebif [44],2016-08-09,, , ,['3 / Week'],IV, 
13133,3665,D-cure (Vitamine D),2016-09-25,,500, ,['2 / Day'],IV, 
13134,3665,Alemtuzumab (Campath),2016-05-17,2019-04-10,5000, ,['/Month'],IV,Patient Choice/Convenience
13135,2834,Endoxan,2016-09-07,2021-02-22, ,mg,['/ Day'],IV,Lack of efficacy
13136,2834,Methylprednisolone,2016-07-04,,5000, ,['2 / Day'],IV, 
13137,2834,Rebif [44],2016-09-16,, , ,['/ Day'], , 
13138,4835,IVIG,2016-10-07,, , ,['2 / Day'],IV, 
13139,4835,IVIG,2016-06-27,,5000,MIU,[' '], , 
13140,4835,Ledertrexaat,2016-08-30,,20, ,['2 / Day'],Oral, 
13141,1681,Gilenya,2016-02-23,2020-05-26,20,mg,['/Month'], ,Persisting MRI activity
13142,1681,Rebif [44],2016-02-29,,5000, ,['2 / Day'], , 
13143,2608,Betaferon,2016-07-17,,1000,mcg,['2 / Day'],IV, 
13144,862,IVIG,2016-07-17,,400, ,['3 / Week'], , 
13145,862,Tecfidera,2015-12-16,2018-08-11,1,mg,['/Month'], ,Patient Choice/Convenience
13146,862,Tysabri,2016-02-29,, ,MIU,['2 / Day'],IV, 
13147,1276,Methylprednisolone,2016-04-16,2021-04-19,300, ,['/ Day'],IV,Persisting MRI activity
13148,1276,Copaxone,2016-07-22,,1000,mg,['/Month'],Oral, 
13149,1276,D-cure (Vitamine D),2016-08-29,, ,mcg,['/Month'],Oral, 
13150,1276,Methylprednisolone,2016-09-26,,400,mcg,['2 / Day'], , 
13151,1931,Teriflunomide,2016-02-25,,1000,mcg,['/Month'],IV, 
13152,1931,Rebif [22],2016-07-01,,500, ,['/ Week'],Oral, 
13153,1931,Rebif [44],2016-05-17,,300,mg,[' '], , 
13154,3798,Ledertrexaat,2016-05-12,,300,mg,['/Month'],IV, 
13155,4814,Endoxan,2016-05-16,2018-02-11, , ,['/Month'], ,Adverse Event
13156,4814,Endoxan,2016-05-08,,1000, ,['/Month'],IV, 
13157,4814,Mitoxantrone,2016-02-05,2019-02-20, ,mg,['/Month'],IV,Patient Choice/Convenience
13158,4814,Rebif [22],2016-01-27,2018-05-14,1000,MIU,['2 / Day'], ,Adverse Event
13159,3970,Ledertrexaat,2016-04-16,2021-06-19, , ,['2 / Day'],Oral,Persisting MRI activity
13160,3970,Alemtuzumab (Campath),2015-12-01,,5000, ,['/Month'], , 
13161,3970,Methylprednisolone,2016-08-25,2020-01-21,20,mg,['2 / Day'],Oral,Patient Choice/Convenience
13162,3970,Avonex,2016-08-26,2021-02-26,400,MIU,['2 / Day'],IV,Persisting MRI activity
13163,2030,Teriflunomide,2016-02-15,,500,mcg,['2 / Day'], , 
13164,2030,Ledertrexaat,2016-10-03,2020-10-09, , ,['/ Day'],Oral,Patient Choice/Convenience
13165,2030,IVIG,2016-08-05,,400,mg,['/Month'], , 
13166,382,IVIG,2016-05-08,, ,mcg,['/Month'], , 
13167,382,Alemtuzumab (Campath),2016-05-22,,500,mg,['2 / Day'],IV, 
13168,1026,Tecfidera,2016-01-26,2019-09-23, ,mg,[' '],IV,Persistence of relapses
13169,2933,Alemtuzumab (Campath),2016-04-19,, ,MIU,['2 / Day'],IV, 
13170,2933,Copaxone,2015-11-14,, ,mg,['2 / Day'],IV, 
13171,3171,Alemtuzumab (Campath),2016-06-11,2019-07-31,5000, ,['/Month'],IV,Patient Choice/Convenience
13172,3171,Rebif [44],2016-05-04,2020-09-09, , ,['/Month'],IV,Patient Choice/Convenience
13173,3970,Gilenya,2016-02-17,,5000, ,['2 / Day'],IV, 
13174,3970,Betaferon,2015-12-15,, , ,['/ Day'],Oral, 
13175,4530,Methylprednisolone,2015-12-07,, ,mg,['/ Week'],IV, 
13176,4530,Avonex,2016-09-17,2021-06-21,300,mg,['/ Week'],IV,Adverse Event
13177,1410,Ledertrexaat,2016-05-08,2019-03-25, ,mcg,[' '],IV,Persisting MRI activity
13178,1410,Alemtuzumab (Campath),2016-02-05,2021-07-06,500, ,['2 / Day'], ,Persisting MRI activity
13179,1410,Rebif [44],2015-12-25,, , ,['/Month'],IV, 
13180,1410,Rebif [44],2016-03-27,, ,mg,['2 / Day'],Oral, 
13181,4569,Gilenya,2016-07-14,2021-09-25,5000,mg,['/Month'], ,Persistence of relapses
13182,4569,Gilenya,2015-12-26,,500,MIU,['2 / Day'], , 
13183,4569,Copaxone,2016-01-23,,1,mg,['2 / Day'],Oral, 
13184,3587,Rebif [44],2016-06-18,2018-03-04, ,mg,['2 / Day'], ,Lack of efficacy
13185,3587,Endoxan,2015-11-15,2021-04-15,400, ,['2 / Day'], ,Lack of efficacy
13186,2306,Alemtuzumab (Campath),2016-01-06,2020-06-22,500, ,['/Month'],Oral,Persistence of relapses
13187,2306,Betaferon,2015-11-15,2019-10-27,300,mcg,['2 / Day'],Oral,Persistence of relapses
13188,2306,Gilenya,2016-04-01,,5000,mcg,['/Month'],IV, 
13189,2306,IVIG,2015-11-26,2019-07-29,300, ,['/Month'],IV,Persisting MRI activity
13190,1303,D-cure (Vitamine D),2016-03-03,2020-04-26,20,mg,['/Month'],Oral,Persisting MRI activity
13191,1303,D-cure (Vitamine D),2016-08-06,2018-01-11, , ,['/ Week'],Oral,Patient Choice/Convenience
13192,1303,Alemtuzumab (Campath),2016-08-23,,20, ,['2 / Day'], , 
13193,1303,D-cure (Vitamine D),2016-02-11,,1000,mcg,['/Month'],IV, 
13194,4714,IVIG,2016-06-13,, , ,[' '],IV, 
13195,4714,Ledertrexaat,2016-10-14,2020-01-15,20,mg,['2 / Day'],IV,Persistence of relapses
13196,4714,Rebif [22],2016-08-06,2021-05-05,20,mg,['/Month'], ,Lack of efficacy
13197,2054,Methylprednisolone,2016-01-31,,1,mg,['/Month'],IV, 
13198,2054,Tysabri,2016-10-05,2021-08-11,1,mg,['3 / Week'], ,Lack of efficacy
13199,2054,Ledertrexaat,2015-12-22,2018-05-11, ,mg,['3 / Week'], ,Adverse Event
13200,2054,Gilenya,2016-01-07,,20,mg,['2 / Day'],IV, 
13201,2542,Endoxan,2016-04-20,2019-06-18,300, ,['2 / Day'],IV,Persisting MRI activity
13202,2542,Tecfidera,2016-05-27,2020-09-08,1,mg,['/Month'], ,Persisting MRI activity
13203,2542,Ledertrexaat,2016-08-11,2020-01-03, , ,['2 / Day'], ,Adverse Event
13204,2417,Rebif [22],2016-05-06,, , ,['/Month'],IV, 
13205,2417,Rebif [44],2015-11-10,2021-06-13, ,mg,['/ Day'], ,Patient Choice/Convenience
13206,2417,IVIG,2016-09-12,2020-04-24,20, ,['2 / Day'], ,Persistence of relapses
13207,3888,Rebif [22],2016-08-11,,5000,mg,['/ Week'],IV, 
13208,341,Tysabri,2016-07-29,2018-11-21,1000, ,['3 / Week'],IV,Patient Choice/Convenience
13209,341,Rebif [22],2016-10-06,2018-11-09,5000,mg,['/ Day'],IV,Lack of efficacy
13210,341,Rebif [44],2016-07-17,2020-02-05,500,mg,['/Month'], ,Persisting MRI activity
13211,1607,D-cure (Vitamine D),2016-04-02,, , ,['/ Week'],IV, 
13212,1607,Methylprednisolone,2016-04-22,2019-11-10,1000,mg,['/Month'],IV,Adverse Event
13213,1607,Gilenya,2016-06-28,,400,mg,['/ Week'],IV, 
13214,161,Mitoxantrone,2016-07-04,2019-08-19,5000, ,['/Month'],IV,Adverse Event
13215,108,Mitoxantrone,2016-01-03,, ,mg,[' '],IV, 
13216,4245,Endoxan,2016-08-02,2018-06-10,5000,mg,[' '],IV,Adverse Event
13217,4245,Tysabri,2016-05-01,, ,mg,[' '],Oral, 
13218,4245,Methylprednisolone,2015-11-22,,500,mg,['/ Week'],IV, 
13219,4245,Alemtuzumab (Campath),2016-04-17,,1000, ,['2 / Day'],Oral, 
13220,3038,Rebif [22],2016-08-11,,500, ,['2 / Day'],IV, 
13221,3038,Ledertrexaat,2016-08-21,2021-02-23,500,mg,['/ Day'],IV,Lack of efficacy
13222,3038,Teriflunomide,2015-11-19,, ,mg,['2 / Day'], , 
13223,3038,D-cure (Vitamine D),2016-05-29,,300,mg,[' '],IV, 
13224,1132,Endoxan,2015-12-25,,20,mg,['/Month'],IV, 
13225,1132,Rebif [22],2015-11-05,2021-09-26, ,mg,[' '], ,Adverse Event
13226,137,D-cure (Vitamine D),2016-08-01,2019-05-18, , ,['3 / Week'], ,Adverse Event
13227,137,Tecfidera,2016-10-20,,300,mg,['3 / Week'], , 
13228,519,Tysabri,2016-06-16,2020-10-17, , ,['2 / Day'],Oral,Lack of efficacy
13229,2836,Teriflunomide,2015-11-12,, , ,[' '],Oral, 
13230,2836,Rebif [22],2016-08-21,,20, ,['/ Day'], , 
13231,2836,IVIG,2016-04-05,,300, ,['/ Day'],Oral, 
13232,2836,Gilenya,2015-11-30,2019-07-28,1, ,['/Month'],IV,Patient Choice/Convenience
13233,4164,Avonex,2016-10-02,, ,mg,['/Month'],IV, 
13234,4680,Rebif [22],2016-09-28,2020-09-26, ,mg,[' '], ,Persisting MRI activity
13235,3506,Tysabri,2015-12-18,,300, ,['/Month'], , 
13236,3506,Alemtuzumab (Campath),2016-08-10,,300, ,['2 / Day'], , 
13237,3150,Tecfidera,2016-07-10,,5000, ,['/Month'],IV, 
13238,3150,Avonex,2016-08-09,2018-08-30,20,mg,['/ Day'],Oral,Adverse Event
13239,3150,Methylprednisolone,2016-03-10,2018-05-19, ,MIU,['2 / Day'], ,Persisting MRI activity
13240,3150,Mitoxantrone,2016-02-18,2018-01-16, ,mg,['2 / Day'],IV,Persisting MRI activity
13241,2032,D-cure (Vitamine D),2016-01-08,,1000, ,['/Month'],IV, 
13242,2032,Gilenya,2016-09-07,,20, ,['2 / Day'],IV, 
13243,2032,Tysabri,2016-09-30,,1000,mg,['2 / Day'],IV, 
13244,2032,Rebif [44],2016-04-30,,20,MIU,['/Month'], , 
13245,2408,Gilenya,2015-11-15,2019-08-08,400,mg,['2 / Day'],IV,Persistence of relapses
13246,2408,Rebif [44],2015-12-24,,500,mg,['/ Week'],IV, 
13247,2159,Tysabri,2016-03-03,, , ,['/ Week'], , 
13248,3871,Avonex,2016-10-13,2019-09-20,5000,mg,['2 / Day'],IV,Adverse Event
13249,3871,D-cure (Vitamine D),2016-01-22,, ,mcg,['2 / Day'],Oral, 
13250,2999,Endoxan,2015-12-24,, , ,['/Month'],IV, 
13251,2999,Rebif [22],2016-05-27,2021-01-10,1,mg,['2 / Day'], ,Persisting MRI activity
13252,2999,Teriflunomide,2016-04-08,,500, ,['2 / Day'],Oral, 
13253,868,Copaxone,2016-03-10,, , ,['2 / Day'], , 
13254,868,Tecfidera,2016-07-28,2020-08-29,20,mg,['2 / Day'], ,Persisting MRI activity
13255,868,Methylprednisolone,2016-09-30,,500, ,['3 / Week'],Oral, 
13256,868,Methylprednisolone,2016-06-08,2020-07-11,300,mcg,['2 / Day'], ,Adverse Event
13257,4644,Mitoxantrone,2016-02-09,, , ,['/ Day'], , 
13258,4644,Alemtuzumab (Campath),2015-10-27,2021-07-26, , ,['/Month'],IV,Adverse Event
13259,4644,Copaxone,2016-09-22,,500,MIU,[' '],IV, 
13260,4644,Ledertrexaat,2016-08-03,,20, ,['/ Day'],IV, 
13261,2632,D-cure (Vitamine D),2016-08-13,2021-03-07,1,mg,['/ Day'], ,Patient Choice/Convenience
13262,2632,Betaferon,2015-11-18,2019-11-09, , ,['/ Day'],Oral,Lack of efficacy
13263,2632,Copaxone,2016-08-11,,1,mg,['3 / Week'],IV, 
13264,2632,D-cure (Vitamine D),2016-02-10,,1,mg,['/ Day'],IV, 
13265,3594,D-cure (Vitamine D),2016-09-18,2018-04-02,1000,mcg,['/Month'], ,Persisting MRI activity
13266,4235,Avonex,2016-03-30,, , ,['/ Day'],Oral, 
13267,1621,Alemtuzumab (Campath),2016-10-21,2021-04-04,1000, ,['/ Day'],IV,Adverse Event
13268,4065,Rebif [22],2016-09-05,2021-01-12,5000,mg,[' '],Oral,Adverse Event
13269,4065,Betaferon,2016-01-02,2020-11-25,400,mg,['3 / Week'], ,Persisting MRI activity
13270,4065,Copaxone,2016-02-09,,5000,mg,['2 / Day'],IV, 
13271,4065,Alemtuzumab (Campath),2016-08-08,,500,mg,[' '],Oral, 
13272,2265,Rebif [22],2016-03-09,2020-03-17,5000,mcg,['/Month'], ,Patient Choice/Convenience
13273,1649,Rebif [22],2016-07-26,2021-02-18, ,mg,['/ Day'], ,Persisting MRI activity
13274,1649,Alemtuzumab (Campath),2016-08-17,2020-12-24, ,mg,['/ Day'],IV,Patient Choice/Convenience
13275,3061,Alemtuzumab (Campath),2016-08-15,2019-09-21,500,mg,['2 / Day'],Oral,Persisting MRI activity
13276,4983,Tecfidera,2016-10-18,,300, ,['3 / Week'],IV, 
13277,4983,Alemtuzumab (Campath),2016-01-06,,20, ,['2 / Day'],Oral, 
13278,4983,Methylprednisolone,2016-02-04,, ,mg,['/ Week'], , 
13279,4983,Tecfidera,2016-03-22,2018-08-22, ,mg,['2 / Day'], ,Patient Choice/Convenience
13280,3386,Copaxone,2016-07-08,, , ,['/Month'], , 
13281,3386,Endoxan,2016-08-15,, , ,['/Month'], , 
13282,3386,Tecfidera,2016-10-19,,1000, ,['3 / Week'], , 
13283,3386,Betaferon,2016-04-23,,300,mcg,['/Month'],IV, 
13284,3724,Betaferon,2016-03-12,2018-12-22,400,mg,['2 / Day'], ,Lack of efficacy
13285,3724,IVIG,2016-01-17,,20,mcg,['/Month'], , 
13286,1677,Avonex,2016-07-20,2020-12-31,20,mg,['/Month'],IV,Lack of efficacy
13287,1677,Copaxone,2016-03-24,,300, ,['3 / Week'],IV, 
13288,290,Gilenya,2015-10-25,2021-04-14,1,MIU,['/ Week'],IV,Patient Choice/Convenience
13289,290,D-cure (Vitamine D),2016-06-07,2019-05-27,500, ,['3 / Week'],IV,Patient Choice/Convenience
13290,290,Tecfidera,2016-01-09,,400,mg,['2 / Day'], , 
13291,2447,Avonex,2016-10-05,,400,mg,['2 / Day'], , 
13292,2447,Tysabri,2016-01-29,2018-02-28,20,mg,[' '],IV,Patient Choice/Convenience
13293,2447,Avonex,2015-11-26,,5000, ,[' '],IV, 
13294,3894,Tecfidera,2015-11-30,,20,mg,['/Month'], , 
13295,3894,Rebif [44],2016-09-28,2021-07-18, , ,['/Month'], ,Lack of efficacy
13296,3894,IVIG,2016-05-23,, ,mcg,['2 / Day'],IV, 
13297,3894,Gilenya,2016-07-21,2018-01-03,5000, ,['3 / Week'],Oral,Adverse Event
13298,2311,Tysabri,2015-12-30,, ,mg,['2 / Day'],IV, 
13299,190,Betaferon,2015-12-16,2020-10-26,1,mcg,['2 / Day'],IV,Adverse Event
13300,190,D-cure (Vitamine D),2016-09-06,,5000,mg,['/ Day'], , 
13301,190,Copaxone,2016-08-06,2018-05-04, , ,['2 / Day'],IV,Adverse Event
13302,210,Copaxone,2016-09-08,,20,mg,['/Month'],IV, 
13303,2897,Teriflunomide,2015-11-11,2018-05-08, ,mg,['2 / Day'],IV,Adverse Event
13304,2897,Rebif [44],2016-07-23,, , ,['2 / Day'],IV, 
13305,2897,Gilenya,2016-04-15,,1000, ,['2 / Day'],IV, 
13306,4715,D-cure (Vitamine D),2016-08-06,, , ,['/Month'],IV, 
13307,4715,Methylprednisolone,2015-12-18,,5000,mg,['2 / Day'],Oral, 
13308,2094,Rebif [22],2016-06-22,,1, ,['/Month'],Oral, 
13309,2094,Ledertrexaat,2016-04-30,,500, ,[' '],IV, 
13310,2094,Avonex,2016-03-08,2021-02-06,500,MIU,['2 / Day'],Oral,Persisting MRI activity
13311,2094,Avonex,2015-12-22,,1, ,[' '],IV, 
13312,3918,Avonex,2016-07-06,,1000,mg,['3 / Week'],IV, 
13313,3918,Ledertrexaat,2016-06-30,,1000,mg,['/Month'],IV, 
13314,3918,Betaferon,2016-09-27,2018-08-17,1000,MIU,['/Month'], ,Adverse Event
13315,3918,D-cure (Vitamine D),2016-03-02,, ,MIU,['/Month'], , 
13316,785,Gilenya,2016-10-15,,5000,mg,['/Month'],IV, 
13317,4130,Gilenya,2016-02-13,2018-07-21, , ,['/Month'],Oral,Lack of efficacy
13318,2962,Avonex,2016-06-01,2018-04-09,20, ,['2 / Day'],IV,Adverse Event
13319,2962,D-cure (Vitamine D),2015-12-31,,1,mg,['3 / Week'], , 
13320,2962,Endoxan,2015-11-01,2020-12-17, , ,['3 / Week'],IV,Persisting MRI activity
13321,2962,Tysabri,2015-12-05,2020-06-30, ,mg,['3 / Week'], ,Patient Choice/Convenience
13322,600,Endoxan,2016-10-07,2021-04-03,500,mg,['2 / Day'], ,Lack of efficacy
13323,600,Tysabri,2015-12-17,2020-06-27,5000,MIU,[' '], ,Persistence of relapses
13324,600,Alemtuzumab (Campath),2016-06-01,, , ,['3 / Week'],IV, 
13325,600,Teriflunomide,2016-02-14,,300,mcg,['2 / Day'], , 
13326,4604,Gilenya,2016-02-23,,500,mg,['2 / Day'],IV, 
13327,4604,Copaxone,2016-07-30,2019-12-19, ,mg,['/ Day'],IV,Adverse Event
13328,4604,Avonex,2016-03-16,2019-09-05,500,mg,['2 / Day'], ,Adverse Event
13329,4604,Teriflunomide,2016-01-20,,1,mg,['2 / Day'], , 
13330,2833,D-cure (Vitamine D),2016-04-01,,1000, ,['2 / Day'],IV, 
13331,2833,Rebif [22],2016-03-09,,1, ,['2 / Day'], , 
13332,2833,Rebif [44],2016-08-07,2021-06-24,300, ,['/ Week'],Oral,Persisting MRI activity
13333,2833,Tecfidera,2015-11-23,2019-02-08, ,mg,['2 / Day'],IV,Adverse Event
13334,2964,IVIG,2016-06-29,,20, ,['2 / Day'],IV, 
13335,2964,D-cure (Vitamine D),2016-04-12,2018-02-09,20,mg,['2 / Day'],IV,Patient Choice/Convenience
13336,2964,Methylprednisolone,2016-05-30,,20,MIU,[' '], , 
13337,417,Endoxan,2016-08-30,, , ,['/Month'], , 
13338,417,IVIG,2016-04-29,,300, ,['2 / Day'], , 
13339,417,Methylprednisolone,2016-02-03,, ,mg,['2 / Day'],IV, 
13340,1057,Alemtuzumab (Campath),2016-09-01,2021-03-19, , ,['/ Week'],IV,Persistence of relapses
13341,1057,Teriflunomide,2015-11-11,2020-01-07,20, ,['/ Week'],Oral,Persisting MRI activity
13342,2062,Rebif [22],2016-07-20,, ,mcg,['3 / Week'],IV, 
13343,2062,D-cure (Vitamine D),2016-09-27,, ,mg,['3 / Week'], , 
13344,2062,Betaferon,2016-05-10,,1000,mg,['/ Day'],Oral, 
13345,2019,Ledertrexaat,2016-08-23,2019-03-12, ,mg,['2 / Day'], ,Adverse Event
13346,2019,Mitoxantrone,2016-02-24,2019-08-09,5000, ,[' '],IV,Persisting MRI activity
13347,3588,Mitoxantrone,2015-12-16,, ,mcg,['3 / Week'],IV, 
13348,3588,Rebif [44],2016-05-29,,5000,mg,['3 / Week'], , 
13349,3588,Rebif [44],2016-06-23,, , ,[' '],IV, 
13350,3588,Rebif [44],2015-11-11,,500,mg,['2 / Day'], , 
13351,4006,Alemtuzumab (Campath),2016-01-27,,400,mg,['2 / Day'], , 
13352,4006,Betaferon,2016-05-12,2018-08-15,500,MIU,['3 / Week'], ,Persisting MRI activity
13353,2639,IVIG,2016-10-16,2019-03-02,400,mcg,['/Month'], ,Patient Choice/Convenience
13354,1633,Avonex,2016-10-21,2020-06-24,300, ,['2 / Day'],IV,Patient Choice/Convenience
13355,782,Tecfidera,2016-07-16,, ,mcg,['2 / Day'],IV, 
13356,782,IVIG,2016-04-28,2018-07-30,500,mg,['/Month'], ,Patient Choice/Convenience
13357,782,Rebif [22],2016-04-17,,400, ,['/ Week'], , 
13358,782,D-cure (Vitamine D),2016-05-23,,300, ,['/Month'], , 
13359,4885,Tysabri,2016-06-23,2019-10-28,5000, ,['2 / Day'], ,Persisting MRI activity
13360,4885,Tysabri,2016-01-17,, , ,['/ Week'],IV, 
13361,4885,Copaxone,2016-10-16,, ,mg,['/ Day'],IV, 
13362,2369,Rebif [22],2016-01-17,, ,mg,[' '],IV, 
13363,2369,Avonex,2016-07-24,2018-04-15, ,mg,['/Month'],IV,Persisting MRI activity
13364,2369,Mitoxantrone,2016-06-10,2018-07-17,500, ,['/ Day'],IV,Adverse Event
13365,2369,Tecfidera,2015-11-01,2021-06-30,1000, ,['3 / Week'],IV,Persisting MRI activity
13366,4221,Avonex,2015-11-18,2021-05-26,500,MIU,[' '], ,Lack of efficacy
13367,4221,Tysabri,2016-06-14,, ,mcg,[' '], , 
13368,4221,Tecfidera,2016-01-10,,300,mcg,['/Month'], , 
13369,4221,IVIG,2016-09-11,,300,mg,['2 / Day'], , 
13370,2162,Tecfidera,2016-01-10,2019-08-01,1000, ,['2 / Day'],Oral,Adverse Event
13371,2162,Gilenya,2016-07-27,2020-10-16,300,mg,['2 / Day'], ,Adverse Event
13372,3023,Teriflunomide,2016-10-13,,1,mg,['/Month'],IV, 
13373,3023,D-cure (Vitamine D),2016-08-24,2020-01-04,20,mg,['/ Week'],Oral,Persistence of relapses
13374,3023,Copaxone,2016-01-02,2020-02-10,300, ,['3 / Week'], ,Patient Choice/Convenience
13375,3023,Copaxone,2016-07-16,2019-05-28, ,mg,['/ Week'],IV,Patient Choice/Convenience
13376,2127,Gilenya,2016-07-31,2021-01-23,300, ,['/ Week'],IV,Adverse Event
13377,2127,Rebif [44],2015-10-25,2020-06-19,500, ,['2 / Day'],IV,Persistence of relapses
13378,4881,Teriflunomide,2016-10-05,,500, ,['3 / Week'],IV, 
13379,4881,Mitoxantrone,2016-05-18,2018-04-04,5000,MIU,['/Month'],IV,Adverse Event
13380,4881,Methylprednisolone,2016-05-03,,300,mcg,[' '],IV, 
13381,1343,Rebif [22],2016-02-06,,300,MIU,['3 / Week'],IV, 
13382,1343,Copaxone,2016-05-27,,1000, ,[' '],IV, 
13383,1343,Teriflunomide,2016-02-18,,500,mg,['/Month'],Oral, 
13384,1343,Tysabri,2016-08-21,,300,MIU,['/Month'],IV, 
13385,2133,Tysabri,2016-07-09,,300,mg,['/ Day'],IV, 
13386,2776,Methylprednisolone,2016-02-28,, ,MIU,['/ Day'],IV, 
13387,2776,Alemtuzumab (Campath),2016-01-09,2021-06-22,1000,mg,['2 / Day'],Oral,Adverse Event
13388,1096,Tecfidera,2016-01-15,, , ,['/ Week'],IV, 
13389,1096,Rebif [44],2016-09-05,, , ,['/Month'], , 
13390,1096,IVIG,2016-10-21,,20,mg,['/ Day'],Oral, 
13391,2450,Methylprednisolone,2016-09-23,,1000,mg,[' '],Oral, 
13392,3101,Avonex,2015-11-06,, , ,['3 / Week'], , 
13393,4310,Alemtuzumab (Campath),2015-11-13,2020-07-03,5000, ,['3 / Week'],IV,Adverse Event
13394,4442,Gilenya,2016-06-27,,1000,mg,['/ Day'],IV, 
13395,4442,Rebif [22],2016-02-15,2020-12-29,20,mg,['/ Week'],Oral,Adverse Event
13396,4442,Rebif [22],2015-11-17,2020-08-21, , ,['/Month'], ,Adverse Event
13397,4442,Endoxan,2016-02-18,2019-11-07,300,mg,['3 / Week'], ,Adverse Event
13398,2868,Teriflunomide,2016-05-20,2020-05-21,400, ,['2 / Day'], ,Patient Choice/Convenience
13399,2868,Gilenya,2016-04-21,, ,MIU,['/Month'], , 
13400,2868,Mitoxantrone,2016-07-21,,1000,mg,['/Month'],IV, 
13401,2868,Tecfidera,2016-10-10,, , ,['2 / Day'],IV, 
13402,4235,Rebif [44],2016-06-27,2019-08-22, ,mcg,['/Month'],Oral,Patient Choice/Convenience
13403,4235,Ledertrexaat,2015-11-09,,5000,mg,['/Month'],IV, 
13404,4235,Tecfidera,2016-01-04,, ,mg,['2 / Day'],IV, 
13405,4235,Tysabri,2016-08-08,,1000,mg,['3 / Week'],IV, 
13406,2353,Mitoxantrone,2016-07-04,,500,mg,[' '],IV, 
13407,2356,IVIG,2016-04-12,2018-09-29,500, ,['2 / Day'],IV,Patient Choice/Convenience
13408,2356,IVIG,2016-08-03,,1000,mg,['2 / Day'],IV, 
13409,2356,Tecfidera,2015-11-07,, , ,['2 / Day'], , 
13410,1009,Avonex,2015-12-09,2021-10-03, ,mg,['/Month'],IV,Persistence of relapses
13411,1009,D-cure (Vitamine D),2016-09-08,2021-09-09,1000,mg,['/Month'],IV,Adverse Event
13412,1009,Methylprednisolone,2016-02-08,2019-04-06, ,mcg,['/ Day'],Oral,Adverse Event
13413,1009,Gilenya,2016-05-28,2019-06-10,5000, ,['2 / Day'], ,Patient Choice/Convenience
13414,3837,Copaxone,2015-12-02,2020-10-04,1000, ,[' '],IV,Persistence of relapses
13415,3231,Tecfidera,2016-03-30,,300,MIU,['/ Day'],Oral, 
13416,4446,Tysabri,2016-03-13,2017-11-26, ,mg,['3 / Week'],IV,Adverse Event
13417,3393,Avonex,2015-11-23,2019-05-20, , ,['2 / Day'], ,Lack of efficacy
13418,3393,Teriflunomide,2016-02-21,,5000, ,['/Month'],IV, 
13419,3393,Endoxan,2016-03-23,, ,mg,['/ Week'],IV, 
13420,1132,Tysabri,2016-07-06,2019-02-13, ,mg,['/Month'],IV,Adverse Event
13421,1132,Endoxan,2015-12-29,2019-03-11, ,mg,['3 / Week'],IV,Adverse Event
13422,1132,Endoxan,2016-05-31,2021-10-09,20, ,['/Month'], ,Adverse Event
13423,1132,Avonex,2016-04-17,,500, ,['/Month'],IV, 
13424,1543,Rebif [22],2016-08-07,2019-03-21, ,mg,['/Month'],IV,Adverse Event
13425,1543,Rebif [22],2016-09-13,2018-07-22,500, ,['/ Day'], ,Adverse Event
13426,3700,Tecfidera,2016-03-19,2020-03-29,400, ,['3 / Week'],IV,Lack of efficacy
13427,3700,Alemtuzumab (Campath),2016-08-31,2018-06-08,500, ,['/ Day'], ,Adverse Event
13428,3700,Copaxone,2016-01-07,, ,mg,['/Month'],Oral, 
13429,3700,Alemtuzumab (Campath),2016-09-21,,1000,MIU,[' '],Oral, 
13430,1623,Copaxone,2016-09-08,2020-10-12,300,MIU,['/Month'],IV,Lack of efficacy
13431,4525,Tysabri,2016-01-24,2019-01-28,300,mg,['3 / Week'],IV,Persistence of relapses
13432,4525,Gilenya,2015-12-06,2020-12-15,1, ,['2 / Day'],IV,Lack of efficacy
13433,1571,D-cure (Vitamine D),2016-02-06,2018-07-18, ,mg,['/ Day'],IV,Patient Choice/Convenience
13434,1571,Ledertrexaat,2016-04-06,,500, ,[' '], , 
13435,3702,D-cure (Vitamine D),2016-10-09,,20, ,['/ Day'],Oral, 
13436,3702,Tecfidera,2016-05-23,2020-05-06,500, ,[' '],IV,Patient Choice/Convenience
13437,3702,Rebif [22],2016-06-07,2021-05-04, ,mg,['/Month'],IV,Persisting MRI activity
13438,4073,Betaferon,2016-05-19,2019-05-29, , ,[' '], ,Patient Choice/Convenience
13439,4073,Betaferon,2016-08-08,,1000,mg,['/Month'],IV, 
13440,4073,IVIG,2016-07-30,,5000, ,['/Month'],IV, 
13441,4073,Alemtuzumab (Campath),2016-04-01,, ,mcg,[' '],IV, 
13442,2355,Betaferon,2016-01-04,,20, ,['2 / Day'],IV, 
13443,2355,Endoxan,2016-07-23,,20,mg,['/Month'],IV, 
13444,2355,Teriflunomide,2016-06-26,,400,MIU,['2 / Day'],IV, 
13445,2355,Endoxan,2016-09-27,,1000, ,['/Month'],IV, 
13446,2592,Rebif [22],2015-11-15,2019-06-02, ,MIU,['/Month'], ,Patient Choice/Convenience
13447,3184,Betaferon,2016-09-04,,300, ,['/Month'], , 
13448,3109,Tecfidera,2016-06-05,2018-12-14,300, ,['3 / Week'],IV,Adverse Event
13449,3109,Rebif [44],2016-04-08,, ,MIU,['/Month'],Oral, 
13450,3109,Tysabri,2015-12-16,2019-06-21,500, ,['2 / Day'], ,Lack of efficacy
13451,290,Teriflunomide,2016-07-07,,1,mg,['2 / Day'], , 
13452,290,IVIG,2016-06-13,2020-05-24, , ,['/Month'], ,Adverse Event
13453,290,IVIG,2016-07-06,, ,mcg,['2 / Day'], , 
13454,4871,Gilenya,2016-08-21,,400, ,['3 / Week'], , 
13455,4871,D-cure (Vitamine D),2016-09-20,2020-11-26,300,mg,['/Month'],IV,Persisting MRI activity
13456,2758,Ledertrexaat,2016-03-27,,20, ,['2 / Day'], , 
13457,2758,Gilenya,2015-12-22,2020-02-13, , ,[' '],IV,Adverse Event
13458,1060,IVIG,2016-04-30,,20,mg,['2 / Day'], , 
13459,2042,Tysabri,2016-08-10,,500,mg,['3 / Week'], , 
13460,2042,Ledertrexaat,2016-05-10,2019-06-18,20,mg,['2 / Day'],IV,Persisting MRI activity
13461,4265,Rebif [22],2016-07-23,,5000,mg,[' '],IV, 
13462,4265,Ledertrexaat,2016-02-27,, ,mg,['/Month'],Oral, 
13463,4265,Tysabri,2016-06-01,,400, ,['/ Week'],IV, 
13464,4265,Tysabri,2016-01-15,2018-05-13,300,mg,[' '],IV,Persisting MRI activity
13465,3332,Endoxan,2015-12-10,, ,mcg,['/ Day'],IV, 
13466,3373,Methylprednisolone,2016-09-17,2019-11-18,5000,mg,['/Month'],Oral,Adverse Event
13467,3373,Gilenya,2016-03-11,,1,mcg,[' '],IV, 
13468,4212,Endoxan,2016-10-15,,1000,mg,['2 / Day'], , 
13469,4212,Endoxan,2016-05-27,2019-02-19,1, ,['2 / Day'],IV,Adverse Event
13470,491,Copaxone,2016-04-19,,5000,mg,['/Month'], , 
13471,491,Alemtuzumab (Campath),2016-05-15,2021-04-01,1000,mcg,['2 / Day'],IV,Persistence of relapses
13472,491,IVIG,2016-02-28,, ,mg,['/ Day'], , 
13473,596,Rebif [22],2016-04-09,2020-10-12, ,mg,['3 / Week'],IV,Lack of efficacy
13474,596,D-cure (Vitamine D),2015-12-15,,400, ,['/Month'],IV, 
13475,596,Tecfidera,2016-01-21,2019-03-07,500,MIU,['/Month'],Oral,Lack of efficacy
13476,596,Endoxan,2016-05-03,2018-01-06, ,MIU,['/Month'],IV,Adverse Event
13477,4211,Gilenya,2016-06-13,,1000,MIU,['2 / Day'],Oral, 
13478,4211,Gilenya,2016-07-07,2018-05-12,500,mg,['/Month'],IV,Persisting MRI activity
13479,4211,D-cure (Vitamine D),2016-04-16,, ,mg,['3 / Week'], , 
13480,2652,Betaferon,2016-06-17,2020-09-10, ,mg,['/Month'], ,Persisting MRI activity
13481,3093,Tysabri,2016-05-27,2019-09-01,5000, ,[' '],IV,Lack of efficacy
13482,3093,Tecfidera,2015-12-04,, ,MIU,['2 / Day'], , 
13483,3093,Alemtuzumab (Campath),2015-10-29,2021-02-16,5000, ,['/Month'], ,Patient Choice/Convenience
13484,3770,Mitoxantrone,2016-01-08,, ,mg,['/ Day'],IV, 
13485,3770,Rebif [44],2016-06-21,,1,mg,['3 / Week'],IV, 
13486,2866,Teriflunomide,2016-10-20,,400,mg,['2 / Day'], , 
13487,2866,Tysabri,2016-09-09,,1000,mg,['2 / Day'], , 
13488,2866,IVIG,2015-11-09,, ,mg,['2 / Day'],IV, 
13489,2812,Tysabri,2016-10-12,,400, ,['2 / Day'],IV, 
13490,2812,Teriflunomide,2015-12-17,2020-11-22,300,mg,['/ Day'], ,Persistence of relapses
13491,2812,Tysabri,2016-10-16,2018-03-14,1000,mcg,['/Month'],IV,Persisting MRI activity
13492,2812,Tecfidera,2016-09-14,,500,mcg,['/Month'], , 
13493,1601,Teriflunomide,2016-04-14,,500,mg,['2 / Day'],Oral, 
13494,1601,Tecfidera,2016-04-19,,5000,mcg,['/ Week'],Oral, 
13495,1601,Rebif [22],2016-03-15,, ,mg,['/ Day'], , 
13496,1601,Teriflunomide,2015-12-13,, , ,['3 / Week'], , 
13497,513,Gilenya,2016-02-21,2019-11-09,20,mg,[' '],IV,Adverse Event
13498,513,Alemtuzumab (Campath),2016-01-31,, , ,['/Month'], , 
13499,513,Copaxone,2016-10-06,2019-12-06,300, ,['/ Day'],Oral,Persistence of relapses
13500,1462,Gilenya,2016-04-25,,1000,mg,[' '],IV, 
13501,1462,Tysabri,2016-10-03,,500,mg,['2 / Day'],IV, 
13502,4892,Copaxone,2016-09-22,,300,mg,['2 / Day'], , 
13503,4892,D-cure (Vitamine D),2016-07-01,2021-06-11, , ,['3 / Week'],IV,Persisting MRI activity
13504,4892,D-cure (Vitamine D),2016-09-14,,400, ,['2 / Day'], , 
13505,213,Rebif [44],2015-11-16,2020-02-04,500,MIU,['/Month'], ,Lack of efficacy
13506,213,Tysabri,2016-03-14,, , ,['/Month'],IV, 
13507,213,Endoxan,2016-02-01,2020-11-29, , ,['2 / Day'], ,Adverse Event
13508,491,Tecfidera,2016-08-03,2019-01-08,400,mg,['/ Day'],IV,Persisting MRI activity
13509,491,Rebif [44],2015-11-04,,300, ,['2 / Day'],IV, 
13510,491,Avonex,2016-02-17,2020-12-18,500,mg,['2 / Day'],IV,Adverse Event
13511,491,D-cure (Vitamine D),2016-01-06,2018-09-21, ,mg,['/Month'],Oral,Lack of efficacy
13512,3785,Mitoxantrone,2015-12-24,,500, ,['2 / Day'], , 
13513,2461,Avonex,2016-02-21,2019-03-31, ,mg,[' '], ,Patient Choice/Convenience
13514,2461,Gilenya,2016-09-03,,20, ,['2 / Day'],IV, 
13515,4753,Mitoxantrone,2016-05-04,,300, ,['/Month'],Oral, 
13516,4753,Avonex,2016-03-17,2019-10-19,300, ,['/Month'], ,Adverse Event
13517,4753,Mitoxantrone,2016-05-25,, , ,['3 / Week'],IV, 
13518,4753,Rebif [44],2016-10-10,, ,MIU,['/Month'],IV, 
13519,4549,Avonex,2016-04-17,,1000,mg,['2 / Day'],IV, 
13520,4549,Rebif [22],2016-04-17,, , ,['/ Week'],IV, 
13521,4549,Gilenya,2015-12-22,, ,mg,['2 / Day'],IV, 
13522,4549,D-cure (Vitamine D),2016-06-07,,500, ,['/ Week'], , 
13523,1090,Endoxan,2016-05-05,,300,mg,['/Month'], , 
13524,1090,Betaferon,2015-12-18,2018-08-23, , ,['2 / Day'],IV,Adverse Event
13525,3820,Tecfidera,2016-06-19,2021-07-15,1000, ,['/ Day'],IV,Patient Choice/Convenience
13526,3820,Rebif [44],2016-05-17,2019-08-27,1000,mg,['2 / Day'], ,Lack of efficacy
13527,3820,D-cure (Vitamine D),2016-05-18,, , ,['2 / Day'], , 
13528,3820,IVIG,2016-08-16,2021-02-07, , ,['2 / Day'],IV,Patient Choice/Convenience
13529,4680,D-cure (Vitamine D),2016-01-04,,5000, ,['3 / Week'], , 
13530,1029,D-cure (Vitamine D),2016-05-04,2019-05-10,500,mg,['/ Week'], ,Adverse Event
13531,2763,Ledertrexaat,2016-07-23,2018-02-07, ,MIU,[' '],IV,Persisting MRI activity
13532,4233,D-cure (Vitamine D),2016-09-27,,5000, ,[' '], , 
13533,4233,Ledertrexaat,2016-09-12,, ,mg,['/ Week'],IV, 
13534,4233,Tysabri,2016-07-24,,20, ,['/ Day'],IV, 
13535,3987,Endoxan,2016-06-29,, , ,['2 / Day'], , 
13536,3987,Tecfidera,2016-08-29,,1,mcg,['2 / Day'],IV, 
13537,1597,D-cure (Vitamine D),2016-05-12,,1000,mg,['2 / Day'], , 
13538,1597,Teriflunomide,2016-09-29,,5000, ,['/ Week'],Oral, 
13539,1597,IVIG,2015-12-23,2018-06-06,20, ,['/ Week'], ,Persisting MRI activity
13540,1597,Methylprednisolone,2016-08-26,, ,mg,['2 / Day'], , 
13541,3095,Betaferon,2015-11-01,2020-10-05, , ,['2 / Day'],IV,Persisting MRI activity
13542,3095,Betaferon,2016-09-09,,500,mcg,['/Month'],IV, 
13543,3095,D-cure (Vitamine D),2016-01-25,2019-09-26,300, ,['2 / Day'],IV,Adverse Event
13544,3095,Avonex,2016-02-01,2020-02-08, , ,['2 / Day'], ,Lack of efficacy
13545,3116,Avonex,2016-04-09,,300,mg,['2 / Day'],IV, 
13546,3116,Tysabri,2016-08-23,2021-04-28, , ,['/ Day'], ,Persistence of relapses
13547,4701,Alemtuzumab (Campath),2016-05-22,2018-10-06, , ,['/Month'],Oral,Lack of efficacy
13548,4701,Tecfidera,2015-12-19,,300,mg,['2 / Day'],IV, 
13549,4019,Rebif [44],2015-10-27,2018-09-02, , ,[' '],Oral,Patient Choice/Convenience
13550,4019,Gilenya,2016-01-25,2018-03-16,300,mcg,['/Month'],IV,Adverse Event
13551,4019,Methylprednisolone,2016-06-17,, ,MIU,['2 / Day'],IV, 
13552,4019,Tecfidera,2016-01-13,, , ,['/Month'],IV, 
13553,4986,Mitoxantrone,2016-09-04,,20,MIU,[' '], , 
13554,4986,IVIG,2016-07-31,,400, ,['2 / Day'],IV, 
13555,4986,Alemtuzumab (Campath),2015-11-16,,1000,mg,['/Month'], , 
13556,3892,Avonex,2015-12-06,, ,mg,['2 / Day'],IV, 
13557,3053,Avonex,2016-09-15,,1000,mg,['/Month'],IV, 
13558,3053,Alemtuzumab (Campath),2016-05-10,2019-11-11,20,MIU,['2 / Day'],Oral,Lack of efficacy
13559,3053,Rebif [22],2016-06-23,, ,mg,['2 / Day'],IV, 
13560,126,Tysabri,2016-10-14,2020-11-15,1000,mg,['/Month'], ,Persisting MRI activity
13561,126,Rebif [44],2016-10-19,,300,MIU,[' '],IV, 
13562,1006,Avonex,2016-05-25,,300,mg,[' '],IV, 
13563,328,IVIG,2016-01-12,,20,mg,['2 / Day'], , 
13564,328,Gilenya,2016-10-17,2021-10-07,1000, ,['2 / Day'], ,Persisting MRI activity
13565,1346,Copaxone,2015-12-25,,20, ,['/ Week'], , 
13566,1346,IVIG,2016-06-20,, , ,['2 / Day'], , 
13567,1346,Tecfidera,2016-06-30,2019-07-28,400,MIU,['/Month'],IV,Patient Choice/Convenience
13568,2085,IVIG,2016-03-30,2018-07-31, , ,['/Month'],IV,Patient Choice/Convenience
13569,2085,IVIG,2016-01-15,2020-08-18,500,mg,['3 / Week'], ,Patient Choice/Convenience
13570,2085,Avonex,2016-04-08,, , ,['/ Week'], , 
13571,1403,D-cure (Vitamine D),2016-03-11,2019-07-16,1000,MIU,['3 / Week'],IV,Lack of efficacy
13572,1403,Ledertrexaat,2016-06-22,,500, ,['/ Day'],IV, 
13573,1403,IVIG,2016-06-16,2018-08-30, , ,['/Month'], ,Lack of efficacy
13574,1341,Alemtuzumab (Campath),2015-11-13,, ,MIU,['2 / Day'], , 
13575,1341,Teriflunomide,2016-07-05,,500,MIU,['/Month'],IV, 
13576,1341,Gilenya,2016-08-12,, ,mg,[' '], , 
13577,1341,Tysabri,2015-10-24,2019-04-14,500,MIU,['/Month'], ,Patient Choice/Convenience
13578,2172,Betaferon,2016-04-17,2019-07-12, , ,['/Month'],Oral,Persistence of relapses
13579,2172,Copaxone,2016-08-07,2018-04-27,1000,MIU,['3 / Week'],IV,Patient Choice/Convenience
13580,4275,IVIG,2015-12-23,2021-01-03,20,mg,[' '],IV,Lack of efficacy
13581,4275,Tecfidera,2016-05-31,2019-09-29,20, ,['2 / Day'],IV,Adverse Event
13582,4275,Copaxone,2016-06-20,, ,mg,['2 / Day'],IV, 
13583,1550,Rebif [22],2015-12-20,,1000,MIU,['3 / Week'],IV, 
13584,1550,Tecfidera,2016-03-10,2021-06-24,500,mg,['2 / Day'], ,Persistence of relapses
13585,696,Endoxan,2016-02-08,, , ,['2 / Day'],IV, 
13586,696,Rebif [44],2016-07-13,,20, ,['2 / Day'],IV, 
13587,1796,D-cure (Vitamine D),2016-02-12,2019-01-07,1000, ,['/ Day'],IV,Adverse Event
13588,1796,IVIG,2016-02-07,2018-01-10,20, ,['/ Day'],IV,Lack of efficacy
13589,836,Mitoxantrone,2016-06-23,2019-08-08,300, ,['2 / Day'],IV,Persistence of relapses
13590,836,Gilenya,2016-03-29,,1,mcg,['2 / Day'],IV, 
13591,1043,Tecfidera,2016-02-11,2017-12-18,500,mg,['2 / Day'], ,Patient Choice/Convenience
13592,1043,Rebif [22],2015-12-28,, ,mg,['2 / Day'],IV, 
13593,1043,D-cure (Vitamine D),2016-08-09,2019-05-16,500, ,['/ Day'], ,Lack of efficacy
13594,1043,Rebif [22],2016-02-26,,300,mcg,['/Month'], , 
13595,3690,D-cure (Vitamine D),2016-06-02,2018-03-20,5000,mg,['2 / Day'], ,Adverse Event
13596,3690,D-cure (Vitamine D),2016-02-10,, , ,[' '],Oral, 
13597,3690,Rebif [44],2016-01-31,2020-06-30, , ,['2 / Day'], ,Persistence of relapses
13598,3690,IVIG,2016-05-31,2019-04-06, ,MIU,['/ Day'],IV,Adverse Event
13599,4434,Tysabri,2015-11-28,2019-10-26, , ,['2 / Day'],Oral,Patient Choice/Convenience
13600,4434,Betaferon,2016-07-20,2021-05-08, , ,['/Month'], ,Adverse Event
13601,4434,Gilenya,2016-05-01,2020-02-15,500,mg,['/Month'],IV,Patient Choice/Convenience
13602,268,Rebif [22],2016-10-02,,20, ,['/Month'],IV, 
13603,268,D-cure (Vitamine D),2016-04-10,2020-02-21,1, ,[' '],IV,Persisting MRI activity
13604,268,IVIG,2016-07-27,2018-08-15,1,mg,['/Month'],IV,Adverse Event
13605,268,Tysabri,2016-03-04,2020-06-04,20,mcg,['/Month'],IV,Lack of efficacy
13606,2214,Endoxan,2016-07-07,, ,mg,['2 / Day'],IV, 
13607,2214,Ledertrexaat,2016-01-30,,500,mg,['2 / Day'],IV, 
13608,2214,IVIG,2015-12-02,2020-07-02,500,mcg,['2 / Day'], ,Lack of efficacy
13609,2935,D-cure (Vitamine D),2016-07-12,,5000, ,['2 / Day'], , 
13610,2246,Tysabri,2016-06-22,, ,MIU,['/Month'],IV, 
13611,334,Avonex,2016-04-18,2018-11-04,400,mg,['2 / Day'],IV,Patient Choice/Convenience
13612,334,Betaferon,2016-08-06,,5000, ,['3 / Week'],IV, 
13613,2055,Endoxan,2016-07-30,2021-08-28,300,mcg,['/Month'],Oral,Patient Choice/Convenience
13614,2055,Mitoxantrone,2016-02-23,2018-01-15, ,mg,[' '],Oral,Adverse Event
13615,188,Rebif [44],2016-04-07,2021-02-15, ,mg,['/Month'],Oral,Adverse Event
13616,188,Tecfidera,2016-01-30,2017-12-28,1000, ,['/ Week'],IV,Adverse Event
13617,188,Betaferon,2016-03-11,2019-01-28,20, ,['2 / Day'], ,Adverse Event
13618,188,IVIG,2016-08-12,2020-11-14,5000, ,['/Month'], ,Lack of efficacy
13619,4001,IVIG,2016-05-10,2018-01-20,300, ,['3 / Week'],IV,Adverse Event
13620,4105,Rebif [44],2015-11-23,2018-01-19,5000, ,['2 / Day'], ,Lack of efficacy
13621,4105,D-cure (Vitamine D),2016-06-08,, ,mg,['/ Week'],IV, 
13622,4105,Rebif [44],2016-03-11,,5000, ,[' '],Oral, 
13623,2645,Betaferon,2016-05-13,2021-05-28, ,mg,['/ Week'],IV,Patient Choice/Convenience
13624,2645,Copaxone,2016-03-20,2020-06-27,20,MIU,['2 / Day'],IV,Patient Choice/Convenience
13625,4145,Rebif [44],2016-09-13,2019-06-11,500, ,['/ Day'],IV,Persistence of relapses
13626,4129,Ledertrexaat,2016-10-04,2019-02-17, , ,[' '],IV,Persisting MRI activity
13627,4129,Endoxan,2016-03-28,,5000, ,['2 / Day'],Oral, 
13628,4129,Endoxan,2016-07-02,,1000, ,['/Month'],IV, 
13629,4129,D-cure (Vitamine D),2016-02-04,2020-12-24,20,mg,['3 / Week'],IV,Adverse Event
13630,4579,Methylprednisolone,2016-06-02,2020-02-08,1, ,['2 / Day'],IV,Persisting MRI activity
13631,3273,Rebif [22],2016-04-26,,1,mg,['/ Day'],Oral, 
13632,3273,Betaferon,2016-06-15,,400,MIU,[' '],IV, 
13633,3273,D-cure (Vitamine D),2015-12-18,2019-02-22,300, ,['2 / Day'],IV,Patient Choice/Convenience
13634,3220,Betaferon,2016-09-14,, , ,['/ Day'], , 
13635,3220,D-cure (Vitamine D),2016-04-15,,500,mcg,['2 / Day'], , 
13636,3220,Mitoxantrone,2016-06-14,2019-05-10,1,mg,['/Month'], ,Patient Choice/Convenience
13637,3220,IVIG,2016-04-09,, ,mg,['2 / Day'],IV, 
13638,4360,D-cure (Vitamine D),2015-12-21,2021-02-20,5000,mcg,['2 / Day'],IV,Lack of efficacy
13639,845,Gilenya,2015-11-16,,500,mg,['2 / Day'],IV, 
13640,3676,Endoxan,2016-10-20,2021-08-07, ,MIU,['2 / Day'],IV,Persistence of relapses
13641,3676,Copaxone,2016-07-29,,1000, ,[' '],IV, 
13642,3676,Copaxone,2016-08-12,2019-08-06, ,MIU,['2 / Day'], ,Lack of efficacy
13643,1160,Copaxone,2016-04-04,2019-04-04,20, ,['/Month'],IV,Lack of efficacy
13644,1160,Rebif [22],2016-01-14,, ,MIU,['/Month'],IV, 
13645,1971,Ledertrexaat,2016-06-06,, ,MIU,['/ Day'], , 
13646,1971,IVIG,2016-02-28,2018-02-27,500,mg,['/Month'], ,Persistence of relapses
13647,1971,Endoxan,2016-03-23,, ,MIU,['2 / Day'],IV, 
13648,1971,Methylprednisolone,2016-09-14,, ,mg,['2 / Day'], , 
13649,854,D-cure (Vitamine D),2015-10-24,,5000,MIU,['2 / Day'],IV, 
13650,854,Methylprednisolone,2016-04-01,,400, ,['2 / Day'],IV, 
13651,854,Rebif [44],2016-07-03,2018-12-25,400, ,['/Month'],IV,Persistence of relapses
13652,3665,D-cure (Vitamine D),2016-09-10,,1000,mcg,['/ Day'], , 
13653,3665,Alemtuzumab (Campath),2016-04-19,2021-06-10,500,mg,['/Month'],IV,Persisting MRI activity
13654,3665,Tecfidera,2015-12-21,,300, ,['/Month'],IV, 
13655,3665,Methylprednisolone,2016-06-21,, ,mcg,[' '],Oral, 
13656,3404,Tecfidera,2016-09-08,,1,MIU,['2 / Day'], , 
13657,2437,Avonex,2015-11-05,2019-11-18,5000, ,['2 / Day'], ,Adverse Event
13658,1564,Teriflunomide,2016-05-04,2018-08-20, , ,['/ Week'],IV,Patient Choice/Convenience
13659,1564,IVIG,2016-05-20,,500,mg,['/ Day'],IV, 
13660,1564,Gilenya,2016-07-30,2021-06-11, ,MIU,['2 / Day'],Oral,Lack of efficacy
13661,341,D-cure (Vitamine D),2016-08-23,, ,mg,[' '],Oral, 
13662,341,Rebif [44],2016-01-21,2021-05-03, ,mg,['/Month'], ,Adverse Event
13663,341,IVIG,2016-02-17,,20,mg,['3 / Week'], , 
13664,2167,Methylprednisolone,2016-05-20,2020-04-29,1,mg,['/ Week'], ,Lack of efficacy
13665,2167,Endoxan,2016-09-27,, ,mcg,['3 / Week'], , 
13666,2167,Tecfidera,2016-04-13,, , ,['3 / Week'],Oral, 
13667,2167,D-cure (Vitamine D),2016-02-11,2018-07-25, ,mg,['/ Week'],IV,Persisting MRI activity
13668,1851,D-cure (Vitamine D),2015-12-20,, ,mg,['/ Week'], , 
13669,1851,Tecfidera,2016-05-24,2019-08-29,500,MIU,['2 / Day'],Oral,Patient Choice/Convenience
13670,1851,D-cure (Vitamine D),2016-04-01,, ,mg,['2 / Day'],IV, 
13671,2436,Methylprednisolone,2016-04-23,2017-12-09,5000,mg,['/Month'], ,Adverse Event
13672,2436,Gilenya,2016-04-02,, ,MIU,['3 / Week'],IV, 
13673,4520,Tecfidera,2016-07-31,,300,mg,['/Month'],IV, 
13674,4520,IVIG,2016-07-20,,500, ,['2 / Day'],IV, 
13675,4490,Betaferon,2016-07-04,, , ,['2 / Day'],IV, 
13676,4490,Alemtuzumab (Campath),2016-08-31,,20,MIU,['2 / Day'], , 
13677,4490,Gilenya,2016-10-22,,5000,mcg,[' '], , 
13678,4490,Rebif [44],2016-01-22,, , ,['/Month'],IV, 
13679,1276,Tysabri,2016-03-05,,500, ,['2 / Day'], , 
13680,1276,Tysabri,2016-05-25,,400, ,['3 / Week'], , 
13681,1276,Copaxone,2015-12-29,2019-08-04,1000,mcg,['/ Week'],Oral,Patient Choice/Convenience
13682,4509,Tecfidera,2016-09-22,,20, ,['/Month'], , 
13683,4509,Gilenya,2016-07-14,,5000, ,['/ Day'],IV, 
13684,4125,Endoxan,2016-01-31,2018-10-14,5000,mg,['/ Week'],Oral,Persisting MRI activity
13685,2215,Methylprednisolone,2016-07-27,2018-09-17,500,MIU,['/ Day'], ,Adverse Event
13686,2440,D-cure (Vitamine D),2016-02-25,, ,MIU,[' '],IV, 
13687,2440,Ledertrexaat,2016-04-03,,300, ,['2 / Day'],Oral, 
13688,2440,D-cure (Vitamine D),2016-01-11,2018-11-02,5000,mg,['/ Week'], ,Lack of efficacy
13689,2440,Betaferon,2016-09-16,2021-04-23,20,mg,['/Month'],Oral,Lack of efficacy
13690,993,D-cure (Vitamine D),2016-09-24,2020-09-02, ,mg,['/Month'],IV,Adverse Event
13691,993,Tecfidera,2016-02-16,2018-05-17,5000,mg,['2 / Day'], ,Persisting MRI activity
13692,993,D-cure (Vitamine D),2016-06-18,, ,mg,['/ Day'],IV, 
13693,993,Teriflunomide,2016-07-12,,300, ,['/Month'], , 
13694,1782,Tecfidera,2016-06-10,,1, ,['2 / Day'],IV, 
13695,1782,Copaxone,2016-05-14,,20,mg,[' '],IV, 
13696,1782,Betaferon,2015-12-27,2020-01-20,1000, ,['2 / Day'], ,Adverse Event
13697,1782,Alemtuzumab (Campath),2016-10-20,,5000, ,['2 / Day'],IV, 
13698,4014,IVIG,2015-11-10,,5000,mg,['/ Week'],IV, 
13699,4014,Alemtuzumab (Campath),2016-09-28,,300, ,[' '], , 
13700,4014,D-cure (Vitamine D),2016-09-30,, , ,[' '],IV, 
13701,4014,IVIG,2016-02-24,2019-07-18,5000,mg,['/ Week'], ,Persisting MRI activity
13702,2454,IVIG,2016-09-25,,5000,mg,['2 / Day'],Oral, 
13703,2454,Methylprednisolone,2016-08-30,, , ,['3 / Week'],Oral, 
13704,978,Gilenya,2016-07-19,,1000, ,['/Month'],IV, 
13705,978,Alemtuzumab (Campath),2016-04-10,2020-03-26, , ,['2 / Day'],IV,Adverse Event
13706,978,Avonex,2016-02-04,2021-04-28,400, ,[' '],IV,Adverse Event
13707,978,D-cure (Vitamine D),2016-06-10,2019-07-09, , ,['/Month'],Oral,Persistence of relapses
13708,1634,Alemtuzumab (Campath),2016-05-10,,300,mg,['2 / Day'],IV, 
13709,4898,Betaferon,2016-05-14,,1000,mcg,['2 / Day'], , 
13710,4898,Tecfidera,2016-01-13,2021-04-27, ,mcg,['/Month'],IV,Lack of efficacy
13711,4898,Tecfidera,2016-02-06,2019-06-27,1, ,['/ Week'], ,Adverse Event
13712,4898,Gilenya,2015-12-12,2020-03-25,1,mg,['2 / Day'],IV,Adverse Event
13713,4748,Rebif [44],2015-11-17,,1000,mg,['2 / Day'],IV, 
13714,4748,Rebif [44],2016-10-22,,1000, ,['2 / Day'],IV, 
13715,4748,Rebif [22],2016-03-30,,1,mg,['/Month'],Oral, 
13716,4748,Rebif [44],2016-06-26,, ,mcg,['3 / Week'],IV, 
13717,1369,Tysabri,2016-03-15,, , ,['2 / Day'], , 
13718,1369,D-cure (Vitamine D),2015-10-26,,300,MIU,['2 / Day'],IV, 
13719,259,Copaxone,2016-07-27,2018-01-20, , ,[' '],IV,Persisting MRI activity
13720,259,Endoxan,2016-07-24,,5000, ,['/Month'],IV, 
13721,259,D-cure (Vitamine D),2016-09-09,2018-12-01, , ,['3 / Week'], ,Adverse Event
13722,3424,Rebif [22],2016-09-04,,300,mcg,['/ Day'], , 
13723,3424,Betaferon,2016-10-10,,1000,mg,['2 / Day'],IV, 
13724,3424,D-cure (Vitamine D),2016-09-28,2018-12-05,1, ,['3 / Week'],IV,Persisting MRI activity
13725,3424,Avonex,2016-07-20,, , ,['2 / Day'],Oral, 
13726,4442,Endoxan,2016-06-09,,500, ,['/Month'],Oral, 
13727,4442,Betaferon,2016-03-19,,1,mg,['/Month'],IV, 
13728,2712,Tysabri,2016-03-03,2018-02-09, ,mg,['3 / Week'],IV,Lack of efficacy
13729,2712,Avonex,2016-10-08,2019-08-16,20,mg,['2 / Day'],IV,Adverse Event
13730,1095,Alemtuzumab (Campath),2016-06-22,2019-12-12,300,mg,['2 / Day'], ,Patient Choice/Convenience
13731,1095,Ledertrexaat,2016-04-05,2018-04-14,1, ,['3 / Week'],IV,Adverse Event
13732,473,Endoxan,2016-04-08,2020-09-15,5000,mg,['2 / Day'],Oral,Adverse Event
13733,473,Tecfidera,2016-04-06,2020-03-23,400,mg,['/Month'],Oral,Lack of efficacy
13734,473,IVIG,2016-02-20,2020-01-18,20, ,['2 / Day'],IV,Persisting MRI activity
13735,473,Rebif [22],2016-07-10,, ,mcg,[' '],IV, 
13736,2451,Tysabri,2015-11-26,2018-10-27,300,mg,['/ Day'], ,Adverse Event
13737,2451,Gilenya,2016-09-02,,300,mg,['3 / Week'],IV, 
13738,2451,IVIG,2016-01-26,,5000,mg,['/ Day'],IV, 
13739,2451,IVIG,2016-05-22,,1000,mg,['/ Day'], , 
13740,1378,Endoxan,2016-09-24,,500, ,['/ Day'], , 
13741,1981,Avonex,2016-01-28,,20,mg,['3 / Week'],IV, 
13742,296,Rebif [44],2016-02-12,2020-12-09, ,MIU,[' '],Oral,Lack of efficacy
13743,296,Tecfidera,2016-02-04,,500, ,['2 / Day'],IV, 
13744,296,Rebif [22],2016-02-27,,300,mcg,['3 / Week'], , 
13745,4573,Ledertrexaat,2016-04-03,, ,MIU,['2 / Day'],IV, 
13746,4573,Endoxan,2016-05-21,2018-10-08,1000,MIU,['/Month'],IV,Adverse Event
13747,4573,D-cure (Vitamine D),2016-10-05,2019-05-13, , ,['/ Day'], ,Adverse Event
13748,3354,IVIG,2016-07-11,2020-11-18, , ,['2 / Day'],IV,Patient Choice/Convenience
13749,3354,Rebif [44],2016-09-08,2019-01-16,300,mg,['2 / Day'], ,Patient Choice/Convenience
13750,3354,Tecfidera,2016-04-08,2021-06-30, , ,['/Month'],IV,Lack of efficacy
13751,4384,Copaxone,2016-07-09,,5000,mg,['/Month'], , 
13752,2967,Tysabri,2016-05-02,, ,mg,['/Month'],IV, 
13753,2304,Tysabri,2016-09-22,,5000, ,['2 / Day'], , 
13754,2304,Gilenya,2016-09-05,2019-08-23,300,mcg,['/ Week'], ,Patient Choice/Convenience
13755,2304,Avonex,2015-10-24,, ,mg,['/Month'],IV, 
13756,2304,Tecfidera,2016-06-27,2019-07-23,1000,mg,['/Month'],IV,Patient Choice/Convenience
13757,1655,Copaxone,2016-03-20,,1000,mg,[' '],Oral, 
13758,1655,Tysabri,2016-01-01,2018-09-30,500, ,['2 / Day'], ,Lack of efficacy
13759,608,Teriflunomide,2016-03-02,,20,mg,['/Month'],IV, 
13760,608,D-cure (Vitamine D),2015-11-12,2020-12-17,500, ,['3 / Week'], ,Patient Choice/Convenience
13761,608,IVIG,2016-05-26,,5000,mg,['3 / Week'], , 
13762,4670,Tysabri,2015-11-13,, ,mcg,['/Month'], , 
13763,4585,Tecfidera,2016-02-28,2018-12-04,1, ,['2 / Day'], ,Persistence of relapses
13764,4585,Mitoxantrone,2016-03-28,, ,mg,['3 / Week'], , 
13765,3834,Gilenya,2015-12-18,2018-05-02, , ,['3 / Week'], ,Patient Choice/Convenience
13766,4381,IVIG,2016-03-06,,1, ,['/ Day'], , 
13767,436,Tysabri,2016-03-02,,1000,mg,['3 / Week'],Oral, 
13768,4830,Rebif [44],2015-11-25,2018-07-27,1000,MIU,['/Month'],Oral,Adverse Event
13769,1118,Tecfidera,2016-06-25,2020-08-29,1000,mg,['/Month'],IV,Adverse Event
13770,1118,Copaxone,2016-07-16,2018-04-26, ,mg,['/ Day'], ,Patient Choice/Convenience
13771,1118,D-cure (Vitamine D),2015-12-13,,500,mg,['2 / Day'],Oral, 
13772,1118,Rebif [22],2016-02-22,,300,mg,['/Month'], , 
13773,3946,Rebif [22],2015-10-30,2021-04-17,20,MIU,['/ Day'], ,Persisting MRI activity
13774,3946,D-cure (Vitamine D),2016-10-09,2019-01-05, ,mg,['2 / Day'], ,Patient Choice/Convenience
13775,3946,D-cure (Vitamine D),2016-06-05,, , ,['/ Day'],Oral, 
13776,2074,D-cure (Vitamine D),2016-03-10,,20,MIU,['/Month'],IV, 
13777,2074,Rebif [22],2015-11-24,2021-09-30,1000,mg,[' '], ,Adverse Event
13778,2074,Methylprednisolone,2015-11-24,2018-10-12,1, ,['2 / Day'],IV,Persisting MRI activity
13779,2074,IVIG,2015-12-19,,1000, ,[' '],IV, 
13780,1815,Tysabri,2016-01-09,2019-04-25,1000, ,['/Month'], ,Persistence of relapses
13781,837,Rebif [22],2015-12-25,2019-02-10,1000,mg,['/Month'],IV,Patient Choice/Convenience
13782,837,Methylprednisolone,2016-07-02,, , ,['/ Week'],IV, 
13783,3284,Alemtuzumab (Campath),2015-11-10,,5000,mcg,['2 / Day'],IV, 
13784,3284,Alemtuzumab (Campath),2016-01-07,2021-10-16,400,mg,['/Month'], ,Lack of efficacy
13785,3284,Methylprednisolone,2016-08-06,2017-11-05, ,mg,['/Month'],IV,Persisting MRI activity
13786,3289,Ledertrexaat,2015-11-29,,1, ,['2 / Day'], , 
13787,3289,Methylprednisolone,2016-10-16,,400,mg,['2 / Day'], , 
13788,3289,Betaferon,2016-01-19,, , ,['3 / Week'], , 
13789,3289,Ledertrexaat,2015-11-11,, ,mg,['/Month'], , 
13790,2643,D-cure (Vitamine D),2016-08-19,,500, ,[' '],IV, 
13791,3190,Avonex,2016-02-09,, ,mg,['3 / Week'],IV, 
13792,3190,Methylprednisolone,2015-11-16,2018-03-22, , ,['/Month'],Oral,Patient Choice/Convenience
13793,453,Avonex,2016-08-09,,20,mg,['/ Week'],IV, 
13794,453,IVIG,2016-05-28,, , ,['/Month'],IV, 
13795,2848,Tysabri,2016-02-20,2018-11-15, ,mg,[' '],IV,Adverse Event
13796,2848,IVIG,2015-12-24,2018-02-23,400, ,['/ Day'], ,Patient Choice/Convenience
13797,435,Tysabri,2016-02-13,, ,mg,['/Month'],IV, 
13798,435,IVIG,2015-11-14,, ,mg,['3 / Week'], , 
13799,435,Methylprednisolone,2016-04-04,,300, ,['/Month'],IV, 
13800,2971,IVIG,2016-01-05,2018-04-19,300, ,[' '], ,Lack of efficacy
13801,2971,IVIG,2015-11-15,,20,mg,['/Month'], , 
13802,2380,Alemtuzumab (Campath),2015-11-18,,500, ,['/Month'],IV, 
13803,2380,Endoxan,2016-09-19,2018-03-10,400, ,['/Month'],IV,Lack of efficacy
13804,4667,D-cure (Vitamine D),2016-04-09,2020-11-14, , ,['/Month'],IV,Patient Choice/Convenience
13805,4667,Gilenya,2016-06-07,, ,mg,[' '],IV, 
13806,4667,Alemtuzumab (Campath),2016-10-19,, ,mcg,['2 / Day'], , 
13807,4667,D-cure (Vitamine D),2016-09-12,, ,mg,['/Month'], , 
13808,2520,D-cure (Vitamine D),2016-10-18,2018-11-17, ,MIU,['/ Week'], ,Adverse Event
13809,2520,Tecfidera,2015-12-08,2020-04-02, ,mg,['/Month'],Oral,Patient Choice/Convenience
13810,2971,Tysabri,2016-08-11,2020-01-06, ,mg,['/ Day'],IV,Persisting MRI activity
13811,2971,Endoxan,2016-06-06,2020-11-01,20,mg,[' '],IV,Patient Choice/Convenience
13812,2971,Rebif [44],2016-01-02,,1000, ,['/ Day'],IV, 
13813,2971,D-cure (Vitamine D),2015-11-18,2018-12-13, ,MIU,[' '], ,Adverse Event
13814,1244,Methylprednisolone,2016-09-01,2021-10-18, ,mg,[' '],IV,Patient Choice/Convenience
13815,1244,Ledertrexaat,2016-04-21,2019-10-30,20,MIU,['/ Day'], ,Adverse Event
13816,1244,Betaferon,2016-10-13,2019-03-01, , ,['/Month'],IV,Patient Choice/Convenience
13817,3044,Methylprednisolone,2016-01-02,2019-09-13, , ,['/ Day'], ,Adverse Event
13818,1508,Ledertrexaat,2015-11-16,, , ,['/Month'],Oral, 
13819,1508,Copaxone,2016-04-07,2018-12-13,500, ,['/ Week'], ,Adverse Event
13820,372,D-cure (Vitamine D),2016-06-30,,500,mg,['/Month'],IV, 
13821,372,Alemtuzumab (Campath),2015-12-11,,1, ,['2 / Day'], , 
13822,372,Endoxan,2016-05-10,, ,mg,['/ Day'], , 
13823,2310,Teriflunomide,2015-12-29,2019-09-11, ,mg,['2 / Day'],IV,Lack of efficacy
13824,507,Endoxan,2016-04-08,2017-11-07,20, ,['2 / Day'],IV,Adverse Event
13825,507,IVIG,2015-11-05,, , ,['2 / Day'], , 
13826,507,Methylprednisolone,2016-03-02,2019-05-17,1000,mg,['/Month'],IV,Adverse Event
13827,4501,Tysabri,2016-01-02,2019-08-21, ,mg,['2 / Day'],IV,Persisting MRI activity
13828,4501,Tecfidera,2015-11-29,2019-01-14,1000, ,['/Month'],IV,Patient Choice/Convenience
13829,4501,IVIG,2016-02-19,,1000, ,['3 / Week'],IV, 
13830,1006,Teriflunomide,2016-01-14,, ,mg,['2 / Day'], , 
13831,417,Methylprednisolone,2016-01-27,,300,mg,['/ Day'],IV, 
13832,417,Rebif [44],2016-03-14,2020-08-06, ,mg,['2 / Day'],IV,Patient Choice/Convenience
13833,417,IVIG,2016-09-26,, ,mg,['/ Day'],IV, 
13834,2531,Methylprednisolone,2016-02-09,,1,mg,['2 / Day'],IV, 
13835,2595,Avonex,2016-02-19,,300,mg,['/ Day'], , 
13836,2595,Alemtuzumab (Campath),2016-02-03,,1000, ,['3 / Week'], , 
13837,2595,Tysabri,2016-01-17,2021-10-19,5000, ,['/Month'],IV,Persistence of relapses
13838,4582,IVIG,2015-12-10,2019-03-15,20,mg,['3 / Week'], ,Lack of efficacy
13839,4582,Tecfidera,2016-06-05,2019-10-26, , ,['3 / Week'],Oral,Patient Choice/Convenience
13840,1347,Endoxan,2015-12-10,, , ,['3 / Week'], , 
13841,1347,Rebif [22],2015-12-03,,20,mg,['2 / Day'],IV, 
13842,1347,Tecfidera,2016-09-09,2020-09-26,20, ,['3 / Week'], ,Lack of efficacy
13843,668,Avonex,2016-06-13,2020-01-05,20,MIU,['2 / Day'],IV,Patient Choice/Convenience
13844,2766,Rebif [22],2016-10-22,,300,mcg,['3 / Week'],Oral, 
13845,1384,Rebif [22],2015-11-10,2018-03-18,500, ,['3 / Week'],IV,Adverse Event
13846,1384,Tecfidera,2016-07-02,,5000,MIU,['/Month'], , 
13847,1384,Betaferon,2016-06-13,2021-08-25,500,mg,['2 / Day'],Oral,Persisting MRI activity
13848,1384,Rebif [22],2016-08-03,,5000,MIU,['2 / Day'],IV, 
13849,4126,Rebif [22],2015-11-15,, ,mg,['/Month'], , 
13850,1310,Tecfidera,2015-11-26,,1000,mcg,['2 / Day'], , 
13851,1310,Mitoxantrone,2016-09-27,,1,MIU,['2 / Day'], , 
13852,1310,Avonex,2016-04-12,2017-11-16,500,mg,['2 / Day'], ,Patient Choice/Convenience
13853,4541,Rebif [44],2015-12-08,, , ,['2 / Day'],IV, 
13854,4541,Tysabri,2015-10-25,,1,mg,['3 / Week'],Oral, 
13855,1963,Tysabri,2015-11-13,,20,MIU,['/Month'],IV, 
13856,1963,Copaxone,2015-12-02,,5000,mg,['/Month'], , 
13857,1963,Endoxan,2016-08-10,,5000, ,['/Month'],IV, 
13858,1963,D-cure (Vitamine D),2016-05-12,2021-05-15,20,mg,['/Month'], ,Lack of efficacy
13859,605,Gilenya,2016-05-19,2020-03-09,400, ,['/ Day'],IV,Adverse Event
13860,605,Tecfidera,2015-11-07,,1000,MIU,['/Month'],IV, 
13861,1668,Tecfidera,2016-01-31,,400,MIU,['2 / Day'], , 
13862,1668,Tysabri,2016-04-05,,1000, ,['2 / Day'], , 
13863,1668,Tecfidera,2015-12-16,,1,MIU,['3 / Week'],IV, 
13864,2676,Tysabri,2016-10-07,2021-09-11,500,mg,['3 / Week'], ,Lack of efficacy
13865,2885,Teriflunomide,2016-02-01,2021-01-05, , ,[' '], ,Patient Choice/Convenience
13866,3764,Avonex,2015-11-06,, ,mg,['/Month'],IV, 
13867,3764,Avonex,2016-02-25,, ,mg,['2 / Day'], , 
13868,3764,Tecfidera,2016-08-24,2020-05-22,1, ,['3 / Week'], ,Adverse Event
13869,1082,Betaferon,2016-08-04,2020-03-15,300,mg,['/Month'],IV,Adverse Event
13870,1082,Tecfidera,2016-05-22,, , ,['3 / Week'],IV, 
13871,1082,Gilenya,2016-08-30,2018-08-11,500, ,['/Month'],IV,Lack of efficacy
13872,2965,Copaxone,2016-04-28,,1000, ,['3 / Week'],IV, 
13873,2965,Copaxone,2016-02-02,, , ,['2 / Day'], , 
13874,2965,IVIG,2015-10-30,2020-12-08,1000, ,['/ Week'],IV,Persisting MRI activity
13875,2691,Avonex,2015-10-30,2019-03-07, ,mg,['3 / Week'],IV,Lack of efficacy
13876,2691,D-cure (Vitamine D),2016-05-26,2021-02-28,1,mg,['/Month'], ,Patient Choice/Convenience
13877,2691,Copaxone,2015-11-25,,1, ,['/Month'], , 
13878,2691,Tysabri,2016-07-23,, ,mg,['2 / Day'],IV, 
13879,4243,IVIG,2016-07-28,,300, ,['2 / Day'],IV, 
13880,4243,Methylprednisolone,2015-11-04,2019-05-12, ,mg,['/ Week'], ,Patient Choice/Convenience
13881,4787,Teriflunomide,2016-07-21,, ,mg,['/Month'],IV, 
13882,4787,Rebif [22],2016-02-05,,1000, ,['/Month'], , 
13883,4787,Alemtuzumab (Campath),2016-05-04,,500, ,['/Month'],Oral, 
13884,4787,Rebif [22],2016-09-03,,400,mcg,['/ Week'],IV, 
13885,4755,D-cure (Vitamine D),2016-06-21,2021-08-22,500,MIU,['2 / Day'], ,Patient Choice/Convenience
13886,4755,Teriflunomide,2016-09-25,,300,mg,['3 / Week'], , 
13887,4755,Teriflunomide,2016-06-27,, , ,['3 / Week'], , 
13888,4755,Rebif [22],2016-08-05,2021-07-22,500,mcg,['3 / Week'], ,Persisting MRI activity
13889,3401,Methylprednisolone,2016-04-11,2018-12-07,300,mg,['3 / Week'], ,Adverse Event
13890,3401,IVIG,2016-05-18,,500, ,['/Month'], , 
13891,3401,Endoxan,2016-04-20,, , ,['/Month'],IV, 
13892,1176,Endoxan,2016-10-19,2019-10-05,300, ,[' '],Oral,Lack of efficacy
13893,1176,Tecfidera,2016-07-09,, , ,['3 / Week'], , 
13894,4021,Rebif [22],2016-01-13,2020-12-21,5000,mcg,['/Month'], ,Lack of efficacy
13895,4021,Gilenya,2016-01-09,2020-06-18,500, ,['/Month'], ,Persisting MRI activity
13896,4021,Methylprednisolone,2015-11-08,2020-02-14,20,mg,['/Month'],IV,Patient Choice/Convenience
13897,787,Tecfidera,2016-05-03,,500,mg,['3 / Week'], , 
13898,787,Mitoxantrone,2016-01-04,, , ,['2 / Day'], , 
13899,787,Endoxan,2015-10-24,,5000,mcg,['/Month'],Oral, 
13900,1678,Rebif [22],2016-04-08,, , ,['2 / Day'],IV, 
13901,1678,Avonex,2016-04-07,2017-12-14,400, ,['2 / Day'], ,Persistence of relapses
13902,1678,IVIG,2016-05-15,2020-05-14, ,mg,['/ Day'],IV,Persistence of relapses
13903,1678,IVIG,2016-09-23,,300,MIU,['2 / Day'],IV, 
13904,1694,Rebif [22],2015-12-14,2021-08-15,500,mg,['2 / Day'], ,Adverse Event
13905,618,IVIG,2016-04-11,,20,mg,['/ Week'],IV, 
13906,618,Rebif [44],2016-02-16,,20,mcg,['2 / Day'],IV, 
13907,618,Alemtuzumab (Campath),2016-03-12,2018-09-21, ,mg,['/Month'],IV,Adverse Event
13908,644,Alemtuzumab (Campath),2016-01-17,2020-03-15,5000,MIU,['/Month'], ,Lack of efficacy
13909,644,Mitoxantrone,2016-09-08,2021-10-05,500,MIU,['2 / Day'], ,Persistence of relapses
13910,644,Rebif [44],2016-05-22,2019-12-30,400,mg,[' '], ,Persisting MRI activity
13911,1046,Copaxone,2016-07-21,,20,mg,['3 / Week'], , 
13912,1046,Gilenya,2016-07-05,2020-05-20,20, ,['/Month'],Oral,Lack of efficacy
13913,1046,Betaferon,2016-08-25,2020-11-15,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
13914,846,Alemtuzumab (Campath),2016-08-20,2018-09-29,20, ,['2 / Day'],IV,Persisting MRI activity
13915,4607,Tysabri,2016-02-08,2021-01-29,500,mg,['2 / Day'], ,Persisting MRI activity
13916,2576,Teriflunomide,2016-06-13,,1,MIU,['/ Week'],IV, 
13917,2576,D-cure (Vitamine D),2016-08-20,,1000, ,['2 / Day'],IV, 
13918,2576,Copaxone,2016-04-15,2018-03-22,500,mg,[' '],Oral,Adverse Event
13919,4049,Rebif [22],2015-11-09,,5000,mg,['3 / Week'], , 
13920,4049,Endoxan,2016-03-13,2018-08-23,500,mg,['/ Day'], ,Adverse Event
13921,4784,Copaxone,2016-07-22,,1,mg,['/Month'],IV, 
13922,4784,Rebif [44],2016-07-22,2019-01-18,300,MIU,['/Month'],Oral,Patient Choice/Convenience
13923,4288,Tecfidera,2016-05-04,2018-01-03,5000, ,['2 / Day'],IV,Persisting MRI activity
13924,4288,Avonex,2016-04-20,,1,MIU,['/ Day'],Oral, 
13925,4288,D-cure (Vitamine D),2016-10-08,, ,mcg,['/Month'],Oral, 
13926,4288,Tecfidera,2016-07-05,,300, ,['/Month'],Oral, 
13927,113,Alemtuzumab (Campath),2016-02-13,2020-09-07,20, ,['/Month'],IV,Persisting MRI activity
13928,113,Tysabri,2016-10-09,2021-02-12,500, ,['/ Day'],IV,Persistence of relapses
13929,113,Tysabri,2016-09-05,,300,mg,['2 / Day'], , 
13930,2374,Rebif [22],2016-04-09,2019-02-24,300, ,['3 / Week'],IV,Persisting MRI activity
13931,2374,Tecfidera,2015-11-29,2021-07-05, , ,['3 / Week'], ,Lack of efficacy
13932,2749,Rebif [44],2016-01-12,,5000,mg,[' '],Oral, 
13933,2749,IVIG,2016-05-23,,5000,mg,['3 / Week'],Oral, 
13934,3840,Tecfidera,2016-07-30,, , ,['2 / Day'], , 
13935,1969,Avonex,2016-03-02,2017-11-14, , ,['2 / Day'], ,Lack of efficacy
13936,1969,D-cure (Vitamine D),2016-09-10,,1000,mg,[' '],IV, 
13937,1969,Tecfidera,2016-04-26,2018-04-05,20,mg,['/Month'], ,Lack of efficacy
13938,2026,Avonex,2016-06-22,, ,mg,['2 / Day'],IV, 
13939,1178,IVIG,2016-06-27,,1000,mg,[' '],IV, 
13940,2653,Gilenya,2016-09-29,,20,mg,['/ Day'],IV, 
13941,2653,IVIG,2016-03-24,2021-06-05, , ,['3 / Week'], ,Patient Choice/Convenience
13942,2653,Mitoxantrone,2016-07-18,2019-08-25, ,mg,['/ Day'],IV,Patient Choice/Convenience
13943,2653,Betaferon,2016-08-17,,20, ,['3 / Week'],IV, 
13944,4176,Methylprednisolone,2016-03-02,2018-12-02,400,mg,['2 / Day'],IV,Adverse Event
13945,253,Alemtuzumab (Campath),2016-02-02,2021-06-16, ,MIU,['/Month'],IV,Patient Choice/Convenience
13946,253,Alemtuzumab (Campath),2016-08-31,2019-09-16,5000, ,['/Month'],IV,Adverse Event
13947,564,Endoxan,2016-04-21,2020-09-29, ,mg,[' '], ,Lack of efficacy
13948,564,D-cure (Vitamine D),2015-12-17,2018-07-28,1000,mg,[' '],IV,Adverse Event
13949,564,D-cure (Vitamine D),2016-07-09,2018-09-30, , ,['/Month'],IV,Persistence of relapses
13950,564,Alemtuzumab (Campath),2016-07-02,2019-11-15,300, ,['/Month'],IV,Adverse Event
13951,1785,Betaferon,2016-01-01,2019-08-24, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
13952,1785,Betaferon,2016-05-28,,500,mg,['/Month'], , 
13953,1785,IVIG,2015-12-18,,400, ,['/Month'],IV, 
13954,1785,Alemtuzumab (Campath),2016-03-08,,500, ,['/Month'], , 
13955,3385,D-cure (Vitamine D),2016-06-10,2019-08-13,500,mg,['2 / Day'],IV,Adverse Event
13956,4849,Mitoxantrone,2016-10-09,,500,mg,['2 / Day'],IV, 
13957,4849,Rebif [44],2015-11-01,,5000,mg,['/ Day'],IV, 
13958,2340,Avonex,2016-05-11,, ,mcg,['/Month'], , 
13959,2340,Ledertrexaat,2015-12-27,2019-06-15, ,mg,['2 / Day'], ,Lack of efficacy
13960,3601,Gilenya,2016-04-08,,500,MIU,['/Month'], , 
13961,3601,Methylprednisolone,2016-10-09,, , ,['/ Day'],Oral, 
13962,3194,Endoxan,2016-08-12,, ,mg,['2 / Day'],Oral, 
13963,3194,Rebif [22],2016-04-02,,5000,mg,['/Month'],IV, 
13964,3194,Tysabri,2016-09-04,,300,mg,['/ Week'],Oral, 
13965,3194,Copaxone,2016-08-23,2020-01-31,1000,MIU,['/Month'],IV,Persisting MRI activity
13966,1280,Tecfidera,2015-11-04,,300, ,['3 / Week'],Oral, 
13967,4524,Tysabri,2016-05-30,2020-10-31, ,mg,['/Month'],Oral,Persisting MRI activity
13968,4524,Tysabri,2016-03-30,,1000, ,['2 / Day'],Oral, 
13969,4524,Tysabri,2016-10-02,,1000,mg,['2 / Day'], , 
13970,4524,Teriflunomide,2016-10-22,2019-02-28, , ,['/Month'],Oral,Lack of efficacy
13971,2746,Tysabri,2016-10-01,,5000, ,[' '],IV, 
13972,1931,D-cure (Vitamine D),2016-06-26,,400, ,['3 / Week'],IV, 
13973,4102,Rebif [44],2016-06-06,2020-04-24,20, ,['/Month'], ,Persisting MRI activity
13974,4102,Endoxan,2016-03-09,,1,MIU,['3 / Week'],IV, 
13975,1884,Gilenya,2016-08-02,2019-01-30,1, ,['2 / Day'], ,Adverse Event
13976,1884,Gilenya,2016-06-26,2017-11-18, , ,['/ Day'], ,Persisting MRI activity
13977,1884,Gilenya,2015-10-30,,5000, ,[' '],Oral, 
13978,2599,IVIG,2016-04-19,2020-02-11,1,MIU,[' '], ,Persistence of relapses
13979,3808,Endoxan,2016-07-25,2019-04-26,1000, ,['2 / Day'],Oral,Adverse Event
13980,3905,Avonex,2015-10-28,, ,mg,['/Month'],IV, 
13981,3905,Alemtuzumab (Campath),2015-12-12,2021-02-17,20,mg,['2 / Day'],IV,Persisting MRI activity
13982,3905,Rebif [22],2016-05-18,2020-10-23,5000,mg,[' '],Oral,Persisting MRI activity
13983,3905,Betaferon,2016-07-06,,300,mg,['/ Week'],IV, 
13984,4767,Copaxone,2016-01-05,2019-12-24,1000,MIU,['/Month'], ,Adverse Event
13985,4767,D-cure (Vitamine D),2015-10-29,2021-03-10,500,mg,['2 / Day'], ,Patient Choice/Convenience
13986,4767,Rebif [22],2016-06-03,2020-07-26,5000,mg,['/ Day'],Oral,Persisting MRI activity
13987,4767,Tysabri,2016-07-24,,1000,MIU,['/ Week'],Oral, 
13988,712,IVIG,2016-04-07,2019-02-09, , ,['/Month'], ,Persistence of relapses
13989,3236,Methylprednisolone,2016-09-14,,300, ,['/ Day'],IV, 
13990,3236,Tecfidera,2016-05-23,,300,MIU,['/Month'],IV, 
13991,3236,IVIG,2015-12-19,,300,MIU,['/ Day'],IV, 
13992,1931,Copaxone,2016-06-28,,20, ,['2 / Day'], , 
13993,1931,Avonex,2015-12-23,, , ,['/ Day'],IV, 
13994,1931,Endoxan,2016-07-17,2019-04-22,500,mg,['2 / Day'], ,Lack of efficacy
13995,664,Betaferon,2015-12-24,,1000,mg,['/Month'],IV, 
13996,664,Copaxone,2016-07-15,2018-11-19, , ,['/Month'],IV,Lack of efficacy
13997,664,Endoxan,2016-10-21,,300,mg,['/ Week'],IV, 
13998,4330,Gilenya,2016-01-29,, , ,['/Month'], , 
13999,4330,Mitoxantrone,2016-03-21,,20,mg,['2 / Day'],IV, 
14000,3554,Alemtuzumab (Campath),2016-03-19,,20,mg,[' '],IV, 
14001,3554,Copaxone,2016-08-29,,1000, ,['3 / Week'], , 
14002,3554,Rebif [22],2016-06-29,2019-07-01,20,mg,['2 / Day'],IV,Lack of efficacy
14003,4325,Rebif [22],2016-03-19,2018-03-17,1000,mg,['3 / Week'], ,Adverse Event
14004,4325,Methylprednisolone,2016-08-20,,1000,MIU,['3 / Week'],IV, 
14005,4325,Ledertrexaat,2016-07-15,2019-06-12,5000,MIU,['3 / Week'],Oral,Patient Choice/Convenience
14006,4325,Rebif [44],2016-05-18,,1,mg,['/Month'],IV, 
14007,4212,Tecfidera,2016-02-04,,5000,mg,['/ Day'],IV, 
14008,1748,Methylprednisolone,2016-05-03,,20,mcg,['/Month'], , 
14009,2818,Mitoxantrone,2016-02-15,, , ,['/Month'], , 
14010,2818,Gilenya,2015-11-15,,5000, ,['2 / Day'],Oral, 
14011,2818,Rebif [22],2016-02-02,2021-01-31,1000,MIU,['/Month'],IV,Persistence of relapses
14012,2818,Ledertrexaat,2015-11-28,, , ,['/Month'],Oral, 
14013,4692,Tecfidera,2016-07-26,, ,MIU,['3 / Week'], , 
14014,4692,Rebif [22],2016-03-10,,20,mg,['/Month'],Oral, 
14015,3934,Rebif [44],2015-12-15,,300,mg,['/ Day'], , 
14016,3934,Endoxan,2016-06-08,2021-10-08, , ,['/Month'], ,Persistence of relapses
14017,3934,Avonex,2016-10-04,, , ,['2 / Day'],IV, 
14018,4737,D-cure (Vitamine D),2016-08-03,,400, ,['/ Day'],IV, 
14019,4737,Endoxan,2016-05-07,,20, ,['/Month'],Oral, 
14020,3382,Avonex,2016-02-23,,1000,mg,['/ Day'], , 
14021,3891,D-cure (Vitamine D),2016-06-12,, , ,['2 / Day'],Oral, 
14022,668,D-cure (Vitamine D),2016-08-13,2019-07-30,20,MIU,['2 / Day'], ,Adverse Event
14023,668,Methylprednisolone,2015-12-10,2020-12-09,500, ,['/Month'], ,Persisting MRI activity
14024,661,Alemtuzumab (Campath),2016-07-05,2020-03-24,1000,mg,[' '],IV,Persistence of relapses
14025,661,Tysabri,2016-08-18,,400,mg,['2 / Day'],Oral, 
14026,2883,D-cure (Vitamine D),2016-05-22,2018-08-24,500,MIU,['2 / Day'], ,Adverse Event
14027,2883,Gilenya,2016-05-10,,5000,mg,['2 / Day'],IV, 
14028,2262,Rebif [22],2016-07-10,, , ,['3 / Week'],Oral, 
14029,2262,Copaxone,2016-07-02,, , ,['/Month'],IV, 
14030,1419,Methylprednisolone,2016-03-06,2018-08-28,1,mg,['2 / Day'],IV,Persisting MRI activity
14031,1419,IVIG,2015-11-20,,20,mg,['3 / Week'],IV, 
14032,1419,Mitoxantrone,2016-10-04,2019-03-14, ,mcg,['2 / Day'],Oral,Lack of efficacy
14033,1419,Rebif [22],2016-02-08,,500,mg,['/ Day'], , 
14034,2956,Rebif [22],2016-10-03,2020-08-31, , ,['/Month'],Oral,Lack of efficacy
14035,2257,Methylprednisolone,2016-02-28,2020-04-02,5000, ,['/Month'], ,Adverse Event
14036,2257,Tecfidera,2016-03-30,2019-11-29,20,MIU,['2 / Day'],Oral,Patient Choice/Convenience
14037,2257,Gilenya,2016-08-28,2021-05-08, ,mg,['/Month'],IV,Lack of efficacy
14038,2257,Teriflunomide,2016-05-25,2019-06-23, ,mg,['3 / Week'],Oral,Adverse Event
14039,167,IVIG,2015-11-09,, , ,['/Month'],IV, 
14040,167,Methylprednisolone,2015-12-09,2021-03-24,300,mg,['2 / Day'],IV,Patient Choice/Convenience
14041,167,Rebif [44],2016-05-26,, , ,['/ Day'],IV, 
14042,3764,Betaferon,2016-09-28,,500,mg,[' '],IV, 
14043,3764,Gilenya,2016-07-24,,20, ,[' '],IV, 
14044,2777,Gilenya,2016-02-20,,1,mg,['3 / Week'],IV, 
14045,2777,Endoxan,2016-08-27,2018-02-03,300,mg,[' '],IV,Adverse Event
14046,4061,Rebif [44],2016-09-22,, , ,[' '],Oral, 
14047,499,Endoxan,2016-04-07,2017-12-05,500, ,['3 / Week'],IV,Patient Choice/Convenience
14048,499,IVIG,2016-01-25,,1,mcg,['/ Day'],IV, 
14049,2555,Gilenya,2016-08-23,,300, ,['/Month'], , 
14050,2555,Alemtuzumab (Campath),2015-12-07,,1,mg,['/Month'],IV, 
14051,3631,Endoxan,2016-07-31,,5000,mg,['/Month'],IV, 
14052,2473,Endoxan,2016-07-17,2021-04-18, , ,[' '], ,Persisting MRI activity
14053,2473,Tecfidera,2016-06-03,,400, ,['2 / Day'],Oral, 
14054,2473,Alemtuzumab (Campath),2016-05-26,2017-11-26, , ,['2 / Day'], ,Persisting MRI activity
14055,3886,IVIG,2015-12-25,2019-08-25,500, ,[' '], ,Adverse Event
14056,3886,D-cure (Vitamine D),2015-12-08,,1,mg,['/Month'], , 
14057,4050,Rebif [22],2016-01-15,2021-08-19, ,mg,['/Month'],IV,Persistence of relapses
14058,3544,Ledertrexaat,2016-09-02,,20,mg,['/Month'], , 
14059,3544,Avonex,2016-01-10,,500, ,['/ Week'],IV, 
14060,3544,Rebif [44],2016-07-30,,500,mg,['2 / Day'], , 
14061,3544,D-cure (Vitamine D),2016-06-26,2019-08-22,500,mg,['3 / Week'],IV,Persisting MRI activity
14062,1065,Betaferon,2016-08-29,, , ,['/ Day'],IV, 
14063,4640,Rebif [22],2016-06-24,2018-05-04, , ,['/Month'],IV,Adverse Event
14064,4640,Copaxone,2016-06-03,2019-09-06,500,mg,['2 / Day'], ,Persistence of relapses
14065,4640,Ledertrexaat,2016-07-28,2018-08-14,500,MIU,['3 / Week'],IV,Persisting MRI activity
14066,3591,Mitoxantrone,2016-05-13,,1, ,['2 / Day'],IV, 
14067,3591,Tecfidera,2016-09-10,2019-10-18,300,mcg,['3 / Week'], ,Adverse Event
14068,3115,IVIG,2016-09-02,,300,mg,[' '],IV, 
14069,3115,D-cure (Vitamine D),2015-12-12,, ,mcg,['2 / Day'], , 
14070,3115,Tysabri,2016-01-27,, ,mg,['/ Day'],IV, 
14071,1830,Methylprednisolone,2016-05-16,,1,MIU,[' '],IV, 
14072,1830,Alemtuzumab (Campath),2016-09-11,,1000,MIU,['/Month'],IV, 
14073,1055,Gilenya,2016-07-03,2019-11-12, ,mg,['3 / Week'],IV,Persisting MRI activity
14074,2258,D-cure (Vitamine D),2016-08-16,2020-11-15, , ,['/Month'], ,Adverse Event
14075,2258,Endoxan,2016-05-03,,400,mg,['2 / Day'],IV, 
14076,2258,Ledertrexaat,2016-01-22,,1000, ,['/Month'], , 
14077,2258,Tysabri,2016-01-12,,20,mg,['/ Day'],IV, 
14078,461,D-cure (Vitamine D),2016-10-20,, , ,['/Month'],Oral, 
14079,461,IVIG,2016-04-21,2020-03-21,500,mg,['2 / Day'],IV,Patient Choice/Convenience
14080,461,Mitoxantrone,2016-10-21,2021-07-09,1,mg,['/ Day'], ,Adverse Event
14081,461,Copaxone,2015-11-04,2018-04-23, , ,['2 / Day'], ,Persistence of relapses
14082,1807,Copaxone,2015-10-30,,300,MIU,['/Month'],Oral, 
14083,150,Rebif [22],2016-07-24,2020-04-15, ,mg,[' '],IV,Adverse Event
14084,150,Teriflunomide,2016-06-27,2021-03-07, , ,['/Month'], ,Adverse Event
14085,150,Betaferon,2016-05-21,2018-12-24, , ,['3 / Week'],IV,Adverse Event
14086,150,D-cure (Vitamine D),2015-11-09,, , ,['/ Day'],IV, 
14087,4603,Alemtuzumab (Campath),2016-10-09,2018-04-23,500,mg,[' '], ,Persistence of relapses
14088,4603,IVIG,2015-11-22,2020-10-27,300,mg,['2 / Day'], ,Patient Choice/Convenience
14089,2456,Gilenya,2016-01-09,2019-03-16, ,mg,['3 / Week'],Oral,Lack of efficacy
14090,2456,Ledertrexaat,2016-10-13,2018-02-11,400, ,['/ Week'],Oral,Lack of efficacy
14091,2456,Tecfidera,2015-11-14,2020-07-15,1,mg,['2 / Day'], ,Patient Choice/Convenience
14092,2456,D-cure (Vitamine D),2015-11-26,, ,MIU,['/ Day'],IV, 
14093,1357,Tysabri,2016-06-21,2019-10-21,500,mg,[' '], ,Adverse Event
14094,1357,Gilenya,2015-12-08,2021-05-08, ,mg,['3 / Week'],IV,Patient Choice/Convenience
14095,4741,D-cure (Vitamine D),2016-05-03,,300, ,['/Month'], , 
14096,4741,Methylprednisolone,2016-08-11,, , ,['2 / Day'],IV, 
14097,4741,IVIG,2016-09-11,2021-06-19,20,mg,['/ Day'], ,Adverse Event
14098,2321,Avonex,2016-04-03,,400, ,['2 / Day'],IV, 
14099,2321,Alemtuzumab (Campath),2015-11-07,,300, ,['2 / Day'],Oral, 
14100,3481,Rebif [22],2015-12-27,2021-02-20, ,mg,['/Month'], ,Patient Choice/Convenience
14101,3481,Rebif [44],2016-07-24,,300,mg,['2 / Day'],IV, 
14102,3481,Teriflunomide,2016-09-24,, ,mg,['/ Day'], , 
14103,345,Gilenya,2016-05-11,,5000, ,['/ Day'],Oral, 
14104,345,IVIG,2016-09-15,2018-02-17,5000,MIU,['2 / Day'], ,Persisting MRI activity
14105,1689,IVIG,2015-11-17,,300,mg,['3 / Week'],IV, 
14106,2458,Alemtuzumab (Campath),2016-01-11,, ,mg,['/Month'], , 
14107,2458,Rebif [44],2016-06-15,, ,MIU,['/Month'],IV, 
14108,4243,IVIG,2016-08-31,2018-04-23,1,mg,['3 / Week'], ,Lack of efficacy
14109,4243,Rebif [22],2016-01-11,2021-09-28,5000,mg,['3 / Week'], ,Lack of efficacy
14110,4243,Rebif [44],2016-06-23,2018-05-08, , ,['2 / Day'],IV,Adverse Event
14111,4243,IVIG,2016-08-10,,300,mg,['/ Week'],IV, 
14112,4561,IVIG,2016-09-03,,300,mg,['/ Day'],IV, 
14113,4561,Avonex,2016-05-05,,300,mg,['/ Day'],IV, 
14114,4561,Gilenya,2016-06-25,2017-12-16, , ,['2 / Day'],IV,Patient Choice/Convenience
14115,4561,Mitoxantrone,2016-10-02,2020-05-24,1000,mg,['3 / Week'],IV,Adverse Event
14116,3714,Tecfidera,2016-05-11,2019-03-25, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
14117,3714,Rebif [22],2016-08-23,, ,mg,['/Month'], , 
14118,3240,IVIG,2016-04-13,2017-11-18,20, ,['3 / Week'],IV,Adverse Event
14119,3240,Gilenya,2016-06-04,,500,mcg,['/ Week'],Oral, 
14120,3240,Copaxone,2015-10-27,,20, ,['/Month'], , 
14121,511,Copaxone,2016-09-12,,500,mcg,['3 / Week'],IV, 
14122,1526,Rebif [22],2016-01-08,,5000, ,[' '],IV, 
14123,1526,Methylprednisolone,2016-07-07,2017-12-23,1,mg,['/Month'],IV,Persisting MRI activity
14124,1526,Endoxan,2016-07-01,, ,mg,['/Month'], , 
14125,1625,Gilenya,2016-01-01,,300,mg,['/Month'],IV, 
14126,1625,Avonex,2016-10-05,,1000,mg,[' '],IV, 
14127,2802,Copaxone,2016-10-02,2019-07-21, ,mg,[' '],IV,Persisting MRI activity
14128,2802,Betaferon,2016-02-08,,20,mg,[' '],Oral, 
14129,2802,Endoxan,2016-09-27,2018-12-10, ,mcg,['2 / Day'],Oral,Persisting MRI activity
14130,2802,IVIG,2015-11-28,2017-12-16,1, ,['3 / Week'], ,Patient Choice/Convenience
14131,4563,Tysabri,2016-04-18,2019-05-08,20, ,['3 / Week'], ,Persistence of relapses
14132,1701,Rebif [22],2016-01-17,2017-12-17,500, ,['/ Day'], ,Adverse Event
14133,1701,Methylprednisolone,2016-10-01,,5000,mcg,['3 / Week'], , 
14134,1701,IVIG,2016-10-01,,300,MIU,['3 / Week'], , 
14135,1701,Rebif [22],2016-03-04,,400, ,['/Month'],IV, 
14136,2179,Rebif [44],2016-10-20,, ,mg,['/ Week'],IV, 
14137,2179,Rebif [44],2016-01-17,2021-09-23,1000,mg,['/Month'],IV,Patient Choice/Convenience
14138,2179,Avonex,2016-06-12,,20, ,['/ Week'], , 
14139,1487,IVIG,2016-08-30,2017-11-04, ,mg,['/Month'],IV,Persistence of relapses
14140,1487,Methylprednisolone,2016-02-14,,20, ,['3 / Week'],IV, 
14141,2671,Teriflunomide,2016-08-30,, ,mg,['/Month'],IV, 
14142,2671,IVIG,2016-05-27,2019-04-14, , ,[' '],IV,Persisting MRI activity
14143,4339,Avonex,2016-03-07,2020-09-16,1, ,['/Month'], ,Adverse Event
14144,4721,Methylprednisolone,2015-11-05,,400, ,['/ Week'],IV, 
14145,922,Ledertrexaat,2016-02-29,2020-07-01,300,MIU,['/Month'],IV,Persisting MRI activity
14146,922,Teriflunomide,2016-06-15,2018-04-24,400, ,[' '],IV,Persisting MRI activity
14147,1827,Teriflunomide,2016-01-03,2019-10-02,1000, ,['3 / Week'],IV,Adverse Event
14148,1827,Endoxan,2016-09-22,2018-08-31,400,mg,['2 / Day'],IV,Adverse Event
14149,1827,D-cure (Vitamine D),2016-01-01,2017-12-21,5000,mcg,['/Month'],IV,Patient Choice/Convenience
14150,1394,Tysabri,2016-05-24,2021-06-05,20,MIU,['/Month'],IV,Lack of efficacy
14151,2920,Alemtuzumab (Campath),2016-06-17,2021-09-29,20,mcg,['/ Week'], ,Adverse Event
14152,2920,Rebif [22],2016-05-27,,1,mg,['2 / Day'],IV, 
14153,2920,D-cure (Vitamine D),2016-04-06,,1000,MIU,['/Month'],IV, 
14154,2920,Mitoxantrone,2016-06-16,,1000,mg,['/Month'], , 
14155,1301,Gilenya,2016-03-25,,1000,MIU,['/ Week'], , 
14156,1708,Rebif [22],2016-10-13,, ,mg,['/Month'],IV, 
14157,1708,Rebif [22],2016-03-22,2019-01-03,1000, ,['/Month'], ,Patient Choice/Convenience
14158,1708,IVIG,2015-12-09,,300, ,['/Month'],IV, 
14159,1427,Gilenya,2016-02-26,,5000,mg,['3 / Week'],IV, 
14160,1427,Copaxone,2016-02-29,, ,mg,['2 / Day'],IV, 
14161,1427,Tysabri,2016-08-08,2020-09-18,400,MIU,[' '],IV,Adverse Event
14162,1427,Methylprednisolone,2016-09-02,,1000,mg,['/Month'],IV, 
14163,2924,Betaferon,2016-02-08,,500, ,['2 / Day'],IV, 
14164,2924,Gilenya,2016-02-09,2020-04-16, ,mg,['2 / Day'],Oral,Persisting MRI activity
14165,2924,Teriflunomide,2016-09-10,2020-11-03,300, ,['/Month'],Oral,Persistence of relapses
14166,2924,Teriflunomide,2016-09-08,, ,mg,['3 / Week'],IV, 
14167,3345,Tysabri,2016-08-31,2018-06-04,1,mcg,['3 / Week'],IV,Persistence of relapses
14168,3345,IVIG,2015-10-24,2020-07-02,5000,mg,['/Month'], ,Patient Choice/Convenience
14169,3345,D-cure (Vitamine D),2016-05-23,,20, ,[' '], , 
14170,2328,Methylprednisolone,2016-01-04,2020-04-15,5000,mg,['/Month'], ,Adverse Event
14171,2328,Methylprednisolone,2015-11-05,2018-11-03,500, ,['/Month'],IV,Patient Choice/Convenience
14172,2328,Alemtuzumab (Campath),2016-09-14,, ,mg,['2 / Day'], , 
14173,1480,IVIG,2015-10-31,, ,mg,['/Month'],IV, 
14174,1480,Copaxone,2015-11-15,, ,mcg,['3 / Week'],Oral, 
14175,1480,Avonex,2015-11-24,,1,mg,['3 / Week'], , 
14176,1480,Alemtuzumab (Campath),2016-02-17,, ,mg,['2 / Day'], , 
14177,3142,Ledertrexaat,2016-04-20,2018-05-15,400,mcg,['/Month'],IV,Persisting MRI activity
14178,3142,Rebif [44],2016-04-20,,300, ,[' '], , 
14179,3142,D-cure (Vitamine D),2016-01-10,2019-06-24, ,mg,['2 / Day'],IV,Patient Choice/Convenience
14180,3142,Avonex,2015-12-21,2020-02-04, ,mg,['2 / Day'],IV,Persistence of relapses
14181,4582,Alemtuzumab (Campath),2016-09-11,,1,mg,[' '],IV, 
14182,4582,Copaxone,2015-12-04,, , ,['/ Week'],Oral, 
14183,4582,Tysabri,2015-11-17,,400, ,['/Month'],Oral, 
14184,4582,Rebif [22],2015-10-24,,1000,mg,['2 / Day'],IV, 
14185,4287,Gilenya,2015-11-29,,20,mg,['2 / Day'],Oral, 
14186,4287,Endoxan,2016-04-06,2021-08-19,5000,mg,['/Month'], ,Patient Choice/Convenience
14187,4287,Copaxone,2016-06-09,2020-10-21,400, ,['2 / Day'],IV,Patient Choice/Convenience
14188,1589,Rebif [22],2016-04-28,2017-12-05, ,mg,['/Month'],IV,Adverse Event
14189,1589,Rebif [22],2015-11-11,2018-07-30,1000, ,['2 / Day'],IV,Adverse Event
14190,1589,Copaxone,2016-08-04,, , ,['/Month'],IV, 
14191,1589,Gilenya,2016-01-05,,300, ,[' '],IV, 
14192,3574,Alemtuzumab (Campath),2016-02-12,, ,MIU,['2 / Day'],IV, 
14193,3574,Ledertrexaat,2016-10-14,2018-10-06,500, ,['3 / Week'], ,Persisting MRI activity
14194,3574,Tysabri,2015-12-31,2018-04-07,1,mg,['/Month'],Oral,Persistence of relapses
14195,3574,D-cure (Vitamine D),2016-04-12,,1000, ,['/ Week'],IV, 
14196,1371,IVIG,2016-03-28,,500,mg,['2 / Day'], , 
14197,1371,Endoxan,2016-03-09,,400,mg,['2 / Day'], , 
14198,1371,D-cure (Vitamine D),2016-07-11,,1000,MIU,['/Month'], , 
14199,1371,Tysabri,2016-05-23,2019-01-13,300, ,['/Month'],Oral,Lack of efficacy
14200,4441,Gilenya,2016-10-16,, , ,['3 / Week'],IV, 
14201,4441,Copaxone,2016-05-01,,20,mg,['/Month'],IV, 
14202,4636,IVIG,2016-10-02,2019-09-03, ,mg,['/Month'],IV,Patient Choice/Convenience
14203,4636,Rebif [22],2016-09-22,, ,mg,['/ Day'],IV, 
14204,364,Tysabri,2016-02-26,2020-05-26,5000,mg,['/Month'], ,Adverse Event
14205,364,Ledertrexaat,2016-10-14,,1,mg,['/Month'], , 
14206,753,Gilenya,2016-07-10,, , ,['/ Week'], , 
14207,753,Avonex,2015-11-03,, , ,[' '],IV, 
14208,753,Endoxan,2015-12-02,2019-09-04,500, ,['2 / Day'],IV,Adverse Event
14209,1843,Rebif [44],2016-08-06,,300, ,['2 / Day'],IV, 
14210,4271,Alemtuzumab (Campath),2016-08-19,2020-02-18,20, ,['3 / Week'], ,Persistence of relapses
14211,4271,D-cure (Vitamine D),2015-12-19,,1000, ,['2 / Day'], , 
14212,4271,Methylprednisolone,2015-12-14,,400,mcg,['2 / Day'],IV, 
14213,1827,Tysabri,2015-12-01,2020-12-28,1000, ,['/Month'], ,Persistence of relapses
14214,1827,Tecfidera,2016-01-03,,500, ,[' '], , 
14215,1827,Avonex,2016-02-09,2019-12-06,400,mcg,['/Month'], ,Persistence of relapses
14216,3571,Gilenya,2016-02-28,,300,mg,[' '],Oral, 
14217,3571,Avonex,2015-11-09,2018-11-21, ,mg,['/Month'],IV,Lack of efficacy
14218,4827,Rebif [44],2016-07-28,,1000,MIU,['/Month'], , 
14219,195,Gilenya,2016-09-13,2017-11-24, , ,['2 / Day'],IV,Lack of efficacy
14220,195,D-cure (Vitamine D),2016-07-16,,5000,mg,['/ Day'],Oral, 
14221,2434,Rebif [22],2016-02-15,,500,mg,['2 / Day'],IV, 
14222,2434,Endoxan,2016-04-14,, ,mcg,['3 / Week'],IV, 
14223,2434,Avonex,2016-06-02,2019-08-02, ,mcg,['/ Day'], ,Lack of efficacy
14224,3612,Endoxan,2016-06-02,2019-02-20,5000,mg,['/ Day'], ,Persisting MRI activity
14225,498,Tysabri,2015-12-31,, , ,['2 / Day'],Oral, 
14226,498,Rebif [22],2016-09-06,,1000,mg,['/Month'],IV, 
14227,498,Ledertrexaat,2016-02-25,,5000,mg,['/ Week'], , 
14228,498,Ledertrexaat,2015-12-12,,5000, ,['2 / Day'],IV, 
14229,1458,Rebif [22],2016-04-23,,400,mg,['/Month'],IV, 
14230,1458,Methylprednisolone,2015-12-25,2021-08-30, ,MIU,['/Month'],IV,Lack of efficacy
14231,1458,Rebif [22],2016-07-22,2018-06-21,5000,mg,['/Month'],IV,Patient Choice/Convenience
14232,1458,Mitoxantrone,2016-09-14,2021-05-31,1000,MIU,['/Month'],Oral,Lack of efficacy
14233,2374,D-cure (Vitamine D),2016-08-22,,1,mg,['/Month'],IV, 
14234,4611,Tysabri,2016-09-15,, ,mg,['/Month'], , 
14235,4611,Alemtuzumab (Campath),2015-12-08,,1000, ,['/Month'], , 
14236,4611,Betaferon,2016-08-16,,300, ,['3 / Week'],Oral, 
14237,2670,Copaxone,2015-11-18,,1,mg,['/Month'],IV, 
14238,2670,D-cure (Vitamine D),2015-11-20,2020-03-12,1, ,['/Month'], ,Patient Choice/Convenience
14239,2670,Betaferon,2016-07-13,, ,mcg,['3 / Week'], , 
14240,2670,Alemtuzumab (Campath),2016-03-02,2020-05-06,1,mg,['2 / Day'],IV,Adverse Event
14241,4433,IVIG,2016-08-27,, , ,['3 / Week'],IV, 
14242,3593,Rebif [22],2016-10-08,,20,MIU,['/ Day'], , 
14243,2738,IVIG,2016-07-10,2021-09-20,1, ,['/Month'],IV,Adverse Event
14244,2738,Rebif [22],2015-11-09,,1,mg,['3 / Week'], , 
14245,2738,Gilenya,2016-09-01,, ,mcg,['/Month'],IV, 
14246,2738,Betaferon,2016-03-06,,20,mg,['2 / Day'],IV, 
14247,3825,Rebif [44],2016-01-10,, , ,['2 / Day'],IV, 
14248,3825,Rebif [22],2016-02-02,, ,mg,['/ Week'], , 
14249,3825,Methylprednisolone,2016-07-31,,300,mg,['2 / Day'],IV, 
14250,916,D-cure (Vitamine D),2016-07-09,,300,mcg,['3 / Week'], , 
14251,916,Ledertrexaat,2016-07-19,2019-11-12, ,mg,['/Month'], ,Adverse Event
14252,2458,Endoxan,2016-01-16,2019-12-14,5000, ,[' '], ,Patient Choice/Convenience
14253,2458,D-cure (Vitamine D),2016-03-29,2019-03-04,500,mg,['/ Week'], ,Persisting MRI activity
14254,1477,D-cure (Vitamine D),2016-05-28,2019-06-29,1,mg,['2 / Day'],IV,Patient Choice/Convenience
14255,4690,Avonex,2016-07-26,2020-10-12,20,MIU,['/ Week'],IV,Adverse Event
14256,4690,Betaferon,2016-04-06,,20, ,['/ Week'],IV, 
14257,4690,Betaferon,2015-10-24,, , ,['/ Day'],IV, 
14258,3359,IVIG,2016-07-10,,1, ,['2 / Day'],IV, 
14259,3359,Rebif [22],2016-07-04,2018-04-20, ,MIU,['/Month'],Oral,Persisting MRI activity
14260,3359,Methylprednisolone,2016-08-09,2020-01-06, ,mcg,['/ Week'],IV,Adverse Event
14261,4403,IVIG,2016-03-01,, ,mg,['2 / Day'],IV, 
14262,3479,Rebif [22],2016-07-02,2021-02-02,5000,mg,['/Month'],IV,Lack of efficacy
14263,3479,Gilenya,2015-10-31,,500, ,['/ Day'], , 
14264,2124,IVIG,2016-01-24,2019-07-11,300,mg,['/Month'],IV,Adverse Event
14265,2124,IVIG,2016-03-04,, , ,['3 / Week'],IV, 
14266,2124,Gilenya,2016-07-06,,400,mg,['/ Week'], , 
14267,400,Betaferon,2016-08-22,2019-04-10,400, ,['2 / Day'], ,Adverse Event
14268,1581,D-cure (Vitamine D),2016-01-24,,1000,mg,['2 / Day'], , 
14269,1581,Avonex,2016-01-10,,400,mg,['/Month'],IV, 
14270,1683,Tysabri,2016-06-19,2020-10-09, ,mg,['2 / Day'], ,Persisting MRI activity
14271,1683,Tecfidera,2016-07-15,2020-08-15,20, ,['3 / Week'],IV,Patient Choice/Convenience
14272,1683,Alemtuzumab (Campath),2016-05-11,2018-02-22,20,mg,[' '],IV,Adverse Event
14273,1683,Gilenya,2015-10-29,,20, ,['/Month'],Oral, 
14274,3326,IVIG,2016-04-26,, ,mcg,['2 / Day'],IV, 
14275,335,Tecfidera,2015-12-01,2018-07-31,20,mg,['3 / Week'], ,Lack of efficacy
14276,335,Copaxone,2016-08-25,,500,mg,['/Month'],Oral, 
14277,1744,Teriflunomide,2016-01-16,, ,mg,['/Month'], , 
14278,1744,Avonex,2016-07-26,, ,mg,['2 / Day'],IV, 
14279,1744,Gilenya,2016-07-23,,300, ,['/Month'],Oral, 
14280,4474,Tecfidera,2016-09-16,,300,mcg,['3 / Week'],Oral, 
14281,4474,Gilenya,2016-02-12,2017-12-18,500,mg,['/ Day'], ,Persistence of relapses
14282,4474,Endoxan,2015-12-20,,1000,mg,['/Month'],IV, 
14283,4474,Gilenya,2016-03-14,,300, ,['/ Day'],IV, 
14284,1399,Methylprednisolone,2015-12-02,,1,mg,['2 / Day'], , 
14285,2572,IVIG,2016-09-14,2019-05-26,400,mg,['/Month'], ,Persisting MRI activity
14286,4770,IVIG,2015-12-19,2019-11-11,1000, ,['/Month'], ,Persisting MRI activity
14287,4770,IVIG,2015-11-14,2021-01-06,20, ,[' '],Oral,Adverse Event
14288,4770,IVIG,2016-07-31,, ,mg,[' '],Oral, 
14289,1986,Mitoxantrone,2016-03-15,,400, ,['3 / Week'],IV, 
14290,1986,Rebif [44],2016-01-29,,500, ,['2 / Day'],IV, 
14291,1986,Avonex,2016-09-19,2018-06-30,500,mg,['/Month'], ,Persisting MRI activity
14292,2263,Tysabri,2016-08-25,,1000,mg,['/ Day'], , 
14293,2263,Tecfidera,2015-11-04,,1000,mg,['/ Week'],Oral, 
14294,2263,Endoxan,2016-06-23,,300,mg,['/Month'],IV, 
14295,1855,Copaxone,2016-02-07,2020-08-30,1000, ,['3 / Week'],IV,Adverse Event
14296,1855,Methylprednisolone,2016-01-05,2020-05-29, , ,['2 / Day'], ,Persisting MRI activity
14297,1855,Methylprednisolone,2016-09-16,2021-07-26, ,MIU,[' '],IV,Patient Choice/Convenience
14298,3927,Tysabri,2016-09-06,2019-05-22,1, ,['2 / Day'],Oral,Lack of efficacy
14299,3927,Betaferon,2016-03-01,,1000,mg,['/Month'],IV, 
14300,535,Betaferon,2015-12-14,,20,mg,['/Month'],IV, 
14301,3696,D-cure (Vitamine D),2016-07-26,,1000,mg,['2 / Day'], , 
14302,3930,Tecfidera,2016-04-18,2019-07-15,20, ,['/Month'],IV,Patient Choice/Convenience
14303,3930,Rebif [22],2015-12-28,2019-12-02,5000,mg,['2 / Day'],Oral,Lack of efficacy
14304,3930,Avonex,2016-03-06,,500,mg,['3 / Week'],IV, 
14305,3930,Tecfidera,2016-05-11,2020-01-09, , ,['2 / Day'],Oral,Persisting MRI activity
14306,4455,Endoxan,2016-06-26,2020-11-10, , ,['/ Day'], ,Patient Choice/Convenience
14307,4455,Rebif [22],2016-04-23,,1000,mg,['2 / Day'], , 
14308,4455,Gilenya,2016-02-18,,1,mg,['2 / Day'], , 
14309,1971,Methylprednisolone,2016-01-29,,300, ,['2 / Day'], , 
14310,1971,Tecfidera,2016-08-17,2019-11-08, ,MIU,['/Month'],Oral,Patient Choice/Convenience
14311,1971,Gilenya,2016-10-14,,20, ,['/Month'], , 
14312,1971,Rebif [22],2015-11-07,,300, ,['2 / Day'],IV, 
14313,2887,Tecfidera,2016-03-17,, ,MIU,['/ Day'], , 
14314,2887,Rebif [44],2016-06-09,2017-11-09,500, ,['/Month'],IV,Adverse Event
14315,2887,Tecfidera,2016-05-06,,20, ,['/ Day'],IV, 
14316,1456,Tecfidera,2016-05-01,,400, ,['/Month'],IV, 
14317,1456,Teriflunomide,2016-08-06,2019-06-07,300, ,['3 / Week'],IV,Patient Choice/Convenience
14318,1456,Betaferon,2016-03-02,,20, ,['2 / Day'],IV, 
14319,1456,IVIG,2015-11-15,, , ,[' '],IV, 
14320,4219,Rebif [22],2016-06-09,2021-07-15,5000, ,['2 / Day'], ,Patient Choice/Convenience
14321,4219,Rebif [22],2016-08-26,2020-11-02, ,mg,['/Month'], ,Lack of efficacy
14322,4219,Rebif [22],2015-12-10,2019-02-24,1000,mg,['2 / Day'], ,Lack of efficacy
14323,4219,Mitoxantrone,2016-06-10,2020-10-06,300,MIU,['2 / Day'],IV,Lack of efficacy
14324,3317,Avonex,2016-07-17,2021-10-04, ,mg,['3 / Week'],Oral,Patient Choice/Convenience
14325,3317,Betaferon,2016-10-02,, ,mg,['2 / Day'], , 
14326,3317,Mitoxantrone,2015-11-22,2021-03-26,20,MIU,['3 / Week'],IV,Patient Choice/Convenience
14327,3317,Gilenya,2016-06-08,2019-12-22,20, ,['/ Day'],Oral,Persistence of relapses
14328,1054,Avonex,2015-11-30,, , ,['2 / Day'], , 
14329,1054,Teriflunomide,2016-05-08,,1, ,['/Month'], , 
14330,1054,Rebif [44],2016-07-19,,20, ,['/Month'],IV, 
14331,2370,Gilenya,2016-08-30,,5000, ,['/Month'], , 
14332,2370,Tecfidera,2016-02-22,,400, ,['2 / Day'], , 
14333,2370,Tecfidera,2016-09-25,2019-03-31, , ,['/ Week'], ,Adverse Event
14334,2370,Rebif [22],2016-08-31,,20,mg,['3 / Week'], , 
14335,1590,Gilenya,2016-01-19,,5000,mg,['3 / Week'],IV, 
14336,1590,Endoxan,2016-03-30,, ,mg,['3 / Week'],Oral, 
14337,1590,Avonex,2016-10-04,2018-08-21,5000,mg,['/Month'], ,Lack of efficacy
14338,2238,D-cure (Vitamine D),2016-01-29,2020-01-03,1000, ,[' '],IV,Patient Choice/Convenience
14339,2238,Methylprednisolone,2015-12-08,2019-04-24,20,mg,['2 / Day'],IV,Persisting MRI activity
14340,738,D-cure (Vitamine D),2016-04-27,,500, ,['3 / Week'], , 
14341,738,Rebif [44],2016-07-01,2019-08-11,1000,mg,['/Month'],IV,Adverse Event
14342,738,IVIG,2016-06-19,,5000,mg,['3 / Week'], , 
14343,738,Endoxan,2016-07-22,2019-12-01,20,mcg,['3 / Week'], ,Lack of efficacy
14344,946,Betaferon,2016-05-25,2019-10-26,20, ,['2 / Day'],IV,Lack of efficacy
14345,946,Rebif [44],2016-10-18,, ,MIU,['/Month'],Oral, 
14346,946,Methylprednisolone,2016-06-06,2018-06-30,1000,mg,['/ Week'],IV,Adverse Event
14347,946,Rebif [44],2016-06-04,, ,mg,['/ Day'],IV, 
14348,2586,Endoxan,2015-12-01,2018-06-10, ,mg,['/Month'],IV,Patient Choice/Convenience
14349,2586,Copaxone,2016-07-14,2020-08-20,5000, ,['2 / Day'],IV,Patient Choice/Convenience
14350,3956,D-cure (Vitamine D),2015-12-28,2021-04-05,1, ,['2 / Day'], ,Patient Choice/Convenience
14351,3956,Gilenya,2015-11-28,,20, ,[' '],IV, 
14352,3956,IVIG,2016-02-10,,1000,mg,['/Month'],IV, 
14353,3956,Mitoxantrone,2016-07-08,2019-12-15, ,MIU,['/Month'], ,Persisting MRI activity
14354,3072,Tecfidera,2016-04-05,2019-11-16,500,MIU,['/ Day'], ,Lack of efficacy
14355,3072,IVIG,2016-01-10,, ,mg,['/Month'], , 
14356,3777,D-cure (Vitamine D),2016-04-11,,20,mg,['2 / Day'],IV, 
14357,3777,Alemtuzumab (Campath),2016-02-02,, , ,[' '],IV, 
14358,3777,Rebif [44],2016-08-08,2019-05-09,300, ,['2 / Day'], ,Lack of efficacy
14359,3777,Avonex,2016-01-15,2021-05-04,20, ,['2 / Day'], ,Persisting MRI activity
14360,588,Teriflunomide,2015-11-10,, ,mg,[' '],Oral, 
14361,508,Tysabri,2016-04-15,,20,mg,['2 / Day'], , 
14362,508,Betaferon,2016-06-15,2019-04-04,20, ,['/Month'],IV,Persistence of relapses
14363,4658,Methylprednisolone,2016-09-20,, ,mg,['/Month'],IV, 
14364,4658,D-cure (Vitamine D),2016-02-29,, ,mg,['/Month'],IV, 
14365,4658,Betaferon,2015-11-28,2018-05-25,400, ,['/ Week'],IV,Persistence of relapses
14366,4658,Rebif [22],2015-12-01,,20,mg,['/Month'],IV, 
14367,4528,Betaferon,2016-05-15,, , ,[' '],Oral, 
14368,4528,Rebif [44],2016-01-18,, ,mg,['/Month'],IV, 
14369,3504,D-cure (Vitamine D),2016-10-02,, ,mg,[' '], , 
14370,3504,Gilenya,2016-05-13,2021-09-20, ,mg,[' '],IV,Persistence of relapses
14371,3504,Tysabri,2016-07-26,,20,MIU,['2 / Day'],Oral, 
14372,1893,Copaxone,2016-07-30,,400, ,['3 / Week'], , 
14373,1893,Betaferon,2015-12-04,,20, ,[' '], , 
14374,1893,IVIG,2015-11-02,2018-11-25,300,mcg,['2 / Day'],IV,Patient Choice/Convenience
14375,1893,Methylprednisolone,2016-04-23,2018-07-15,400,mg,[' '], ,Adverse Event
14376,1726,IVIG,2016-04-03,, ,mg,['/ Week'], , 
14377,1726,Tecfidera,2016-08-19,2020-11-08,500,MIU,['/Month'],IV,Patient Choice/Convenience
14378,1726,Gilenya,2015-11-18,, ,mg,['3 / Week'], , 
14379,3229,Betaferon,2015-12-17,,20, ,['/ Week'],IV, 
14380,3229,Ledertrexaat,2016-03-12,2018-07-18, , ,['/Month'],IV,Adverse Event
14381,3809,D-cure (Vitamine D),2015-12-28,,1000, ,['/Month'],IV, 
14382,1807,Methylprednisolone,2016-03-04,,400,mg,[' '],IV, 
14383,1807,Ledertrexaat,2016-06-01,2019-08-23,1000,mg,['3 / Week'],Oral,Lack of efficacy
14384,3220,Alemtuzumab (Campath),2016-03-02,2017-12-08, ,mg,['/Month'],Oral,Adverse Event
14385,3220,Methylprednisolone,2016-07-22,, ,mg,['3 / Week'], , 
14386,4571,IVIG,2016-08-07,2018-06-03,500,mg,['2 / Day'], ,Persisting MRI activity
14387,4571,D-cure (Vitamine D),2016-01-25,, ,mg,['3 / Week'],IV, 
14388,3040,Rebif [44],2016-04-12,2018-09-16, ,mcg,['2 / Day'],IV,Adverse Event
14389,3040,Methylprednisolone,2015-11-18,2021-06-13,5000,mcg,['/ Week'], ,Persistence of relapses
14390,3040,Gilenya,2016-04-07,2020-05-30, ,MIU,['2 / Day'],IV,Persistence of relapses
14391,1566,Mitoxantrone,2016-06-06,,20,mg,['2 / Day'], , 
14392,2891,Tecfidera,2016-05-21,2020-01-26,500,MIU,['/Month'],IV,Lack of efficacy
14393,2524,Rebif [22],2016-06-24,,1000, ,['3 / Week'], , 
14394,2524,Avonex,2016-05-25,,500,mg,['/ Week'],Oral, 
14395,1765,Rebif [44],2016-02-05,,300,mcg,['/ Day'],IV, 
14396,1765,Gilenya,2015-11-17,2018-02-03,1,mg,['/ Day'], ,Adverse Event
14397,1765,Tysabri,2016-01-15,,5000, ,['/Month'],IV, 
14398,1765,Betaferon,2016-09-02,2019-06-21, ,mg,['2 / Day'],IV,Adverse Event
14399,4595,Teriflunomide,2015-12-10,,20,mg,['3 / Week'],Oral, 
14400,4595,Methylprednisolone,2016-07-08,2021-04-17, ,mg,['/Month'], ,Adverse Event
14401,4595,Gilenya,2016-02-27,,20, ,['3 / Week'],IV, 
14402,3136,Mitoxantrone,2016-09-08,,500,mg,['/Month'],IV, 
14403,3136,Copaxone,2015-11-25,2020-12-13, , ,['/ Day'], ,Patient Choice/Convenience
14404,1421,Avonex,2016-01-19,2019-04-28, ,mcg,['2 / Day'],IV,Persistence of relapses
14405,1421,Endoxan,2016-02-15,2019-12-12,1,mg,['/Month'], ,Lack of efficacy
14406,1421,Methylprednisolone,2016-03-15,2019-04-05,1, ,['2 / Day'],IV,Adverse Event
14407,1899,Copaxone,2015-12-03,2019-07-02,500,mg,['/Month'],IV,Persisting MRI activity
14408,4252,Gilenya,2016-01-28,, , ,['/ Week'], , 
14409,4252,Tysabri,2016-09-07,,300,mcg,['2 / Day'], , 
14410,4252,Rebif [22],2016-08-01,,1,mg,['/ Day'],IV, 
14411,1995,Teriflunomide,2016-05-18,2020-02-19,5000,mcg,['2 / Day'],IV,Patient Choice/Convenience
14412,1995,Teriflunomide,2016-06-11,,500,mg,['2 / Day'],IV, 
14413,1995,Tecfidera,2016-04-08,2018-05-15,1000, ,['3 / Week'], ,Persistence of relapses
14414,1995,Rebif [44],2016-08-07,2019-03-29,5000, ,['2 / Day'], ,Persistence of relapses
14415,4569,Tecfidera,2016-03-01,2018-10-21, ,mg,['3 / Week'],IV,Adverse Event
14416,4569,Tecfidera,2016-06-03,2020-06-18, , ,['/Month'], ,Patient Choice/Convenience
14417,4569,IVIG,2016-05-27,2018-04-27, ,mg,['/Month'], ,Adverse Event
14418,4569,IVIG,2016-03-12,2019-02-28, ,mg,['2 / Day'], ,Adverse Event
14419,3626,D-cure (Vitamine D),2016-08-25,, ,mcg,[' '],IV, 
14420,3626,Gilenya,2016-01-26,2020-05-16,5000, ,['/ Week'], ,Adverse Event
14421,3626,D-cure (Vitamine D),2016-02-02,2018-08-02,1000, ,['/Month'], ,Persisting MRI activity
14422,3626,D-cure (Vitamine D),2016-07-23,,400, ,['2 / Day'],IV, 
14423,2591,Tecfidera,2016-05-20,,1000,MIU,[' '],IV, 
14424,2898,Tecfidera,2016-01-21,2021-04-14,20,mg,[' '], ,Patient Choice/Convenience
14425,3389,IVIG,2015-12-18,, , ,['2 / Day'], , 
14426,3672,D-cure (Vitamine D),2015-12-07,2017-10-26,400, ,['/Month'],Oral,Persisting MRI activity
14427,3672,Gilenya,2015-11-27,,300, ,['/ Day'], , 
14428,3672,Alemtuzumab (Campath),2016-08-13,2019-05-20,20,mg,['2 / Day'], ,Patient Choice/Convenience
14429,4001,Copaxone,2016-01-30,2020-04-26,1,mg,['/ Day'],IV,Persistence of relapses
14430,369,IVIG,2015-12-15,2018-04-10,1000,mg,['2 / Day'], ,Adverse Event
14431,3310,Betaferon,2016-06-09,,1,mcg,['3 / Week'], , 
14432,3310,Copaxone,2015-12-20,,20, ,['3 / Week'],Oral, 
14433,461,Avonex,2016-09-20,2018-12-09, , ,['/Month'], ,Adverse Event
14434,461,Mitoxantrone,2016-03-07,2019-09-22,500,mcg,['/Month'],IV,Persisting MRI activity
14435,1998,Tecfidera,2015-12-12,, , ,['/Month'],IV, 
14436,1998,Methylprednisolone,2016-04-02,, , ,['/Month'],Oral, 
14437,1998,Endoxan,2016-07-22,2019-01-31,1,mg,['/Month'], ,Patient Choice/Convenience
14438,2209,Ledertrexaat,2016-04-11,,500,mcg,['2 / Day'], , 
14439,2209,Alemtuzumab (Campath),2016-08-22,,1000,mcg,['/Month'], , 
14440,2209,Avonex,2016-06-13,, ,mg,['/Month'], , 
14441,2209,Betaferon,2016-04-04,2021-05-28, , ,['3 / Week'],Oral,Lack of efficacy
14442,3351,Endoxan,2016-03-12,2020-04-12,500,MIU,['/ Day'], ,Persisting MRI activity
14443,3351,Tysabri,2016-01-16,, , ,['/Month'],Oral, 
14444,3351,Betaferon,2015-11-14,2019-05-29, ,MIU,['/Month'], ,Lack of efficacy
14445,2498,Gilenya,2016-09-19,,20,mg,['2 / Day'], , 
14446,2498,Teriflunomide,2016-07-13,,400, ,['2 / Day'],IV, 
14447,2498,Rebif [44],2016-07-08,2018-02-19,300,MIU,['3 / Week'],IV,Persisting MRI activity
14448,2498,Gilenya,2016-04-11,,1000, ,['/ Week'],IV, 
14449,3810,Alemtuzumab (Campath),2016-10-06,, , ,['3 / Week'], , 
14450,3251,Avonex,2015-11-22,2020-09-27, ,MIU,['3 / Week'],Oral,Patient Choice/Convenience
14451,3251,Methylprednisolone,2016-07-03,, , ,['2 / Day'],IV, 
14452,1494,Gilenya,2016-09-26,,1,mg,['/ Day'], , 
14453,1604,Endoxan,2016-07-29,,1000,mg,['/Month'],IV, 
14454,1604,Rebif [22],2015-12-19,2019-04-18, ,mcg,['/ Day'],IV,Lack of efficacy
14455,293,D-cure (Vitamine D),2016-10-04,2019-02-21,20,mg,['2 / Day'],Oral,Adverse Event
14456,2419,Alemtuzumab (Campath),2016-07-07,, ,MIU,[' '], , 
14457,3541,Teriflunomide,2016-08-21,2018-09-20,20,MIU,['/ Day'], ,Persisting MRI activity
14458,3541,Tysabri,2016-01-11,2018-12-04, ,MIU,['/Month'],IV,Persistence of relapses
14459,2304,Gilenya,2016-08-25,,20,mg,['2 / Day'],IV, 
14460,2304,Ledertrexaat,2015-11-01,2021-02-05,400,mg,['2 / Day'],IV,Persistence of relapses
14461,2304,IVIG,2016-07-25,2021-03-06, ,mg,['/Month'],IV,Patient Choice/Convenience
14462,811,Tecfidera,2016-05-18,,500,mg,['/Month'],IV, 
14463,811,Rebif [44],2016-01-11,,500,mg,['/Month'],IV, 
14464,811,IVIG,2016-10-08,2018-07-17,300, ,['2 / Day'], ,Persisting MRI activity
14465,4547,Endoxan,2016-10-10,,1000,mg,['/Month'],Oral, 
14466,4547,Tecfidera,2015-12-14,, , ,['2 / Day'], , 
14467,4547,Rebif [22],2016-03-11,2018-10-24, , ,['/Month'],IV,Persisting MRI activity
14468,4547,Methylprednisolone,2016-10-19,2021-09-03, , ,['/Month'], ,Persisting MRI activity
14469,3829,IVIG,2016-07-18,2020-11-24,1000, ,['2 / Day'], ,Persisting MRI activity
14470,3829,Teriflunomide,2015-10-29,,1000, ,['2 / Day'],IV, 
14471,3829,Rebif [22],2015-10-29,, ,mg,['2 / Day'], , 
14472,4996,Mitoxantrone,2015-12-08,2019-12-04, ,mcg,['/Month'],IV,Adverse Event
14473,4996,Methylprednisolone,2016-01-16,,1,mg,['/Month'],IV, 
14474,4996,Methylprednisolone,2016-04-16,2019-02-02,1000, ,['/Month'],IV,Adverse Event
14475,2641,IVIG,2015-11-01,2020-03-24,20,MIU,['2 / Day'], ,Patient Choice/Convenience
14476,2641,IVIG,2015-12-11,, ,MIU,['2 / Day'], , 
14477,3734,Tysabri,2015-11-29,2018-08-09, ,mg,['2 / Day'],IV,Persisting MRI activity
14478,3734,Tysabri,2016-09-13,,5000, ,['/Month'],IV, 
14479,4466,Copaxone,2016-03-18,2021-10-09,1, ,['/Month'],IV,Patient Choice/Convenience
14480,4466,Rebif [44],2016-08-27,,400,mg,['/Month'], , 
14481,4466,IVIG,2016-06-01,,500,mg,[' '],IV, 
14482,1952,Tysabri,2016-01-28,2018-06-05,5000, ,['/Month'],IV,Patient Choice/Convenience
14483,3735,Endoxan,2016-04-11,, , ,['2 / Day'],IV, 
14484,3735,Rebif [22],2016-03-20,, , ,['3 / Week'],Oral, 
14485,3735,Gilenya,2015-11-25,, , ,['/Month'],IV, 
14486,2480,Mitoxantrone,2016-06-23,,1,MIU,['2 / Day'], , 
14487,2480,Rebif [22],2016-06-16,,5000, ,['/Month'], , 
14488,2480,Gilenya,2016-01-12,, ,mg,['/Month'], , 
14489,1218,Copaxone,2016-07-28,,5000,mg,['3 / Week'], , 
14490,1218,IVIG,2016-09-10,2020-04-11, , ,['/Month'], ,Lack of efficacy
14491,1218,Gilenya,2015-12-30,, ,mg,['3 / Week'], , 
14492,3061,Avonex,2016-02-22,2018-05-10,5000,mg,['3 / Week'],IV,Lack of efficacy
14493,3061,IVIG,2016-07-06,, , ,['/Month'],IV, 
14494,3061,Teriflunomide,2016-04-16,2020-02-11,500,mg,['/Month'],Oral,Persisting MRI activity
14495,3061,Endoxan,2016-10-15,,300, ,['2 / Day'],IV, 
14496,4674,Betaferon,2016-06-10,2020-06-14,5000,mg,['/ Day'],Oral,Patient Choice/Convenience
14497,4674,IVIG,2016-06-11,2018-06-17,1000, ,['/Month'], ,Adverse Event
14498,4674,Betaferon,2016-07-01,2018-11-26,300,mg,['2 / Day'], ,Adverse Event
14499,3421,Gilenya,2016-02-07,, , ,['/Month'], , 
14500,3421,Rebif [22],2016-01-10,,5000, ,['/ Day'],IV, 
14501,1698,D-cure (Vitamine D),2016-02-10,2019-06-16, ,mg,[' '],IV,Adverse Event
14502,1698,Tecfidera,2016-05-28,, ,MIU,['/Month'], , 
14503,4588,Tecfidera,2016-08-27,2018-01-12,400, ,['2 / Day'], ,Lack of efficacy
14504,4705,Rebif [22],2016-04-13,,500,mg,[' '],IV, 
14505,4705,Endoxan,2016-05-28,2020-11-28,500,mg,[' '],IV,Persisting MRI activity
14506,4705,Gilenya,2015-12-15,,500, ,['/Month'], , 
14507,3648,Ledertrexaat,2016-09-14,, , ,['/Month'], , 
14508,3648,Mitoxantrone,2016-05-12,2021-04-06,5000,mg,[' '],IV,Patient Choice/Convenience
14509,1571,IVIG,2016-05-24,,500,mg,['2 / Day'],IV, 
14510,1571,Teriflunomide,2016-08-05,2019-01-15,1,mg,['/ Day'],IV,Lack of efficacy
14511,4334,IVIG,2016-05-10,,20,MIU,['/Month'],IV, 
14512,4334,Betaferon,2016-07-26,, , ,['2 / Day'],IV, 
14513,4676,Tysabri,2016-04-22,, ,mg,[' '], , 
14514,4766,Gilenya,2016-02-22,2020-08-10,20,mg,['3 / Week'],Oral,Adverse Event
14515,4698,D-cure (Vitamine D),2016-10-13,2021-07-06,5000, ,['2 / Day'], ,Lack of efficacy
14516,4698,Avonex,2016-06-03,,500,mg,['/ Day'],IV, 
14517,4698,Methylprednisolone,2016-10-06,2017-12-31,20, ,['3 / Week'],IV,Patient Choice/Convenience
14518,3350,D-cure (Vitamine D),2016-08-28,2018-10-02, ,MIU,['/Month'], ,Adverse Event
14519,3350,Tysabri,2015-10-30,2017-12-05,400,mg,['3 / Week'],IV,Persistence of relapses
14520,3093,Copaxone,2016-03-07,,1000, ,['/Month'],IV, 
14521,3093,D-cure (Vitamine D),2016-01-05,,500, ,['/Month'],Oral, 
14522,3093,Betaferon,2016-09-24,,400,mg,['/Month'],IV, 
14523,4002,Rebif [44],2015-12-20,,300,mg,['2 / Day'],IV, 
14524,4002,IVIG,2016-06-27,2018-10-17,5000,mg,[' '],Oral,Patient Choice/Convenience
14525,4002,D-cure (Vitamine D),2015-11-16,,300,mg,['/Month'],IV, 
14526,4002,Rebif [44],2016-02-23,2017-12-31,500,mg,['/ Day'], ,Adverse Event
14527,3455,IVIG,2016-09-25,2019-11-11,20,mg,['/ Week'],IV,Persisting MRI activity
14528,392,Tysabri,2016-04-08,,5000,mg,['/Month'],IV, 
14529,392,Tecfidera,2016-08-26,, , ,[' '], , 
14530,392,Tecfidera,2016-08-16,2019-04-12, ,MIU,['/Month'],IV,Patient Choice/Convenience
14531,392,Copaxone,2016-09-14,,5000,mg,[' '], , 
14532,4462,Avonex,2016-06-01,2021-09-01,300, ,['2 / Day'], ,Lack of efficacy
14533,4462,Tecfidera,2016-08-20,,20,mg,['2 / Day'], , 
14534,4462,Ledertrexaat,2016-06-17,2018-05-06,300, ,['2 / Day'], ,Adverse Event
14535,4462,Rebif [44],2016-08-16,,5000,mg,['/Month'], , 
14536,3863,Tecfidera,2016-07-02,,5000, ,['3 / Week'], , 
14537,3863,D-cure (Vitamine D),2016-07-14,,20,mg,[' '], , 
14538,3863,IVIG,2016-10-04,,1000, ,['/ Day'],IV, 
14539,299,Gilenya,2016-07-12,,5000,mg,['/ Day'], , 
14540,299,D-cure (Vitamine D),2016-08-13,, ,MIU,['2 / Day'],IV, 
14541,1834,Tecfidera,2016-04-10,,1,mg,['/Month'],IV, 
14542,1834,Rebif [44],2016-08-15,2018-05-21,400,mg,['/ Day'],IV,Patient Choice/Convenience
14543,1834,Endoxan,2016-06-04,2018-04-22,400, ,['3 / Week'],IV,Lack of efficacy
14544,1834,Betaferon,2015-12-03,2018-01-09,500,mg,['2 / Day'],IV,Persisting MRI activity
14545,3025,Gilenya,2016-07-19,,500, ,['2 / Day'], , 
14546,3025,Copaxone,2016-03-10,,500,mg,['/ Day'],IV, 
14547,3025,Methylprednisolone,2016-01-15,, ,mg,['/ Week'], , 
14548,3025,IVIG,2016-08-22,,500,mg,['2 / Day'],Oral, 
14549,4472,IVIG,2015-11-01,, , ,['/Month'],IV, 
14550,4186,IVIG,2016-07-01,2020-11-22, , ,['/Month'],IV,Persisting MRI activity
14551,4186,Gilenya,2015-10-28,2019-06-03,400, ,['/Month'], ,Lack of efficacy
14552,1511,D-cure (Vitamine D),2016-10-08,,1000,MIU,[' '], , 
14553,1511,Betaferon,2016-09-13,,20,MIU,['3 / Week'], , 
14554,3233,Rebif [44],2015-12-16,,1,mg,['2 / Day'], , 
14555,2805,Avonex,2016-09-09,,300,MIU,['/Month'], , 
14556,2805,Tecfidera,2016-07-30,2020-07-21,20,mg,['2 / Day'],Oral,Lack of efficacy
14557,2841,Tysabri,2016-04-30,2021-10-11,20,MIU,[' '], ,Adverse Event
14558,2841,Tecfidera,2016-03-09,, , ,['/Month'],Oral, 
14559,2841,Endoxan,2016-10-02,,1,mg,['2 / Day'],IV, 
14560,2841,Betaferon,2016-07-04,,500, ,['2 / Day'],IV, 
14561,1008,Tysabri,2016-06-19,2019-01-06,300,mg,['2 / Day'], ,Persisting MRI activity
14562,1008,Betaferon,2015-11-13,,5000,mg,['3 / Week'], , 
14563,2989,Rebif [44],2015-11-28,2018-02-23,5000, ,['2 / Day'],IV,Lack of efficacy
14564,3349,Avonex,2016-06-03,2020-07-04, , ,['/Month'],IV,Persisting MRI activity
14565,3349,Rebif [22],2016-03-02,2020-03-03,1000,mg,['/ Week'],IV,Adverse Event
14566,864,Avonex,2016-10-11,,5000,mg,['2 / Day'], , 
14567,864,Alemtuzumab (Campath),2015-11-12,2018-11-24,500,mg,['2 / Day'],IV,Patient Choice/Convenience
14568,864,Alemtuzumab (Campath),2016-07-22,,1, ,['/ Day'],Oral, 
14569,864,Gilenya,2016-03-18,, ,mg,['2 / Day'],IV, 
14570,476,IVIG,2015-11-03,, ,mg,['/Month'], , 
14571,1500,Tecfidera,2016-04-15,,500,mg,['2 / Day'],IV, 
14572,997,Methylprednisolone,2016-04-10,, ,MIU,['2 / Day'],IV, 
14573,997,IVIG,2016-05-21,2021-10-04,500,MIU,['/Month'],IV,Adverse Event
14574,997,Endoxan,2015-12-21,,5000,mg,['/Month'],IV, 
14575,3461,Ledertrexaat,2016-04-24,,300, ,['/ Day'], , 
14576,3461,Mitoxantrone,2016-08-14,2018-08-03,500, ,['2 / Day'], ,Lack of efficacy
14577,1614,Tysabri,2016-09-06,,300, ,['2 / Day'],IV, 
14578,1614,Copaxone,2016-02-10,2019-03-17,1,mg,[' '],IV,Persisting MRI activity
14579,1614,D-cure (Vitamine D),2016-09-07,,20,mg,['2 / Day'], , 
14580,1614,D-cure (Vitamine D),2016-05-01,,500,mg,['2 / Day'],IV, 
14581,4195,Mitoxantrone,2016-07-06,2021-01-25,1,MIU,['2 / Day'], ,Patient Choice/Convenience
14582,4195,Endoxan,2016-03-26,,500,MIU,['2 / Day'], , 
14583,4195,Rebif [22],2016-04-06,,500, ,['/Month'],IV, 
14584,4195,Rebif [22],2016-01-18,2019-08-29,300, ,['/ Day'], ,Patient Choice/Convenience
14585,3707,Rebif [22],2016-01-14,2021-06-26,1,mcg,['/Month'],IV,Lack of efficacy
14586,950,IVIG,2016-09-17,2019-07-08,1, ,['/Month'],IV,Adverse Event
14587,2102,Tecfidera,2016-02-29,2018-10-23,400, ,['/ Day'],IV,Adverse Event
14588,2102,Methylprednisolone,2016-08-14,2018-02-25,1000, ,['2 / Day'],IV,Adverse Event
14589,2102,Tecfidera,2015-11-23,2021-07-21, , ,['2 / Day'], ,Adverse Event
14590,4569,Rebif [44],2016-04-17,, , ,['/ Day'], , 
14591,4879,Avonex,2016-06-22,,20,mg,['/ Week'],IV, 
14592,4879,Methylprednisolone,2015-12-04,2018-05-29,1000, ,['3 / Week'],IV,Persistence of relapses
14593,1859,Mitoxantrone,2016-08-04,2019-02-06, ,mg,[' '],IV,Patient Choice/Convenience
14594,1465,Methylprednisolone,2016-01-18,2021-01-16, ,mg,[' '], ,Patient Choice/Convenience
14595,2257,Rebif [44],2016-10-06,,500, ,['/Month'],IV, 
14596,2257,Endoxan,2016-04-18,,1, ,['/Month'],IV, 
14597,164,Rebif [44],2016-09-22,,300, ,['/Month'],IV, 
14598,164,Mitoxantrone,2016-02-10,,300, ,['3 / Week'], , 
14599,164,Betaferon,2015-11-05,, ,mg,['3 / Week'],IV, 
14600,164,Endoxan,2015-12-23,2018-06-03,5000, ,['/Month'],Oral,Persisting MRI activity
14601,4395,Tecfidera,2016-07-04,,400,mg,[' '], , 
14602,4395,Methylprednisolone,2016-05-31,2021-08-27,5000, ,['2 / Day'], ,Persisting MRI activity
14603,4395,IVIG,2016-03-08,,300, ,['/ Day'],IV, 
14604,4395,Ledertrexaat,2015-11-09,,1000,mg,['3 / Week'], , 
14605,4651,Tecfidera,2016-01-30,,300,mg,['/ Week'],IV, 
14606,4641,Ledertrexaat,2015-12-09,,1000,MIU,['/ Day'],IV, 
14607,4641,IVIG,2016-02-04,, , ,[' '],IV, 
14608,3934,D-cure (Vitamine D),2016-08-12,2021-09-01,1000,mg,['2 / Day'],IV,Adverse Event
14609,3934,Methylprednisolone,2015-12-02,2019-01-18,300,mg,['/ Day'], ,Patient Choice/Convenience
14610,3934,Rebif [44],2016-03-29,,5000,mg,['2 / Day'], , 
14611,3517,Copaxone,2016-03-03,2018-07-25,1000, ,['/ Day'],Oral,Lack of efficacy
14612,3517,Mitoxantrone,2016-09-28,, , ,['/Month'], , 
14613,3517,Avonex,2015-11-24,2019-09-13,400, ,['2 / Day'],IV,Adverse Event
14614,2806,Endoxan,2016-03-05,2021-06-19, , ,['/Month'], ,Patient Choice/Convenience
14615,2806,Tecfidera,2016-01-26,, , ,['/ Day'],IV, 
14616,4201,Ledertrexaat,2016-02-17,2019-12-23, ,mg,['/Month'],IV,Patient Choice/Convenience
14617,4201,Tecfidera,2015-12-11,2018-01-30,1000,mg,['/Month'],Oral,Lack of efficacy
14618,347,Tysabri,2016-01-06,, , ,['/Month'], , 
14619,347,Tecfidera,2016-01-24,2020-02-14, ,MIU,['2 / Day'],IV,Adverse Event
14620,347,Tysabri,2016-06-14,2018-06-29, ,mg,['/ Day'], ,Persisting MRI activity
14621,347,D-cure (Vitamine D),2016-03-31,2020-06-23, ,mg,['3 / Week'],IV,Persisting MRI activity
14622,3308,IVIG,2016-02-29,2018-07-22,20, ,['/Month'], ,Persisting MRI activity
14623,3308,Gilenya,2016-02-14,,20,MIU,['/Month'],IV, 
14624,3308,Tecfidera,2015-11-07,2018-12-31,5000,mg,['/Month'],IV,Patient Choice/Convenience
14625,3544,Methylprednisolone,2015-11-13,2017-12-30,5000,mg,['3 / Week'],IV,Persisting MRI activity
14626,3544,Methylprednisolone,2016-09-15,2021-03-25,1000,mg,['3 / Week'],Oral,Adverse Event
14627,3544,Tysabri,2016-10-08,2021-03-19,500,MIU,['/ Day'],IV,Adverse Event
14628,824,Methylprednisolone,2016-06-19,, ,mg,['2 / Day'],IV, 
14629,824,Methylprednisolone,2015-11-10,, ,mg,['/ Day'],IV, 
14630,824,Avonex,2016-08-28,,20, ,['2 / Day'], , 
14631,824,Ledertrexaat,2015-11-10,2018-09-18, , ,['/Month'], ,Adverse Event
14632,210,Tecfidera,2016-06-03,,20, ,[' '],IV, 
14633,210,Endoxan,2016-03-06,2019-12-31,20,mcg,['/Month'],IV,Lack of efficacy
14634,2569,Endoxan,2015-11-13,,5000, ,['2 / Day'], , 
14635,4250,Endoxan,2016-09-05,,1000, ,[' '], , 
14636,4250,D-cure (Vitamine D),2016-07-12,,5000,mcg,['/Month'], , 
14637,4250,Tecfidera,2016-03-23,,5000,MIU,['/ Day'], , 
14638,4250,Rebif [44],2016-08-15,2018-04-19,5000,mg,['/Month'], ,Adverse Event
14639,1587,IVIG,2016-10-02,,500, ,[' '],Oral, 
14640,4943,Rebif [22],2015-12-21,2018-12-06, ,MIU,['2 / Day'],IV,Lack of efficacy
14641,4943,Teriflunomide,2016-03-06,,500,mg,['2 / Day'], , 
14642,1041,Betaferon,2016-07-08,, ,mg,['/Month'],IV, 
14643,1041,Copaxone,2016-06-23,, ,mg,['/Month'],IV, 
14644,1041,Copaxone,2016-04-02,,1000,mg,['/Month'],IV, 
14645,3000,Mitoxantrone,2016-05-22,, ,mcg,['/ Day'],IV, 
14646,3000,Endoxan,2015-12-08,,20,mg,['2 / Day'], , 
14647,4083,Copaxone,2016-03-22,,1000, ,['3 / Week'], , 
14648,2971,Tecfidera,2016-04-28,2020-07-16,300,mg,['/Month'],Oral,Patient Choice/Convenience
14649,2971,Tecfidera,2015-11-25,2020-08-05, ,mg,['/Month'],IV,Patient Choice/Convenience
14650,2971,Copaxone,2016-03-30,2019-08-24, ,mg,['/Month'],IV,Adverse Event
14651,2971,Avonex,2016-01-04,2021-07-04,1000, ,['/Month'], ,Patient Choice/Convenience
14652,1060,Alemtuzumab (Campath),2016-08-10,2019-10-31,20,mcg,['/ Week'], ,Lack of efficacy
14653,4177,Betaferon,2015-11-30,, ,mg,['/Month'], , 
14654,4177,Teriflunomide,2016-08-13,,300,mg,['/ Week'],IV, 
14655,1269,D-cure (Vitamine D),2016-09-29,,400,mg,['2 / Day'],Oral, 
14656,1269,IVIG,2016-07-02,2020-02-14,20,mg,['/Month'],IV,Patient Choice/Convenience
14657,1269,Mitoxantrone,2016-02-07,2021-05-04,1000, ,['/Month'], ,Persisting MRI activity
14658,125,Gilenya,2015-12-24,,400, ,['/Month'],IV, 
14659,125,IVIG,2016-04-02,,1000, ,['3 / Week'],IV, 
14660,4354,Betaferon,2016-07-31,,500,mcg,['3 / Week'],IV, 
14661,4354,D-cure (Vitamine D),2016-06-24,2019-10-06,400,MIU,['/ Week'],Oral,Persisting MRI activity
14662,4354,Rebif [22],2016-02-05,2018-12-01,1,mg,['/Month'], ,Persisting MRI activity
14663,4085,Tecfidera,2016-09-02,, ,mcg,['/Month'], , 
14664,4085,Teriflunomide,2016-04-18,2020-09-17,1000, ,['/Month'],IV,Adverse Event
14665,4085,Rebif [22],2016-02-10,,1000, ,['/Month'],IV, 
14666,4665,IVIG,2016-02-15,2018-11-23,5000,mg,['/Month'], ,Adverse Event
14667,4665,Teriflunomide,2016-01-27,2018-02-27,300,mg,['/ Day'],IV,Adverse Event
14668,4665,Gilenya,2016-01-12,, ,MIU,['2 / Day'], , 
14669,3974,Endoxan,2016-02-29,,1,mg,['/Month'], , 
14670,3974,Methylprednisolone,2016-02-12,,1,mcg,['2 / Day'], , 
14671,3974,Gilenya,2016-05-02,, , ,['/ Day'],Oral, 
14672,1194,Tecfidera,2016-10-22,2021-04-06, ,mcg,['/ Day'],Oral,Persisting MRI activity
14673,1194,Methylprednisolone,2016-08-15,,300, ,[' '], , 
14674,1194,Avonex,2016-09-27,2021-01-31,1, ,['2 / Day'], ,Lack of efficacy
14675,1666,D-cure (Vitamine D),2016-06-13,,5000, ,[' '], , 
14676,4265,Gilenya,2015-11-23,2018-12-28,400,mg,['/Month'], ,Persisting MRI activity
14677,4265,Copaxone,2016-05-08,2019-09-16,1, ,['/ Day'],IV,Persisting MRI activity
14678,1523,Copaxone,2016-02-12,, ,MIU,['/Month'], , 
14679,4299,Teriflunomide,2016-01-02,,500, ,[' '], , 
14680,4299,IVIG,2016-05-17,,1,MIU,[' '], , 
14681,2239,Rebif [22],2016-05-29,,20, ,['3 / Week'],IV, 
14682,2804,Teriflunomide,2016-10-15,2019-10-03,20,mg,['/ Week'], ,Persistence of relapses
14683,2804,Gilenya,2016-03-21,,20, ,['/Month'], , 
14684,2804,Ledertrexaat,2016-09-17,2018-05-25,1,mg,['/Month'],Oral,Persisting MRI activity
14685,2804,Gilenya,2016-02-25,, ,mg,['2 / Day'],IV, 
14686,2022,Gilenya,2016-10-06,2018-02-06,1000, ,['2 / Day'],IV,Adverse Event
14687,1660,Ledertrexaat,2016-05-06,,1000,mg,['/Month'],Oral, 
14688,1660,Ledertrexaat,2016-06-13,2018-10-17,1000,MIU,['/ Day'],Oral,Adverse Event
14689,1660,D-cure (Vitamine D),2016-09-24,, ,mg,['2 / Day'], , 
14690,1660,Gilenya,2015-10-31,,20,MIU,['/Month'],IV, 
14691,3446,Tecfidera,2016-02-18,2017-12-02, , ,['3 / Week'],IV,Patient Choice/Convenience
14692,3440,D-cure (Vitamine D),2016-03-08,,500,mg,['/ Day'],Oral, 
14693,3440,Gilenya,2015-11-07,2018-03-09, ,mg,['2 / Day'],Oral,Adverse Event
14694,3440,Betaferon,2016-04-02,2019-06-18,20,mg,['3 / Week'], ,Lack of efficacy
14695,3440,Ledertrexaat,2016-05-01,,20, ,['3 / Week'], , 
14696,2281,D-cure (Vitamine D),2016-09-25,2019-02-22,20,MIU,['2 / Day'],Oral,Persistence of relapses
14697,4578,Gilenya,2016-02-21,2021-08-06,1,mg,['2 / Day'],IV,Adverse Event
14698,4578,Tysabri,2016-05-24,,1000,mg,['2 / Day'],Oral, 
14699,4578,Gilenya,2016-09-30,2021-08-20,300,MIU,['/Month'],IV,Lack of efficacy
14700,4578,Tysabri,2015-12-10,2019-06-08,300, ,['2 / Day'],IV,Persisting MRI activity
14701,2565,Gilenya,2016-10-19,,1000, ,['/Month'], , 
14702,2565,Alemtuzumab (Campath),2016-03-07,2019-06-26, , ,['2 / Day'], ,Adverse Event
14703,2812,D-cure (Vitamine D),2016-07-22,2020-08-31,20,mg,[' '],IV,Adverse Event
14704,2812,Rebif [44],2016-02-11,2018-09-17, , ,['/Month'],IV,Patient Choice/Convenience
14705,2812,Tecfidera,2016-04-28,, , ,['/Month'],IV, 
14706,2812,Alemtuzumab (Campath),2015-11-16,,500,mcg,['/ Day'],Oral, 
14707,3418,Teriflunomide,2016-08-22,2021-01-03, , ,['2 / Day'],IV,Adverse Event
14708,3418,Methylprednisolone,2016-06-18,, ,mg,[' '],IV, 
14709,3418,D-cure (Vitamine D),2016-05-31,2020-10-12, ,mg,[' '], ,Patient Choice/Convenience
14710,3259,Methylprednisolone,2016-04-20,,20,mg,['3 / Week'], , 
14711,3259,Tysabri,2015-11-06,2020-01-31, ,mg,['/Month'],Oral,Adverse Event
14712,3259,Gilenya,2016-03-25,2021-04-02,300,mg,['/Month'], ,Adverse Event
14713,4564,Gilenya,2016-05-31,, ,mg,['/Month'], , 
14714,4564,Rebif [22],2016-01-20,2018-06-20, , ,['3 / Week'],IV,Patient Choice/Convenience
14715,3069,Mitoxantrone,2016-09-22,, , ,['/Month'], , 
14716,4884,Alemtuzumab (Campath),2016-04-11,,500,mg,['/Month'],IV, 
14717,4884,Ledertrexaat,2015-12-19,, ,mg,[' '],IV, 
14718,4884,Tysabri,2016-05-17,,20,mg,['/ Day'], , 
14719,4884,Endoxan,2015-11-14,2019-04-23,1000, ,['3 / Week'],IV,Lack of efficacy
14720,2950,D-cure (Vitamine D),2015-11-06,,1000,mg,['/Month'],IV, 
14721,2950,IVIG,2016-09-02,,400, ,['3 / Week'], , 
14722,2052,Tysabri,2016-01-06,2020-04-06,1,mg,['2 / Day'], ,Persisting MRI activity
14723,2052,Tecfidera,2016-02-07,2020-02-06,20,mg,['/ Week'], ,Persisting MRI activity
14724,2052,Tecfidera,2016-02-22,, ,mg,['2 / Day'], , 
14725,2052,IVIG,2016-05-25,2019-05-07, , ,['/Month'], ,Lack of efficacy
14726,3775,Gilenya,2016-02-27,,300,mcg,[' '],Oral, 
14727,3775,Methylprednisolone,2016-10-07,,500, ,[' '], , 
14728,1718,Gilenya,2016-07-07,, ,MIU,['3 / Week'],IV, 
14729,2754,Gilenya,2015-12-14,, , ,['/Month'], , 
14730,2754,Copaxone,2016-02-15,,500, ,['/ Day'], , 
14731,2754,Gilenya,2016-04-01,,5000, ,['2 / Day'], , 
14732,1261,D-cure (Vitamine D),2016-07-15,,1, ,['/Month'],IV, 
14733,1261,Rebif [22],2016-08-13,2021-06-29, ,MIU,[' '], ,Lack of efficacy
14734,1261,Avonex,2016-05-02,2019-06-19,1000, ,['/Month'],IV,Persisting MRI activity
14735,1261,Mitoxantrone,2016-06-03,,5000,mg,['2 / Day'], , 
14736,282,Alemtuzumab (Campath),2016-06-23,,5000,mg,[' '],IV, 
14737,282,Tysabri,2016-04-03,2021-08-24, , ,['/ Day'],Oral,Persisting MRI activity
14738,282,Rebif [22],2016-09-06,, ,mcg,['/Month'],Oral, 
14739,4022,D-cure (Vitamine D),2015-12-08,,1000, ,['2 / Day'],IV, 
14740,4022,Gilenya,2016-03-30,,500, ,['/Month'],IV, 
14741,4022,Tecfidera,2016-10-22,,400, ,['/ Day'],Oral, 
14742,1572,Teriflunomide,2016-01-21,, ,mg,[' '], , 
14743,1572,Tecfidera,2016-01-11,,500,mcg,[' '], , 
14744,1572,IVIG,2016-04-16,,500, ,['/Month'],IV, 
14745,798,Copaxone,2016-05-16,, ,mg,['/Month'], , 
14746,798,Tecfidera,2016-05-20,, , ,['/Month'],IV, 
14747,798,Copaxone,2016-05-20,2021-10-19, , ,['2 / Day'],IV,Persisting MRI activity
14748,1245,Rebif [44],2016-02-06,, , ,['2 / Day'],IV, 
14749,1245,Rebif [44],2016-05-05,, ,mg,[' '],IV, 
14750,1245,Tysabri,2016-08-27,2020-09-18, ,mg,['2 / Day'],IV,Patient Choice/Convenience
14751,4403,Tysabri,2016-01-31,, ,mg,['/ Day'],IV, 
14752,4403,D-cure (Vitamine D),2016-01-31,, , ,['2 / Day'],Oral, 
14753,4403,Rebif [44],2016-01-22,2021-07-25, ,mg,['/Month'], ,Adverse Event
14754,4403,Endoxan,2016-01-16,2020-02-26, , ,[' '], ,Lack of efficacy
14755,2864,Tecfidera,2016-08-06,, ,mg,['3 / Week'],Oral, 
14756,2864,Endoxan,2016-07-23,,300,mg,['2 / Day'],Oral, 
14757,4143,Gilenya,2016-06-08,,400, ,['/Month'], , 
14758,4143,Tysabri,2016-08-27,,1000,MIU,['2 / Day'],IV, 
14759,3169,Betaferon,2016-10-06,2019-11-03,1000,MIU,['2 / Day'],IV,Adverse Event
14760,3169,Endoxan,2015-10-26,, ,mg,['2 / Day'],IV, 
14761,3169,IVIG,2016-07-15,2019-02-28,500,mg,['/Month'], ,Persisting MRI activity
14762,3400,Betaferon,2016-02-10,2019-02-11,5000,mg,['/Month'], ,Persistence of relapses
14763,3400,Alemtuzumab (Campath),2016-05-12,,500, ,['2 / Day'], , 
14764,3400,Avonex,2016-05-13,2021-02-12,300,mg,['2 / Day'], ,Patient Choice/Convenience
14765,350,IVIG,2016-05-30,2021-03-12,20,mcg,['3 / Week'],IV,Adverse Event
14766,350,Gilenya,2016-08-16,,300, ,['2 / Day'], , 
14767,350,Rebif [44],2016-04-17,, ,mg,['/Month'],IV, 
14768,1388,Betaferon,2016-09-24,,20, ,['/ Day'], , 
14769,1388,Endoxan,2015-12-21,2018-11-30,20,MIU,['/Month'], ,Patient Choice/Convenience
14770,4190,Ledertrexaat,2016-01-29,2019-08-01, ,mg,['/Month'], ,Persisting MRI activity
14771,4190,Endoxan,2016-05-02,, ,MIU,['3 / Week'], , 
14772,3628,Endoxan,2016-03-04,, , ,['/Month'], , 
14773,362,Methylprednisolone,2016-10-18,2018-03-04, ,mg,['/Month'], ,Persisting MRI activity
14774,362,Endoxan,2016-01-02,,400,mg,['/Month'],IV, 
14775,362,D-cure (Vitamine D),2016-05-05,,5000,mg,['/Month'], , 
14776,362,Gilenya,2016-10-01,,1000, ,['/ Day'], , 
14777,4842,Tysabri,2015-12-14,,500,mg,['2 / Day'], , 
14778,4842,Gilenya,2015-12-11,,5000,mg,['2 / Day'],IV, 
14779,4842,Tecfidera,2016-04-13,, ,mcg,[' '],IV, 
14780,4842,IVIG,2016-01-23,,1,mg,['3 / Week'],Oral, 
14781,791,Tecfidera,2016-09-20,2020-11-18,1000, ,['/Month'], ,Patient Choice/Convenience
14782,791,Tecfidera,2016-01-29,,20,mg,['/Month'], , 
14783,791,Rebif [22],2016-07-18,,20,mg,['/ Week'],IV, 
14784,791,Gilenya,2016-03-23,,1, ,['/Month'], , 
14785,4157,Tysabri,2016-02-19,2019-07-08, ,mg,['/Month'],IV,Lack of efficacy
14786,4157,Gilenya,2016-06-20,,500,mg,[' '],IV, 
14787,4157,Methylprednisolone,2016-02-07,2019-05-09,500, ,['/Month'], ,Persisting MRI activity
14788,2102,IVIG,2016-08-20,2018-06-08, , ,['/Month'], ,Persistence of relapses
14789,2102,Copaxone,2016-06-28,,20, ,['/ Week'],IV, 
14790,2164,Betaferon,2015-11-14,,1000, ,['/Month'],IV, 
14791,324,Tecfidera,2016-06-01,2018-01-18,300, ,[' '], ,Adverse Event
14792,2596,D-cure (Vitamine D),2016-01-14,,5000,mg,['3 / Week'],IV, 
14793,2596,Ledertrexaat,2016-08-02,2018-12-06,300,mg,['/Month'],IV,Lack of efficacy
14794,2596,Avonex,2016-09-01,, , ,['/Month'],IV, 
14795,1806,Tecfidera,2016-05-27,2018-11-29,20,mg,['/Month'],IV,Adverse Event
14796,1806,Tysabri,2016-01-28,2019-11-07, ,mcg,['3 / Week'], ,Persistence of relapses
14797,1806,Methylprednisolone,2016-07-25,, ,mg,['2 / Day'],Oral, 
14798,1806,Alemtuzumab (Campath),2016-10-08,2021-06-20, ,mg,['/Month'],IV,Patient Choice/Convenience
14799,2170,IVIG,2016-07-15,,1000,mg,['2 / Day'],IV, 
14800,2170,Tecfidera,2016-04-04,2019-08-10,300, ,['3 / Week'],IV,Adverse Event
14801,2170,Avonex,2016-06-19,,5000, ,['/Month'], , 
14802,2170,Methylprednisolone,2015-11-04,, , ,['2 / Day'],IV, 
14803,880,Tysabri,2016-08-07,2019-05-15,5000, ,['2 / Day'],Oral,Persisting MRI activity
14804,880,Methylprednisolone,2016-08-29,, , ,['/Month'],IV, 
14805,880,Ledertrexaat,2016-05-15,, ,mcg,['/Month'],IV, 
14806,3852,Tysabri,2016-10-17,,400, ,['/ Day'],IV, 
14807,492,Betaferon,2016-05-09,,20,mg,['2 / Day'],Oral, 
14808,492,Mitoxantrone,2016-05-11,,20,mcg,['2 / Day'], , 
14809,492,Betaferon,2016-07-18,2021-04-30,300, ,['2 / Day'],Oral,Patient Choice/Convenience
14810,317,Methylprednisolone,2016-09-24,,500,mg,['/ Week'],Oral, 
14811,3150,Alemtuzumab (Campath),2016-09-03,,20,mg,['2 / Day'], , 
14812,3150,Betaferon,2016-09-12,,20, ,['2 / Day'],IV, 
14813,3150,Avonex,2015-11-24,,5000,mg,['3 / Week'],Oral, 
14814,1215,D-cure (Vitamine D),2015-12-13,, , ,['/Month'],IV, 
14815,1215,Ledertrexaat,2015-11-03,2019-04-02,5000,mcg,['2 / Day'],IV,Persisting MRI activity
14816,1215,Tecfidera,2016-10-18,,300, ,['/Month'],Oral, 
14817,1215,Mitoxantrone,2016-06-20,,400,mg,['2 / Day'],Oral, 
14818,469,Alemtuzumab (Campath),2016-02-08,2019-03-31,300,MIU,['3 / Week'], ,Adverse Event
14819,4915,Gilenya,2015-11-19,,500,mg,['2 / Day'],IV, 
14820,4915,Tecfidera,2016-07-27,,500, ,[' '],IV, 
14821,3045,D-cure (Vitamine D),2016-06-05,2018-08-17,1000, ,['2 / Day'],Oral,Persisting MRI activity
14822,3045,IVIG,2016-10-07,2020-12-12,20, ,['/Month'],Oral,Persisting MRI activity
14823,3045,Alemtuzumab (Campath),2015-12-13,, ,mg,['2 / Day'],Oral, 
14824,446,Rebif [22],2015-12-01,2018-09-23,400,mg,['/ Week'], ,Lack of efficacy
14825,446,D-cure (Vitamine D),2016-09-20,,1000, ,['2 / Day'],IV, 
14826,446,Tecfidera,2016-08-30,,20,mg,[' '], , 
14827,446,Rebif [44],2016-04-06,2019-09-30,1000, ,['/ Day'], ,Persisting MRI activity
14828,4414,Copaxone,2016-07-18,, ,mg,['3 / Week'],Oral, 
14829,343,Methylprednisolone,2016-08-20,,1000,mcg,['/Month'], , 
14830,343,IVIG,2016-08-05,,300,mg,['2 / Day'], , 
14831,343,Ledertrexaat,2016-08-28,,1000, ,['3 / Week'], , 
14832,343,Endoxan,2016-03-15,2019-07-11,20,mcg,['/ Week'],IV,Persisting MRI activity
14833,2549,Copaxone,2016-09-15,2020-02-29,20,mg,['/Month'],IV,Lack of efficacy
14834,2558,Gilenya,2015-12-31,2018-11-02,500, ,['2 / Day'],IV,Adverse Event
14835,2558,D-cure (Vitamine D),2016-04-26,,1000, ,[' '],Oral, 
14836,2558,D-cure (Vitamine D),2015-11-15,2021-03-04,5000, ,[' '],IV,Persisting MRI activity
14837,3493,Rebif [22],2016-03-06,,1000,mg,[' '],IV, 
14838,3493,IVIG,2016-02-18,,500,mcg,['2 / Day'],IV, 
14839,3493,Rebif [44],2016-01-26,, ,mg,['2 / Day'],IV, 
14840,3493,Gilenya,2016-04-26,, ,mg,['2 / Day'],IV, 
14841,616,Betaferon,2016-02-14,,500,mg,['2 / Day'], , 
14842,286,Ledertrexaat,2016-07-02,2020-12-25,1000, ,[' '],IV,Patient Choice/Convenience
14843,286,Teriflunomide,2016-09-21,2018-11-08, ,mg,['/Month'],IV,Persisting MRI activity
14844,286,Mitoxantrone,2016-06-17,,1,mg,['/Month'], , 
14845,286,Methylprednisolone,2016-02-10,,500,MIU,['/Month'],Oral, 
14846,1397,Avonex,2016-05-20,2020-04-07,400,mg,['2 / Day'],IV,Persisting MRI activity
14847,1397,Copaxone,2016-10-10,, , ,['3 / Week'],IV, 
14848,1397,Rebif [22],2016-03-12,2020-05-11, ,mg,['2 / Day'],Oral,Adverse Event
14849,1397,Alemtuzumab (Campath),2016-02-14,, ,mcg,['3 / Week'],IV, 
14850,3303,Ledertrexaat,2016-08-01,2018-10-30,1, ,['/Month'],IV,Persisting MRI activity
14851,3303,Tecfidera,2016-09-30,2019-06-20,1, ,['3 / Week'],IV,Adverse Event
14852,3303,Gilenya,2016-01-28,,5000,mg,['/ Day'],IV, 
14853,3303,IVIG,2016-07-06,2021-01-12,1000, ,['2 / Day'], ,Adverse Event
14854,2666,Gilenya,2015-11-10,,20, ,['2 / Day'],IV, 
14855,552,Ledertrexaat,2015-12-05,,500, ,['2 / Day'],IV, 
14856,552,IVIG,2015-11-03,2018-01-16, ,mg,['/Month'], ,Lack of efficacy
14857,970,Methylprednisolone,2016-06-13,2017-12-20,5000, ,['/Month'], ,Adverse Event
14858,970,Rebif [44],2015-12-15,2020-08-31,20, ,[' '], ,Persisting MRI activity
14859,1376,Tecfidera,2016-08-06,2019-11-22,300,mg,['/Month'], ,Patient Choice/Convenience
14860,1376,D-cure (Vitamine D),2016-02-21,2019-03-05, , ,['/ Week'], ,Adverse Event
14861,1376,D-cure (Vitamine D),2016-06-24,,300, ,['3 / Week'],IV, 
14862,4317,D-cure (Vitamine D),2016-06-08,,400, ,['/Month'],Oral, 
14863,4194,Tysabri,2016-04-17,,300, ,['/Month'], , 
14864,4194,Betaferon,2016-02-03,2019-02-22, ,mg,['2 / Day'], ,Adverse Event
14865,4194,Tecfidera,2016-03-10,2017-11-06, ,MIU,['2 / Day'], ,Adverse Event
14866,4194,Avonex,2016-10-09,, ,mg,['2 / Day'],Oral, 
14867,2639,Rebif [44],2016-07-05,2019-06-17,5000,mg,['2 / Day'], ,Patient Choice/Convenience
14868,2639,Gilenya,2016-07-26,2021-01-06,500, ,['2 / Day'], ,Patient Choice/Convenience
14869,2639,Rebif [44],2016-02-26,2018-08-04,400,mcg,['/ Day'],Oral,Persisting MRI activity
14870,2639,Alemtuzumab (Campath),2016-07-03,2021-06-22,5000,mg,['/Month'], ,Adverse Event
14871,1377,Methylprednisolone,2016-09-18,, , ,['/Month'],IV, 
14872,410,Betaferon,2016-07-07,2019-04-19,400,mg,['/Month'], ,Adverse Event
14873,410,Rebif [44],2016-05-27,,300,MIU,['2 / Day'], , 
14874,4986,D-cure (Vitamine D),2016-04-19,,300,mg,['/ Day'], , 
14875,4986,D-cure (Vitamine D),2016-01-01,2018-01-17, ,mg,['/Month'], ,Patient Choice/Convenience
14876,338,Tecfidera,2016-09-05,, , ,['/Month'],IV, 
14877,338,Rebif [22],2016-01-17,2018-03-21, ,mg,['2 / Day'],IV,Patient Choice/Convenience
14878,2139,IVIG,2015-12-05,, ,mcg,['/ Day'],IV, 
14879,2139,D-cure (Vitamine D),2016-09-17,2019-10-23, ,mg,['2 / Day'],IV,Adverse Event
14880,2139,D-cure (Vitamine D),2016-01-07,, , ,['2 / Day'],IV, 
14881,2900,Endoxan,2015-11-26,2020-09-27,500, ,['3 / Week'],IV,Persistence of relapses
14882,2900,Gilenya,2015-12-18,,500,mg,['2 / Day'],IV, 
14883,2900,Tecfidera,2016-01-08,,400,mg,['2 / Day'], , 
14884,2900,IVIG,2016-07-23,2019-01-24, ,mg,[' '],IV,Persisting MRI activity
14885,2775,Alemtuzumab (Campath),2015-11-14,,20,MIU,['3 / Week'],IV, 
14886,4817,Methylprednisolone,2016-03-05,,300, ,['3 / Week'], , 
14887,4817,Ledertrexaat,2016-06-06,2018-06-15,500, ,['2 / Day'],IV,Patient Choice/Convenience
14888,4522,D-cure (Vitamine D),2016-08-16,2019-10-01,300, ,['/Month'],IV,Adverse Event
14889,4522,Rebif [22],2016-09-13,, ,MIU,['/Month'],IV, 
14890,4522,IVIG,2016-07-23,2019-06-25, ,mg,['2 / Day'],IV,Lack of efficacy
14891,3788,Betaferon,2016-04-26,2021-04-02,1000,mg,['2 / Day'],IV,Adverse Event
14892,2394,Tecfidera,2016-04-23,2018-08-01,1000, ,[' '], ,Persisting MRI activity
14893,2394,D-cure (Vitamine D),2016-03-09,2021-08-18, ,MIU,['2 / Day'], ,Adverse Event
14894,2394,Betaferon,2016-02-04,2017-10-27,300,MIU,[' '],IV,Lack of efficacy
14895,112,Endoxan,2016-02-24,,500,mg,[' '], , 
14896,4820,D-cure (Vitamine D),2016-05-22,2018-09-03,20, ,['2 / Day'], ,Persistence of relapses
14897,4820,Ledertrexaat,2016-04-26,2019-09-04, , ,['/Month'],Oral,Persisting MRI activity
14898,4820,IVIG,2016-01-25,, , ,[' '],Oral, 
14899,1224,Copaxone,2016-03-18,,1000,mg,['2 / Day'], , 
14900,1224,Tecfidera,2016-08-13,,500,mcg,['3 / Week'],Oral, 
14901,1224,Ledertrexaat,2016-06-04,,1, ,['/ Day'],Oral, 
14902,1224,Tysabri,2015-11-23,2019-01-03, ,mg,['3 / Week'],IV,Adverse Event
14903,3593,Endoxan,2016-08-15,2020-11-06,300, ,['2 / Day'],IV,Adverse Event
14904,3593,Tecfidera,2016-08-30,,1,MIU,['/Month'],IV, 
14905,2514,IVIG,2015-11-18,2021-03-23,1000, ,['/Month'],Oral,Patient Choice/Convenience
14906,2514,D-cure (Vitamine D),2016-10-08,,400,mg,['/Month'], , 
14907,2514,Tysabri,2016-09-24,,1,mg,['/Month'],IV, 
14908,4776,Alemtuzumab (Campath),2016-09-06,,1, ,['/ Day'],Oral, 
14909,4776,Gilenya,2016-04-16,2020-02-17,5000, ,['/Month'], ,Adverse Event
14910,4776,Rebif [22],2016-09-20,,5000, ,['/Month'],IV, 
14911,4776,Betaferon,2016-05-18,,300,mg,['3 / Week'],IV, 
14912,2438,Gilenya,2016-05-03,2021-02-01,5000,mg,['3 / Week'],IV,Lack of efficacy
14913,2438,Alemtuzumab (Campath),2016-07-14,,300, ,[' '],IV, 
14914,2438,Rebif [22],2016-10-17,,500, ,['/Month'], , 
14915,2077,IVIG,2016-04-04,, , ,['/Month'], , 
14916,2077,Copaxone,2016-01-26,,20,mg,['/Month'],IV, 
14917,3840,IVIG,2016-07-22,,400, ,['2 / Day'],Oral, 
14918,3840,IVIG,2016-10-13,,20,mg,['2 / Day'],IV, 
14919,3840,Rebif [44],2015-10-27,2020-08-06,1,mg,['3 / Week'],IV,Patient Choice/Convenience
14920,3840,Methylprednisolone,2016-03-02,,400,MIU,['/Month'],IV, 
14921,1528,Rebif [22],2015-12-08,,20,mg,['/Month'], , 
14922,1528,Tecfidera,2016-10-16,,5000,mg,['/Month'], , 
14923,1528,Betaferon,2016-03-13,2019-08-01, , ,['/Month'], ,Lack of efficacy
14924,4741,Mitoxantrone,2016-09-23,2021-09-08,300,mg,['/ Day'], ,Persisting MRI activity
14925,4741,Betaferon,2016-06-09,2017-11-22,500, ,['2 / Day'],IV,Lack of efficacy
14926,4380,Teriflunomide,2016-06-24,, , ,[' '],IV, 
14927,4380,Ledertrexaat,2016-07-17,2020-11-22,1,mg,['2 / Day'],Oral,Patient Choice/Convenience
14928,4380,Gilenya,2016-06-06,2021-02-05, ,mg,['3 / Week'],IV,Persistence of relapses
14929,4380,D-cure (Vitamine D),2016-03-04,2020-11-23,1, ,['2 / Day'], ,Patient Choice/Convenience
14930,406,Rebif [44],2016-04-20,,500,mcg,['/Month'],IV, 
14931,406,Endoxan,2016-10-22,2021-09-05, ,MIU,['3 / Week'],IV,Patient Choice/Convenience
14932,406,Endoxan,2016-04-16,2017-12-26,20,mg,['2 / Day'], ,Lack of efficacy
14933,406,Copaxone,2015-11-27,,1,MIU,['/Month'], , 
14934,1662,IVIG,2016-06-08,,400, ,['/Month'],IV, 
14935,1662,Avonex,2015-11-17,, ,mg,['2 / Day'],IV, 
14936,1662,Betaferon,2016-08-21,2019-04-03,1000,mg,['/Month'],IV,Lack of efficacy
14937,3637,Gilenya,2016-08-18,,1,MIU,['2 / Day'],IV, 
14938,1776,Betaferon,2016-06-10,2019-07-28, , ,['/ Day'], ,Adverse Event
14939,1776,IVIG,2016-01-23,,400, ,['/ Day'],IV, 
14940,1776,Betaferon,2016-05-13,2019-10-27,300,mg,['/Month'],Oral,Lack of efficacy
14941,4901,IVIG,2016-09-29,2020-03-28, ,mg,['2 / Day'], ,Adverse Event
14942,4901,Betaferon,2015-12-04,2019-07-27,1000, ,[' '], ,Adverse Event
14943,4901,Tecfidera,2016-07-21,,5000,mg,['3 / Week'],IV, 
14944,4901,IVIG,2016-09-30,,300,mg,['/ Day'],IV, 
14945,1035,IVIG,2016-04-13,,300,MIU,['2 / Day'], , 
14946,1035,Rebif [44],2016-01-22,,1000,mg,['2 / Day'],IV, 
14947,1035,Rebif [44],2016-06-20,2020-12-13,1000,mcg,['/Month'],Oral,Adverse Event
14948,1250,Methylprednisolone,2015-12-29,,5000, ,['/Month'],IV, 
14949,4140,Copaxone,2016-02-28,2018-02-04, , ,['2 / Day'],IV,Lack of efficacy
14950,4140,Methylprednisolone,2016-08-31,, , ,[' '], , 
14951,970,Copaxone,2015-12-06,2020-05-01,500,MIU,['2 / Day'],IV,Persisting MRI activity
14952,970,Rebif [22],2016-02-23,2020-08-01,20,mg,['3 / Week'],IV,Adverse Event
14953,4063,Tysabri,2016-08-30,2021-07-22,400,MIU,['2 / Day'],Oral,Lack of efficacy
14954,4487,Methylprednisolone,2015-11-01,2018-10-13,20, ,['/ Day'], ,Persisting MRI activity
14955,4307,Tecfidera,2016-06-23,2020-01-25,400,mg,['2 / Day'], ,Patient Choice/Convenience
14956,588,Rebif [22],2016-03-03,2019-09-26, , ,['2 / Day'],IV,Adverse Event
14957,588,Tysabri,2016-06-03,,500, ,['/ Day'],IV, 
14958,588,Alemtuzumab (Campath),2015-11-05,,1,MIU,['2 / Day'], , 
14959,2438,Endoxan,2016-07-04,,1,MIU,['3 / Week'],IV, 
14960,2438,Methylprednisolone,2016-09-14,,1000,mg,['2 / Day'], , 
14961,2438,Betaferon,2016-07-19,2021-04-19, ,mg,['2 / Day'], ,Lack of efficacy
14962,2438,Tecfidera,2016-04-07,2020-07-22, ,mcg,['/ Week'],IV,Persistence of relapses
14963,4925,Rebif [44],2016-08-19,,5000,MIU,['/Month'],IV, 
14964,4925,Betaferon,2016-08-16,, ,mg,['/Month'],IV, 
14965,519,Tecfidera,2016-04-30,,400, ,['/ Week'],IV, 
14966,519,Alemtuzumab (Campath),2015-12-15,2019-08-21,500,mg,[' '], ,Persistence of relapses
14967,3547,Endoxan,2016-01-20,2019-11-11,300, ,['3 / Week'],IV,Adverse Event
14968,3547,Copaxone,2016-04-30,,400,MIU,['/Month'],Oral, 
14969,4442,Teriflunomide,2016-02-10,, ,mg,['/ Day'],IV, 
14970,4442,Avonex,2016-09-22,,1000,mg,['3 / Week'], , 
14971,4442,Gilenya,2016-09-11,,5000,mcg,[' '],IV, 
14972,4960,Methylprednisolone,2016-01-01,,20,mg,['2 / Day'],Oral, 
14973,4960,Teriflunomide,2016-10-08,, , ,['3 / Week'], , 
14974,4960,Ledertrexaat,2016-09-03,2019-05-10,500,MIU,['/ Day'],Oral,Persisting MRI activity
14975,4960,Rebif [44],2016-02-21,2020-12-12,500,MIU,['/Month'], ,Adverse Event
14976,2483,IVIG,2015-10-30,,400, ,['/ Day'],IV, 
14977,2483,Tecfidera,2015-11-25,2020-09-09,500,MIU,[' '],IV,Patient Choice/Convenience
14978,3389,Rebif [44],2015-11-11,,5000,mg,['/ Week'],IV, 
14979,3389,D-cure (Vitamine D),2016-04-09,,300,MIU,['/Month'], , 
14980,3389,Mitoxantrone,2015-11-15,,1,mg,['/Month'],IV, 
14981,2654,Copaxone,2016-05-14,,1000,MIU,['3 / Week'], , 
14982,3792,Tecfidera,2016-05-15,2021-03-09, ,MIU,['2 / Day'],Oral,Persisting MRI activity
14983,3792,Ledertrexaat,2016-09-20,2019-02-28,300,mg,['/ Day'],IV,Patient Choice/Convenience
14984,1144,Endoxan,2016-02-29,2020-09-06, , ,[' '], ,Lack of efficacy
14985,4326,Teriflunomide,2016-03-07,,5000, ,[' '],IV, 
14986,4983,Avonex,2016-09-30,, ,mg,['2 / Day'],IV, 
14987,4983,IVIG,2016-05-31,,5000,MIU,['2 / Day'],Oral, 
14988,4983,Methylprednisolone,2016-06-19,,300,mg,['3 / Week'], , 
14989,1081,Alemtuzumab (Campath),2016-03-07,,300,MIU,['2 / Day'], , 
14990,1081,D-cure (Vitamine D),2016-03-26,2021-09-19, ,mg,['/Month'], ,Adverse Event
14991,2119,Methylprednisolone,2016-03-07,,1, ,['/Month'],Oral, 
14992,2119,Copaxone,2015-11-18,, ,mg,['3 / Week'],IV, 
14993,2119,Methylprednisolone,2016-02-01,2018-10-02, , ,['/Month'],Oral,Patient Choice/Convenience
14994,2610,Gilenya,2016-05-14,2021-06-18, , ,['2 / Day'], ,Adverse Event
14995,2610,Endoxan,2016-04-29,,500, ,['3 / Week'],IV, 
14996,2610,Tecfidera,2016-03-17,, , ,['2 / Day'],IV, 
14997,1471,Tysabri,2016-01-22,2018-04-07,300,mg,['3 / Week'],IV,Persistence of relapses
14998,123,Avonex,2016-09-18,,1,mg,['/Month'],IV, 
14999,123,Betaferon,2016-10-10,,1,mg,['2 / Day'],Oral, 
15000,123,Ledertrexaat,2016-07-31,2019-05-19,20,mcg,['2 / Day'],IV,Lack of efficacy
15001,1200,D-cure (Vitamine D),2016-08-30,,400, ,['/ Day'], , 
15002,1200,Endoxan,2016-10-20,,5000,MIU,['3 / Week'],IV, 
15003,1200,D-cure (Vitamine D),2016-07-28,,1,mg,['3 / Week'],Oral, 
15004,1200,Alemtuzumab (Campath),2015-11-20,, ,mg,['3 / Week'], , 
15005,3343,D-cure (Vitamine D),2016-08-23,2019-06-09,1000,mg,['/Month'],IV,Adverse Event
15006,3343,Tysabri,2016-03-08,2019-01-13, , ,['2 / Day'],IV,Patient Choice/Convenience
15007,151,Copaxone,2016-10-10,2020-07-19,500,mg,['/ Week'],IV,Adverse Event
15008,151,D-cure (Vitamine D),2016-02-08,,1000, ,['/Month'],IV, 
15009,540,Alemtuzumab (Campath),2016-03-04,,300, ,['2 / Day'],IV, 
15010,1875,Gilenya,2016-05-20,,5000,MIU,[' '], , 
15011,786,Tecfidera,2016-05-01,,300,mcg,['/Month'], , 
15012,1812,Alemtuzumab (Campath),2015-12-14,, ,mg,['/Month'],IV, 
15013,1812,Teriflunomide,2016-04-10,2019-05-23,1000, ,['2 / Day'], ,Persistence of relapses
15014,1812,Avonex,2015-12-31,,500,MIU,['/Month'],IV, 
15015,2841,Methylprednisolone,2016-10-14,,300,mg,['2 / Day'], , 
15016,2841,Tecfidera,2016-07-12,2018-07-17,500, ,['2 / Day'], ,Adverse Event
15017,2841,Endoxan,2016-06-22,2020-06-13,400, ,['2 / Day'],IV,Lack of efficacy
15018,2841,Gilenya,2015-12-11,,20,mcg,['/ Day'], , 
15019,700,Rebif [22],2016-05-09,,5000, ,['3 / Week'], , 
15020,3047,D-cure (Vitamine D),2015-12-10,2021-07-22, ,mg,['2 / Day'], ,Persisting MRI activity
15021,3047,Rebif [44],2015-11-08,2020-01-04,1,mg,['/ Week'],IV,Persistence of relapses
15022,3047,Methylprednisolone,2016-02-02,,1000, ,['/ Day'],Oral, 
15023,1354,Mitoxantrone,2016-08-17,,5000,mg,['/Month'],Oral, 
15024,3794,IVIG,2015-12-10,2017-11-25, , ,['2 / Day'],IV,Adverse Event
15025,2030,Copaxone,2016-10-02,2019-02-28,500,MIU,['3 / Week'],IV,Lack of efficacy
15026,2356,Rebif [44],2016-03-23,,1,mg,['2 / Day'],IV, 
15027,4646,D-cure (Vitamine D),2016-08-15,, ,mg,['/Month'],Oral, 
15028,4646,Tecfidera,2016-01-31,, ,MIU,[' '],IV, 
15029,762,Endoxan,2016-06-18,,500, ,['2 / Day'],Oral, 
15030,762,Copaxone,2016-09-23,,1,mg,['2 / Day'],IV, 
15031,762,IVIG,2015-12-03,, ,mcg,['/Month'], , 
15032,4111,Alemtuzumab (Campath),2016-04-22,,400, ,['3 / Week'],IV, 
15033,4111,Betaferon,2016-02-12,,5000,mg,['/ Week'],IV, 
15034,4111,Rebif [22],2016-05-30,, , ,['/Month'],IV, 
15035,3034,IVIG,2016-02-28,, , ,['/Month'],IV, 
15036,469,Gilenya,2016-09-26,2019-03-29, , ,['3 / Week'], ,Patient Choice/Convenience
15037,469,Avonex,2016-06-27,,400, ,['/Month'],IV, 
15038,469,Alemtuzumab (Campath),2016-03-23,,300,mg,[' '], , 
15039,469,Gilenya,2015-11-02,2020-08-13, ,mg,['/ Day'],IV,Patient Choice/Convenience
15040,304,Endoxan,2016-02-06,,1, ,['/ Day'],IV, 
15041,304,Alemtuzumab (Campath),2016-02-18,,5000,mg,['/Month'],Oral, 
15042,304,Rebif [44],2016-07-26,,500,mg,['/ Day'], , 
15043,304,D-cure (Vitamine D),2016-06-16,2020-07-23, ,mg,[' '], ,Patient Choice/Convenience
15044,955,Rebif [22],2016-10-02,2019-11-17,300, ,['3 / Week'],IV,Adverse Event
15045,955,Ledertrexaat,2016-01-28,2020-06-12,1000,mg,['3 / Week'],Oral,Lack of efficacy
15046,4491,Gilenya,2015-12-06,, ,mg,['/Month'], , 
15047,4491,Rebif [22],2016-01-24,,400, ,[' '],IV, 
15048,4491,D-cure (Vitamine D),2015-12-20,2019-11-08,300,mg,[' '],IV,Adverse Event
15049,987,Ledertrexaat,2016-01-14,,5000,mg,['3 / Week'], , 
15050,593,Methylprednisolone,2016-05-09,2018-10-10,500, ,['/Month'],IV,Adverse Event
15051,593,Rebif [22],2016-01-15,2021-08-13,20, ,['/Month'],IV,Adverse Event
15052,3561,Copaxone,2016-04-07,, ,MIU,[' '],IV, 
15053,3561,Methylprednisolone,2016-05-31,2018-01-13,1000,MIU,['3 / Week'], ,Persisting MRI activity
15054,3561,Gilenya,2015-11-09,,1000,mg,['2 / Day'],IV, 
15055,436,D-cure (Vitamine D),2016-09-24,2019-06-08,5000, ,['2 / Day'], ,Patient Choice/Convenience
15056,3399,Methylprednisolone,2016-09-16,2020-08-15,20,mcg,['/ Day'],Oral,Persisting MRI activity
15057,3399,Endoxan,2016-03-02,, , ,['/Month'],Oral, 
15058,1498,Tecfidera,2016-04-12,, ,mg,['/Month'], , 
15059,1498,IVIG,2016-04-25,, ,mg,['2 / Day'],IV, 
15060,2540,Gilenya,2015-10-28,2018-08-02, ,mg,['2 / Day'],IV,Persisting MRI activity
15061,2540,IVIG,2016-01-25,,20, ,[' '],IV, 
15062,2967,Rebif [22],2016-02-11,,1,MIU,['3 / Week'],IV, 
15063,2967,Mitoxantrone,2016-05-30,2018-06-14, , ,['/ Day'], ,Persistence of relapses
15064,1876,Gilenya,2016-06-21,2020-06-08,500,mg,['/Month'], ,Lack of efficacy
15065,313,Alemtuzumab (Campath),2016-04-19,2021-07-30,500, ,['/Month'],IV,Adverse Event
15066,313,Tecfidera,2016-01-16,,500,mcg,['2 / Day'], , 
15067,2687,Tecfidera,2016-09-02,2018-03-01,500,MIU,['/Month'],Oral,Patient Choice/Convenience
15068,869,Avonex,2016-06-20,,400,MIU,['/Month'],Oral, 
15069,869,D-cure (Vitamine D),2016-06-24,,1,MIU,['/Month'],IV, 
15070,869,Tecfidera,2016-06-03,2020-02-26, ,mg,['2 / Day'],IV,Persisting MRI activity
15071,869,D-cure (Vitamine D),2016-02-15,,1,MIU,['3 / Week'],IV, 
15072,2305,Mitoxantrone,2015-12-15,2020-10-03,300, ,['3 / Week'],IV,Patient Choice/Convenience
15073,2305,Endoxan,2016-03-05,,500,mg,['/ Day'],IV, 
15074,2305,Endoxan,2016-06-13,,1,mg,['/Month'], , 
15075,2305,D-cure (Vitamine D),2016-02-07,2020-03-06,20, ,['3 / Week'], ,Adverse Event
15076,4209,Ledertrexaat,2016-04-24,,1,mg,['2 / Day'],Oral, 
15077,3450,Methylprednisolone,2016-01-23,,400,mg,[' '],IV, 
15078,3450,Rebif [44],2016-04-26,2020-09-13,5000,mg,[' '],IV,Lack of efficacy
15079,3450,Copaxone,2016-04-04,,1,mg,['/Month'], , 
15080,3450,Rebif [22],2016-05-08,2020-10-03, , ,['2 / Day'],IV,Persistence of relapses
15081,449,IVIG,2016-04-15,, ,MIU,['2 / Day'],IV, 
15082,198,Mitoxantrone,2016-08-16,2020-03-14,20,mg,['/Month'],IV,Persisting MRI activity
15083,198,D-cure (Vitamine D),2016-02-15,, ,mg,['/ Day'],IV, 
15084,198,Gilenya,2015-12-03,,5000, ,['/ Day'],IV, 
15085,2700,Tecfidera,2016-01-25,2021-06-26,500, ,[' '],IV,Lack of efficacy
15086,2700,Tecfidera,2016-06-09,2019-02-20,1000, ,[' '], ,Persistence of relapses
15087,2700,Tysabri,2016-01-05,,300,mg,['3 / Week'],IV, 
15088,1503,Tecfidera,2016-04-30,, , ,['/ Day'],Oral, 
15089,1172,Methylprednisolone,2016-06-05,,500, ,['/ Day'], , 
15090,1172,Gilenya,2015-12-29,, ,mg,['/Month'],IV, 
15091,1172,Copaxone,2016-05-24,,20,mg,['3 / Week'],IV, 
15092,2038,Mitoxantrone,2016-07-16,, , ,['/Month'],IV, 
15093,2038,IVIG,2016-03-16,,1000,mg,['/Month'],IV, 
15094,524,Endoxan,2016-07-09,,500,mg,['/Month'],IV, 
15095,524,Copaxone,2016-01-18,, ,mg,['2 / Day'],Oral, 
15096,524,Rebif [22],2016-09-16,2018-01-17, , ,['3 / Week'], ,Adverse Event
15097,524,Tecfidera,2016-10-11,2021-08-12,300,mg,['/Month'], ,Lack of efficacy
15098,4709,Tecfidera,2016-08-23,2021-04-05,300, ,['/Month'], ,Persisting MRI activity
15099,4709,Methylprednisolone,2015-11-14,2021-07-25, ,mg,['3 / Week'],IV,Patient Choice/Convenience
15100,4915,Tecfidera,2016-04-10,2019-09-10,20,mg,['3 / Week'],IV,Adverse Event
15101,4915,Tecfidera,2016-09-18,2019-04-26, ,mcg,['2 / Day'],IV,Adverse Event
15102,4915,Avonex,2016-08-11,,300, ,['2 / Day'],IV, 
15103,4915,Endoxan,2016-01-24,2019-01-30, ,mg,['/ Day'], ,Adverse Event
15104,4392,D-cure (Vitamine D),2016-06-13,, , ,['2 / Day'],IV, 
15105,4392,IVIG,2016-09-06,,1, ,['2 / Day'], , 
15106,4392,D-cure (Vitamine D),2016-05-30,,500,mg,['2 / Day'],IV, 
15107,4392,Alemtuzumab (Campath),2016-07-16,,300,mg,[' '],IV, 
15108,3349,IVIG,2016-06-04,,20,MIU,['3 / Week'],IV, 
15109,3349,Copaxone,2015-10-24,, ,mg,['2 / Day'],IV, 
15110,3349,IVIG,2016-05-24,2019-08-26,1,mg,['3 / Week'], ,Adverse Event
15111,3349,IVIG,2016-02-12,, ,mcg,['3 / Week'], , 
15112,2880,Tecfidera,2015-10-30,2019-11-13,20, ,[' '], ,Adverse Event
15113,2880,Teriflunomide,2016-05-21,,500, ,['2 / Day'],IV, 
15114,2880,IVIG,2015-11-04,2021-04-28, , ,[' '], ,Lack of efficacy
15115,2822,Avonex,2016-09-12,2019-08-28,300,MIU,['2 / Day'],IV,Patient Choice/Convenience
15116,2822,Gilenya,2015-12-28,2018-10-23, , ,['3 / Week'],IV,Persistence of relapses
15117,1342,Rebif [44],2016-03-19,2018-01-04,500,MIU,['/Month'],IV,Patient Choice/Convenience
15118,1342,Alemtuzumab (Campath),2016-01-19,2019-08-18,300,mg,['2 / Day'],Oral,Persistence of relapses
15119,712,Alemtuzumab (Campath),2016-02-29,, , ,['/ Day'],IV, 
15120,712,Rebif [22],2015-11-25,2018-06-28,1000,mg,['/Month'],IV,Adverse Event
15121,712,Teriflunomide,2016-08-19,2021-09-07, ,mg,['/Month'],IV,Adverse Event
15122,3294,Tecfidera,2016-10-21,,500,mcg,['2 / Day'],IV, 
15123,3294,D-cure (Vitamine D),2016-09-05,,5000,MIU,['/Month'],Oral, 
15124,3294,Tysabri,2016-01-01,2020-06-19,300,mcg,[' '], ,Adverse Event
15125,2289,Alemtuzumab (Campath),2015-11-02,,1000,mg,['3 / Week'], , 
15126,4124,Rebif [44],2016-02-10,2019-06-20, ,mg,['3 / Week'], ,Patient Choice/Convenience
15127,4124,Rebif [22],2016-02-10,2020-01-03,5000,mcg,[' '],IV,Adverse Event
15128,4124,Tecfidera,2015-11-30,,400,MIU,['/ Day'],IV, 
15129,3763,D-cure (Vitamine D),2016-03-26,2021-06-06,20, ,['/Month'], ,Lack of efficacy
15130,1513,Alemtuzumab (Campath),2016-01-21,, , ,['/ Day'],IV, 
15131,1513,Avonex,2016-09-04,,1000,mg,['3 / Week'], , 
15132,1513,Ledertrexaat,2015-10-28,2020-04-05,1000,MIU,['2 / Day'], ,Lack of efficacy
15133,1513,Betaferon,2016-03-30,, ,mcg,['3 / Week'], , 
15134,283,Teriflunomide,2016-09-04,2018-03-05, ,mg,['2 / Day'],IV,Persistence of relapses
15135,2748,Ledertrexaat,2015-11-19,,20, ,['2 / Day'],IV, 
15136,3759,Tecfidera,2016-07-06,,1000,mcg,[' '],IV, 
15137,3759,Rebif [22],2016-05-20,2020-09-06, ,mg,['/Month'], ,Lack of efficacy
15138,3759,Gilenya,2016-06-25,,500,mg,[' '],Oral, 
15139,3759,Teriflunomide,2016-02-03,2021-05-05,20,mg,['/Month'],Oral,Persistence of relapses
15140,4724,Copaxone,2016-05-24,2021-01-24,1, ,['/ Day'],Oral,Adverse Event
15141,4724,Gilenya,2016-07-28,,300,MIU,['2 / Day'], , 
15142,4724,Gilenya,2016-08-28,,500,MIU,[' '],IV, 
15143,4724,Gilenya,2016-09-18,,400,mg,['/ Week'],IV, 
15144,3908,Rebif [44],2016-08-06,,1000, ,['/Month'], , 
15145,3908,Tysabri,2016-04-12,2017-12-12,5000,mg,['2 / Day'],Oral,Persistence of relapses
15146,3205,Copaxone,2016-10-11,,400, ,['3 / Week'], , 
15147,3609,Gilenya,2016-07-20,,300,mg,['2 / Day'], , 
15148,1454,Endoxan,2016-03-10,,300,mg,['/Month'],IV, 
15149,1454,D-cure (Vitamine D),2016-07-18,,300,mg,['/ Day'],Oral, 
15150,1454,IVIG,2016-09-08,2019-03-17, ,mg,[' '],Oral,Adverse Event
15151,1454,Teriflunomide,2016-07-19,2020-03-26,20,mg,['/ Day'],IV,Adverse Event
15152,4170,Rebif [22],2015-12-16,,5000, ,[' '], , 
15153,4170,Rebif [22],2016-02-28,, , ,['/ Day'], , 
15154,4170,IVIG,2015-12-22,,300, ,['/Month'],IV, 
15155,1294,Avonex,2015-11-03,2021-02-28,300,mg,[' '], ,Adverse Event
15156,1294,Tysabri,2016-08-17,,300,MIU,['2 / Day'],IV, 
15157,1294,Avonex,2015-12-26,,5000,mg,[' '],IV, 
15158,4504,Gilenya,2016-02-02,,20, ,['2 / Day'], , 
15159,4504,Gilenya,2016-03-02,2018-01-27,500,mg,['2 / Day'],IV,Patient Choice/Convenience
15160,1797,IVIG,2016-03-28,,300,mg,['/Month'],Oral, 
15161,1797,Tysabri,2016-05-18,, ,mg,['3 / Week'],IV, 
15162,1797,Tecfidera,2016-10-10,,1000,MIU,[' '],IV, 
15163,4818,Betaferon,2016-07-08,2017-11-30,5000,MIU,['3 / Week'],IV,Adverse Event
15164,4818,Tecfidera,2016-05-02,2019-09-26,300, ,['/Month'],IV,Lack of efficacy
15165,1395,Rebif [44],2016-06-24,,400,MIU,['2 / Day'],IV, 
15166,2953,Rebif [44],2016-08-08,2018-03-01,300,MIU,['/ Day'],IV,Persisting MRI activity
15167,2953,Rebif [44],2016-09-04,2018-03-29,500,mg,['/Month'],IV,Persisting MRI activity
15168,1832,Teriflunomide,2016-04-06,2020-03-16,1, ,['/ Day'],IV,Adverse Event
15169,2266,Betaferon,2016-07-28,2019-04-22,1000, ,['/ Week'],IV,Lack of efficacy
15170,2266,Tecfidera,2015-11-04,,20, ,['2 / Day'],IV, 
15171,2266,Alemtuzumab (Campath),2015-11-29,2020-08-02,500,mcg,['2 / Day'], ,Patient Choice/Convenience
15172,2266,Copaxone,2015-12-10,,500, ,['/ Day'],IV, 
15173,4541,Methylprednisolone,2016-04-27,,500,mg,['2 / Day'], , 
15174,4541,Tysabri,2016-07-03,2019-02-17,5000,mg,['/Month'], ,Persistence of relapses
15175,4541,IVIG,2016-03-20,,500, ,['/ Day'],IV, 
15176,2504,D-cure (Vitamine D),2015-11-25,, ,mg,['/Month'], , 
15177,2504,Methylprednisolone,2016-10-16,,500, ,['/Month'], , 
15178,355,Rebif [44],2016-10-03,,20,mg,['/ Week'],IV, 
15179,1782,Tysabri,2016-06-01,2019-01-21,20,MIU,['2 / Day'], ,Adverse Event
15180,1782,Tysabri,2015-11-03,2021-04-15,500,mg,['2 / Day'],Oral,Adverse Event
15181,1782,Rebif [44],2016-08-07,2019-05-06,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
15182,1782,Mitoxantrone,2016-05-13,,300,mg,[' '],Oral, 
15183,241,Rebif [44],2015-10-31,,400,MIU,['2 / Day'],Oral, 
15184,2732,IVIG,2016-05-07,,1, ,['/Month'], , 
15185,2732,Teriflunomide,2016-06-19,, ,mg,['/ Week'],Oral, 
15186,2732,Tysabri,2015-11-18,2019-12-06,500,mg,['/ Day'],Oral,Persisting MRI activity
15187,2464,Tecfidera,2016-05-14,2020-10-24,500, ,['/Month'],Oral,Patient Choice/Convenience
15188,2464,Endoxan,2016-01-22,, , ,['/Month'],Oral, 
15189,4886,Copaxone,2015-12-16,2021-09-11, ,mg,['/Month'], ,Patient Choice/Convenience
15190,4886,Methylprednisolone,2016-06-27,,1000, ,['/ Week'], , 
15191,874,Alemtuzumab (Campath),2016-08-14,2019-12-08,1,mg,[' '], ,Persistence of relapses
15192,874,Tysabri,2016-10-10,,500,mg,['/Month'],IV, 
15193,874,D-cure (Vitamine D),2016-07-22,, ,mg,[' '], , 
15194,874,Rebif [44],2016-08-28,, ,MIU,['3 / Week'], , 
15195,2209,IVIG,2015-12-03,,20,mg,['/Month'],IV, 
15196,2465,Tecfidera,2015-12-07,, ,MIU,['2 / Day'],IV, 
15197,2465,Mitoxantrone,2016-06-13,, ,mcg,['/ Week'], , 
15198,2465,Avonex,2015-11-11,2019-06-12, , ,['3 / Week'], ,Adverse Event
15199,2465,Methylprednisolone,2016-06-28,, ,MIU,['/Month'], , 
15200,4371,Tecfidera,2016-07-21,2020-05-06,300, ,[' '],IV,Patient Choice/Convenience
15201,4371,Methylprednisolone,2016-08-25,2019-06-16,5000, ,['/Month'],Oral,Patient Choice/Convenience
15202,4371,Avonex,2016-03-02,2018-07-12,500,mcg,['/Month'],IV,Persisting MRI activity
15203,373,Rebif [22],2016-10-17,,1000,MIU,['2 / Day'], , 
15204,3877,Rebif [22],2016-05-02,,500, ,['/ Week'], , 
15205,3877,Rebif [44],2016-08-12,,20, ,['/Month'], , 
15206,3877,Rebif [22],2016-05-31,,500, ,['/ Day'],IV, 
15207,3324,Rebif [22],2016-04-23,2019-06-16,20,mcg,['2 / Day'],IV,Adverse Event
15208,3324,Betaferon,2016-01-21,2019-03-01,500,mg,['2 / Day'],IV,Patient Choice/Convenience
15209,3324,IVIG,2015-12-07,,1000,MIU,['2 / Day'], , 
15210,3324,Rebif [44],2016-09-02,,500, ,['2 / Day'], , 
15211,4855,Mitoxantrone,2016-07-16,, ,mg,['/Month'],Oral, 
15212,4855,IVIG,2016-08-21,2019-06-05,1,mg,['3 / Week'],IV,Patient Choice/Convenience
15213,4855,Copaxone,2015-10-29,2021-09-19,1000, ,['/ Day'],IV,Persisting MRI activity
15214,4855,Tecfidera,2016-05-26,, ,MIU,['2 / Day'], , 
15215,4851,Endoxan,2015-11-03,,1,mg,['3 / Week'], , 
15216,2247,Gilenya,2015-11-17,,500, ,['/ Day'], , 
15217,2247,Mitoxantrone,2015-10-31,,400,mg,['/Month'], , 
15218,2247,Rebif [22],2016-01-29,, ,mg,[' '],IV, 
15219,2247,Teriflunomide,2016-04-01,2018-01-24,5000, ,['2 / Day'],Oral,Adverse Event
15220,778,Copaxone,2016-02-02,, , ,['2 / Day'],Oral, 
15221,778,Rebif [44],2016-08-20,,1,mg,['/Month'], , 
15222,778,Mitoxantrone,2016-04-29,,1,MIU,['2 / Day'],Oral, 
15223,778,Methylprednisolone,2016-01-15,,500, ,['3 / Week'],IV, 
15224,1386,Rebif [22],2016-01-10,,1,MIU,['/Month'],IV, 
15225,1386,Copaxone,2016-08-04,2021-10-07,20,mcg,['/ Day'],Oral,Lack of efficacy
15226,1386,D-cure (Vitamine D),2016-02-27,,300, ,['/Month'],Oral, 
15227,1439,Endoxan,2016-07-23,2019-10-10, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
15228,1439,Endoxan,2016-05-24,,1, ,['/ Day'], , 
15229,1439,Tecfidera,2016-04-16,,20, ,['2 / Day'],IV, 
15230,3965,Avonex,2016-01-22,2021-01-29,1000,MIU,['/ Week'],Oral,Lack of efficacy
15231,3965,Tecfidera,2016-09-29,2020-09-06, ,mg,['2 / Day'],IV,Adverse Event
15232,3965,Alemtuzumab (Campath),2015-12-06,,400, ,[' '],IV, 
15233,833,D-cure (Vitamine D),2015-12-15,2018-01-19,500,mg,[' '],IV,Patient Choice/Convenience
15234,833,D-cure (Vitamine D),2015-11-02,2018-11-05,20, ,[' '],Oral,Persistence of relapses
15235,833,Gilenya,2015-12-22,, ,mg,['3 / Week'], , 
15236,833,IVIG,2016-03-21,,20, ,['3 / Week'],Oral, 
15237,4818,Endoxan,2016-10-20,2017-11-25,1000,mg,['/Month'], ,Persisting MRI activity
15238,4818,IVIG,2015-12-04,,5000,mg,['/Month'],IV, 
15239,4818,Methylprednisolone,2016-06-12,,500, ,['3 / Week'],IV, 
15240,4818,Rebif [22],2016-03-05,2021-10-21, ,mg,['2 / Day'], ,Persisting MRI activity
15241,178,Tysabri,2016-05-05,,5000,mg,['2 / Day'],Oral, 
15242,178,D-cure (Vitamine D),2015-11-23,,20,mg,['/Month'],IV, 
15243,178,Gilenya,2016-09-19,,1000, ,['2 / Day'],Oral, 
15244,178,D-cure (Vitamine D),2016-08-31,, ,MIU,['/ Day'],Oral, 
15245,2029,IVIG,2016-02-21,2021-10-16, ,mg,['/ Day'],IV,Persisting MRI activity
15246,2029,Endoxan,2016-08-15,, , ,['2 / Day'],IV, 
15247,2029,Copaxone,2016-01-15,,300,mg,['/Month'], , 
15248,2376,Rebif [22],2016-09-24,,1000,mg,['/ Day'],IV, 
15249,2376,IVIG,2016-03-16,2018-07-10, , ,['3 / Week'],IV,Lack of efficacy
15250,2205,IVIG,2016-06-05,,1000,MIU,['/Month'], , 
15251,2205,Betaferon,2016-10-08,,1000,mg,['/Month'],IV, 
15252,2205,Tecfidera,2016-07-30,,400,mg,['/ Day'],IV, 
15253,2205,IVIG,2016-08-17,,1,mg,[' '],IV, 
15254,4279,Rebif [22],2016-09-13,,400,mg,['2 / Day'], , 
15255,2700,Tysabri,2016-05-01,2021-10-02,300, ,['/ Day'],Oral,Adverse Event
15256,2700,Tecfidera,2016-08-19,2019-01-15,300,mg,['2 / Day'],IV,Lack of efficacy
15257,2865,Betaferon,2016-10-13,,1000,mg,['2 / Day'],Oral, 
15258,3848,Mitoxantrone,2016-04-18,, , ,['3 / Week'], , 
15259,3848,Tecfidera,2016-09-17,,1,MIU,[' '],IV, 
15260,3848,IVIG,2016-09-19,,1000,MIU,['/ Day'],Oral, 
15261,3848,Rebif [22],2016-04-22,, ,mg,['3 / Week'],IV, 
15262,2015,Tecfidera,2016-08-26,,300,MIU,['2 / Day'],IV, 
15263,2015,Teriflunomide,2016-10-11,2018-03-25,20,mg,['/ Day'],IV,Persistence of relapses
15264,2382,IVIG,2016-10-08,2020-09-01,500,MIU,[' '],IV,Adverse Event
15265,2382,Gilenya,2016-09-15,,1000, ,['2 / Day'],Oral, 
15266,2382,Betaferon,2016-03-26,,400, ,['/Month'],IV, 
15267,519,Methylprednisolone,2016-04-08,2021-09-24,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
15268,519,Teriflunomide,2016-09-05,2019-02-18,20,mcg,['2 / Day'], ,Lack of efficacy
15269,519,Teriflunomide,2016-08-27,2020-11-16,400, ,['/Month'], ,Adverse Event
15270,3304,Copaxone,2016-07-30,,20,mg,['/Month'], , 
15271,3304,Methylprednisolone,2016-05-14,2018-08-15, ,mcg,['3 / Week'], ,Persisting MRI activity
15272,3326,D-cure (Vitamine D),2016-04-19,2019-09-03,20,mg,['3 / Week'], ,Persisting MRI activity
15273,3326,Tecfidera,2016-05-03,,300,MIU,['2 / Day'], , 
15274,3326,Avonex,2015-12-22,2018-11-18,1,mcg,['3 / Week'], ,Adverse Event
15275,3326,IVIG,2016-08-10,,5000,mg,['3 / Week'],Oral, 
15276,2670,Tysabri,2016-03-17,,500,mg,[' '], , 
15277,2670,Rebif [22],2015-12-17,2019-08-01,5000,mg,['/Month'],Oral,Adverse Event
15278,2670,Avonex,2016-03-19,2019-10-23,20, ,['2 / Day'], ,Adverse Event
15279,700,Gilenya,2016-03-11,,1, ,['/Month'], , 
15280,700,Avonex,2016-08-23,2017-11-26,20, ,[' '],IV,Persisting MRI activity
15281,700,IVIG,2016-01-03,,5000,MIU,['/Month'], , 
15282,700,Copaxone,2016-09-27,,1000, ,['2 / Day'],IV, 
15283,2177,Methylprednisolone,2016-07-05,2020-12-27,500,mg,['2 / Day'],IV,Adverse Event
15284,2177,Rebif [22],2015-11-28,,5000,mg,['/Month'],IV, 
15285,2177,D-cure (Vitamine D),2016-04-08,2018-05-06,1,mg,['/ Day'],IV,Patient Choice/Convenience
15286,2011,IVIG,2016-02-23,,1000,mg,['3 / Week'],IV, 
15287,564,Avonex,2016-05-27,, , ,['/Month'],IV, 
15288,564,Avonex,2016-10-02,,1000,MIU,['/Month'], , 
15289,564,IVIG,2016-08-27,2020-12-30, ,mg,['2 / Day'], ,Adverse Event
15290,2637,D-cure (Vitamine D),2016-06-30,,20,mg,['3 / Week'],IV, 
15291,2637,Betaferon,2016-04-15,2020-01-01,5000, ,['/Month'], ,Adverse Event
15292,2637,Gilenya,2016-03-18,,5000, ,['3 / Week'],Oral, 
15293,2637,Methylprednisolone,2016-01-09,2019-11-29,20,mcg,['/Month'],IV,Persistence of relapses
15294,3095,IVIG,2016-08-28,2018-09-11,500,MIU,['/Month'],Oral,Adverse Event
15295,3095,Tecfidera,2016-08-31,,500,mg,['2 / Day'], , 
15296,3287,Betaferon,2015-11-05,,500,mg,['/Month'],Oral, 
15297,3287,Teriflunomide,2016-04-15,,1,MIU,['2 / Day'], , 
15298,376,Tysabri,2016-03-09,,400,mg,[' '], , 
15299,376,Ledertrexaat,2016-09-27,,300, ,['/Month'],IV, 
15300,376,Ledertrexaat,2016-01-19,,500, ,['/Month'], , 
15301,4457,Gilenya,2016-02-12,,1000, ,['2 / Day'],Oral, 
15302,4457,Tecfidera,2015-12-03,,20,MIU,['/ Day'], , 
15303,2232,Rebif [22],2016-03-08,,5000, ,['2 / Day'],IV, 
15304,2232,Endoxan,2015-12-12,,20,mcg,[' '],Oral, 
15305,2232,Rebif [44],2016-03-12,2019-05-05,1, ,['/Month'],IV,Adverse Event
15306,2232,Methylprednisolone,2016-07-15,2021-03-18, ,mg,['2 / Day'],IV,Persisting MRI activity
15307,2607,Teriflunomide,2016-05-03,2019-01-20,500, ,['/Month'], ,Persisting MRI activity
15308,2607,Endoxan,2016-09-26,,300,mg,['2 / Day'],IV, 
15309,2607,IVIG,2015-10-27,, ,mg,['/Month'], , 
15310,2607,Tysabri,2016-08-21,2017-10-29,5000,MIU,['/Month'],Oral,Patient Choice/Convenience
15311,2501,Rebif [22],2016-03-14,, ,mg,['2 / Day'], , 
15312,2501,Methylprednisolone,2016-04-17,, ,mcg,['/Month'],Oral, 
15313,2501,Avonex,2016-01-09,2019-03-28,300,MIU,['/Month'],IV,Adverse Event
15314,2501,IVIG,2015-12-28,,500,MIU,['3 / Week'], , 
15315,833,Tysabri,2016-08-06,,1000,MIU,['2 / Day'], , 
15316,833,Copaxone,2016-03-31,2020-09-28,1000,mcg,['/Month'],IV,Lack of efficacy
15317,833,Tecfidera,2016-09-29,,300, ,['2 / Day'],IV, 
15318,2256,D-cure (Vitamine D),2015-10-28,,1000,mg,['/Month'], , 
15319,2256,Tysabri,2016-06-15,2020-04-20,500,mg,['2 / Day'],IV,Patient Choice/Convenience
15320,2256,Gilenya,2016-05-11,2020-10-11, ,MIU,['3 / Week'],IV,Adverse Event
15321,4843,Methylprednisolone,2016-09-10,, ,mg,['/Month'], , 
15322,4843,Tysabri,2016-03-25,,1,mg,['2 / Day'],IV, 
15323,4843,Teriflunomide,2015-11-14,,300,mg,[' '],IV, 
15324,4843,Rebif [44],2016-07-14,2020-04-30,1000,mcg,[' '],IV,Adverse Event
15325,899,Ledertrexaat,2016-01-22,2017-11-18,300, ,[' '], ,Persisting MRI activity
15326,899,Alemtuzumab (Campath),2016-06-28,2019-12-16,20,mg,['/ Day'],IV,Adverse Event
15327,816,Endoxan,2016-03-21,2020-05-18,5000,mg,['/ Day'], ,Adverse Event
15328,1694,Avonex,2015-11-11,,400,mcg,['/ Week'], , 
15329,1694,IVIG,2016-03-12,2020-04-10,1000, ,['/ Day'],Oral,Lack of efficacy
15330,3607,Gilenya,2016-02-16,, , ,['/ Day'],IV, 
15331,1761,Methylprednisolone,2016-07-01,2020-07-18, ,mg,['3 / Week'], ,Patient Choice/Convenience
15332,1761,Copaxone,2016-04-05,2021-03-29,400,mg,['2 / Day'], ,Persisting MRI activity
15333,1718,Betaferon,2016-07-04,2020-09-17, ,mg,[' '],IV,Persisting MRI activity
15334,1718,Teriflunomide,2016-01-28,2021-01-30,400, ,['/Month'],IV,Persistence of relapses
15335,1718,Gilenya,2015-11-29,, , ,['2 / Day'],IV, 
15336,4299,Avonex,2015-12-24,,5000,mg,['2 / Day'], , 
15337,996,IVIG,2016-09-27,,5000, ,['/ Week'], , 
15338,3790,Rebif [44],2016-08-29,2019-07-24, ,mg,['3 / Week'],IV,Patient Choice/Convenience
15339,3350,Gilenya,2016-02-11,, , ,['/ Day'], , 
15340,3350,D-cure (Vitamine D),2016-09-29,2018-03-09, ,MIU,['/Month'],IV,Adverse Event
15341,2669,Gilenya,2016-07-07,,300,mg,['/ Day'],IV, 
15342,2669,D-cure (Vitamine D),2016-09-03,,20,MIU,[' '], , 
15343,2669,Rebif [22],2015-11-25,2020-11-01,500,mg,['/Month'], ,Patient Choice/Convenience
15344,2669,Tecfidera,2016-07-23,, ,mg,['3 / Week'], , 
15345,4190,Teriflunomide,2016-01-02,,500,mg,['3 / Week'], , 
15346,4190,Mitoxantrone,2016-05-27,, , ,[' '],IV, 
15347,3768,Tecfidera,2016-03-29,, ,MIU,['/ Day'],IV, 
15348,3768,Endoxan,2016-03-11,,1,mg,['/ Week'],Oral, 
15349,3768,D-cure (Vitamine D),2016-03-12,, ,mg,['2 / Day'],Oral, 
15350,4165,Gilenya,2016-04-27,,500,mg,['/Month'],IV, 
15351,4165,Teriflunomide,2016-07-10,,20, ,[' '],IV, 
15352,4596,Rebif [44],2016-03-31,,20, ,['/Month'],Oral, 
15353,1703,Avonex,2016-07-30,,1,mg,['/Month'],IV, 
15354,2493,Rebif [22],2016-09-08,, ,mg,['/ Week'],IV, 
15355,4595,Tysabri,2016-09-26,2020-09-09,20, ,[' '], ,Adverse Event
15356,2909,Rebif [22],2016-04-22,,300, ,['/ Day'],IV, 
15357,2909,Endoxan,2015-11-29,, , ,['/Month'], , 
15358,2909,Endoxan,2016-02-01,2020-12-22,500, ,['2 / Day'],IV,Adverse Event
15359,2171,Alemtuzumab (Campath),2016-07-28,,1000,mg,['/Month'], , 
15360,2171,Teriflunomide,2016-09-19,2019-05-26,500,MIU,['2 / Day'], ,Persisting MRI activity
15361,2171,D-cure (Vitamine D),2016-01-01,2017-12-10,400, ,['2 / Day'],IV,Adverse Event
15362,2822,Tysabri,2016-03-18,2020-02-03,400,mg,['2 / Day'],IV,Adverse Event
15363,2822,Betaferon,2016-06-24,,400,MIU,['3 / Week'],IV, 
15364,4377,D-cure (Vitamine D),2016-04-17,2020-08-01,300,mg,['3 / Week'], ,Adverse Event
15365,1143,Rebif [44],2016-05-23,2020-12-28,1000, ,['3 / Week'],Oral,Adverse Event
15366,1143,IVIG,2016-10-20,2019-01-25,500,mcg,[' '],IV,Patient Choice/Convenience
15367,1143,Betaferon,2016-07-29,,5000, ,['2 / Day'],IV, 
15368,1505,Rebif [44],2016-01-25,2018-10-03, ,mg,['2 / Day'],IV,Adverse Event
15369,1505,Rebif [22],2016-06-02,2019-10-17,20,mcg,['/Month'],IV,Patient Choice/Convenience
15370,1505,Copaxone,2016-09-14,,300, ,['3 / Week'],IV, 
15371,1505,Rebif [44],2016-08-13,,500, ,['2 / Day'],IV, 
15372,1210,Tysabri,2016-08-25,,5000,mg,['/ Day'],Oral, 
15373,1210,Tysabri,2016-09-23,2020-05-20, ,mg,['2 / Day'],Oral,Lack of efficacy
15374,1210,D-cure (Vitamine D),2016-10-18,, , ,['/Month'],IV, 
15375,1210,Avonex,2016-03-04,,300, ,['/ Week'],IV, 
15376,1082,Rebif [22],2016-02-11,2021-01-27,5000,mg,['3 / Week'], ,Patient Choice/Convenience
15377,1082,Avonex,2016-03-05,2020-01-24, , ,['3 / Week'], ,Persisting MRI activity
15378,1082,Methylprednisolone,2016-05-05,2019-09-22,1000,mcg,[' '],IV,Patient Choice/Convenience
15379,1614,Tecfidera,2016-08-30,, ,MIU,[' '],IV, 
15380,1614,Alemtuzumab (Campath),2016-09-07,,400,MIU,['2 / Day'],IV, 
15381,1614,Copaxone,2015-12-13,2020-08-19, ,mg,['/Month'],IV,Lack of efficacy
15382,1614,Rebif [44],2016-06-28,, ,mg,['/Month'], , 
15383,4534,Rebif [44],2015-12-27,,1, ,['/ Week'],IV, 
15384,4534,Gilenya,2016-08-31,,1000,mg,['/Month'],IV, 
15385,4534,Avonex,2016-06-24,, ,mcg,['3 / Week'], , 
15386,1988,Ledertrexaat,2016-03-06,,500,mg,['2 / Day'], , 
15387,1988,IVIG,2016-08-14,,300, ,[' '],IV, 
15388,1988,Tecfidera,2016-03-14,, , ,['/Month'],IV, 
15389,2386,IVIG,2015-11-12,2020-02-08,20,mg,['2 / Day'],IV,Lack of efficacy
15390,2386,Rebif [44],2016-06-10,2019-09-04,400,mg,['/Month'],IV,Adverse Event
15391,2386,Methylprednisolone,2015-12-24,2020-05-16,20,mg,['/ Day'],IV,Lack of efficacy
15392,122,Teriflunomide,2016-07-02,,20, ,['/Month'],IV, 
15393,122,Rebif [44],2016-01-10,2018-08-21,400, ,['/Month'],IV,Lack of efficacy
15394,122,Rebif [22],2016-06-05,,1, ,[' '], , 
15395,122,Tecfidera,2015-12-17,2019-08-30,300,mg,['3 / Week'], ,Adverse Event
15396,4006,Endoxan,2016-10-07,,500,mg,['2 / Day'],IV, 
15397,4006,Avonex,2016-10-16,,1000, ,['/Month'], , 
15398,4006,Methylprednisolone,2016-10-13,2018-06-19,1,mg,['/Month'], ,Patient Choice/Convenience
15399,4006,IVIG,2016-04-11,,5000,mg,['2 / Day'],Oral, 
15400,2401,Gilenya,2016-07-04,,5000, ,['2 / Day'],Oral, 
15401,2401,Mitoxantrone,2015-11-09,,1000,mg,['3 / Week'], , 
15402,2401,Copaxone,2016-05-01,2019-05-02, ,mg,[' '],IV,Lack of efficacy
15403,954,Endoxan,2016-09-12,, , ,['3 / Week'], , 
15404,954,Alemtuzumab (Campath),2015-12-15,2018-07-16,400,mg,['/Month'],IV,Lack of efficacy
15405,954,Mitoxantrone,2016-03-04,,1000,mg,['2 / Day'],IV, 
15406,2024,Tecfidera,2016-06-23,2020-04-09,1000, ,['3 / Week'], ,Adverse Event
15407,2024,IVIG,2016-01-18,,1000,MIU,['2 / Day'],IV, 
15408,1467,Teriflunomide,2016-03-10,2019-09-20, ,mg,['/Month'],IV,Adverse Event
15409,1467,Gilenya,2015-12-13,2017-10-31,500, ,['2 / Day'],IV,Lack of efficacy
15410,1467,Alemtuzumab (Campath),2016-05-16,2019-05-16, ,mg,['2 / Day'],IV,Persistence of relapses
15411,1467,Gilenya,2016-01-15,2019-03-19,20, ,['/ Week'],IV,Persistence of relapses
15412,1969,Alemtuzumab (Campath),2015-11-30,,1000,mg,['/Month'],IV, 
15413,1969,Alemtuzumab (Campath),2016-05-30,2020-09-19,400, ,[' '],IV,Lack of efficacy
15414,3913,D-cure (Vitamine D),2016-09-29,2018-11-06, , ,['3 / Week'], ,Patient Choice/Convenience
15415,3913,Tecfidera,2015-12-26,, ,mg,['/Month'], , 
15416,4599,Alemtuzumab (Campath),2015-11-23,,1,MIU,['3 / Week'],IV, 
15417,4599,Mitoxantrone,2015-11-30,2018-06-05,500,MIU,['3 / Week'],IV,Persisting MRI activity
15418,4599,Copaxone,2016-03-16,, ,mg,['3 / Week'], , 
15419,1194,Tysabri,2016-01-03,, , ,['2 / Day'], , 
15420,1194,D-cure (Vitamine D),2016-06-03,2019-01-09,300,mg,['2 / Day'],IV,Patient Choice/Convenience
15421,1194,Avonex,2016-07-18,2021-05-28,20, ,['/Month'],Oral,Persisting MRI activity
15422,2892,Avonex,2015-12-15,,300, ,['/ Week'], , 
15423,2892,Ledertrexaat,2015-12-01,, , ,['/ Day'],IV, 
15424,2892,Endoxan,2015-11-12,, , ,['/ Week'],IV, 
15425,2892,Teriflunomide,2016-06-21,, ,mcg,['/Month'],IV, 
15426,744,Tysabri,2016-02-28,,500,mg,['/Month'],IV, 
15427,744,Gilenya,2016-02-13,,1,mg,['2 / Day'], , 
15428,744,Tecfidera,2015-11-06,,1000,mcg,['/Month'],Oral, 
15429,4046,Avonex,2016-04-24,2019-08-25, ,mg,['/Month'],IV,Persisting MRI activity
15430,4046,Endoxan,2016-01-14,, ,mg,['/ Day'], , 
15431,390,Rebif [22],2016-10-05,,1, ,['/Month'], , 
15432,390,Tecfidera,2016-06-05,2021-02-28,1000,mg,['3 / Week'],IV,Lack of efficacy
15433,390,IVIG,2016-06-02,2017-11-23,300, ,['2 / Day'],IV,Lack of efficacy
15434,2549,Methylprednisolone,2016-05-05,,500,mg,['3 / Week'],IV, 
15435,1168,Rebif [22],2016-10-17,2018-11-06, ,mg,['3 / Week'], ,Persistence of relapses
15436,1168,Methylprednisolone,2016-04-11,2019-05-19,1000, ,['2 / Day'], ,Persisting MRI activity
15437,1737,Copaxone,2016-02-28,2020-01-26, ,mg,['3 / Week'], ,Patient Choice/Convenience
15438,1737,Tecfidera,2016-08-11,2020-05-21,500,mg,['/Month'],IV,Patient Choice/Convenience
15439,1737,Mitoxantrone,2016-03-20,2019-08-13, ,mg,['3 / Week'], ,Lack of efficacy
15440,1298,Tysabri,2015-12-12,,1000,mg,['2 / Day'], , 
15441,1298,Ledertrexaat,2016-04-03,2021-08-23,500,mg,['3 / Week'],IV,Adverse Event
15442,1298,Avonex,2016-07-23,2020-09-29, ,MIU,['/ Week'], ,Lack of efficacy
15443,1103,Gilenya,2016-02-19,,5000,MIU,['/Month'],IV, 
15444,2707,Betaferon,2016-04-19,2021-08-23, , ,['2 / Day'], ,Patient Choice/Convenience
15445,2707,Endoxan,2016-06-26,, , ,['/ Day'], , 
15446,2707,Tysabri,2016-06-18,2021-02-06,500,mg,['/Month'],IV,Adverse Event
15447,1871,Rebif [44],2016-07-14,, ,MIU,['2 / Day'], , 
15448,1871,Copaxone,2015-11-30,2020-10-30,20, ,['/ Day'],IV,Persisting MRI activity
15449,1871,Endoxan,2016-05-14,2019-05-22,20,mg,[' '],IV,Adverse Event
15450,1871,Gilenya,2016-05-29,,500, ,['/Month'], , 
15451,605,Copaxone,2016-06-03,2020-03-04,1000,mg,['/Month'], ,Patient Choice/Convenience
15452,605,Copaxone,2016-06-01,2021-05-11,5000,MIU,['/Month'],IV,Patient Choice/Convenience
15453,605,Teriflunomide,2016-03-27,, ,mg,['/Month'],IV, 
15454,605,Mitoxantrone,2016-08-15,2019-12-15,300,mg,[' '],IV,Patient Choice/Convenience
15455,440,Copaxone,2015-11-10,,20, ,['3 / Week'],IV, 
15456,440,Avonex,2016-05-01,,300, ,['/Month'], , 
15457,440,Tysabri,2016-04-17,,5000, ,['/ Week'],Oral, 
15458,3311,Tysabri,2016-04-30,, , ,['/Month'],IV, 
15459,3311,Tecfidera,2016-09-24,2020-06-06, , ,['/Month'],IV,Lack of efficacy
15460,1356,Avonex,2016-07-26,,500,MIU,['2 / Day'],IV, 
15461,1356,Tecfidera,2016-02-29,2018-02-22, , ,['/Month'],IV,Adverse Event
15462,972,Betaferon,2016-06-15,2021-07-12, ,mg,['2 / Day'],IV,Lack of efficacy
15463,972,Rebif [44],2016-03-22,,1, ,['/Month'],IV, 
15464,972,Tysabri,2016-02-22,,1000,mg,['3 / Week'], , 
15465,972,Avonex,2015-12-15,,1, ,['/ Day'], , 
15466,4851,Betaferon,2016-01-26,2018-04-10, ,mg,['2 / Day'], ,Lack of efficacy
15467,4851,Avonex,2016-02-09,,1000,mg,['/Month'],IV, 
15468,2258,Methylprednisolone,2016-01-16,, ,mg,['/Month'],IV, 
15469,461,Avonex,2016-07-22,2019-05-27,500,MIU,['/Month'],IV,Adverse Event
15470,3360,Alemtuzumab (Campath),2016-10-08,2017-11-01,400,mg,['/Month'], ,Adverse Event
15471,3360,Avonex,2015-11-28,, ,mg,['3 / Week'],Oral, 
15472,3360,Rebif [22],2016-02-23,2017-10-26, , ,['/Month'],Oral,Lack of efficacy
15473,102,IVIG,2016-05-26,2020-03-02,1,mg,['3 / Week'],IV,Adverse Event
15474,102,Mitoxantrone,2016-09-02,,300,mg,[' '], , 
15475,102,Tysabri,2016-05-16,,500,mcg,['/Month'],IV, 
15476,102,Rebif [44],2016-05-03,,300,mg,['/Month'], , 
15477,3129,Methylprednisolone,2016-03-21,,1,mg,['/Month'],IV, 
15478,3129,Tecfidera,2016-05-02,, , ,['/ Week'],IV, 
15479,3039,Tecfidera,2016-02-19,,500, ,['/Month'],Oral, 
15480,3039,Tysabri,2016-10-11,, ,mg,[' '],IV, 
15481,4832,Avonex,2016-01-11,,1,mg,['2 / Day'],IV, 
15482,4832,D-cure (Vitamine D),2016-04-27,,1000,mg,['2 / Day'], , 
15483,4832,Teriflunomide,2016-06-15,2019-02-11,300,mg,['3 / Week'],IV,Patient Choice/Convenience
15484,4832,Teriflunomide,2015-11-07,, , ,['2 / Day'], , 
15485,976,Betaferon,2016-06-24,,1, ,['2 / Day'], , 
15486,976,Methylprednisolone,2016-01-15,2020-10-13,1000,mg,['2 / Day'],IV,Lack of efficacy
15487,533,Endoxan,2016-09-18,2021-08-08, ,mcg,['/Month'],IV,Patient Choice/Convenience
15488,533,Rebif [22],2016-08-12,, , ,['/Month'],IV, 
15489,533,Betaferon,2016-02-01,2021-06-01,1,MIU,['/Month'], ,Patient Choice/Convenience
15490,533,Alemtuzumab (Campath),2016-08-24,,400,mg,['2 / Day'],IV, 
15491,2866,Betaferon,2016-06-23,2020-02-02,1, ,['3 / Week'],IV,Lack of efficacy
15492,2866,Tecfidera,2016-03-11,,1,MIU,['/Month'], , 
15493,2866,Copaxone,2016-04-10,2019-12-18,5000, ,['/Month'],Oral,Lack of efficacy
15494,2866,IVIG,2016-05-22,,400, ,['/ Day'],Oral, 
15495,4882,Alemtuzumab (Campath),2016-02-11,,500, ,['/Month'], , 
15496,3916,Rebif [22],2016-08-04,, ,mg,['/Month'], , 
15497,2286,Tecfidera,2016-07-05,2019-11-05, ,MIU,['/Month'], ,Lack of efficacy
15498,2286,Rebif [22],2016-07-12,,1,mg,['3 / Week'],Oral, 
15499,4189,Tysabri,2015-11-06,2019-06-13,500,mcg,['/Month'], ,Adverse Event
15500,1771,IVIG,2016-01-22,2021-02-10,1000, ,['/Month'],Oral,Persistence of relapses
15501,1526,Avonex,2016-01-05,2020-11-08,500, ,['/Month'],IV,Patient Choice/Convenience
15502,1526,Rebif [44],2016-02-25,,1,mcg,['3 / Week'],IV, 
15503,4794,Betaferon,2016-04-13,,400, ,['3 / Week'], , 
15504,4794,Rebif [44],2016-07-23,, , ,['/ Week'],IV, 
15505,304,Tecfidera,2015-12-07,,1, ,['/Month'],IV, 
15506,304,D-cure (Vitamine D),2016-01-24,,1000, ,['2 / Day'],Oral, 
15507,304,Tysabri,2016-03-06,2019-09-30,500, ,['/Month'],IV,Adverse Event
15508,304,Methylprednisolone,2016-02-29,2019-04-03, , ,['2 / Day'],IV,Adverse Event
15509,4694,Methylprednisolone,2015-12-06,, ,mg,['/Month'], , 
15510,2832,Rebif [44],2015-12-09,2020-03-18, ,mg,['/Month'],IV,Persisting MRI activity
15511,3297,D-cure (Vitamine D),2016-07-16,, ,mcg,['/ Week'],IV, 
15512,3297,Alemtuzumab (Campath),2016-04-22,,5000,mcg,['/ Day'], , 
15513,3297,Alemtuzumab (Campath),2015-12-07,,300, ,[' '],IV, 
15514,4416,IVIG,2016-04-27,,500,mg,['/Month'], , 
15515,4416,Rebif [44],2016-01-11,,1000, ,['2 / Day'],IV, 
15516,4416,Rebif [22],2016-03-05,, , ,['/Month'], , 
15517,4416,Alemtuzumab (Campath),2015-11-06,,1,mg,['/Month'],Oral, 
15518,3370,Methylprednisolone,2016-03-22,2020-10-17, , ,['/Month'],Oral,Persisting MRI activity
15519,4461,Copaxone,2016-07-30,, ,MIU,['/ Week'],IV, 
15520,4461,Copaxone,2016-03-01,2020-06-07,1000,mcg,['/ Week'],IV,Persistence of relapses
15521,4461,IVIG,2016-07-08,,400, ,[' '],IV, 
15522,2376,Copaxone,2016-02-20,,1000, ,['2 / Day'], , 
15523,2376,Betaferon,2016-01-19,2018-07-25,5000, ,['/Month'],Oral,Adverse Event
15524,2376,D-cure (Vitamine D),2015-11-09,,400,mg,[' '],IV, 
15525,2848,Gilenya,2016-09-01,, , ,['2 / Day'],IV, 
15526,2848,Avonex,2016-07-22,2020-11-03,20,mg,[' '],IV,Persisting MRI activity
15527,2848,Endoxan,2016-08-23,2018-07-13, , ,['2 / Day'], ,Lack of efficacy
15528,2848,Copaxone,2015-12-20,, ,mcg,['3 / Week'], , 
15529,1426,Endoxan,2015-10-24,, , ,['/Month'],IV, 
15530,2682,Ledertrexaat,2015-12-22,,20,mg,['2 / Day'],Oral, 
15531,2682,Ledertrexaat,2016-01-23,, ,MIU,['2 / Day'],IV, 
15532,2682,Endoxan,2016-03-05,, ,mg,['3 / Week'],IV, 
15533,2682,Endoxan,2016-07-09,,1000, ,['2 / Day'], , 
15534,249,Rebif [22],2016-06-14,,1,MIU,['2 / Day'],IV, 
15535,1921,Betaferon,2016-03-03,2020-08-14,1,mg,['/Month'], ,Patient Choice/Convenience
15536,1921,Copaxone,2016-07-14,, ,MIU,[' '],IV, 
15537,1446,IVIG,2016-02-23,2021-03-26,1000,mg,['2 / Day'], ,Persisting MRI activity
15538,1446,Mitoxantrone,2016-02-19,, ,mg,['2 / Day'],IV, 
15539,1446,Tecfidera,2016-02-03,,1,mg,[' '], , 
15540,4253,Methylprednisolone,2016-05-19,, ,mg,['2 / Day'],IV, 
15541,1741,Tecfidera,2016-10-10,2020-12-31,5000, ,['/Month'],IV,Adverse Event
15542,1741,D-cure (Vitamine D),2016-08-07,2018-02-04,20, ,['/Month'],IV,Adverse Event
15543,1741,Tecfidera,2016-01-09,2020-04-21, , ,['/Month'],IV,Adverse Event
15544,1741,Tysabri,2016-03-12,,1000,MIU,['2 / Day'], , 
15545,681,D-cure (Vitamine D),2016-07-09,2018-04-26,400,MIU,['2 / Day'],IV,Lack of efficacy
15546,681,D-cure (Vitamine D),2015-10-26,2020-06-08, ,MIU,['3 / Week'],IV,Persisting MRI activity
15547,681,Rebif [44],2016-02-06,2021-08-25, ,mg,['/Month'],IV,Lack of efficacy
15548,681,IVIG,2016-06-05,,300,mg,['3 / Week'], , 
15549,4648,Avonex,2016-08-08,,300,mg,['/ Day'],IV, 
15550,4648,D-cure (Vitamine D),2016-02-28,2018-06-28,20,MIU,['2 / Day'],IV,Persisting MRI activity
15551,4648,Gilenya,2016-06-08,2018-08-09, , ,['/ Day'],IV,Adverse Event
15552,3443,Betaferon,2015-10-31,,1,mcg,[' '], , 
15553,3443,Copaxone,2016-06-06,2021-08-23,300,mg,['2 / Day'], ,Lack of efficacy
15554,3443,Teriflunomide,2016-06-22,2020-05-31,5000,MIU,['/ Day'],Oral,Adverse Event
15555,3443,Tecfidera,2016-03-14,,1,mg,['3 / Week'], , 
15556,1630,Endoxan,2016-03-18,, ,mg,['3 / Week'], , 
15557,1630,D-cure (Vitamine D),2016-05-12,,20, ,['/ Day'],IV, 
15558,1630,Rebif [44],2016-09-25,, , ,['/Month'],IV, 
15559,1630,Alemtuzumab (Campath),2015-10-26,,500, ,['/Month'],Oral, 
15560,4526,Teriflunomide,2016-03-30,,500,mg,['2 / Day'],Oral, 
15561,1836,Tecfidera,2016-03-30,2018-08-02,1000, ,['/Month'],IV,Patient Choice/Convenience
15562,1836,Alemtuzumab (Campath),2016-08-07,,1,mg,['2 / Day'],IV, 
15563,1836,Mitoxantrone,2016-03-12,,5000, ,['3 / Week'],IV, 
15564,1836,Rebif [44],2015-11-01,2020-03-06,500,mg,['/Month'],Oral,Adverse Event
15565,4316,Betaferon,2016-03-28,,1000,mg,['3 / Week'], , 
15566,4316,Tecfidera,2016-02-09,2018-04-04, ,mg,['3 / Week'], ,Persistence of relapses
15567,4316,Betaferon,2016-10-05,,20,MIU,['2 / Day'],IV, 
15568,3192,D-cure (Vitamine D),2016-08-14,,20, ,['/ Day'],IV, 
15569,3192,Tecfidera,2016-03-05,,500, ,['/ Day'],IV, 
15570,3192,Rebif [22],2016-03-06,, , ,['/Month'], , 
15571,2494,Tecfidera,2016-06-12,2021-07-06,1000, ,['/ Week'], ,Adverse Event
15572,2494,IVIG,2016-09-07,2018-11-07,1000, ,[' '],Oral,Adverse Event
15573,2537,Tysabri,2016-02-18,,300,mg,['/Month'],IV, 
15574,2537,IVIG,2016-09-13,, , ,['3 / Week'], , 
15575,2537,Alemtuzumab (Campath),2016-09-06,, ,mg,['3 / Week'], , 
15576,3393,Teriflunomide,2016-02-02,,500,MIU,['/Month'], , 
15577,3393,Copaxone,2016-05-14,2019-07-27,300,mg,['/Month'],Oral,Persistence of relapses
15578,3393,Copaxone,2016-01-29,2019-08-22, ,MIU,[' '],IV,Persisting MRI activity
15579,1425,D-cure (Vitamine D),2016-01-19,2018-05-24, ,mcg,['/Month'],IV,Adverse Event
15580,1425,Copaxone,2016-08-17,2019-10-16, ,mg,['/Month'], ,Adverse Event
15581,1425,IVIG,2015-12-16,,300,mg,['/ Day'],IV, 
15582,1425,Betaferon,2016-01-08,2020-04-12,5000,mg,['2 / Day'],IV,Adverse Event
15583,2278,Rebif [22],2016-03-07,,500,mg,['2 / Day'],IV, 
15584,4401,Ledertrexaat,2016-09-10,,20,mg,['3 / Week'],Oral, 
15585,4401,Mitoxantrone,2016-06-08,,5000,mg,['/Month'], , 
15586,4401,Rebif [22],2016-08-15,2019-01-02, ,MIU,['2 / Day'], ,Persisting MRI activity
15587,4401,Alemtuzumab (Campath),2016-02-25,2020-02-23,20, ,['3 / Week'],Oral,Lack of efficacy
15588,2796,Alemtuzumab (Campath),2016-02-15,, , ,['2 / Day'],IV, 
15589,2796,D-cure (Vitamine D),2015-11-12,,500,mg,['3 / Week'],IV, 
15590,2796,Tecfidera,2016-03-03,,1,mg,['/Month'],IV, 
15591,1176,Tysabri,2016-06-30,,500,mg,['2 / Day'],Oral, 
15592,3509,D-cure (Vitamine D),2016-01-25,2019-12-13, , ,['/Month'], ,Persistence of relapses
15593,3509,Copaxone,2016-01-01,2021-04-25, ,mg,['/ Day'],IV,Adverse Event
15594,3509,IVIG,2016-07-21,,20,mg,[' '], , 
15595,4816,Ledertrexaat,2016-01-06,,1,mg,['/Month'], , 
15596,4816,Copaxone,2015-11-05,2018-11-06,300,mg,['3 / Week'],Oral,Persisting MRI activity
15597,4816,Alemtuzumab (Campath),2016-02-28,, , ,[' '],IV, 
15598,3120,Tecfidera,2015-12-28,2017-12-07,300, ,[' '],IV,Lack of efficacy
15599,3120,Gilenya,2016-09-17,2021-06-17,500,mg,['/ Week'],Oral,Persistence of relapses
15600,3120,Gilenya,2016-04-18,,20,mg,['3 / Week'],IV, 
15601,2886,Rebif [22],2016-08-27,2020-12-29,5000, ,['/Month'],IV,Patient Choice/Convenience
15602,2886,Teriflunomide,2016-06-03,2020-07-25,500,mg,['/Month'],IV,Persisting MRI activity
15603,2886,D-cure (Vitamine D),2016-01-30,, ,mg,['3 / Week'],IV, 
15604,281,Rebif [44],2016-05-01,,1000,mg,[' '],Oral, 
15605,1901,D-cure (Vitamine D),2016-07-09,,20,mg,['/Month'],IV, 
15606,1901,Tysabri,2015-11-14,, ,mg,['/ Week'], , 
15607,1901,Avonex,2015-11-20,2018-04-17, , ,[' '], ,Patient Choice/Convenience
15608,1901,Alemtuzumab (Campath),2015-12-19,2019-09-11,1000,mg,['/ Week'], ,Persistence of relapses
15609,494,Methylprednisolone,2016-06-03,,1000, ,[' '],IV, 
15610,494,Rebif [44],2016-07-17,, , ,['2 / Day'],IV, 
15611,2963,Ledertrexaat,2015-12-18,2020-08-05,500,MIU,['2 / Day'], ,Patient Choice/Convenience
15612,2963,Tysabri,2016-06-04,,5000,mg,[' '],IV, 
15613,2963,Methylprednisolone,2016-01-23,,500, ,['3 / Week'],IV, 
15614,3811,Endoxan,2016-07-30,2018-09-29,1000,mg,['/Month'],IV,Patient Choice/Convenience
15615,1075,Methylprednisolone,2016-05-04,2020-11-13,300, ,['/Month'], ,Adverse Event
15616,1075,Tecfidera,2015-10-25,, ,mcg,['2 / Day'],IV, 
15617,1075,Alemtuzumab (Campath),2016-03-26,,400,mg,['/Month'],IV, 
15618,1075,Rebif [22],2016-09-24,2018-09-21,5000,mg,['/Month'], ,Persistence of relapses
15619,4589,Rebif [44],2016-07-16,,500,mg,['/Month'],IV, 
15620,4299,Alemtuzumab (Campath),2016-02-23,,300,mg,['2 / Day'],IV, 
15621,4299,D-cure (Vitamine D),2016-03-03,2017-11-08,500,mg,['/Month'],IV,Persisting MRI activity
15622,4299,Ledertrexaat,2016-02-03,,20,mg,['2 / Day'],IV, 
15623,3448,Alemtuzumab (Campath),2016-07-01,,5000,mg,['/ Day'],IV, 
15624,3448,Endoxan,2016-10-22,,400,mg,['/Month'],IV, 
15625,4357,Endoxan,2016-03-01,,1000, ,['/Month'], , 
15626,4357,Gilenya,2016-04-18,, , ,['/Month'], , 
15627,4357,D-cure (Vitamine D),2016-03-20,2020-03-17,500,mg,['/Month'],IV,Patient Choice/Convenience
15628,4357,D-cure (Vitamine D),2016-04-14,, , ,[' '],Oral, 
15629,3739,Rebif [44],2016-02-28,,20, ,['2 / Day'], , 
15630,3739,Methylprednisolone,2016-06-08,,20,mg,['2 / Day'],IV, 
15631,1079,Teriflunomide,2016-10-12,,500,mg,['/ Day'], , 
15632,1079,Avonex,2016-02-04,2020-09-18,500,MIU,[' '],Oral,Persisting MRI activity
15633,1079,IVIG,2015-11-19,,20, ,['3 / Week'],Oral, 
15634,1079,Avonex,2015-11-29,,20, ,['2 / Day'],IV, 
15635,2696,Tysabri,2016-03-23,,5000, ,['3 / Week'],IV, 
15636,4327,Tysabri,2015-11-20,,300, ,['3 / Week'], , 
15637,3175,Rebif [44],2016-07-07,,300, ,['3 / Week'], , 
15638,3175,IVIG,2016-03-08,2019-01-07, ,mg,['/ Day'], ,Persisting MRI activity
15639,615,IVIG,2016-03-03,2020-07-01,500, ,['3 / Week'],IV,Lack of efficacy
15640,615,Tecfidera,2016-02-11,, ,mg,[' '],IV, 
15641,615,Methylprednisolone,2016-07-19,,20,MIU,['/Month'],IV, 
15642,2949,Copaxone,2015-11-17,, ,mg,['/Month'],IV, 
15643,2949,Copaxone,2015-11-29,2019-03-28,500,mg,['2 / Day'],IV,Persistence of relapses
15644,2949,IVIG,2016-08-07,, ,mg,['/Month'],IV, 
15645,4658,Teriflunomide,2016-09-13,,500,MIU,['2 / Day'],IV, 
15646,4658,Alemtuzumab (Campath),2016-08-04,2018-07-29,1000, ,['/Month'], ,Persisting MRI activity
15647,4658,Avonex,2015-11-16,2018-05-15, , ,['2 / Day'],IV,Patient Choice/Convenience
15648,4658,Ledertrexaat,2016-03-17,,1000,mg,['/Month'],IV, 
15649,3045,Endoxan,2016-08-04,2019-05-29,1000,mg,['/Month'], ,Lack of efficacy
15650,3045,IVIG,2015-11-15,2018-12-07, ,mg,[' '], ,Persisting MRI activity
15651,3882,Methylprednisolone,2016-06-02,2019-05-27,300,mg,['/ Day'], ,Persisting MRI activity
15652,3882,Alemtuzumab (Campath),2016-09-02,2020-09-15,500,mg,['/ Week'],IV,Lack of efficacy
15653,3882,Rebif [44],2015-11-30,2019-01-28,500,mg,['2 / Day'],Oral,Adverse Event
15654,498,Methylprednisolone,2016-01-12,2018-03-25,5000,mcg,['3 / Week'],IV,Adverse Event
15655,498,D-cure (Vitamine D),2016-09-25,, ,mg,['2 / Day'], , 
15656,376,Tecfidera,2015-12-01,,5000, ,['2 / Day'],IV, 
15657,376,Tecfidera,2016-09-19,2020-03-31,1000,mg,['/Month'], ,Persistence of relapses
15658,376,Copaxone,2016-06-11,,1000,MIU,['/ Week'], , 
15659,495,D-cure (Vitamine D),2015-12-11,, ,mg,['/Month'],IV, 
15660,495,IVIG,2016-06-19,,500,mg,['/Month'],IV, 
15661,968,Methylprednisolone,2016-01-11,2019-11-29,400, ,['/Month'],IV,Persistence of relapses
15662,3074,Copaxone,2016-01-31,2017-12-31,1000, ,['/Month'],IV,Lack of efficacy
15663,3074,Methylprednisolone,2016-07-26,2020-09-16,300,mg,['/ Week'], ,Lack of efficacy
15664,3074,Gilenya,2016-01-03,2019-05-30,500, ,[' '],IV,Lack of efficacy
15665,3074,Betaferon,2016-07-28,2018-02-25,300, ,['2 / Day'], ,Persistence of relapses
15666,2125,Tecfidera,2016-02-11,, , ,['2 / Day'], , 
15667,3476,Copaxone,2016-05-12,,20, ,['/ Week'], , 
15668,3476,Methylprednisolone,2016-09-25,, ,mg,['/Month'],Oral, 
15669,3476,Rebif [22],2016-09-14,2020-02-13,5000,mg,['2 / Day'],Oral,Adverse Event
15670,3476,Gilenya,2016-04-18,,5000,MIU,['/Month'],IV, 
15671,1908,Rebif [22],2016-05-19,2018-05-30,400, ,['/Month'],IV,Lack of efficacy
15672,877,Tecfidera,2016-05-23,,20,mg,['/Month'],IV, 
15673,877,Rebif [44],2016-08-08,,5000, ,[' '],IV, 
15674,877,Betaferon,2016-08-16,,400,mg,['2 / Day'],Oral, 
15675,877,Betaferon,2016-08-13,,20,mg,['3 / Week'],IV, 
15676,4539,Rebif [22],2016-03-10,2020-10-09,500, ,['2 / Day'],IV,Adverse Event
15677,2316,Tysabri,2015-12-16,,500, ,['/ Week'],IV, 
15678,2316,Copaxone,2016-06-06,, , ,[' '],Oral, 
15679,2316,Copaxone,2016-09-07,, ,mcg,['/Month'],IV, 
15680,2316,Rebif [22],2016-06-25,,300,MIU,['3 / Week'],Oral, 
15681,1744,Alemtuzumab (Campath),2015-11-27,,500,mg,['2 / Day'],IV, 
15682,1744,Alemtuzumab (Campath),2016-02-23,,500,MIU,['/ Day'], , 
15683,354,Mitoxantrone,2016-04-28,2020-11-18, ,mg,['2 / Day'],IV,Patient Choice/Convenience
15684,354,Betaferon,2016-04-09,2018-01-04,1000, ,['3 / Week'], ,Lack of efficacy
15685,354,Methylprednisolone,2016-05-30,,500,MIU,['2 / Day'], , 
15686,4377,D-cure (Vitamine D),2016-04-21,2021-10-15,20,mg,['/Month'],IV,Patient Choice/Convenience
15687,4377,Rebif [44],2016-08-29,2019-02-04,1000, ,['/Month'],IV,Adverse Event
15688,2393,Copaxone,2016-04-28,2018-01-13,1,mg,['2 / Day'], ,Patient Choice/Convenience
15689,2393,IVIG,2016-06-21,2019-11-03, ,mcg,['/Month'], ,Adverse Event
15690,2393,Rebif [22],2016-01-21,2021-01-06, , ,['2 / Day'], ,Adverse Event
15691,584,Endoxan,2015-10-26,2019-12-08, ,MIU,['2 / Day'],IV,Adverse Event
15692,1252,Tysabri,2015-12-18,,20,mg,['/ Day'], , 
15693,1252,Rebif [44],2016-05-05,2018-12-19,500, ,['/ Week'],Oral,Adverse Event
15694,4304,Rebif [22],2016-07-08,2020-12-05, ,mg,['/Month'],IV,Persisting MRI activity
15695,4304,Alemtuzumab (Campath),2016-03-09,,500, ,['2 / Day'],IV, 
15696,4304,Tecfidera,2016-07-19,,5000,mg,['/ Day'],Oral, 
15697,4304,Tysabri,2015-12-19,2021-03-09,400, ,['2 / Day'],IV,Patient Choice/Convenience
15698,1095,Avonex,2015-11-16,2018-01-19,1000,MIU,['3 / Week'], ,Adverse Event
15699,1095,Mitoxantrone,2016-10-22,, ,mg,[' '], , 
15700,946,Alemtuzumab (Campath),2016-01-03,,20,MIU,['2 / Day'], , 
15701,946,Endoxan,2016-07-16,2017-11-15,500,mg,['/Month'],IV,Patient Choice/Convenience
15702,946,IVIG,2015-12-09,,1,MIU,['/Month'], , 
15703,946,Alemtuzumab (Campath),2016-01-21,,500, ,['/ Week'], , 
15704,2683,Copaxone,2016-03-27,2018-12-04, , ,['2 / Day'],IV,Persistence of relapses
15705,2683,Tecfidera,2016-10-13,2019-10-14,5000,mg,['2 / Day'], ,Adverse Event
15706,2683,Ledertrexaat,2016-06-22,, ,mg,['2 / Day'],Oral, 
15707,2683,Betaferon,2015-12-23,2018-02-08,500, ,['2 / Day'],IV,Lack of efficacy
15708,1770,Teriflunomide,2016-10-14,, ,MIU,['/ Week'], , 
15709,1770,Tecfidera,2016-01-01,, , ,['2 / Day'],IV, 
15710,1770,D-cure (Vitamine D),2015-12-30,, , ,['/Month'],IV, 
15711,1770,IVIG,2016-01-09,,500, ,['2 / Day'],IV, 
15712,191,Avonex,2016-04-28,2019-12-19,1000,mcg,['/Month'], ,Adverse Event
15713,191,Alemtuzumab (Campath),2016-01-12,,300, ,['2 / Day'],IV, 
15714,191,Mitoxantrone,2016-05-19,, ,mg,['2 / Day'],IV, 
15715,191,Betaferon,2016-02-07,, , ,['2 / Day'], , 
15716,3674,D-cure (Vitamine D),2015-10-24,2018-07-26,1000,MIU,['/Month'],IV,Persisting MRI activity
15717,3674,Gilenya,2016-02-10,,1000, ,['2 / Day'],Oral, 
15718,3674,Ledertrexaat,2016-07-08,,400,mg,[' '], , 
15719,3674,Rebif [22],2015-12-22,2019-04-09, , ,['3 / Week'],IV,Persisting MRI activity
15720,3669,Rebif [22],2016-06-28,2019-08-10,500, ,['/Month'],IV,Adverse Event
15721,3669,Teriflunomide,2016-05-23,,20, ,['2 / Day'],IV, 
15722,3669,Gilenya,2016-05-29,,20,mg,['/Month'], , 
15723,3669,Methylprednisolone,2016-09-16,2018-03-12,1000, ,['/ Week'],IV,Persisting MRI activity
15724,3201,Gilenya,2016-05-05,,300,mg,[' '],IV, 
15725,1980,Alemtuzumab (Campath),2016-04-13,2020-01-01,20,mcg,['2 / Day'], ,Adverse Event
15726,1980,Endoxan,2016-01-20,,500,mg,['2 / Day'], , 
15727,4417,D-cure (Vitamine D),2016-02-03,2018-12-26,1,mg,['/Month'],IV,Persistence of relapses
15728,4417,Rebif [44],2016-09-24,2018-10-04, ,mg,['/ Day'],IV,Persisting MRI activity
15729,4417,Ledertrexaat,2016-04-22,,400,MIU,[' '],IV, 
15730,4417,Gilenya,2016-09-19,2019-07-18,1000,mg,['/Month'],IV,Persisting MRI activity
15731,159,Avonex,2016-06-02,, , ,[' '],IV, 
15732,159,Teriflunomide,2015-11-07,,500,mg,['3 / Week'],IV, 
15733,159,Tecfidera,2015-12-15,2018-04-25,500, ,['/Month'], ,Persistence of relapses
15734,3002,Gilenya,2015-11-16,, , ,[' '],IV, 
15735,3002,IVIG,2016-09-23,2020-08-13,1,mg,['2 / Day'],IV,Persisting MRI activity
15736,3002,Methylprednisolone,2015-12-22,,500,mg,['3 / Week'], , 
15737,3002,IVIG,2016-04-10,,500, ,['2 / Day'],Oral, 
15738,1117,D-cure (Vitamine D),2016-08-06,,500,mg,['3 / Week'],IV, 
15739,1117,Ledertrexaat,2016-02-17,2020-09-02,20, ,['2 / Day'],IV,Adverse Event
15740,1117,Gilenya,2016-02-03,, ,mg,['/Month'],IV, 
15741,3274,Alemtuzumab (Campath),2016-08-03,, ,mg,['2 / Day'],Oral, 
15742,3518,Rebif [44],2016-08-27,,300,mcg,['/Month'],IV, 
15743,3518,D-cure (Vitamine D),2016-02-06,2019-09-30,500,mg,['/Month'], ,Persistence of relapses
15744,2950,Copaxone,2016-09-25,2018-12-28, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
15745,2503,Gilenya,2016-10-09,,1000, ,[' '], , 
15746,2503,Avonex,2016-06-22,2019-07-04,1,MIU,['/Month'],IV,Persisting MRI activity
15747,2503,Rebif [22],2016-01-12,,300, ,['2 / Day'],IV, 
15748,3075,Mitoxantrone,2016-04-29,2020-08-30,1, ,['2 / Day'],IV,Patient Choice/Convenience
15749,3075,IVIG,2015-12-19,2019-12-09,400, ,['2 / Day'],IV,Persisting MRI activity
15750,3075,Teriflunomide,2015-12-12,,300, ,['/Month'], , 
15751,3075,Copaxone,2016-09-20,2020-10-30,300,mg,['/Month'],IV,Patient Choice/Convenience
15752,4595,Tecfidera,2016-08-23,,400,mg,['3 / Week'],IV, 
15753,4595,Rebif [22],2016-07-19,2017-12-26,400, ,['2 / Day'],IV,Patient Choice/Convenience
15754,4595,D-cure (Vitamine D),2016-09-02,, ,mg,['2 / Day'],IV, 
15755,4334,Tysabri,2016-10-12,, ,MIU,[' '], , 
15756,4334,Tysabri,2015-11-19,2020-03-07,1,mcg,['3 / Week'],IV,Persisting MRI activity
15757,2904,Teriflunomide,2016-03-26,2020-09-29,500,mg,['2 / Day'], ,Lack of efficacy
15758,370,Avonex,2016-02-18,2020-12-10, , ,['/Month'],IV,Persisting MRI activity
15759,2205,Avonex,2016-06-09,2018-09-13,20,mg,['/Month'],IV,Adverse Event
15760,2020,Mitoxantrone,2016-08-01,2018-04-03, ,MIU,['/Month'], ,Persisting MRI activity
15761,2020,Gilenya,2016-04-23,,20, ,[' '],Oral, 
15762,958,Copaxone,2016-05-24,2021-10-04, , ,['/ Day'],IV,Persisting MRI activity
15763,3220,Tysabri,2016-05-03,,400,mg,['/Month'],IV, 
15764,3349,Gilenya,2015-12-02,,5000, ,['/Month'],IV, 
15765,3349,Ledertrexaat,2016-02-29,, , ,['2 / Day'],IV, 
15766,4720,Betaferon,2016-07-04,,1000, ,['2 / Day'], , 
15767,4720,Tysabri,2015-12-25,2018-06-11,20,mcg,['/ Day'],Oral,Lack of efficacy
15768,4720,Rebif [22],2015-12-25,,400, ,['/Month'], , 
15769,4720,Mitoxantrone,2015-12-08,2020-11-03,1000,mg,['/Month'], ,Adverse Event
15770,3824,D-cure (Vitamine D),2016-06-22,, ,MIU,['/Month'], , 
15771,1772,Rebif [44],2015-10-24,,20,mg,['/Month'], , 
15772,4307,Gilenya,2015-11-26,2019-05-07,1000, ,['2 / Day'],Oral,Patient Choice/Convenience
15773,4307,Avonex,2016-07-19,, ,mg,['/Month'], , 
15774,4307,Gilenya,2016-04-21,2019-03-19,20, ,['2 / Day'],IV,Adverse Event
15775,1801,Rebif [22],2015-12-08,,400, ,['/Month'],IV, 
15776,1801,Alemtuzumab (Campath),2016-07-06,,500, ,['/Month'],IV, 
15777,1801,Tecfidera,2016-08-12,2019-01-09,300, ,['2 / Day'], ,Lack of efficacy
15778,4321,Methylprednisolone,2016-07-08,, ,mg,['/ Day'],Oral, 
15779,4321,Alemtuzumab (Campath),2016-10-06,,1000, ,['2 / Day'],IV, 
15780,1038,Gilenya,2016-09-13,2021-09-14,1, ,['2 / Day'],IV,Adverse Event
15781,1038,IVIG,2016-09-07,, ,MIU,[' '],IV, 
15782,1038,Rebif [22],2016-03-20,, , ,[' '], , 
15783,823,Gilenya,2016-04-21,2021-01-13,1,mg,['2 / Day'],IV,Adverse Event
15784,823,Endoxan,2016-04-13,,1,mg,['/ Week'], , 
15785,3532,Tecfidera,2016-10-19,,300, ,['2 / Day'], , 
15786,3532,Rebif [44],2016-03-04,2019-09-10,5000,MIU,['2 / Day'], ,Adverse Event
15787,3532,Rebif [44],2016-01-13,, ,mcg,['2 / Day'], , 
15788,347,Tysabri,2016-03-07,, , ,['/Month'],IV, 
15789,4923,Rebif [22],2016-07-08,,1,MIU,[' '],IV, 
15790,4923,Mitoxantrone,2016-05-29,2019-09-02, ,mg,['/Month'],Oral,Adverse Event
15791,4923,Rebif [44],2016-04-03,2019-12-31,20,mcg,['/Month'],IV,Lack of efficacy
15792,2647,Endoxan,2016-10-14,,300,mcg,['/ Day'], , 
15793,2647,Tysabri,2015-12-08,, ,mg,['3 / Week'], , 
15794,2647,Avonex,2016-03-28,, , ,['/Month'],Oral, 
15795,2647,Alemtuzumab (Campath),2015-12-12,2019-08-27,400,mg,['2 / Day'], ,Patient Choice/Convenience
15796,1788,Ledertrexaat,2016-05-15,, ,mcg,[' '], , 
15797,3904,Gilenya,2015-11-04,2018-05-15,20,mg,['2 / Day'],Oral,Adverse Event
15798,3904,Gilenya,2016-09-24,2020-01-22, ,mcg,['2 / Day'],IV,Patient Choice/Convenience
15799,3904,Tecfidera,2016-03-06,,20, ,['2 / Day'], , 
15800,3904,Methylprednisolone,2016-10-10,2019-10-08, , ,['/ Day'], ,Adverse Event
15801,334,Alemtuzumab (Campath),2016-04-13,, , ,[' '], , 
15802,334,Rebif [44],2016-03-02,,5000, ,['2 / Day'],Oral, 
15803,334,Mitoxantrone,2016-08-05,2018-01-27, , ,['/Month'], ,Patient Choice/Convenience
15804,334,Gilenya,2016-05-25,, , ,['/Month'],IV, 
15805,3279,Methylprednisolone,2016-05-20,2018-01-03,1000,mcg,['/Month'],IV,Persistence of relapses
15806,969,Tysabri,2016-01-20,2019-12-19,300, ,['/Month'],IV,Patient Choice/Convenience
15807,4283,Gilenya,2016-04-09,,20,mg,['2 / Day'],IV, 
15808,4283,Betaferon,2015-12-27,,300, ,[' '], , 
15809,1562,Mitoxantrone,2016-06-27,2019-01-24,500,mg,['/Month'],IV,Adverse Event
15810,1562,Rebif [44],2016-07-24,2020-10-30,1,MIU,[' '],IV,Lack of efficacy
15811,1562,Mitoxantrone,2016-10-19,2021-06-05, , ,['/ Day'],IV,Adverse Event
15812,1562,Betaferon,2015-10-31,,20,mcg,['2 / Day'],Oral, 
15813,2658,Gilenya,2016-02-17,2019-03-29,500, ,['/Month'],Oral,Adverse Event
15814,3607,Mitoxantrone,2016-07-02,2017-12-17,1000,mg,['/Month'], ,Adverse Event
15815,3607,Teriflunomide,2016-07-10,2019-12-02, , ,['/ Day'], ,Lack of efficacy
15816,3607,IVIG,2015-12-29,2020-09-10,1,MIU,['/Month'],IV,Adverse Event
15817,3607,Tecfidera,2015-12-22,2019-10-31,5000,mg,['/ Week'],IV,Lack of efficacy
15818,3663,Gilenya,2016-09-30,,1000,mg,[' '],IV, 
15819,3663,Endoxan,2015-10-28,2017-12-02, , ,['2 / Day'],Oral,Patient Choice/Convenience
15820,3663,Teriflunomide,2016-01-15,,500,mcg,[' '], , 
15821,4280,D-cure (Vitamine D),2016-02-11,,300,MIU,['2 / Day'], , 
15822,4280,Ledertrexaat,2015-12-04,,500,mg,['/ Week'], , 
15823,2414,Endoxan,2016-08-31,2019-08-20,500, ,['/Month'],IV,Adverse Event
15824,2414,Copaxone,2016-03-21,, , ,['/Month'],IV, 
15825,2414,Endoxan,2016-06-16,2018-03-12, ,mg,['2 / Day'], ,Lack of efficacy
15826,3020,Tecfidera,2016-03-08,2018-03-22,1, ,['/Month'],IV,Adverse Event
15827,3020,Teriflunomide,2016-07-15,2019-09-25,300,mg,['/Month'], ,Patient Choice/Convenience
15828,3020,Gilenya,2015-10-28,,1,mg,['/ Week'],IV, 
15829,3020,Rebif [22],2016-01-01,,500,mg,['/ Week'], , 
15830,4789,Tysabri,2016-01-27,,5000, ,['2 / Day'],IV, 
15831,4789,Gilenya,2016-06-01,2018-04-23,1000,MIU,['/Month'],IV,Lack of efficacy
15832,4789,Copaxone,2016-04-27,2020-02-05,20,mg,['/Month'],IV,Lack of efficacy
15833,1754,Tecfidera,2016-10-13,2018-08-26, , ,['/Month'],IV,Adverse Event
15834,1754,Tysabri,2016-08-15,2020-06-25, ,mg,['/Month'],Oral,Lack of efficacy
15835,912,Avonex,2016-08-19,,500, ,['2 / Day'], , 
15836,912,Teriflunomide,2016-01-07,2020-04-09,20,mg,['3 / Week'],Oral,Lack of efficacy
15837,912,Rebif [44],2015-10-28,,20,MIU,['3 / Week'],IV, 
15838,912,D-cure (Vitamine D),2015-12-04,,1,mg,['/ Day'],IV, 
15839,3813,Rebif [44],2016-02-23,2019-02-10,1, ,[' '], ,Adverse Event
15840,3813,Alemtuzumab (Campath),2015-12-29,,1,mg,['2 / Day'],Oral, 
15841,2765,Methylprednisolone,2016-08-01,, , ,['2 / Day'],IV, 
15842,2765,D-cure (Vitamine D),2015-11-05,2018-04-29,500,mcg,['/Month'],Oral,Patient Choice/Convenience
15843,369,Rebif [22],2016-06-30,2017-11-13, ,MIU,['2 / Day'],IV,Adverse Event
15844,369,Ledertrexaat,2016-01-11,2019-08-10,500,mg,['2 / Day'], ,Adverse Event
15845,2200,Tecfidera,2015-12-16,,1,mg,['3 / Week'], , 
15846,2200,IVIG,2016-09-08,2020-07-14,5000, ,['2 / Day'],Oral,Patient Choice/Convenience
15847,2200,Endoxan,2016-09-13,2018-07-02,400,mg,['/Month'], ,Patient Choice/Convenience
15848,2200,Tecfidera,2015-12-08,2018-02-15,20,mcg,['2 / Day'], ,Patient Choice/Convenience
15849,4180,IVIG,2016-03-15,,1,MIU,['2 / Day'],IV, 
15850,4180,Copaxone,2015-12-26,2021-04-16, , ,['3 / Week'], ,Lack of efficacy
15851,4180,Copaxone,2016-06-30,,300,mg,['2 / Day'],IV, 
15852,4180,Ledertrexaat,2016-07-20,, ,MIU,['/ Week'],IV, 
15853,3698,Avonex,2015-12-22,2020-05-15,500,mg,['/Month'],IV,Adverse Event
15854,3698,D-cure (Vitamine D),2016-10-05,2018-07-20,500,MIU,['2 / Day'], ,Persisting MRI activity
15855,1077,Tysabri,2015-10-31,2018-04-08,5000, ,['2 / Day'], ,Persisting MRI activity
15856,1077,Alemtuzumab (Campath),2016-01-11,,20, ,['2 / Day'],Oral, 
15857,1077,D-cure (Vitamine D),2016-05-28,2018-05-16,1,mg,[' '], ,Persisting MRI activity
15858,1077,Tysabri,2016-05-07,,1,mg,['/Month'],IV, 
15859,2770,Copaxone,2016-01-13,2018-03-04,1000,mcg,['/Month'],IV,Adverse Event
15860,2770,Avonex,2016-08-19,, ,mg,['2 / Day'],IV, 
15861,2770,Alemtuzumab (Campath),2016-09-05,,500,MIU,['3 / Week'],Oral, 
15862,4834,Tecfidera,2016-04-18,,20, ,['2 / Day'], , 
15863,3298,IVIG,2016-03-20,2021-04-01,400,MIU,['2 / Day'],IV,Persistence of relapses
15864,3298,Avonex,2016-01-26,, ,mg,['/ Day'], , 
15865,3298,Tecfidera,2016-02-14,2018-02-16,400,mg,['/Month'], ,Adverse Event
15866,3298,D-cure (Vitamine D),2016-03-20,, ,mg,['2 / Day'],IV, 
15867,753,D-cure (Vitamine D),2016-08-15,, , ,['/ Day'],IV, 
15868,753,Rebif [44],2016-10-11,2019-12-16,1,mg,[' '],Oral,Lack of efficacy
15869,753,IVIG,2016-08-09,2019-09-16,1000, ,['/Month'],Oral,Persisting MRI activity
15870,3647,D-cure (Vitamine D),2016-09-12,2018-08-09, ,mg,['/Month'], ,Lack of efficacy
15871,3647,Tecfidera,2016-07-23,2021-10-14, , ,['2 / Day'], ,Adverse Event
15872,3647,Tecfidera,2015-12-20,2020-10-11, , ,['2 / Day'],IV,Patient Choice/Convenience
15873,806,IVIG,2016-10-19,,1000,mg,['3 / Week'], , 
15874,323,Rebif [44],2016-03-29,2020-07-18,500,mg,['/Month'],IV,Patient Choice/Convenience
15875,323,Copaxone,2015-11-21,,400, ,['3 / Week'], , 
15876,323,Tysabri,2016-09-08,2021-09-11,1000, ,['2 / Day'],IV,Patient Choice/Convenience
15877,323,Copaxone,2016-07-24,2018-08-13, ,MIU,['/ Day'],IV,Persistence of relapses
15878,177,Avonex,2016-06-25,,500,mg,['/Month'],IV, 
15879,177,Copaxone,2015-12-31,, , ,['/ Day'],IV, 
15880,4982,IVIG,2016-08-14,2020-12-14, ,mcg,[' '], ,Adverse Event
15881,4982,Tecfidera,2016-08-07,2020-06-06,300,mg,['/Month'], ,Persistence of relapses
15882,1220,Rebif [22],2016-04-06,2019-11-23,1000, ,['3 / Week'],Oral,Persistence of relapses
15883,1220,Gilenya,2016-04-30,2019-05-01,1000,mg,['/ Week'],IV,Persisting MRI activity
15884,1220,Gilenya,2016-02-08,, ,MIU,['3 / Week'],IV, 
15885,2579,Tecfidera,2016-07-28,2018-07-18,300, ,['3 / Week'], ,Adverse Event
15886,2579,Alemtuzumab (Campath),2016-04-30,2019-10-17, ,MIU,['/ Day'], ,Persisting MRI activity
15887,1206,Alemtuzumab (Campath),2016-02-27,,500,mg,['2 / Day'],Oral, 
15888,259,Tecfidera,2015-11-21,2018-09-07,500, ,['/ Week'],IV,Adverse Event
15889,259,Endoxan,2016-02-05,,1000, ,['/ Week'],IV, 
15890,3295,Methylprednisolone,2016-08-31,2020-09-23,300, ,['2 / Day'],IV,Persisting MRI activity
15891,3295,Gilenya,2016-06-29,2020-04-21, ,mg,['2 / Day'], ,Adverse Event
15892,2922,Betaferon,2016-08-08,2021-10-02,400,mg,['/Month'], ,Adverse Event
15893,2922,Teriflunomide,2015-11-11,2020-09-21,1,mg,['2 / Day'],IV,Persistence of relapses
15894,2922,Teriflunomide,2016-05-26,2018-11-18,1,mg,[' '], ,Patient Choice/Convenience
15895,2922,IVIG,2016-04-27,, ,mg,[' '],IV, 
15896,508,Betaferon,2015-12-17,,300,MIU,['/Month'],IV, 
15897,2704,Tysabri,2016-06-30,2018-01-26, ,mg,['/Month'],IV,Persistence of relapses
15898,2704,Tecfidera,2016-02-10,,5000, ,['2 / Day'],Oral, 
15899,2704,D-cure (Vitamine D),2016-05-29,2018-06-28, ,mg,['/Month'], ,Adverse Event
15900,550,Rebif [22],2016-02-23,,300, ,['/ Day'],IV, 
15901,550,Ledertrexaat,2016-07-29,2019-11-16, ,mg,['/Month'],IV,Lack of efficacy
15902,550,Methylprednisolone,2016-04-20,,1000,mg,['2 / Day'], , 
15903,2381,D-cure (Vitamine D),2016-08-24,,400,mg,['2 / Day'],IV, 
15904,2381,IVIG,2016-09-01,, , ,['2 / Day'], , 
15905,2381,Gilenya,2015-11-04,,500, ,['/Month'], , 
15906,2381,Teriflunomide,2016-05-31,,400,mg,['/Month'],IV, 
15907,919,Avonex,2015-12-03,,20,mg,['2 / Day'], , 
15908,919,D-cure (Vitamine D),2016-04-25,2017-10-24,1,MIU,['2 / Day'], ,Adverse Event
15909,919,Alemtuzumab (Campath),2016-07-23,,1, ,['/ Day'], , 
15910,2038,D-cure (Vitamine D),2016-09-23,2018-12-20, , ,['/ Day'],IV,Adverse Event
15911,4023,D-cure (Vitamine D),2016-03-20,2020-09-28, , ,['/ Day'],Oral,Persistence of relapses
15912,4023,Tysabri,2015-12-25,2019-02-09,300, ,['/Month'],IV,Persisting MRI activity
15913,4023,Rebif [22],2016-10-18,, , ,['/Month'],IV, 
15914,3054,Mitoxantrone,2016-04-29,,5000,MIU,['/ Day'], , 
15915,3054,Tysabri,2016-07-18,,20, ,[' '],Oral, 
15916,3054,IVIG,2016-01-21,,1000,mg,['/Month'], , 
15917,3054,Tysabri,2015-11-23,2018-12-01,5000, ,['/ Week'],Oral,Lack of efficacy
15918,1732,Rebif [22],2016-07-03,,1, ,['/Month'],IV, 
15919,1732,Rebif [44],2016-05-02,, ,mcg,['/ Week'],IV, 
15920,1861,D-cure (Vitamine D),2016-07-17,2021-07-18, , ,['/Month'], ,Adverse Event
15921,1861,Methylprednisolone,2015-11-11,,500,mg,['/Month'],IV, 
15922,1861,Endoxan,2016-08-10,2019-08-29,300,mg,['/ Week'], ,Adverse Event
15923,1861,Gilenya,2016-01-24,2017-10-24,1000, ,[' '],IV,Adverse Event
15924,3699,Endoxan,2016-09-25,2018-09-24,1, ,['3 / Week'],IV,Adverse Event
15925,3699,Tecfidera,2016-05-12,,1000,mg,['2 / Day'],IV, 
15926,3699,Teriflunomide,2016-03-25,2019-12-12,300,MIU,['/Month'],IV,Persisting MRI activity
15927,1616,Tecfidera,2016-09-11,, ,MIU,['/Month'], , 
15928,1616,D-cure (Vitamine D),2016-07-30,,500, ,['2 / Day'],IV, 
15929,2567,Tecfidera,2015-12-11,, ,mg,['/Month'],IV, 
15930,604,Rebif [44],2015-12-01,,500,mg,['2 / Day'],IV, 
15931,604,Ledertrexaat,2015-12-27,, , ,['2 / Day'], , 
15932,604,Gilenya,2016-05-03,, ,mg,['2 / Day'], , 
15933,604,Endoxan,2015-12-18,,1, ,[' '],IV, 
15934,946,Alemtuzumab (Campath),2016-06-12,, ,mg,['/Month'],IV, 
15935,946,D-cure (Vitamine D),2016-04-01,2020-07-14,500,mg,['3 / Week'],IV,Patient Choice/Convenience
15936,946,Tysabri,2016-05-15,2020-04-28,300,mcg,['3 / Week'],IV,Persisting MRI activity
15937,946,Methylprednisolone,2016-09-07,2020-07-18,500,MIU,['3 / Week'],IV,Patient Choice/Convenience
15938,4463,Tecfidera,2016-08-18,,1, ,['2 / Day'],IV, 
15939,4463,Betaferon,2015-11-01,2019-12-16,20,mg,['/ Week'], ,Persisting MRI activity
15940,4463,Alemtuzumab (Campath),2015-10-25,, ,mg,['/Month'], , 
15941,1630,Alemtuzumab (Campath),2016-01-19,,20,mg,['/Month'], , 
15942,1211,Gilenya,2015-11-05,2020-11-27,5000,mg,['3 / Week'],IV,Adverse Event
15943,1211,Copaxone,2016-01-07,,5000, ,['2 / Day'], , 
15944,1211,D-cure (Vitamine D),2016-02-13,2021-09-24,1,mg,['2 / Day'], ,Persisting MRI activity
15945,4220,Tysabri,2015-11-11,2018-05-20,500,mg,['/Month'], ,Persisting MRI activity
15946,4220,Ledertrexaat,2016-05-22,2018-05-19,20,mg,['/Month'],IV,Adverse Event
15947,4220,Tysabri,2016-10-13,2018-10-24,1000, ,['/Month'],IV,Adverse Event
15948,4220,Tysabri,2016-04-05,, , ,['/Month'],IV, 
15949,1056,Teriflunomide,2016-02-16,,500, ,['/Month'],IV, 
15950,1056,Ledertrexaat,2016-05-26,,5000,mg,['2 / Day'], , 
15951,3310,Copaxone,2015-11-26,,300,mcg,['2 / Day'],IV, 
15952,3310,Copaxone,2016-09-18,2019-02-26,1000,mg,['2 / Day'],IV,Persisting MRI activity
15953,3578,Endoxan,2016-09-14,2018-05-15,1000,mg,['2 / Day'], ,Persisting MRI activity
15954,3578,Tecfidera,2016-03-09,,1000,mg,['2 / Day'],Oral, 
15955,3578,Betaferon,2016-09-15,, , ,['2 / Day'], , 
15956,3578,Rebif [44],2016-06-13,2018-07-30,500, ,['2 / Day'],IV,Patient Choice/Convenience
15957,4200,Gilenya,2016-01-01,,400, ,['/ Day'], , 
15958,4200,Mitoxantrone,2015-11-26,, ,mcg,['/Month'],IV, 
15959,4200,Tecfidera,2015-10-25,,1000,MIU,['/ Day'],IV, 
15960,4200,D-cure (Vitamine D),2016-09-19,2021-03-12, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
15961,4036,Avonex,2016-03-15,,500,MIU,['3 / Week'], , 
15962,4036,Methylprednisolone,2016-06-21,2020-10-28,5000, ,['2 / Day'], ,Adverse Event
15963,4036,Tysabri,2015-12-30,2021-09-11, ,mg,['2 / Day'],IV,Patient Choice/Convenience
15964,4036,Gilenya,2016-07-24,2021-05-10,1000,mg,['3 / Week'],IV,Adverse Event
15965,1585,Alemtuzumab (Campath),2016-08-02,2020-10-22,1000,mg,['3 / Week'], ,Adverse Event
15966,3551,IVIG,2015-11-21,2018-05-23, , ,['3 / Week'], ,Patient Choice/Convenience
15967,3551,D-cure (Vitamine D),2016-03-27,,500,mg,['2 / Day'],IV, 
15968,3551,Gilenya,2016-04-28,,1000, ,['/Month'],IV, 
15969,3551,Endoxan,2016-05-11,,5000,mg,['/Month'],IV, 
15970,1550,Tysabri,2016-01-10,,5000, ,['3 / Week'], , 
15971,1550,Gilenya,2016-02-26,, ,MIU,['2 / Day'], , 
15972,1550,Mitoxantrone,2016-02-27,2018-08-05,400, ,[' '],IV,Adverse Event
15973,2763,Gilenya,2016-06-02,2021-10-20,500,mg,['/ Week'], ,Adverse Event
15974,2763,Gilenya,2015-11-30,2020-02-24,300,mg,['/ Week'],IV,Patient Choice/Convenience
15975,4189,Rebif [22],2016-05-12,2018-12-31,400, ,['/Month'],IV,Persisting MRI activity
15976,652,Betaferon,2016-02-10,2018-11-10,400, ,['3 / Week'],IV,Lack of efficacy
15977,652,Endoxan,2016-01-26,2020-06-13,500,mg,['2 / Day'], ,Lack of efficacy
15978,2991,Gilenya,2016-09-26,,20,mg,['/Month'], , 
15979,2991,Gilenya,2015-12-24,,500, ,['/Month'], , 
15980,2991,Endoxan,2016-06-04,2019-06-17,5000,mg,['/ Week'], ,Persisting MRI activity
15981,2991,Endoxan,2016-08-12,, ,mg,['/Month'], , 
15982,4576,Teriflunomide,2016-09-17,, , ,['2 / Day'],IV, 
15983,4576,Mitoxantrone,2016-07-07,2020-07-14,20,mcg,['2 / Day'], ,Adverse Event
15984,4576,Betaferon,2016-10-13,, , ,['/Month'],IV, 
15985,1230,Avonex,2016-08-26,2020-05-28, , ,[' '],IV,Lack of efficacy
15986,1230,Copaxone,2016-10-21,,500,mg,['2 / Day'],Oral, 
15987,1230,Ledertrexaat,2016-05-26,,5000,MIU,[' '],IV, 
15988,1230,Avonex,2016-02-13,,5000,MIU,['/Month'], , 
15989,3959,D-cure (Vitamine D),2016-03-03,,500, ,['/Month'], , 
15990,3959,Rebif [44],2016-03-08,2020-05-14,5000, ,['3 / Week'],IV,Lack of efficacy
15991,472,Rebif [22],2016-03-19,2019-11-03,500,mg,['2 / Day'],IV,Patient Choice/Convenience
15992,472,Teriflunomide,2016-03-28,,500,mg,['3 / Week'],IV, 
15993,472,Copaxone,2015-11-29,2019-11-03, ,mg,['/Month'],IV,Adverse Event
15994,1913,Rebif [22],2016-01-20,2018-08-13,5000, ,[' '],IV,Adverse Event
15995,1913,Rebif [44],2016-05-02,, ,mg,['2 / Day'],Oral, 
15996,1913,Rebif [22],2016-07-17,2020-08-25,1,MIU,[' '],IV,Patient Choice/Convenience
15997,1913,Rebif [22],2016-09-18,,500,mg,['/Month'], , 
15998,1113,D-cure (Vitamine D),2016-04-29,2019-09-23,5000,mg,['/Month'],IV,Persisting MRI activity
15999,1113,D-cure (Vitamine D),2016-10-18,2020-12-29,1000, ,['/Month'],IV,Persisting MRI activity
16000,869,Alemtuzumab (Campath),2016-09-25,,400,mg,[' '],Oral, 
16001,869,Avonex,2016-03-15,,5000,mcg,['/Month'],IV, 
16002,869,Methylprednisolone,2016-06-12,2019-09-24,1,mcg,['2 / Day'],IV,Persisting MRI activity
16003,2593,Avonex,2015-11-18,, ,mg,['/Month'], , 
16004,2593,Copaxone,2015-11-03,,300,mg,['/Month'],IV, 
16005,2593,Rebif [44],2016-05-15,2019-01-14,300,mg,['/ Day'],Oral,Persisting MRI activity
16006,392,Rebif [22],2016-08-05,2021-01-25,300, ,['/Month'],Oral,Patient Choice/Convenience
16007,392,Rebif [44],2016-02-27,,5000, ,['/Month'],IV, 
16008,3906,D-cure (Vitamine D),2016-02-07,2019-12-06,5000,mg,['/Month'], ,Adverse Event
16009,3906,Methylprednisolone,2016-09-08,,300, ,['/Month'],IV, 
16010,3906,Ledertrexaat,2016-04-13,,1,mg,['2 / Day'], , 
16011,607,Rebif [22],2015-12-05,,500, ,['2 / Day'], , 
16012,607,Alemtuzumab (Campath),2016-03-15,2020-03-12, ,mg,['/Month'],IV,Lack of efficacy
16013,607,Avonex,2016-04-01,,20, ,['3 / Week'], , 
16014,607,Alemtuzumab (Campath),2016-09-05,,300, ,['/Month'],Oral, 
16015,3218,Alemtuzumab (Campath),2016-09-20,2019-02-10,300, ,['/Month'],IV,Persistence of relapses
16016,230,Endoxan,2016-04-30,2019-04-09, ,mg,['2 / Day'],IV,Persistence of relapses
16017,1324,Avonex,2015-12-07,,500,mg,['/ Day'], , 
16018,1324,Rebif [44],2015-11-05,2019-01-26,400,mg,['/Month'],IV,Adverse Event
16019,1324,Tecfidera,2016-01-08,2018-06-28,500,mg,['/Month'],Oral,Adverse Event
16020,3984,Alemtuzumab (Campath),2016-09-11,2019-11-30,500,mg,['2 / Day'], ,Adverse Event
16021,3984,Ledertrexaat,2016-04-02,,5000,mg,['2 / Day'],Oral, 
16022,4852,D-cure (Vitamine D),2015-11-20,2018-01-26,500,mg,['/Month'],IV,Lack of efficacy
16023,1073,Gilenya,2015-11-20,, ,MIU,['2 / Day'], , 
16024,1073,D-cure (Vitamine D),2015-11-07,2018-04-26,1000, ,['/ Day'], ,Persisting MRI activity
16025,1073,Betaferon,2016-09-20,,500,mg,['/Month'],Oral, 
16026,1397,D-cure (Vitamine D),2016-05-14,2019-02-05,500,mg,['/Month'],IV,Persisting MRI activity
16027,1397,Rebif [22],2016-06-21,2019-06-15, ,mg,['2 / Day'],IV,Adverse Event
16028,1397,D-cure (Vitamine D),2016-07-11,2019-12-16,500,mg,['/Month'],Oral,Persisting MRI activity
16029,1397,Tecfidera,2016-03-23,, , ,['2 / Day'],IV, 
16030,2759,IVIG,2016-04-14,2019-10-13,500,mg,['/ Week'], ,Patient Choice/Convenience
16031,2759,Tecfidera,2016-02-14,,20, ,['/Month'],IV, 
16032,3922,Rebif [22],2016-10-11,2021-06-15,500,mg,[' '],IV,Patient Choice/Convenience
16033,2173,Gilenya,2016-07-14,2018-05-23,500, ,['/ Day'],IV,Adverse Event
16034,2173,IVIG,2016-05-15,2019-11-18,400,mg,['2 / Day'], ,Lack of efficacy
16035,2173,Copaxone,2016-05-08,,500,mg,['2 / Day'], , 
16036,2173,Copaxone,2016-05-19,,1,mg,['3 / Week'],IV, 
16037,1575,Gilenya,2016-05-22,,1,mcg,['3 / Week'],Oral, 
16038,1575,Betaferon,2016-06-14,2020-06-07,1,mg,['2 / Day'],IV,Adverse Event
16039,2129,IVIG,2016-02-15,,20, ,[' '],IV, 
16040,2129,IVIG,2016-06-08,,5000,mg,[' '],IV, 
16041,4775,Tysabri,2016-04-17,,1000,MIU,['/Month'], , 
16042,4775,Rebif [44],2016-02-29,2018-10-26,20, ,[' '], ,Patient Choice/Convenience
16043,4775,Ledertrexaat,2016-06-01,,300,mg,['2 / Day'],IV, 
16044,4775,Alemtuzumab (Campath),2015-12-08,,500,mcg,['2 / Day'],IV, 
16045,1974,Avonex,2015-11-11,,500,mg,['3 / Week'],IV, 
16046,1974,Mitoxantrone,2016-02-01,2017-12-07,300,mg,['2 / Day'],IV,Persisting MRI activity
16047,1974,Copaxone,2016-10-16,,20, ,['3 / Week'], , 
16048,1974,Gilenya,2015-12-28,,1000, ,[' '], , 
16049,4421,IVIG,2016-07-08,2021-01-14,400,mg,['/Month'],Oral,Persisting MRI activity
16050,4291,Avonex,2016-06-15,,20,mg,[' '], , 
16051,4291,Betaferon,2016-08-11,2019-12-09,500,mg,['3 / Week'],IV,Adverse Event
16052,1342,Endoxan,2016-10-16,,20,mg,['3 / Week'], , 
16053,4305,Rebif [44],2016-01-07,,1,mg,['2 / Day'],Oral, 
16054,1756,IVIG,2016-04-07,, , ,['/Month'],IV, 
16055,1756,Rebif [22],2016-01-31,,400, ,['/ Week'],IV, 
16056,1577,Teriflunomide,2016-05-30,2021-04-27, , ,['3 / Week'],Oral,Persisting MRI activity
16057,1577,Tysabri,2016-07-23,2021-04-08,500, ,['/Month'], ,Patient Choice/Convenience
16058,1577,Tecfidera,2016-10-20,2020-03-16,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
16059,3659,Rebif [44],2016-02-05,2018-12-18,20,mg,['/Month'],IV,Persistence of relapses
16060,3659,Tysabri,2016-02-10,,5000, ,['/Month'],IV, 
16061,2748,D-cure (Vitamine D),2016-04-21,,400,MIU,['2 / Day'],IV, 
16062,2748,Avonex,2016-09-16,,1000,mg,['3 / Week'], , 
16063,2101,Methylprednisolone,2015-11-16,,5000, ,['/Month'],IV, 
16064,2101,Tecfidera,2016-08-10,,5000,mg,['/Month'],IV, 
16065,2101,Rebif [22],2016-02-13,,5000,mg,['/Month'], , 
16066,2101,Betaferon,2016-10-06,2018-12-06,500, ,['2 / Day'],IV,Persisting MRI activity
16067,960,Tecfidera,2016-01-04,, ,mg,['2 / Day'], , 
16068,960,Alemtuzumab (Campath),2016-07-28,,1, ,['2 / Day'],IV, 
16069,1226,Copaxone,2016-01-22,2018-09-13,5000, ,['/Month'], ,Persisting MRI activity
16070,1226,Teriflunomide,2016-10-11,2020-10-07, ,mg,['2 / Day'], ,Adverse Event
16071,2356,Rebif [22],2015-12-28,2021-04-04,500, ,['2 / Day'],Oral,Patient Choice/Convenience
16072,2356,D-cure (Vitamine D),2016-04-07,,500, ,['/ Day'],Oral, 
16073,279,IVIG,2016-10-10,, ,mg,['/Month'],IV, 
16074,279,Ledertrexaat,2016-10-09,,300, ,['/Month'],IV, 
16075,3316,Ledertrexaat,2016-04-15,,1000,mg,['3 / Week'],IV, 
16076,3316,D-cure (Vitamine D),2016-10-13,,5000, ,['/ Day'], , 
16077,1446,Ledertrexaat,2016-01-26,,20,mg,['3 / Week'],IV, 
16078,4951,Tecfidera,2016-04-19,2019-10-08,500, ,['/Month'],IV,Patient Choice/Convenience
16079,4951,IVIG,2016-02-08,,400,mg,['2 / Day'],IV, 
16080,3953,Ledertrexaat,2016-02-13,2020-08-31,500,MIU,[' '], ,Patient Choice/Convenience
16081,3953,D-cure (Vitamine D),2016-06-10,2018-11-23,1,mg,['2 / Day'],IV,Persisting MRI activity
16082,1431,Tecfidera,2016-05-31,2019-03-18, ,mg,['/ Day'], ,Adverse Event
16083,284,Ledertrexaat,2016-03-14,,5000,mg,['/Month'],Oral, 
16084,702,Copaxone,2016-07-12,,1000,mcg,['2 / Day'],Oral, 
16085,702,IVIG,2016-08-15,2017-12-25,300,mg,['/Month'],IV,Patient Choice/Convenience
16086,875,Betaferon,2016-01-22,, ,MIU,['3 / Week'],IV, 
16087,875,Avonex,2016-05-10,,1000,MIU,['3 / Week'],IV, 
16088,875,D-cure (Vitamine D),2016-02-27,,5000, ,['/ Day'],IV, 
16089,875,Rebif [22],2015-12-17,, , ,['/Month'], , 
16090,1097,Tecfidera,2016-06-25,,300,mg,['/ Day'], , 
16091,1097,Betaferon,2015-12-31,2019-04-30,20,mg,['/ Week'],IV,Persisting MRI activity
16092,1097,IVIG,2016-08-29,, , ,['/Month'],IV, 
16093,1097,D-cure (Vitamine D),2016-02-26,,500,mg,['2 / Day'],Oral, 
16094,871,Copaxone,2016-06-30,,1, ,['/Month'],IV, 
16095,871,Rebif [22],2016-01-28,,1000,MIU,['/Month'], , 
16096,295,Tecfidera,2016-08-05,2020-08-27,20,mg,['/Month'],Oral,Lack of efficacy
16097,295,D-cure (Vitamine D),2016-03-07,,1000, ,['/Month'],IV, 
16098,4789,IVIG,2016-06-25,,1000, ,['/Month'],IV, 
16099,3845,IVIG,2016-08-17,, ,MIU,['3 / Week'],IV, 
16100,3845,Endoxan,2015-10-25,2020-06-02,400, ,[' '], ,Adverse Event
16101,2356,IVIG,2016-01-13,, ,mg,[' '],IV, 
16102,641,Mitoxantrone,2016-07-05,,500, ,['2 / Day'],IV, 
16103,641,Tysabri,2016-07-01,,500,mg,['3 / Week'],IV, 
16104,1256,Gilenya,2015-11-06,,500, ,['/Month'],IV, 
16105,1256,Tecfidera,2016-09-07,,5000, ,['/Month'],Oral, 
16106,1256,Teriflunomide,2016-04-14,,1000,mg,['/Month'],IV, 
16107,1415,Methylprednisolone,2015-12-14,, , ,['3 / Week'],IV, 
16108,2714,Tecfidera,2016-01-09,2019-08-03,1, ,['/Month'], ,Adverse Event
16109,2714,Tecfidera,2015-12-05,2021-09-06, ,mg,['/ Week'],Oral,Adverse Event
16110,2044,Copaxone,2016-08-27,2019-04-23,500, ,['2 / Day'],Oral,Lack of efficacy
16111,2044,IVIG,2016-06-14,, ,mg,['/Month'],IV, 
16112,3887,Tecfidera,2016-05-06,2019-11-27, ,mcg,['/Month'],IV,Persisting MRI activity
16113,3887,Alemtuzumab (Campath),2015-11-21,, ,mg,['2 / Day'],IV, 
16114,3887,Methylprednisolone,2016-06-23,2018-05-17,1000,mg,['3 / Week'],IV,Patient Choice/Convenience
16115,4297,Rebif [44],2016-03-16,, , ,['/Month'],IV, 
16116,1114,D-cure (Vitamine D),2015-12-09,2021-01-29,20,mg,['2 / Day'],IV,Lack of efficacy
16117,4669,Gilenya,2016-07-29,2018-07-09, ,mg,['/Month'],IV,Adverse Event
16118,1787,Methylprednisolone,2016-02-04,,500,mg,['3 / Week'], , 
16119,1787,Gilenya,2016-02-23,,300,mg,['/Month'], , 
16120,1787,Alemtuzumab (Campath),2016-08-12,, ,mg,['2 / Day'],IV, 
16121,1787,Ledertrexaat,2016-07-21,2018-05-11,300, ,['2 / Day'],IV,Adverse Event
16122,4894,Gilenya,2016-05-01,2020-07-30, , ,['2 / Day'],IV,Persistence of relapses
16123,4894,Teriflunomide,2016-08-12,2020-05-09, , ,[' '], ,Persistence of relapses
16124,4894,Mitoxantrone,2016-07-21,2019-05-01,20,mg,['/Month'], ,Patient Choice/Convenience
16125,4224,Methylprednisolone,2015-11-11,2020-04-15,500,mg,['2 / Day'], ,Lack of efficacy
16126,4224,Copaxone,2016-03-08,,5000,mg,['/Month'],IV, 
16127,1975,Gilenya,2016-04-23,2020-07-22, ,mg,['/Month'], ,Persistence of relapses
16128,1975,Teriflunomide,2016-04-01,,500,mcg,['/Month'], , 
16129,1975,IVIG,2016-09-26,2018-05-31, ,mg,['3 / Week'],IV,Patient Choice/Convenience
16130,4544,Methylprednisolone,2016-08-26,,500, ,['/ Week'], , 
16131,4544,D-cure (Vitamine D),2016-06-04,,300, ,['/ Day'], , 
16132,4544,Gilenya,2016-09-02,2020-06-14,1000, ,['2 / Day'],IV,Persisting MRI activity
16133,4544,Gilenya,2016-06-17,2021-06-14,500,mg,['2 / Day'], ,Patient Choice/Convenience
16134,4329,Alemtuzumab (Campath),2016-06-22,2020-11-04,20, ,['/Month'],Oral,Lack of efficacy
16135,3272,Betaferon,2015-11-10,,5000,mg,['2 / Day'], , 
16136,207,Methylprednisolone,2016-02-19,2019-01-24, ,MIU,['2 / Day'], ,Adverse Event
16137,185,Tecfidera,2016-05-30,, ,mg,['/Month'],Oral, 
16138,185,IVIG,2016-10-09,2020-10-15,400,mg,['2 / Day'],IV,Patient Choice/Convenience
16139,185,Endoxan,2016-05-08,2021-04-20,400, ,[' '],Oral,Persisting MRI activity
16140,185,Rebif [22],2016-05-11,2018-08-03,300, ,['2 / Day'], ,Adverse Event
16141,3494,Tecfidera,2016-07-03,2019-05-20,20, ,['2 / Day'], ,Adverse Event
16142,3494,Gilenya,2016-09-19,,400,mg,[' '],IV, 
16143,3494,Rebif [22],2016-04-05,2019-11-25,5000, ,[' '],IV,Lack of efficacy
16144,2494,Rebif [44],2016-06-27,,400,mg,['2 / Day'],IV, 
16145,2494,Rebif [44],2016-05-06,2021-07-08, ,mg,['/Month'], ,Lack of efficacy
16146,2494,Tecfidera,2016-10-13,,300, ,['/Month'],Oral, 
16147,2494,D-cure (Vitamine D),2016-07-13,, ,mg,['2 / Day'],IV, 
16148,4256,Copaxone,2016-02-27,, ,mg,['2 / Day'],IV, 
16149,4256,Tecfidera,2015-11-19,2018-11-19,500,MIU,['3 / Week'],Oral,Persistence of relapses
16150,4256,Rebif [44],2016-08-18,,500, ,['2 / Day'],IV, 
16151,4256,Rebif [44],2016-06-23,,300,mg,['/Month'],IV, 
16152,1713,Betaferon,2015-11-09,,1000,MIU,['2 / Day'],Oral, 
16153,1713,Rebif [44],2015-10-26,2021-08-14,1000, ,['2 / Day'],IV,Adverse Event
16154,968,Methylprednisolone,2016-08-24,,1000, ,['/Month'],Oral, 
16155,968,Teriflunomide,2016-01-21,2019-12-21,1000, ,['2 / Day'],IV,Persisting MRI activity
16156,968,Gilenya,2015-11-27,2021-07-14,500,mcg,['3 / Week'], ,Persisting MRI activity
16157,3607,Rebif [22],2015-11-21,2018-10-04, ,mg,['/Month'], ,Adverse Event
16158,3607,Mitoxantrone,2016-09-30,,300,mg,[' '],IV, 
16159,3607,D-cure (Vitamine D),2015-11-04,2019-03-04,1, ,['/ Week'],IV,Patient Choice/Convenience
16160,3607,Rebif [22],2016-01-20,2020-07-20,300,mg,['/Month'],IV,Adverse Event
16161,2296,Mitoxantrone,2016-07-14,,20, ,['2 / Day'], , 
16162,2296,Avonex,2016-04-18,, ,mg,['2 / Day'],Oral, 
16163,2296,Methylprednisolone,2015-12-14,,400,mg,['2 / Day'],IV, 
16164,2296,Alemtuzumab (Campath),2016-02-07,2021-07-14,500,mg,['/Month'],IV,Patient Choice/Convenience
16165,3829,Tecfidera,2016-01-04,2019-06-17,1000,mg,['3 / Week'],IV,Adverse Event
16166,3829,Tecfidera,2015-11-05,2020-05-15,1,mg,['/Month'], ,Persisting MRI activity
16167,3829,Rebif [44],2016-04-09,, ,mg,['/Month'],IV, 
16168,3829,Rebif [22],2015-12-26,,300,mg,['3 / Week'],IV, 
16169,3313,Mitoxantrone,2016-08-31,2021-06-07,500, ,['/ Day'],IV,Persistence of relapses
16170,2265,Avonex,2016-01-08,, , ,['2 / Day'],IV, 
16171,2265,Copaxone,2015-11-23,2018-06-19,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
16172,2265,Alemtuzumab (Campath),2016-02-25,, , ,['3 / Week'],IV, 
16173,2805,Tecfidera,2016-05-08,, ,MIU,['2 / Day'], , 
16174,2805,Gilenya,2016-09-14,, ,mg,['2 / Day'],IV, 
16175,235,D-cure (Vitamine D),2016-01-13,,5000, ,['/Month'], , 
16176,235,Tecfidera,2016-05-31,,500,mcg,['/ Day'],IV, 
16177,4746,Teriflunomide,2015-12-29,, ,mg,['2 / Day'], , 
16178,4746,Alemtuzumab (Campath),2015-12-20,, ,mg,['2 / Day'],Oral, 
16179,944,Mitoxantrone,2016-04-29,2018-11-14,400,mg,['/Month'], ,Adverse Event
16180,944,D-cure (Vitamine D),2016-09-14,,400, ,['/ Day'],IV, 
16181,4819,D-cure (Vitamine D),2016-03-29,2020-08-24, ,mg,['/Month'], ,Persistence of relapses
16182,4819,Rebif [22],2015-12-29,2021-10-03,5000, ,['3 / Week'],Oral,Lack of efficacy
16183,4819,Copaxone,2016-05-30,2020-06-18, ,mg,['/Month'],Oral,Patient Choice/Convenience
16184,4819,Betaferon,2016-04-12,, , ,['/Month'],IV, 
16185,581,Methylprednisolone,2015-12-11,, , ,['/Month'],IV, 
16186,581,Methylprednisolone,2016-06-04,, ,mg,['3 / Week'], , 
16187,581,Endoxan,2016-04-18,,5000, ,['/ Day'],Oral, 
16188,4691,IVIG,2015-10-25,2018-09-01, ,mg,['/ Week'],IV,Patient Choice/Convenience
16189,4691,Avonex,2015-12-29,2017-12-15,300,mg,['/Month'],IV,Patient Choice/Convenience
16190,4691,Teriflunomide,2016-05-15,,5000,mg,['/ Week'], , 
16191,4574,Ledertrexaat,2016-08-25,2021-04-08,400,mg,['/Month'],IV,Adverse Event
16192,2319,Ledertrexaat,2016-08-16,2018-01-21,500,mg,['/ Day'], ,Persistence of relapses
16193,2319,Ledertrexaat,2016-03-25,,500,mg,['2 / Day'], , 
16194,2319,Rebif [22],2016-03-11,,1,MIU,['3 / Week'], , 
16195,2319,Methylprednisolone,2016-01-12,, ,mg,['/ Day'],Oral, 
16196,347,Mitoxantrone,2016-07-23,, , ,['/Month'],IV, 
16197,347,D-cure (Vitamine D),2016-08-16,, , ,['/ Day'],Oral, 
16198,2629,IVIG,2016-05-17,2018-03-03, , ,['/Month'],IV,Adverse Event
16199,2629,D-cure (Vitamine D),2016-02-09,,500, ,['2 / Day'], , 
16200,3131,Tysabri,2016-09-13,2021-01-19,20, ,['/Month'],Oral,Persisting MRI activity
16201,386,Rebif [44],2016-05-15,2021-05-16,1000, ,['2 / Day'], ,Adverse Event
16202,386,Avonex,2016-08-09,,500, ,['2 / Day'], , 
16203,386,Tysabri,2016-04-02,, ,mcg,['3 / Week'],IV, 
16204,2075,Rebif [44],2016-01-12,, , ,['2 / Day'],Oral, 
16205,2075,Rebif [22],2016-08-23,2018-06-26,1,MIU,['2 / Day'],IV,Adverse Event
16206,2075,D-cure (Vitamine D),2016-05-03,2021-05-13,20,MIU,['2 / Day'], ,Patient Choice/Convenience
16207,2075,Betaferon,2016-03-28,, ,MIU,['2 / Day'],IV, 
16208,4250,Ledertrexaat,2016-10-05,,20,mg,['/Month'], , 
16209,4250,Tysabri,2016-02-09,2018-12-30,500, ,['/ Week'],Oral,Adverse Event
16210,4250,Alemtuzumab (Campath),2016-07-26,,300,MIU,['3 / Week'],Oral, 
16211,4250,Tysabri,2016-10-08,2018-05-17,500,mg,['/Month'], ,Patient Choice/Convenience
16212,987,Mitoxantrone,2016-07-15,,500,mg,['/Month'],IV, 
16213,987,IVIG,2016-10-15,2018-12-28,5000, ,[' '],IV,Persisting MRI activity
16214,987,Alemtuzumab (Campath),2016-05-09,2018-04-17,20,mg,['/Month'],IV,Adverse Event
16215,3675,Rebif [44],2015-11-12,2020-01-22, , ,['2 / Day'], ,Persisting MRI activity
16216,3675,Methylprednisolone,2016-02-21,2021-03-21,400,mg,[' '],IV,Patient Choice/Convenience
16217,3463,D-cure (Vitamine D),2016-06-26,2018-10-27,1,mg,['/Month'], ,Adverse Event
16218,3463,Ledertrexaat,2016-09-16,,5000,mg,['2 / Day'], , 
16219,3463,Copaxone,2016-05-19,,300,mg,['/Month'],IV, 
16220,712,Copaxone,2015-11-11,2021-05-14,500,MIU,['/Month'], ,Patient Choice/Convenience
16221,712,Endoxan,2016-08-01,,500,mcg,['2 / Day'],IV, 
16222,712,Rebif [22],2016-06-24,2018-08-15,20,MIU,['/ Week'],Oral,Adverse Event
16223,712,Avonex,2016-10-21,,300,mg,[' '], , 
16224,1035,Methylprednisolone,2016-07-24,2020-07-25, ,MIU,['3 / Week'],IV,Lack of efficacy
16225,1035,Rebif [44],2016-10-16,2017-11-11,300, ,['/Month'],IV,Adverse Event
16226,1035,Methylprednisolone,2016-08-17,2021-04-15, , ,['/Month'],IV,Lack of efficacy
16227,1035,Methylprednisolone,2016-09-12,,20,MIU,['/Month'],IV, 
16228,3510,Endoxan,2016-07-10,,500,mg,['3 / Week'],IV, 
16229,395,Copaxone,2016-01-08,, ,mg,['2 / Day'], , 
16230,395,IVIG,2016-02-21,2018-03-05,1,mcg,['2 / Day'],IV,Patient Choice/Convenience
16231,395,Betaferon,2016-06-26,2020-10-22,500,mg,['3 / Week'],Oral,Persisting MRI activity
16232,2999,Alemtuzumab (Campath),2016-07-14,2018-12-19,1000,mg,['/Month'],IV,Adverse Event
16233,2999,Rebif [22],2016-07-23,2018-11-30,1000,mg,['/Month'],IV,Lack of efficacy
16234,2999,Methylprednisolone,2016-04-28,,400,mg,['3 / Week'],IV, 
16235,2946,Alemtuzumab (Campath),2016-01-03,2020-03-26, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
16236,2946,Methylprednisolone,2015-12-24,,20,mg,['/Month'],IV, 
16237,2946,Rebif [22],2016-09-04,,5000, ,['2 / Day'],IV, 
16238,1538,Rebif [44],2016-03-03,,1,mg,['/Month'],IV, 
16239,1538,D-cure (Vitamine D),2016-09-05,2020-04-03, , ,['/ Day'],IV,Patient Choice/Convenience
16240,1538,Methylprednisolone,2016-09-27,,500,mg,['/Month'],IV, 
16241,1538,Endoxan,2015-11-21,2020-09-02, ,mg,['/Month'],IV,Lack of efficacy
16242,667,Endoxan,2015-11-07,2018-11-20, , ,['2 / Day'],IV,Lack of efficacy
16243,4204,D-cure (Vitamine D),2016-03-06,,500,MIU,['2 / Day'],IV, 
16244,4204,Betaferon,2016-05-07,,20,mg,['2 / Day'],IV, 
16245,4204,Tecfidera,2016-03-15,, , ,['2 / Day'], , 
16246,3198,Rebif [22],2016-09-25,,300,MIU,['/ Day'],IV, 
16247,4405,Rebif [22],2016-03-29,2021-10-18, ,mg,['/Month'],IV,Patient Choice/Convenience
16248,4405,Betaferon,2016-10-12,,5000,MIU,['2 / Day'],IV, 
16249,1956,Tecfidera,2016-06-17,, ,mg,['/ Day'], , 
16250,1956,Ledertrexaat,2015-10-28,2018-07-16, ,mg,['2 / Day'], ,Persisting MRI activity
16251,1956,Methylprednisolone,2016-01-08,2020-10-15, , ,['2 / Day'],IV,Patient Choice/Convenience
16252,852,Rebif [44],2016-05-04,2019-09-03,1000, ,['/Month'],IV,Adverse Event
16253,2842,Alemtuzumab (Campath),2016-08-05,2018-11-17,20, ,['2 / Day'], ,Lack of efficacy
16254,2842,Alemtuzumab (Campath),2016-08-17,,1,MIU,['/Month'],IV, 
16255,2842,Tecfidera,2016-06-25,,400,mg,[' '],IV, 
16256,4733,Endoxan,2016-02-17,2019-03-17,500,mcg,['2 / Day'], ,Adverse Event
16257,3051,IVIG,2016-04-08,2019-12-11,5000,mg,['/Month'],IV,Adverse Event
16258,2800,Ledertrexaat,2015-12-15,, , ,['3 / Week'],IV, 
16259,271,Ledertrexaat,2016-10-04,2018-04-01,20, ,[' '],IV,Adverse Event
16260,271,IVIG,2016-05-02,,1000,mcg,['2 / Day'], , 
16261,2356,Gilenya,2016-02-16,2018-02-08,300, ,['3 / Week'], ,Patient Choice/Convenience
16262,2356,D-cure (Vitamine D),2016-07-30,2017-11-08, , ,['/Month'],IV,Patient Choice/Convenience
16263,2356,Rebif [22],2016-04-30,, ,MIU,['2 / Day'], , 
16264,2356,Rebif [22],2015-12-26,2018-10-28,1,mg,['/Month'],IV,Lack of efficacy
16265,926,Mitoxantrone,2016-08-15,,500,MIU,['/Month'],Oral, 
16266,1356,Ledertrexaat,2016-08-01,,1000, ,['/Month'],Oral, 
16267,2601,Mitoxantrone,2016-10-08,, ,mg,['/Month'], , 
16268,2601,IVIG,2016-09-06,2019-07-20, , ,['3 / Week'],IV,Persistence of relapses
16269,3412,Rebif [44],2016-01-24,, ,mg,['/ Week'],IV, 
16270,3412,Endoxan,2016-08-30,,1,mg,['2 / Day'],IV, 
16271,4569,Teriflunomide,2015-11-27,, , ,['2 / Day'],IV, 
16272,4569,Tecfidera,2016-09-27,2021-06-02, , ,['2 / Day'],IV,Adverse Event
16273,4569,IVIG,2016-02-25,, ,mg,['/Month'],IV, 
16274,325,IVIG,2016-04-14,,400,mg,['2 / Day'], , 
16275,325,Avonex,2015-12-29,, , ,['/Month'],IV, 
16276,1951,Endoxan,2016-05-05,2019-07-04,5000, ,['2 / Day'], ,Persisting MRI activity
16277,1951,Tecfidera,2016-09-11,,400, ,['/Month'],Oral, 
16278,1951,Teriflunomide,2016-04-24,,1,mg,[' '], , 
16279,1951,Alemtuzumab (Campath),2016-01-20,,400,mg,['/Month'],IV, 
16280,2400,Betaferon,2016-07-21,2020-03-30, ,mcg,['/Month'],IV,Patient Choice/Convenience
16281,2400,Tysabri,2015-11-22,2021-04-26,400,MIU,['3 / Week'], ,Patient Choice/Convenience
16282,2400,Avonex,2016-08-16,, ,mg,['/Month'],IV, 
16283,2400,Teriflunomide,2016-01-20,, , ,['/Month'], , 
16284,160,Mitoxantrone,2016-09-23,,500,mg,['2 / Day'],Oral, 
16285,2861,Copaxone,2016-06-05,, ,mg,['2 / Day'],IV, 
16286,2861,Tecfidera,2016-05-20,,1000,mg,['/Month'], , 
16287,2861,Endoxan,2016-06-06,2019-06-27,5000,mg,['2 / Day'], ,Adverse Event
16288,2861,Avonex,2016-02-26,2019-02-06, , ,['/Month'],IV,Persistence of relapses
16289,4292,Endoxan,2016-03-01,, ,mg,['/Month'], , 
16290,4292,Mitoxantrone,2016-08-01,, ,mg,['2 / Day'],IV, 
16291,4292,Methylprednisolone,2015-11-13,,300,mg,['2 / Day'],Oral, 
16292,3399,Endoxan,2016-08-22,2019-09-11, ,mg,['/ Day'], ,Lack of efficacy
16293,3399,Ledertrexaat,2016-08-27,2019-08-12,1000, ,['/ Week'], ,Adverse Event
16294,3491,Tysabri,2016-10-11,,20,mg,['/Month'], , 
16295,3491,Tecfidera,2016-06-07,2019-10-12,20,mg,['2 / Day'], ,Adverse Event
16296,4912,IVIG,2016-04-04,,20,mg,['/Month'],Oral, 
16297,4912,Tysabri,2016-08-18,,1000, ,['2 / Day'],IV, 
16298,1576,Tecfidera,2016-10-21,2018-03-21,300,mg,['/Month'],IV,Lack of efficacy
16299,1576,Tecfidera,2015-10-27,2019-12-20,20,mg,['3 / Week'],IV,Persisting MRI activity
16300,4571,Tysabri,2016-02-12,,1000, ,['/Month'],IV, 
16301,4571,Methylprednisolone,2016-05-09,, ,mg,['2 / Day'], , 
16302,1852,Rebif [44],2015-11-11,2021-01-21,1000,mg,['3 / Week'], ,Adverse Event
16303,1852,Endoxan,2016-02-06,2019-02-10,20, ,['/ Day'], ,Adverse Event
16304,3058,IVIG,2016-04-23,2018-08-18,5000, ,['2 / Day'], ,Patient Choice/Convenience
16305,207,Rebif [44],2016-08-24,, ,mg,['3 / Week'],Oral, 
16306,3492,IVIG,2016-10-07,, ,MIU,['/ Week'],IV, 
16307,3492,Mitoxantrone,2016-03-28,,5000,mg,['2 / Day'], , 
16308,3492,IVIG,2016-06-15,,5000, ,['2 / Day'],IV, 
16309,3492,Rebif [44],2016-09-20,,20,mcg,['2 / Day'], , 
16310,2456,Methylprednisolone,2016-01-12,,400,MIU,['/Month'],Oral, 
16311,2456,Betaferon,2015-11-09,2019-12-20,1,mg,[' '],IV,Persisting MRI activity
16312,2456,Tysabri,2015-11-25,2018-05-24,300,mcg,[' '],IV,Persistence of relapses
16313,2456,Ledertrexaat,2016-10-11,, , ,['/Month'], , 
16314,244,Tysabri,2015-10-24,,20,mg,[' '], , 
16315,244,Mitoxantrone,2016-09-01,,400,mg,[' '],IV, 
16316,244,Alemtuzumab (Campath),2016-04-06,2019-11-27, ,mg,['2 / Day'],IV,Patient Choice/Convenience
16317,4350,Tysabri,2016-08-28,, ,MIU,['2 / Day'],IV, 
16318,3483,Methylprednisolone,2016-06-13,,1,mg,['3 / Week'],IV, 
16319,3483,Tecfidera,2016-05-31,2020-05-05,20, ,['3 / Week'], ,Lack of efficacy
16320,3483,Endoxan,2016-05-03,2019-05-30,20,mg,['/ Day'],Oral,Adverse Event
16321,3483,Tysabri,2016-06-06,2018-12-25,400,mg,['2 / Day'],IV,Adverse Event
16322,3231,D-cure (Vitamine D),2016-05-01,2017-10-26, ,mcg,['/Month'],IV,Persistence of relapses
16323,3231,Copaxone,2016-06-06,,500, ,['/ Day'],IV, 
16324,3231,Methylprednisolone,2015-12-17,,1000, ,['/Month'],IV, 
16325,3231,Ledertrexaat,2016-03-31,, , ,['/Month'],IV, 
16326,215,Gilenya,2016-06-07,, , ,['/Month'], , 
16327,215,D-cure (Vitamine D),2015-12-03,2019-10-25,300,mg,['/Month'],Oral,Adverse Event
16328,215,IVIG,2016-02-17,2018-11-23,20, ,['/Month'],IV,Lack of efficacy
16329,215,Rebif [44],2016-08-02,, ,mg,['/ Day'],IV, 
16330,4686,Ledertrexaat,2015-11-10,,400, ,['/Month'],IV, 
16331,4686,Tecfidera,2016-03-01,2019-07-29,1,mg,['3 / Week'],IV,Persisting MRI activity
16332,4686,IVIG,2016-07-23,2019-02-28, ,mg,['/Month'], ,Persisting MRI activity
16333,4686,Methylprednisolone,2016-03-22,,20,mg,['/Month'],IV, 
16334,535,IVIG,2016-06-15,2019-08-21,20, ,['/Month'],IV,Persisting MRI activity
16335,157,Tecfidera,2016-06-23,2019-12-06, ,MIU,['2 / Day'],IV,Persistence of relapses
16336,157,D-cure (Vitamine D),2016-04-13,, , ,['2 / Day'],Oral, 
16337,4915,Methylprednisolone,2016-01-27,,500,mg,['/Month'],IV, 
16338,664,Betaferon,2015-11-07,, ,mg,['/ Week'],IV, 
16339,664,Betaferon,2016-07-18,2021-08-01,500, ,['2 / Day'], ,Adverse Event
16340,3585,Tecfidera,2016-02-23,,1,mcg,[' '],IV, 
16341,3620,Endoxan,2016-01-19,, , ,[' '],IV, 
16342,3620,Tysabri,2016-01-01,2020-05-03, ,mg,['2 / Day'],IV,Lack of efficacy
16343,3620,Tysabri,2015-11-27,2020-11-25, , ,['/Month'], ,Patient Choice/Convenience
16344,3155,Rebif [22],2016-04-16,, , ,['/Month'],IV, 
16345,3155,Rebif [44],2016-02-17,,20, ,['2 / Day'],IV, 
16346,3910,D-cure (Vitamine D),2016-09-26,2020-02-22,20, ,['3 / Week'], ,Adverse Event
16347,3910,Gilenya,2016-03-14,,20,mg,['2 / Day'], , 
16348,3910,Avonex,2015-10-29,, , ,['/Month'],Oral, 
16349,3910,IVIG,2016-09-30,2019-03-17,20, ,['/Month'],Oral,Patient Choice/Convenience
16350,4002,Alemtuzumab (Campath),2016-06-05,2019-04-01,1000,mg,['3 / Week'],IV,Adverse Event
16351,4002,Mitoxantrone,2016-08-21,,300, ,['2 / Day'], , 
16352,4002,Methylprednisolone,2016-08-25,2019-11-24, , ,['2 / Day'],Oral,Patient Choice/Convenience
16353,4229,Rebif [22],2016-05-12,,500,mg,[' '],IV, 
16354,4229,Endoxan,2016-10-01,,1000,mg,['2 / Day'],Oral, 
16355,4229,Avonex,2016-09-04,2018-11-05,300, ,['3 / Week'], ,Adverse Event
16356,4250,Mitoxantrone,2016-05-27,2018-06-06,300,mg,['/Month'], ,Adverse Event
16357,4250,Gilenya,2015-11-03,2019-01-10,1000, ,['3 / Week'],IV,Adverse Event
16358,4250,Endoxan,2016-05-27,2017-12-05, , ,['3 / Week'],IV,Persisting MRI activity
16359,4250,Rebif [22],2016-05-30,2020-01-11,300, ,['/Month'],IV,Persisting MRI activity
16360,2134,Rebif [22],2016-01-16,, ,mg,['/Month'],IV, 
16361,2134,Rebif [44],2016-05-07,2020-08-13,1,mg,['3 / Week'], ,Adverse Event
16362,1302,Gilenya,2016-03-23,2019-07-30,1000,mg,['/Month'], ,Persisting MRI activity
16363,1302,IVIG,2016-02-24,2019-08-05,1000, ,['2 / Day'],Oral,Persisting MRI activity
16364,2770,Avonex,2016-07-12,2019-03-03, ,mg,['2 / Day'],IV,Persisting MRI activity
16365,2537,Rebif [22],2015-12-21,,300, ,['/Month'],IV, 
16366,2137,Gilenya,2015-12-07,, ,mg,['2 / Day'], , 
16367,2137,Tysabri,2015-10-27,2021-08-11,500,mg,['/Month'], ,Adverse Event
16368,2961,D-cure (Vitamine D),2016-01-22,, , ,['/Month'],IV, 
16369,2961,IVIG,2016-08-01,2018-08-05,20,MIU,['/Month'],IV,Adverse Event
16370,4021,Tecfidera,2016-09-30,, , ,[' '],IV, 
16371,4021,Copaxone,2016-04-23,2018-09-27,20, ,['2 / Day'],IV,Persistence of relapses
16372,4021,Rebif [44],2016-10-12,2021-07-04,1000, ,['/Month'], ,Persisting MRI activity
16373,4021,Tecfidera,2016-04-01,,400,mg,['3 / Week'],IV, 
16374,2159,D-cure (Vitamine D),2015-12-02,2019-03-07, , ,['/ Day'],IV,Persisting MRI activity
16375,865,Gilenya,2016-01-12,,500, ,['/Month'],IV, 
16376,865,IVIG,2016-09-30,,1000,MIU,['2 / Day'],Oral, 
16377,865,Ledertrexaat,2016-06-17,2021-01-22,1000, ,['3 / Week'],IV,Lack of efficacy
16378,1732,Tecfidera,2016-10-03,2020-08-24,20,MIU,['2 / Day'],IV,Persisting MRI activity
16379,1732,Tysabri,2016-01-19,2019-03-22, ,mg,['2 / Day'], ,Patient Choice/Convenience
16380,1732,Tysabri,2016-09-03,2019-05-01,1000,MIU,['3 / Week'],IV,Patient Choice/Convenience
16381,1732,Avonex,2016-04-18,,1,mg,['/Month'], , 
16382,3889,Ledertrexaat,2016-08-25,2021-04-03,20,mg,['/ Week'],IV,Adverse Event
16383,1685,Rebif [44],2015-10-25,2020-12-07,20,mg,['2 / Day'],IV,Persisting MRI activity
16384,1685,Endoxan,2015-11-15,, , ,['/ Day'],IV, 
16385,1685,Rebif [44],2016-09-05,2019-09-23,500,mg,['/Month'],IV,Adverse Event
16386,4440,Endoxan,2016-08-01,,5000, ,['2 / Day'],IV, 
16387,4440,Methylprednisolone,2016-06-11,2018-12-04,500, ,['/Month'],Oral,Patient Choice/Convenience
16388,4440,Rebif [44],2016-07-22,,400, ,['/Month'],IV, 
16389,4440,Avonex,2016-01-14,2018-11-25, ,mg,[' '],IV,Persisting MRI activity
16390,2327,Alemtuzumab (Campath),2016-02-13,2020-04-12,5000,mg,['2 / Day'],IV,Adverse Event
16391,2327,D-cure (Vitamine D),2016-05-03,,300, ,['/Month'], , 
16392,2327,Tysabri,2016-04-28,,500,mg,['2 / Day'],IV, 
16393,983,D-cure (Vitamine D),2016-02-23,,500,mg,['2 / Day'],Oral, 
16394,983,IVIG,2015-12-03,,5000, ,['3 / Week'], , 
16395,4763,IVIG,2016-10-15,2020-09-20,5000,mg,['2 / Day'],Oral,Persistence of relapses
16396,4763,Endoxan,2016-09-19,2020-10-16,20,mg,['/Month'],IV,Lack of efficacy
16397,4763,Methylprednisolone,2016-04-28,,20, ,['2 / Day'], , 
16398,1836,Ledertrexaat,2016-04-21,2020-11-04, , ,['3 / Week'],IV,Lack of efficacy
16399,1836,Tysabri,2016-05-10,2020-05-12,400,MIU,['2 / Day'],IV,Lack of efficacy
16400,532,IVIG,2016-01-01,2021-07-05,5000,mg,['/ Day'],IV,Adverse Event
16401,532,Tecfidera,2016-08-10,,300, ,['3 / Week'], , 
16402,532,Teriflunomide,2016-06-08,, , ,['/Month'], , 
16403,532,Ledertrexaat,2016-08-03,2021-09-27,500,MIU,['2 / Day'], ,Lack of efficacy
16404,3809,Methylprednisolone,2016-01-24,,1,mg,[' '], , 
16405,3809,Rebif [44],2016-07-14,,1000,mg,['2 / Day'],IV, 
16406,3653,Tecfidera,2016-10-01,, ,mg,[' '],Oral, 
16407,3653,Rebif [44],2016-04-23,, , ,['3 / Week'], , 
16408,3653,Alemtuzumab (Campath),2015-12-24,, ,mg,['2 / Day'], , 
16409,3653,Endoxan,2016-04-21,,5000,mg,['2 / Day'], , 
16410,2614,Teriflunomide,2016-02-26,,500,MIU,['/Month'], , 
16411,2614,Endoxan,2015-11-02,2018-05-08,5000,mcg,['/ Day'],IV,Patient Choice/Convenience
16412,2614,Gilenya,2016-09-12,2021-05-13,20, ,['/Month'],Oral,Adverse Event
16413,1182,Alemtuzumab (Campath),2015-12-21,2019-08-25,1000,mg,['2 / Day'],IV,Persisting MRI activity
16414,430,Rebif [44],2015-11-06,, ,mg,['2 / Day'],IV, 
16415,430,Tecfidera,2015-11-27,,500,mg,['2 / Day'], , 
16416,1288,IVIG,2016-02-10,2020-06-24,1, ,[' '], ,Adverse Event
16417,1288,Copaxone,2016-09-14,,300, ,['3 / Week'],IV, 
16418,4301,Tecfidera,2016-05-14,,1000,mg,['/Month'], , 
16419,4301,Gilenya,2016-01-01,2019-11-30,500,mg,['/ Day'],IV,Adverse Event
16420,3869,Rebif [44],2016-08-13,2018-07-23,20,MIU,['/Month'],Oral,Adverse Event
16421,3869,Rebif [22],2016-10-07,,300, ,['/Month'], , 
16422,3869,Ledertrexaat,2016-02-12,2020-08-02,1000, ,['3 / Week'],IV,Persisting MRI activity
16423,3869,Tysabri,2016-08-04,,5000,mcg,['/ Day'],Oral, 
16424,1997,Avonex,2016-07-16,2020-11-20,1000,mg,['/ Week'], ,Lack of efficacy
16425,1997,Endoxan,2016-09-16,,20,mg,['2 / Day'],Oral, 
16426,1668,Rebif [22],2015-10-30,,1,mg,['2 / Day'],IV, 
16427,1668,Tecfidera,2016-09-29,2021-05-30,5000, ,['/Month'], ,Adverse Event
16428,559,Rebif [22],2016-09-02,,300, ,['3 / Week'],Oral, 
16429,3699,Betaferon,2016-06-24,,1,mcg,['2 / Day'],IV, 
16430,451,Gilenya,2016-06-07,, , ,['3 / Week'], , 
16431,451,IVIG,2016-07-24,,1, ,['/Month'],IV, 
16432,451,Tysabri,2016-06-20,2019-07-19, , ,['/ Day'],IV,Adverse Event
16433,3413,Rebif [44],2016-03-28,, , ,['/ Day'],Oral, 
16434,3413,IVIG,2016-06-26,,5000,MIU,['2 / Day'],IV, 
16435,3413,IVIG,2016-10-09,2019-06-06,20,mg,['2 / Day'], ,Persistence of relapses
16436,3411,Copaxone,2016-06-06,2021-04-01,20,mg,['/Month'], ,Patient Choice/Convenience
16437,3411,D-cure (Vitamine D),2016-01-13,,5000, ,['/Month'], , 
16438,3411,Methylprednisolone,2016-04-24,,1000,mg,['2 / Day'],IV, 
16439,3411,IVIG,2016-08-07,, , ,['/Month'],IV, 
16440,847,Endoxan,2015-12-28,2020-08-26,300, ,['/Month'],Oral,Adverse Event
16441,847,Alemtuzumab (Campath),2016-08-11,,1, ,['/Month'],IV, 
16442,847,Tecfidera,2016-04-26,,300, ,['2 / Day'],IV, 
16443,847,Teriflunomide,2016-04-28,2018-02-07,5000,MIU,['2 / Day'],IV,Persisting MRI activity
16444,4313,Rebif [22],2016-10-16,, , ,['2 / Day'],IV, 
16445,4313,Tecfidera,2016-08-09,2018-09-25, , ,['2 / Day'],IV,Persistence of relapses
16446,4313,D-cure (Vitamine D),2015-11-29,,5000, ,['2 / Day'], , 
16447,1961,D-cure (Vitamine D),2016-08-19,2019-08-17, , ,['3 / Week'],IV,Patient Choice/Convenience
16448,1961,Rebif [44],2015-10-31,2019-12-21, ,mg,['/ Week'],IV,Persisting MRI activity
16449,1961,Betaferon,2016-04-30,,1000,mg,['/Month'],IV, 
16450,3299,D-cure (Vitamine D),2016-02-22,,500, ,['3 / Week'], , 
16451,350,D-cure (Vitamine D),2016-06-02,, ,mg,['2 / Day'],IV, 
16452,350,Teriflunomide,2015-10-29,,1000, ,['/ Day'],IV, 
16453,1614,Tecfidera,2016-08-08,,5000, ,['/Month'],IV, 
16454,1614,IVIG,2015-11-04,2018-01-21, , ,['/Month'],IV,Patient Choice/Convenience
16455,1614,Alemtuzumab (Campath),2016-08-19,,1,mg,['/Month'],IV, 
16456,3673,Tysabri,2016-07-24,2021-08-02,300, ,['3 / Week'],IV,Lack of efficacy
16457,3673,Tecfidera,2015-11-09,, ,MIU,['3 / Week'],IV, 
16458,2366,Alemtuzumab (Campath),2015-10-28,2021-08-28,5000,mg,['2 / Day'],Oral,Patient Choice/Convenience
16459,2366,Methylprednisolone,2016-10-20,, ,MIU,['/Month'],IV, 
16460,2366,Tecfidera,2015-12-13,, ,mg,['3 / Week'],IV, 
16461,203,Endoxan,2016-03-10,,5000,mg,['3 / Week'],IV, 
16462,134,Rebif [22],2016-05-04,2017-10-27,300, ,['2 / Day'],Oral,Adverse Event
16463,134,Endoxan,2016-08-14,,5000,mg,['2 / Day'], , 
16464,134,Alemtuzumab (Campath),2016-08-17,2019-02-21, ,MIU,[' '], ,Persistence of relapses
16465,712,Avonex,2015-11-25,2019-10-27,1,mg,[' '],Oral,Adverse Event
16466,712,Endoxan,2016-04-13,2018-08-17,20, ,['3 / Week'],Oral,Patient Choice/Convenience
16467,3994,Gilenya,2015-11-23,2020-01-15,400,MIU,['3 / Week'],IV,Patient Choice/Convenience
16468,3994,Rebif [22],2016-09-30,,5000, ,['2 / Day'],IV, 
16469,3994,Copaxone,2016-04-20,, ,mg,['/Month'], , 
16470,1439,IVIG,2016-01-28,,400,mg,['2 / Day'],IV, 
16471,1439,Ledertrexaat,2016-08-05,,20, ,['/Month'],IV, 
16472,1439,Alemtuzumab (Campath),2016-09-16,2018-05-16, ,mcg,['2 / Day'], ,Persisting MRI activity
16473,1439,Gilenya,2016-07-11,,1000, ,['3 / Week'],Oral, 
16474,4651,Tecfidera,2016-01-18,2018-10-23,300,mcg,['3 / Week'],IV,Lack of efficacy
16475,2603,Rebif [44],2016-10-19,2020-12-02, ,mcg,['/ Day'],IV,Adverse Event
16476,2603,IVIG,2015-11-08,, ,mg,['2 / Day'],Oral, 
16477,3302,Tecfidera,2016-08-06,,20,mg,['/ Day'], , 
16478,4848,Betaferon,2016-08-16,,300, ,['/Month'], , 
16479,3563,Tecfidera,2016-04-10,, ,mg,['/Month'],IV, 
16480,3563,Teriflunomide,2016-01-25,2020-11-20,1000,mg,['/Month'], ,Persisting MRI activity
16481,3563,Mitoxantrone,2016-10-08,,500, ,['2 / Day'],IV, 
16482,3563,Teriflunomide,2016-04-11,,1, ,[' '],IV, 
16483,183,Ledertrexaat,2016-07-08,2017-12-18,1000,MIU,['2 / Day'],IV,Persisting MRI activity
16484,183,Tysabri,2016-04-06,,5000, ,['/ Week'],IV, 
16485,183,Methylprednisolone,2016-07-10,,20, ,['/Month'],Oral, 
16486,697,D-cure (Vitamine D),2016-08-25,2020-11-06,300,mcg,['/Month'], ,Persisting MRI activity
16487,697,Rebif [44],2016-10-20,2019-09-26,1000, ,['/ Day'],IV,Adverse Event
16488,697,Betaferon,2016-10-12,2019-12-20,300,mcg,['2 / Day'], ,Patient Choice/Convenience
16489,697,D-cure (Vitamine D),2016-03-30,2019-03-12,400,mcg,['/ Week'],IV,Adverse Event
16490,4533,Teriflunomide,2015-10-25,,5000,mg,['2 / Day'], , 
16491,4533,Tysabri,2015-12-24,,1000,MIU,['/Month'], , 
16492,2369,Gilenya,2016-05-19,,5000,mg,['2 / Day'],IV, 
16493,2369,IVIG,2016-09-02,,300,mg,['/Month'],Oral, 
16494,2369,Rebif [44],2016-08-19,2020-06-25,500,mcg,['/ Day'],IV,Persisting MRI activity
16495,2369,IVIG,2016-07-18,, ,mg,['2 / Day'],IV, 
16496,3001,Avonex,2016-04-16,,1,mg,['/Month'],IV, 
16497,3001,Alemtuzumab (Campath),2016-09-25,,500,mg,['2 / Day'],IV, 
16498,4124,Rebif [44],2016-08-29,2021-09-20,20, ,['2 / Day'], ,Lack of efficacy
16499,4124,Rebif [44],2016-04-12,,20, ,['/Month'],Oral, 
16500,4124,Mitoxantrone,2016-02-15,2020-02-04,5000, ,['/Month'],IV,Persistence of relapses
16501,1639,Teriflunomide,2016-06-03,, , ,[' '], , 
16502,1639,Betaferon,2016-05-28,,5000, ,['2 / Day'],IV, 
16503,2090,Avonex,2015-11-23,,20,mg,['2 / Day'], , 
16504,2090,Endoxan,2015-11-18,2020-04-21,1000, ,['/Month'], ,Persisting MRI activity
16505,2090,Gilenya,2016-05-23,,1000,mg,['2 / Day'], , 
16506,417,Alemtuzumab (Campath),2016-04-03,2019-08-04,1000, ,['2 / Day'],IV,Adverse Event
16507,417,Rebif [44],2016-01-02,2021-09-27,20, ,['2 / Day'],IV,Patient Choice/Convenience
16508,4944,Avonex,2016-02-04,, ,mg,['2 / Day'],Oral, 
16509,4944,Gilenya,2016-02-16,,1000,mg,['2 / Day'], , 
16510,280,IVIG,2016-01-11,,5000, ,['3 / Week'], , 
16511,280,D-cure (Vitamine D),2016-09-23,2018-04-01,1, ,['/Month'], ,Persistence of relapses
16512,280,Endoxan,2016-06-09,,500,MIU,['/ Day'],IV, 
16513,280,Mitoxantrone,2016-06-25,2019-04-18,500, ,['3 / Week'], ,Adverse Event
16514,312,Tecfidera,2016-04-22,,300,mg,['2 / Day'], , 
16515,312,Ledertrexaat,2016-09-24,2020-12-21,20,mg,['2 / Day'], ,Persisting MRI activity
16516,2919,Avonex,2016-08-15,, , ,['/Month'],Oral, 
16517,3049,Tysabri,2015-12-29,, ,mg,['2 / Day'],IV, 
16518,3049,Copaxone,2016-05-15,,500, ,['3 / Week'],IV, 
16519,3049,Betaferon,2015-10-29,,500, ,['/Month'], , 
16520,3049,Tysabri,2016-01-16,2018-03-17, , ,['2 / Day'], ,Persistence of relapses
16521,2319,Avonex,2016-06-08,2021-01-04,1, ,['3 / Week'], ,Persisting MRI activity
16522,2319,Rebif [44],2016-10-04,2019-01-09,300, ,['2 / Day'],Oral,Patient Choice/Convenience
16523,2709,IVIG,2015-12-01,2021-07-21,20,mg,['/Month'],IV,Persistence of relapses
16524,2709,D-cure (Vitamine D),2016-01-20,,20,mg,['/ Week'],IV, 
16525,3846,Copaxone,2016-09-18,2019-07-13, ,mcg,['/ Week'],IV,Persistence of relapses
16526,3846,Tysabri,2016-08-28,2018-01-27, ,mg,['2 / Day'],IV,Patient Choice/Convenience
16527,4388,Gilenya,2016-04-09,,500,mg,['2 / Day'], , 
16528,4388,Betaferon,2016-08-15,,500,mg,['/ Week'],IV, 
16529,4388,Alemtuzumab (Campath),2016-02-23,,20,mg,['2 / Day'],IV, 
16530,4388,Betaferon,2015-12-22,2021-06-21,1000, ,['2 / Day'], ,Adverse Event
16531,2496,Gilenya,2016-01-14,2021-02-07, ,mcg,['2 / Day'],Oral,Adverse Event
16532,2496,Tecfidera,2016-05-10,2020-06-15,400, ,['/Month'],IV,Patient Choice/Convenience
16533,2496,Rebif [22],2016-05-02,,400,mg,['3 / Week'],IV, 
16534,2496,Teriflunomide,2016-05-10,,20,mg,[' '],Oral, 
16535,3365,Mitoxantrone,2015-10-26,2021-05-07,20,mg,[' '],IV,Adverse Event
16536,3365,D-cure (Vitamine D),2016-09-08,,300,mg,['/Month'],Oral, 
16537,3365,Endoxan,2016-04-16,2018-11-23, ,MIU,['/Month'], ,Persisting MRI activity
16538,3365,Gilenya,2016-08-21,,1000,mg,['2 / Day'], , 
16539,2073,Rebif [22],2016-06-13,,1000, ,['2 / Day'],IV, 
16540,2073,Alemtuzumab (Campath),2016-08-27,, ,mcg,['2 / Day'], , 
16541,2073,Ledertrexaat,2016-07-28,2021-02-07,400, ,['/ Week'],IV,Lack of efficacy
16542,4356,Copaxone,2016-10-03,,500,mg,['2 / Day'], , 
16543,4356,Methylprednisolone,2015-11-24,2020-10-07, , ,['/Month'],IV,Patient Choice/Convenience
16544,4356,Tysabri,2015-12-30,, ,mcg,['2 / Day'],Oral, 
16545,4356,Avonex,2016-05-17,2019-02-20,500,MIU,['/Month'], ,Patient Choice/Convenience
16546,342,D-cure (Vitamine D),2015-11-21,2018-11-21, , ,['/Month'],IV,Persistence of relapses
16547,342,Betaferon,2016-04-29,,500,MIU,['/ Day'], , 
16548,342,Betaferon,2016-03-19,,1000,mg,['/Month'], , 
16549,342,Alemtuzumab (Campath),2016-05-12,, , ,['/Month'],IV, 
16550,4696,Copaxone,2016-10-10,, , ,['3 / Week'],IV, 
16551,4696,Avonex,2016-06-08,, , ,['/Month'],IV, 
16552,3697,Tecfidera,2016-08-13,,400, ,['/Month'],Oral, 
16553,3697,Betaferon,2016-10-13,,300,mg,['3 / Week'],IV, 
16554,1392,Gilenya,2016-08-21,, ,mg,[' '],IV, 
16555,1392,Rebif [22],2016-01-19,2019-07-07, , ,['2 / Day'],IV,Adverse Event
16556,1392,Methylprednisolone,2016-10-15,, , ,['2 / Day'],IV, 
16557,1731,Ledertrexaat,2016-02-27,, ,mcg,['2 / Day'],IV, 
16558,3066,IVIG,2016-08-04,2021-09-10,300,mcg,['/Month'], ,Lack of efficacy
16559,3066,Endoxan,2016-01-13,,20,MIU,['/Month'],IV, 
16560,2157,Avonex,2016-01-26,2020-08-04,1, ,['/Month'],IV,Adverse Event
16561,2157,Methylprednisolone,2016-01-20,, ,mg,['2 / Day'],IV, 
16562,3973,IVIG,2016-04-04,,1,mg,['/ Day'],IV, 
16563,295,Gilenya,2016-05-22,2021-05-04, , ,['/ Week'], ,Lack of efficacy
16564,295,Gilenya,2016-10-16,,300,mg,['2 / Day'], , 
16565,295,Tysabri,2015-12-07,2019-08-07, , ,['2 / Day'],Oral,Lack of efficacy
16566,1740,Tysabri,2015-11-08,, , ,['/ Week'], , 
16567,1740,D-cure (Vitamine D),2016-02-04,2017-12-13, ,MIU,['2 / Day'],IV,Persistence of relapses
16568,1740,Gilenya,2016-08-16,2020-02-11,500,MIU,['/ Day'],IV,Patient Choice/Convenience
16569,3879,Tecfidera,2016-10-03,, , ,['/ Week'],IV, 
16570,3879,Tysabri,2016-01-01,2020-05-12,500, ,['/ Day'], ,Persisting MRI activity
16571,3879,Rebif [22],2016-05-17,2017-12-25,5000,mg,['2 / Day'],IV,Persisting MRI activity
16572,4485,Copaxone,2016-03-26,, ,mg,[' '],IV, 
16573,4485,Copaxone,2016-06-26,2021-07-07,5000,MIU,['2 / Day'],IV,Lack of efficacy
16574,4475,Methylprednisolone,2016-01-04,2021-07-10,300,MIU,['/ Day'], ,Lack of efficacy
16575,4475,D-cure (Vitamine D),2016-06-14,2021-05-12, ,mg,['/Month'],IV,Adverse Event
16576,4475,Gilenya,2016-08-20,, ,mcg,['2 / Day'], , 
16577,4475,Gilenya,2016-09-19,,500,mg,['2 / Day'], , 
16578,4280,Gilenya,2015-11-29,,1,mg,['2 / Day'],IV, 
16579,2477,Teriflunomide,2015-12-31,,500,mg,['/Month'],Oral, 
16580,3077,Mitoxantrone,2015-12-14,, ,mcg,['/Month'], , 
16581,3077,Teriflunomide,2016-10-04,,300,mcg,['2 / Day'],Oral, 
16582,3077,Tysabri,2015-12-17,2018-09-08,300,mg,['/ Day'],IV,Patient Choice/Convenience
16583,3077,Tysabri,2016-09-30,, , ,['3 / Week'], , 
16584,1700,IVIG,2016-05-30,, ,mg,['2 / Day'],Oral, 
16585,1227,Methylprednisolone,2016-07-11,, ,mg,['2 / Day'],Oral, 
16586,4908,Tecfidera,2016-02-16,,20,mg,['2 / Day'],IV, 
16587,4908,D-cure (Vitamine D),2016-08-27,2021-02-11,1000, ,['2 / Day'], ,Adverse Event
16588,4908,Mitoxantrone,2015-10-30,2019-08-17,500, ,['/Month'],IV,Patient Choice/Convenience
16589,4908,Alemtuzumab (Campath),2016-01-20,,1,MIU,['/Month'],IV, 
16590,3008,Betaferon,2015-12-02,, ,mcg,['/Month'],IV, 
16591,3008,Methylprednisolone,2016-09-14,, ,mg,['2 / Day'],IV, 
16592,3008,Copaxone,2015-12-07,2019-07-03,300,MIU,['3 / Week'],IV,Adverse Event
16593,3008,Copaxone,2016-06-17,2019-04-03,5000, ,[' '],IV,Adverse Event
16594,3683,Gilenya,2016-06-02,2018-06-22, , ,['2 / Day'],IV,Patient Choice/Convenience
16595,3683,Gilenya,2016-09-29,2021-10-03, ,mg,['/ Day'],Oral,Adverse Event
16596,4213,Tecfidera,2016-09-22,2019-09-24,500, ,['/Month'],Oral,Adverse Event
16597,4213,D-cure (Vitamine D),2016-04-08,, ,mg,[' '],Oral, 
16598,4213,Tysabri,2016-05-25,,1,mcg,['2 / Day'],IV, 
16599,4213,Gilenya,2015-12-03,, ,mg,['3 / Week'],IV, 
16600,1181,Rebif [44],2016-03-25,, ,MIU,['/Month'],IV, 
16601,1181,Avonex,2016-10-17,,500,mg,['/Month'],IV, 
16602,694,Tysabri,2016-04-15,, ,MIU,['/Month'], , 
16603,694,Alemtuzumab (Campath),2016-09-12,2021-02-07, , ,['3 / Week'],IV,Lack of efficacy
16604,694,Endoxan,2016-05-09,, ,MIU,['/Month'],IV, 
16605,2060,Teriflunomide,2016-03-20,, , ,['3 / Week'], , 
16606,2060,D-cure (Vitamine D),2015-10-29,2018-08-08, ,mg,['2 / Day'],IV,Lack of efficacy
16607,2060,Copaxone,2016-02-22,,20,mg,['/Month'], , 
16608,2060,D-cure (Vitamine D),2015-11-06,2018-04-18, ,mg,['3 / Week'],IV,Persisting MRI activity
16609,3837,Teriflunomide,2016-10-09,2020-10-21,1000,mcg,['3 / Week'],Oral,Adverse Event
16610,3837,Alemtuzumab (Campath),2016-04-27,, ,MIU,[' '],IV, 
16611,3837,D-cure (Vitamine D),2016-03-09,2020-03-01,5000,mg,['3 / Week'],IV,Patient Choice/Convenience
16612,988,Rebif [44],2016-10-20,,300,mg,[' '],Oral, 
16613,988,Tecfidera,2016-04-05,2019-02-25,300, ,['/Month'],IV,Persisting MRI activity
16614,988,Tecfidera,2015-11-11,2019-03-29,1,mg,['2 / Day'],IV,Patient Choice/Convenience
16615,2763,Rebif [22],2016-10-05,2020-09-11,1000,mg,['3 / Week'], ,Adverse Event
16616,2763,Methylprednisolone,2016-03-08,,20, ,['2 / Day'],Oral, 
16617,2372,Copaxone,2016-10-12,,20,MIU,['/Month'],IV, 
16618,2961,Alemtuzumab (Campath),2016-01-06,,1, ,['/Month'],IV, 
16619,2961,Methylprednisolone,2016-02-05,2020-06-02,300, ,['/ Week'],IV,Patient Choice/Convenience
16620,2961,D-cure (Vitamine D),2016-08-12,2019-10-15,400, ,['/Month'],IV,Patient Choice/Convenience
16621,2961,IVIG,2016-07-29,, ,mg,['/ Week'], , 
16622,3873,Tysabri,2016-08-03,,1000, ,['/Month'],IV, 
16623,3873,D-cure (Vitamine D),2016-10-10,2020-08-19,500, ,['/Month'], ,Persisting MRI activity
16624,3873,Tecfidera,2015-11-08,, ,MIU,['/Month'],Oral, 
16625,2083,IVIG,2016-02-23,,20, ,['2 / Day'],IV, 
16626,2083,Betaferon,2016-04-29,2018-12-12,500,mcg,['2 / Day'],IV,Persisting MRI activity
16627,2083,D-cure (Vitamine D),2016-07-20,2018-02-10, ,mcg,['/Month'],IV,Lack of efficacy
16628,2083,Tecfidera,2016-08-12,,500,MIU,[' '], , 
16629,4330,IVIG,2016-04-26,,500,mg,['/ Day'],IV, 
16630,4330,D-cure (Vitamine D),2016-01-16,, ,mg,['2 / Day'],IV, 
16631,4330,Gilenya,2016-08-05,2021-03-17, , ,['2 / Day'],IV,Persistence of relapses
16632,4330,Gilenya,2016-07-01,2020-06-23, , ,['3 / Week'],Oral,Lack of efficacy
16633,4330,Rebif [44],2016-03-21,,5000,MIU,['2 / Day'], , 
16634,4190,Rebif [44],2016-01-27,,500, ,['/Month'],IV, 
16635,4190,Alemtuzumab (Campath),2016-05-31,, ,mg,['2 / Day'], , 
16636,4190,Copaxone,2016-05-06,2021-10-13, ,mg,['/Month'],IV,Adverse Event
16637,3942,Tysabri,2016-01-12,,500, ,['2 / Day'],Oral, 
16638,3942,Avonex,2015-11-29,2019-12-17, ,mg,['/Month'],Oral,Lack of efficacy
16639,4070,Tecfidera,2015-11-19,2021-06-22, , ,['2 / Day'], ,Persistence of relapses
16640,3511,IVIG,2016-02-11,, ,mg,[' '],IV, 
16641,3511,Ledertrexaat,2016-05-23,2021-10-18,1000,mg,['2 / Day'],Oral,Lack of efficacy
16642,285,Ledertrexaat,2016-04-10,,1000, ,['3 / Week'],IV, 
16643,285,Avonex,2016-04-15,2020-10-23,300,mg,['/Month'], ,Lack of efficacy
16644,4595,Rebif [22],2015-12-24,2021-09-25,1000,mg,['2 / Day'], ,Persistence of relapses
16645,4595,Tysabri,2016-09-25,2018-06-23, , ,['/Month'],Oral,Lack of efficacy
16646,4990,Tecfidera,2016-03-09,2020-03-13, , ,['2 / Day'],IV,Persisting MRI activity
16647,4990,Gilenya,2016-01-14,,1000, ,['2 / Day'],Oral, 
16648,2137,IVIG,2016-09-13,2020-07-02, ,mg,['/Month'],IV,Adverse Event
16649,2137,Copaxone,2016-02-06,,1000,mg,[' '],IV, 
16650,2137,D-cure (Vitamine D),2015-11-05,,20, ,['2 / Day'],Oral, 
16651,910,Mitoxantrone,2016-09-30,2019-01-02,400, ,['3 / Week'], ,Adverse Event
16652,910,Ledertrexaat,2016-10-12,,1000,mg,['/ Week'],Oral, 
16653,910,D-cure (Vitamine D),2015-10-26,, , ,['/Month'], , 
16654,910,Copaxone,2016-07-06,2019-10-11, , ,['/Month'],IV,Persisting MRI activity
16655,3233,Rebif [22],2015-12-05,,20,mg,['/ Day'],IV, 
16656,1160,Betaferon,2016-02-01,2019-08-13, ,mg,['/ Day'], ,Persisting MRI activity
16657,1160,Betaferon,2015-12-25,, , ,[' '],IV, 
16658,290,D-cure (Vitamine D),2016-09-17,,500,MIU,['/ Week'],Oral, 
16659,108,Tysabri,2016-05-16,2020-07-02, , ,['/Month'], ,Lack of efficacy
16660,108,Methylprednisolone,2016-03-03,2020-03-22,500,mg,['2 / Day'],IV,Lack of efficacy
16661,4755,Copaxone,2016-10-11,,20, ,['2 / Day'],Oral, 
16662,1592,IVIG,2016-01-09,,20, ,['2 / Day'], , 
16663,4786,Rebif [44],2015-11-09,2020-09-29,1000,MIU,[' '],IV,Persisting MRI activity
16664,4786,D-cure (Vitamine D),2016-07-08,2018-09-17, ,mg,['/Month'], ,Persistence of relapses
16665,4786,Rebif [44],2015-11-14,,300,mg,[' '], , 
16666,4908,Avonex,2016-03-16,2021-03-07,400,mg,['3 / Week'], ,Adverse Event
16667,4908,Methylprednisolone,2016-02-26,, , ,['2 / Day'],IV, 
16668,4908,Gilenya,2016-07-17,2019-05-30,400, ,['/Month'], ,Patient Choice/Convenience
16669,1649,Rebif [22],2015-12-08,,20, ,['2 / Day'],IV, 
16670,1649,Gilenya,2016-01-29,2019-03-03, , ,['2 / Day'],Oral,Persisting MRI activity
16671,3433,D-cure (Vitamine D),2016-08-11,2019-01-06, , ,['2 / Day'],IV,Adverse Event
16672,4599,Ledertrexaat,2016-07-03,,300, ,['/ Day'],IV, 
16673,4599,Rebif [44],2016-02-14,2020-09-30,400, ,[' '],Oral,Patient Choice/Convenience
16674,3441,Rebif [44],2016-03-09,2021-07-02,1, ,['2 / Day'], ,Adverse Event
16675,3441,D-cure (Vitamine D),2015-12-03,2019-09-04,5000,MIU,['/Month'], ,Lack of efficacy
16676,3441,Rebif [22],2015-10-31,2018-02-07,5000,mg,['/Month'], ,Patient Choice/Convenience
16677,3266,Endoxan,2016-01-12,2018-01-05,5000,mcg,['3 / Week'], ,Persisting MRI activity
16678,3266,Rebif [44],2015-12-19,, ,MIU,['2 / Day'],IV, 
16679,301,Endoxan,2016-04-06,, , ,[' '], , 
16680,301,Tecfidera,2016-09-08,2018-01-19,5000,mg,['2 / Day'],Oral,Persisting MRI activity
16681,339,Teriflunomide,2015-10-24,2019-03-09,1000,mg,['3 / Week'], ,Persisting MRI activity
16682,339,D-cure (Vitamine D),2016-08-07,, , ,['2 / Day'],IV, 
16683,3880,Mitoxantrone,2016-10-12,,1000,MIU,['/ Day'],IV, 
16684,3880,Avonex,2016-03-28,,5000,mg,['2 / Day'],IV, 
16685,2070,D-cure (Vitamine D),2015-10-30,,400, ,['/Month'],Oral, 
16686,2070,D-cure (Vitamine D),2016-07-20,,300,mg,['2 / Day'],Oral, 
16687,2070,D-cure (Vitamine D),2016-10-08,2019-07-24,400, ,['/Month'], ,Persistence of relapses
16688,1924,D-cure (Vitamine D),2016-03-30,2021-01-26,20,mg,[' '],IV,Lack of efficacy
16689,1924,Tysabri,2016-03-02,2018-01-03, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
16690,1924,Gilenya,2016-06-20,2019-02-16,20,mg,[' '], ,Lack of efficacy
16691,1924,Avonex,2015-11-04,2018-12-19,1000,mg,[' '],IV,Adverse Event
16692,1230,Ledertrexaat,2016-02-06,2018-09-09,400,mg,['/ Week'],IV,Patient Choice/Convenience
16693,1230,D-cure (Vitamine D),2016-01-16,,20, ,['2 / Day'], , 
16694,1230,Tecfidera,2016-01-07,2019-07-06, ,mcg,['3 / Week'], ,Persistence of relapses
16695,1230,Endoxan,2016-01-31,,400,mg,['2 / Day'], , 
16696,1741,Betaferon,2016-08-21,,5000,mcg,['2 / Day'], , 
16697,1741,Avonex,2016-04-25,,5000,MIU,['2 / Day'], , 
16698,403,Tysabri,2016-10-04,2019-03-15,500, ,['2 / Day'],IV,Persistence of relapses
16699,403,Teriflunomide,2016-07-11,, , ,['/Month'], , 
16700,4642,Avonex,2016-02-10,2019-02-16,1, ,['/ Day'],Oral,Adverse Event
16701,4642,Rebif [44],2016-04-24,,1000,mg,['2 / Day'],IV, 
16702,4642,Rebif [44],2015-10-28,, ,mg,['/ Day'],Oral, 
16703,552,Tecfidera,2016-01-20,,1, ,['/Month'], , 
16704,552,Gilenya,2015-12-14,2021-08-06, ,MIU,['2 / Day'],IV,Persisting MRI activity
16705,552,Tysabri,2016-09-24,,300, ,['/Month'], , 
16706,552,D-cure (Vitamine D),2015-12-08,2017-12-20,20,mg,['/ Day'], ,Patient Choice/Convenience
16707,4250,Endoxan,2016-08-26,2018-04-12,1,mg,['/Month'], ,Persisting MRI activity
16708,4250,Tysabri,2016-01-08,, ,mg,[' '],Oral, 
16709,4250,Alemtuzumab (Campath),2016-01-30,,500,mg,['/Month'], , 
16710,387,Rebif [44],2016-05-18,2018-04-12,1000,mg,['2 / Day'],IV,Adverse Event
16711,387,Ledertrexaat,2015-11-04,, ,mcg,['/Month'],IV, 
16712,1967,D-cure (Vitamine D),2016-09-25,2020-05-12, , ,['2 / Day'],IV,Persistence of relapses
16713,1967,Betaferon,2015-11-19,2020-01-18,400,mcg,[' '], ,Adverse Event
16714,3375,Teriflunomide,2016-06-19,,300, ,['2 / Day'],IV, 
16715,2073,Alemtuzumab (Campath),2016-01-26,,1000,mg,['2 / Day'], , 
16716,3177,Tecfidera,2015-12-25,2018-03-15, ,mg,['3 / Week'],IV,Persisting MRI activity
16717,3177,D-cure (Vitamine D),2016-06-10,, , ,['3 / Week'],IV, 
16718,3177,D-cure (Vitamine D),2016-01-09,2019-03-08, ,mg,['/ Week'],IV,Adverse Event
16719,141,Betaferon,2016-01-23,2021-01-31,1000,mg,['2 / Day'],IV,Lack of efficacy
16720,2553,D-cure (Vitamine D),2015-10-29,,500, ,['2 / Day'], , 
16721,1013,Gilenya,2016-10-21,, ,mg,['/Month'], , 
16722,2992,Gilenya,2016-03-18,2019-02-15, , ,['/ Week'], ,Patient Choice/Convenience
16723,2992,Tecfidera,2016-04-15,,1000,mg,['2 / Day'],Oral, 
16724,2992,Avonex,2016-02-18,2018-03-18,300, ,['2 / Day'],IV,Lack of efficacy
16725,1572,Alemtuzumab (Campath),2016-09-27,2018-06-25,20, ,['/ Day'],IV,Patient Choice/Convenience
16726,1572,Methylprednisolone,2016-04-13,, ,MIU,['3 / Week'],IV, 
16727,955,Copaxone,2016-09-17,2019-12-11, ,MIU,['2 / Day'],IV,Adverse Event
16728,4545,Tysabri,2016-02-07,2019-07-08,400,mg,['/Month'], ,Adverse Event
16729,4545,Endoxan,2016-05-21,2018-06-03, ,mg,['3 / Week'], ,Lack of efficacy
16730,4545,Rebif [22],2015-11-07,2021-01-01,1,mg,['/ Day'], ,Adverse Event
16731,768,Alemtuzumab (Campath),2016-03-30,, ,mcg,['/Month'],Oral, 
16732,768,Alemtuzumab (Campath),2016-09-22,2019-07-29, ,mg,['3 / Week'], ,Adverse Event
16733,768,IVIG,2016-05-03,,1000, ,['/Month'],IV, 
16734,2957,Tysabri,2015-11-20,, ,mg,['/Month'],IV, 
16735,2958,Avonex,2016-03-24,,1000, ,[' '],IV, 
16736,2958,Tysabri,2016-04-24,,500,mg,['/Month'],IV, 
16737,2958,Tecfidera,2016-05-07,,300,mg,['/Month'],IV, 
16738,2958,Rebif [22],2016-02-06,2020-09-17,20, ,['2 / Day'], ,Patient Choice/Convenience
16739,793,Copaxone,2016-10-16,,300,mg,['/Month'],IV, 
16740,793,Tysabri,2016-08-14,,1000, ,['/ Day'], , 
16741,793,Rebif [22],2016-08-10,2017-12-30,1000,MIU,['/Month'], ,Persistence of relapses
16742,793,Rebif [22],2016-06-18,2018-01-17,1,mg,['/Month'],IV,Patient Choice/Convenience
16743,1645,Mitoxantrone,2016-03-29,,1,mg,['2 / Day'],IV, 
16744,4534,Tysabri,2016-08-09,2018-03-18,300, ,['/ Day'], ,Lack of efficacy
16745,2733,Rebif [44],2016-02-23,2019-10-21,1000,mg,['/Month'], ,Lack of efficacy
16746,2733,Rebif [44],2016-05-03,,1,mg,['/ Week'],IV, 
16747,2579,Methylprednisolone,2016-10-15,2020-06-28, , ,['2 / Day'], ,Lack of efficacy
16748,2579,Tysabri,2016-06-02,,400,mg,['/Month'], , 
16749,2579,Rebif [44],2016-04-30,,500, ,['/Month'], , 
16750,4466,Mitoxantrone,2016-03-08,, ,mg,[' '],IV, 
16751,4466,Methylprednisolone,2016-04-17,,400, ,['/Month'],IV, 
16752,4466,Betaferon,2016-07-21,2020-02-29,300,mg,['2 / Day'], ,Persistence of relapses
16753,4466,Copaxone,2016-10-18,,1,mg,['2 / Day'], , 
16754,2479,Betaferon,2016-05-20,,1000,mg,['3 / Week'],IV, 
16755,2479,Methylprednisolone,2015-11-29,, , ,['/Month'],IV, 
16756,2479,Mitoxantrone,2016-03-25,,20,mg,['/Month'],IV, 
16757,2479,Alemtuzumab (Campath),2016-05-30,2021-05-08,500,mg,['3 / Week'],Oral,Lack of efficacy
16758,3640,IVIG,2016-06-08,,5000, ,['/Month'], , 
16759,1428,Copaxone,2016-03-25,2018-12-22, ,mg,['3 / Week'],IV,Lack of efficacy
16760,1428,Avonex,2016-05-09,,1000, ,['/ Week'],IV, 
16761,1428,Methylprednisolone,2016-09-16,, ,mg,['/ Day'],IV, 
16762,1428,D-cure (Vitamine D),2016-03-14,, , ,[' '],IV, 
16763,4419,Tysabri,2016-07-19,2021-04-14,300,mg,['2 / Day'],IV,Adverse Event
16764,4419,Alemtuzumab (Campath),2016-05-16,,1000, ,['2 / Day'],IV, 
16765,4419,D-cure (Vitamine D),2016-05-03,,500, ,['2 / Day'],IV, 
16766,523,Copaxone,2016-06-24,,400,mcg,['/Month'],IV, 
16767,523,Alemtuzumab (Campath),2016-05-09,2021-08-17,20,mg,['/Month'],IV,Adverse Event
16768,523,D-cure (Vitamine D),2016-08-12,,400,mg,['/Month'],IV, 
16769,1914,D-cure (Vitamine D),2016-07-07,2019-08-24, , ,['2 / Day'], ,Patient Choice/Convenience
16770,3459,Endoxan,2016-08-07,2019-10-06, , ,['2 / Day'], ,Adverse Event
16771,3459,Gilenya,2016-08-13,,5000,mcg,['2 / Day'],Oral, 
16772,4127,Tysabri,2016-04-21,2018-06-18,20,mcg,['3 / Week'],IV,Adverse Event
16773,2094,D-cure (Vitamine D),2015-11-13,2020-03-19,300, ,['2 / Day'], ,Adverse Event
16774,2094,Teriflunomide,2015-10-31,,300, ,[' '],Oral, 
16775,2094,Tecfidera,2016-02-27,, ,mg,['3 / Week'],IV, 
16776,2094,IVIG,2016-09-15,,20,mg,['3 / Week'],IV, 
16777,3362,Betaferon,2015-12-13,,20,mg,['/Month'],IV, 
16778,3423,Teriflunomide,2016-02-11,,20,mg,[' '],IV, 
16779,3423,Endoxan,2015-12-25,,500,mg,['2 / Day'],IV, 
16780,3694,IVIG,2015-10-25,, , ,['/Month'],IV, 
16781,2783,Rebif [22],2016-10-13,,400, ,['/Month'],IV, 
16782,2783,Endoxan,2016-08-03,2018-09-27, ,MIU,['3 / Week'],IV,Persisting MRI activity
16783,280,Gilenya,2016-09-25,, ,mg,['2 / Day'],IV, 
16784,280,Betaferon,2016-07-06,,20,mg,['2 / Day'],Oral, 
16785,280,Methylprednisolone,2016-06-04,2019-04-27,300, ,['/Month'],IV,Lack of efficacy
16786,280,Rebif [22],2016-08-08,,20, ,['3 / Week'],Oral, 
16787,2046,D-cure (Vitamine D),2016-01-17,,20,mcg,[' '],IV, 
16788,2046,IVIG,2015-12-01,,1000, ,[' '],IV, 
16789,2046,Tecfidera,2015-12-16,2020-01-01,300, ,['/Month'],IV,Persisting MRI activity
16790,216,Mitoxantrone,2015-12-10,, ,mg,['2 / Day'],Oral, 
16791,216,Rebif [44],2016-02-12,2020-10-16, , ,['/Month'],Oral,Patient Choice/Convenience
16792,216,Methylprednisolone,2016-06-21,,1, ,['/Month'], , 
16793,216,Copaxone,2016-05-04,, ,mg,['3 / Week'],IV, 
16794,4271,Avonex,2016-10-18,2020-09-09,500,mg,['2 / Day'], ,Lack of efficacy
16795,4271,D-cure (Vitamine D),2016-04-15,2020-09-07, ,mg,['/Month'], ,Patient Choice/Convenience
16796,4271,IVIG,2016-07-01,, ,mg,['2 / Day'], , 
16797,4271,Gilenya,2016-02-22,, ,MIU,[' '],IV, 
16798,616,Endoxan,2016-03-29,,1,mg,['3 / Week'],IV, 
16799,616,Rebif [22],2015-12-26,,1000,mg,['/ Day'], , 
16800,616,Betaferon,2016-08-10,, , ,['/Month'],IV, 
16801,616,Endoxan,2015-12-29,,5000, ,['/Month'], , 
16802,2902,Betaferon,2016-10-02,2018-10-11, ,mg,['3 / Week'], ,Adverse Event
16803,2902,Rebif [22],2016-02-03,, ,mg,['/Month'],IV, 
16804,2902,Methylprednisolone,2016-01-19,,20,mg,['3 / Week'], , 
16805,2980,Rebif [22],2016-02-18,2018-01-12,300,mg,['3 / Week'], ,Patient Choice/Convenience
16806,3972,Rebif [44],2016-10-05,, , ,['3 / Week'], , 
16807,222,Mitoxantrone,2015-10-28,,300,mg,['3 / Week'],IV, 
16808,3683,Rebif [44],2016-10-09,,500,mg,['/Month'], , 
16809,3683,Betaferon,2016-05-04,2019-03-07,20,mg,['/Month'], ,Persisting MRI activity
16810,3683,Avonex,2016-09-26,2019-03-14, , ,['2 / Day'], ,Persisting MRI activity
16811,3683,IVIG,2016-04-07,2019-05-07,1, ,['/Month'], ,Persistence of relapses
16812,4283,Methylprednisolone,2016-09-28,2021-01-31,20, ,['2 / Day'],IV,Lack of efficacy
16813,4283,Tysabri,2016-07-14,, ,mcg,['2 / Day'],Oral, 
16814,469,Copaxone,2016-02-09,,5000, ,['/ Day'],IV, 
16815,469,Copaxone,2015-11-17,, , ,['3 / Week'],IV, 
16816,3562,Gilenya,2016-02-28,,500, ,['/Month'], , 
16817,3562,D-cure (Vitamine D),2016-08-23,2019-06-15, ,MIU,['/Month'],IV,Persistence of relapses
16818,3562,Methylprednisolone,2016-10-07,2019-03-10, , ,['/ Day'],IV,Persisting MRI activity
16819,3562,Rebif [22],2016-07-12,2020-01-23,20,mg,['/ Week'],IV,Patient Choice/Convenience
16820,1911,Tecfidera,2016-09-01,2018-05-31, ,mg,['/Month'],IV,Adverse Event
16821,1911,Tecfidera,2015-10-31,2019-04-17,20,MIU,['/Month'],IV,Lack of efficacy
16822,1911,Tecfidera,2016-01-29,2019-04-08, ,mg,['2 / Day'],IV,Lack of efficacy
16823,1786,Rebif [22],2016-06-20,, , ,[' '], , 
16824,1786,Gilenya,2015-12-12,2018-09-25,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
16825,3972,Tecfidera,2016-09-04,, ,mcg,[' '],IV, 
16826,3972,Mitoxantrone,2015-11-12,2018-04-16,400,MIU,['2 / Day'],IV,Adverse Event
16827,3972,IVIG,2016-10-10,2018-10-30,300, ,['/Month'],IV,Persisting MRI activity
16828,3972,Tysabri,2015-12-26,2017-10-31,1000,mg,[' '],IV,Patient Choice/Convenience
16829,3438,Tecfidera,2016-10-01,,500,MIU,[' '],Oral, 
16830,3438,Teriflunomide,2016-02-27,,1,mg,['/Month'],IV, 
16831,2843,IVIG,2016-06-04,2021-10-19, ,mcg,['/ Week'],IV,Persistence of relapses
16832,2843,IVIG,2016-07-30,,400, ,['/Month'], , 
16833,2843,Copaxone,2016-07-28,2018-01-14,500,mg,[' '],Oral,Patient Choice/Convenience
16834,416,D-cure (Vitamine D),2016-08-07,2019-05-30, ,MIU,['/Month'],IV,Persisting MRI activity
16835,416,Endoxan,2016-05-13,, , ,['3 / Week'], , 
16836,416,Copaxone,2016-01-23,, ,MIU,['/ Week'],Oral, 
16837,416,Rebif [44],2016-05-30,2021-07-29,5000,mg,['/ Week'], ,Persisting MRI activity
16838,3702,Tysabri,2016-03-11,, , ,['3 / Week'],IV, 
16839,3702,Rebif [44],2015-10-29,2020-11-15, ,mg,['/Month'],IV,Patient Choice/Convenience
16840,3999,Gilenya,2016-02-08,2020-09-25, , ,[' '], ,Lack of efficacy
16841,3999,Copaxone,2016-10-22,, ,mg,['/Month'], , 
16842,3999,Copaxone,2016-01-15,,300,mg,['/ Week'],Oral, 
16843,3999,D-cure (Vitamine D),2016-01-26,2019-09-03,300,mg,['2 / Day'], ,Adverse Event
16844,2423,Rebif [22],2016-07-19,, , ,['2 / Day'], , 
16845,2423,Copaxone,2016-01-18,,500, ,[' '], , 
16846,3693,Tysabri,2016-01-30,2021-09-27,20,mg,['/ Week'],IV,Lack of efficacy
16847,3693,Endoxan,2016-05-03,2018-07-20,500,mg,['3 / Week'],Oral,Adverse Event
16848,673,Rebif [44],2015-11-05,, ,mg,['/Month'],IV, 
16849,673,Tecfidera,2016-10-05,, ,mg,['/ Day'], , 
16850,673,IVIG,2016-06-25,2021-03-27, , ,['/ Day'],IV,Adverse Event
16851,2136,IVIG,2016-08-09,,1, ,['2 / Day'], , 
16852,2136,Teriflunomide,2016-10-15,,500,mg,['/ Day'],IV, 
16853,2136,Teriflunomide,2016-04-07,, ,MIU,['3 / Week'], , 
16854,2136,IVIG,2016-04-14,2018-01-04, ,mg,['2 / Day'],IV,Adverse Event
16855,1222,Alemtuzumab (Campath),2016-07-18,2021-08-12,5000, ,['2 / Day'],Oral,Adverse Event
16856,1222,Gilenya,2016-04-26,, ,mcg,['2 / Day'],IV, 
16857,1222,Tecfidera,2016-01-13,2019-03-13,1000, ,[' '], ,Adverse Event
16858,1222,Teriflunomide,2016-08-14,,1,mg,['3 / Week'], , 
16859,1036,Copaxone,2016-07-11,,500, ,['/Month'],IV, 
16860,1036,Endoxan,2016-06-10,2020-11-16, ,mg,[' '],IV,Persisting MRI activity
16861,4603,D-cure (Vitamine D),2015-11-15,,500,MIU,['3 / Week'], , 
16862,4603,D-cure (Vitamine D),2016-08-06,,1000, ,['2 / Day'],IV, 
16863,4603,Endoxan,2016-09-12,, ,mg,['2 / Day'], , 
16864,4603,D-cure (Vitamine D),2015-11-03,2019-06-27, ,mg,['/Month'],Oral,Adverse Event
16865,3924,D-cure (Vitamine D),2016-02-01,2018-06-18,300, ,['3 / Week'],IV,Adverse Event
16866,3924,IVIG,2016-09-24,,5000, ,['2 / Day'], , 
16867,3924,Rebif [22],2016-08-01,,20,mg,['/Month'],IV, 
16868,3924,Tecfidera,2016-01-12,,5000,mg,['2 / Day'], , 
16869,3637,Avonex,2016-06-20,2018-02-06,20, ,[' '], ,Lack of efficacy
16870,3637,Tysabri,2016-10-17,, ,mcg,['2 / Day'],IV, 
16871,657,Ledertrexaat,2016-02-04,,500,mg,['/ Day'],IV, 
16872,657,Copaxone,2016-03-04,,5000,mg,['2 / Day'],IV, 
16873,657,Tysabri,2016-02-04,, ,MIU,['2 / Day'],IV, 
16874,2770,Mitoxantrone,2016-09-04,2020-06-21,500,mcg,['2 / Day'], ,Lack of efficacy
16875,2770,Rebif [44],2015-12-17,, ,mg,['2 / Day'], , 
16876,2770,Tecfidera,2015-11-29,,300,MIU,[' '],IV, 
16877,3500,Endoxan,2016-06-19,,20,MIU,[' '],IV, 
16878,3500,Endoxan,2016-10-07,2019-11-14,500,mg,['/ Day'],IV,Lack of efficacy
16879,3500,Teriflunomide,2016-06-03,,20,mg,['2 / Day'],IV, 
16880,2630,Methylprednisolone,2015-10-30,2018-07-01,300,mg,['3 / Week'],IV,Adverse Event
16881,319,Rebif [44],2016-06-26,, ,MIU,['3 / Week'],Oral, 
16882,3098,Teriflunomide,2016-07-14,,1000,mg,['2 / Day'],Oral, 
16883,3098,Copaxone,2015-11-14,2020-10-31, , ,['3 / Week'],IV,Persisting MRI activity
16884,3098,Tecfidera,2016-08-21,,1000, ,['3 / Week'],Oral, 
16885,3098,Methylprednisolone,2015-12-08,, , ,['3 / Week'], , 
16886,1865,D-cure (Vitamine D),2016-02-12,2019-01-14,300,mg,['/Month'], ,Adverse Event
16887,1865,Tecfidera,2015-12-02,,400,MIU,['/Month'], , 
16888,1865,Copaxone,2016-10-22,,1000,mcg,['/Month'],IV, 
16889,1389,Alemtuzumab (Campath),2016-10-01,2019-10-07,500, ,['3 / Week'], ,Persisting MRI activity
16890,1389,D-cure (Vitamine D),2015-11-25,2021-01-02,1000,mcg,['2 / Day'],IV,Patient Choice/Convenience
16891,1389,Gilenya,2016-03-24,,500,mg,['/Month'],IV, 
16892,3437,Endoxan,2016-10-09,,20,mg,[' '],IV, 
16893,3437,Tysabri,2016-08-26,2018-07-14,5000,mg,['/Month'], ,Patient Choice/Convenience
16894,3437,Tysabri,2015-12-22,,1,mcg,['2 / Day'],IV, 
16895,4205,Alemtuzumab (Campath),2015-10-30,,500,mg,['/ Day'], , 
16896,133,Mitoxantrone,2016-07-27,2020-10-14,300, ,['2 / Day'],IV,Patient Choice/Convenience
16897,133,Avonex,2016-02-12,2019-03-26, ,mg,[' '],IV,Adverse Event
16898,133,Tysabri,2015-12-26,2020-09-13,20,mg,['/Month'], ,Patient Choice/Convenience
16899,133,Betaferon,2015-11-21,2018-07-11,500, ,['3 / Week'], ,Patient Choice/Convenience
16900,3136,Alemtuzumab (Campath),2016-07-29,, , ,['/ Week'],Oral, 
16901,3136,D-cure (Vitamine D),2016-05-15,,300,mg,['/Month'],IV, 
16902,763,Avonex,2015-10-30,,500, ,[' '],IV, 
16903,763,D-cure (Vitamine D),2015-11-30,, ,mg,['2 / Day'], , 
16904,763,Tysabri,2016-05-15,,1, ,['2 / Day'], , 
16905,1165,Rebif [44],2016-09-02,,1,MIU,[' '],IV, 
16906,1165,Endoxan,2016-08-31,,300,MIU,['/Month'],IV, 
16907,1165,Avonex,2016-03-26,, ,MIU,['2 / Day'], , 
16908,2652,D-cure (Vitamine D),2015-12-09,2017-12-24, ,MIU,['/Month'],IV,Lack of efficacy
16909,2652,Endoxan,2016-07-29,2020-09-01,500,mg,['3 / Week'], ,Persisting MRI activity
16910,4584,IVIG,2016-01-09,2019-05-08,500, ,['/ Week'],Oral,Persisting MRI activity
16911,4530,Endoxan,2016-08-03,2020-03-03, , ,[' '],Oral,Adverse Event
16912,4530,Teriflunomide,2016-03-05,2021-03-11,400, ,['2 / Day'],IV,Persisting MRI activity
16913,4530,Avonex,2016-07-20,,1000,MIU,['/Month'], , 
16914,1701,Tysabri,2016-02-16,,1000,mg,['2 / Day'],IV, 
16915,1562,Tecfidera,2016-02-11,2021-02-27,1000,MIU,['2 / Day'],IV,Persistence of relapses
16916,1562,D-cure (Vitamine D),2015-11-08,,20, ,['2 / Day'], , 
16917,3457,Endoxan,2016-08-22,2017-11-19,300,mcg,['2 / Day'], ,Persistence of relapses
16918,4613,Teriflunomide,2015-11-25,,400,mg,['/Month'], , 
16919,4613,Endoxan,2016-05-28,, , ,['/ Day'],IV, 
16920,4613,Ledertrexaat,2016-03-19,2019-08-19, ,mg,['3 / Week'], ,Patient Choice/Convenience
16921,1650,Gilenya,2015-12-23,,1, ,['/ Day'], , 
16922,1650,Copaxone,2015-11-13,, ,MIU,['/Month'],IV, 
16923,961,Rebif [44],2016-04-12,,500,mg,['/Month'],IV, 
16924,961,Gilenya,2015-10-28,,500,mg,['/ Day'],IV, 
16925,961,Ledertrexaat,2015-11-27,2018-02-08,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
16926,961,Alemtuzumab (Campath),2016-10-04,2018-07-09, ,mg,[' '], ,Adverse Event
16927,107,Methylprednisolone,2015-11-30,,500,mg,['2 / Day'], , 
16928,107,Betaferon,2016-05-05,2018-10-23,1,mg,['2 / Day'], ,Persisting MRI activity
16929,107,IVIG,2016-07-02,2017-12-27,400,mg,['2 / Day'], ,Lack of efficacy
16930,107,Avonex,2016-05-17,,300,MIU,['/Month'], , 
16931,652,Rebif [44],2015-11-17,2020-05-05, , ,['/Month'],IV,Lack of efficacy
16932,652,Rebif [44],2015-11-27,,300,mg,['/Month'],IV, 
16933,652,Gilenya,2016-05-27,,400,mcg,['2 / Day'],IV, 
16934,652,Tysabri,2016-06-11,,5000,MIU,['/Month'], , 
16935,1825,Rebif [22],2016-09-16,,20,mg,['/Month'],IV, 
16936,1825,Endoxan,2015-11-16,,300,MIU,['/ Day'],IV, 
16937,1825,Tecfidera,2016-01-08,2018-12-17,1, ,['/Month'],IV,Lack of efficacy
16938,445,Teriflunomide,2016-02-06,,20, ,['/Month'],IV, 
16939,445,Methylprednisolone,2015-12-10,, ,mcg,['/ Week'],IV, 
16940,445,Copaxone,2016-09-07,,400, ,[' '], , 
16941,1397,Gilenya,2016-08-16,2018-09-18,400,mg,['2 / Day'],Oral,Adverse Event
16942,1397,Avonex,2015-12-15,2019-04-05,400,mg,[' '],Oral,Persisting MRI activity
16943,1397,Copaxone,2015-12-16,, , ,['/ Day'], , 
16944,1397,Endoxan,2016-06-12,,5000,MIU,['2 / Day'],IV, 
16945,3319,D-cure (Vitamine D),2015-10-24,,1000,mg,['/ Day'], , 
16946,3319,Teriflunomide,2015-10-30,2021-04-22,1,mg,['/Month'],Oral,Patient Choice/Convenience
16947,3319,Mitoxantrone,2016-06-29,,500,MIU,['2 / Day'],IV, 
16948,3039,Rebif [22],2016-04-08,2021-10-21,1, ,['2 / Day'],IV,Persisting MRI activity
16949,3039,Rebif [44],2015-11-30,,500, ,['/Month'],IV, 
16950,3039,Mitoxantrone,2016-04-14,, ,mg,['/Month'],IV, 
16951,4304,Copaxone,2016-06-03,, ,mg,['2 / Day'],IV, 
16952,4304,Tysabri,2016-06-21,2019-04-13,500,MIU,['3 / Week'], ,Patient Choice/Convenience
16953,2785,Rebif [44],2016-02-27,,1000, ,['/Month'],IV, 
16954,2785,Tecfidera,2016-01-15,,400, ,['2 / Day'],IV, 
16955,2819,Rebif [22],2016-06-16,2019-11-08,500, ,['2 / Day'],IV,Patient Choice/Convenience
16956,2819,Tysabri,2016-04-01,2021-06-05,1, ,['2 / Day'],Oral,Persistence of relapses
16957,1250,Mitoxantrone,2016-09-25,2018-05-16,300,MIU,[' '], ,Persistence of relapses
16958,1250,Avonex,2016-06-29,2021-07-19,1000, ,[' '], ,Persistence of relapses
16959,2644,Copaxone,2015-10-27,2019-05-12, ,mcg,['2 / Day'],IV,Persistence of relapses
16960,2644,IVIG,2016-05-13,, ,MIU,['/Month'],Oral, 
16961,2644,Teriflunomide,2016-05-27,, , ,['2 / Day'], , 
16962,2055,Copaxone,2016-02-27,,1000,mcg,['/Month'],IV, 
16963,2055,D-cure (Vitamine D),2015-11-04,,1000, ,['3 / Week'],IV, 
16964,2055,Rebif [44],2016-07-05,,5000, ,['/Month'],IV, 
16965,4124,Endoxan,2016-09-13,,1,mg,['2 / Day'],IV, 
16966,4124,Rebif [44],2016-05-03,, , ,['2 / Day'], , 
16967,4124,Methylprednisolone,2016-02-06,,300,mg,['/Month'],IV, 
16968,4124,Tecfidera,2016-06-21,,1000, ,['/ Day'],IV, 
16969,906,Tysabri,2016-04-21,2018-02-27,20,mg,['/ Day'],Oral,Persistence of relapses
16970,906,Teriflunomide,2016-09-11,, , ,['/Month'],IV, 
16971,906,Avonex,2016-09-29,2020-08-05, , ,['2 / Day'],Oral,Lack of efficacy
16972,906,D-cure (Vitamine D),2016-07-24,2018-09-02,400,mg,['/Month'],IV,Lack of efficacy
16973,2459,Alemtuzumab (Campath),2016-07-30,,1000,mg,['3 / Week'],IV, 
16974,2459,IVIG,2016-01-26,,20, ,['/Month'],Oral, 
16975,2459,Betaferon,2016-06-17,, ,mg,[' '],IV, 
16976,1976,Tysabri,2016-02-14,,20, ,['/Month'], , 
16977,1976,Avonex,2015-12-10,, , ,['/Month'], , 
16978,3704,Tecfidera,2016-05-28,,500, ,['/Month'],IV, 
16979,3704,Rebif [22],2016-03-29,, ,mg,['3 / Week'],IV, 
16980,3704,Betaferon,2016-02-24,,1000, ,['/Month'],IV, 
16981,3704,Betaferon,2015-12-31,2019-04-25, ,mcg,['2 / Day'],IV,Patient Choice/Convenience
16982,1406,Avonex,2016-02-14,2019-08-07,500,mg,['/Month'],IV,Adverse Event
16983,1406,Rebif [44],2016-08-21,,20, ,[' '],IV, 
16984,1406,Endoxan,2016-10-16,,1000,mg,['3 / Week'],Oral, 
16985,1406,Rebif [22],2016-09-22,,300,mcg,['/Month'],IV, 
16986,3057,IVIG,2016-02-21,2021-08-08,5000,mg,[' '], ,Lack of efficacy
16987,3057,IVIG,2016-07-06,, , ,['3 / Week'],IV, 
16988,3057,Tysabri,2016-02-25,2020-12-13,1, ,['/ Day'], ,Persistence of relapses
16989,3057,Tecfidera,2016-03-07,,20,mg,[' '], , 
16990,3471,Betaferon,2016-03-29,2017-11-05,20,mg,['2 / Day'],IV,Patient Choice/Convenience
16991,3471,Endoxan,2016-05-06,,500,mg,['/Month'],IV, 
16992,3471,Copaxone,2016-09-27,2021-10-02, ,mg,['/Month'],IV,Persisting MRI activity
16993,1735,Gilenya,2016-09-29,,500,mg,[' '],IV, 
16994,3928,Avonex,2015-12-15,,300, ,['/Month'],IV, 
16995,3928,Tecfidera,2016-09-01,, ,mg,['/Month'], , 
16996,719,Tecfidera,2015-12-21,2021-08-30,1000,mg,['/Month'], ,Lack of efficacy
16997,719,Tysabri,2016-02-11,2021-04-01,300,mg,['/Month'],IV,Patient Choice/Convenience
16998,3877,Rebif [22],2016-05-05,,500,mg,['2 / Day'],IV, 
16999,3877,Mitoxantrone,2016-08-15,2020-09-26,20, ,['/Month'],IV,Adverse Event
17000,3877,Ledertrexaat,2016-08-01,,1, ,['3 / Week'],IV, 
17001,1025,Tysabri,2016-09-09,2020-03-28,500, ,['/Month'],Oral,Patient Choice/Convenience
17002,4699,Ledertrexaat,2016-09-02,, , ,['2 / Day'], , 
17003,4699,Teriflunomide,2015-12-20,,1000,mg,['/Month'],IV, 
17004,4699,Tecfidera,2015-11-11,, ,mg,['/ Week'], , 
17005,1062,IVIG,2016-01-30,, , ,['/Month'],IV, 
17006,1062,Alemtuzumab (Campath),2016-04-03,, , ,['/Month'],Oral, 
17007,874,IVIG,2016-09-25,2018-12-29, , ,[' '],Oral,Adverse Event
17008,874,Tysabri,2016-06-03,2021-05-24,1,mg,['/ Day'],IV,Patient Choice/Convenience
17009,4714,IVIG,2016-03-03,,500,mg,['3 / Week'],IV, 
17010,4714,Rebif [22],2016-05-02,2020-05-18,1, ,[' '],IV,Patient Choice/Convenience
17011,4714,Copaxone,2016-05-15,2021-06-18, , ,['2 / Day'],Oral,Persisting MRI activity
17012,2421,Teriflunomide,2016-09-20,2020-01-09,300,mg,['/ Day'], ,Patient Choice/Convenience
17013,1861,Alemtuzumab (Campath),2016-03-23,,1000,mg,['/Month'],IV, 
17014,1861,Tysabri,2016-08-31,,20,mg,['3 / Week'], , 
17015,1861,Tysabri,2016-10-03,, ,mcg,['/Month'], , 
17016,1861,Copaxone,2016-09-22,,500, ,['2 / Day'],IV, 
17017,4037,Endoxan,2015-11-24,2019-02-03, ,mg,['/ Day'],IV,Lack of efficacy
17018,4037,Gilenya,2016-01-28,2018-10-10,300,mg,['/Month'],IV,Lack of efficacy
17019,4037,Mitoxantrone,2016-10-08,,5000, ,['/Month'], , 
17020,4037,Rebif [44],2015-12-11,2018-08-15,1000,mg,['/Month'],IV,Adverse Event
17021,2306,Rebif [44],2015-12-02,,1,mg,[' '],IV, 
17022,1841,IVIG,2016-08-16,2018-12-11, , ,['/Month'],IV,Persisting MRI activity
17023,1841,Rebif [44],2016-02-12,2018-01-29,20,mg,['2 / Day'], ,Lack of efficacy
17024,1841,Avonex,2016-03-26,2021-07-31,300,mcg,['/Month'], ,Lack of efficacy
17025,1841,Tecfidera,2016-07-25,, , ,['2 / Day'],IV, 
17026,842,Methylprednisolone,2016-06-24,2018-06-24,300, ,['2 / Day'], ,Patient Choice/Convenience
17027,842,Gilenya,2016-08-29,,5000,mg,['2 / Day'],IV, 
17028,842,Teriflunomide,2016-08-08,2021-08-26,20,mg,['/Month'],IV,Persistence of relapses
17029,842,IVIG,2016-04-26,2020-04-26,500, ,['/Month'],IV,Lack of efficacy
17030,4350,Mitoxantrone,2016-08-29,2019-04-06,300,MIU,['/Month'], ,Adverse Event
17031,4350,D-cure (Vitamine D),2016-09-30,,300, ,['/Month'], , 
17032,4350,Rebif [44],2016-08-12,2018-10-18,300, ,['/Month'],Oral,Adverse Event
17033,2738,Gilenya,2016-08-16,, ,mg,['2 / Day'],IV, 
17034,2738,Betaferon,2016-01-07,2020-03-29,400,MIU,['/ Day'],IV,Lack of efficacy
17035,2738,Teriflunomide,2016-07-07,2018-12-06, ,mg,[' '],IV,Persisting MRI activity
17036,2738,Methylprednisolone,2016-08-04,,20,mcg,['2 / Day'],Oral, 
17037,3719,Copaxone,2015-12-30,,1000,mg,[' '], , 
17038,3719,Avonex,2016-06-11,,5000,MIU,['/ Day'], , 
17039,3719,D-cure (Vitamine D),2016-07-27,2021-05-12,20, ,[' '],IV,Lack of efficacy
17040,3719,Betaferon,2016-09-28,2018-12-17, ,mg,['3 / Week'], ,Patient Choice/Convenience
17041,3316,Betaferon,2016-06-02,, ,mg,['/Month'], , 
17042,1377,Tysabri,2016-09-29,,1000,mcg,['2 / Day'],Oral, 
17043,1377,Tecfidera,2016-05-02,2018-09-05, , ,['/ Day'],Oral,Adverse Event
17044,1377,Gilenya,2015-12-05,2019-02-21,500,mg,['/Month'], ,Persisting MRI activity
17045,222,Tecfidera,2016-05-25,, , ,['/Month'],IV, 
17046,1259,Rebif [22],2016-05-13,2018-04-21,300, ,['3 / Week'],IV,Persistence of relapses
17047,1259,D-cure (Vitamine D),2015-12-22,,1000,mg,['2 / Day'],IV, 
17048,1259,Tecfidera,2016-05-21,,300, ,['2 / Day'],Oral, 
17049,1259,Tysabri,2016-07-07,2018-08-12, , ,['/Month'],IV,Patient Choice/Convenience
17050,1239,D-cure (Vitamine D),2015-11-12,,500,mg,['/Month'],IV, 
17051,924,IVIG,2016-07-16,2021-01-19, , ,['2 / Day'],IV,Persisting MRI activity
17052,924,Gilenya,2016-03-02,2020-02-15,500, ,['/Month'],IV,Patient Choice/Convenience
17053,924,Rebif [22],2016-09-26,, , ,['3 / Week'], , 
17054,1220,IVIG,2016-05-14,2020-06-11,500, ,[' '], ,Adverse Event
17055,1220,Betaferon,2016-02-07,2021-08-24,1,mg,['/ Week'], ,Lack of efficacy
17056,859,Rebif [44],2016-02-26,2018-08-17, , ,['2 / Day'], ,Lack of efficacy
17057,859,Endoxan,2016-06-08,, , ,['/Month'],IV, 
17058,859,Methylprednisolone,2016-06-11,,1000, ,['/Month'],IV, 
17059,859,Teriflunomide,2015-12-23,,1,mcg,['/Month'],Oral, 
17060,4414,IVIG,2016-02-05,, ,mg,['/ Week'], , 
17061,4414,Rebif [44],2016-01-09,, , ,['/Month'],IV, 
17062,4414,Ledertrexaat,2016-06-22,,5000, ,['/ Day'], , 
17063,392,Methylprednisolone,2016-05-24,,1000, ,['/Month'],Oral, 
17064,392,Ledertrexaat,2016-06-03,,5000,mg,[' '], , 
17065,3407,Tysabri,2016-04-23,2019-04-09, ,mcg,['/Month'],IV,Adverse Event
17066,3407,Rebif [22],2016-07-31,, , ,['2 / Day'],IV, 
17067,3407,D-cure (Vitamine D),2015-11-24,2020-12-15,400, ,['/Month'],IV,Adverse Event
17068,3407,Copaxone,2016-04-20,, , ,['3 / Week'],IV, 
17069,4550,Tecfidera,2016-10-11,2019-01-06,500,mg,['2 / Day'],Oral,Patient Choice/Convenience
17070,4550,D-cure (Vitamine D),2016-05-19,2020-07-13,300,mg,['2 / Day'],IV,Lack of efficacy
17071,4550,D-cure (Vitamine D),2016-01-06,2019-04-25, ,mg,['2 / Day'],IV,Persisting MRI activity
17072,4550,Gilenya,2016-03-18,, , ,['/Month'], , 
17073,702,Tecfidera,2016-02-02,2021-01-13,20, ,['2 / Day'],IV,Adverse Event
17074,702,D-cure (Vitamine D),2016-05-07,2018-12-02,500,MIU,['/ Week'],IV,Adverse Event
17075,3897,Rebif [44],2016-08-20,2018-02-16,20,mg,['3 / Week'],IV,Persisting MRI activity
17076,3047,Rebif [22],2016-06-26,,20,mg,['/ Week'],IV, 
17077,3047,Tysabri,2016-04-12,,20,mg,['/ Week'],IV, 
17078,3047,Rebif [22],2016-06-28,,1000, ,['/Month'],IV, 
17079,3047,Tecfidera,2016-07-27,2018-11-05, ,MIU,['2 / Day'],IV,Persistence of relapses
17080,1995,D-cure (Vitamine D),2016-05-13,2021-03-12,500,MIU,['/Month'], ,Patient Choice/Convenience
17081,1995,Rebif [22],2015-10-29,,300, ,['/Month'], , 
17082,1995,IVIG,2016-05-20,, ,mg,['/Month'],IV, 
17083,1995,IVIG,2016-01-31,, , ,['/Month'],IV, 
17084,2237,Gilenya,2015-10-25,,300,MIU,['/ Day'], , 
17085,2237,Copaxone,2016-07-14,,5000,mg,['2 / Day'],Oral, 
17086,2237,Gilenya,2016-07-17,,400,mcg,['2 / Day'],IV, 
17087,2827,IVIG,2015-11-11,, ,MIU,['/Month'],IV, 
17088,2827,Rebif [22],2016-05-14,2020-01-28,5000, ,['2 / Day'], ,Persistence of relapses
17089,2827,Tysabri,2016-03-30,2020-12-31,5000,mg,['2 / Day'], ,Persistence of relapses
17090,2827,Copaxone,2016-06-04,,5000,mg,['2 / Day'], , 
17091,701,Gilenya,2016-02-10,,5000,mcg,['2 / Day'],Oral, 
17092,2238,Tysabri,2015-11-15,2020-02-25,1000, ,['/Month'],IV,Lack of efficacy
17093,2238,IVIG,2016-07-26,2018-09-25,20,mcg,['3 / Week'], ,Patient Choice/Convenience
17094,2238,Avonex,2016-02-19,,20, ,['/Month'],IV, 
17095,309,D-cure (Vitamine D),2016-04-12,,1000, ,[' '], , 
17096,309,Tecfidera,2016-05-18,2019-06-08,500, ,['/ Day'],Oral,Adverse Event
17097,309,Methylprednisolone,2016-07-31,2020-10-05,500,MIU,['/Month'],IV,Persistence of relapses
17098,309,Copaxone,2015-11-11,, ,mg,[' '],Oral, 
17099,1422,Ledertrexaat,2016-07-14,2019-11-20,500, ,['2 / Day'],Oral,Adverse Event
17100,1422,Betaferon,2016-02-17,,400, ,['3 / Week'],IV, 
17101,1422,IVIG,2016-09-07,2018-02-08, ,mg,['3 / Week'], ,Adverse Event
17102,1422,D-cure (Vitamine D),2015-11-13,,5000,MIU,['2 / Day'],IV, 
17103,1672,Betaferon,2016-02-09,,500, ,['2 / Day'],IV, 
17104,1672,Endoxan,2016-04-17,2021-03-09, ,mg,['/Month'],IV,Lack of efficacy
17105,1411,Rebif [22],2016-06-10,,20, ,['2 / Day'], , 
17106,1411,Alemtuzumab (Campath),2016-08-20,, ,MIU,['3 / Week'],Oral, 
17107,1411,D-cure (Vitamine D),2016-04-10,2019-09-09, , ,['/Month'],IV,Adverse Event
17108,1411,Avonex,2016-08-10,, ,mg,['/Month'], , 
17109,2723,IVIG,2016-08-06,2018-04-04, , ,['2 / Day'],IV,Adverse Event
17110,3596,Rebif [22],2016-02-25,,300,mg,[' '],Oral, 
17111,3596,Gilenya,2016-02-03,,20,MIU,['2 / Day'],Oral, 
17112,3596,Copaxone,2016-03-20,,5000, ,['2 / Day'],IV, 
17113,3271,Alemtuzumab (Campath),2015-12-31,,20, ,[' '], , 
17114,3271,Rebif [22],2016-06-05,, ,MIU,['/Month'], , 
17115,3271,Methylprednisolone,2016-01-20,,20, ,['2 / Day'],Oral, 
17116,3705,IVIG,2016-04-23,,400,mg,['2 / Day'], , 
17117,3705,Avonex,2016-04-06,,1000, ,['/Month'],IV, 
17118,3705,Teriflunomide,2016-10-11,2021-07-13, , ,[' '],IV,Patient Choice/Convenience
17119,4524,Rebif [44],2016-08-05,,500, ,['/ Week'],IV, 
17120,4524,Gilenya,2016-02-06,2021-08-05, ,mg,['/Month'],Oral,Adverse Event
17121,4524,Tecfidera,2016-01-23,, , ,['/Month'], , 
17122,4524,Endoxan,2015-10-29,2020-02-08,500, ,['2 / Day'],IV,Persistence of relapses
17123,3969,Alemtuzumab (Campath),2016-07-16,2021-04-28, ,MIU,['2 / Day'], ,Adverse Event
17124,3969,Rebif [22],2016-04-05,,300,mg,['3 / Week'],IV, 
17125,3969,Gilenya,2016-09-22,2018-01-24,500, ,['/Month'],IV,Adverse Event
17126,3969,Tecfidera,2016-09-06,2019-10-26, , ,['/Month'],IV,Patient Choice/Convenience
17127,2080,Tysabri,2016-02-27,, , ,['3 / Week'],IV, 
17128,2080,IVIG,2015-12-25,2020-04-27, ,mg,['/Month'],IV,Adverse Event
17129,2080,Rebif [22],2016-04-30,2018-03-06,400,mcg,['/Month'], ,Persistence of relapses
17130,2080,Rebif [44],2016-09-28,,1000, ,[' '],IV, 
17131,937,Endoxan,2016-02-02,,300,mg,['/Month'],Oral, 
17132,937,Tecfidera,2016-08-23,2019-12-25, ,mg,['3 / Week'],IV,Adverse Event
17133,937,Rebif [44],2016-10-08,,400, ,['2 / Day'],IV, 
17134,937,D-cure (Vitamine D),2016-07-04,2020-05-06,300,mg,['/Month'],IV,Adverse Event
17135,4024,IVIG,2016-01-08,,500, ,['/Month'],IV, 
17136,4024,Avonex,2016-01-08,2020-09-24, , ,['/Month'],Oral,Lack of efficacy
17137,4024,Tysabri,2015-12-24,2020-12-26,1,mg,['/ Day'],Oral,Patient Choice/Convenience
17138,4024,IVIG,2016-09-30,2018-06-08,300, ,['3 / Week'],Oral,Persistence of relapses
17139,550,Rebif [44],2015-11-27,2020-07-16, ,mg,['/Month'], ,Adverse Event
17140,1455,Methylprednisolone,2016-08-28,,1, ,[' '],Oral, 
17141,1455,Tecfidera,2016-02-25,,400,mg,['3 / Week'],Oral, 
17142,1455,D-cure (Vitamine D),2016-05-08,2017-12-30,1,mg,['/ Day'],IV,Adverse Event
17143,1455,D-cure (Vitamine D),2015-12-07,,400,mg,['2 / Day'],IV, 
17144,1945,IVIG,2015-12-14,2018-11-29,400, ,['/Month'],IV,Patient Choice/Convenience
17145,1945,Betaferon,2016-08-15,2019-06-30,1000,MIU,['/Month'],IV,Patient Choice/Convenience
17146,1945,Tecfidera,2016-05-10,,5000,mg,['3 / Week'],IV, 
17147,1945,Endoxan,2016-02-27,,300,mg,['2 / Day'], , 
17148,4752,Alemtuzumab (Campath),2016-01-31,, , ,['/ Week'],IV, 
17149,4752,IVIG,2016-08-24,2020-04-29,5000,mg,[' '],IV,Persisting MRI activity
17150,4752,Gilenya,2016-02-11,,300,MIU,['/Month'], , 
17151,4573,Methylprednisolone,2016-02-06,,400, ,['/ Week'], , 
17152,4573,Rebif [44],2015-10-24,2018-12-24, ,mg,['/ Day'], ,Patient Choice/Convenience
17153,4573,IVIG,2016-01-19,2020-08-16,1, ,['2 / Day'],IV,Adverse Event
17154,4573,Gilenya,2016-09-23,2020-05-09,500, ,['/ Week'], ,Adverse Event
17155,4845,Endoxan,2016-10-13,,1,MIU,['/Month'], , 
17156,4845,Tecfidera,2015-12-08,2017-12-12,500,mg,['/Month'], ,Persistence of relapses
17157,4845,Methylprednisolone,2016-06-11,2019-07-25,300,mg,['3 / Week'], ,Adverse Event
17158,4845,Tecfidera,2016-05-27,, , ,['3 / Week'],Oral, 
17159,1902,IVIG,2016-09-10,2019-08-02,1,mg,[' '],IV,Persistence of relapses
17160,1902,Methylprednisolone,2015-11-18,,5000, ,['2 / Day'], , 
17161,1902,Avonex,2016-10-18,,20,mg,['/Month'], , 
17162,478,Endoxan,2015-12-17,, , ,['/Month'], , 
17163,4128,Ledertrexaat,2016-06-06,,500, ,['/Month'], , 
17164,4128,Ledertrexaat,2015-11-24,2020-09-14, ,mcg,['/Month'], ,Patient Choice/Convenience
17165,4128,Teriflunomide,2016-03-03,2020-07-21,1000, ,['/Month'],IV,Adverse Event
17166,4128,Copaxone,2016-04-16,,400,mg,['2 / Day'], , 
17167,269,Alemtuzumab (Campath),2016-04-19,2020-08-01,500,mg,['/Month'], ,Adverse Event
17168,269,Rebif [44],2016-01-27,, ,MIU,['/ Week'],IV, 
17169,269,Tecfidera,2016-01-25,2019-06-19,20,mg,['/ Day'],IV,Adverse Event
17170,1979,Rebif [22],2016-08-19,,1, ,['3 / Week'],IV, 
17171,1979,Copaxone,2016-01-01,2018-11-04, , ,['/ Week'],Oral,Adverse Event
17172,1979,Rebif [22],2016-10-22,, ,mg,['/ Week'],Oral, 
17173,4075,D-cure (Vitamine D),2016-07-07,, , ,['3 / Week'],IV, 
17174,4075,Tecfidera,2016-09-20,,500, ,['2 / Day'], , 
17175,4075,D-cure (Vitamine D),2016-09-03,2020-04-04,20,MIU,[' '],Oral,Lack of efficacy
17176,2489,D-cure (Vitamine D),2016-02-24,,20,mg,['3 / Week'],IV, 
17177,1764,Rebif [44],2016-08-10,2021-01-05,500,MIU,['/Month'], ,Persisting MRI activity
17178,2135,Mitoxantrone,2015-11-16,,1000, ,['/ Day'],Oral, 
17179,2135,Ledertrexaat,2016-07-06,,20, ,['/Month'],IV, 
17180,2135,Tysabri,2016-05-02,2019-02-28,400,mcg,['/ Week'], ,Persisting MRI activity
17181,2135,Methylprednisolone,2016-04-26,,500, ,['/Month'],IV, 
17182,3867,Gilenya,2015-11-14,2020-11-17, , ,['/Month'], ,Patient Choice/Convenience
17183,3867,IVIG,2016-09-03,2019-04-06,5000,MIU,['/Month'],IV,Patient Choice/Convenience
17184,3867,Ledertrexaat,2016-05-05,2020-03-02,400,mg,['/ Day'],IV,Lack of efficacy
17185,4716,Endoxan,2016-01-14,2020-04-30, ,MIU,['3 / Week'],Oral,Persistence of relapses
17186,4716,Endoxan,2016-04-11,2021-05-05, ,mg,['2 / Day'],Oral,Adverse Event
17187,4716,Tecfidera,2015-12-07,2017-10-31, , ,['2 / Day'], ,Persistence of relapses
17188,4716,D-cure (Vitamine D),2016-03-05,2020-12-06,500,MIU,['2 / Day'],Oral,Patient Choice/Convenience
17189,4604,Avonex,2016-09-03,, , ,['2 / Day'],IV, 
17190,4604,Rebif [44],2015-12-25,2020-07-13,400,mg,['/Month'],IV,Patient Choice/Convenience
17191,2126,Endoxan,2016-04-28,,300, ,['/Month'],Oral, 
17192,2126,Tysabri,2016-07-27,,20,mcg,['/Month'],IV, 
17193,2126,Mitoxantrone,2016-07-04,,1000,mg,['2 / Day'],IV, 
17194,3968,Rebif [44],2016-06-11,, ,MIU,['3 / Week'], , 
17195,3968,Tecfidera,2016-06-23,,300,MIU,['3 / Week'],IV, 
17196,3968,Rebif [44],2016-08-06,, ,mg,['/Month'], , 
17197,3968,Copaxone,2016-09-27,, , ,[' '], , 
17198,646,D-cure (Vitamine D),2015-10-30,2021-04-03,1000, ,['/ Week'],IV,Persisting MRI activity
17199,646,Endoxan,2016-06-30,,500, ,['/ Week'],IV, 
17200,646,Betaferon,2015-12-24,2018-02-19,500,mg,['/ Day'],IV,Adverse Event
17201,1119,Copaxone,2016-08-17,2020-11-30, , ,['/Month'],Oral,Lack of efficacy
17202,1119,Copaxone,2016-08-29,2018-10-29,5000,mg,[' '],Oral,Adverse Event
17203,1119,Rebif [44],2016-04-04,,1,mg,['/ Day'],IV, 
17204,1119,Methylprednisolone,2016-01-19,2020-11-09,500,MIU,['2 / Day'], ,Persisting MRI activity
17205,248,Methylprednisolone,2016-05-29,2021-01-15,20, ,[' '],Oral,Adverse Event
17206,248,Methylprednisolone,2016-08-05,, , ,['/ Week'],IV, 
17207,4964,IVIG,2016-08-29,,500, ,['2 / Day'],IV, 
17208,4527,D-cure (Vitamine D),2016-07-02,2019-09-21,5000,mg,['/Month'], ,Patient Choice/Convenience
17209,4527,Alemtuzumab (Campath),2016-10-02,,5000, ,['2 / Day'],IV, 
17210,4527,Rebif [44],2015-11-27,2021-05-28,5000, ,['/Month'],IV,Adverse Event
17211,1672,Copaxone,2016-08-20,,20,mg,['2 / Day'],IV, 
17212,1672,IVIG,2016-02-05,2019-03-13,400,mg,['/ Week'],IV,Lack of efficacy
17213,1005,D-cure (Vitamine D),2016-07-31,, ,mg,['2 / Day'], , 
17214,1005,Tecfidera,2016-09-01,2018-11-15, ,mg,['3 / Week'],Oral,Persisting MRI activity
17215,1005,Betaferon,2016-08-22,2019-03-18,300,mg,['/ Week'],IV,Patient Choice/Convenience
17216,1005,Alemtuzumab (Campath),2016-09-04,,300,mg,['/Month'],Oral, 
17217,2458,Gilenya,2016-01-24,,500,mg,[' '],IV, 
17218,3215,Betaferon,2016-03-26,,5000,mg,['2 / Day'], , 
17219,3215,D-cure (Vitamine D),2016-04-11,2019-12-04,500, ,['/ Day'], ,Adverse Event
17220,3215,Endoxan,2016-07-13,2018-07-20, ,mg,['/Month'], ,Adverse Event
17221,3215,D-cure (Vitamine D),2016-06-18,,500, ,['2 / Day'],IV, 
17222,2305,Alemtuzumab (Campath),2016-01-13,, , ,['2 / Day'],IV, 
17223,2305,Endoxan,2016-04-29,2019-08-17,400, ,['/Month'], ,Patient Choice/Convenience
17224,2305,D-cure (Vitamine D),2016-03-17,2021-07-09, , ,['/Month'], ,Adverse Event
17225,2305,Tecfidera,2016-09-18,2018-09-23,1,mg,['2 / Day'], ,Adverse Event
17226,3016,Betaferon,2016-03-11,2020-06-14,300,MIU,['3 / Week'],IV,Lack of efficacy
17227,4090,Endoxan,2016-06-01,,300, ,['3 / Week'],IV, 
17228,4090,Endoxan,2016-09-12,,400,mg,['2 / Day'],IV, 
17229,3776,Ledertrexaat,2016-06-15,2018-01-06,300,mg,['2 / Day'], ,Adverse Event
17230,3776,Methylprednisolone,2016-02-11,2021-03-04, , ,['3 / Week'],IV,Adverse Event
17231,3239,Methylprednisolone,2016-04-13,, , ,['/ Day'], , 
17232,3239,Ledertrexaat,2016-01-28,, ,mg,['/Month'],IV, 
17233,3239,IVIG,2016-03-21,2019-06-19,20, ,['2 / Day'],IV,Patient Choice/Convenience
17234,3239,IVIG,2016-01-04,,20, ,['/Month'],IV, 
17235,1469,Rebif [44],2016-01-06,2020-12-29, , ,['/ Week'],IV,Persisting MRI activity
17236,1469,Endoxan,2016-06-14,,5000,mg,['2 / Day'],IV, 
17237,1469,Endoxan,2016-01-26,, ,mcg,['2 / Day'],IV, 
17238,866,IVIG,2016-02-04,, ,mg,['/Month'], , 
17239,866,Avonex,2015-11-20,,20,MIU,['3 / Week'],IV, 
17240,866,Tysabri,2016-09-12,,5000, ,['/Month'], , 
17241,866,Avonex,2016-07-27,2018-09-13, , ,['2 / Day'], ,Persisting MRI activity
17242,1164,Copaxone,2016-04-09,2019-11-03, ,mg,['/Month'], ,Lack of efficacy
17243,1164,Betaferon,2016-02-12,2021-09-23,400,mg,[' '],Oral,Patient Choice/Convenience
17244,1164,D-cure (Vitamine D),2015-10-24,, , ,['/Month'],Oral, 
17245,1164,Rebif [22],2016-05-21,2018-04-19,1000, ,['/Month'],IV,Persistence of relapses
17246,1199,Mitoxantrone,2016-09-06,, ,MIU,['3 / Week'],IV, 
17247,4796,Copaxone,2016-04-21,, , ,['2 / Day'],IV, 
17248,4796,Copaxone,2016-02-03,,1000,mg,['2 / Day'], , 
17249,4796,Methylprednisolone,2016-04-30,, , ,['2 / Day'], , 
17250,326,D-cure (Vitamine D),2016-06-10,,300, ,['2 / Day'],Oral, 
17251,326,Tysabri,2016-09-14,2018-09-19,5000,mg,['/Month'], ,Lack of efficacy
17252,326,Endoxan,2016-09-08,2020-10-05,5000,mg,['/Month'],Oral,Persistence of relapses
17253,4537,Methylprednisolone,2016-02-14,,5000,mg,[' '], , 
17254,4537,Gilenya,2016-07-01,,1000, ,['/Month'],IV, 
17255,4537,Endoxan,2016-10-06,,1000, ,['/ Day'],IV, 
17256,2178,Mitoxantrone,2016-05-21,,400, ,['2 / Day'],IV, 
17257,2178,Tecfidera,2016-09-22,,5000, ,['/Month'], , 
17258,2582,Copaxone,2015-12-16,,5000, ,['2 / Day'],IV, 
17259,2582,Betaferon,2016-05-26,2020-10-11,1,mcg,['2 / Day'],IV,Persisting MRI activity
17260,3043,Ledertrexaat,2016-06-06,,300,mg,['2 / Day'],IV, 
17261,4405,Rebif [44],2016-07-13,2020-02-04, ,mg,['/Month'],IV,Adverse Event
17262,4405,IVIG,2016-08-10,,5000,mg,['/ Week'],IV, 
17263,4405,Avonex,2016-03-20,2017-10-25, ,mg,['2 / Day'], ,Persisting MRI activity
17264,3017,Copaxone,2015-10-27,,20,mg,[' '], , 
17265,3017,D-cure (Vitamine D),2016-08-08,2019-01-11, ,mg,['2 / Day'],IV,Persistence of relapses
17266,2784,Methylprednisolone,2016-01-25,,300,MIU,['2 / Day'], , 
17267,2784,D-cure (Vitamine D),2015-12-26,,20,mg,['2 / Day'], , 
17268,2784,Mitoxantrone,2016-02-11,2019-10-18,5000,MIU,['/Month'],IV,Adverse Event
17269,487,Rebif [44],2016-08-22,2021-06-28,5000,mg,['/Month'], ,Persisting MRI activity
17270,3859,Copaxone,2016-05-17,,1000,mg,['3 / Week'], , 
17271,3859,Rebif [44],2016-10-18,,1000,mg,['/ Day'],IV, 
17272,3859,Tysabri,2016-08-09,2019-06-12,500,MIU,['/Month'], ,Persisting MRI activity
17273,3859,Endoxan,2015-12-12,,300,mg,['/Month'], , 
17274,1948,Copaxone,2015-12-22,,1000,mg,['/Month'],IV, 
17275,1948,Ledertrexaat,2015-12-20,,500,MIU,['/Month'], , 
17276,1948,Alemtuzumab (Campath),2016-01-15,2021-09-07, , ,['/Month'],IV,Lack of efficacy
17277,4637,D-cure (Vitamine D),2016-02-25,2021-04-05, , ,['/ Day'], ,Adverse Event
17278,4637,Rebif [44],2016-08-14,,5000, ,['/Month'],IV, 
17279,3148,Rebif [44],2016-06-15,,1000, ,['/Month'],IV, 
17280,3148,Tecfidera,2016-04-01,,5000,mcg,[' '],Oral, 
17281,3148,Gilenya,2016-08-05,, ,MIU,[' '],IV, 
17282,3148,Endoxan,2015-12-03,,5000,mcg,['/Month'], , 
17283,3052,IVIG,2016-07-30,2018-01-29,500,MIU,['/Month'],IV,Adverse Event
17284,3052,IVIG,2016-08-02,,400, ,['/Month'],IV, 
17285,1092,IVIG,2016-06-08,,20,mg,['3 / Week'],IV, 
17286,1092,Gilenya,2016-09-30,2020-06-13,500,mg,['3 / Week'],IV,Patient Choice/Convenience
17287,1092,D-cure (Vitamine D),2016-02-14,2019-04-27,500,MIU,[' '], ,Patient Choice/Convenience
17288,2640,Tysabri,2016-10-02,,20, ,['/Month'],IV, 
17289,2640,Avonex,2015-11-02,,400, ,['2 / Day'],IV, 
17290,2640,D-cure (Vitamine D),2016-10-17,, ,mg,['3 / Week'], , 
17291,2640,Rebif [22],2016-07-26,,1,mg,['/ Day'], , 
17292,3663,Teriflunomide,2016-09-24,,1,MIU,['/ Week'],Oral, 
17293,3663,Tecfidera,2015-11-26,, , ,['/Month'],IV, 
17294,3663,Gilenya,2016-06-10,, , ,[' '], , 
17295,2172,Copaxone,2016-08-29,, , ,['/Month'],Oral, 
17296,1976,Betaferon,2015-11-24,,20,MIU,['/Month'], , 
17297,1976,D-cure (Vitamine D),2016-03-31,2021-02-16, ,mg,['2 / Day'], ,Patient Choice/Convenience
17298,1976,Rebif [44],2016-04-14,2019-12-07,300, ,['/ Day'],IV,Adverse Event
17299,1976,Betaferon,2016-06-27,,1000,mcg,['3 / Week'], , 
17300,761,Endoxan,2016-03-28,2019-09-14,300,MIU,['/Month'],IV,Adverse Event
17301,761,D-cure (Vitamine D),2016-06-20,2017-12-26,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
17302,2037,Rebif [22],2016-08-08,2021-07-15,5000,mg,[' '],IV,Persistence of relapses
17303,2037,Avonex,2016-06-29,2018-11-16,1000, ,[' '],IV,Lack of efficacy
17304,2037,Tysabri,2016-07-30,2020-02-24,5000,mg,[' '], ,Patient Choice/Convenience
17305,2506,Tecfidera,2015-11-29,2021-07-26, , ,['3 / Week'],IV,Lack of efficacy
17306,2506,Tecfidera,2015-11-30,2020-07-13,1000,mg,[' '], ,Persistence of relapses
17307,2318,Rebif [22],2016-04-15,2018-09-16,400,MIU,[' '],IV,Adverse Event
17308,4017,Alemtuzumab (Campath),2015-11-04,2019-01-03, ,mcg,['3 / Week'], ,Persisting MRI activity
17309,4017,Tysabri,2016-04-23,, ,MIU,['2 / Day'],IV, 
17310,4017,Teriflunomide,2015-12-21,2017-12-19,500,mcg,['/Month'],Oral,Adverse Event
17311,4017,Rebif [44],2016-02-04,,500,mcg,['/ Day'],IV, 
17312,492,Endoxan,2016-09-01,2020-12-19,500,mg,['/Month'], ,Persisting MRI activity
17313,492,IVIG,2015-11-18,2018-06-22,500, ,['2 / Day'], ,Patient Choice/Convenience
17314,492,Gilenya,2016-10-15,, , ,['/ Day'],Oral, 
17315,966,Endoxan,2016-08-16,2020-12-25,300, ,['3 / Week'],IV,Adverse Event
17316,966,Rebif [44],2015-12-27,2018-06-04,400,mg,['/ Week'], ,Persistence of relapses
17317,966,Gilenya,2015-12-15,2019-05-24, ,mcg,['/ Day'], ,Persisting MRI activity
17318,966,Avonex,2015-11-27,2021-01-09, ,mg,['/ Day'], ,Adverse Event
17319,3659,Copaxone,2016-09-11,2020-03-16,500,mg,[' '], ,Persisting MRI activity
17320,3659,Teriflunomide,2016-09-23,2019-08-08,1, ,[' '], ,Adverse Event
17321,3659,Rebif [44],2016-07-17,, ,MIU,['2 / Day'], , 
17322,2175,Gilenya,2016-03-26,,1000, ,['/ Day'],IV, 
17323,2175,Endoxan,2016-01-06,,5000, ,['/Month'],Oral, 
17324,1830,D-cure (Vitamine D),2016-02-09,,400,mg,[' '], , 
17325,1830,Tysabri,2016-03-22,,400,mcg,['3 / Week'], , 
17326,1830,Tysabri,2016-06-25,,5000, ,['/ Week'],IV, 
17327,1830,Rebif [44],2016-04-27,2021-07-27,20,mg,['/Month'],Oral,Persisting MRI activity
17328,2703,Endoxan,2016-10-20,,1000,MIU,['/Month'],IV, 
17329,2703,Alemtuzumab (Campath),2016-04-24,, ,mcg,['2 / Day'],IV, 
17330,1342,Rebif [22],2015-11-30,,1000,mg,['2 / Day'],Oral, 
17331,1342,Betaferon,2016-03-26,2020-11-23,500,mg,['2 / Day'],IV,Patient Choice/Convenience
17332,2874,Tysabri,2016-09-30,,20,mg,['/Month'],IV, 
17333,313,D-cure (Vitamine D),2016-05-23,2019-11-17,300, ,['/Month'], ,Lack of efficacy
17334,313,Methylprednisolone,2015-11-26,2020-10-21,500,mg,['2 / Day'],IV,Persisting MRI activity
17335,313,Copaxone,2015-12-29,,1000,MIU,['2 / Day'],IV, 
17336,313,IVIG,2016-04-04,2020-05-02, ,MIU,['/Month'],Oral,Patient Choice/Convenience
17337,4526,Tecfidera,2016-10-06,2020-02-08,500, ,['2 / Day'],Oral,Persistence of relapses
17338,400,Betaferon,2016-02-18,2021-03-19,500, ,['2 / Day'],IV,Persisting MRI activity
17339,400,Methylprednisolone,2016-02-10,2020-07-20, ,MIU,['/ Day'],IV,Patient Choice/Convenience
17340,400,Endoxan,2016-08-23,,20, ,['/Month'], , 
17341,400,D-cure (Vitamine D),2016-06-29,2019-03-11,5000,mg,['/Month'],IV,Adverse Event
17342,4450,Ledertrexaat,2016-03-30,,500, ,['/Month'], , 
17343,1285,Tecfidera,2016-02-13,2018-11-28,500,mg,['/Month'],IV,Persisting MRI activity
17344,2826,Endoxan,2016-10-13,,5000,mcg,['2 / Day'],IV, 
17345,3427,Tysabri,2016-06-02,2021-05-12,20, ,['2 / Day'],IV,Lack of efficacy
17346,3427,IVIG,2016-09-21,2021-05-14,300,mg,['/Month'],IV,Patient Choice/Convenience
17347,3427,Ledertrexaat,2016-03-28,2021-07-07,1, ,['/Month'],IV,Patient Choice/Convenience
17348,3427,Methylprednisolone,2016-02-21,, ,mg,['/ Week'],IV, 
17349,4064,Ledertrexaat,2016-05-19,2019-03-30, , ,['3 / Week'],IV,Adverse Event
17350,4064,Copaxone,2015-12-13,, , ,['2 / Day'],IV, 
17351,4064,Rebif [44],2016-06-05,2019-07-29,500, ,['2 / Day'],Oral,Adverse Event
17352,4064,Copaxone,2016-01-05,,500,mg,['2 / Day'], , 
17353,3014,D-cure (Vitamine D),2016-08-31,2018-04-15,500,mg,['/Month'], ,Adverse Event
17354,3014,Alemtuzumab (Campath),2016-09-10,,300,mg,['/Month'],IV, 
17355,2912,Teriflunomide,2016-10-16,2018-05-09,400, ,['/Month'],IV,Patient Choice/Convenience
17356,2912,D-cure (Vitamine D),2016-09-13,2021-10-02,1,mg,['3 / Week'], ,Patient Choice/Convenience
17357,2912,Rebif [44],2016-04-25,2017-11-01, ,mg,['/Month'],Oral,Patient Choice/Convenience
17358,2636,Copaxone,2016-04-08,2020-02-10,300,mg,['/Month'], ,Lack of efficacy
17359,2636,Alemtuzumab (Campath),2016-06-18,2020-12-24,400, ,['2 / Day'],IV,Adverse Event
17360,2894,IVIG,2016-04-23,2020-01-21, ,MIU,['/Month'],Oral,Adverse Event
17361,3513,Gilenya,2016-08-02,, , ,[' '],IV, 
17362,3513,Tysabri,2015-11-14,2019-06-15, , ,[' '],IV,Patient Choice/Convenience
17363,3513,Gilenya,2016-10-03,2019-11-22,1,mcg,['2 / Day'],Oral,Persistence of relapses
17364,3513,D-cure (Vitamine D),2015-10-30,,1000, ,['/ Day'],IV, 
17365,4594,Avonex,2016-02-29,2021-09-25,1000, ,['2 / Day'], ,Persistence of relapses
17366,4594,Betaferon,2016-05-18,,1, ,['/Month'],IV, 
17367,4180,Alemtuzumab (Campath),2016-07-27,,500, ,[' '], , 
17368,4180,Ledertrexaat,2015-10-26,, ,mg,['/Month'],IV, 
17369,1424,Tecfidera,2015-11-24,, , ,[' '], , 
17370,1424,Gilenya,2016-09-24,2018-10-16,500, ,['/ Week'],Oral,Persisting MRI activity
17371,3662,Betaferon,2016-09-15,,5000, ,['2 / Day'],IV, 
17372,3662,Tysabri,2016-01-30,, ,MIU,['/ Day'],IV, 
17373,4378,Rebif [22],2016-01-30,2019-07-01, , ,[' '],Oral,Lack of efficacy
17374,348,Ledertrexaat,2015-10-28,,5000, ,['/Month'],IV, 
17375,2756,Tysabri,2016-09-24,2017-12-21,300, ,[' '],IV,Patient Choice/Convenience
17376,2756,IVIG,2016-06-29,, ,mg,['2 / Day'],Oral, 
17377,2756,Gilenya,2016-09-24,,1000, ,['/Month'],IV, 
17378,2756,Gilenya,2016-05-29,2019-07-09, , ,['2 / Day'],IV,Persisting MRI activity
17379,2997,Alemtuzumab (Campath),2016-07-25,,5000, ,['2 / Day'],Oral, 
17380,2997,Gilenya,2016-05-18,,20,mg,['3 / Week'], , 
17381,2997,Alemtuzumab (Campath),2016-09-30,2018-03-26,20,mg,['/Month'], ,Adverse Event
17382,2997,Tecfidera,2016-04-07,2018-09-18,500,mg,['2 / Day'],IV,Persisting MRI activity
17383,896,Methylprednisolone,2016-04-26,2021-10-17, , ,['2 / Day'],IV,Adverse Event
17384,896,Endoxan,2016-05-12,, , ,['/Month'], , 
17385,896,Rebif [22],2016-06-26,2019-03-23,400, ,['/Month'],IV,Patient Choice/Convenience
17386,4983,Rebif [44],2016-09-29,,300,mg,[' '], , 
17387,4983,Methylprednisolone,2016-09-17,2019-09-24,1000,mg,['/Month'], ,Patient Choice/Convenience
17388,1643,Alemtuzumab (Campath),2016-01-03,2019-05-30,1000,mg,['/Month'], ,Patient Choice/Convenience
17389,1643,Rebif [44],2016-07-28,,500, ,['2 / Day'],IV, 
17390,1643,Tysabri,2016-02-21,, ,mg,['2 / Day'],IV, 
17391,2053,Tecfidera,2016-08-27,,5000, ,['3 / Week'],IV, 
17392,2053,Endoxan,2016-08-12,,500, ,['/Month'], , 
17393,2053,Mitoxantrone,2015-12-20,2019-05-11,20,mg,['2 / Day'], ,Adverse Event
17394,2762,Rebif [22],2016-07-14,2018-01-03,1000,mg,['2 / Day'], ,Persisting MRI activity
17395,2762,Tecfidera,2016-01-09,2020-01-15,20,mcg,['3 / Week'],IV,Patient Choice/Convenience
17396,2762,Teriflunomide,2016-04-25,,300,mg,[' '],Oral, 
17397,2762,Betaferon,2015-12-28,,400,mcg,['2 / Day'],Oral, 
17398,3762,Rebif [22],2016-03-07,2020-07-06,300,mg,[' '],IV,Lack of efficacy
17399,3762,Teriflunomide,2015-11-08,2021-03-11, ,MIU,['/Month'], ,Adverse Event
17400,3762,Ledertrexaat,2016-07-04,2020-07-03,400,mg,['/ Day'],Oral,Persisting MRI activity
17401,469,Tecfidera,2015-11-22,,1,mg,['2 / Day'],Oral, 
17402,469,Copaxone,2016-08-10,, ,MIU,[' '],IV, 
17403,469,Tecfidera,2016-08-29,, ,mg,['/ Day'],IV, 
17404,3764,Avonex,2016-02-18,2020-06-09,20, ,[' '],Oral,Persistence of relapses
17405,3764,Methylprednisolone,2016-09-02,, ,mcg,['2 / Day'], , 
17406,3764,Rebif [44],2016-10-20,2019-02-28,1000,mcg,['/ Week'],Oral,Patient Choice/Convenience
17407,4214,IVIG,2016-05-31,,500, ,[' '],IV, 
17408,4214,Endoxan,2016-03-21,2020-05-14,1000, ,['2 / Day'], ,Persistence of relapses
17409,4300,Tysabri,2015-11-03,,400, ,[' '],IV, 
17410,4300,Betaferon,2016-03-17,,400,mg,['2 / Day'], , 
17411,4300,Tecfidera,2016-04-10,, ,MIU,['2 / Day'],IV, 
17412,4300,Ledertrexaat,2016-05-11,2019-02-01,1000,mg,['/Month'], ,Patient Choice/Convenience
17413,2154,Endoxan,2016-07-01,2020-05-07,400, ,['/Month'], ,Patient Choice/Convenience
17414,2154,Tecfidera,2016-07-23,,300, ,[' '],IV, 
17415,2154,IVIG,2015-10-27,2018-02-01,1000,mg,['/ Week'], ,Patient Choice/Convenience
17416,2154,D-cure (Vitamine D),2015-12-16,,20, ,['2 / Day'],IV, 
17417,1536,Alemtuzumab (Campath),2016-01-19,,20, ,[' '],IV, 
17418,1536,D-cure (Vitamine D),2016-09-16,2018-08-06, ,mcg,['/Month'],IV,Persisting MRI activity
17419,1536,Tysabri,2016-06-13,,5000,mg,['/Month'],IV, 
17420,1635,Rebif [44],2015-11-12,, , ,[' '], , 
17421,1754,D-cure (Vitamine D),2016-07-04,,1,mg,['/ Week'],IV, 
17422,1754,Alemtuzumab (Campath),2016-01-01,,500,mg,['2 / Day'], , 
17423,3506,Endoxan,2016-09-19,,1000,MIU,['/Month'],Oral, 
17424,3506,IVIG,2016-10-14,,1, ,['2 / Day'],IV, 
17425,3506,Methylprednisolone,2016-02-20,,500,mg,[' '],Oral, 
17426,3506,D-cure (Vitamine D),2016-05-02,2020-07-18,400, ,['2 / Day'], ,Patient Choice/Convenience
17427,3798,Tecfidera,2016-09-22,2018-05-31, ,mg,['2 / Day'], ,Persistence of relapses
17428,3798,IVIG,2016-05-09,2021-03-26,1000, ,['2 / Day'], ,Persistence of relapses
17429,2603,Tysabri,2016-08-29,,20,mg,['/Month'],IV, 
17430,2603,Rebif [22],2016-08-15,2018-08-30,300, ,['3 / Week'],IV,Adverse Event
17431,2597,Rebif [44],2015-12-06,2018-04-02,500, ,['2 / Day'], ,Lack of efficacy
17432,2597,Ledertrexaat,2016-09-06,,1000,mg,['2 / Day'],Oral, 
17433,2597,Tecfidera,2016-07-23,2017-11-11,300,mg,['/ Day'],IV,Adverse Event
17434,2597,Tecfidera,2016-03-22,,5000,mg,['/Month'],IV, 
17435,4920,Methylprednisolone,2016-07-15,, ,mg,['2 / Day'], , 
17436,4920,Gilenya,2016-08-11,,1000, ,[' '],IV, 
17437,4920,Copaxone,2016-03-08,,1000, ,['2 / Day'],Oral, 
17438,4920,Endoxan,2016-06-20,2021-05-25,1,mg,['/Month'],IV,Patient Choice/Convenience
17439,1650,Gilenya,2016-08-02,2019-12-07, ,mg,['2 / Day'], ,Lack of efficacy
17440,4496,Mitoxantrone,2016-08-08,, , ,[' '],IV, 
17441,1792,Gilenya,2016-02-17,2021-01-17,300,mg,['/Month'],IV,Persisting MRI activity
17442,1792,Tysabri,2015-12-18,2021-02-22, ,mg,['3 / Week'], ,Persisting MRI activity
17443,1792,Ledertrexaat,2016-08-12,, ,mcg,['/Month'],IV, 
17444,4739,D-cure (Vitamine D),2016-06-03,, , ,['/ Day'],Oral, 
17445,4739,Methylprednisolone,2016-06-26,,500,MIU,['/Month'],IV, 
17446,4739,Rebif [44],2016-10-05,, ,mcg,['2 / Day'],IV, 
17447,2460,Gilenya,2016-01-03,2020-10-24,1000, ,['/Month'],IV,Patient Choice/Convenience
17448,2460,Tecfidera,2016-10-02,2021-05-29,20,mg,['3 / Week'], ,Persistence of relapses
17449,4656,IVIG,2016-08-01,,1,mg,['/ Day'],IV, 
17450,1546,Rebif [44],2016-06-26,, , ,['2 / Day'], , 
17451,1546,Betaferon,2016-07-29,,20,mg,['3 / Week'],IV, 
17452,4979,Betaferon,2016-06-22,2019-02-06,5000, ,['/Month'], ,Persisting MRI activity
17453,4979,Mitoxantrone,2015-11-18,,1000,mg,['/Month'],Oral, 
17454,4333,Teriflunomide,2016-07-15,2018-06-18, ,MIU,['2 / Day'],IV,Lack of efficacy
17455,4333,D-cure (Vitamine D),2016-08-11,2019-05-12,1,mg,['/Month'],IV,Adverse Event
17456,4333,Rebif [44],2015-12-28,,300, ,['2 / Day'],IV, 
17457,4333,Methylprednisolone,2015-12-22,2021-03-15, , ,['/ Day'],IV,Adverse Event
17458,540,Betaferon,2015-11-01,2020-09-15, ,MIU,['/Month'],IV,Patient Choice/Convenience
17459,540,Tecfidera,2016-01-03,,20, ,[' '],IV, 
17460,540,Copaxone,2016-04-23,2020-11-28, ,mg,[' '],IV,Lack of efficacy
17461,540,Betaferon,2016-07-20,, ,mg,['2 / Day'], , 
17462,2321,Gilenya,2016-04-15,2021-09-20,20, ,['2 / Day'],IV,Patient Choice/Convenience
17463,2531,Tysabri,2016-01-05,2020-04-02,1000,mg,['/Month'], ,Patient Choice/Convenience
17464,2531,Teriflunomide,2016-04-22,2017-11-15,20,mcg,['2 / Day'],IV,Adverse Event
17465,2531,D-cure (Vitamine D),2016-09-07,, , ,['3 / Week'],IV, 
17466,121,IVIG,2015-11-30,2020-12-12,20, ,['2 / Day'], ,Patient Choice/Convenience
17467,121,D-cure (Vitamine D),2016-02-25,, , ,[' '],IV, 
17468,121,D-cure (Vitamine D),2016-08-24,2018-07-27, ,mg,['/ Week'], ,Lack of efficacy
17469,199,Rebif [44],2016-07-06,,500,mg,['/Month'],IV, 
17470,1379,Alemtuzumab (Campath),2015-11-30,2018-04-09,1000,mg,['/Month'],Oral,Persisting MRI activity
17471,1379,Gilenya,2016-07-06,, ,mg,['2 / Day'],IV, 
17472,1379,Copaxone,2016-06-08,,5000, ,['2 / Day'], , 
17473,1379,Gilenya,2016-10-20,,400, ,[' '],IV, 
17474,3713,Tecfidera,2016-07-19,2021-06-17, ,mg,['/ Week'],IV,Patient Choice/Convenience
17475,1380,Gilenya,2016-05-10,,1, ,['3 / Week'],Oral, 
17476,1380,Methylprednisolone,2016-07-10,, ,MIU,['3 / Week'],IV, 
17477,1380,D-cure (Vitamine D),2016-02-17,,1, ,['3 / Week'],Oral, 
17478,3313,Copaxone,2016-02-16,2021-06-19,1000,mg,['/ Week'],IV,Persisting MRI activity
17479,2047,Methylprednisolone,2016-09-07,, , ,['2 / Day'],IV, 
17480,2047,Betaferon,2016-03-13,,500,mg,['/Month'], , 
17481,2047,Rebif [44],2016-02-15,2018-08-22,20, ,['3 / Week'],IV,Lack of efficacy
17482,4253,Teriflunomide,2016-08-28,,300,mg,['/Month'],IV, 
17483,326,Betaferon,2015-12-26,2020-04-26,20, ,[' '],Oral,Lack of efficacy
17484,326,Gilenya,2016-08-13,,1,mcg,['2 / Day'],IV, 
17485,326,Methylprednisolone,2015-12-04,,300, ,['2 / Day'], , 
17486,326,Betaferon,2016-04-13,, , ,['2 / Day'],Oral, 
17487,938,Endoxan,2016-10-13,,300,mg,['3 / Week'], , 
17488,938,Alemtuzumab (Campath),2015-11-12,, ,MIU,[' '],Oral, 
17489,938,Methylprednisolone,2016-01-13,,5000,MIU,['2 / Day'],Oral, 
17490,2078,Gilenya,2016-09-04,,20,MIU,['3 / Week'],Oral, 
17491,2078,Gilenya,2016-07-01,2020-12-19,5000, ,['/Month'],IV,Persistence of relapses
17492,2078,Rebif [44],2016-10-17,,20,MIU,[' '], , 
17493,230,Betaferon,2016-06-17,2020-03-26, ,MIU,['/Month'],Oral,Adverse Event
17494,230,Methylprednisolone,2016-04-15,,1000, ,['2 / Day'], , 
17495,230,Methylprednisolone,2016-02-11,, , ,['2 / Day'],IV, 
17496,220,Teriflunomide,2016-02-04,2021-06-22,1000,mg,['2 / Day'],IV,Adverse Event
17497,4475,Avonex,2016-02-05,,300,mg,['/ Day'],Oral, 
17498,4475,Tecfidera,2016-07-16,,5000, ,[' '],IV, 
17499,4475,Teriflunomide,2015-11-30,2021-04-06,500, ,['2 / Day'],IV,Adverse Event
17500,2437,Tysabri,2016-10-16,2020-04-14, , ,['3 / Week'], ,Lack of efficacy
17501,2437,Methylprednisolone,2016-01-16,2019-08-01, ,mcg,['/ Day'], ,Persisting MRI activity
17502,4228,Alemtuzumab (Campath),2016-02-23,, , ,['/Month'], , 
17503,4228,Avonex,2016-04-10,2019-02-11, , ,['/Month'], ,Patient Choice/Convenience
17504,4228,Copaxone,2016-08-04,,20,mg,['2 / Day'],Oral, 
17505,2405,Rebif [22],2016-08-27,, , ,[' '],IV, 
17506,1583,Tysabri,2015-12-06,,1000, ,['/ Day'],IV, 
17507,3879,Tysabri,2016-01-17,,20, ,['2 / Day'],IV, 
17508,4940,Copaxone,2016-05-18,,20,MIU,['/ Day'],IV, 
17509,4940,Gilenya,2016-08-09,, , ,['/ Day'],Oral, 
17510,4194,Methylprednisolone,2016-02-02,2020-02-15,1, ,['/Month'], ,Lack of efficacy
17511,4194,Tecfidera,2016-08-28,2019-08-21, , ,['2 / Day'], ,Patient Choice/Convenience
17512,4194,Gilenya,2015-11-02,2020-10-29,20,mg,['/ Day'], ,Lack of efficacy
17513,1438,Tysabri,2016-06-26,,20,mcg,[' '],IV, 
17514,1438,IVIG,2015-12-09,2019-06-29,5000, ,['3 / Week'],IV,Lack of efficacy
17515,3634,Methylprednisolone,2016-02-09,,500,mg,['2 / Day'],Oral, 
17516,3634,Alemtuzumab (Campath),2016-06-06,,5000,mg,['/Month'], , 
17517,3045,IVIG,2016-02-02,,400, ,['/Month'],IV, 
17518,3423,Alemtuzumab (Campath),2016-10-19,,20, ,['/ Day'], , 
17519,3423,Copaxone,2016-01-04,2021-01-03,20, ,[' '], ,Patient Choice/Convenience
17520,3423,Endoxan,2016-05-21,, ,mg,['2 / Day'],IV, 
17521,3423,Tysabri,2016-02-23,,20, ,['2 / Day'], , 
17522,1907,Avonex,2016-06-20,2021-04-30,1000,mg,['2 / Day'],Oral,Persisting MRI activity
17523,1907,Methylprednisolone,2016-03-14,2020-02-15,1000,MIU,['/Month'],IV,Patient Choice/Convenience
17524,1907,Methylprednisolone,2016-07-08,,300,mg,['2 / Day'], , 
17525,1907,IVIG,2016-09-04,,1000,mg,['2 / Day'],IV, 
17526,4724,Avonex,2016-03-23,2021-06-09,500, ,['/Month'],Oral,Lack of efficacy
17527,4724,Alemtuzumab (Campath),2016-08-19,,500, ,['/Month'], , 
17528,3646,Rebif [22],2016-10-05,,300,mg,['/Month'],IV, 
17529,3646,Alemtuzumab (Campath),2016-09-08,,300,MIU,['/ Day'],IV, 
17530,3646,Ledertrexaat,2016-06-06,2020-01-30,5000,MIU,['/ Day'], ,Lack of efficacy
17531,3646,Endoxan,2016-07-12,2021-08-30, ,mg,['/Month'], ,Lack of efficacy
17532,4880,D-cure (Vitamine D),2016-02-11,2020-01-17,20, ,['/Month'], ,Persistence of relapses
17533,4880,Gilenya,2016-06-01,,500, ,['/Month'],IV, 
17534,4880,Tecfidera,2016-07-25,,300, ,['/Month'],IV, 
17535,2168,Rebif [22],2016-05-11,, ,MIU,['/Month'],IV, 
17536,3805,D-cure (Vitamine D),2016-08-06,2019-05-28, ,mg,['/ Day'], ,Persisting MRI activity
17537,4863,Tecfidera,2016-06-11,,5000,mg,['2 / Day'],IV, 
17538,4863,Rebif [22],2016-09-08,2019-01-19,300, ,['2 / Day'], ,Adverse Event
17539,4863,Alemtuzumab (Campath),2016-06-05,2018-03-04,400,mg,['3 / Week'],Oral,Persistence of relapses
17540,4117,Gilenya,2016-10-07,2020-07-11,20,mg,['/ Week'],IV,Patient Choice/Convenience
17541,4117,Tysabri,2016-01-16,,1000, ,['/Month'], , 
17542,4117,Endoxan,2016-05-27,,500,mg,['2 / Day'],Oral, 
17543,4409,Teriflunomide,2016-01-04,,400, ,['2 / Day'],IV, 
17544,4409,Gilenya,2015-11-06,,1000,mg,['/Month'],IV, 
17545,4409,Teriflunomide,2016-07-24,2021-09-23,300,mg,['/Month'],IV,Persisting MRI activity
17546,4184,Rebif [22],2016-04-10,,5000, ,['/ Day'],IV, 
17547,4184,Endoxan,2016-01-24,,400, ,['2 / Day'],IV, 
17548,4184,Endoxan,2015-10-25,2018-03-21,20, ,['2 / Day'],IV,Lack of efficacy
17549,4184,Tysabri,2016-09-22,2020-10-18, ,mg,['/Month'],IV,Lack of efficacy
17550,3608,Copaxone,2016-08-21,, ,mg,['/ Day'], , 
17551,3608,Methylprednisolone,2015-12-27,2017-12-19,20,mg,['/Month'], ,Lack of efficacy
17552,3608,Alemtuzumab (Campath),2016-03-08,,20,mg,['2 / Day'],IV, 
17553,3535,D-cure (Vitamine D),2016-09-18,, ,mg,['/Month'], , 
17554,3535,Rebif [22],2016-09-04,,500, ,['/Month'],IV, 
17555,3535,D-cure (Vitamine D),2016-03-24,2018-09-11, ,mg,['/Month'],IV,Lack of efficacy
17556,3535,Mitoxantrone,2015-10-25,, ,mg,['2 / Day'], , 
17557,3037,Tysabri,2016-07-20,,1000, ,['2 / Day'],IV, 
17558,3037,Tecfidera,2016-03-27,2020-06-13,500,mg,['/ Day'], ,Persisting MRI activity
17559,3037,Teriflunomide,2016-03-21,,1,mg,['3 / Week'], , 
17560,784,Avonex,2016-04-14,2021-07-28,300, ,['3 / Week'],Oral,Adverse Event
17561,784,D-cure (Vitamine D),2016-07-30,2021-06-23,1,mg,['2 / Day'],IV,Lack of efficacy
17562,2171,IVIG,2016-04-29,2017-11-21, , ,['2 / Day'], ,Adverse Event
17563,1124,Mitoxantrone,2015-12-09,2019-01-07,500, ,['2 / Day'], ,Persistence of relapses
17564,536,Mitoxantrone,2016-06-18,,1000,mg,['3 / Week'],IV, 
17565,536,Methylprednisolone,2016-09-07,2021-10-16,1000,mg,['/Month'],Oral,Lack of efficacy
17566,4374,Ledertrexaat,2016-02-12,, ,mg,['2 / Day'], , 
17567,3484,Endoxan,2016-07-01,,300,mg,['/Month'],IV, 
17568,3484,Rebif [22],2015-11-13,,500,mg,['2 / Day'],IV, 
17569,3484,Betaferon,2016-07-02,, , ,['/ Day'], , 
17570,4308,Alemtuzumab (Campath),2016-10-10,2018-07-15,20,mg,['/Month'],IV,Lack of efficacy
17571,1089,D-cure (Vitamine D),2016-08-01,, , ,['2 / Day'],IV, 
17572,1089,Endoxan,2016-02-01,2018-11-13,5000,mg,['2 / Day'],Oral,Persistence of relapses
17573,1089,Avonex,2016-07-21,2020-08-13, ,mcg,[' '], ,Patient Choice/Convenience
17574,360,Betaferon,2016-05-04,,1000, ,['3 / Week'],IV, 
17575,360,Gilenya,2016-10-08,,500,MIU,['/Month'], , 
17576,3383,IVIG,2015-11-09,,300,mg,['3 / Week'], , 
17577,2478,Rebif [22],2016-06-02,, , ,['/Month'],IV, 
17578,3939,Methylprednisolone,2016-06-18,, ,MIU,['/Month'], , 
17579,2228,Mitoxantrone,2016-09-01,,500,mg,['3 / Week'],IV, 
17580,2228,IVIG,2016-01-30,2021-03-13, ,mg,['2 / Day'],IV,Persisting MRI activity
17581,2228,Gilenya,2016-09-25,,1, ,['2 / Day'], , 
17582,2228,Rebif [44],2015-10-25,, ,MIU,['2 / Day'],IV, 
17583,3685,Tysabri,2016-03-15,,300,mg,['2 / Day'],IV, 
17584,3685,Gilenya,2016-04-02,2019-07-02,1, ,[' '], ,Patient Choice/Convenience
17585,1800,Rebif [22],2016-01-05,2019-05-02, , ,['3 / Week'], ,Persisting MRI activity
17586,1800,Endoxan,2016-01-30,,20, ,['2 / Day'],IV, 
17587,2241,Methylprednisolone,2016-04-15,2021-08-20,500,mcg,['/Month'],IV,Patient Choice/Convenience
17588,2241,Gilenya,2015-12-25,2019-07-07,500,mg,['/Month'],IV,Patient Choice/Convenience
17589,2241,D-cure (Vitamine D),2016-02-24,,20,mg,['/ Week'],IV, 
17590,2241,Rebif [44],2016-03-15,2020-08-19, ,mg,['/Month'],Oral,Persistence of relapses
17591,1728,Gilenya,2016-01-16,2021-04-24, ,mg,[' '],Oral,Patient Choice/Convenience
17592,2536,Mitoxantrone,2016-02-12,2020-10-03,400,mg,['3 / Week'],IV,Adverse Event
17593,2536,Teriflunomide,2016-07-05,, , ,[' '],IV, 
17594,2536,Gilenya,2016-09-11,2019-02-04,1000,mg,['2 / Day'], ,Lack of efficacy
17595,3000,Alemtuzumab (Campath),2016-10-18,2019-10-13, ,mg,['3 / Week'], ,Patient Choice/Convenience
17596,3000,Teriflunomide,2016-09-24,2018-08-27, ,mcg,['2 / Day'],IV,Patient Choice/Convenience
17597,3000,Teriflunomide,2016-04-20,2017-11-22, , ,['2 / Day'],IV,Adverse Event
17598,731,Ledertrexaat,2016-08-09,, , ,['/Month'],Oral, 
17599,731,IVIG,2016-10-14,,5000,mg,['/Month'],Oral, 
17600,2909,IVIG,2015-10-24,2018-11-29,500,mg,['/Month'],IV,Persistence of relapses
17601,2909,Avonex,2015-11-28,,300,mg,['2 / Day'],IV, 
17602,2452,Tysabri,2016-05-15,2018-09-29, ,mg,['2 / Day'],IV,Adverse Event
17603,2452,Tecfidera,2016-06-27,, , ,['2 / Day'], , 
17604,2452,Tysabri,2015-12-08,, ,MIU,['/Month'],IV, 
17605,574,IVIG,2016-02-11,2019-10-08,5000,mg,['/ Day'],IV,Adverse Event
17606,574,IVIG,2016-10-21,,300,mg,[' '],IV, 
17607,1438,Tecfidera,2016-06-02,2021-07-05,400,mg,['2 / Day'],IV,Persisting MRI activity
17608,1438,Methylprednisolone,2016-08-16,,500,mg,['2 / Day'],IV, 
17609,1438,Tecfidera,2016-08-01,2019-10-12, ,MIU,[' '],IV,Patient Choice/Convenience
17610,3233,Ledertrexaat,2015-11-23,,1000,mcg,['/ Week'],IV, 
17611,1076,Mitoxantrone,2016-09-24,2021-06-21,5000, ,[' '],IV,Patient Choice/Convenience
17612,1076,Betaferon,2016-03-22,2020-10-26,1, ,['/ Day'],IV,Patient Choice/Convenience
17613,1076,Alemtuzumab (Campath),2016-02-24,, , ,['/Month'],IV, 
17614,1076,Ledertrexaat,2016-10-21,2018-12-13,20, ,[' '], ,Patient Choice/Convenience
17615,2971,Rebif [22],2016-09-04,,300,mg,['/Month'],Oral, 
17616,2971,D-cure (Vitamine D),2016-03-23,2020-09-15,400,mg,['/Month'],IV,Adverse Event
17617,2971,Rebif [22],2016-05-19,2019-09-03, , ,['/ Week'],IV,Lack of efficacy
17618,2971,Tecfidera,2016-02-05,,400,mcg,['3 / Week'], , 
17619,4779,Teriflunomide,2016-07-24,, ,MIU,['2 / Day'],IV, 
17620,4779,Betaferon,2016-04-28,2018-11-29, ,mg,['2 / Day'], ,Lack of efficacy
17621,2165,Rebif [22],2016-06-13,2019-09-04, ,MIU,['3 / Week'],IV,Adverse Event
17622,2131,Methylprednisolone,2016-10-16,,20, ,['2 / Day'],IV, 
17623,2131,Endoxan,2016-04-08,,5000, ,['2 / Day'],IV, 
17624,2131,Rebif [22],2016-03-17,2018-12-31,500,mg,['3 / Week'],IV,Persistence of relapses
17625,2466,Endoxan,2015-12-23,,1000,mg,['/Month'],Oral, 
17626,3391,Gilenya,2016-02-25,2019-10-23,1000, ,['2 / Day'], ,Persistence of relapses
17627,3391,Gilenya,2016-01-17,2021-03-28, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
17628,3391,D-cure (Vitamine D),2016-07-01,2017-11-07,300,mcg,['/Month'],IV,Adverse Event
17629,3391,Tecfidera,2015-12-17,,400,mg,['/ Week'],IV, 
17630,656,Rebif [22],2016-04-06,,400, ,['/Month'],IV, 
17631,656,Rebif [44],2016-06-29,2018-01-07,400, ,['3 / Week'],IV,Patient Choice/Convenience
17632,656,Rebif [22],2016-03-28,,20,mg,['/ Day'], , 
17633,3751,Gilenya,2016-08-24,2018-11-20,500, ,['3 / Week'], ,Persisting MRI activity
17634,3751,Mitoxantrone,2016-05-26,2021-02-10,1, ,[' '],IV,Adverse Event
17635,3751,Gilenya,2016-01-14,,5000,mg,['2 / Day'], , 
17636,4348,Tysabri,2016-02-18,2019-06-07,300,mg,['/ Day'],IV,Patient Choice/Convenience
17637,4348,Gilenya,2016-10-04,,20,mg,['/Month'],IV, 
17638,1597,Avonex,2016-05-24,2018-12-26,1000,MIU,['2 / Day'], ,Persistence of relapses
17639,1597,Alemtuzumab (Campath),2015-12-06,, ,mg,['2 / Day'],IV, 
17640,2052,Methylprednisolone,2016-10-14,2018-09-10,300,mg,['2 / Day'], ,Lack of efficacy
17641,2052,Alemtuzumab (Campath),2015-11-07,, , ,['2 / Day'],IV, 
17642,2052,Alemtuzumab (Campath),2016-05-31,,300,mcg,['2 / Day'],IV, 
17643,4870,Mitoxantrone,2016-07-10,,500,mg,['/Month'],IV, 
17644,4870,IVIG,2015-11-16,, , ,['3 / Week'],IV, 
17645,4637,Endoxan,2016-07-22,,300,mg,['2 / Day'], , 
17646,4637,Teriflunomide,2016-08-03,,1000,mg,['/Month'], , 
17647,4637,Rebif [22],2016-03-21,2018-10-25, , ,['/ Week'],IV,Persistence of relapses
17648,4637,Endoxan,2016-02-15,2020-07-18, , ,['3 / Week'],IV,Persisting MRI activity
17649,2343,Rebif [44],2016-06-18,,20,mg,['2 / Day'],IV, 
17650,2343,Tysabri,2016-01-23,,1000,MIU,['2 / Day'],IV, 
17651,2343,D-cure (Vitamine D),2016-08-21,2020-04-04,400,mg,['3 / Week'], ,Adverse Event
17652,2282,Gilenya,2015-12-15,2018-01-07, ,mg,[' '],IV,Adverse Event
17653,2282,Methylprednisolone,2016-05-29,2020-05-08, ,MIU,['3 / Week'],IV,Persisting MRI activity
17654,2104,Tecfidera,2016-01-10,2020-06-30, , ,['3 / Week'],IV,Patient Choice/Convenience
17655,2104,D-cure (Vitamine D),2016-04-26,,500,mg,['3 / Week'], , 
17656,4576,Methylprednisolone,2015-11-23,,1,mg,['/ Day'], , 
17657,3310,IVIG,2016-02-15,2020-05-22, , ,['2 / Day'],IV,Adverse Event
17658,1880,D-cure (Vitamine D),2016-04-16,2018-01-16,1, ,['2 / Day'], ,Lack of efficacy
17659,1880,Rebif [22],2016-03-20,2021-07-16,20,mg,['2 / Day'],IV,Persistence of relapses
17660,1880,Tysabri,2016-03-10,2021-04-13, ,mg,['/Month'], ,Adverse Event
17661,1615,Rebif [22],2016-01-06,2018-07-20,400, ,['/Month'],IV,Adverse Event
17662,1615,Gilenya,2016-03-02,,500, ,[' '],IV, 
17663,2648,Copaxone,2015-11-17,2021-08-31,1000, ,['/Month'], ,Adverse Event
17664,2648,Endoxan,2016-09-11,,20, ,['2 / Day'],IV, 
17665,1398,Rebif [44],2016-04-18,2020-12-16,1000, ,['3 / Week'],Oral,Lack of efficacy
17666,1398,Tysabri,2015-12-24,,400,mg,['2 / Day'],IV, 
17667,1398,Endoxan,2016-04-25,2018-02-27, , ,['2 / Day'],IV,Patient Choice/Convenience
17668,273,IVIG,2016-09-14,,5000,MIU,[' '], , 
17669,273,Endoxan,2016-04-18,,20, ,['2 / Day'], , 
17670,273,D-cure (Vitamine D),2016-09-10,, ,MIU,['3 / Week'], , 
17671,4371,Tysabri,2016-01-10,2019-03-24,500,mg,['2 / Day'], ,Adverse Event
17672,2662,Endoxan,2016-05-01,, ,MIU,['/Month'], , 
17673,2662,D-cure (Vitamine D),2016-06-24,, , ,['/Month'],IV, 
17674,2662,Tecfidera,2016-03-24,,500,MIU,[' '],IV, 
17675,2662,D-cure (Vitamine D),2016-02-21,,5000, ,[' '],IV, 
17676,899,Rebif [44],2016-06-03,, , ,['2 / Day'],IV, 
17677,899,Betaferon,2016-05-13,,5000,mcg,['3 / Week'],Oral, 
17678,899,Ledertrexaat,2016-06-26,, ,mg,['/Month'],Oral, 
17679,899,Gilenya,2016-06-19,, ,mg,['/Month'], , 
17680,4631,Tecfidera,2016-01-02,2021-05-01,5000,MIU,['/Month'],IV,Lack of efficacy
17681,1862,D-cure (Vitamine D),2015-12-14,,300, ,['2 / Day'],IV, 
17682,1862,Betaferon,2016-09-23,2020-09-03, ,mg,['3 / Week'], ,Adverse Event
17683,1862,D-cure (Vitamine D),2016-10-16,,1000,MIU,['2 / Day'], , 
17684,1862,Gilenya,2015-11-27,2021-06-08, ,mg,[' '],IV,Adverse Event
17685,3772,Avonex,2015-11-24,,300,mg,['/Month'], , 
17686,4669,Alemtuzumab (Campath),2016-05-24,, ,mg,['2 / Day'], , 
17687,4669,Ledertrexaat,2016-07-15,,300, ,['3 / Week'],IV, 
17688,2962,Rebif [44],2015-12-13,,5000, ,[' '], , 
17689,2962,Rebif [22],2016-03-01,,1000, ,[' '],IV, 
17690,2962,Mitoxantrone,2015-11-28,,500,MIU,['3 / Week'],Oral, 
17691,418,Tysabri,2015-11-12,2018-11-03,5000, ,['/ Week'], ,Persisting MRI activity
17692,418,D-cure (Vitamine D),2016-01-11,,20, ,['/ Day'], , 
17693,418,Rebif [22],2016-03-30,,5000,mg,['/Month'], , 
17694,418,D-cure (Vitamine D),2016-07-27,,1, ,['/Month'], , 
17695,815,Endoxan,2016-04-06,2019-03-04,500,mg,['/Month'],Oral,Persisting MRI activity
17696,815,Rebif [22],2016-07-26,,300, ,['/Month'],Oral, 
17697,815,Rebif [22],2016-08-21,2020-11-04, ,mcg,['3 / Week'],Oral,Patient Choice/Convenience
17698,4464,Methylprednisolone,2016-09-07,2021-07-03, ,mcg,[' '],IV,Patient Choice/Convenience
17699,2862,Rebif [44],2016-01-01,,300, ,['3 / Week'],IV, 
17700,2862,Ledertrexaat,2016-02-23,, , ,['/Month'], , 
17701,2862,Endoxan,2015-12-04,, , ,['2 / Day'],IV, 
17702,2862,Alemtuzumab (Campath),2016-09-30,, ,mg,['2 / Day'], , 
17703,2138,Tecfidera,2016-06-11,2020-01-05,500,MIU,['/ Week'],IV,Patient Choice/Convenience
17704,2138,Gilenya,2016-05-31,,20,mg,['/ Day'],Oral, 
17705,2138,Ledertrexaat,2015-12-27,2019-01-29,5000,mg,['2 / Day'],IV,Adverse Event
17706,1719,Teriflunomide,2016-03-19,,300,mg,['/Month'],Oral, 
17707,1719,Teriflunomide,2016-03-11,,500,mcg,[' '],IV, 
17708,1719,Teriflunomide,2016-03-13,, ,mg,['2 / Day'],Oral, 
17709,1719,Betaferon,2016-01-17,2020-09-29, ,mg,['2 / Day'], ,Patient Choice/Convenience
17710,4357,IVIG,2016-08-19,,1000, ,['/Month'], , 
17711,4357,Alemtuzumab (Campath),2015-10-26,2018-12-04,300, ,['2 / Day'],Oral,Adverse Event
17712,4357,Avonex,2016-05-15,2020-05-07,1000,mg,['2 / Day'],Oral,Adverse Event
17713,654,Methylprednisolone,2015-11-06,,1000,mg,['/ Day'], , 
17714,654,D-cure (Vitamine D),2016-09-06,,300, ,['/ Day'], , 
17715,654,Tysabri,2016-04-19,,1,mg,['2 / Day'],Oral, 
17716,1499,D-cure (Vitamine D),2016-06-03,2020-01-21,500, ,['2 / Day'], ,Persisting MRI activity
17717,1499,Mitoxantrone,2016-01-22,, , ,['/Month'],Oral, 
17718,1499,Teriflunomide,2016-02-21,,300,MIU,['/Month'], , 
17719,3855,Tecfidera,2015-11-01,,5000,mg,['/ Week'], , 
17720,3855,Rebif [44],2015-12-08,, ,MIU,['/Month'],IV, 
17721,3855,Rebif [44],2016-04-27,,400, ,['/ Day'],IV, 
17722,2186,D-cure (Vitamine D),2015-12-29,2021-08-02,1,mg,['/ Week'], ,Lack of efficacy
17723,1618,Tysabri,2016-06-26,2019-05-09, , ,['/ Week'],IV,Persisting MRI activity
17724,1618,Endoxan,2016-07-11,2021-01-29,500,MIU,['2 / Day'], ,Adverse Event
17725,3598,Tecfidera,2016-04-28,2021-08-14,1000,mcg,['/ Week'], ,Patient Choice/Convenience
17726,3121,Tysabri,2016-10-01,,1, ,['/Month'], , 
17727,3121,Rebif [44],2016-07-09,2018-02-25, , ,['/Month'],IV,Lack of efficacy
17728,3121,Avonex,2016-08-26,,500,mg,['/Month'], , 
17729,3121,Avonex,2015-11-24,2020-08-02,1000,mg,['/Month'],IV,Adverse Event
17730,3323,Teriflunomide,2016-03-30,,500,mg,['2 / Day'],IV, 
17731,3323,Tecfidera,2016-02-04,, ,MIU,['2 / Day'], , 
17732,3323,Betaferon,2016-01-31,2021-10-17,1, ,['3 / Week'],Oral,Lack of efficacy
17733,4378,Avonex,2016-06-21,,300, ,['/Month'],IV, 
17734,4378,Rebif [44],2016-07-14,2018-11-17,1,mg,['/Month'],IV,Lack of efficacy
17735,4378,Gilenya,2016-09-22,,300, ,['2 / Day'], , 
17736,4378,D-cure (Vitamine D),2016-08-10,, ,mg,['2 / Day'], , 
17737,2282,Tecfidera,2015-12-23,2017-11-19,1000,mg,['2 / Day'], ,Lack of efficacy
17738,2770,Copaxone,2016-02-27,,500, ,['/Month'],IV, 
17739,2770,Alemtuzumab (Campath),2016-01-27,2020-03-31,300,mg,['/Month'],Oral,Adverse Event
17740,2770,Copaxone,2016-04-12,, , ,['3 / Week'],Oral, 
17741,885,Avonex,2015-11-03,,500,MIU,['2 / Day'],IV, 
17742,4662,Copaxone,2016-09-03,2020-07-09, ,mg,['/ Week'],IV,Lack of efficacy
17743,4662,Rebif [22],2016-04-04,2019-04-17, ,mg,['2 / Day'],IV,Lack of efficacy
17744,1497,Rebif [22],2016-03-09,2018-09-30,5000,mg,['/Month'],IV,Persisting MRI activity
17745,1497,Alemtuzumab (Campath),2015-11-08,2018-12-07, ,mg,['/Month'], ,Lack of efficacy
17746,1497,IVIG,2016-08-07,, ,mcg,['2 / Day'],IV, 
17747,1497,Gilenya,2015-11-27,,300,mg,['/Month'], , 
17748,4881,Tysabri,2015-12-18,,1000,mg,['2 / Day'],Oral, 
17749,3114,Avonex,2016-03-24,, , ,[' '], , 
17750,3114,Rebif [44],2016-02-22,, , ,['2 / Day'],IV, 
17751,3114,Betaferon,2016-10-01,2018-07-01,400, ,['/Month'],IV,Adverse Event
17752,1663,Teriflunomide,2016-05-05,,1, ,['/ Day'], , 
17753,4630,Methylprednisolone,2016-03-01,, ,MIU,['3 / Week'],Oral, 
17754,4630,Avonex,2016-05-17,, ,mg,['2 / Day'],IV, 
17755,1351,Rebif [22],2016-04-29,, ,mg,['2 / Day'], , 
17756,1351,Alemtuzumab (Campath),2015-10-29,, ,mg,['2 / Day'], , 
17757,1351,Gilenya,2016-08-02,, ,mg,['/Month'],Oral, 
17758,1351,Ledertrexaat,2016-03-11,, ,mg,['3 / Week'],IV, 
17759,1794,Methylprednisolone,2016-07-25,,20,mg,['/Month'],Oral, 
17760,1794,Copaxone,2016-01-11,,400,MIU,['/Month'],IV, 
17761,1794,IVIG,2016-08-27,2021-06-06,1000, ,['3 / Week'],IV,Patient Choice/Convenience
17762,1274,Avonex,2016-07-16,, ,mcg,['/Month'],Oral, 
17763,1274,Methylprednisolone,2015-12-25,,300,mg,['/Month'], , 
17764,2530,IVIG,2016-05-15,,300, ,['/Month'],IV, 
17765,2530,Gilenya,2016-02-05,2018-06-01,500,mg,['2 / Day'], ,Persisting MRI activity
17766,2530,Mitoxantrone,2016-10-08,2021-07-25,500, ,['2 / Day'],IV,Persistence of relapses
17767,1138,Methylprednisolone,2016-09-14,, ,MIU,['/Month'],IV, 
17768,1138,Tecfidera,2016-09-03,,500,MIU,['2 / Day'],IV, 
17769,1138,Avonex,2016-02-12,2020-06-18,20, ,['2 / Day'],IV,Patient Choice/Convenience
17770,1461,Tecfidera,2016-02-09,2019-11-02,1,mg,['/ Day'],IV,Lack of efficacy
17771,1461,Methylprednisolone,2016-06-09,2018-08-04, ,mg,['2 / Day'],IV,Persisting MRI activity
17772,1461,Tecfidera,2016-08-17,2018-10-19,1000,mg,['/Month'],IV,Lack of efficacy
17773,2204,Rebif [44],2015-10-26,2018-04-13,5000,mg,['3 / Week'],IV,Lack of efficacy
17774,2204,Alemtuzumab (Campath),2016-04-20,2021-04-02,1,MIU,['2 / Day'],IV,Adverse Event
17775,2204,Betaferon,2016-08-08,,1000,mcg,['/Month'], , 
17776,1438,Alemtuzumab (Campath),2015-11-03,,1000,mcg,['/ Day'],IV, 
17777,1438,IVIG,2016-08-24,,400,MIU,['/Month'],IV, 
17778,3352,Rebif [22],2016-08-05,2018-11-21,300,MIU,['2 / Day'], ,Persisting MRI activity
17779,3352,Tysabri,2016-05-18,2020-04-07,300,MIU,['/Month'],IV,Persistence of relapses
17780,3352,Alemtuzumab (Campath),2016-02-22,, , ,['2 / Day'],IV, 
17781,4657,Endoxan,2016-03-18,,400,mg,['/Month'], , 
17782,4657,Avonex,2015-12-14,,20,mg,[' '],IV, 
17783,4657,Methylprednisolone,2015-10-29,,20, ,[' '], , 
17784,4657,Ledertrexaat,2016-04-30,,500,MIU,['/Month'],IV, 
17785,364,Ledertrexaat,2016-08-28,,500, ,['3 / Week'],IV, 
17786,364,Alemtuzumab (Campath),2016-08-28,2018-01-14, , ,['/ Day'], ,Lack of efficacy
17787,364,D-cure (Vitamine D),2016-06-12,,400, ,[' '], , 
17788,364,Rebif [44],2016-02-21,2019-08-01, , ,['/Month'],IV,Lack of efficacy
17789,2859,Gilenya,2016-09-04,,500, ,['/ Day'],IV, 
17790,2859,Rebif [44],2016-05-12,2019-01-05, ,MIU,['/ Day'],IV,Adverse Event
17791,2859,Tecfidera,2016-09-12,, ,mcg,['2 / Day'],Oral, 
17792,3235,IVIG,2016-09-07,2018-02-24,500,mg,['/Month'], ,Adverse Event
17793,3235,Gilenya,2016-10-22,2020-01-04,300,mg,['3 / Week'],IV,Persistence of relapses
17794,3235,Gilenya,2016-07-15,,400, ,[' '],IV, 
17795,3169,Ledertrexaat,2016-04-28,2017-11-03,300,mg,['2 / Day'],Oral,Persistence of relapses
17796,3169,Rebif [22],2015-12-09,,5000,mg,['/ Week'],IV, 
17797,3169,Copaxone,2016-06-19,2019-10-02, , ,['/ Week'], ,Patient Choice/Convenience
17798,654,D-cure (Vitamine D),2016-05-04,,300,mg,['/ Day'],IV, 
17799,1695,IVIG,2016-08-06,2020-07-31, , ,['3 / Week'],IV,Persisting MRI activity
17800,1695,IVIG,2016-03-22,, , ,['/Month'],IV, 
17801,2798,Tecfidera,2016-01-24,, ,mg,['/ Week'],IV, 
17802,2798,Mitoxantrone,2016-01-11,,300,MIU,['/Month'],IV, 
17803,2798,Endoxan,2015-10-30,2019-10-30, , ,['2 / Day'],IV,Persisting MRI activity
17804,3824,Methylprednisolone,2016-06-13,2021-01-22,300,mg,['2 / Day'],IV,Patient Choice/Convenience
17805,3824,IVIG,2016-08-29,2021-04-24,1000, ,['2 / Day'], ,Lack of efficacy
17806,3824,Endoxan,2016-04-26,, ,mg,['/ Day'], , 
17807,3824,Ledertrexaat,2016-08-10,2020-10-28,20,mg,['2 / Day'],IV,Lack of efficacy
17808,3596,Copaxone,2016-02-02,, ,mg,['/Month'], , 
17809,3596,Copaxone,2016-03-09,,300,mg,['2 / Day'],IV, 
17810,3596,Alemtuzumab (Campath),2016-04-03,,1,mg,['2 / Day'],IV, 
17811,533,Rebif [44],2016-02-15,2019-11-13,400, ,['3 / Week'],Oral,Persistence of relapses
17812,533,D-cure (Vitamine D),2016-05-05,2020-12-22, ,mg,['2 / Day'],IV,Patient Choice/Convenience
17813,2044,Rebif [22],2016-04-05,2020-10-10,500,mg,['/Month'],IV,Lack of efficacy
17814,2044,Copaxone,2015-12-04,,500,mg,['2 / Day'], , 
17815,965,Tecfidera,2016-07-27,,500, ,['3 / Week'], , 
17816,965,Mitoxantrone,2016-06-01,,5000,mcg,['/Month'],IV, 
17817,965,Copaxone,2016-07-02,,300,mg,['2 / Day'],Oral, 
17818,965,Betaferon,2016-06-14,2019-07-01,5000, ,[' '],IV,Adverse Event
17819,108,Gilenya,2016-03-29,2019-12-09, , ,['3 / Week'],IV,Adverse Event
17820,4417,D-cure (Vitamine D),2016-03-22,,20,MIU,['2 / Day'],Oral, 
17821,4417,Copaxone,2016-06-04,2018-08-27,1000, ,['2 / Day'],IV,Persisting MRI activity
17822,4417,IVIG,2016-05-19,2017-10-27,1000,mg,['/Month'],Oral,Persisting MRI activity
17823,4417,D-cure (Vitamine D),2016-07-12,,1000,mcg,['/ Day'],IV, 
17824,2013,Rebif [44],2015-11-11,,300, ,['2 / Day'],IV, 
17825,2013,Tysabri,2015-11-15,,20,mcg,['2 / Day'],IV, 
17826,2013,Avonex,2016-02-28,2018-10-05,400,mg,['2 / Day'],IV,Adverse Event
17827,2013,Tysabri,2016-04-27,, , ,['2 / Day'],IV, 
17828,4123,Methylprednisolone,2016-06-14,,1000, ,['/ Day'], , 
17829,4123,Gilenya,2015-12-21,,300,MIU,['2 / Day'], , 
17830,4123,Methylprednisolone,2016-04-07,2020-11-24, ,mg,['2 / Day'],IV,Adverse Event
17831,4123,IVIG,2015-11-24,, , ,['3 / Week'],IV, 
17832,2461,Tysabri,2016-07-09,2021-08-14,20, ,['/ Day'], ,Lack of efficacy
17833,2461,Methylprednisolone,2016-08-19,2019-03-22,5000,mg,['2 / Day'], ,Persisting MRI activity
17834,2461,Ledertrexaat,2016-09-22,,400,mg,['2 / Day'],IV, 
17835,4971,Endoxan,2016-07-25,2019-12-30, ,MIU,['/Month'],IV,Adverse Event
17836,4971,Methylprednisolone,2015-11-11,2018-09-20,300, ,['3 / Week'],IV,Adverse Event
17837,1064,D-cure (Vitamine D),2016-08-14,,500,mg,['2 / Day'], , 
17838,1064,Endoxan,2016-08-08,, , ,[' '],IV, 
17839,1064,Tecfidera,2016-07-10,,20, ,['/ Week'],IV, 
17840,1898,IVIG,2016-03-22,2017-12-03,400,mg,['2 / Day'],Oral,Lack of efficacy
17841,1898,Rebif [22],2016-03-23,2020-04-28,20,MIU,[' '], ,Patient Choice/Convenience
17842,989,D-cure (Vitamine D),2016-10-13,,1, ,['/ Day'],IV, 
17843,989,Copaxone,2015-11-26,2018-05-20, ,mg,[' '],IV,Persisting MRI activity
17844,989,Tysabri,2016-09-18,2019-10-09, ,mg,['2 / Day'],IV,Persisting MRI activity
17845,4655,Endoxan,2016-01-25,,500, ,['/Month'], , 
17846,4655,D-cure (Vitamine D),2016-05-03,,1000, ,['/Month'],IV, 
17847,4655,Teriflunomide,2016-09-22,2020-11-16,5000,mg,['/Month'],IV,Persisting MRI activity
17848,4655,Tecfidera,2016-02-18,,1,MIU,['/Month'], , 
17849,323,Methylprednisolone,2016-06-20,2019-01-18,500, ,['/ Day'],IV,Patient Choice/Convenience
17850,323,Endoxan,2016-09-08,,20, ,['/Month'],IV, 
17851,1553,Rebif [22],2015-11-05,2021-10-19,5000,mg,['/Month'], ,Persistence of relapses
17852,1553,Betaferon,2016-04-12,,1, ,['/Month'], , 
17853,4333,Teriflunomide,2016-01-25,, ,mg,['3 / Week'],Oral, 
17854,4083,Copaxone,2016-08-18,2019-11-25,20,mg,['2 / Day'],IV,Patient Choice/Convenience
17855,4083,Mitoxantrone,2015-12-15,,1,MIU,['/Month'],IV, 
17856,463,Alemtuzumab (Campath),2016-05-27,2020-09-28,20, ,['/Month'],Oral,Persistence of relapses
17857,2589,Teriflunomide,2016-03-02,2019-11-21,1, ,['/Month'],Oral,Persistence of relapses
17858,2589,IVIG,2016-04-28,,1000, ,['2 / Day'],IV, 
17859,2589,Methylprednisolone,2016-01-12,2020-02-03,300,mg,['/Month'],Oral,Persistence of relapses
17860,4215,Copaxone,2016-07-26,,1000,mg,[' '], , 
17861,1252,Rebif [22],2016-01-08,2021-10-13,20, ,[' '], ,Adverse Event
17862,3327,Rebif [44],2015-11-19,2019-10-20, ,mcg,['/Month'],IV,Adverse Event
17863,3327,Endoxan,2016-01-17,,500, ,['3 / Week'], , 
17864,4124,D-cure (Vitamine D),2015-11-15,2020-06-25, ,MIU,['2 / Day'], ,Persistence of relapses
17865,4124,D-cure (Vitamine D),2016-02-14,2020-01-31,1,mg,['/Month'],IV,Patient Choice/Convenience
17866,4124,Teriflunomide,2016-01-15,,1000, ,['2 / Day'],IV, 
17867,4124,Betaferon,2016-03-13,2018-06-15,5000, ,['/Month'],IV,Persisting MRI activity
17868,1253,Tecfidera,2016-01-27,,500,mg,['2 / Day'],IV, 
17869,1927,Copaxone,2016-10-07,, ,MIU,['2 / Day'],Oral, 
17870,634,Copaxone,2015-11-18,, , ,['2 / Day'],IV, 
17871,634,Rebif [44],2016-02-20,,1000,mcg,['2 / Day'],IV, 
17872,634,Tecfidera,2015-12-22,,1,mg,['3 / Week'],IV, 
17873,634,Tecfidera,2016-03-09,,500, ,[' '],IV, 
17874,2236,Avonex,2016-03-25,2020-05-16,20,mcg,['/ Day'], ,Lack of efficacy
17875,2236,IVIG,2015-12-21,,500,mg,['2 / Day'],IV, 
17876,2236,Gilenya,2015-11-28,2021-09-23,20,mg,['/ Day'],IV,Adverse Event
17877,623,Avonex,2015-10-27,,300,mg,['/Month'],IV, 
17878,623,D-cure (Vitamine D),2016-05-30,,300, ,['/Month'], , 
17879,2371,Rebif [22],2015-12-20,2018-12-10,20, ,['3 / Week'],IV,Persisting MRI activity
17880,2371,Gilenya,2016-07-25,2021-03-02,1000,mg,['/Month'],IV,Patient Choice/Convenience
17881,2371,IVIG,2015-12-03,, , ,['/ Week'], , 
17882,3253,Methylprednisolone,2015-12-17,,1,mg,['2 / Day'],IV, 
17883,3253,Endoxan,2016-01-29,2021-05-24, ,mg,['/ Day'], ,Persisting MRI activity
17884,406,Ledertrexaat,2016-09-01,,1,mg,['3 / Week'],Oral, 
17885,2701,Rebif [22],2016-05-21,,5000, ,[' '],IV, 
17886,2029,D-cure (Vitamine D),2016-08-16,2019-10-19,500,mg,['2 / Day'], ,Adverse Event
17887,2029,Endoxan,2016-06-23,,5000,mg,[' '],IV, 
17888,775,Rebif [22],2016-07-29,2017-10-31,1000, ,['/Month'],IV,Adverse Event
17889,775,IVIG,2016-02-06,,1,mg,['/Month'], , 
17890,4652,Gilenya,2016-04-27,,400, ,['2 / Day'], , 
17891,4811,Rebif [44],2016-02-26,,5000,mg,['/ Week'],IV, 
17892,4811,Tysabri,2016-09-17,2021-09-26, , ,['/ Day'], ,Persisting MRI activity
17893,3534,Tysabri,2016-04-27,, ,mg,['/ Day'],IV, 
17894,3534,Teriflunomide,2015-12-25,2018-05-13, ,mcg,['3 / Week'],IV,Persisting MRI activity
17895,3534,Betaferon,2016-07-02,2021-05-21,500, ,[' '], ,Persisting MRI activity
17896,2077,Methylprednisolone,2016-05-22,2020-02-07,300,mcg,['/ Day'],IV,Patient Choice/Convenience
17897,2077,Gilenya,2016-04-05,,500, ,[' '], , 
17898,1197,Rebif [44],2016-04-02,, ,mg,[' '], , 
17899,1197,Avonex,2016-03-20,,400,mg,['/Month'],IV, 
17900,981,D-cure (Vitamine D),2016-03-06,2020-09-28, , ,['3 / Week'],Oral,Patient Choice/Convenience
17901,981,Teriflunomide,2016-06-19,2020-11-22, , ,['3 / Week'], ,Persisting MRI activity
17902,981,Rebif [44],2016-09-13,, , ,['/Month'],IV, 
17903,981,Gilenya,2016-01-02,,400,mcg,['2 / Day'],IV, 
17904,4365,Mitoxantrone,2016-08-01,,20,mcg,[' '],IV, 
17905,194,Methylprednisolone,2016-07-28,2018-03-27, ,mg,['/Month'], ,Adverse Event
17906,194,Methylprednisolone,2016-01-23,2021-03-25,500,mg,['/ Week'],IV,Persisting MRI activity
17907,4361,Betaferon,2016-03-09,2018-05-09,1000, ,['2 / Day'],IV,Lack of efficacy
17908,4361,Alemtuzumab (Campath),2016-02-05,,500,mcg,['/Month'],IV, 
17909,4361,Copaxone,2016-10-12,2018-06-08, ,mg,['/ Week'],Oral,Patient Choice/Convenience
17910,1241,Copaxone,2016-09-14,, , ,['/Month'],IV, 
17911,1241,Tysabri,2016-07-03,,300,mg,['/Month'],IV, 
17912,2288,Teriflunomide,2016-04-11,,300,MIU,[' '],IV, 
17913,3475,D-cure (Vitamine D),2016-05-27,,300,mg,['3 / Week'],IV, 
17914,1632,Tecfidera,2016-03-16,2021-07-05,1000, ,['/ Week'],IV,Persistence of relapses
17915,4814,Copaxone,2016-06-21,,20, ,['/Month'], , 
17916,4814,Gilenya,2016-06-16,,5000,MIU,['2 / Day'], , 
17917,4814,D-cure (Vitamine D),2015-11-06,2019-08-28,1000, ,['/Month'], ,Adverse Event
17918,4814,Endoxan,2016-01-07,2021-08-28, , ,['/ Day'],Oral,Adverse Event
17919,2589,Tecfidera,2016-09-25,2021-05-20,500,mg,['/ Week'],Oral,Adverse Event
17920,2589,Betaferon,2016-04-07,,5000,mg,[' '],Oral, 
17921,1021,Avonex,2015-12-02,,300,mg,[' '], , 
17922,1021,D-cure (Vitamine D),2015-11-17,2019-08-13,20, ,['/Month'], ,Patient Choice/Convenience
17923,3591,Gilenya,2016-01-17,,500,mg,['/Month'], , 
17924,3591,Rebif [22],2016-09-03,,500, ,['/ Day'], , 
17925,4490,Methylprednisolone,2016-01-07,2020-07-23, ,mg,[' '],IV,Lack of efficacy
17926,4490,Alemtuzumab (Campath),2016-06-07,2020-02-24,400,mg,['/ Week'],IV,Patient Choice/Convenience
17927,4490,Tecfidera,2015-11-11,, ,MIU,['/Month'],IV, 
17928,4636,Ledertrexaat,2015-11-22,, ,mg,['/Month'],IV, 
17929,4636,IVIG,2016-04-07,,20, ,['2 / Day'],IV, 
17930,4636,D-cure (Vitamine D),2016-09-11,2021-07-13,1,mg,['/Month'],Oral,Adverse Event
17931,3774,Tysabri,2016-04-01,2019-03-02,1, ,[' '], ,Adverse Event
17932,3774,Rebif [44],2015-12-06,2021-03-05,500,mg,['/Month'],Oral,Adverse Event
17933,3038,Endoxan,2016-04-19,, ,MIU,['2 / Day'], , 
17934,3038,Ledertrexaat,2016-02-14,, ,mg,['/Month'], , 
17935,3038,Avonex,2015-12-14,,1000, ,['2 / Day'],IV, 
17936,3038,Alemtuzumab (Campath),2016-07-28,,20, ,['3 / Week'],IV, 
17937,4497,Methylprednisolone,2015-12-21,2020-06-07,20, ,['/Month'], ,Persisting MRI activity
17938,4497,Avonex,2016-04-13,2018-05-23,1000, ,['/ Day'],Oral,Lack of efficacy
17939,1986,Avonex,2015-12-24,,400,MIU,[' '],IV, 
17940,1986,Betaferon,2016-09-21,,5000,mg,['/Month'],IV, 
17941,1986,Ledertrexaat,2015-11-08,, ,MIU,['2 / Day'],Oral, 
17942,4914,IVIG,2016-09-11,2018-06-15,500,mg,['/ Week'], ,Adverse Event
17943,4914,Ledertrexaat,2016-02-19,, , ,['/Month'],IV, 
17944,2822,Alemtuzumab (Campath),2016-07-08,,1000,mg,['2 / Day'], , 
17945,2750,Gilenya,2016-02-09,2020-05-10,20, ,['2 / Day'],Oral,Patient Choice/Convenience
17946,2750,IVIG,2016-05-28,,1000, ,[' '],IV, 
17947,2750,Tysabri,2016-03-06,,20,mg,['/Month'], , 
17948,3162,D-cure (Vitamine D),2016-10-14,, , ,['3 / Week'],IV, 
17949,3162,Teriflunomide,2016-08-06,, , ,['2 / Day'],IV, 
17950,3162,D-cure (Vitamine D),2016-03-02,2021-07-07, ,mg,['/Month'],IV,Lack of efficacy
17951,3707,Teriflunomide,2016-10-10,2021-04-10,5000,mcg,['/ Day'],IV,Adverse Event
17952,4065,Rebif [22],2015-10-30,,500,mg,['/Month'],IV, 
17953,4065,Avonex,2016-10-11,2018-08-01,500, ,['3 / Week'], ,Persisting MRI activity
17954,2700,IVIG,2016-03-17,2018-08-06,5000,mg,['/Month'],IV,Persistence of relapses
17955,2700,Ledertrexaat,2016-01-08,2018-12-05,1, ,['/Month'], ,Adverse Event
17956,2700,Rebif [44],2016-02-23,,1000,mg,['/Month'], , 
17957,2700,Ledertrexaat,2016-07-21,2018-10-01,300,mg,['2 / Day'],Oral,Persisting MRI activity
17958,2933,Tecfidera,2016-06-22,,1,mcg,['2 / Day'], , 
17959,2933,IVIG,2015-12-01,,1, ,['/Month'],IV, 
17960,2933,D-cure (Vitamine D),2015-11-25,,20,mg,['2 / Day'],IV, 
17961,4260,Gilenya,2016-05-18,, ,mg,['/ Day'],IV, 
17962,4260,Endoxan,2016-05-08,, , ,['/Month'],Oral, 
17963,166,Tecfidera,2016-06-25,,20, ,['2 / Day'], , 
17964,166,IVIG,2015-12-01,2020-04-28, ,MIU,['/Month'], ,Persisting MRI activity
17965,166,Teriflunomide,2016-02-01,, ,mg,['3 / Week'], , 
17966,3382,IVIG,2015-11-14,2018-04-08, , ,['/ Day'],IV,Patient Choice/Convenience
17967,3382,Mitoxantrone,2015-12-08,,500,mg,['/ Day'],IV, 
17968,974,Tysabri,2016-08-30,, ,MIU,['/Month'],IV, 
17969,4993,Methylprednisolone,2016-05-18,,400, ,['2 / Day'], , 
17970,4993,Ledertrexaat,2015-11-06,,1000, ,['3 / Week'],IV, 
17971,4993,Tysabri,2016-08-28,2021-07-17, , ,['3 / Week'], ,Patient Choice/Convenience
17972,1310,Rebif [22],2016-06-14,,1000, ,['3 / Week'],IV, 
17973,1310,Methylprednisolone,2016-10-05,2018-10-16,5000,mg,['/Month'],IV,Persisting MRI activity
17974,2922,Avonex,2016-05-29,,400,mg,['/ Day'], , 
17975,2922,Rebif [44],2015-11-22,,5000,MIU,['3 / Week'],IV, 
17976,2922,D-cure (Vitamine D),2016-05-18,2018-03-05,1000,mg,['3 / Week'], ,Adverse Event
17977,792,IVIG,2016-01-27,2019-01-02,400, ,['3 / Week'], ,Adverse Event
17978,792,Gilenya,2016-03-13,2020-07-26,400, ,['/Month'],IV,Adverse Event
17979,792,Betaferon,2016-03-26,2020-09-14,20,MIU,['3 / Week'], ,Lack of efficacy
17980,792,Avonex,2016-06-03,2019-05-05, ,mg,['3 / Week'],IV,Persisting MRI activity
17981,898,Tecfidera,2016-04-20,,400, ,['3 / Week'],IV, 
17982,898,Avonex,2016-04-23,,300, ,['2 / Day'], , 
17983,898,Alemtuzumab (Campath),2016-01-19,2017-11-26, ,MIU,['/Month'], ,Persisting MRI activity
17984,4537,Copaxone,2016-03-23,2020-07-11,20,mg,[' '],IV,Persisting MRI activity
17985,706,Mitoxantrone,2016-10-09,,500, ,['/ Day'], , 
17986,3245,Copaxone,2016-09-04,2021-04-29,500,mg,['3 / Week'], ,Patient Choice/Convenience
17987,3245,Rebif [44],2016-05-20,,20,mg,['2 / Day'],Oral, 
17988,3710,Alemtuzumab (Campath),2016-01-05,,1000, ,['2 / Day'],IV, 
17989,3710,Copaxone,2016-06-12,, ,MIU,['2 / Day'],IV, 
17990,3710,Ledertrexaat,2016-07-29,2020-08-10, ,MIU,['/Month'],IV,Persisting MRI activity
17991,685,Avonex,2016-08-18,2021-01-02,20, ,['/ Day'], ,Persisting MRI activity
17992,685,IVIG,2016-04-05,2018-11-09, ,mcg,['/Month'], ,Persistence of relapses
17993,685,Tecfidera,2016-10-01,, , ,['/ Day'], , 
17994,685,Copaxone,2016-08-22,,5000,mg,['/Month'],Oral, 
17995,519,Alemtuzumab (Campath),2016-05-11,2021-06-09, , ,['3 / Week'], ,Adverse Event
17996,519,Betaferon,2016-10-15,,300,mg,['2 / Day'], , 
17997,519,Teriflunomide,2016-07-31,2019-05-02, , ,['2 / Day'],IV,Adverse Event
17998,519,Mitoxantrone,2016-06-06,,500, ,['2 / Day'], , 
17999,2861,Copaxone,2016-08-14,2018-03-27,5000,mg,['2 / Day'],IV,Adverse Event
18000,2861,Avonex,2016-09-18,2017-11-20,500,MIU,['/Month'],Oral,Lack of efficacy
18001,2861,Rebif [22],2016-09-13,2021-02-12,1, ,['/Month'], ,Persisting MRI activity
18002,2861,D-cure (Vitamine D),2016-07-20,,1000,mg,['/ Day'], , 
18003,2993,Rebif [44],2016-01-10,, ,mcg,['2 / Day'],IV, 
18004,2582,Endoxan,2016-04-17,,20,mg,['2 / Day'],Oral, 
18005,2582,Avonex,2016-03-31,, ,MIU,['/Month'], , 
18006,2582,Gilenya,2016-06-04,, ,mg,['/Month'], , 
18007,1425,Gilenya,2016-09-02,2020-03-13,500,MIU,['/ Day'], ,Adverse Event
18008,2975,IVIG,2016-07-11,,1, ,['/Month'], , 
18009,2975,Tysabri,2016-09-19,,300,mcg,['/Month'],IV, 
18010,2975,Tysabri,2016-09-28,2020-04-23, ,mg,['3 / Week'], ,Adverse Event
18011,1342,Rebif [44],2016-02-15,2020-05-09, , ,['/Month'],IV,Adverse Event
18012,3479,Rebif [22],2016-07-12,, ,mg,[' '], , 
18013,390,Endoxan,2016-03-06,,5000,mg,['3 / Week'],Oral, 
18014,390,Methylprednisolone,2016-01-11,,20, ,[' '],IV, 
18015,2058,IVIG,2016-01-02,,5000,mg,[' '], , 
18016,2058,Methylprednisolone,2016-08-10,2019-06-11,5000,mcg,['2 / Day'],IV,Persisting MRI activity
18017,2058,D-cure (Vitamine D),2016-08-04,2018-11-17,20, ,[' '],IV,Persistence of relapses
18018,2058,Ledertrexaat,2016-09-05,,300,MIU,['2 / Day'],IV, 
18019,243,Rebif [22],2016-07-01,,300,MIU,['/ Day'],IV, 
18020,243,Teriflunomide,2016-10-04,2019-11-27,300, ,['2 / Day'],Oral,Adverse Event
18021,243,Betaferon,2016-07-21,2019-12-10,1,mg,['2 / Day'],Oral,Adverse Event
18022,243,Gilenya,2015-12-11,,1000,MIU,['3 / Week'],Oral, 
18023,3049,Endoxan,2015-12-29,,5000,mg,['2 / Day'],Oral, 
18024,3049,D-cure (Vitamine D),2016-09-16,2020-06-07,20, ,['/ Day'],IV,Lack of efficacy
18025,3049,Rebif [22],2016-08-09,, , ,['/Month'],IV, 
18026,3049,Rebif [44],2016-04-25,, ,mg,['2 / Day'], , 
18027,324,Methylprednisolone,2015-12-12,2021-09-30, ,mg,['/Month'],Oral,Adverse Event
18028,324,Gilenya,2016-08-28,, ,mcg,['/Month'], , 
18029,324,Tysabri,2016-04-01,2019-06-13,500,mcg,['3 / Week'], ,Persisting MRI activity
18030,324,Gilenya,2016-04-02,,1000,mg,['/ Day'],IV, 
18031,4139,Methylprednisolone,2016-08-19,2017-12-20,1000, ,['/ Day'], ,Lack of efficacy
18032,4139,Copaxone,2015-12-07,,5000, ,['/Month'],Oral, 
18033,930,Tecfidera,2016-02-02,2020-11-06,20,mg,['/ Day'],IV,Persistence of relapses
18034,2946,Gilenya,2016-08-08,,1000, ,['/ Day'],IV, 
18035,2946,IVIG,2016-01-24,2018-02-23,1,mcg,['2 / Day'], ,Patient Choice/Convenience
18036,2946,Tecfidera,2016-05-12,2018-09-12,400,mg,['/Month'],IV,Persisting MRI activity
18037,2946,Avonex,2016-05-17,2019-04-01, , ,['2 / Day'], ,Lack of efficacy
18038,3727,Avonex,2016-10-19,,500,MIU,['/ Day'],IV, 
18039,3727,Rebif [22],2016-01-09,2019-12-20, ,mg,['/Month'], ,Adverse Event
18040,1169,Tysabri,2016-04-02,, , ,['2 / Day'], , 
18041,1169,Alemtuzumab (Campath),2016-06-01,2020-12-05,400, ,['/Month'],IV,Adverse Event
18042,2243,Tysabri,2016-10-10,2019-02-15,1000,mg,['/Month'],IV,Persisting MRI activity
18043,2243,Rebif [44],2016-01-05,,300,MIU,['/Month'],Oral, 
18044,2243,Rebif [22],2015-11-17,, ,MIU,['/Month'],IV, 
18045,3579,Copaxone,2016-09-23,2019-06-20,1000, ,['2 / Day'],Oral,Patient Choice/Convenience
18046,3579,Rebif [44],2015-11-27,2018-05-08,500,mg,['3 / Week'], ,Persisting MRI activity
18047,3579,Rebif [44],2016-06-22,2021-05-18,20, ,['2 / Day'],IV,Patient Choice/Convenience
18048,3579,IVIG,2015-12-08,, ,mg,[' '],IV, 
18049,4531,Gilenya,2015-12-11,, , ,['3 / Week'],Oral, 
18050,4531,Rebif [22],2016-03-03,,1, ,['2 / Day'],IV, 
18051,4531,Ledertrexaat,2016-09-18,,1000,mg,['/Month'], , 
18052,4256,Endoxan,2016-04-12,,20,mg,['2 / Day'],IV, 
18053,4256,Methylprednisolone,2016-08-23,2020-10-04,5000, ,['/ Day'],IV,Persistence of relapses
18054,3714,Methylprednisolone,2016-06-17,, ,MIU,['/ Week'],IV, 
18055,3714,Methylprednisolone,2016-10-03,,5000,mg,['/Month'],IV, 
18056,2850,Copaxone,2016-04-26,,5000,mg,[' '], , 
18057,1778,Gilenya,2016-02-14,2019-11-02,1000, ,['/Month'],Oral,Persistence of relapses
18058,1778,Copaxone,2016-02-21,2021-08-29, ,mg,['/Month'],IV,Adverse Event
18059,4255,IVIG,2016-03-02,2021-05-17,20,mg,['2 / Day'],IV,Persisting MRI activity
18060,4255,Avonex,2016-09-27,2020-04-12, ,mg,['/Month'],IV,Adverse Event
18061,4255,D-cure (Vitamine D),2016-08-07,,500,mg,['/Month'],IV, 
18062,448,Gilenya,2016-05-14,, , ,['/Month'], , 
18063,881,Methylprednisolone,2016-08-14,, ,MIU,['/Month'],IV, 
18064,881,Tysabri,2016-08-19,,1000, ,[' '],IV, 
18065,464,Gilenya,2016-03-16,, , ,['2 / Day'], , 
18066,464,Methylprednisolone,2016-03-05,2018-10-13,400, ,['3 / Week'], ,Lack of efficacy
18067,4166,IVIG,2016-01-30,,20,mg,['/ Week'],Oral, 
18068,1970,Tysabri,2016-01-18,,5000,mg,['2 / Day'],IV, 
18069,849,IVIG,2016-05-19,, , ,[' '],IV, 
18070,849,Tecfidera,2016-08-08,2019-07-21,5000,mg,['2 / Day'], ,Persisting MRI activity
18071,2124,Betaferon,2016-10-16,2021-10-16,1, ,['3 / Week'],IV,Patient Choice/Convenience
18072,2124,Methylprednisolone,2016-06-22,,500,mcg,['/Month'],IV, 
18073,4835,Betaferon,2016-08-25,2020-03-19,300, ,['/Month'],IV,Persisting MRI activity
18074,4835,Alemtuzumab (Campath),2016-04-12,2020-10-31,1000,mg,[' '],IV,Adverse Event
18075,4835,Tecfidera,2016-06-25,2020-06-26,1000, ,['/ Week'], ,Persisting MRI activity
18076,4218,Rebif [44],2016-01-17,2018-07-05, ,mg,['/Month'],IV,Adverse Event
18077,4218,D-cure (Vitamine D),2016-09-05,,5000,mg,['/Month'], , 
18078,4043,Rebif [44],2015-11-16,2021-09-09, , ,['2 / Day'], ,Adverse Event
18079,4568,Rebif [44],2016-01-05,, ,mg,['2 / Day'],IV, 
18080,4568,D-cure (Vitamine D),2015-11-17,2020-12-03,5000, ,['/Month'],Oral,Patient Choice/Convenience
18081,4568,Teriflunomide,2016-04-24,, , ,['2 / Day'], , 
18082,4549,D-cure (Vitamine D),2016-05-23,2021-06-04,1000, ,['3 / Week'],IV,Adverse Event
18083,4549,Avonex,2016-09-19,,500,MIU,['/Month'],IV, 
18084,4549,Rebif [22],2016-07-08,,1000, ,['3 / Week'],IV, 
18085,3994,IVIG,2016-04-19,2019-06-24,300,mg,['2 / Day'], ,Persistence of relapses
18086,3994,Endoxan,2016-07-11,2020-07-24,20,mcg,['/Month'], ,Lack of efficacy
18087,3994,Gilenya,2015-10-29,2020-12-07,300, ,['2 / Day'],IV,Adverse Event
18088,2669,Rebif [22],2016-02-12,2019-02-04,500,mg,['2 / Day'], ,Persisting MRI activity
18089,2669,Tecfidera,2016-02-28,,500, ,['/Month'],Oral, 
18090,554,Tecfidera,2016-08-25,2018-09-21, , ,['3 / Week'], ,Persisting MRI activity
18091,554,Tecfidera,2016-07-20,2018-09-06, ,mg,['2 / Day'],IV,Adverse Event
18092,554,D-cure (Vitamine D),2016-03-08,, ,mg,['/ Day'], , 
18093,554,Gilenya,2016-08-30,,500,MIU,[' '],IV, 
18094,4714,Methylprednisolone,2016-09-19,,1,mg,['/ Day'], , 
18095,4714,Tysabri,2015-11-16,2019-02-05,5000, ,['/Month'],IV,Adverse Event
18096,297,Methylprednisolone,2016-06-05,2018-03-08, ,mcg,['3 / Week'],IV,Persisting MRI activity
18097,234,IVIG,2016-05-31,, ,mg,['2 / Day'],IV, 
18098,234,D-cure (Vitamine D),2016-06-27,2019-06-29, ,mcg,['/Month'], ,Persisting MRI activity
18099,234,Tysabri,2016-02-24,2019-09-11,500,mg,['2 / Day'],IV,Persistence of relapses
18100,234,Gilenya,2016-04-17,2019-11-09,300,mg,['3 / Week'],IV,Persisting MRI activity
18101,1457,Endoxan,2016-09-06,,5000,MIU,[' '],IV, 
18102,1457,Copaxone,2016-10-02,,20, ,['2 / Day'],IV, 
18103,1457,Methylprednisolone,2016-08-22,,400, ,['2 / Day'],IV, 
18104,1457,Gilenya,2016-04-20,2021-08-20, ,mg,['/Month'], ,Persisting MRI activity
18105,1833,Rebif [44],2016-08-29,, ,mg,['/Month'],Oral, 
18106,1833,Betaferon,2015-12-24,2019-01-03, ,mg,['2 / Day'], ,Adverse Event
18107,494,Avonex,2016-08-28,,300,mg,['3 / Week'],IV, 
18108,494,IVIG,2016-09-26,,5000,mg,['2 / Day'],IV, 
18109,494,Betaferon,2016-04-28,2019-05-17,1000, ,['2 / Day'], ,Adverse Event
18110,1066,Methylprednisolone,2015-11-30,2019-07-13, ,mg,['3 / Week'],Oral,Patient Choice/Convenience
18111,2144,Betaferon,2016-05-04,,500,MIU,['3 / Week'],IV, 
18112,2144,D-cure (Vitamine D),2016-07-25,,1000,MIU,['3 / Week'], , 
18113,2144,Methylprednisolone,2016-10-10,,300,MIU,['/Month'], , 
18114,2144,Tysabri,2016-02-20,, ,mg,['2 / Day'], , 
18115,3751,Ledertrexaat,2016-06-12,, , ,['2 / Day'],IV, 
18116,3751,Alemtuzumab (Campath),2015-11-26,,1000, ,['2 / Day'],IV, 
18117,598,Copaxone,2016-03-05,2021-10-18, ,MIU,['3 / Week'],IV,Persistence of relapses
18118,598,Copaxone,2016-07-22,2018-09-29, , ,['/Month'], ,Patient Choice/Convenience
18119,598,IVIG,2015-11-20,2018-11-10, , ,['/Month'],IV,Patient Choice/Convenience
18120,598,Rebif [44],2016-07-08,,300,mg,['2 / Day'], , 
18121,3599,Betaferon,2015-11-21,2020-12-25,20,mg,['/ Day'],Oral,Lack of efficacy
18122,3599,Mitoxantrone,2016-03-07,, , ,['/Month'],IV, 
18123,3611,D-cure (Vitamine D),2016-10-17,2018-05-24, ,MIU,[' '],IV,Patient Choice/Convenience
18124,3611,Copaxone,2016-06-21,2018-07-23, ,mg,[' '],IV,Patient Choice/Convenience
18125,3611,Tysabri,2016-06-07,2021-05-29, , ,[' '],Oral,Patient Choice/Convenience
18126,3611,Alemtuzumab (Campath),2016-09-23,2021-03-26,5000,mcg,[' '], ,Patient Choice/Convenience
18127,1132,Methylprednisolone,2016-10-06,2018-10-10,20, ,['2 / Day'],IV,Persisting MRI activity
18128,1132,Tysabri,2015-12-26,,5000,mg,['3 / Week'], , 
18129,1132,Betaferon,2016-02-01,,5000, ,['3 / Week'], , 
18130,4297,Tecfidera,2016-09-15,,500, ,['3 / Week'],IV, 
18131,2496,Rebif [44],2015-12-04,, ,mg,['2 / Day'],IV, 
18132,144,Rebif [22],2016-08-06,2020-04-30,500,mg,['2 / Day'], ,Persistence of relapses
18133,1652,Tysabri,2016-03-28,, , ,['/ Day'], , 
18134,1652,Ledertrexaat,2015-12-15,,300, ,['3 / Week'],IV, 
18135,2005,Methylprednisolone,2016-08-04,,1000, ,['2 / Day'],IV, 
18136,1969,Methylprednisolone,2016-01-06,2020-07-23,1,mg,['/Month'],IV,Persisting MRI activity
18137,1969,Tysabri,2016-05-25,2020-02-08, ,mg,['/Month'], ,Lack of efficacy
18138,1969,Mitoxantrone,2016-05-20,,1,mcg,['/Month'],IV, 
18139,1969,Rebif [44],2015-11-09,,5000,mg,['/ Day'], , 
18140,3434,Avonex,2016-07-09,,20, ,['/Month'], , 
18141,3434,Ledertrexaat,2016-01-12,,5000, ,['2 / Day'],Oral, 
18142,3434,Methylprednisolone,2015-12-12,,500,mcg,['/Month'],Oral, 
18143,3434,D-cure (Vitamine D),2015-12-27,,20, ,['/ Day'],IV, 
18144,839,Endoxan,2016-05-20,2018-04-25,300,MIU,['/Month'], ,Persistence of relapses
18145,839,Rebif [22],2016-04-19,2018-01-02, ,MIU,['2 / Day'],IV,Persisting MRI activity
18146,839,Ledertrexaat,2015-11-26,, , ,['/ Week'], , 
18147,839,Copaxone,2015-11-05,,1000, ,['/Month'], , 
18148,2703,Tecfidera,2015-11-20,,500,mg,['/Month'],IV, 
18149,2703,Tecfidera,2016-02-14,2017-12-12,20,mg,['/Month'],IV,Adverse Event
18150,2703,Endoxan,2016-01-02,2021-08-24, ,mg,['/Month'],IV,Patient Choice/Convenience
18151,2703,Methylprednisolone,2016-09-26,2018-04-08,20,mg,['2 / Day'], ,Adverse Event
18152,1913,D-cure (Vitamine D),2016-04-09,, , ,[' '],IV, 
18153,1913,Tysabri,2016-08-16,,500,mg,['/Month'],IV, 
18154,4393,Rebif [44],2016-04-30,, ,mg,['2 / Day'],Oral, 
18155,4393,Rebif [44],2015-12-08,,300,mg,[' '], , 
18156,4393,Tecfidera,2016-02-15,, ,mg,['/Month'], , 
18157,1236,Avonex,2016-06-17,,500,MIU,['2 / Day'], , 
18158,1236,Betaferon,2016-06-05,2019-06-27,20,mg,['2 / Day'], ,Patient Choice/Convenience
18159,1236,Betaferon,2015-10-29,,300,MIU,['/Month'],IV, 
18160,1236,Teriflunomide,2016-09-04,,300,mg,['2 / Day'],IV, 
18161,3082,Alemtuzumab (Campath),2016-01-07,2019-02-16,1000, ,['/ Day'],IV,Lack of efficacy
18162,207,Gilenya,2016-04-28,2020-05-12,500,mg,['/Month'],IV,Persisting MRI activity
18163,207,Copaxone,2016-08-05,, , ,['2 / Day'],Oral, 
18164,4405,IVIG,2016-08-08,,1,mg,['2 / Day'], , 
18165,4405,Rebif [22],2016-06-27,,1000,mg,['2 / Day'],Oral, 
18166,3018,Methylprednisolone,2016-06-26,2017-11-22, ,mg,['2 / Day'], ,Adverse Event
18167,378,Copaxone,2016-07-06,, , ,['/ Week'],Oral, 
18168,378,Gilenya,2016-06-05,2018-10-13,5000, ,['/ Week'],IV,Adverse Event
18169,4165,Gilenya,2016-01-31,, ,mg,[' '], , 
18170,4165,D-cure (Vitamine D),2016-02-14,, ,mg,['/Month'],IV, 
18171,4438,Methylprednisolone,2015-11-13,2020-12-30, ,mg,['2 / Day'], ,Adverse Event
18172,4438,Tecfidera,2016-05-09,,1000, ,['/Month'],IV, 
18173,4438,Tecfidera,2016-05-04,,20,MIU,['2 / Day'],IV, 
18174,4438,Endoxan,2016-03-11,2020-09-23, ,mg,['2 / Day'], ,Patient Choice/Convenience
18175,1153,D-cure (Vitamine D),2015-11-13,,400, ,['3 / Week'],IV, 
18176,1153,Mitoxantrone,2015-10-25,,1, ,['/Month'],IV, 
18177,1153,Avonex,2016-04-02,,5000,mg,['3 / Week'], , 
18178,4626,Gilenya,2016-02-12,2019-11-21,20,mg,['/Month'],Oral,Lack of efficacy
18179,2053,Rebif [22],2015-11-19,2020-12-05,1000,MIU,['/Month'],IV,Persistence of relapses
18180,2643,Betaferon,2016-08-19,, , ,['/Month'], , 
18181,1730,IVIG,2016-08-30,2019-04-17, ,mg,['3 / Week'],IV,Persisting MRI activity
18182,1730,Teriflunomide,2015-11-18,,5000, ,['3 / Week'],IV, 
18183,1730,Teriflunomide,2016-04-10,2021-07-28,20,mg,['2 / Day'], ,Lack of efficacy
18184,1339,Alemtuzumab (Campath),2016-04-11,,1000,MIU,['2 / Day'], , 
18185,1217,IVIG,2016-06-13,, ,mg,['/Month'], , 
18186,1217,Ledertrexaat,2016-10-08,2020-10-05,1000,mg,['2 / Day'],IV,Persisting MRI activity
18187,2408,Rebif [22],2016-10-20,2018-08-09, ,mg,['2 / Day'],IV,Lack of efficacy
18188,2408,Teriflunomide,2016-03-27,,20, ,['/Month'], , 
18189,2408,IVIG,2016-02-13,, , ,['2 / Day'],IV, 
18190,2408,Rebif [44],2016-09-15,, , ,['2 / Day'], , 
18191,4612,Gilenya,2016-10-16,,20, ,['/Month'], , 
18192,4612,D-cure (Vitamine D),2016-02-18,,20, ,['/ Day'], , 
18193,2574,IVIG,2016-05-08,,20, ,['2 / Day'], , 
18194,1293,Tecfidera,2016-10-15,2019-10-02, ,MIU,['/Month'],IV,Adverse Event
18195,1293,Alemtuzumab (Campath),2016-06-08,, , ,['2 / Day'], , 
18196,1293,Methylprednisolone,2016-07-14,2019-08-17,300, ,['/Month'], ,Adverse Event
18197,1293,Endoxan,2016-05-13,2021-07-29, ,mg,['/Month'],IV,Persistence of relapses
18198,4834,Methylprednisolone,2016-10-22,,300,mg,['2 / Day'],IV, 
18199,4834,Alemtuzumab (Campath),2015-12-18,, ,MIU,['/Month'],IV, 
18200,4834,Rebif [44],2016-06-25,, , ,['2 / Day'],IV, 
18201,2919,Endoxan,2016-09-02,, ,MIU,['2 / Day'],Oral, 
18202,2919,D-cure (Vitamine D),2016-06-21,,300,MIU,['2 / Day'],IV, 
18203,2919,Rebif [44],2016-07-20,,5000, ,['/Month'],IV, 
18204,2919,Teriflunomide,2016-04-10,2020-05-20,20,MIU,['2 / Day'],IV,Persisting MRI activity
18205,3177,Rebif [44],2016-04-29,2019-07-23, , ,['2 / Day'],IV,Patient Choice/Convenience
18206,3177,Mitoxantrone,2016-01-04,2020-02-15, ,MIU,['2 / Day'],IV,Adverse Event
18207,3177,Methylprednisolone,2016-07-22,2020-10-16, ,mg,['/Month'], ,Lack of efficacy
18208,3177,Gilenya,2016-07-01,,400,mg,['/Month'], , 
18209,983,IVIG,2016-01-16,,1, ,['/ Week'], , 
18210,983,Rebif [22],2015-11-05,2020-08-20,1,mg,['2 / Day'], ,Persisting MRI activity
18211,2736,Rebif [22],2016-08-07,,5000,mg,['/ Day'], , 
18212,2736,Tysabri,2016-09-05,,300,MIU,['3 / Week'],Oral, 
18213,2736,Mitoxantrone,2016-06-05,2020-05-03,400,mg,['3 / Week'],IV,Persisting MRI activity
18214,4535,Rebif [22],2015-11-13,,300, ,['2 / Day'],IV, 
18215,4535,Alemtuzumab (Campath),2016-01-27,, ,mcg,['2 / Day'], , 
18216,3239,Tysabri,2016-03-28,, , ,[' '],IV, 
18217,3239,Alemtuzumab (Campath),2016-02-27,2021-01-09, ,MIU,['/Month'],IV,Persistence of relapses
18218,3239,Teriflunomide,2016-01-17,,300, ,['/ Week'],IV, 
18219,3239,Endoxan,2016-09-29,2020-06-26, ,mg,['3 / Week'],IV,Adverse Event
18220,1802,Rebif [44],2016-01-03,,5000,mg,['/ Day'],Oral, 
18221,1802,Copaxone,2016-03-02,,1000,MIU,['/ Day'], , 
18222,570,Mitoxantrone,2015-12-21,,1000,mg,['2 / Day'], , 
18223,570,Endoxan,2016-07-09,,1000, ,['/ Day'],IV, 
18224,4625,Gilenya,2016-07-26,, ,mg,['3 / Week'],Oral, 
18225,953,Mitoxantrone,2016-09-13,, ,MIU,['/Month'],IV, 
18226,953,Rebif [44],2016-03-04,, ,mg,['/Month'],IV, 
18227,953,Ledertrexaat,2016-07-04,,500, ,['/Month'],IV, 
18228,3966,Methylprednisolone,2016-07-30,2019-03-23,300, ,['/ Day'],IV,Persisting MRI activity
18229,917,Gilenya,2016-04-08,2019-06-16,5000,mg,['2 / Day'], ,Patient Choice/Convenience
18230,3003,Rebif [22],2015-10-30,, ,mg,['/Month'],IV, 
18231,3003,Copaxone,2016-04-06,,400, ,['3 / Week'],IV, 
18232,3003,Rebif [44],2016-06-23,,500,mg,['2 / Day'],IV, 
18233,3003,Endoxan,2016-07-11,, ,mg,['2 / Day'],Oral, 
18234,1508,Copaxone,2016-06-27,,1000,mg,['2 / Day'], , 
18235,1508,Rebif [22],2016-04-05,,300,mg,['3 / Week'], , 
18236,1508,Ledertrexaat,2016-04-18,,300,MIU,[' '],IV, 
18237,2402,Rebif [44],2016-06-21,2020-10-29, , ,['2 / Day'],IV,Persistence of relapses
18238,2402,Rebif [44],2015-12-11,2018-08-02, , ,['/ Week'],IV,Adverse Event
18239,2402,Ledertrexaat,2016-04-05,2021-07-07,20, ,[' '], ,Adverse Event
18240,2402,IVIG,2016-08-12,, ,mg,['2 / Day'],IV, 
18241,3067,Methylprednisolone,2016-09-30,,20,mg,['2 / Day'],IV, 
18242,1433,Avonex,2016-04-15,,400, ,[' '],IV, 
18243,3670,Avonex,2016-07-13,,20,mg,['2 / Day'],IV, 
18244,4007,IVIG,2016-01-17,2017-10-26, ,mg,['/ Week'],IV,Lack of efficacy
18245,4007,Betaferon,2015-12-20,,20, ,['/Month'],IV, 
18246,4007,Methylprednisolone,2016-02-25,,5000, ,['/ Day'],IV, 
18247,2723,Ledertrexaat,2016-10-02,2019-05-26, , ,['2 / Day'],IV,Persisting MRI activity
18248,2723,Rebif [44],2016-06-26,,5000, ,['/Month'], , 
18249,2723,Copaxone,2016-07-11,, , ,['/Month'],IV, 
18250,4976,Endoxan,2016-03-27,,1000,MIU,['/ Day'],IV, 
18251,2315,Betaferon,2016-01-20,, , ,['/Month'],IV, 
18252,2315,Methylprednisolone,2016-02-25,2019-08-15, ,mg,['2 / Day'],IV,Adverse Event
18253,3027,Endoxan,2016-02-09,,400,mg,['/ Week'], , 
18254,3027,Endoxan,2015-12-11,, , ,['/ Day'],IV, 
18255,4163,Gilenya,2016-02-29,,300,mg,['/Month'],IV, 
18256,4163,Mitoxantrone,2016-01-07,,400,mg,[' '],IV, 
18257,4163,Mitoxantrone,2016-09-23,, ,MIU,['/ Day'],IV, 
18258,2880,Rebif [22],2016-05-12,2021-03-25,1000,mcg,['2 / Day'], ,Persisting MRI activity
18259,1490,Ledertrexaat,2016-01-02,2018-06-09,1,mg,['/Month'],IV,Patient Choice/Convenience
18260,1490,Gilenya,2016-05-18,2020-10-06,5000,mg,['2 / Day'], ,Adverse Event
18261,4278,Endoxan,2016-01-04,, ,mg,[' '], , 
18262,1359,D-cure (Vitamine D),2016-06-16,,500, ,['2 / Day'],Oral, 
18263,1828,IVIG,2015-11-16,2019-03-21,20, ,[' '],IV,Persistence of relapses
18264,1828,Teriflunomide,2016-01-23,, ,MIU,[' '], , 
18265,3012,Tecfidera,2016-01-04,,20,MIU,['2 / Day'], , 
18266,293,Mitoxantrone,2016-09-22,2018-06-20, , ,[' '], ,Lack of efficacy
18267,293,Tecfidera,2016-02-16,,300,mg,['/Month'],IV, 
18268,1877,Tecfidera,2016-01-19,,1000,mg,[' '], , 
18269,197,Rebif [22],2016-07-22,,300, ,['/ Day'],IV, 
18270,197,Endoxan,2015-11-01,2020-05-30,20,mg,['/Month'], ,Adverse Event
18271,2529,Rebif [22],2016-02-21,2019-10-20, ,mg,['2 / Day'], ,Adverse Event
18272,1546,Rebif [22],2016-02-17,,1,mg,['/Month'],IV, 
18273,335,Ledertrexaat,2016-03-17,,20,mg,['/Month'],IV, 
18274,335,Tecfidera,2016-08-24,, ,mg,['2 / Day'],IV, 
18275,4877,Gilenya,2016-07-02,,20,mg,['/Month'],IV, 
18276,4877,Tecfidera,2016-08-12,,5000, ,['/ Week'], , 
18277,4877,Gilenya,2016-05-10,2019-11-21, ,mg,['/ Week'],IV,Adverse Event
18278,4796,Methylprednisolone,2015-11-10,,5000,mg,['/Month'], , 
18279,4796,Copaxone,2016-08-27,2021-07-18,400, ,[' '],IV,Adverse Event
18280,4796,D-cure (Vitamine D),2015-12-21,,400,mg,[' '],Oral, 
18281,2273,Endoxan,2016-09-25,2019-06-04,20,mg,['2 / Day'], ,Adverse Event
18282,2273,Endoxan,2015-12-08,, , ,['2 / Day'],IV, 
18283,2273,Alemtuzumab (Campath),2015-11-11,2021-07-26, ,mg,['/Month'], ,Patient Choice/Convenience
18284,2273,Gilenya,2016-04-16,, , ,['/Month'],IV, 
18285,2377,Betaferon,2016-02-29,2018-09-15,5000,mcg,['2 / Day'],Oral,Persisting MRI activity
18286,2377,Tysabri,2015-12-20,2018-06-16,20,mg,['3 / Week'],IV,Adverse Event
18287,1151,Gilenya,2016-04-17,, ,mg,['2 / Day'], , 
18288,4686,Endoxan,2015-11-13,,400,mg,['/ Day'],IV, 
18289,385,Tysabri,2016-10-12,2020-10-29,300, ,['2 / Day'], ,Persistence of relapses
18290,385,Methylprednisolone,2016-06-10,,300,mg,['/Month'], , 
18291,385,Avonex,2016-04-02,,500,mg,['/ Day'], , 
18292,385,Rebif [44],2016-08-20,2019-01-25,1000,MIU,[' '],IV,Adverse Event
18293,771,Gilenya,2016-07-24,,1000,MIU,['2 / Day'],IV, 
18294,771,Endoxan,2016-10-16,,5000, ,['/ Day'],Oral, 
18295,1702,Methylprednisolone,2016-03-31,2019-06-13, ,mg,['/Month'], ,Adverse Event
18296,2257,Tysabri,2016-07-12,,500,mg,['/ Week'],IV, 
18297,2257,Tysabri,2016-08-31,,20,mg,['/Month'],Oral, 
18298,2257,Methylprednisolone,2015-12-22,2021-06-14,300, ,['2 / Day'],Oral,Persistence of relapses
18299,3397,Alemtuzumab (Campath),2016-10-10,2020-10-06,5000, ,['3 / Week'],IV,Persisting MRI activity
18300,3397,Betaferon,2016-01-01,,500,MIU,['/Month'],Oral, 
18301,2176,Alemtuzumab (Campath),2016-07-04,,20, ,['/ Day'],IV, 
18302,2176,Ledertrexaat,2016-03-05,,20,mg,['/Month'], , 
18303,837,IVIG,2016-08-05,2021-10-03,500,mcg,['/Month'], ,Patient Choice/Convenience
18304,837,D-cure (Vitamine D),2016-03-06,,1000,MIU,['/Month'], , 
18305,837,Endoxan,2016-06-25,,1000,mg,['2 / Day'],IV, 
18306,2356,Endoxan,2016-09-21,,20,mg,['3 / Week'],IV, 
18307,2012,D-cure (Vitamine D),2016-02-14,,400,mg,['/ Week'],IV, 
18308,2012,Copaxone,2016-09-17,2019-04-17, ,mcg,['2 / Day'], ,Adverse Event
18309,3809,Rebif [44],2016-09-20,2021-07-23,1000,mg,[' '],IV,Persistence of relapses
18310,3809,Ledertrexaat,2016-08-24,,5000, ,['/Month'],Oral, 
18311,3809,Tecfidera,2016-01-23,2020-01-21, , ,['2 / Day'],IV,Adverse Event
18312,529,D-cure (Vitamine D),2016-02-03,, ,MIU,[' '],IV, 
18313,575,IVIG,2016-04-02,,300,MIU,[' '], , 
18314,575,Tysabri,2016-08-11,, , ,['2 / Day'], , 
18315,3634,Alemtuzumab (Campath),2016-09-11,,1, ,['2 / Day'], , 
18316,3634,Tecfidera,2016-06-12,2019-02-07,300, ,['2 / Day'],Oral,Persisting MRI activity
18317,3634,Alemtuzumab (Campath),2016-07-03,,1000,mg,['3 / Week'],IV, 
18318,1624,IVIG,2016-01-11,,400,mcg,['2 / Day'],Oral, 
18319,1624,Rebif [22],2016-02-05,, ,mg,['/Month'],Oral, 
18320,1624,Gilenya,2016-04-24,2017-12-25, ,MIU,[' '],IV,Lack of efficacy
18321,1624,IVIG,2016-10-02,2020-04-11,1,mg,['/ Day'], ,Lack of efficacy
18322,3171,Alemtuzumab (Campath),2016-07-26,, , ,['2 / Day'], , 
18323,3171,Gilenya,2016-09-14,2021-01-11,20, ,['2 / Day'],IV,Persisting MRI activity
18324,3171,Endoxan,2015-11-02,2020-03-10,1000,mcg,['/Month'], ,Patient Choice/Convenience
18325,3483,Tysabri,2016-06-24,,20, ,['2 / Day'],Oral, 
18326,103,Alemtuzumab (Campath),2015-11-01,2019-12-09,5000,mg,['/Month'],IV,Lack of efficacy
18327,103,D-cure (Vitamine D),2016-10-04,,500,MIU,['/ Day'],Oral, 
18328,103,Copaxone,2016-04-08,,400, ,['2 / Day'], , 
18329,1882,Gilenya,2015-12-22,2020-11-04,400,mcg,['2 / Day'], ,Patient Choice/Convenience
18330,1882,Rebif [44],2016-04-14,, ,mg,['/Month'],IV, 
18331,3314,Tysabri,2016-08-10,2019-09-04,1,mg,[' '],IV,Adverse Event
18332,3314,Tysabri,2016-07-12,, , ,['2 / Day'],Oral, 
18333,4788,Methylprednisolone,2016-01-04,,1,mg,['/Month'],IV, 
18334,4788,Tysabri,2016-09-28,2019-07-16,1000, ,['/ Week'],IV,Adverse Event
18335,4788,IVIG,2016-01-18,,1000, ,['/Month'],IV, 
18336,4865,Tecfidera,2015-11-01,2018-03-05, ,mg,['/Month'], ,Persistence of relapses
18337,4783,Methylprednisolone,2016-05-24,2018-01-29,20,mg,['/Month'],IV,Persisting MRI activity
18338,4783,Teriflunomide,2016-09-01,2018-08-06, , ,['/ Day'],IV,Patient Choice/Convenience
18339,4783,Methylprednisolone,2015-12-21,,1000,MIU,['/Month'], , 
18340,4783,D-cure (Vitamine D),2016-05-21,2021-09-15,300,mg,['3 / Week'],IV,Persistence of relapses
18341,287,Tysabri,2016-10-12,, , ,['/ Day'],IV, 
18342,287,Copaxone,2016-01-19,2020-12-30,5000, ,['/ Week'], ,Adverse Event
18343,305,Teriflunomide,2016-06-07,2020-01-23,500,mg,['2 / Day'], ,Adverse Event
18344,4366,IVIG,2016-03-27,, , ,['/ Day'],IV, 
18345,4366,Methylprednisolone,2016-08-11,,1000,MIU,['3 / Week'],Oral, 
18346,4366,IVIG,2016-03-02,,1000, ,['/Month'],IV, 
18347,4366,Endoxan,2016-07-19,,300, ,['/Month'],Oral, 
18348,4250,Avonex,2016-05-12,2017-11-20,5000,mg,['/Month'], ,Persisting MRI activity
18349,2771,Methylprednisolone,2016-04-17,2020-09-03,1000,mg,['3 / Week'], ,Patient Choice/Convenience
18350,2771,D-cure (Vitamine D),2016-04-04,2019-12-24,400,mcg,['/ Day'],IV,Patient Choice/Convenience
18351,2771,Teriflunomide,2015-11-10,, ,mcg,['/Month'], , 
18352,2771,Endoxan,2016-05-21,2019-03-06,400,mg,['2 / Day'],IV,Adverse Event
18353,2438,Ledertrexaat,2016-07-17,2020-09-20,500, ,['/ Day'],IV,Adverse Event
18354,2438,IVIG,2016-06-17,, , ,['2 / Day'],IV, 
18355,3715,Alemtuzumab (Campath),2015-12-25,2021-02-17, ,mg,['2 / Day'],IV,Persisting MRI activity
18356,3715,Tecfidera,2016-03-27,,20,mg,['2 / Day'], , 
18357,3715,Tecfidera,2016-01-07,,300, ,['3 / Week'],IV, 
18358,1940,Methylprednisolone,2016-08-04,2018-06-23,1000,mg,['/Month'], ,Adverse Event
18359,1940,IVIG,2016-06-13,2018-09-12, ,MIU,[' '], ,Persisting MRI activity
18360,3123,IVIG,2016-07-27,2021-07-27, ,MIU,['/ Day'],IV,Patient Choice/Convenience
18361,3123,Tecfidera,2016-07-08,,500, ,['2 / Day'], , 
18362,4119,Mitoxantrone,2016-06-26,,1000,mg,['/Month'],IV, 
18363,4119,Gilenya,2016-01-01,,300, ,[' '], , 
18364,1521,Alemtuzumab (Campath),2015-12-21,2019-04-21,300,mg,['/Month'],IV,Adverse Event
18365,1307,D-cure (Vitamine D),2016-05-09,,400,mcg,[' '],IV, 
18366,1307,Betaferon,2015-12-23,, ,mg,['2 / Day'], , 
18367,1307,Avonex,2015-12-02,2021-05-28,1,mg,['/Month'],IV,Persistence of relapses
18368,1307,IVIG,2016-03-10,2018-06-27,300, ,['3 / Week'],Oral,Persisting MRI activity
18369,3311,Mitoxantrone,2016-05-18,,300,MIU,['/ Day'], , 
18370,3311,Endoxan,2016-10-18,, , ,['/Month'], , 
18371,3311,Endoxan,2015-11-23,, , ,[' '], , 
18372,1482,D-cure (Vitamine D),2015-12-03,,500,mg,['2 / Day'],IV, 
18373,1482,Rebif [44],2016-07-05,,5000,MIU,['3 / Week'],IV, 
18374,1312,Teriflunomide,2016-03-07,,20,MIU,['3 / Week'], , 
18375,1312,Teriflunomide,2015-11-16,2018-06-25,500, ,['/Month'],IV,Persistence of relapses
18376,1312,Gilenya,2016-10-20,2019-04-25,5000, ,['/Month'],IV,Lack of efficacy
18377,2999,Avonex,2016-05-17,,20,MIU,['2 / Day'],IV, 
18378,2999,Rebif [22],2016-07-06,2019-11-02, , ,['2 / Day'], ,Persisting MRI activity
18379,2999,Avonex,2016-08-21,2019-05-22,20,mcg,['/Month'],IV,Patient Choice/Convenience
18380,140,Rebif [22],2016-01-29,2019-12-17,300,mg,['2 / Day'],IV,Lack of efficacy
18381,3154,Rebif [44],2015-12-14,2019-02-28, ,mg,['2 / Day'], ,Adverse Event
18382,3154,D-cure (Vitamine D),2016-07-27,2019-06-25,400,MIU,['/ Day'],IV,Adverse Event
18383,3154,Endoxan,2016-06-15,2018-02-15, ,mg,['/ Week'],Oral,Lack of efficacy
18384,576,Alemtuzumab (Campath),2016-01-15,,1000,mg,['2 / Day'],IV, 
18385,576,Mitoxantrone,2016-04-14,,500,mg,['2 / Day'], , 
18386,576,Teriflunomide,2016-01-04,, ,mg,['/ Day'], , 
18387,576,Gilenya,2016-03-21,2021-05-25, , ,['/ Day'],Oral,Persisting MRI activity
18388,409,Teriflunomide,2016-04-25,2019-04-05, , ,['/Month'],IV,Lack of efficacy
18389,409,Rebif [44],2015-12-15,,20, ,[' '],Oral, 
18390,409,Rebif [22],2016-06-02,2020-05-14,5000,MIU,['2 / Day'], ,Adverse Event
18391,409,D-cure (Vitamine D),2016-04-01,2019-07-28,500,mg,['2 / Day'],Oral,Adverse Event
18392,4166,Tecfidera,2016-05-07,2019-08-24,20, ,['/ Day'],Oral,Lack of efficacy
18393,4166,IVIG,2016-01-22,2020-05-17,500,mcg,['2 / Day'],Oral,Persistence of relapses
18394,3998,Tecfidera,2016-01-08,,500, ,['/Month'], , 
18395,3998,Tysabri,2016-06-14,2018-01-28,20,mg,['2 / Day'],IV,Persistence of relapses
18396,3998,Rebif [44],2016-05-08,2018-02-13, ,mg,['2 / Day'],IV,Patient Choice/Convenience
18397,3998,Betaferon,2016-10-05,, ,mg,['/Month'], , 
18398,2376,Methylprednisolone,2016-07-09,,500,mg,['/ Day'],Oral, 
18399,2376,Rebif [44],2015-12-05,, ,MIU,['/Month'], , 
18400,2579,Tecfidera,2016-08-31,, , ,['2 / Day'],IV, 
18401,2579,Tysabri,2016-06-10,2018-01-09,300, ,['/Month'],IV,Patient Choice/Convenience
18402,353,Rebif [44],2016-04-05,2018-08-04, , ,['2 / Day'],IV,Patient Choice/Convenience
18403,353,Avonex,2015-12-06,,400, ,['/Month'], , 
18404,3998,Rebif [44],2016-07-10,2018-08-25,20,mg,['/ Day'], ,Lack of efficacy
18405,3998,Methylprednisolone,2016-10-21,,300,mg,['/ Day'],IV, 
18406,3998,Tysabri,2016-01-01,, , ,['/ Day'], , 
18407,3998,Avonex,2016-02-11,,500, ,['/Month'],IV, 
18408,3822,Ledertrexaat,2016-04-18,,1000, ,['3 / Week'],Oral, 
18409,3822,Tecfidera,2016-09-21,2021-10-17,500,mcg,['/Month'], ,Adverse Event
18410,3822,Alemtuzumab (Campath),2016-02-08,2020-08-28, , ,['3 / Week'], ,Adverse Event
18411,3636,Ledertrexaat,2016-06-29,2020-01-18,20, ,['/Month'], ,Adverse Event
18412,3636,Gilenya,2015-11-02,,1,mg,['2 / Day'], , 
18413,3636,Betaferon,2016-08-12,2021-09-02, ,mg,['3 / Week'],IV,Persisting MRI activity
18414,3636,Betaferon,2016-01-05,,20, ,['2 / Day'], , 
18415,4664,D-cure (Vitamine D),2016-10-01,2020-03-17,1,MIU,[' '],IV,Lack of efficacy
18416,4664,Methylprednisolone,2015-11-03,,500,mg,['3 / Week'],IV, 
18417,4664,Tysabri,2016-05-09,2021-04-10,20, ,['/Month'],IV,Adverse Event
18418,4664,Ledertrexaat,2015-12-07,2018-08-21,20,mg,['2 / Day'], ,Lack of efficacy
18419,4337,Gilenya,2015-12-29,,5000,mg,['/Month'],IV, 
18420,4337,Endoxan,2015-11-29,2019-08-01,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
18421,4337,D-cure (Vitamine D),2016-06-28,,5000,mg,['3 / Week'],IV, 
18422,4337,Rebif [44],2016-02-20,2017-12-30, , ,[' '],IV,Patient Choice/Convenience
18423,3146,IVIG,2016-03-27,2018-12-19, ,mg,['/ Week'],IV,Persisting MRI activity
18424,4343,Rebif [22],2015-11-29,,20,mcg,['/Month'], , 
18425,4343,Tysabri,2016-02-07,,300, ,['2 / Day'],IV, 
18426,4343,Copaxone,2015-11-28,, ,MIU,['2 / Day'],IV, 
18427,2396,Gilenya,2016-08-23,2019-08-22,1000, ,['/Month'],IV,Adverse Event
18428,2396,D-cure (Vitamine D),2016-03-03,, ,mg,['/Month'],Oral, 
18429,2396,D-cure (Vitamine D),2016-07-23,2021-10-17,1000,mg,[' '],IV,Persisting MRI activity
18430,2396,Endoxan,2016-08-28,2018-10-29,300, ,['2 / Day'],Oral,Lack of efficacy
18431,4802,Rebif [44],2016-07-04,,500,mg,['/ Day'],IV, 
18432,4802,Tysabri,2016-04-27,,1000, ,['3 / Week'], , 
18433,4802,Gilenya,2016-07-21,,500, ,['/Month'],IV, 
18434,4802,Gilenya,2016-03-17,,500, ,['2 / Day'], , 
18435,3079,Copaxone,2016-08-11,2019-12-19, , ,['2 / Day'], ,Patient Choice/Convenience
18436,3079,Rebif [44],2016-08-29,,500,MIU,['/Month'],IV, 
18437,3079,Alemtuzumab (Campath),2016-07-19,2020-04-08,20, ,['/ Day'],IV,Patient Choice/Convenience
18438,3079,Teriflunomide,2016-05-20,2018-03-08, , ,['2 / Day'], ,Lack of efficacy
18439,782,Gilenya,2016-08-30,, ,mg,['/ Week'],IV, 
18440,974,Tecfidera,2015-12-21,2018-05-24, , ,['/Month'],IV,Patient Choice/Convenience
18441,3508,Alemtuzumab (Campath),2016-06-15,,500, ,['2 / Day'],IV, 
18442,3323,Methylprednisolone,2015-11-24,2020-12-26, ,mg,['/Month'],IV,Persisting MRI activity
18443,3323,Endoxan,2016-03-27,2018-07-26,500,mg,['/ Day'], ,Persisting MRI activity
18444,3323,Tecfidera,2016-09-03,2019-09-04, ,mg,['3 / Week'], ,Persisting MRI activity
18445,3323,Avonex,2016-08-18,2020-01-07,500,mg,['/Month'],IV,Adverse Event
18446,1212,D-cure (Vitamine D),2016-01-09,,5000,mg,['2 / Day'],IV, 
18447,3656,Mitoxantrone,2016-06-27,,1,mg,[' '], , 
18448,4813,Tysabri,2015-12-30,,20,MIU,[' '],IV, 
18449,4813,Mitoxantrone,2016-09-13,2019-02-16, , ,['2 / Day'],IV,Persisting MRI activity
18450,4813,Copaxone,2016-04-21,,20,mg,['/Month'],IV, 
18451,4813,Methylprednisolone,2015-10-26,2019-07-31, , ,['3 / Week'],Oral,Adverse Event
18452,2753,Gilenya,2016-07-13,2020-11-12,1000,mg,['/ Day'], ,Adverse Event
18453,2753,Alemtuzumab (Campath),2016-01-09,,5000,mcg,['/Month'],IV, 
18454,2753,D-cure (Vitamine D),2015-12-20,, ,mg,['2 / Day'],IV, 
18455,2753,Tecfidera,2016-07-27,2018-06-23, ,mg,['/Month'], ,Adverse Event
18456,1804,Betaferon,2016-03-16,,400,mg,[' '],IV, 
18457,1804,Tysabri,2016-05-04,,500,mcg,['/ Day'],IV, 
18458,1804,Alemtuzumab (Campath),2016-10-13,,1000,mg,['/Month'],IV, 
18459,3241,Mitoxantrone,2015-11-13,2019-08-20, , ,['/Month'],IV,Patient Choice/Convenience
18460,3241,D-cure (Vitamine D),2016-04-28,, ,mcg,[' '], , 
18461,3241,Endoxan,2016-06-08,2021-07-09,1, ,['/ Day'], ,Persistence of relapses
18462,3241,Methylprednisolone,2016-09-26,,5000, ,['/ Week'], , 
18463,3757,Betaferon,2016-07-04,, ,mcg,['3 / Week'],Oral, 
18464,3107,IVIG,2015-11-21,,300, ,['/Month'], , 
18465,3107,Ledertrexaat,2016-01-14,2018-06-11, , ,['3 / Week'],IV,Adverse Event
18466,3107,Endoxan,2015-11-08,, , ,['/Month'],Oral, 
18467,3107,Tysabri,2016-04-25,2020-07-02, , ,[' '], ,Patient Choice/Convenience
18468,1820,Methylprednisolone,2015-11-26,,5000,mg,['2 / Day'],IV, 
18469,1277,Methylprednisolone,2016-05-17,,500, ,['/Month'],IV, 
18470,1277,Gilenya,2016-02-27,2020-08-09,5000, ,['2 / Day'],IV,Patient Choice/Convenience
18471,1871,Methylprednisolone,2016-09-29,2017-11-09,20,mg,['/Month'],IV,Patient Choice/Convenience
18472,1871,Teriflunomide,2015-12-15,2021-03-07, ,mg,['/Month'],IV,Adverse Event
18473,1871,D-cure (Vitamine D),2016-02-24,,20, ,['/ Day'],IV, 
18474,1871,Teriflunomide,2016-09-05,,400, ,[' '], , 
18475,2675,Betaferon,2016-05-14,,300,MIU,['3 / Week'],IV, 
18476,2675,Gilenya,2016-05-06,,1000, ,['/ Week'],IV, 
18477,170,IVIG,2016-10-17,,1, ,['/Month'],Oral, 
18478,359,Alemtuzumab (Campath),2016-04-06,,1000,mg,['/Month'], , 
18479,359,Avonex,2016-09-17,,500,mg,['/Month'],Oral, 
18480,1492,IVIG,2016-06-22,,1, ,['/ Week'],Oral, 
18481,1492,Avonex,2016-04-29,,500,mg,['3 / Week'], , 
18482,1492,Methylprednisolone,2016-07-24,2020-12-26, ,mg,[' '],IV,Persistence of relapses
18483,4201,Tysabri,2016-10-10,,1,mg,['2 / Day'],IV, 
18484,4201,Rebif [22],2016-03-09,2019-03-11,20,mcg,['/ Day'],Oral,Lack of efficacy
18485,2315,Rebif [22],2015-12-27,2020-09-20,400, ,['2 / Day'], ,Patient Choice/Convenience
18486,2315,IVIG,2016-06-17,, , ,['2 / Day'], , 
18487,2315,Copaxone,2015-11-20,,1,mg,['3 / Week'],IV, 
18488,2315,Alemtuzumab (Campath),2016-06-20,, ,mg,['3 / Week'],Oral, 
18489,2163,D-cure (Vitamine D),2016-05-22,,20,mg,['/ Week'],IV, 
18490,2163,IVIG,2016-09-21,2018-07-01,1000, ,['2 / Day'], ,Patient Choice/Convenience
18491,2163,Avonex,2016-07-23,2018-12-07, , ,['3 / Week'],IV,Adverse Event
18492,2163,Tecfidera,2016-09-29,2020-01-28, ,MIU,['/ Day'],IV,Adverse Event
18493,3925,D-cure (Vitamine D),2016-07-01,2018-08-24,400, ,['/Month'],IV,Persisting MRI activity
18494,3925,Alemtuzumab (Campath),2016-08-31,, , ,['/Month'], , 
18495,534,Ledertrexaat,2016-03-18,2019-06-23, ,mcg,['2 / Day'],IV,Lack of efficacy
18496,534,D-cure (Vitamine D),2016-10-06,,20, ,['/Month'], , 
18497,534,Alemtuzumab (Campath),2016-08-16,,1000, ,['/ Week'],Oral, 
18498,534,Tysabri,2016-05-20,2019-02-11,1,mg,['/Month'],IV,Persistence of relapses
18499,3390,Tecfidera,2016-05-13,2021-02-01, ,mg,['3 / Week'],IV,Persistence of relapses
18500,3390,D-cure (Vitamine D),2016-01-10,, ,mg,['2 / Day'], , 
18501,3390,Methylprednisolone,2015-12-13,,400, ,['2 / Day'],IV, 
18502,3390,Gilenya,2016-01-21,,500,mg,['2 / Day'], , 
18503,4192,Tysabri,2016-03-22,2018-09-30, ,mcg,['/Month'],IV,Patient Choice/Convenience
18504,4192,Copaxone,2016-01-20,,1, ,['/ Day'],IV, 
18505,3865,Copaxone,2016-06-23,2018-04-03, ,mcg,['2 / Day'],Oral,Adverse Event
18506,3865,Endoxan,2016-06-27,,1,mg,['/Month'],IV, 
18507,3865,Avonex,2016-05-24,,1000, ,['/ Week'], , 
18508,3865,D-cure (Vitamine D),2016-05-23,2020-10-02, , ,['/ Week'],Oral,Persistence of relapses
18509,668,D-cure (Vitamine D),2016-06-17,,500,mg,['/ Week'],Oral, 
18510,1283,Alemtuzumab (Campath),2016-05-03,,500,mg,[' '],Oral, 
18511,1283,Endoxan,2016-03-29,2018-03-29,300,mcg,['2 / Day'],IV,Lack of efficacy
18512,676,Methylprednisolone,2016-10-06,2020-01-09, ,MIU,['/ Day'],IV,Adverse Event
18513,782,Gilenya,2016-05-18,2020-01-19,20,MIU,['2 / Day'],IV,Lack of efficacy
18514,782,IVIG,2016-10-07,2018-06-11,300, ,['2 / Day'],IV,Persisting MRI activity
18515,782,Alemtuzumab (Campath),2016-05-06,,5000,mg,['/ Week'],IV, 
18516,3352,Rebif [44],2015-12-05,2019-10-06, , ,['/Month'],IV,Adverse Event
18517,3352,Tysabri,2015-12-06,,20, ,['2 / Day'],IV, 
18518,3352,Tecfidera,2016-06-23,,5000,mg,['/Month'],IV, 
18519,4562,D-cure (Vitamine D),2015-11-09,,1,mg,[' '], , 
18520,4562,Alemtuzumab (Campath),2016-09-11,, ,mg,['3 / Week'],IV, 
18521,4562,Copaxone,2016-09-20,2018-10-14,300, ,['/Month'], ,Persisting MRI activity
18522,3813,Rebif [22],2016-06-08,2018-01-22, ,mg,['3 / Week'],IV,Lack of efficacy
18523,3813,Copaxone,2016-07-08,2021-01-08,400,mg,['/ Day'],IV,Persistence of relapses
18524,3813,Ledertrexaat,2016-10-05,2018-04-25, ,mg,['3 / Week'],Oral,Adverse Event
18525,3813,Avonex,2016-09-21,2020-06-20,500, ,['3 / Week'], ,Adverse Event
18526,4263,Tecfidera,2016-08-10,2020-10-17,300,mg,['/Month'],IV,Persistence of relapses
18527,4263,IVIG,2016-04-11,,300,mcg,['/ Day'], , 
18528,4263,Rebif [44],2016-06-19,,300, ,['2 / Day'], , 
18529,3809,Rebif [44],2016-10-03,2020-12-18, ,mg,[' '], ,Lack of efficacy
18530,3306,Mitoxantrone,2016-07-03,,300,mg,['/Month'],IV, 
18531,1867,Gilenya,2016-07-01,,1,mg,['/Month'],IV, 
18532,1867,D-cure (Vitamine D),2015-12-11,,1,MIU,['/Month'],Oral, 
18533,2763,Gilenya,2016-04-25,2020-08-06,400, ,[' '],IV,Persisting MRI activity
18534,2763,Copaxone,2016-04-15,, ,mcg,['2 / Day'],IV, 
18535,2763,IVIG,2016-02-27,,5000,mg,['2 / Day'],IV, 
18536,2763,Gilenya,2015-12-16,, ,mg,['3 / Week'], , 
18537,1272,Alemtuzumab (Campath),2015-10-26,2020-02-12, ,MIU,['/Month'],IV,Adverse Event
18538,1272,Alemtuzumab (Campath),2016-10-10,2020-10-08,400,mg,['/Month'], ,Persisting MRI activity
18539,1272,Rebif [44],2016-06-08,2019-11-15,1000,MIU,['3 / Week'],IV,Adverse Event
18540,1272,Alemtuzumab (Campath),2016-07-28,,20,MIU,['2 / Day'],IV, 
18541,1876,Rebif [22],2016-07-20,, , ,['2 / Day'],IV, 
18542,1876,Ledertrexaat,2016-01-29,2019-07-23, ,mg,['/Month'],IV,Adverse Event
18543,480,Tysabri,2016-09-01,,300,MIU,['/Month'],IV, 
18544,480,D-cure (Vitamine D),2016-07-10,,300,mg,['2 / Day'],IV, 
18545,480,Endoxan,2016-01-12,2018-09-21,1, ,['/Month'],IV,Adverse Event
18546,4120,Methylprednisolone,2016-06-13,,5000, ,['3 / Week'],Oral, 
18547,4120,Gilenya,2016-06-20,2021-06-14, ,mg,['3 / Week'],IV,Patient Choice/Convenience
18548,4120,Gilenya,2016-06-02,, , ,['/ Day'], , 
18549,4120,Methylprednisolone,2016-03-16,,20,mg,['2 / Day'],IV, 
18550,2639,Tecfidera,2016-10-07,,1, ,['/ Day'],IV, 
18551,2226,IVIG,2016-07-01,2018-07-26,5000,MIU,['2 / Day'], ,Adverse Event
18552,2226,Copaxone,2015-11-12,2018-02-22, , ,['2 / Day'], ,Patient Choice/Convenience
18553,748,Avonex,2016-05-17,, ,mcg,['2 / Day'], , 
18554,748,Endoxan,2016-09-06,2020-11-21,5000,mg,[' '],IV,Lack of efficacy
18555,748,Betaferon,2015-11-01,,1000, ,['3 / Week'], , 
18556,3228,Endoxan,2016-06-06,, ,mg,['2 / Day'],IV, 
18557,269,Ledertrexaat,2016-01-05,, ,mg,['/Month'], , 
18558,269,IVIG,2016-07-22,,1000,mg,[' '],IV, 
18559,756,Rebif [22],2016-01-23,, ,mcg,['/Month'], , 
18560,3826,Gilenya,2016-04-07,,400,mg,['2 / Day'], , 
18561,3826,Tecfidera,2016-02-16,2020-07-05,1, ,['/Month'], ,Adverse Event
18562,3826,Avonex,2016-04-05,, , ,[' '], , 
18563,3826,Copaxone,2016-01-14,2021-02-15,1,MIU,['/Month'],Oral,Persisting MRI activity
18564,2588,Mitoxantrone,2016-04-20,,300,mcg,['/Month'],IV, 
18565,2588,Tecfidera,2016-04-06,, ,mcg,['/Month'],IV, 
18566,3138,Gilenya,2015-12-26,2018-01-27,1,mg,['2 / Day'],Oral,Persisting MRI activity
18567,877,Copaxone,2016-02-20,,400,mcg,['/Month'], , 
18568,4035,Mitoxantrone,2016-07-13,, ,MIU,['/ Week'],IV, 
18569,4035,Rebif [22],2016-10-21,,20, ,['/Month'],Oral, 
18570,4035,Tecfidera,2016-07-10,, ,mg,['/ Week'],IV, 
18571,4035,Teriflunomide,2016-05-16,,5000,mg,['2 / Day'],IV, 
18572,2189,Tysabri,2015-11-27,2018-02-04,500, ,['2 / Day'], ,Patient Choice/Convenience
18573,2189,Methylprednisolone,2015-12-05,,300, ,['3 / Week'],IV, 
18574,2189,Gilenya,2015-10-26,,1000,MIU,['/ Week'], , 
18575,4686,Methylprednisolone,2016-04-02,, ,mg,['/Month'],Oral, 
18576,4686,Teriflunomide,2015-12-26,,500,mcg,['3 / Week'],IV, 
18577,4686,Tecfidera,2016-02-18,, , ,['/Month'], , 
18578,4686,Copaxone,2015-11-09,,500, ,['/Month'], , 
18579,1246,Betaferon,2016-06-20,2019-02-15,1,MIU,['/Month'], ,Lack of efficacy
18580,1246,Methylprednisolone,2016-04-19,, ,mg,['2 / Day'],IV, 
18581,2748,Rebif [22],2016-02-13,,20,mg,['3 / Week'],IV, 
18582,2743,Rebif [44],2016-06-18,,500,mg,['2 / Day'],IV, 
18583,2743,Teriflunomide,2016-04-02,2020-01-29,5000, ,['/Month'],IV,Patient Choice/Convenience
18584,2743,Tecfidera,2016-07-03,,400, ,['/Month'],IV, 
18585,2743,Tysabri,2016-08-14,, ,MIU,['2 / Day'],Oral, 
18586,1758,Betaferon,2016-06-20,2019-01-16,400,mg,[' '],Oral,Persisting MRI activity
18587,1758,IVIG,2016-04-29,, , ,[' '],IV, 
18588,952,D-cure (Vitamine D),2016-03-27,,300,MIU,['2 / Day'], , 
18589,952,IVIG,2016-07-17,,300,mg,['2 / Day'],Oral, 
18590,952,Copaxone,2016-09-02,, ,mg,['/Month'],Oral, 
18591,952,Endoxan,2015-12-04,,1000,mcg,['2 / Day'],IV, 
18592,3016,D-cure (Vitamine D),2016-03-03,2020-09-02,1000,mcg,[' '],IV,Lack of efficacy
18593,2447,Rebif [44],2016-08-25,,400,mg,[' '],IV, 
18594,2447,IVIG,2016-07-09,,300, ,['2 / Day'], , 
18595,2447,Copaxone,2016-06-09,2020-09-03, ,mg,[' '],IV,Adverse Event
18596,1035,Betaferon,2016-10-08,2019-12-18,20,mg,[' '], ,Adverse Event
18597,1035,Copaxone,2016-01-26,, ,mcg,['/Month'],Oral, 
18598,1035,D-cure (Vitamine D),2015-11-20,,1, ,[' '],Oral, 
18599,4795,Alemtuzumab (Campath),2016-10-09,2019-11-08,20, ,['2 / Day'],IV,Adverse Event
18600,4795,Betaferon,2016-06-09,2021-03-25, , ,['/ Week'], ,Adverse Event
18601,4795,Tysabri,2016-07-23,2021-09-15,300,mg,['/Month'],IV,Lack of efficacy
18602,4795,Rebif [44],2016-01-14,2020-03-04,300,mg,[' '],IV,Patient Choice/Convenience
18603,800,Endoxan,2016-04-07,,300, ,['/Month'], , 
18604,800,Gilenya,2016-07-21,,20,mg,['/Month'],IV, 
18605,442,Methylprednisolone,2016-07-23,2021-08-31,500,MIU,['/Month'],IV,Adverse Event
18606,442,Endoxan,2016-08-10,,5000,MIU,['/Month'],IV, 
18607,442,Copaxone,2016-01-09,,5000,MIU,[' '], , 
18608,442,Rebif [44],2016-08-03,, , ,['/ Day'], , 
18609,2525,Rebif [44],2016-02-03,,20,mg,['/Month'], , 
18610,2525,Avonex,2016-04-22,, ,mg,['/ Day'],IV, 
18611,2525,Endoxan,2015-12-03,2019-10-24, , ,[' '],IV,Adverse Event
18612,3450,Alemtuzumab (Campath),2016-04-30,2018-10-14,300,MIU,[' '],IV,Adverse Event
18613,4149,Tysabri,2016-02-19,2019-08-28, , ,['/Month'],Oral,Lack of efficacy
18614,4149,Teriflunomide,2016-05-04,2018-06-19, , ,['2 / Day'],IV,Patient Choice/Convenience
18615,4149,D-cure (Vitamine D),2016-01-20,,1,mg,['2 / Day'],IV, 
18616,4149,Tysabri,2015-12-14,2019-07-16,1,mg,['3 / Week'],IV,Lack of efficacy
18617,3666,Alemtuzumab (Campath),2015-12-23,, ,mg,['/ Day'],IV, 
18618,3666,Rebif [22],2016-08-28,2017-11-13,500,mg,['/Month'], ,Lack of efficacy
18619,2659,Tysabri,2016-04-26,,20, ,['2 / Day'], , 
18620,2659,Avonex,2015-11-14,2021-05-27, ,mg,['3 / Week'],Oral,Adverse Event
18621,2659,Betaferon,2016-06-02,2018-12-17,1,mg,['2 / Day'], ,Adverse Event
18622,114,Alemtuzumab (Campath),2016-05-14,,1000, ,['2 / Day'],Oral, 
18623,419,Rebif [22],2015-11-15,2018-08-11,5000,mg,['/ Week'],IV,Patient Choice/Convenience
18624,1860,D-cure (Vitamine D),2016-03-15,2021-10-19, ,MIU,['2 / Day'],IV,Lack of efficacy
18625,4356,Tysabri,2016-05-11,,400, ,['2 / Day'],Oral, 
18626,4356,Betaferon,2016-01-11,2018-10-02,500,mg,['3 / Week'],IV,Adverse Event
18627,4356,IVIG,2016-08-21,2020-12-05,500,mg,['2 / Day'],Oral,Lack of efficacy
18628,4968,Methylprednisolone,2016-01-13,,1, ,['/Month'],IV, 
18629,4968,Avonex,2016-08-12,, ,mg,['/ Week'],IV, 
18630,1273,Endoxan,2016-01-18,2019-08-20,300, ,['/Month'],Oral,Patient Choice/Convenience
18631,1273,Copaxone,2016-01-24,,5000,mg,['/Month'], , 
18632,1273,Methylprednisolone,2016-02-14,, ,mg,['/Month'],IV, 
18633,2790,Alemtuzumab (Campath),2016-05-23,2018-11-08,500, ,['2 / Day'],IV,Lack of efficacy
18634,2790,Copaxone,2016-06-16,2018-07-01,20, ,['/Month'],IV,Persistence of relapses
18635,3689,IVIG,2016-09-07,,300, ,['3 / Week'],IV, 
18636,4899,Mitoxantrone,2015-12-27,,20, ,['/ Day'], , 
18637,4899,Tysabri,2016-01-12,2018-08-12, , ,['2 / Day'], ,Adverse Event
18638,4899,Methylprednisolone,2016-10-07,2021-05-14,5000, ,['/Month'],IV,Adverse Event
18639,4193,Gilenya,2016-05-27,, ,mg,[' '], , 
18640,4193,Gilenya,2016-04-10,, , ,['2 / Day'],IV, 
18641,4193,Copaxone,2016-02-17,2018-09-16, ,mg,['/Month'],IV,Persisting MRI activity
18642,4193,Tecfidera,2015-12-04,2018-11-03,1,mg,['/Month'],IV,Adverse Event
18643,3708,Avonex,2016-05-29,2020-08-08, ,mcg,['3 / Week'],IV,Persisting MRI activity
18644,3708,Avonex,2016-09-29,2019-02-05,500, ,['/Month'],IV,Patient Choice/Convenience
18645,4143,Mitoxantrone,2016-06-05,2018-08-11,1, ,['2 / Day'],IV,Lack of efficacy
18646,4143,IVIG,2015-11-23,2021-03-07,1000, ,['3 / Week'],IV,Lack of efficacy
18647,4143,Endoxan,2016-01-01,,400, ,['2 / Day'], , 
18648,2371,Betaferon,2016-05-17,2019-02-08,1000,mg,[' '], ,Lack of efficacy
18649,2371,Alemtuzumab (Campath),2016-08-15,2019-04-22,1, ,['/Month'],IV,Patient Choice/Convenience
18650,2371,Methylprednisolone,2016-07-28,, ,mcg,['/Month'],IV, 
18651,2371,Betaferon,2016-01-26,2018-05-25,1000, ,['/Month'],IV,Persisting MRI activity
18652,1311,Avonex,2016-07-04,2020-01-26,300, ,['2 / Day'],IV,Lack of efficacy
18653,2822,Copaxone,2016-09-25,,1000,mg,['/ Day'],IV, 
18654,2822,Rebif [44],2015-11-01,,5000,MIU,[' '],IV, 
18655,2822,Betaferon,2016-03-16,,400,mg,[' '], , 
18656,2822,Mitoxantrone,2016-01-01,2019-03-13, ,mg,[' '],Oral,Patient Choice/Convenience
18657,4695,Tysabri,2016-08-25,,20,mcg,['2 / Day'],IV, 
18658,4695,Copaxone,2016-03-12,,20, ,['3 / Week'],IV, 
18659,4695,D-cure (Vitamine D),2016-05-13,2021-07-06, , ,['/ Day'], ,Persistence of relapses
18660,1516,Rebif [44],2016-06-26,2020-11-04, ,mg,['/Month'], ,Patient Choice/Convenience
18661,742,Tysabri,2016-03-13,2018-08-20,400, ,['2 / Day'],IV,Adverse Event
18662,2139,Mitoxantrone,2016-06-25,2020-06-02,1000, ,['2 / Day'],IV,Patient Choice/Convenience
18663,2139,Methylprednisolone,2015-10-29,2021-01-21,20, ,['2 / Day'], ,Adverse Event
18664,2139,IVIG,2016-06-19,2021-10-18, ,mg,['/ Day'],IV,Adverse Event
18665,2139,Avonex,2016-06-16,, , ,['/Month'],IV, 
18666,3213,Tysabri,2016-09-18,, ,mg,[' '], , 
18667,3854,Rebif [44],2016-09-12,2020-02-23,20, ,['2 / Day'],IV,Adverse Event
18668,747,Endoxan,2016-10-06,,5000,mg,['/ Day'],IV, 
18669,747,Tysabri,2016-02-10,,1,MIU,['/Month'], , 
18670,747,Endoxan,2016-04-21,2020-04-13, ,mg,[' '],Oral,Adverse Event
18671,2799,Ledertrexaat,2016-06-06,, ,mg,['/Month'], , 
18672,2799,Ledertrexaat,2016-01-28,2018-06-02,500, ,['/Month'],IV,Persistence of relapses
18673,2799,Gilenya,2016-06-21,2018-05-28, ,mg,['3 / Week'],Oral,Adverse Event
18674,2799,Methylprednisolone,2015-11-06,,1, ,['3 / Week'], , 
18675,1539,Gilenya,2016-07-07,2020-07-23, ,mg,['/Month'],IV,Persistence of relapses
18676,1539,IVIG,2016-09-28,2021-03-09, ,mg,['2 / Day'], ,Persisting MRI activity
18677,1539,Betaferon,2016-05-11,2018-04-14, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
18678,1539,Tysabri,2015-12-03,2019-10-20,1000, ,['/ Day'],IV,Adverse Event
18679,2170,Rebif [22],2016-07-10,2019-12-07,300,mg,['/Month'], ,Persisting MRI activity
18680,2170,D-cure (Vitamine D),2016-04-10,, ,mg,['/Month'], , 
18681,2170,Gilenya,2016-05-19,,20,mg,['2 / Day'], , 
18682,2170,Copaxone,2016-09-22,,1000,MIU,['3 / Week'],Oral, 
18683,4079,Tysabri,2016-01-19,,300, ,[' '],IV, 
18684,4079,Methylprednisolone,2015-12-08,, ,mg,[' '],IV, 
18685,4079,IVIG,2016-03-10,, ,mg,['/Month'], , 
18686,3323,Alemtuzumab (Campath),2015-11-30,, , ,['3 / Week'],IV, 
18687,3323,Rebif [22],2015-12-24,,5000, ,['3 / Week'], , 
18688,3323,D-cure (Vitamine D),2016-02-11,,1000, ,['2 / Day'],IV, 
18689,3164,Alemtuzumab (Campath),2016-09-05,2018-10-22,1000,MIU,[' '],Oral,Patient Choice/Convenience
18690,1053,IVIG,2016-04-18,,20,MIU,['/Month'],IV, 
18691,1053,Betaferon,2016-08-21,, ,MIU,['2 / Day'], , 
18692,3910,Alemtuzumab (Campath),2015-11-02,2020-09-27,1, ,['/Month'],IV,Patient Choice/Convenience
18693,3207,Ledertrexaat,2016-07-03,,500, ,['/Month'],IV, 
18694,3207,Avonex,2016-10-03,,1000, ,['3 / Week'], , 
18695,4816,Rebif [44],2016-02-03,2018-09-13,300,mg,['/Month'],IV,Adverse Event
18696,4816,Gilenya,2016-04-02,,400,MIU,['2 / Day'],Oral, 
18697,2033,Alemtuzumab (Campath),2016-07-08,,1000, ,['/ Day'],IV, 
18698,2033,Copaxone,2016-08-16,2017-11-02,1000,MIU,['2 / Day'], ,Patient Choice/Convenience
18699,459,IVIG,2015-12-08,,500,mg,['2 / Day'],IV, 
18700,2427,Endoxan,2016-05-25,2021-10-17, , ,[' '], ,Persisting MRI activity
18701,2427,IVIG,2015-12-13,,400,mg,['/Month'],IV, 
18702,948,Tecfidera,2016-07-19,,5000,MIU,['/Month'],IV, 
18703,948,Methylprednisolone,2016-05-03,, ,mg,['/Month'], , 
18704,948,D-cure (Vitamine D),2016-03-17,,5000,mg,['2 / Day'],IV, 
18705,3499,Endoxan,2016-08-03,, ,mg,['/ Day'], , 
18706,3499,D-cure (Vitamine D),2016-09-29,2018-01-29, ,mg,['2 / Day'],Oral,Persistence of relapses
18707,451,Gilenya,2016-05-31,, , ,['/Month'],IV, 
18708,451,Endoxan,2016-06-07,, ,MIU,['/Month'],Oral, 
18709,721,Rebif [44],2016-01-20,,1,mg,['2 / Day'],Oral, 
18710,721,Teriflunomide,2016-01-29,2018-01-31,500, ,['/Month'],IV,Adverse Event
18711,721,D-cure (Vitamine D),2016-05-17,, , ,[' '],IV, 
18712,2567,Mitoxantrone,2016-09-14,, ,MIU,['/Month'],IV, 
18713,2567,Rebif [44],2016-09-29,2020-07-31,20,mcg,['3 / Week'],Oral,Adverse Event
18714,2567,IVIG,2015-12-26,,400, ,[' '],IV, 
18715,2999,IVIG,2015-10-31,2018-10-05,300,mg,['2 / Day'], ,Adverse Event
18716,2999,Copaxone,2016-03-16,,500,mg,['2 / Day'],IV, 
18717,3465,IVIG,2016-03-20,2017-10-30,5000,mg,['2 / Day'], ,Patient Choice/Convenience
18718,3465,D-cure (Vitamine D),2016-02-29,, ,MIU,['/Month'], , 
18719,3465,Endoxan,2015-12-19,2019-12-18, , ,['2 / Day'],IV,Patient Choice/Convenience
18720,3465,Mitoxantrone,2016-05-11,,5000, ,['/Month'], , 
18721,1579,IVIG,2016-01-28,,500,mg,['/Month'],IV, 
18722,1579,Endoxan,2016-01-06,2017-11-10,5000,mg,['2 / Day'], ,Persisting MRI activity
18723,1579,Methylprednisolone,2015-12-01,2021-05-23,20, ,['2 / Day'],IV,Lack of efficacy
18724,2265,Ledertrexaat,2016-02-23,,400,mg,['/Month'],IV, 
18725,1658,Methylprednisolone,2016-05-17,, ,mg,['2 / Day'],IV, 
18726,1658,Rebif [22],2015-12-02,,20, ,['2 / Day'], , 
18727,1658,Methylprednisolone,2016-09-21,,20, ,['/Month'],IV, 
18728,4617,Rebif [44],2016-01-09,, ,MIU,['2 / Day'],IV, 
18729,4617,Gilenya,2015-12-21,2020-09-04,1000,mcg,['/Month'],IV,Adverse Event
18730,4617,Ledertrexaat,2016-08-18,, ,mg,['3 / Week'],IV, 
18731,2816,Copaxone,2015-12-26,,300,MIU,['2 / Day'], , 
18732,2816,Gilenya,2015-12-02,2020-02-15,500,mg,['/Month'],Oral,Patient Choice/Convenience
18733,2816,Ledertrexaat,2016-07-18,,1,mg,['/Month'],IV, 
18734,2667,Avonex,2016-04-06,,500,mg,['2 / Day'],Oral, 
18735,2667,D-cure (Vitamine D),2016-07-27,,400, ,[' '],IV, 
18736,2102,Mitoxantrone,2016-05-01,2019-06-27, ,mg,['/Month'],IV,Adverse Event
18737,769,Methylprednisolone,2016-10-08,,5000, ,['/Month'], , 
18738,769,Ledertrexaat,2016-10-18,,1000,mg,['3 / Week'],Oral, 
18739,769,Tysabri,2015-11-07,2017-12-24,5000,mcg,['/Month'],IV,Patient Choice/Convenience
18740,769,IVIG,2016-05-22,2020-07-06, ,MIU,['/Month'], ,Lack of efficacy
18741,3503,Betaferon,2016-01-21,2020-03-22,500,mg,['3 / Week'],Oral,Patient Choice/Convenience
18742,3956,Endoxan,2016-04-12,, ,mg,['2 / Day'], , 
18743,3956,Avonex,2015-12-17,,5000,mg,['2 / Day'], , 
18744,3956,IVIG,2015-11-23,,300, ,['/Month'],IV, 
18745,4249,D-cure (Vitamine D),2016-08-10,,500, ,['/Month'],Oral, 
18746,3555,Ledertrexaat,2016-09-30,2019-12-05,1000, ,['/Month'], ,Lack of efficacy
18747,3555,Teriflunomide,2016-04-04,, ,MIU,['3 / Week'],IV, 
18748,2273,Gilenya,2016-09-02,, , ,['2 / Day'], , 
18749,2273,Teriflunomide,2016-01-31,,1000,mg,['2 / Day'], , 
18750,2191,Gilenya,2016-02-14,, ,MIU,[' '], , 
18751,1827,Tecfidera,2016-08-18,, , ,['2 / Day'],Oral, 
18752,1827,Alemtuzumab (Campath),2016-09-26,,20, ,['2 / Day'],IV, 
18753,2868,Tysabri,2015-11-08,, , ,['3 / Week'], , 
18754,2868,Methylprednisolone,2016-09-04,2018-03-30,400,mg,['2 / Day'], ,Patient Choice/Convenience
18755,4513,Teriflunomide,2016-03-16,,500,mg,['/ Day'], , 
18756,4513,Methylprednisolone,2016-06-11,2020-02-05,20,mcg,['/Month'],IV,Persisting MRI activity
18757,4513,Rebif [44],2016-09-11,, , ,['/Month'],IV, 
18758,3754,Rebif [44],2016-01-09,,400,mcg,['/Month'], , 
18759,3754,Teriflunomide,2016-10-13,,1,mg,['/ Week'],IV, 
18760,3754,IVIG,2016-08-15,, , ,['2 / Day'],IV, 
18761,4163,D-cure (Vitamine D),2016-09-09,,1000,mg,['2 / Day'], , 
18762,4163,Methylprednisolone,2016-07-27,, ,mcg,['2 / Day'],Oral, 
18763,4163,Avonex,2016-06-11,,400,MIU,['/Month'],Oral, 
18764,1940,Rebif [44],2016-07-15,,1,mcg,['/ Week'],Oral, 
18765,1940,Gilenya,2016-10-01,,20,mg,['2 / Day'],IV, 
18766,1940,Gilenya,2016-05-10,, ,mg,['3 / Week'], , 
18767,1940,Betaferon,2016-07-24,2018-06-28,20, ,['/Month'],IV,Persisting MRI activity
18768,2476,D-cure (Vitamine D),2015-11-26,2021-04-24,20, ,['3 / Week'],IV,Persisting MRI activity
18769,2476,Rebif [22],2016-09-12,,400,MIU,['2 / Day'],IV, 
18770,2476,Methylprednisolone,2016-02-02,2019-02-22,1, ,['2 / Day'],IV,Lack of efficacy
18771,2476,D-cure (Vitamine D),2015-11-05,,20, ,['/ Day'], , 
18772,423,Ledertrexaat,2016-05-01,,300,mg,['/Month'],IV, 
18773,423,Alemtuzumab (Campath),2016-04-17,2020-05-13,400,MIU,['/ Week'],IV,Adverse Event
18774,1889,IVIG,2016-07-13,2021-08-08,500, ,['3 / Week'],IV,Persistence of relapses
18775,1889,D-cure (Vitamine D),2016-01-31,, , ,['2 / Day'],IV, 
18776,1146,Avonex,2016-04-18,,20,mg,[' '],IV, 
18777,1146,Endoxan,2016-01-24,,5000, ,['2 / Day'], , 
18778,1146,Endoxan,2016-06-23,, ,mcg,['/Month'],IV, 
18779,2699,Gilenya,2016-02-22,2018-10-14,1000,mg,['/Month'],IV,Adverse Event
18780,2699,Avonex,2016-01-12,2021-05-28,500,mcg,['/ Day'],IV,Persistence of relapses
18781,1095,Betaferon,2016-09-02,2018-11-08,5000, ,['/Month'],IV,Persisting MRI activity
18782,2556,Gilenya,2016-07-10,,1,mg,['/ Week'],IV, 
18783,2556,IVIG,2016-06-13,, , ,['/ Day'],IV, 
18784,2556,Endoxan,2016-03-18,,1000,mg,['3 / Week'], , 
18785,2556,IVIG,2016-09-23,2021-02-11, ,mg,['/ Day'],IV,Adverse Event
18786,3253,Betaferon,2016-01-21,2018-02-05,5000,mcg,['2 / Day'],IV,Lack of efficacy
18787,4536,Methylprednisolone,2016-04-29,2020-12-31,300,mg,['/Month'], ,Adverse Event
18788,4536,Endoxan,2016-01-21,2020-04-19, ,MIU,['2 / Day'],Oral,Patient Choice/Convenience
18789,4536,Gilenya,2016-04-20,2019-01-16, , ,['2 / Day'],IV,Adverse Event
18790,2463,Rebif [22],2015-11-03,2021-01-23,1, ,['2 / Day'],Oral,Adverse Event
18791,2463,Teriflunomide,2015-11-25,2021-08-30,500,mg,['/ Day'],IV,Patient Choice/Convenience
18792,2463,Rebif [44],2016-08-24,2019-08-29,20,MIU,['/ Week'], ,Persisting MRI activity
18793,580,Tysabri,2016-05-02,2018-08-07,1000,mg,['/Month'], ,Adverse Event
18794,580,Copaxone,2015-10-29,,300, ,['3 / Week'], , 
18795,580,Avonex,2015-10-27,,1000,MIU,['/Month'], , 
18796,3291,Tysabri,2016-06-29,,300, ,['2 / Day'], , 
18797,3291,Tecfidera,2016-03-01,2020-03-08,5000, ,['/ Day'],IV,Adverse Event
18798,1725,IVIG,2016-02-05,,1,mg,['3 / Week'],Oral, 
18799,2450,D-cure (Vitamine D),2016-08-30,2020-06-18,5000, ,[' '], ,Patient Choice/Convenience
18800,2450,Methylprednisolone,2016-10-16,2018-05-28, ,mg,['2 / Day'],IV,Lack of efficacy
18801,2450,Betaferon,2016-04-22,2018-10-16,1000,mcg,['/Month'],IV,Lack of efficacy
18802,2597,Copaxone,2016-03-02,, ,mg,['3 / Week'],IV, 
18803,2597,Rebif [44],2016-03-25,2018-04-07,300,MIU,['/Month'],IV,Lack of efficacy
18804,2597,D-cure (Vitamine D),2016-03-27,2021-03-15, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
18805,3899,D-cure (Vitamine D),2016-09-15,,500,mcg,['3 / Week'], , 
18806,3899,Rebif [44],2016-02-23,2019-02-23,5000, ,['2 / Day'], ,Patient Choice/Convenience
18807,3899,Endoxan,2015-12-17,, , ,['3 / Week'], , 
18808,1978,Ledertrexaat,2016-05-24,2020-11-12, , ,['3 / Week'],IV,Patient Choice/Convenience
18809,1978,Tysabri,2016-06-16,,1000,mg,[' '],IV, 
18810,3089,D-cure (Vitamine D),2016-10-06,, ,mg,['/Month'],Oral, 
18811,3635,Betaferon,2015-10-31,2020-07-06,5000, ,['2 / Day'],Oral,Adverse Event
18812,3635,Tysabri,2015-12-25,,5000,mg,['2 / Day'], , 
18813,1946,Avonex,2016-05-31,2019-01-10, , ,['2 / Day'],Oral,Adverse Event
18814,2086,Alemtuzumab (Campath),2016-04-02,,1,mcg,['3 / Week'],IV, 
18815,2086,Avonex,2015-10-28,,500,mg,[' '], , 
18816,3488,Avonex,2016-10-01,2020-09-18,1000, ,['3 / Week'],IV,Persisting MRI activity
18817,3488,Methylprednisolone,2015-10-24,,500,mg,['/ Day'],IV, 
18818,3488,Rebif [22],2015-12-13,,20, ,['3 / Week'],IV, 
18819,2019,Rebif [44],2016-09-11,, ,MIU,['2 / Day'], , 
18820,2019,IVIG,2016-10-18,, , ,['2 / Day'],Oral, 
18821,2019,Betaferon,2016-08-27,,300,mg,['/Month'],IV, 
18822,2363,Rebif [44],2016-03-28,,1, ,['/Month'],IV, 
18823,2363,Rebif [22],2016-03-19,,20, ,['2 / Day'], , 
18824,1639,Avonex,2016-06-09,,1000, ,['2 / Day'],IV, 
18825,1639,Betaferon,2015-12-09,,400, ,['/Month'], , 
18826,1639,Copaxone,2015-11-17,2018-02-04, ,mg,['3 / Week'],IV,Persisting MRI activity
18827,1639,Copaxone,2016-07-23,2020-02-01, ,mcg,['/Month'], ,Lack of efficacy
18828,1989,Rebif [44],2016-10-16,,20,mg,['2 / Day'],IV, 
18829,1989,Rebif [44],2016-03-16,2021-03-30,1, ,['/ Week'], ,Adverse Event
18830,1989,Betaferon,2016-08-16,2019-11-23,500,mcg,['/ Week'], ,Adverse Event
18831,1989,Rebif [22],2016-01-14,,20, ,['/ Day'], , 
18832,2207,Betaferon,2016-01-10,,300,mg,['2 / Day'],IV, 
18833,3978,IVIG,2016-10-02,2018-06-10,20, ,['2 / Day'], ,Lack of efficacy
18834,3978,Tecfidera,2016-06-23,2020-08-12,1000, ,['2 / Day'],IV,Persisting MRI activity
18835,534,Alemtuzumab (Campath),2016-03-01,,500, ,['3 / Week'],IV, 
18836,534,Betaferon,2016-01-08,,1,MIU,['/ Day'],IV, 
18837,534,IVIG,2015-11-27,, ,mg,['2 / Day'],IV, 
18838,534,Endoxan,2016-05-12,,5000,mcg,['/Month'], , 
18839,2769,Gilenya,2015-12-13,2018-12-12,1000,MIU,['/ Week'],Oral,Lack of efficacy
18840,4211,Rebif [22],2015-11-10,,400,MIU,[' '],IV, 
18841,4211,Copaxone,2015-12-19,2020-10-27,20,MIU,['/Month'],Oral,Adverse Event
18842,4759,Rebif [44],2015-12-06,2019-09-14,500, ,[' '],IV,Adverse Event
18843,4759,Tecfidera,2016-06-16,2021-08-08,20,mg,['2 / Day'], ,Persisting MRI activity
18844,4759,Avonex,2015-11-29,2018-11-13,500,mg,['/Month'], ,Persistence of relapses
18845,565,Teriflunomide,2016-06-30,2020-06-18,300,mcg,['3 / Week'],Oral,Adverse Event
18846,565,D-cure (Vitamine D),2016-06-09,, , ,['2 / Day'],IV, 
18847,618,Tysabri,2016-06-28,,20, ,['2 / Day'], , 
18848,618,D-cure (Vitamine D),2016-06-18,, ,mg,['3 / Week'],IV, 
18849,618,IVIG,2016-03-22,,5000, ,[' '],IV, 
18850,618,Methylprednisolone,2016-08-26,,500, ,['2 / Day'],IV, 
18851,3589,Betaferon,2015-12-24,2019-12-30,500,MIU,[' '],IV,Persisting MRI activity
18852,3589,Mitoxantrone,2016-09-15,,500,mg,['2 / Day'],IV, 
18853,3589,D-cure (Vitamine D),2016-04-25,2020-06-09,5000, ,['/Month'], ,Patient Choice/Convenience
18854,3589,Methylprednisolone,2016-10-21,2018-08-04, ,mg,['2 / Day'],IV,Lack of efficacy
18855,3394,Tysabri,2016-03-28,2019-06-30,400,mg,['2 / Day'],IV,Lack of efficacy
18856,3394,Methylprednisolone,2016-10-21,,1,mg,['2 / Day'],IV, 
18857,3394,Tecfidera,2016-02-28,, , ,['/Month'],Oral, 
18858,3394,Tysabri,2016-05-14,2020-05-28,300,mcg,['/Month'], ,Adverse Event
18859,1541,IVIG,2016-04-30,2021-10-08,20,MIU,[' '],IV,Adverse Event
18860,1541,Ledertrexaat,2016-08-28,,20,mg,['/ Day'],IV, 
18861,1541,Alemtuzumab (Campath),2016-10-07,, , ,['/Month'], , 
18862,1026,Endoxan,2016-07-28,2021-03-02,1000, ,['2 / Day'], ,Adverse Event
18863,3569,Rebif [22],2016-10-18,2019-11-30,400, ,['/ Day'], ,Adverse Event
18864,3569,Gilenya,2016-01-07,,1000,mcg,['/ Week'], , 
18865,3569,Avonex,2016-04-07,2017-11-09, ,mg,['/ Day'],IV,Persisting MRI activity
18866,3429,Teriflunomide,2016-04-12,,5000, ,['2 / Day'],IV, 
18867,3429,Teriflunomide,2015-11-06,2019-07-13, ,mg,['3 / Week'],IV,Adverse Event
18868,3429,Copaxone,2016-06-08,,1000,mg,['3 / Week'], , 
18869,3429,Avonex,2016-02-28,,20,mg,['3 / Week'],IV, 
18870,1283,Methylprednisolone,2016-05-09,2019-10-25,1, ,['2 / Day'], ,Patient Choice/Convenience
18871,4413,Rebif [22],2016-05-01,,5000,mg,['/Month'],Oral, 
18872,4657,Copaxone,2016-08-03,2019-07-16,300,MIU,[' '],IV,Lack of efficacy
18873,2971,Alemtuzumab (Campath),2016-01-31,, ,mcg,['2 / Day'],IV, 
18874,4275,IVIG,2016-06-30,2018-11-16,500,mg,['/Month'],IV,Persistence of relapses
18875,4275,Tysabri,2016-09-19,2020-12-25,1000,mg,['/ Day'], ,Persisting MRI activity
18876,4275,Methylprednisolone,2016-01-29,2020-12-05,5000,mg,['/Month'],IV,Patient Choice/Convenience
18877,4275,Methylprednisolone,2015-12-19,,300, ,['2 / Day'],IV, 
18878,4146,Rebif [22],2015-11-18,2019-08-15,20,MIU,['3 / Week'], ,Persistence of relapses
18879,4146,IVIG,2016-10-03,2018-04-08,400, ,['/Month'],IV,Persistence of relapses
18880,4146,Methylprednisolone,2016-08-05,,400,mcg,[' '],IV, 
18881,195,Rebif [22],2016-01-04,2019-05-02,5000,MIU,['/Month'],IV,Lack of efficacy
18882,195,Rebif [22],2016-02-28,,20, ,['/Month'],IV, 
18883,195,Tysabri,2016-04-20,,5000,MIU,['/ Day'], , 
18884,195,Avonex,2015-12-05,2018-08-14,1000,MIU,['/ Week'],IV,Patient Choice/Convenience
18885,1510,Endoxan,2015-11-03,2021-02-12,5000, ,['2 / Day'],IV,Adverse Event
18886,1510,IVIG,2016-08-02,2018-05-12,1000, ,['/Month'],IV,Adverse Event
18887,4340,Gilenya,2016-06-11,2021-08-28, ,mg,[' '],IV,Adverse Event
18888,4340,Methylprednisolone,2016-03-31,2019-12-03,400,MIU,['3 / Week'],IV,Adverse Event
18889,1013,IVIG,2015-12-21,2021-09-11, , ,['2 / Day'],IV,Lack of efficacy
18890,1013,Rebif [44],2016-05-01,,1, ,[' '],IV, 
18891,1013,Avonex,2015-11-05,2019-01-01,300, ,['/Month'], ,Persisting MRI activity
18892,1013,Rebif [22],2015-10-28,,400, ,['/Month'],IV, 
18893,792,Gilenya,2015-11-29,, ,MIU,['/Month'],IV, 
18894,792,Rebif [44],2015-11-06,,1, ,['/Month'],IV, 
18895,792,Teriflunomide,2016-08-29,2019-06-25,1000,mcg,['2 / Day'],IV,Adverse Event
18896,1352,D-cure (Vitamine D),2016-05-05,,1000,mcg,['/ Day'],IV, 
18897,1352,Gilenya,2016-07-24,2021-01-28, , ,['/ Day'], ,Adverse Event
18898,1352,Methylprednisolone,2016-10-14,,1000, ,['2 / Day'],IV, 
18899,1743,Rebif [22],2015-12-04,,500,MIU,['/Month'],Oral, 
18900,1743,Ledertrexaat,2016-09-06,2018-10-06,5000,MIU,['/Month'], ,Persistence of relapses
18901,1743,Rebif [44],2015-11-09,,20, ,['2 / Day'],Oral, 
18902,3635,Tecfidera,2016-01-27,2021-01-20,1000,mg,['/ Day'],Oral,Persistence of relapses
18903,3635,IVIG,2016-01-19,,5000,mg,['3 / Week'],IV, 
18904,3635,Rebif [44],2015-12-27,,300,mg,['2 / Day'], , 
18905,2092,Endoxan,2016-10-22,2021-07-12,300, ,['/Month'],IV,Patient Choice/Convenience
18906,2092,Methylprednisolone,2016-01-31,2020-03-11,500,mcg,['/Month'],Oral,Patient Choice/Convenience
18907,2092,Avonex,2016-05-22,,20,MIU,['/Month'],IV, 
18908,2092,D-cure (Vitamine D),2015-11-27,2021-05-02,300,mcg,['2 / Day'],IV,Persistence of relapses
18909,3768,IVIG,2016-06-17,2019-02-13,500, ,[' '],IV,Adverse Event
18910,3768,Tysabri,2015-12-21,, ,mg,['2 / Day'], , 
18911,3768,Endoxan,2015-12-29,2020-10-07,500,mg,['/Month'], ,Patient Choice/Convenience
18912,2394,Endoxan,2016-06-13,,5000, ,['/Month'], , 
18913,2394,Methylprednisolone,2015-12-24,, ,MIU,['/Month'],IV, 
18914,3485,Tysabri,2015-11-08,2019-01-22,20, ,['/Month'], ,Lack of efficacy
18915,3485,Rebif [44],2016-10-04,, , ,[' '],IV, 
18916,3485,Mitoxantrone,2016-03-05,,400, ,['3 / Week'],IV, 
18917,3485,D-cure (Vitamine D),2015-12-10,2021-02-25,5000, ,[' '],IV,Persisting MRI activity
18918,827,Avonex,2015-12-03,, ,mg,['/Month'], , 
18919,827,Endoxan,2015-12-04,,300,mg,['/Month'], , 
18920,827,Methylprednisolone,2016-01-14,,400,mg,['2 / Day'],Oral, 
18921,2722,Endoxan,2015-12-15,2020-01-04, , ,[' '],IV,Persistence of relapses
18922,2722,Teriflunomide,2015-11-19,2018-02-03,500,mg,['2 / Day'],Oral,Lack of efficacy
18923,4216,Copaxone,2016-09-28,,500, ,[' '], , 
18924,4216,Copaxone,2016-02-03,2021-01-07,1,mg,['/Month'],IV,Adverse Event
18925,4216,Ledertrexaat,2016-05-01,,500, ,['2 / Day'],IV, 
18926,4216,Ledertrexaat,2015-10-31,2020-09-18,5000, ,['/Month'],IV,Lack of efficacy
18927,951,Rebif [44],2016-02-05,2021-05-03,1000, ,['3 / Week'],IV,Persisting MRI activity
18928,951,Rebif [44],2016-03-16,,300,mcg,['3 / Week'], , 
18929,3896,Tecfidera,2015-11-09,,300, ,['3 / Week'], , 
18930,3896,Endoxan,2016-09-03,2018-06-22, ,mg,['2 / Day'], ,Patient Choice/Convenience
18931,901,Gilenya,2016-01-20,2020-10-29, ,mg,['/Month'],Oral,Lack of efficacy
18932,4064,IVIG,2016-08-11,2019-11-11, ,mg,[' '],IV,Lack of efficacy
18933,4064,Endoxan,2015-10-25,,400,mg,['/Month'],IV, 
18934,3188,Ledertrexaat,2016-03-15,2018-05-28,1,MIU,['/Month'],IV,Patient Choice/Convenience
18935,3188,IVIG,2016-06-14,2020-10-10,500,mg,['3 / Week'], ,Persisting MRI activity
18936,1194,Tysabri,2016-08-21,2021-09-22, , ,['3 / Week'], ,Persisting MRI activity
18937,1194,Copaxone,2016-02-03,2020-01-02,1,mg,['2 / Day'], ,Persisting MRI activity
18938,1194,IVIG,2016-02-15,, ,mg,['/ Day'],IV, 
18939,1194,Methylprednisolone,2016-08-06,2020-10-02, , ,['/Month'],IV,Persisting MRI activity
18940,3078,Tecfidera,2016-08-21,, ,mg,['2 / Day'],Oral, 
18941,4140,Methylprednisolone,2016-06-05,,5000,mcg,['/Month'], , 
18942,4140,Methylprednisolone,2016-09-09,,20,mg,['/ Day'],IV, 
18943,4140,Avonex,2016-06-05,2020-12-07,300, ,['/Month'],IV,Lack of efficacy
18944,4083,Ledertrexaat,2016-01-21,,20, ,['/ Day'],IV, 
18945,4083,D-cure (Vitamine D),2016-01-04,2020-07-27, , ,['3 / Week'],Oral,Persisting MRI activity
18946,3056,Endoxan,2015-12-21,2019-07-11, ,mg,['/Month'], ,Persisting MRI activity
18947,3056,IVIG,2015-12-03,2021-05-18,400,mg,['3 / Week'],Oral,Persisting MRI activity
18948,3056,Alemtuzumab (Campath),2016-06-14,, , ,[' '], , 
18949,3056,Tysabri,2015-12-27,2018-08-02,1000,mg,['3 / Week'],IV,Adverse Event
18950,1117,Rebif [44],2016-06-24,2019-07-24, , ,['/Month'],IV,Adverse Event
18951,1117,Rebif [44],2015-11-24,2018-06-02,500,mcg,['/ Day'],IV,Lack of efficacy
18952,1793,Gilenya,2016-06-08,, ,mg,['/ Week'], , 
18953,4417,Methylprednisolone,2016-04-20,2020-07-28, ,mg,['/Month'],IV,Patient Choice/Convenience
18954,4417,Endoxan,2015-12-06,,20,mg,['3 / Week'],IV, 
18955,4417,Copaxone,2016-02-17,,500,mg,['2 / Day'],IV, 
18956,1724,Rebif [44],2016-07-17,2019-12-02,1000,mg,['/ Day'], ,Persistence of relapses
18957,1724,Gilenya,2015-12-05,,20,mg,['2 / Day'],IV, 
18958,1724,Rebif [44],2016-01-27,2020-03-19,500, ,['2 / Day'],IV,Patient Choice/Convenience
18959,4707,Mitoxantrone,2015-12-11,2020-11-01, ,mg,['2 / Day'], ,Persisting MRI activity
18960,4707,IVIG,2015-12-05,2021-06-21,300, ,['/Month'], ,Persisting MRI activity
18961,4707,Ledertrexaat,2015-12-07,2021-03-31,20,mg,['2 / Day'], ,Adverse Event
18962,1033,Teriflunomide,2016-06-02,,300,mg,['2 / Day'], , 
18963,2056,Rebif [22],2015-12-11,,1000, ,['/ Day'], , 
18964,2056,Tecfidera,2016-05-13,, ,mg,['2 / Day'], , 
18965,2056,Alemtuzumab (Campath),2016-05-30,2019-03-07, ,mcg,['3 / Week'],IV,Lack of efficacy
18966,2056,D-cure (Vitamine D),2016-08-04,,20,mg,['2 / Day'],Oral, 
18967,3919,Betaferon,2015-12-18,2021-10-04,1,mg,['3 / Week'],IV,Adverse Event
18968,3178,Alemtuzumab (Campath),2015-11-19,,1000,mg,['/ Week'], , 
18969,3178,Betaferon,2015-12-01,,20, ,['/Month'],Oral, 
18970,3178,Rebif [22],2016-03-25,2019-07-08,5000,mg,[' '], ,Persisting MRI activity
18971,3178,Teriflunomide,2016-03-14,2021-08-30,1000,mcg,['2 / Day'],IV,Patient Choice/Convenience
18972,3836,Tysabri,2016-01-02,, ,mg,['3 / Week'],IV, 
18973,2572,Avonex,2016-10-14,2021-01-19,500,mcg,['/ Day'],Oral,Adverse Event
18974,2572,Avonex,2016-05-16,,500, ,['2 / Day'],Oral, 
18975,2572,Methylprednisolone,2015-10-31,,300, ,[' '],IV, 
18976,4012,Tysabri,2016-06-13,2019-04-27,20, ,['3 / Week'],IV,Persistence of relapses
18977,4012,Gilenya,2016-01-16,,20, ,['/ Day'],IV, 
18978,4012,Tecfidera,2016-03-24,,5000,mg,['3 / Week'], , 
18979,4012,Alemtuzumab (Campath),2016-04-15,2017-12-19,5000, ,['2 / Day'],Oral,Persisting MRI activity
18980,835,Copaxone,2016-09-16,2018-09-29,300, ,['3 / Week'],IV,Adverse Event
18981,835,Copaxone,2016-05-09,2021-10-22,20,MIU,[' '],IV,Persistence of relapses
18982,1205,D-cure (Vitamine D),2016-05-21,,5000,mg,['/ Week'], , 
18983,3751,Betaferon,2016-02-09,,5000, ,['/Month'],IV, 
18984,3751,Betaferon,2016-06-07,,20,mg,['/Month'],IV, 
18985,3751,Tecfidera,2016-02-27,,1000,mg,['2 / Day'], , 
18986,2564,Tysabri,2016-06-30,, , ,['2 / Day'], , 
18987,2564,Mitoxantrone,2015-12-29,,1000,mg,['/ Day'], , 
18988,4112,Gilenya,2016-05-20,,1000, ,['/Month'], , 
18989,4112,Alemtuzumab (Campath),2016-08-26,2019-01-08,1,mg,['2 / Day'],IV,Adverse Event
18990,4112,Alemtuzumab (Campath),2015-11-24,2018-09-28, , ,['2 / Day'], ,Persisting MRI activity
18991,865,D-cure (Vitamine D),2015-11-26,,500,mg,['3 / Week'],IV, 
18992,865,Rebif [22],2016-05-17,2017-10-28,1000,mg,['/ Week'],Oral,Patient Choice/Convenience
18993,4701,Endoxan,2016-10-14,2018-02-16,400,mg,['3 / Week'],IV,Adverse Event
18994,4701,Teriflunomide,2016-01-25,,300,mg,['3 / Week'],IV, 
18995,4701,Tecfidera,2016-04-05,,300, ,['/Month'],IV, 
18996,4004,Rebif [44],2016-06-06,, ,MIU,['/ Week'],IV, 
18997,4462,Methylprednisolone,2016-08-25,,5000,mcg,['3 / Week'],Oral, 
18998,4462,Copaxone,2015-12-19,,1000,mg,['/ Day'], , 
18999,4462,Gilenya,2016-10-20,2020-12-31, ,MIU,['2 / Day'],Oral,Lack of efficacy
19000,4462,Betaferon,2016-05-26,2020-09-06, ,mg,['/ Day'],IV,Patient Choice/Convenience
19001,746,Teriflunomide,2015-11-09,2020-12-27,5000,mg,['/ Week'],IV,Patient Choice/Convenience
19002,746,Avonex,2016-08-30,,1000,mg,['/Month'], , 
19003,746,Teriflunomide,2016-06-05,,20,mg,['/Month'], , 
19004,746,Ledertrexaat,2015-12-30,, ,MIU,['/Month'],IV, 
19005,137,Gilenya,2016-02-03,2020-06-10, ,mg,['3 / Week'],IV,Persisting MRI activity
19006,2019,Betaferon,2016-01-02,2018-12-14,300,MIU,['3 / Week'],IV,Persisting MRI activity
19007,2019,Teriflunomide,2015-12-14,2021-10-02,300, ,['3 / Week'], ,Patient Choice/Convenience
19008,2019,IVIG,2016-04-11,2018-02-26,1,mcg,['2 / Day'],IV,Persisting MRI activity
19009,4733,Alemtuzumab (Campath),2016-10-17,,300,mg,['/Month'],Oral, 
19010,4733,Rebif [22],2015-11-11,2019-11-13,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
19011,4733,Rebif [22],2016-07-30,,1,MIU,[' '], , 
19012,4733,Gilenya,2016-06-01,, ,mg,['2 / Day'],IV, 
19013,2859,Tecfidera,2016-09-05,,20,MIU,['3 / Week'],IV, 
19014,4908,Teriflunomide,2016-04-30,2021-05-02,5000,MIU,[' '],IV,Adverse Event
19015,4908,IVIG,2016-10-20,,500,mcg,['2 / Day'],Oral, 
19016,4908,Teriflunomide,2016-01-14,,5000,mg,['2 / Day'], , 
19017,2501,Copaxone,2016-01-18,, , ,['/Month'],IV, 
19018,2501,Gilenya,2016-05-07,, ,mg,['/ Day'],IV, 
19019,776,Mitoxantrone,2015-10-29,2021-01-03,500,mg,['3 / Week'],Oral,Lack of efficacy
19020,776,Gilenya,2016-01-16,,20,mg,[' '], , 
19021,979,Teriflunomide,2016-03-17,2018-02-06, ,mg,['2 / Day'], ,Patient Choice/Convenience
19022,688,Teriflunomide,2016-07-20,,20,mg,['2 / Day'], , 
19023,688,Endoxan,2016-06-08,, ,mg,[' '], , 
19024,688,Gilenya,2016-08-04,, ,mg,['/ Week'],IV, 
19025,2438,Alemtuzumab (Campath),2016-05-15,,5000,MIU,['2 / Day'],IV, 
19026,2438,Tecfidera,2016-01-17,, , ,[' '],IV, 
19027,2438,Rebif [22],2016-10-14,,500, ,['/Month'],IV, 
19028,833,IVIG,2016-10-16,2019-01-01,500,mcg,['/Month'], ,Persisting MRI activity
19029,833,Tysabri,2016-05-24,2017-11-23, , ,[' '],Oral,Persistence of relapses
19030,833,Gilenya,2015-12-08,2017-10-29,300,mg,['/Month'],IV,Lack of efficacy
19031,833,Methylprednisolone,2016-02-23,,500,mcg,['2 / Day'], , 
19032,3983,Avonex,2016-07-15,2018-01-22, , ,['3 / Week'],IV,Lack of efficacy
19033,3983,Alemtuzumab (Campath),2015-10-29,,1000, ,['/ Week'], , 
19034,3983,Ledertrexaat,2016-04-16,,500,mcg,['/Month'], , 
19035,3983,D-cure (Vitamine D),2016-03-29,, ,mg,['/ Week'], , 
19036,1186,Copaxone,2016-06-24,2019-08-05,1000,mg,['/Month'],Oral,Persisting MRI activity
19037,1186,Mitoxantrone,2016-09-12,2018-02-20, ,mg,['/Month'],IV,Patient Choice/Convenience
19038,1186,Copaxone,2016-01-16,,1, ,['/Month'], , 
19039,3456,Methylprednisolone,2016-02-05,, ,mg,['/ Day'],IV, 
19040,3456,D-cure (Vitamine D),2016-07-14,, , ,['/Month'],IV, 
19041,3456,Tecfidera,2015-12-26,,20,mg,['3 / Week'],IV, 
19042,3456,Methylprednisolone,2016-01-28,,400,mg,['3 / Week'],IV, 
19043,1848,D-cure (Vitamine D),2016-03-23,,20, ,['2 / Day'],IV, 
19044,1848,Ledertrexaat,2015-11-25,,20,mg,['/ Week'],IV, 
19045,1848,Rebif [22],2015-10-27,, ,MIU,['/Month'],IV, 
19046,1302,Tysabri,2016-06-09,2018-03-06,500,mg,['2 / Day'],IV,Lack of efficacy
19047,1302,Gilenya,2016-09-23,,1000,mg,['3 / Week'],Oral, 
19048,3222,Rebif [22],2016-04-07,,500,mg,['/Month'],IV, 
19049,3222,Rebif [44],2016-09-29,2018-09-22, ,mg,['2 / Day'], ,Persisting MRI activity
19050,4926,Methylprednisolone,2016-06-13,,300,MIU,['2 / Day'],IV, 
19051,4926,Rebif [22],2016-08-05,2020-09-05,500,MIU,['2 / Day'],Oral,Adverse Event
19052,4601,Copaxone,2016-07-11,, ,mg,['2 / Day'], , 
19053,4601,Alemtuzumab (Campath),2016-08-31,,500, ,['2 / Day'],Oral, 
19054,4601,Endoxan,2016-05-30,2020-11-04,500,mg,['/Month'],IV,Persistence of relapses
19055,4601,Tecfidera,2016-01-10,2020-11-06, ,mg,['3 / Week'],IV,Patient Choice/Convenience
19056,3550,D-cure (Vitamine D),2016-04-08,2019-05-05,300,MIU,['/ Day'],IV,Lack of efficacy
19057,3550,D-cure (Vitamine D),2016-03-08,2018-02-11,1,mcg,['3 / Week'],IV,Lack of efficacy
19058,4991,Rebif [22],2015-12-15,2019-09-18, ,mg,['2 / Day'],Oral,Adverse Event
19059,4991,Tecfidera,2016-09-29,2021-09-02, ,mg,['/Month'],IV,Persistence of relapses
19060,4991,IVIG,2015-11-29,,1000, ,['2 / Day'],IV, 
19061,4991,Betaferon,2015-11-25,2018-08-24,1,mg,['2 / Day'], ,Lack of efficacy
19062,1984,Avonex,2016-06-13,2018-08-21,300,MIU,[' '],IV,Lack of efficacy
19063,1984,Methylprednisolone,2016-10-08,2018-03-03, ,mg,['2 / Day'],IV,Lack of efficacy
19064,3164,Tysabri,2016-06-11,2018-08-27,1000,mg,['2 / Day'],IV,Lack of efficacy
19065,3164,Endoxan,2016-09-02,2021-02-17,5000, ,['/Month'],IV,Lack of efficacy
19066,3164,Tecfidera,2016-01-16,, ,mcg,['3 / Week'],IV, 
19067,953,Endoxan,2016-07-24,2021-08-26, ,mg,['/Month'], ,Patient Choice/Convenience
19068,953,Rebif [22],2016-04-14,2018-05-27,1,mg,['/ Week'],Oral,Adverse Event
19069,953,Methylprednisolone,2016-02-14,2019-07-03,300, ,['/Month'], ,Persisting MRI activity
19070,3181,IVIG,2016-05-19,2018-03-15,500,mg,['/ Week'],IV,Persistence of relapses
19071,3181,Rebif [22],2016-04-19,, , ,['/ Day'],Oral, 
19072,3181,D-cure (Vitamine D),2016-04-17,,1000,MIU,['/Month'], , 
19073,2356,Mitoxantrone,2016-07-26,, , ,[' '],IV, 
19074,2356,Avonex,2016-01-13,, , ,['3 / Week'],IV, 
19075,2356,Copaxone,2016-01-31,,300, ,['2 / Day'],IV, 
19076,1800,Rebif [22],2016-05-06,2020-11-16, , ,['2 / Day'],IV,Adverse Event
19077,785,Methylprednisolone,2016-01-25,2020-09-02,1000, ,[' '], ,Patient Choice/Convenience
19078,785,Betaferon,2016-04-24,,300,mcg,['2 / Day'],IV, 
19079,785,Betaferon,2016-02-14,2019-12-06,500,mcg,['2 / Day'], ,Adverse Event
19080,2175,Betaferon,2016-06-28,,500, ,['3 / Week'],IV, 
19081,2175,IVIG,2016-07-26,, ,mg,['3 / Week'], , 
19082,2175,Copaxone,2016-05-26,2020-07-14,300,mg,['/Month'], ,Adverse Event
19083,4820,D-cure (Vitamine D),2016-04-24,,500, ,['2 / Day'], , 
19084,466,D-cure (Vitamine D),2016-05-15,2019-10-31,5000,mg,['2 / Day'], ,Patient Choice/Convenience
19085,466,Tysabri,2016-02-26,2019-05-25,1, ,['/Month'], ,Adverse Event
19086,466,Gilenya,2016-02-28,2020-10-20,500,MIU,['2 / Day'],IV,Persisting MRI activity
19087,926,Tecfidera,2016-04-27,,300,mcg,['/Month'], , 
19088,926,Copaxone,2016-08-08,2021-09-20,20, ,['3 / Week'],IV,Persistence of relapses
19089,926,Avonex,2016-10-18,2019-05-24,1, ,['/Month'], ,Persistence of relapses
19090,926,Tecfidera,2015-12-12,2020-09-02, , ,['/Month'], ,Persisting MRI activity
19091,2118,IVIG,2016-04-21,2019-11-09, , ,['3 / Week'],Oral,Patient Choice/Convenience
19092,2118,Betaferon,2016-06-26,2021-01-12,500,mcg,['/Month'], ,Persistence of relapses
19093,2118,IVIG,2016-07-14,2018-04-25,20,mcg,['/Month'],IV,Adverse Event
19094,4877,Rebif [44],2016-01-05,2019-02-27, , ,[' '], ,Persisting MRI activity
19095,4877,Rebif [44],2016-06-08,, ,mg,[' '],IV, 
19096,736,Gilenya,2016-02-16,2018-06-21,300,mg,['/ Day'],IV,Adverse Event
19097,736,Rebif [44],2016-02-06,,1000,mg,['/ Week'],Oral, 
19098,736,D-cure (Vitamine D),2016-04-26,, ,MIU,['3 / Week'],Oral, 
19099,108,Betaferon,2016-09-13,2018-06-06,1000, ,['2 / Day'],IV,Persisting MRI activity
19100,3323,Gilenya,2016-01-04,,500,mg,['/Month'],IV, 
19101,3323,D-cure (Vitamine D),2015-12-10,,5000,MIU,['2 / Day'], , 
19102,3323,Teriflunomide,2016-09-12,, ,mcg,['/Month'],IV, 
19103,3323,Teriflunomide,2016-05-17,,300, ,['/Month'],IV, 
19104,4214,Rebif [44],2016-03-17,, ,mg,['/Month'],IV, 
19105,4214,Rebif [44],2016-04-30,2018-03-08,5000,MIU,['2 / Day'], ,Persisting MRI activity
19106,551,Ledertrexaat,2016-08-26,,500, ,['3 / Week'],IV, 
19107,551,Rebif [22],2016-03-10,,400, ,['/Month'], , 
19108,551,Gilenya,2016-03-16,, ,mg,['3 / Week'], , 
19109,2511,Alemtuzumab (Campath),2015-11-21,,400,mg,['2 / Day'],IV, 
19110,2511,IVIG,2016-06-04,2019-09-05, , ,[' '],IV,Patient Choice/Convenience
19111,2511,Methylprednisolone,2016-05-21,, , ,['2 / Day'], , 
19112,2511,Tysabri,2016-06-22,,500, ,['2 / Day'], , 
19113,2720,D-cure (Vitamine D),2016-08-19,,300,mg,['/Month'], , 
19114,2720,D-cure (Vitamine D),2015-11-14,2020-03-28,300, ,['/ Week'],IV,Patient Choice/Convenience
19115,3490,Methylprednisolone,2015-12-25,2018-05-13,1,mg,['2 / Day'],IV,Lack of efficacy
19116,3490,Rebif [22],2015-11-18,2019-04-08, ,mg,['2 / Day'], ,Lack of efficacy
19117,551,D-cure (Vitamine D),2015-11-18,2019-01-05,1,MIU,[' '], ,Adverse Event
19118,2228,Teriflunomide,2016-07-20,,1000,mg,['2 / Day'],Oral, 
19119,2228,Methylprednisolone,2016-01-27,2021-01-13,400, ,['/Month'],IV,Adverse Event
19120,4213,Methylprednisolone,2016-10-15,,1,mg,['/Month'], , 
19121,4213,D-cure (Vitamine D),2016-03-06,2018-05-04,1000, ,['/ Day'],Oral,Persisting MRI activity
19122,4213,Rebif [22],2016-03-15,, , ,['/Month'],IV, 
19123,215,Ledertrexaat,2016-09-30,,1000,mg,[' '],IV, 
19124,1481,Gilenya,2016-05-08,2021-09-14,1000, ,['3 / Week'], ,Adverse Event
19125,1481,Teriflunomide,2016-06-02,2018-12-25,1000,mg,['/Month'],IV,Patient Choice/Convenience
19126,680,Alemtuzumab (Campath),2015-12-05,,20,mg,['2 / Day'],IV, 
19127,3118,D-cure (Vitamine D),2016-10-11,,20,MIU,['2 / Day'],IV, 
19128,3118,Tecfidera,2016-07-29,,20,mg,[' '], , 
19129,3118,D-cure (Vitamine D),2016-03-16,, , ,['/Month'], , 
19130,3118,Rebif [44],2016-08-28,,5000, ,['3 / Week'], , 
19131,1450,Tecfidera,2016-01-10,2021-08-14, ,mg,['3 / Week'],IV,Patient Choice/Convenience
19132,1450,IVIG,2016-03-03,,5000, ,['/Month'],IV, 
19133,1450,Endoxan,2016-04-09,2021-02-20, ,mg,['/ Day'], ,Persisting MRI activity
19134,4713,Alemtuzumab (Campath),2016-02-22,,1000,mg,['/Month'],IV, 
19135,4713,Copaxone,2016-02-10,,5000, ,['2 / Day'], , 
19136,4713,Mitoxantrone,2016-05-10,2019-05-14, ,mg,['2 / Day'], ,Patient Choice/Convenience
19137,4713,Rebif [44],2015-12-03,,300,mg,['2 / Day'], , 
19138,1183,Tecfidera,2016-05-20,2021-05-24, ,mg,[' '],IV,Adverse Event
19139,1183,Alemtuzumab (Campath),2016-04-13,,300,mg,['/Month'], , 
19140,1183,Tysabri,2016-03-01,2019-08-10,400,mg,['/Month'], ,Patient Choice/Convenience
19141,1183,Tecfidera,2016-01-30,2018-12-13,300,mg,['/Month'], ,Persisting MRI activity
19142,1605,Mitoxantrone,2016-05-04,, , ,['/Month'],IV, 
19143,1605,Alemtuzumab (Campath),2016-01-30,2020-12-07,300, ,['2 / Day'],Oral,Lack of efficacy
19144,4388,Betaferon,2016-10-19,,5000,MIU,['/Month'],IV, 
19145,4388,Tecfidera,2015-11-12,, ,MIU,['2 / Day'], , 
19146,4388,Rebif [44],2016-01-03,2020-04-17,500,mg,['2 / Day'],IV,Lack of efficacy
19147,4388,Avonex,2015-10-25,2019-08-18,1000,mcg,['2 / Day'], ,Persisting MRI activity
19148,2554,Tecfidera,2016-07-21,2019-08-02,500, ,['2 / Day'],IV,Persistence of relapses
19149,2554,Methylprednisolone,2016-10-07,, ,mg,['/Month'],IV, 
19150,3468,Tysabri,2016-01-05,,500,mg,['/Month'],IV, 
19151,539,Gilenya,2015-12-27,,300,mg,['/Month'],IV, 
19152,539,Tecfidera,2016-05-20,, , ,['/Month'], , 
19153,539,Avonex,2016-05-07,2018-07-19,400,mg,['/Month'], ,Adverse Event
19154,539,Methylprednisolone,2016-10-11,2020-06-14,1000,mg,[' '], ,Adverse Event
19155,3712,Methylprednisolone,2015-10-24,, , ,['/Month'],IV, 
19156,3712,Ledertrexaat,2016-08-05,,500,mg,['/ Day'],IV, 
19157,4170,Tecfidera,2016-08-02,, , ,['/ Week'],IV, 
19158,2966,Tecfidera,2016-05-26,,400,mg,['2 / Day'],IV, 
19159,1268,Betaferon,2016-02-26,2021-08-22,5000,mcg,[' '],IV,Adverse Event
19160,4795,Tysabri,2016-02-24,, ,mg,['/Month'], , 
19161,4795,Alemtuzumab (Campath),2016-04-29,, ,mg,['/ Week'],IV, 
19162,4795,Copaxone,2016-10-11,,5000,mcg,['2 / Day'],Oral, 
19163,4795,Rebif [44],2016-05-11,2021-06-15,20,mg,['/Month'],IV,Persisting MRI activity
19164,4029,IVIG,2016-10-16,2019-04-06,1,mg,['/Month'],IV,Lack of efficacy
19165,4029,Teriflunomide,2016-03-06,2017-10-29,5000,mcg,['/ Day'],IV,Adverse Event
19166,4943,IVIG,2015-11-14,,1, ,['3 / Week'], , 
19167,332,IVIG,2016-05-07,, ,MIU,['3 / Week'], , 
19168,332,D-cure (Vitamine D),2016-03-03,2021-08-08, ,mg,['3 / Week'], ,Persisting MRI activity
19169,332,D-cure (Vitamine D),2015-11-07,2018-08-29,5000, ,['/Month'],IV,Persisting MRI activity
19170,332,Endoxan,2016-04-18,, , ,['/Month'],Oral, 
19171,4440,Methylprednisolone,2016-03-29,,20, ,[' '], , 
19172,4440,Teriflunomide,2016-03-01,,300,MIU,['/Month'],Oral, 
19173,1371,D-cure (Vitamine D),2016-03-05,2018-12-21,5000, ,['/ Day'],IV,Lack of efficacy
19174,4309,Teriflunomide,2016-05-14,2020-08-18,20, ,['2 / Day'],Oral,Persisting MRI activity
19175,4309,IVIG,2016-05-18,, ,mg,['/ Week'], , 
19176,4309,Methylprednisolone,2016-07-16,,1000,mcg,['/ Day'], , 
19177,4309,Rebif [22],2016-07-23,, ,mcg,['2 / Day'], , 
19178,2667,D-cure (Vitamine D),2015-11-24,2018-01-22,5000,mg,['3 / Week'],IV,Persistence of relapses
19179,2667,Betaferon,2016-04-25,, ,mg,[' '],IV, 
19180,2667,Endoxan,2016-10-20,2020-03-21,1,mg,['/Month'],IV,Patient Choice/Convenience
19181,2667,Endoxan,2016-05-27,, ,mg,['/Month'], , 
19182,1398,Rebif [22],2016-01-19,2018-04-07,500,MIU,[' '],IV,Adverse Event
19183,1398,Ledertrexaat,2015-12-27,,5000, ,['2 / Day'],IV, 
19184,1398,Tysabri,2016-03-21,2019-12-14, ,mcg,['3 / Week'],IV,Adverse Event
19185,2078,D-cure (Vitamine D),2016-02-19,,500,mg,['/ Day'],IV, 
19186,2078,Teriflunomide,2016-02-28,2019-03-13,1000,mg,['/Month'], ,Adverse Event
19187,2078,Tysabri,2015-11-15,, , ,['/Month'], , 
19188,479,D-cure (Vitamine D),2016-06-30,, ,MIU,['3 / Week'], , 
19189,479,Mitoxantrone,2015-12-29,,1, ,['2 / Day'],IV, 
19190,2215,D-cure (Vitamine D),2015-11-12,2020-05-24, ,mg,[' '],IV,Adverse Event
19191,1267,Endoxan,2016-10-10,,500,MIU,[' '],IV, 
19192,1267,Alemtuzumab (Campath),2016-04-23,2021-05-05,400, ,['3 / Week'],IV,Lack of efficacy
19193,533,Tecfidera,2016-06-05,,500, ,['2 / Day'], , 
19194,533,IVIG,2016-09-16,2018-07-12, ,mg,['2 / Day'],Oral,Adverse Event
19195,3072,Betaferon,2016-02-09,2019-01-14,400, ,['3 / Week'], ,Persisting MRI activity
19196,3072,Methylprednisolone,2016-02-07,,500, ,['2 / Day'],IV, 
19197,969,Methylprednisolone,2016-08-17,,5000,mcg,['2 / Day'], , 
19198,969,D-cure (Vitamine D),2016-03-10,,5000,mg,[' '], , 
19199,3141,Methylprednisolone,2016-10-16,2021-04-27,20,mg,['2 / Day'], ,Lack of efficacy
19200,3141,Rebif [22],2016-03-09,,1, ,[' '],Oral, 
19201,186,Teriflunomide,2016-02-14,, ,mcg,['2 / Day'], , 
19202,4613,Rebif [44],2015-12-17,, ,MIU,['/Month'], , 
19203,4613,Betaferon,2016-03-21,2018-09-04,400, ,['2 / Day'],Oral,Persisting MRI activity
19204,4613,D-cure (Vitamine D),2015-12-22,2019-08-01,1000, ,['/Month'],Oral,Lack of efficacy
19205,3621,Rebif [44],2015-11-28,2018-10-18, , ,['2 / Day'], ,Persisting MRI activity
19206,4498,IVIG,2016-06-11,,5000,mg,['/Month'],IV, 
19207,173,Gilenya,2016-09-15,, ,mg,['/ Day'], , 
19208,173,Tysabri,2016-09-10,2021-04-30,20,MIU,['3 / Week'], ,Adverse Event
19209,173,Rebif [22],2016-07-19,2021-04-20, , ,[' '], ,Patient Choice/Convenience
19210,173,Teriflunomide,2016-07-04,2018-12-03,1,mcg,['/Month'], ,Patient Choice/Convenience
19211,2122,IVIG,2016-08-26,,500,mg,[' '],IV, 
19212,2122,Avonex,2016-04-04,2021-09-07, , ,['3 / Week'], ,Adverse Event
19213,2261,Rebif [44],2016-09-23,2020-04-27, ,mcg,['3 / Week'],IV,Lack of efficacy
19214,2261,Teriflunomide,2016-01-29,2020-10-11,5000, ,['3 / Week'],IV,Adverse Event
19215,764,Ledertrexaat,2016-03-10,,500, ,['2 / Day'], , 
19216,462,Ledertrexaat,2016-02-19,2021-08-02,500,mcg,['/ Week'],IV,Adverse Event
19217,2350,Copaxone,2015-11-03,,400,mg,[' '],IV, 
19218,2350,Rebif [22],2016-02-10,,400,mg,[' '],Oral, 
19219,4424,Rebif [22],2016-05-03,,1, ,['2 / Day'], , 
19220,4424,IVIG,2016-02-09,2018-04-27, ,mg,['/Month'],Oral,Persisting MRI activity
19221,4424,D-cure (Vitamine D),2016-10-01,,500,mg,['/ Week'], , 
19222,4424,Tysabri,2016-02-07,,1, ,['/Month'], , 
19223,4295,Gilenya,2016-05-06,, , ,['/Month'], , 
19224,4295,Ledertrexaat,2016-10-09,,400,mcg,[' '],IV, 
19225,4295,IVIG,2016-03-10,,1000,mg,['/ Day'], , 
19226,4853,Endoxan,2016-01-31,, , ,['2 / Day'], , 
19227,4853,Avonex,2016-08-21,,20,mg,['/ Week'],IV, 
19228,4853,Copaxone,2015-11-14,2020-11-30, , ,['2 / Day'],IV,Persistence of relapses
19229,4853,Methylprednisolone,2016-04-16,, ,mg,['/Month'],IV, 
19230,4201,Methylprednisolone,2016-06-07,2021-05-14, , ,['2 / Day'], ,Persisting MRI activity
19231,1276,Methylprednisolone,2016-04-30,,300, ,['2 / Day'],IV, 
19232,2914,Tecfidera,2016-06-17,2020-07-27,20, ,['/Month'], ,Patient Choice/Convenience
19233,2914,Endoxan,2016-06-05,,1000, ,['/Month'],Oral, 
19234,2914,Gilenya,2016-09-15,,300,mg,['3 / Week'], , 
19235,4635,Gilenya,2016-01-31,2018-10-11, , ,['/Month'],IV,Persistence of relapses
19236,4635,Methylprednisolone,2016-03-05,, ,mg,['/Month'],IV, 
19237,4635,Rebif [22],2016-07-18,,500,MIU,['/Month'],IV, 
19238,641,Methylprednisolone,2016-02-10,, ,mg,['/Month'], , 
19239,641,Teriflunomide,2016-08-03,2019-08-01,500,mg,['2 / Day'], ,Adverse Event
19240,641,Tecfidera,2016-10-13,,1,mg,['2 / Day'],IV, 
19241,641,Copaxone,2016-03-15,2021-05-17,1000,mcg,['/ Week'],Oral,Patient Choice/Convenience
19242,2384,Alemtuzumab (Campath),2016-10-07,2020-04-05,5000, ,['/Month'],IV,Adverse Event
19243,2384,Tysabri,2016-05-21,2019-12-20, , ,['2 / Day'],Oral,Lack of efficacy
19244,2384,Endoxan,2016-04-27,,1000,MIU,['/ Day'],IV, 
19245,1191,IVIG,2016-07-09,2018-06-15,400,mg,['2 / Day'],Oral,Persisting MRI activity
19246,1191,Rebif [44],2016-04-25,,1000, ,['2 / Day'], , 
19247,1191,Mitoxantrone,2016-08-12,,20,MIU,['/Month'], , 
19248,4786,D-cure (Vitamine D),2015-11-15,,1000,MIU,['/Month'],IV, 
19249,4127,Gilenya,2015-11-16,,1,mg,[' '],Oral, 
19250,4127,Alemtuzumab (Campath),2015-12-25,,1,mg,['/Month'],IV, 
19251,4622,Rebif [44],2016-03-24,2019-10-28, ,mg,['/Month'],IV,Patient Choice/Convenience
19252,4622,Avonex,2016-01-26,2021-05-30,1, ,[' '],IV,Adverse Event
19253,4734,Teriflunomide,2016-01-19,,1,mg,['/ Day'],Oral, 
19254,4734,Gilenya,2016-08-15,, , ,['2 / Day'],Oral, 
19255,4734,Rebif [44],2016-04-15,,1,MIU,['2 / Day'], , 
19256,4734,Ledertrexaat,2016-05-22,,300, ,['3 / Week'], , 
19257,2358,Endoxan,2016-08-04,,5000, ,['/Month'],IV, 
19258,2358,IVIG,2016-08-15,, ,mg,['/Month'],IV, 
19259,2617,Tysabri,2016-07-12,,5000,MIU,['2 / Day'], , 
19260,2617,IVIG,2016-04-24,,1000,mcg,['/Month'],IV, 
19261,2604,Rebif [44],2016-05-16,, ,MIU,['/ Day'], , 
19262,464,Gilenya,2016-05-24,2017-11-05,1,MIU,['/Month'], ,Patient Choice/Convenience
19263,464,Gilenya,2016-08-09,,1000,mg,['2 / Day'], , 
19264,464,Ledertrexaat,2016-01-30,,300,MIU,['/Month'],IV, 
19265,464,Tecfidera,2016-08-05,,1,mg,['3 / Week'], , 
19266,1340,Betaferon,2016-03-01,,1,MIU,['3 / Week'], , 
19267,1340,IVIG,2016-09-20,,5000, ,['/Month'],IV, 
19268,1340,Gilenya,2016-05-09,2020-07-27, , ,['2 / Day'], ,Adverse Event
19269,1340,Tecfidera,2016-06-13,,20,mg,['2 / Day'],IV, 
19270,2398,Avonex,2016-08-29,2020-02-26,500,mg,['2 / Day'], ,Persistence of relapses
19271,2398,Endoxan,2016-07-06,,1000,mg,['2 / Day'], , 
19272,3713,Endoxan,2016-06-27,2021-02-22, , ,['2 / Day'],IV,Persisting MRI activity
19273,476,Copaxone,2016-02-17,2020-10-02,20,mg,['/Month'], ,Adverse Event
19274,2999,Mitoxantrone,2016-01-11,, , ,['/ Week'],IV, 
19275,2999,D-cure (Vitamine D),2015-12-27,,1000,mg,['3 / Week'], , 
19276,2999,Avonex,2016-08-17,,5000,mg,['/Month'],Oral, 
19277,4003,Tysabri,2016-04-10,2020-09-20,300, ,['/Month'], ,Persistence of relapses
19278,4003,Tysabri,2016-02-26,,500,mg,['/Month'],Oral, 
19279,1952,Tecfidera,2016-03-21,2020-11-26,500,mg,['2 / Day'],IV,Adverse Event
19280,1952,Rebif [22],2016-10-17,2019-09-16,1000,MIU,['2 / Day'],IV,Adverse Event
19281,1952,D-cure (Vitamine D),2016-06-22,2021-07-24,500,MIU,['/Month'],IV,Adverse Event
19282,1952,Tysabri,2016-06-30,, , ,['3 / Week'],Oral, 
19283,1120,Alemtuzumab (Campath),2016-09-07,2018-03-05, ,mg,['/ Day'], ,Lack of efficacy
19284,1120,Copaxone,2016-08-30,2020-07-12,1000,mcg,['2 / Day'],IV,Adverse Event
19285,1120,Alemtuzumab (Campath),2016-09-13,2017-11-21, ,mg,['3 / Week'], ,Persisting MRI activity
19286,1120,IVIG,2016-07-27,2018-12-02,1000, ,['/Month'],IV,Adverse Event
19287,590,Avonex,2015-12-02,, , ,['2 / Day'],IV, 
19288,590,Methylprednisolone,2015-12-29,2018-05-25, , ,['/Month'],IV,Patient Choice/Convenience
19289,590,Alemtuzumab (Campath),2016-02-03,2018-01-26, ,mg,['/Month'],IV,Persistence of relapses
19290,590,IVIG,2016-09-10,2018-12-08,5000, ,['2 / Day'], ,Persisting MRI activity
19291,1264,Rebif [44],2016-02-25,,1, ,['3 / Week'],IV, 
19292,1264,D-cure (Vitamine D),2016-06-08,2020-02-15, ,MIU,['/Month'],Oral,Adverse Event
19293,1264,Betaferon,2016-04-04,,1000, ,['2 / Day'], , 
19294,2082,IVIG,2016-09-08,, , ,['/Month'],IV, 
19295,2082,Endoxan,2016-06-19,,500,mcg,['/Month'],IV, 
19296,569,Endoxan,2016-09-24,2018-05-28, ,mg,['/Month'],Oral,Patient Choice/Convenience
19297,569,Ledertrexaat,2016-01-15,, ,mg,['/ Week'],IV, 
19298,569,D-cure (Vitamine D),2016-03-13,2018-10-31,5000,mg,['/ Day'],IV,Adverse Event
19299,3752,Mitoxantrone,2016-06-12,2018-04-09,1,mg,['2 / Day'],Oral,Persisting MRI activity
19300,3752,D-cure (Vitamine D),2016-01-31,,1,mg,['2 / Day'],IV, 
19301,3752,Rebif [22],2016-01-10,,1000, ,['/ Day'], , 
19302,3752,Teriflunomide,2015-11-22,2021-09-10,500,mg,['/Month'],IV,Persisting MRI activity
19303,2252,Rebif [44],2016-08-05,,300,mg,['3 / Week'],IV, 
19304,2252,Gilenya,2016-01-28,2019-05-25,5000, ,['/Month'], ,Persisting MRI activity
19305,2252,Rebif [22],2016-05-03,2018-07-27,300,mg,['2 / Day'],IV,Adverse Event
19306,1688,Alemtuzumab (Campath),2016-10-16,,1,mg,['2 / Day'], , 
19307,1688,Tecfidera,2015-12-31,, ,MIU,['/Month'],IV, 
19308,765,D-cure (Vitamine D),2015-11-07,,300, ,['/ Day'],IV, 
19309,765,Tysabri,2015-11-18,,1000,mg,['2 / Day'], , 
19310,1389,Copaxone,2016-09-02,,1, ,['/Month'],IV, 
19311,3793,Tysabri,2016-04-07,2019-09-04,1000, ,[' '], ,Adverse Event
19312,3793,Tecfidera,2016-03-02,,1000, ,['/ Day'], , 
19313,3793,Teriflunomide,2016-07-08,2018-07-06,20,mcg,['/ Day'],IV,Persisting MRI activity
19314,3793,IVIG,2016-10-13,2019-08-19,1,mg,['2 / Day'], ,Lack of efficacy
19315,1263,Tecfidera,2016-07-23,2018-07-16,5000,mg,['3 / Week'],IV,Persisting MRI activity
19316,743,Rebif [22],2015-11-09,,1000,mg,['/Month'],IV, 
19317,743,Endoxan,2015-11-05,,1,mg,['2 / Day'],IV, 
19318,743,Methylprednisolone,2016-01-21,2017-11-11,5000,MIU,['/Month'],IV,Persisting MRI activity
19319,4385,Tysabri,2016-07-31,,20, ,['/Month'],IV, 
19320,4385,Tysabri,2015-11-02,2021-06-20,1, ,['2 / Day'],IV,Persisting MRI activity
19321,4385,Avonex,2016-02-26,2019-06-03, ,MIU,['3 / Week'], ,Patient Choice/Convenience
19322,4385,Tysabri,2015-11-04,2018-12-04,400, ,['/Month'],IV,Persisting MRI activity
19323,3657,IVIG,2015-12-22,2018-09-16,300,MIU,['/Month'], ,Adverse Event
19324,3657,Copaxone,2016-09-01,, , ,[' '], , 
19325,3657,Gilenya,2016-01-16,,1, ,['/Month'], , 
19326,4550,Alemtuzumab (Campath),2016-05-04,2019-07-13, ,MIU,['/Month'],IV,Persistence of relapses
19327,4550,D-cure (Vitamine D),2015-11-03,,1,mg,['/Month'],IV, 
19328,4550,Rebif [44],2016-08-31,2021-04-22,400,mg,['2 / Day'],IV,Persisting MRI activity
19329,2101,Rebif [44],2016-02-01,, ,mg,['/Month'],IV, 
19330,3205,IVIG,2016-01-23,2018-06-26,20,mcg,['3 / Week'], ,Adverse Event
19331,3205,Ledertrexaat,2016-09-19,2018-05-04,1,mg,['2 / Day'],IV,Lack of efficacy
19332,3205,Avonex,2016-01-10,,500,mg,['/Month'],IV, 
19333,978,Tysabri,2015-11-23,,1000, ,['/Month'],IV, 
19334,978,Betaferon,2016-07-02,, ,mg,['/Month'],IV, 
19335,978,Rebif [22],2016-08-06,2020-03-01, ,mg,['/Month'], ,Adverse Event
19336,834,D-cure (Vitamine D),2016-06-17,2019-12-30,1000,mg,['/Month'],IV,Lack of efficacy
19337,546,IVIG,2015-12-02,,500,MIU,['2 / Day'], , 
19338,432,Copaxone,2016-04-11,2019-12-30,20,MIU,['/Month'],IV,Patient Choice/Convenience
19339,278,Tysabri,2016-03-26,2021-09-23,20, ,[' '],IV,Persisting MRI activity
19340,278,Gilenya,2016-02-18,,300,mg,['2 / Day'],IV, 
19341,278,Methylprednisolone,2015-11-15,2018-10-12,20,mcg,[' '],IV,Adverse Event
19342,2518,Endoxan,2016-08-15,,400, ,['2 / Day'],IV, 
19343,2518,Alemtuzumab (Campath),2016-06-27,,1000, ,['3 / Week'],IV, 
19344,3820,Gilenya,2016-08-16,2020-08-12,20, ,['2 / Day'],IV,Adverse Event
19345,3820,IVIG,2016-03-20,, ,mcg,['3 / Week'], , 
19346,3820,Betaferon,2016-08-10,2020-04-27,1000,mg,['2 / Day'], ,Lack of efficacy
19347,1611,Copaxone,2016-08-11,, ,mg,['/Month'],IV, 
19348,1611,Teriflunomide,2016-04-09,2020-03-06,1000,mg,['2 / Day'],IV,Lack of efficacy
19349,1775,Methylprednisolone,2016-03-07,2019-03-08,5000, ,['/ Week'],IV,Lack of efficacy
19350,1775,IVIG,2016-04-05,,500,mcg,['/Month'],IV, 
19351,1775,Tecfidera,2015-12-20,2018-04-21,1000,mg,['/ Day'], ,Adverse Event
19352,1775,Methylprednisolone,2016-02-09,,20,mcg,['/Month'],IV, 
19353,3987,Alemtuzumab (Campath),2016-01-21,,5000,mg,[' '], , 
19354,3987,D-cure (Vitamine D),2016-02-14,,1000,mcg,['2 / Day'],IV, 
19355,3987,D-cure (Vitamine D),2016-07-18,2019-11-05,1000,mg,['2 / Day'], ,Patient Choice/Convenience
19356,1510,Gilenya,2016-07-07,2018-02-09,1000,mg,[' '],IV,Persisting MRI activity
19357,787,Tecfidera,2016-02-23,2020-12-13,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
19358,787,Alemtuzumab (Campath),2016-06-24,,300, ,['/ Day'], , 
19359,787,Tysabri,2016-01-16,,500,mg,['2 / Day'],IV, 
19360,3307,Tecfidera,2016-02-13,2018-12-14,300, ,['2 / Day'],Oral,Adverse Event
19361,2384,Methylprednisolone,2016-06-07,2017-11-07,5000,MIU,[' '],IV,Patient Choice/Convenience
19362,2384,Rebif [44],2016-09-23,,20, ,['/ Day'], , 
19363,1234,Tysabri,2016-09-01,,20, ,['/Month'],Oral, 
19364,1234,Methylprednisolone,2016-10-21,2019-03-26,400, ,['/ Week'],IV,Adverse Event
19365,1234,Tecfidera,2016-08-10,,1000,mg,['/Month'], , 
19366,3689,Rebif [44],2016-05-04,,5000,mg,['/Month'], , 
19367,3689,Rebif [44],2016-07-31,,1,mg,['2 / Day'],IV, 
19368,3791,Rebif [44],2016-09-30,,500,mg,['/Month'],IV, 
19369,3791,Gilenya,2016-10-22,,500, ,[' '],IV, 
19370,3791,D-cure (Vitamine D),2016-09-23,,1000, ,['/Month'],Oral, 
19371,4277,Rebif [22],2016-03-29,2019-10-02,300,MIU,['2 / Day'],IV,Adverse Event
19372,4461,Teriflunomide,2016-07-02,,20,mg,['2 / Day'],IV, 
19373,1599,Gilenya,2016-04-18,,500, ,['2 / Day'],Oral, 
19374,1599,Tysabri,2016-01-17,,400,mg,['/ Day'], , 
19375,1599,Tecfidera,2016-09-26,,1, ,['3 / Week'], , 
19376,1691,Avonex,2016-08-09,, , ,['/ Day'], , 
19377,1691,Rebif [44],2015-11-27,2018-10-06,400, ,['2 / Day'],IV,Lack of efficacy
19378,2371,Tysabri,2016-08-21,, , ,['2 / Day'], , 
19379,2371,D-cure (Vitamine D),2016-01-17,,5000,mg,['/Month'], , 
19380,2371,Rebif [44],2016-05-21,,500, ,['2 / Day'],IV, 
19381,2371,Rebif [22],2016-07-29,,1,MIU,['/Month'], , 
19382,3824,IVIG,2016-10-11,,300,mg,['/Month'],Oral, 
19383,3824,Rebif [22],2016-07-12,2021-07-22, , ,['/ Day'], ,Patient Choice/Convenience
19384,4692,Betaferon,2016-04-04,2020-10-29,1, ,['/Month'],Oral,Persisting MRI activity
19385,4685,Betaferon,2016-03-05,,20, ,['/Month'],Oral, 
19386,1473,D-cure (Vitamine D),2016-06-30,,1000,MIU,[' '], , 
19387,1473,Alemtuzumab (Campath),2016-07-28,, ,mg,['/Month'],IV, 
19388,1855,D-cure (Vitamine D),2016-07-28,,300,mg,['/ Week'], , 
19389,1855,Alemtuzumab (Campath),2015-11-14,,1000,mg,['/Month'],IV, 
19390,1855,Rebif [22],2016-03-03,2020-08-15,1, ,['2 / Day'],IV,Adverse Event
19391,1855,Tecfidera,2016-01-19,, ,mg,['3 / Week'],IV, 
19392,651,D-cure (Vitamine D),2016-01-01,,500,MIU,['/Month'],IV, 
19393,4444,Gilenya,2016-07-14,,1000, ,['2 / Day'],Oral, 
19394,4444,Gilenya,2016-07-17,2019-05-28,300,mg,['2 / Day'],IV,Lack of efficacy
19395,3077,Teriflunomide,2016-04-02,, ,mg,['/Month'],IV, 
19396,3077,Teriflunomide,2016-08-19,2021-05-07,300,mg,['3 / Week'], ,Adverse Event
19397,3077,Gilenya,2016-08-10,2019-06-07,20,mg,['/Month'], ,Patient Choice/Convenience
19398,3077,Gilenya,2016-03-10,,20, ,['/Month'],IV, 
19399,2327,Rebif [44],2016-09-12,, , ,['/Month'], , 
19400,4105,Tysabri,2016-06-17,, ,mg,['/ Day'],IV, 
19401,4105,Mitoxantrone,2016-01-10,2019-07-19,300, ,['3 / Week'],IV,Adverse Event
19402,846,Endoxan,2015-12-12,2021-06-01, , ,[' '], ,Persistence of relapses
19403,3334,Rebif [44],2016-05-14,2017-11-17,300,mg,['2 / Day'],IV,Lack of efficacy
19404,3334,Avonex,2015-11-30,2018-12-17,5000,mg,['2 / Day'], ,Persisting MRI activity
19405,3334,Rebif [22],2015-11-09,,1, ,['/Month'],IV, 
19406,3334,Alemtuzumab (Campath),2016-02-04,, ,mg,['2 / Day'],IV, 
19407,309,IVIG,2016-09-05,,1000, ,['/Month'], , 
19408,309,D-cure (Vitamine D),2015-11-10,,5000,mg,['/Month'], , 
19409,3713,Rebif [22],2016-01-09,2019-02-04,5000,mg,['/Month'],IV,Adverse Event
19410,2355,Tysabri,2016-09-26,,1,mg,['/Month'], , 
19411,2355,Tysabri,2016-10-20,2017-12-12,500,mg,['/Month'], ,Lack of efficacy
19412,2355,Rebif [22],2015-11-22,,400, ,['2 / Day'],Oral, 
19413,3272,Avonex,2016-10-20,,20, ,['/Month'], , 
19414,3272,Rebif [22],2015-12-31,, ,mg,['2 / Day'],IV, 
19415,3272,D-cure (Vitamine D),2016-04-18,2019-04-17,400, ,['2 / Day'], ,Patient Choice/Convenience
19416,3305,Rebif [44],2016-06-05,2018-05-27,1000,mg,['2 / Day'],IV,Patient Choice/Convenience
19417,3305,IVIG,2016-07-12,2019-03-15,300,MIU,['/Month'], ,Adverse Event
19418,3305,Rebif [44],2016-06-24,,1000, ,['/Month'],IV, 
19419,1262,Betaferon,2016-02-19,,400,mg,['2 / Day'],IV, 
19420,1262,Betaferon,2015-12-27,2020-03-20,1000,mg,['3 / Week'], ,Patient Choice/Convenience
19421,4841,Betaferon,2015-11-16,2021-10-03,1, ,['/Month'], ,Patient Choice/Convenience
19422,2848,IVIG,2016-10-16,,1000,mg,['/Month'], , 
19423,1691,Methylprednisolone,2015-12-12,,5000, ,['/Month'],IV, 
19424,1691,Alemtuzumab (Campath),2016-07-30,,300,mg,['/Month'],Oral, 
19425,1131,Copaxone,2016-09-06,,1000,mg,['2 / Day'], , 
19426,1131,Tysabri,2016-06-18,,500,mcg,['/Month'],IV, 
19427,1131,IVIG,2016-09-29,2018-11-04,1000,MIU,['3 / Week'],Oral,Patient Choice/Convenience
19428,4530,Rebif [22],2016-06-01,2019-11-20,1,MIU,['2 / Day'],Oral,Persisting MRI activity
19429,4530,Alemtuzumab (Campath),2016-10-11,,500, ,['/Month'],Oral, 
19430,2383,Mitoxantrone,2015-11-19,,500,mg,['/Month'], , 
19431,2383,IVIG,2016-10-17,, ,mg,['/Month'], , 
19432,2383,IVIG,2016-07-25,, , ,['2 / Day'],IV, 
19433,1505,Methylprednisolone,2016-09-15,,500, ,['3 / Week'], , 
19434,1505,D-cure (Vitamine D),2016-03-16,,5000,mg,['2 / Day'], , 
19435,1505,D-cure (Vitamine D),2016-01-28,,20,mg,['2 / Day'], , 
19436,837,Alemtuzumab (Campath),2016-02-22,,5000,mg,['/Month'],IV, 
19437,837,Copaxone,2015-11-26,,300, ,['2 / Day'],IV, 
19438,837,Alemtuzumab (Campath),2016-02-22,, , ,['3 / Week'], , 
19439,153,Betaferon,2016-08-11,,20,mg,['2 / Day'],Oral, 
19440,153,Rebif [22],2016-09-12,,1,mg,['/Month'], , 
19441,153,Ledertrexaat,2016-06-16,2021-05-19,300, ,['3 / Week'],IV,Patient Choice/Convenience
19442,153,Methylprednisolone,2016-06-26,,400,mg,['/Month'],Oral, 
19443,4738,Tecfidera,2015-12-08,, ,mg,['/Month'],IV, 
19444,4738,Rebif [44],2016-08-13,2018-11-13, ,mg,['/Month'], ,Adverse Event
19445,2748,Methylprednisolone,2016-05-04,2018-01-31,500,mg,['/Month'], ,Persistence of relapses
19446,3267,D-cure (Vitamine D),2016-08-26,,1,mg,['/Month'], , 
19447,3267,Betaferon,2016-07-21,2021-10-08,500,mg,['/Month'],IV,Persistence of relapses
19448,3267,Tysabri,2016-07-26,,400,MIU,['/Month'],IV, 
19449,3267,Alemtuzumab (Campath),2016-02-23,,500, ,['2 / Day'],IV, 
19450,4236,Tecfidera,2016-06-01,, ,mcg,['2 / Day'],Oral, 
19451,4236,Tecfidera,2015-10-27,2018-12-23, ,MIU,['/Month'], ,Patient Choice/Convenience
19452,4236,Methylprednisolone,2016-02-18,,1, ,['2 / Day'],Oral, 
19453,3871,Ledertrexaat,2016-04-12,,20,mg,['2 / Day'],IV, 
19454,3871,Gilenya,2016-05-09,2020-02-10,500,mcg,['/Month'],IV,Persisting MRI activity
19455,3871,D-cure (Vitamine D),2016-04-03,, ,mg,[' '], , 
19456,460,Endoxan,2016-04-03,, , ,['2 / Day'],Oral, 
19457,460,Rebif [44],2016-03-26,2018-04-27, ,mcg,['/Month'], ,Adverse Event
19458,460,Tecfidera,2016-02-28,,400,mg,[' '], , 
19459,460,Mitoxantrone,2016-07-02,, ,MIU,[' '], , 
19460,3468,Tecfidera,2015-12-21,,5000, ,['/Month'],IV, 
19461,3569,Rebif [22],2015-12-24,, , ,['2 / Day'], , 
19462,3569,Gilenya,2016-03-22,,1000,mg,['2 / Day'], , 
19463,3569,Copaxone,2016-04-20,2019-11-10,20, ,['2 / Day'], ,Adverse Event
19464,3569,Tecfidera,2016-07-29,2020-01-03, ,mcg,['/Month'], ,Patient Choice/Convenience
19465,2472,Rebif [44],2016-02-13,2021-03-23,400,mcg,['2 / Day'],IV,Patient Choice/Convenience
19466,2472,IVIG,2016-07-23,2019-06-06, ,mg,['/Month'], ,Persisting MRI activity
19467,2472,Copaxone,2016-04-06,,1000, ,['/Month'],IV, 
19468,2472,Tecfidera,2016-01-07,, , ,['/Month'],IV, 
19469,4286,Alemtuzumab (Campath),2016-06-05,,20, ,[' '],IV, 
19470,4286,Endoxan,2016-04-08,, , ,['2 / Day'],Oral, 
19471,2418,Tysabri,2016-01-21,,300,MIU,[' '], , 
19472,2418,Gilenya,2016-10-13,2021-08-02,1000, ,['/Month'], ,Adverse Event
19473,1958,Tecfidera,2016-08-06,,5000,mg,['2 / Day'], , 
19474,1958,Alemtuzumab (Campath),2016-05-01,2020-10-23,1,mg,['/Month'], ,Persisting MRI activity
19475,3387,Tecfidera,2016-01-25,2020-01-30,300, ,['2 / Day'],IV,Persistence of relapses
19476,4947,Gilenya,2015-11-05,,20, ,['3 / Week'],IV, 
19477,4947,Endoxan,2016-05-06,2020-09-03,300, ,['/Month'], ,Adverse Event
19478,4947,Ledertrexaat,2016-10-03,,400,mg,['/Month'],IV, 
19479,4947,D-cure (Vitamine D),2016-09-26,2021-08-01,1, ,['/ Day'],IV,Persisting MRI activity
19480,1569,Methylprednisolone,2015-12-07,, ,mg,['/ Day'], , 
19481,1569,Mitoxantrone,2016-01-18,2018-04-15, ,MIU,['/Month'], ,Persisting MRI activity
19482,1767,Rebif [44],2016-09-01,2019-05-06,500,mg,['/Month'], ,Patient Choice/Convenience
19483,1767,Rebif [22],2015-12-31,2018-10-25, ,MIU,['/Month'], ,Persisting MRI activity
19484,4346,Tysabri,2015-11-10,2021-08-02,1000, ,['/Month'], ,Adverse Event
19485,2293,Endoxan,2015-11-14,2019-12-16, , ,['/Month'],IV,Adverse Event
19486,130,Avonex,2015-12-14,, , ,['/ Day'],IV, 
19487,3351,Mitoxantrone,2016-03-10,2020-05-20,5000,MIU,['/ Day'], ,Adverse Event
19488,3351,Endoxan,2016-04-23,2017-10-27,1000,MIU,['3 / Week'],IV,Patient Choice/Convenience
19489,3644,Rebif [22],2015-11-14,,5000,mg,[' '], , 
19490,3644,Copaxone,2015-12-01,,5000,MIU,['/ Day'],Oral, 
19491,3644,Rebif [44],2016-07-24,,5000,MIU,['/Month'],IV, 
19492,308,Avonex,2015-11-10,2019-08-18,1000,mg,['3 / Week'], ,Patient Choice/Convenience
19493,308,D-cure (Vitamine D),2016-02-17,,5000,mg,['3 / Week'],Oral, 
19494,2973,Copaxone,2016-05-01,2018-05-29,500,MIU,[' '], ,Persistence of relapses
19495,2973,D-cure (Vitamine D),2016-03-03,,5000,mg,[' '], , 
19496,2973,IVIG,2016-02-17,,300,MIU,['/Month'],IV, 
19497,3383,Methylprednisolone,2016-10-01,2020-06-27,20,MIU,['/ Day'], ,Adverse Event
19498,3383,Tecfidera,2016-08-22,2020-12-13,1, ,['/Month'], ,Patient Choice/Convenience
19499,3383,Rebif [22],2016-01-25,, ,mg,['2 / Day'],Oral, 
19500,3151,Copaxone,2016-10-22,,300,mg,['2 / Day'], , 
19501,3151,Methylprednisolone,2015-11-11,,500,MIU,['/ Week'],IV, 
19502,3151,Rebif [44],2016-01-01,2019-02-12,500,mg,['2 / Day'],IV,Persisting MRI activity
19503,935,Alemtuzumab (Campath),2016-02-21,2020-11-09, ,mg,['3 / Week'],Oral,Adverse Event
19504,100,Gilenya,2015-12-01,,500, ,['3 / Week'],IV, 
19505,100,D-cure (Vitamine D),2016-10-13,2019-05-06,20, ,['2 / Day'],IV,Adverse Event
19506,100,Avonex,2016-03-12,2020-04-20,1000,MIU,['/Month'],IV,Patient Choice/Convenience
19507,979,Rebif [22],2016-06-29,, ,mg,['/Month'],Oral, 
19508,1683,D-cure (Vitamine D),2016-04-30,,1,mg,['/Month'],IV, 
19509,1683,D-cure (Vitamine D),2016-06-30,2021-03-26,20, ,['/ Week'], ,Adverse Event
19510,1683,Copaxone,2016-06-18,,300, ,['/ Week'],Oral, 
19511,1683,Rebif [22],2016-05-29,,20,mg,['/Month'],IV, 
19512,2756,Copaxone,2016-02-05,, ,mg,['/Month'],IV, 
19513,2756,D-cure (Vitamine D),2016-09-30,,400,mg,['/Month'], , 
19514,594,Gilenya,2016-04-02,2021-10-20, ,mcg,['/Month'],IV,Persistence of relapses
19515,594,Ledertrexaat,2016-06-04,,300, ,['3 / Week'], , 
19516,594,Endoxan,2016-04-07,,300, ,['/Month'],IV, 
19517,2253,Tecfidera,2016-04-18,,5000, ,['/ Week'],Oral, 
19518,2253,Avonex,2016-07-22,2021-02-19,5000,MIU,['/Month'],IV,Persisting MRI activity
19519,2253,Rebif [44],2016-02-16,,1000, ,['/Month'], , 
19520,2253,IVIG,2016-07-09,2021-01-21,5000,mg,[' '], ,Persisting MRI activity
19521,2678,Ledertrexaat,2016-01-09,2018-01-10,20, ,['/ Day'], ,Adverse Event
19522,2678,Gilenya,2016-09-12,,5000,mg,['3 / Week'],IV, 
19523,2678,Alemtuzumab (Campath),2016-10-14,,1000,MIU,['/Month'], , 
19524,2842,Rebif [22],2016-02-28,2021-01-02, ,mg,[' '], ,Persisting MRI activity
19525,2842,Rebif [22],2016-09-04,,1000, ,['/Month'],IV, 
19526,2842,Tecfidera,2016-02-03,2018-02-18,400,MIU,[' '],Oral,Persisting MRI activity
19527,2842,Gilenya,2016-09-07,2018-05-18, ,MIU,['/ Week'],Oral,Persisting MRI activity
19528,3462,Tysabri,2016-07-21,,500, ,['2 / Day'],IV, 
19529,3462,Alemtuzumab (Campath),2016-10-02,2021-03-24, ,MIU,['/Month'], ,Persisting MRI activity
19530,3462,Tysabri,2016-06-27,2020-07-17,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
19531,3462,IVIG,2016-09-22,,500,mg,['2 / Day'], , 
19532,4577,Betaferon,2016-10-14,2018-06-11, , ,['/Month'],IV,Adverse Event
19533,4577,Alemtuzumab (Campath),2016-08-12,,20,mcg,[' '],Oral, 
19534,4577,Betaferon,2016-03-25,,5000,mg,['2 / Day'],IV, 
19535,1555,Endoxan,2016-05-19,,5000, ,['2 / Day'],Oral, 
19536,3009,Rebif [44],2016-04-14,,5000, ,['3 / Week'],IV, 
19537,3009,Rebif [44],2016-06-27,,5000,mg,['/Month'],IV, 
19538,2372,IVIG,2016-04-26,2019-06-09,400,mcg,['3 / Week'],IV,Adverse Event
19539,2372,Mitoxantrone,2016-02-18,2020-02-17, ,mg,['3 / Week'],IV,Lack of efficacy
19540,2372,Endoxan,2016-10-04,2020-06-05, , ,[' '],IV,Patient Choice/Convenience
19541,1666,Alemtuzumab (Campath),2015-12-03,,1000,mg,['2 / Day'],Oral, 
19542,1666,Alemtuzumab (Campath),2015-11-09,,20,mg,[' '], , 
19543,1666,Endoxan,2016-07-30,, ,mg,['2 / Day'],Oral, 
19544,3388,IVIG,2016-02-20,, ,mg,['3 / Week'],Oral, 
19545,3388,Gilenya,2016-04-27,,20,mg,['/Month'],IV, 
19546,3388,Tecfidera,2016-08-26,,300,mg,['/Month'],Oral, 
19547,999,Gilenya,2015-11-13,,300,mg,['/Month'],IV, 
19548,999,Endoxan,2016-05-13,2020-12-24,20,mg,[' '],IV,Adverse Event
19549,999,IVIG,2015-10-26,2018-06-14,400, ,['/Month'],Oral,Adverse Event
19550,3603,Rebif [44],2016-01-26,, , ,['/Month'], , 
19551,3603,Mitoxantrone,2015-12-20,,400,mcg,['/ Week'],Oral, 
19552,3603,Tecfidera,2016-03-15,, ,mg,['/Month'],IV, 
19553,3603,Methylprednisolone,2016-08-24,2019-04-18,400,mg,['/Month'],Oral,Adverse Event
19554,1311,Betaferon,2015-11-08,, ,mg,['2 / Day'], , 
19555,3921,Mitoxantrone,2016-09-06,,300,mcg,['/Month'],Oral, 
19556,3921,Alemtuzumab (Campath),2016-04-15,2018-11-02,20,mg,['2 / Day'], ,Patient Choice/Convenience
19557,3921,Alemtuzumab (Campath),2016-05-15,2021-06-20,300,mcg,['/Month'],IV,Adverse Event
19558,1140,Rebif [44],2016-07-25,, , ,['/Month'], , 
19559,1003,Alemtuzumab (Campath),2015-11-23,,500,mcg,['3 / Week'],IV, 
19560,1003,IVIG,2016-02-09,,500,mg,['2 / Day'], , 
19561,1003,IVIG,2016-08-05,2021-05-10, , ,['2 / Day'],IV,Lack of efficacy
19562,1978,IVIG,2016-04-07,, , ,[' '],IV, 
19563,1978,Rebif [44],2016-03-05,,1000,mg,['2 / Day'],IV, 
19564,1978,Tysabri,2015-11-18,2021-03-17,500, ,['/Month'], ,Adverse Event
19565,3669,Tecfidera,2015-10-29,,20,MIU,['/ Day'],IV, 
19566,3669,IVIG,2015-11-06,,1000,mcg,['/Month'],IV, 
19567,4537,Methylprednisolone,2016-01-15,2017-11-13,400,mg,['2 / Day'],IV,Persistence of relapses
19568,4537,Endoxan,2016-08-21,2018-05-10,500,mg,['3 / Week'], ,Persisting MRI activity
19569,4537,Tecfidera,2016-06-01,2021-06-21,5000,mg,['/Month'], ,Patient Choice/Convenience
19570,2450,Tecfidera,2016-09-14,2020-11-21,500,mg,[' '],IV,Persisting MRI activity
19571,2450,Copaxone,2016-03-02,,1000, ,['2 / Day'], , 
19572,2450,Gilenya,2016-05-24,,300,mcg,['/Month'], , 
19573,2450,Rebif [22],2016-09-29,2018-11-04,1000,mcg,['2 / Day'], ,Persistence of relapses
19574,2478,Mitoxantrone,2015-11-15,,400,mg,['/Month'],IV, 
19575,2478,Gilenya,2016-05-21,,1000, ,[' '],IV, 
19576,2478,Alemtuzumab (Campath),2016-08-16,,300, ,['/Month'],IV, 
19577,4539,Rebif [22],2015-11-15,,1000, ,['/Month'],IV, 
19578,4539,Teriflunomide,2015-11-06,, , ,['3 / Week'], , 
19579,1076,Rebif [22],2016-01-26,2019-05-09,20,MIU,['/Month'],IV,Persisting MRI activity
19580,1076,Endoxan,2015-10-28,,1, ,['3 / Week'], , 
19581,1076,Rebif [44],2016-09-05,, ,MIU,['2 / Day'],IV, 
19582,2079,Gilenya,2016-10-15,2021-07-08,500,mg,['2 / Day'],IV,Persisting MRI activity
19583,2079,Gilenya,2016-10-04,,300,mg,['/ Day'], , 
19584,2850,Gilenya,2016-06-09,,20, ,['/Month'],IV, 
19585,4944,Tecfidera,2016-06-01,, , ,['/Month'], , 
19586,3983,Betaferon,2016-02-10,,1,mg,['2 / Day'],IV, 
19587,3983,Rebif [44],2016-01-12,2018-07-30,1, ,['2 / Day'],Oral,Patient Choice/Convenience
19588,3983,D-cure (Vitamine D),2016-05-07,,500,mg,[' '], , 
19589,3983,Gilenya,2016-08-25,, ,mg,['/Month'],IV, 
19590,2344,Tecfidera,2016-02-16,,5000, ,['2 / Day'], , 
19591,2344,Methylprednisolone,2016-05-23,,400,mg,['2 / Day'], , 
19592,2344,Alemtuzumab (Campath),2016-01-14,,400,mg,['/Month'],IV, 
19593,2344,Rebif [22],2016-03-27,,5000,mg,['/ Day'], , 
19594,4091,Rebif [22],2016-05-07,,1, ,['2 / Day'], , 
19595,4091,Rebif [44],2016-09-21,,1,MIU,['2 / Day'],Oral, 
19596,2226,Tysabri,2016-04-12,,1, ,['2 / Day'],IV, 
19597,4948,Copaxone,2016-07-26,,300,mcg,['2 / Day'],IV, 
19598,4948,D-cure (Vitamine D),2016-07-22,,20, ,['/Month'],IV, 
19599,4948,D-cure (Vitamine D),2016-07-20,,500,mg,['2 / Day'],IV, 
19600,210,Rebif [44],2016-10-19,2018-02-24,5000,MIU,['2 / Day'], ,Persistence of relapses
19601,210,Tysabri,2016-02-23,, , ,['2 / Day'],IV, 
19602,210,Gilenya,2016-09-24,2017-11-08,300,mg,['2 / Day'],IV,Adverse Event
19603,210,Tecfidera,2016-01-16,,400, ,['/Month'],IV, 
19604,1671,IVIG,2015-12-14,,400,mg,['2 / Day'],Oral, 
19605,1671,Alemtuzumab (Campath),2016-08-22,2021-06-13,1000,mg,['2 / Day'], ,Persisting MRI activity
19606,1671,Endoxan,2016-07-14,2019-01-28,500,mg,['/Month'], ,Lack of efficacy
19607,1671,D-cure (Vitamine D),2016-10-11,2019-12-20, ,mg,['/Month'],Oral,Persisting MRI activity
19608,2183,Copaxone,2016-01-06,,1000,mg,['2 / Day'],IV, 
19609,2183,D-cure (Vitamine D),2016-04-01,, ,mg,['/Month'],Oral, 
19610,2183,Rebif [44],2015-12-03,2019-03-17, ,MIU,['/Month'],IV,Persisting MRI activity
19611,366,Rebif [22],2016-08-24,, ,mcg,['3 / Week'],IV, 
19612,366,D-cure (Vitamine D),2016-01-20,,500, ,['2 / Day'], , 
19613,366,Endoxan,2015-11-02,2017-11-04,1, ,['/Month'],IV,Patient Choice/Convenience
19614,2818,Rebif [22],2016-06-29,,1, ,['/Month'], , 
19615,2818,Mitoxantrone,2015-11-17,, ,mg,['3 / Week'],IV, 
19616,2818,Methylprednisolone,2016-10-22,, ,mg,['/ Day'],IV, 
19617,2818,Tecfidera,2016-07-11,,300, ,['/Month'],IV, 
19618,3483,D-cure (Vitamine D),2016-04-11,,20, ,['/Month'], , 
19619,3483,IVIG,2016-01-18,, , ,['/Month'],IV, 
19620,3483,Methylprednisolone,2016-04-18,2020-12-17, ,mg,['2 / Day'],IV,Patient Choice/Convenience
19621,3483,D-cure (Vitamine D),2016-09-07,, ,mg,['/Month'], , 
19622,4485,Ledertrexaat,2016-08-30,2020-12-12,1, ,['2 / Day'],Oral,Lack of efficacy
19623,4503,Tecfidera,2015-12-06,,5000,mcg,[' '],IV, 
19624,4503,Teriflunomide,2015-11-22,,5000,mg,['2 / Day'], , 
19625,4503,Tysabri,2016-10-08,,20,mg,['3 / Week'], , 
19626,411,Teriflunomide,2015-12-28,2020-12-29,300,mcg,[' '],IV,Patient Choice/Convenience
19627,411,Methylprednisolone,2016-01-15,2017-12-18,5000,mg,[' '],IV,Persistence of relapses
19628,411,Methylprednisolone,2016-08-10,, , ,['3 / Week'], , 
19629,2755,Copaxone,2015-11-16,2018-10-30,5000,mg,['/Month'],Oral,Persisting MRI activity
19630,2755,Alemtuzumab (Campath),2016-03-09,, ,mcg,['/Month'], , 
19631,1460,D-cure (Vitamine D),2015-11-10,,300,mg,['/ Week'], , 
19632,1548,Gilenya,2015-12-24,2019-06-21,300,mcg,['/ Day'],IV,Adverse Event
19633,1548,Avonex,2016-09-12,2020-10-31, , ,['/ Day'],IV,Adverse Event
19634,1548,Endoxan,2016-06-02,2017-11-20,1000, ,['/Month'],IV,Lack of efficacy
19635,2920,Rebif [22],2016-06-05,, ,mg,['2 / Day'],IV, 
19636,2289,Betaferon,2016-01-13,2019-01-18, ,MIU,['/ Week'],IV,Lack of efficacy
19637,2289,IVIG,2016-10-01,, ,MIU,['/Month'],IV, 
19638,935,D-cure (Vitamine D),2015-12-14,,20,mg,['2 / Day'],IV, 
19639,3798,Rebif [22],2016-06-17,,300,mg,['2 / Day'],IV, 
19640,3798,Tysabri,2015-12-14,,5000, ,['/Month'], , 
19641,1359,Copaxone,2016-04-12,, , ,['/Month'],IV, 
19642,1359,Alemtuzumab (Campath),2016-02-08,2018-08-23, , ,['/Month'],IV,Persistence of relapses
19643,1359,Rebif [22],2016-09-22,2018-02-21,300,mcg,['3 / Week'],IV,Patient Choice/Convenience
19644,3794,Teriflunomide,2015-12-02,,1000,mcg,[' '], , 
19645,3794,Rebif [44],2016-02-28,,1000, ,['/Month'], , 
19646,752,Gilenya,2016-01-10,,5000,mg,[' '], , 
19647,3491,Methylprednisolone,2016-02-08,2021-08-06, ,MIU,['2 / Day'],IV,Lack of efficacy
19648,3491,Alemtuzumab (Campath),2016-06-05,,1,MIU,[' '],IV, 
19649,3927,IVIG,2016-02-08,2020-03-13, ,mg,[' '],Oral,Persisting MRI activity
19650,3927,Alemtuzumab (Campath),2016-04-11,2019-05-06,5000,mg,['2 / Day'],Oral,Adverse Event
19651,3927,Ledertrexaat,2016-09-14,2018-02-28, ,mg,['/Month'],IV,Persisting MRI activity
19652,3927,Teriflunomide,2016-01-19,2019-09-26, ,mg,[' '],IV,Adverse Event
19653,2317,Methylprednisolone,2016-05-11,2018-11-05, ,mg,['3 / Week'], ,Patient Choice/Convenience
19654,4710,Betaferon,2015-11-07,,20,mg,['/Month'],IV, 
19655,4710,Gilenya,2015-12-13,2018-12-26,1000, ,['3 / Week'],IV,Persistence of relapses
19656,4710,Endoxan,2016-04-26,2020-07-30,400,mg,[' '],IV,Patient Choice/Convenience
19657,4710,Alemtuzumab (Campath),2016-07-26,,20,mg,['/Month'],IV, 
19658,3702,Teriflunomide,2015-10-26,2020-07-29,1, ,['2 / Day'],Oral,Adverse Event
19659,4232,Tysabri,2016-02-24,, , ,['/Month'],Oral, 
19660,4232,Tecfidera,2016-01-21,,20,MIU,['/Month'], , 
19661,4232,Gilenya,2016-01-05,, , ,['/Month'], , 
19662,1007,Avonex,2016-10-08,2019-12-29,5000, ,['3 / Week'],Oral,Adverse Event
19663,1007,Gilenya,2016-06-28,,1,mg,['/Month'], , 
19664,161,IVIG,2015-12-10,2021-05-31,1, ,['2 / Day'],IV,Lack of efficacy
19665,204,Rebif [44],2016-08-24,,500, ,['3 / Week'],IV, 
19666,204,Tecfidera,2016-09-01,,1000,mg,['3 / Week'],Oral, 
19667,1638,D-cure (Vitamine D),2016-06-13,2021-08-14,500,MIU,['2 / Day'],Oral,Lack of efficacy
19668,1638,Avonex,2016-07-29,2019-04-04,1000, ,['/Month'], ,Adverse Event
19669,1638,Rebif [22],2016-02-03,, ,mg,['3 / Week'], , 
19670,1975,Rebif [22],2016-04-29,2019-04-28, , ,['3 / Week'],IV,Lack of efficacy
19671,1975,Ledertrexaat,2016-01-28,2019-05-19,1000,mg,['2 / Day'], ,Lack of efficacy
19672,1975,Mitoxantrone,2016-07-16,2018-10-11,20, ,['2 / Day'],IV,Adverse Event
19673,4755,Ledertrexaat,2016-06-16,2019-06-16, ,mg,['/Month'], ,Adverse Event
19674,4755,Mitoxantrone,2016-05-02,2021-09-03,1000,mg,['/Month'], ,Persisting MRI activity
19675,4755,Methylprednisolone,2016-01-07,, ,MIU,['2 / Day'], , 
19676,1980,IVIG,2016-08-18,,5000, ,['3 / Week'], , 
19677,1980,Gilenya,2016-01-09,2018-09-15, ,MIU,['/Month'], ,Lack of efficacy
19678,1980,Methylprednisolone,2016-02-16,2018-07-08,1000, ,['/Month'],IV,Lack of efficacy
19679,2895,Methylprednisolone,2016-09-09,2018-09-26, , ,['/ Day'], ,Patient Choice/Convenience
19680,2895,D-cure (Vitamine D),2016-07-02,2020-03-19,1,mg,['2 / Day'], ,Persistence of relapses
19681,2895,Gilenya,2016-07-19,, ,mg,['2 / Day'], , 
19682,2895,Endoxan,2016-10-20,,20,mg,['/Month'], , 
19683,3685,Rebif [22],2016-04-18,2018-11-08,500,mg,['2 / Day'],IV,Persisting MRI activity
19684,3685,Tysabri,2015-11-07,,300,mg,['2 / Day'],IV, 
19685,3685,Rebif [44],2016-06-02,2018-10-08,500,mg,['2 / Day'],IV,Lack of efficacy
19686,1839,Tecfidera,2016-05-31,,500,mg,['/Month'],IV, 
19687,4252,Alemtuzumab (Campath),2015-12-10,2021-04-03,300, ,['/ Day'], ,Lack of efficacy
19688,4252,Rebif [44],2015-11-27,,20,mg,['2 / Day'], , 
19689,1802,Gilenya,2016-01-20,,300,mg,['3 / Week'],IV, 
19690,1802,Endoxan,2015-12-26,2020-07-23,20, ,['/Month'],IV,Persistence of relapses
19691,2553,Copaxone,2016-01-08,2018-08-16, , ,[' '], ,Lack of efficacy
19692,2553,Avonex,2016-08-27,, ,mg,['2 / Day'], , 
19693,2553,Gilenya,2016-02-10,2018-10-04,1000,mg,['/ Day'],IV,Adverse Event
19694,2073,D-cure (Vitamine D),2016-03-04,,5000,mg,['/Month'],IV, 
19695,2073,Teriflunomide,2016-05-05,2018-03-31,5000, ,['/ Week'],IV,Persistence of relapses
19696,2073,IVIG,2016-08-09,2017-11-01,1,mg,['/Month'],IV,Adverse Event
19697,2073,Mitoxantrone,2016-07-28,2019-06-01,1000,mg,['2 / Day'], ,Lack of efficacy
19698,456,Methylprednisolone,2016-01-24,,1000, ,['2 / Day'],IV, 
19699,3976,Alemtuzumab (Campath),2016-08-26,, ,mg,['/Month'],IV, 
19700,3976,Mitoxantrone,2016-08-22,2018-01-24,300, ,['/Month'],IV,Persisting MRI activity
19701,3976,Alemtuzumab (Campath),2016-01-05,2018-12-13, ,mg,['/Month'], ,Adverse Event
19702,3976,Methylprednisolone,2016-03-21,,1000, ,['2 / Day'], , 
19703,2193,Avonex,2016-10-06,, ,mg,['/Month'],IV, 
19704,2193,Endoxan,2016-01-29,2021-07-13, , ,['/Month'],IV,Persisting MRI activity
19705,2193,D-cure (Vitamine D),2016-06-05,,300, ,['/Month'], , 
19706,687,Tecfidera,2016-04-15,2019-06-07, , ,[' '], ,Persisting MRI activity
19707,687,D-cure (Vitamine D),2016-03-01,2018-10-19,5000, ,['2 / Day'],IV,Persistence of relapses
19708,3013,Gilenya,2016-02-17,,500,mg,['/Month'],IV, 
19709,3013,Rebif [44],2016-02-23,2018-09-05, , ,['3 / Week'], ,Persistence of relapses
19710,3013,Alemtuzumab (Campath),2015-12-16,,1000,MIU,['3 / Week'],IV, 
19711,3013,Tecfidera,2015-12-19,2020-03-20, ,mg,['3 / Week'],IV,Persisting MRI activity
19712,4809,Alemtuzumab (Campath),2016-07-31,, ,mg,['3 / Week'],IV, 
19713,4809,Endoxan,2016-05-11,2020-09-02,1000,mg,['/Month'],IV,Adverse Event
19714,4809,Ledertrexaat,2016-09-26,2021-04-25,20,mg,['/Month'],Oral,Adverse Event
19715,4570,Methylprednisolone,2016-02-14,2018-08-14, ,MIU,['/ Week'],IV,Adverse Event
19716,4570,D-cure (Vitamine D),2016-02-05,,20, ,['/ Week'], , 
19717,4570,Gilenya,2016-09-21,2019-06-05,300,mg,['3 / Week'],IV,Patient Choice/Convenience
19718,518,IVIG,2016-03-18,,5000,mg,['2 / Day'],Oral, 
19719,3012,Avonex,2016-07-04,2018-02-28, , ,['3 / Week'], ,Adverse Event
19720,3012,Avonex,2015-11-29,2018-12-13,500,mg,['/Month'], ,Patient Choice/Convenience
19721,3012,D-cure (Vitamine D),2016-10-18,2018-01-09, , ,['/Month'],Oral,Persisting MRI activity
19722,4836,Rebif [44],2015-12-30,,1000,mg,['/Month'],IV, 
19723,4836,Teriflunomide,2016-02-19,2020-12-04,400,MIU,['3 / Week'],IV,Adverse Event
19724,4265,Methylprednisolone,2016-07-22,,5000, ,['2 / Day'],IV, 
19725,3327,Endoxan,2016-04-05,,500,mg,['/ Day'], , 
19726,4298,D-cure (Vitamine D),2016-03-31,, ,mg,['2 / Day'],IV, 
19727,4298,Endoxan,2015-11-28,2018-10-17,400,mg,['/Month'],Oral,Adverse Event
19728,348,Avonex,2016-05-12,2018-03-05,1, ,['/Month'], ,Persisting MRI activity
19729,250,Tecfidera,2016-07-09,,20,MIU,['2 / Day'],IV, 
19730,250,Ledertrexaat,2015-12-21,2021-01-13, ,mg,['/ Day'], ,Adverse Event
19731,250,Rebif [22],2016-06-08,,20,mg,['/ Week'], , 
19732,2745,Betaferon,2015-12-30,,1, ,['/Month'],IV, 
19733,4724,D-cure (Vitamine D),2016-08-11,, ,mg,['3 / Week'], , 
19734,4724,Teriflunomide,2016-08-26,,1000, ,['2 / Day'],IV, 
19735,4724,IVIG,2016-04-22,,500, ,['2 / Day'],Oral, 
19736,4189,IVIG,2016-03-26,, ,mcg,[' '],IV, 
19737,1475,Copaxone,2016-08-10,, ,MIU,['3 / Week'],Oral, 
19738,1475,Tysabri,2016-09-14,, ,MIU,[' '],IV, 
19739,1475,Teriflunomide,2016-10-15,2019-12-30,1000,mg,['2 / Day'], ,Adverse Event
19740,1475,IVIG,2016-09-25,,1000,mg,['2 / Day'],IV, 
19741,2386,D-cure (Vitamine D),2015-12-29,2020-12-08,1,mg,['3 / Week'],Oral,Lack of efficacy
19742,2386,Methylprednisolone,2016-07-04,2019-08-15,500,MIU,['/ Day'], ,Patient Choice/Convenience
19743,1487,Tysabri,2016-09-03,,1000,mg,[' '],IV, 
19744,3238,Tysabri,2016-06-19,2021-06-25,500, ,['2 / Day'], ,Adverse Event
19745,4770,Teriflunomide,2015-11-13,2020-08-02,1, ,['/Month'],IV,Persisting MRI activity
19746,4770,Endoxan,2016-10-05,,1000,mg,['2 / Day'],IV, 
19747,4770,Gilenya,2016-05-20,,300, ,['/ Day'],Oral, 
19748,1951,IVIG,2016-01-17,2018-07-24,5000,mg,['2 / Day'],IV,Lack of efficacy
19749,1951,Endoxan,2016-09-29,2018-06-09,500,MIU,[' '],Oral,Patient Choice/Convenience
19750,2546,Teriflunomide,2016-07-18,,5000, ,['3 / Week'],IV, 
19751,2546,Avonex,2015-11-30,2021-09-15,5000,mg,['2 / Day'],IV,Lack of efficacy
19752,2546,Tecfidera,2015-12-23,2018-12-24,1000,mg,['2 / Day'], ,Patient Choice/Convenience
19753,2546,Tecfidera,2016-06-24,,300,mg,['2 / Day'],IV, 
19754,4246,IVIG,2016-10-10,2021-10-21, , ,['/ Day'],IV,Persisting MRI activity
19755,4246,Avonex,2016-06-18,, , ,[' '],IV, 
19756,4246,Avonex,2016-04-17,,300,mg,['3 / Week'], , 
19757,4246,Gilenya,2016-06-12,2020-08-12,5000, ,['2 / Day'],IV,Lack of efficacy
19758,1826,D-cure (Vitamine D),2016-08-26,2018-04-28,5000,mg,['/Month'],IV,Persistence of relapses
19759,1826,Gilenya,2016-06-01,2019-12-13,500, ,['2 / Day'],Oral,Lack of efficacy
19760,1543,Gilenya,2015-12-06,2018-06-23, ,mg,['/ Day'], ,Persisting MRI activity
19761,1543,IVIG,2016-10-11,2020-10-19,500,mg,['/Month'],IV,Persistence of relapses
19762,4067,Ledertrexaat,2016-03-03,2019-07-26,500,mg,['/Month'],IV,Lack of efficacy
19763,4692,Tecfidera,2016-08-24,2021-09-30,500, ,['/Month'], ,Adverse Event
19764,4692,Rebif [22],2016-06-12,2019-06-28,20, ,[' '],IV,Adverse Event
19765,2257,Tecfidera,2016-01-24,2018-06-17,1000, ,['/Month'],IV,Persisting MRI activity
19766,3828,Tysabri,2016-05-01,,1,mg,['/Month'],IV, 
19767,3485,Teriflunomide,2016-05-08,2020-05-13,1000, ,[' '],IV,Adverse Event
19768,3485,Alemtuzumab (Campath),2015-12-10,,1,mg,['/Month'], , 
19769,3485,Betaferon,2015-11-16,2020-03-20,1000,mg,['3 / Week'], ,Adverse Event
19770,3485,D-cure (Vitamine D),2015-12-09,,500, ,['/ Week'],IV, 
19771,4623,Ledertrexaat,2016-05-22,2020-05-10,20, ,['/ Week'],Oral,Patient Choice/Convenience
19772,4623,Copaxone,2016-08-15,2020-12-05,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
19773,2672,Tysabri,2016-07-29,2020-12-12,20, ,['/Month'], ,Persisting MRI activity
19774,2484,Avonex,2016-01-28,, ,MIU,['/ Day'],IV, 
19775,927,Betaferon,2016-05-07,2018-04-17,400,mg,['2 / Day'], ,Adverse Event
19776,1938,Gilenya,2016-04-10,, ,mg,['/Month'],IV, 
19777,1938,Avonex,2016-05-23,,5000,mg,['/Month'], , 
19778,1938,Copaxone,2016-04-19,,1000, ,['3 / Week'],IV, 
19779,124,Tecfidera,2016-06-08,2019-12-19, , ,['/Month'],IV,Lack of efficacy
19780,124,Methylprednisolone,2015-11-29,2019-11-11,20,mg,['/Month'], ,Persisting MRI activity
19781,124,IVIG,2016-05-09,2018-09-15,300,mg,['/Month'], ,Persistence of relapses
19782,124,Gilenya,2016-07-20,,5000,mg,['2 / Day'], , 
19783,4458,Mitoxantrone,2016-08-24,, ,mg,['/Month'],IV, 
19784,4458,D-cure (Vitamine D),2015-12-20,2018-04-10,1000,mg,['/ Day'], ,Patient Choice/Convenience
19785,1914,Tysabri,2016-07-04,, ,mg,[' '],IV, 
19786,1914,D-cure (Vitamine D),2016-08-18,,500,mg,['/ Day'],IV, 
19787,1914,Methylprednisolone,2016-10-12,2021-01-12,5000,MIU,['3 / Week'],Oral,Lack of efficacy
19788,1235,D-cure (Vitamine D),2016-02-26,2019-06-27, ,mg,['/Month'],IV,Persistence of relapses
19789,904,Gilenya,2015-11-28,2017-12-07, , ,[' '],IV,Persisting MRI activity
19790,3364,Methylprednisolone,2016-07-01,,400,mg,['/ Day'],IV, 
19791,3364,Endoxan,2015-12-26,2018-10-01, , ,['3 / Week'],Oral,Persisting MRI activity
19792,3364,Copaxone,2016-06-03,,500, ,['/Month'], , 
19793,3364,Rebif [22],2016-02-06,, , ,['/Month'],IV, 
19794,4531,Tecfidera,2016-04-04,2019-06-21,20, ,[' '],IV,Adverse Event
19795,4531,Gilenya,2016-01-14,2019-05-15,20, ,['/Month'], ,Lack of efficacy
19796,2482,Avonex,2016-03-17,, ,MIU,['2 / Day'],IV, 
19797,2482,Betaferon,2016-06-28,2019-06-07, ,mg,['/ Day'], ,Persisting MRI activity
19798,2482,Tysabri,2016-08-10,2020-01-27,20, ,['2 / Day'], ,Lack of efficacy
19799,2482,Alemtuzumab (Campath),2016-07-04,2019-06-04, ,MIU,['/ Day'],IV,Persisting MRI activity
19800,1086,Rebif [22],2015-12-18,,20,mg,['3 / Week'],IV, 
19801,1086,Tecfidera,2016-08-17,, , ,['2 / Day'],IV, 
19802,189,IVIG,2016-06-02,2020-12-14,5000, ,[' '],Oral,Lack of efficacy
19803,189,Endoxan,2016-10-20,, , ,['3 / Week'],IV, 
19804,1760,Copaxone,2016-04-03,,300,MIU,['/ Week'],Oral, 
19805,1760,Ledertrexaat,2016-02-11,2018-11-05,1000,MIU,['/ Day'],IV,Adverse Event
19806,888,Rebif [44],2016-09-24,,1000, ,[' '],IV, 
19807,888,Rebif [22],2016-02-16,2020-12-07,1000,mg,['/Month'], ,Patient Choice/Convenience
19808,888,D-cure (Vitamine D),2015-11-16,,300, ,['/Month'], , 
19809,2493,Rebif [22],2016-09-14,2018-07-15,500, ,['2 / Day'],IV,Patient Choice/Convenience
19810,2493,Gilenya,2016-09-17,, ,mg,['/Month'], , 
19811,3252,Rebif [44],2016-09-08,,1,mg,['2 / Day'],IV, 
19812,3252,Betaferon,2016-09-29,, ,mcg,['/Month'],IV, 
19813,3252,D-cure (Vitamine D),2016-07-30,, , ,[' '], , 
19814,1550,Tysabri,2016-06-17,,1000,mg,['/Month'],IV, 
19815,1550,Alemtuzumab (Campath),2016-07-23,,20,mg,['/Month'],IV, 
19816,1550,D-cure (Vitamine D),2016-04-06,2019-09-24,300,mg,['/Month'], ,Patient Choice/Convenience
19817,4986,Tysabri,2016-09-30,, , ,[' '],Oral, 
19818,3193,D-cure (Vitamine D),2016-06-14,2021-03-01, ,mg,['2 / Day'],IV,Persisting MRI activity
19819,2251,Endoxan,2016-05-22,2020-11-04,20,mg,['2 / Day'],IV,Persisting MRI activity
19820,2251,Rebif [44],2016-06-21,,500, ,['/ Week'],IV, 
19821,2996,Alemtuzumab (Campath),2016-09-28,2021-04-20,400, ,['2 / Day'], ,Adverse Event
19822,2996,Gilenya,2016-02-23,, ,mg,['2 / Day'],Oral, 
19823,3308,Ledertrexaat,2016-02-20,2019-01-23,500,mg,['/Month'], ,Persistence of relapses
19824,2445,D-cure (Vitamine D),2015-11-19,, , ,['2 / Day'], , 
19825,4936,Ledertrexaat,2016-09-21,,300, ,['/ Day'],IV, 
19826,4166,Gilenya,2015-11-26,,1000,mcg,['2 / Day'],IV, 
19827,158,D-cure (Vitamine D),2016-10-16,2018-12-07,20,MIU,['2 / Day'],IV,Adverse Event
19828,4108,D-cure (Vitamine D),2015-10-30,,400, ,['/Month'], , 
19829,1077,Copaxone,2016-07-20,, ,mcg,['2 / Day'], , 
19830,1077,Mitoxantrone,2016-03-29,2018-08-18, , ,['/Month'],IV,Persisting MRI activity
19831,3125,IVIG,2016-01-23,2019-09-14,500,MIU,['2 / Day'],IV,Adverse Event
19832,3125,Tysabri,2016-02-22,,500, ,['/ Week'],IV, 
19833,3125,D-cure (Vitamine D),2016-08-22,,1,MIU,['2 / Day'],IV, 
19834,3125,Methylprednisolone,2016-06-14,2017-10-25,20,MIU,['2 / Day'], ,Patient Choice/Convenience
19835,2050,Gilenya,2015-11-13,2018-12-05, ,mg,[' '], ,Persisting MRI activity
19836,2050,Tecfidera,2016-06-09,2017-12-05,400, ,[' '], ,Adverse Event
19837,3449,Copaxone,2016-09-25,, , ,[' '],IV, 
19838,3449,Rebif [44],2016-06-28,, ,MIU,['/Month'], , 
19839,3449,Tysabri,2016-09-24,2018-04-28,500,mg,['/Month'], ,Persistence of relapses
19840,2737,Gilenya,2016-06-16,2019-10-22, , ,['2 / Day'],IV,Persisting MRI activity
19841,2737,Mitoxantrone,2016-02-25,, ,mg,[' '],IV, 
19842,2737,Endoxan,2016-06-25,,300, ,['/ Day'],IV, 
19843,1510,Copaxone,2016-01-18,, , ,['/Month'], , 
19844,1510,Alemtuzumab (Campath),2015-11-14,2018-02-03,1,mg,[' '],IV,Lack of efficacy
19845,1510,Rebif [22],2016-01-24,,5000,mg,['/Month'], , 
19846,3349,Mitoxantrone,2015-10-30,,500, ,['3 / Week'],IV, 
19847,3349,Copaxone,2016-05-30,, , ,['3 / Week'],IV, 
19848,3349,Tysabri,2016-03-01,2019-10-09,1000,mg,['/Month'],IV,Persisting MRI activity
19849,3349,Betaferon,2016-01-14,, ,mg,['3 / Week'],IV, 
19850,1018,Alemtuzumab (Campath),2016-04-10,,400,mg,['2 / Day'], , 
19851,1018,Gilenya,2015-11-06,2019-05-13,500, ,['2 / Day'],IV,Persisting MRI activity
19852,643,Alemtuzumab (Campath),2016-07-08,,20,MIU,['3 / Week'],IV, 
19853,643,Methylprednisolone,2015-11-26,, , ,['2 / Day'], , 
19854,643,Ledertrexaat,2016-06-11,2019-06-16,20, ,['2 / Day'],IV,Adverse Event
19855,1778,Tecfidera,2015-11-15,2020-07-20,300,mg,['2 / Day'],Oral,Patient Choice/Convenience
19856,1778,Betaferon,2016-10-18,2019-08-28, , ,[' '],IV,Lack of efficacy
19857,3071,Copaxone,2015-11-30,2020-01-06,20,MIU,['/Month'], ,Lack of efficacy
19858,3071,Teriflunomide,2016-05-26,2018-01-19,500, ,['2 / Day'],IV,Persistence of relapses
19859,3071,Ledertrexaat,2015-11-14,,500,mg,['2 / Day'],IV, 
19860,4032,Tysabri,2015-11-26,2018-11-23,300,mg,['2 / Day'],IV,Adverse Event
19861,4032,Rebif [22],2016-09-24,,500, ,['/Month'],IV, 
19862,4767,Methylprednisolone,2016-03-02,2018-01-03, , ,['2 / Day'],IV,Adverse Event
19863,936,Avonex,2016-09-26,2017-10-26,5000,mg,[' '],Oral,Persisting MRI activity
19864,3573,Rebif [22],2016-04-26,,1,mcg,['2 / Day'],Oral, 
19865,3573,Methylprednisolone,2016-04-13,, ,mg,['2 / Day'], , 
19866,981,Endoxan,2016-09-19,2021-10-22, ,mg,['/Month'], ,Persistence of relapses
19867,981,Copaxone,2016-01-23,, , ,['3 / Week'],Oral, 
19868,981,D-cure (Vitamine D),2016-09-07,2018-02-26, ,mg,['/Month'], ,Adverse Event
19869,4475,D-cure (Vitamine D),2016-08-04,,20,mg,['3 / Week'],IV, 
19870,4453,Endoxan,2016-04-13,,5000, ,[' '],Oral, 
19871,4183,IVIG,2016-01-02,2019-11-27,1000,mg,['/ Day'],IV,Adverse Event
19872,4183,Tysabri,2016-09-30,2018-10-05,500,mg,['2 / Day'],Oral,Patient Choice/Convenience
19873,3067,Rebif [22],2016-06-27,,300,mg,['/Month'],Oral, 
19874,3067,Endoxan,2016-08-21,2018-10-23,500,mg,['/Month'],IV,Adverse Event
19875,3067,IVIG,2016-07-14,, ,MIU,['3 / Week'],Oral, 
19876,3067,Ledertrexaat,2016-03-07,2021-03-14, , ,['/Month'], ,Persisting MRI activity
19877,3214,Gilenya,2016-02-14,2021-07-13,20, ,['3 / Week'],IV,Adverse Event
19878,3214,Ledertrexaat,2016-09-04,2021-08-22,300,mg,['2 / Day'],Oral,Persisting MRI activity
19879,3214,D-cure (Vitamine D),2016-05-04,2020-01-20, ,mcg,['/ Week'],IV,Persisting MRI activity
19880,3214,Teriflunomide,2016-09-03,2020-07-11,1000,mg,['/Month'],IV,Lack of efficacy
19881,3043,Methylprednisolone,2016-09-17,, , ,[' '],Oral, 
19882,2242,Rebif [22],2016-02-09,2020-02-18,20,mg,['3 / Week'], ,Lack of efficacy
19883,2242,Ledertrexaat,2016-04-05,,500, ,['/ Week'], , 
19884,2242,IVIG,2016-02-25,2019-05-21,500, ,['2 / Day'], ,Lack of efficacy
19885,2242,Alemtuzumab (Campath),2016-03-28,,300,mg,['3 / Week'],Oral, 
19886,1544,Alemtuzumab (Campath),2016-02-15,, ,MIU,['/Month'],IV, 
19887,1544,Tysabri,2016-05-21,2020-05-03, ,mg,['/Month'],Oral,Patient Choice/Convenience
19888,2359,Gilenya,2016-09-06,, , ,['2 / Day'], , 
19889,2359,Betaferon,2015-12-21,2018-05-15,5000,mg,['2 / Day'], ,Persisting MRI activity
19890,2624,D-cure (Vitamine D),2016-10-21,2018-01-26, ,mg,['2 / Day'],IV,Lack of efficacy
19891,2624,Avonex,2015-10-27,,1, ,['/Month'],IV, 
19892,2624,Gilenya,2016-07-17,, ,MIU,['/Month'],IV, 
19893,4798,IVIG,2016-05-24,2019-01-10,500,mg,['/Month'],IV,Patient Choice/Convenience
19894,4798,Betaferon,2016-02-06,2021-02-22,500, ,['2 / Day'],IV,Adverse Event
19895,4798,Rebif [22],2016-04-24,2020-07-04,400,mg,['/Month'],Oral,Patient Choice/Convenience
19896,4798,Copaxone,2016-09-07,2020-07-21,400,MIU,['2 / Day'], ,Lack of efficacy
19897,2544,Copaxone,2016-01-22,2020-05-08, , ,['/Month'],IV,Patient Choice/Convenience
19898,2544,Ledertrexaat,2016-07-28,,1000, ,['2 / Day'],IV, 
19899,2544,Endoxan,2016-01-01,2021-02-25,1,mg,['2 / Day'],IV,Persisting MRI activity
19900,1270,Copaxone,2016-04-18,, ,mg,['/ Day'], , 
19901,1270,Teriflunomide,2016-03-05,,300,mg,['2 / Day'],IV, 
19902,161,Methylprednisolone,2016-04-27,,500, ,['2 / Day'],IV, 
19903,161,Teriflunomide,2016-04-21,,300,mg,['2 / Day'], , 
19904,161,Teriflunomide,2016-04-14,, , ,['2 / Day'],IV, 
19905,2378,Rebif [22],2015-12-02,, ,mcg,['2 / Day'],Oral, 
19906,2378,D-cure (Vitamine D),2016-05-06,2020-11-23,400,MIU,['/ Day'],Oral,Persistence of relapses
19907,2378,Ledertrexaat,2015-12-18,,500, ,['/Month'],IV, 
19908,1624,Gilenya,2016-03-31,, ,MIU,['/Month'], , 
19909,1624,Rebif [44],2016-01-07,2020-08-08, , ,['2 / Day'],IV,Patient Choice/Convenience
19910,1624,Endoxan,2016-03-05,,1,mcg,['/ Week'],IV, 
19911,1624,Alemtuzumab (Campath),2016-01-26,,20,mg,['2 / Day'],IV, 
19912,3453,Methylprednisolone,2016-01-13,,300, ,['/ Day'], , 
19913,3453,Tecfidera,2016-04-05,,5000,mcg,['3 / Week'],Oral, 
19914,3453,Avonex,2016-06-16,2019-06-03,300,mg,['3 / Week'], ,Lack of efficacy
19915,3453,Copaxone,2016-07-21,, , ,['/Month'],IV, 
19916,3155,Copaxone,2016-07-13,2018-03-03,1000,mg,['/Month'],IV,Adverse Event
19917,3155,Avonex,2016-07-01,2021-09-17,5000,mg,['/Month'], ,Persisting MRI activity
19918,3155,Avonex,2016-09-08,2020-05-18,300, ,['/ Day'],IV,Lack of efficacy
19919,3155,Mitoxantrone,2016-06-12,,300, ,['/Month'],Oral, 
19920,2728,Copaxone,2016-05-28,,5000,mg,['3 / Week'],IV, 
19921,2728,Methylprednisolone,2016-09-06,, , ,['2 / Day'],IV, 
19922,2258,Endoxan,2016-06-06,2019-07-03, , ,['/Month'],IV,Patient Choice/Convenience
19923,2258,IVIG,2016-03-29,,20,mg,['2 / Day'], , 
19924,2258,Alemtuzumab (Campath),2016-03-04,2021-08-26,500,MIU,['/Month'],IV,Persisting MRI activity
19925,3735,D-cure (Vitamine D),2016-03-02,,1,mg,['/ Day'],IV, 
19926,3735,Copaxone,2016-10-07,2021-06-26,1,mg,['/Month'],IV,Lack of efficacy
19927,203,Tecfidera,2015-12-04,2019-02-07, ,mcg,['2 / Day'], ,Lack of efficacy
19928,203,Teriflunomide,2016-01-23,2020-03-10,500,mg,['/ Week'], ,Persisting MRI activity
19929,203,Teriflunomide,2016-09-21,2018-11-05,20, ,['3 / Week'], ,Persisting MRI activity
19930,1459,Avonex,2015-11-28,,500, ,['2 / Day'],IV, 
19931,1459,Endoxan,2016-03-23,2019-01-02,1000,mcg,['/Month'],IV,Persisting MRI activity
19932,1459,Tecfidera,2016-10-08,2018-01-26,400, ,['2 / Day'], ,Adverse Event
19933,1459,Teriflunomide,2016-04-02,2020-11-12,300, ,['2 / Day'],Oral,Persisting MRI activity
19934,3743,D-cure (Vitamine D),2016-02-05,2021-03-07,400, ,['/Month'],IV,Persisting MRI activity
19935,1073,IVIG,2015-11-19,,300, ,['/Month'],IV, 
19936,1073,Endoxan,2016-05-22,,5000,mg,['/Month'],IV, 
19937,1073,Copaxone,2016-02-28,,1000,mcg,['2 / Day'], , 
19938,1073,Endoxan,2016-04-09,,500,mg,['/Month'], , 
19939,3025,Betaferon,2016-07-05,, ,mcg,['3 / Week'],IV, 
19940,3025,Ledertrexaat,2016-09-04,,500, ,['/ Week'],IV, 
19941,3025,Tysabri,2016-01-03,, ,mg,['/Month'],IV, 
19942,3025,Teriflunomide,2016-06-24,2019-03-19, ,mcg,['/ Day'],IV,Persisting MRI activity
19943,2301,Tecfidera,2016-02-11,,5000,mg,['/ Day'],IV, 
19944,2301,D-cure (Vitamine D),2016-10-05,2021-07-31, , ,['/ Day'],IV,Adverse Event
19945,2301,Copaxone,2016-09-17,2019-01-11,500,mg,['3 / Week'], ,Lack of efficacy
19946,2301,Mitoxantrone,2015-11-05,, ,mg,['/Month'],IV, 
19947,4058,Methylprednisolone,2016-08-22,2021-03-05,500, ,['2 / Day'],IV,Persistence of relapses
19948,4058,Endoxan,2016-06-11,,20,mg,['2 / Day'], , 
19949,4029,IVIG,2016-09-19,2021-03-08,300, ,['2 / Day'], ,Lack of efficacy
19950,4029,Betaferon,2016-10-16,2021-05-17,1,mg,['/Month'],IV,Patient Choice/Convenience
19951,4029,Betaferon,2016-09-25,2018-07-28,500,mg,['/Month'], ,Patient Choice/Convenience
19952,4029,D-cure (Vitamine D),2016-04-12,2018-12-06,1,MIU,['/Month'],IV,Patient Choice/Convenience
19953,2430,Alemtuzumab (Campath),2016-01-26,2021-05-14,5000,mg,['3 / Week'],Oral,Lack of efficacy
19954,1845,Rebif [22],2016-01-14,,1,mg,['/Month'],IV, 
19955,1845,D-cure (Vitamine D),2016-10-06,2020-01-25,1000, ,['2 / Day'],IV,Adverse Event
19956,1845,Ledertrexaat,2016-01-03,,20,mcg,['2 / Day'], , 
19957,1697,Endoxan,2016-06-20,2019-06-12,500,MIU,['/Month'],IV,Patient Choice/Convenience
19958,1697,Tecfidera,2015-12-17,2021-05-18,20,mg,['3 / Week'],IV,Patient Choice/Convenience
19959,1697,Gilenya,2015-12-05,, ,mg,['/Month'],IV, 
19960,2984,Teriflunomide,2016-04-03,2017-12-31,500,mcg,['3 / Week'],IV,Adverse Event
19961,2984,Avonex,2016-05-16,, ,mg,['2 / Day'],IV, 
19962,2984,Endoxan,2016-09-30,,20,MIU,['2 / Day'],IV, 
19963,2984,Methylprednisolone,2015-12-31,2019-12-31,1000, ,[' '], ,Persistence of relapses
19964,727,Tysabri,2016-03-07,,500,mg,['2 / Day'], , 
19965,727,IVIG,2016-10-14,,1000, ,['2 / Day'],IV, 
19966,4092,Rebif [22],2016-07-20,2021-03-24, ,mg,['3 / Week'], ,Adverse Event
19967,4092,Tysabri,2016-08-27,2018-10-25, , ,[' '], ,Persistence of relapses
19968,4092,D-cure (Vitamine D),2016-03-09,2020-12-07, ,mg,['2 / Day'],Oral,Persisting MRI activity
19969,2848,Endoxan,2016-09-24,2018-11-27,5000, ,['3 / Week'],IV,Patient Choice/Convenience
19970,2848,Tecfidera,2016-08-29,,400,mg,['3 / Week'], , 
19971,3438,Mitoxantrone,2016-04-02,2020-12-24,1000, ,['/Month'],IV,Patient Choice/Convenience
19972,1684,Copaxone,2016-03-29,2019-07-18,500, ,['2 / Day'],IV,Adverse Event
19973,1684,Gilenya,2016-08-13,,20,mg,['/Month'], , 
19974,1684,Gilenya,2015-11-01,,1000,MIU,['/ Day'], , 
19975,3322,Mitoxantrone,2016-09-29,,20, ,['2 / Day'],IV, 
19976,3322,Rebif [44],2016-03-28,,1,mg,['2 / Day'], , 
19977,3322,Copaxone,2016-09-06,2020-07-02,400, ,['2 / Day'],IV,Patient Choice/Convenience
19978,3322,Teriflunomide,2016-07-09,2020-01-27, ,mg,['/ Week'],Oral,Patient Choice/Convenience
19979,1454,D-cure (Vitamine D),2015-12-28,2020-08-05, , ,['/Month'],IV,Patient Choice/Convenience
19980,250,Mitoxantrone,2016-06-17,2019-05-23,20, ,['/Month'],IV,Patient Choice/Convenience
19981,250,IVIG,2015-11-19,, ,mg,['/Month'], , 
19982,3770,Copaxone,2016-07-23,,20,mg,[' '], , 
19983,3770,Endoxan,2015-11-10,,5000, ,['/ Week'],IV, 
19984,2061,Rebif [22],2016-07-05,,500,MIU,['/Month'],IV, 
19985,2061,IVIG,2016-03-29,,1,MIU,['2 / Day'],IV, 
19986,2061,Rebif [44],2016-04-02,2021-08-15,1,mcg,['2 / Day'],Oral,Adverse Event
19987,2292,Copaxone,2016-10-04,,400, ,['3 / Week'],IV, 
19988,2292,Methylprednisolone,2016-07-26,, , ,['2 / Day'],Oral, 
19989,2292,Rebif [22],2016-04-13,2019-11-09,400,mg,['/ Day'], ,Adverse Event
19990,2203,Rebif [44],2016-07-18,2019-03-28,20,MIU,['2 / Day'],IV,Adverse Event
19991,2203,Mitoxantrone,2016-05-14,,1, ,[' '], , 
19992,2203,IVIG,2016-07-05,2018-09-19,20,mg,['2 / Day'],IV,Persistence of relapses
19993,1177,Gilenya,2016-05-17,,400,mg,['/ Day'], , 
19994,1177,IVIG,2015-11-04,,20, ,['2 / Day'],Oral, 
19995,1177,Rebif [44],2015-11-12,2020-11-20,300, ,['/Month'], ,Persisting MRI activity
19996,1177,Mitoxantrone,2016-10-03,2018-05-30,20,mg,[' '], ,Persisting MRI activity
19997,4001,Rebif [44],2015-11-20,,500,mg,['/Month'],IV, 
19998,3523,IVIG,2016-06-01,, , ,['/Month'], , 
19999,3523,Copaxone,2016-03-10,,300,MIU,['/Month'], , 
20000,3523,Mitoxantrone,2016-07-19,2018-11-15,1000,mg,['2 / Day'],Oral,Persistence of relapses
20001,1758,Avonex,2016-04-21,2019-12-03,5000,mg,['/Month'], ,Persisting MRI activity
20002,1758,Rebif [22],2016-01-18,, ,mcg,['2 / Day'], , 
20003,1758,Gilenya,2016-06-14,,20,mcg,['2 / Day'], , 
20004,4852,Copaxone,2016-04-23,,1000, ,['2 / Day'],IV, 
20005,4852,Alemtuzumab (Campath),2016-01-22,2020-07-05,20, ,['3 / Week'],Oral,Adverse Event
20006,3830,Gilenya,2016-01-23,,5000,MIU,['3 / Week'], , 
20007,3830,D-cure (Vitamine D),2016-04-03,, , ,['2 / Day'],IV, 
20008,3830,D-cure (Vitamine D),2015-12-02,,5000,mg,['/Month'],IV, 
20009,1471,Ledertrexaat,2016-10-13,2020-11-03, ,mg,['/ Week'],IV,Patient Choice/Convenience
20010,1471,Tecfidera,2016-08-20,2019-06-18,500,mg,['3 / Week'], ,Lack of efficacy
20011,1471,Tecfidera,2016-04-06,2019-02-21, , ,['3 / Week'],IV,Lack of efficacy
20012,1698,Betaferon,2016-04-19,2018-04-26, ,mg,['/ Week'],Oral,Patient Choice/Convenience
20013,1698,Betaferon,2016-04-05,,500, ,['/ Day'], , 
20014,425,Methylprednisolone,2016-05-05,,20, ,[' '],IV, 
20015,425,Gilenya,2015-12-01,2017-10-30,400, ,['/Month'], ,Persisting MRI activity
20016,425,Gilenya,2016-03-20,2019-02-26,500, ,['2 / Day'], ,Persisting MRI activity
20017,425,Endoxan,2016-10-12,2019-06-10,1, ,['2 / Day'], ,Persisting MRI activity
20018,539,Tecfidera,2016-07-11,,1000, ,['/Month'],IV, 
20019,539,Methylprednisolone,2016-04-06,,20, ,['/Month'], , 
20020,539,Ledertrexaat,2016-08-06,2018-09-18, ,MIU,['2 / Day'],IV,Persisting MRI activity
20021,539,D-cure (Vitamine D),2016-03-23,2018-09-11,300,mg,['/ Day'],IV,Adverse Event
20022,3271,Betaferon,2016-05-29,2018-05-01,1000,mcg,['/Month'],Oral,Patient Choice/Convenience
20023,3271,Tecfidera,2016-02-07,,400,MIU,['/Month'],IV, 
20024,3271,Tysabri,2016-01-20,, ,MIU,['2 / Day'], , 
20025,3844,Alemtuzumab (Campath),2015-11-01,, ,MIU,['/ Day'],IV, 
20026,4439,Rebif [44],2016-08-06,2018-03-24,300,mg,['/Month'],IV,Adverse Event
20027,2787,Betaferon,2016-10-06,2018-07-18, ,mg,['2 / Day'],IV,Adverse Event
20028,2787,Copaxone,2016-05-29,, ,mg,['2 / Day'],IV, 
20029,3724,Methylprednisolone,2016-08-21,,500,mg,['3 / Week'],Oral, 
20030,2734,Ledertrexaat,2016-07-06,,1000, ,['/Month'],IV, 
20031,2734,Alemtuzumab (Campath),2016-03-18,2018-08-27,300,mg,['2 / Day'], ,Patient Choice/Convenience
20032,2734,Mitoxantrone,2016-09-25,2020-11-15,300,mg,['/Month'],IV,Lack of efficacy
20033,670,Copaxone,2016-09-01,,400, ,['2 / Day'], , 
20034,951,Mitoxantrone,2016-04-24,, , ,[' '], , 
20035,1831,Tysabri,2016-08-27,,500,MIU,['/Month'],IV, 
20036,2040,Gilenya,2016-03-21,, ,mg,['2 / Day'],Oral, 
20037,2040,Rebif [22],2016-05-17,,300,mg,['/ Day'],IV, 
20038,2297,IVIG,2016-01-25,,1000,mg,['/Month'], , 
20039,2297,Gilenya,2015-12-28,,20, ,['/Month'],IV, 
20040,2297,Gilenya,2015-11-28,,1000,mg,['2 / Day'],IV, 
20041,2297,Rebif [44],2016-01-14,, , ,['/Month'],IV, 
20042,1260,Tysabri,2016-08-06,,5000,mg,['/Month'],IV, 
20043,394,Mitoxantrone,2016-06-28,2020-08-23, , ,['3 / Week'], ,Adverse Event
20044,394,Tysabri,2016-02-07,, ,mg,['/Month'],Oral, 
20045,394,Rebif [22],2016-07-06,,1000,mg,['3 / Week'], , 
20046,2641,Rebif [44],2016-05-23,, ,mg,['2 / Day'], , 
20047,2641,Avonex,2016-02-04,2018-12-13,5000, ,['3 / Week'],IV,Adverse Event
20048,4486,Endoxan,2015-11-14,2019-10-31,20,mg,['/Month'], ,Adverse Event
20049,4486,Tecfidera,2016-04-22,, ,mg,['/Month'], , 
20050,4486,Rebif [22],2016-07-21,, ,MIU,['2 / Day'],IV, 
20051,4486,Tecfidera,2016-08-23,,500, ,['2 / Day'],IV, 
20052,2321,Gilenya,2015-12-27,, , ,['/ Day'],IV, 
20053,2321,Gilenya,2016-05-10,,300, ,['2 / Day'],IV, 
20054,2321,IVIG,2016-08-25,,500, ,['3 / Week'],IV, 
20055,2321,Avonex,2016-10-21,,1000, ,['2 / Day'],IV, 
20056,2845,Copaxone,2015-12-18,2019-12-12,300,mg,['/ Week'], ,Lack of efficacy
20057,2845,Alemtuzumab (Campath),2016-01-02,, ,mg,['/Month'], , 
20058,3629,Endoxan,2015-10-24,2021-06-20, , ,['/ Day'], ,Lack of efficacy
20059,1233,Endoxan,2016-03-25,,500,mg,[' '],Oral, 
20060,1233,Rebif [44],2015-11-25,,5000, ,['/Month'],IV, 
20061,1233,Avonex,2015-12-16,2019-01-25,20,mg,['3 / Week'],IV,Lack of efficacy
20062,2962,Copaxone,2015-11-08,2017-12-09,1,MIU,['3 / Week'], ,Adverse Event
20063,2962,Gilenya,2016-01-12,,20,mg,['2 / Day'],Oral, 
20064,2962,Teriflunomide,2016-05-26,, , ,['2 / Day'],IV, 
20065,2962,Betaferon,2016-01-11,,20,MIU,['/ Day'], , 
20066,186,Ledertrexaat,2016-06-11,,500,mg,['/ Day'],IV, 
20067,186,Rebif [22],2016-08-24,,1000, ,['/Month'],IV, 
20068,186,D-cure (Vitamine D),2016-01-30,, , ,['/Month'],IV, 
20069,186,Mitoxantrone,2016-01-31,2019-09-02,400,mg,['3 / Week'], ,Persistence of relapses
20070,746,Ledertrexaat,2016-06-13,2019-12-17, ,mg,['2 / Day'], ,Adverse Event
20071,746,Betaferon,2016-05-04,2018-09-22,500,mg,['2 / Day'],IV,Persistence of relapses
20072,746,Mitoxantrone,2015-12-27,, ,MIU,['/ Day'], , 
20073,746,IVIG,2015-11-21,,400,mg,['2 / Day'], , 
20074,2317,Mitoxantrone,2016-07-04,, ,mg,['3 / Week'],Oral, 
20075,1912,Avonex,2016-01-09,2018-05-18,300, ,['2 / Day'],IV,Adverse Event
20076,1912,Tecfidera,2015-11-01,,1,mg,['/Month'],IV, 
20077,1912,Tecfidera,2016-03-18,,1, ,['2 / Day'],IV, 
20078,1912,Teriflunomide,2015-12-31,2020-08-26,300,MIU,['/Month'], ,Lack of efficacy
20079,417,Alemtuzumab (Campath),2016-03-22,,20, ,['2 / Day'],IV, 
20080,417,Tysabri,2015-12-21,,400,mg,['/Month'],IV, 
20081,417,Tysabri,2016-05-17,,1000,MIU,['2 / Day'],IV, 
20082,417,IVIG,2016-10-19,,20,mg,[' '],IV, 
20083,3881,Rebif [22],2015-11-21,,5000,mg,['3 / Week'],IV, 
20084,3881,Betaferon,2016-08-11,,5000, ,['/Month'],IV, 
20085,3881,IVIG,2016-02-05,,1000, ,['/ Week'], , 
20086,3881,Methylprednisolone,2016-09-30,, , ,['/Month'], , 
20087,3147,D-cure (Vitamine D),2016-06-11,,1000, ,['2 / Day'], , 
20088,3147,Teriflunomide,2016-05-08,2018-06-07,1, ,['/Month'], ,Patient Choice/Convenience
20089,3147,Rebif [44],2016-06-08,,20,MIU,['/ Week'],IV, 
20090,323,IVIG,2016-06-15,, ,mg,['/ Week'],IV, 
20091,323,Gilenya,2016-07-16,2019-11-01,1,MIU,['/ Week'], ,Persisting MRI activity
20092,3834,Teriflunomide,2016-04-12,2021-03-26, ,mcg,['/Month'], ,Adverse Event
20093,3834,Avonex,2016-06-08,2018-09-18,1000,mg,[' '],Oral,Patient Choice/Convenience
20094,3834,Methylprednisolone,2015-12-14,,1000,mcg,['/Month'], , 
20095,3834,Copaxone,2016-01-14,,500, ,['2 / Day'],IV, 
20096,3763,IVIG,2016-02-14,2020-02-14,400, ,['2 / Day'],Oral,Lack of efficacy
20097,3763,Tecfidera,2016-04-21,2021-08-10,1,mg,['2 / Day'],Oral,Persisting MRI activity
20098,3763,Alemtuzumab (Campath),2016-03-09,, ,mg,['2 / Day'], , 
20099,3259,Tecfidera,2016-03-29,,300, ,['/Month'],Oral, 
20100,3259,Alemtuzumab (Campath),2016-06-19,,1,mg,['2 / Day'],IV, 
20101,4036,IVIG,2016-09-23,2020-03-01,1000,mg,['2 / Day'],Oral,Patient Choice/Convenience
20102,4036,Endoxan,2016-06-16,2021-07-27,500,mg,['3 / Week'],IV,Persisting MRI activity
20103,4047,Rebif [44],2016-01-22,2020-07-23, ,mg,['3 / Week'],IV,Adverse Event
20104,447,Rebif [44],2015-11-24,2020-08-08,1000,MIU,['3 / Week'], ,Persisting MRI activity
20105,3412,Rebif [44],2016-02-06,,5000,mg,['3 / Week'], , 
20106,1938,Betaferon,2015-12-30,2021-02-07,5000,mcg,['2 / Day'],IV,Patient Choice/Convenience
20107,2627,D-cure (Vitamine D),2016-03-11,2019-06-22,5000, ,['/Month'], ,Adverse Event
20108,2627,Copaxone,2016-09-18,2021-10-23,300,mg,['/ Week'], ,Adverse Event
20109,693,Gilenya,2016-01-29,2021-03-21, , ,['/Month'],IV,Patient Choice/Convenience
20110,693,Gilenya,2016-08-10,,500,mg,['2 / Day'], , 
20111,693,Methylprednisolone,2016-09-20,, ,mg,['/Month'],IV, 
20112,2112,Teriflunomide,2016-04-09,2020-02-02,1000, ,['2 / Day'],Oral,Persisting MRI activity
20113,2112,Avonex,2016-08-17,2020-05-04, , ,['2 / Day'],IV,Adverse Event
20114,2112,Alemtuzumab (Campath),2016-09-25,2020-03-07,300, ,['/ Day'],Oral,Adverse Event
20115,2112,Alemtuzumab (Campath),2016-03-16,2020-08-01, , ,['2 / Day'],IV,Adverse Event
20116,4929,Betaferon,2016-06-24,,5000,MIU,['/Month'],IV, 
20117,4929,Tecfidera,2016-03-10,2018-01-02,400, ,['/ Day'],Oral,Persisting MRI activity
20118,4929,Methylprednisolone,2016-01-18,,20,mg,['2 / Day'],IV, 
20119,4929,D-cure (Vitamine D),2016-01-07,,20, ,['2 / Day'],IV, 
20120,3118,Alemtuzumab (Campath),2015-12-04,, ,mg,['/ Week'], , 
20121,3118,Rebif [44],2015-12-05,2021-07-22, , ,['2 / Day'],Oral,Adverse Event
20122,1547,Tysabri,2016-01-30,,500, ,['/ Week'], , 
20123,3336,Mitoxantrone,2016-07-24,,500, ,['3 / Week'], , 
20124,3604,Rebif [44],2016-06-06,2021-06-24, ,mg,['3 / Week'],IV,Persisting MRI activity
20125,3604,Avonex,2016-05-21,, , ,[' '],Oral, 
20126,3604,Endoxan,2016-03-13,2017-11-19,300,mg,['2 / Day'],IV,Adverse Event
20127,4385,IVIG,2016-08-22,, , ,['/Month'],Oral, 
20128,1134,Gilenya,2016-08-16,,300,mg,['/Month'],IV, 
20129,1134,Tecfidera,2016-06-11,,400, ,['/Month'],IV, 
20130,1134,Rebif [44],2015-11-04,, , ,['2 / Day'],IV, 
20131,1134,Methylprednisolone,2016-01-15,2019-08-16,20, ,['3 / Week'], ,Adverse Event
20132,3699,Tecfidera,2016-04-17,,1000,mg,['2 / Day'],IV, 
20133,3699,Rebif [44],2016-06-19,2021-09-08, ,mcg,['3 / Week'],IV,Patient Choice/Convenience
20134,3699,Methylprednisolone,2016-05-01,,1,mg,['2 / Day'],IV, 
20135,3645,Rebif [22],2016-05-12,, , ,['2 / Day'],IV, 
20136,3645,Methylprednisolone,2016-05-17,,20, ,['2 / Day'], , 
20137,3645,Methylprednisolone,2016-02-13,2020-12-08,500,mg,['/ Day'], ,Lack of efficacy
20138,2591,Rebif [22],2016-10-19,2019-05-18, ,mg,[' '], ,Lack of efficacy
20139,2591,Rebif [44],2016-04-05,2020-03-15,20, ,['/Month'],IV,Lack of efficacy
20140,4110,IVIG,2016-04-14,2019-12-03,1000,mg,['/Month'], ,Adverse Event
20141,4110,Gilenya,2016-10-18,,5000,mg,['/ Day'], , 
20142,4110,Tecfidera,2016-08-24,, ,mg,['3 / Week'],IV, 
20143,406,Gilenya,2016-01-02,2018-10-26, , ,['3 / Week'], ,Patient Choice/Convenience
20144,406,Gilenya,2015-11-16,2019-07-25, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
20145,406,Rebif [22],2016-10-08,,1, ,['/Month'], , 
20146,406,Ledertrexaat,2015-12-03,2018-06-07,20,mg,['3 / Week'], ,Persisting MRI activity
20147,1609,Gilenya,2016-01-15,, ,mg,[' '],IV, 
20148,4522,Gilenya,2016-09-15,2018-06-20, ,mg,['/Month'], ,Patient Choice/Convenience
20149,4522,Teriflunomide,2015-12-04,2020-03-17, , ,[' '], ,Persistence of relapses
20150,2920,Tysabri,2016-03-26,,500,mg,['3 / Week'],IV, 
20151,2920,Copaxone,2016-07-08,2018-06-04,5000, ,['/Month'], ,Lack of efficacy
20152,576,Gilenya,2015-11-04,,5000,MIU,['3 / Week'],IV, 
20153,576,Gilenya,2016-04-08,,300, ,['2 / Day'],IV, 
20154,576,Teriflunomide,2015-11-16,, ,MIU,['/Month'], , 
20155,576,Teriflunomide,2016-06-22,,400,mg,['/ Day'],IV, 
20156,2161,IVIG,2016-10-01,2018-03-04,500, ,['/Month'],Oral,Adverse Event
20157,1490,D-cure (Vitamine D),2016-01-11,, ,mcg,['2 / Day'],IV, 
20158,1490,D-cure (Vitamine D),2016-06-03,2019-11-16, ,MIU,['/Month'], ,Persisting MRI activity
20159,1490,Gilenya,2015-12-26,2019-08-21,5000,mg,['/Month'], ,Patient Choice/Convenience
20160,1823,IVIG,2016-08-22,2019-01-09,5000,mcg,['/ Week'],IV,Persisting MRI activity
20161,1823,Rebif [44],2015-12-18,,500,mg,['2 / Day'],IV, 
20162,1823,Rebif [22],2015-12-15,2019-05-30,300,mg,['/Month'], ,Patient Choice/Convenience
20163,1823,Tysabri,2016-01-09,2019-04-11, ,mg,['/ Week'],IV,Adverse Event
20164,2660,Tecfidera,2016-09-05,,400,mg,[' '],IV, 
20165,2660,Endoxan,2016-10-13,,20,mcg,['2 / Day'], , 
20166,2660,Tysabri,2016-01-03,2020-04-20,1000,mg,[' '],Oral,Persistence of relapses
20167,2660,Rebif [22],2016-06-12,,5000,mg,[' '],IV, 
20168,3498,IVIG,2016-01-23,,1,MIU,['/Month'], , 
20169,3498,D-cure (Vitamine D),2016-03-18,, , ,[' '],IV, 
20170,3498,Copaxone,2015-10-29,,500,mg,['3 / Week'], , 
20171,3498,Gilenya,2016-05-30,2020-11-05, , ,['3 / Week'], ,Adverse Event
20172,2346,Ledertrexaat,2016-07-08,2018-03-31, , ,[' '],IV,Patient Choice/Convenience
20173,2346,Tecfidera,2016-09-23,2019-07-12, , ,['/Month'], ,Persisting MRI activity
20174,2346,D-cure (Vitamine D),2015-11-27,2020-11-09,300, ,['/Month'],IV,Patient Choice/Convenience
20175,2346,Methylprednisolone,2016-04-12,, , ,['/Month'], , 
20176,1847,Endoxan,2016-03-04,, ,mg,['/Month'],IV, 
20177,2431,Gilenya,2016-03-13,2018-06-28,300,MIU,['/ Day'],IV,Persisting MRI activity
20178,2431,Avonex,2015-12-13,,20, ,['2 / Day'], , 
20179,1075,Methylprednisolone,2016-07-25,, , ,['/Month'], , 
20180,1075,Teriflunomide,2016-01-08,2017-11-29, , ,['3 / Week'],Oral,Persisting MRI activity
20181,4314,Copaxone,2016-09-17,,300, ,['/Month'],Oral, 
20182,4314,Teriflunomide,2016-05-27,2020-10-25,5000,mg,['2 / Day'], ,Persistence of relapses
20183,546,Avonex,2016-04-21,2018-08-23, ,mcg,['/ Week'],Oral,Persisting MRI activity
20184,546,Tysabri,2016-01-07,2021-05-29,20, ,['2 / Day'],Oral,Persisting MRI activity
20185,4834,Rebif [44],2016-10-06,,5000, ,['/Month'], , 
20186,3958,Tecfidera,2016-04-15,, , ,['2 / Day'],IV, 
20187,3596,Gilenya,2016-02-15,,500,mg,['3 / Week'],Oral, 
20188,3596,Tysabri,2015-10-24,,1000, ,['3 / Week'],IV, 
20189,3596,D-cure (Vitamine D),2016-07-11,,1000,mg,['/ Day'],IV, 
20190,3596,Rebif [44],2016-04-17,,300, ,['3 / Week'],IV, 
20191,4560,Teriflunomide,2016-10-03,2021-05-22, ,MIU,['/Month'],IV,Lack of efficacy
20192,4560,Tecfidera,2016-07-31,2020-07-16,1,mg,['/Month'],IV,Adverse Event
20193,1220,Methylprednisolone,2016-05-09,2019-09-29,1, ,['3 / Week'],IV,Persistence of relapses
20194,1220,Avonex,2016-03-03,,1000, ,['/ Week'],IV, 
20195,3902,Teriflunomide,2016-08-12,, , ,['/ Day'],IV, 
20196,2477,D-cure (Vitamine D),2016-08-25,,400,mg,['/Month'],Oral, 
20197,2477,D-cure (Vitamine D),2016-10-17,,1000, ,['/Month'],IV, 
20198,2213,Gilenya,2016-04-18,2019-08-01,20,mcg,['2 / Day'],IV,Persisting MRI activity
20199,4633,Ledertrexaat,2016-08-10,2020-03-23,1,mg,['/Month'],Oral,Adverse Event
20200,4633,Alemtuzumab (Campath),2016-01-18,2019-06-11,5000, ,['/Month'], ,Adverse Event
20201,4633,Tysabri,2015-11-21,2019-01-17, ,mg,[' '],IV,Adverse Event
20202,4633,IVIG,2016-07-22,2018-03-23,20,MIU,['2 / Day'],Oral,Patient Choice/Convenience
20203,4939,Betaferon,2016-10-08,,1,mg,['3 / Week'],IV, 
20204,4505,Tysabri,2016-03-24,,5000,mg,['3 / Week'],IV, 
20205,730,Betaferon,2016-03-03,2019-04-16, ,MIU,['2 / Day'],Oral,Adverse Event
20206,486,Endoxan,2016-06-23,2020-05-25,300, ,['3 / Week'],IV,Persisting MRI activity
20207,486,Rebif [22],2016-06-30,2018-04-01,20, ,['2 / Day'],IV,Persisting MRI activity
20208,486,Rebif [22],2016-01-17,,300,mg,[' '],IV, 
20209,382,Gilenya,2016-07-02,, , ,['/ Day'],IV, 
20210,382,Copaxone,2016-08-26,2018-04-17, , ,['/Month'], ,Lack of efficacy
20211,382,Copaxone,2015-11-09,2019-01-06,500,mg,['/Month'],Oral,Lack of efficacy
20212,2566,Rebif [44],2016-07-04,,20,mg,['/ Day'], , 
20213,2566,IVIG,2016-04-19,2018-01-01, ,mg,['2 / Day'],IV,Patient Choice/Convenience
20214,1307,IVIG,2015-12-22,2018-05-02,1000,mg,['/Month'], ,Lack of efficacy
20215,1307,Alemtuzumab (Campath),2016-06-01,2020-03-21,400,mg,['2 / Day'],IV,Lack of efficacy
20216,1307,Teriflunomide,2016-01-31,2020-07-14, ,mg,['2 / Day'], ,Patient Choice/Convenience
20217,3328,Rebif [22],2016-06-28,2021-02-17,20,mg,['2 / Day'],Oral,Adverse Event
20218,3328,IVIG,2016-06-26,,1000,MIU,[' '],Oral, 
20219,3328,Methylprednisolone,2016-03-08,2019-02-15, ,mg,['/ Day'], ,Lack of efficacy
20220,3328,Endoxan,2016-02-09,,300, ,['2 / Day'],IV, 
20221,341,Methylprednisolone,2016-04-30,2019-01-14,300, ,['/Month'],IV,Persisting MRI activity
20222,341,Avonex,2016-03-26,,400,MIU,['/Month'],IV, 
20223,4069,Endoxan,2016-03-30,2021-05-01, ,mg,['/ Day'], ,Persistence of relapses
20224,4069,IVIG,2016-05-28,, , ,['/Month'],IV, 
20225,4069,IVIG,2016-01-20,2018-09-07,1000,mg,['/Month'],Oral,Persistence of relapses
20226,2635,Gilenya,2016-09-20,, ,MIU,['2 / Day'], , 
20227,3894,Rebif [22],2015-11-05,, , ,['/Month'],Oral, 
20228,3894,Endoxan,2016-09-01,2019-12-15,1,mg,['/Month'],IV,Patient Choice/Convenience
20229,3894,Avonex,2016-02-23,2021-03-05,500, ,['2 / Day'],IV,Lack of efficacy
20230,3894,Copaxone,2016-04-03,,20, ,['2 / Day'],Oral, 
20231,2234,Alemtuzumab (Campath),2016-01-03,2019-10-13, , ,['/Month'], ,Lack of efficacy
20232,2591,Tysabri,2016-10-09,2018-02-07,1000, ,['3 / Week'],IV,Adverse Event
20233,2591,Ledertrexaat,2015-11-27,, ,mg,[' '],IV, 
20234,2591,Tysabri,2016-07-04,2020-10-13, , ,['2 / Day'], ,Persistence of relapses
20235,2591,Tysabri,2016-07-05,,1,mg,['/ Week'],IV, 
20236,1153,Alemtuzumab (Campath),2016-08-21,2019-06-15,20,mg,['/ Day'],IV,Adverse Event
20237,1153,Rebif [22],2016-09-03,2020-04-27, , ,['/ Day'],IV,Adverse Event
20238,2098,Copaxone,2015-11-22,2018-11-14,20, ,['/ Week'], ,Persisting MRI activity
20239,2098,D-cure (Vitamine D),2016-09-07,2018-08-23,1000,mg,['2 / Day'], ,Persisting MRI activity
20240,1272,Endoxan,2015-12-01,2021-02-28,400, ,['2 / Day'],IV,Patient Choice/Convenience
20241,1953,Teriflunomide,2016-04-30,2019-02-24,300, ,['/Month'],IV,Adverse Event
20242,4292,Ledertrexaat,2016-04-03,2021-05-10,400,mg,['2 / Day'],Oral,Persistence of relapses
20243,505,Tysabri,2015-11-15,,20,mg,['/Month'], , 
20244,505,Methylprednisolone,2016-08-03,, ,mg,['/ Day'],IV, 
20245,4356,Copaxone,2016-01-30,,500, ,['/ Week'],IV, 
20246,1435,Rebif [22],2016-10-13,,1000, ,['/Month'], , 
20247,743,Copaxone,2016-02-09,2017-12-16,500,mg,['2 / Day'],IV,Persisting MRI activity
20248,743,Rebif [22],2016-01-11,, , ,['/Month'], , 
20249,743,Endoxan,2016-04-03,2019-06-21,400,mcg,['2 / Day'],IV,Patient Choice/Convenience
20250,4682,Mitoxantrone,2016-05-06,,300, ,[' '],IV, 
20251,4682,Endoxan,2016-09-30,,400,mg,['3 / Week'],IV, 
20252,4682,IVIG,2016-09-20,2019-04-19,500, ,['3 / Week'], ,Patient Choice/Convenience
20253,3004,D-cure (Vitamine D),2016-09-27,2020-07-23, , ,[' '], ,Adverse Event
20254,2917,Avonex,2016-01-02,,300,mg,['2 / Day'], , 
20255,1449,IVIG,2016-06-08,, ,mg,['3 / Week'], , 
20256,1449,Rebif [22],2016-02-16,, ,mg,[' '],IV, 
20257,1449,Mitoxantrone,2016-06-06,,300, ,['/Month'],IV, 
20258,1449,Rebif [22],2016-07-13,,20,mg,['2 / Day'],IV, 
20259,2421,Betaferon,2015-12-26,,500,mg,['/Month'],Oral, 
20260,4193,Copaxone,2016-07-28,2020-04-10,20,mg,['/Month'],IV,Lack of efficacy
20261,4193,Methylprednisolone,2016-09-26,2018-09-10, , ,['/Month'],Oral,Patient Choice/Convenience
20262,4193,IVIG,2016-02-01,,1,mg,['/Month'], , 
20263,3719,Rebif [22],2016-04-27,,20, ,['/Month'], , 
20264,3592,Tecfidera,2016-06-04,2020-05-08, ,mcg,['/ Week'], ,Persisting MRI activity
20265,3592,IVIG,2016-03-15,2020-03-14,20, ,['3 / Week'],IV,Lack of efficacy
20266,2729,Gilenya,2016-01-07,2020-06-13,500, ,['2 / Day'],IV,Persisting MRI activity
20267,2282,D-cure (Vitamine D),2015-11-16,2019-02-19, ,mg,['/Month'],IV,Patient Choice/Convenience
20268,2282,Alemtuzumab (Campath),2016-09-12,, , ,['/Month'],IV, 
20269,2282,Gilenya,2016-06-22,2019-02-13, , ,['/Month'], ,Persistence of relapses
20270,2282,Endoxan,2016-07-13,2018-06-22,300, ,['2 / Day'],IV,Lack of efficacy
20271,2396,Alemtuzumab (Campath),2016-08-19,2021-06-29, ,MIU,['/Month'], ,Patient Choice/Convenience
20272,2396,Rebif [44],2016-05-30,2018-01-26,300, ,['/Month'], ,Patient Choice/Convenience
20273,2396,Gilenya,2016-06-13,,300,MIU,['2 / Day'],IV, 
20274,2396,Gilenya,2016-09-29,,300,MIU,['/Month'],IV, 
20275,755,Rebif [44],2016-08-20,2018-12-12,1,mg,['2 / Day'], ,Adverse Event
20276,2795,Tysabri,2016-02-23,2021-07-29,400,MIU,['2 / Day'],IV,Persistence of relapses
20277,2795,Rebif [44],2016-04-27,2021-05-21, , ,['2 / Day'],IV,Adverse Event
20278,3253,IVIG,2015-11-16,2021-06-23, ,mg,['/Month'],IV,Adverse Event
20279,149,Rebif [22],2016-10-04,,20, ,['/Month'],IV, 
20280,4134,Teriflunomide,2015-11-26,, ,mg,['2 / Day'], , 
20281,4134,Rebif [22],2016-01-19,,1000,mg,['/ Day'], , 
20282,4134,IVIG,2016-03-07,2019-04-15,400, ,['/Month'],IV,Lack of efficacy
20283,3302,Alemtuzumab (Campath),2016-01-03,,5000, ,['2 / Day'], , 
20284,3302,Endoxan,2015-11-17,, ,MIU,['/Month'],IV, 
20285,2223,Alemtuzumab (Campath),2016-01-08,,20,mcg,['2 / Day'],Oral, 
20286,2223,D-cure (Vitamine D),2016-10-06,,300, ,['3 / Week'], , 
20287,2223,Mitoxantrone,2015-12-16,, ,mg,['2 / Day'],IV, 
20288,2223,IVIG,2016-01-22,2020-07-15, ,mg,[' '], ,Adverse Event
20289,1627,Avonex,2015-11-21,, ,mg,['/Month'],Oral, 
20290,524,Tysabri,2016-01-12,,400,MIU,['/ Day'],IV, 
20291,2294,Rebif [44],2016-01-22,, ,mcg,['/ Week'], , 
20292,4002,Rebif [22],2015-10-31,,300, ,['3 / Week'],IV, 
20293,4002,Methylprednisolone,2015-12-24,,5000,mg,['3 / Week'],IV, 
20294,4002,Ledertrexaat,2016-06-17,,20,mg,['/Month'],IV, 
20295,4002,Rebif [22],2016-01-14,2018-09-30, ,mcg,['2 / Day'],IV,Patient Choice/Convenience
20296,2827,Teriflunomide,2016-01-14,,1000, ,['2 / Day'],IV, 
20297,1745,D-cure (Vitamine D),2016-07-17,,5000,mg,['/ Week'],IV, 
20298,1662,IVIG,2016-07-09,2018-11-14,20,mg,['3 / Week'],IV,Patient Choice/Convenience
20299,1662,Teriflunomide,2016-02-11,, ,mg,['/Month'], , 
20300,3861,Alemtuzumab (Campath),2016-03-15,2019-01-31,500,mg,['/Month'], ,Adverse Event
20301,3861,Copaxone,2016-10-19,,1000,mcg,['/Month'],IV, 
20302,3861,Methylprednisolone,2016-08-02,2018-11-09,5000, ,['3 / Week'], ,Lack of efficacy
20303,197,Rebif [22],2016-02-04,,1000, ,['3 / Week'], , 
20304,3432,Tysabri,2016-02-23,,20, ,['2 / Day'],IV, 
20305,3432,D-cure (Vitamine D),2016-02-15,2019-04-11, ,mcg,['3 / Week'],Oral,Patient Choice/Convenience
20306,3432,D-cure (Vitamine D),2016-09-25,2021-07-22, ,mg,['3 / Week'],IV,Persisting MRI activity
20307,3432,IVIG,2016-07-14,,500, ,['/ Day'],Oral, 
20308,3427,Copaxone,2016-06-26,,400, ,['/Month'],IV, 
20309,3427,IVIG,2016-07-03,2020-09-20,400,mg,['2 / Day'],IV,Lack of efficacy
20310,2596,Tysabri,2016-01-27,, , ,['2 / Day'], , 
20311,2596,Methylprednisolone,2016-04-27,,20,mg,[' '], , 
20312,3474,Methylprednisolone,2016-10-04,2018-09-30, ,mg,[' '], ,Persisting MRI activity
20313,2707,IVIG,2016-02-08,, ,mg,['3 / Week'], , 
20314,2707,Methylprednisolone,2016-04-11,2019-03-29,5000, ,[' '], ,Lack of efficacy
20315,2707,Ledertrexaat,2016-03-22,,300,mg,['/ Day'],IV, 
20316,896,Rebif [44],2016-09-12,, , ,['/ Day'], , 
20317,896,Tecfidera,2016-10-15,2019-10-10,5000,mg,['2 / Day'], ,Patient Choice/Convenience
20318,3369,D-cure (Vitamine D),2016-05-28,, , ,[' '],Oral, 
20319,3369,Teriflunomide,2016-04-17,2021-10-05,20, ,['2 / Day'], ,Adverse Event
20320,3369,Methylprednisolone,2016-07-02,,5000,mg,['2 / Day'],IV, 
20321,3369,Betaferon,2016-02-29,,1, ,['/ Week'],IV, 
20322,2529,Ledertrexaat,2016-04-12,, ,mg,['2 / Day'], , 
20323,2529,Copaxone,2016-03-27,,1000, ,['/Month'],IV, 
20324,809,Rebif [44],2016-03-31,2019-11-20, ,mg,['/Month'],IV,Patient Choice/Convenience
20325,809,Betaferon,2016-06-01,2018-07-09,20, ,['2 / Day'],Oral,Lack of efficacy
20326,809,Rebif [22],2016-07-31,, ,mcg,['/Month'],IV, 
20327,809,Mitoxantrone,2016-01-27,2019-10-05,20,mg,['/Month'],IV,Persisting MRI activity
20328,145,Tysabri,2016-02-24,2020-11-04,5000,mg,['/ Week'], ,Lack of efficacy
20329,145,Avonex,2016-10-07,2018-12-09,500, ,['3 / Week'], ,Patient Choice/Convenience
20330,145,Gilenya,2015-12-12,,300, ,['2 / Day'], , 
20331,145,Copaxone,2015-11-03,2019-02-15,1,mg,['2 / Day'], ,Patient Choice/Convenience
20332,3619,Gilenya,2016-10-16,,300,mg,['3 / Week'], , 
20333,1014,Avonex,2016-07-19,2018-02-15,5000,mg,['/Month'],IV,Persisting MRI activity
20334,1014,Tysabri,2016-05-29,,400,MIU,[' '],IV, 
20335,1014,Copaxone,2016-08-26,2019-01-08, , ,['/ Day'], ,Patient Choice/Convenience
20336,1014,Tysabri,2016-04-07,2020-10-15, ,mcg,['2 / Day'], ,Persistence of relapses
20337,3424,Endoxan,2016-01-20,,1000, ,['3 / Week'],IV, 
20338,3424,Tysabri,2015-12-23,, , ,['3 / Week'], , 
20339,3424,Teriflunomide,2016-01-19,,5000,mg,[' '],IV, 
20340,842,Ledertrexaat,2016-06-26,2019-09-07, ,mg,['/Month'],IV,Lack of efficacy
20341,842,D-cure (Vitamine D),2015-12-01,, , ,['/Month'],IV, 
20342,842,D-cure (Vitamine D),2016-01-05,, , ,['/Month'], , 
20343,1316,Betaferon,2015-11-09,, ,mcg,['/Month'],IV, 
20344,1316,Ledertrexaat,2016-07-29,2019-05-30,300,mg,['2 / Day'], ,Persisting MRI activity
20345,1190,Rebif [22],2016-04-05,2019-08-24,5000, ,['/Month'],IV,Adverse Event
20346,1190,Avonex,2016-10-01,,500,mg,['3 / Week'],IV, 
20347,3476,IVIG,2016-06-14,, ,MIU,['3 / Week'],IV, 
20348,3695,Alemtuzumab (Campath),2016-10-12,2020-07-04,20,mg,['/Month'], ,Persisting MRI activity
20349,899,Mitoxantrone,2016-10-10,, ,mg,[' '],IV, 
20350,899,Methylprednisolone,2016-09-19,2021-09-05,500,mg,['/Month'],Oral,Adverse Event
20351,899,Avonex,2016-01-18,2020-03-12,300, ,['2 / Day'], ,Patient Choice/Convenience
20352,3613,Alemtuzumab (Campath),2016-03-28,,300, ,['2 / Day'], , 
20353,3613,IVIG,2016-04-28,, , ,['2 / Day'],IV, 
20354,3613,Endoxan,2016-03-20,2019-09-29,1000,mg,['2 / Day'], ,Adverse Event
20355,590,Copaxone,2016-06-15,, ,mg,['/Month'],IV, 
20356,590,IVIG,2016-10-03,,1000, ,['/ Day'],IV, 
20357,590,Endoxan,2015-12-09,,300,MIU,['/Month'], , 
20358,590,Gilenya,2016-01-23,,300, ,['/Month'],IV, 
20359,2062,Rebif [44],2016-07-23,2018-06-15,1,mg,['2 / Day'], ,Patient Choice/Convenience
20360,2062,Alemtuzumab (Campath),2016-07-26,2020-09-07,20, ,['2 / Day'],Oral,Persisting MRI activity
20361,1301,Copaxone,2016-08-30,2019-10-25,500, ,['3 / Week'],IV,Adverse Event
20362,1301,Rebif [22],2016-03-04,,1, ,['/Month'], , 
20363,1301,Betaferon,2015-10-31,2019-05-16,1000, ,['3 / Week'], ,Adverse Event
20364,1301,D-cure (Vitamine D),2016-05-01,2018-03-01,300,mg,['/Month'],IV,Lack of efficacy
20365,1849,Ledertrexaat,2016-05-08,,20, ,['2 / Day'], , 
20366,1849,Tysabri,2016-02-21,2018-08-10,20,MIU,[' '], ,Persisting MRI activity
20367,1849,Betaferon,2016-07-22,, , ,['2 / Day'],Oral, 
20368,2776,Copaxone,2016-01-04,2021-03-08, ,MIU,['3 / Week'],IV,Adverse Event
20369,3267,Methylprednisolone,2016-03-09,,1,mg,['/Month'],Oral, 
20370,3267,Avonex,2015-11-13,, , ,['2 / Day'],IV, 
20371,3267,Tysabri,2016-07-26,,5000,MIU,['2 / Day'], , 
20372,3267,Teriflunomide,2016-06-09,,1000,mg,['/Month'], , 
20373,3998,Tysabri,2016-09-18,,500, ,['/ Day'],IV, 
20374,3998,D-cure (Vitamine D),2016-10-15,2021-01-19,20, ,['/Month'],IV,Adverse Event
20375,3998,Betaferon,2016-03-20,,5000,mg,['/Month'],IV, 
20376,3465,Rebif [44],2016-05-22,,1000, ,['3 / Week'],Oral, 
20377,2279,Endoxan,2016-08-07,,1, ,['/ Week'], , 
20378,2279,IVIG,2016-01-18,, , ,['2 / Day'], , 
20379,3267,Copaxone,2016-03-26,,5000, ,['/Month'],Oral, 
20380,3267,Endoxan,2016-09-13,2019-07-24,300,mcg,['/Month'],IV,Lack of efficacy
20381,3267,Gilenya,2016-06-10,2020-04-18, ,mg,['/Month'],IV,Patient Choice/Convenience
20382,3267,Gilenya,2016-05-04,,20,MIU,['/ Week'],IV, 
20383,4253,Alemtuzumab (Campath),2016-02-15,2020-05-13,20, ,['2 / Day'], ,Persisting MRI activity
20384,1140,IVIG,2016-03-14,, ,MIU,[' '], , 
20385,3606,Tysabri,2016-03-02,2017-11-10,300,mg,['/ Week'], ,Persistence of relapses
20386,2895,Copaxone,2016-06-05,, , ,['/Month'],Oral, 
20387,2895,IVIG,2016-09-07,,5000,mg,['2 / Day'], , 
20388,2895,Rebif [44],2015-12-29,, ,mg,[' '],IV, 
20389,2895,Gilenya,2015-11-20,,20,mg,['2 / Day'], , 
20390,4404,Methylprednisolone,2016-10-05,,1,mcg,['/Month'],IV, 
20391,4404,Endoxan,2016-09-13,2019-09-04,1000, ,['/Month'],Oral,Adverse Event
20392,4404,IVIG,2016-02-01,, , ,['/ Day'], , 
20393,2558,Copaxone,2015-12-26,,500, ,['/Month'],IV, 
20394,2558,Tecfidera,2016-08-12,, , ,[' '],IV, 
20395,2558,Methylprednisolone,2015-11-16,,5000,MIU,['/ Week'],IV, 
20396,3651,IVIG,2016-10-04,2021-06-05,5000,mg,['/Month'],Oral,Adverse Event
20397,3651,Rebif [22],2016-09-30,2018-01-12,1000,mcg,['2 / Day'], ,Lack of efficacy
20398,3651,Betaferon,2016-07-11,2018-10-31,5000, ,['2 / Day'], ,Persisting MRI activity
20399,3651,Rebif [22],2016-03-31,,20, ,['2 / Day'],IV, 
20400,4138,Methylprednisolone,2016-08-06,2019-06-14,5000,mg,['/Month'],IV,Patient Choice/Convenience
20401,4138,Gilenya,2016-08-15,2020-03-18,300,MIU,['/Month'],IV,Persisting MRI activity
20402,4138,Avonex,2016-10-14,2019-01-23, ,mcg,['3 / Week'], ,Lack of efficacy
20403,4138,Rebif [44],2015-12-15,2018-07-16,300,MIU,[' '],IV,Lack of efficacy
20404,2388,Gilenya,2015-12-05,,500,MIU,['2 / Day'],IV, 
20405,616,D-cure (Vitamine D),2016-02-21,,20,mg,['2 / Day'], , 
20406,2174,IVIG,2016-01-07,,1000, ,['/ Day'],IV, 
20407,2174,D-cure (Vitamine D),2016-05-21,2019-05-08,20,mg,['/ Day'],IV,Adverse Event
20408,2174,Copaxone,2016-05-09,,300, ,['/Month'],IV, 
20409,2174,Copaxone,2016-05-31,2020-12-28, , ,['2 / Day'],Oral,Adverse Event
20410,2119,Rebif [22],2016-02-02,,1000,mg,['3 / Week'],IV, 
20411,2119,Avonex,2016-03-08,,400, ,['2 / Day'],IV, 
20412,2119,Mitoxantrone,2015-11-12,2020-09-27,5000, ,['/Month'],IV,Persisting MRI activity
20413,2119,Teriflunomide,2016-01-17,, ,MIU,['2 / Day'],IV, 
20414,1864,Ledertrexaat,2016-08-20,2020-10-21, ,mg,['/ Week'], ,Persisting MRI activity
20415,1258,Methylprednisolone,2016-06-08,2020-01-20, , ,['2 / Day'], ,Adverse Event
20416,1258,Methylprednisolone,2016-05-20,2021-06-01,20,mg,['2 / Day'], ,Lack of efficacy
20417,1258,Gilenya,2016-01-18,2021-06-29,400,mg,['3 / Week'], ,Lack of efficacy
20418,399,Gilenya,2016-04-30,2020-12-28,300,mg,['3 / Week'],IV,Persisting MRI activity
20419,399,IVIG,2015-12-29,, , ,['/ Week'],IV, 
20420,4056,Gilenya,2015-10-31,2017-12-21,5000, ,['/ Day'],IV,Patient Choice/Convenience
20421,4056,Copaxone,2016-05-05,,1,mcg,['/ Day'],Oral, 
20422,4056,Methylprednisolone,2016-05-13,,1000, ,['/Month'], , 
20423,4056,Copaxone,2015-12-26,2019-10-15,500,mcg,['/ Week'],IV,Lack of efficacy
20424,2626,Tysabri,2016-05-30,2020-09-08,20,mg,['/ Day'], ,Patient Choice/Convenience
20425,2626,Teriflunomide,2016-01-29,,300,mg,['/Month'], , 
20426,2657,Betaferon,2016-03-30,,20,MIU,['/Month'],IV, 
20427,2657,Teriflunomide,2015-11-28,2019-01-27,400,mcg,['3 / Week'],IV,Adverse Event
20428,1827,Betaferon,2016-01-03,2020-06-26, , ,['3 / Week'],IV,Patient Choice/Convenience
20429,1827,D-cure (Vitamine D),2016-03-20,, , ,['/Month'],Oral, 
20430,1827,Ledertrexaat,2016-03-14,2018-09-28,300, ,[' '],Oral,Adverse Event
20431,1265,Endoxan,2016-08-10,,1, ,['/Month'],IV, 
20432,1265,D-cure (Vitamine D),2015-12-19,,300,mg,['/Month'], , 
20433,1265,D-cure (Vitamine D),2016-06-27,,1,mg,['3 / Week'],IV, 
20434,1265,Ledertrexaat,2016-08-18,,20, ,['2 / Day'],IV, 
20435,1504,Methylprednisolone,2016-01-08,, ,mg,['/Month'],IV, 
20436,1504,Tysabri,2016-04-20,,1000,mg,['/Month'],IV, 
20437,3571,Gilenya,2016-10-15,2020-08-29, ,mg,['2 / Day'],IV,Persisting MRI activity
20438,3571,Endoxan,2016-08-13,2019-06-26, ,MIU,['/Month'],IV,Patient Choice/Convenience
20439,3571,D-cure (Vitamine D),2016-03-31,2020-11-08, , ,['3 / Week'], ,Persisting MRI activity
20440,3571,Tecfidera,2016-04-15,,500,mg,['/Month'],IV, 
20441,2285,Rebif [22],2016-06-17,,20,MIU,['3 / Week'], , 
20442,3014,D-cure (Vitamine D),2015-11-19,, , ,['3 / Week'], , 
20443,4315,IVIG,2015-12-16,,500,mg,['2 / Day'],IV, 
20444,4315,Gilenya,2016-10-13,,400,mg,['/Month'], , 
20445,4315,Rebif [22],2016-08-22,2021-08-28,500,MIU,[' '],IV,Lack of efficacy
20446,3529,Tysabri,2016-10-13,2018-04-20, ,mg,['/ Week'],Oral,Adverse Event
20447,3529,Methylprednisolone,2016-06-01,2019-10-07,400, ,[' '], ,Lack of efficacy
20448,3529,IVIG,2016-02-23,,300, ,['/ Day'],IV, 
20449,3529,Methylprednisolone,2016-05-04,, ,mg,['/Month'], , 
20450,2251,Mitoxantrone,2016-07-11,2020-03-31,400,mg,['3 / Week'],IV,Persisting MRI activity
20451,1397,Tysabri,2015-11-27,,500, ,['/Month'],IV, 
20452,1397,Gilenya,2016-06-06,2020-09-28,500,mg,['2 / Day'],Oral,Adverse Event
20453,1397,Copaxone,2016-08-06,2019-02-04,1,MIU,['/ Day'], ,Adverse Event
20454,4206,D-cure (Vitamine D),2015-12-27,2020-04-15, ,mcg,['2 / Day'], ,Patient Choice/Convenience
20455,4206,Rebif [22],2016-07-09,,1000, ,['/ Day'],IV, 
20456,3915,Methylprednisolone,2016-06-01,, , ,['/Month'], , 
20457,2648,Tysabri,2016-08-26,2019-02-10, ,mg,['/ Day'],IV,Persisting MRI activity
20458,3270,Copaxone,2016-03-30,2019-05-18,300,MIU,['/Month'], ,Lack of efficacy
20459,409,IVIG,2016-06-08,,5000, ,['/Month'],IV, 
20460,409,Endoxan,2016-08-07,, ,mcg,['2 / Day'],IV, 
20461,3519,IVIG,2016-01-07,,1,mcg,['2 / Day'], , 
20462,4616,Alemtuzumab (Campath),2016-10-21,, ,mg,['/ Day'],IV, 
20463,1153,Rebif [22],2015-11-29,,500,mg,['/Month'], , 
20464,1153,Gilenya,2016-08-21,2019-12-10,500,mg,['2 / Day'], ,Persisting MRI activity
20465,1153,Endoxan,2016-02-03,,500, ,['/Month'], , 
20466,4065,Tecfidera,2015-11-14,,5000, ,['/ Day'],IV, 
20467,4065,D-cure (Vitamine D),2016-09-25,,1000, ,['/Month'],Oral, 
20468,4065,Mitoxantrone,2016-09-06,,1,mg,['/Month'],IV, 
20469,1255,Tecfidera,2016-04-27,,5000, ,[' '], , 
20470,1255,Gilenya,2016-01-11,2020-06-15,400,mg,['/Month'],Oral,Adverse Event
20471,1255,Methylprednisolone,2016-01-04,,1000, ,['/Month'],IV, 
20472,459,Tecfidera,2016-05-27,,20,MIU,['/Month'], , 
20473,459,Endoxan,2015-12-22,2021-06-07,400, ,[' '], ,Patient Choice/Convenience
20474,1990,Tecfidera,2016-06-30,2018-04-20,20, ,['/Month'], ,Adverse Event
20475,1990,Gilenya,2016-07-06,2018-04-05,20, ,['/ Week'],IV,Adverse Event
20476,1990,Gilenya,2015-12-23,,500,MIU,['/Month'],IV, 
20477,1990,Tecfidera,2015-12-23,2019-02-28, , ,['2 / Day'],Oral,Adverse Event
20478,130,D-cure (Vitamine D),2016-06-27,2020-10-29,300,mg,['2 / Day'],IV,Persistence of relapses
20479,442,Mitoxantrone,2016-05-05,2018-05-26,1000,mg,[' '], ,Adverse Event
20480,3912,Avonex,2016-09-15,,1000,mg,['/ Day'],IV, 
20481,3912,D-cure (Vitamine D),2016-01-02,,1,mcg,['3 / Week'],IV, 
20482,3912,Rebif [22],2016-02-04,2018-05-17,500,mg,['2 / Day'],IV,Adverse Event
20483,4628,Avonex,2016-01-18,, ,mg,[' '],Oral, 
20484,4628,IVIG,2016-04-14,2018-11-25,500,mg,['2 / Day'],IV,Persistence of relapses
20485,4628,Endoxan,2016-04-24,2018-10-09,1, ,['2 / Day'], ,Adverse Event
20486,2950,Ledertrexaat,2016-09-02,2021-08-21, , ,['2 / Day'],IV,Adverse Event
20487,2950,Rebif [44],2015-10-28,2018-08-26,1000,mg,['/Month'],IV,Adverse Event
20488,1286,Rebif [22],2016-05-29,,1,mg,['/ Day'],IV, 
20489,1286,Betaferon,2015-12-30,2020-06-26,400,MIU,[' '],Oral,Adverse Event
20490,1286,Avonex,2015-12-31,2020-07-10,1,mg,['2 / Day'],Oral,Persistence of relapses
20491,1286,Ledertrexaat,2016-10-21,2018-08-16,300, ,['/Month'], ,Persistence of relapses
20492,1085,Endoxan,2015-12-14,2018-03-03,300, ,['/ Day'],IV,Persistence of relapses
20493,1085,Methylprednisolone,2015-12-28,,500,mg,['/Month'], , 
20494,1990,D-cure (Vitamine D),2016-02-12,,500,mg,['/Month'], , 
20495,1990,Rebif [44],2016-07-03,2019-01-23,20,mg,['/Month'],Oral,Patient Choice/Convenience
20496,1990,Copaxone,2015-11-21,2020-06-30,5000,mg,['/ Day'],IV,Persisting MRI activity
20497,2155,IVIG,2016-02-01,, ,MIU,['2 / Day'], , 
20498,2155,Gilenya,2016-01-24,2018-03-04,1, ,[' '],Oral,Lack of efficacy
20499,3216,Rebif [22],2016-01-24,2021-04-16, ,mg,['2 / Day'],IV,Persisting MRI activity
20500,3216,Copaxone,2016-02-14,, ,MIU,['3 / Week'],IV, 
20501,3216,Tecfidera,2015-11-11,2019-01-24, , ,['3 / Week'], ,Adverse Event
20502,3216,Copaxone,2016-04-06,2021-03-25,5000,mg,['/Month'],IV,Lack of efficacy
20503,4461,Betaferon,2016-04-18,2019-04-10, ,mg,['/Month'],IV,Persisting MRI activity
20504,4461,Avonex,2016-06-25,,400,mcg,['2 / Day'],Oral, 
20505,4461,IVIG,2016-04-19,, , ,['/Month'],IV, 
20506,3242,Avonex,2016-05-12,,500,MIU,['/Month'],IV, 
20507,2740,Tecfidera,2016-04-12,,400,mg,['2 / Day'],Oral, 
20508,2009,Avonex,2016-09-21,2018-01-23,300, ,['/Month'],Oral,Patient Choice/Convenience
20509,2009,Rebif [44],2016-03-27,, ,mg,['/Month'],IV, 
20510,2009,Teriflunomide,2016-07-10,,500,mcg,['3 / Week'],Oral, 
20511,1065,Tysabri,2016-06-26,2018-03-04,300, ,['/Month'],IV,Persistence of relapses
20512,2478,Tecfidera,2016-05-04,,20, ,['2 / Day'],IV, 
20513,2478,Methylprednisolone,2016-09-09,2020-09-29,5000, ,['/ Week'],IV,Adverse Event
20514,2243,Tysabri,2016-06-06,, , ,['/ Day'],IV, 
20515,2243,Avonex,2016-01-27,,20, ,['/Month'], , 
20516,2243,D-cure (Vitamine D),2015-12-24,,1000, ,['3 / Week'],IV, 
20517,4494,D-cure (Vitamine D),2016-04-19,2021-04-07, , ,['/ Week'], ,Adverse Event
20518,4494,Gilenya,2015-12-12,,1, ,['/Month'],IV, 
20519,4494,D-cure (Vitamine D),2016-08-03,,5000,mg,['2 / Day'],IV, 
20520,2418,Tecfidera,2016-09-10,2020-10-31,20,mg,['/Month'], ,Adverse Event
20521,2418,Mitoxantrone,2016-02-03,2019-05-21,20,mg,['3 / Week'],IV,Lack of efficacy
20522,264,Methylprednisolone,2016-08-12,,20,MIU,[' '],IV, 
20523,264,Copaxone,2016-06-18,,1000, ,['/Month'], , 
20524,264,Gilenya,2016-04-25,,1000,MIU,['/ Day'],Oral, 
20525,386,Methylprednisolone,2016-03-16,, ,mg,['/Month'],IV, 
20526,4634,Alemtuzumab (Campath),2016-05-24,,5000, ,['3 / Week'],Oral, 
20527,4634,Endoxan,2016-08-03,2018-08-31,500,MIU,['/Month'],IV,Patient Choice/Convenience
20528,4634,Endoxan,2016-07-30,,300,mg,[' '],IV, 
20529,1258,Ledertrexaat,2016-10-04,, ,mg,['/Month'],IV, 
20530,1258,IVIG,2016-01-20,,400,mg,['/Month'], , 
20531,2300,Copaxone,2016-03-07,2020-10-04,400, ,[' '],IV,Adverse Event
20532,3537,Rebif [44],2016-02-12,2019-03-07,500, ,['2 / Day'], ,Adverse Event
20533,3537,IVIG,2016-02-22,,20,mcg,['/ Day'],IV, 
20534,3537,D-cure (Vitamine D),2016-07-21,2018-07-13,300,mcg,['3 / Week'], ,Lack of efficacy
20535,3222,Avonex,2016-02-11,, , ,['2 / Day'], , 
20536,3222,Ledertrexaat,2016-07-10,,500,mg,['2 / Day'], , 
20537,3222,Gilenya,2015-11-04,, , ,['2 / Day'], , 
20538,3222,Avonex,2016-02-22,,20,mcg,['2 / Day'],Oral, 
20539,3159,Tecfidera,2016-05-15,,1,mg,[' '],Oral, 
20540,3159,Gilenya,2015-12-02,2021-03-28,1000,mg,['/Month'],Oral,Lack of efficacy
20541,3159,Gilenya,2016-09-05,,400,mg,['3 / Week'], , 
20542,3159,Methylprednisolone,2016-07-17,,1000,mg,['/Month'],IV, 
20543,153,Gilenya,2016-04-12,,1000, ,['3 / Week'],IV, 
20544,153,Tysabri,2015-12-10,,400, ,['/Month'], , 
20545,153,Methylprednisolone,2015-11-09,2019-12-24,1000,mcg,['2 / Day'], ,Adverse Event
20546,2028,Betaferon,2016-01-11,,20,mg,['/Month'],Oral, 
20547,2234,Mitoxantrone,2016-10-14,,400,mcg,['2 / Day'],IV, 
20548,2234,Rebif [22],2016-04-09,,400, ,['2 / Day'],IV, 
20549,2234,IVIG,2016-01-05,,20,mcg,['2 / Day'],Oral, 
20550,2234,Methylprednisolone,2016-01-17,,500, ,['/Month'], , 
20551,3795,Rebif [22],2016-03-05,,300,mg,['3 / Week'],Oral, 
20552,3795,Avonex,2016-04-29,,1000,mg,['/Month'],IV, 
20553,3795,Endoxan,2016-04-03,2019-02-19, ,mg,['2 / Day'],IV,Patient Choice/Convenience
20554,3962,Rebif [22],2016-08-19,2020-12-12,300, ,['/Month'],Oral,Persistence of relapses
20555,3962,Tecfidera,2016-02-27,, , ,['/Month'],Oral, 
20556,3962,Gilenya,2016-03-24,2020-12-14,400,MIU,['2 / Day'],IV,Lack of efficacy
20557,4853,Rebif [44],2016-07-07,,500,mcg,['2 / Day'],Oral, 
20558,4853,Endoxan,2016-10-02,2018-02-24,400,mg,['2 / Day'],Oral,Adverse Event
20559,4853,Tysabri,2016-04-17,,500, ,['2 / Day'], , 
20560,177,Mitoxantrone,2016-03-11,, ,mcg,['2 / Day'], , 
20561,177,Tecfidera,2016-07-19,, , ,['/ Day'], , 
20562,2675,Rebif [44],2016-02-29,,1000, ,['3 / Week'],IV, 
20563,2675,Gilenya,2016-08-13,,500,mg,['2 / Day'], , 
20564,3033,Tysabri,2015-10-31,,20, ,['/ Day'],IV, 
20565,3033,Tysabri,2016-02-09,,400,mg,['/ Day'],IV, 
20566,2519,Alemtuzumab (Campath),2016-01-24,,20, ,['2 / Day'], , 
20567,2519,Gilenya,2016-05-26,, , ,['/Month'], , 
20568,2519,D-cure (Vitamine D),2015-11-29,,1000,mg,['3 / Week'],Oral, 
20569,1502,Methylprednisolone,2015-11-07,, , ,[' '],IV, 
20570,1502,Endoxan,2016-03-13,,1000,mcg,['/Month'],Oral, 
20571,3825,Copaxone,2016-09-01,2020-10-20,500,mg,['2 / Day'],IV,Adverse Event
20572,3825,IVIG,2016-10-01,2020-11-15, ,mg,['3 / Week'], ,Persistence of relapses
20573,3825,Gilenya,2016-05-26,2018-09-07,20, ,['/Month'], ,Lack of efficacy
20574,3825,Teriflunomide,2016-10-03,2019-04-19,300,mcg,['2 / Day'],IV,Lack of efficacy
20575,4538,Endoxan,2015-12-25,2018-12-20,300, ,['2 / Day'],IV,Persisting MRI activity
20576,108,Betaferon,2016-07-28,,5000, ,['2 / Day'],IV, 
20577,108,Tecfidera,2016-01-20,,5000,mg,['2 / Day'],IV, 
20578,108,IVIG,2016-09-27,, ,mcg,['3 / Week'], , 
20579,2758,Rebif [44],2016-04-07,, ,mg,['2 / Day'],Oral, 
20580,2758,Mitoxantrone,2016-09-30,, ,mg,['3 / Week'],IV, 
20581,2758,Tysabri,2016-07-28,2018-03-04,400, ,['/ Day'],IV,Adverse Event
20582,2758,IVIG,2016-06-22,,20,mg,['/Month'],IV, 
20583,3833,Copaxone,2015-12-29,,1,mg,[' '], , 
20584,3833,Methylprednisolone,2016-08-23,, , ,['3 / Week'], , 
20585,3833,Rebif [44],2016-04-25,2018-02-10, , ,['/Month'], ,Patient Choice/Convenience
20586,3833,D-cure (Vitamine D),2015-12-08,2020-08-09, , ,['2 / Day'],IV,Lack of efficacy
20587,886,Betaferon,2015-12-02,,400, ,['/ Day'],IV, 
20588,886,IVIG,2016-03-03,2019-03-13,500, ,['/Month'],IV,Adverse Event
20589,886,D-cure (Vitamine D),2016-04-03,,500,mg,['3 / Week'], , 
20590,886,Methylprednisolone,2016-09-06,, , ,['/Month'],IV, 
20591,3184,Teriflunomide,2016-06-20,2020-07-31,5000,mg,['2 / Day'],IV,Patient Choice/Convenience
20592,3184,Gilenya,2016-06-04,2019-04-09, ,MIU,['/Month'],IV,Adverse Event
20593,3184,Teriflunomide,2016-06-23,, ,MIU,['3 / Week'], , 
20594,2877,Avonex,2016-07-03,, , ,['2 / Day'],IV, 
20595,2877,Avonex,2015-10-26,, , ,['2 / Day'],IV, 
20596,2877,Alemtuzumab (Campath),2016-05-16,, ,mg,['/ Day'],IV, 
20597,4511,Tysabri,2016-09-01,2019-06-28, ,mg,['2 / Day'], ,Patient Choice/Convenience
20598,498,Avonex,2016-01-11,2021-01-11,20,mg,['2 / Day'], ,Persistence of relapses
20599,2959,Methylprednisolone,2016-08-25,2018-07-21,300,mg,['2 / Day'], ,Lack of efficacy
20600,1457,Rebif [44],2016-01-07,2019-11-15,20,mg,['/Month'],IV,Patient Choice/Convenience
20601,1457,Rebif [44],2016-10-11,, ,mg,['2 / Day'], , 
20602,1457,D-cure (Vitamine D),2016-02-14,,1000, ,['/Month'],IV, 
20603,1457,Gilenya,2016-06-29,2018-08-25,500, ,['3 / Week'],IV,Adverse Event
20604,4996,IVIG,2016-08-20,, , ,['/Month'], , 
20605,4847,IVIG,2016-01-10,2021-03-11,1,mg,[' '],Oral,Lack of efficacy
20606,4847,Tecfidera,2015-11-09,, ,mg,['/ Week'],IV, 
20607,1464,IVIG,2016-02-26,, ,mg,[' '],IV, 
20608,1773,Gilenya,2016-02-11,,1,MIU,['2 / Day'],Oral, 
20609,1773,Rebif [22],2016-07-24,2019-05-07, ,mg,['/ Week'],IV,Patient Choice/Convenience
20610,1773,Rebif [22],2016-05-24,2018-06-24,1, ,['/Month'], ,Lack of efficacy
20611,3409,Rebif [44],2015-12-24,2021-10-07,1,mg,['/Month'],IV,Patient Choice/Convenience
20612,1570,Teriflunomide,2016-05-16,2018-09-13,500, ,['2 / Day'],IV,Persistence of relapses
20613,1570,Tecfidera,2016-03-11,, , ,['/ Day'],Oral, 
20614,4320,Avonex,2016-04-24,, , ,['/Month'],IV, 
20615,4320,Tysabri,2015-11-26,,300,MIU,[' '], , 
20616,3850,Teriflunomide,2016-06-15,2020-08-24,20, ,['/Month'], ,Adverse Event
20617,3850,Gilenya,2016-10-16,, , ,['/Month'],IV, 
20618,854,Alemtuzumab (Campath),2015-11-17,,1,mg,['/Month'],IV, 
20619,1150,Rebif [44],2016-07-16,, ,MIU,['3 / Week'],IV, 
20620,3187,Mitoxantrone,2016-08-09,, ,mg,['/Month'],IV, 
20621,3187,Rebif [22],2016-10-03,,20, ,['3 / Week'],IV, 
20622,3899,Rebif [22],2016-04-12,2017-12-18,20,mg,['3 / Week'],Oral,Persisting MRI activity
20623,3899,Betaferon,2016-02-25,,1000,MIU,['2 / Day'],IV, 
20624,891,Mitoxantrone,2016-03-07,, , ,['/ Week'], , 
20625,891,IVIG,2015-11-13,2019-05-31,1, ,['3 / Week'], ,Persistence of relapses
20626,891,Tysabri,2016-01-05,2020-09-11, , ,['/Month'],Oral,Persistence of relapses
20627,891,Rebif [44],2016-08-02,2019-11-20,400,mg,['3 / Week'], ,Patient Choice/Convenience
20628,227,Tecfidera,2016-06-02,,20,mg,['2 / Day'], , 
20629,3436,Methylprednisolone,2016-09-28,2019-11-07, ,mg,['2 / Day'], ,Lack of efficacy
20630,993,Teriflunomide,2016-09-14,, , ,['2 / Day'],IV, 
20631,993,Tecfidera,2016-05-02,2019-02-15, ,mg,['2 / Day'],IV,Persistence of relapses
20632,993,D-cure (Vitamine D),2016-08-01,, ,mg,['2 / Day'], , 
20633,2813,Mitoxantrone,2016-07-26,,5000, ,['/Month'], , 
20634,2813,Tecfidera,2016-05-16,,500,mg,['2 / Day'],IV, 
20635,4835,Rebif [22],2016-05-13,,500, ,['/Month'],IV, 
20636,4835,Gilenya,2016-10-12,2019-04-23,300, ,['2 / Day'],IV,Adverse Event
20637,4835,Rebif [44],2016-03-17,2019-07-05, ,mcg,['/Month'], ,Persistence of relapses
20638,3375,Mitoxantrone,2016-09-03,,5000,mg,['2 / Day'], , 
20639,3375,Mitoxantrone,2016-05-25,,500,mg,['2 / Day'], , 
20640,3375,Teriflunomide,2016-10-08,,20,mg,['3 / Week'], , 
20641,3375,Methylprednisolone,2016-09-27,2018-09-14,500, ,['/ Week'], ,Persisting MRI activity
20642,3406,Gilenya,2016-06-07,,300, ,['/Month'], , 
20643,3406,Tecfidera,2016-04-25,2018-10-21, ,mg,['/ Day'],Oral,Lack of efficacy
20644,1482,Endoxan,2016-02-14,, ,mg,['/Month'], , 
20645,1482,Rebif [44],2016-10-20,,5000, ,[' '],IV, 
20646,1482,D-cure (Vitamine D),2016-06-03,2021-03-18,500, ,['2 / Day'],IV,Patient Choice/Convenience
20647,1482,Teriflunomide,2015-11-17,,20,mg,['/Month'],IV, 
20648,1206,Avonex,2016-04-24,2018-07-09,1, ,['/Month'],IV,Lack of efficacy
20649,1206,Ledertrexaat,2016-08-28,, ,mg,['/Month'],IV, 
20650,1206,Mitoxantrone,2016-05-10,2018-07-07, ,MIU,['3 / Week'],IV,Adverse Event
20651,4637,Alemtuzumab (Campath),2016-04-20,,1000,mg,[' '],IV, 
20652,4637,IVIG,2015-10-31,, ,MIU,['2 / Day'],IV, 
20653,4637,Betaferon,2016-08-26,, , ,['2 / Day'], , 
20654,4637,Gilenya,2016-09-28,2020-07-15,300,mg,['2 / Day'],Oral,Persistence of relapses
20655,4793,Rebif [44],2016-09-14,, ,mg,['2 / Day'],IV, 
20656,3188,Rebif [44],2016-06-26,2021-03-19, , ,['2 / Day'], ,Patient Choice/Convenience
20657,3188,Teriflunomide,2016-06-10,, ,MIU,['/Month'], , 
20658,3310,Copaxone,2016-01-02,,300, ,[' '],Oral, 
20659,1762,Gilenya,2016-01-06,,5000,mg,['2 / Day'], , 
20660,1762,Avonex,2016-08-15,,300,mg,['/Month'], , 
20661,1762,Ledertrexaat,2015-12-21,, ,mg,['2 / Day'],IV, 
20662,1762,Tecfidera,2016-10-21,,5000,mcg,['2 / Day'],IV, 
20663,1856,Rebif [44],2016-10-17,,1000,mg,['3 / Week'],IV, 
20664,1856,Ledertrexaat,2016-01-09,2018-12-27,5000,MIU,['/Month'],IV,Patient Choice/Convenience
20665,4342,Alemtuzumab (Campath),2016-01-05,2019-01-06,300,mg,['/Month'],IV,Lack of efficacy
20666,4342,D-cure (Vitamine D),2016-05-28,2021-03-21, ,mg,['/Month'],IV,Persisting MRI activity
20667,3330,Rebif [22],2016-07-04,,400,mg,['2 / Day'], , 
20668,3330,Tysabri,2015-12-30,,300,mg,[' '],IV, 
20669,3330,Mitoxantrone,2016-08-06,2019-12-23,1000, ,['/Month'], ,Lack of efficacy
20670,1887,Tysabri,2016-04-10,2020-07-20, ,MIU,['2 / Day'],IV,Lack of efficacy
20671,2865,Gilenya,2015-11-19,2021-04-25,1000, ,['/ Day'],IV,Lack of efficacy
20672,1421,Methylprednisolone,2016-08-25,2020-02-25,400,mg,['/ Day'],Oral,Persistence of relapses
20673,1421,Tecfidera,2016-08-19,,1,mg,['3 / Week'],IV, 
20674,1421,Rebif [44],2016-03-09,,1,mg,['/Month'], , 
20675,3908,Avonex,2016-02-17,,300,MIU,['3 / Week'],Oral, 
20676,3908,Endoxan,2016-04-13,2020-06-30, , ,['/Month'],IV,Adverse Event
20677,4599,Rebif [44],2016-02-15,, , ,['/Month'],Oral, 
20678,4599,Mitoxantrone,2016-01-24,,400,mg,['2 / Day'], , 
20679,4599,Ledertrexaat,2016-02-24,2020-11-15,5000,mg,[' '],IV,Adverse Event
20680,4663,Rebif [44],2016-03-13,2019-03-10,1, ,['/Month'], ,Adverse Event
20681,4663,Endoxan,2016-09-19,2019-08-21,20,mg,['3 / Week'], ,Lack of efficacy
20682,4663,IVIG,2016-06-21,2018-07-12,500,mcg,[' '],IV,Persistence of relapses
20683,4663,Methylprednisolone,2016-03-04,,500,mg,['/Month'],IV, 
20684,949,Methylprednisolone,2016-03-08,2019-09-18,5000, ,['2 / Day'],IV,Lack of efficacy
20685,1590,Copaxone,2016-03-17,2018-03-06,1,mg,['2 / Day'], ,Patient Choice/Convenience
20686,1590,D-cure (Vitamine D),2016-02-02,, ,mg,['/Month'], , 
20687,1590,Tecfidera,2016-01-11,,1, ,['2 / Day'],IV, 
20688,1792,Tysabri,2016-03-20,, ,mg,['2 / Day'],IV, 
20689,1792,Tecfidera,2016-04-03,2021-07-24,1,mg,['2 / Day'], ,Adverse Event
20690,1358,Gilenya,2016-02-20,,1,mcg,['2 / Day'],IV, 
20691,1358,Methylprednisolone,2016-02-05,2020-12-30,500, ,['/ Day'], ,Patient Choice/Convenience
20692,1358,D-cure (Vitamine D),2015-10-26,,400, ,['/ Week'],IV, 
20693,1358,IVIG,2016-03-07,2020-02-03, ,mg,['2 / Day'], ,Lack of efficacy
20694,4525,Rebif [22],2016-05-27,,300, ,['/Month'],IV, 
20695,2841,Copaxone,2016-09-28,,1, ,['2 / Day'], , 
20696,2841,Endoxan,2016-08-17,,500, ,['2 / Day'], , 
20697,2841,Rebif [44],2016-06-04,2020-02-27,5000,mg,['/ Day'],IV,Lack of efficacy
20698,3695,Alemtuzumab (Campath),2016-10-06,, , ,['/Month'],IV, 
20699,3695,Rebif [44],2015-11-02,2021-02-13,500,mg,['3 / Week'],IV,Patient Choice/Convenience
20700,3695,Gilenya,2016-10-06,2021-10-15, ,mg,['/ Day'],IV,Persisting MRI activity
20701,2516,Alemtuzumab (Campath),2016-04-16,,500,mg,['3 / Week'], , 
20702,2516,Tecfidera,2015-12-12,,1,mg,['3 / Week'], , 
20703,2516,Rebif [44],2016-01-19,2019-12-17,20, ,[' '],Oral,Adverse Event
20704,419,Tecfidera,2016-10-07,, ,mcg,['/Month'], , 
20705,1848,D-cure (Vitamine D),2016-09-08,,5000,mg,['/Month'],IV, 
20706,1848,Betaferon,2015-11-24,2018-06-20,5000,mg,['/Month'],IV,Persisting MRI activity
20707,1848,Avonex,2016-05-28,,1000,MIU,['/ Week'],IV, 
20708,1848,Mitoxantrone,2016-09-02,,1000,mg,['/ Day'], , 
20709,4417,Avonex,2016-05-30,,1000,MIU,[' '],Oral, 
20710,4417,Betaferon,2016-10-15,, , ,['/ Day'],IV, 
20711,4417,IVIG,2016-02-04,, ,mcg,['/Month'],IV, 
20712,4923,Rebif [22],2016-09-25,,20,mcg,['/Month'],IV, 
20713,4923,Mitoxantrone,2016-01-03,2018-12-24,300,mg,['2 / Day'],IV,Persisting MRI activity
20714,4923,Avonex,2016-10-01,2019-04-22,20,mg,['2 / Day'],IV,Adverse Event
20715,4923,Alemtuzumab (Campath),2016-10-10,2021-09-08, ,mg,['/ Day'], ,Persistence of relapses
20716,1048,Rebif [44],2016-04-29,, ,mg,['/Month'], , 
20717,2431,Alemtuzumab (Campath),2015-12-31,2019-02-20,300,mg,['/ Day'],IV,Adverse Event
20718,1460,Tysabri,2015-11-18,,500,mg,['2 / Day'],IV, 
20719,1460,Alemtuzumab (Campath),2016-09-17,2019-07-12, ,mg,['/Month'],Oral,Adverse Event
20720,1460,Rebif [44],2016-03-29,,1000,mg,['/Month'],IV, 
20721,2307,Teriflunomide,2016-02-25,2019-05-20,1000,mg,['2 / Day'], ,Patient Choice/Convenience
20722,1736,Alemtuzumab (Campath),2016-09-23,2020-08-07,400,mg,['3 / Week'],Oral,Adverse Event
20723,1736,Tysabri,2016-06-11,2021-03-15,1000,mg,['/ Day'],Oral,Adverse Event
20724,1736,D-cure (Vitamine D),2016-07-03,2021-10-18,400,mg,['/Month'],IV,Adverse Event
20725,1003,D-cure (Vitamine D),2016-05-24,,5000,mg,['/Month'],IV, 
20726,1003,D-cure (Vitamine D),2016-09-11,,500,mcg,['/ Day'],IV, 
20727,3008,Gilenya,2016-05-11,,20,mg,['/Month'], , 
20728,3008,Gilenya,2016-03-24,2019-02-12, ,mg,['/Month'], ,Adverse Event
20729,3008,Ledertrexaat,2016-02-03,, , ,['/Month'],IV, 
20730,3008,Endoxan,2016-05-23,, , ,['/ Day'], , 
20731,335,Methylprednisolone,2015-12-13,,5000, ,['3 / Week'],IV, 
20732,335,Mitoxantrone,2016-10-02,, ,mg,['/Month'],IV, 
20733,670,Gilenya,2016-03-24,2018-12-12, ,mg,['2 / Day'],IV,Lack of efficacy
20734,670,Avonex,2015-12-03,,1000,mg,['/Month'],IV, 
20735,670,Teriflunomide,2016-09-26,,5000,mg,['/Month'], , 
20736,670,Methylprednisolone,2015-12-24,2018-07-05, ,mg,['2 / Day'],IV,Patient Choice/Convenience
20737,914,Gilenya,2015-12-26,,400,mg,['2 / Day'],IV, 
20738,914,Rebif [22],2016-05-08,2018-06-24,5000, ,['2 / Day'], ,Adverse Event
20739,914,Tysabri,2016-05-02,2020-04-28,500,mg,['2 / Day'],IV,Lack of efficacy
20740,4394,Endoxan,2016-03-06,, ,MIU,[' '],Oral, 
20741,622,Betaferon,2016-03-05,,1, ,['/Month'],IV, 
20742,622,IVIG,2016-01-23,2019-05-20,400,mg,[' '],IV,Lack of efficacy
20743,622,Rebif [22],2016-04-03,, , ,['/Month'], , 
20744,3436,Gilenya,2016-04-26,,20,mg,['/ Day'],Oral, 
20745,3436,Rebif [44],2015-12-21,2018-12-26,20,MIU,['/ Week'],Oral,Patient Choice/Convenience
20746,2130,Rebif [44],2015-12-03,2019-07-17,1000,mg,['/Month'], ,Adverse Event
20747,2130,Tysabri,2016-08-03,2020-08-18,1000,mcg,['/Month'], ,Adverse Event
20748,2130,Rebif [44],2016-08-16,2018-12-12,300, ,['3 / Week'],IV,Persisting MRI activity
20749,2130,Tysabri,2015-12-14,2018-04-23,500,MIU,[' '],IV,Persisting MRI activity
20750,2482,Alemtuzumab (Campath),2016-06-20,,1000, ,['/Month'],Oral, 
20751,2482,Gilenya,2015-12-29,,1, ,['2 / Day'],IV, 
20752,2482,Endoxan,2015-11-17,2021-08-01,300,MIU,[' '], ,Patient Choice/Convenience
20753,3052,Tysabri,2015-12-14,,20, ,['/ Day'],IV, 
20754,3052,Rebif [22],2016-06-19,2017-11-29,1,mcg,['2 / Day'],IV,Lack of efficacy
20755,3052,Tysabri,2015-12-18,2017-11-23,300, ,['/Month'],IV,Persisting MRI activity
20756,1826,Methylprednisolone,2016-09-08,,500, ,['/Month'], , 
20757,1826,IVIG,2016-03-01,2017-12-12, , ,['2 / Day'],IV,Adverse Event
20758,1826,Rebif [44],2016-09-13,,1,mg,['/ Week'], , 
20759,4729,Alemtuzumab (Campath),2016-04-15,, , ,['/Month'],IV, 
20760,1454,Gilenya,2015-11-14,,20, ,['/Month'],IV, 
20761,1454,Rebif [22],2016-01-07,,20, ,['/Month'],IV, 
20762,1454,D-cure (Vitamine D),2016-08-01,,1, ,['/Month'], , 
20763,2741,Tysabri,2016-08-27,2018-08-06,20,mg,['3 / Week'],IV,Patient Choice/Convenience
20764,652,Teriflunomide,2016-04-16,, ,mcg,['3 / Week'],IV, 
20765,652,D-cure (Vitamine D),2016-02-04,,20, ,['/Month'],IV, 
20766,652,Tysabri,2016-03-21,,400, ,['/Month'], , 
20767,652,IVIG,2016-08-28,,1000, ,['/Month'], , 
20768,4282,Endoxan,2016-09-03,,300, ,['/ Day'],IV, 
20769,375,Rebif [44],2016-01-13,,500, ,['2 / Day'], , 
20770,375,Rebif [22],2016-08-06,, ,mcg,['/ Day'],IV, 
20771,375,Tecfidera,2016-06-11,,400,mg,['3 / Week'],Oral, 
20772,380,Teriflunomide,2016-08-31,,5000,mg,['/ Week'], , 
20773,380,Betaferon,2016-06-26,, ,MIU,['/ Day'],IV, 
20774,380,Ledertrexaat,2016-04-29,2019-02-25, , ,['/Month'], ,Adverse Event
20775,380,Teriflunomide,2016-07-03,,300, ,['2 / Day'],IV, 
20776,1907,Ledertrexaat,2016-10-14,2018-08-16,300,MIU,['/Month'],IV,Patient Choice/Convenience
20777,2449,Rebif [44],2016-06-03,2019-11-27, ,mg,['/Month'],IV,Adverse Event
20778,3660,Rebif [44],2016-03-07,2018-04-21,300,mg,['2 / Day'], ,Lack of efficacy
20779,3660,Tecfidera,2016-08-14,2019-01-29,1, ,['3 / Week'],Oral,Adverse Event
20780,1700,D-cure (Vitamine D),2016-07-13,2018-07-12,500,MIU,['/Month'], ,Persisting MRI activity
20781,1700,Rebif [44],2016-02-12,2021-07-01, , ,['/Month'], ,Persisting MRI activity
20782,3635,Tysabri,2016-03-21,, , ,['2 / Day'],IV, 
20783,3635,Gilenya,2016-03-18,, ,mg,['/ Week'],IV, 
20784,3635,Methylprednisolone,2016-08-14,2018-01-04,500,mcg,['3 / Week'],IV,Lack of efficacy
20785,1855,D-cure (Vitamine D),2015-12-17,,20,MIU,['/Month'],IV, 
20786,1855,D-cure (Vitamine D),2016-09-14,2017-12-21,500,MIU,['2 / Day'],Oral,Adverse Event
20787,1855,Teriflunomide,2015-12-18,,400,mg,['3 / Week'], , 
20788,1855,Gilenya,2015-12-02,2019-08-24,400,mcg,['2 / Day'],IV,Persistence of relapses
20789,2851,Tecfidera,2016-05-22,,1000, ,['3 / Week'], , 
20790,2851,IVIG,2016-01-31,2021-01-30,1,MIU,['2 / Day'],IV,Adverse Event
20791,2851,Ledertrexaat,2016-09-29,2018-04-03,1000,mg,['3 / Week'],IV,Lack of efficacy
20792,574,Methylprednisolone,2016-07-29,2019-01-03, ,mg,['2 / Day'],IV,Persistence of relapses
20793,574,Tecfidera,2016-02-01,, ,mg,[' '],IV, 
20794,3747,Methylprednisolone,2016-04-15,2021-01-14,1000,mg,['/ Week'],IV,Patient Choice/Convenience
20795,3747,Teriflunomide,2015-12-27,,500, ,['/Month'], , 
20796,2335,Avonex,2016-08-10,2019-10-19,20,mcg,['/Month'],IV,Lack of efficacy
20797,2335,Gilenya,2015-12-05,, , ,['/Month'],IV, 
20798,2335,Methylprednisolone,2016-08-08,2021-03-02,20, ,['2 / Day'],Oral,Patient Choice/Convenience
20799,4262,Gilenya,2016-01-22,2020-09-20,500,MIU,['3 / Week'], ,Adverse Event
20800,4262,IVIG,2015-11-05,, ,MIU,[' '],IV, 
20801,1605,Avonex,2016-04-19,, , ,['/Month'],IV, 
20802,1605,IVIG,2016-09-21,,500,mg,['/ Day'],IV, 
20803,4192,Gilenya,2016-02-26,,300,mg,['2 / Day'], , 
20804,4192,Rebif [22],2016-08-27,,500, ,['/Month'],Oral, 
20805,4192,Teriflunomide,2015-12-02,,400, ,['3 / Week'],Oral, 
20806,1529,Tecfidera,2016-08-05,2018-09-22,300,mg,[' '],IV,Persistence of relapses
20807,4538,Tecfidera,2016-07-02,2020-04-06,5000,mg,[' '],IV,Adverse Event
20808,1300,Gilenya,2016-03-20,,1000,mg,['/Month'],IV, 
20809,1300,Alemtuzumab (Campath),2016-08-23,2018-09-24,20,mg,['/Month'], ,Lack of efficacy
20810,1300,Alemtuzumab (Campath),2016-08-27,,20, ,['/ Day'],Oral, 
20811,3623,Tecfidera,2015-12-08,,500,MIU,['2 / Day'],Oral, 
20812,4388,D-cure (Vitamine D),2016-08-19,,500,mg,['3 / Week'],Oral, 
20813,4388,D-cure (Vitamine D),2016-07-14,, , ,['/Month'], , 
20814,4388,Betaferon,2016-04-18,,1000, ,['/Month'],IV, 
20815,4388,Teriflunomide,2016-07-16,,20, ,[' '], , 
20816,3407,Tecfidera,2015-10-29,,1000,mg,['/Month'],IV, 
20817,4499,Betaferon,2016-08-22,2019-05-18, ,MIU,['/Month'],Oral,Patient Choice/Convenience
20818,4499,Mitoxantrone,2016-04-29,2021-01-24, ,mg,['/ Day'],IV,Adverse Event
20819,4499,Endoxan,2016-04-17,2020-07-22,20,mcg,['/ Week'],IV,Persisting MRI activity
20820,4499,Gilenya,2016-07-10,2020-10-29, ,mg,['/Month'],IV,Persistence of relapses
20821,3707,Tecfidera,2016-06-15,2020-07-27,1000,mg,['3 / Week'], ,Persistence of relapses
20822,3707,Methylprednisolone,2016-08-24,2018-03-29, , ,['/Month'],IV,Persisting MRI activity
20823,4668,Tysabri,2016-08-26,, , ,['2 / Day'], , 
20824,4668,D-cure (Vitamine D),2016-04-14,2019-04-06,500, ,['3 / Week'],IV,Adverse Event
20825,4668,Tysabri,2016-09-16,2020-08-16,400,mg,['/Month'],Oral,Persisting MRI activity
20826,2756,Ledertrexaat,2016-03-29,, , ,['/Month'], , 
20827,2756,Teriflunomide,2016-05-27,,20,mg,[' '],IV, 
20828,2756,Betaferon,2016-03-11,,500,mg,['/Month'], , 
20829,2756,IVIG,2016-10-05,,500, ,['/Month'], , 
20830,1775,Tysabri,2016-03-19,,1000,MIU,['/Month'],Oral, 
20831,1775,Mitoxantrone,2015-11-26,2019-10-29, , ,['/Month'], ,Lack of efficacy
20832,1775,Tecfidera,2016-04-29,2019-04-04,500, ,['2 / Day'], ,Persistence of relapses
20833,1775,Methylprednisolone,2016-01-30,2020-07-21, ,mg,['2 / Day'], ,Patient Choice/Convenience
20834,4713,Tecfidera,2016-03-08,,1000, ,['/Month'],Oral, 
20835,2357,Copaxone,2016-03-05,,300,mg,['3 / Week'], , 
20836,2357,Gilenya,2016-03-31,2018-01-10, , ,['2 / Day'],IV,Patient Choice/Convenience
20837,2357,Endoxan,2016-07-30,2021-08-17, , ,['/Month'],IV,Lack of efficacy
20838,3741,Copaxone,2015-12-20,, ,mg,['/ Day'],IV, 
20839,3741,Avonex,2016-02-03,2021-06-20, ,mg,['2 / Day'], ,Adverse Event
20840,3741,D-cure (Vitamine D),2016-06-16,, ,mg,['2 / Day'],IV, 
20841,3741,Tecfidera,2016-07-17,, , ,['3 / Week'],Oral, 
20842,774,Tecfidera,2016-04-25,, ,mcg,['/Month'],Oral, 
20843,774,D-cure (Vitamine D),2015-12-06,,300,mg,['/ Day'],IV, 
20844,1524,Rebif [22],2016-07-07,,1000,mg,['/Month'],Oral, 
20845,1524,Rebif [44],2015-11-02,2018-08-29,20,mg,['2 / Day'], ,Lack of efficacy
20846,1524,Avonex,2015-11-04,2020-11-18, ,mcg,['/Month'],IV,Persistence of relapses
20847,1231,Tysabri,2016-10-22,,500,MIU,['/ Day'],IV, 
20848,1231,Rebif [44],2015-12-01,2020-04-20,20, ,['2 / Day'], ,Lack of efficacy
20849,1231,Rebif [22],2016-08-01,,1000,mg,['/Month'],IV, 
20850,1448,D-cure (Vitamine D),2015-11-09,, ,mg,['/ Day'],IV, 
20851,1448,Rebif [44],2016-07-07,2019-08-26, ,MIU,['2 / Day'],IV,Adverse Event
20852,1448,Ledertrexaat,2016-03-27,2018-03-19, ,MIU,['2 / Day'],IV,Persistence of relapses
20853,1448,Avonex,2016-07-14,,400,mg,['/Month'],IV, 
20854,1064,Endoxan,2016-02-07,2019-03-04, , ,['/Month'],IV,Patient Choice/Convenience
20855,2190,Methylprednisolone,2015-11-27,,1000, ,['/Month'], , 
20856,3468,Endoxan,2016-02-10,,5000,mg,['2 / Day'],IV, 
20857,3468,Tysabri,2016-10-15,, ,MIU,['2 / Day'], , 
20858,420,D-cure (Vitamine D),2016-07-14,,5000,MIU,['2 / Day'],IV, 
20859,420,Betaferon,2016-08-24,2020-10-28, ,mg,['2 / Day'],Oral,Lack of efficacy
20860,420,Tecfidera,2015-12-23,2020-01-30,5000,MIU,['3 / Week'], ,Persisting MRI activity
20861,420,Mitoxantrone,2016-08-31,2019-03-29,5000, ,['3 / Week'], ,Patient Choice/Convenience
20862,2413,Copaxone,2016-10-06,2019-04-22,20,mg,['/Month'], ,Patient Choice/Convenience
20863,1579,IVIG,2016-01-18,2018-03-23,5000,mg,['2 / Day'],Oral,Adverse Event
20864,1797,Teriflunomide,2016-10-21,2019-11-13,500,mg,['3 / Week'],IV,Adverse Event
20865,1797,Betaferon,2016-06-21,, , ,['2 / Day'],IV, 
20866,2930,Rebif [44],2016-05-23,2020-12-27,5000,mg,['/ Day'], ,Lack of efficacy
20867,2930,Rebif [22],2016-07-12,,500, ,['/ Day'],IV, 
20868,2930,Avonex,2016-09-05,2019-03-01,500, ,['/Month'], ,Persisting MRI activity
20869,4028,Tecfidera,2016-04-28,2017-11-29, ,MIU,['3 / Week'], ,Adverse Event
20870,4028,Ledertrexaat,2016-09-25,,20,mg,['2 / Day'],IV, 
20871,4028,Ledertrexaat,2016-02-15,2018-09-22,1000,mg,['2 / Day'],IV,Adverse Event
20872,4028,Methylprednisolone,2016-10-15,, , ,['/Month'], , 
20873,3035,IVIG,2016-09-21,, ,MIU,['2 / Day'],Oral, 
20874,3035,Gilenya,2016-01-31,,1000,mg,['/Month'],Oral, 
20875,3035,Gilenya,2015-11-24,,5000,mcg,['/Month'],Oral, 
20876,1078,Tysabri,2016-08-28,,500, ,['2 / Day'],IV, 
20877,1078,Alemtuzumab (Campath),2016-03-26,,300,MIU,['3 / Week'],IV, 
20878,1078,Endoxan,2016-10-21,,500,mg,['3 / Week'],IV, 
20879,1078,Tysabri,2016-05-28,,5000, ,['2 / Day'],IV, 
20880,752,IVIG,2016-02-23,, ,MIU,['3 / Week'],IV, 
20881,752,Methylprednisolone,2016-03-13,2020-03-27,5000, ,['/Month'],IV,Persisting MRI activity
20882,752,Methylprednisolone,2016-10-08,,20, ,[' '],IV, 
20883,3996,D-cure (Vitamine D),2016-10-05,,5000, ,['2 / Day'],IV, 
20884,3996,Endoxan,2016-05-16,,500, ,['/Month'],IV, 
20885,3996,Rebif [22],2016-01-14,2021-09-24,400,mcg,['/Month'], ,Adverse Event
20886,3730,Gilenya,2016-10-10,, ,mg,['2 / Day'],Oral, 
20887,3730,IVIG,2016-10-19,2018-04-29,5000,mg,['/ Week'],IV,Adverse Event
20888,1621,IVIG,2015-12-09,2019-12-10,500,mg,['/Month'],IV,Persistence of relapses
20889,2674,Methylprednisolone,2016-03-22,,400, ,['2 / Day'],IV, 
20890,2674,Ledertrexaat,2016-02-15,, ,MIU,['/ Day'],Oral, 
20891,2674,Tecfidera,2016-01-31,2019-04-17, ,mg,['/Month'],IV,Adverse Event
20892,2674,Avonex,2016-06-24,, ,mg,['/Month'],IV, 
20893,4063,Tecfidera,2016-05-01,,500,mg,['2 / Day'],IV, 
20894,4063,Avonex,2016-08-15,,1,mg,['/ Day'],IV, 
20895,3586,Ledertrexaat,2016-10-18,,500,mg,['/Month'],IV, 
20896,3586,Rebif [44],2016-07-01,2021-02-17,1000, ,['2 / Day'],IV,Lack of efficacy
20897,338,Rebif [44],2016-02-14,, , ,['/Month'], , 
20898,338,Endoxan,2016-10-17,2018-04-19,1, ,[' '],IV,Persisting MRI activity
20899,979,Teriflunomide,2016-02-19,2020-12-24,300,mg,['/ Day'],IV,Lack of efficacy
20900,743,Avonex,2016-10-07,,5000,mg,['/Month'],Oral, 
20901,743,Gilenya,2016-02-16,,5000,mg,['/Month'], , 
20902,194,Tysabri,2016-10-12,2018-08-28,1,mg,['2 / Day'], ,Persistence of relapses
20903,194,D-cure (Vitamine D),2016-02-11,2020-03-06,5000,MIU,['2 / Day'],IV,Adverse Event
20904,194,IVIG,2016-02-22,,1, ,['2 / Day'], , 
20905,194,Avonex,2016-09-05,2021-02-16,500,mg,['2 / Day'], ,Lack of efficacy
20906,1640,Copaxone,2016-10-13,2019-11-22,1000,mg,['2 / Day'],IV,Persisting MRI activity
20907,228,Mitoxantrone,2016-04-22,2018-08-28,1000, ,['/Month'],IV,Lack of efficacy
20908,3463,Mitoxantrone,2016-09-11,,300,mg,['2 / Day'],Oral, 
20909,3463,Tysabri,2016-09-07,,5000,MIU,['3 / Week'],IV, 
20910,3463,Ledertrexaat,2016-09-17,,500, ,['/Month'],IV, 
20911,3463,Methylprednisolone,2016-02-18,2018-10-23,300,mg,['3 / Week'], ,Patient Choice/Convenience
20912,4330,Mitoxantrone,2016-01-30,,20,mg,['/Month'],IV, 
20913,786,Copaxone,2016-07-07,,400, ,['3 / Week'], , 
20914,786,Mitoxantrone,2016-10-06,,1000, ,['2 / Day'], , 
20915,3465,Copaxone,2016-04-24,, ,mg,['2 / Day'],IV, 
20916,3465,Teriflunomide,2016-10-08,,20, ,['/ Week'],IV, 
20917,3465,Teriflunomide,2016-01-22,,400,mg,['/ Day'], , 
20918,3465,D-cure (Vitamine D),2016-06-16,,20, ,['3 / Week'],IV, 
20919,2807,Methylprednisolone,2015-12-10,2018-01-19,500, ,['3 / Week'],IV,Patient Choice/Convenience
20920,2807,Copaxone,2016-02-14,2018-12-30, , ,['2 / Day'], ,Persistence of relapses
20921,2807,Tecfidera,2016-01-20,, , ,['/Month'],IV, 
20922,4238,Tysabri,2016-01-05,, , ,['2 / Day'],IV, 
20923,4238,Copaxone,2016-05-28,,400,mg,['/Month'], , 
20924,1284,Rebif [22],2016-06-11,2020-02-26,400,mg,['2 / Day'],IV,Patient Choice/Convenience
20925,1284,D-cure (Vitamine D),2016-04-23,,1000, ,[' '],Oral, 
20926,1364,D-cure (Vitamine D),2016-07-23,,1000,mcg,['2 / Day'],Oral, 
20927,1364,Avonex,2016-04-22,,1,mg,['2 / Day'],IV, 
20928,267,Avonex,2016-05-23,,1000,mg,['2 / Day'], , 
20929,267,Rebif [44],2016-08-02,,1,MIU,['/ Week'], , 
20930,267,Teriflunomide,2015-11-24,2021-02-03,300,mg,['/ Day'],IV,Adverse Event
20931,1850,Betaferon,2016-03-22,2018-04-18,1000,mg,['/ Day'],Oral,Persisting MRI activity
20932,1850,Copaxone,2016-08-10,, , ,['/Month'], , 
20933,4574,Tecfidera,2016-04-24,,500,mg,['/Month'],IV, 
20934,4574,Endoxan,2015-11-08,2019-03-16,5000, ,['/Month'], ,Persisting MRI activity
20935,4574,IVIG,2016-05-15,2021-01-19,300, ,['/ Day'],Oral,Adverse Event
20936,4574,Alemtuzumab (Campath),2016-07-22,,400,MIU,['3 / Week'],IV, 
20937,3322,Alemtuzumab (Campath),2016-01-04,2019-08-05, , ,['2 / Day'], ,Persisting MRI activity
20938,3322,Gilenya,2016-08-15,,5000,MIU,['3 / Week'], , 
20939,451,IVIG,2016-03-24,, ,mg,['/ Week'],IV, 
20940,451,D-cure (Vitamine D),2015-11-08,2019-01-18,500,mg,['2 / Day'],IV,Lack of efficacy
20941,4153,Teriflunomide,2015-11-08,2018-06-25, ,mg,['2 / Day'],IV,Persisting MRI activity
20942,3461,Tecfidera,2016-05-21,, ,mg,['/Month'], , 
20943,3461,Avonex,2016-08-24,,1000, ,['2 / Day'], , 
20944,3461,Copaxone,2016-01-17,,5000,mg,['3 / Week'],IV, 
20945,3461,Ledertrexaat,2016-01-06,2018-05-14, ,mcg,['2 / Day'],IV,Persistence of relapses
20946,249,Methylprednisolone,2016-03-20,2021-09-06,1000,MIU,['/Month'], ,Patient Choice/Convenience
20947,249,IVIG,2016-04-17,2018-08-04, ,mg,['/Month'],IV,Persisting MRI activity
20948,935,Rebif [22],2016-04-13,,300, ,['2 / Day'],IV, 
20949,935,Gilenya,2015-11-23,2021-06-18, , ,[' '],IV,Persisting MRI activity
20950,2705,Rebif [22],2016-03-16,,400,mg,['2 / Day'],IV, 
20951,1226,Alemtuzumab (Campath),2015-10-31,,5000,mg,['/Month'],IV, 
20952,1226,Avonex,2016-03-19,2018-12-10,1000, ,['2 / Day'], ,Lack of efficacy
20953,1226,Betaferon,2016-06-08,,1,mg,['/Month'],IV, 
20954,4570,Tecfidera,2016-08-17,,300,mg,['/ Day'],IV, 
20955,4226,Methylprednisolone,2016-08-19,,5000,mg,['/Month'],IV, 
20956,4226,Methylprednisolone,2016-09-22,, , ,['/Month'], , 
20957,4226,Tecfidera,2016-06-16,2021-06-16,1, ,['/Month'], ,Lack of efficacy
20958,4226,Betaferon,2016-04-04,2018-03-28,20, ,['2 / Day'], ,Lack of efficacy
20959,3202,IVIG,2016-08-23,, ,mg,['/ Week'],IV, 
20960,3202,Rebif [44],2016-02-23,2017-12-24, ,mg,[' '], ,Persisting MRI activity
20961,3202,Betaferon,2016-02-13,2019-06-07,1000, ,['/Month'],Oral,Patient Choice/Convenience
20962,3202,Endoxan,2016-03-09,,500,mg,['/Month'],Oral, 
20963,3364,Rebif [44],2016-09-17,, ,mg,['3 / Week'], , 
20964,3364,IVIG,2016-01-08,,500,mg,['2 / Day'],IV, 
20965,3364,Alemtuzumab (Campath),2016-06-23,2018-07-11,1000, ,['/ Day'],IV,Lack of efficacy
20966,4458,IVIG,2016-01-18,, , ,['2 / Day'],IV, 
20967,4458,Betaferon,2016-07-02,2020-04-14,20,mg,['2 / Day'],IV,Adverse Event
20968,1063,Methylprednisolone,2016-04-03,, ,mg,[' '], , 
20969,1063,Alemtuzumab (Campath),2015-12-19,, , ,['/Month'],IV, 
20970,1063,Copaxone,2016-07-17,, ,mg,['/Month'], , 
20971,2207,Rebif [22],2016-08-09,,300,mg,['2 / Day'], , 
20972,2207,Gilenya,2016-07-26,, ,mg,['2 / Day'],IV, 
20973,2207,Tecfidera,2016-06-25,2019-04-03, ,mg,['2 / Day'],IV,Patient Choice/Convenience
20974,4813,Rebif [22],2016-04-26,2019-12-20, , ,[' '], ,Adverse Event
20975,4813,IVIG,2016-05-29,2019-08-11,500, ,['/Month'],IV,Persisting MRI activity
20976,1375,D-cure (Vitamine D),2016-10-06,,1,mg,['/Month'],IV, 
20977,1375,D-cure (Vitamine D),2016-03-26,, , ,['2 / Day'],IV, 
20978,1375,D-cure (Vitamine D),2016-04-30,,20,mcg,['2 / Day'], , 
20979,1375,Methylprednisolone,2016-08-13,2020-10-13, ,mcg,[' '], ,Persisting MRI activity
20980,3553,Alemtuzumab (Campath),2016-07-18,2019-03-25,400,mcg,['/Month'],IV,Lack of efficacy
20981,3553,Ledertrexaat,2016-09-24,, ,mg,['3 / Week'],IV, 
20982,3553,D-cure (Vitamine D),2016-09-16,2018-03-08,20,mg,['2 / Day'], ,Lack of efficacy
20983,3553,Tecfidera,2016-10-12,2018-08-24, ,mg,['/Month'],IV,Patient Choice/Convenience
20984,1958,Tecfidera,2016-08-31,2020-01-28, ,mcg,['/Month'], ,Lack of efficacy
20985,1958,Mitoxantrone,2015-10-31,, ,mg,['3 / Week'],IV, 
20986,1958,IVIG,2016-09-26,2019-08-06, , ,['/Month'],IV,Adverse Event
20987,1958,Teriflunomide,2016-09-06,,5000,mg,['2 / Day'],IV, 
20988,1132,D-cure (Vitamine D),2016-04-11,, ,mcg,['/ Week'],IV, 
20989,1132,Alemtuzumab (Campath),2016-07-17,,500, ,['2 / Day'],IV, 
20990,1258,Gilenya,2016-10-19,2020-08-05,1000, ,['2 / Day'],IV,Persisting MRI activity
20991,1258,IVIG,2015-11-27,2018-10-31,1,MIU,['/Month'],IV,Persisting MRI activity
20992,1258,Gilenya,2015-12-02,2018-03-24,1, ,['/Month'], ,Persistence of relapses
20993,1258,Rebif [22],2015-11-09,2021-09-02,300, ,['2 / Day'], ,Patient Choice/Convenience
20994,4655,Tecfidera,2016-03-29,2018-03-27,1,mg,['3 / Week'], ,Lack of efficacy
20995,4655,Gilenya,2016-08-28,, ,MIU,['/Month'],IV, 
20996,4655,Tysabri,2016-07-29,, ,mg,['3 / Week'],IV, 
20997,4655,Endoxan,2016-04-11,2021-08-26,20,mg,['3 / Week'],IV,Adverse Event
20998,491,IVIG,2016-06-19,2021-09-25, , ,['3 / Week'], ,Adverse Event
20999,491,Tecfidera,2016-02-07,2019-08-24,400, ,['/ Day'],IV,Persisting MRI activity
21000,1278,Rebif [22],2016-10-01,, ,mg,['/ Day'], , 
21001,3790,Betaferon,2015-12-26,2020-12-29,300,mg,[' '], ,Persisting MRI activity
21002,3790,Tecfidera,2016-09-01,,400, ,['/Month'], , 
21003,3790,Teriflunomide,2016-06-19,2018-10-28,300, ,['3 / Week'],IV,Adverse Event
21004,3790,Methylprednisolone,2016-07-02,,20,mg,['2 / Day'],IV, 
21005,1850,Gilenya,2016-05-25,2018-04-13,500,mg,['2 / Day'], ,Patient Choice/Convenience
21006,1924,Avonex,2015-11-12,2017-10-28, , ,['2 / Day'],IV,Adverse Event
21007,1924,Methylprednisolone,2016-05-15,2021-09-05,20, ,['/Month'], ,Persisting MRI activity
21008,1924,Tysabri,2015-11-27,, ,mg,['2 / Day'], , 
21009,3445,Alemtuzumab (Campath),2016-06-29,2018-11-24,500, ,['/Month'],IV,Persistence of relapses
21010,3445,D-cure (Vitamine D),2016-03-17,,400, ,['/Month'], , 
21011,3445,Tysabri,2016-03-21,2019-04-21,300,mg,[' '], ,Lack of efficacy
21012,3445,D-cure (Vitamine D),2016-02-07,,400, ,['/ Week'],IV, 
21013,983,Alemtuzumab (Campath),2016-04-23,,300,mg,['2 / Day'],Oral, 
21014,983,Betaferon,2015-11-01,2018-11-20, ,mg,['/Month'],Oral,Persisting MRI activity
21015,4159,Tysabri,2016-03-28,2018-12-20,300, ,[' '],IV,Persistence of relapses
21016,4159,Betaferon,2016-08-21,, ,mg,[' '],Oral, 
21017,2724,Tysabri,2016-09-26,2021-06-01, , ,['3 / Week'],IV,Patient Choice/Convenience
21018,3879,Gilenya,2016-04-02,2020-01-18,1000,mg,[' '], ,Lack of efficacy
21019,3879,Endoxan,2016-03-03,2019-11-03, ,mg,['/Month'],IV,Patient Choice/Convenience
21020,3879,Tysabri,2016-08-29,,1, ,[' '],IV, 
21021,3879,Betaferon,2016-08-12,, , ,['2 / Day'],IV, 
21022,2411,D-cure (Vitamine D),2016-09-16,2018-10-28,500,mg,[' '], ,Patient Choice/Convenience
21023,2411,Mitoxantrone,2016-06-11,2021-09-07, , ,['/Month'], ,Lack of efficacy
21024,1853,Rebif [44],2016-09-20,,20, ,['/Month'],IV, 
21025,149,Rebif [44],2016-10-18,,20, ,['2 / Day'],IV, 
21026,149,Mitoxantrone,2016-08-31,,500,mg,['2 / Day'],IV, 
21027,149,Mitoxantrone,2016-04-30,,300,mg,['2 / Day'], , 
21028,149,Mitoxantrone,2016-08-19,, ,mg,['/ Day'], , 
21029,1309,D-cure (Vitamine D),2015-11-11,2020-06-15,300, ,['/Month'],Oral,Adverse Event
21030,3021,Methylprednisolone,2016-07-09,, ,MIU,[' '],IV, 
21031,3021,Tecfidera,2015-12-15,,300, ,['/ Week'], , 
21032,3021,D-cure (Vitamine D),2016-05-02,, ,mg,['2 / Day'], , 
21033,3021,Ledertrexaat,2016-04-14,,20, ,['/ Day'], , 
21034,2118,Tysabri,2016-09-15,2019-12-30,300, ,['3 / Week'], ,Adverse Event
21035,2118,Tecfidera,2016-07-01,2020-06-22, ,mg,['/ Week'],IV,Patient Choice/Convenience
21036,4745,Tecfidera,2015-12-27,,1000,MIU,['/Month'], , 
21037,4745,Rebif [44],2016-03-11,, ,mg,['/Month'], , 
21038,2418,Alemtuzumab (Campath),2015-11-11,,20, ,['3 / Week'],IV, 
21039,2418,IVIG,2016-04-19,,500,mg,['/ Day'], , 
21040,2418,IVIG,2016-08-24,,400,mcg,['2 / Day'], , 
21041,4746,D-cure (Vitamine D),2016-10-13,2018-08-06,500, ,[' '], ,Patient Choice/Convenience
21042,2545,Betaferon,2016-07-14,2019-02-05,500,mcg,['/ Week'],IV,Persistence of relapses
21043,2545,Tecfidera,2016-02-04,2019-03-01, ,mcg,['/ Week'], ,Lack of efficacy
21044,4803,Rebif [44],2016-04-06,2019-03-22,20,MIU,['2 / Day'],Oral,Adverse Event
21045,4803,D-cure (Vitamine D),2016-05-08,2018-06-21,300, ,[' '],IV,Persisting MRI activity
21046,4803,Methylprednisolone,2016-03-18,2020-06-26,20, ,['2 / Day'], ,Adverse Event
21047,4803,Methylprednisolone,2016-08-04,2018-06-29,400,mg,[' '],Oral,Lack of efficacy
21048,3555,Endoxan,2016-08-03,2020-04-01,20,mg,[' '],IV,Adverse Event
21049,3555,Betaferon,2015-11-11,,500,mg,['/Month'],IV, 
21050,3555,Gilenya,2016-09-09,2021-02-27,20,mg,['2 / Day'], ,Patient Choice/Convenience
21051,3555,Tecfidera,2016-01-23,,300, ,['/Month'],IV, 
21052,3195,Tysabri,2016-06-15,2021-05-08,400,MIU,['/Month'], ,Patient Choice/Convenience
21053,1491,Endoxan,2016-05-05,2019-04-23,1000, ,['/ Day'], ,Adverse Event
21054,1491,Rebif [44],2016-01-03,2018-06-30,1000,mg,['3 / Week'], ,Patient Choice/Convenience
21055,436,Teriflunomide,2016-09-02,2021-05-02, , ,['/ Day'], ,Adverse Event
21056,436,IVIG,2016-03-07,,500,mg,['2 / Day'], , 
21057,615,Rebif [22],2016-09-17,,5000,MIU,['/Month'],IV, 
21058,615,IVIG,2016-04-22,2017-11-29,5000,mcg,[' '], ,Adverse Event
21059,615,Rebif [44],2016-01-20,, , ,['3 / Week'],IV, 
21060,615,D-cure (Vitamine D),2016-03-06,2019-06-29,1,MIU,['/Month'], ,Persistence of relapses
21061,3757,D-cure (Vitamine D),2016-03-10,2019-06-30,20,mg,['2 / Day'],IV,Lack of efficacy
21062,3757,Ledertrexaat,2016-07-10,2020-11-27,20, ,['2 / Day'],Oral,Lack of efficacy
21063,3009,Methylprednisolone,2016-05-29,,20,mcg,['2 / Day'], , 
21064,344,Mitoxantrone,2015-11-20,, ,mcg,['/ Day'],IV, 
21065,344,Endoxan,2015-12-19,2019-09-02, ,mg,['/Month'],IV,Persisting MRI activity
21066,344,Tysabri,2016-09-26,,1, ,['/Month'],IV, 
21067,344,Methylprednisolone,2016-03-08,, ,mg,[' '],IV, 
21068,3369,Endoxan,2016-08-18,,5000,MIU,['2 / Day'], , 
21069,3369,Tecfidera,2016-04-11,2018-03-16, , ,['/Month'],Oral,Persisting MRI activity
21070,3369,Gilenya,2016-03-21,2019-11-05,300,mg,['2 / Day'], ,Patient Choice/Convenience
21071,171,Ledertrexaat,2016-06-14,,500, ,['/Month'], , 
21072,171,Tysabri,2016-08-07,,1000,mg,['/ Day'],IV, 
21073,171,Tecfidera,2016-06-05,,300,mg,['3 / Week'], , 
21074,3319,Tysabri,2016-05-07,2017-10-28,500,MIU,['/ Day'],IV,Persistence of relapses
21075,2260,Avonex,2015-11-27,,400,mg,['2 / Day'], , 
21076,2260,D-cure (Vitamine D),2016-02-07,2019-04-16,5000,mg,['2 / Day'], ,Persisting MRI activity
21077,2919,Betaferon,2016-02-28,2021-06-22,5000,mg,['2 / Day'],Oral,Patient Choice/Convenience
21078,2919,Alemtuzumab (Campath),2016-04-26,2019-10-11,5000,MIU,['/Month'],Oral,Persisting MRI activity
21079,2919,Tysabri,2016-05-24,2020-02-25, , ,['/Month'],IV,Adverse Event
21080,2919,Methylprednisolone,2016-04-10,2021-02-14, ,mg,['/ Day'],Oral,Patient Choice/Convenience
21081,2087,Ledertrexaat,2016-02-27,2019-05-24,20,mg,['2 / Day'],IV,Persisting MRI activity
21082,2087,Rebif [22],2016-04-15,,1,mg,['2 / Day'],IV, 
21083,2087,Rebif [44],2016-10-20,2019-10-12, ,MIU,['3 / Week'], ,Patient Choice/Convenience
21084,2087,Tecfidera,2015-11-17,, , ,[' '],IV, 
21085,4158,Ledertrexaat,2016-05-07,2021-06-03,20,MIU,[' '], ,Persisting MRI activity
21086,4158,Methylprednisolone,2016-05-08,, , ,['/Month'],IV, 
21087,4158,Copaxone,2016-01-04,,500,mg,['/Month'],IV, 
21088,4158,Avonex,2016-05-23,,20, ,['/ Day'], , 
21089,4055,Mitoxantrone,2016-06-29,,1000,mg,[' '],IV, 
21090,4055,D-cure (Vitamine D),2015-11-24,,300, ,['2 / Day'],Oral, 
21091,1336,Rebif [44],2016-02-11,2018-11-17,300, ,['2 / Day'],IV,Adverse Event
21092,1336,Mitoxantrone,2016-06-06,,1000, ,['2 / Day'],Oral, 
21093,1336,Tysabri,2015-12-06,, ,mg,['/Month'],IV, 
21094,2899,Betaferon,2016-05-01,,20,mg,['2 / Day'],IV, 
21095,2899,Betaferon,2016-08-15,,300,mg,['3 / Week'],Oral, 
21096,2899,Ledertrexaat,2016-04-03,2020-09-20,1, ,['3 / Week'], ,Adverse Event
21097,4786,Methylprednisolone,2015-11-18,2021-04-04, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
21098,4786,Alemtuzumab (Campath),2015-12-01,,500,MIU,['3 / Week'],IV, 
21099,4786,Gilenya,2016-07-20,2020-10-31, ,mg,['3 / Week'],Oral,Lack of efficacy
21100,4614,Avonex,2016-07-02,2019-03-25,20, ,['/Month'],Oral,Patient Choice/Convenience
21101,1623,Avonex,2016-10-11,2020-06-30,20, ,['/Month'],IV,Patient Choice/Convenience
21102,1623,Rebif [44],2016-09-11,,500, ,['3 / Week'],IV, 
21103,1623,Betaferon,2015-12-25,2021-04-18,300,mg,['2 / Day'],IV,Patient Choice/Convenience
21104,1623,Methylprednisolone,2016-03-20,,300, ,['2 / Day'],IV, 
21105,3255,IVIG,2016-02-01,, , ,['/ Day'], , 
21106,3255,Endoxan,2015-12-30,,5000,mg,['/ Day'], , 
21107,3255,Endoxan,2016-05-18,2021-02-24,20,mg,['/Month'],IV,Patient Choice/Convenience
21108,610,Tecfidera,2016-01-10,, ,mg,['/Month'], , 
21109,610,Tecfidera,2016-06-04,,20,MIU,['/Month'], , 
21110,2857,Rebif [44],2016-04-26,, ,mcg,['3 / Week'],Oral, 
21111,4700,Rebif [44],2016-06-08,,1000,mg,['3 / Week'],Oral, 
21112,4700,Teriflunomide,2016-07-11,2021-01-12,20,mg,['3 / Week'],IV,Lack of efficacy
21113,716,Gilenya,2016-01-11,2019-08-11,300, ,['/ Day'],Oral,Patient Choice/Convenience
21114,716,Avonex,2016-02-29,, ,MIU,['/Month'], , 
21115,716,Gilenya,2016-09-12,2018-03-19, ,mcg,['2 / Day'], ,Adverse Event
21116,716,Methylprednisolone,2016-09-12,2021-08-11,1,MIU,['2 / Day'], ,Patient Choice/Convenience
21117,2990,Avonex,2016-01-18,,500,mg,['3 / Week'],Oral, 
21118,2990,Mitoxantrone,2016-04-05,,1000, ,[' '],Oral, 
21119,2428,Tysabri,2015-12-28,, , ,['2 / Day'],IV, 
21120,2428,Tecfidera,2016-09-08,2019-08-29,500,mg,['3 / Week'],IV,Persisting MRI activity
21121,2428,Gilenya,2016-04-30,,1,mg,['/Month'],Oral, 
21122,3588,Endoxan,2016-07-14,,1000, ,['/Month'], , 
21123,3588,Tysabri,2016-02-14,,5000,mg,['/Month'],Oral, 
21124,3588,Gilenya,2016-05-15,, ,mg,['/Month'],IV, 
21125,3588,Copaxone,2015-11-28,, ,mg,['2 / Day'],IV, 
21126,4477,D-cure (Vitamine D),2016-08-27,,1000, ,['2 / Day'], , 
21127,2179,Ledertrexaat,2015-11-02,2019-04-14, ,mg,['/Month'],Oral,Adverse Event
21128,4015,Tysabri,2016-05-28,,500,mg,['2 / Day'], , 
21129,4015,Tecfidera,2016-05-31,, ,mg,['/Month'], , 
21130,4015,Tecfidera,2015-12-12,2020-04-14,1000,mg,['2 / Day'], ,Lack of efficacy
21131,4015,Alemtuzumab (Campath),2016-02-24,2021-06-12,5000,mg,['2 / Day'], ,Lack of efficacy
21132,4628,Copaxone,2016-03-12,2019-08-31,300,mg,[' '], ,Adverse Event
21133,4628,Gilenya,2016-04-13,2018-04-05,300,mg,['/Month'], ,Patient Choice/Convenience
21134,2045,Tecfidera,2016-09-11,2019-10-27,500, ,['/ Week'], ,Adverse Event
21135,4773,Endoxan,2016-01-29,, , ,[' '], , 
21136,4773,Methylprednisolone,2015-12-27,,400, ,['/Month'], , 
21137,2276,Copaxone,2015-12-14,, ,mg,['/Month'],IV, 
21138,2276,Rebif [44],2016-08-16,2020-04-15, ,mg,['/Month'], ,Adverse Event
21139,2276,D-cure (Vitamine D),2016-08-07,,500,mg,['2 / Day'], , 
21140,2276,Rebif [44],2016-02-17,, ,mg,['/Month'],IV, 
21141,570,Endoxan,2015-11-07,2018-01-18,5000,mcg,['2 / Day'],Oral,Persistence of relapses
21142,3174,Betaferon,2016-10-10,,20,MIU,['2 / Day'], , 
21143,3174,D-cure (Vitamine D),2016-08-07,2021-03-15,400, ,['/Month'], ,Adverse Event
21144,2954,Tecfidera,2015-12-21,2018-05-24,5000,mg,['3 / Week'],IV,Persistence of relapses
21145,2902,Betaferon,2016-09-03,2020-10-10, ,mg,[' '], ,Adverse Event
21146,2902,Tecfidera,2015-11-01,,500,mg,['/Month'],Oral, 
21147,261,Copaxone,2016-04-12,2019-12-14, , ,['/Month'], ,Adverse Event
21148,261,Alemtuzumab (Campath),2016-10-22,2019-05-23, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
21149,261,Tecfidera,2015-12-28,, , ,['3 / Week'],IV, 
21150,261,Rebif [44],2015-12-06,,1, ,['/ Day'], , 
21151,680,Tysabri,2016-02-10,,20, ,['/Month'],Oral, 
21152,1051,Tecfidera,2016-08-22,,500,mg,['/ Week'],IV, 
21153,1051,Betaferon,2016-06-25,2020-03-13,300, ,['2 / Day'],IV,Adverse Event
21154,1051,D-cure (Vitamine D),2015-11-17,2019-03-19,500,mg,[' '],IV,Persistence of relapses
21155,1051,Endoxan,2016-02-04,,20,mcg,['/Month'], , 
21156,1826,Gilenya,2016-05-22,2021-05-13, , ,['3 / Week'],IV,Lack of efficacy
21157,1826,Avonex,2015-11-21,2019-12-12,1000,MIU,['3 / Week'],IV,Persistence of relapses
21158,1826,Mitoxantrone,2016-01-20,,1000, ,['/Month'],Oral, 
21159,1826,Endoxan,2016-08-15,, ,mg,['2 / Day'],IV, 
21160,3991,Copaxone,2015-12-18,2021-02-11,400,mg,[' '],IV,Adverse Event
21161,3991,Ledertrexaat,2016-01-30,, , ,['3 / Week'],IV, 
21162,1966,Tecfidera,2016-03-07,2018-06-28,20,mg,['2 / Day'], ,Lack of efficacy
21163,1966,Endoxan,2015-12-04,,500,mg,['/Month'], , 
21164,1966,Rebif [22],2016-09-19,,500, ,['/Month'], , 
21165,1484,Ledertrexaat,2016-05-19,2018-03-26,20, ,['2 / Day'],IV,Adverse Event
21166,1484,Endoxan,2015-11-03,,1000,mcg,['/Month'],Oral, 
21167,1484,Tecfidera,2016-02-11,,5000, ,['/ Week'],IV, 
21168,2840,Methylprednisolone,2016-03-19,,500,MIU,['/Month'],IV, 
21169,2840,Gilenya,2016-01-26,2020-11-02, , ,['2 / Day'],Oral,Lack of efficacy
21170,2840,Mitoxantrone,2016-04-19,2019-07-25, , ,['3 / Week'], ,Adverse Event
21171,2840,Avonex,2016-06-21,,5000, ,['/ Day'], , 
21172,150,IVIG,2016-08-08,,400,mg,[' '],IV, 
21173,957,Tysabri,2016-05-15,, ,MIU,['2 / Day'],IV, 
21174,957,Gilenya,2016-03-03,, , ,['/ Week'],IV, 
21175,957,Avonex,2015-11-19,2018-12-15, ,MIU,['3 / Week'], ,Lack of efficacy
21176,4539,Teriflunomide,2016-05-04,,400, ,['/Month'],IV, 
21177,4539,Alemtuzumab (Campath),2016-04-13,2021-03-18,20, ,[' '], ,Persisting MRI activity
21178,4539,IVIG,2016-03-11,,400,MIU,['3 / Week'],IV, 
21179,1441,IVIG,2016-07-08,, ,MIU,['/Month'], , 
21180,224,IVIG,2016-03-27,,20,mg,['3 / Week'], , 
21181,224,Tecfidera,2015-11-25,2021-06-18, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
21182,224,Alemtuzumab (Campath),2016-04-16,, , ,['/ Day'],IV, 
21183,224,D-cure (Vitamine D),2015-12-14,,5000, ,[' '],IV, 
21184,366,Methylprednisolone,2016-09-10,, ,MIU,['/Month'], , 
21185,3423,Tysabri,2015-12-03,, , ,['2 / Day'],IV, 
21186,3423,Mitoxantrone,2016-04-12,2018-05-09,5000, ,['2 / Day'],IV,Adverse Event
21187,608,Gilenya,2016-08-02,, , ,['2 / Day'],Oral, 
21188,608,Betaferon,2016-03-03,, , ,['2 / Day'], , 
21189,608,Rebif [44],2016-09-19,2018-09-19, ,mg,['2 / Day'], ,Persistence of relapses
21190,2302,Ledertrexaat,2016-04-17,,500, ,['3 / Week'],IV, 
21191,2302,Teriflunomide,2016-05-31,2019-11-30,5000, ,['/Month'],IV,Patient Choice/Convenience
21192,3733,Copaxone,2015-11-10,2017-12-14, ,mg,['/Month'],IV,Lack of efficacy
21193,3733,Endoxan,2016-05-11,,300,mg,['2 / Day'],IV, 
21194,2693,Avonex,2016-05-24,,20, ,['2 / Day'],IV, 
21195,2693,Methylprednisolone,2015-11-21,2020-12-08, , ,['3 / Week'], ,Lack of efficacy
21196,4155,Teriflunomide,2015-12-15,2018-05-01,1,mg,['/Month'],IV,Adverse Event
21197,4155,Rebif [44],2015-11-14,,1000, ,['/Month'], , 
21198,2147,Tysabri,2016-01-02,, , ,['/ Week'], , 
21199,2147,Endoxan,2016-09-01,, , ,['/ Week'],Oral, 
21200,2147,Rebif [22],2015-11-25,,5000,mcg,['/ Week'], , 
21201,2147,D-cure (Vitamine D),2016-01-30,2020-12-03,500,mg,['/ Week'], ,Patient Choice/Convenience
21202,4729,Copaxone,2016-06-16,2019-04-14, ,mg,[' '],IV,Lack of efficacy
21203,4729,Tecfidera,2016-06-26,,300,mg,['2 / Day'],Oral, 
21204,945,Endoxan,2016-09-07,,1,mg,['/Month'],IV, 
21205,945,IVIG,2016-09-13,,300,mcg,['3 / Week'], , 
21206,945,Avonex,2016-10-15,,500,mg,['2 / Day'],IV, 
21207,945,Tecfidera,2016-05-17,,400, ,['/Month'], , 
21208,4849,Endoxan,2015-11-15,2018-05-10, ,mg,['/Month'],IV,Adverse Event
21209,4849,IVIG,2016-07-03,,500, ,[' '],IV, 
21210,4849,Methylprednisolone,2015-12-14,, ,mg,['2 / Day'], , 
21211,4849,IVIG,2016-01-02,,400,MIU,['2 / Day'], , 
21212,4982,Copaxone,2016-04-18,,1000, ,['2 / Day'], , 
21213,1532,D-cure (Vitamine D),2016-07-05,,5000, ,['2 / Day'],IV, 
21214,1532,Gilenya,2016-06-25,2021-07-28,500,mg,['/ Week'],Oral,Persisting MRI activity
21215,1532,Avonex,2015-11-18,,500, ,['/Month'],IV, 
21216,1532,Rebif [44],2016-04-16,, , ,['3 / Week'],IV, 
21217,1203,Alemtuzumab (Campath),2016-01-26,2020-01-22,5000,mg,['2 / Day'],IV,Adverse Event
21218,3032,Copaxone,2016-08-16,,500, ,['3 / Week'],IV, 
21219,3032,IVIG,2016-05-24,2019-11-12,500,mg,['/Month'],IV,Adverse Event
21220,3032,Ledertrexaat,2015-12-07,,500,mg,['/Month'],IV, 
21221,3032,Gilenya,2016-05-16,2020-05-27,1, ,['/ Week'],Oral,Adverse Event
21222,987,Endoxan,2015-12-31,2019-06-24, ,MIU,['/Month'], ,Adverse Event
21223,987,Rebif [22],2016-10-03,2021-06-03,300,mcg,['2 / Day'], ,Persisting MRI activity
21224,987,Gilenya,2016-08-27,2018-07-22,500,mg,['/Month'],IV,Persisting MRI activity
21225,1698,Teriflunomide,2016-09-12,2021-10-02,5000, ,['/Month'],Oral,Patient Choice/Convenience
21226,935,Copaxone,2016-04-28,2017-12-28,5000,mg,['2 / Day'],IV,Adverse Event
21227,935,Betaferon,2015-11-30,, ,MIU,['/Month'], , 
21228,2023,Teriflunomide,2015-12-04,,20,mg,['/ Day'],IV, 
21229,2023,Avonex,2016-09-20,2018-04-22,5000, ,['/Month'],IV,Persistence of relapses
21230,2023,Endoxan,2016-08-01,,5000, ,['2 / Day'],IV, 
21231,1018,Tysabri,2016-05-03,2018-03-23, ,mg,['3 / Week'],IV,Lack of efficacy
21232,1018,D-cure (Vitamine D),2016-04-22,2019-03-20,5000,mg,['2 / Day'],IV,Persisting MRI activity
21233,1018,Ledertrexaat,2016-03-17,2018-07-06, ,mg,['/Month'], ,Patient Choice/Convenience
21234,1018,Betaferon,2016-03-14,,400,MIU,['2 / Day'],IV, 
21235,3319,Rebif [22],2016-07-04,,1000,mg,['/Month'], , 
21236,3319,Rebif [44],2016-08-21,,500,mg,['2 / Day'],Oral, 
21237,4950,Gilenya,2016-10-10,2020-11-16,1,mg,['2 / Day'], ,Adverse Event
21238,4950,Tecfidera,2016-08-26,, , ,['2 / Day'], , 
21239,4950,Alemtuzumab (Campath),2015-12-30,,300,mg,['/Month'],IV, 
21240,2461,Teriflunomide,2015-11-20,,5000,mg,['/ Week'], , 
21241,2461,Betaferon,2015-12-22,,300,mg,['/ Day'], , 
21242,2461,Rebif [44],2016-05-28,, ,mg,['2 / Day'],IV, 
21243,4061,Ledertrexaat,2016-01-06,,5000, ,['/ Day'],Oral, 
21244,1013,Copaxone,2015-12-30,2021-04-20,1,mg,['2 / Day'],Oral,Adverse Event
21245,1013,IVIG,2016-09-29,,1000, ,['2 / Day'],Oral, 
21246,1637,Tecfidera,2015-12-15,,1, ,['3 / Week'], , 
21247,1637,Endoxan,2015-11-21,, ,mg,['/ Day'],IV, 
21248,3675,D-cure (Vitamine D),2016-06-02,,5000, ,['3 / Week'],Oral, 
21249,3675,Copaxone,2016-05-25,,20, ,['2 / Day'],IV, 
21250,3675,Rebif [44],2016-08-10,,1, ,['/Month'], , 
21251,3675,Rebif [22],2016-05-04,2021-03-15,300,mg,['/Month'],IV,Adverse Event
21252,421,Avonex,2015-10-31,,500, ,['2 / Day'], , 
21253,421,Alemtuzumab (Campath),2015-10-30,,300,mg,['2 / Day'], , 
21254,421,Tysabri,2016-04-19,2018-08-27, , ,['2 / Day'],IV,Patient Choice/Convenience
21255,421,D-cure (Vitamine D),2016-01-19,,1,mg,['3 / Week'], , 
21256,2469,Tecfidera,2016-08-18,,5000,mg,[' '],IV, 
21257,3927,Gilenya,2016-07-21,, ,MIU,['/Month'],Oral, 
21258,3927,Teriflunomide,2015-12-09,,400,mg,['/ Week'], , 
21259,3927,Endoxan,2016-08-31,,300,mg,['2 / Day'],Oral, 
21260,4831,Avonex,2016-02-12,,300,mg,['2 / Day'],IV, 
21261,4831,Ledertrexaat,2016-07-01,,400,MIU,['2 / Day'], , 
21262,564,Ledertrexaat,2016-08-09,,5000,mcg,['/ Day'], , 
21263,564,D-cure (Vitamine D),2016-04-22,2021-09-02,1000, ,[' '],IV,Lack of efficacy
21264,564,Copaxone,2016-03-02,, ,mg,['3 / Week'],IV, 
21265,564,Tysabri,2016-02-18,, , ,['2 / Day'], , 
21266,1662,Endoxan,2016-04-13,2018-12-17, , ,['2 / Day'], ,Patient Choice/Convenience
21267,1662,Betaferon,2016-04-07,,20,mg,['/ Week'], , 
21268,1662,Endoxan,2016-01-18,2020-04-27, ,mcg,['2 / Day'],IV,Adverse Event
21269,1662,IVIG,2016-06-21,,400, ,[' '],IV, 
21270,2318,Rebif [22],2016-09-21,2019-07-20,500,mg,['/ Week'],IV,Persistence of relapses
21271,4361,Gilenya,2015-12-17,,1000,mg,['/Month'], , 
21272,159,Rebif [44],2015-12-17,,1000, ,['3 / Week'], , 
21273,4485,Tysabri,2016-05-28,,1,MIU,['/Month'], , 
21274,4485,Rebif [44],2016-09-18,,1,mg,['/Month'], , 
21275,4485,D-cure (Vitamine D),2016-10-17,,20,MIU,['3 / Week'],IV, 
21276,3124,Endoxan,2016-07-05,, ,MIU,['/Month'],IV, 
21277,3124,D-cure (Vitamine D),2016-09-25,, , ,['/ Day'], , 
21278,3124,IVIG,2016-08-01,,1, ,['3 / Week'],IV, 
21279,3131,Teriflunomide,2015-11-06,2019-08-18, ,MIU,['/Month'],IV,Adverse Event
21280,3131,Tecfidera,2015-12-10,,500, ,['/Month'],IV, 
21281,3131,Copaxone,2016-04-16,,20, ,['3 / Week'], , 
21282,801,Rebif [44],2016-06-30,2020-08-05, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
21283,801,Teriflunomide,2016-06-14,, ,mg,['/ Day'], , 
21284,801,Tecfidera,2016-02-24,2019-06-04,20,mg,['2 / Day'],IV,Patient Choice/Convenience
21285,801,Endoxan,2015-12-18,2021-06-26,500,mg,['3 / Week'], ,Patient Choice/Convenience
21286,1041,Tecfidera,2016-02-22,2021-08-22,1, ,['/Month'],IV,Adverse Event
21287,4149,Alemtuzumab (Campath),2016-06-18,2019-03-26,5000,mg,['/ Week'],IV,Adverse Event
21288,4149,IVIG,2016-06-22,2019-02-06,1,mg,['3 / Week'],IV,Adverse Event
21289,4149,Gilenya,2015-12-20,,400,MIU,['/Month'],IV, 
21290,4149,Endoxan,2016-02-24,2018-03-21,500,MIU,['3 / Week'],Oral,Persistence of relapses
21291,367,Alemtuzumab (Campath),2016-10-15,, , ,['/ Day'], , 
21292,367,Alemtuzumab (Campath),2015-11-07,2018-04-21,300, ,['/Month'], ,Adverse Event
21293,367,Tysabri,2016-09-17,2020-09-29,500,mg,['/Month'],IV,Adverse Event
21294,367,Alemtuzumab (Campath),2016-05-06,2021-10-20,500,mg,['3 / Week'],IV,Persisting MRI activity
21295,902,Alemtuzumab (Campath),2016-01-19,2020-06-24,20, ,['2 / Day'],IV,Adverse Event
21296,902,IVIG,2016-06-16,2019-02-02,1, ,['/ Day'],IV,Patient Choice/Convenience
21297,1602,Alemtuzumab (Campath),2016-04-21,,300,mg,['/ Week'], , 
21298,4547,Ledertrexaat,2016-02-21,, , ,['/ Week'], , 
21299,4547,Gilenya,2016-03-31,2020-12-04,400, ,['/ Week'], ,Lack of efficacy
21300,998,Methylprednisolone,2015-12-25,,500,mg,[' '],IV, 
21301,2560,Endoxan,2016-10-01,2018-07-10, ,MIU,[' '],IV,Lack of efficacy
21302,2560,D-cure (Vitamine D),2015-11-26,,400,mg,['2 / Day'],IV, 
21303,3956,Gilenya,2016-09-09,2018-11-21,20,mg,['2 / Day'], ,Persisting MRI activity
21304,3956,Rebif [44],2016-07-08,,5000,mg,['2 / Day'],IV, 
21305,3956,Alemtuzumab (Campath),2016-07-23,2018-06-27, ,mg,['/Month'], ,Adverse Event
21306,380,Gilenya,2016-04-01,2019-07-28, ,mg,['2 / Day'],IV,Adverse Event
21307,380,Tysabri,2016-10-17,,20,mg,['/ Day'],IV, 
21308,224,Gilenya,2016-08-03,, ,mcg,['/ Week'],IV, 
21309,426,Gilenya,2016-01-31,, ,mg,['/Month'], , 
21310,426,Avonex,2016-07-19,,300,mg,['2 / Day'], , 
21311,1667,Copaxone,2015-11-01,, ,mcg,['3 / Week'],IV, 
21312,1667,Tecfidera,2016-04-01,,300,mg,['2 / Day'],IV, 
21313,4353,Gilenya,2016-08-26,, , ,['/ Week'],IV, 
21314,2797,Ledertrexaat,2016-06-03,2020-05-29,1000,mg,[' '],IV,Persisting MRI activity
21315,2797,Ledertrexaat,2015-12-11,2021-04-28, , ,['/Month'],IV,Patient Choice/Convenience
21316,2797,Tecfidera,2016-07-24,, ,MIU,['/Month'],IV, 
21317,2797,Rebif [44],2016-08-10,2021-09-17,300, ,['2 / Day'], ,Patient Choice/Convenience
21318,4233,D-cure (Vitamine D),2016-03-28,2019-01-20, , ,['/Month'],IV,Persistence of relapses
21319,4233,Copaxone,2016-08-11,2020-05-21,5000,MIU,['2 / Day'],IV,Lack of efficacy
21320,4233,Gilenya,2016-01-07,,500, ,['3 / Week'],IV, 
21321,4233,Tysabri,2016-06-25,,500, ,['3 / Week'],IV, 
21322,2645,Avonex,2015-12-12,,400,mg,['2 / Day'],IV, 
21323,2645,Tecfidera,2016-07-26,,500,mcg,['/Month'],IV, 
21324,364,Tecfidera,2016-01-01,, ,mcg,[' '], , 
21325,3872,Gilenya,2015-10-24,2021-06-10,1000,mg,['/Month'], ,Adverse Event
21326,3872,Betaferon,2016-01-17,,20,mg,['2 / Day'],IV, 
21327,3872,Teriflunomide,2015-11-25,,500,mg,['/Month'], , 
21328,4787,IVIG,2016-06-11,,20, ,['/Month'], , 
21329,4787,IVIG,2016-09-29,, ,mg,['/Month'], , 
21330,4787,IVIG,2016-08-19,,20,mg,['2 / Day'], , 
21331,268,Copaxone,2015-11-22,2020-08-29, ,mg,['2 / Day'],IV,Lack of efficacy
21332,268,Betaferon,2016-06-29,,20, ,['3 / Week'],IV, 
21333,1898,Ledertrexaat,2016-04-27,,500,mg,['2 / Day'],IV, 
21334,3538,Mitoxantrone,2015-10-24,,5000,mg,['/ Week'],IV, 
21335,3538,Tysabri,2016-09-19,2018-05-10,5000,mg,['/Month'], ,Adverse Event
21336,3538,Alemtuzumab (Campath),2016-07-26,2018-12-30, ,mg,['3 / Week'], ,Persisting MRI activity
21337,3538,Rebif [44],2016-08-10,,300,mcg,['/ Day'],Oral, 
21338,3553,IVIG,2016-10-12,,1,mcg,['/Month'],Oral, 
21339,3553,Gilenya,2016-10-14,2021-07-29,1, ,['2 / Day'],Oral,Persistence of relapses
21340,3115,D-cure (Vitamine D),2016-01-29,,300, ,['/Month'],IV, 
21341,423,Methylprednisolone,2016-07-03,2018-06-17,1, ,['/ Week'], ,Patient Choice/Convenience
21342,423,Methylprednisolone,2016-06-18,,1,mcg,['2 / Day'],IV, 
21343,423,Tecfidera,2016-09-25,,1000,mg,[' '],Oral, 
21344,423,Alemtuzumab (Campath),2015-11-18,2017-11-14, , ,['/ Week'],IV,Patient Choice/Convenience
21345,3454,Endoxan,2016-01-17,,300,mg,['2 / Day'],Oral, 
21346,3454,Tecfidera,2016-06-05,2017-12-28,500,mg,['/Month'],Oral,Adverse Event
21347,3454,Avonex,2016-08-08,, , ,[' '],IV, 
21348,4539,Rebif [44],2016-10-02,, , ,['/Month'], , 
21349,4539,Avonex,2016-08-02,,5000,MIU,[' '],IV, 
21350,4539,Endoxan,2016-01-26,2020-07-04, , ,[' '], ,Adverse Event
21351,4539,D-cure (Vitamine D),2016-02-24,2021-01-24,400,MIU,['2 / Day'],IV,Adverse Event
21352,3611,Rebif [22],2015-12-25,2021-07-04, , ,['3 / Week'],IV,Adverse Event
21353,3611,IVIG,2016-06-10,,1000, ,['/ Day'], , 
21354,3611,Teriflunomide,2016-07-20,2021-01-17,300, ,['3 / Week'],Oral,Patient Choice/Convenience
21355,812,Tecfidera,2016-03-27,2018-10-10,500,mcg,['/ Day'],IV,Adverse Event
21356,4127,IVIG,2016-02-10,2018-10-14, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
21357,4127,Rebif [44],2015-11-29,2019-12-14, ,mg,['/Month'], ,Patient Choice/Convenience
21358,921,Endoxan,2016-05-22,2021-05-24,5000,mg,['2 / Day'],Oral,Patient Choice/Convenience
21359,921,Gilenya,2016-07-19,, ,mg,['/Month'],Oral, 
21360,921,Betaferon,2016-06-11,, ,mg,['3 / Week'], , 
21361,921,Betaferon,2016-01-01,, ,mg,[' '],IV, 
21362,3965,Teriflunomide,2016-08-26,2021-08-21,1, ,['2 / Day'], ,Lack of efficacy
21363,4755,Teriflunomide,2016-08-23,2020-08-15, ,mg,['3 / Week'], ,Patient Choice/Convenience
21364,1581,Methylprednisolone,2016-09-22,2017-12-13,20,mg,[' '], ,Lack of efficacy
21365,1874,Methylprednisolone,2016-02-25,,5000,mg,['2 / Day'], , 
21366,1874,Copaxone,2016-02-28,,1,mg,['/Month'],IV, 
21367,1874,Endoxan,2015-12-04,,1000, ,['2 / Day'], , 
21368,1823,Rebif [22],2016-04-15,, , ,['/ Day'], , 
21369,1823,Copaxone,2016-05-13,,20,mg,[' '],IV, 
21370,1823,Methylprednisolone,2015-11-28,2019-04-05,5000,mg,['/Month'],IV,Patient Choice/Convenience
21371,1823,Alemtuzumab (Campath),2015-11-22,2019-08-16,1,MIU,['3 / Week'], ,Lack of efficacy
21372,3832,Teriflunomide,2016-08-31,2019-05-09, , ,['/Month'],Oral,Patient Choice/Convenience
21373,3832,Rebif [22],2016-04-23,,1, ,['/Month'], , 
21374,3004,Rebif [22],2016-08-15,,1000,mg,['/Month'],IV, 
21375,3004,Avonex,2016-08-15,,1000,mg,['/Month'], , 
21376,1535,Gilenya,2015-10-26,2021-05-18,1000, ,['2 / Day'], ,Persisting MRI activity
21377,1535,D-cure (Vitamine D),2015-11-25,2021-07-28,1,mg,['/Month'],IV,Lack of efficacy
21378,2178,Ledertrexaat,2016-04-11,2020-10-12,400, ,['3 / Week'],IV,Patient Choice/Convenience
21379,2178,Gilenya,2016-05-01,,1000, ,['2 / Day'],IV, 
21380,790,Rebif [44],2016-03-20,,300, ,['2 / Day'],IV, 
21381,790,Tysabri,2016-01-20,2018-04-04,20,mcg,['/Month'],IV,Patient Choice/Convenience
21382,790,Tysabri,2015-12-11,, , ,['2 / Day'], , 
21383,790,Methylprednisolone,2016-05-02,,20, ,['/ Day'],Oral, 
21384,3854,Tecfidera,2016-02-07,, , ,[' '],IV, 
21385,4453,IVIG,2016-03-26,2019-09-11,1,mcg,['2 / Day'], ,Adverse Event
21386,4453,Tysabri,2016-06-17,,20,mg,['2 / Day'],IV, 
21387,4453,Tecfidera,2016-10-13,2018-11-24,500,mg,['3 / Week'], ,Persisting MRI activity
21388,2033,Tecfidera,2016-03-12,,1000,MIU,['/Month'], , 
21389,2033,Avonex,2016-09-18,2019-03-01, ,mg,['2 / Day'],IV,Lack of efficacy
21390,2033,Tysabri,2016-06-09,, ,mg,['3 / Week'],IV, 
21391,2033,Tecfidera,2016-10-14,2019-01-23,400,MIU,[' '],IV,Persisting MRI activity
21392,3364,D-cure (Vitamine D),2016-05-30,2020-12-12,500,mg,['/ Week'], ,Adverse Event
21393,3364,D-cure (Vitamine D),2016-07-31,,1000,mg,['3 / Week'], , 
21394,3364,Tysabri,2016-06-29,, , ,['/Month'],Oral, 
21395,1927,Gilenya,2015-12-12,2018-09-06, ,mg,['/ Week'], ,Adverse Event
21396,1927,Copaxone,2016-07-19,2020-07-01, , ,['/Month'],IV,Persistence of relapses
21397,3122,Betaferon,2016-03-20,2020-04-27,300, ,[' '],IV,Persisting MRI activity
21398,3122,Copaxone,2016-01-28,, ,mg,['2 / Day'],IV, 
21399,4995,Tysabri,2015-10-26,,500,mcg,['/Month'], , 
21400,4995,Gilenya,2016-05-24,,300,mg,['2 / Day'],IV, 
21401,814,D-cure (Vitamine D),2016-06-26,2020-10-16,20, ,['2 / Day'], ,Persisting MRI activity
21402,814,Ledertrexaat,2016-05-21,2019-09-13, ,mcg,['2 / Day'], ,Lack of efficacy
21403,814,Avonex,2016-05-09,,20,mcg,['/Month'],IV, 
21404,2278,Alemtuzumab (Campath),2016-04-30,,500,MIU,['2 / Day'],Oral, 
21405,2278,Ledertrexaat,2016-04-07,, ,mg,['2 / Day'], , 
21406,3505,Gilenya,2016-06-30,2021-09-23, ,MIU,['/Month'],IV,Lack of efficacy
21407,3505,Gilenya,2016-02-14,2021-02-25,400,mg,['/ Week'], ,Patient Choice/Convenience
21408,999,Methylprednisolone,2016-07-02,,1,mg,['2 / Day'],IV, 
21409,3892,Methylprednisolone,2016-02-17,2020-06-01, , ,['/ Day'],IV,Adverse Event
21410,3892,Methylprednisolone,2016-04-01,,20, ,[' '],IV, 
21411,3892,Methylprednisolone,2016-04-09,,1000,mg,['2 / Day'], , 
21412,4717,Mitoxantrone,2016-03-31,,1000, ,['3 / Week'],IV, 
21413,4717,Tysabri,2016-07-15,2021-09-05,1,mg,['2 / Day'],IV,Lack of efficacy
21414,4717,Alemtuzumab (Campath),2016-03-08,,300,MIU,['/Month'],IV, 
21415,4717,Alemtuzumab (Campath),2016-02-03,2017-12-13,400, ,['/ Week'],IV,Lack of efficacy
21416,1357,IVIG,2015-10-26,, ,mg,['/Month'],Oral, 
21417,4093,Ledertrexaat,2016-03-19,2019-08-17,1000,mg,['/Month'],IV,Patient Choice/Convenience
21418,4093,Rebif [22],2016-10-08,2020-02-21,400,MIU,['/Month'], ,Lack of efficacy
21419,4093,Endoxan,2016-02-16,, ,mg,['2 / Day'], , 
21420,3999,Tecfidera,2016-07-08,,400,mg,['3 / Week'], , 
21421,3999,D-cure (Vitamine D),2015-10-29,,300, ,['3 / Week'], , 
21422,3999,D-cure (Vitamine D),2016-02-09,,1000,mg,['2 / Day'],IV, 
21423,1158,Tysabri,2016-09-01,2018-08-21, ,mg,['2 / Day'],Oral,Persistence of relapses
21424,1158,Tecfidera,2016-07-14,,400,MIU,[' '],IV, 
21425,1158,D-cure (Vitamine D),2015-12-05,,300,mg,[' '], , 
21426,2641,Tysabri,2016-01-11,2019-09-24,500,mg,['2 / Day'],IV,Persistence of relapses
21427,2641,Methylprednisolone,2016-06-28,2017-11-11, , ,['3 / Week'],IV,Persisting MRI activity
21428,2641,Endoxan,2016-06-13,,500,mg,['/Month'], , 
21429,2641,Ledertrexaat,2015-11-03,,20, ,[' '], , 
21430,1279,Mitoxantrone,2016-07-11,2018-03-11,1000,mcg,['2 / Day'],IV,Adverse Event
21431,653,D-cure (Vitamine D),2016-09-25,,1000, ,['/ Week'],IV, 
21432,485,Tecfidera,2016-03-06,,20,mg,['3 / Week'],IV, 
21433,2996,Mitoxantrone,2016-05-28,,300,mg,['3 / Week'], , 
21434,1037,Tecfidera,2016-07-02,2019-08-31,20,mg,['2 / Day'], ,Patient Choice/Convenience
21435,1037,Betaferon,2016-06-24,2018-05-29,1000,mg,['2 / Day'],IV,Adverse Event
21436,3973,D-cure (Vitamine D),2016-05-14,2019-06-30,1000, ,['/ Week'],Oral,Persisting MRI activity
21437,2455,Gilenya,2015-11-21,,1000,mcg,['/Month'],Oral, 
21438,1689,Rebif [44],2016-09-30,2019-09-11,1,mg,['2 / Day'], ,Lack of efficacy
21439,1689,Tecfidera,2015-12-23,,5000,mg,['/Month'], , 
21440,1689,IVIG,2016-07-08,,500,MIU,[' '],IV, 
21441,532,IVIG,2016-10-03,2019-02-02,500,mg,['/Month'],IV,Adverse Event
21442,1727,Ledertrexaat,2016-06-26,2018-12-06, , ,['2 / Day'],Oral,Persistence of relapses
21443,3825,Methylprednisolone,2016-07-26,2020-05-26, , ,['/Month'],Oral,Adverse Event
21444,1789,IVIG,2016-07-26,2020-11-16,20,mg,['2 / Day'],Oral,Lack of efficacy
21445,3605,Alemtuzumab (Campath),2016-04-24,2018-10-11, ,mg,['3 / Week'],IV,Adverse Event
21446,3273,Teriflunomide,2016-02-05,2019-11-04,300,mg,['2 / Day'],IV,Persistence of relapses
21447,3273,Teriflunomide,2016-08-25,2019-03-03,1000, ,['2 / Day'],IV,Lack of efficacy
21448,3273,Alemtuzumab (Campath),2016-02-27,2018-10-12, , ,['/Month'], ,Adverse Event
21449,3273,Tecfidera,2016-09-22,, ,mg,['3 / Week'],Oral, 
21450,2788,Alemtuzumab (Campath),2016-10-16,, , ,['3 / Week'],IV, 
21451,2788,Methylprednisolone,2015-11-24,, ,mg,['/Month'], , 
21452,2788,D-cure (Vitamine D),2015-12-17,2019-02-24,400,mg,['2 / Day'],IV,Lack of efficacy
21453,924,Tecfidera,2015-12-18,,300, ,['/Month'], , 
21454,4404,Alemtuzumab (Campath),2016-02-28,2017-11-03,1000, ,['2 / Day'],IV,Adverse Event
21455,396,Endoxan,2016-04-23,2019-07-13,300,mg,['2 / Day'],IV,Lack of efficacy
21456,396,Rebif [44],2015-11-13,, , ,['/Month'], , 
21457,396,Rebif [22],2016-07-20,,500,mg,['2 / Day'],IV, 
21458,3338,Gilenya,2016-01-18,2018-02-12,1000, ,['/ Day'],IV,Adverse Event
21459,586,Mitoxantrone,2015-12-15,2018-04-19,20,mg,['/ Day'],IV,Lack of efficacy
21460,586,Alemtuzumab (Campath),2016-06-22,2020-02-25,1000,mcg,['/Month'],IV,Persistence of relapses
21461,507,Endoxan,2016-07-28,2018-01-04,5000,mg,['/Month'],IV,Lack of efficacy
21462,2643,D-cure (Vitamine D),2015-11-07,2021-08-09,500, ,['/Month'],IV,Lack of efficacy
21463,2643,Gilenya,2016-01-04,,20, ,['/Month'], , 
21464,2643,Tecfidera,2016-09-26,2021-01-27,500, ,['3 / Week'], ,Persistence of relapses
21465,2643,Rebif [22],2015-11-30,,20,MIU,['/ Week'], , 
21466,406,D-cure (Vitamine D),2016-04-29,2018-11-02, ,mg,['/ Day'],IV,Persisting MRI activity
21467,406,Gilenya,2016-05-06,, ,MIU,['3 / Week'], , 
21468,406,Gilenya,2015-12-18,, , ,['/Month'], , 
21469,1292,Rebif [22],2015-11-16,2021-04-23,1000,mg,['2 / Day'], ,Adverse Event
21470,1292,Tecfidera,2015-12-19,,500,mg,['3 / Week'],IV, 
21471,1292,Gilenya,2016-04-16,,500, ,[' '],IV, 
21472,2526,D-cure (Vitamine D),2016-05-09,,1000,mg,['2 / Day'], , 
21473,2526,Tysabri,2016-04-06,, , ,['2 / Day'],IV, 
21474,2526,Avonex,2016-09-28,,1,mg,['2 / Day'],Oral, 
21475,3486,Teriflunomide,2016-03-26,2021-08-03,20, ,['3 / Week'], ,Adverse Event
21476,3486,IVIG,2015-12-20,2020-07-03, ,MIU,['/Month'], ,Adverse Event
21477,3486,Ledertrexaat,2016-10-07,,20, ,['3 / Week'],IV, 
21478,4215,Ledertrexaat,2016-07-28,, ,mg,['2 / Day'], , 
21479,4052,Avonex,2016-03-31,2019-03-19,20,mg,['2 / Day'], ,Lack of efficacy
21480,4052,Avonex,2016-02-29,2021-10-14, , ,['3 / Week'],IV,Persistence of relapses
21481,4052,Copaxone,2016-02-09,2021-05-31, ,mg,['2 / Day'],Oral,Lack of efficacy
21482,219,Endoxan,2015-11-12,2018-07-05, , ,['2 / Day'], ,Lack of efficacy
21483,219,Alemtuzumab (Campath),2016-08-23,2020-06-16,500,mg,['2 / Day'],IV,Adverse Event
21484,219,Mitoxantrone,2015-12-28,2019-04-14,1,mg,['2 / Day'], ,Persistence of relapses
21485,1391,Rebif [22],2016-03-11,,300,mg,['/ Week'],Oral, 
21486,1391,D-cure (Vitamine D),2016-09-15,2018-02-13,1, ,['2 / Day'],IV,Patient Choice/Convenience
21487,1391,D-cure (Vitamine D),2016-01-05,2018-12-29, , ,['/Month'],Oral,Patient Choice/Convenience
21488,2495,D-cure (Vitamine D),2016-01-30,2021-07-23, ,mg,[' '],IV,Lack of efficacy
21489,2495,Copaxone,2015-12-12,2018-10-11,1000,mg,['2 / Day'],IV,Persisting MRI activity
21490,2495,D-cure (Vitamine D),2016-04-28,,1000, ,['/Month'],IV, 
21491,2495,Copaxone,2016-09-03,2020-07-07,20,mg,['2 / Day'], ,Adverse Event
21492,720,Endoxan,2016-08-01,,400, ,['2 / Day'], , 
21493,720,Gilenya,2016-06-07,2018-07-09, ,MIU,['/Month'], ,Persistence of relapses
21494,1417,Tecfidera,2016-04-10,,1000, ,['3 / Week'],IV, 
21495,2810,Gilenya,2015-12-13,2020-09-25,500,mg,[' '],IV,Lack of efficacy
21496,2810,Ledertrexaat,2016-10-16,, , ,['2 / Day'],IV, 
21497,2810,IVIG,2015-11-20,, , ,['/Month'], , 
21498,2810,Rebif [22],2016-07-25,2020-11-07, , ,['/ Week'],Oral,Patient Choice/Convenience
21499,3941,Tysabri,2016-10-02,2018-09-26,20, ,['/ Day'],IV,Persisting MRI activity
21500,3941,Tecfidera,2016-01-26,, , ,[' '], , 
21501,3594,Gilenya,2015-10-27,,20,mg,['/Month'], , 
21502,4789,D-cure (Vitamine D),2016-05-26,2017-12-23,300, ,['2 / Day'],IV,Adverse Event
21503,4789,Rebif [22],2016-05-23,2020-01-29,500, ,['/Month'],IV,Persisting MRI activity
21504,787,Gilenya,2016-04-20,, ,mg,[' '],IV, 
21505,787,Betaferon,2016-01-02,,20,mg,['2 / Day'],IV, 
21506,787,Betaferon,2016-08-31,,300, ,['/Month'], , 
21507,3685,Avonex,2016-04-30,, ,MIU,['/Month'],IV, 
21508,3685,IVIG,2016-01-08,, ,mg,['3 / Week'],IV, 
21509,2908,Ledertrexaat,2016-06-01,,1000,MIU,['2 / Day'], , 
21510,3888,Methylprednisolone,2016-07-26,, ,mg,['2 / Day'],IV, 
21511,3888,Copaxone,2016-06-20,,400,mg,['2 / Day'],IV, 
21512,3888,D-cure (Vitamine D),2016-07-06,,500,mg,['/ Week'], , 
21513,3888,Rebif [22],2016-07-05,2021-02-18, , ,['/Month'],Oral,Persisting MRI activity
21514,4408,Rebif [22],2016-04-17,, ,mg,['2 / Day'],IV, 
21515,4408,Avonex,2016-06-20,2020-01-02, , ,['2 / Day'],Oral,Lack of efficacy
21516,4408,Teriflunomide,2016-07-07,,500,mg,['2 / Day'], , 
21517,3247,Tecfidera,2016-06-30,, ,mg,[' '], , 
21518,3247,Endoxan,2016-02-19,2018-07-12, , ,['/Month'],Oral,Patient Choice/Convenience
21519,3247,Betaferon,2016-03-24,2019-11-05,1000,mg,['/Month'], ,Persistence of relapses
21520,4222,Tysabri,2016-05-21,2021-05-08,20, ,['2 / Day'],Oral,Persistence of relapses
21521,4222,Teriflunomide,2015-11-29,2019-12-31,400,mg,['2 / Day'], ,Lack of efficacy
21522,158,Endoxan,2016-04-23,2020-12-07, , ,['2 / Day'],IV,Adverse Event
21523,158,Tysabri,2016-02-27,2018-04-03, , ,['3 / Week'],IV,Patient Choice/Convenience
21524,920,Ledertrexaat,2016-09-25,,5000,MIU,['2 / Day'], , 
21525,920,Methylprednisolone,2015-11-03,,400,MIU,['/ Day'], , 
21526,920,Alemtuzumab (Campath),2015-11-21,2020-07-18,500,mg,['3 / Week'],IV,Patient Choice/Convenience
21527,1543,IVIG,2016-01-17,,1000,mg,['/ Week'], , 
21528,4178,Betaferon,2015-12-22,, , ,['/Month'], , 
21529,4178,Ledertrexaat,2016-09-25,,5000,mg,['/ Day'], , 
21530,4178,Copaxone,2016-05-16,2021-05-30, ,mg,['/ Week'], ,Lack of efficacy
21531,2187,Ledertrexaat,2015-10-31,2018-06-27,20, ,['/Month'],IV,Persisting MRI activity
21532,2187,Alemtuzumab (Campath),2015-11-21,,400,mcg,['/Month'],IV, 
21533,2187,Copaxone,2016-03-16,2018-02-14,500,mg,['3 / Week'],Oral,Adverse Event
21534,2187,D-cure (Vitamine D),2015-12-04,,20,mg,['2 / Day'],IV, 
21535,4307,Avonex,2015-11-18,2021-03-19,1000,mg,['/Month'], ,Lack of efficacy
21536,4307,Rebif [22],2015-12-07,,500,mg,['/ Day'],Oral, 
21537,3107,Betaferon,2016-03-29,2021-04-15,500, ,['/Month'], ,Adverse Event
21538,3107,IVIG,2015-11-29,2019-11-11,300, ,['2 / Day'],Oral,Persisting MRI activity
21539,3486,Tysabri,2015-12-19,2021-06-22, , ,['/Month'], ,Persistence of relapses
21540,3486,Gilenya,2016-01-17,,20, ,['/Month'],IV, 
21541,3466,Avonex,2016-03-24,,500, ,['2 / Day'],IV, 
21542,3466,Betaferon,2016-06-18,,5000,mg,['/ Week'], , 
21543,3466,Rebif [44],2016-09-11,2020-06-13,20, ,['/Month'],IV,Adverse Event
21544,1472,Methylprednisolone,2016-02-02,,1000, ,[' '],IV, 
21545,1472,Mitoxantrone,2016-05-19,,5000, ,['3 / Week'], , 
21546,1472,Alemtuzumab (Campath),2015-11-03,2018-12-11, ,mcg,[' '],IV,Persisting MRI activity
21547,1472,Teriflunomide,2016-09-10,2019-06-26,400, ,['/Month'], ,Lack of efficacy
21548,3294,Tysabri,2016-04-23,2019-09-22,1, ,[' '],IV,Patient Choice/Convenience
21549,3294,D-cure (Vitamine D),2016-01-31,2020-12-11,500, ,['/Month'], ,Lack of efficacy
21550,3294,Endoxan,2016-10-07,,300,mg,['2 / Day'], , 
21551,3294,Avonex,2016-08-04,2019-04-12,500,mg,['/Month'],Oral,Patient Choice/Convenience
21552,4494,Avonex,2016-07-28,2018-06-04, , ,['/ Day'],IV,Persistence of relapses
21553,2561,Gilenya,2016-03-20,,1000, ,[' '],IV, 
21554,2561,Copaxone,2015-11-02,,1000, ,['2 / Day'], , 
21555,3960,Rebif [22],2016-08-29,2019-02-17,400, ,['3 / Week'],IV,Lack of efficacy
21556,3960,Copaxone,2016-05-15,2019-01-29,1, ,['3 / Week'],IV,Lack of efficacy
21557,3960,Methylprednisolone,2016-05-20,, ,mg,[' '], , 
21558,3960,Gilenya,2016-04-17,2019-12-30, ,mg,['/Month'], ,Lack of efficacy
21559,2361,D-cure (Vitamine D),2016-01-17,2018-10-01,500,mg,['/Month'],IV,Patient Choice/Convenience
21560,2498,Alemtuzumab (Campath),2016-08-09,, , ,['/Month'], , 
21561,2498,Avonex,2016-02-14,2018-04-13, ,MIU,['2 / Day'],IV,Lack of efficacy
21562,2498,D-cure (Vitamine D),2016-02-14,,500,mcg,['/Month'],IV, 
21563,836,Betaferon,2016-02-28,2019-12-18,20,MIU,['/Month'],IV,Lack of efficacy
21564,836,Rebif [22],2016-06-22,,500, ,['/Month'], , 
21565,836,Methylprednisolone,2016-02-19,2019-07-25, ,mg,['/Month'], ,Patient Choice/Convenience
21566,170,Tecfidera,2016-07-27,, , ,['3 / Week'],Oral, 
21567,3227,Tecfidera,2016-02-04,2020-09-02,5000,mg,['/Month'],IV,Adverse Event
21568,3227,Tecfidera,2016-01-23,2021-08-17,1000, ,['3 / Week'],IV,Persistence of relapses
21569,2786,Copaxone,2016-02-08,,500,mg,['2 / Day'], , 
21570,2786,Tysabri,2016-02-06,, ,mg,['/ Day'],IV, 
21571,2786,Rebif [44],2016-07-28,,300,mg,['2 / Day'],IV, 
21572,2135,Rebif [44],2016-02-17,2019-02-08,400,MIU,['/Month'], ,Patient Choice/Convenience
21573,2135,D-cure (Vitamine D),2016-10-10,,300, ,['/Month'],IV, 
21574,2135,D-cure (Vitamine D),2015-11-15,,5000, ,['/Month'],IV, 
21575,4421,D-cure (Vitamine D),2016-02-21,2019-03-04, , ,['/Month'],IV,Lack of efficacy
21576,4421,Rebif [44],2015-10-29,, , ,['2 / Day'], , 
21577,4421,Copaxone,2016-05-13,,500,mg,['2 / Day'], , 
21578,1714,Methylprednisolone,2016-08-29,, ,mg,['/Month'],IV, 
21579,1714,Rebif [22],2016-08-05,, , ,[' '],IV, 
21580,1714,Copaxone,2016-03-13,,500,mg,['3 / Week'], , 
21581,1714,Copaxone,2015-11-27,2020-07-05,20, ,['2 / Day'],IV,Patient Choice/Convenience
21582,1615,Methylprednisolone,2015-11-15,2019-04-24, ,mg,['3 / Week'], ,Lack of efficacy
21583,1615,Rebif [22],2015-11-22,2018-03-15,5000, ,['/Month'], ,Patient Choice/Convenience
21584,1615,IVIG,2016-05-15,,1,mg,['/Month'], , 
21585,1615,Gilenya,2016-02-04,, ,mg,['/Month'],IV, 
21586,825,Ledertrexaat,2016-07-16,, ,mg,['/Month'], , 
21587,825,Teriflunomide,2016-04-27,,1000, ,['3 / Week'], , 
21588,825,Gilenya,2016-07-17,2017-11-15,400, ,['2 / Day'],IV,Lack of efficacy
21589,825,Tecfidera,2016-01-20,,20,mg,['2 / Day'], , 
21590,3328,Tecfidera,2016-08-13,,500,mg,[' '],IV, 
21591,3328,D-cure (Vitamine D),2016-02-14,,1, ,['/Month'],IV, 
21592,3328,Avonex,2015-12-11,2019-09-01,5000, ,['/Month'],IV,Adverse Event
21593,3328,Gilenya,2016-02-20,,300,mcg,['/Month'],Oral, 
21594,3238,IVIG,2016-08-03,,300,mg,['/ Day'], , 
21595,3238,Ledertrexaat,2016-02-22,2021-02-14, , ,['2 / Day'],IV,Adverse Event
21596,3674,Mitoxantrone,2016-01-18,,1000,MIU,['/Month'],IV, 
21597,3674,Ledertrexaat,2015-11-05,2019-05-26,500, ,['3 / Week'],IV,Persisting MRI activity
21598,4324,Tysabri,2015-12-29,, ,mg,[' '], , 
21599,4324,Gilenya,2016-10-03,,5000,MIU,['/Month'],IV, 
21600,3423,Endoxan,2016-04-04,, , ,['3 / Week'], , 
21601,3336,Avonex,2016-07-30,2018-10-10,20,mg,['3 / Week'],IV,Lack of efficacy
21602,4547,Tecfidera,2016-08-15,, ,mg,['2 / Day'], , 
21603,4547,Endoxan,2015-12-16,,1000,mg,['2 / Day'],IV, 
21604,615,Gilenya,2016-05-14,2021-07-28,5000, ,['/Month'],IV,Persisting MRI activity
21605,615,D-cure (Vitamine D),2016-06-04,,500,MIU,['3 / Week'],IV, 
21606,615,D-cure (Vitamine D),2016-06-29,,300,MIU,['/Month'],IV, 
21607,615,IVIG,2016-07-24,2018-01-25,300, ,['/ Week'],Oral,Patient Choice/Convenience
21608,4388,Endoxan,2016-03-16,,20,MIU,['2 / Day'],IV, 
21609,4388,Tecfidera,2016-07-20,2018-09-30, ,mg,[' '],IV,Lack of efficacy
21610,541,Methylprednisolone,2016-06-19,2018-06-12,20,mg,['2 / Day'],IV,Adverse Event
21611,541,Endoxan,2016-10-06,2021-04-07, , ,['2 / Day'],IV,Patient Choice/Convenience
21612,3476,Tysabri,2016-07-17,, ,MIU,['/Month'],IV, 
21613,2814,Alemtuzumab (Campath),2016-10-20,2020-12-17,500,mg,['/Month'], ,Persistence of relapses
21614,2814,Avonex,2015-11-25,,500,mg,['/ Day'],IV, 
21615,2814,Tecfidera,2016-08-09,,500,mg,['/Month'],IV, 
21616,4004,Rebif [22],2015-12-06,,300,MIU,['/ Day'],IV, 
21617,4004,Rebif [22],2016-08-15,,300,MIU,['2 / Day'],IV, 
21618,4934,D-cure (Vitamine D),2015-12-23,,1000, ,[' '],IV, 
21619,4934,IVIG,2016-03-02,,300,mg,['2 / Day'],Oral, 
21620,1433,Alemtuzumab (Campath),2015-12-31,,400,MIU,['/ Day'],Oral, 
21621,4294,Tecfidera,2016-09-02,,300,MIU,['/Month'], , 
21622,3156,Gilenya,2016-02-19,,300, ,['/Month'], , 
21623,3156,D-cure (Vitamine D),2016-02-19,2020-07-02,300, ,['/Month'],IV,Patient Choice/Convenience
21624,4632,Gilenya,2016-05-02,2018-10-29,500, ,['/ Day'],Oral,Adverse Event
21625,4632,Rebif [22],2016-04-22,2018-01-18,20,mg,[' '],Oral,Lack of efficacy
21626,4632,Avonex,2016-08-06,2019-12-10,500,mcg,['2 / Day'],Oral,Persisting MRI activity
21627,3883,Methylprednisolone,2016-02-20,,1000,mg,[' '],IV, 
21628,3883,Endoxan,2016-02-29,2019-07-08,1,mg,['/ Day'], ,Persistence of relapses
21629,3883,Copaxone,2015-12-03,,500,mg,['2 / Day'], , 
21630,3883,D-cure (Vitamine D),2016-04-08,2018-04-11,500,mg,['/ Day'], ,Persisting MRI activity
21631,2595,Avonex,2016-05-06,,1,mg,['/Month'], , 
21632,2595,Alemtuzumab (Campath),2016-08-20,, ,mg,['/Month'], , 
21633,2595,Teriflunomide,2016-04-17,,1000, ,['/Month'],IV, 
21634,4902,Tecfidera,2016-01-15,2017-11-30, , ,['/ Day'],IV,Lack of efficacy
21635,4902,Mitoxantrone,2016-07-31,,20,mg,['2 / Day'],IV, 
21636,4902,Rebif [22],2016-04-20,,1000, ,['/Month'],Oral, 
21637,4902,Copaxone,2015-12-10,,1000, ,['/Month'],IV, 
21638,4218,Endoxan,2016-01-04,2020-08-10,5000, ,['2 / Day'], ,Persisting MRI activity
21639,4408,Gilenya,2016-08-18,, , ,[' '],IV, 
21640,4408,Mitoxantrone,2016-04-17,,400,mg,['2 / Day'],IV, 
21641,4408,Alemtuzumab (Campath),2016-06-22,,500, ,['2 / Day'],IV, 
21642,4408,D-cure (Vitamine D),2016-08-05,2021-05-03, , ,['/Month'],IV,Adverse Event
21643,2293,IVIG,2016-10-20,, ,mg,['2 / Day'],IV, 
21644,1152,Rebif [22],2016-06-06,2021-03-08,300, ,['3 / Week'],Oral,Lack of efficacy
21645,289,Copaxone,2016-04-20,,1, ,['/ Day'], , 
21646,289,Tysabri,2016-09-04,,300,MIU,['/Month'],IV, 
21647,289,Tysabri,2016-02-13,2020-04-29, ,mg,['/Month'],IV,Patient Choice/Convenience
21648,289,IVIG,2016-01-29,, , ,['2 / Day'],Oral, 
21649,3764,Tysabri,2016-05-29,,5000,mg,['/ Week'],Oral, 
21650,3764,Alemtuzumab (Campath),2016-09-04,,1,mg,['3 / Week'], , 
21651,425,D-cure (Vitamine D),2016-09-22,,500,MIU,['/Month'], , 
21652,425,Rebif [22],2016-04-13,,5000,mg,['/Month'],IV, 
21653,425,Endoxan,2016-04-19,2019-01-14,500,mg,['3 / Week'], ,Patient Choice/Convenience
21654,4237,Tysabri,2016-10-19,,20, ,['3 / Week'],Oral, 
21655,4237,D-cure (Vitamine D),2016-07-15,,1000,MIU,['/Month'],IV, 
21656,4237,Methylprednisolone,2016-03-11,,300,MIU,['/ Day'], , 
21657,4237,Rebif [44],2016-03-10,, , ,['2 / Day'],IV, 
21658,4948,Rebif [22],2016-05-10,, ,mg,['/Month'],IV, 
21659,2406,IVIG,2016-07-26,,1000, ,['2 / Day'],Oral, 
21660,2406,Methylprednisolone,2016-04-07,,1000,mg,['/ Day'], , 
21661,2406,Copaxone,2015-11-28,,20,mg,['2 / Day'], , 
21662,3998,IVIG,2016-09-09,,20, ,['/Month'],IV, 
21663,2016,D-cure (Vitamine D),2016-05-14,,20,MIU,['/ Week'],IV, 
21664,2016,Avonex,2016-02-01,,500,MIU,['/Month'], , 
21665,2016,IVIG,2016-08-02,, ,mg,['/ Day'],IV, 
21666,2016,Tysabri,2016-10-07,,300,MIU,['/Month'],IV, 
21667,3265,D-cure (Vitamine D),2015-11-27,2021-09-11, ,mg,['3 / Week'],IV,Adverse Event
21668,1186,Copaxone,2016-04-17,2020-09-09, ,mg,['2 / Day'], ,Persisting MRI activity
21669,1186,D-cure (Vitamine D),2016-08-22,,5000,mg,['/Month'], , 
21670,1186,IVIG,2016-01-16,2018-03-19,20,mg,[' '],Oral,Patient Choice/Convenience
21671,2112,IVIG,2016-07-08,, ,mcg,[' '], , 
21672,1294,Gilenya,2016-01-17,,500, ,['/Month'],IV, 
21673,687,Endoxan,2016-10-11,2018-09-04,500, ,['2 / Day'], ,Patient Choice/Convenience
21674,2462,Methylprednisolone,2016-05-28,2018-04-23,500,MIU,['3 / Week'],Oral,Adverse Event
21675,2462,Gilenya,2015-10-28,2018-01-01, ,mg,['3 / Week'],IV,Adverse Event
21676,365,D-cure (Vitamine D),2016-09-20,2017-11-07,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
21677,365,IVIG,2016-05-23,, ,mg,['3 / Week'],IV, 
21678,365,Endoxan,2016-03-11,2018-06-22,1000,mcg,['3 / Week'],IV,Adverse Event
21679,3563,IVIG,2016-10-06,,1,MIU,['/ Week'],Oral, 
21680,3563,Rebif [44],2016-06-22,,300, ,['3 / Week'], , 
21681,3563,Rebif [44],2015-11-14,2021-10-16, ,mg,['2 / Day'],IV,Adverse Event
21682,3302,Teriflunomide,2016-02-14,2021-06-10,1,mg,[' '],Oral,Persisting MRI activity
21683,4402,Rebif [22],2016-05-29,, , ,['/ Day'],IV, 
21684,1954,Mitoxantrone,2016-02-23,2018-07-16,20, ,['/ Week'],IV,Adverse Event
21685,4937,D-cure (Vitamine D),2016-02-28,,5000,mg,['2 / Day'],Oral, 
21686,4937,D-cure (Vitamine D),2016-04-23,,20,MIU,['3 / Week'],Oral, 
21687,4937,Gilenya,2016-02-19,,300, ,['2 / Day'],IV, 
21688,4937,Rebif [44],2015-11-07,2021-08-19, , ,['2 / Day'], ,Lack of efficacy
21689,1328,Copaxone,2016-02-25,2017-11-07,1, ,['/Month'],Oral,Persisting MRI activity
21690,1328,Rebif [44],2016-10-22,,20,MIU,['/Month'], , 
21691,1328,Rebif [22],2016-04-25,2021-02-10,300,mg,['3 / Week'],IV,Persisting MRI activity
21692,1328,Mitoxantrone,2015-11-17,2018-01-14,20,MIU,['3 / Week'],IV,Lack of efficacy
21693,3845,Rebif [22],2015-10-25,2021-03-07,300, ,['/ Day'],IV,Lack of efficacy
21694,3845,Methylprednisolone,2015-11-08,,1000, ,['2 / Day'],IV, 
21695,3845,Endoxan,2016-01-15,,1, ,['2 / Day'], , 
21696,3660,Mitoxantrone,2015-12-03,2019-06-18,300,mg,['2 / Day'], ,Persisting MRI activity
21697,4763,Rebif [22],2016-06-10,, ,mg,['/ Day'],IV, 
21698,4763,Tysabri,2016-04-30,,20, ,['/ Day'], , 
21699,2132,Teriflunomide,2016-08-21,2020-02-15,1000,mg,['2 / Day'], ,Adverse Event
21700,1596,D-cure (Vitamine D),2016-09-29,2021-10-21,1, ,['3 / Week'],IV,Patient Choice/Convenience
21701,1925,Avonex,2016-08-02,,500,MIU,['/ Week'], , 
21702,1925,Methylprednisolone,2016-03-25,2021-08-21,400,MIU,[' '], ,Lack of efficacy
21703,1925,Rebif [44],2016-02-08,2018-04-19,1,mcg,['/ Day'],IV,Adverse Event
21704,1925,Tysabri,2016-02-26,,1000,mg,['2 / Day'], , 
21705,3159,Tecfidera,2016-01-11,2019-02-25, ,mg,['/Month'], ,Persistence of relapses
21706,3159,Copaxone,2016-01-04,2020-01-28,500,MIU,['3 / Week'],IV,Persisting MRI activity
21707,3159,Copaxone,2016-08-20,,1000,mg,[' '],IV, 
21708,3159,Mitoxantrone,2016-01-01,,300, ,['2 / Day'],IV, 
21709,978,Tysabri,2016-03-24,, ,mg,['2 / Day'],Oral, 
21710,3096,Gilenya,2016-10-22,,5000, ,['/ Day'], , 
21711,3957,Betaferon,2016-10-09,2018-02-28, ,mg,['/Month'],IV,Persistence of relapses
21712,3957,Betaferon,2016-02-20,,500, ,['/Month'],IV, 
21713,357,Methylprednisolone,2016-08-07,2021-01-21, ,mcg,['/Month'],IV,Adverse Event
21714,357,Alemtuzumab (Campath),2016-07-30,, ,mg,['2 / Day'],IV, 
21715,3181,IVIG,2015-11-13,2019-04-13,300, ,['3 / Week'], ,Adverse Event
21716,3181,Teriflunomide,2016-05-14,,5000,mg,['2 / Day'], , 
21717,3181,Gilenya,2015-11-24,2018-04-24,1000,mg,['/ Day'], ,Patient Choice/Convenience
21718,3126,Gilenya,2016-08-21,2021-10-22,1000, ,['2 / Day'], ,Persisting MRI activity
21719,3126,Gilenya,2016-07-12,,300, ,['3 / Week'], , 
21720,3126,Mitoxantrone,2015-11-08,,500,mcg,['/ Day'],Oral, 
21721,803,Rebif [22],2016-03-05,, ,mg,['3 / Week'],IV, 
21722,1030,Gilenya,2015-12-31,2021-01-05,5000,mg,['/Month'], ,Persisting MRI activity
21723,1030,Gilenya,2016-08-13,2020-12-14, ,mg,['/Month'],Oral,Adverse Event
21724,1030,Gilenya,2015-10-31,2019-10-19,500,mg,['/ Day'],IV,Adverse Event
21725,1030,Ledertrexaat,2016-06-10,2019-03-11,20,mg,['2 / Day'], ,Patient Choice/Convenience
21726,3392,D-cure (Vitamine D),2016-08-30,2018-09-11,300,MIU,['2 / Day'], ,Adverse Event
21727,3392,Endoxan,2015-10-28,, , ,['/Month'], , 
21728,3392,Gilenya,2016-06-19,,1000,mg,['3 / Week'], , 
21729,1925,Alemtuzumab (Campath),2016-06-11,,5000,mg,['2 / Day'], , 
21730,1925,Ledertrexaat,2016-06-02,, ,mg,['/Month'], , 
21731,2407,Alemtuzumab (Campath),2016-04-22,2018-08-12, ,mg,['3 / Week'], ,Persistence of relapses
21732,2407,Rebif [44],2016-06-01,,300, ,['/Month'],IV, 
21733,2407,IVIG,2016-09-11,2019-07-08,300, ,['2 / Day'],IV,Persisting MRI activity
21734,415,IVIG,2016-08-17,,400, ,['/Month'],Oral, 
21735,415,Tysabri,2016-08-06,, , ,[' '], , 
21736,415,Copaxone,2016-02-28,2021-09-02,1,MIU,['/Month'],IV,Patient Choice/Convenience
21737,415,Rebif [22],2016-02-08,2020-09-15,500,MIU,['3 / Week'], ,Persisting MRI activity
21738,3234,Alemtuzumab (Campath),2015-11-28,, , ,['/Month'],IV, 
21739,3234,Betaferon,2016-02-23,,20,mg,['/Month'],IV, 
21740,3234,Avonex,2016-04-21,2018-03-14,500,mg,['2 / Day'], ,Persisting MRI activity
21741,1204,Mitoxantrone,2016-07-30,2019-08-28,20,MIU,['2 / Day'],IV,Persistence of relapses
21742,1204,D-cure (Vitamine D),2016-06-25,,5000, ,['/ Week'], , 
21743,117,Alemtuzumab (Campath),2016-03-08,, ,mg,['3 / Week'],IV, 
21744,117,Rebif [22],2016-04-29,, , ,['2 / Day'],IV, 
21745,117,Copaxone,2016-01-20,,20,mg,['2 / Day'],IV, 
21746,1901,Rebif [22],2016-02-23,, , ,['/Month'],IV, 
21747,1901,Tecfidera,2016-02-14,,1,mg,['3 / Week'],IV, 
21748,1901,Alemtuzumab (Campath),2016-08-29,,1000,mg,['/Month'], , 
21749,1901,Methylprednisolone,2016-01-24,,5000,mg,['/Month'], , 
21750,626,Avonex,2016-02-15,,300, ,['/Month'],Oral, 
21751,626,IVIG,2016-04-08,, , ,['3 / Week'], , 
21752,626,D-cure (Vitamine D),2015-11-14,,500,mg,['2 / Day'],IV, 
21753,4132,Ledertrexaat,2015-12-31,, ,mcg,['/Month'],IV, 
21754,4132,Tysabri,2016-02-28,,300,mg,['/Month'],IV, 
21755,4132,Ledertrexaat,2015-11-08,, , ,['/ Week'],IV, 
21756,4431,IVIG,2016-09-22,2020-02-13,20,mg,[' '], ,Persistence of relapses
21757,1608,Copaxone,2016-04-15,, , ,['2 / Day'],IV, 
21758,3523,Methylprednisolone,2016-06-08,,500,MIU,['/Month'],IV, 
21759,3523,D-cure (Vitamine D),2015-12-14,2019-06-13,5000,mg,[' '],IV,Lack of efficacy
21760,3523,Copaxone,2016-01-23,2018-06-27, , ,['3 / Week'],IV,Lack of efficacy
21761,3039,Rebif [44],2016-10-15,2020-09-26,1, ,['2 / Day'],Oral,Persisting MRI activity
21762,1590,Teriflunomide,2016-09-16,,1000, ,['/Month'],IV, 
21763,1590,Tysabri,2015-11-20,,500, ,['3 / Week'],IV, 
21764,1590,Betaferon,2016-08-31,2021-05-04, ,MIU,['/Month'], ,Adverse Event
21765,1590,Rebif [44],2015-11-13,2020-08-17,500,mg,[' '],IV,Adverse Event
21766,4063,Gilenya,2016-06-10,,1000,mg,['/Month'], , 
21767,4063,Rebif [22],2015-11-10,,1,mg,['/ Day'], , 
21768,1789,Methylprednisolone,2016-01-03,2021-07-06,1000,mcg,['2 / Day'], ,Adverse Event
21769,1789,Tecfidera,2016-10-17,2020-05-04, , ,['/ Day'], ,Adverse Event
21770,1789,Copaxone,2016-10-20,, ,mg,['2 / Day'],IV, 
21771,4807,Endoxan,2016-07-19,,20, ,['/Month'],Oral, 
21772,3324,Tecfidera,2016-08-28,2018-10-26,500,mcg,['2 / Day'], ,Patient Choice/Convenience
21773,3324,Rebif [44],2016-08-21,,300,MIU,['3 / Week'],Oral, 
21774,3324,Methylprednisolone,2016-05-20,,300, ,['3 / Week'], , 
21775,1565,D-cure (Vitamine D),2015-12-18,,300,mg,['3 / Week'],IV, 
21776,396,Avonex,2016-09-12,, , ,[' '],IV, 
21777,396,Rebif [22],2015-12-02,, ,MIU,['2 / Day'],IV, 
21778,4034,D-cure (Vitamine D),2016-07-12,2021-06-01,300,mg,['/Month'], ,Patient Choice/Convenience
21779,4034,Gilenya,2016-08-24,2020-02-28, ,mg,['2 / Day'],IV,Adverse Event
21780,4311,Mitoxantrone,2015-11-29,2018-08-30, , ,['/Month'],Oral,Persistence of relapses
21781,4311,IVIG,2016-06-20,2019-03-25, ,mg,['/Month'],IV,Patient Choice/Convenience
21782,4311,Alemtuzumab (Campath),2016-05-11,2021-06-21, ,mg,['2 / Day'], ,Persisting MRI activity
21783,4311,Mitoxantrone,2016-08-23,, ,mcg,['2 / Day'], , 
21784,2958,Tysabri,2016-08-18,2021-04-24, ,mg,['2 / Day'],IV,Adverse Event
21785,2958,D-cure (Vitamine D),2016-05-13,, , ,[' '],IV, 
21786,2958,Alemtuzumab (Campath),2015-11-06,, , ,['2 / Day'],Oral, 
21787,2958,Copaxone,2016-05-17,2021-01-20, ,mcg,['3 / Week'], ,Lack of efficacy
21788,2482,Teriflunomide,2015-12-30,2021-03-02, , ,['/Month'],Oral,Adverse Event
21789,2482,Rebif [44],2016-03-30,2021-03-06, ,mg,[' '], ,Lack of efficacy
21790,2145,Ledertrexaat,2016-03-21,, ,mg,[' '],Oral, 
21791,2276,Copaxone,2016-01-24,,20,mg,['/ Day'],IV, 
21792,2276,Tysabri,2016-08-16,, ,MIU,['2 / Day'],IV, 
21793,2276,D-cure (Vitamine D),2016-06-13,2018-07-28,300,mg,['2 / Day'],Oral,Persisting MRI activity
21794,2276,IVIG,2016-10-20,2019-03-21,300,MIU,['2 / Day'],Oral,Persisting MRI activity
21795,500,Copaxone,2016-02-27,,5000,mg,['2 / Day'], , 
21796,500,Betaferon,2015-12-17,2019-03-23,500,mg,['2 / Day'],IV,Lack of efficacy
21797,4361,Rebif [22],2015-11-06,2020-07-09,5000,mg,['3 / Week'],IV,Persistence of relapses
21798,2652,Betaferon,2016-09-17,2019-11-09,500,mg,['/Month'],IV,Persisting MRI activity
21799,3649,Ledertrexaat,2015-12-21,,1,mg,['/ Day'], , 
21800,3649,Teriflunomide,2016-01-05,,400,mg,['/Month'],IV, 
21801,2897,Tysabri,2016-10-08,,500,mg,['2 / Day'], , 
21802,2897,Rebif [22],2016-09-15,, , ,['/ Week'],IV, 
21803,4782,Tecfidera,2016-09-07,2018-12-10,5000,mg,['2 / Day'],IV,Lack of efficacy
21804,4782,Tecfidera,2016-06-15,,5000,MIU,['/Month'], , 
21805,4782,Tysabri,2016-09-08,2018-01-04, ,mg,['2 / Day'], ,Patient Choice/Convenience
21806,4782,Betaferon,2016-01-07,,300,MIU,['3 / Week'],IV, 
21807,4305,Endoxan,2016-02-25,2020-07-19,20,mg,['/ Week'], ,Adverse Event
21808,4305,Avonex,2016-05-27,,300,mg,['3 / Week'],IV, 
21809,4305,Copaxone,2016-03-09,2018-04-11, , ,['/Month'],IV,Lack of efficacy
21810,4305,Gilenya,2015-12-31,,300,mg,['/Month'],IV, 
21811,517,Tecfidera,2015-11-07,,1000,mg,['3 / Week'],IV, 
21812,4588,Copaxone,2016-04-27,2018-08-24,5000,mg,['/ Day'], ,Lack of efficacy
21813,4588,Rebif [44],2016-03-26,,20,mg,['2 / Day'], , 
21814,4588,IVIG,2016-10-09,,300,mg,[' '],IV, 
21815,364,Teriflunomide,2016-06-23,,20, ,['3 / Week'],Oral, 
21816,364,Tysabri,2016-04-02,,300, ,['/ Day'], , 
21817,364,Ledertrexaat,2016-04-28,2018-02-14,500, ,['/Month'], ,Patient Choice/Convenience
21818,796,Alemtuzumab (Campath),2015-12-13,,400,mcg,['2 / Day'],IV, 
21819,796,Methylprednisolone,2016-03-06,2018-03-13,500, ,['3 / Week'],IV,Lack of efficacy
21820,796,Tecfidera,2016-02-11,2017-11-08,500, ,['/Month'], ,Persisting MRI activity
21821,1968,Avonex,2016-02-29,2021-05-18,1000, ,['/Month'],IV,Lack of efficacy
21822,1968,Rebif [22],2016-04-03,,1000,mg,['/ Day'],Oral, 
21823,1968,Mitoxantrone,2015-11-02,, ,mg,['3 / Week'], , 
21824,1968,Gilenya,2016-01-26,,300, ,['2 / Day'],IV, 
21825,3013,IVIG,2015-12-04,,20,mg,['2 / Day'],IV, 
21826,3013,Mitoxantrone,2015-11-13,,1000,mg,['2 / Day'],Oral, 
21827,2634,Avonex,2015-11-08,2017-10-28,500, ,['2 / Day'], ,Adverse Event
21828,2634,Teriflunomide,2015-10-24,,5000,mg,['2 / Day'], , 
21829,1048,Rebif [22],2015-12-25,2020-10-23,500,mg,[' '],IV,Persisting MRI activity
21830,1048,Gilenya,2015-12-19,, , ,['3 / Week'],IV, 
21831,1048,Alemtuzumab (Campath),2015-10-31,, ,mg,['2 / Day'], , 
21832,1567,Copaxone,2015-12-18,,5000,mg,['/ Day'],IV, 
21833,1567,Gilenya,2016-01-01,2018-09-14,5000,mg,['/Month'],IV,Persistence of relapses
21834,1567,Copaxone,2016-03-12,2019-09-09, , ,[' '], ,Persistence of relapses
21835,1567,Rebif [22],2016-10-06,, , ,['/Month'],Oral, 
21836,343,Avonex,2016-04-07,2018-06-01,1000,mg,['3 / Week'],IV,Adverse Event
21837,343,Copaxone,2015-12-02,2018-08-05,300,mg,['/Month'],Oral,Patient Choice/Convenience
21838,4112,Rebif [44],2016-03-06,,1, ,['2 / Day'],IV, 
21839,4112,Teriflunomide,2016-09-12,,500, ,['/Month'],IV, 
21840,4112,Avonex,2016-02-25,,1000, ,['3 / Week'], , 
21841,4112,Copaxone,2015-12-13,, ,mg,['/ Week'], , 
21842,2895,IVIG,2016-02-24,, ,mg,['/Month'],Oral, 
21843,3506,Alemtuzumab (Campath),2016-09-05,,1000,mg,['/Month'],Oral, 
21844,3506,Rebif [44],2016-07-24,,400,mg,['3 / Week'],IV, 
21845,3225,D-cure (Vitamine D),2016-05-10,,500, ,['/ Day'],IV, 
21846,3225,D-cure (Vitamine D),2016-09-05,, ,MIU,['2 / Day'], , 
21847,3225,IVIG,2016-08-19,2020-02-09,500,mg,['/Month'], ,Persisting MRI activity
21848,3225,Endoxan,2016-08-25,,1000,mg,['/Month'],Oral, 
21849,2254,Tecfidera,2016-01-04,2021-07-28,500,mg,['2 / Day'],Oral,Patient Choice/Convenience
21850,2428,Methylprednisolone,2016-04-18,,400,mg,['/Month'],IV, 
21851,2428,IVIG,2016-09-27,2018-11-02,1,MIU,['/Month'],IV,Adverse Event
21852,3608,Ledertrexaat,2016-10-04,,300,mg,['/Month'], , 
21853,3608,Copaxone,2016-04-27,, , ,[' '],Oral, 
21854,4447,Avonex,2016-04-21,2017-11-24, , ,['3 / Week'],IV,Patient Choice/Convenience
21855,4447,Copaxone,2016-02-08,,500, ,['3 / Week'],IV, 
21856,4447,IVIG,2016-01-31,,1000,mg,['/Month'],IV, 
21857,3975,IVIG,2016-02-26,, ,mg,['3 / Week'],IV, 
21858,3975,Endoxan,2016-01-13,,300, ,['/Month'], , 
21859,565,D-cure (Vitamine D),2016-07-13,,500,mg,['3 / Week'], , 
21860,4068,Teriflunomide,2016-07-18,,20,mg,['2 / Day'],IV, 
21861,4068,Rebif [44],2016-09-28,,500,mg,['/ Day'],IV, 
21862,4068,Tysabri,2016-06-07,2019-06-22,20,mg,['2 / Day'], ,Adverse Event
21863,3605,Teriflunomide,2016-03-17,2018-06-23,1000,MIU,['3 / Week'],IV,Adverse Event
21864,439,Betaferon,2016-01-25,, ,mg,['3 / Week'],IV, 
21865,4533,Tysabri,2016-03-05,, ,mg,['2 / Day'],IV, 
21866,4533,Tysabri,2016-06-25,2019-08-19,500,mg,['/Month'],IV,Persistence of relapses
21867,4533,IVIG,2016-02-15,2019-01-27,20,mg,['/ Day'], ,Persisting MRI activity
21868,1020,Endoxan,2016-03-25,,5000, ,['2 / Day'],IV, 
21869,3878,D-cure (Vitamine D),2015-10-30,,20,mg,['2 / Day'],IV, 
21870,3878,Rebif [44],2016-08-16,2018-01-08,20, ,['2 / Day'],IV,Persisting MRI activity
21871,3878,Gilenya,2016-10-12,,5000,mg,['/Month'],IV, 
21872,3878,Ledertrexaat,2016-02-24,, , ,[' '],IV, 
21873,2720,Alemtuzumab (Campath),2016-03-28,2020-06-04,1000,mg,['/Month'],IV,Persistence of relapses
21874,2720,IVIG,2016-06-12,2017-11-18, ,mg,['3 / Week'], ,Lack of efficacy
21875,2017,Methylprednisolone,2016-08-21,2018-10-05,300,MIU,['2 / Day'], ,Persisting MRI activity
21876,2017,Copaxone,2016-06-17,2021-05-19,300,MIU,['2 / Day'],IV,Adverse Event
21877,2017,Copaxone,2016-07-11,,5000,mg,['/Month'], , 
21878,413,Copaxone,2016-09-10,, ,MIU,['/ Day'], , 
21879,413,Tecfidera,2016-10-13,2018-01-08,1,MIU,['/ Week'], ,Persisting MRI activity
21880,413,Gilenya,2016-08-22,2019-12-29, ,mg,['/Month'],IV,Lack of efficacy
21881,413,Gilenya,2016-05-28,2020-02-23,300,mg,['/ Day'], ,Patient Choice/Convenience
21882,535,Mitoxantrone,2016-05-13,,20, ,['2 / Day'],Oral, 
21883,535,IVIG,2016-09-07,,300,mcg,['/ Week'], , 
21884,1101,Copaxone,2015-11-18,2021-09-03,1000,mg,['2 / Day'], ,Lack of efficacy
21885,1101,Methylprednisolone,2016-01-31,,300, ,['3 / Week'],IV, 
21886,2152,IVIG,2016-10-16,,400,mg,[' '], , 
21887,2152,Rebif [44],2016-08-01,, ,mg,['2 / Day'],IV, 
21888,2152,Endoxan,2015-10-27,,400, ,['2 / Day'], , 
21889,2152,Tysabri,2016-10-19,2020-12-28,1, ,['/Month'], ,Lack of efficacy
21890,533,Teriflunomide,2015-12-25,2018-12-11,1000,mg,['/Month'], ,Patient Choice/Convenience
21891,1357,IVIG,2016-02-22,2020-03-15,300,mg,['3 / Week'],IV,Persisting MRI activity
21892,2719,Endoxan,2016-10-07,2021-09-11,300,mg,['/Month'],IV,Patient Choice/Convenience
21893,2719,D-cure (Vitamine D),2016-03-12,, ,mg,['2 / Day'],Oral, 
21894,2719,Tysabri,2016-01-05,2020-04-08,1, ,['/Month'],IV,Persisting MRI activity
21895,2719,Ledertrexaat,2016-03-15,, ,mg,['2 / Day'], , 
21896,4671,Ledertrexaat,2016-05-18,, ,mcg,[' '],IV, 
21897,4671,D-cure (Vitamine D),2016-08-01,2018-10-22,20,mg,['2 / Day'],IV,Persistence of relapses
21898,1428,IVIG,2016-01-22,2019-04-13,5000,MIU,['2 / Day'], ,Patient Choice/Convenience
21899,1428,Gilenya,2016-03-05,,5000,mg,['2 / Day'],IV, 
21900,1428,Gilenya,2015-11-16,2019-05-23,1000,MIU,['3 / Week'],IV,Adverse Event
21901,915,Copaxone,2016-02-22,,300, ,['3 / Week'],IV, 
21902,915,Teriflunomide,2015-11-14,,300,mcg,['2 / Day'],IV, 
21903,915,Gilenya,2016-05-09,2020-08-12,1000,mg,[' '],IV,Adverse Event
21904,1924,Avonex,2016-05-31,,1,mg,['3 / Week'], , 
21905,1924,Betaferon,2016-02-25,,1,MIU,['2 / Day'],Oral, 
21906,3740,IVIG,2016-06-08,,5000, ,[' '], , 
21907,3740,Mitoxantrone,2016-10-18,,5000,mcg,['2 / Day'],Oral, 
21908,3740,Tecfidera,2016-03-09,2018-12-10, ,mcg,['/ Week'],IV,Persistence of relapses
21909,3740,Teriflunomide,2016-10-14,, ,mg,['2 / Day'],IV, 
21910,4685,Alemtuzumab (Campath),2016-03-27,,500,mg,['2 / Day'], , 
21911,4685,IVIG,2016-09-21,,1000,mg,['2 / Day'],IV, 
21912,4685,Tysabri,2015-11-07,2020-03-04, , ,['2 / Day'],IV,Adverse Event
21913,321,D-cure (Vitamine D),2016-02-27,2019-10-15,1000, ,['/ Day'], ,Patient Choice/Convenience
21914,321,Rebif [44],2016-05-23,,5000, ,['2 / Day'],IV, 
21915,321,Teriflunomide,2016-03-17,,1000,mg,['/ Day'],IV, 
21916,2712,Ledertrexaat,2016-03-27,2018-02-24,500,mg,['2 / Day'],IV,Patient Choice/Convenience
21917,2712,Copaxone,2015-12-19,2021-08-28,5000,mg,['3 / Week'],IV,Patient Choice/Convenience
21918,2712,Mitoxantrone,2016-02-20,2019-07-27, ,mg,['/Month'],IV,Adverse Event
21919,2712,Mitoxantrone,2016-09-11,2020-04-02,500,mg,['/ Day'],IV,Patient Choice/Convenience
21920,4135,Gilenya,2016-02-09,,5000, ,['2 / Day'], , 
21921,4135,Gilenya,2016-10-19,2018-05-19, ,mg,['2 / Day'],Oral,Persisting MRI activity
21922,4135,Endoxan,2016-04-20,,20,mg,['2 / Day'],IV, 
21923,4135,Tecfidera,2016-03-07,,5000,mg,['/ Day'],IV, 
21924,205,Gilenya,2015-11-21,2020-07-18,20,mg,['/Month'], ,Patient Choice/Convenience
21925,205,IVIG,2016-03-31,2019-06-13,20,mcg,['2 / Day'], ,Adverse Event
21926,205,Rebif [22],2016-10-06,2018-02-07, , ,[' '], ,Adverse Event
21927,205,Tecfidera,2015-12-16,,300, ,['2 / Day'], , 
21928,2211,Avonex,2016-02-28,2019-04-05, ,mcg,[' '],IV,Adverse Event
21929,2211,Mitoxantrone,2016-09-09,2020-11-07,500,mg,[' '],IV,Adverse Event
21930,2211,Betaferon,2016-10-22,,20, ,[' '],Oral, 
21931,416,D-cure (Vitamine D),2016-03-29,2018-11-13,1,MIU,['3 / Week'],IV,Adverse Event
21932,416,Endoxan,2016-03-09,2021-05-06,1000,MIU,['/ Day'], ,Lack of efficacy
21933,416,IVIG,2016-05-03,,20,mg,['/Month'], , 
21934,416,Tecfidera,2016-07-12,2019-12-02,20, ,['2 / Day'], ,Persistence of relapses
21935,2154,Rebif [44],2016-09-29,2018-12-10,5000, ,['3 / Week'],IV,Persistence of relapses
21936,2154,Rebif [44],2016-01-07,2019-06-11,1, ,['/ Week'],Oral,Patient Choice/Convenience
21937,2154,Endoxan,2016-05-13,2018-10-29, ,mg,['/ Day'], ,Persistence of relapses
21938,1509,IVIG,2016-06-18,,1000, ,['/Month'],IV, 
21939,4433,D-cure (Vitamine D),2016-09-16,,20,MIU,['2 / Day'],IV, 
21940,4433,Rebif [22],2016-08-05,,1, ,['/Month'], , 
21941,4344,Betaferon,2016-03-21,, , ,['2 / Day'],Oral, 
21942,4870,Copaxone,2016-02-14,,1000, ,['2 / Day'], , 
21943,4870,Rebif [44],2016-05-02,, , ,['/ Day'],Oral, 
21944,4870,Teriflunomide,2016-01-16,, ,mg,['/Month'], , 
21945,1404,D-cure (Vitamine D),2015-12-27,, , ,[' '],Oral, 
21946,1404,Rebif [44],2016-06-24,,1000, ,['2 / Day'],Oral, 
21947,1605,Tysabri,2016-03-20,2020-07-16,20, ,[' '],IV,Patient Choice/Convenience
21948,4832,Avonex,2016-02-05,2020-09-14,5000,mg,['/Month'],IV,Adverse Event
21949,4832,Methylprednisolone,2015-11-22,2018-10-26, ,mg,['2 / Day'],Oral,Persisting MRI activity
21950,4832,IVIG,2016-08-01,2017-11-02,20, ,[' '], ,Patient Choice/Convenience
21951,4832,Rebif [22],2016-03-23,, ,mg,['/Month'],IV, 
21952,2716,Rebif [22],2016-03-02,2018-03-30,1000,mg,['/ Day'],Oral,Persistence of relapses
21953,2716,Rebif [22],2016-06-22,,1,mg,['/Month'], , 
21954,2716,Tysabri,2016-09-09,, ,mg,['2 / Day'], , 
21955,2511,D-cure (Vitamine D),2015-12-05,,500,mg,['/Month'], , 
21956,2511,Endoxan,2016-01-02,2019-04-29, ,mg,['/Month'], ,Persistence of relapses
21957,4555,Tysabri,2016-02-05,2021-01-31,5000,MIU,['3 / Week'],IV,Adverse Event
21958,4555,Rebif [22],2015-11-04,,300,mcg,['3 / Week'],IV, 
21959,4555,Tecfidera,2016-01-08,,400, ,[' '], , 
21960,3364,Rebif [44],2016-09-18,2021-07-20,1000,mg,['/ Week'],IV,Persisting MRI activity
21961,3364,Avonex,2015-11-02,2017-11-03,20, ,['/ Day'], ,Patient Choice/Convenience
21962,3364,Tecfidera,2015-11-03,,1000, ,['/Month'], , 
21963,3364,D-cure (Vitamine D),2016-04-18,, , ,['/ Week'],Oral, 
21964,377,Gilenya,2016-06-08,2017-12-06,1000, ,['2 / Day'], ,Lack of efficacy
21965,377,Endoxan,2016-04-11,,20,mg,['3 / Week'], , 
21966,377,Avonex,2016-06-23,, ,mg,['/Month'],IV, 
21967,3417,Teriflunomide,2016-01-21,,500,mg,['/Month'],Oral, 
21968,3417,Methylprednisolone,2016-10-14,2021-04-09,400,mg,['3 / Week'],IV,Persisting MRI activity
21969,3417,Betaferon,2016-06-04,2021-05-11,500, ,['3 / Week'],IV,Persistence of relapses
21970,1921,Rebif [44],2016-01-01,2019-11-14, ,MIU,['/Month'],IV,Patient Choice/Convenience
21971,1921,IVIG,2015-12-24,,500,mg,['3 / Week'],IV, 
21972,1921,Methylprednisolone,2016-06-22,2018-07-10, , ,['2 / Day'], ,Patient Choice/Convenience
21973,1921,Alemtuzumab (Campath),2016-02-07,2020-06-26,20,MIU,[' '],IV,Persisting MRI activity
21974,3180,Copaxone,2015-10-24,2018-03-12,1000,mg,['2 / Day'], ,Patient Choice/Convenience
21975,3180,Tecfidera,2016-05-02,, ,mg,['2 / Day'],Oral, 
21976,3180,Gilenya,2016-10-22,2019-07-30,20,mg,['3 / Week'],IV,Patient Choice/Convenience
21977,922,D-cure (Vitamine D),2016-10-06,2021-03-23, ,mg,['2 / Day'],IV,Patient Choice/Convenience
21978,1980,Endoxan,2016-06-14,2019-05-27,500, ,['3 / Week'], ,Adverse Event
21979,1980,Tecfidera,2016-02-26,2017-11-29,1000, ,['/Month'],Oral,Adverse Event
21980,1980,Rebif [22],2016-09-03,,400,mg,['2 / Day'],IV, 
21981,1816,Mitoxantrone,2016-09-11,2020-05-25,500,mg,['/Month'],IV,Patient Choice/Convenience
21982,1816,Rebif [44],2016-01-25,2019-01-15,5000,mg,['/Month'], ,Persisting MRI activity
21983,1816,Tysabri,2016-04-18,, , ,['/Month'],IV, 
21984,3268,Tecfidera,2016-04-04,,1, ,['3 / Week'],Oral, 
21985,3268,Mitoxantrone,2016-07-28,2020-12-05, , ,['/ Week'], ,Persisting MRI activity
21986,1307,Endoxan,2016-07-03,2021-05-24,400,mg,['/Month'],IV,Adverse Event
21987,1307,Alemtuzumab (Campath),2016-01-11,,20,mg,['/Month'],IV, 
21988,4851,Tecfidera,2016-02-07,2021-02-06, , ,['/Month'],IV,Patient Choice/Convenience
21989,4851,Copaxone,2016-01-23,, , ,['2 / Day'],IV, 
21990,4851,Mitoxantrone,2016-07-22,,500,mg,['/ Day'],IV, 
21991,926,Copaxone,2016-05-14,2018-07-01,5000, ,['2 / Day'], ,Lack of efficacy
21992,926,Methylprednisolone,2016-07-04,,500,MIU,['3 / Week'],IV, 
21993,926,Endoxan,2015-12-17,,20,mg,[' '],Oral, 
21994,926,D-cure (Vitamine D),2016-07-04,, ,MIU,['/ Day'],IV, 
21995,2898,Rebif [44],2016-04-03,,1000,mg,['2 / Day'], , 
21996,413,Tysabri,2016-06-02,,300,mg,['/Month'], , 
21997,1468,Copaxone,2016-09-06,2019-12-19,20,mg,['/Month'],IV,Patient Choice/Convenience
21998,1468,Copaxone,2016-08-30,, ,mg,['2 / Day'], , 
21999,1468,Endoxan,2016-06-20,,1,mg,[' '], , 
22000,1468,Rebif [44],2016-05-10,2021-01-10,1,mg,['2 / Day'],IV,Lack of efficacy
22001,1692,Alemtuzumab (Campath),2016-01-19,2021-09-03,5000,mg,['2 / Day'],Oral,Adverse Event
22002,1692,Copaxone,2016-09-11,2018-02-26,20, ,['/ Week'],IV,Adverse Event
22003,1692,Endoxan,2016-07-15,2021-05-05, , ,['/Month'],IV,Patient Choice/Convenience
22004,1736,Copaxone,2016-07-04,2021-03-27,1, ,[' '],Oral,Lack of efficacy
22005,3434,Ledertrexaat,2016-04-04,,20, ,['/Month'],IV, 
22006,3434,Rebif [44],2016-07-15,,5000,mg,['2 / Day'],IV, 
22007,3434,Ledertrexaat,2016-01-19,,300, ,[' '],IV, 
22008,3434,D-cure (Vitamine D),2016-04-10,2018-11-07,300,mg,['/Month'],IV,Persisting MRI activity
22009,672,Avonex,2016-07-15,2019-03-07,1,mg,['2 / Day'],IV,Persisting MRI activity
22010,3470,Tecfidera,2016-10-06,,5000,MIU,['/Month'],Oral, 
22011,2671,Alemtuzumab (Campath),2015-11-24,,1000, ,[' '],IV, 
22012,2671,Teriflunomide,2016-04-17,2020-01-25, ,mg,['/ Week'],Oral,Patient Choice/Convenience
22013,2671,D-cure (Vitamine D),2016-04-18,,400,mg,['/Month'], , 
22014,4767,Methylprednisolone,2016-04-10,, , ,['/Month'],IV, 
22015,4767,Tecfidera,2016-10-10,,20,mcg,['/Month'],IV, 
22016,4767,Ledertrexaat,2016-04-23,,1,mg,['2 / Day'], , 
22017,1345,IVIG,2016-07-18,2021-06-17, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
22018,1345,Ledertrexaat,2016-03-14,, , ,['/ Day'], , 
22019,1345,Rebif [22],2016-07-08,,1000,MIU,['/Month'],IV, 
22020,4594,Endoxan,2016-01-29,,1000,mg,['2 / Day'],IV, 
22021,4227,Alemtuzumab (Campath),2016-05-19,,500,mg,[' '], , 
22022,4227,Rebif [44],2016-08-14,,300, ,['2 / Day'],Oral, 
22023,4227,Endoxan,2015-12-08,,20,mg,['3 / Week'],IV, 
22024,2352,Ledertrexaat,2016-05-25,,1000,mg,['/Month'], , 
22025,2352,Rebif [44],2016-06-26,,20, ,['/Month'],Oral, 
22026,2352,IVIG,2016-01-08,, ,mg,['3 / Week'],IV, 
22027,4821,Copaxone,2016-09-15,2019-01-27,300, ,['/Month'],Oral,Persisting MRI activity
22028,4821,Tysabri,2016-06-20,2019-12-27,20,mg,['2 / Day'],IV,Adverse Event
22029,4821,Tecfidera,2015-11-26,2021-08-30, , ,[' '], ,Patient Choice/Convenience
22030,1140,Gilenya,2016-08-05,,20, ,['2 / Day'], , 
22031,2051,Methylprednisolone,2016-05-26,2019-12-15,20, ,[' '],IV,Adverse Event
22032,677,Gilenya,2015-11-19,,500, ,['3 / Week'], , 
22033,677,Rebif [44],2016-08-09,,5000, ,['2 / Day'], , 
22034,677,Tysabri,2015-12-21,,500,mg,['3 / Week'],IV, 
22035,236,Methylprednisolone,2016-05-25,, ,mg,['3 / Week'],IV, 
22036,236,Methylprednisolone,2015-11-30,,5000,MIU,['3 / Week'], , 
22037,781,Rebif [44],2016-10-17,2018-05-29,300,mg,[' '],IV,Adverse Event
22038,781,Tecfidera,2015-12-15,2018-09-26, ,MIU,['2 / Day'],Oral,Persistence of relapses
22039,528,Ledertrexaat,2016-04-07,, , ,['2 / Day'],Oral, 
22040,4167,Mitoxantrone,2016-09-13,2020-07-26,20,mg,['3 / Week'], ,Lack of efficacy
22041,4167,Rebif [22],2016-02-17,, , ,['/Month'],IV, 
22042,3997,Alemtuzumab (Campath),2016-06-02,,400,MIU,['3 / Week'],IV, 
22043,3284,Tecfidera,2015-12-08,2018-12-02, ,mg,['/Month'], ,Persistence of relapses
22044,1472,IVIG,2016-05-17,2021-03-31,400,mg,[' '], ,Patient Choice/Convenience
22045,1573,Methylprednisolone,2016-08-13,,5000, ,[' '], , 
22046,1573,Endoxan,2016-10-20,,400, ,['3 / Week'], , 
22047,201,Mitoxantrone,2016-04-21,,500,mg,['/Month'], , 
22048,201,Gilenya,2015-12-16,2020-06-08,5000,mg,['/ Week'], ,Adverse Event
22049,1438,Tecfidera,2015-11-11,2017-12-11,20, ,['2 / Day'],IV,Adverse Event
22050,1438,Alemtuzumab (Campath),2016-05-21,, , ,['/Month'],IV, 
22051,1438,Gilenya,2016-10-22,, , ,['2 / Day'], , 
22052,1438,D-cure (Vitamine D),2015-12-17,,5000,mg,[' '],IV, 
22053,4539,Tysabri,2016-06-30,,1,mg,['/Month'], , 
22054,1429,Teriflunomide,2016-03-26,2019-02-18,500,mg,['/Month'], ,Lack of efficacy
22055,1429,Avonex,2016-05-30,, ,mg,['2 / Day'], , 
22056,1429,Gilenya,2016-07-31,,300,mg,['/ Day'],IV, 
22057,1429,Avonex,2015-12-01,, , ,['3 / Week'], , 
22058,3001,Endoxan,2016-07-06,,20,mg,['/ Day'], , 
22059,2333,Methylprednisolone,2016-06-30,, ,MIU,['2 / Day'],Oral, 
22060,4416,Rebif [22],2016-05-25,2019-12-21, ,mcg,['/Month'],IV,Patient Choice/Convenience
22061,4416,Betaferon,2016-09-11,,20, ,['3 / Week'],IV, 
22062,4416,Tysabri,2016-03-28,,1,MIU,['/Month'],IV, 
22063,4416,Rebif [44],2016-10-02,2020-05-03, ,mcg,['3 / Week'],IV,Adverse Event
22064,2578,Mitoxantrone,2016-10-15,,1000,mg,[' '],IV, 
22065,2578,Avonex,2016-08-16,2018-08-01,300,mg,['/Month'],IV,Patient Choice/Convenience
22066,2578,Ledertrexaat,2016-04-28,,5000, ,['2 / Day'], , 
22067,4716,Teriflunomide,2016-07-11,2020-11-18,1000,mg,['/Month'],IV,Patient Choice/Convenience
22068,619,Rebif [44],2016-05-05,2020-08-22,500,mg,[' '],IV,Persisting MRI activity
22069,2351,IVIG,2016-03-08,,20,mg,['/Month'], , 
22070,2351,Gilenya,2016-03-28,2019-10-20,1000,mg,['/Month'], ,Adverse Event
22071,2351,Rebif [22],2015-11-11,,500,mcg,['/Month'],IV, 
22072,2937,Betaferon,2016-10-21,,20,mg,['2 / Day'], , 
22073,1821,Gilenya,2015-11-02,,1000,MIU,['/Month'],Oral, 
22074,1821,Copaxone,2016-10-14,2021-10-12,5000,mg,['/Month'],IV,Patient Choice/Convenience
22075,3435,D-cure (Vitamine D),2016-06-10,,1,mg,['/Month'],IV, 
22076,249,Teriflunomide,2016-05-10,, ,MIU,['2 / Day'], , 
22077,249,Mitoxantrone,2016-03-31,2020-05-18,20, ,['2 / Day'],IV,Patient Choice/Convenience
22078,249,Mitoxantrone,2016-02-21,2020-01-21,300,mcg,['2 / Day'],IV,Adverse Event
22079,916,Methylprednisolone,2016-04-09,, ,MIU,['2 / Day'], , 
22080,916,Ledertrexaat,2016-02-03,2018-01-17, , ,['2 / Day'], ,Adverse Event
22081,558,Endoxan,2016-02-28,,300,MIU,['3 / Week'], , 
22082,558,Methylprednisolone,2016-03-01,,20,mg,['2 / Day'], , 
22083,2476,Gilenya,2016-01-05,2018-06-06, ,mg,['/ Day'],IV,Adverse Event
22084,2476,Tysabri,2015-12-14,,1000, ,['/ Day'],IV, 
22085,4001,Endoxan,2016-03-21,,20, ,['2 / Day'], , 
22086,3676,Methylprednisolone,2016-04-19,, , ,['/ Week'],Oral, 
22087,3676,Rebif [22],2016-09-03,2020-07-27,1000,mg,[' '], ,Patient Choice/Convenience
22088,3676,Tysabri,2016-10-08,, , ,['/ Day'], , 
22089,463,Tecfidera,2016-10-22,2018-10-05,300,mg,['/Month'], ,Lack of efficacy
22090,463,Rebif [22],2016-06-19,,300,MIU,['/Month'], , 
22091,508,Gilenya,2016-05-31,,1,mg,['/Month'],IV, 
22092,508,Alemtuzumab (Campath),2016-06-05,2018-07-27,300,MIU,['/Month'],IV,Patient Choice/Convenience
22093,508,Avonex,2016-10-02,2019-01-17,5000,MIU,['/Month'], ,Patient Choice/Convenience
22094,508,Endoxan,2016-04-18,2018-04-10,500, ,[' '],IV,Lack of efficacy
22095,1600,Endoxan,2016-08-12,,400,mg,['/Month'],Oral, 
22096,1600,Endoxan,2016-01-12,,1,mg,['/Month'],IV, 
22097,2718,Tysabri,2016-10-02,2020-10-10,1, ,['/ Week'],Oral,Patient Choice/Convenience
22098,382,Tysabri,2016-06-03,2021-10-15,1, ,['/Month'], ,Adverse Event
22099,382,Endoxan,2016-07-03,,500, ,['2 / Day'],IV, 
22100,3216,Alemtuzumab (Campath),2016-06-01,2018-12-22,300,mg,[' '],IV,Adverse Event
22101,3216,Tecfidera,2016-08-04,2020-04-23,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
22102,3216,Rebif [44],2016-09-23,, ,mg,['/Month'],IV, 
22103,3216,Rebif [22],2016-08-23,2018-07-08,500,mg,['/Month'], ,Patient Choice/Convenience
22104,217,Gilenya,2016-06-15,,300,MIU,['3 / Week'],Oral, 
22105,217,Gilenya,2015-12-17,2020-09-15,1,mg,['2 / Day'],IV,Lack of efficacy
22106,217,D-cure (Vitamine D),2015-11-03,,20,MIU,['3 / Week'],Oral, 
22107,217,IVIG,2016-09-28,,400,mg,['2 / Day'],IV, 
22108,4007,Rebif [44],2015-10-26,2020-03-22,300,mg,['2 / Day'], ,Patient Choice/Convenience
22109,4007,Copaxone,2016-07-13,2020-03-24,1,mg,['3 / Week'],IV,Persistence of relapses
22110,4997,Gilenya,2016-01-06,,1000, ,['/ Day'],IV, 
22111,4384,Methylprednisolone,2015-11-23,,5000,MIU,['/Month'],IV, 
22112,4384,Rebif [22],2016-06-16,,5000,MIU,['2 / Day'], , 
22113,4522,Rebif [22],2016-09-19,2018-11-12,500,mg,['/Month'],IV,Adverse Event
22114,4522,Alemtuzumab (Campath),2016-08-02,2018-01-22,400,mg,[' '],IV,Patient Choice/Convenience
22115,4522,Teriflunomide,2015-11-01,2018-09-25, , ,['/Month'],IV,Adverse Event
22116,4595,IVIG,2015-12-13,,20, ,['/Month'],IV, 
22117,4595,Tecfidera,2016-02-14,2020-01-22, , ,['/Month'],Oral,Adverse Event
22118,2612,D-cure (Vitamine D),2016-05-28,,300, ,['3 / Week'],IV, 
22119,2612,Endoxan,2016-09-21,2019-02-17, ,mcg,['/ Day'],IV,Patient Choice/Convenience
22120,2612,Rebif [22],2015-12-05,2018-02-05,20,mg,['3 / Week'],Oral,Patient Choice/Convenience
22121,2612,Rebif [44],2016-09-13,2021-04-16,300, ,['2 / Day'], ,Lack of efficacy
22122,111,Copaxone,2016-10-06,2018-02-09, , ,['/Month'],IV,Lack of efficacy
22123,4997,IVIG,2016-07-28,, ,MIU,['/Month'], , 
22124,4997,Methylprednisolone,2016-08-13,,300,MIU,['2 / Day'], , 
22125,1328,IVIG,2016-01-03,, , ,['/Month'],IV, 
22126,1328,Betaferon,2016-04-27,,1000,mg,[' '],IV, 
22127,2295,D-cure (Vitamine D),2016-01-09,2020-04-02,500, ,['3 / Week'], ,Patient Choice/Convenience
22128,1439,Ledertrexaat,2016-05-30,,1,mg,['/Month'],Oral, 
22129,1439,Gilenya,2015-12-11,2018-06-20, ,mg,['/ Day'], ,Persistence of relapses
22130,1439,D-cure (Vitamine D),2016-08-26,, ,mg,['2 / Day'],IV, 
22131,1214,Rebif [44],2016-05-02,, , ,['2 / Day'], , 
22132,1214,IVIG,2016-08-05,2019-01-17,1, ,['2 / Day'], ,Lack of efficacy
22133,1214,Tysabri,2016-05-02,2018-06-02,500,mg,['3 / Week'], ,Lack of efficacy
22134,1103,IVIG,2016-02-16,,500,mg,['2 / Day'],Oral, 
22135,1171,Rebif [22],2016-04-29,2019-11-18,1, ,[' '],IV,Patient Choice/Convenience
22136,1171,Endoxan,2016-07-23,,300,mg,['/Month'],IV, 
22137,1171,Tecfidera,2016-01-13,, ,mg,['/Month'],Oral, 
22138,1171,D-cure (Vitamine D),2016-06-19,2018-12-07,1000,mcg,['/Month'],IV,Adverse Event
22139,3212,Alemtuzumab (Campath),2016-04-12,2019-04-12,1000, ,['/Month'],IV,Patient Choice/Convenience
22140,3776,Gilenya,2016-06-09,2021-06-28,5000,mg,['/Month'],IV,Adverse Event
22141,3776,Tecfidera,2016-07-09,2021-05-18,20,MIU,['/Month'],IV,Persistence of relapses
22142,3776,Gilenya,2015-11-02,,300,mg,['2 / Day'],IV, 
22143,4034,Methylprednisolone,2016-01-13,,300,MIU,['2 / Day'],IV, 
22144,4034,Alemtuzumab (Campath),2016-02-18,,1000,mg,['2 / Day'], , 
22145,4034,D-cure (Vitamine D),2016-04-14,, ,mg,['2 / Day'],IV, 
22146,4034,Methylprednisolone,2016-06-17,2019-03-11,1000, ,[' '],IV,Persistence of relapses
22147,1119,Alemtuzumab (Campath),2016-02-21,,20,mg,['2 / Day'],IV, 
22148,4419,D-cure (Vitamine D),2016-09-08,,1000, ,['2 / Day'],IV, 
22149,4419,Rebif [44],2015-12-25,2019-11-29,20, ,[' '], ,Adverse Event
22150,4419,Ledertrexaat,2016-06-01,2021-06-08,500, ,['/Month'], ,Adverse Event
22151,4419,Methylprednisolone,2016-01-16,, ,MIU,['/ Day'],IV, 
22152,4872,Avonex,2015-11-05,, ,mg,['2 / Day'], , 
22153,4580,Rebif [44],2016-02-24,, , ,['2 / Day'],IV, 
22154,3460,Avonex,2016-04-13,,400,mcg,['3 / Week'],IV, 
22155,3460,Tysabri,2016-03-28,,300,mg,['/ Day'], , 
22156,3460,Avonex,2016-02-04,2021-02-25,20, ,['/Month'], ,Lack of efficacy
22157,3699,Avonex,2016-02-25,, , ,['/Month'],IV, 
22158,2408,Endoxan,2015-12-30,2019-01-11,1000, ,['/ Day'], ,Adverse Event
22159,641,Methylprednisolone,2016-05-13,,20,mg,['/Month'],IV, 
22160,1387,Rebif [44],2016-07-25,2020-12-13,400, ,['2 / Day'],IV,Persistence of relapses
22161,1387,Copaxone,2016-04-02,2020-04-07,1000, ,['3 / Week'],IV,Lack of efficacy
22162,1387,Alemtuzumab (Campath),2016-01-10,,1,MIU,['3 / Week'],Oral, 
22163,1387,Tecfidera,2016-02-14,2020-01-18,5000,mcg,['3 / Week'],IV,Adverse Event
22164,3688,Endoxan,2016-02-20,,500,mg,['/ Day'],IV, 
22165,3688,Tysabri,2016-02-23,2018-10-08,300,mg,['/ Day'], ,Patient Choice/Convenience
22166,3688,Rebif [44],2016-02-16,2019-11-12, ,mg,['/Month'],IV,Patient Choice/Convenience
22167,692,IVIG,2016-05-07,2018-07-16, ,MIU,['/Month'], ,Persisting MRI activity
22168,4733,Gilenya,2016-03-14,2019-06-18, , ,['3 / Week'],IV,Persisting MRI activity
22169,4733,Copaxone,2016-10-22,, , ,['/ Day'],IV, 
22170,4733,IVIG,2016-05-01,2019-05-13,300,mg,['2 / Day'],Oral,Persistence of relapses
22171,4733,Methylprednisolone,2016-01-09,,300, ,['3 / Week'], , 
22172,3316,Copaxone,2015-12-27,2018-12-17, ,mg,['2 / Day'],IV,Adverse Event
22173,3316,Rebif [44],2016-09-05,,500,mg,['2 / Day'],IV, 
22174,3316,Alemtuzumab (Campath),2016-02-22,2018-06-13,1,mg,['/Month'],IV,Lack of efficacy
22175,3316,Tecfidera,2016-05-31,,300,mcg,['/ Week'], , 
22176,3396,Gilenya,2016-09-12,,20, ,['3 / Week'],IV, 
22177,669,Alemtuzumab (Campath),2016-01-06,, , ,['3 / Week'], , 
22178,669,Tysabri,2016-07-19,2018-01-11,20,mg,['/Month'], ,Adverse Event
22179,669,Tysabri,2016-04-02,2019-06-04,1000,mg,['2 / Day'],IV,Adverse Event
22180,2672,Tecfidera,2016-08-31,2018-02-13,20,MIU,['/Month'],IV,Persistence of relapses
22181,292,Tecfidera,2015-12-06,2019-07-03,1,mcg,['2 / Day'], ,Persisting MRI activity
22182,292,Tysabri,2016-08-11,,1, ,['2 / Day'],IV, 
22183,488,D-cure (Vitamine D),2015-12-25,,20, ,['2 / Day'],IV, 
22184,488,Methylprednisolone,2016-02-29,,500, ,['/ Day'],IV, 
22185,913,Tysabri,2016-08-19,, , ,['3 / Week'],Oral, 
22186,913,Alemtuzumab (Campath),2016-06-16,2020-06-25,5000, ,[' '], ,Patient Choice/Convenience
22187,2937,Tysabri,2016-01-24,2019-01-24, ,MIU,['/Month'], ,Adverse Event
22188,2937,IVIG,2016-02-21,2018-10-10,400,mg,[' '],Oral,Adverse Event
22189,2937,Ledertrexaat,2015-11-02,2020-08-07, ,mg,[' '],IV,Patient Choice/Convenience
22190,4859,Mitoxantrone,2016-01-31,2019-10-15, ,mg,['/ Day'],IV,Persisting MRI activity
22191,4859,IVIG,2016-09-26,,1000, ,[' '],IV, 
22192,4859,Tysabri,2016-01-05,, ,mcg,['2 / Day'],IV, 
22193,4859,Betaferon,2016-09-13,, , ,['/Month'], , 
22194,4915,Endoxan,2016-08-22,2021-09-24, ,mg,['3 / Week'],IV,Adverse Event
22195,4915,Tysabri,2015-11-11,,300,mg,[' '], , 
22196,399,Gilenya,2016-01-08,,300, ,['2 / Day'],IV, 
22197,399,D-cure (Vitamine D),2016-07-28,, , ,['2 / Day'], , 
22198,3276,Rebif [44],2016-03-05,, , ,['2 / Day'],IV, 
22199,3276,Gilenya,2016-01-14,, , ,['3 / Week'], , 
22200,3479,Rebif [44],2016-08-13,,500,MIU,['2 / Day'],IV, 
22201,3479,Copaxone,2015-12-12,2021-02-09,500, ,[' '],Oral,Adverse Event
22202,4438,Copaxone,2016-09-01,,1, ,['/Month'], , 
22203,4438,Methylprednisolone,2015-12-30,,400,mg,[' '], , 
22204,4750,IVIG,2016-06-10,2021-04-27,5000, ,['/Month'], ,Lack of efficacy
22205,2937,Avonex,2016-05-25,, ,mcg,['3 / Week'], , 
22206,2937,D-cure (Vitamine D),2016-02-05,2017-11-18,20, ,['/ Week'], ,Persistence of relapses
22207,2937,Gilenya,2015-11-11,, , ,['/ Day'],IV, 
22208,2937,Betaferon,2016-06-01,2019-05-28,20,mg,['/Month'], ,Patient Choice/Convenience
22209,1907,Avonex,2016-05-11,,400, ,['/ Week'],IV, 
22210,2034,IVIG,2016-09-11,2018-04-15,500,MIU,['2 / Day'], ,Patient Choice/Convenience
22211,2034,IVIG,2016-02-03,,500,mg,['/Month'], , 
22212,2034,Tysabri,2016-09-09,, ,mg,['/Month'], , 
22213,2034,Methylprednisolone,2016-09-26,2021-03-21,5000, ,['3 / Week'], ,Adverse Event
22214,3459,Rebif [22],2016-04-03,2018-03-28,400,mg,['/Month'],Oral,Adverse Event
22215,245,Avonex,2016-05-19,2020-11-12,500,mcg,['3 / Week'],IV,Adverse Event
22216,245,Gilenya,2016-05-26,2019-01-19,1,mg,['2 / Day'],IV,Persisting MRI activity
22217,245,Teriflunomide,2016-04-27,,400,mcg,['2 / Day'], , 
22218,245,Rebif [22],2016-08-26,2021-01-26, , ,['/Month'],IV,Persistence of relapses
22219,4222,Copaxone,2016-09-16,,400, ,['2 / Day'],IV, 
22220,4222,Teriflunomide,2016-02-23,2020-06-07,5000, ,['3 / Week'], ,Persisting MRI activity
22221,4222,Endoxan,2016-03-08,,1000, ,['/Month'],Oral, 
22222,2054,Endoxan,2016-10-10,2020-02-22,20,mg,['/Month'],IV,Lack of efficacy
22223,2054,Methylprednisolone,2016-05-31,,1000,mg,['/ Day'],IV, 
22224,2054,Methylprednisolone,2015-11-15,,20, ,['/Month'],IV, 
22225,868,Alemtuzumab (Campath),2016-10-18,,5000,MIU,['/Month'],IV, 
22226,868,Teriflunomide,2016-07-01,,5000,mg,['/ Week'], , 
22227,868,Avonex,2016-03-26,, , ,['2 / Day'], , 
22228,3922,Betaferon,2016-04-01,2020-12-06,400,MIU,['/Month'],IV,Persisting MRI activity
22229,3922,Copaxone,2016-02-25,2020-05-06,1000, ,['/Month'],Oral,Adverse Event
22230,3922,IVIG,2016-09-30,,20,mcg,['/ Day'],Oral, 
22231,3922,Tecfidera,2016-02-13,, ,mg,['/Month'],IV, 
22232,2503,Rebif [22],2016-08-08,2020-03-19,1,MIU,[' '],IV,Adverse Event
22233,169,Avonex,2015-12-24,, ,mg,['/ Week'],IV, 
22234,169,Tecfidera,2015-11-22,2020-11-03,1000,MIU,['3 / Week'],IV,Adverse Event
22235,255,Tecfidera,2016-03-27,, ,mcg,['/ Week'], , 
22236,255,Avonex,2016-02-05,2018-09-09,300,mg,['/ Week'], ,Adverse Event
22237,255,Betaferon,2016-04-22,, , ,['2 / Day'], , 
22238,255,Betaferon,2016-08-14,2019-11-09,20, ,[' '],Oral,Adverse Event
22239,4866,Methylprednisolone,2015-12-25,2019-05-29, , ,[' '],Oral,Adverse Event
22240,4866,Tecfidera,2015-12-06,2019-09-14,1000, ,['/ Day'], ,Lack of efficacy
22241,1093,Methylprednisolone,2015-12-06,2019-01-26,1000,mg,['2 / Day'], ,Patient Choice/Convenience
22242,1093,Endoxan,2016-07-30,2018-12-27,400,mg,['/ Day'],IV,Persistence of relapses
22243,4355,Alemtuzumab (Campath),2016-09-03,, , ,['2 / Day'],IV, 
22244,4355,Mitoxantrone,2016-04-25,,5000, ,['2 / Day'], , 
22245,4355,D-cure (Vitamine D),2016-03-03,,20, ,['/Month'],IV, 
22246,4355,Teriflunomide,2016-02-21,2020-08-05,1,MIU,['/ Day'], ,Lack of efficacy
22247,2472,D-cure (Vitamine D),2016-07-16,2018-02-06,1,MIU,['/Month'],IV,Persistence of relapses
22248,2472,Tysabri,2016-07-01,, ,mcg,['/Month'], , 
22249,2472,Teriflunomide,2015-12-04,2018-11-25,20, ,['/Month'],Oral,Patient Choice/Convenience
22250,2472,Rebif [22],2015-11-25,2020-08-22,400,mg,['/Month'],IV,Adverse Event
22251,2296,Endoxan,2016-01-11,2021-08-01, ,mg,['2 / Day'], ,Lack of efficacy
22252,2296,Methylprednisolone,2015-12-18,2020-08-16, ,mcg,['/ Day'],IV,Lack of efficacy
22253,2296,Alemtuzumab (Campath),2016-01-19,2019-11-11,1,MIU,['2 / Day'], ,Persisting MRI activity
22254,2296,Alemtuzumab (Campath),2016-04-14,2021-03-17,500,MIU,['3 / Week'],IV,Lack of efficacy
22255,1651,Alemtuzumab (Campath),2016-04-13,2020-05-25,300,mcg,['3 / Week'], ,Persistence of relapses
22256,3989,Rebif [44],2015-11-13,2018-12-10,1000, ,[' '], ,Patient Choice/Convenience
22257,3989,Betaferon,2016-09-14,,500, ,[' '],IV, 
22258,4684,D-cure (Vitamine D),2016-08-04,2019-09-08,300, ,['/Month'],Oral,Adverse Event
22259,4684,Gilenya,2016-07-29,,300,mg,['3 / Week'], , 
22260,3260,Alemtuzumab (Campath),2016-05-17,2017-12-02, ,MIU,['2 / Day'],Oral,Adverse Event
22261,639,Tecfidera,2016-07-23,, , ,['2 / Day'],IV, 
22262,639,IVIG,2016-03-02,2020-10-30,5000,mg,['3 / Week'],IV,Persistence of relapses
22263,3823,IVIG,2015-11-02,, ,mg,['/ Day'], , 
22264,4084,Methylprednisolone,2016-06-18,2019-05-03,1,mg,['2 / Day'],Oral,Persisting MRI activity
22265,4084,Rebif [22],2016-10-16,, , ,['/Month'],IV, 
22266,4084,Teriflunomide,2016-04-06,, ,mg,['/Month'],IV, 
22267,4316,Alemtuzumab (Campath),2016-10-11,2018-10-01,400,mg,['/ Day'],IV,Patient Choice/Convenience
22268,4316,IVIG,2016-04-19,,500,MIU,['/Month'], , 
22269,4316,Rebif [44],2016-05-21,,500, ,['3 / Week'], , 
22270,4316,Rebif [44],2016-10-05,2021-05-27,500,mg,['/Month'], ,Lack of efficacy
22271,2878,Ledertrexaat,2016-04-12,2019-01-23,1000, ,['3 / Week'],IV,Adverse Event
22272,2878,Tecfidera,2016-08-21,,5000,mg,['/Month'],IV, 
22273,2878,Alemtuzumab (Campath),2016-10-03,,20, ,['2 / Day'],Oral, 
22274,2878,Avonex,2015-12-27,2020-06-20,1000,MIU,['2 / Day'],Oral,Persisting MRI activity
22275,4643,IVIG,2016-10-21,2021-08-20,1000,mg,['/Month'], ,Persisting MRI activity
22276,4478,Tecfidera,2016-04-26,2020-06-21,300, ,['/ Day'],IV,Lack of efficacy
22277,4478,Tecfidera,2016-08-20,2019-09-07,500,mg,['2 / Day'], ,Patient Choice/Convenience
22278,1271,Avonex,2016-09-11,, , ,['3 / Week'], , 
22279,106,Endoxan,2016-09-06,,20, ,['/ Day'], , 
22280,4405,Endoxan,2016-09-07,2019-11-23,1000,mg,['/Month'],Oral,Patient Choice/Convenience
22281,1409,Alemtuzumab (Campath),2016-07-15,, ,mg,['2 / Day'],IV, 
22282,1409,Avonex,2016-03-27,,500,mg,['3 / Week'],IV, 
22283,1409,Tysabri,2016-06-02,2019-11-11,500,mcg,['2 / Day'],IV,Adverse Event
22284,1409,Endoxan,2016-09-10,, , ,['2 / Day'],IV, 
22285,3779,Gilenya,2016-09-20,2020-09-04,20, ,['/ Week'], ,Persisting MRI activity
22286,3779,Mitoxantrone,2016-09-22,,1000,mg,['/Month'], , 
22287,3779,Methylprednisolone,2015-12-13,2021-07-17, ,mg,['/Month'], ,Patient Choice/Convenience
22288,2084,Alemtuzumab (Campath),2015-11-23,,20,mg,['2 / Day'], , 
22289,2084,Methylprednisolone,2016-06-13,2021-02-08,1, ,['/Month'],Oral,Persistence of relapses
22290,914,Rebif [22],2015-11-18,, ,mg,['3 / Week'],IV, 
22291,914,Alemtuzumab (Campath),2016-09-07,,1, ,['2 / Day'],IV, 
22292,914,Copaxone,2016-10-10,2020-03-07,500,mg,['2 / Day'], ,Lack of efficacy
22293,914,Copaxone,2015-12-16,,1000,mg,['2 / Day'],IV, 
22294,1020,Gilenya,2016-05-14,2020-04-23,400, ,['2 / Day'],IV,Patient Choice/Convenience
22295,1020,D-cure (Vitamine D),2015-11-05,,5000,MIU,['/ Day'],Oral, 
22296,1020,Endoxan,2015-12-26,, ,MIU,['/Month'],IV, 
22297,651,D-cure (Vitamine D),2015-12-01,2018-01-05,500,mg,['2 / Day'],Oral,Adverse Event
22298,651,Avonex,2016-05-19,,20, ,['/ Day'], , 
22299,651,Copaxone,2016-03-25,,1, ,['3 / Week'],IV, 
22300,565,Tecfidera,2016-02-13,,300,mcg,['3 / Week'],IV, 
22301,565,Copaxone,2016-08-25,,400,mg,['2 / Day'], , 
22302,565,Teriflunomide,2016-08-30,2021-03-08, ,MIU,['/ Week'],IV,Lack of efficacy
22303,4385,IVIG,2016-04-09,,5000, ,['3 / Week'], , 
22304,4385,Methylprednisolone,2016-04-07,,1000,mg,['2 / Day'],IV, 
22305,4385,Methylprednisolone,2016-10-06,,1, ,['2 / Day'],Oral, 
22306,4385,Tecfidera,2016-09-05,, ,mcg,['/Month'],IV, 
22307,1447,Tysabri,2016-08-26,2020-08-22, ,mg,['/Month'],Oral,Adverse Event
22308,868,D-cure (Vitamine D),2016-10-10,2020-02-10,1000,mg,['/Month'],Oral,Adverse Event
22309,868,Tecfidera,2016-09-28,, ,mg,['2 / Day'],Oral, 
22310,3690,Copaxone,2016-01-09,2018-08-29, , ,['2 / Day'], ,Persisting MRI activity
22311,3690,IVIG,2015-11-19,2019-01-10,1,mcg,['/Month'],IV,Patient Choice/Convenience
22312,916,Tysabri,2016-09-30,2018-09-14,500,mcg,['3 / Week'],IV,Patient Choice/Convenience
22313,916,IVIG,2016-07-11,2018-01-06,1, ,['3 / Week'],Oral,Patient Choice/Convenience
22314,916,Gilenya,2016-02-07,,20, ,['2 / Day'], , 
22315,3527,Endoxan,2016-08-17,,20,mg,['/Month'],IV, 
22316,3527,Endoxan,2016-01-11,2018-10-05,1,mg,['2 / Day'],Oral,Adverse Event
22317,2242,Copaxone,2016-05-21,2019-04-16, ,mg,['/Month'],IV,Lack of efficacy
22318,1617,Gilenya,2016-02-19,,500,mg,['2 / Day'],IV, 
22319,1059,Ledertrexaat,2016-01-23,2021-03-15,500,mcg,['3 / Week'], ,Adverse Event
22320,3194,Rebif [44],2016-07-06,2021-02-05,20,mg,['/Month'],IV,Adverse Event
22321,3194,Mitoxantrone,2016-05-15,2018-01-12, , ,['/Month'],IV,Adverse Event
22322,3194,Endoxan,2015-12-06,2017-11-18,400, ,['3 / Week'],IV,Patient Choice/Convenience
22323,1608,D-cure (Vitamine D),2016-05-20,,20,MIU,['/Month'],Oral, 
22324,2271,Rebif [22],2015-11-12,,1, ,[' '],IV, 
22325,2271,Rebif [44],2016-04-12,2020-02-05, ,mcg,['/Month'], ,Persistence of relapses
22326,2271,Mitoxantrone,2016-04-11,,1000, ,['/Month'],IV, 
22327,4671,Methylprednisolone,2015-12-16,,20, ,['/Month'], , 
22328,3566,Gilenya,2015-11-14,,5000, ,['/Month'],IV, 
22329,3566,Tysabri,2015-12-15,2020-08-18,5000,mg,['/Month'],IV,Lack of efficacy
22330,3566,Methylprednisolone,2016-06-23,,300,mg,['3 / Week'],IV, 
22331,3566,Methylprednisolone,2016-03-25,2021-06-11,300,mg,['/Month'],IV,Patient Choice/Convenience
22332,4988,Gilenya,2016-07-10,,1000,mg,['3 / Week'],IV, 
22333,4988,Avonex,2015-11-12,, ,mg,[' '],IV, 
22334,4988,Rebif [44],2016-04-02,,1,mg,['/Month'], , 
22335,1095,IVIG,2016-03-15,, ,MIU,['/Month'],IV, 
22336,3898,Endoxan,2016-06-01,,1,mcg,['2 / Day'], , 
22337,3898,Gilenya,2016-07-21,,500, ,['2 / Day'],IV, 
22338,3898,Gilenya,2015-12-16,2020-07-13,1000,mg,['2 / Day'],IV,Persisting MRI activity
22339,3898,D-cure (Vitamine D),2016-07-19,2017-11-27,1000, ,['/Month'],Oral,Lack of efficacy
22340,4512,D-cure (Vitamine D),2016-03-20,2020-07-17, ,mg,['/Month'],IV,Adverse Event
22341,4512,Teriflunomide,2016-04-22,,5000,mg,['2 / Day'],IV, 
22342,4512,Gilenya,2016-06-11,2018-01-03,20, ,['/Month'], ,Persistence of relapses
22343,4774,Teriflunomide,2016-01-16,, , ,['/Month'], , 
22344,1247,D-cure (Vitamine D),2016-03-17,2019-08-21, ,MIU,['3 / Week'],IV,Persisting MRI activity
22345,1574,D-cure (Vitamine D),2016-06-20,,400,mg,['/Month'],IV, 
22346,1574,Betaferon,2016-04-10,2018-06-12, , ,['3 / Week'],IV,Adverse Event
22347,1574,Rebif [22],2015-11-03,,300, ,['2 / Day'],IV, 
22348,1574,Endoxan,2016-08-08,2017-12-14, , ,['3 / Week'],IV,Persistence of relapses
22349,2928,Teriflunomide,2016-07-07,2019-09-06, ,mg,['/ Day'],IV,Adverse Event
22350,2928,Tecfidera,2016-09-16,,300,MIU,['/Month'], , 
22351,2928,Avonex,2016-05-25,,500, ,['/ Day'],IV, 
22352,2928,Gilenya,2015-11-03,,5000, ,['2 / Day'],IV, 
22353,3669,IVIG,2016-06-03,, ,mg,['/Month'],IV, 
22354,3669,IVIG,2016-07-22,2020-05-26, ,mg,['/Month'], ,Adverse Event
22355,1631,Tysabri,2016-09-26,,1,MIU,['2 / Day'],IV, 
22356,4795,Gilenya,2016-04-28,2021-08-06, , ,['2 / Day'], ,Adverse Event
22357,4795,Gilenya,2016-02-17,,20, ,['/Month'],IV, 
22358,4795,Rebif [22],2016-04-10,2020-06-28,1,mg,['2 / Day'], ,Adverse Event
22359,4795,Copaxone,2016-04-12,2018-01-06,5000, ,[' '], ,Persisting MRI activity
22360,4199,Tecfidera,2016-04-05,2020-11-25,400,MIU,['3 / Week'],IV,Persistence of relapses
22361,2402,Avonex,2016-04-07,,5000,MIU,['3 / Week'],IV, 
22362,2402,Avonex,2016-03-03,,1, ,['/Month'], , 
22363,245,IVIG,2016-06-24,2017-12-19,500,MIU,['2 / Day'],IV,Patient Choice/Convenience
22364,4030,Mitoxantrone,2016-01-20,2021-01-27,1, ,['/Month'],IV,Lack of efficacy
22365,222,Tecfidera,2016-08-05,, ,mg,['2 / Day'], , 
22366,222,D-cure (Vitamine D),2016-03-29,, ,mcg,['2 / Day'],IV, 
22367,222,IVIG,2016-05-07,, , ,['/Month'],IV, 
22368,2810,Ledertrexaat,2016-04-11,,1000, ,['2 / Day'], , 
22369,2810,Mitoxantrone,2016-08-03,, ,MIU,['2 / Day'],IV, 
22370,2810,Tysabri,2015-11-06,, ,mg,['3 / Week'], , 
22371,2810,Rebif [44],2016-07-18,2021-02-27,5000,mg,[' '],IV,Persistence of relapses
22372,3861,Copaxone,2016-02-10,2017-11-16,1, ,['/Month'], ,Lack of efficacy
22373,3861,Gilenya,2016-10-12,,20,mg,['/ Week'], , 
22374,3861,IVIG,2016-08-08,, , ,['/Month'],IV, 
22375,3861,Avonex,2016-04-13,2018-05-24,20,mg,['2 / Day'],IV,Patient Choice/Convenience
22376,2883,Alemtuzumab (Campath),2016-03-18,2017-11-20, ,mg,['3 / Week'], ,Adverse Event
22377,4099,Tysabri,2016-05-02,,20,MIU,['2 / Day'],IV, 
22378,4099,Rebif [22],2016-05-14,,1,mg,[' '],IV, 
22379,4099,IVIG,2016-08-16,2019-11-10, , ,[' '],IV,Adverse Event
22380,4099,Ledertrexaat,2015-11-26,2018-06-22,1, ,['/Month'],IV,Adverse Event
22381,2972,Rebif [44],2016-09-07,,1000,mg,['/Month'],IV, 
22382,2972,Rebif [22],2016-01-19,2020-01-25,300,mg,['3 / Week'],IV,Lack of efficacy
22383,2972,D-cure (Vitamine D),2016-05-02,2020-06-14,1000, ,['2 / Day'],IV,Persisting MRI activity
22384,2972,Teriflunomide,2016-01-02,2019-08-23,20,mg,['2 / Day'],IV,Patient Choice/Convenience
22385,4781,Endoxan,2016-10-12,2021-06-28, ,mg,['3 / Week'],IV,Patient Choice/Convenience
22386,4781,Methylprednisolone,2016-05-24,, ,mcg,['/Month'],Oral, 
22387,4781,IVIG,2016-05-30,2018-12-07,500, ,['/Month'],IV,Adverse Event
22388,4781,IVIG,2016-10-14,, ,mcg,['3 / Week'],IV, 
22389,513,Teriflunomide,2015-12-13,2021-09-21,300, ,['2 / Day'],IV,Adverse Event
22390,513,D-cure (Vitamine D),2015-12-24,,5000,MIU,['2 / Day'],IV, 
22391,513,Teriflunomide,2016-03-08,2020-12-17,5000,MIU,['2 / Day'], ,Patient Choice/Convenience
22392,4593,Endoxan,2016-01-25,, , ,['2 / Day'], , 
22393,4593,Mitoxantrone,2016-08-17,,500,mg,['2 / Day'],IV, 
22394,2199,Teriflunomide,2016-06-05,,1000,mg,[' '],IV, 
22395,2199,Copaxone,2016-02-02,,300,mg,['3 / Week'],IV, 
22396,2199,Avonex,2015-11-09,, , ,[' '],Oral, 
22397,2418,Methylprednisolone,2016-02-12,2020-11-15, , ,['2 / Day'],Oral,Adverse Event
22398,2418,Rebif [22],2015-10-30,,300, ,['/Month'], , 
22399,920,Methylprednisolone,2015-12-20,, ,mg,['/Month'],IV, 
22400,920,Rebif [22],2015-12-04,, ,mg,['/Month'], , 
22401,920,Mitoxantrone,2015-12-08,2019-05-05,20,mg,[' '], ,Persistence of relapses
22402,920,Rebif [44],2016-09-07,2021-08-01, ,mg,['2 / Day'], ,Lack of efficacy
22403,1738,D-cure (Vitamine D),2016-10-13,,1000, ,['3 / Week'],Oral, 
22404,1738,D-cure (Vitamine D),2016-06-22,2018-04-30,1000,mcg,['/Month'], ,Lack of efficacy
22405,2251,Gilenya,2016-07-16,2018-05-04, ,mg,['/Month'],IV,Persisting MRI activity
22406,2251,Betaferon,2016-08-13,, , ,['/Month'], , 
22407,877,Ledertrexaat,2016-06-15,2017-10-24,300, ,['/ Day'], ,Adverse Event
22408,2595,Rebif [44],2016-05-27,, , ,['/Month'],IV, 
22409,1150,Methylprednisolone,2016-08-06,2018-04-16,300,mg,['/Month'], ,Persistence of relapses
22410,1150,Avonex,2016-09-20,, ,mg,['/Month'], , 
22411,1150,Alemtuzumab (Campath),2016-09-18,,400, ,['2 / Day'],IV, 
22412,1150,Tecfidera,2015-12-22,2021-02-02,500,mg,['3 / Week'], ,Persistence of relapses
22413,4676,D-cure (Vitamine D),2016-07-26,,1000, ,[' '],IV, 
22414,4676,Endoxan,2016-08-23,, , ,['/Month'],IV, 
22415,759,Avonex,2016-08-04,2018-03-23, ,mcg,['2 / Day'],IV,Adverse Event
22416,759,Betaferon,2016-05-02,,500, ,[' '], , 
22417,759,Alemtuzumab (Campath),2016-06-09,2020-03-29,300, ,['2 / Day'],IV,Adverse Event
22418,759,Rebif [22],2016-09-17,2021-10-08, ,mg,['2 / Day'],IV,Persisting MRI activity
22419,1444,Rebif [22],2016-03-25,,500,mg,['/ Day'], , 
22420,1444,Betaferon,2015-12-07,,5000, ,['2 / Day'],IV, 
22421,1444,D-cure (Vitamine D),2016-04-15,,400,mg,['/Month'],IV, 
22422,1444,Gilenya,2016-09-26,,20,MIU,['/Month'],IV, 
22423,4812,Rebif [44],2015-12-23,,1000,MIU,['2 / Day'], , 
22424,4812,Alemtuzumab (Campath),2016-07-11,2021-07-21, ,mcg,[' '],IV,Persisting MRI activity
22425,4756,IVIG,2016-09-21,, , ,['2 / Day'], , 
22426,4756,Copaxone,2016-07-28,,300,mg,['/Month'], , 
22427,4756,Alemtuzumab (Campath),2016-06-22,2018-06-08,1000, ,['/Month'],IV,Lack of efficacy
22428,4756,Rebif [44],2016-06-23,2018-08-09,500,mcg,['3 / Week'],IV,Persisting MRI activity
22429,4079,Teriflunomide,2015-12-04,,20,mg,[' '], , 
22430,4079,Alemtuzumab (Campath),2016-05-23,2017-12-20,20,mg,['/ Day'], ,Persisting MRI activity
22431,1375,Betaferon,2016-07-03,2018-12-21,5000, ,[' '],IV,Patient Choice/Convenience
22432,1375,Tecfidera,2016-06-23,,1000,mg,[' '], , 
22433,1375,D-cure (Vitamine D),2015-11-20,2020-08-17,1000, ,['2 / Day'], ,Patient Choice/Convenience
22434,4166,Methylprednisolone,2016-06-20,2019-12-12,20,mg,['/Month'], ,Lack of efficacy
22435,4166,Teriflunomide,2016-05-07,2018-12-21,500,mg,['3 / Week'], ,Patient Choice/Convenience
22436,2652,Copaxone,2016-02-05,,1000,mg,['3 / Week'],Oral, 
22437,2652,IVIG,2016-05-11,2017-11-25,300,mg,['2 / Day'],IV,Persisting MRI activity
22438,2652,D-cure (Vitamine D),2016-01-13,,5000, ,['/Month'],Oral, 
22439,2652,Endoxan,2016-02-14,2020-12-09,20, ,['2 / Day'],IV,Lack of efficacy
22440,3027,Betaferon,2016-06-20,2021-07-28,300, ,['3 / Week'], ,Persistence of relapses
22441,1412,Gilenya,2016-09-15,2020-11-07, , ,['/Month'],Oral,Persisting MRI activity
22442,1412,Tecfidera,2016-02-06,,5000,MIU,['2 / Day'],Oral, 
22443,1412,Tysabri,2016-10-13,, ,mg,['/Month'],IV, 
22444,1412,Gilenya,2015-11-20,,500, ,['3 / Week'],Oral, 
22445,3053,Tecfidera,2016-05-19,,500, ,['2 / Day'], , 
22446,3053,Rebif [44],2015-11-11,,5000,mg,['/Month'], , 
22447,3053,Methylprednisolone,2016-03-20,2020-02-17,500,mg,['/Month'],IV,Patient Choice/Convenience
22448,1967,Rebif [44],2016-02-18,2017-11-29,20,mg,['2 / Day'],IV,Adverse Event
22449,1967,IVIG,2016-05-10,2019-04-17, ,mg,['/Month'],IV,Adverse Event
22450,806,Avonex,2016-01-17,2021-01-02,300, ,['/ Day'],IV,Patient Choice/Convenience
22451,806,Tysabri,2016-04-05,,400,mg,[' '],IV, 
22452,806,Alemtuzumab (Campath),2015-11-09,,400, ,[' '], , 
22453,806,IVIG,2016-04-04,,400,MIU,['2 / Day'],IV, 
22454,2449,D-cure (Vitamine D),2016-03-02,,300,mcg,['/ Week'],IV, 
22455,2449,Betaferon,2016-05-09,2018-10-24,1000,mg,['/Month'], ,Patient Choice/Convenience
22456,1565,Avonex,2015-11-30,2019-11-19, , ,['/Month'],IV,Lack of efficacy
22457,1565,Methylprednisolone,2016-01-27,, ,mg,['/ Week'],IV, 
22458,1565,D-cure (Vitamine D),2015-11-25,,500,mg,['/ Day'],IV, 
22459,1565,Tecfidera,2016-02-15,2019-03-04,400, ,['2 / Day'],IV,Patient Choice/Convenience
22460,4607,Gilenya,2016-08-26,, , ,['2 / Day'],IV, 
22461,2311,Tysabri,2016-09-10,2020-05-20, , ,['2 / Day'],IV,Patient Choice/Convenience
22462,2311,Methylprednisolone,2016-09-02,2018-07-05,500,mg,['3 / Week'], ,Patient Choice/Convenience
22463,2311,Rebif [22],2015-11-05,2021-02-04,500, ,['/ Day'], ,Adverse Event
22464,3811,D-cure (Vitamine D),2016-02-03,, ,mg,['2 / Day'],IV, 
22465,3811,Gilenya,2016-08-05,,1000, ,['2 / Day'],IV, 
22466,3811,Copaxone,2016-09-30,2021-07-19, ,mg,[' '],IV,Lack of efficacy
22467,2781,Tecfidera,2016-01-26,2019-09-15,500, ,['/ Week'],IV,Lack of efficacy
22468,2781,Teriflunomide,2016-08-28,,1000,mg,['/ Week'],IV, 
22469,4605,Betaferon,2016-08-27,2021-03-21,500, ,['/ Day'],IV,Adverse Event
22470,1704,D-cure (Vitamine D),2016-07-21,,1000, ,['2 / Day'],IV, 
22471,1107,Avonex,2015-12-21,,5000,mg,['3 / Week'], , 
22472,4698,IVIG,2016-01-29,,1,mg,['/Month'],IV, 
22473,4698,Tecfidera,2015-11-10,, ,mg,['/Month'],IV, 
22474,4698,Endoxan,2016-09-21,,1,mcg,['/Month'], , 
22475,1030,Endoxan,2016-01-11,,20,MIU,['2 / Day'],IV, 
22476,1030,Tecfidera,2016-06-08,,20,mg,['3 / Week'],IV, 
22477,1030,IVIG,2016-01-23,2020-02-29,500,mg,['2 / Day'],IV,Persisting MRI activity
22478,1030,Avonex,2015-11-24,,400,MIU,['3 / Week'], , 
22479,819,Gilenya,2015-12-01,2019-07-22, ,mg,['/Month'], ,Adverse Event
22480,1365,Avonex,2015-11-25,2021-08-26,20, ,['/Month'],IV,Adverse Event
22481,1365,Gilenya,2016-08-16,,1,mg,['/ Week'], , 
22482,1365,Tecfidera,2016-04-03,,1, ,['/ Day'], , 
22483,2459,D-cure (Vitamine D),2015-12-26,,5000,mg,['2 / Day'],IV, 
22484,2459,Gilenya,2015-11-04,2019-04-25,400,mg,['/ Day'],IV,Adverse Event
22485,2459,Rebif [44],2016-08-28,,300,mcg,['2 / Day'],Oral, 
22486,2459,Rebif [44],2016-05-19,2019-10-01, ,mg,['/Month'], ,Adverse Event
22487,3457,Avonex,2015-12-27,, ,mg,['/ Day'],Oral, 
22488,3457,Betaferon,2016-02-04,,1, ,['/ Day'],Oral, 
22489,3457,Alemtuzumab (Campath),2016-08-13,2018-12-06, ,mg,['/Month'], ,Patient Choice/Convenience
22490,3457,Copaxone,2016-07-14,,20,mcg,['2 / Day'], , 
22491,1225,IVIG,2016-08-30,2021-03-16,300,mg,['/Month'], ,Lack of efficacy
22492,1225,Rebif [22],2016-07-03,,300, ,['/Month'], , 
22493,1225,Alemtuzumab (Campath),2015-12-17,,20,mg,['/Month'], , 
22494,1225,Rebif [22],2016-04-04,,300, ,['/Month'],IV, 
22495,2435,Tysabri,2016-07-07,,400,mcg,['/Month'],IV, 
22496,1771,Rebif [44],2016-07-18,,20,mg,['2 / Day'],IV, 
22497,1771,Avonex,2016-05-25,2021-01-03, ,mg,['/ Week'], ,Adverse Event
22498,2955,Rebif [44],2016-06-02,2019-02-24, ,mcg,['3 / Week'],IV,Adverse Event
22499,4309,Rebif [22],2016-09-19,,1000, ,['2 / Day'], , 
22500,4309,D-cure (Vitamine D),2016-06-12,2018-07-23,300,mg,['/ Day'],IV,Adverse Event
22501,4309,Methylprednisolone,2016-10-01,, , ,[' '], , 
22502,1852,Mitoxantrone,2016-01-19,2019-06-24, , ,[' '], ,Adverse Event
22503,2283,Mitoxantrone,2016-03-01,2018-04-23,500,mg,['2 / Day'],IV,Persisting MRI activity
22504,2283,Tysabri,2016-09-13,2019-06-17,1000, ,['/ Day'],IV,Persisting MRI activity
22505,4992,D-cure (Vitamine D),2016-07-05,2020-04-25, ,mcg,['/Month'],IV,Patient Choice/Convenience
22506,1679,Alemtuzumab (Campath),2016-05-11,, , ,['/Month'],IV, 
22507,1679,Endoxan,2016-02-05,,1000,mg,['2 / Day'], , 
22508,1679,Ledertrexaat,2015-12-11,, , ,['/ Week'],IV, 
22509,1679,D-cure (Vitamine D),2016-05-24,,5000,mg,['2 / Day'], , 
22510,2036,IVIG,2016-02-02,,20,mg,['2 / Day'], , 
22511,2036,Tecfidera,2016-08-17,2017-12-18, , ,['2 / Day'],IV,Adverse Event
22512,559,Tysabri,2016-01-20,,20, ,['/Month'], , 
22513,559,Rebif [44],2016-05-20,2018-05-29,20,mg,[' '], ,Persistence of relapses
22514,3435,Mitoxantrone,2016-03-22,,500,mg,['/Month'],IV, 
22515,3435,Gilenya,2015-10-29,,20, ,['3 / Week'],IV, 
22516,3435,Mitoxantrone,2016-02-03,2019-09-30,20,mg,['2 / Day'],IV,Patient Choice/Convenience
22517,3435,Rebif [44],2015-11-30,2019-12-14, ,MIU,['/Month'],IV,Persistence of relapses
22518,4776,Copaxone,2016-10-14,, , ,['/Month'],Oral, 
22519,4776,Tysabri,2015-10-31,, , ,['/Month'],IV, 
22520,4776,Endoxan,2015-11-24,2018-09-25,500, ,['/Month'], ,Persisting MRI activity
22521,1718,Alemtuzumab (Campath),2015-12-06,2017-11-02,1,MIU,['3 / Week'],IV,Lack of efficacy
22522,3282,Alemtuzumab (Campath),2016-07-29,2018-01-07,20, ,[' '],Oral,Persisting MRI activity
22523,3282,Mitoxantrone,2016-06-08,2020-10-13,20,MIU,['2 / Day'],IV,Adverse Event
22524,2502,Gilenya,2016-02-08,,1,MIU,['/Month'],IV, 
22525,2502,Alemtuzumab (Campath),2015-11-17,2020-02-16,1000, ,['/ Week'],IV,Lack of efficacy
22526,4291,Gilenya,2016-09-11,2020-03-03,500,mg,['/Month'],IV,Patient Choice/Convenience
22527,4291,IVIG,2016-08-07,2018-09-14,20,mg,['2 / Day'], ,Persisting MRI activity
22528,4291,Copaxone,2016-08-12,,400,mg,['2 / Day'],IV, 
22529,3432,D-cure (Vitamine D),2016-10-10,,1000,mg,[' '],IV, 
22530,3432,Methylprednisolone,2016-02-16,,300,MIU,['/Month'],IV, 
22531,3432,Teriflunomide,2016-09-08,,20,mcg,['2 / Day'], , 
22532,3432,IVIG,2015-11-25,,1,mcg,['2 / Day'],IV, 
22533,3422,Gilenya,2016-02-21,2019-09-13, ,mg,['2 / Day'], ,Persistence of relapses
22534,3422,Rebif [44],2016-10-07,,300,MIU,['/Month'], , 
22535,3422,Betaferon,2016-01-08,, ,mcg,['2 / Day'], , 
22536,4388,IVIG,2015-12-02,2019-08-18, , ,['2 / Day'],IV,Patient Choice/Convenience
22537,4388,Endoxan,2016-09-29,, ,mg,['2 / Day'], , 
22538,4830,Gilenya,2016-10-01,,500,mg,['3 / Week'],IV, 
22539,4830,Teriflunomide,2016-06-12,, ,mg,['2 / Day'], , 
22540,4830,Copaxone,2015-12-15,, ,mg,['3 / Week'],IV, 
22541,4808,Rebif [44],2016-05-09,2021-03-22,1000, ,['/Month'],IV,Lack of efficacy
22542,4808,Teriflunomide,2016-08-23,2020-09-01,20,mg,['3 / Week'],IV,Lack of efficacy
22543,4808,Betaferon,2016-05-09,, , ,['3 / Week'],IV, 
22544,4808,Endoxan,2016-06-19,,1, ,['2 / Day'],Oral, 
22545,3139,Tecfidera,2016-01-07,, , ,['/Month'], , 
22546,3834,Gilenya,2016-06-23,,300,MIU,['2 / Day'],IV, 
22547,3834,Alemtuzumab (Campath),2016-04-12,2021-04-25,300, ,['2 / Day'], ,Adverse Event
22548,3834,Rebif [44],2016-03-11,2017-12-16,5000,MIU,['/Month'], ,Patient Choice/Convenience
22549,1873,Betaferon,2016-05-11,2018-05-29, , ,['2 / Day'], ,Adverse Event
22550,1873,Mitoxantrone,2016-07-01,,1000,MIU,['2 / Day'], , 
22551,1873,Ledertrexaat,2015-11-09,, ,mg,['2 / Day'],IV, 
22552,1873,Avonex,2015-10-31,,5000,mg,['2 / Day'], , 
22553,1864,Alemtuzumab (Campath),2016-04-29,2021-07-27, ,mg,['/ Day'], ,Adverse Event
22554,1864,Endoxan,2016-03-08,,20, ,['2 / Day'],IV, 
22555,1864,Endoxan,2016-07-18,2018-12-29,20,mg,['2 / Day'],IV,Adverse Event
22556,1864,Teriflunomide,2016-03-31,,500, ,['/Month'],IV, 
22557,3314,Gilenya,2016-03-08,, , ,['2 / Day'],IV, 
22558,3314,Mitoxantrone,2016-01-10,,5000, ,['2 / Day'],IV, 
22559,3314,Methylprednisolone,2015-10-27,2020-09-10,500,MIU,['/Month'],IV,Lack of efficacy
22560,3454,Rebif [44],2016-07-17,,5000,mg,['3 / Week'],Oral, 
22561,350,Tysabri,2016-09-01,,20,MIU,['2 / Day'],IV, 
22562,789,Methylprednisolone,2016-07-18,2020-04-21,300,mg,['2 / Day'], ,Lack of efficacy
22563,789,Methylprednisolone,2016-04-05,2020-03-22, ,mg,['3 / Week'], ,Adverse Event
22564,789,Tecfidera,2016-07-20,,300,mcg,['/ Day'],IV, 
22565,3706,Rebif [44],2016-02-19,2018-09-28,500, ,[' '], ,Adverse Event
22566,3706,Betaferon,2016-08-13,2020-08-20, ,mg,['2 / Day'],IV,Lack of efficacy
22567,1878,Betaferon,2016-10-06,, ,mg,['/ Day'], , 
22568,3702,Copaxone,2016-09-30,,1000, ,[' '], , 
22569,3702,Rebif [44],2016-09-05,2020-02-24, , ,['3 / Week'],Oral,Adverse Event
22570,2174,Betaferon,2016-01-10,,400, ,['2 / Day'],Oral, 
22571,2174,Alemtuzumab (Campath),2016-07-18,,1000,mg,[' '],IV, 
22572,4706,Methylprednisolone,2016-04-24,2019-10-18, ,mg,['3 / Week'],IV,Lack of efficacy
22573,4706,Gilenya,2016-05-17,2020-10-05,20,mg,['2 / Day'], ,Patient Choice/Convenience
22574,4706,Tecfidera,2016-01-15,, , ,['2 / Day'], , 
22575,4706,IVIG,2015-11-24,,300,MIU,[' '],Oral, 
22576,1454,Gilenya,2016-09-16,2021-07-23,20,mg,['/ Day'],IV,Lack of efficacy
22577,3796,Tecfidera,2016-01-24,2021-07-18,5000, ,['/ Day'],IV,Adverse Event
22578,3796,Mitoxantrone,2016-03-24,2021-03-13,1000, ,[' '],Oral,Persistence of relapses
22579,3796,Endoxan,2016-04-01,,20, ,['/Month'],IV, 
22580,4613,Copaxone,2016-05-13,,500, ,['3 / Week'],IV, 
22581,4613,Rebif [22],2016-01-04,, , ,['3 / Week'],Oral, 
22582,4613,Avonex,2016-08-23,,5000,mg,['2 / Day'], , 
22583,3698,Endoxan,2016-02-06,2019-04-13,5000,mg,['2 / Day'],IV,Adverse Event
22584,3698,IVIG,2016-10-18,2019-05-31, , ,['2 / Day'], ,Adverse Event
22585,3698,Tysabri,2016-04-10,, ,mg,['/Month'], , 
22586,3698,Mitoxantrone,2016-01-06,, , ,['3 / Week'],Oral, 
22587,633,Tysabri,2016-09-18,2021-04-16, , ,['3 / Week'],Oral,Patient Choice/Convenience
22588,633,Methylprednisolone,2015-12-14,2019-05-20,20, ,['2 / Day'], ,Persistence of relapses
22589,2793,Tysabri,2016-06-10,2020-03-01,1000,mg,['/ Day'],IV,Patient Choice/Convenience
22590,2793,Alemtuzumab (Campath),2016-04-24,2020-03-04,300,mg,[' '], ,Persistence of relapses
22591,3638,Methylprednisolone,2016-07-23,,500, ,['2 / Day'],IV, 
22592,3638,Rebif [22],2016-07-20,2020-10-15, ,mg,['/ Week'], ,Adverse Event
22593,3638,Tecfidera,2016-01-01,,1000,mg,['/Month'],IV, 
22594,3638,Copaxone,2016-07-18,,500, ,['3 / Week'],IV, 
22595,4505,IVIG,2016-05-11,2018-09-07,5000,mg,['2 / Day'],IV,Lack of efficacy
22596,3263,Tecfidera,2015-12-20,, , ,[' '], , 
22597,3263,Gilenya,2015-12-11,,20, ,['/Month'], , 
22598,3263,Rebif [44],2016-06-29,,400,mg,['2 / Day'], , 
22599,3263,IVIG,2016-01-08,2017-12-20, ,mg,['/Month'], ,Adverse Event
22600,3944,Methylprednisolone,2015-12-03,2020-10-01,300, ,[' '], ,Adverse Event
22601,3944,Rebif [22],2015-10-30,2021-01-14,5000, ,['/Month'], ,Adverse Event
22602,643,Tysabri,2016-09-16,,300, ,['3 / Week'],IV, 
22603,4366,Endoxan,2016-07-19,,5000, ,['/ Week'], , 
22604,4366,Endoxan,2015-12-18,, ,mcg,['2 / Day'], , 
22605,4366,Gilenya,2016-02-25,2020-07-31,300, ,['/Month'],Oral,Lack of efficacy
22606,1439,Methylprednisolone,2016-08-12,2021-05-18,5000, ,['/Month'],Oral,Adverse Event
22607,1439,Tysabri,2016-07-09,,500, ,['2 / Day'], , 
22608,1439,Tecfidera,2016-02-09,, , ,['/Month'], , 
22609,3837,Methylprednisolone,2016-07-21,2020-06-14,300,mcg,[' '], ,Adverse Event
22610,3443,Alemtuzumab (Campath),2015-12-11,2021-01-10,300, ,[' '],Oral,Lack of efficacy
22611,3443,Gilenya,2015-11-19,2019-11-02, ,mcg,[' '], ,Adverse Event
22612,3443,Gilenya,2016-07-12,2020-06-14, ,mg,['/Month'],IV,Patient Choice/Convenience
22613,492,Ledertrexaat,2015-12-19,2020-08-05, ,mg,['/Month'], ,Patient Choice/Convenience
22614,492,Avonex,2016-03-09,2020-12-06,1,mg,['/ Week'],IV,Adverse Event
22615,2466,Methylprednisolone,2016-07-17,2019-01-01,1000,MIU,['/Month'],IV,Persisting MRI activity
22616,1356,Endoxan,2016-03-29,,20,mcg,[' '], , 
22617,1253,Gilenya,2016-07-06,2017-12-16,500,mg,['/ Week'], ,Persisting MRI activity
22618,1253,Avonex,2016-01-26,2021-09-06,5000,mcg,['2 / Day'], ,Persisting MRI activity
22619,1253,Alemtuzumab (Campath),2016-05-10,,1, ,['2 / Day'],IV, 
22620,1253,Gilenya,2016-09-16,, , ,['/Month'],IV, 
22621,3808,Rebif [22],2016-07-01,, , ,[' '],IV, 
22622,2189,Alemtuzumab (Campath),2016-05-05,2019-02-14,300,mg,['2 / Day'],IV,Patient Choice/Convenience
22623,4053,Teriflunomide,2016-02-11,,1000, ,['2 / Day'],IV, 
22624,4053,Gilenya,2015-12-17,2021-02-03, ,mg,['/Month'], ,Persistence of relapses
22625,4457,Gilenya,2016-07-07,, ,mg,['2 / Day'], , 
22626,4457,Tysabri,2016-01-24,2021-07-20,1000, ,['2 / Day'],IV,Persistence of relapses
22627,3802,Methylprednisolone,2016-10-22,2019-11-19,5000,MIU,['/Month'], ,Adverse Event
22628,341,D-cure (Vitamine D),2016-09-20,,500, ,['/Month'],IV, 
22629,341,Tysabri,2015-12-20,2018-03-14,500,mg,['2 / Day'],IV,Persisting MRI activity
22630,341,Rebif [44],2016-02-24,, ,mg,['/Month'],IV, 
22631,341,IVIG,2016-10-18,,5000, ,[' '],IV, 
22632,752,Betaferon,2016-09-08,2021-08-13,20,mcg,['/ Day'],IV,Adverse Event
22633,4645,D-cure (Vitamine D),2016-09-19,, ,mcg,['2 / Day'],IV, 
22634,4645,Endoxan,2016-01-29,,1, ,['/Month'], , 
22635,4645,Ledertrexaat,2016-07-10,, , ,['2 / Day'], , 
22636,1754,Methylprednisolone,2016-03-01,,500, ,['/Month'],IV, 
22637,1754,Tecfidera,2015-11-26,,1000, ,['3 / Week'], , 
22638,2952,Alemtuzumab (Campath),2016-08-12,, , ,['2 / Day'],IV, 
22639,2952,Tysabri,2015-10-28,2018-01-07, ,mg,[' '], ,Adverse Event
22640,2952,IVIG,2016-02-19,2021-06-28,1, ,['/Month'],IV,Patient Choice/Convenience
22641,2952,Copaxone,2016-10-19,2019-06-30, , ,['2 / Day'],IV,Patient Choice/Convenience
22642,2079,Betaferon,2016-08-14,2021-01-20,500,mg,[' '],IV,Adverse Event
22643,2079,Avonex,2015-11-24,,1,MIU,['2 / Day'],Oral, 
22644,2079,Tecfidera,2016-01-23,,1, ,['2 / Day'], , 
22645,2079,Tecfidera,2015-10-27,,1000,mcg,['/ Week'],IV, 
22646,392,Copaxone,2015-10-25,, ,mg,['2 / Day'], , 
22647,2760,Copaxone,2016-09-10,,1000,MIU,['2 / Day'],IV, 
22648,2760,Rebif [22],2015-11-08,,1, ,['2 / Day'],IV, 
22649,2760,Alemtuzumab (Campath),2015-12-03,, ,mcg,['/ Week'],IV, 
22650,2760,Alemtuzumab (Campath),2016-07-03,2019-04-24,500, ,['2 / Day'], ,Persisting MRI activity
22651,2727,D-cure (Vitamine D),2015-11-21,2018-12-12,1000, ,['/ Week'],IV,Lack of efficacy
22652,2727,Endoxan,2015-12-07,,500,mg,['2 / Day'],IV, 
22653,3197,Ledertrexaat,2016-05-04,, ,mg,['3 / Week'],IV, 
22654,3197,Betaferon,2015-12-11,2020-06-07, ,mcg,[' '],IV,Lack of efficacy
22655,3197,Copaxone,2016-01-07,2021-08-24, ,mg,['/Month'],IV,Patient Choice/Convenience
22656,3197,Rebif [22],2015-12-03,2018-01-08, , ,['2 / Day'],IV,Persistence of relapses
22657,540,Avonex,2016-06-26,, ,mg,['/Month'], , 
22658,540,Tysabri,2016-09-04,2018-06-29, ,mg,['/ Day'],IV,Patient Choice/Convenience
22659,4682,Avonex,2016-01-17,, ,mg,['/Month'],IV, 
22660,4682,Gilenya,2016-04-09,2020-10-16,1000, ,['/Month'],IV,Adverse Event
22661,1446,D-cure (Vitamine D),2016-03-04,,1, ,['/Month'],Oral, 
22662,1446,Copaxone,2016-05-13,2021-07-25,1,mg,['2 / Day'], ,Adverse Event
22663,1446,IVIG,2016-05-04,2018-04-22, , ,['/Month'], ,Persistence of relapses
22664,1446,D-cure (Vitamine D),2016-03-13,2017-11-16, ,mg,['2 / Day'],IV,Adverse Event
22665,179,Rebif [22],2016-03-28,,1000, ,['/Month'],IV, 
22666,179,Tecfidera,2016-04-16,, ,mg,['/Month'],IV, 
22667,179,Methylprednisolone,2016-08-05,, , ,['/Month'],IV, 
22668,4177,Alemtuzumab (Campath),2016-03-04,,1000, ,['/ Week'],Oral, 
22669,4177,Rebif [44],2016-01-23,2018-05-24,500,MIU,['2 / Day'],IV,Lack of efficacy
22670,4177,Betaferon,2015-12-04,2018-04-16,500,mg,['/Month'], ,Adverse Event
22671,3475,Tecfidera,2016-01-30,,20, ,['2 / Day'], , 
22672,1269,D-cure (Vitamine D),2015-12-23,, ,mcg,['/Month'],IV, 
22673,1269,Teriflunomide,2016-09-21,,300, ,['3 / Week'],IV, 
22674,133,Tecfidera,2016-01-23,, ,mg,['/Month'],IV, 
22675,2560,IVIG,2016-10-02,,400,mg,['/Month'],IV, 
22676,2560,Methylprednisolone,2015-11-05,,400,mg,['2 / Day'], , 
22677,2560,Alemtuzumab (Campath),2016-10-04,, ,MIU,[' '],IV, 
22678,2560,Rebif [44],2016-06-23,,20,mg,['2 / Day'], , 
22679,4253,D-cure (Vitamine D),2016-01-19,,5000,mg,[' '],IV, 
22680,4253,Mitoxantrone,2015-11-25,,300, ,['/Month'],Oral, 
22681,4253,Methylprednisolone,2016-03-25,2020-07-04,300, ,['2 / Day'], ,Patient Choice/Convenience
22682,4253,Avonex,2016-02-18,2020-02-20,1000,mg,['/ Day'],Oral,Patient Choice/Convenience
22683,4171,IVIG,2016-06-15,, ,mg,['2 / Day'],IV, 
22684,4171,Rebif [44],2016-05-15,,300,MIU,[' '],IV, 
22685,631,Alemtuzumab (Campath),2016-07-05,2020-03-26, ,mg,['/ Day'], ,Persistence of relapses
22686,4898,Tysabri,2016-01-30,2021-09-10, ,MIU,['/Month'],IV,Adverse Event
22687,4898,Tecfidera,2016-07-16,2018-11-06,1000,MIU,['2 / Day'],IV,Patient Choice/Convenience
22688,4950,Endoxan,2016-04-02,2018-09-14,300, ,['3 / Week'], ,Adverse Event
22689,4950,Mitoxantrone,2015-12-05,,1000, ,['2 / Day'], , 
22690,4950,Alemtuzumab (Campath),2016-07-15,,500,MIU,['2 / Day'],IV, 
22691,4950,Endoxan,2016-03-03,2019-11-15,1000,mg,['2 / Day'], ,Persisting MRI activity
22692,2935,Betaferon,2016-06-12,2021-02-12,1000,mg,['/ Week'], ,Patient Choice/Convenience
22693,2935,IVIG,2016-07-07,,300,MIU,['/Month'],Oral, 
22694,2935,Tecfidera,2016-03-11,,500,mcg,['/Month'], , 
22695,1674,Teriflunomide,2016-10-12,, , ,['/Month'],IV, 
22696,1674,Endoxan,2015-11-25,2019-05-29,1000,mcg,['2 / Day'], ,Lack of efficacy
22697,1674,Ledertrexaat,2016-01-22,,5000,mg,['2 / Day'], , 
22698,1674,Gilenya,2016-07-03,,500,mg,[' '], , 
22699,4243,Rebif [44],2016-06-24,,300,mg,['/Month'], , 
22700,4243,Gilenya,2016-04-23,,500,mcg,[' '],IV, 
22701,4243,Ledertrexaat,2016-06-07,, ,MIU,['2 / Day'],Oral, 
22702,534,Betaferon,2015-11-14,2018-04-24, , ,['/ Day'], ,Patient Choice/Convenience
22703,4194,Tysabri,2016-03-16,2020-06-25,300,MIU,['/ Week'],Oral,Persisting MRI activity
22704,4194,Gilenya,2016-06-08,2020-12-20,500,mg,['/Month'], ,Adverse Event
22705,991,Tecfidera,2016-08-23,, ,mg,['/ Day'],IV, 
22706,1249,Betaferon,2016-10-12,,500,mcg,['/Month'],IV, 
22707,1249,Tecfidera,2016-06-05,, ,mg,['/Month'],IV, 
22708,1249,Gilenya,2016-05-24,,1,mg,[' '], , 
22709,2899,D-cure (Vitamine D),2016-02-15,,400, ,['/Month'],IV, 
22710,2899,Rebif [44],2016-09-28,2019-01-14,400,mg,['2 / Day'], ,Patient Choice/Convenience
22711,2899,Ledertrexaat,2016-08-27,,1,mg,['/Month'],IV, 
22712,497,Rebif [22],2015-11-17,2019-06-27,1,mg,['2 / Day'],IV,Patient Choice/Convenience
22713,3037,Gilenya,2016-09-04,, ,mg,['/ Day'],IV, 
22714,3037,Gilenya,2016-09-26,2019-03-13, , ,['/Month'],Oral,Adverse Event
22715,3229,D-cure (Vitamine D),2016-02-28,2021-09-11,5000,mg,['/Month'],Oral,Adverse Event
22716,3229,Rebif [44],2016-08-09,,300, ,[' '], , 
22717,3229,Teriflunomide,2016-06-24,,500,mg,[' '],IV, 
22718,1385,Ledertrexaat,2016-06-30,,300,mg,['/Month'],IV, 
22719,1385,Rebif [44],2016-02-06,2019-08-18, ,mg,['/Month'], ,Persisting MRI activity
22720,1385,Copaxone,2016-01-14,2019-03-10, , ,['2 / Day'], ,Lack of efficacy
22721,4079,Tecfidera,2016-05-27,,5000,mg,['2 / Day'],IV, 
22722,4079,Copaxone,2016-04-25,, , ,['2 / Day'],IV, 
22723,3028,IVIG,2016-06-18,2020-11-15, ,MIU,['/Month'],IV,Persistence of relapses
22724,3028,D-cure (Vitamine D),2016-09-23,,20, ,['2 / Day'], , 
22725,4645,Rebif [22],2016-02-21,2020-04-18,400, ,['/Month'], ,Adverse Event
22726,3508,Gilenya,2016-07-10,2020-01-11, ,mcg,['/Month'],Oral,Adverse Event
22727,3508,Endoxan,2016-04-21,2020-01-08,1000, ,['/Month'],IV,Patient Choice/Convenience
22728,3661,Tecfidera,2016-05-22,2020-05-13,500,mg,['2 / Day'], ,Patient Choice/Convenience
22729,3661,Avonex,2016-08-17,, , ,['3 / Week'],Oral, 
22730,3661,D-cure (Vitamine D),2016-09-23,,1000,mg,['/Month'], , 
22731,3661,Betaferon,2016-01-14,2018-12-15,500,MIU,['/ Week'],IV,Adverse Event
22732,2077,IVIG,2016-07-22,,500,mg,['/Month'], , 
22733,2077,Tecfidera,2016-01-08,, , ,['/Month'],Oral, 
22734,2077,Tecfidera,2015-12-08,,1000,mcg,[' '],Oral, 
22735,2077,Copaxone,2016-01-01,,5000,mg,['/Month'], , 
22736,2534,Gilenya,2015-12-17,,1000,mcg,['/ Week'], , 
22737,2062,Tecfidera,2016-03-19,2018-09-13,1000,mcg,['3 / Week'],IV,Adverse Event
22738,2062,Alemtuzumab (Campath),2016-01-03,,1,mg,['/ Day'], , 
22739,2062,IVIG,2016-06-28,,500, ,['3 / Week'], , 
22740,4175,Methylprednisolone,2016-10-14,,5000,mg,['3 / Week'], , 
22741,4175,IVIG,2015-12-23,2018-06-08, , ,['2 / Day'],IV,Patient Choice/Convenience
22742,2258,Endoxan,2016-02-09,2019-06-23,1,mg,['/ Day'], ,Persisting MRI activity
22743,2258,Alemtuzumab (Campath),2016-01-24,,500,mg,['/Month'], , 
22744,2258,Betaferon,2016-03-05,,5000,mcg,['/ Week'],IV, 
22745,2258,Gilenya,2016-02-18,,1000,MIU,['/ Day'], , 
22746,1743,Tecfidera,2016-04-05,,5000, ,['/Month'], , 
22747,1743,IVIG,2016-02-03,,5000,mg,['2 / Day'],Oral, 
22748,1743,Rebif [44],2016-01-03,2021-05-21, , ,[' '],Oral,Adverse Event
22749,1743,Alemtuzumab (Campath),2016-10-07,2021-07-15,1, ,['/ Day'],IV,Adverse Event
22750,1459,Gilenya,2016-06-09,2019-03-01, ,mg,['3 / Week'], ,Adverse Event
22751,2004,Rebif [44],2016-03-19,2021-06-26,1000,mg,['3 / Week'],IV,Lack of efficacy
22752,3144,Rebif [22],2016-09-01,, ,mg,['/ Week'],Oral, 
22753,3144,Rebif [22],2016-03-27,,500,MIU,['2 / Day'],IV, 
22754,3144,Alemtuzumab (Campath),2016-05-29,,500,mcg,['3 / Week'],IV, 
22755,3144,Tysabri,2015-12-07,2018-10-19,500,MIU,['/Month'],IV,Patient Choice/Convenience
22756,1548,Tysabri,2015-12-18,,20, ,['/Month'],IV, 
22757,1548,Mitoxantrone,2016-01-27,2020-03-15,5000, ,['3 / Week'],IV,Persisting MRI activity
22758,1548,Alemtuzumab (Campath),2016-05-27,2020-02-24,400, ,['2 / Day'],IV,Adverse Event
22759,2426,Rebif [44],2016-10-11,2018-11-11, ,mg,['/ Day'],IV,Adverse Event
22760,2426,Tecfidera,2015-12-05,,500,mg,['/Month'],IV, 
22761,2426,Methylprednisolone,2016-10-06,, ,mcg,['/Month'], , 
22762,2243,Rebif [22],2016-08-03,2019-07-21, ,mcg,['/ Day'],IV,Persistence of relapses
22763,2243,Endoxan,2015-12-03,2020-03-19,500, ,['/Month'],IV,Lack of efficacy
22764,2243,Betaferon,2016-08-26,2021-02-17,400,MIU,['3 / Week'],IV,Persisting MRI activity
22765,1339,Tecfidera,2016-05-13,,400,mg,['2 / Day'],Oral, 
22766,1339,Gilenya,2016-09-03,,5000, ,['2 / Day'], , 
22767,1339,Methylprednisolone,2016-04-14,2019-06-17,5000,mg,['2 / Day'],Oral,Adverse Event
22768,1339,Endoxan,2016-08-30,,500, ,['2 / Day'],IV, 
22769,3441,Betaferon,2015-10-27,2019-06-22,1, ,['/ Day'], ,Adverse Event
22770,3441,Tecfidera,2016-07-03,, , ,['/Month'], , 
22771,1165,Methylprednisolone,2015-10-29,2018-11-27, ,MIU,['2 / Day'],IV,Lack of efficacy
22772,1165,Gilenya,2015-12-18,, ,mg,['2 / Day'],IV, 
22773,1165,Tecfidera,2016-04-08,2019-10-30, ,mg,['/Month'],IV,Adverse Event
22774,1165,Alemtuzumab (Campath),2016-08-24,2018-08-09, , ,[' '],IV,Adverse Event
22775,2002,Alemtuzumab (Campath),2016-04-01,,300,mcg,['/Month'], , 
22776,2002,Alemtuzumab (Campath),2016-06-16,2018-05-30, ,mg,['2 / Day'], ,Patient Choice/Convenience
22777,2002,Ledertrexaat,2016-03-05,2020-04-29, ,mg,['3 / Week'], ,Patient Choice/Convenience
22778,2584,Rebif [22],2016-01-13,, ,mg,['2 / Day'], , 
22779,2584,Tysabri,2016-10-14,2018-07-10,500, ,['/Month'],IV,Patient Choice/Convenience
22780,2584,Tecfidera,2016-03-06,,5000,mg,['/Month'], , 
22781,2584,IVIG,2016-07-14,2021-08-31, , ,['/Month'],IV,Adverse Event
22782,3129,Copaxone,2016-06-05,2020-12-02, , ,['/ Day'], ,Adverse Event
22783,3129,Betaferon,2015-11-01,, ,mg,['/ Day'],IV, 
22784,1673,Rebif [22],2016-09-20,2020-09-01, , ,['2 / Day'], ,Persisting MRI activity
22785,4548,Methylprednisolone,2016-07-13,,300,MIU,['2 / Day'],IV, 
22786,4518,Copaxone,2016-04-18,2018-10-29, ,mg,['/ Day'], ,Adverse Event
22787,4518,Tysabri,2016-04-26,2019-06-11,1,mg,[' '],IV,Persisting MRI activity
22788,4518,Betaferon,2016-01-04,2020-08-24,500, ,['2 / Day'], ,Adverse Event
22789,264,IVIG,2016-08-16,, , ,['/Month'],IV, 
22790,264,Tysabri,2015-12-06,2021-02-03,400, ,['/ Day'],IV,Persisting MRI activity
22791,264,Betaferon,2015-12-25,, ,mcg,['2 / Day'],IV, 
22792,264,Tecfidera,2016-02-24,2018-05-12,20,mg,['2 / Day'], ,Lack of efficacy
22793,3737,Ledertrexaat,2015-11-26,,20,mg,['3 / Week'],IV, 
22794,3737,Gilenya,2016-02-22,2018-02-19,1,mcg,['2 / Day'], ,Lack of efficacy
22795,3737,Tysabri,2016-08-24,2019-06-01,20, ,['3 / Week'],IV,Adverse Event
22796,3737,Gilenya,2016-01-31,,5000,mg,[' '],IV, 
22797,4067,Gilenya,2015-12-23,,500,mg,['2 / Day'], , 
22798,1818,Rebif [22],2016-04-26,,5000, ,['/Month'],IV, 
22799,2699,Rebif [44],2016-09-26,,20,mg,['3 / Week'],IV, 
22800,2699,Copaxone,2016-06-25,,20,mg,['/Month'], , 
22801,2699,Mitoxantrone,2016-05-05,2019-09-09,300, ,['/Month'], ,Adverse Event
22802,3552,Copaxone,2016-04-02,2020-04-22, ,MIU,['/Month'], ,Persistence of relapses
22803,3755,Ledertrexaat,2016-03-11,2018-02-08, ,mg,['2 / Day'],IV,Patient Choice/Convenience
22804,3755,Rebif [44],2016-07-29,2021-09-02,400, ,['2 / Day'], ,Adverse Event
22805,3755,Teriflunomide,2016-04-26,2020-09-04,1000, ,['2 / Day'],IV,Adverse Event
22806,3391,Tecfidera,2016-09-24,2019-12-02, , ,['/Month'],IV,Lack of efficacy
22807,1297,Tysabri,2015-12-07,2018-01-23, , ,['/Month'],IV,Persisting MRI activity
22808,2065,Copaxone,2016-07-05,2018-10-11, ,mg,['2 / Day'], ,Persistence of relapses
22809,2065,Rebif [44],2016-05-03,,400, ,['2 / Day'],IV, 
22810,2065,Tecfidera,2016-05-29,2019-10-25,1, ,['2 / Day'],Oral,Adverse Event
22811,4526,D-cure (Vitamine D),2016-07-11,2019-03-01, ,mg,['/Month'],IV,Adverse Event
22812,3746,Tysabri,2015-11-15,,1000, ,['/Month'], , 
22813,4757,Tecfidera,2016-06-23,, , ,[' '],IV, 
22814,4757,Endoxan,2016-03-12,, , ,['/Month'], , 
22815,4757,Betaferon,2016-05-01,,500,mg,[' '],IV, 
22816,4105,Rebif [44],2016-05-23,,1,mg,['/ Day'],Oral, 
22817,4840,Gilenya,2016-05-04,,1,MIU,['/ Day'], , 
22818,4840,Methylprednisolone,2016-05-16,2018-02-26,300, ,['/Month'],IV,Adverse Event
22819,1607,D-cure (Vitamine D),2015-11-09,2019-08-24,500, ,['/ Day'],IV,Patient Choice/Convenience
22820,518,Tecfidera,2016-03-22,2020-10-09,400,MIU,['3 / Week'],IV,Persisting MRI activity
22821,518,Alemtuzumab (Campath),2016-02-08,,5000, ,['2 / Day'],IV, 
22822,518,Rebif [44],2016-05-16,2021-06-16,20, ,['/Month'],IV,Adverse Event
22823,518,Alemtuzumab (Campath),2016-04-25,2018-06-05,300, ,['/ Week'],IV,Lack of efficacy
22824,3985,Tysabri,2016-03-02,2020-03-20,400, ,['/Month'], ,Patient Choice/Convenience
22825,3985,Rebif [22],2015-11-24,, ,mg,['3 / Week'],IV, 
22826,3985,Methylprednisolone,2016-05-11,2021-03-25,5000,MIU,['/Month'],IV,Patient Choice/Convenience
22827,2766,Methylprednisolone,2016-09-07,2019-09-11, ,mcg,['/Month'],IV,Lack of efficacy
22828,4576,Betaferon,2015-12-29,2019-02-05,1,mg,['2 / Day'],IV,Lack of efficacy
22829,3329,Gilenya,2016-05-19,,500,mcg,['/Month'], , 
22830,3329,Mitoxantrone,2016-09-21,,1,MIU,['2 / Day'],IV, 
22831,3329,Teriflunomide,2016-07-02,,1000,mg,[' '],IV, 
22832,4724,Tecfidera,2016-01-01,,500,mg,[' '], , 
22833,3731,Mitoxantrone,2016-03-01,,400,mg,['/ Week'], , 
22834,3731,Rebif [22],2016-01-05,,20,mcg,['/ Day'],IV, 
22835,2265,Endoxan,2015-12-04,,300,mg,['2 / Day'], , 
22836,2265,Betaferon,2016-10-18,, ,mg,['/Month'],IV, 
22837,1141,Mitoxantrone,2016-03-11,2019-06-24,1,mcg,['3 / Week'],IV,Adverse Event
22838,4873,Gilenya,2016-02-14,,1000,mg,['2 / Day'], , 
22839,4873,Endoxan,2016-04-23,,20, ,['/Month'],IV, 
22840,313,Rebif [22],2016-08-24,2018-09-26, ,mg,['/ Day'],IV,Persistence of relapses
22841,4956,Tecfidera,2016-09-19,,500,mg,['3 / Week'],IV, 
22842,4956,Rebif [44],2015-11-04,2021-10-12,500, ,['/Month'], ,Adverse Event
22843,4956,Endoxan,2016-10-14,2018-07-06, ,mg,['2 / Day'],IV,Patient Choice/Convenience
22844,3023,Rebif [22],2015-12-10,2018-02-12,300,mg,['/Month'],IV,Patient Choice/Convenience
22845,3023,Endoxan,2016-03-27,2020-06-08,500,MIU,['3 / Week'], ,Persisting MRI activity
22846,3023,Rebif [22],2016-06-29,, ,mg,['/ Day'],IV, 
22847,3023,Copaxone,2016-08-30,, , ,['/Month'],IV, 
22848,2747,Betaferon,2016-10-08,2020-04-15,300,mg,['/Month'], ,Persistence of relapses
22849,4026,Betaferon,2016-04-03,2021-06-04,20,mg,['/Month'],IV,Adverse Event
22850,4026,Gilenya,2016-06-06,, , ,['2 / Day'], , 
22851,4026,Copaxone,2016-01-19,,1, ,['/Month'], , 
22852,4026,D-cure (Vitamine D),2016-03-22,2021-03-21,500,mg,['/ Day'],IV,Lack of efficacy
22853,1772,Rebif [22],2016-01-25,,20,MIU,['3 / Week'], , 
22854,1772,Ledertrexaat,2016-07-07,, ,mg,['2 / Day'], , 
22855,1772,IVIG,2016-03-01,2020-03-26, ,mg,['3 / Week'],IV,Lack of efficacy
22856,1278,D-cure (Vitamine D),2016-07-14,2018-08-06,500, ,['/ Day'],IV,Adverse Event
22857,1278,Avonex,2016-06-19,,5000, ,['/Month'], , 
22858,1278,Alemtuzumab (Campath),2016-04-12,,20,mg,['2 / Day'],IV, 
22859,1278,Copaxone,2016-04-15,2021-07-22,20, ,['2 / Day'],IV,Patient Choice/Convenience
22860,2010,Tecfidera,2016-10-12,, , ,['/Month'], , 
22861,2010,Betaferon,2016-10-22,2020-06-16,300,MIU,['2 / Day'],Oral,Adverse Event
22862,2010,Alemtuzumab (Campath),2016-07-03,, ,MIU,['/Month'], , 
22863,3092,IVIG,2016-01-17,2019-08-18, , ,['/Month'],IV,Patient Choice/Convenience
22864,3727,Copaxone,2015-12-12,2020-04-16,500,MIU,[' '], ,Adverse Event
22865,4070,Teriflunomide,2016-04-27,2020-10-08, ,mcg,['2 / Day'],Oral,Adverse Event
22866,4070,Tysabri,2016-03-31,,1,MIU,['2 / Day'],Oral, 
22867,4070,D-cure (Vitamine D),2016-07-20,,20, ,['/Month'],Oral, 
22868,2009,Tysabri,2016-04-09,2020-09-18,5000,mcg,['/Month'],IV,Adverse Event
22869,2009,Tecfidera,2016-03-23,2021-06-05, ,mg,['/Month'],Oral,Patient Choice/Convenience
22870,2009,Teriflunomide,2016-05-13,, ,mg,['2 / Day'],Oral, 
22871,4785,Methylprednisolone,2016-02-13,,5000,mg,['/Month'],Oral, 
22872,4785,D-cure (Vitamine D),2016-04-23,2018-01-11,500,mg,['2 / Day'],IV,Adverse Event
22873,2478,Avonex,2016-09-10,2019-02-25,300,mg,['2 / Day'],IV,Lack of efficacy
22874,2478,IVIG,2016-10-14,2018-04-04,500,MIU,['/Month'], ,Lack of efficacy
22875,3802,Alemtuzumab (Campath),2016-05-24,2017-11-26,500, ,['/Month'],Oral,Lack of efficacy
22876,3802,IVIG,2016-03-23,,20,mg,['/ Day'],Oral, 
22877,3802,Ledertrexaat,2016-09-22,,1, ,['2 / Day'],IV, 
22878,3802,Endoxan,2016-10-21,2019-09-09,400,MIU,['/Month'],IV,Lack of efficacy
22879,1356,Alemtuzumab (Campath),2016-08-16,2018-10-16,300,MIU,['3 / Week'], ,Lack of efficacy
22880,1356,Rebif [44],2016-08-15,,5000,MIU,[' '], , 
22881,1356,Methylprednisolone,2015-10-25,,300, ,['2 / Day'],IV, 
22882,2999,Mitoxantrone,2016-01-28,2020-08-04,400,mg,['/ Day'],Oral,Adverse Event
22883,2999,Mitoxantrone,2016-05-08,,5000, ,['2 / Day'],Oral, 
22884,2999,Rebif [22],2016-01-15,,300,mg,['3 / Week'],IV, 
22885,2399,Tysabri,2016-01-27,,1000, ,['2 / Day'],IV, 
22886,2399,IVIG,2016-06-22,,300,mg,['3 / Week'], , 
22887,2399,Mitoxantrone,2016-03-27,,5000,MIU,['2 / Day'], , 
22888,2399,Endoxan,2016-10-20,,5000, ,['3 / Week'],IV, 
22889,4901,Tysabri,2015-12-23,2021-01-21, ,MIU,['/Month'],IV,Persistence of relapses
22890,4901,Ledertrexaat,2016-02-23,2017-12-07,300, ,['/Month'],IV,Patient Choice/Convenience
22891,4901,Gilenya,2015-12-15,2020-03-24,1,mcg,['2 / Day'],IV,Adverse Event
22892,4901,Copaxone,2016-03-18,2020-04-09, , ,['2 / Day'],IV,Persisting MRI activity
22893,2498,D-cure (Vitamine D),2016-09-06,,400, ,['2 / Day'],IV, 
22894,4513,Rebif [44],2016-09-09,2021-09-25,300, ,['/Month'],IV,Adverse Event
22895,811,Avonex,2016-09-18,2018-08-02,1000, ,['/ Week'], ,Persisting MRI activity
22896,811,Ledertrexaat,2016-10-09,2018-02-13,300, ,['2 / Day'],IV,Adverse Event
22897,3388,Tecfidera,2016-04-28,2021-04-11,1000,mg,['2 / Day'], ,Persisting MRI activity
22898,3388,D-cure (Vitamine D),2016-06-05,2021-03-05, ,mg,['2 / Day'], ,Adverse Event
22899,3481,Teriflunomide,2016-03-30,2019-03-07,1000, ,['/ Week'], ,Patient Choice/Convenience
22900,3481,Tysabri,2016-01-23,,400,MIU,['2 / Day'], , 
22901,3372,IVIG,2016-10-04,, ,mg,['/Month'],IV, 
22902,3372,Rebif [44],2016-07-19,2019-10-30,5000, ,['3 / Week'], ,Adverse Event
22903,3372,D-cure (Vitamine D),2016-05-05,2020-05-06,500,mg,['3 / Week'],IV,Persistence of relapses
22904,3372,IVIG,2015-12-29,2020-03-27,1000,mg,['/ Day'], ,Lack of efficacy
22905,2238,Copaxone,2016-09-22,,500,MIU,['2 / Day'],Oral, 
22906,2238,Endoxan,2016-05-17,2020-01-14,500, ,['3 / Week'], ,Adverse Event
22907,2238,D-cure (Vitamine D),2016-09-14,2018-10-24,300, ,['/Month'],IV,Persisting MRI activity
22908,3372,Gilenya,2016-03-13,2018-11-02,1,mcg,['2 / Day'],IV,Persisting MRI activity
22909,3372,Rebif [22],2016-02-18,,300,mg,['2 / Day'],IV, 
22910,3372,Mitoxantrone,2015-12-12,,20,mg,['/Month'], , 
22911,3372,Teriflunomide,2016-05-29,,500,mg,['/Month'],IV, 
22912,990,Gilenya,2016-01-18,, ,mcg,['2 / Day'],Oral, 
22913,990,Methylprednisolone,2016-09-22,,1000, ,['2 / Day'], , 
22914,990,Endoxan,2015-10-25,, , ,['/ Day'],IV, 
22915,990,Tecfidera,2016-04-09,, ,mcg,['2 / Day'],Oral, 
22916,985,Copaxone,2016-03-06,2017-11-25, ,mg,['3 / Week'],Oral,Adverse Event
22917,2001,Methylprednisolone,2016-10-13,,1000, ,['/Month'],IV, 
22918,127,Methylprednisolone,2016-02-22,2018-12-24,1, ,['3 / Week'],IV,Patient Choice/Convenience
22919,127,Gilenya,2016-05-01,2021-05-23, , ,['2 / Day'],IV,Adverse Event
22920,2827,Tecfidera,2016-06-15,2019-08-17,300,mg,['/ Day'], ,Patient Choice/Convenience
22921,2827,Rebif [22],2016-09-19,, ,mg,['2 / Day'], , 
22922,3486,Rebif [44],2016-08-03,2021-08-23,20,mg,['/Month'],Oral,Adverse Event
22923,3486,Methylprednisolone,2016-06-22,2018-09-17, ,mg,['/Month'],Oral,Persisting MRI activity
22924,2570,Avonex,2016-07-09,,20,mg,['2 / Day'], , 
22925,2570,Rebif [22],2016-07-02,2019-09-08,20, ,['2 / Day'],Oral,Adverse Event
22926,2570,Avonex,2016-09-14,,1000,mg,['2 / Day'],IV, 
22927,2570,Avonex,2016-04-23,,500, ,['/Month'],IV, 
22928,1752,Rebif [22],2015-11-10,,400, ,['2 / Day'], , 
22929,1752,Tysabri,2016-05-09,2020-08-10,500, ,['2 / Day'],IV,Adverse Event
22930,1752,Rebif [22],2016-04-30,,300,mg,['3 / Week'],Oral, 
22931,3463,IVIG,2016-03-22,2020-03-28, , ,['/Month'],IV,Adverse Event
22932,2660,Alemtuzumab (Campath),2016-03-19,2019-09-06, , ,['/Month'],IV,Patient Choice/Convenience
22933,2660,Mitoxantrone,2016-04-30,2018-10-03,5000,mg,['/Month'],Oral,Persisting MRI activity
22934,2660,Endoxan,2016-02-27,2018-01-30, ,mg,['/ Week'],IV,Patient Choice/Convenience
22935,2660,Teriflunomide,2016-04-04,,300,mg,['/ Week'],IV, 
22936,3239,Rebif [22],2016-04-06,, , ,['/Month'], , 
22937,3239,IVIG,2016-04-28,,20,mg,['2 / Day'], , 
22938,3239,IVIG,2016-06-06,, , ,['2 / Day'], , 
22939,3239,Gilenya,2016-10-06,, ,mg,[' '],IV, 
22940,3737,Rebif [44],2016-07-27,, , ,['3 / Week'],IV, 
22941,3737,Methylprednisolone,2016-02-17,,300, ,['/Month'],Oral, 
22942,3737,Copaxone,2016-04-15,, , ,['3 / Week'],IV, 
22943,4368,Tecfidera,2016-01-03,2020-12-05,500, ,['2 / Day'], ,Patient Choice/Convenience
22944,4368,Rebif [22],2016-05-28,, ,mcg,['2 / Day'],Oral, 
22945,4368,Rebif [44],2015-12-11,2020-04-11,20, ,['/ Day'], ,Adverse Event
22946,2638,D-cure (Vitamine D),2016-10-16,2020-09-16, ,mg,['2 / Day'],IV,Persisting MRI activity
22947,4455,Alemtuzumab (Campath),2015-10-26,, ,mg,['/ Week'], , 
22948,4455,Teriflunomide,2016-09-02,2018-11-21, ,mg,['3 / Week'],IV,Persisting MRI activity
22949,4455,Methylprednisolone,2016-09-12,,300, ,['/Month'],IV, 
22950,4455,IVIG,2016-03-29,2021-02-09,1000,mg,['2 / Day'],IV,Adverse Event
22951,771,Betaferon,2015-12-23,2020-03-21,400,mg,['/Month'],IV,Patient Choice/Convenience
22952,1957,Rebif [44],2015-11-21,2018-12-09,1, ,['/ Day'],IV,Patient Choice/Convenience
22953,4432,IVIG,2016-05-10,,300, ,['2 / Day'],IV, 
22954,2455,D-cure (Vitamine D),2016-08-02,,20, ,['/ Day'],Oral, 
22955,2455,D-cure (Vitamine D),2016-01-07,,1000,mg,['/Month'], , 
22956,2455,Alemtuzumab (Campath),2015-11-26,,5000, ,['/Month'], , 
22957,2455,Avonex,2016-02-13,2018-12-05, , ,['/Month'],Oral,Lack of efficacy
22958,2325,Rebif [22],2016-02-24,2018-02-03,300,MIU,['2 / Day'],Oral,Patient Choice/Convenience
22959,2216,D-cure (Vitamine D),2016-03-06,,1, ,['/Month'],Oral, 
22960,2216,D-cure (Vitamine D),2016-08-04,2020-11-13,1000, ,['/Month'],IV,Persistence of relapses
22961,4738,D-cure (Vitamine D),2016-05-16,,1,mg,['/Month'],IV, 
22962,4738,Tysabri,2016-04-17,,1,MIU,[' '],Oral, 
22963,4738,Rebif [22],2016-05-28,2020-12-02,1000,mg,['/ Week'],IV,Persisting MRI activity
22964,108,Tecfidera,2015-11-05,,400, ,['2 / Day'], , 
22965,108,Alemtuzumab (Campath),2016-08-04,2018-07-01,20,mg,['3 / Week'],IV,Patient Choice/Convenience
22966,108,Teriflunomide,2015-12-31,2017-12-06,20,mg,['/Month'], ,Persisting MRI activity
22967,108,Endoxan,2016-04-13,, , ,[' '], , 
22968,4738,Rebif [44],2016-10-06,2020-07-22,5000,mcg,['/ Day'],IV,Persistence of relapses
22969,4738,IVIG,2016-10-18,,5000, ,['2 / Day'],IV, 
22970,1514,Ledertrexaat,2016-03-14,,400, ,['2 / Day'], , 
22971,1514,D-cure (Vitamine D),2016-02-05,2019-07-04,500,mcg,['/ Day'],Oral,Persisting MRI activity
22972,1514,Rebif [44],2016-02-08,2020-06-26,1000, ,['2 / Day'],IV,Adverse Event
22973,112,D-cure (Vitamine D),2016-02-28,, ,mg,['/Month'], , 
22974,112,D-cure (Vitamine D),2016-01-25,, ,mg,['2 / Day'],Oral, 
22975,4738,Avonex,2016-01-26,, ,mg,['/Month'], , 
22976,4738,Avonex,2016-08-11,,500,MIU,['/Month'],IV, 
22977,4738,Avonex,2016-08-26,, ,mg,['3 / Week'],Oral, 
22978,4738,D-cure (Vitamine D),2016-08-23,2020-07-28,400,mg,['/Month'],IV,Patient Choice/Convenience
22979,450,Copaxone,2016-03-01,2021-07-25, , ,['/Month'],IV,Persistence of relapses
22980,1638,Ledertrexaat,2016-10-04,,400,mcg,['/ Week'],IV, 
22981,2879,Betaferon,2016-10-20,, , ,['3 / Week'], , 
22982,2455,Gilenya,2016-05-28,, ,mg,['/Month'],IV, 
22983,2455,Rebif [44],2015-12-13,,5000, ,['3 / Week'],Oral, 
22984,2960,Rebif [44],2016-03-06,2018-02-12,1, ,['2 / Day'],IV,Adverse Event
22985,3789,IVIG,2016-04-04,, ,mg,['/Month'],IV, 
22986,3789,Betaferon,2016-02-16,2020-01-16,1000,mg,['/ Day'],Oral,Patient Choice/Convenience
22987,3789,Endoxan,2015-12-31,,1000,mcg,['/Month'],IV, 
22988,992,Rebif [44],2016-07-04,,300,mg,[' '], , 
22989,992,Tecfidera,2016-03-23,, ,mg,[' '],IV, 
22990,992,Alemtuzumab (Campath),2016-05-23,2019-11-15,5000,mcg,['2 / Day'], ,Patient Choice/Convenience
22991,992,Rebif [22],2016-04-10,2020-04-02, ,mg,['/Month'],IV,Patient Choice/Convenience
22992,4749,Avonex,2016-06-24,,1000, ,['/ Week'],IV, 
22993,4749,D-cure (Vitamine D),2016-07-20,2017-11-15, ,mg,['/Month'],IV,Adverse Event
22994,4749,Copaxone,2016-03-16,2021-02-03,20,mg,['/Month'], ,Persistence of relapses
22995,2466,Betaferon,2016-09-19,,20,mcg,['2 / Day'], , 
22996,2466,Copaxone,2016-05-18,2019-05-16, ,mg,['/Month'],IV,Persisting MRI activity
22997,2886,Tecfidera,2016-04-27,,500,mg,['/Month'], , 
22998,2886,IVIG,2015-12-13,,1000, ,['/Month'], , 
22999,2886,Tecfidera,2016-08-01,,400,mg,['3 / Week'],IV, 
23000,3730,Betaferon,2016-09-06,2018-07-18, ,mg,['/Month'],Oral,Patient Choice/Convenience
23001,704,D-cure (Vitamine D),2016-09-29,2018-10-18,300,mg,['/Month'], ,Lack of efficacy
23002,704,Gilenya,2016-09-13,, , ,['/Month'],IV, 
23003,4654,IVIG,2016-08-11,, , ,['2 / Day'], , 
23004,4654,Mitoxantrone,2016-04-18,2021-02-15,1000, ,['/Month'],IV,Persisting MRI activity
23005,4654,IVIG,2016-04-14,2021-04-27,300,mg,['3 / Week'],IV,Patient Choice/Convenience
23006,4599,Rebif [22],2016-09-23,,5000,MIU,[' '],IV, 
23007,4599,IVIG,2016-06-23,2021-09-20,5000,mg,['2 / Day'], ,Patient Choice/Convenience
23008,4599,Gilenya,2016-06-29,,1,mg,[' '],Oral, 
23009,4599,Betaferon,2015-11-07,2021-08-29,1, ,['/ Day'],Oral,Adverse Event
23010,1128,Alemtuzumab (Campath),2016-09-15,2021-09-03, ,mg,['2 / Day'],IV,Persistence of relapses
23011,1128,Tecfidera,2016-03-14,2018-08-02, ,mg,['/Month'], ,Persisting MRI activity
23012,1128,IVIG,2016-01-12,2018-05-29,400, ,['/Month'],IV,Persisting MRI activity
23013,3227,Mitoxantrone,2016-05-24,2019-09-17,500,MIU,['/Month'],IV,Persisting MRI activity
23014,3633,Copaxone,2016-04-07,2019-09-09,500, ,['/ Day'], ,Patient Choice/Convenience
23015,3633,Gilenya,2016-05-23,,1000,MIU,['/Month'], , 
23016,3440,IVIG,2016-08-12,,500,mg,['/ Week'],IV, 
23017,3908,Teriflunomide,2016-03-16,,1, ,['/Month'], , 
23018,3908,Avonex,2016-09-04,,5000, ,['/ Day'],IV, 
23019,2589,Endoxan,2015-12-11,,1, ,['/Month'],IV, 
23020,2589,Rebif [44],2016-07-16,, ,mg,['/Month'],IV, 
23021,2448,D-cure (Vitamine D),2015-11-06,,300, ,['/ Day'],IV, 
23022,2448,Copaxone,2016-07-08,, ,mg,[' '],IV, 
23023,2448,Copaxone,2016-04-30,2021-08-05,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
23024,2448,Tysabri,2016-09-07,,1000,MIU,[' '],Oral, 
23025,1150,Endoxan,2016-07-15,2018-05-21,500,MIU,['/Month'],IV,Adverse Event
23026,1150,Copaxone,2016-10-02,, ,mcg,['3 / Week'],IV, 
23027,1150,Teriflunomide,2016-01-28,,1,mg,['/ Day'],IV, 
23028,3388,Tysabri,2016-08-08,, , ,['2 / Day'],IV, 
23029,3388,Tysabri,2016-01-27,, ,mg,['2 / Day'],Oral, 
23030,3388,Copaxone,2016-08-23,2018-05-24, , ,[' '],IV,Patient Choice/Convenience
23031,3388,Methylprednisolone,2016-04-04,,1000, ,['/Month'],IV, 
23032,4767,Copaxone,2016-07-01,2018-01-21,400,mg,['/Month'], ,Persistence of relapses
23033,4767,Endoxan,2016-08-15,2020-05-09, ,mg,['/Month'],IV,Lack of efficacy
23034,4767,Alemtuzumab (Campath),2016-03-14,2018-04-12,1000,mg,['/Month'],IV,Lack of efficacy
23035,3922,Ledertrexaat,2016-08-14,,1000, ,['/ Day'], , 
23036,3922,IVIG,2015-12-05,,1, ,['2 / Day'], , 
23037,3922,Avonex,2016-05-08,, ,mg,['2 / Day'], , 
23038,3922,Rebif [44],2015-12-21,, , ,['/Month'],IV, 
23039,4644,Methylprednisolone,2016-07-09,2018-09-26, ,mg,['3 / Week'],Oral,Adverse Event
23040,4644,Betaferon,2016-03-16,2021-03-23,5000,mg,['2 / Day'],Oral,Lack of efficacy
23041,4720,Gilenya,2016-06-01,,400, ,[' '], , 
23042,4788,Rebif [44],2016-01-15,2019-04-30,1000,mg,['2 / Day'], ,Patient Choice/Convenience
23043,213,Rebif [22],2016-10-03,2020-08-29, ,mg,['/Month'], ,Adverse Event
23044,213,Tysabri,2016-05-09,2018-04-26,5000, ,['/Month'], ,Patient Choice/Convenience
23045,213,Rebif [22],2015-12-30,, , ,['/ Day'],Oral, 
23046,726,Betaferon,2015-11-30,2020-09-03, , ,['/Month'], ,Persisting MRI activity
23047,726,IVIG,2016-01-13,,500,mg,['3 / Week'], , 
23048,726,Rebif [44],2016-04-06,,1000, ,['3 / Week'],IV, 
23049,726,Gilenya,2016-09-23,2019-08-27,1000,mg,['/ Week'], ,Patient Choice/Convenience
23050,3787,Teriflunomide,2016-03-17,,1, ,['3 / Week'],IV, 
23051,3787,Gilenya,2016-07-26,,1000,mg,['/Month'],IV, 
23052,3787,Tysabri,2016-05-10,2019-08-29,500,mg,['/Month'],IV,Patient Choice/Convenience
23053,3960,Gilenya,2016-01-24,2020-05-07,500, ,['2 / Day'],IV,Persisting MRI activity
23054,2510,Tysabri,2016-03-08,2019-05-14,1, ,['2 / Day'],IV,Lack of efficacy
23055,126,IVIG,2016-08-07,, ,mg,['3 / Week'],IV, 
23056,2126,Teriflunomide,2015-11-29,,300, ,['2 / Day'],IV, 
23057,2126,Betaferon,2016-01-10,2018-05-02, , ,['/ Week'],IV,Adverse Event
23058,3003,Alemtuzumab (Campath),2016-04-11,2020-09-29,5000,mcg,['3 / Week'],IV,Adverse Event
23059,3003,Copaxone,2016-06-06,2019-08-09,20, ,['/Month'], ,Adverse Event
23060,3003,D-cure (Vitamine D),2016-10-03,2018-08-12,5000,mg,['2 / Day'], ,Lack of efficacy
23061,3003,Tecfidera,2016-05-17,,400,mg,['2 / Day'], , 
23062,2829,Methylprednisolone,2016-10-20,2020-05-21, ,mg,['/Month'], ,Lack of efficacy
23063,2829,Alemtuzumab (Campath),2015-10-29,2018-02-16,500,mcg,['3 / Week'],Oral,Patient Choice/Convenience
23064,2829,Rebif [22],2016-04-11,,400,mcg,['2 / Day'],Oral, 
23065,1291,D-cure (Vitamine D),2016-03-07,2020-05-23,400,mg,['/Month'],IV,Adverse Event
23066,1291,D-cure (Vitamine D),2016-01-16,, ,mg,['2 / Day'],IV, 
23067,437,Teriflunomide,2016-09-03,2018-08-19,500, ,['2 / Day'],IV,Lack of efficacy
23068,437,Gilenya,2016-07-28,2021-04-14,1000,mg,['/Month'],IV,Adverse Event
23069,437,Mitoxantrone,2016-01-06,2019-06-03, , ,['/ Week'],Oral,Persistence of relapses
23070,2680,Methylprednisolone,2016-04-09,,1000,mg,[' '], , 
23071,2680,Rebif [22],2016-02-23,2020-11-27,500,mg,['/Month'],IV,Adverse Event
23072,3340,Teriflunomide,2016-07-12,, ,MIU,['/Month'], , 
23073,3340,Rebif [22],2016-08-28,, ,MIU,['/Month'],IV, 
23074,3340,Methylprednisolone,2015-12-27,2017-12-03,1,mcg,['/Month'],IV,Patient Choice/Convenience
23075,3370,Gilenya,2016-06-09,2019-02-25, ,mg,['/Month'], ,Lack of efficacy
23076,3370,Avonex,2016-04-29,2019-09-10,500, ,['3 / Week'],Oral,Patient Choice/Convenience
23077,3370,Rebif [44],2015-11-14,,1000, ,['2 / Day'],IV, 
23078,3370,Alemtuzumab (Campath),2016-08-02,2020-10-09, , ,['3 / Week'], ,Persistence of relapses
23079,2085,Rebif [22],2016-07-11,2018-12-27,1000,mg,['2 / Day'],Oral,Persisting MRI activity
23080,2085,IVIG,2016-01-14,2020-10-22,1000, ,['/Month'], ,Adverse Event
23081,2085,Avonex,2016-03-03,2019-09-23, , ,['2 / Day'],Oral,Adverse Event
23082,2085,IVIG,2016-06-28,2018-03-07,400, ,['3 / Week'],IV,Patient Choice/Convenience
23083,3877,IVIG,2016-10-17,, ,mg,['/ Day'],IV, 
23084,4055,IVIG,2015-11-20,,500,MIU,['2 / Day'], , 
23085,4055,Tysabri,2016-10-12,,300,mg,['/Month'], , 
23086,4055,Endoxan,2015-12-18,2021-03-25,1,mg,[' '], ,Persisting MRI activity
23087,4055,Mitoxantrone,2016-01-10,2021-09-30,500,MIU,['2 / Day'],Oral,Patient Choice/Convenience
23088,3659,Rebif [44],2016-04-07,2019-10-14,1000, ,['/Month'],IV,Lack of efficacy
23089,3659,Tysabri,2016-04-12,,500,mg,['2 / Day'],IV, 
23090,3659,Mitoxantrone,2016-04-11,2020-12-31, ,MIU,['2 / Day'], ,Lack of efficacy
23091,648,Teriflunomide,2015-12-19,2021-01-16,1000, ,['/Month'],IV,Persistence of relapses
23092,246,D-cure (Vitamine D),2016-02-21,2020-05-11, , ,['/Month'], ,Persisting MRI activity
23093,246,D-cure (Vitamine D),2016-07-14,2021-06-10,20, ,['/Month'],IV,Persisting MRI activity
23094,246,Methylprednisolone,2016-02-25,2021-08-08,500,mg,['2 / Day'],IV,Persisting MRI activity
23095,4060,Rebif [22],2016-09-29,2018-08-04,5000, ,['2 / Day'],IV,Persistence of relapses
23096,4060,Rebif [44],2016-01-06,,20, ,['/Month'],IV, 
23097,2878,Rebif [22],2015-11-23,,400, ,['3 / Week'],IV, 
23098,2878,Methylprednisolone,2016-06-13,2020-06-07,300,mg,['2 / Day'],IV,Persisting MRI activity
23099,2878,Gilenya,2016-07-27,,5000, ,['3 / Week'],IV, 
23100,3680,Gilenya,2016-08-19,2017-12-07,1000, ,[' '],IV,Patient Choice/Convenience
23101,3680,Teriflunomide,2016-01-18,2020-06-06,20,MIU,['/Month'], ,Adverse Event
23102,3680,Tysabri,2016-08-12,,20, ,[' '],Oral, 
23103,4391,Tysabri,2016-06-21,,400,mg,['3 / Week'], , 
23104,4391,Tysabri,2016-09-14,2020-04-14,500,mg,['2 / Day'],IV,Adverse Event
23105,4391,Rebif [22],2016-06-23,,1, ,['2 / Day'], , 
23106,4391,Mitoxantrone,2016-09-04,,20,MIU,['2 / Day'],IV, 
23107,3585,Mitoxantrone,2015-12-05,2020-09-21, ,mg,['2 / Day'],IV,Persisting MRI activity
23108,1016,Tecfidera,2016-03-20,2021-08-30, ,mg,['/ Day'],Oral,Adverse Event
23109,1016,IVIG,2016-06-14,2020-03-05,20,MIU,['3 / Week'],IV,Lack of efficacy
23110,1016,Avonex,2016-05-28,2018-12-12,5000,mg,['/Month'], ,Patient Choice/Convenience
23111,3605,Tecfidera,2015-12-04,2019-05-16,400,mg,['/Month'],IV,Persisting MRI activity
23112,3605,D-cure (Vitamine D),2016-04-10,,1, ,['/Month'],IV, 
23113,3982,Tysabri,2016-06-05,,300,mg,[' '], , 
23114,3982,Tecfidera,2016-03-12,2021-10-23,300,mg,['2 / Day'],IV,Persisting MRI activity
23115,654,D-cure (Vitamine D),2016-02-15,2019-10-16,20,mg,['/ Day'],IV,Persistence of relapses
23116,654,Teriflunomide,2016-04-06,,1000,mcg,[' '], , 
23117,1383,Mitoxantrone,2016-07-03,,1000,mg,['/Month'], , 
23118,2615,Tysabri,2016-06-03,2019-07-03,20, ,['/Month'], ,Persisting MRI activity
23119,2615,Rebif [22],2016-09-07,,300, ,['/Month'],IV, 
23120,1145,Tecfidera,2016-05-15,2020-05-20, ,mg,['2 / Day'],IV,Adverse Event
23121,1145,IVIG,2016-01-14,,300,MIU,['/ Week'], , 
23122,1145,Mitoxantrone,2016-03-12,2021-06-08, ,mg,['/Month'],IV,Persistence of relapses
23123,1145,Copaxone,2016-08-11,2021-03-09,400, ,['/Month'],IV,Adverse Event
23124,238,Ledertrexaat,2015-10-26,2019-08-22,1, ,['2 / Day'], ,Lack of efficacy
23125,1172,Endoxan,2016-09-06,,1000, ,['/Month'], , 
23126,4281,Endoxan,2015-11-03,, ,mg,['/ Day'], , 
23127,4281,Tysabri,2016-03-29,2017-12-22, ,mg,[' '], ,Adverse Event
23128,3493,Tecfidera,2016-05-01,,400, ,['3 / Week'],IV, 
23129,3493,Tecfidera,2016-01-05,2021-08-17, ,mg,['3 / Week'],Oral,Adverse Event
23130,3493,D-cure (Vitamine D),2016-06-08,2021-01-05, , ,['/ Day'], ,Patient Choice/Convenience
23131,4583,Endoxan,2015-12-04,2017-10-31,1000,mcg,['/Month'], ,Lack of efficacy
23132,4583,Tysabri,2016-05-27,2018-08-02,20,mg,['/Month'],IV,Persisting MRI activity
23133,4583,Methylprednisolone,2016-04-13,,500,mg,['2 / Day'],IV, 
23134,4583,Alemtuzumab (Campath),2016-08-10,, ,mg,['/ Week'],IV, 
23135,1099,Endoxan,2015-11-03,,300,mg,['2 / Day'], , 
23136,1099,Rebif [22],2016-09-21,, ,mg,['2 / Day'],Oral, 
23137,1099,Tecfidera,2016-04-28,,20, ,['2 / Day'], , 
23138,1099,Endoxan,2016-04-19,,1,mg,['2 / Day'],Oral, 
23139,4073,Rebif [44],2016-09-14,,300, ,[' '],IV, 
23140,4073,Gilenya,2016-07-20,2019-01-03,400,mg,['/Month'], ,Lack of efficacy
23141,4073,Copaxone,2015-12-24,, ,mg,['2 / Day'],IV, 
23142,3167,Tysabri,2016-05-16,,5000, ,['2 / Day'],IV, 
23143,3167,D-cure (Vitamine D),2015-12-02,, , ,['3 / Week'],IV, 
23144,3429,Alemtuzumab (Campath),2016-01-28,2018-11-26,1, ,['2 / Day'],IV,Patient Choice/Convenience
23145,3429,D-cure (Vitamine D),2016-05-09,, , ,['3 / Week'], , 
23146,1614,Ledertrexaat,2016-04-14,2018-08-05, , ,['3 / Week'],Oral,Adverse Event
23147,3680,Rebif [22],2016-04-16,, ,mg,['2 / Day'],IV, 
23148,3680,D-cure (Vitamine D),2016-10-19,2019-11-22,1000,mg,['/Month'], ,Lack of efficacy
23149,884,Endoxan,2016-01-15,, , ,['3 / Week'],IV, 
23150,884,Gilenya,2016-08-03,, ,MIU,['2 / Day'], , 
23151,884,Gilenya,2016-07-04,2018-08-09,300, ,['/Month'],IV,Lack of efficacy
23152,884,Betaferon,2016-02-02,,300,mg,['3 / Week'],IV, 
23153,3769,Copaxone,2016-08-06,,5000, ,['/Month'],Oral, 
23154,3769,Rebif [44],2016-08-17,,1000,mg,['/ Day'],IV, 
23155,3769,Betaferon,2016-07-20,,20, ,['/Month'],IV, 
23156,1792,Ledertrexaat,2016-01-19,2017-10-26,1,mg,['2 / Day'],Oral,Persistence of relapses
23157,1792,Tecfidera,2015-11-07,2020-09-14,500,mg,['/ Week'],Oral,Persistence of relapses
23158,1792,Avonex,2016-10-22,2018-09-28, ,MIU,['3 / Week'],IV,Adverse Event
23159,1792,Gilenya,2016-10-10,2021-06-30,1000,MIU,['3 / Week'], ,Adverse Event
23160,2068,Avonex,2016-09-25,,500,mg,[' '], , 
23161,2068,Tecfidera,2016-08-14,2018-03-31,300,mg,['/Month'], ,Persisting MRI activity
23162,2068,Avonex,2016-05-08,2019-06-21, ,mg,['/Month'],IV,Adverse Event
23163,2068,Tecfidera,2016-01-29,2019-07-14,5000,mg,['/Month'], ,Patient Choice/Convenience
23164,1471,Gilenya,2016-09-04,2018-10-23,20,MIU,['2 / Day'],IV,Persisting MRI activity
23165,1471,Gilenya,2016-09-08,, ,mcg,['3 / Week'], , 
23166,1471,Rebif [44],2015-12-07,,1,mg,['2 / Day'], , 
23167,1307,Rebif [44],2015-10-27,,5000, ,['2 / Day'], , 
23168,1307,Ledertrexaat,2016-09-25,, , ,['/Month'], , 
23169,1307,Gilenya,2016-05-19,2018-05-31,300, ,[' '],IV,Adverse Event
23170,2068,Gilenya,2016-05-03,, ,mcg,['2 / Day'],IV, 
23171,2068,IVIG,2016-09-02,2021-02-10, ,mg,['/Month'],IV,Adverse Event
23172,1300,Copaxone,2016-04-04,,5000, ,['/ Week'],IV, 
23173,1300,Endoxan,2016-08-12,, , ,['2 / Day'],IV, 
23174,1300,Tecfidera,2016-01-11,2021-07-19,500,mg,['/Month'], ,Lack of efficacy
23175,1300,Ledertrexaat,2016-10-21,, ,mg,['2 / Day'],IV, 
23176,3492,Betaferon,2016-09-14,2019-06-16, ,mg,['2 / Day'],IV,Lack of efficacy
23177,4328,Tecfidera,2016-04-21,,20,mg,['2 / Day'],IV, 
23178,4328,Endoxan,2016-08-17,2021-03-02,20, ,['/Month'],IV,Lack of efficacy
23179,4328,Gilenya,2016-04-07,2021-04-12, , ,[' '], ,Persistence of relapses
23180,4328,Rebif [44],2016-06-04,,400, ,['/Month'],IV, 
23181,2083,Betaferon,2016-02-21,,500,mg,['/Month'], , 
23182,2083,Avonex,2016-05-27,2020-08-15,20, ,['2 / Day'], ,Persisting MRI activity
23183,2323,Avonex,2016-06-12,2019-10-22,1,mg,['2 / Day'],IV,Patient Choice/Convenience
23184,106,Copaxone,2016-06-10,,300, ,['/Month'], , 
23185,106,Rebif [44],2015-12-01,,300, ,['/Month'],IV, 
23186,106,Ledertrexaat,2016-02-11,, ,mg,[' '],Oral, 
23187,106,Avonex,2016-07-03,,5000,mg,['3 / Week'], , 
23188,3016,Betaferon,2016-03-24,,300, ,['/ Week'],IV, 
23189,3364,Tecfidera,2016-04-08,2020-06-19,5000,mcg,['/ Day'],IV,Adverse Event
23190,3364,IVIG,2016-08-09,,20, ,['/Month'],IV, 
23191,3364,Copaxone,2016-01-11,,5000,MIU,[' '],IV, 
23192,2382,Alemtuzumab (Campath),2016-02-10,,1, ,['2 / Day'],IV, 
23193,2382,Tysabri,2016-07-22,,500,MIU,['/Month'],Oral, 
23194,2382,Methylprednisolone,2016-01-24,2021-09-05, , ,['/Month'],IV,Persisting MRI activity
23195,2382,Rebif [44],2016-07-18,,1000, ,['/Month'],IV, 
23196,2893,Betaferon,2016-10-20,2021-05-10,1, ,['2 / Day'], ,Lack of efficacy
23197,2893,Ledertrexaat,2016-02-13,2019-09-04,1,mg,[' '],IV,Adverse Event
23198,798,Rebif [44],2016-04-28,,20, ,[' '], , 
23199,798,Copaxone,2016-07-23,,1,mg,['2 / Day'], , 
23200,1777,Tecfidera,2015-11-13,2018-03-18,500, ,['3 / Week'], ,Persisting MRI activity
23201,3459,Methylprednisolone,2016-08-14,,300,mg,['/Month'], , 
23202,3459,Copaxone,2016-03-19,2019-06-02, ,mg,['/Month'],IV,Lack of efficacy
23203,3944,Rebif [44],2015-10-29,, ,mg,['/ Day'], , 
23204,3944,Rebif [22],2016-03-18,,20,MIU,['/ Week'], , 
23205,4700,Teriflunomide,2016-06-24,, , ,['/ Day'],IV, 
23206,4428,Rebif [22],2016-01-29,,20,mg,['2 / Day'],IV, 
23207,4428,Rebif [44],2016-01-08,2018-06-01, ,mg,['3 / Week'], ,Patient Choice/Convenience
23208,3139,Tecfidera,2015-12-06,, ,mg,['3 / Week'], , 
23209,3139,Tecfidera,2016-06-02,,5000,mg,[' '],IV, 
23210,3139,Rebif [22],2016-10-04,,300,mg,['/Month'],IV, 
23211,1392,D-cure (Vitamine D),2016-09-09,2018-09-10,300, ,['/Month'], ,Persisting MRI activity
23212,1392,Gilenya,2016-03-04,2018-04-17,20, ,['3 / Week'],IV,Adverse Event
23213,1903,Avonex,2015-11-24,2018-03-01, ,mg,['/ Day'], ,Adverse Event
23214,2544,Ledertrexaat,2016-02-25,, , ,[' '],IV, 
23215,2544,Mitoxantrone,2016-08-09,2021-05-27,1,mg,['/Month'], ,Lack of efficacy
23216,2544,D-cure (Vitamine D),2015-11-27,,300,MIU,['/Month'], , 
23217,2544,IVIG,2016-02-12,2020-11-15,1,mg,['/Month'],IV,Patient Choice/Convenience
23218,846,Tecfidera,2016-06-28,2021-09-16,20,mg,['3 / Week'], ,Adverse Event
23219,846,IVIG,2016-04-26,, ,mg,['2 / Day'], , 
23220,4953,Mitoxantrone,2016-02-26,,500,MIU,['/ Day'],IV, 
23221,4953,IVIG,2016-09-03,2020-09-14,500,mg,['3 / Week'],IV,Adverse Event
23222,4953,Avonex,2016-04-08,2019-07-10,1000, ,['/Month'], ,Persistence of relapses
23223,1235,Methylprednisolone,2016-02-01,, ,mg,['2 / Day'],Oral, 
23224,3497,Tecfidera,2016-06-08,, , ,['/Month'],IV, 
23225,3497,Tecfidera,2016-09-04,, ,MIU,['2 / Day'], , 
23226,3497,Ledertrexaat,2015-12-14,,20, ,['3 / Week'], , 
23227,3497,Rebif [22],2016-06-30,,20,mg,[' '],IV, 
23228,4990,Endoxan,2016-02-07,,1,mg,['2 / Day'],IV, 
23229,4990,Betaferon,2016-06-21,2020-02-28,300,MIU,[' '],IV,Persistence of relapses
23230,4990,IVIG,2016-06-14,2019-01-02,20,mcg,['/ Day'], ,Adverse Event
23231,2774,Gilenya,2016-10-09,2018-06-09, , ,['/ Day'],IV,Adverse Event
23232,2774,Methylprednisolone,2016-05-10,, ,MIU,['2 / Day'], , 
23233,2774,D-cure (Vitamine D),2015-10-24,2018-09-24, ,mg,['2 / Day'],Oral,Persisting MRI activity
23234,2774,Gilenya,2015-11-25,2020-11-22,1,mcg,[' '],Oral,Persistence of relapses
23235,978,Rebif [44],2015-12-01,2018-05-18,300, ,['3 / Week'],IV,Adverse Event
23236,978,Copaxone,2016-07-13,2018-05-06,20, ,['/ Day'],IV,Lack of efficacy
23237,978,Tecfidera,2015-11-02,2021-03-07,20, ,['2 / Day'], ,Patient Choice/Convenience
23238,978,Teriflunomide,2016-01-12,2021-05-07, , ,['/Month'], ,Adverse Event
23239,1238,Copaxone,2015-10-25,,1000, ,['2 / Day'], , 
23240,1238,Avonex,2016-04-17,2018-02-23,20, ,['2 / Day'], ,Lack of efficacy
23241,1238,Gilenya,2016-03-22,,1,mg,['2 / Day'],IV, 
23242,1238,Avonex,2016-02-01,,1,mg,['/Month'], , 
23243,1302,Tysabri,2016-05-05,2019-10-15,1000,MIU,[' '],IV,Persisting MRI activity
23244,1302,Gilenya,2016-05-09,2020-02-21, ,mg,['/ Day'],IV,Adverse Event
23245,2971,Mitoxantrone,2016-02-02,2019-07-09, ,MIU,['/ Day'],IV,Patient Choice/Convenience
23246,2971,Endoxan,2016-05-01,2020-05-23, , ,['/ Day'],IV,Patient Choice/Convenience
23247,3338,Avonex,2016-08-07,2019-05-15, , ,['/Month'], ,Adverse Event
23248,3338,Betaferon,2016-10-10,2018-10-15,1000, ,['2 / Day'],IV,Adverse Event
23249,3338,Rebif [22],2016-08-20,, ,mg,['/Month'],IV, 
23250,3338,Methylprednisolone,2016-08-20,2019-08-26,5000,mg,['2 / Day'],IV,Adverse Event
23251,1657,Rebif [22],2016-05-19,2021-05-23, , ,['/Month'],Oral,Persistence of relapses
23252,4237,Tysabri,2016-01-13,, ,mg,['2 / Day'], , 
23253,4237,IVIG,2015-10-30,2020-02-28, , ,['/Month'],IV,Lack of efficacy
23254,4237,Teriflunomide,2016-08-06,,1,mg,['2 / Day'],Oral, 
23255,614,Tecfidera,2015-12-25,, , ,['3 / Week'],IV, 
23256,614,Teriflunomide,2016-02-23,2020-07-04,1000, ,['2 / Day'],IV,Lack of efficacy
23257,310,Gilenya,2016-10-10,2018-03-28,5000, ,['/Month'],IV,Adverse Event
23258,1409,Gilenya,2016-01-20,,300, ,['2 / Day'],IV, 
23259,3500,Copaxone,2015-11-12,2018-09-21, , ,[' '],IV,Patient Choice/Convenience
23260,3500,Methylprednisolone,2016-01-21,,5000, ,['/Month'], , 
23261,2111,Tecfidera,2016-05-29,, , ,['3 / Week'],IV, 
23262,2111,IVIG,2016-07-29,2018-09-02,400, ,['3 / Week'], ,Persisting MRI activity
23263,3663,Mitoxantrone,2016-04-14,, , ,['2 / Day'],IV, 
23264,1345,IVIG,2016-06-11,2020-05-31,500, ,['/ Day'],Oral,Adverse Event
23265,1345,Rebif [44],2016-02-18,,1,mg,['2 / Day'],Oral, 
23266,1345,Endoxan,2016-03-21,2019-12-07,500, ,['/Month'], ,Lack of efficacy
23267,4009,IVIG,2016-09-04,2020-05-25,400,mg,['/ Day'],IV,Persistence of relapses
23268,4009,Gilenya,2016-01-28,, ,mg,[' '], , 
23269,4009,Endoxan,2015-11-08,,1000,MIU,['/Month'],IV, 
23270,4009,IVIG,2016-08-07,,500,mg,['/ Day'],IV, 
23271,3004,Copaxone,2016-10-22,2020-02-26,400, ,['/Month'],IV,Adverse Event
23272,3004,Alemtuzumab (Campath),2015-12-29,2020-12-11, , ,[' '],Oral,Patient Choice/Convenience
23273,3004,IVIG,2016-05-06,, , ,[' '],IV, 
23274,844,Alemtuzumab (Campath),2016-08-10,, , ,['/Month'], , 
23275,844,Rebif [44],2016-01-29,, ,mg,['2 / Day'],IV, 
23276,4126,Copaxone,2016-07-18,2018-09-22, ,mg,['/ Week'],IV,Persisting MRI activity
23277,4126,D-cure (Vitamine D),2016-08-30,,400, ,['2 / Day'],Oral, 
23278,4126,Mitoxantrone,2016-08-02,2020-08-26,500, ,['3 / Week'], ,Lack of efficacy
23279,1221,D-cure (Vitamine D),2016-07-15,,300, ,['2 / Day'],IV, 
23280,1221,Ledertrexaat,2016-04-23,2020-06-03,20, ,['/Month'],IV,Lack of efficacy
23281,1221,Ledertrexaat,2016-01-27,,5000,mg,['/ Day'],IV, 
23282,2042,Ledertrexaat,2016-02-21,2019-04-02,500, ,['/Month'], ,Persisting MRI activity
23283,2042,IVIG,2016-06-12,,300, ,['/Month'],IV, 
23284,2042,Alemtuzumab (Campath),2016-06-15,, ,mg,[' '],IV, 
23285,2042,Tysabri,2015-12-07,,500,mg,['2 / Day'],Oral, 
23286,149,IVIG,2015-10-30,2020-01-17,20, ,['/ Day'],Oral,Adverse Event
23287,4528,Betaferon,2016-02-27,2019-12-14, ,mcg,['/ Day'], ,Lack of efficacy
23288,4528,Tysabri,2016-07-04,,1000, ,['/Month'],IV, 
23289,3960,Tysabri,2016-07-10,2019-08-01, ,mcg,['3 / Week'], ,Lack of efficacy
23290,3960,Endoxan,2016-01-19,2019-01-15,5000,mg,['2 / Day'], ,Adverse Event
23291,1036,Mitoxantrone,2016-07-07,,1000,mg,['/Month'], , 
23292,4545,Tysabri,2016-10-10,,400, ,['/ Day'],Oral, 
23293,4545,D-cure (Vitamine D),2016-05-01,2021-03-27,1, ,['2 / Day'],Oral,Patient Choice/Convenience
23294,3422,Copaxone,2016-01-04,2020-10-10,20, ,['3 / Week'],IV,Patient Choice/Convenience
23295,3422,Mitoxantrone,2016-09-06,2021-02-23,1,MIU,['2 / Day'],IV,Lack of efficacy
23296,3370,Copaxone,2016-06-16,2019-08-24,500, ,['2 / Day'],Oral,Adverse Event
23297,3370,D-cure (Vitamine D),2016-09-13,2021-01-11, ,mcg,[' '],IV,Adverse Event
23298,3370,Tecfidera,2016-07-04,2018-12-17,300,mcg,['2 / Day'],IV,Patient Choice/Convenience
23299,3370,Gilenya,2016-01-13,2021-04-10,20,mg,['/Month'], ,Lack of efficacy
23300,797,Gilenya,2016-04-02,2018-07-29,500,mg,['/Month'],Oral,Patient Choice/Convenience
23301,797,Teriflunomide,2016-02-10,, ,mg,['2 / Day'],IV, 
23302,797,Rebif [22],2016-10-02,2019-02-19,5000, ,['/ Week'], ,Lack of efficacy
23303,4989,Rebif [22],2016-08-06,2019-03-04,500,mg,['2 / Day'], ,Adverse Event
23304,4989,D-cure (Vitamine D),2015-10-29,2021-06-21, ,mcg,['2 / Day'],Oral,Persisting MRI activity
23305,4582,Endoxan,2016-10-09,,300,mcg,['2 / Day'], , 
23306,4582,Endoxan,2015-11-06,, ,mg,['/Month'],IV, 
23307,1366,Endoxan,2015-10-30,2020-07-16, ,mg,['2 / Day'],IV,Adverse Event
23308,1366,Alemtuzumab (Campath),2016-05-01,2020-12-02,20, ,['/Month'], ,Patient Choice/Convenience
23309,3570,Teriflunomide,2016-07-16,2019-05-21,500, ,[' '],Oral,Patient Choice/Convenience
23310,3570,Mitoxantrone,2016-09-20,2021-05-12, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
23311,2052,Teriflunomide,2016-08-06,,300, ,['/ Day'],IV, 
23312,2508,Gilenya,2016-09-24,, ,mg,['/ Week'],IV, 
23313,2508,Tecfidera,2016-09-12,2018-06-23,400, ,['/ Day'],IV,Persistence of relapses
23314,2508,Methylprednisolone,2016-05-01,,20,mcg,['2 / Day'],Oral, 
23315,2508,Avonex,2016-09-30,2017-12-14,5000,mcg,['2 / Day'],Oral,Lack of efficacy
23316,3420,Betaferon,2016-03-20,2018-01-23,20,mg,['2 / Day'],IV,Adverse Event
23317,1507,Betaferon,2016-09-06,,1,mg,['2 / Day'], , 
23318,1507,Methylprednisolone,2016-02-10,,1,mg,['2 / Day'],IV, 
23319,1507,Tysabri,2016-07-10,, ,mg,['2 / Day'],IV, 
23320,3165,Tecfidera,2016-01-01,2021-07-27,1, ,['2 / Day'], ,Patient Choice/Convenience
23321,2562,Gilenya,2016-08-27,2019-10-31,20,mg,['2 / Day'],IV,Persistence of relapses
23322,2562,Ledertrexaat,2016-06-23,,400,MIU,['2 / Day'], , 
23323,2562,Betaferon,2015-12-23,,20,mg,['/ Day'],IV, 
23324,372,Gilenya,2015-11-20,, ,mg,['/Month'],IV, 
23325,372,Rebif [22],2016-01-01,, ,mg,['/Month'], , 
23326,372,Methylprednisolone,2016-06-15,2017-11-29,1000,MIU,['/ Week'],IV,Adverse Event
23327,173,Endoxan,2016-01-22,, ,mg,[' '], , 
23328,4427,IVIG,2015-12-10,,5000, ,[' '], , 
23329,4427,Rebif [22],2016-03-20,,300, ,['/Month'],IV, 
23330,4427,Rebif [22],2016-05-14,2018-09-03,5000, ,['2 / Day'],IV,Persisting MRI activity
23331,3381,Rebif [22],2015-11-11,, ,mg,['2 / Day'], , 
23332,3381,Betaferon,2016-06-09,2021-01-26, ,mg,['2 / Day'], ,Persisting MRI activity
23333,3381,Rebif [44],2016-05-23,,5000, ,[' '],IV, 
23334,3381,Avonex,2016-10-01,,1000, ,['/ Week'],IV, 
23335,1569,Methylprednisolone,2016-09-10,,300,mg,['/Month'],Oral, 
23336,1569,Ledertrexaat,2016-08-02,,1, ,['3 / Week'],IV, 
23337,1569,Copaxone,2016-07-20,,500, ,['2 / Day'],IV, 
23338,1569,D-cure (Vitamine D),2016-04-20,2020-03-03,1000,mg,['/Month'], ,Lack of efficacy
23339,3290,Betaferon,2016-01-28,2020-10-02,20,mg,['/Month'],IV,Adverse Event
23340,3290,Rebif [22],2016-10-09,, , ,['/ Day'],IV, 
23341,3290,Copaxone,2016-03-17,, ,MIU,['2 / Day'],IV, 
23342,3746,Tysabri,2015-11-10,,400,mg,['/ Day'], , 
23343,3746,Gilenya,2016-09-27,2020-07-09,400,mg,[' '], ,Adverse Event
23344,877,Ledertrexaat,2015-12-14,, ,mg,[' '],IV, 
23345,877,Rebif [44],2016-07-30,2020-06-11,1000,MIU,['/Month'], ,Patient Choice/Convenience
23346,4786,Rebif [44],2016-01-11,2020-03-05,1,mg,['/Month'], ,Patient Choice/Convenience
23347,4786,Ledertrexaat,2015-11-01,, ,mg,['3 / Week'],Oral, 
23348,1114,Endoxan,2016-02-17,, , ,['/Month'],IV, 
23349,1114,Rebif [22],2016-06-16,,1000, ,['2 / Day'],IV, 
23350,1114,Methylprednisolone,2016-08-25,2020-06-05,400, ,[' '], ,Persisting MRI activity
23351,2551,Endoxan,2015-12-31,2021-10-21,1,MIU,[' '],IV,Persisting MRI activity
23352,3799,Avonex,2016-08-23,, , ,['/ Week'],IV, 
23353,3799,Endoxan,2016-08-05,2019-09-07, ,MIU,['/ Week'], ,Persisting MRI activity
23354,3799,Betaferon,2016-06-04,, , ,['/Month'], , 
23355,2268,Alemtuzumab (Campath),2016-04-07,2017-12-03, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
23356,2268,Betaferon,2016-09-30,, ,mg,['/Month'],IV, 
23357,2268,Methylprednisolone,2016-03-05,, ,mcg,['2 / Day'], , 
23358,2268,IVIG,2016-09-21,,1000,mg,['2 / Day'],IV, 
23359,246,D-cure (Vitamine D),2015-12-27,2019-03-22, ,mg,['2 / Day'],IV,Persisting MRI activity
23360,246,Alemtuzumab (Campath),2015-11-20,2019-08-10,400, ,['/Month'], ,Persisting MRI activity
23361,246,Gilenya,2016-04-05,2019-08-18,20, ,['2 / Day'],IV,Persistence of relapses
23362,4112,Mitoxantrone,2015-10-25,2021-07-23,1, ,['3 / Week'],IV,Persisting MRI activity
23363,4112,D-cure (Vitamine D),2016-06-12,2018-11-06, ,mg,['2 / Day'],IV,Adverse Event
23364,4112,Ledertrexaat,2016-06-08,,5000, ,['3 / Week'], , 
23365,4112,Rebif [22],2015-12-25,2020-08-15,1000,mg,['/Month'],IV,Patient Choice/Convenience
23366,2655,IVIG,2016-09-27,,500,mcg,['3 / Week'],IV, 
23367,2655,Betaferon,2016-03-22,2019-07-31, , ,['/ Week'],IV,Adverse Event
23368,2655,Methylprednisolone,2016-02-18,2018-04-13, , ,['2 / Day'],IV,Adverse Event
23369,1774,IVIG,2015-11-29,,300, ,['/Month'], , 
23370,3257,Rebif [44],2015-12-21,, ,mg,['3 / Week'],IV, 
23371,1182,D-cure (Vitamine D),2016-01-03,2020-11-23, ,mg,['/ Day'],IV,Lack of efficacy
23372,1182,Mitoxantrone,2016-09-06,2019-02-04,300, ,['2 / Day'],IV,Lack of efficacy
23373,1182,IVIG,2016-09-21,2019-10-20,1000,MIU,['/Month'],IV,Lack of efficacy
23374,1476,Tecfidera,2016-07-20,, , ,['/ Day'],IV, 
23375,1476,Mitoxantrone,2016-09-13,2018-10-19, ,MIU,['/Month'],Oral,Persistence of relapses
23376,1476,Rebif [22],2016-04-01,,1,mg,['/Month'], , 
23377,3306,Copaxone,2015-12-24,,1000, ,[' '], , 
23378,3306,Copaxone,2016-03-09,,5000,mg,['2 / Day'],IV, 
23379,537,IVIG,2016-07-11,2019-12-24,5000,mg,['/ Day'],IV,Adverse Event
23380,537,Endoxan,2016-06-21,2018-11-17, ,mg,['2 / Day'],IV,Lack of efficacy
23381,537,Tysabri,2016-07-26,2018-03-02, ,mg,['2 / Day'], ,Patient Choice/Convenience
23382,4996,Copaxone,2016-06-18,2020-07-31,1,mg,['/Month'],IV,Adverse Event
23383,168,Ledertrexaat,2016-08-24,,400,mg,['/Month'],IV, 
23384,168,D-cure (Vitamine D),2016-07-08,,20, ,['2 / Day'],IV, 
23385,168,Gilenya,2016-06-02,2019-03-14,500,mcg,['2 / Day'], ,Adverse Event
23386,4807,Mitoxantrone,2016-05-18,,300, ,['/Month'], , 
23387,4807,Copaxone,2015-10-29,2021-01-25,5000, ,[' '], ,Persisting MRI activity
23388,4807,Betaferon,2015-12-11,, , ,['/Month'],IV, 
23389,3892,IVIG,2016-02-19,, ,mg,['/Month'],IV, 
23390,1761,Mitoxantrone,2016-03-14,2017-12-05,1,mg,['2 / Day'], ,Persistence of relapses
23391,1761,Tecfidera,2016-06-07,2020-03-03, , ,['/Month'],IV,Patient Choice/Convenience
23392,4354,Rebif [44],2015-11-05,, , ,['/Month'], , 
23393,4354,Rebif [44],2016-02-19,2020-12-14, ,mg,['/Month'],IV,Persisting MRI activity
23394,4790,Tysabri,2016-06-30,2019-07-05, ,MIU,['/Month'], ,Patient Choice/Convenience
23395,4790,Methylprednisolone,2016-01-01,,20, ,['3 / Week'],IV, 
23396,4790,Avonex,2016-10-15,, ,MIU,['2 / Day'],IV, 
23397,4790,Betaferon,2016-04-07,, , ,['/Month'], , 
23398,1030,Betaferon,2016-02-03,2020-12-14,20, ,['/Month'], ,Lack of efficacy
23399,1030,Betaferon,2016-01-16,,20,MIU,[' '],IV, 
23400,1030,Endoxan,2016-08-04,,400, ,['/Month'],Oral, 
23401,1030,D-cure (Vitamine D),2016-07-24,,500,mcg,['/ Day'],Oral, 
23402,4093,Alemtuzumab (Campath),2016-08-13,,1, ,['/Month'],IV, 
23403,4093,Gilenya,2016-05-15,2021-06-27,20,mg,[' '],IV,Adverse Event
23404,3016,Tecfidera,2016-01-01,2020-08-15,500, ,['/Month'], ,Adverse Event
23405,3016,Methylprednisolone,2016-07-18,,500,mg,['2 / Day'],Oral, 
23406,3016,Rebif [44],2016-05-20,2019-03-19,500,MIU,[' '],Oral,Patient Choice/Convenience
23407,3016,Copaxone,2016-01-30,,300, ,[' '], , 
23408,4399,Gilenya,2015-12-30,,20,mg,['/Month'], , 
23409,4399,Alemtuzumab (Campath),2016-09-19,2018-11-28,300, ,['2 / Day'], ,Lack of efficacy
23410,4399,D-cure (Vitamine D),2016-07-04,2019-08-17,500,mg,['/Month'],IV,Persisting MRI activity
23411,1492,Gilenya,2016-09-12,,5000, ,['3 / Week'], , 
23412,1492,Ledertrexaat,2015-12-24,, , ,['/Month'],IV, 
23413,1492,Mitoxantrone,2016-07-09,,500, ,[' '],IV, 
23414,680,Tysabri,2016-06-21,,1000,mg,['2 / Day'],IV, 
23415,3232,D-cure (Vitamine D),2015-11-08,2019-04-28,300, ,['2 / Day'], ,Persistence of relapses
23416,3232,Teriflunomide,2016-07-14,2021-05-21,1000,mg,['/Month'],Oral,Persistence of relapses
23417,1260,Rebif [22],2015-11-30,2019-06-17,1, ,['/ Day'],IV,Persisting MRI activity
23418,1260,Rebif [22],2016-02-13,2018-04-12,300, ,['3 / Week'],IV,Persisting MRI activity
23419,4936,Tysabri,2016-05-02,2019-11-25,20,mg,['/Month'], ,Adverse Event
23420,4936,D-cure (Vitamine D),2015-12-22,2018-08-26,1,mg,['/ Day'], ,Adverse Event
23421,1401,Rebif [22],2015-10-27,2019-09-26, ,mg,['/Month'],Oral,Lack of efficacy
23422,2516,Tysabri,2015-12-18,, ,mg,['3 / Week'],IV, 
23423,2516,Alemtuzumab (Campath),2016-06-28,2018-01-12, ,mg,['/Month'],IV,Persistence of relapses
23424,2516,Rebif [22],2016-05-07,,1,mg,['/Month'],IV, 
23425,4206,Alemtuzumab (Campath),2015-11-22,2020-01-07,5000, ,['2 / Day'],IV,Patient Choice/Convenience
23426,4206,Avonex,2016-03-11,, ,mg,['2 / Day'], , 
23427,4206,Rebif [22],2015-11-14,,500, ,['3 / Week'],IV, 
23428,3558,Methylprednisolone,2016-05-26,,400, ,['2 / Day'],IV, 
23429,3558,Tysabri,2016-07-18,, ,mg,['/Month'], , 
23430,3558,Rebif [22],2016-06-07,2019-09-28, , ,['/Month'],IV,Adverse Event
23431,3558,D-cure (Vitamine D),2016-09-09,,300, ,['/Month'],IV, 
23432,2713,Tecfidera,2016-10-18,2021-01-18,20,mcg,['/ Week'],IV,Patient Choice/Convenience
23433,2713,IVIG,2016-03-25,2018-12-16,5000,MIU,['2 / Day'],Oral,Persistence of relapses
23434,2713,IVIG,2016-01-29,2020-05-08,1,mg,['2 / Day'], ,Adverse Event
23435,2713,IVIG,2016-10-14,,20, ,['/ Week'],Oral, 
23436,3032,Methylprednisolone,2015-11-11,,1,mg,['2 / Day'],IV, 
23437,413,Alemtuzumab (Campath),2016-03-18,,300,mg,[' '],IV, 
23438,413,Gilenya,2016-10-22,, ,mg,['2 / Day'],Oral, 
23439,1785,Tysabri,2016-07-03,2017-12-20, , ,['2 / Day'], ,Adverse Event
23440,1785,D-cure (Vitamine D),2016-09-12,2018-10-24, , ,['2 / Day'], ,Persisting MRI activity
23441,1785,Gilenya,2016-03-31,, ,mg,['3 / Week'], , 
23442,580,Endoxan,2016-04-24,2019-05-26,20, ,['/ Week'], ,Adverse Event
23443,580,Teriflunomide,2015-12-11,2019-10-04,1000, ,['2 / Day'],IV,Lack of efficacy
23444,580,Gilenya,2016-02-15,2019-09-21, , ,['/ Day'], ,Patient Choice/Convenience
23445,580,Tecfidera,2016-08-20,, ,mg,['/Month'],IV, 
23446,3817,Endoxan,2016-10-02,2021-10-06,300, ,[' '], ,Persistence of relapses
23447,3817,Gilenya,2016-01-03,2018-11-14,5000,MIU,['2 / Day'],IV,Patient Choice/Convenience
23448,3817,Methylprednisolone,2016-07-22,2021-01-09, ,mg,[' '], ,Patient Choice/Convenience
23449,3461,IVIG,2016-06-05,, ,mg,['/ Week'],IV, 
23450,3461,IVIG,2016-03-06,2021-06-03,500, ,['/Month'], ,Persistence of relapses
23451,3887,Alemtuzumab (Campath),2016-04-29,2021-10-19,20, ,['3 / Week'],IV,Persisting MRI activity
23452,3887,Rebif [44],2015-10-30,2019-01-07, ,mg,['2 / Day'],IV,Persistence of relapses
23453,3887,Tysabri,2016-07-23,,400, ,['/ Day'], , 
23454,3887,Tysabri,2016-07-16,2020-01-12,1, ,['/Month'],IV,Persistence of relapses
23455,653,Tysabri,2016-08-14,2019-03-20, ,mg,['2 / Day'], ,Patient Choice/Convenience
23456,653,Teriflunomide,2015-12-17,,20, ,['2 / Day'],Oral, 
23457,653,IVIG,2016-10-07,, ,mg,[' '], , 
23458,1730,Gilenya,2016-05-27,, ,mg,['/Month'],IV, 
23459,1730,Mitoxantrone,2015-12-13,, , ,['2 / Day'],Oral, 
23460,3738,Rebif [44],2016-04-03,, ,mg,['2 / Day'],IV, 
23461,4969,D-cure (Vitamine D),2016-02-12,, ,mg,['2 / Day'], , 
23462,4314,Teriflunomide,2016-07-14,2018-11-27, ,mg,['/Month'],IV,Patient Choice/Convenience
23463,2612,Copaxone,2016-06-23,2019-09-08, , ,['3 / Week'],IV,Lack of efficacy
23464,2612,D-cure (Vitamine D),2016-07-01,, , ,['2 / Day'],IV, 
23465,3360,Rebif [22],2015-10-24,, ,mg,['/Month'],IV, 
23466,3360,Copaxone,2016-10-03,, , ,['3 / Week'],IV, 
23467,4830,Avonex,2016-08-05,2020-12-10,20, ,['/Month'],Oral,Persisting MRI activity
23468,3019,Endoxan,2016-08-24,2018-11-27,300, ,['/Month'], ,Persisting MRI activity
23469,3019,Tecfidera,2015-12-12,2021-09-05,5000, ,['/ Day'], ,Persisting MRI activity
23470,3019,Betaferon,2015-12-15,2017-12-10,500,mg,['/Month'],Oral,Patient Choice/Convenience
23471,321,D-cure (Vitamine D),2016-02-10,2019-05-27,1000,MIU,['2 / Day'], ,Patient Choice/Convenience
23472,321,Betaferon,2016-06-13,2020-02-22,20, ,['/ Week'],IV,Persistence of relapses
23473,321,Tysabri,2016-05-23,2021-08-17,1,mg,['/Month'], ,Persisting MRI activity
23474,3263,Methylprednisolone,2016-02-26,2021-07-27,400,mg,['2 / Day'],IV,Persisting MRI activity
23475,3263,Ledertrexaat,2016-09-14,, , ,['2 / Day'], , 
23476,341,Methylprednisolone,2016-09-24,2019-01-23, ,MIU,['2 / Day'],IV,Patient Choice/Convenience
23477,341,IVIG,2016-04-03,2018-06-17,500,mg,['/ Week'],IV,Patient Choice/Convenience
23478,726,D-cure (Vitamine D),2016-08-25,,400,mg,['/Month'], , 
23479,4316,Avonex,2016-01-13,2019-08-14,1, ,['3 / Week'], ,Lack of efficacy
23480,4316,Rebif [44],2015-12-06,,500, ,['/Month'],Oral, 
23481,4316,Teriflunomide,2016-09-24,,5000,mg,['/ Week'], , 
23482,4316,Rebif [44],2016-07-17,2020-02-03, ,mg,['/ Day'],IV,Patient Choice/Convenience
23483,4932,D-cure (Vitamine D),2015-11-07,,1000,mg,['/Month'], , 
23484,4932,Rebif [22],2016-07-02,, ,mg,['2 / Day'],IV, 
23485,4932,Methylprednisolone,2016-10-21,,20, ,['/Month'],IV, 
23486,4932,Mitoxantrone,2016-06-17,,300, ,['3 / Week'], , 
23487,4249,Methylprednisolone,2016-05-08,2021-05-21,300,mg,['/ Day'],IV,Lack of efficacy
23488,4249,Methylprednisolone,2016-05-19,,400,mg,['2 / Day'], , 
23489,4249,Alemtuzumab (Campath),2016-05-03,, ,MIU,['3 / Week'],IV, 
23490,4249,D-cure (Vitamine D),2016-01-14,2019-12-10,500, ,['2 / Day'], ,Patient Choice/Convenience
23491,3310,Ledertrexaat,2016-08-27,,20,mg,['/ Day'],Oral, 
23492,1943,Methylprednisolone,2016-10-15,,1000, ,['/Month'], , 
23493,1943,Alemtuzumab (Campath),2016-09-09,2019-07-07,5000,MIU,['3 / Week'],IV,Persistence of relapses
23494,1943,D-cure (Vitamine D),2016-06-26,2017-10-30,500, ,['3 / Week'], ,Patient Choice/Convenience
23495,786,Gilenya,2016-10-16,,1000, ,['3 / Week'],Oral, 
23496,786,Rebif [22],2015-12-29,2020-08-31, ,mg,['/Month'], ,Lack of efficacy
23497,786,Tecfidera,2016-02-01,, , ,['2 / Day'],IV, 
23498,4836,Betaferon,2016-02-18,, ,mcg,['2 / Day'],IV, 
23499,4836,Methylprednisolone,2015-12-16,2021-08-05, ,MIU,['2 / Day'], ,Lack of efficacy
23500,1056,Tysabri,2016-02-06,, , ,['2 / Day'], , 
23501,1056,Mitoxantrone,2016-06-21,,1000,mg,['2 / Day'], , 
23502,3556,D-cure (Vitamine D),2016-09-25,, ,mg,['/ Day'],Oral, 
23503,3556,Gilenya,2015-12-19,,20,mg,[' '],IV, 
23504,3556,D-cure (Vitamine D),2015-12-21,2021-01-24, ,mg,['/Month'], ,Lack of efficacy
23505,833,Alemtuzumab (Campath),2016-01-03,2018-07-17, ,mg,['2 / Day'],Oral,Lack of efficacy
23506,833,Tysabri,2016-03-17,, , ,['/Month'],Oral, 
23507,833,D-cure (Vitamine D),2016-07-03,2020-04-10,1000,MIU,['2 / Day'], ,Lack of efficacy
23508,4819,Gilenya,2016-01-02,2019-12-16,300,mg,['3 / Week'], ,Persistence of relapses
23509,4819,Gilenya,2016-06-04,, , ,['3 / Week'],Oral, 
23510,4306,Rebif [22],2016-04-08,, ,mg,[' '], , 
23511,4306,Betaferon,2015-11-30,2019-02-24,500, ,['/Month'],IV,Persisting MRI activity
23512,4306,Methylprednisolone,2015-11-02,2020-11-26, ,mg,['2 / Day'],Oral,Patient Choice/Convenience
23513,1194,D-cure (Vitamine D),2015-11-27,2021-10-04,400, ,[' '], ,Lack of efficacy
23514,1194,Betaferon,2016-01-16,, ,mg,['/ Week'], , 
23515,1194,Betaferon,2015-11-10,,20,MIU,['/Month'],IV, 
23516,1213,Rebif [22],2016-04-12,2018-03-04,5000,MIU,['3 / Week'],IV,Persisting MRI activity
23517,3782,Rebif [22],2016-10-02,,300,mcg,['/Month'], , 
23518,3782,Teriflunomide,2016-05-01,2021-07-08, ,mg,[' '], ,Adverse Event
23519,3782,Betaferon,2016-01-23,2021-07-29,500, ,['2 / Day'],IV,Lack of efficacy
23520,1800,D-cure (Vitamine D),2016-07-05,,20, ,['/Month'],IV, 
23521,1800,Gilenya,2016-10-13,2018-01-20,20,mg,['/ Week'],IV,Patient Choice/Convenience
23522,650,Endoxan,2016-08-04,2019-12-31,500,mg,['/Month'],Oral,Patient Choice/Convenience
23523,650,Rebif [22],2016-10-06,, , ,['2 / Day'],IV, 
23524,650,Avonex,2016-08-08,2018-12-06,20,mcg,['3 / Week'],Oral,Persisting MRI activity
23525,650,D-cure (Vitamine D),2016-10-20,2018-07-28, ,mcg,['2 / Day'], ,Persistence of relapses
23526,4406,Ledertrexaat,2016-06-14,2018-04-26,400, ,['/ Week'],IV,Lack of efficacy
23527,4406,Endoxan,2016-09-21,,5000,mcg,['2 / Day'],Oral, 
23528,4406,D-cure (Vitamine D),2015-12-05,,5000, ,['2 / Day'], , 
23529,4406,IVIG,2015-11-21,2019-04-23, ,mg,['/Month'],IV,Patient Choice/Convenience
23530,2240,Tysabri,2016-08-29,2018-12-18,20,MIU,['3 / Week'], ,Adverse Event
23531,2240,Tecfidera,2015-11-21,2018-08-06,400, ,['/Month'],IV,Patient Choice/Convenience
23532,2240,IVIG,2016-04-30,,300,mg,['/Month'],IV, 
23533,2430,Tecfidera,2016-03-02,,1, ,['2 / Day'], , 
23534,2430,Rebif [22],2016-05-28,,500,mg,['/Month'], , 
23535,2430,Tecfidera,2016-02-26,,20,mg,['/ Week'],IV, 
23536,4802,Tecfidera,2016-07-19,2020-01-22,20, ,['2 / Day'],IV,Persisting MRI activity
23537,4802,Endoxan,2016-07-29,2020-12-06,20, ,['3 / Week'],IV,Persistence of relapses
23538,4802,Endoxan,2016-08-26,2019-07-06,5000,mg,['/ Day'],IV,Persisting MRI activity
23539,867,D-cure (Vitamine D),2016-02-06,, ,mg,['2 / Day'],IV, 
23540,2902,D-cure (Vitamine D),2016-01-14,, ,mg,['2 / Day'],IV, 
23541,1801,Betaferon,2016-09-13,2020-04-14, ,mg,['2 / Day'],IV,Adverse Event
23542,1801,Gilenya,2016-03-12,2020-02-21,1000, ,['2 / Day'],IV,Adverse Event
23543,3249,Gilenya,2016-04-26,,5000,MIU,['3 / Week'],IV, 
23544,2741,Endoxan,2016-07-09,2019-12-03,1000,mg,['2 / Day'],IV,Adverse Event
23545,2741,Alemtuzumab (Campath),2015-11-27,,400, ,['2 / Day'],IV, 
23546,2741,Avonex,2016-01-16,2019-07-20,500,mg,['3 / Week'],IV,Lack of efficacy
23547,2741,Alemtuzumab (Campath),2016-07-02,,400, ,['/Month'],Oral, 
23548,4279,Teriflunomide,2016-10-22,2019-06-17,300,mg,['3 / Week'],IV,Persisting MRI activity
23549,4279,Mitoxantrone,2016-04-20,,20, ,['2 / Day'],Oral, 
23550,4279,Rebif [22],2016-03-07,,5000, ,['2 / Day'], , 
23551,4279,D-cure (Vitamine D),2016-02-12,, ,MIU,['2 / Day'],IV, 
23552,1731,Copaxone,2016-07-11,,5000,MIU,['3 / Week'],IV, 
23553,1731,Teriflunomide,2015-11-12,,20,mg,['/Month'], , 
23554,1731,Betaferon,2016-08-17,2020-08-29, ,mg,['/Month'], ,Adverse Event
23555,1731,Teriflunomide,2016-02-24,2020-07-22,500,mcg,['/ Week'], ,Adverse Event
23556,2516,Copaxone,2016-07-31,,1000,mg,['/Month'],IV, 
23557,2268,Alemtuzumab (Campath),2016-06-21,,5000, ,['3 / Week'],IV, 
23558,2268,Methylprednisolone,2016-02-23,,300, ,['3 / Week'], , 
23559,4766,Rebif [44],2016-09-21,,20,mg,['/Month'],IV, 
23560,4766,Gilenya,2016-03-15,2019-10-10,1000, ,['/ Day'],IV,Lack of efficacy
23561,4766,IVIG,2015-11-27,2019-03-15,400,mg,[' '], ,Lack of efficacy
23562,4766,Rebif [22],2016-06-18,,1,MIU,[' '],Oral, 
23563,2297,Methylprednisolone,2016-05-13,, ,mg,['2 / Day'],Oral, 
23564,2297,Ledertrexaat,2015-11-29,2020-01-03,400, ,['2 / Day'],IV,Adverse Event
23565,2297,Gilenya,2016-04-07,, ,mcg,['2 / Day'],IV, 
23566,2459,Betaferon,2016-02-11,2020-11-06, ,mg,['/Month'], ,Patient Choice/Convenience
23567,594,Teriflunomide,2016-05-31,, ,mg,['/Month'],IV, 
23568,4552,Tysabri,2016-07-11,,500,mcg,['/Month'], , 
23569,4552,Methylprednisolone,2016-03-07,,1000, ,['2 / Day'], , 
23570,4552,Rebif [22],2016-02-01,2020-08-27,300,mg,['/ Week'],IV,Patient Choice/Convenience
23571,4552,Rebif [22],2015-11-27,, ,MIU,['2 / Day'],IV, 
23572,2461,Endoxan,2016-06-01,,300,mg,['/Month'],IV, 
23573,2461,IVIG,2016-10-12,, ,MIU,['3 / Week'],IV, 
23574,2461,Gilenya,2016-08-01,, ,mg,['2 / Day'],IV, 
23575,4765,Tecfidera,2016-09-10,,5000, ,['3 / Week'], , 
23576,4765,Endoxan,2016-06-21,2020-04-19,1000, ,['/Month'],IV,Patient Choice/Convenience
23577,4765,Avonex,2016-02-13,, , ,['2 / Day'],IV, 
23578,3998,IVIG,2016-03-11,2019-08-19,400,mg,['2 / Day'], ,Adverse Event
23579,3998,Rebif [22],2016-10-07,,1000,mg,['2 / Day'],IV, 
23580,3998,Methylprednisolone,2016-07-19,2018-01-30,20,mg,['2 / Day'], ,Lack of efficacy
23581,3998,Rebif [22],2016-05-01,,5000,MIU,['3 / Week'], , 
23582,3259,IVIG,2015-10-30,, ,mg,['2 / Day'],IV, 
23583,341,Gilenya,2015-12-22,, ,mg,['/Month'],IV, 
23584,3855,Methylprednisolone,2016-10-05,, ,mg,['2 / Day'],IV, 
23585,3855,Tecfidera,2016-06-11,2020-06-19,1, ,['/ Day'],IV,Persistence of relapses
23586,3855,Gilenya,2016-06-04,2020-02-24, ,mg,['2 / Day'],IV,Lack of efficacy
23587,593,Methylprednisolone,2016-06-11,, ,mg,[' '], , 
23588,593,Avonex,2016-10-21,,1000, ,['3 / Week'],Oral, 
23589,2486,Avonex,2016-04-22,, ,mg,['2 / Day'],IV, 
23590,246,Tysabri,2016-08-30,,20,mg,['/Month'], , 
23591,4490,Ledertrexaat,2016-01-11,2019-03-12,20,mcg,['2 / Day'], ,Persisting MRI activity
23592,4490,Tysabri,2016-06-11,, ,mg,['2 / Day'], , 
23593,4490,Endoxan,2016-05-20,2019-02-07,20, ,['3 / Week'], ,Adverse Event
23594,1444,Methylprednisolone,2016-09-01,2019-08-09,300,MIU,['2 / Day'],IV,Patient Choice/Convenience
23595,1444,Copaxone,2015-12-05,2021-08-24,1000, ,['/Month'],IV,Persistence of relapses
23596,1444,Endoxan,2016-02-16,,300,mg,['2 / Day'],IV, 
23597,2878,Rebif [22],2016-01-08,2019-02-02,1,mcg,['/ Day'],IV,Patient Choice/Convenience
23598,2878,Teriflunomide,2016-04-06,,300,mg,['/Month'],IV, 
23599,2878,Avonex,2016-05-15,,300,mg,['/ Week'],IV, 
23600,2878,Rebif [44],2015-12-18,2018-03-26,400,mg,['/Month'],IV,Patient Choice/Convenience
23601,4493,Methylprednisolone,2016-05-30,,500,mg,['/Month'], , 
23602,4493,Copaxone,2016-04-10,2020-08-04, ,mcg,['/Month'],IV,Patient Choice/Convenience
23603,4493,Gilenya,2016-04-09,2018-04-06,1000,mg,['/ Week'], ,Lack of efficacy
23604,4493,Endoxan,2016-06-08,,1000,mg,['/ Week'],Oral, 
23605,2781,Tecfidera,2016-08-29,2019-12-16,300, ,[' '], ,Lack of efficacy
23606,2781,Betaferon,2016-07-08,2019-08-27, ,mg,['2 / Day'],IV,Persisting MRI activity
23607,829,IVIG,2015-11-19,2021-02-16,1000,mg,['/Month'],IV,Lack of efficacy
23608,829,Alemtuzumab (Campath),2016-03-01,2021-07-02,400, ,[' '],IV,Persisting MRI activity
23609,829,D-cure (Vitamine D),2016-06-12,,20, ,['2 / Day'],IV, 
23610,1109,D-cure (Vitamine D),2016-09-25,2019-07-10,1000, ,[' '], ,Lack of efficacy
23611,1989,Betaferon,2015-10-29,,500,MIU,['/Month'],IV, 
23612,2652,Rebif [22],2016-04-07,2021-07-25,400,mg,['/ Day'],IV,Patient Choice/Convenience
23613,2652,Avonex,2015-11-25,,300,mg,['/Month'],IV, 
23614,874,Avonex,2015-10-31,2019-07-27, , ,['/Month'], ,Patient Choice/Convenience
23615,874,Copaxone,2016-02-17,2019-11-10, , ,['2 / Day'],IV,Lack of efficacy
23616,3785,Avonex,2016-08-24,2018-11-14, , ,[' '], ,Persisting MRI activity
23617,2998,Tecfidera,2016-09-29,,500,mg,['2 / Day'],IV, 
23618,2998,Methylprednisolone,2015-12-21,, ,mcg,['/ Week'],IV, 
23619,2998,Gilenya,2016-07-11,2021-04-30,1000, ,['/ Week'], ,Patient Choice/Convenience
23620,3815,Rebif [44],2016-10-22,, ,mg,['/Month'],IV, 
23621,3815,Ledertrexaat,2016-06-18,,500, ,['/ Day'],IV, 
23622,2587,D-cure (Vitamine D),2016-05-07,2018-11-17,5000,mg,['/Month'],Oral,Adverse Event
23623,2587,Ledertrexaat,2016-05-11,, ,MIU,['2 / Day'],IV, 
23624,2757,Ledertrexaat,2015-12-30,,300,mg,['3 / Week'],IV, 
23625,2757,Rebif [44],2015-11-11,2017-11-19,1000, ,['2 / Day'],Oral,Persisting MRI activity
23626,2757,Tecfidera,2016-03-18,2019-08-19,400, ,['2 / Day'], ,Adverse Event
23627,1216,Endoxan,2016-07-12,,300,mg,['/Month'],IV, 
23628,1216,Mitoxantrone,2016-04-20,, ,mg,['/Month'],IV, 
23629,1216,Tecfidera,2016-10-09,2019-06-07,500,mg,[' '],IV,Patient Choice/Convenience
23630,1642,Rebif [22],2016-01-26,2020-12-24,20, ,['/ Week'],IV,Lack of efficacy
23631,2677,Tysabri,2016-10-18,,1, ,['/Month'], , 
23632,2677,Gilenya,2016-04-10,2020-10-01,300,mg,['2 / Day'],IV,Lack of efficacy
23633,2677,D-cure (Vitamine D),2016-09-23,2019-03-19,300, ,[' '], ,Patient Choice/Convenience
23634,3077,Ledertrexaat,2016-08-22,, , ,[' '],Oral, 
23635,3908,Tecfidera,2016-10-09,, ,mcg,['2 / Day'],IV, 
23636,3908,Ledertrexaat,2016-05-07,2019-08-12, ,mcg,['2 / Day'], ,Lack of efficacy
23637,3908,Gilenya,2016-04-10,, , ,['2 / Day'],IV, 
23638,3908,Tecfidera,2016-05-17,2020-12-06,400,mg,['/ Week'],IV,Lack of efficacy
23639,3617,Teriflunomide,2016-05-02,2018-10-22, ,mg,['/Month'],Oral,Lack of efficacy
23640,791,IVIG,2016-07-21,2020-05-13,300,mcg,['/ Week'],IV,Lack of efficacy
23641,791,D-cure (Vitamine D),2015-11-20,2019-11-13, ,mg,['/ Week'],IV,Lack of efficacy
23642,4286,Endoxan,2016-08-29,2020-11-20, , ,['3 / Week'], ,Patient Choice/Convenience
23643,4286,Avonex,2016-08-14,2018-12-23,20,mg,['/Month'],IV,Adverse Event
23644,4286,Tysabri,2016-08-14,2021-08-24,400, ,['/ Day'],Oral,Adverse Event
23645,3932,Tecfidera,2016-08-01,,300,mg,['/Month'],Oral, 
23646,3932,Methylprednisolone,2016-07-26,,500,mg,['3 / Week'],IV, 
23647,3932,IVIG,2016-03-09,, ,mcg,['/ Day'], , 
23648,982,Tecfidera,2016-06-25,,1000,mg,['/Month'],Oral, 
23649,982,D-cure (Vitamine D),2016-05-09,, ,mg,['3 / Week'],IV, 
23650,3662,Rebif [44],2016-07-04,,1000, ,['/Month'], , 
23651,3662,Avonex,2016-04-23,,1, ,['/Month'], , 
23652,1860,Mitoxantrone,2016-07-20,,300,mg,['2 / Day'],IV, 
23653,1860,Methylprednisolone,2016-08-17,2020-01-15,1000, ,['/ Week'],IV,Lack of efficacy
23654,4582,Endoxan,2015-12-20,,20,mg,['2 / Day'],IV, 
23655,4582,Endoxan,2015-12-17,2021-03-09, ,MIU,['3 / Week'], ,Patient Choice/Convenience
23656,4582,Avonex,2015-12-14,2017-11-05,500, ,['/Month'], ,Lack of efficacy
23657,4582,Methylprednisolone,2016-08-08,2018-08-29,400, ,['2 / Day'], ,Adverse Event
23658,674,Rebif [44],2016-03-09,2018-10-23,20, ,['3 / Week'],IV,Adverse Event
23659,674,Rebif [44],2016-08-29,2020-08-07,20, ,['2 / Day'],Oral,Lack of efficacy
23660,674,Rebif [44],2016-03-22,2020-03-21, ,MIU,['/Month'], ,Persisting MRI activity
23661,674,D-cure (Vitamine D),2016-02-03,2018-11-28, ,mg,['/ Day'], ,Patient Choice/Convenience
23662,1854,D-cure (Vitamine D),2016-08-07,2021-01-21,1000, ,[' '], ,Patient Choice/Convenience
23663,1854,Methylprednisolone,2016-03-25,,1,mcg,['3 / Week'], , 
23664,1651,IVIG,2016-09-10,2020-07-24,400,mg,['2 / Day'], ,Adverse Event
23665,2780,D-cure (Vitamine D),2016-06-16,2021-01-09, , ,['2 / Day'], ,Lack of efficacy
23666,2780,Betaferon,2016-02-03,2018-03-07,20, ,['2 / Day'],IV,Adverse Event
23667,2780,Gilenya,2016-06-09,2020-04-12, , ,['2 / Day'], ,Patient Choice/Convenience
23668,2780,Endoxan,2016-07-20,,20, ,['/Month'],IV, 
23669,856,Methylprednisolone,2016-01-31,, ,mg,['2 / Day'],Oral, 
23670,856,Gilenya,2015-12-09,, ,mg,['/Month'],Oral, 
23671,3216,Teriflunomide,2016-01-03,2019-06-19,5000, ,['2 / Day'],IV,Adverse Event
23672,3216,Betaferon,2015-11-22,2018-12-01,1, ,['2 / Day'],IV,Adverse Event
23673,3216,D-cure (Vitamine D),2016-02-25,,1000, ,['3 / Week'], , 
23674,3216,Ledertrexaat,2016-04-29,2020-01-21, , ,[' '],Oral,Lack of efficacy
23675,3925,Gilenya,2015-12-25,2021-10-13,500,mg,['2 / Day'],IV,Adverse Event
23676,3925,IVIG,2016-09-23,, , ,['3 / Week'],IV, 
23677,1659,Alemtuzumab (Campath),2016-01-05,,5000, ,['/Month'], , 
23678,3398,Ledertrexaat,2016-05-18,2018-03-21,400, ,[' '], ,Patient Choice/Convenience
23679,3398,Copaxone,2016-07-28,,400,mg,['/Month'],IV, 
23680,3398,Copaxone,2016-05-15,,500,mcg,[' '], , 
23681,3398,D-cure (Vitamine D),2016-03-10,,1, ,['/ Week'],IV, 
23682,1045,D-cure (Vitamine D),2016-09-27,,5000, ,['/ Week'], , 
23683,1045,Avonex,2016-03-02,2021-09-30,20, ,[' '],IV,Persistence of relapses
23684,2879,Copaxone,2016-02-24,2018-02-24,300, ,['3 / Week'],Oral,Adverse Event
23685,2879,D-cure (Vitamine D),2016-03-15,2021-02-09, ,mcg,['2 / Day'],IV,Lack of efficacy
23686,2879,D-cure (Vitamine D),2015-11-06,,500,mg,['3 / Week'],IV, 
23687,2879,Methylprednisolone,2015-10-27,, ,MIU,['2 / Day'],Oral, 
23688,4621,Ledertrexaat,2016-01-19,, ,mg,['/Month'],Oral, 
23689,4621,Avonex,2015-12-02,2021-01-07,1,mg,['3 / Week'],Oral,Adverse Event
23690,1834,Tysabri,2015-10-25,, , ,['/Month'],Oral, 
23691,1834,Rebif [44],2016-07-27,,500,mg,['/Month'], , 
23692,2170,IVIG,2016-10-20,2020-05-08, ,mg,['/Month'], ,Patient Choice/Convenience
23693,2170,Tecfidera,2016-02-19,,500,mg,[' '],IV, 
23694,4367,Rebif [44],2015-12-21,,400, ,['2 / Day'],IV, 
23695,4185,Tysabri,2016-07-07,, ,mg,['/Month'],IV, 
23696,4185,Tecfidera,2016-07-29,2018-12-15, ,mg,[' '],IV,Patient Choice/Convenience
23697,2294,IVIG,2016-08-21,,20,mg,['/ Week'],IV, 
23698,2294,Betaferon,2016-01-08,,20, ,['/Month'],Oral, 
23699,2294,Betaferon,2015-12-12,2018-07-12, , ,[' '], ,Persistence of relapses
23700,2294,Tecfidera,2016-02-11,,300,MIU,['/ Day'],IV, 
23701,4332,Alemtuzumab (Campath),2016-06-18,2019-11-21,5000, ,['2 / Day'],IV,Patient Choice/Convenience
23702,4332,D-cure (Vitamine D),2015-11-27,2019-11-08,5000, ,[' '],IV,Persistence of relapses
23703,2477,Alemtuzumab (Campath),2016-01-08,2018-07-25,20,mcg,['2 / Day'],IV,Persisting MRI activity
23704,2477,D-cure (Vitamine D),2016-04-03,2021-08-08, ,mcg,['2 / Day'],IV,Persisting MRI activity
23705,2477,Alemtuzumab (Campath),2016-05-13,,400, ,['2 / Day'], , 
23706,4809,Methylprednisolone,2016-03-29,2018-07-12,20,mg,['/Month'],IV,Adverse Event
23707,3818,Tecfidera,2016-08-08,,20, ,['2 / Day'],IV, 
23708,3818,Ledertrexaat,2016-06-26,,300, ,[' '], , 
23709,3818,IVIG,2015-11-03,,1, ,[' '], , 
23710,4790,Copaxone,2016-09-04,, , ,['/Month'],IV, 
23711,4790,Tecfidera,2016-06-12,,500,mg,['/ Day'], , 
23712,4790,Avonex,2016-09-13,,20,mg,['/Month'],Oral, 
23713,4748,Copaxone,2016-01-07,,300, ,['2 / Day'],IV, 
23714,4748,Rebif [22],2015-10-25,,1000, ,['3 / Week'],IV, 
23715,4748,Methylprednisolone,2015-12-13,2019-12-16,1000,mg,['2 / Day'], ,Persistence of relapses
23716,4748,D-cure (Vitamine D),2016-04-16,,300, ,['3 / Week'],Oral, 
23717,2215,D-cure (Vitamine D),2016-02-09,2017-11-24,300,mg,[' '], ,Adverse Event
23718,2215,Endoxan,2016-03-22,2019-08-13, ,mg,['2 / Day'],Oral,Lack of efficacy
23719,2215,Mitoxantrone,2016-01-06,2019-12-20, ,mg,['2 / Day'], ,Persisting MRI activity
23720,4582,Rebif [22],2016-03-28,2018-05-14,20, ,['3 / Week'], ,Persisting MRI activity
23721,4582,Betaferon,2015-11-27,2021-04-11, ,mg,['2 / Day'], ,Adverse Event
23722,4582,Copaxone,2016-10-01,2018-01-03, ,mcg,[' '],Oral,Persisting MRI activity
23723,4437,Rebif [44],2016-08-04,2018-12-01, , ,['2 / Day'],IV,Adverse Event
23724,4437,Tysabri,2015-12-17,,20,mg,['3 / Week'],Oral, 
23725,4437,Alemtuzumab (Campath),2015-10-28,2020-05-09,300,mg,['/Month'], ,Adverse Event
23726,2329,Endoxan,2016-01-27,2020-06-21, ,mcg,['3 / Week'],Oral,Lack of efficacy
23727,2329,Rebif [22],2016-04-30,, ,mg,['/Month'], , 
23728,2329,Rebif [22],2016-05-12,,300, ,['/Month'], , 
23729,2329,Teriflunomide,2016-06-27,2020-11-30, ,mg,['/Month'],IV,Persisting MRI activity
23730,3018,Rebif [44],2016-10-22,,1, ,['2 / Day'],IV, 
23731,3018,Alemtuzumab (Campath),2016-08-26,2020-04-19,5000, ,['2 / Day'],IV,Lack of efficacy
23732,4619,Copaxone,2016-04-05,,500,mg,['/Month'], , 
23733,3810,Tecfidera,2016-06-24,,1, ,['/ Day'],Oral, 
23734,3810,Tecfidera,2016-03-05,2020-03-12, ,mg,['3 / Week'], ,Adverse Event
23735,3810,D-cure (Vitamine D),2016-04-17,,1,MIU,['2 / Day'],IV, 
23736,3810,Betaferon,2016-06-25,2020-06-02,500,mg,['/Month'], ,Adverse Event
23737,2746,D-cure (Vitamine D),2016-03-30,2020-07-31,5000, ,['/ Day'], ,Adverse Event
23738,3543,Copaxone,2016-04-25,,5000, ,[' '], , 
23739,373,D-cure (Vitamine D),2016-03-18,2019-01-21,1000,mg,['2 / Day'], ,Persistence of relapses
23740,3369,Rebif [22],2016-06-25,,20,mcg,[' '],Oral, 
23741,3369,Gilenya,2016-03-27,2019-12-03,300,mg,['/Month'],IV,Patient Choice/Convenience
23742,2240,IVIG,2016-08-04,,500, ,['2 / Day'], , 
23743,2240,Rebif [22],2016-05-31,2019-03-15, , ,['3 / Week'], ,Lack of efficacy
23744,3127,Avonex,2016-09-12,2018-11-30,20, ,['3 / Week'], ,Persisting MRI activity
23745,3127,Rebif [22],2016-06-30,2020-03-20,500, ,['2 / Day'],IV,Patient Choice/Convenience
23746,3127,Betaferon,2016-06-02,2019-12-20,1000, ,['3 / Week'], ,Persistence of relapses
23747,3127,Teriflunomide,2016-05-10,2017-10-29,5000, ,['3 / Week'],IV,Patient Choice/Convenience
23748,1645,Copaxone,2016-03-28,2019-02-22,1000,mcg,['/Month'],IV,Patient Choice/Convenience
23749,1645,Tysabri,2016-01-26,2020-03-05, ,mg,['/Month'], ,Adverse Event
23750,1645,Rebif [44],2016-09-07,,500,mg,[' '],Oral, 
23751,2433,Gilenya,2016-07-06,2020-09-16,400, ,['/Month'], ,Adverse Event
23752,2433,Methylprednisolone,2016-05-30,,5000, ,['/ Day'],IV, 
23753,3256,Betaferon,2016-07-17,2018-05-05,1, ,['/ Day'], ,Patient Choice/Convenience
23754,3256,D-cure (Vitamine D),2015-12-03,2018-01-18, ,MIU,['/Month'],IV,Adverse Event
23755,3256,Ledertrexaat,2015-12-27,2019-07-08, ,MIU,['/Month'],IV,Patient Choice/Convenience
23756,2791,Tecfidera,2016-05-11,,20,mcg,['/Month'],IV, 
23757,2791,Methylprednisolone,2016-06-14,2019-08-12, , ,[' '], ,Lack of efficacy
23758,1040,Avonex,2016-05-09,, , ,['/Month'], , 
23759,3149,Rebif [22],2016-03-24,,20, ,['2 / Day'],IV, 
23760,3149,Tysabri,2016-01-29,, , ,['2 / Day'], , 
23761,3149,Gilenya,2016-10-13,2021-02-06,5000,mg,['2 / Day'],IV,Persistence of relapses
23762,3149,Rebif [44],2015-12-31,2018-05-18,500,MIU,['/Month'],IV,Adverse Event
23763,3303,D-cure (Vitamine D),2016-02-19,2018-08-16, , ,['/Month'],IV,Persisting MRI activity
23764,3303,D-cure (Vitamine D),2016-01-16,,20, ,['/ Day'], , 
23765,3303,IVIG,2015-10-30,,5000, ,['/ Day'],IV, 
23766,1483,Rebif [22],2015-12-19,,500, ,['/ Week'], , 
23767,1483,Tecfidera,2016-01-15,, ,mcg,['2 / Day'], , 
23768,2428,Tysabri,2016-05-25,2019-06-06,300,mg,['/Month'],IV,Adverse Event
23769,621,Rebif [44],2016-08-30,,1000, ,['2 / Day'], , 
23770,621,Methylprednisolone,2016-06-16,2019-03-17, ,mg,['3 / Week'],IV,Lack of efficacy
23771,621,Tysabri,2015-11-16,2020-10-29,5000, ,['3 / Week'],Oral,Adverse Event
23772,621,Rebif [44],2016-07-29,,1000, ,['/Month'], , 
23773,630,D-cure (Vitamine D),2015-12-01,2018-01-22, ,MIU,['/Month'],IV,Lack of efficacy
23774,630,Betaferon,2016-01-17,2018-11-09, ,mg,['/Month'],IV,Persisting MRI activity
23775,2761,Rebif [22],2015-11-30,2021-05-14, , ,['/Month'], ,Adverse Event
23776,2761,Copaxone,2016-04-11,, , ,['/Month'],IV, 
23777,2628,Rebif [44],2016-07-13,2021-03-19, ,mg,['/ Week'], ,Lack of efficacy
23778,1023,D-cure (Vitamine D),2016-04-13,, , ,['/Month'],IV, 
23779,1023,Rebif [22],2016-10-06,, ,mg,['2 / Day'],IV, 
23780,984,Copaxone,2016-08-17,2018-04-21,500,mg,['2 / Day'], ,Persistence of relapses
23781,984,Betaferon,2015-12-29,, ,mg,[' '],IV, 
23782,984,Rebif [22],2016-08-13,,400, ,['/ Day'],Oral, 
23783,984,Gilenya,2016-10-13,,300, ,[' '],Oral, 
23784,1393,Avonex,2016-10-16,, , ,['3 / Week'],IV, 
23785,4675,Methylprednisolone,2016-10-14,,1000,mcg,['/ Week'],IV, 
23786,299,Mitoxantrone,2016-07-27,,500, ,['/Month'],IV, 
23787,354,Teriflunomide,2015-12-31,2021-05-18, ,mg,['/Month'],IV,Persisting MRI activity
23788,354,IVIG,2016-10-05,2021-01-21,500, ,['/Month'], ,Adverse Event
23789,354,Teriflunomide,2016-10-02,2019-07-06, ,mcg,[' '],Oral,Adverse Event
23790,2529,Rebif [22],2016-07-27,2019-04-22,20,mg,['2 / Day'],IV,Persisting MRI activity
23791,2529,Copaxone,2015-10-30,2019-05-16,1, ,['/Month'],IV,Adverse Event
23792,2529,Betaferon,2016-01-20,,1,mcg,['2 / Day'],IV, 
23793,2529,Rebif [44],2016-01-14,2019-12-28,400,MIU,['2 / Day'],IV,Persistence of relapses
23794,3326,IVIG,2016-10-04,2020-02-17,1,mg,['/ Week'], ,Persisting MRI activity
23795,3326,D-cure (Vitamine D),2016-04-14,,500,mg,['/Month'], , 
23796,3326,IVIG,2016-03-10,,1,mg,['/ Week'], , 
23797,3326,Avonex,2016-09-06,,1, ,['2 / Day'],IV, 
23798,608,IVIG,2016-06-28,, , ,['/ Day'], , 
23799,608,Rebif [44],2015-12-13,2018-03-07,500,MIU,['2 / Day'],IV,Lack of efficacy
23800,4583,Tecfidera,2016-10-10,2018-09-11,500,mg,['/Month'],IV,Lack of efficacy
23801,4387,Avonex,2016-06-02,, ,mg,['/Month'],IV, 
23802,1709,Ledertrexaat,2015-12-20,2020-09-09,1,mg,['2 / Day'],IV,Persisting MRI activity
23803,1709,Rebif [44],2016-09-13,2019-02-26, , ,['/Month'], ,Patient Choice/Convenience
23804,1709,Rebif [22],2016-08-18,,1000,mg,['/Month'],IV, 
23805,2024,Gilenya,2016-06-06,2020-12-31, ,mg,[' '],IV,Adverse Event
23806,2024,Rebif [44],2016-06-19,,1,mg,['/Month'],IV, 
23807,2024,Tysabri,2015-10-26,,5000,mg,['/Month'],IV, 
23808,1122,Ledertrexaat,2015-12-15,,500, ,['/Month'], , 
23809,1122,Tecfidera,2016-03-09,,400,mg,['/ Day'],IV, 
23810,1161,Gilenya,2016-09-16,, ,mcg,['/Month'],IV, 
23811,1161,Rebif [22],2016-06-01,,1, ,['3 / Week'],IV, 
23812,1161,Tecfidera,2016-02-17,2020-02-13,1000,mg,['2 / Day'],IV,Adverse Event
23813,825,Copaxone,2016-05-20,,20,mg,['3 / Week'],IV, 
23814,825,D-cure (Vitamine D),2016-06-06,, ,mg,['/Month'],IV, 
23815,1712,Endoxan,2016-06-30,2018-08-21,1000, ,['3 / Week'], ,Lack of efficacy
23816,1712,Rebif [22],2016-07-01,2018-03-10,5000, ,['/Month'], ,Adverse Event
23817,3467,Ledertrexaat,2016-06-05,2020-10-07, , ,['/Month'], ,Patient Choice/Convenience
23818,3467,D-cure (Vitamine D),2016-09-17,,1000,mg,['2 / Day'],Oral, 
23819,3467,Gilenya,2015-12-07,2021-01-29,400, ,['/Month'], ,Persistence of relapses
23820,3467,Copaxone,2016-03-22,,20, ,['/ Day'], , 
23821,4775,Rebif [22],2016-06-06,,1, ,[' '],IV, 
23822,4775,Tysabri,2015-12-20,2020-12-01,1, ,['/ Day'],IV,Persistence of relapses
23823,4775,Gilenya,2016-04-16,2019-09-09,500,mg,['2 / Day'],IV,Persistence of relapses
23824,4775,Endoxan,2016-07-29,, , ,['/Month'],Oral, 
23825,542,IVIG,2016-10-11,,20,MIU,['2 / Day'],IV, 
23826,2447,Copaxone,2016-09-03,2021-02-15, ,mcg,[' '],IV,Patient Choice/Convenience
23827,2447,IVIG,2016-05-25,, ,mg,['2 / Day'],Oral, 
23828,2447,Tecfidera,2016-01-07,,5000,mg,['2 / Day'], , 
23829,2141,Gilenya,2015-11-20,,20, ,['/Month'],IV, 
23830,2141,Tysabri,2016-04-21,,1,mcg,['2 / Day'],IV, 
23831,295,D-cure (Vitamine D),2015-11-13,,300,mg,['3 / Week'],IV, 
23832,4554,Rebif [22],2016-05-31,, ,mg,['3 / Week'],IV, 
23833,4554,Rebif [22],2016-08-06,,20,mg,['3 / Week'],IV, 
23834,2594,Tecfidera,2016-07-15,, , ,['/ Day'],IV, 
23835,2594,Teriflunomide,2016-03-21,,5000,mcg,[' '],IV, 
23836,2594,Rebif [44],2015-11-14,,20,mg,['/Month'],IV, 
23837,2594,Tecfidera,2016-01-20,2018-01-11,1000, ,['2 / Day'],IV,Patient Choice/Convenience
23838,3206,Rebif [44],2016-01-20,2021-08-13,500,mg,['3 / Week'],IV,Persisting MRI activity
23839,3206,IVIG,2015-11-09,,5000,mg,['/ Day'], , 
23840,2149,Endoxan,2016-08-07,, , ,['2 / Day'], , 
23841,2149,Rebif [22],2016-04-26,2019-04-29,1000,mg,['/Month'],IV,Patient Choice/Convenience
23842,2149,Alemtuzumab (Campath),2016-05-06,,300, ,['/Month'],Oral, 
23843,2781,Tecfidera,2016-10-08,, ,mg,['2 / Day'], , 
23844,2781,Mitoxantrone,2016-09-21,, , ,['2 / Day'], , 
23845,2781,Avonex,2015-10-28,2021-01-20,300,MIU,['/Month'],IV,Adverse Event
23846,1440,Copaxone,2016-03-15,2019-10-08,20, ,['2 / Day'],IV,Persistence of relapses
23847,1440,D-cure (Vitamine D),2016-03-11,,500, ,['/Month'], , 
23848,1440,Rebif [44],2016-02-21,2021-04-03,20, ,['2 / Day'], ,Persistence of relapses
23849,544,Rebif [22],2016-09-10,2020-03-23,5000,mcg,['/ Day'], ,Adverse Event
23850,579,Endoxan,2016-10-12,, ,mg,['/Month'],Oral, 
23851,579,Copaxone,2016-08-23,, ,mg,['/Month'],IV, 
23852,579,Methylprednisolone,2015-12-19,,500,mcg,[' '],IV, 
23853,579,Alemtuzumab (Campath),2016-02-09,2019-06-03,400,mg,['3 / Week'],IV,Persisting MRI activity
23854,3156,Teriflunomide,2016-08-02,2018-01-09,300, ,['/Month'],IV,Lack of efficacy
23855,3156,Rebif [22],2015-10-29,,1, ,['2 / Day'],IV, 
23856,938,D-cure (Vitamine D),2016-05-31,,500,MIU,['2 / Day'],IV, 
23857,938,Teriflunomide,2016-10-01,2020-12-26,1000, ,['/Month'],IV,Persistence of relapses
23858,938,Tecfidera,2015-12-12,, ,mg,[' '],IV, 
23859,938,Rebif [44],2016-01-18,2021-07-25, , ,['2 / Day'],IV,Lack of efficacy
23860,4958,D-cure (Vitamine D),2016-01-29,2021-10-03,500,MIU,['/Month'], ,Patient Choice/Convenience
23861,4958,Methylprednisolone,2016-04-21,2020-04-03, , ,['2 / Day'],IV,Persisting MRI activity
23862,792,Mitoxantrone,2016-10-06,,1000,mg,['/Month'],IV, 
23863,792,Endoxan,2016-04-19,,1000,mg,['/ Week'],IV, 
23864,792,Tecfidera,2016-08-23,2018-04-22,20,mg,['/Month'], ,Patient Choice/Convenience
23865,792,Rebif [44],2016-09-20,2020-02-04,1000, ,['/Month'], ,Patient Choice/Convenience
23866,391,Gilenya,2016-01-07,2021-09-29,300, ,['/Month'],IV,Persisting MRI activity
23867,1094,Gilenya,2016-04-07,2019-07-14,500,MIU,['2 / Day'],IV,Lack of efficacy
23868,1094,IVIG,2016-07-10,2020-05-20, , ,['/Month'], ,Persisting MRI activity
23869,1094,Avonex,2016-10-09,, , ,[' '],IV, 
23870,3715,Copaxone,2016-09-26,2020-03-19,5000,mg,['/Month'],IV,Lack of efficacy
23871,3715,Tysabri,2015-11-16,2018-02-21,500,mg,['/Month'],IV,Persisting MRI activity
23872,3715,Alemtuzumab (Campath),2016-02-26,, , ,['3 / Week'],IV, 
23873,4745,Mitoxantrone,2016-03-26,,300, ,['/ Week'],Oral, 
23874,4745,Betaferon,2015-12-25,2020-12-29,300,mcg,['/Month'],IV,Patient Choice/Convenience
23875,4745,Betaferon,2015-10-25,,1000, ,['2 / Day'],Oral, 
23876,3023,Tecfidera,2016-03-08,2020-09-14,5000,mg,['/Month'], ,Patient Choice/Convenience
23877,3023,Betaferon,2016-08-13,2021-04-29,500, ,['/Month'],IV,Lack of efficacy
23878,3023,Ledertrexaat,2016-08-03,, ,mg,['2 / Day'],IV, 
23879,3023,Avonex,2016-08-09,2020-04-21,300,mg,['/ Week'],IV,Patient Choice/Convenience
23880,3979,Endoxan,2016-05-24,,300,mg,[' '], , 
23881,3979,D-cure (Vitamine D),2016-07-31,2019-12-20,5000, ,['2 / Day'],IV,Adverse Event
23882,3979,Rebif [44],2016-09-01,,1000,mg,['/Month'], , 
23883,4821,IVIG,2016-09-04,,400,mg,['/Month'], , 
23884,4821,Tecfidera,2016-07-25,,400,mg,['3 / Week'],IV, 
23885,1915,Gilenya,2015-12-06,2019-12-11,400,mg,['/Month'], ,Persisting MRI activity
23886,1915,Endoxan,2016-05-12,2020-02-18,500,mcg,['/ Day'], ,Lack of efficacy
23887,1915,Tysabri,2016-04-24,,300, ,['/Month'], , 
23888,1915,Ledertrexaat,2016-01-12,, ,mg,['3 / Week'], , 
23889,286,D-cure (Vitamine D),2016-10-17,, ,MIU,['/ Day'],IV, 
23890,708,IVIG,2015-12-25,,1, ,['/Month'], , 
23891,708,Rebif [44],2016-08-22,2019-12-15,1,mg,['2 / Day'], ,Patient Choice/Convenience
23892,708,Methylprednisolone,2016-08-28,,500, ,['/Month'],IV, 
23893,708,Copaxone,2016-10-11,,500, ,['2 / Day'], , 
23894,2501,Ledertrexaat,2016-06-12,,1, ,['3 / Week'],IV, 
23895,1290,Avonex,2015-11-09,,1000,mcg,['/ Week'], , 
23896,1290,Gilenya,2015-11-30,,20,mg,['/Month'], , 
23897,1002,Tecfidera,2015-12-24,,20,mcg,['2 / Day'],IV, 
23898,265,Alemtuzumab (Campath),2016-05-30,2020-08-17,5000,mcg,['2 / Day'], ,Lack of efficacy
23899,3723,Rebif [22],2015-12-29,2019-04-21,500, ,['/Month'],IV,Persisting MRI activity
23900,496,Gilenya,2016-04-16,,500, ,['2 / Day'],IV, 
23901,496,Copaxone,2016-04-18,2020-10-28,500, ,[' '],IV,Lack of efficacy
23902,3080,Alemtuzumab (Campath),2016-07-25,,20,mg,['/Month'], , 
23903,3080,Tecfidera,2016-08-27,, , ,['/Month'],Oral, 
23904,3080,IVIG,2016-05-17,2020-09-22,1000,mg,['2 / Day'],IV,Lack of efficacy
23905,3696,IVIG,2016-04-02,,5000,mcg,['/ Day'], , 
23906,1549,IVIG,2016-01-26,2021-05-06,300,mg,['2 / Day'],IV,Adverse Event
23907,1549,Tecfidera,2016-07-13,2021-03-15,500,mg,['3 / Week'],IV,Lack of efficacy
23908,1549,Mitoxantrone,2016-02-18,, , ,['2 / Day'],IV, 
23909,2308,D-cure (Vitamine D),2015-11-17,, ,mg,['/ Day'], , 
23910,2308,Copaxone,2016-05-06,2019-08-04,20,mg,['/Month'],IV,Patient Choice/Convenience
23911,2308,D-cure (Vitamine D),2016-05-05,,400,mg,['/Month'],IV, 
23912,2308,D-cure (Vitamine D),2016-06-27,2018-12-11,20,mg,[' '],IV,Lack of efficacy
23913,528,Gilenya,2016-01-04,, ,mg,['2 / Day'],IV, 
23914,528,Gilenya,2015-12-12,,5000, ,['2 / Day'], , 
23915,528,Gilenya,2016-01-18,2020-10-15, ,mg,['2 / Day'], ,Lack of efficacy
23916,1377,Avonex,2016-07-01,,20,mcg,['/ Day'],IV, 
23917,1377,Rebif [44],2016-07-19,, , ,['2 / Day'],IV, 
23918,1377,Copaxone,2016-06-24,, ,mg,[' '],IV, 
23919,1377,Methylprednisolone,2016-03-17,2018-05-31, ,MIU,['/Month'],IV,Lack of efficacy
23920,3253,Endoxan,2016-02-07,2018-12-14,5000,mg,[' '],IV,Persisting MRI activity
23921,3976,Betaferon,2016-06-03,2018-06-11, , ,['/Month'], ,Lack of efficacy
23922,3976,Tecfidera,2015-12-25,2020-06-27,1000,mg,[' '], ,Lack of efficacy
23923,3531,Tysabri,2016-07-12,, ,mg,['2 / Day'],IV, 
23924,3531,Rebif [44],2016-08-06,2019-08-16,5000, ,['/Month'],IV,Persistence of relapses
23925,919,Teriflunomide,2015-11-30,,5000, ,['/Month'], , 
23926,919,IVIG,2015-12-22,2021-01-27,20,mg,['/ Day'], ,Adverse Event
23927,919,Betaferon,2016-09-28,,300, ,['3 / Week'],IV, 
23928,919,D-cure (Vitamine D),2016-09-13,,20,mg,[' '],Oral, 
23929,1606,Rebif [44],2016-06-03,,500, ,['/Month'], , 
23930,1606,Tysabri,2016-10-02,, ,mcg,['2 / Day'],IV, 
23931,1606,Teriflunomide,2016-09-28,,500,mcg,['2 / Day'],Oral, 
23932,1581,Betaferon,2016-04-29,2019-10-04, ,mg,['/ Day'], ,Adverse Event
23933,1581,Gilenya,2016-10-08,2020-06-26,20, ,['/Month'],IV,Lack of efficacy
23934,1581,Rebif [44],2015-11-16,,1, ,['2 / Day'],IV, 
23935,2648,Ledertrexaat,2016-03-29,, ,mg,['/Month'],IV, 
23936,763,Gilenya,2016-04-18,,20,MIU,['/Month'], , 
23937,763,D-cure (Vitamine D),2015-11-23,,500, ,['2 / Day'],IV, 
23938,763,Rebif [22],2016-03-09,,400, ,['3 / Week'], , 
23939,2508,IVIG,2015-12-08,, , ,['/Month'], , 
23940,2508,Rebif [22],2016-08-24,2020-08-13,1000, ,['/Month'], ,Adverse Event
23941,2508,Methylprednisolone,2016-03-27,,300,mg,['/Month'], , 
23942,2508,Rebif [44],2015-12-03,2018-04-03,300,MIU,['/ Day'], ,Lack of efficacy
23943,4191,Rebif [22],2016-04-20,2021-09-26,300, ,['/Month'],IV,Adverse Event
23944,3626,Gilenya,2016-04-13,,1, ,['2 / Day'],IV, 
23945,3626,Methylprednisolone,2016-05-01,,300,mg,[' '],Oral, 
23946,3626,D-cure (Vitamine D),2016-02-14,2019-03-21, ,MIU,['/Month'],Oral,Lack of efficacy
23947,1455,Tecfidera,2016-08-14,,400,MIU,['3 / Week'],IV, 
23948,1455,Endoxan,2016-07-14,2021-05-21,300,mg,['2 / Day'],IV,Persistence of relapses
23949,1455,Tecfidera,2016-07-30,2020-01-16, ,mg,['3 / Week'],IV,Lack of efficacy
23950,1455,Methylprednisolone,2016-07-12,,300, ,['/ Day'], , 
23951,2400,Gilenya,2016-02-25,2020-10-12,20, ,['/ Week'],IV,Adverse Event
23952,3670,Ledertrexaat,2016-02-03,2020-01-01, ,mg,['3 / Week'], ,Lack of efficacy
23953,3670,Ledertrexaat,2016-02-17,2020-01-14,1000,mcg,['/Month'],IV,Persisting MRI activity
23954,1098,Endoxan,2016-10-16,,20,mcg,['/ Week'], , 
23955,886,D-cure (Vitamine D),2016-03-10,, ,mg,['/Month'], , 
23956,886,Tysabri,2016-07-17,2019-09-21,1,MIU,['/Month'], ,Adverse Event
23957,886,Endoxan,2015-12-17,2020-10-27, ,MIU,['2 / Day'], ,Patient Choice/Convenience
23958,886,Tecfidera,2016-09-25,, ,mg,['/ Day'], , 
23959,2852,Ledertrexaat,2015-11-25,,1000,MIU,['/ Day'],Oral, 
23960,495,D-cure (Vitamine D),2016-06-12,,300, ,[' '], , 
23961,495,Endoxan,2016-09-27,2020-03-31, , ,['2 / Day'], ,Persisting MRI activity
23962,495,Mitoxantrone,2015-12-15,2021-09-27,500, ,['2 / Day'], ,Lack of efficacy
23963,1296,Copaxone,2016-05-28,2020-12-10,5000,MIU,['2 / Day'],Oral,Patient Choice/Convenience
23964,204,D-cure (Vitamine D),2015-11-18,,300, ,['/ Week'],IV, 
23965,204,Ledertrexaat,2016-09-23,, ,mcg,['/Month'], , 
23966,204,Tecfidera,2016-03-13,2019-01-29, ,MIU,['/ Week'],Oral,Lack of efficacy
23967,204,Gilenya,2016-02-08,2019-03-05,500, ,['/Month'],Oral,Adverse Event
23968,830,Rebif [44],2016-10-19,2019-06-27,1, ,['/Month'], ,Persisting MRI activity
23969,830,Rebif [44],2016-01-06,, ,mg,['3 / Week'], , 
23970,830,D-cure (Vitamine D),2016-06-11,2018-01-24,1000,MIU,['/Month'],Oral,Patient Choice/Convenience
23971,830,D-cure (Vitamine D),2016-01-21,,1000,mg,['/Month'], , 
23972,1659,Rebif [22],2015-12-31,,500, ,['3 / Week'], , 
23973,1423,Avonex,2016-02-09,,400,mg,['2 / Day'],IV, 
23974,1423,IVIG,2016-09-09,2021-03-22,1, ,['/Month'],Oral,Adverse Event
23975,1423,Betaferon,2016-01-26,,500, ,[' '],IV, 
23976,1423,Tysabri,2016-05-23,,20,mg,['/Month'],IV, 
23977,4350,Tysabri,2016-03-13,,5000,mcg,['2 / Day'],IV, 
23978,4350,Methylprednisolone,2016-05-12,2018-08-17, ,MIU,[' '],IV,Adverse Event
23979,4350,Endoxan,2016-04-01,, ,mcg,['/ Day'], , 
23980,3849,Tysabri,2015-12-06,2019-08-23,20, ,['/ Week'],Oral,Patient Choice/Convenience
23981,3849,Tysabri,2016-02-23,, ,mg,['/Month'],Oral, 
23982,3849,Betaferon,2016-03-21,,1,mg,['2 / Day'],IV, 
23983,2412,Gilenya,2016-04-30,2018-09-21, ,MIU,[' '],Oral,Adverse Event
23984,2412,Betaferon,2016-05-06,, , ,['/Month'], , 
23985,2412,Tecfidera,2016-09-29,,1000,mg,['2 / Day'],IV, 
23986,3286,Endoxan,2016-03-13,,20,mg,['/Month'],IV, 
23987,3286,Rebif [44],2016-01-06,,400,mg,['/Month'],IV, 
23988,3286,Teriflunomide,2016-09-27,,20,mg,['3 / Week'], , 
23989,1531,Tecfidera,2016-10-17,,500,mg,['2 / Day'],IV, 
23990,1531,Tysabri,2016-03-30,,500, ,['/Month'], , 
23991,940,Alemtuzumab (Campath),2015-11-05,,5000,mg,['/ Day'], , 
23992,940,Endoxan,2016-01-29,,1000,mg,['/Month'], , 
23993,940,Gilenya,2016-01-04,, , ,['/Month'],Oral, 
23994,842,Methylprednisolone,2016-01-17,,5000,mg,['/Month'],IV, 
23995,842,Avonex,2016-09-11,2021-10-18,5000,mg,[' '], ,Adverse Event
23996,1110,Gilenya,2016-04-04,2019-12-15, , ,[' '], ,Persistence of relapses
23997,751,Gilenya,2015-10-28,,400,MIU,['/ Day'], , 
23998,751,Tysabri,2016-07-06,,500,mg,['/Month'], , 
23999,751,Tysabri,2016-02-04,2021-09-04, , ,['/Month'], ,Patient Choice/Convenience
24000,2210,Tysabri,2015-11-24,2019-01-14,300,MIU,['3 / Week'],IV,Lack of efficacy
24001,2658,Avonex,2016-08-21,2019-07-04,1, ,['/Month'],IV,Lack of efficacy
24002,2658,Copaxone,2016-06-14,2018-04-06,5000,MIU,['/Month'], ,Adverse Event
24003,2207,D-cure (Vitamine D),2015-12-21,2018-06-07, ,mcg,['3 / Week'], ,Adverse Event
24004,2207,Rebif [44],2016-05-31,2020-01-05, ,mg,['2 / Day'], ,Adverse Event
24005,2207,Tecfidera,2016-09-16,2020-03-15,300,mcg,['3 / Week'],IV,Patient Choice/Convenience
24006,1110,Rebif [22],2016-08-06,, ,mg,[' '],IV, 
24007,1110,Ledertrexaat,2016-10-02,, , ,['/ Week'],Oral, 
24008,4932,Teriflunomide,2015-12-18,,5000,MIU,['/Month'],IV, 
24009,4932,Methylprednisolone,2016-05-29,,1,mg,['3 / Week'],IV, 
24010,4932,Betaferon,2016-04-07,2020-03-28,5000, ,['/Month'], ,Patient Choice/Convenience
24011,1152,Alemtuzumab (Campath),2016-03-20,2019-04-29,5000, ,['/Month'], ,Lack of efficacy
24012,1152,Gilenya,2016-01-30,2018-07-04,1000, ,['/ Day'],IV,Persisting MRI activity
24013,1152,Tysabri,2016-10-01,,500, ,['2 / Day'], , 
24014,1434,Rebif [22],2016-10-09,2020-06-20, ,mg,['/ Week'],IV,Adverse Event
24015,1434,Betaferon,2016-09-29,2020-04-10,20,mg,[' '],IV,Lack of efficacy
24016,2481,IVIG,2015-11-15,2021-08-15,5000,mg,['/Month'],IV,Persisting MRI activity
24017,2481,D-cure (Vitamine D),2016-03-18,,1,MIU,['3 / Week'], , 
24018,4392,Avonex,2016-03-20,2021-02-11,20, ,['3 / Week'], ,Adverse Event
24019,4392,Avonex,2015-12-25,2018-02-26, , ,['/ Day'],IV,Adverse Event
24020,4392,D-cure (Vitamine D),2016-08-15,,500,mg,['/ Week'],IV, 
24021,3978,Alemtuzumab (Campath),2016-10-16,2017-12-19,400,mg,['/ Day'], ,Persisting MRI activity
24022,2193,Tysabri,2016-07-12,,1000, ,['/Month'], , 
24023,2193,Copaxone,2016-03-13,2020-02-06,1000, ,['/Month'], ,Patient Choice/Convenience
24024,1281,Gilenya,2015-11-05,2020-11-06,5000,mg,['2 / Day'],IV,Adverse Event
24025,1281,Betaferon,2016-09-23,, , ,['/Month'],IV, 
24026,1281,Rebif [22],2015-11-08,2019-10-09,300,mg,['2 / Day'], ,Lack of efficacy
24027,4838,Rebif [22],2016-07-07,2021-04-14,500, ,['/Month'],IV,Lack of efficacy
24028,4838,IVIG,2016-03-16,,5000,mg,['3 / Week'],IV, 
24029,4838,Copaxone,2016-03-09,, , ,['3 / Week'],IV, 
24030,691,Methylprednisolone,2016-07-10,, ,mg,['/ Day'],IV, 
24031,691,Rebif [22],2016-09-14,2018-07-14,5000,mcg,['2 / Day'], ,Lack of efficacy
24032,691,Mitoxantrone,2016-01-17,2021-03-05,400,mg,['2 / Day'], ,Adverse Event
24033,691,Gilenya,2015-11-25,2021-01-13,500,mg,['/ Day'], ,Persisting MRI activity
24034,673,Endoxan,2016-07-30,2019-03-22, , ,['/ Day'],IV,Lack of efficacy
24035,3944,Teriflunomide,2015-12-25,, ,mg,['2 / Day'],IV, 
24036,1625,Rebif [44],2016-02-04,,1000, ,[' '], , 
24037,1625,IVIG,2016-03-09,, ,mg,['/Month'],IV, 
24038,1625,D-cure (Vitamine D),2016-08-21,2018-08-10,5000,mcg,['/ Day'], ,Lack of efficacy
24039,4975,IVIG,2016-02-23,2019-02-19, ,mg,['/Month'],IV,Adverse Event
24040,4975,Gilenya,2016-08-25,2020-11-29,20,mg,['3 / Week'],IV,Patient Choice/Convenience
24041,4612,D-cure (Vitamine D),2015-12-09,2019-06-04, , ,['/Month'],IV,Patient Choice/Convenience
24042,4437,Ledertrexaat,2016-10-16,2020-04-14,400,mg,['2 / Day'],Oral,Patient Choice/Convenience
24043,4437,D-cure (Vitamine D),2015-12-15,, , ,[' '],IV, 
24044,895,Gilenya,2016-03-09,2018-09-09,1,mg,['3 / Week'], ,Persistence of relapses
24045,895,D-cure (Vitamine D),2016-02-06,2019-01-27,500, ,['2 / Day'],Oral,Lack of efficacy
24046,895,Alemtuzumab (Campath),2016-01-10,2018-11-20, , ,['3 / Week'], ,Adverse Event
24047,895,D-cure (Vitamine D),2016-10-20,, , ,['3 / Week'],IV, 
24048,4808,Ledertrexaat,2016-07-11,,1,mcg,['2 / Day'], , 
24049,1115,Mitoxantrone,2016-10-22,,400,mg,['/Month'],Oral, 
24050,1115,Alemtuzumab (Campath),2016-05-30,,400,MIU,[' '],Oral, 
24051,1115,Betaferon,2016-02-26,,300, ,['/Month'],IV, 
24052,1227,Tecfidera,2016-09-02,, ,mcg,['/Month'],IV, 
24053,1227,Gilenya,2015-12-28,2019-09-06,500,mg,['3 / Week'],IV,Patient Choice/Convenience
24054,1227,Betaferon,2016-02-03,,1,mg,['/ Week'],IV, 
24055,1227,Ledertrexaat,2015-11-27,, ,mg,['/Month'], , 
24056,3498,Endoxan,2016-03-23,2018-11-02, ,mg,['/ Week'], ,Patient Choice/Convenience
24057,3498,Rebif [44],2015-12-29,,1000,mg,['3 / Week'],IV, 
24058,3498,Endoxan,2016-09-03,,5000,mg,['/ Day'], , 
24059,4532,Copaxone,2016-01-09,2020-07-22,500,mg,['/ Week'],IV,Adverse Event
24060,201,Tecfidera,2016-04-03,2018-01-27,5000,mg,['/Month'],IV,Adverse Event
24061,201,Tysabri,2016-08-14,2021-05-15,1, ,['2 / Day'],IV,Lack of efficacy
24062,201,Tecfidera,2016-04-20,, ,mg,['/Month'],IV, 
24063,201,Tecfidera,2016-05-08,2019-01-31, , ,['/ Week'],IV,Persistence of relapses
24064,2455,Copaxone,2016-02-28,,20, ,['2 / Day'], , 
24065,2455,Gilenya,2016-03-26,,400,mcg,['/ Day'],IV, 
24066,4246,Avonex,2016-03-01,,500, ,['/Month'], , 
24067,4246,Betaferon,2016-04-23,,5000, ,['/ Day'], , 
24068,4246,Methylprednisolone,2016-08-12,2018-10-14,300,mg,['/Month'],IV,Adverse Event
24069,4246,Mitoxantrone,2016-08-14,,5000,MIU,['3 / Week'],IV, 
24070,3786,Gilenya,2015-11-14,, ,mcg,['2 / Day'], , 
24071,3786,Rebif [44],2016-03-15,2020-11-03,1000,mg,['2 / Day'],IV,Persistence of relapses
24072,3786,Copaxone,2016-03-27,,300, ,['3 / Week'],IV, 
24073,3786,Tecfidera,2016-05-31,,5000,mg,['/Month'], , 
24074,1069,Tecfidera,2015-12-24,,1, ,['2 / Day'],IV, 
24075,1069,Tysabri,2016-02-06,2019-10-08,20,MIU,[' '],IV,Adverse Event
24076,3040,Endoxan,2016-05-29,, , ,['3 / Week'],IV, 
24077,3040,Tecfidera,2016-02-01,, ,mg,['/Month'],IV, 
24078,3040,Teriflunomide,2016-04-03,,1000, ,['2 / Day'],IV, 
24079,992,Methylprednisolone,2016-08-29,,1, ,['2 / Day'],IV, 
24080,992,D-cure (Vitamine D),2016-06-10,,1, ,['2 / Day'],IV, 
24081,992,Copaxone,2015-10-25,,5000,MIU,['/ Day'], , 
24082,4755,Rebif [44],2016-02-10,2018-01-14,300, ,[' '], ,Adverse Event
24083,4755,IVIG,2016-05-22,2018-04-24,20, ,['/Month'],IV,Persisting MRI activity
24084,4755,Gilenya,2016-07-24,2019-02-15,400,mg,['/Month'],Oral,Adverse Event
24085,4755,IVIG,2016-06-23,2018-09-11, ,mg,['/Month'], ,Patient Choice/Convenience
24086,1880,D-cure (Vitamine D),2016-03-06,, ,MIU,['2 / Day'],IV, 
24087,4870,IVIG,2016-02-26,2018-12-14,20,mg,['/ Day'], ,Adverse Event
24088,4079,Rebif [44],2016-04-21,,20, ,['/Month'],IV, 
24089,1642,Mitoxantrone,2016-01-27,2019-07-20,1000,mg,['/Month'],IV,Patient Choice/Convenience
24090,1642,Ledertrexaat,2016-06-27,2020-09-09,20,mg,['2 / Day'],IV,Lack of efficacy
24091,1925,Endoxan,2016-01-14,2021-05-31, , ,['2 / Day'], ,Lack of efficacy
24092,1925,Alemtuzumab (Campath),2016-01-03,2020-05-30,1, ,['/Month'],IV,Lack of efficacy
24093,1925,Avonex,2016-03-10,2020-07-22, ,MIU,['/Month'],IV,Patient Choice/Convenience
24094,1925,Alemtuzumab (Campath),2016-02-15,2021-10-21, ,MIU,['/Month'],IV,Adverse Event
24095,1033,Teriflunomide,2015-11-16,2018-01-09,300,mg,['2 / Day'],IV,Adverse Event
24096,1033,Copaxone,2016-07-22,,20, ,['/Month'], , 
24097,4177,Tecfidera,2016-07-11,,20, ,['3 / Week'],IV, 
24098,532,Tysabri,2015-11-30,,400,mg,['/Month'],IV, 
24099,532,Alemtuzumab (Campath),2016-03-15,2018-01-22,1000,mg,['/Month'], ,Adverse Event
24100,532,Avonex,2016-02-09,, , ,['/ Day'], , 
24101,3263,IVIG,2016-06-01,, , ,['2 / Day'],IV, 
24102,168,Rebif [22],2015-11-20,,5000, ,['/Month'], , 
24103,168,Gilenya,2016-05-02,, ,MIU,['/Month'], , 
24104,1882,Alemtuzumab (Campath),2016-06-21,2020-08-23,300, ,[' '],IV,Patient Choice/Convenience
24105,1882,Methylprednisolone,2015-12-28,, ,mg,['/ Day'],Oral, 
24106,4135,Betaferon,2016-02-10,,1, ,['2 / Day'],IV, 
24107,4135,D-cure (Vitamine D),2016-02-10,2020-09-12, ,mg,['/Month'],IV,Adverse Event
24108,1017,Methylprednisolone,2016-07-05,2018-10-12, , ,['/Month'],IV,Patient Choice/Convenience
24109,1017,Rebif [44],2016-02-09,2021-03-31, ,mg,[' '], ,Persisting MRI activity
24110,1017,D-cure (Vitamine D),2016-10-07,2020-08-18, , ,['2 / Day'],IV,Patient Choice/Convenience
24111,3857,IVIG,2015-11-29,2020-05-05, , ,[' '],IV,Patient Choice/Convenience
24112,934,Ledertrexaat,2016-05-19,, ,mg,['/Month'], , 
24113,934,Methylprednisolone,2016-04-08,,1000, ,['2 / Day'], , 
24114,934,D-cure (Vitamine D),2016-09-25,2018-02-07,1,mcg,['2 / Day'],IV,Persisting MRI activity
24115,934,D-cure (Vitamine D),2015-10-28,2020-09-28, , ,['2 / Day'], ,Persisting MRI activity
24116,1384,Tecfidera,2016-03-25,2021-04-21, ,mg,['2 / Day'], ,Persisting MRI activity
24117,1384,Methylprednisolone,2016-02-20,2021-03-13,500,mg,['3 / Week'], ,Persisting MRI activity
24118,2344,IVIG,2016-08-24,2021-06-23,5000,MIU,[' '],IV,Lack of efficacy
24119,2344,Copaxone,2015-11-29,2017-11-27,5000, ,['/ Week'],Oral,Adverse Event
24120,224,Gilenya,2016-09-22,,5000,mg,['/ Week'],Oral, 
24121,224,Methylprednisolone,2016-02-05,2021-04-28,1,mg,['/Month'],Oral,Lack of efficacy
24122,224,Gilenya,2016-06-15,,500,mg,['/Month'],IV, 
24123,2706,Avonex,2016-01-08,,300,mg,['2 / Day'],IV, 
24124,2706,Endoxan,2016-01-08,,1, ,['2 / Day'],IV, 
24125,2706,Gilenya,2016-09-17,,5000, ,['2 / Day'],Oral, 
24126,3512,Copaxone,2016-03-04,2020-09-28,300, ,[' '], ,Patient Choice/Convenience
24127,2778,Rebif [44],2016-02-06,2020-04-06, , ,['/ Week'],IV,Patient Choice/Convenience
24128,2778,Alemtuzumab (Campath),2016-03-29,2019-12-31,300,MIU,['2 / Day'],IV,Adverse Event
24129,2778,Tecfidera,2015-11-13,,1,mcg,['/Month'],IV, 
24130,2778,Gilenya,2016-09-28,,300,mg,['3 / Week'],Oral, 
24131,2904,Avonex,2016-10-17,2021-08-04,20,mg,['2 / Day'], ,Persisting MRI activity
24132,2904,IVIG,2016-05-17,, , ,['2 / Day'], , 
24133,2904,Alemtuzumab (Campath),2016-09-25,,500,mg,['3 / Week'],IV, 
24134,1761,Methylprednisolone,2015-11-28,,20,MIU,['2 / Day'],IV, 
24135,1761,Betaferon,2016-07-22,,400,mg,[' '], , 
24136,1761,Methylprednisolone,2016-03-15,,500,mg,['/ Week'], , 
24137,4612,Tecfidera,2016-03-09,,500,mg,['2 / Day'],IV, 
24138,567,Copaxone,2015-12-01,,1000, ,['2 / Day'], , 
24139,268,Tecfidera,2016-07-20,2021-01-21, ,MIU,['3 / Week'], ,Lack of efficacy
24140,960,Alemtuzumab (Campath),2015-12-20,,20, ,['2 / Day'], , 
24141,960,Endoxan,2016-02-06,,20,mcg,['/Month'],IV, 
24142,4095,Alemtuzumab (Campath),2016-02-10,,20,mg,['2 / Day'], , 
24143,4095,Tecfidera,2016-06-11,,5000, ,['2 / Day'], , 
24144,4095,Gilenya,2016-08-02,,500, ,['/Month'], , 
24145,4095,Gilenya,2016-07-28,,400,mg,['/Month'],IV, 
24146,4204,Methylprednisolone,2016-01-26,2018-12-24,5000,mg,['3 / Week'], ,Persisting MRI activity
24147,4204,Copaxone,2016-09-17,2021-01-26,500,MIU,['2 / Day'],IV,Adverse Event
24148,4204,Methylprednisolone,2016-04-04,,500, ,['2 / Day'],IV, 
24149,3888,Copaxone,2016-08-15,2020-06-12, ,mg,['/Month'],IV,Persisting MRI activity
24150,4375,Rebif [22],2016-10-14,, , ,['2 / Day'],IV, 
24151,4375,Tysabri,2015-12-04,2019-09-17, , ,['3 / Week'],Oral,Lack of efficacy
24152,4685,Rebif [44],2016-09-08,2019-08-20, , ,['/ Week'],IV,Lack of efficacy
24153,4685,Alemtuzumab (Campath),2016-02-20,2018-04-27,1000,mg,['2 / Day'], ,Patient Choice/Convenience
24154,4685,IVIG,2016-03-20,2018-02-22,500, ,['2 / Day'],Oral,Persisting MRI activity
24155,4685,Tysabri,2015-11-26,2021-07-02,20,mg,['2 / Day'], ,Patient Choice/Convenience
24156,1654,D-cure (Vitamine D),2016-09-26,2018-05-31, ,MIU,['3 / Week'], ,Lack of efficacy
24157,1654,Rebif [22],2016-06-03,2019-12-23,5000,mg,['/ Week'],Oral,Lack of efficacy
24158,3346,Gilenya,2016-01-25,,400,MIU,['2 / Day'],IV, 
24159,2199,Endoxan,2015-11-16,,300,mg,['2 / Day'], , 
24160,2199,IVIG,2015-11-09,2020-01-01,300, ,['/Month'],IV,Adverse Event
24161,2199,Rebif [22],2016-09-14,2020-10-27,500, ,['2 / Day'],IV,Persistence of relapses
24162,2199,Teriflunomide,2016-05-30,2019-07-02,1000, ,['/Month'],IV,Adverse Event
24163,3417,D-cure (Vitamine D),2016-09-05,,500, ,['3 / Week'],IV, 
24164,3417,Endoxan,2016-05-26,,1000,MIU,['/Month'],IV, 
24165,2072,Alemtuzumab (Campath),2016-04-14,2018-02-22,20,mg,[' '], ,Lack of efficacy
24166,2072,Endoxan,2016-03-15,, ,MIU,['3 / Week'],IV, 
24167,2072,Copaxone,2016-05-29,2019-12-26,20, ,['/ Day'],IV,Lack of efficacy
24168,1791,IVIG,2016-05-08,,300,mg,['/Month'],IV, 
24169,1791,Teriflunomide,2016-01-02,2019-11-26,1, ,['2 / Day'],IV,Lack of efficacy
24170,1791,Endoxan,2016-05-22,2018-11-08,5000, ,['/Month'], ,Patient Choice/Convenience
24171,697,Gilenya,2016-01-25,2018-03-31,20,mg,['2 / Day'],Oral,Lack of efficacy
24172,697,Tysabri,2016-03-05,,1000, ,['/Month'], , 
24173,697,Tysabri,2016-07-18,,20,mcg,['3 / Week'], , 
24174,697,Rebif [44],2016-05-17,,5000, ,['3 / Week'], , 
24175,2531,IVIG,2015-11-07,2018-04-02, ,mcg,['/Month'],Oral,Adverse Event
24176,2531,Copaxone,2016-09-04,,20,mg,['2 / Day'],Oral, 
24177,2531,D-cure (Vitamine D),2016-07-09,,20, ,['/Month'], , 
24178,2978,Rebif [22],2016-03-09,2019-03-08,300,MIU,['/Month'],Oral,Persisting MRI activity
24179,2978,Gilenya,2015-11-24,, , ,['3 / Week'], , 
24180,2978,Copaxone,2016-07-21,,500,mg,[' '],IV, 
24181,2978,Rebif [22],2015-12-17,2021-04-05,1000, ,['2 / Day'],IV,Adverse Event
24182,3390,Copaxone,2016-07-31,2021-03-13,500,mg,[' '],IV,Patient Choice/Convenience
24183,3967,Betaferon,2016-08-04,,500, ,['3 / Week'], , 
24184,3967,Gilenya,2016-01-07,,20, ,['2 / Day'], , 
24185,3967,Rebif [22],2016-08-20,2017-12-25, , ,[' '],IV,Persistence of relapses
24186,2716,Endoxan,2015-12-09,,1,MIU,['2 / Day'],IV, 
24187,2716,Ledertrexaat,2016-08-30,, ,mg,[' '],IV, 
24188,2716,Rebif [22],2015-11-14,,1000,mg,['/Month'],IV, 
24189,763,D-cure (Vitamine D),2016-03-03,,300, ,[' '], , 
24190,763,Betaferon,2016-06-30,2020-03-19,20, ,['2 / Day'], ,Persistence of relapses
24191,763,Tysabri,2016-08-04,, , ,['/Month'], , 
24192,1864,D-cure (Vitamine D),2016-06-15,,20,mg,['2 / Day'],IV, 
24193,1864,Copaxone,2016-06-20,2021-10-19,500, ,['/Month'],IV,Lack of efficacy
24194,1864,IVIG,2015-12-04,, ,mg,['/Month'],IV, 
24195,1864,Tecfidera,2016-04-09,2020-01-14, ,mcg,['2 / Day'],IV,Patient Choice/Convenience
24196,2620,Tysabri,2016-10-05,, , ,['/Month'],Oral, 
24197,2620,D-cure (Vitamine D),2016-08-06,2021-06-19, ,mg,['2 / Day'],IV,Adverse Event
24198,3835,Tysabri,2016-02-25,,1,mg,[' '], , 
24199,3835,Teriflunomide,2015-11-02,, ,mg,['/Month'],IV, 
24200,3835,Endoxan,2016-05-12,,500, ,['2 / Day'], , 
24201,3835,Alemtuzumab (Campath),2016-05-15,2020-12-17,500,mg,['3 / Week'],IV,Adverse Event
24202,2187,Copaxone,2016-10-14,2019-07-13, ,mg,['2 / Day'],IV,Persisting MRI activity
24203,2187,IVIG,2016-02-17,,400, ,['/Month'], , 
24204,697,IVIG,2016-02-04,2021-07-10,1000,MIU,['2 / Day'], ,Adverse Event
24205,4493,Tysabri,2016-06-27,2018-05-16, , ,['/Month'],IV,Patient Choice/Convenience
24206,4493,Gilenya,2016-08-08,,1, ,['3 / Week'],IV, 
24207,735,Rebif [44],2016-08-21,2020-12-20,1000,mg,['3 / Week'],IV,Adverse Event
24208,735,D-cure (Vitamine D),2016-06-09,2018-10-06,1000,MIU,['/Month'], ,Persistence of relapses
24209,735,Copaxone,2016-07-31,2020-12-08,1000, ,['/Month'],IV,Persistence of relapses
24210,735,Tysabri,2016-06-03,,1000, ,[' '],IV, 
24211,338,Avonex,2015-12-26,2019-12-02, ,mg,['/Month'], ,Persistence of relapses
24212,338,Alemtuzumab (Campath),2016-05-19,,400, ,['/ Day'],IV, 
24213,338,Methylprednisolone,2016-07-01,, ,mcg,[' '],IV, 
24214,338,Gilenya,2016-04-30,,300,mcg,['/Month'], , 
24215,3515,Endoxan,2016-09-17,, , ,['2 / Day'], , 
24216,3515,Betaferon,2016-01-19,,300, ,['2 / Day'], , 
24217,3515,Copaxone,2016-03-28,2019-11-16, , ,['2 / Day'],IV,Lack of efficacy
24218,1701,Gilenya,2016-06-04,,1,mg,['2 / Day'],IV, 
24219,1701,Rebif [44],2016-05-07,,1000, ,['2 / Day'], , 
24220,1844,Avonex,2016-03-22,, ,mg,['3 / Week'],IV, 
24221,1844,D-cure (Vitamine D),2016-05-30,,20,MIU,['2 / Day'], , 
24222,308,Alemtuzumab (Campath),2016-09-24,2021-05-05, ,mg,['2 / Day'], ,Patient Choice/Convenience
24223,4764,IVIG,2015-12-22,2019-09-21,1000,mcg,[' '], ,Persistence of relapses
24224,919,Tysabri,2016-07-23,2020-07-27, ,mg,[' '],IV,Adverse Event
24225,919,Endoxan,2016-02-28,,500, ,[' '],Oral, 
24226,3903,Tecfidera,2016-09-05,,500,mg,['/Month'], , 
24227,4759,Teriflunomide,2016-09-30,2019-12-13, ,mg,['/Month'], ,Adverse Event
24228,4759,Methylprednisolone,2016-05-16,,300,mg,['2 / Day'],Oral, 
24229,855,Avonex,2016-05-02,, , ,['3 / Week'],IV, 
24230,855,Rebif [22],2016-02-27,2018-09-25, ,mg,['2 / Day'],IV,Patient Choice/Convenience
24231,2272,Teriflunomide,2015-12-12,2021-09-06,20,mg,['/Month'], ,Adverse Event
24232,2272,Mitoxantrone,2015-12-30,,500,mg,['2 / Day'], , 
24233,4512,Tysabri,2015-11-10,2019-03-18, ,mg,['/ Week'], ,Persistence of relapses
24234,4512,Ledertrexaat,2015-12-24,,300,MIU,[' '],Oral, 
24235,1966,Tecfidera,2016-04-05,,300, ,['/Month'],IV, 
24236,1966,Copaxone,2016-03-05,,5000,mcg,['3 / Week'],IV, 
24237,955,Mitoxantrone,2016-06-14,,500, ,['/Month'],Oral, 
24238,955,IVIG,2016-06-23,, , ,['/Month'], , 
24239,955,Avonex,2016-05-24,2021-06-29,400, ,['2 / Day'],IV,Persisting MRI activity
24240,955,Endoxan,2016-09-20,2020-10-02,500,MIU,['3 / Week'],IV,Adverse Event
24241,625,IVIG,2016-01-31,, ,mg,['3 / Week'], , 
24242,625,Copaxone,2016-02-20,,1000, ,['/ Day'], , 
24243,625,Gilenya,2016-04-11,2020-12-26, , ,['2 / Day'], ,Patient Choice/Convenience
24244,625,Ledertrexaat,2016-10-10,2020-07-21, ,mg,['2 / Day'], ,Adverse Event
24245,1042,Rebif [22],2016-05-17,,400,MIU,['/Month'], , 
24246,1042,Tysabri,2015-10-30,2020-05-01,20, ,['/ Week'], ,Adverse Event
24247,1042,Alemtuzumab (Campath),2016-08-01,,5000,mcg,['/Month'],IV, 
24248,3176,Copaxone,2016-10-06,2020-07-31,20, ,['3 / Week'],IV,Patient Choice/Convenience
24249,3176,Ledertrexaat,2015-10-31,, ,mg,['/Month'],IV, 
24250,1044,IVIG,2016-07-14,2020-04-26, , ,['2 / Day'], ,Lack of efficacy
24251,1044,Endoxan,2016-09-11,,400, ,['3 / Week'], , 
24252,1044,D-cure (Vitamine D),2015-12-29,2018-01-06, ,mg,[' '], ,Adverse Event
24253,4529,Teriflunomide,2016-07-12,2019-07-23, ,mg,['/Month'], ,Persisting MRI activity
24254,4529,D-cure (Vitamine D),2016-07-15,2020-01-29,20,mg,['/Month'],Oral,Patient Choice/Convenience
24255,1425,Tysabri,2015-12-19,2017-11-21,500, ,['2 / Day'], ,Adverse Event
24256,1425,Betaferon,2015-12-27,,1, ,['/Month'],Oral, 
24257,3951,D-cure (Vitamine D),2016-05-27,,300,mg,['3 / Week'],IV, 
24258,3951,Tysabri,2016-10-21,,1000,mg,['2 / Day'], , 
24259,3951,D-cure (Vitamine D),2016-03-26,2019-07-24, ,mcg,['/Month'],IV,Persisting MRI activity
24260,450,Tysabri,2016-06-12,, ,mg,['/Month'],Oral, 
24261,450,Rebif [44],2016-07-27,,1, ,['/ Day'], , 
24262,450,D-cure (Vitamine D),2016-01-08,,5000,mg,['2 / Day'],Oral, 
24263,662,Methylprednisolone,2016-04-03,, ,mcg,['2 / Day'],Oral, 
24264,662,Avonex,2016-07-04,2020-06-14, ,mcg,['/ Day'],Oral,Persistence of relapses
24265,662,IVIG,2016-03-23,2020-11-13,1000, ,['/Month'],IV,Lack of efficacy
24266,467,Methylprednisolone,2016-03-02,, , ,['/Month'],Oral, 
24267,2105,D-cure (Vitamine D),2016-09-11,, , ,['/Month'],IV, 
24268,1114,D-cure (Vitamine D),2016-10-14,,5000,MIU,['3 / Week'],IV, 
24269,1114,IVIG,2015-12-17,,300,mcg,['/Month'], , 
24270,1114,Copaxone,2015-12-14,2017-11-09, ,mcg,['/Month'], ,Adverse Event
24271,383,Copaxone,2016-09-26,, ,mg,['2 / Day'],IV, 
24272,383,Copaxone,2015-11-23,,400,mg,['2 / Day'],IV, 
24273,2864,Methylprednisolone,2016-06-21,,5000,mg,['3 / Week'],IV, 
24274,2864,Mitoxantrone,2016-03-24,2018-06-21,500,mg,['/ Day'], ,Patient Choice/Convenience
24275,2664,Copaxone,2016-09-07,2021-02-24,20,mg,['/Month'], ,Persistence of relapses
24276,1120,Copaxone,2016-02-10,2021-09-13,20, ,['3 / Week'],IV,Adverse Event
24277,3410,Tecfidera,2016-08-04,2019-10-07,5000, ,['3 / Week'],IV,Adverse Event
24278,3410,Rebif [22],2016-05-28,,5000, ,['/Month'],IV, 
24279,3410,Ledertrexaat,2015-12-31,2019-07-03,20,mg,[' '], ,Persisting MRI activity
24280,2470,Methylprednisolone,2016-02-21,,20,mg,['/ Day'],IV, 
24281,2470,Mitoxantrone,2016-06-22,2017-12-13,1000, ,['/Month'],Oral,Adverse Event
24282,2470,Mitoxantrone,2016-10-19,,300,mg,['/Month'],IV, 
24283,728,Rebif [44],2016-01-25,,300, ,['/Month'], , 
24284,1049,Ledertrexaat,2016-07-03,, , ,['/Month'], , 
24285,1049,Gilenya,2016-02-09,2021-04-07,300, ,['/Month'], ,Persistence of relapses
24286,247,Endoxan,2016-10-22,2017-12-07,400,mcg,['/ Day'], ,Persisting MRI activity
24287,247,Gilenya,2016-09-11,2019-05-30,20, ,['2 / Day'],Oral,Persisting MRI activity
24288,247,Tysabri,2016-01-03,2019-12-06,5000,mg,['2 / Day'],IV,Adverse Event
24289,247,Ledertrexaat,2016-01-05,, ,mg,['/Month'],IV, 
24290,3550,Teriflunomide,2015-10-25,,1000, ,['2 / Day'],IV, 
24291,2899,Methylprednisolone,2016-08-02,,1000,MIU,['/ Day'],IV, 
24292,2899,Tecfidera,2016-08-22,,5000,mg,['2 / Day'], , 
24293,3198,Methylprednisolone,2016-03-31,2018-07-31,400,mg,['/Month'],IV,Adverse Event
24294,3198,D-cure (Vitamine D),2016-08-16,2020-06-11, ,mg,[' '], ,Adverse Event
24295,3198,Endoxan,2016-10-01,2018-02-03,1000, ,[' '], ,Adverse Event
24296,3821,Alemtuzumab (Campath),2016-01-17,,500, ,['2 / Day'],IV, 
24297,2151,D-cure (Vitamine D),2016-09-27,, , ,['3 / Week'], , 
24298,210,Copaxone,2016-03-02,,400, ,['2 / Day'],IV, 
24299,210,Tysabri,2016-06-10,,500,mg,[' '], , 
24300,210,Betaferon,2016-06-26,2021-06-23,300,mg,['2 / Day'],IV,Persisting MRI activity
24301,3837,Mitoxantrone,2016-08-14,,300,mg,['/Month'],Oral, 
24302,3837,Tecfidera,2015-12-20,,1000,mg,['/ Day'],IV, 
24303,3837,IVIG,2016-05-29,,20,mg,['3 / Week'],IV, 
24304,3207,Mitoxantrone,2016-03-05,, ,MIU,['/ Day'],Oral, 
24305,3207,Betaferon,2015-11-09,,1,mg,['2 / Day'],IV, 
24306,3814,IVIG,2015-12-22,2021-06-09, , ,['/Month'], ,Persistence of relapses
24307,3814,Betaferon,2015-11-10,2020-01-16, ,mcg,['2 / Day'], ,Lack of efficacy
24308,3814,Tecfidera,2016-03-14,,1000,mg,['/Month'],IV, 
24309,3814,Betaferon,2016-07-11,2019-07-31, ,mg,['/Month'], ,Lack of efficacy
24310,2930,Tysabri,2016-08-07,,500, ,['2 / Day'], , 
24311,2930,Teriflunomide,2015-12-01,,500,mg,['/Month'], , 
24312,2930,Methylprednisolone,2015-11-05,2018-11-24,500,mg,['2 / Day'],IV,Patient Choice/Convenience
24313,3413,Teriflunomide,2016-07-05,,500, ,['2 / Day'], , 
24314,3413,Betaferon,2015-11-17,2021-03-10, , ,['/ Week'],IV,Adverse Event
24315,2432,Rebif [44],2015-12-19,2019-05-13, , ,['/Month'],Oral,Lack of efficacy
24316,2432,Avonex,2016-04-20,2018-02-04, ,mg,['/Month'], ,Adverse Event
24317,2432,Alemtuzumab (Campath),2016-01-10,2018-11-19,400, ,['2 / Day'],IV,Persisting MRI activity
24318,673,IVIG,2016-03-22,,1000,mg,['/Month'],IV, 
24319,673,Methylprednisolone,2016-01-08,,1000, ,['/Month'], , 
24320,673,Gilenya,2016-01-26,2020-10-11, , ,['3 / Week'], ,Persisting MRI activity
24321,3132,Methylprednisolone,2015-11-02,,5000,MIU,['2 / Day'], , 
24322,3132,D-cure (Vitamine D),2015-12-12,2020-11-10, ,mg,['/ Day'],Oral,Patient Choice/Convenience
24323,3132,Methylprednisolone,2016-10-05,,1000,mg,['/ Day'],IV, 
24324,3132,Ledertrexaat,2016-01-17,2019-06-03,5000,mg,['/Month'],IV,Adverse Event
24325,3122,Rebif [44],2016-10-21,2020-03-02,5000,mg,[' '],Oral,Adverse Event
24326,3122,Alemtuzumab (Campath),2016-01-28,2021-04-16,1, ,['2 / Day'],IV,Patient Choice/Convenience
24327,3784,Gilenya,2016-01-12,2021-05-05,20, ,['3 / Week'], ,Adverse Event
24328,1260,Tysabri,2015-12-21,,400, ,['/ Week'],IV, 
24329,1260,D-cure (Vitamine D),2016-07-22,2020-08-13,1000,mg,['/Month'],IV,Adverse Event
24330,2057,Rebif [44],2016-01-08,,5000, ,['2 / Day'],Oral, 
24331,2057,Endoxan,2016-08-10,,20,mg,['/ Week'],Oral, 
24332,4445,Endoxan,2015-11-28,2021-10-02,5000, ,['/Month'], ,Adverse Event
24333,4445,Betaferon,2016-07-31,2017-11-18,300,MIU,['/ Week'], ,Adverse Event
24334,4445,Rebif [22],2015-12-20,, ,mg,['/Month'],IV, 
24335,4445,Mitoxantrone,2016-05-05,, , ,['/Month'], , 
24336,3784,Teriflunomide,2016-10-12,,300,MIU,['/Month'],Oral, 
24337,3784,Mitoxantrone,2016-05-29,2021-08-30, , ,['/Month'],IV,Adverse Event
24338,3784,Rebif [22],2016-03-21,2021-03-15,5000,mg,['/Month'], ,Patient Choice/Convenience
24339,3784,Rebif [44],2016-08-31,2020-05-27,500,mcg,['/Month'],IV,Persisting MRI activity
24340,3526,Methylprednisolone,2016-09-24,,500, ,['/ Day'],Oral, 
24341,3526,Endoxan,2016-10-11,, , ,['/Month'],Oral, 
24342,742,Betaferon,2015-11-20,2020-06-19,400,MIU,['2 / Day'],IV,Patient Choice/Convenience
24343,2019,Rebif [44],2016-01-17,2020-08-22,5000,mg,['2 / Day'],IV,Adverse Event
24344,1068,Tecfidera,2015-12-09,2021-02-05,500, ,[' '], ,Lack of efficacy
24345,1068,Tecfidera,2016-09-29,, , ,['/Month'],Oral, 
24346,4805,Copaxone,2016-08-19,,20, ,['/Month'],Oral, 
24347,4805,Gilenya,2016-10-05,, ,mg,['/ Day'], , 
24348,1919,Betaferon,2016-03-07,,400,mcg,['2 / Day'],IV, 
24349,1919,IVIG,2016-09-07,2019-09-17, ,mg,['2 / Day'],IV,Adverse Event
24350,3170,Teriflunomide,2016-07-27,2018-01-29,300,mg,['2 / Day'],IV,Adverse Event
24351,3170,Avonex,2016-09-10,, ,mg,['/Month'], , 
24352,3170,IVIG,2015-10-31,2018-08-20, ,mg,['/Month'], ,Persisting MRI activity
24353,3459,Rebif [44],2016-08-08,,300, ,['3 / Week'],IV, 
24354,2008,Methylprednisolone,2016-08-20,2018-04-26,20,mg,['2 / Day'], ,Adverse Event
24355,2540,Copaxone,2015-12-23,2019-10-20,5000,mg,['/ Day'],IV,Lack of efficacy
24356,435,Betaferon,2016-04-26,,5000, ,['/Month'], , 
24357,3923,Rebif [22],2015-12-10,, , ,['2 / Day'],IV, 
24358,3923,Endoxan,2016-04-26,2018-08-26, ,mg,['/Month'],IV,Patient Choice/Convenience
24359,3923,Copaxone,2016-05-29,,5000, ,['/ Day'],Oral, 
24360,3923,IVIG,2016-04-03,2018-03-03,20,mcg,['2 / Day'],IV,Adverse Event
24361,3975,Methylprednisolone,2016-04-01,,1000,mg,['2 / Day'], , 
24362,3975,Endoxan,2016-09-21,,20,MIU,['3 / Week'],IV, 
24363,3975,Copaxone,2016-06-22,2019-04-28,1000, ,['/ Day'], ,Persisting MRI activity
24364,3975,Mitoxantrone,2016-07-11,2020-09-19,500,mg,['2 / Day'],Oral,Lack of efficacy
24365,3785,IVIG,2016-06-04,2018-05-17,1000,MIU,['2 / Day'],IV,Persistence of relapses
24366,3785,Alemtuzumab (Campath),2016-09-05,, ,mg,['3 / Week'], , 
24367,4017,D-cure (Vitamine D),2015-12-11,2019-03-31, ,mg,['/ Day'], ,Persisting MRI activity
24368,4017,D-cure (Vitamine D),2016-05-10,, , ,['2 / Day'],IV, 
24369,4017,Alemtuzumab (Campath),2016-02-22,,400,mcg,['2 / Day'], , 
24370,3597,IVIG,2016-02-28,2020-04-23,20, ,['/Month'],IV,Persistence of relapses
24371,1608,Ledertrexaat,2016-07-09,2020-11-05, ,mg,['3 / Week'], ,Adverse Event
24372,1608,Alemtuzumab (Campath),2016-08-30,,400, ,['/Month'], , 
24373,2468,IVIG,2016-07-02,, ,mg,[' '],IV, 
24374,2468,Tysabri,2016-06-18,,400,mg,['/ Day'], , 
24375,2468,Endoxan,2016-01-27,2020-12-31,300, ,['2 / Day'], ,Patient Choice/Convenience
24376,351,Gilenya,2016-05-07,,300, ,[' '],Oral, 
24377,351,Avonex,2016-06-20,2018-12-20,20,mg,['/Month'],IV,Persisting MRI activity
24378,1934,Endoxan,2015-10-28,2021-05-17,5000, ,['/ Day'],Oral,Patient Choice/Convenience
24379,1934,D-cure (Vitamine D),2016-04-14,2020-12-20,1000,mg,['/Month'],IV,Lack of efficacy
24380,3169,Rebif [22],2015-11-13,2019-09-17,1000, ,['2 / Day'],IV,Adverse Event
24381,1761,Tecfidera,2016-03-28,2019-12-27,300,mg,['/Month'],IV,Patient Choice/Convenience
24382,3296,Avonex,2016-07-17,2019-07-29,1000,MIU,['/Month'], ,Adverse Event
24383,3296,D-cure (Vitamine D),2016-05-14,, ,mg,['/Month'],IV, 
24384,3296,Alemtuzumab (Campath),2015-12-04,2020-07-14,5000,mg,['2 / Day'], ,Lack of efficacy
24385,1130,Methylprednisolone,2016-04-26,2019-09-29,1000,MIU,['2 / Day'], ,Patient Choice/Convenience
24386,1130,Ledertrexaat,2015-12-10,,5000,MIU,['/Month'],IV, 
24387,1130,Endoxan,2016-06-06,,400, ,['2 / Day'],IV, 
24388,4259,Gilenya,2015-12-09,,1000, ,['/Month'],Oral, 
24389,4259,Rebif [22],2016-09-26,2018-06-13, ,MIU,['/ Week'], ,Patient Choice/Convenience
24390,4259,D-cure (Vitamine D),2016-08-26,, ,mg,['/Month'],IV, 
24391,4259,Alemtuzumab (Campath),2016-03-23,2018-09-07,5000,mg,[' '],IV,Lack of efficacy
24392,262,Tecfidera,2016-05-11,,500, ,['/ Day'],IV, 
24393,545,Teriflunomide,2016-03-04,2020-06-10,300, ,['2 / Day'],IV,Patient Choice/Convenience
24394,545,Tysabri,2015-12-14,2021-04-26, ,mg,['/Month'], ,Adverse Event
24395,545,Betaferon,2016-03-14,,20,mg,['2 / Day'],IV, 
24396,3360,Copaxone,2015-12-31,,300,mg,['2 / Day'],IV, 
24397,3360,Gilenya,2016-02-12,2018-07-26,400, ,['2 / Day'],IV,Adverse Event
24398,3360,Methylprednisolone,2016-10-19,,1, ,['/ Day'],IV, 
24399,3360,Tecfidera,2016-07-04,,300,MIU,['/Month'],IV, 
24400,1735,Tysabri,2016-07-30,, ,mg,['2 / Day'], , 
24401,962,Betaferon,2016-06-30,2021-01-31,5000,mg,['/Month'],IV,Adverse Event
24402,4673,D-cure (Vitamine D),2016-02-16,,1,mg,['2 / Day'],IV, 
24403,4673,Mitoxantrone,2016-03-04,,300,mcg,['2 / Day'], , 
24404,790,Gilenya,2016-05-27,2021-06-12, , ,['2 / Day'],IV,Adverse Event
24405,790,Endoxan,2016-05-17,2019-12-15,20,mg,['2 / Day'],IV,Patient Choice/Convenience
24406,4230,Ledertrexaat,2016-07-11,2021-07-31,20,mg,['/Month'], ,Patient Choice/Convenience
24407,2418,Avonex,2016-04-01,,20, ,['/ Day'], , 
24408,2418,Rebif [22],2016-09-22,,500,MIU,[' '], , 
24409,2418,Rebif [22],2016-03-10,,500, ,['/Month'], , 
24410,4509,Betaferon,2015-12-04,,20,MIU,['3 / Week'],IV, 
24411,4509,Gilenya,2015-11-18,,1000, ,['2 / Day'], , 
24412,4509,Copaxone,2016-01-16,,400, ,['2 / Day'], , 
24413,3460,D-cure (Vitamine D),2016-09-26,,300,MIU,['/Month'],Oral, 
24414,3460,Tysabri,2016-10-19,, ,mcg,['/Month'], , 
24415,3460,Methylprednisolone,2016-01-30,,400, ,['/ Day'], , 
24416,3023,Tysabri,2016-07-08,, ,mcg,['2 / Day'],Oral, 
24417,3023,Rebif [44],2016-01-16,2021-03-04,400,mg,['3 / Week'],Oral,Adverse Event
24418,3023,Tecfidera,2015-11-14,2018-09-10, , ,['/Month'], ,Adverse Event
24419,3819,Rebif [44],2016-09-09,2020-08-11,20,mg,['/ Week'],IV,Lack of efficacy
24420,3819,Ledertrexaat,2016-10-18,, , ,['/Month'], , 
24421,3819,Mitoxantrone,2015-11-22,2021-05-30,5000, ,['2 / Day'],IV,Persistence of relapses
24422,2974,Rebif [44],2015-11-06,,300,mg,['3 / Week'],IV, 
24423,2974,Copaxone,2016-02-06,2021-03-15,1000, ,['2 / Day'],IV,Adverse Event
24424,1897,Copaxone,2015-12-29,2020-02-14, ,mg,['/Month'],IV,Lack of efficacy
24425,1897,Gilenya,2015-11-21,2020-05-30,5000,mg,['/Month'],IV,Adverse Event
24426,1971,Rebif [44],2016-04-01,,20,mg,['2 / Day'],Oral, 
24427,1971,Methylprednisolone,2016-04-14,2020-12-18,5000,MIU,[' '],IV,Lack of efficacy
24428,2003,Ledertrexaat,2016-01-13,2017-11-20, ,MIU,['3 / Week'],IV,Persisting MRI activity
24429,2003,Methylprednisolone,2016-04-22,2019-01-15,20, ,['/Month'],IV,Adverse Event
24430,2003,Tecfidera,2016-05-14,2018-12-04,500,mg,['/Month'],Oral,Lack of efficacy
24431,2003,D-cure (Vitamine D),2016-04-17,, ,mg,['/ Day'],Oral, 
24432,2587,Alemtuzumab (Campath),2016-04-09,2021-08-18,1000, ,['2 / Day'], ,Adverse Event
24433,2587,Teriflunomide,2016-03-16,,1000, ,[' '],IV, 
24434,1570,Alemtuzumab (Campath),2016-09-17,, , ,['/Month'],IV, 
24435,1570,IVIG,2016-08-17,2021-05-05,500, ,['2 / Day'],IV,Persistence of relapses
24436,1570,Gilenya,2016-02-10,2018-12-10,300, ,['2 / Day'], ,Persisting MRI activity
24437,793,IVIG,2016-04-01,2018-02-22,1,mg,['3 / Week'],IV,Persisting MRI activity
24438,793,Endoxan,2016-09-04,,400, ,['/Month'], , 
24439,793,Mitoxantrone,2016-05-11,,1000,mg,['3 / Week'], , 
24440,793,Rebif [44],2016-03-15,,5000,MIU,['/Month'],IV, 
24441,1325,IVIG,2015-11-25,2020-01-10,1000,mg,['2 / Day'],IV,Persisting MRI activity
24442,1325,Avonex,2016-05-15,,300,mg,['2 / Day'],IV, 
24443,1325,Betaferon,2016-08-20,2021-03-22,400,MIU,['/Month'],IV,Persisting MRI activity
24444,1325,IVIG,2016-05-26,,1000, ,['2 / Day'], , 
24445,2053,IVIG,2015-12-24,,1,mg,['/Month'],IV, 
24446,2053,Tysabri,2016-06-19,,500,mg,['2 / Day'], , 
24447,131,Betaferon,2016-01-10,2021-09-03, ,mcg,['3 / Week'], ,Persisting MRI activity
24448,131,Endoxan,2016-07-16,,1000, ,['/ Day'],Oral, 
24449,131,D-cure (Vitamine D),2015-11-05,2018-11-28,1,mg,['2 / Day'], ,Patient Choice/Convenience
24450,2793,Rebif [44],2016-04-24,,500, ,['2 / Day'], , 
24451,2793,Rebif [22],2016-07-18,, ,mg,['/ Week'], , 
24452,641,Tysabri,2015-12-06,,1, ,['/Month'],IV, 
24453,641,Mitoxantrone,2015-11-28,2021-08-13,300, ,['/ Day'],IV,Lack of efficacy
24454,641,Mitoxantrone,2015-11-05,,1,mg,['/Month'],IV, 
24455,641,Tecfidera,2015-12-29,2020-08-01,1000,mg,['3 / Week'], ,Persisting MRI activity
24456,1385,Ledertrexaat,2016-09-30,2021-10-13,20,mg,['2 / Day'],IV,Lack of efficacy
24457,1385,Avonex,2015-12-02,2020-09-08,1,MIU,['/ Day'],IV,Persistence of relapses
24458,1385,Mitoxantrone,2015-12-02,,20, ,['/ Week'],IV, 
24459,1385,Avonex,2016-04-14,, , ,['3 / Week'],IV, 
24460,1766,Teriflunomide,2016-01-24,,20,mg,['/Month'], , 
24461,1766,Rebif [44],2016-01-09,2021-06-18,1000, ,['2 / Day'],IV,Patient Choice/Convenience
24462,1766,Copaxone,2016-08-29,,1000,mg,['/Month'], , 
24463,3055,Alemtuzumab (Campath),2015-11-24,2020-02-10,500,mg,['3 / Week'],IV,Adverse Event
24464,3055,Ledertrexaat,2015-11-07,2017-12-21,1, ,['2 / Day'], ,Persisting MRI activity
24465,3055,Tecfidera,2016-09-03,,20,mg,[' '], , 
24466,2675,Gilenya,2016-07-21,2020-12-19,300, ,['2 / Day'],Oral,Patient Choice/Convenience
24467,2675,Rebif [22],2016-03-03,2018-06-01,5000,MIU,['/Month'], ,Lack of efficacy
24468,2675,Mitoxantrone,2016-07-24,2021-05-05, ,MIU,['2 / Day'],IV,Adverse Event
24469,2675,Copaxone,2016-10-12,,5000,mg,['2 / Day'],IV, 
24470,581,Endoxan,2016-05-04,2018-08-12,500,mg,['/Month'], ,Persistence of relapses
24471,803,Betaferon,2016-01-28,, ,MIU,['3 / Week'],IV, 
24472,803,Teriflunomide,2015-11-30,,400, ,['/Month'],IV, 
24473,1383,Betaferon,2015-12-25,,500, ,['2 / Day'], , 
24474,1383,Teriflunomide,2016-04-11,2021-02-22,500,mcg,['/Month'],IV,Adverse Event
24475,4232,Endoxan,2015-12-30,2018-01-28,1000,mg,['/ Day'],IV,Persistence of relapses
24476,4232,Endoxan,2016-01-17,,300,mg,[' '], , 
24477,4232,D-cure (Vitamine D),2016-03-04,2021-05-02, , ,['/Month'],IV,Patient Choice/Convenience
24478,4232,Tysabri,2016-07-24,, ,mg,['3 / Week'],IV, 
24479,3368,Alemtuzumab (Campath),2016-09-12,2018-07-29, ,mg,['/Month'], ,Persisting MRI activity
24480,3728,Gilenya,2016-08-04,2017-11-30, ,mcg,['/Month'],IV,Lack of efficacy
24481,3728,Rebif [22],2016-03-18,2019-07-24,1000,mcg,['/Month'],IV,Patient Choice/Convenience
24482,3140,Methylprednisolone,2016-04-27,2018-05-16, , ,['2 / Day'], ,Persistence of relapses
24483,3140,Endoxan,2015-11-20,,1000,mg,['/Month'], , 
24484,3140,D-cure (Vitamine D),2016-03-12,2018-11-11,20,mg,['/Month'], ,Lack of efficacy
24485,3140,Tysabri,2016-08-18,,5000, ,['2 / Day'],IV, 
24486,489,IVIG,2016-05-06,2018-07-23, ,mg,['/Month'], ,Persisting MRI activity
24487,489,Endoxan,2016-04-16,, ,MIU,[' '],IV, 
24488,489,Ledertrexaat,2015-11-19,2019-10-23, , ,['/Month'],IV,Patient Choice/Convenience
24489,3078,Alemtuzumab (Campath),2016-02-14,, , ,['3 / Week'],IV, 
24490,3078,D-cure (Vitamine D),2015-11-05,2021-02-06,20,mg,['2 / Day'],IV,Adverse Event
24491,3078,IVIG,2016-09-09,2019-08-20,1000, ,['/Month'],IV,Adverse Event
24492,3122,Tysabri,2015-12-09,2021-09-16,400,MIU,['/Month'],IV,Persisting MRI activity
24493,3122,Teriflunomide,2016-02-15,,20, ,['3 / Week'], , 
24494,1506,Tysabri,2016-02-24,2018-05-03, , ,['/Month'],Oral,Persistence of relapses
24495,1506,Avonex,2016-07-09,2021-08-15,400,mg,['3 / Week'],IV,Adverse Event
24496,4598,Tecfidera,2016-05-21,,1, ,['2 / Day'], , 
24497,3462,Tysabri,2016-09-10,,1000,mg,['/Month'], , 
24498,3462,Avonex,2016-01-27,,500, ,['/Month'], , 
24499,841,Methylprednisolone,2016-01-08,,20,mg,['/Month'], , 
24500,2004,D-cure (Vitamine D),2016-03-31,2018-11-21,500,mcg,['/Month'],IV,Adverse Event
24501,2165,Methylprednisolone,2016-05-03,2020-01-21, , ,['/Month'],IV,Adverse Event
24502,2165,Gilenya,2016-02-29,2018-08-10, ,mg,['/Month'],Oral,Persistence of relapses
24503,1789,Tecfidera,2016-06-04,2021-05-09,1000,mg,['3 / Week'],IV,Lack of efficacy
24504,1789,Copaxone,2016-02-29,2018-02-06,500,mg,['2 / Day'],IV,Persisting MRI activity
24505,1789,Tysabri,2016-07-27,, , ,['3 / Week'], , 
24506,3389,Tecfidera,2016-02-06,2020-05-15,500,mg,['3 / Week'], ,Adverse Event
24507,3389,Methylprednisolone,2016-08-15,,1,mcg,['2 / Day'],IV, 
24508,3389,Betaferon,2016-10-14,, ,mg,['/ Day'],IV, 
24509,3389,D-cure (Vitamine D),2016-08-26,,5000, ,['2 / Day'],IV, 
24510,3128,Endoxan,2015-12-18,2018-03-02,20, ,['2 / Day'],IV,Adverse Event
24511,2142,Copaxone,2016-07-21,2018-09-09,300,mg,['/ Day'], ,Lack of efficacy
24512,2142,Tecfidera,2015-10-31,2021-04-22, , ,['/Month'],IV,Persisting MRI activity
24513,2142,Methylprednisolone,2016-06-27,, ,mg,['/Month'],IV, 
24514,2705,D-cure (Vitamine D),2016-04-09,2020-10-18, ,MIU,['/ Day'],IV,Persisting MRI activity
24515,2705,Rebif [22],2016-07-01,,1, ,['2 / Day'], , 
24516,2705,Methylprednisolone,2016-09-13,2018-09-28,300,mg,['/ Week'],IV,Persistence of relapses
24517,2705,D-cure (Vitamine D),2016-07-31,, , ,[' '], , 
24518,983,D-cure (Vitamine D),2016-10-19,2021-04-27,5000,mg,[' '],IV,Adverse Event
24519,983,Rebif [44],2016-08-11,2020-06-22,400,mg,['/Month'],IV,Persistence of relapses
24520,983,Tysabri,2015-11-07,,20,MIU,['/Month'],IV, 
24521,3019,Rebif [22],2016-02-17,,20,mcg,['3 / Week'],IV, 
24522,3019,Methylprednisolone,2016-05-09,,500,mg,['/Month'],IV, 
24523,3019,Alemtuzumab (Campath),2016-10-22,,300,MIU,[' '], , 
24524,545,Teriflunomide,2016-08-13,,500,mg,['/Month'], , 
24525,545,Ledertrexaat,2015-10-25,2020-02-08,1,mg,['3 / Week'], ,Lack of efficacy
24526,2756,Methylprednisolone,2016-02-13,2021-08-02, , ,['/Month'],IV,Lack of efficacy
24527,2756,Rebif [22],2015-12-15,,1000,mg,['/Month'], , 
24528,2756,Teriflunomide,2016-03-26,2019-02-05,500, ,['/Month'],IV,Lack of efficacy
24529,2002,Rebif [22],2016-10-12,,20, ,['2 / Day'], , 
24530,2002,Endoxan,2016-07-05,2019-05-25,1000, ,['/Month'],IV,Patient Choice/Convenience
24531,2002,Rebif [22],2016-02-18,2021-01-09,300, ,['/Month'],IV,Persisting MRI activity
24532,2002,D-cure (Vitamine D),2016-10-07,,20,MIU,['2 / Day'],IV, 
24533,3319,Rebif [44],2015-12-16,2020-09-01,20, ,['2 / Day'], ,Adverse Event
24534,3319,Gilenya,2016-04-11,2021-09-19,500,mg,['/Month'],IV,Lack of efficacy
24535,3319,Teriflunomide,2016-09-02,2019-05-17,300,mg,['2 / Day'],IV,Adverse Event
24536,3319,Tecfidera,2016-05-06,2018-12-25,1,mg,[' '],IV,Adverse Event
24537,712,Tysabri,2016-01-09,2020-06-02,400,mcg,['2 / Day'],IV,Persisting MRI activity
24538,712,Alemtuzumab (Campath),2016-02-09,2021-03-13,500,mg,['/Month'],IV,Persisting MRI activity
24539,712,Alemtuzumab (Campath),2016-09-02,,1000,mg,['2 / Day'], , 
24540,712,Rebif [22],2015-12-04,,500,mg,['2 / Day'],Oral, 
24541,2621,Rebif [22],2016-02-28,,300, ,['2 / Day'],Oral, 
24542,2621,Rebif [44],2016-06-27,2018-09-08, ,MIU,['/ Day'],IV,Patient Choice/Convenience
24543,2621,Tysabri,2015-11-11,, ,mcg,['2 / Day'], , 
24544,1438,D-cure (Vitamine D),2016-07-23,, ,mg,['/Month'], , 
24545,1438,D-cure (Vitamine D),2016-05-11,2020-04-09, ,MIU,['/ Week'],IV,Adverse Event
24546,1438,D-cure (Vitamine D),2016-02-02,2018-04-08,400,MIU,['/Month'],IV,Patient Choice/Convenience
24547,1438,Rebif [44],2016-05-29,,500,mcg,[' '],IV, 
24548,1297,Avonex,2015-12-17,, ,mg,['/ Week'],IV, 
24549,2168,Rebif [44],2016-08-19,2020-02-18, ,MIU,['3 / Week'], ,Persistence of relapses
24550,3978,Tecfidera,2015-11-14,2021-07-26,20,mg,['/Month'], ,Patient Choice/Convenience
24551,2470,IVIG,2016-04-22,,1000,mcg,['/Month'],IV, 
24552,2470,Endoxan,2016-01-08,2019-06-12,1000, ,[' '],IV,Adverse Event
24553,2470,Betaferon,2016-02-12,2019-08-18,1000, ,['2 / Day'], ,Lack of efficacy
24554,2470,Rebif [44],2016-07-09,, ,mg,['2 / Day'],Oral, 
24555,3135,Tysabri,2016-03-11,2020-03-19,400,mcg,['2 / Day'],IV,Persisting MRI activity
24556,3135,Rebif [44],2016-08-30,,300, ,['2 / Day'],Oral, 
24557,3135,IVIG,2016-02-12,,400,mg,['3 / Week'], , 
24558,3135,Ledertrexaat,2016-04-13,2018-10-05,1,mcg,['2 / Day'], ,Patient Choice/Convenience
24559,3664,Alemtuzumab (Campath),2016-03-27,,5000,mg,['2 / Day'], , 
24560,3664,Rebif [22],2016-03-30,2018-05-22, ,mg,['3 / Week'],Oral,Adverse Event
24561,3664,Gilenya,2015-12-28,,1000,mg,['2 / Day'], , 
24562,3184,Rebif [22],2016-09-05,,1000,mg,['2 / Day'],IV, 
24563,3184,Tecfidera,2016-09-09,,5000,mg,['2 / Day'],IV, 
24564,3184,Methylprednisolone,2016-08-18,, ,MIU,['/Month'],IV, 
24565,3399,Tysabri,2016-09-06,2019-06-30,1000,mg,['/Month'],IV,Lack of efficacy
24566,3399,Endoxan,2015-12-08,,5000,mg,['/Month'], , 
24567,245,Endoxan,2016-09-10,,300,mg,['2 / Day'], , 
24568,2433,D-cure (Vitamine D),2016-05-09,,1000, ,['/Month'], , 
24569,2592,Betaferon,2016-05-12,, , ,['3 / Week'],IV, 
24570,2592,Copaxone,2016-05-23,2021-09-17, ,mg,[' '], ,Adverse Event
24571,4701,Copaxone,2016-07-11,2018-02-09,300,MIU,['/ Day'],Oral,Adverse Event
24572,583,Rebif [44],2016-05-01,,500,mg,['/Month'],Oral, 
24573,583,Methylprednisolone,2015-12-02,2021-07-07, ,MIU,['/ Week'],IV,Patient Choice/Convenience
24574,583,Gilenya,2015-12-06,, ,mg,['2 / Day'],IV, 
24575,583,Tysabri,2016-04-02,,400,MIU,['/Month'],IV, 
24576,2869,Copaxone,2016-02-07,,1000,mg,['2 / Day'], , 
24577,2869,IVIG,2016-03-20,2021-07-07,1,mg,['/Month'],IV,Lack of efficacy
24578,3357,Ledertrexaat,2015-12-16,,1000,mg,['/Month'],IV, 
24579,3357,D-cure (Vitamine D),2016-04-06,, ,mg,['/ Week'],IV, 
24580,3357,Avonex,2016-02-13,, ,mg,['2 / Day'],IV, 
24581,3499,IVIG,2016-04-12,,300,mg,[' '],IV, 
24582,3499,Avonex,2016-10-06,,5000,mg,['3 / Week'],IV, 
24583,3499,IVIG,2016-05-17,2019-01-24,1, ,['/Month'],IV,Persisting MRI activity
24584,4394,Betaferon,2016-08-08,, ,mg,['3 / Week'],IV, 
24585,2249,D-cure (Vitamine D),2016-01-17,, , ,['/ Week'], , 
24586,2249,Mitoxantrone,2016-01-07,2018-06-04,500,mg,['3 / Week'],IV,Patient Choice/Convenience
24587,2022,Avonex,2016-07-02,,1,MIU,['/ Week'],IV, 
24588,2022,Ledertrexaat,2016-08-08,,1000,mg,['/Month'],IV, 
24589,2022,Gilenya,2016-09-16,2021-02-18,500,mg,['2 / Day'],IV,Adverse Event
24590,2022,IVIG,2015-11-05,, ,mcg,['2 / Day'], , 
24591,4649,Tecfidera,2016-01-28,2021-03-21,1000, ,['/ Week'], ,Persistence of relapses
24592,4649,Gilenya,2016-05-06,,300,mg,['2 / Day'], , 
24593,2593,Gilenya,2016-04-19,,20,mg,['2 / Day'],IV, 
24594,2593,Gilenya,2016-07-31,, ,mg,['/ Week'],Oral, 
24595,4153,Avonex,2016-05-06,2018-09-08,500, ,['/Month'],Oral,Persisting MRI activity
24596,4153,Gilenya,2016-09-02,,500,mg,['/Month'], , 
24597,4153,Tysabri,2015-11-27,,1000, ,['/ Day'], , 
24598,4354,Endoxan,2016-05-19,,5000, ,['3 / Week'], , 
24599,858,Endoxan,2016-07-03,2018-01-16,20,mg,['/Month'],IV,Persisting MRI activity
24600,858,Rebif [44],2016-01-09,, , ,['2 / Day'],IV, 
24601,858,IVIG,2016-01-10,, ,mg,['2 / Day'], , 
24602,858,IVIG,2016-04-30,2018-05-25, , ,['2 / Day'], ,Lack of efficacy
24603,2341,Mitoxantrone,2016-08-16,2018-11-18, ,mg,['3 / Week'], ,Lack of efficacy
24604,2341,Teriflunomide,2016-07-16,,5000,mg,['/Month'], , 
24605,2341,Copaxone,2015-10-31,,1,MIU,['3 / Week'],IV, 
24606,1603,Alemtuzumab (Campath),2016-07-30,2018-01-26, , ,['2 / Day'],IV,Lack of efficacy
24607,1603,Mitoxantrone,2016-09-24,2020-05-17,5000, ,['2 / Day'],IV,Adverse Event
24608,1603,Tecfidera,2016-03-03,,500,mg,['2 / Day'],IV, 
24609,1603,Rebif [22],2016-04-14,,500,mg,['2 / Day'], , 
24610,4360,IVIG,2016-01-07,, ,mg,[' '],Oral, 
24611,4360,Rebif [22],2016-04-09,2021-08-31,1,mg,['2 / Day'],IV,Persisting MRI activity
24612,4360,Rebif [44],2015-12-14,, , ,['2 / Day'],Oral, 
24613,4360,Methylprednisolone,2016-07-01,, ,MIU,['/Month'],IV, 
24614,4081,D-cure (Vitamine D),2016-06-09,2018-12-29,300, ,['2 / Day'], ,Adverse Event
24615,4081,Rebif [44],2016-05-20,2021-01-20,20,mg,['2 / Day'],IV,Patient Choice/Convenience
24616,4081,Rebif [44],2016-03-06,2018-03-20,400, ,['2 / Day'], ,Patient Choice/Convenience
24617,3610,Rebif [44],2016-02-20,, ,mg,['3 / Week'],Oral, 
24618,3610,Betaferon,2016-04-22,,20,MIU,['/ Day'],IV, 
24619,3610,Avonex,2016-04-04,2020-05-16,300,mg,['3 / Week'], ,Adverse Event
24620,4106,Tysabri,2016-08-16,2019-09-05,20,mcg,['/ Week'],Oral,Persisting MRI activity
24621,2718,Tysabri,2016-01-09,,20,mg,['2 / Day'], , 
24622,2718,Alemtuzumab (Campath),2016-03-17,,1000, ,['/Month'], , 
24623,3248,Tecfidera,2016-02-10,,300, ,['/Month'],IV, 
24624,3248,IVIG,2016-05-25,,1000,mg,['3 / Week'], , 
24625,3248,Rebif [44],2016-04-15,2019-07-29, , ,['/Month'],IV,Adverse Event
24626,3248,IVIG,2016-05-23,2018-05-31, ,mg,['3 / Week'],IV,Patient Choice/Convenience
24627,913,Tecfidera,2016-04-30,2021-08-29,20,MIU,['/ Day'],IV,Lack of efficacy
24628,913,D-cure (Vitamine D),2015-12-17,2020-03-07,300,MIU,['3 / Week'], ,Adverse Event
24629,913,D-cure (Vitamine D),2016-08-25,,5000,mg,['2 / Day'],IV, 
24630,3120,D-cure (Vitamine D),2016-04-01,2020-10-07, , ,['2 / Day'], ,Lack of efficacy
24631,3120,Rebif [22],2016-07-20,2019-12-03,300,mcg,['2 / Day'], ,Persisting MRI activity
24632,1067,Tysabri,2016-05-30,2020-07-31, , ,['/Month'],IV,Persisting MRI activity
24633,298,Tysabri,2016-04-06,, ,mg,['2 / Day'], , 
24634,298,Methylprednisolone,2016-03-18,,1000,mg,['2 / Day'], , 
24635,298,IVIG,2016-05-08,,300,mg,['/ Week'],IV, 
24636,4163,Teriflunomide,2016-05-22,,300,mg,['/Month'],Oral, 
24637,4585,Endoxan,2016-09-13,2017-12-07, , ,['/Month'],IV,Patient Choice/Convenience
24638,4585,Tysabri,2016-09-04,,20,mg,[' '], , 
24639,4585,Copaxone,2016-09-21,,1000, ,['2 / Day'],IV, 
24640,4585,Mitoxantrone,2016-02-17,,20,mg,['/Month'],IV, 
24641,2675,Methylprednisolone,2015-11-08,2020-03-15,500, ,['/Month'],IV,Lack of efficacy
24642,2675,IVIG,2016-01-06,2018-06-08, ,mg,['2 / Day'], ,Lack of efficacy
24643,2675,D-cure (Vitamine D),2016-02-22,,300,mg,['/Month'], , 
24644,3796,D-cure (Vitamine D),2016-05-13,,1, ,['2 / Day'],IV, 
24645,383,Gilenya,2016-09-23,2018-09-27,1000, ,['/Month'],Oral,Persistence of relapses
24646,1711,Ledertrexaat,2016-04-24,2021-02-28, ,MIU,['/Month'], ,Patient Choice/Convenience
24647,1711,Tysabri,2015-11-03,2020-12-22,20,mg,['/Month'],IV,Adverse Event
24648,4667,Methylprednisolone,2015-11-28,2019-12-21,400,mg,['2 / Day'],IV,Patient Choice/Convenience
24649,4667,IVIG,2016-05-31,,20,mg,['/ Day'],IV, 
24650,3911,Betaferon,2015-12-04,,300, ,['/Month'], , 
24651,3911,Betaferon,2015-12-02,2018-07-29, ,MIU,['/Month'],IV,Lack of efficacy
24652,3911,Tysabri,2016-09-24,2021-01-21, ,MIU,['2 / Day'],IV,Persistence of relapses
24653,3911,Betaferon,2016-02-08,, ,mg,['/Month'],IV, 
24654,3248,Methylprednisolone,2016-02-20,,500, ,['/ Day'],IV, 
24655,2335,Betaferon,2015-12-05,,500, ,['3 / Week'],IV, 
24656,2335,Tysabri,2016-07-19,2018-04-24,1000,MIU,['2 / Day'],IV,Adverse Event
24657,2522,Avonex,2016-08-17,2021-03-23,500, ,['2 / Day'], ,Lack of efficacy
24658,2522,Endoxan,2016-06-08,2019-05-17,1000,mg,['3 / Week'], ,Adverse Event
24659,2522,Teriflunomide,2016-04-05,, , ,[' '],IV, 
24660,2530,Tysabri,2016-03-23,,400,mg,['/Month'], , 
24661,685,Alemtuzumab (Campath),2016-04-05,2018-04-12, ,mg,['2 / Day'],IV,Patient Choice/Convenience
24662,3577,D-cure (Vitamine D),2016-06-17,, ,MIU,['3 / Week'], , 
24663,3577,Tecfidera,2016-03-24,2018-07-25,1, ,['3 / Week'], ,Patient Choice/Convenience
24664,3577,Copaxone,2016-05-10,,500,mg,['3 / Week'],IV, 
24665,2802,Tysabri,2016-10-05,, , ,['2 / Day'], , 
24666,2802,D-cure (Vitamine D),2016-07-16,,500,mg,[' '], , 
24667,648,Avonex,2016-03-21,,20,mg,['2 / Day'],IV, 
24668,648,Tecfidera,2016-04-15,,400, ,['/Month'],IV, 
24669,648,Tysabri,2016-01-17,2018-03-31,20,mg,['/Month'],Oral,Patient Choice/Convenience
24670,648,IVIG,2016-10-12,,400, ,['/ Day'],Oral, 
24671,1557,Alemtuzumab (Campath),2016-04-06,2018-08-02,400,mg,['/Month'], ,Lack of efficacy
24672,1363,Teriflunomide,2016-03-21,2020-01-05, , ,['2 / Day'], ,Adverse Event
24673,1363,Gilenya,2016-08-08,2021-02-04,500, ,['/Month'], ,Patient Choice/Convenience
24674,1363,D-cure (Vitamine D),2016-10-20,,300, ,['3 / Week'],Oral, 
24675,682,IVIG,2016-07-26,2019-05-16,5000,mg,['/Month'],IV,Lack of efficacy
24676,682,Methylprednisolone,2015-12-03,2018-05-21, , ,['2 / Day'],Oral,Adverse Event
24677,682,Gilenya,2016-05-04,,20,mg,['/Month'],Oral, 
24678,4542,IVIG,2016-02-11,2018-08-19,20, ,['/Month'], ,Persisting MRI activity
24679,4542,Copaxone,2016-03-19,,20, ,[' '],IV, 
24680,4542,Methylprednisolone,2016-05-26,2019-10-27,1,mg,[' '],IV,Persistence of relapses
24681,4542,Avonex,2016-08-27,2020-06-14, ,mg,['2 / Day'], ,Persisting MRI activity
24682,4027,Endoxan,2016-02-02,,300, ,['/Month'], , 
24683,4027,Copaxone,2016-09-15,,20,mcg,['3 / Week'], , 
24684,4027,Rebif [22],2016-07-16,,400, ,['/ Week'], , 
24685,3200,Tysabri,2015-11-13,,1, ,['/ Day'], , 
24686,3200,Tysabri,2016-02-19,,400, ,['2 / Day'], , 
24687,3200,Alemtuzumab (Campath),2016-07-20,,500,MIU,['/Month'], , 
24688,3200,Rebif [44],2016-06-07,,500, ,['/Month'],IV, 
24689,4427,Avonex,2016-09-10,2021-04-27,20,mg,['3 / Week'],IV,Persisting MRI activity
24690,4427,Avonex,2015-12-29,,300, ,['/Month'], , 
24691,320,Tecfidera,2016-01-24,2021-08-15,20,mcg,['/ Week'],IV,Persistence of relapses
24692,320,Betaferon,2016-06-15,,20,mg,['/Month'],Oral, 
24693,320,Alemtuzumab (Campath),2016-04-10,,300,mg,['/ Week'],IV, 
24694,320,Endoxan,2016-05-01,2020-09-09,500, ,['2 / Day'],IV,Lack of efficacy
24695,1870,Tysabri,2016-09-15,2021-04-09, ,mg,['3 / Week'], ,Patient Choice/Convenience
24696,330,Endoxan,2016-03-14,2018-10-31,500, ,['/ Day'], ,Adverse Event
24697,330,Methylprednisolone,2016-09-25,2021-05-01,500, ,['3 / Week'], ,Lack of efficacy
24698,330,Alemtuzumab (Campath),2016-07-22,,1000, ,['/ Day'],IV, 
24699,330,Avonex,2016-06-12,,300,mg,[' '],IV, 
24700,4389,Gilenya,2015-12-12,2018-07-24,1,mg,['/Month'],IV,Persisting MRI activity
24701,4389,Endoxan,2016-04-29,2019-09-29,500,mcg,['/Month'],IV,Persistence of relapses
24702,4389,Tysabri,2016-07-19,2018-05-22,300,mg,['2 / Day'],IV,Lack of efficacy
24703,4389,Tysabri,2016-02-14,2018-09-06,1, ,['/ Day'],IV,Patient Choice/Convenience
24704,474,Endoxan,2016-04-15,, ,mcg,['/Month'], , 
24705,4484,Gilenya,2016-09-17,,1,mg,['/ Day'],IV, 
24706,2258,Tecfidera,2016-06-13,2020-08-10,400,MIU,['/Month'],IV,Patient Choice/Convenience
24707,2258,Tysabri,2016-09-21,2020-11-04,1000,mg,['/ Week'],IV,Persisting MRI activity
24708,2258,Mitoxantrone,2016-08-23,2019-09-06, ,mg,['2 / Day'],IV,Patient Choice/Convenience
24709,4385,Copaxone,2016-01-20,,300,mg,['2 / Day'],Oral, 
24710,4385,Rebif [44],2016-09-23,, ,mg,['2 / Day'],IV, 
24711,4385,Rebif [22],2016-10-15,2018-08-22,500, ,['2 / Day'], ,Adverse Event
24712,4385,Tysabri,2016-09-23,,1000, ,['2 / Day'],Oral, 
24713,1978,Gilenya,2016-06-19,,1,mg,[' '], , 
24714,1978,D-cure (Vitamine D),2016-04-28,, , ,[' '],IV, 
24715,4404,Alemtuzumab (Campath),2016-09-15,2019-08-21, ,MIU,['3 / Week'], ,Adverse Event
24716,4404,Tysabri,2016-02-12,, ,mcg,['2 / Day'],IV, 
24717,4404,Tecfidera,2016-03-12,2018-01-09,1000,mcg,['/Month'],IV,Adverse Event
24718,4404,Methylprednisolone,2016-07-18,,300, ,['2 / Day'],IV, 
24719,4825,Mitoxantrone,2016-02-26,,5000,mg,[' '],IV, 
24720,4825,Rebif [22],2015-12-22,2018-08-07,1000,mg,['/Month'],IV,Lack of efficacy
24721,4825,Tecfidera,2016-10-22,2018-08-01, , ,['/ Day'], ,Adverse Event
24722,4500,Tecfidera,2016-01-22,,1, ,['/Month'], , 
24723,4500,Alemtuzumab (Campath),2015-12-25,,5000, ,['2 / Day'],IV, 
24724,4500,Rebif [44],2015-11-21,,300,mg,['/ Day'],IV, 
24725,1796,Tecfidera,2016-05-05,,20,mg,['3 / Week'],IV, 
24726,1796,Betaferon,2016-09-11,,400,mg,['/Month'], , 
24727,3715,Tysabri,2016-04-05,2020-01-14, ,mg,['/Month'], ,Adverse Event
24728,3833,Alemtuzumab (Campath),2015-11-02,, ,mcg,['2 / Day'], , 
24729,3833,Gilenya,2016-01-25,,400,MIU,['2 / Day'],Oral, 
24730,3833,Mitoxantrone,2016-10-04,2018-01-26,300, ,['3 / Week'], ,Persisting MRI activity
24731,3833,D-cure (Vitamine D),2016-01-29,2019-04-10,1, ,['2 / Day'],Oral,Lack of efficacy
24732,3426,Avonex,2016-10-06,2020-09-11, , ,[' '], ,Persisting MRI activity
24733,3426,Betaferon,2016-01-10,,5000,mg,['3 / Week'], , 
24734,3222,Methylprednisolone,2016-05-24,, ,mg,['/Month'],IV, 
24735,2152,Rebif [44],2016-07-07,,1, ,['2 / Day'], , 
24736,2152,Ledertrexaat,2015-11-03,2020-08-15, ,mg,['2 / Day'], ,Adverse Event
24737,2152,D-cure (Vitamine D),2016-03-18,2018-05-31, , ,['2 / Day'],IV,Persisting MRI activity
24738,1148,IVIG,2015-11-30,,500,mg,['/Month'],IV, 
24739,1148,Tecfidera,2015-11-02,, ,mg,['/Month'],Oral, 
24740,1148,Rebif [44],2016-07-15,,400,mg,['2 / Day'],Oral, 
24741,505,Endoxan,2016-03-05,2020-12-23,5000,mg,['3 / Week'],IV,Adverse Event
24742,505,Tecfidera,2016-07-29,,500, ,['/Month'], , 
24743,505,Mitoxantrone,2015-11-29,2020-06-23, ,MIU,['/Month'],IV,Persistence of relapses
24744,505,Endoxan,2016-04-20,2019-03-12,400, ,['/Month'], ,Adverse Event
24745,284,Methylprednisolone,2016-01-06,,500,MIU,['2 / Day'], , 
24746,284,Rebif [44],2016-09-14,,5000,MIU,['/ Week'],IV, 
24747,284,Alemtuzumab (Campath),2016-10-16,2020-09-08, ,MIU,['2 / Day'],IV,Persisting MRI activity
24748,284,Tysabri,2016-10-05,2020-07-18,20,mg,['3 / Week'], ,Persisting MRI activity
24749,4451,Betaferon,2016-03-25,2020-10-16, ,mg,['/Month'],IV,Lack of efficacy
24750,1331,Tecfidera,2016-06-02,2019-06-01,400, ,['/ Day'], ,Persisting MRI activity
24751,843,Rebif [44],2016-08-23,, , ,['/ Day'], , 
24752,843,D-cure (Vitamine D),2016-02-06,,20,mg,['/Month'],IV, 
24753,843,Rebif [44],2016-02-10,2021-06-23,1,mg,['/ Day'], ,Persistence of relapses
24754,843,IVIG,2016-08-11,2021-05-11,500, ,['/ Week'], ,Patient Choice/Convenience
24755,2716,Gilenya,2016-03-06,,20,mg,['3 / Week'], , 
24756,2716,Teriflunomide,2016-10-19,,20,MIU,['2 / Day'],Oral, 
24757,3960,D-cure (Vitamine D),2016-04-01,2018-10-13,1000,mg,['/ Day'],Oral,Patient Choice/Convenience
24758,3192,Tysabri,2016-04-24,,1,mg,['/Month'],Oral, 
24759,3192,Endoxan,2016-08-30,2019-02-20, , ,['2 / Day'],Oral,Patient Choice/Convenience
24760,1477,Tecfidera,2015-12-18,,20, ,['2 / Day'], , 
24761,1477,Betaferon,2015-11-20,2018-06-12,1,mg,['/Month'], ,Lack of efficacy
24762,1477,Endoxan,2015-12-23,2019-04-19,500,MIU,['2 / Day'], ,Persisting MRI activity
24763,3215,Methylprednisolone,2016-05-10,, ,MIU,['2 / Day'],IV, 
24764,3215,Copaxone,2015-12-03,,20,mg,['/Month'], , 
24765,4267,Methylprednisolone,2016-06-10,, ,mg,['/Month'], , 
24766,2105,Alemtuzumab (Campath),2015-11-16,, , ,['/ Day'],IV, 
24767,2105,Methylprednisolone,2016-01-02,,5000,MIU,['2 / Day'],IV, 
24768,3631,D-cure (Vitamine D),2016-09-17,, ,mg,['/ Day'],IV, 
24769,3631,Tecfidera,2016-07-23,,1000,mg,['/ Week'],IV, 
24770,3631,D-cure (Vitamine D),2016-09-25,2018-11-04,20, ,['2 / Day'], ,Persistence of relapses
24771,2045,Endoxan,2015-10-28,, , ,['2 / Day'],IV, 
24772,1429,Avonex,2016-06-21,, ,mg,['2 / Day'],IV, 
24773,1429,Copaxone,2015-11-07,2018-01-22,300, ,['/Month'],IV,Adverse Event
24774,1429,Avonex,2016-01-03,, ,mg,[' '],IV, 
24775,1385,Copaxone,2015-12-26,2018-10-23,400,mg,['2 / Day'],IV,Persisting MRI activity
24776,1385,IVIG,2016-05-31,2019-10-05,500, ,['/Month'],Oral,Persisting MRI activity
24777,4812,Rebif [44],2016-02-24,, ,mg,['3 / Week'],IV, 
24778,1463,Alemtuzumab (Campath),2016-01-28,,1000,mg,['/ Day'],IV, 
24779,1463,Tysabri,2016-07-21,,1000,mg,['/Month'],IV, 
24780,1463,Mitoxantrone,2016-03-12,,20,mg,[' '], , 
24781,2125,Copaxone,2015-12-17,, , ,['3 / Week'], , 
24782,2125,Methylprednisolone,2016-04-22,2018-12-07,500, ,['2 / Day'],Oral,Patient Choice/Convenience
24783,1404,Tecfidera,2016-03-28,2018-10-03, ,mg,['3 / Week'], ,Persisting MRI activity
24784,1404,Tysabri,2016-03-02,,1,mcg,['/Month'],IV, 
24785,1404,Endoxan,2016-03-05,2018-05-18, ,mg,['2 / Day'],IV,Persisting MRI activity
24786,4276,Betaferon,2016-10-20,, , ,['/Month'], , 
24787,4276,Rebif [22],2016-02-03,,1000, ,['/Month'], , 
24788,4276,Avonex,2016-08-23,,1, ,['/ Week'],IV, 
24789,4276,Tysabri,2015-11-19,2020-03-14,500,MIU,['2 / Day'],IV,Lack of efficacy
